<?xml version="1.0" encoding="UTF-8"?><root created="1301616061"><categories><category title="Rads"/><category title="Cards"/><category title="ID"/><category title="GI"/><category title="Peds"/><category title="OB/GYN"/><category title="Derm"/><category title="Tox"/><category title="Ortho"/><category title="ENT"/><category title="Ophtho"/><category title="GU"/><category title="Harbor Admin"/><category title="Endo"/><category title="Airway/Resus"/><category title=""/><category title="Neuro"/><category title="Trauma"/><category title="Heme/Onc"/><category title="Procedures"/><category title="Pulm"/><category title="FEN"/><category title="Drugs"/><category title="Policy"/><category title="WikEM"/><category title="Environ"/><category title="Psych"/><category title="Rheum"/><category title="Misc/General"/></categories><pages><page id="abd_series"><name>ABD Series</name><content>&lt;p&gt;To differentiate Large and small bowel, remember:
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;1) Large bowel have haustra which appear as lines 1/3-1/2 of the way through the bowel, but not all the way through.
&lt;/p&gt;&lt;p&gt;2) Small bowel have lines (plica circulares) all the way through the bowel
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Acute Abd XR have poor sensitivity and specificity for SBO...if you are really concerned, get the CT.
&lt;/p&gt;



</content><folder>Rads</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="acs_anatomical_correlation"><name>ACS Anatomical Correlation</name><content>&lt;table style="width: 500px" border="1" cellpadding="1" cellspacing="1"&gt;

&lt;tr&gt;
&lt;td&gt; &lt;b&gt;Coronary Artery&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Location&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;ECG Leads&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Complications&lt;/b&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; LAD
&lt;/td&gt;&lt;td&gt; Anteroseptal
&lt;/td&gt;&lt;td&gt; V1-V3
&lt;/td&gt;&lt;td colspan="1" rowspan="2"&gt; Left ventricular dysfunction:
&lt;p&gt;-Decreased CO2
&lt;/p&gt;&lt;p&gt;-CHFLBBB, RBBB
&lt;/p&gt;&lt;p&gt;-Left PFB
&lt;/p&gt;&lt;p&gt;-Infranodal block (2 &#778;or 3 &#778;)
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; LAD
&lt;/td&gt;&lt;td&gt; Anterior
&lt;/td&gt;&lt;td&gt; V2-V4
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; LCA
&lt;/td&gt;&lt;td&gt; Lateral
&lt;/td&gt;&lt;td&gt; I, aVL, V4-6
&lt;/td&gt;&lt;td&gt; Left ventricular dysfunction:
&lt;p&gt;-Decreased CO2
&lt;/p&gt;&lt;p&gt;-CHFInfranodal block (2 &#778;or 3 &#778;)
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; RCA
&lt;/td&gt;&lt;td&gt; Inferior
&lt;/td&gt;&lt;td&gt; II, III, aVF
&lt;/td&gt;&lt;td colspan="1" rowspan="3"&gt; Hypotension (NTG/morphine)Supranodal 1 &#778; HB
&lt;p&gt;Atrial fibrillation/flutter
&lt;/p&gt;&lt;p&gt;PACs
&lt;/p&gt;&lt;p&gt;Infranodal block (2 &#778;and 3 &#778;) Papillary muscle rupture (murmur)
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; CA
&lt;/td&gt;&lt;td&gt; Right ventricular
&lt;/td&gt;&lt;td&gt; V4R (also II, III, aVF)
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; RCA (90%), LCA (10%)
&lt;/td&gt;&lt;td&gt; Posterior
&lt;/td&gt;&lt;td&gt; R waves in V1, V2 (also V7-9)
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; LCMA
&lt;/td&gt;&lt;td&gt; Anterolateral
&lt;/td&gt;&lt;td&gt; avR (STE)
&lt;/td&gt;&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;p&gt;&amp;nbsp;&lt;br /&gt;
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="acs_risk_stratification_(cad)"><name>ACS Risk Stratification (CAD)</name><content>&lt;p&gt;Likelihood That Signs/Symptoms represent ACS 2/2 CAD  	High Likelihood 
&lt;/p&gt;&lt;p&gt;Any of the following:
&lt;/p&gt;&lt;p&gt;	Intermediate Likelihood 
&lt;/p&gt;&lt;p&gt;Absence of high-likelihood features and presence of any of the following:
&lt;/p&gt;&lt;p&gt;	Low Likelihood 
&lt;/p&gt;&lt;p&gt;Absence of high or intermediate likelihood features but may have:
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;	
History 	* Chest or L arm pain/discomfort as chief symptom reproducing prior documented angina/MI
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; Known history of CAD, including MI 
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;	* Chest or left arm pain/discomfort as chief symptom
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; Age &amp;gt; 70yrs
&lt;/li&gt;&lt;li&gt; Male sex
&lt;/li&gt;&lt;li&gt; DM
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;	Probable ischemic symptoms in absence of any of the intermediate likelihood characteristics
&lt;/p&gt;&lt;p&gt;Recent cocaine use
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;	
Exam 	Transient MR murmur, hypotension, diaphoresis, pulm edema, or rales 	Extracardiac vascular disease	Chest discomfort reproduced by palpation 	
ECG 	New transient ST-segment deviation (1mm or greater) or T-wave inversion in multiple precordial leads 	Fixed Q waves
&lt;/p&gt;&lt;p&gt;ST depression 0.5 to 1mm or TWI &amp;gt; 1mm
&lt;/p&gt;&lt;p&gt;	T-wave flattening or inversio n less than 1mm in leads with dominant R waves
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;	
Biomarkers 	Elevated troponin or CK-MB 	Normal 	Normal 	
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
Short-Term Risk of Death or Nonfatal MI in Patients With UA/NSTEMI 
&lt;/p&gt;
&lt;pre&gt;	High Risk
&lt;/pre&gt;
&lt;p&gt;At least 1 of the following must be present:
&lt;/p&gt;&lt;p&gt;	Intermediate Risk
&lt;/p&gt;&lt;p&gt;No high-risk feature, but must have 1 of the following:
&lt;/p&gt;&lt;p&gt;	Low Risk
&lt;/p&gt;&lt;p&gt;No high or intermediate-risk features but may have any of the following:
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;	
History 	Accelerating tempo of ischemic symptoms in preceding 48 h 	Prior MI, peripheral or cerebrovascular disease, or CABG; prior ASA use 	 	
Character of Pain 	Prolonged ongoing (greater than 20 min)
&lt;/p&gt;&lt;p&gt;Rest pain
&lt;/p&gt;&lt;p&gt;	* Prolonged (greater than 20 min) rest angina, now resolved, with moderate or high likelihood of CAD
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; Rest angina (greater than 20 min) or relieved with rest or sublingual NTG
&lt;/li&gt;&lt;li&gt; Nocturnal angina
&lt;/li&gt;&lt;li&gt; New-onset or progressive CCS class III or IV angina in the past 2 weeks without prolonged (greater than 20 min) rest pain but with intermediate or high likelihood of CAD 
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
	Increased angina frequency, severity, or duration
&lt;/p&gt;&lt;p&gt;Angina provoked at a lower threshold
&lt;/p&gt;&lt;p&gt;New onset angina with onset 2 weeks to 2 months prior to presentation
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;	
Clinical Findings 	Pulmonary edema, most likely due to ischemia
&lt;/p&gt;&lt;p&gt;New or worsening MR murmur
&lt;/p&gt;&lt;p&gt;S3 or new/worsening rales
&lt;/p&gt;&lt;p&gt;Hypotension, bradycardia, tachycardia
&lt;/p&gt;&lt;p&gt;Age &amp;gt; 75 yrs
&lt;/p&gt;&lt;p&gt;	Age &amp;gt; 70 yrs 	 	
ECG 	Angina at rest with transient ST-segment changes greater than 0.5mm
&lt;/p&gt;&lt;p&gt;New Bundle-branch block
&lt;/p&gt;&lt;p&gt;Sustained ventricular tachycardia
&lt;/p&gt;&lt;p&gt;	T-wave changes
&lt;/p&gt;&lt;p&gt;Pathological Q waves or resting ST-depression less than 1mm in multiple lead groups
&lt;/p&gt;&lt;p&gt;	Normal or unchanged ECG 	
Biomarkers 	Elevated Troponin or CK-MB 	Slightly elevated troponin or CK-MB (e.g. trop &amp;gt; 0.01 but less than 0.1) 	Normal 	
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ACS_Risk_Stratification_(CAD)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Source:"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source:"&gt;Source:&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;2007 ACC/AHA Guidelines for the Management of Patients with UA/NSTEMI
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="acs_tests"><name>ACS Tests</name><content>&lt;table style="width: 500px" border="1" cellpadding="1" cellspacing="1"&gt;

&lt;tr&gt;
&lt;td&gt; &lt;b&gt;Test&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Sensitivity&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Specificity&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;PPV&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;NPV&lt;/b&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 12 lead ECG (liberal criteria)
&lt;/td&gt;&lt;td&gt; 94-99
&lt;/td&gt;&lt;td&gt; 19-27
&lt;/td&gt;&lt;td&gt; 21
&lt;/td&gt;&lt;td&gt; 98
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 12 lead ECG (intermed criteria)
&lt;/td&gt;&lt;td&gt; 69-75
&lt;/td&gt;&lt;td&gt; 83-86
&lt;/td&gt;&lt;td&gt; 44
&lt;/td&gt;&lt;td&gt; 95
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 12 lead ECG (strict criteria)
&lt;/td&gt;&lt;td&gt; 38-44
&lt;/td&gt;&lt;td&gt; 97-98
&lt;/td&gt;&lt;td&gt; 76
&lt;/td&gt;&lt;td&gt; 91
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Troponin, 2hr after pain onset
&lt;/td&gt;&lt;td&gt; 33
&lt;/td&gt;&lt;td&gt; 100
&lt;/td&gt;&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Troponin, 6hr after pain onset
&lt;/td&gt;&lt;td&gt; 78
&lt;/td&gt;&lt;td&gt; 99
&lt;/td&gt;&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Troponin, 12hr after pain onset
&lt;/td&gt;&lt;td&gt; 93
&lt;/td&gt;&lt;td&gt; 99
&lt;/td&gt;&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;p&gt;Strict Criteria = ST elevation or pathologic Q waves not known to be old
&lt;/p&gt;&lt;p&gt;Intermed Criteria = ST elevation, ST depression, or T wave changes consistent with ischemia/strain, not known to be old
&lt;/p&gt;&lt;p&gt;Liberal Criteria = nonspecific ST segment or T wave changes abnl, but not diagnositic of ischemia; or ischemia, strain, or infarction known or not known to be old
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ACS_Tests&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt; Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Tarascon Adult Emergency Pocketbook
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="aids_fuo"><name>AIDS FUO</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=AIDS_FUO&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Workup"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Workup"&gt;Workup&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;cbc
&lt;/li&gt;&lt;li&gt;lytes
&lt;/li&gt;&lt;li&gt;lfts
&lt;/li&gt;&lt;li&gt;rpr
&lt;/li&gt;&lt;li&gt;u/a c/s
&lt;/li&gt;&lt;li&gt;blood cx aero, anaerob, fungal
&lt;/li&gt;&lt;li&gt;crypto antigen
&lt;/li&gt;&lt;li&gt;toxo
&lt;/li&gt;&lt;li&gt;coccidioides
&lt;/li&gt;&lt;li&gt;cxr
&lt;/li&gt;&lt;li&gt;stool cx o/p
&lt;/li&gt;&lt;li&gt;urine fungus / myocobacteria
&lt;/li&gt;&lt;li&gt;sputum smear culture fungus /myco
&lt;/li&gt;&lt;li&gt;CT &amp;amp; LP check for:
&lt;ol&gt;&lt;li&gt;cell count, protein, glucose, vdrl, cryptocoocal antigen, cytology (cns lymphoma), pcr for toxo, cmv, jc virus, ebv (lymphoma)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;




</content><folder>ID</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="ami_in_lbbb_(sgarbossa)"><name>AMI in LBBB (Sgarbossa)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Sgarbossa_Criteria"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Sgarbossa Criteria&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Notes"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Notes&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=AMI_in_LBBB_(Sgarbossa)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Sgarbossa Criteria help in assessing the likelihood that a patient with chest pain and a baseline LBBB is having a STEMI
&lt;/li&gt;&lt;li&gt;Low Sensitivity, High Specificity
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=AMI_in_LBBB_(Sgarbossa)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Sgarbossa Criteria"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Sgarbossa_Criteria"&gt;Sgarbossa Criteria&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;ST-segment elevation &#8805;1 mm in a lead with upward (concordant) QRS complex (5 points)
&lt;/li&gt;&lt;li&gt;ST-segment depression &#8805;1 mm in lead V1, V2, or V3 (3 points)
&lt;/li&gt;&lt;li&gt;ST-segment elevation &#8805;5 mm in a lead with downward (discordant) QRS complex (2 points)
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;Points	Probability STEMI	
0	16%	
5-10	88-100%	
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=AMI_in_LBBB_(Sgarbossa)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Notes"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Notes"&gt;Notes&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Unlike general AHA STEMI criteria, the Sgarbossa criteria do NOT need to be found in contiguous leads
&lt;/li&gt;&lt;li&gt;RBBB should NEVER have ST elevation 
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=AMI_in_LBBB_(Sgarbossa)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Sgarbossa, American Heart Journal 2006
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="a_fib_with_rvr"><name>A Fib with RVR</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Unstable"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Unstable&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Stable_.28Rate_Control.29"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Stable (Rate Control)&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Diltiazem"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;Diltiazem&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#.C3.9F-blocker"&gt;&lt;span class="tocnumber"&gt;2.2&lt;/span&gt; &lt;span class="toctext"&gt;&#223;-blocker&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Digoxin"&gt;&lt;span class="tocnumber"&gt;2.3&lt;/span&gt; &lt;span class="toctext"&gt;Digoxin&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-6"&gt;&lt;a href="#Amiodarone"&gt;&lt;span class="tocnumber"&gt;2.4&lt;/span&gt; &lt;span class="toctext"&gt;Amiodarone&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Cardioversion"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Cardioversion&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=A_Fib_with_RVR&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Unstable"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Unstable"&gt; Unstable &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;CP, SOB, ALOC or low SBP, Pulmonary Edema --&amp;gt; urgent cardioversion
&lt;/p&gt;&lt;p&gt;1. Sedate: Versed / Ativan / Fentanyl
&lt;/p&gt;&lt;p&gt;2. 100J (synchronized cardioversion)
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;100J - 50%
&lt;/li&gt;&lt;li&gt;200J - 85%
&lt;/li&gt;&lt;li&gt;360J - 100%
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=A_Fib_with_RVR&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Stable (Rate Control)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Stable_.28Rate_Control.29"&gt; Stable (Rate Control) &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Be very careful that you are not slowing down a normal physiologic response
&lt;/p&gt;&lt;p&gt;(i.e the equivalent of ST in a pt with A.Fib; normally RVR &amp;lt;180, e.g. consider if patient is septic, hypovolemic)
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=A_Fib_with_RVR&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Diltiazem"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diltiazem"&gt; Diltiazem&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;0.25 mg/kg or 5-20 mg IV over 2 min (watch for hypotension)
&lt;/p&gt;&lt;p&gt;-Rebolus in 15 min prn with 0.35 mg/kg or 25 mg
&lt;/p&gt;&lt;p&gt;-Drip 5-15 mg/hr if unable to control rate
&lt;/p&gt;&lt;p&gt;(90% effective, takes 2-5 minutes to work, last 1-4 hours)
&lt;/p&gt;&lt;p&gt;contraindications: VT, 2d or 3d degree AV block without pacemaker, severe hypotension, cardiogenic shock, bypass tracts, close administration with IV &#223; blockers
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=A_Fib_with_RVR&amp;amp;action=edit&amp;amp;section=4" title="Edit section: &#223;-blocker"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id=".C3.9F-blocker"&gt; &#223;-blocker&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Metoprolol 5 mg IV q5 min x5 (contraindicated in COPD, low EF CHF)
&lt;/p&gt;&lt;p&gt;Esmolol = short acting
&lt;/p&gt;&lt;p&gt;-PO load with 25-50mg following successful rate control with IV
&lt;/p&gt;&lt;p&gt;contraindications: if unsure of low EF, safer to use dilt as first line agent
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=A_Fib_with_RVR&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Digoxin"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Digoxin"&gt; Digoxin&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;load 0.5 mg, then 0.25 mg IV q6h to 1 mg, then 0.125-0.25 mg PO or IV QD (not for acute a-fib)
&lt;/p&gt;&lt;p&gt;-adjust dose in presence of renal failure, amiodarone, etc
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=A_Fib_with_RVR&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Amiodarone"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Amiodarone"&gt; Amiodarone&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;load 5 mg/kg IV over 30 min; then 1200 mg over 24 h
&lt;/p&gt;&lt;p&gt;- Consider if hypotensive
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=A_Fib_with_RVR&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Cardioversion"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Cardioversion"&gt; Cardioversion &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Can consider procainamide, ibultide for chemical cardioversion in the appropriate patient
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=A_Fib_with_RVR&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt; Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1/30/06 DONALDSON (adapted from Lampe)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="abdominal_aortic_aneyurism_(aaa)"><name>Abdominal Aortic Aneyurism (AAA)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#Risk_Factors"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;Risk Factors&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Workup"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Workup&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Abdominal_Aortic_Aneyurism_(AAA)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt; Background &lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Infrarenal diameter &amp;gt;3cm or &amp;gt;50% increase in size of diameter
&lt;/li&gt;&lt;li&gt;Rupture Risk
&lt;ul&gt;&lt;li&gt;&amp;lt;4cm: low risk for rupture
&lt;/li&gt;&lt;li&gt;4-5cm: 5 year risk 3-12%
&lt;/li&gt;&lt;li&gt;&amp;gt;5cm: 25-41%
&lt;/li&gt;&lt;li&gt;Rupture poss at any size, most commonly &amp;gt;5cm
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Abdominal_Aortic_Aneyurism_(AAA)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Risk Factors"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Risk_Factors"&gt;Risk Factors&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Age
&lt;ol&gt;&lt;li&gt;Prevalence is negligible in age &amp;lt; 50 yrs
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Smoking
&lt;ol&gt;&lt;li&gt;Risk factor most strongly assoc with AAA
&lt;/li&gt;&lt;li&gt;Also promotes the rate of aneurysm growth
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Family history
&lt;/li&gt;&lt;li&gt;HTN
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Abdominal_Aortic_Aneyurism_(AAA)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt; Diagnosis &lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;May be asymptomatic or abdominal/back pain
&lt;/li&gt;&lt;li&gt;Pain + AAA = rupture until proven otherwise
&lt;/li&gt;&lt;li&gt;Acute abdomen + hypotension = possible rupture
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Abdominal_Aortic_Aneyurism_(AAA)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Workup"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Workup"&gt; Workup &lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;US (cannot see rupture)
&lt;/li&gt;&lt;li&gt;CT Noncon (if stable)
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Abdominal_Aortic_Aneyurism_(AAA)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt; Treatment &lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Rupture
&lt;ul&gt;&lt;li&gt;--&amp;gt;EMERGENT SURG/Endovasc
&lt;/li&gt;&lt;li&gt;Do not waste time for stablization --&amp;gt; OR
&lt;/li&gt;&lt;li&gt;T&amp;amp;C x 6-10U PRBCs, 4U FFP and 4U platelets
&lt;/li&gt;&lt;li&gt;Maintain BP high enough to keep asymptomatic end organ (like penetrating tauma)
&lt;/li&gt;&lt;li&gt;Do not lower BP if R/O rupture (chronic ok)
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Asymptomatic
&lt;ul&gt;&lt;li&gt;--&amp;gt;Incidental finding: f/u Vascular
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Abdominal_Aortic_Aneyurism_(AAA)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt; Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Donaldson, Bessen, H-N, UpToDate
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="abdominal_pain"><name>Abdominal Pain</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Workup"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Workup&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#DDX"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;DDX&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Killers"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;Killers&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Diffuse"&gt;&lt;span class="tocnumber"&gt;2.2&lt;/span&gt; &lt;span class="toctext"&gt;Diffuse&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#RUQ"&gt;&lt;span class="tocnumber"&gt;2.3&lt;/span&gt; &lt;span class="toctext"&gt;RUQ&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-6"&gt;&lt;a href="#Epigastric"&gt;&lt;span class="tocnumber"&gt;2.4&lt;/span&gt; &lt;span class="toctext"&gt;Epigastric&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-7"&gt;&lt;a href="#LUQ"&gt;&lt;span class="tocnumber"&gt;2.5&lt;/span&gt; &lt;span class="toctext"&gt;LUQ&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-8"&gt;&lt;a href="#RLQ"&gt;&lt;span class="tocnumber"&gt;2.6&lt;/span&gt; &lt;span class="toctext"&gt;RLQ&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-9"&gt;&lt;a href="#LLQ"&gt;&lt;span class="tocnumber"&gt;2.7&lt;/span&gt; &lt;span class="toctext"&gt;LLQ&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-10"&gt;&lt;a href="#Pelvic"&gt;&lt;span class="tocnumber"&gt;2.8&lt;/span&gt; &lt;span class="toctext"&gt;Pelvic&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-11"&gt;&lt;a href="#Extra-Abdominal"&gt;&lt;span class="tocnumber"&gt;2.9&lt;/span&gt; &lt;span class="toctext"&gt;Extra-Abdominal&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-12"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Abdominal_Pain&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Workup"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Workup"&gt;Workup&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; B-hCG
&lt;/li&gt;&lt;li&gt; CBC
&lt;/li&gt;&lt;li&gt; Chem 7
&lt;/li&gt;&lt;li&gt; LFTs
&lt;/li&gt;&lt;li&gt; Lipase
&lt;/li&gt;&lt;li&gt; UA/Gm stain/UCx
&lt;/li&gt;&lt;li&gt; Guaiac
&lt;/li&gt;&lt;li&gt; IVF
&lt;/li&gt;&lt;li&gt; ECG (&amp;gt;50 yo)
&lt;/li&gt;&lt;li&gt;&amp;nbsp;?CXR
&lt;/li&gt;&lt;li&gt;&amp;nbsp;?Coags
&lt;/li&gt;&lt;li&gt;&amp;nbsp;?contrast --&amp;gt; CT
&lt;/li&gt;&lt;li&gt;&amp;nbsp;?US
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Abdominal_Pain&amp;amp;action=edit&amp;amp;section=2" title="Edit section: DDX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX"&gt;DDX &lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Abdominal_Pain&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Killers"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Killers"&gt;Killers&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; AAA
&lt;/li&gt;&lt;li&gt; Mesenteric Ischemia
&lt;/li&gt;&lt;li&gt; Bowel Perforation
&lt;/li&gt;&lt;li&gt; Small Bowel Obstruction
&lt;/li&gt;&lt;li&gt; Sigmoid Volvulus
&lt;/li&gt;&lt;li&gt; Ectopic Pregnancy
&lt;/li&gt;&lt;li&gt; Placental Abruption
&lt;/li&gt;&lt;li&gt; MI
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Abdominal_Pain&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Diffuse"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diffuse"&gt;Diffuse&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Peritonitis
&lt;/li&gt;&lt;li&gt; Acute pancreatitis
&lt;/li&gt;&lt;li&gt; Sickle cell crisis
&lt;/li&gt;&lt;li&gt; Early appendicitis
&lt;/li&gt;&lt;li&gt; Mesenteric thrombosis
&lt;/li&gt;&lt;li&gt; Gastroenteritis
&lt;/li&gt;&lt;li&gt; Dissecting/rupturing aneurysm
&lt;/li&gt;&lt;li&gt; Intestinal obstruction
&lt;/li&gt;&lt;li&gt; Diabetes
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Abdominal_Pain&amp;amp;action=edit&amp;amp;section=5" title="Edit section: RUQ"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="RUQ"&gt;RUQ&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Acute cholecystitis/biliary colic
&lt;/li&gt;&lt;li&gt; Acute hepatitis
&lt;/li&gt;&lt;li&gt; Hepatic abscess
&lt;/li&gt;&lt;li&gt; Hepatomegaly due to CHF
&lt;/li&gt;&lt;li&gt; Perforated duodenal ulcer
&lt;/li&gt;&lt;li&gt; Acute pancreatitis (can be bilateral)
&lt;/li&gt;&lt;li&gt; Retrocecal appendicitis
&lt;/li&gt;&lt;li&gt; Herpes zoster
&lt;/li&gt;&lt;li&gt; Myocardial ischemia
&lt;/li&gt;&lt;li&gt; Right lower lobe pneumonia
&lt;/li&gt;&lt;li&gt; Bowel obstruction
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Abdominal_Pain&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Epigastric"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Epigastric"&gt;Epigastric&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Gallbladder disease
&lt;/li&gt;&lt;li&gt; GERD
&lt;/li&gt;&lt;li&gt; PUD
&lt;/li&gt;&lt;li&gt; Gastritis
&lt;/li&gt;&lt;li&gt; Acute pancreatitis
&lt;/li&gt;&lt;li&gt; Splenic enlargement/rupture/infarction/aneurysm
&lt;/li&gt;&lt;li&gt; Myocardial ischemia
&lt;/li&gt;&lt;li&gt; Pericarditis/Myocarditis 
&lt;/li&gt;&lt;li&gt; Aortic dissection 
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Abdominal_Pain&amp;amp;action=edit&amp;amp;section=7" title="Edit section: LUQ"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="LUQ"&gt;LUQ&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Gastritis
&lt;/li&gt;&lt;li&gt; Acute pancreatitis
&lt;/li&gt;&lt;li&gt; Splenic enlargement/rupture/infarction/aneurysm
&lt;/li&gt;&lt;li&gt; Myocardial ischemia
&lt;/li&gt;&lt;li&gt; Left lower lobe pneumonia
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Abdominal_Pain&amp;amp;action=edit&amp;amp;section=8" title="Edit section: RLQ"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="RLQ"&gt;RLQ&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Appendicitis
&lt;/li&gt;&lt;li&gt; Regional enteritis
&lt;/li&gt;&lt;li&gt; Meckel's diverticulitis
&lt;/li&gt;&lt;li&gt; Cecal diverticulitis
&lt;/li&gt;&lt;li&gt; Leaking aneurysm
&lt;/li&gt;&lt;li&gt; Abdominal wall hematoma
&lt;/li&gt;&lt;li&gt; Ruptured ectopic
&lt;/li&gt;&lt;li&gt; Twisted ovarian cyst
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Abdominal_Pain&amp;amp;action=edit&amp;amp;section=9" title="Edit section: LLQ"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="LLQ"&gt;LLQ&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Sigmoid diverticulitis
&lt;/li&gt;&lt;li&gt; Leaking aneurysm
&lt;/li&gt;&lt;li&gt; Ruptured ectopic
&lt;/li&gt;&lt;li&gt; Mittleshmerz
&lt;/li&gt;&lt;li&gt; Twisted ovarian cyst
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Abdominal_Pain&amp;amp;action=edit&amp;amp;section=10" title="Edit section: Pelvic"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Pelvic"&gt;Pelvic&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Mittelschmerz
&lt;/li&gt;&lt;li&gt; Endometriosis
&lt;/li&gt;&lt;li&gt; Ureteral calculi
&lt;/li&gt;&lt;li&gt; Seminal vesiculitis
&lt;/li&gt;&lt;li&gt; Psoas abscess
&lt;/li&gt;&lt;li&gt; Mesenteric adenitis
&lt;/li&gt;&lt;li&gt; Incarcerated hernia
&lt;/li&gt;&lt;li&gt; Endometriosis
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Abdominal_Pain&amp;amp;action=edit&amp;amp;section=11" title="Edit section: Extra-Abdominal"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Extra-Abdominal"&gt;Extra-Abdominal&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; MI
&lt;/li&gt;&lt;li&gt; Aortic Dissection
&lt;/li&gt;&lt;li&gt; AAA 
&lt;/li&gt;&lt;li&gt; PNA
&lt;/li&gt;&lt;li&gt; PE
&lt;/li&gt;&lt;li&gt; Testicular Torsion
&lt;/li&gt;&lt;li&gt; Herpes zoster
&lt;/li&gt;&lt;li&gt; Muscle spasm
&lt;/li&gt;&lt;li&gt; Strep pharyngitis (children)
&lt;/li&gt;&lt;li&gt; Mononucleosis
&lt;/li&gt;&lt;li&gt; DKA
&lt;/li&gt;&lt;li&gt; ETOH ketoacidosis
&lt;/li&gt;&lt;li&gt; Uremia
&lt;/li&gt;&lt;li&gt; Sickle cell disease
&lt;/li&gt;&lt;li&gt; Porphyria
&lt;/li&gt;&lt;li&gt; SLE
&lt;/li&gt;&lt;li&gt; Vasculitis
&lt;/li&gt;&lt;li&gt; Glaucoma
&lt;/li&gt;&lt;li&gt; Hyperthyroidsim
&lt;/li&gt;&lt;li&gt; Methanol poisoning
&lt;/li&gt;&lt;li&gt; Heavy metal toxicity
&lt;/li&gt;&lt;li&gt; Addison's Disease 
&lt;/li&gt;&lt;li&gt; Acute Porphyria
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Abdominal_Pain&amp;amp;action=edit&amp;amp;section=12" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;3/20/06 DONALDSON (adapted from Rosen)
&lt;/p&gt;



</content><folder>GI</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="abdominal_pain_(peds)"><name>Abdominal Pain (Peds)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Epidemiology"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Epidemiology&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#_2"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#DDx_1"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;DDx 1&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#_3"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#DDX_2"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;DDX 2&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-8"&gt;&lt;a href="#Infant:"&gt;&lt;span class="tocnumber"&gt;7.1&lt;/span&gt; &lt;span class="toctext"&gt;Infant:&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-9"&gt;&lt;a href="#2-5_years:"&gt;&lt;span class="tocnumber"&gt;7.2&lt;/span&gt; &lt;span class="toctext"&gt;2-5 years:&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-10"&gt;&lt;a href="#5-12_years:"&gt;&lt;span class="tocnumber"&gt;7.3&lt;/span&gt; &lt;span class="toctext"&gt;5-12 years:&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-11"&gt;&lt;a href="#Adolescent:"&gt;&lt;span class="tocnumber"&gt;7.4&lt;/span&gt; &lt;span class="toctext"&gt;Adolescent:&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-12"&gt;&lt;a href="#Workup"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;Workup&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-13"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;9&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-14"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;10&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Abdominal_Pain_(Peds)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Remember: bilious emesis in a kid is a surgical emergency until proven otherwise
&lt;/p&gt;&lt;p&gt;Visceral pain is dull &amp;amp; non-specific
&lt;/p&gt;&lt;p&gt;Somatic pain is sharp &amp;amp; localized d/t peritoneal or diaphragm irritation
&lt;/p&gt;&lt;p&gt;Guarding &amp;amp; TTP/rebound are most c/w surgical DZ in kids
&lt;/p&gt;&lt;p&gt;Infants eat, sleep &amp;amp; poop, probs w/ these can be a bad sign
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Abdominal_Pain_(Peds)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: "&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id=""&gt; &lt;/span&gt;&lt;/h2&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Abdominal_Pain_(Peds)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Epidemiology"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Epidemiology"&gt;Epidemiology&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Ten most common Dx in order:
&lt;/p&gt;&lt;p&gt;AGE (26%)
&lt;/p&gt;&lt;p&gt;Nonspecific AP (26%)
&lt;/p&gt;&lt;p&gt;Viral Illness (6%)
&lt;/p&gt;&lt;p&gt;Constipation (5%)
&lt;/p&gt;&lt;p&gt;UTI (5%)
&lt;/p&gt;&lt;p&gt;Pharyngitis (5%)
&lt;/p&gt;&lt;p&gt;Appy (4%)
&lt;/p&gt;&lt;p&gt;Asthma (2%)
&lt;/p&gt;&lt;p&gt;OM (2%)
&lt;/p&gt;&lt;p&gt;PNA (2%)
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Also look for extra-abdominal (collagen dz, HSP, DKA, poison, IBD, CF, nephrotic syndrome) 
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Abdominal_Pain_(Peds)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: "&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="_2"&gt; &lt;/span&gt;&lt;/h2&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Abdominal_Pain_(Peds)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: DDx 1"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx_1"&gt;DDx 1&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Infancy 
&lt;/li&gt;&lt;li&gt; gastroenteritis, intussusception, volvulus, incarcerated hernia, Hirschrung's dz, NEC, perforation, colic, pneumonia, pyloric stenosis
&lt;/li&gt;&lt;li&gt; Childhood 
&lt;/li&gt;&lt;li&gt; AGE, appy, pancreatitis, HSP, HUS, Incarcerated Hernia, constipation, UTI, pyelo, PNA, GAS phryngitis, ulcers, meckels, IBD
&lt;/li&gt;&lt;li&gt; Adolescence 
&lt;/li&gt;&lt;li&gt; same as before but add ectopic, PID, torsion (testicular, ovarian), IBD, biliary disease, nephrolithiasis
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Abdominal_Pain_(Peds)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: "&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="_3"&gt; &lt;/span&gt;&lt;/h2&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Abdominal_Pain_(Peds)&amp;amp;action=edit&amp;amp;section=7" title="Edit section: DDX 2"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX_2"&gt;DDX 2&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Abdominal_Pain_(Peds)&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Infant:"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Infant:"&gt;Infant:&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;green vomit: bad sign
&lt;/p&gt;&lt;p&gt;obstruction: volvulus, malrotation
&lt;/p&gt;&lt;p&gt;abd pain also caused by trauma, intuss.(air enema is dx and tx), intestinal anomalies, incarcerated hernia, sickling syndromes, (acute intermittent porphyria), appy, milk allergy, wilms tumor, toxins (heavy metals), disaccharide deficiency.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Abdominal_Pain_(Peds)&amp;amp;action=edit&amp;amp;section=9" title="Edit section: 2-5 years:"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="2-5_years:"&gt;2-5 years:&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;viral, gastroenteritis, pnemonia, asthma, constipation, trauma, appy, sickling syndrome, UTI, meckel's diverticulum, HSP, nephrotic syndrome, intuss, IBD, HUS, DM, pancreatitis
&lt;/p&gt;&lt;p&gt;order: amylase, LFT's
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Abdominal_Pain_(Peds)&amp;amp;action=edit&amp;amp;section=10" title="Edit section: 5-12 years:"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="5-12_years:"&gt;5-12 years:&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;appy (CT c rectal contrast-very sens. + spec.), testicular torsion (or appendix testis torsion), functional abd pain, gastroenteritis, constipation, URI, CF, DM, torsion, renal calculi, Rheumatic fever
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Abdominal_Pain_(Peds)&amp;amp;action=edit&amp;amp;section=11" title="Edit section: Adolescent:"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Adolescent:"&gt;Adolescent:&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;ectopic: get &#223;hCG, type + cross (rhogam), pelvic US--be sure well-hydrated for US for optimal imaging, PID, IBP, Rheumatic fever, abd abscess
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Abdominal_Pain_(Peds)&amp;amp;action=edit&amp;amp;section=12" title="Edit section: Workup"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Workup"&gt;Workup&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; UA, Upreg
&lt;/li&gt;&lt;li&gt; Dehydration: electrolytes, renal fxn tests
&lt;/li&gt;&lt;li&gt; Vomiting without diarrhea: LFTs, lipase, toxin screen
&lt;/li&gt;&lt;li&gt; Fever: CBC, CRP
&lt;/li&gt;&lt;li&gt; Diagnostic imaging 
&lt;/li&gt;&lt;li&gt; Role of abdominal xrays: only good if positive (ann emerg med-1992 rothrock et al)
&lt;/li&gt;&lt;li&gt; 50% of of patients with major disease had normal radiographs
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Abdominal_Pain_(Peds)&amp;amp;action=edit&amp;amp;section=13" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Peds:  Necrotizing Enterocolitis (NEC)
&lt;/p&gt;&lt;p&gt;Peds:  Volvulus 
&lt;/p&gt;&lt;p&gt;Peds:  Pyloric Stenosis
&lt;/p&gt;&lt;p&gt;Peds:  Intussusception
&lt;/p&gt;&lt;p&gt;Peds:  Meckel's Diverticulum
&lt;/p&gt;&lt;p&gt;Peds:  Appendicitis (Peds)
&lt;/p&gt;&lt;p&gt;Peds:  Inguinal Hernia (Peds)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Abdominal_Pain_(Peds)&amp;amp;action=edit&amp;amp;section=14" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Gausche 11/03- By Lampe
&lt;/p&gt;&lt;p&gt;7/2/09 PANI
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="abruption"><name>Abruption</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Risk_Factors"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Risk Factors&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Symptoms"&gt;&lt;span class="tocnumber"&gt;3.1&lt;/span&gt; &lt;span class="toctext"&gt;Symptoms&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Labs"&gt;&lt;span class="tocnumber"&gt;3.2&lt;/span&gt; &lt;span class="toctext"&gt;Labs&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-6"&gt;&lt;a href="#UTZ"&gt;&lt;span class="tocnumber"&gt;3.3&lt;/span&gt; &lt;span class="toctext"&gt;UTZ&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Abruption&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; premature separation of placenta from uterus
&lt;/li&gt;&lt;li&gt; amount of external bleeding may not correlate with severity of abruption since bleeding may be concealed.
&lt;/li&gt;&lt;li&gt; fetal death by hypoxia. can also cause fetal blood loss, maternal Rh sens, amniotic fluid embolism, DIC.
&lt;/li&gt;&lt;li&gt; GRADE 3/ COMPLETE- mod to severe bleeding with painful tetanic uterine contractions.  maternal hypotension and tachycardia.  DIC with fibrinogen levels less than 150 mg/%, representing a blood loss of 2L. Maternal coagulopathy with thrombocytopenia, clooting factor, fibrinogen depletion. fetal death common.
&lt;/li&gt;&lt;li&gt; GRADE 2/ PARTIAL- ex ut bleeding mild to mod, uterine irritability with tetanic comtractions at times, maternal orthostatic hypotension, fibrinogen levels 150- 250 mg/%, fetal distress with compromised fetal heart rate patterns
&lt;/li&gt;&lt;li&gt; GRADE 1/ MILD- spotting with limited ut irritabillity- no organizedcontractions. Mat BP normal, fibrinogen normal at 450 mg/%, normalfetal heart rate.
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Abruption&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Risk Factors"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Risk_Factors"&gt;Risk Factors&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; mat hypertension
&lt;/li&gt;&lt;li&gt; eclampsia, preeclampsia
&lt;/li&gt;&lt;li&gt; h/o prev abruption
&lt;/li&gt;&lt;li&gt; ut distension from multiple gestations, hydramnios, tumors
&lt;/li&gt;&lt;li&gt; vascular dz- collagen vasc, DM, CRF
&lt;/li&gt;&lt;li&gt; smoking
&lt;/li&gt;&lt;li&gt; coccaine- increases BP
&lt;/li&gt;&lt;li&gt; microangiopathic hemolytic anemia
&lt;/li&gt;&lt;li&gt; premature rupture of membranes
&lt;/li&gt;&lt;li&gt; uterine blunt trauma- mva, domestic violence
&lt;/li&gt;&lt;li&gt; short umbilical cord
&lt;/li&gt;&lt;li&gt; advanced mat age,
&lt;/li&gt;&lt;li&gt; male fetal gender
&lt;/li&gt;&lt;li&gt; short umbilical cord
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Abruption&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Abruption&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Symptoms"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Symptoms"&gt;Symptoms&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;abd pain, ut contractions, vag bleeding.  possibly also mat hypoTN,tachycardia, ARDS, ATN, DIC- (bruising, hematuria)
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Abruption&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Labs"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Labs"&gt;Labs&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Thrombomodulin (marker for endothelial cell damage) is elevated
&lt;/li&gt;&lt;li&gt; DIC- triggered by massive hem.  stumulates production of tissue thromboplastin causing extensive microvascular clotting; these small clots stumulate the fibrinolytic cascade which leads to  cosumpiton of platelets, fibrinogen and other clotting factors.
&lt;/li&gt;&lt;li&gt; normal fibrinogen is 450, at 300 see spont bleeding at puncture sites, at 150- mother has already lost 2L
&lt;/li&gt;&lt;li&gt; DIC panel- fibrinogen, platelets, pt/ptt, raised D- dimer- from fibrin degredation
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Abruption&amp;amp;action=edit&amp;amp;section=6" title="Edit section: UTZ"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="UTZ"&gt;UTZ&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; will still fail to detect 50% of cases
&lt;/li&gt;&lt;li&gt; can measure gest age if mom unsure- if near term do crash c seciton.
&lt;/li&gt;&lt;li&gt; will see if hematoma is subchorionic, retroplacental or preplacental- will not change management other that to rule out placenta previa
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Abruption&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; stable/ grade 1- admit for observation and elective delivery
&lt;/li&gt;&lt;li&gt; if pt with large concealed hem, are at risk for ut rupture. tx c decompression of  of ut cavity by amniotomy- only do if all other resuscitative measures are failing.
&lt;/li&gt;&lt;li&gt; xfuse saline, blood, ffp, platelets as needed.
&lt;/li&gt;&lt;li&gt; emergent c section if near term. if preterm, use tocolytics- mag sulfate and terbutaline to prevent ut contractions and prevent labor
&lt;/li&gt;&lt;/ol&gt;




</content><folder>OB/GYN</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="abscess"><name>Abscess</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Incision_.26_Drainage"&gt;&lt;span class="tocnumber"&gt;3.1&lt;/span&gt; &lt;span class="toctext"&gt;Incision &amp;amp; Drainage&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Follow-up"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Follow-up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Abscess&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Abscess&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;May use US or needle aspiration
&lt;/li&gt;&lt;li&gt;Check: Blood Glucose, IV drug use (XR r/o needle), consider HIV counseling/testing
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Abscess&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Antibiotics
&lt;ol&gt;&lt;li&gt;give if there is a large cellulitic component or fever
&lt;/li&gt;&lt;li&gt;Need to cover staph and strep.
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Update Tetanus
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Abscess&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Incision &amp;amp; Drainage"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Incision_.26_Drainage"&gt;Incision &amp;amp; Drainage&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Be sure to document if packing was placed in the wound
&lt;/li&gt;&lt;li&gt;Anesthesia should be lidocaine or Marcaine without epinephrine
&lt;/li&gt;&lt;li&gt;Most patients need some pain medicine prior to procedure
&lt;/li&gt;&lt;/ol&gt;
&lt;ul&gt;&lt;li&gt;Toxic dose of Lidocaine is 5mg/kg with NO epi &amp;amp; 7 mg/kg w/ Epi! (toxic= ring in ears &amp;amp; se). Lido from code cart has no HCl that floor epi has, use HCO3 (1cc to 10cc Lido) to decr pain of floor lido d/t HCl! inject through wound edges NOT intact skin!
&lt;/li&gt;&lt;li&gt;Lido lasts 30-90 min, bupivicaine (.25%)  max= 2mg/kg lasts 6-8 hr. Do NOT inject bupivicaine intravascularly b/c= refractory cardiac arrest!!!
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Abscess&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Follow-up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Follow-up"&gt;Follow-up&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Wound check in 1-2 days and wound care sheet
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Abscess&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;




</content><folder>Derm</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="abuse_(nonaccidental_trauma)"><name>Abuse (Nonaccidental Trauma)</name><content>&lt;p&gt;&lt;br /&gt;
NONACCIDENTAL TRAUMA
&lt;/p&gt;&lt;p&gt;-    abusive head trauma most common cause of traumatic death in infants
&lt;/p&gt;&lt;p&gt;-    risk factors for abuse
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; infant
&lt;/li&gt;&lt;li&gt; lower status
&lt;/li&gt;&lt;li&gt; family problems
&lt;/li&gt;&lt;li&gt; disability or prematurity of infant
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;-    historical alternans,  or may present with medical complaints like irreg breathing, apnea, sz, irritable, lethargic, vomiting, poor feeding
&lt;/p&gt;&lt;p&gt;-    retinal hem usually from abuse may rarely be from other trauma
&lt;/p&gt;&lt;p&gt;-    most common abusive lesions are
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; subarach hem
&lt;/li&gt;&lt;li&gt; subdural
&lt;/li&gt;&lt;li&gt; interhemispheric blood
&lt;/li&gt;&lt;li&gt; cerebral edema
&lt;/li&gt;&lt;li&gt; same lesion not common with accidental trauma but possible
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;-    fx assoc with abuse are multiple, bilateral, cross sutures, diastatic, nonparietal, assoc with subdural
&lt;/p&gt;&lt;p&gt;-    skull fx from short fall &amp;lt;3 ft usually linear
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Recommendations
&lt;/p&gt;&lt;p&gt;-    ct if ams
&lt;/p&gt;&lt;p&gt;-    consider ct if h/o loc, amnesia, sz, HA, vomiting, irritable, behavioral change
&lt;/p&gt;&lt;p&gt;-    if mild sxs, no ct but observe at home
&lt;/p&gt;&lt;p&gt;-    lower threshold if young &amp;lt;1-2 yrs since skull fx more common and more risk for abuse
&lt;/p&gt;&lt;p&gt;-    image if significant scalp findings
&lt;/p&gt;&lt;p&gt;-    consider abuse if no hx of trauma, delay in seeking care, changing story, repeated injuries, mismatch of hx with physical exam, wounds of diff stages of healing
&lt;/p&gt;&lt;p&gt;-    call neurosurg if intracranial inj, skull fx depressed or widely diastatic
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Abuse_(Nonaccidental_Trauma)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: See also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_also"&gt;See also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Peds: Head CT (Peds)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Abuse_(Nonaccidental_Trauma)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from Pani
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="acetaminophen_(tylenol)"><name>Acetaminophen (Tylenol)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Pathophysiology"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Pathophysiology&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Risk_Factors_for_Toxicity"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Risk Factors for Toxicity&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Kinetics"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Kinetics&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Metabolism:"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Metabolism:&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Symptoms"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Symptoms&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Work_UP"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Work UP&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Toxic_levels"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Toxic levels&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-8"&gt;&lt;a href="#Extended_release_preparations_.28Tylenol7_.22Extended_Relief.22.29"&gt;&lt;span class="tocnumber"&gt;7.1&lt;/span&gt; &lt;span class="toctext"&gt;Extended release preparations (Tylenol7 "Extended Relief")&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-10"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;9&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Acetaminophen_(Tylenol)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Pathophysiology"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Pathophysiology"&gt;Pathophysiology&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; APAP (n-acetyl-p-aminophenol) liver metabolized by oxidation and/or conjugation
&lt;ul&gt;&lt;li&gt; toxic metabolites, including N-acetyl-benzoquinonimine (NAPQI), metabolized via all 3
&lt;/li&gt;&lt;li&gt; conjugation with glucuronide (40-60%) or sulfate (20-40%)
&lt;/li&gt;&lt;li&gt; oxidation via CYP450 2E1 (&amp;lt;10%) and then conjugated
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; In excessive amounts, glutathione depleted --&amp;gt; CYP450 pathway overwhelmed  --&amp;gt; NAPQI accum = liver injury
&lt;/li&gt;&lt;li&gt; N-acetylcysteine (NAC) increases availability of glutathione thus prevents accumulation of NAPQI
&lt;/li&gt;&lt;li&gt; Additional effects of NAC: Antioxidant effects, microcirculatory changes (improved tissue oxygenation)
&lt;/li&gt;&lt;li&gt; Activated charcoal: Adsorbs (and prevents absorption of) acetaminophen
&lt;/li&gt;&lt;li&gt; However, also adsorbs (and prevents absorption of) N-acetylcysteine
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Acetaminophen_(Tylenol)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Risk Factors for Toxicity"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Risk_Factors_for_Toxicity"&gt;Risk Factors for Toxicity&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Hepatic disease, alcoholics, geriatric: chronic toxicity
&lt;/li&gt;&lt;li&gt;Toxicity enhanced with inducers of CYP450 (alcoholics, drugs), poor nutrition (lower glutathione stores)
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Acetaminophen_(Tylenol)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Kinetics"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Kinetics"&gt;Kinetics&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;t1/2: 4 hrs in OD, otherwise 1-3 hrs
&lt;/li&gt;&lt;li&gt;Usual maximum daily recommended dose: 2.4 - 4.0 g/day
&lt;/li&gt;&lt;li&gt;Thx dose: 
&lt;ol&gt;&lt;li&gt;Peds - 15mg/kg/dose Q4-6
&lt;/li&gt;&lt;li&gt;Adults - 325mg-1000mg Q4-6
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Toxic dose 140mg/kg; 10g or 200mg/kg; 4g or 100mg/kg in high risk pt
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Acetaminophen_(Tylenol)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Metabolism:"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Metabolism:"&gt;Metabolism: &lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;CYP450 dependent (in absence of sufficient glutathione)
&lt;/li&gt;&lt;li&gt;Children with less of cytochrome; less likely to suffer effects of toxicity
&lt;/li&gt;&lt;li&gt;Pediatric to Adult "metabolism" typically occurs between 6 to 9 years old
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Acetaminophen_(Tylenol)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Symptoms"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Symptoms"&gt;Symptoms&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Phase 1 (0-24 hrs): asymptomatic, N/V, abd. tenderness, diaphoresis
&lt;/li&gt;&lt;li&gt;Phase 2 (24-72 hrs): asymptomatic, LFT's &amp;amp; coagulation tests, Cr may begin to incr.
&lt;/li&gt;&lt;li&gt;Phase 3 (72-124 hrs): PEAK hepatotoxicity, hepatic necrosis, jaundice, encephalopathy, renal failure, death, pancreatitis (hyperamylasemia)
&lt;ol&gt;&lt;li&gt;Seen in 18% of overdoses
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Phase 4 (5-14 d): recovery
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Acetaminophen_(Tylenol)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Work UP"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work_UP"&gt;Work UP&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Lytes, BUN/Cr, glucose: metabolic acidos seen w/ extremely large (&amp;gt; 75 g, &amp;gt; 10 g peds) ingestion, renal function
&lt;/li&gt;&lt;li&gt;LFT's: AST usually incr. first; may rise over 10,000
&lt;/li&gt;&lt;li&gt;Monitor qd x3 with bilirubin
&lt;/li&gt;&lt;li&gt;Coagulation studies: indicator of liver function; monitor qD x3
&lt;/li&gt;&lt;li&gt;Acetaminophen level: 4 hours post ingestion and repeat in 4 hours
&lt;/li&gt;&lt;li&gt;Estimated ingestion &amp;gt;150 mg/kg and 8 hr post ingestion may start NAC while awaiting levels
&lt;/li&gt;&lt;li&gt;Rumack-Matthews nomogram guide for Tx in acute overdose; do not use for chronic ingestions or late ingestions
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Acetaminophen_(Tylenol)&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Toxic levels"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Toxic_levels"&gt;Toxic levels&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;4 hr level &amp;gt;150 mcg/mL [993 umol/L]
&lt;/li&gt;&lt;li&gt;6 hr &amp;gt;110 mcg/mL [728 umol/L]
&lt;/li&gt;&lt;li&gt;8 hr &amp;gt;75 mcg/mL [496.5 umol/L]
&lt;/li&gt;&lt;li&gt;24 hr &amp;gt;4.5 mcg/mL [29.8 umol/L]
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;Acetaminophen half-life &amp;gt; 4 hr also may indicate toxicity
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Acetaminophen_(Tylenol)&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Extended release preparations (Tylenol7 &amp;quot;Extended Relief&amp;quot;)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Extended_release_preparations_.28Tylenol7_.22Extended_Relief.22.29"&gt;Extended release preparations (Tylenol7 "Extended Relief")&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Bi-layer caplet; each layer contains 325 mg acetaminophen
&lt;/li&gt;&lt;li&gt;One layer "immediate release," second layer "extended release" (up to  8 hrs; 95% released by 5 hrs)
&lt;/li&gt;&lt;li&gt;Peak blood levels with therapeutic doses @ 1-2 hrs; may be longer  after overdose
&lt;/li&gt;&lt;li&gt;Requires serial levels (x2-3) as will drop and can be misleading
&lt;/li&gt;&lt;li&gt;Cannot use nomogram
&lt;/li&gt;&lt;li&gt;If suspicious, treat with NAC
&lt;/li&gt;&lt;li&gt;Does not qualify for new shorter course 48 hr NAC therapy
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Acetaminophen_(Tylenol)&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Call poison control
&lt;/li&gt;&lt;li&gt;ABCs, IV, O2, monitor
&lt;/li&gt;&lt;li&gt;Decrease absorption
&lt;ol&gt;&lt;li&gt;Do not induce emesis
&lt;/li&gt;&lt;li&gt;Gastric lavage if &amp;lt; 1 hr post-ingestion
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Activated charcoal if &amp;lt; 3 hr post-ingestion or if other coingestants
&lt;ol&gt;&lt;li&gt;Does not interfere with NAC administration
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Antidote: N-acetylcysteine (NAC or Mucomyst)
&lt;ol&gt;&lt;li&gt;Obtain acetaminophen level at least 4 hrs after ingestion (if uncertain time, obtain level immediately and then 4hrs later; determine 1/2 life)
&lt;/li&gt;&lt;li&gt;Wait for level before initiating therapy if level will return within 8 hrs post-ingestion
&lt;/li&gt;&lt;li&gt;Plot on Rumack-Matthew nomogram; if acetaminophen level in non-toxic range, NAC not indicated
&lt;/li&gt;&lt;li&gt;If level will not return within 8 hrs post-ingestion, give first dose of NAC empirically with suspected toxic ingestion; discontinue therapy if level non-toxic
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;If toxic:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;NAC
&lt;ol&gt;&lt;li&gt;PO:
&lt;ol&gt;&lt;li&gt;140 mg/kg PO load
&lt;/li&gt;&lt;li&gt;70 mg/kg PO q4hr x17 doses additional; dilute to 5% soln
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;IV (Acetadote)
&lt;ol&gt;&lt;li&gt;Loading dose 150 mg/kg in 200 mL D5W over 60 min
&lt;/li&gt;&lt;li&gt;Second (maintenance) dose 50 mg/kg in 500 mL D5W over 4 hrs
&lt;/li&gt;&lt;li&gt;Third dose 100 mg/kg in 1000 mL D5W over 16 hrs
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Virtually 100% effective if given &amp;lt; 8 hr post-ingestion; less effective if 16-24 hr post-ingestion
&lt;/li&gt;&lt;li&gt;May still be useful &amp;gt; 24 hr post-ingestion; even with fulminant hepatic failure
&lt;/li&gt;&lt;li&gt;Do not stop when acetaminophen concentrations fall to 0: free radicals are still causing hepatic damage
&lt;/li&gt;&lt;li&gt;In pts who develop hepatic injury, NAC tx should be continued until liver function improves (follow LFT's)
&lt;/li&gt;&lt;li&gt;May require strong anti-emetic (ondansetron 0.15 mg/kg IV, metoclopramide 20-40mg IV) or NGT if severe vomiting
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Increase elimination
&lt;ol&gt;&lt;li&gt;Charcoal hemoperfusion
&lt;ol&gt;&lt;li&gt;Also effective in removing acetaminophen
&lt;/li&gt;&lt;li&gt;Not useful in usual clinical circumstances
&lt;/li&gt;&lt;li&gt;Indicated when pt. has fulminant hepatic encephalopathy with significant levels of acetaminophen present
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Follow acetaminophen levels q4h, LFT, Coags
&lt;/li&gt;&lt;li&gt;Evaluate potential need for liver transplant: pH&amp;lt;7.25, Cr &amp;gt;2.5, INR &amp;gt;4.5
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Acetaminophen_(Tylenol)&amp;amp;action=edit&amp;amp;section=10" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Psych hold
&lt;/li&gt;&lt;li&gt;Admit
&lt;ol&gt;&lt;li&gt;Pre-school child with ingestions &amp;gt; 200 mg/kg
&lt;/li&gt;&lt;li&gt;Older child, adult w/ingestion &amp;gt;150 mg/kg or a total dose of 7.5 g
&lt;/li&gt;&lt;li&gt;Liver function abnormalities
&lt;/li&gt;&lt;li&gt;Delayed presentation or requirement for NAC therapy
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Discharge
&lt;ol&gt;&lt;li&gt;Asymptomatic pts. w/o need of NAC therapy
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;




</content><folder>Tox</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="acromioclavicular_injuries"><name>Acromioclavicular Injuries</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Imaging"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Imaging&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Classification"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Classification&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Acromioclavicular_Injuries&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Usually occurs from direct trauma to the adducted shoulder 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Acromioclavicular_Injuries&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Tenderness directly over AC joint, possibly with deformity
&lt;ol&gt;&lt;li&gt; Also palpate sternoclavicular joint, coracoclavicular ligaments for assoc injuries
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; AC compression test
&lt;ol&gt;&lt;li&gt; Passively flex arm so is parallel with ground; then passively adduct across body
&lt;/li&gt;&lt;li&gt; Pain suggests AC joint injury 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Acromioclavicular_Injuries&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Imaging"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Imaging"&gt;Imaging&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; AP shoulder (highly consider comparison view)
&lt;ol&gt;&lt;li&gt; AC joint
&lt;ol&gt;&lt;li&gt; Normal width of AC joint in adults is 1-3mm
&lt;/li&gt;&lt;li&gt; By age 60 width is often less than 1mm 
&lt;/li&gt;&lt;li&gt; Children and adolescents have a slightly wider joint space
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; CC joint
&lt;ol&gt;&lt;li&gt; Normal distance is 11-13mm
&lt;/li&gt;&lt;li&gt; Comparison to opposite CC joint space is more important 
&lt;/li&gt;&lt;li&gt; Increase in CC distance of 25-50% indicates complete CC ligament disruption
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Zanca view  (AP w/ 10-15 degree cephalic tilt)
&lt;ol&gt;&lt;li&gt; Consider if AP view is ambiguous or injury is suspicious for type II AC injury or distal clavicle injury:
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Axillary view
&lt;ol&gt;&lt;li&gt; Obtain if coracoid tenderness is present to rule-out associated coracoid fx 
&lt;/li&gt;&lt;li&gt; Helps to confirm ant-post position of clavicle in injury types III-IV
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Acromioclavicular_Injuries&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Classification"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Classification"&gt;Classification&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Type 1 - AC ligament sprain; AC joint intact
&lt;ol&gt;&lt;li&gt; Exam
&lt;ol&gt;&lt;li&gt; Mild swelling, no deformity
&lt;/li&gt;&lt;li&gt; CC ligaments are nontender
&lt;/li&gt;&lt;li&gt; Only distal-most 1-2cm of clavicle is tender
&lt;/li&gt;&lt;li&gt; Active overhead and cross-body ROM are limited by pain 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Xray
&lt;ol&gt;&lt;li&gt; Often no abnormality is seen on xray; slight widening of the AC joint may occur 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Type 2 - AC ligament torn and subluxed; coracoclavicular (CC) ligament may be partially torn but is intact
&lt;ol&gt;&lt;li&gt; Exam
&lt;ol&gt;&lt;li&gt; Prominent and tender AC joint w/ significant swelling      
&lt;/li&gt;&lt;li&gt; Minimal tenderness of CC ligaments reflecting lack of significant injury
&lt;/li&gt;&lt;li&gt; There may be instability of the distal clavicle in the horizontal plane 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Xray 
&lt;ol&gt;&lt;li&gt; Partial elevation of the distal clavicle w/ no or minimal widening of the CC distance 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Type 3 - AC and CC ligaments torn; complete dislocation of the joint
&lt;ol&gt;&lt;li&gt; Exam
&lt;ol&gt;&lt;li&gt; Deformity of the AC joint is clearly visible
&lt;/li&gt;&lt;li&gt; Marked tenderness of the CC ligaments (helps distinguish Type 3 from type 2)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Xray
&lt;ol&gt;&lt;li&gt; Elevated distal clavicle and increased CC distance
&lt;/li&gt;&lt;li&gt; Distal clavicle is positioned above the plane of the top of the acromion 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Type 4 - Complete dislocation with posterior displacement of distal clavicle into or through the trapezius
&lt;ol&gt;&lt;li&gt; Exam
&lt;ol&gt;&lt;li&gt; Palpable posterior fullness or deformity despite significant swelling
&lt;/li&gt;&lt;li&gt; SC dislocation may be appreciated 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Type 5 - Superior dislocation of the joint of 1-3x the normal spacing
&lt;ol&gt;&lt;li&gt; CC ligament distance is increased 2-3x normal
&lt;/li&gt;&lt;li&gt; Disruption of the deltotrapezial fascia
&lt;/li&gt;&lt;li&gt; Exam
&lt;ol&gt;&lt;li&gt; Shoulder appears to droop
&lt;/li&gt;&lt;li&gt; Severe superior displacement of the clavicle, which may cause tenting, ischemia of skin
&lt;/li&gt;&lt;li&gt; Clavicle is perhced above the muscle and does not reduce when the pt shrugs shoulder
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Xray
&lt;ol&gt;&lt;li&gt; Clavicle is elevated above acromion approximately 1-3x width of the clavicle 
&lt;/li&gt;&lt;li&gt; CC distance is increased two to three times the normal range 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Type 6 -  Complete dislocation with inf. displacement of distal clavicle into a subacromial or subcoracoid position
&lt;ol&gt;&lt;li&gt; Xray
&lt;ol&gt;&lt;li&gt; Complete disruption of the AC and CC ligaments
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Acromioclavicular_Injuries&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Type 1
&lt;ol&gt;&lt;li&gt; Rest, ice, protection with a sling
&lt;/li&gt;&lt;li&gt; ROM and strengthening exercises indicated as soon as tolerated
&lt;/li&gt;&lt;li&gt; Return to sport or work is limited only by pain 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Type 2
&lt;ol&gt;&lt;li&gt; Rest, ice, 3-7 days of immobilization in a sling
&lt;/li&gt;&lt;li&gt; ROM and strenghtnening exercises as soon as tolerated
&lt;/li&gt;&lt;li&gt; Return to sport or work once full ROM and strength are regained
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Type 3
&lt;ol&gt;&lt;li&gt; Rest ice, 2-3 weeks of immobilization in a sling 
&lt;/li&gt;&lt;li&gt; ROM and strengthening exercises indicated as soon as tolerated
&lt;/li&gt;&lt;li&gt;  Return to sport or work 6-12 weeks following injury
&lt;/li&gt;&lt;li&gt; Ortho consultation within 1 week
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Type 4-6
&lt;ol&gt;&lt;li&gt; Require orthopedic evaluation; emergent if neurovascular compromise exists 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Acromioclavicular_Injuries&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;UpToDate
&lt;/p&gt;



</content><folder>Ortho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="acute_alveolar_osteitis_(dry_socket)"><name>Acute Alveolar Osteitis (Dry Socket)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Acute_Alveolar_Osteitis_(Dry_Socket)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Osteomyelitis of the alveolar bone due to premature loss of the healing clot after tooth extraction
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Acute_Alveolar_Osteitis_(Dry_Socket)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;2-4 days after tooth extraction
&lt;/li&gt;&lt;li&gt;Initial post-extraction pain subsides followed by sudden/severe pain at extraction site
&lt;/li&gt;&lt;li&gt;Physical exam often unremarkable
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Acute_Alveolar_Osteitis_(Dry_Socket)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Analgesia
&lt;ol&gt;&lt;li&gt;Often requires dental block
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Irrigate and suction
&lt;/li&gt;&lt;li&gt;Pack with gauze soaked with eugenol or local anesthetic
&lt;/li&gt;&lt;li&gt;Refer to dentist or have pt return to ED in 24-36 hrs to have the gauze replaced
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Acute_Alveolar_Osteitis_(Dry_Socket)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Dental Problems
&lt;/p&gt;&lt;p&gt;Dental Numbers
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Acute_Alveolar_Osteitis_(Dry_Socket)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;EBmedicine: Acute Dental Emergencies in Emergency Medicine
&lt;/p&gt;



</content><folder>ENT</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="acute_angle_glaucoma"><name>Acute Angle Glaucoma</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Acute_Angle_Glaucoma&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt; Diagnosis &lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;IOP &amp;gt;30, usually higher (no definitive cut-off)
&lt;/li&gt;&lt;li&gt;deep conjunctival and episcleral injection in a circumlimbal fashion, ciliary flush, edematous "steamy" cornea, pupil mid-dilated and non-reactive
&lt;/li&gt;&lt;li&gt;shallow anterior chamber
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Acute_Angle_Glaucoma&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Symptoms"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Symptoms"&gt; Symptoms &lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;headache, ocular, facial pain
&lt;/li&gt;&lt;li&gt;nausea/vomiting
&lt;/li&gt;&lt;li&gt;visual acuity change, seeing "halos"
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Acute_Angle_Glaucoma&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt; Treatment &lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; emergent ophthalmic consult
&lt;/li&gt;&lt;li&gt; ocular massage
&lt;/li&gt;&lt;li&gt; IOP &amp;gt; 40mmHg
&lt;ol&gt;&lt;li&gt; immediately treat with timolol 0.5% concentration and/or apraclonidine 1%
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;IOP &amp;lt; 40mmHg: above plus...
&lt;ol&gt;&lt;li&gt; pilocarpine 2% +prednisolone acetate 1% every 15 minutes to abate the attack and reopen the angle
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;IOP &amp;lt; 30mmHg (maintenance):
&lt;ol&gt;&lt;li&gt; timolol (or equivalent) 0.5% BID
&lt;/li&gt;&lt;li&gt; pilocarpine 2% QID
&lt;/li&gt;&lt;li&gt; prednisolone acetate 1% QID
&lt;/li&gt;&lt;li&gt; oral acetazolamide 500mg BID
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;Definitive
- surgical iridectomy
&lt;/p&gt;&lt;p&gt;^Most miotics are ineffective at IOP &amp;gt; 40mmHg due to iris ischemia
&lt;/p&gt;



</content><folder>Ophtho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="acute_chest_syndrome"><name>Acute Chest Syndrome</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#Causes"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;Causes&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Exchange_Transfusion"&gt;&lt;span class="tocnumber"&gt;3.1&lt;/span&gt; &lt;span class="toctext"&gt;Exchange Transfusion&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Complications"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Complications&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-7"&gt;&lt;a href="#Neuro"&gt;&lt;span class="tocnumber"&gt;4.1&lt;/span&gt; &lt;span class="toctext"&gt;Neuro&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Acute_Chest_Syndrome&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Any chest symptoms with a new finding on CXR (however, CXR finding may be delayed)
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt; low grade fever
&lt;/li&gt;&lt;li&gt; chest pain
&lt;/li&gt;&lt;li&gt; cough
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Acute_Chest_Syndrome&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Causes"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Causes"&gt;Causes&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; most common pathogen- C.pneumonia then M.pneumonia and RSV
&lt;/li&gt;&lt;li&gt; cause of acute chest were fat emb, infc and infarction
&lt;/li&gt;&lt;li&gt; xray findings of acute chest occur ~2.5d after admission
&lt;/li&gt;&lt;li&gt; multilobar involvement, esp of lower lobes common
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;DISCUSSION
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt; sx at presentation are age dependent
&lt;ol&gt;&lt;li&gt;age less than 10 were wheeze, cough and fever.
&lt;/li&gt;&lt;li&gt;Age older than 20 is arm/ leg pain and dyspnea
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; pain is prodrome
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;WORRISOME
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt; Dec Hb
&lt;/li&gt;&lt;li&gt; inc WBC x 2
&lt;/li&gt;&lt;li&gt; platelet &amp;lt;200
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Acute_Chest_Syndrome&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; CBC
&lt;/li&gt;&lt;li&gt; retic
&lt;/li&gt;&lt;li&gt; ABG
&lt;/li&gt;&lt;li&gt; BC/sputum cx
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Acute_Chest_Syndrome&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Bonchodilators (even if no wheezing)
&lt;/li&gt;&lt;li&gt; Incentive spirometry
&lt;/li&gt;&lt;li&gt; Empiric ABX (for PNA)
&lt;/li&gt;&lt;li&gt; Pain management (to avoid splinting, hypoventilation, and narcosis)
&lt;/li&gt;&lt;li&gt; O2 only if nec (maintian PaO2 &amp;lt;100)
&lt;/li&gt;&lt;li&gt; IVF for hypovolemia only
&lt;/li&gt;&lt;li&gt; Consider transfusion (Leukocyte depleted blood products!) for
&lt;ol&gt;&lt;li&gt;for heart dz
&lt;/li&gt;&lt;li&gt;severe/worsening anemia
&lt;/li&gt;&lt;li&gt;multilobar PNA
&lt;/li&gt;&lt;li&gt;unresponsive hypoxemia
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Consider exchange transfusion for PaO2 &amp;lt;70 on high O2 + not improving
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Acute_Chest_Syndrome&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Exchange Transfusion"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Exchange_Transfusion"&gt;Exchange Transfusion&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Phlebotomize 500mL
&lt;/li&gt;&lt;li&gt; NS 300mL bolus
&lt;/li&gt;&lt;li&gt; Phlebotimize 500m:
&lt;/li&gt;&lt;li&gt; Infuse 4-5 units PRBC
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Acute_Chest_Syndrome&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Complications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Complications"&gt;Complications&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; older pt more likely to have complications and die
&lt;/li&gt;&lt;li&gt; resp failure predictors: bad xray, thrombocytopenia (&amp;lt;200), h/o cardiac dz
&lt;/li&gt;&lt;li&gt; primary cause of death were resp failure- from PE (bone marrow, fat or thrombotic) and pneumonia
&lt;/li&gt;&lt;li&gt; other causes of death include pulm hem, cor pulm, hypovolemic shock from splenic seq, sepsis, intracranial hem, sz
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Acute_Chest_Syndrome&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Neuro"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Neuro"&gt;Neuro&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; neuro events = ams, neuromusc events, sz, anoxia
&lt;/li&gt;&lt;li&gt; strong relation between acute chest and neuro complications
&lt;/li&gt;&lt;li&gt; RF = low platelets
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Acute_Chest_Syndrome&amp;amp;action=edit&amp;amp;section=8" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Heme: Sickle Cell Crisis
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Acute_Chest_Syndrome&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;8/07 DONALDSON (adapted from Mistry)
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="acute_fever_ddx"><name>Acute Fever Ddx</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Definition"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Definition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#DDX"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;DDX&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Infectious"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;Infectious&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Non-infectious"&gt;&lt;span class="tocnumber"&gt;2.2&lt;/span&gt; &lt;span class="toctext"&gt;Non-infectious&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#DDx_by_Heart_Rate"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;DDx by Heart Rate&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Acute_Fever_Ddx&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Definition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Definition"&gt;Definition&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Defined as Temp &amp;gt;37.8 C (100.4 F)
&lt;/p&gt;&lt;p&gt;&amp;gt;41.0 C (105 F) needs urgent Tx (damage neurons)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Acute_Fever_Ddx&amp;amp;action=edit&amp;amp;section=2" title="Edit section: DDX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX"&gt;DDX&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Acute_Fever_Ddx&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Infectious"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Infectious"&gt;Infectious&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Critical
&lt;ol&gt;&lt;li&gt; Sepsis
&lt;/li&gt;&lt;li&gt; PNA w/ resp failure
&lt;/li&gt;&lt;li&gt; Peritonitis
&lt;/li&gt;&lt;li&gt; Meningitis
&lt;/li&gt;&lt;li&gt; Cavernous sinus thrombosis
&lt;/li&gt;&lt;li&gt; Necrotizing fasciitis
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Emergent
&lt;ol&gt;&lt;li&gt; PNA
&lt;/li&gt;&lt;li&gt; Peritonsillar abscess
&lt;/li&gt;&lt;li&gt; Retropharyngeal abscess
&lt;/li&gt;&lt;li&gt; Epiglottitis
&lt;/li&gt;&lt;li&gt; Endocarditis
&lt;/li&gt;&lt;li&gt; Pericarditis
&lt;/li&gt;&lt;li&gt; Appendicitis
&lt;/li&gt;&lt;li&gt; Cholecystitis
&lt;/li&gt;&lt;li&gt; Diverticulitis
&lt;/li&gt;&lt;li&gt; Intra-abdominal abscess
&lt;/li&gt;&lt;li&gt; Pyelo
&lt;/li&gt;&lt;li&gt; Tubo-ovarian abscess
&lt;/li&gt;&lt;li&gt; Encephalitis
&lt;/li&gt;&lt;li&gt; Brain abscess
&lt;/li&gt;&lt;li&gt; Cellulitis
&lt;/li&gt;&lt;li&gt; Abscess
&lt;/li&gt;&lt;li&gt; Malaria
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Non-emergent
&lt;ol&gt;&lt;li&gt; OM
&lt;/li&gt;&lt;li&gt; Sinusitis
&lt;/li&gt;&lt;li&gt; Pharyngitis
&lt;/li&gt;&lt;li&gt; Influenza
&lt;/li&gt;&lt;li&gt; Tb
&lt;/li&gt;&lt;li&gt; UTI
&lt;/li&gt;&lt;li&gt; Epididymitis
&lt;/li&gt;&lt;li&gt; Prostatitis
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Acute_Fever_Ddx&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Non-infectious"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Non-infectious"&gt;Non-infectious&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Critical
&lt;ol&gt;&lt;li&gt; AMI
&lt;/li&gt;&lt;li&gt; PE
&lt;/li&gt;&lt;li&gt; Intracranial hemorrhage
&lt;/li&gt;&lt;li&gt; CVA
&lt;/li&gt;&lt;li&gt; NMS
&lt;/li&gt;&lt;li&gt; Thyroid storm
&lt;/li&gt;&lt;li&gt; Acute adrenal insufficiency
&lt;/li&gt;&lt;li&gt; Transfusion Rx
&lt;/li&gt;&lt;li&gt; Pulmonary edema
&lt;/li&gt;&lt;li&gt; Heatstroke
&lt;/li&gt;&lt;li&gt; Malignant hyperthermia
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Emergent
&lt;ol&gt;&lt;li&gt; CHF
&lt;/li&gt;&lt;li&gt; Dehydration
&lt;/li&gt;&lt;li&gt; Recent Seizure
&lt;/li&gt;&lt;li&gt; Sickle cell dz
&lt;/li&gt;&lt;li&gt; Transplant rejection
&lt;/li&gt;&lt;li&gt; Pancreatitis
&lt;/li&gt;&lt;li&gt; DVT
&lt;/li&gt;&lt;li&gt; Serotonin Syndrome
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Non-emergent
&lt;ol&gt;&lt;li&gt; Drug fever (except as in NMS, Serotonin syndrome)
&lt;/li&gt;&lt;li&gt; Malignancy
&lt;/li&gt;&lt;li&gt; Gout
&lt;/li&gt;&lt;li&gt; Sarcoidosis
&lt;/li&gt;&lt;li&gt; Crohn's dz
&lt;/li&gt;&lt;li&gt; Postmyocardiotomy sy
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Acute_Fever_Ddx&amp;amp;action=edit&amp;amp;section=5" title="Edit section: DDx by Heart Rate"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx_by_Heart_Rate"&gt;DDx by Heart Rate&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Fever 0.55 C increases HR ~10bts/min
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Relative bradycardia
&lt;ol&gt;&lt;li&gt; Concomitant medication
&lt;/li&gt;&lt;li&gt; Drug fever
&lt;/li&gt;&lt;li&gt; Typhoid
&lt;/li&gt;&lt;li&gt; Brucellosis
&lt;/li&gt;&lt;li&gt; Leptospirosis
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Frank bradycardia
&lt;ol&gt;&lt;li&gt; Rheumatic fever
&lt;/li&gt;&lt;li&gt; Lyme dz
&lt;/li&gt;&lt;li&gt; Viral myocarditis
&lt;/li&gt;&lt;li&gt; Endocarditis
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Acute_Fever_Ddx&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;2/26/06 DONALDSON (adapted from Rosen)
&lt;/p&gt;



</content><folder>ID</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="acute_renal_failure"><name>Acute Renal Failure</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Definitions"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Definitions&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Etiology"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Etiology&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Work-up"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Work-up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Acute_Renal_Failure&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Definitions"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Definitions"&gt;Definitions&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;ARF: Recent (over hours to days) decline in renal function
&lt;/p&gt;&lt;p&gt;Oliguria: UO &amp;lt; 400cc/day
&lt;/p&gt;&lt;p&gt;Anuria: UO &amp;lt; 100cc/day
&lt;/p&gt;&lt;p&gt;Azotemia: Elevation in BUN
&lt;/p&gt;&lt;p&gt;Uremia: Clinical syndrome resulting from the adverse effects of renal failure on other organ systems eg cardiovascular, central nervous, GI, heme, immunologic
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Acute_Renal_Failure&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Etiology"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Etiology"&gt;Etiology&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Prerenal
&lt;ol&gt;&lt;li&gt; BUN/Cr ratio &amp;gt; 20
&lt;/li&gt;&lt;li&gt; FeNa &amp;lt; 1%
&lt;/li&gt;&lt;li&gt; FeUN &amp;lt;35%
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Intrarenal
&lt;ol&gt;&lt;li&gt; FeNa &amp;lt;&amp;gt;1%
&lt;/li&gt;&lt;li&gt; FeUN &amp;gt;50%
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Post-obstructive
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Acute_Renal_Failure&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Work-up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-up"&gt;Work-up&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Urinalysis
&lt;/li&gt;&lt;li&gt;Urine sodium, creatinine, urea (for those on diuretics)
&lt;/li&gt;&lt;li&gt;Foley
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Acute_Renal_Failure&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Admit
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Acute_Renal_Failure&amp;amp;action=edit&amp;amp;section=5" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;FEN: Hyperkalemia
&lt;/p&gt;



</content><folder>GU</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="acute_rheumatic_fever"><name>Acute Rheumatic Fever</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Symptoms"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Symptoms&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Acute_Rheumatic_Fever&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Modified Jones Criteria (1992) for Acute Rheumatic Fever
&lt;/p&gt;&lt;p&gt;REQUIRE: 2 major or 1 major and 2 minor criteria and evidence of previous GAS pharyngitis.
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Major diagnostic criteria
&lt;ol&gt;&lt;li&gt;Carditis
&lt;/li&gt;&lt;li&gt;Polyarthritis
&lt;/li&gt;&lt;li&gt;Chorea
&lt;/li&gt;&lt;li&gt;Subcutaneous nodules
&lt;/li&gt;&lt;li&gt;Erythema marginatum
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Minor diagnostic criteria
&lt;ol&gt;&lt;li&gt;Fever
&lt;/li&gt;&lt;li&gt;Arthralgia
&lt;/li&gt;&lt;li&gt;Prolonged PR interval on ECG
&lt;/li&gt;&lt;li&gt;Elevated acute-phase reactants (APRs), i.e ESR and CRP
&lt;/li&gt;&lt;li&gt;Evidence of previous GAS pharyngitis: 
&lt;/li&gt;&lt;li&gt;Positive throat Cx or rapid strep test or Elevated or rising streptococcal antibody titer
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Acute_Rheumatic_Fever&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Symptoms"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Symptoms"&gt;Symptoms&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Polyarthritis: most common symptom and often earliest (70-75%). Begins in knees and ankles, migrates to other large joints.  Responds to aspirin
&lt;/li&gt;&lt;li&gt;Carditis: Most serious complication and the second most common (50%). The murmurs of acute RF are from valve regurgitation, and the murmurs of chronic RF are from valve stenosis
&lt;/li&gt;&lt;li&gt;Sydenham Chorea: 10-30%. P/W difficulty writing, involuntary grimacing, purposeless movements of the arms and legs, speech impairment, generalized weakness, and emotional lability
&lt;/li&gt;&lt;li&gt;Erythema marginatum: aka erythema annulare, occurs in 5-13%. Erythema marginatum begins as 1- to 3-cm diameter, pink-to-red nonpruritic macules or papules located on the trunk and proximal limbs but never on the face. Spreads outward to form a serpiginous ring with central clearing. Can be accentuated by warm towels/hot bath. Occurs early, remains past the resolution of other sx
&lt;/li&gt;&lt;/ol&gt;
&lt;ul&gt;&lt;li&gt;DDx includes sepsis, drug reactions, and glomerulonephritis. 
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;Subcutaneous nodules: Frequency has declined to 0-8%. Extensor surfaces. Firm, nontender, mobile, seveal millimeters to 1-2 cm.  
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Histo: Like Aschoff bodies observed in the heart. Subcutaneous nodules generallyoccur several weeks into the disease and resolve within a month
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Acute_Rheumatic_Fever&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Eradicate GAS infection
&lt;ol&gt;&lt;li&gt;PCN 0.6 to 1.3 million Units IM x 1 or
&lt;/li&gt;&lt;li&gt;Oral PCN for 10 days or
&lt;/li&gt;&lt;li&gt;Erythromycin if PCN-allergic
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Future prophylaxis
&lt;/li&gt;&lt;li&gt;Treatment of symptoms, e.g. arthritis
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Acute_Rheumatic_Fever&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;7/2/09 PANI
&lt;/p&gt;&lt;p&gt;3/10 Rosen
&lt;/p&gt;&lt;p&gt;Dermatoglyphics in ARF: Axial triradius shows ulnar deviation and +/- proximal placement. (Sanyal, SK, Mukherjee, et al. Am J Dis Child, 1978: 132:692-695.
&lt;/p&gt;



</content><folder>ID</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="acute_vision_loss_(noninflamed)"><name>Acute Vision Loss (Noninflamed)</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Acute_Vision_Loss_(Noninflamed)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis &lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Retinal detachment^
&lt;/li&gt;&lt;li&gt;Central retinal art occlusion^
&lt;/li&gt;&lt;li&gt;Central retinal vein occlusion^
&lt;/li&gt;&lt;li&gt;Arteritic anterior ischemic optic neuropathy
&lt;/li&gt;&lt;li&gt;Vitreous hemorrhage
&lt;/li&gt;&lt;li&gt;High-altitude retinal hemorrhage
&lt;/li&gt;&lt;li&gt;Temporal arteritis^
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;^ Emergent Diagnosis
&lt;/p&gt;&lt;p&gt;^^ Critiacal Diagnosis
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Acute_Vision_Loss_(Noninflamed)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;3/20/06 DONALDSON (adapted from Rosen, WMS Practice Guidelines 2000)
&lt;/p&gt;



</content><folder>Ophtho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="admin_resident_role"><name>Admin Resident Role</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#GENERAL"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;GENERAL&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#RUNNING_THE_ROOM"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;RUNNING THE ROOM&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#PHONE_CALLS.2FCALLBACKS"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;PHONE CALLS/CALLBACKS&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Admin_Resident_Role&amp;amp;action=edit&amp;amp;section=1" title="Edit section: GENERAL"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="GENERAL"&gt;GENERAL&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Always make yourself available to the nursing staff, attending, as they will come to you with questions about patients, if you are going to go grab food, let someone know.
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Admin_Resident_Role&amp;amp;action=edit&amp;amp;section=2" title="Edit section: RUNNING THE ROOM"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="RUNNING_THE_ROOM"&gt;RUNNING THE ROOM&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Make sure everyone in the ED is seen in expediently
&lt;ol&gt;&lt;li&gt; Screen patients---eyeball and maybe write orders as not everyone comes via MSE or may speed pass MSE without orders because they are too sick. Also N.B. patients sent from clinic will have nothing ordered, and on top of that, you will not have screened as those that come via BLS  
&lt;ol&gt;&lt;li&gt; BBN or beds 1-3-- ASAP
&lt;/li&gt;&lt;li&gt; Beds 4-13 or RUSH within about 15 minutes, if possible
&lt;/li&gt;&lt;li&gt; Otherwise within 30-45 minutes
&lt;/li&gt;&lt;li&gt; Possible critical complaints you should also eyeball: low BP, CP, LN (=?stroke), K+, VB +preg, GIB, SB in a monitored bed.
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Assigning patients
&lt;ol&gt;&lt;li&gt; if it's been &amp;gt;30min, try to see the pt yourself OR assign the pt to a co-worker
&lt;/li&gt;&lt;li&gt; DO NOT try to see everyone yourself. You will need to be available to run the board, move pts around, triage the BLS runs
&lt;/li&gt;&lt;li&gt; Don't get stuck in the hallways doing pelvics, or in the suture room doing I&amp;amp;D's and lacs
&lt;/li&gt;&lt;li&gt; BE AWARE of all the Tiers that come and assign someone. Often, the nurses do not tell you directly. Keep your eye on the board and listen for the pager to go off. 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Any trauma patient in Peds needs a senior (you guys for now!) resident for intubations, so again, assign someone.
&lt;/li&gt;&lt;li&gt; Be wary of the intern/med student who has not presented in 1 hour+ -- Actually, as you are busy running the board, it may be easier to take presentations from them, rather than see pt's primarily -- Good trick: assign a student/intern to I&amp;amp;D/lac/easy dispo you have eyeballed 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Opening up beds (esp monitored) 
&lt;ol&gt;&lt;li&gt; One bed in bed 1-3 must be opened at all times
&lt;/li&gt;&lt;li&gt; After you get your long list of "follows" try to eyeball all your admitted patients as this will help you decide if they can be downgraded (you need to confirm with admitting team)
&lt;ol&gt;&lt;li&gt; Tele for r/o ACS patients who have stable vitals, one neg enzyme, and only need to monitor for arrythmias
&lt;/li&gt;&lt;li&gt; neg AFBs x 3 can get off ISO 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; At night Ward Call is in charge of all boarded ED patients
&lt;/li&gt;&lt;li&gt; You can write holding orders for Fam Med or Med patients (not hospitalists), for WARD immediately, for PCU within 30 minutes
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Triaging patients that are BLS runs
&lt;ol&gt;&lt;li&gt; Do a quick H&amp;amp;P/exam, can also get BS, hemeaccu
&lt;/li&gt;&lt;li&gt; Normal vitals, normal MS, non-worrisome complaint, can walk/sit in chair, not heavily intoxicated, not suicidal, no active vomiting can go to triage -- if in doubt, ask an attending
&lt;/li&gt;&lt;li&gt; Tier-0s
&lt;ol&gt;&lt;li&gt; Feel their belly, check MS and extremities, ask if they were knocked out-- if anything is "off" you can make it a delayed Tier-1
&lt;/li&gt;&lt;li&gt; Try to clear c-spine, or at least get them off the backboard
&lt;/li&gt;&lt;li&gt; Can send triage, but if you are feeling nice, and we have spaces open, you may want to keep them
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Try not to get bullied by the charge nurse to send patients out. You know better!
&lt;/li&gt;&lt;li&gt; "Clear to Psych with no medical complaint" needs a quick note on a 254 (the same the medicine residents use) explaining that you have cleared them
&lt;ol&gt;&lt;li&gt; ETOH &amp;lt; 0.2 (use the breathlyzer)
&lt;/li&gt;&lt;li&gt; no history of overdose, and same guidelines as above
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; In general, we aren't really supposed to send out any (MLK) transfers to triage, but in severely overcrowded cases, it's been done, just run it by the attending
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Admin_Resident_Role&amp;amp;action=edit&amp;amp;section=3" title="Edit section: PHONE CALLS/CALLBACKS"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="PHONE_CALLS.2FCALLBACKS"&gt;PHONE CALLS/CALLBACKS&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Abnormal lab callbacks
&lt;ol&gt;&lt;li&gt; Try to locate patient, check if patient is still in the ED (or even in MSE), admitted
&lt;/li&gt;&lt;li&gt; If admitted, tell the tech/rads that they need to call the admitting doctor by calling up to the floor
&lt;/li&gt;&lt;li&gt; Check out what was done for the patients -- EDM -- if not yet in EDM, to find out WHO SAW THE PATIENT and the pt's DISCHARGE DIAGNOSIS--- on regular Affinity, go to the Results scroll down for "chemistry" vs "comprehensive" select "ED Log", a new window pops up that should give you the resident who saw them and their diagnosis
&lt;/li&gt;&lt;li&gt; If pt was sent home and you feel they need to be recontacted look up pt contact info - I do so by using the "affinity clinic work station" as this has a separate "Administrative data" scroll down button with phone number and address. There is supposed to be a Demographics button on the regular affinity too - Call patient or send them a telegram if they are hard to reach
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; ED Discrepancy Folder....... (over reads)
&lt;ol&gt;&lt;li&gt; You are responsible for taking a look at this folder every shift, and clearing 2-3 over-reads
&lt;/li&gt;&lt;li&gt; Open synapse and go to --&amp;gt;Conferences---&amp;gt;ED discrepancy
&lt;/li&gt;&lt;li&gt; If the patient is admitted, then just write that the pt is admitted in the note section
&lt;/li&gt;&lt;li&gt; if not, then it's the same process for pt with abnl labs, depending on the situation you may have to track down the patient and call them/send a telegram
&lt;/li&gt;&lt;li&gt; Again, ask an attdg if you have questions
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Outside clinics, MLK, Hubert-Humphrey transfers
&lt;ol&gt;&lt;li&gt; We generally don't refuse any transfers
&lt;/li&gt;&lt;li&gt; However, if the pt is unstable, they should call 911 and go to the nearest hospital
&lt;/li&gt;&lt;li&gt; Inform the charge nurse that there is someone coming and if they need to be monitored d) You generally cannot triage MLK/HH transfers back out to triage...but if we are severely overcrowded (as above) it's acceptable if the attdg is ok with it
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Harbor Clinic patients
&lt;ol&gt;&lt;li&gt; Again, generally cannot refuse patients
&lt;/li&gt;&lt;li&gt; if they do not need to be monitored bed, they can go to Urgent Care instead
&lt;/li&gt;&lt;li&gt; if they are being admitted, and are otherwise stable (do not need monitor) then they should bypass the ED and go through pt flow coordinator
&lt;/li&gt;&lt;li&gt; When Urgent care closes, pt get sent to the ED
&lt;/li&gt;&lt;li&gt; Again FYI the charge nurse about all incoming patients
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; MAC transfer requests
&lt;ol&gt;&lt;li&gt; Often for "higher level of care"
&lt;/li&gt;&lt;li&gt; Make sure you run the patient by the specialist and admitting team, e.g. multi-trauma pt who needs NSG intervention needs to be accepted by neurosurgery AND trauma
&lt;/li&gt;&lt;li&gt; Good trick: tell MAC to call consultant directly, can then bypass the ED if they have a bed.
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Admin_Resident_Role&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Hsiao 10/09
&lt;/p&gt;



</content><folder>Harbor Admin</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="adrenal_crisis"><name>Adrenal Crisis</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Backgrounds"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Backgrounds&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Clinical_Picture"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;Clinical Picture&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Lab_tests"&gt;&lt;span class="tocnumber"&gt;2.2&lt;/span&gt; &lt;span class="toctext"&gt;Lab tests&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Workup"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Workup&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Adrenal_Crisis&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Backgrounds"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Backgrounds"&gt;Backgrounds&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Major factor precipitating adrenal crisis is mineralocorticoid, not glucocorticoid, deficiency
&lt;ul&gt;&lt;li&gt; Major clinical problem is hypotension
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; Most commonly presents as shock
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Adrenal_Crisis&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Adrenal_Crisis&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Clinical Picture"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Clinical_Picture"&gt;Clinical Picture&lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt; Hypotension
&lt;ul&gt;&lt;li&gt; Refractory to fluids 
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; Volume depletion 
&lt;/li&gt;&lt;li&gt; Abdominal tenderness
&lt;ul&gt;&lt;li&gt; Usually generalized
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; Fever
&lt;ul&gt;&lt;li&gt; Usually caused by infection (source must be identified and treated)
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;ol&gt;&lt;li&gt;fever, hypoTN (refractory to fluids), hyperpigmentation by increased ACTH
&lt;/li&gt;&lt;li&gt;cushingoid look by chronic steroid use
&lt;/li&gt;&lt;li&gt;think about in kids with congenital adrenal hyperplasia (CAH) who present with shock
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Adrenal_Crisis&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Lab tests"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Lab_tests"&gt;Lab tests&lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt; Hyperkalemia
&lt;/li&gt;&lt;li&gt; Hyponatremia
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Adrenal_Crisis&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Workup"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Workup"&gt;Workup&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Chemistry/glucose
&lt;ol&gt;&lt;li&gt; Guides therapy 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Cortisol level
&lt;ol&gt;&lt;li&gt; Confirms diagnosis 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Renin, ACTH
&lt;ol&gt;&lt;li&gt; For evaluating differential diagnosis if cortisol level normal  
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Adrenal_Crisis&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Do not wait for lab results to start treatment
&lt;/li&gt;&lt;li&gt; Fluids
&lt;ol&gt;&lt;li&gt; Infuse 2-3L of NS or D5NS (to correct hypoglycemia)
&lt;/li&gt;&lt;li&gt; Avoid hypotonic fluids (may worsen hyponatremia)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Glucocorticoids
&lt;ol&gt;&lt;li&gt; Patient without previous diagnosis of adrenal insufficiency 
&lt;ol&gt;&lt;li&gt; Dexamethasone 4mg IV bolus is preferred tx
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Patient with known primary adrenal insufficiency w/ potassium &amp;gt; 6
&lt;ol&gt;&lt;li&gt; Hydrocortisone 100mg IV bolus (preferred due to its mineralcorticoid activity)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Mineralocorticoids are not indicated in acute management
&lt;/li&gt;&lt;li&gt; Treat underlying cause 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Adrenal_Crisis&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;7/2/09 PANI (Adapted from Mistry), UpToDate
&lt;/p&gt;



</content><folder>Endo</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="adult_quick_drug_card"><name>Adult Quick Drug Card</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#ACLS"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;ACLS&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Other_Cardiac"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Other Cardiac&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#RSI_.2870kg.29"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;RSI (70kg)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#CNS"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;CNS&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Pressors"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Pressors&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Adult_Quick_Drug_Card&amp;amp;action=edit&amp;amp;section=1" title="Edit section: ACLS"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="ACLS"&gt;ACLS&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Cardioversion 100J, 200J, 300J, 360J (sync)
&lt;/p&gt;&lt;p&gt;Defibrilation 360J, 360J, 360J
&lt;/p&gt;&lt;p&gt;Amiodarone 300 mg IV bolus (arrest); 150 mg over 10 min, then 1mg/min x 6 hrs (perfusing)
&lt;/p&gt;&lt;p&gt;Atropine 0.5-1mg IV [0.02 mg/kg] (max x 3)
&lt;/p&gt;&lt;p&gt;Epi 1mg IV (1:10,000) [0.1 cc/kg] IV/IO
&lt;/p&gt;&lt;p&gt;Lidocaine 100mg IV [1mg/kg]
&lt;/p&gt;&lt;p&gt;Procainamide 20mg/min over 1 hr
&lt;/p&gt;&lt;p&gt;Vasopressin 40 Units IV (once)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Adult_Quick_Drug_Card&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Other Cardiac"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Other_Cardiac"&gt;Other Cardiac&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adenosine 6mg, 12mg, 12mg IVP
&lt;/p&gt;&lt;p&gt;Diltiazem 20mg IV over 2min [0.25mg/kg ], may repeat 25mg after 15min
&lt;/p&gt;&lt;p&gt;Esmolol 500ug/kg (slow load then 50ug/kg/min)
&lt;/p&gt;&lt;p&gt;Magnessium 2gm IVP (4cc of 50% solu) diluted in 10mL D5W
&lt;/p&gt;&lt;p&gt;Metoprolol 5mg IVP Q5min (x 3)
&lt;/p&gt;&lt;p&gt;NTG 10ug/min (titrate up to 200 ug/min, mix 50mg/250cc D5W)
&lt;/p&gt;&lt;p&gt;Nipride 0.5ug/kg/min (titrate up, mix 50mg/250cc D5W)
&lt;/p&gt;&lt;p&gt;Glucagon 1-5 mg IV
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Adult_Quick_Drug_Card&amp;amp;action=edit&amp;amp;section=3" title="Edit section: RSI (70kg)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="RSI_.2870kg.29"&gt;RSI (70kg)&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Etomidate 20mg [0.3 mg/kg]
&lt;/p&gt;&lt;p&gt;Versed 5-10 mg [0.1 mg/kg]
&lt;/p&gt;&lt;p&gt;Propofol 150mg [2-3 mg/kg]
&lt;/p&gt;&lt;p&gt;Succ 100mg [1.5 mg/kg] (if &amp;lt;10 y/o 2.0 mg/kg)
&lt;/p&gt;&lt;p&gt;Roc 70mg [1 mg/kg]
&lt;/p&gt;&lt;p&gt;Vec 7mg [0.1 mg/kg]
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Adult_Quick_Drug_Card&amp;amp;action=edit&amp;amp;section=4" title="Edit section: CNS"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="CNS"&gt;CNS&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Ativan 2-4 mg IV [0.1mg/kgIV/IM]
&lt;/p&gt;&lt;p&gt;Valium [0.2mg/kg IV/IO; 0.5 mg/kg PR]
&lt;/p&gt;&lt;p&gt;Dilantin 1gm over 20 min [20mg/kg IV load, &amp;lt; 50 mg/min]
&lt;/p&gt;&lt;p&gt;Phenobarbital 20mg/kg IV
&lt;/p&gt;&lt;p&gt;Pentobarbital Coma 10mg/kg IV
&lt;/p&gt;&lt;p&gt;Mannitol 25-100 gm over 20 min [0.25-1gm/kg IV]
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Adult_Quick_Drug_Card&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Pressors"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Pressors"&gt;Pressors&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Dopamine 10-20ug/kg/min (mix 400mg in 250 D5W)
&lt;/p&gt;&lt;p&gt;Dobutamine 5-20ug/kg/min (mix 250mg in 250 mg D5W)
&lt;/p&gt;&lt;p&gt;Levophed/NE 5-100ug/min (8mg in 500cc D5W)
&lt;/p&gt;&lt;p&gt;Neosynephrine/phenylephrine 20-100ug/min (20mg in 250 cc D5W)
&lt;/p&gt;&lt;p&gt;Epi 1-20ug/min (1:10,000 mix 1mg in 250 D5W)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Adult_Quick_Drug_Card&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from ACLS, Lampe, Matt Smith, Donaldson
&lt;/p&gt;



</content><folder>Airway/Resus</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="airway_sizes_(peds)"><name>Airway Sizes (Peds)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Airway_Adjuncts"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Airway Adjuncts&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#ETT"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;ETT&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Other_Tubes:"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Other Tubes:&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#ETT_Drug_Delivery"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;ETT Drug Delivery&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Airway_Sizes_(Peds)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Airway Adjuncts"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Airway_Adjuncts"&gt;Airway Adjuncts&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;OP Airway Size:
&lt;/p&gt;&lt;p&gt;from lip/teeth to angle of jaw
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;NP Airway:
&lt;/p&gt;&lt;p&gt;tip of nose to tragus
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;BVM in Kids: 10cc/kg
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Airway_Sizes_(Peds)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: ETT"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="ETT"&gt;ETT&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;ETT Size:
&lt;/p&gt;&lt;p&gt;(Age/4) + 4
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Preemies:
&lt;/p&gt;&lt;p&gt;1kg 2.5mm tube at 7cm depth
&lt;/p&gt;&lt;p&gt;2g 3.0mm tube at 8 cm depth
&lt;/p&gt;&lt;p&gt;3kg  3.5 tube at 9 cm depth
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Cuffed 1/2 size smaller than cuffless
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Depth of Tube Placement: 3 x ETT
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Why uncuffed in kids:
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;because cricoid ring is narrowest portion of the airway...uncuffed up to 6
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Airway_Sizes_(Peds)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Other Tubes:"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Other_Tubes:"&gt;Other Tubes:&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;NG, OG, foley: 2 x ETT
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Chest Tube (max) 4x ETT
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Airway_Sizes_(Peds)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: ETT Drug Delivery"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="ETT_Drug_Delivery"&gt;ETT Drug Delivery&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Endotracheal Drug Delivery: 1:1000 solution @ 0.1 mg/kg = 0.1ml/kg
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Airway_Sizes_(Peds)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from Pani, DeBonis
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="alcohol_withdrawl"><name>Alcohol Withdrawl</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Alcohol_Withdrawl&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; &#65279;Withdrawal symptoms due to reduced GABA pathway and increased glutamate transmission
&lt;/li&gt;&lt;li&gt; Benzos useful d&#65279;ue to cross tolerance at ethanol GABA receptor (&#65279;&#65279;&#65279;&#65279;&#65279;same place carbemazipine and valproate also work
&lt;/li&gt;&lt;li&gt; Symptom Triggered Tx- quantify sx and give meds upon reaching threshold- as effective as fixed dose tx  and needs less drug and get more rapid detox&#65279;&#65279;&#65279;&#65279;&#65279;&#65279;
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Alcohol_Withdrawl&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Sweating, anxiety, tremor, hallucinations, N/V, HA, visual disturbance, disorientation
&lt;/li&gt;&lt;li&gt; A&#65279;lcohol&#65279;&#65279;&#65279;&#65279;&#65279;&#65279; withdrawal &#65279;symptoms peak in 72&#65279; hrs
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Alcohol_Withdrawl&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment &lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Do not need meds for more than 7 days unless have DT's
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
BANANA BAG
&lt;/p&gt;&lt;p&gt;100mg thiamine IV
&lt;/p&gt;&lt;p&gt;1mg folate IV (cheaper PO)
&lt;/p&gt;&lt;p&gt;1 tab MVI IV (cheaper PO)
&lt;/p&gt;&lt;p&gt;2mg magnesium sulfate IV
&lt;/p&gt;&lt;p&gt;1 L NS IV
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Benzodiazapines PRN
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; Valium 5-10mg IV or Ativan 2-4mg IV Q10min until no tremor, then Q1hr)
&lt;/li&gt;&lt;li&gt; Valium quicker to theraputic CNS levels
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
Consider Dilantin in non-classic cases
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Medicationss
&lt;/p&gt;&lt;p&gt;-    benzos- decrease severity of sx, sz, dt
&lt;/p&gt;&lt;p&gt;-    anticonvulsants- same
&lt;/p&gt;&lt;p&gt;-    beta blockers- improve vital signs and reduce craving
&lt;/p&gt;&lt;p&gt;-    alpha agonists- decrease severity of sxs
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Treatment
&lt;/p&gt;&lt;p&gt;-    benzos best of alcohol wd- decrease severity, szs and dt
&lt;/p&gt;&lt;p&gt;-    more abuse if have rapid onset of effect- valium, xanax, ativan,
&lt;/p&gt;&lt;p&gt;-    phenobarb- less abused but poorer safety profile- resp depression
&lt;/p&gt;&lt;p&gt;-    carbemazipine similar to benzos for adverse effects
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Adjuvant Txs- not sole txs but for combination
&lt;/p&gt;&lt;p&gt;-    phenothiazines- reduce signs and sxs but less effective than benzos for sz and dt
&lt;/p&gt;&lt;p&gt;-    beta blockers/ clonidine- no sz protection, not for benzo wd
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Anticonvulsants
&lt;/p&gt;&lt;p&gt;-    dilantin no role
&lt;/p&gt;&lt;p&gt;-    carb- less emotional distress and has anti sz prop too, does not inhibit mem like benzos, less abuse potential
&lt;/p&gt;&lt;p&gt;o    can have dizzy, n/v
&lt;/p&gt;&lt;p&gt;o    not for dts
&lt;/p&gt;&lt;p&gt;o    has fewer protracted sxs than benzos, less relapse, less side effect
&lt;/p&gt;&lt;p&gt;-    carb may be used for benzo wd
&lt;/p&gt;&lt;p&gt;-    valproate- also useful 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Alcohol_Withdrawl&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Admission Criteria
&lt;/p&gt;&lt;p&gt;-status
&lt;/p&gt;&lt;p&gt;-DTs
&lt;/p&gt;&lt;p&gt;-focal/first sz
&lt;/p&gt;&lt;p&gt;-dec loc
&lt;/p&gt;&lt;p&gt;-inability to control wthdl
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Consider D/C with 3 day course if want to quit
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Alcohol_Withdrawl&amp;amp;action=edit&amp;amp;section=5" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;FEN: Beer Potomania Syndrome
&lt;/p&gt;&lt;p&gt;Tox: ETOH Intoxication
&lt;/p&gt;



</content><folder>Tox</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="allergic_reaction"><name>Allergic Reaction</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Allergic_Reaction&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;H1 blocker
&lt;ol&gt;&lt;li&gt;Diphenhydramine 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;H2 blocker
&lt;ol&gt;&lt;li&gt;Famotidine 40/ Cimetidine 300
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Prednisone
&lt;/li&gt;&lt;li&gt;R/O anaphylaxis
&lt;/li&gt;&lt;li&gt;6 units FFP if hereditary angioedema
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Allergic_Reaction&amp;amp;action=edit&amp;amp;section=2" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt; See Also &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Air/Resus: Anaphlaxis
&lt;/p&gt;



</content><folder>Airway/Resus</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="allergic_rx"><name>Allergic Rx</name><content>&lt;ol&gt;&lt;li&gt;REDIRECT &lt;a href="/wiki/Allergic_Reaction" title="Allergic Reaction"&gt;Allergic Reaction&lt;/a&gt;
&lt;/li&gt;&lt;/ol&gt;




</content><folder></folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="altered_mental_status_(ams)"><name>Altered Mental Status (AMS)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Overall_Causes"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Overall Causes&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Workup.2FTreatment"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Workup/Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#DDx_Confusion"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;DDx Confusion&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#DDx_Coma_and..."&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;DDx Coma and...&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#DIFFUSE_CNS_DYSFUNCTION"&gt;&lt;span class="tocnumber"&gt;4.1&lt;/span&gt; &lt;span class="toctext"&gt;DIFFUSE CNS DYSFUNCTION&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-6"&gt;&lt;a href="#FOCAL_CNS_LESION"&gt;&lt;span class="tocnumber"&gt;4.2&lt;/span&gt; &lt;span class="toctext"&gt;FOCAL CNS LESION&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Altered_Mental_Status_(AMS)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Overall Causes"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Overall_Causes"&gt;Overall Causes&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Delirium
&lt;/li&gt;&lt;li&gt; Dementia
&lt;/li&gt;&lt;li&gt; Psych
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Altered_Mental_Status_(AMS)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Workup/Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Workup.2FTreatment"&gt;Workup/Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Check glucose/SaO2 --&amp;gt; correct
&lt;/li&gt;&lt;li&gt; Focal neuro def --&amp;gt; R/O CVA/mass/bleed
&lt;/li&gt;&lt;li&gt; Fever --&amp;gt; positive = find source
&lt;/li&gt;&lt;li&gt; Obvious cause --&amp;gt; positive = pursue
&lt;/li&gt;&lt;li&gt; Non-obvious --&amp;gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;ol&gt;&lt;li&gt;Give thiamine &amp;amp; narcan
&lt;/li&gt;&lt;li&gt;CBC
&lt;/li&gt;&lt;li&gt;Chem 10
&lt;/li&gt;&lt;li&gt;UA
&lt;/li&gt;&lt;li&gt;ECG
&lt;/li&gt;&lt;li&gt;UTox
&lt;/li&gt;&lt;li&gt;CXR
&lt;/li&gt;&lt;li&gt;Head CT
&lt;/li&gt;&lt;li&gt;LFTs
&lt;/li&gt;&lt;li&gt;PT
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;Consider:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;CSF
&lt;/li&gt;&lt;li&gt;ABG
&lt;/li&gt;&lt;li&gt;TSH
&lt;/li&gt;&lt;li&gt;EEG
&lt;/li&gt;&lt;li&gt;ASA/Tylenol levels
&lt;/li&gt;&lt;li&gt;Ammonia
&lt;/li&gt;&lt;li&gt;HIV
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Altered_Mental_Status_(AMS)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: DDx Confusion"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx_Confusion"&gt;DDx Confusion&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Hypoxia/diffuse ischemia
&lt;ol&gt;&lt;li&gt; Respiratory failure
&lt;/li&gt;&lt;li&gt; CHF
&lt;/li&gt;&lt;li&gt; MI
&lt;/li&gt;&lt;li&gt; Severe anemia
&lt;/li&gt;&lt;li&gt; Shock
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Systemic
&lt;ol&gt;&lt;li&gt; Hypoglycemia
&lt;/li&gt;&lt;li&gt; Electrolyte/fluid disturbance
&lt;/li&gt;&lt;li&gt; Endocrine dz
&lt;ol&gt;&lt;li&gt; Thyroid
&lt;/li&gt;&lt;li&gt; Adrenal
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Hepatic failure (ammonia)
&lt;/li&gt;&lt;li&gt; Wernicke's
&lt;/li&gt;&lt;li&gt; Infection/sepsis
&lt;ol&gt;&lt;li&gt; Urine
&lt;/li&gt;&lt;li&gt; PNA
&lt;/li&gt;&lt;li&gt; Other
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; CNS Disease
&lt;ol&gt;&lt;li&gt; Infection
&lt;/li&gt;&lt;li&gt; Trauma
&lt;/li&gt;&lt;li&gt; CVA/TIA
&lt;/li&gt;&lt;li&gt; SAH
&lt;/li&gt;&lt;li&gt; Seizure
&lt;ol&gt;&lt;li&gt; Postictal
&lt;/li&gt;&lt;li&gt; Nonconvulsive
&lt;/li&gt;&lt;li&gt; Complex partial
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Hypertensive encephalopathy
&lt;/li&gt;&lt;li&gt; Increased ICP
&lt;/li&gt;&lt;li&gt; Toxins/withdrawal
&lt;ol&gt;&lt;li&gt; Sedatives
&lt;/li&gt;&lt;li&gt; ETOH
&lt;/li&gt;&lt;li&gt; Anticholinergics
&lt;/li&gt;&lt;li&gt; Other
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Neoplasm
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Altered_Mental_Status_(AMS)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: DDx Coma and..."&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx_Coma_and..."&gt;DDx Coma and...&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Altered_Mental_Status_(AMS)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: DIFFUSE CNS DYSFUNCTION"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DIFFUSE_CNS_DYSFUNCTION"&gt;DIFFUSE CNS DYSFUNCTION&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Diffuse Neuronal Deprivation
&lt;ol&gt;&lt;li&gt; Hypoglycemia
&lt;/li&gt;&lt;li&gt; Hypoxia (with nl Cerebral Blood Flow (CBF))
&lt;ol&gt;&lt;li&gt; Respiratory failure
&lt;ol&gt;&lt;li&gt; CHF
&lt;/li&gt;&lt;li&gt; PNA
&lt;/li&gt;&lt;li&gt; Obstructive
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Severe anemia
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Decreased CBF
&lt;ol&gt;&lt;li&gt; Shock
&lt;ol&gt;&lt;li&gt; AMI
&lt;/li&gt;&lt;li&gt; Hypovolemia
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Post arrest
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Cellular Toxin
&lt;ol&gt;&lt;li&gt; CO
&lt;/li&gt;&lt;li&gt; Cyanide
&lt;/li&gt;&lt;li&gt; Hydrogen sulfide
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Thiamine deficiency (Wernicke-Korsakoff)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Endogenous CNS Toxins
&lt;ol&gt;&lt;li&gt; Hyperammonemia (hepatic coma)
&lt;/li&gt;&lt;li&gt; Uremia (renal failure)
&lt;/li&gt;&lt;li&gt; CO2 Narcosis
&lt;/li&gt;&lt;li&gt; Hyperglycemia
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Exogenous CNS Toxins
&lt;ol&gt;&lt;li&gt; Alcohols
&lt;ol&gt;&lt;li&gt; ETOH
&lt;/li&gt;&lt;li&gt; Isopropyl
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Acids
&lt;ol&gt;&lt;li&gt; Methanol
&lt;/li&gt;&lt;li&gt; Ethylene glycol
&lt;/li&gt;&lt;li&gt; Salicylate
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Sedatives
&lt;/li&gt;&lt;li&gt; Narcotics
&lt;/li&gt;&lt;li&gt; Anticonvulsants
&lt;/li&gt;&lt;li&gt; Psychotropics
&lt;/li&gt;&lt;li&gt; Isoniazid
&lt;/li&gt;&lt;li&gt; Heavy metals
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Endocrine disorders
&lt;ol&gt;&lt;li&gt; Myxedema coma
&lt;/li&gt;&lt;li&gt; Thyrotoxicosis
&lt;/li&gt;&lt;li&gt; Addison's
&lt;/li&gt;&lt;li&gt; Cushing's
&lt;/li&gt;&lt;li&gt; Pheochromocytoma
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Ionic abnormalities
&lt;ol&gt;&lt;li&gt; Hypo/hyper-natremia
&lt;/li&gt;&lt;li&gt; Hypo/hyper-calcemia
&lt;/li&gt;&lt;li&gt; Hypo/hyper-magnesemia
&lt;/li&gt;&lt;li&gt; Hypophosphatemia
&lt;/li&gt;&lt;li&gt; Acidosis/alkalosis
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Temperature abnormalities
&lt;ol&gt;&lt;li&gt; Hypothermia
&lt;/li&gt;&lt;li&gt; Heat stroke
&lt;/li&gt;&lt;li&gt; NMS
&lt;/li&gt;&lt;li&gt; Malignant hyperthermia
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Intracranial HTN
&lt;ol&gt;&lt;li&gt; Hypertensive encephalopathy
&lt;/li&gt;&lt;li&gt; Pseudotumor cerebri
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; CNS inflammation/infection
&lt;ol&gt;&lt;li&gt; Meningitis
&lt;/li&gt;&lt;li&gt; Encephalitis
&lt;/li&gt;&lt;li&gt; Cerebral vasculitis
&lt;/li&gt;&lt;li&gt; SAH
&lt;/li&gt;&lt;li&gt; Carcinoid meningitis
&lt;/li&gt;&lt;li&gt; Traumatic axonal shear
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Primay neuronal/glial
&lt;ol&gt;&lt;li&gt; CJD
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Seizure/postical
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Altered_Mental_Status_(AMS)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: FOCAL CNS LESION"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="FOCAL_CNS_LESION"&gt;FOCAL CNS LESION&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Supratentorial
&lt;ol&gt;&lt;li&gt; Hemorrhage
&lt;ol&gt;&lt;li&gt; Intracerebral
&lt;/li&gt;&lt;li&gt; Epidural
&lt;/li&gt;&lt;li&gt; Subdural
&lt;/li&gt;&lt;li&gt; Pituitary apoplexy
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Infarction
&lt;ol&gt;&lt;li&gt; Thrombotic arterial
&lt;/li&gt;&lt;li&gt; Embolic arterial
&lt;/li&gt;&lt;li&gt; Venous
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Tumors
&lt;/li&gt;&lt;li&gt; Abscess
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Infratentorial
&lt;ol&gt;&lt;li&gt; Compressive
&lt;ol&gt;&lt;li&gt; Cerebellar hemorrhage
&lt;/li&gt;&lt;li&gt; Post fossa sub/extra-dural
&lt;/li&gt;&lt;li&gt; Cerebellar infarct
&lt;/li&gt;&lt;li&gt; Cerebellar tumor
&lt;/li&gt;&lt;li&gt; Cerebellar abscess
&lt;/li&gt;&lt;li&gt; Basilar aneurysm
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Destructive
&lt;ol&gt;&lt;li&gt; Pontine hemorrhage
&lt;/li&gt;&lt;li&gt; Brainstem infarct
&lt;/li&gt;&lt;li&gt; Basilar migraine
&lt;/li&gt;&lt;li&gt; Brainstem demyelination
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Altered_Mental_Status_(AMS)&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;2/27/06 DONALDSON (adapted from Rosen)
&lt;/p&gt;



</content><folder>Neuro</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="amniotic_fluid_embolus"><name>Amniotic Fluid Embolus</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Amniotic_Fluid_Embolus&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Pathophysiology"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Pathophysiology"&gt;Pathophysiology&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; release of amn fluid to maternal vessels during intense ut contractions or manipulation or at areas of placental separation.
&lt;/li&gt;&lt;li&gt; most common during labor
&lt;/li&gt;&lt;li&gt; leading cause of death during induced abortions
&lt;/li&gt;&lt;li&gt; can also be spontaneous or blunt trauma with abruption
&lt;/li&gt;&lt;li&gt; also post amniocentesis
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Amniotic_Fluid_Embolus&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; 2 or 3 trimester
&lt;/li&gt;&lt;li&gt; ut contraction or manipulation
&lt;/li&gt;&lt;li&gt; sudden hypotension, hypoxia, or coagulopathy
&lt;/li&gt;&lt;li&gt; triggers immunological response
&lt;/li&gt;&lt;li&gt; death by vasospasm, release of vasoactive substances, mechanical plugging of mat pulm vasc tree
&lt;/li&gt;&lt;li&gt; get ARDS and L vent dysfnctn
&lt;/li&gt;&lt;li&gt; fetal hair, squamous epithelial cells and debris in mat circulation
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Amniotic_Fluid_Embolus&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;7/09 PANI
&lt;/p&gt;



</content><folder>OB/GYN</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="amphetamines"><name>Amphetamines</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Theraputic_Uses"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Theraputic Uses&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Types"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Types&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Amphetamines&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Actions
&lt;/p&gt;&lt;p&gt;- central action- increase release &amp;amp; decrease reuptak of dopamine &amp;amp; seratonin. Leads to euphoria &amp;amp; strength
&lt;/p&gt;&lt;p&gt;- perif action- facilitate synaptic
&lt;/p&gt;&lt;p&gt;xmission @ spinal cord by unknown mech
&lt;/p&gt;&lt;p&gt;- also cause release of norepi- leads to alpha &amp;amp; beta stim
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Amphetamines&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Alpha
&lt;/p&gt;&lt;p&gt;- pupils dilate
&lt;/p&gt;&lt;p&gt;- sweat
&lt;/p&gt;&lt;p&gt;- decrease gi peristalsis
&lt;/p&gt;&lt;p&gt;- constrict blood vessels
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Beta
&lt;/p&gt;&lt;p&gt;- inc HR and contractility
&lt;/p&gt;&lt;p&gt;- dilate bronchi
&lt;/p&gt;&lt;p&gt;- dilate muscle beds
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Mixed
&lt;/p&gt;&lt;p&gt;- delusions, paranoia, aggression, poor judgement, hallucinate, confusion
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Amphetamines&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Benzos
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Amphetamines&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Theraputic Uses"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Theraputic_Uses"&gt;Theraputic Uses&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- appetite suppression
&lt;/p&gt;&lt;p&gt;- inc alertness
&lt;/p&gt;&lt;p&gt;- narcolepsy
&lt;/p&gt;&lt;p&gt;- adhd
&lt;/p&gt;&lt;p&gt;- inc mood
&lt;/p&gt;&lt;p&gt;- avoid boredom on repetitive task jobs
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Amphetamines&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Types"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Types"&gt;Types&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;GENERAL
&lt;/p&gt;&lt;p&gt;- Time- oral- 30min, inhaled instant
&lt;/p&gt;&lt;p&gt;- hepatic and renal excretion- lasts 6- 24 hrs
&lt;/p&gt;&lt;p&gt;- if tolerance developes- physical exam may yield normal findings
&lt;/p&gt;&lt;p&gt;- desipramine and amantadine can give false positive for urine amphet test
&lt;/p&gt;&lt;p&gt;- hallucinogenic amphet deriv may not show up on tox screen
&lt;/p&gt;&lt;p&gt;AKA Entactogens- enabling user to touch within.
&lt;/p&gt;&lt;p&gt;Hallucinogenic amphet are methoxylated or methylene dioxylated
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;METH AMPHET
&lt;/p&gt;&lt;p&gt;- more combative- delusions of parasites- formication\ self mutilate
&lt;/p&gt;&lt;p&gt;- more dysphoric
&lt;/p&gt;&lt;p&gt;- AKA ice crystal speed go crank
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;MDMA ECSTACY
&lt;/p&gt;&lt;p&gt;- changes 5HT neuroxmitter
&lt;/p&gt;&lt;p&gt;- inc dopamine
&lt;/p&gt;&lt;p&gt;- lasts 3 - 5hrs
&lt;/p&gt;&lt;p&gt;- usual dose for psychgTx- 50 - 200mg
&lt;/p&gt;&lt;p&gt;- cardiac effects
&lt;/p&gt;&lt;p&gt;- euphoria- interpersonal clgseness- introspection
&lt;/p&gt;&lt;p&gt;- enhanced socialibility (rave)
&lt;/p&gt;&lt;p&gt;- deep empathy
&lt;/p&gt;&lt;p&gt;- severe withdrawal with anxiety and depression
&lt;/p&gt;&lt;p&gt;- tolerance developes to positve and neg effects with inc use
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Amphetamines&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;MISTRY 6/06
&lt;/p&gt;



</content><folder>Tox</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="amputation"><name>Amputation</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Indications_for_Replantation"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Indications for Replantation&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Contraindications"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Contraindications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Warm_Ischemia"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Warm Ischemia&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Cold_Ischemia"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Cold Ischemia&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Amputation&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Indications for Replantation"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Indications_for_Replantation"&gt;Indications for Replantation&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Thumb
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Multiple digits
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Amputation level between palm and distal forearm
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Distal to FDS insertion
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Amputations in healthy children
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Amputation&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Contraindications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Contraindications"&gt;Contraindications&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Severely crushed or mangled parts
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Prolonged warm ischemia time
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Single digit
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Severe contamination
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Age &amp;gt;60, poor health, atherosclerotic disease
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Avulsion injury
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Lower extremity amputations
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Amputation&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Warm Ischemia"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Warm_Ischemia"&gt;Warm Ischemia&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;12 hours for digit; 6 hours for muscle bearing extremity
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Amputation&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Cold Ischemia"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Cold_Ischemia"&gt;Cold Ischemia&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;24 hours for digit; 12 hours for a muscle bearing extremity
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Amputation&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Irrigate amputated part
&lt;/li&gt;&lt;li&gt;Place moist, sterile gauze around amputated part
&lt;/li&gt;&lt;li&gt;Place in water tight container in ice water
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Xray limb and part
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Tdap
&lt;/li&gt;&lt;li&gt;Abx ppx
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Consult surgery
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Amputation&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;DeBonis 7/09 Adapted Burbulys
&lt;/p&gt;



</content><folder>Trauma</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="anaphylaxis"><name>Anaphylaxis</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Definition"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Definition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#DDX"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;DDX&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Presentation"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Presentation&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Course"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Course&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Sources"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Sources&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Anaphylaxis&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Definition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Definition"&gt;Definition&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Highly likely when ANY ONE of the following criteria is fulfilled:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Criterion 1 (90% of pts)
&lt;ol&gt;&lt;li&gt;Acute onset of an illness involving the skin, mucosal tissue, or both AND at least one of the following:
&lt;ol&gt;&lt;li&gt;Respiratory compromise
&lt;/li&gt;&lt;li&gt;Reduced BP or associated symptoms (syncope, dizziness)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Criterion 2 (10-20% of pts)
&lt;ol&gt;&lt;li&gt;TWO OR MORE of the following that that occur rapidly after exposure to a LIKELY allergen for that pt
&lt;ol&gt;&lt;li&gt;Involvement of the skin-mucosal tissue (hives, swollen lips-tongue-uvula)
&lt;/li&gt;&lt;li&gt;Respiratory compromise
&lt;/li&gt;&lt;li&gt;Reduced BP or associated symptoms 
&lt;/li&gt;&lt;li&gt;Persistent GI symptoms (vomiting, diarrhea, crampy abd pain)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Criterion 3
&lt;ol&gt;&lt;li&gt;Reduced BP after exposure to a KNOWN allergy for that pt (minutes to hours):
&lt;ol&gt;&lt;li&gt;Adults
&lt;ol&gt;&lt;li&gt;Systolic &amp;lt; 90 or &amp;gt; 30% from baseline
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Peds
&lt;ol&gt;&lt;li&gt;Less than 70 mmHg from 1 month up to 1 year
&lt;/li&gt;&lt;li&gt;Less than (70 mmHg + [2 x age]) from 1 to 10 years
&lt;/li&gt;&lt;li&gt;Less than 90 mmHg from 11 to 17 years
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Anaphylaxis&amp;amp;action=edit&amp;amp;section=2" title="Edit section: DDX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX"&gt;DDX&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Generalized urticaria
&lt;/li&gt;&lt;li&gt;Angioedema
&lt;/li&gt;&lt;li&gt;Asthma exacerbation
&lt;/li&gt;&lt;li&gt;Anxiety attack
&lt;/li&gt;&lt;li&gt;MI
&lt;/li&gt;&lt;li&gt;Scombroidosis 
&lt;/li&gt;&lt;li&gt;Other forms of shock
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Anaphylaxis&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Presentation"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Presentation"&gt;Presentation&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Cutaneous symptoms - 90%
&lt;/li&gt;&lt;li&gt; Respiratory symptoms - 70%
&lt;/li&gt;&lt;li&gt; GI symptoms - 40%
&lt;/li&gt;&lt;li&gt; Cardiovascular symptoms - 35%
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Anaphylaxis&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Epinephrine 1:1000 &lt;b&gt;IM&lt;/b&gt; 0.3-0.5mg (0.3-0.5mL) Q5-15min 
&lt;ol&gt;&lt;li&gt;Always IM initially 
&lt;/li&gt;&lt;li&gt;Start epinephrine infusion 1:10,000 2-10&#181;g/min if inadequate response to IM
&lt;/li&gt;&lt;li&gt;Peds
&lt;ol&gt;&lt;li&gt;IM - 0.01mg/kg/dose (max 0.5mg)
&lt;/li&gt;&lt;li&gt;IV infusion - 0.05-1 mcg/kg/min
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Oxygen
&lt;/li&gt;&lt;li&gt;NS bolus
&lt;ol&gt;&lt;li&gt;If unresponsive to Epi must assume pt to be severely intravascularly depleted 
&lt;/li&gt;&lt;li&gt;Supine positioning 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Glucagon 1-2mg IV over 5 min, followed by infusion of 5-15&#181;g/min (if on B-blocker AND unresponsive to epi) 
&lt;/li&gt;&lt;li&gt;Also consider:
&lt;ol&gt;&lt;li&gt;Albuterol: For bronchospasm resistant to IM epinephrine
&lt;/li&gt;&lt;li&gt;Antihistamines
&lt;ol&gt;&lt;li&gt;Only for sympton control (hives, itching) AFTER hemodynamically stable
&lt;ol&gt;&lt;li&gt;Diphenhydramine 25 to 50 mg IV
&lt;/li&gt;&lt;li&gt;Ranitidine 50 mg IV (minimal evidence to support this)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Glucocorticoid: May blunt biphasic reaction
&lt;ol&gt;&lt;li&gt;Methylprednisolone 125 mg IV
&lt;/li&gt;&lt;li&gt;Three day PO course (biphasic reaction always occurs within 72hrs)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Anaphylaxis&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Course"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Course"&gt;Course&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Uniphasic (80-90%)
&lt;ol&gt;&lt;li&gt;Symptoms peak within 30min-1hr after onset, resolves within 30min-1hr of receiving Tx
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Biphasic (10-20%)
&lt;ol&gt;&lt;li&gt;Uniphasic response, followed by asymptomatic period of hour or more, then return of symptoms
&lt;/li&gt;&lt;li&gt;The second phase does not necessarily resemble the first!
&lt;/li&gt;&lt;li&gt;Possible risk factors
&lt;ol&gt;&lt;li&gt;Severe initial symptoms
&lt;/li&gt;&lt;li&gt;Late administration of epi
&lt;/li&gt;&lt;li&gt;Delayed resolution of initial symptoms 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Little evidence that glucocorticoids blunt a biphasic presentation 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Protracted (case reports)
&lt;/li&gt;&lt;li&gt;Lasts hours to days without resolving completely 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Anaphylaxis&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Admit: Severe and moderate (especially if symptoms did not respond promptly to epi)
&lt;/li&gt;&lt;li&gt;Home: Anaphylaxis that responded promptly after ED observation
&lt;ol&gt;&lt;li&gt;Send home with an epi autoinjector!
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Anaphylaxis&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Sources"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Sources"&gt;Sources&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Tintinalli 
&lt;/li&gt;&lt;li&gt; Brown SGA, Mullins RJ and Gold MS, Anaphylaxis: diagnosis and management, MJA 2006; 185: 283&#8211;289  
&lt;/li&gt;&lt;li&gt; Ewan PW, ABC of allergies &#8211; Anaphylaxis, BMJ 1998; 316: 1442-1445 
&lt;/li&gt;&lt;li&gt; Simons FER, Gu X, Simons KJ, Epinephrine absorption in adults: Intramuscular versus subcutaneous injection, J Allergy Clin Immunol 2001;108:871-3 
&lt;/li&gt;&lt;li&gt; Lieberman P et al, The diagnosis and management of anaphyalxis: An updated practice parameter, J Allergy Clin Immunol 2005;115;3:S483-S523 
&lt;/li&gt;&lt;li&gt; Sheikh A, Shehata YA, Brown SGA, Simons FER. Adrenaline (epinephrine) for the treatment of anaphylaxis with and without shock.Cochrane Database of Systematic Reviews2008, Issue 4. Art. No.: CD006312. DOI:10.1002/14651858.CD006312.pub2.
&lt;/li&gt;&lt;li&gt; Second symposium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium.
&lt;/li&gt;&lt;/ul&gt;




</content><folder>Airway/Resus</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="anemia_(ddx)"><name>Anemia (DDx)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Iron_Deficiency.2FMicrocytic"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Iron Deficiency/Microcytic&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Anemia_of_Chronic_Dz"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Anemia of Chronic Dz&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Normocytic_Anemia"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Normocytic Anemia&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Macrocytic_Anemia"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Macrocytic Anemia&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Pernicious_Anemia"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Pernicious Anemia&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Anemia_(DDx)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Iron Deficiency/Microcytic"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Iron_Deficiency.2FMicrocytic"&gt;Iron Deficiency/Microcytic&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; increased RDW
&lt;/li&gt;&lt;li&gt; microcytic- MCV &amp;lt; 70
&lt;/li&gt;&lt;li&gt; elevated serum transferrin- is iron binding protein
&lt;/li&gt;&lt;li&gt; dietary or chronic blood loss
&lt;/li&gt;&lt;li&gt; low serum ferritn lvl- is bound iron
&lt;/li&gt;&lt;li&gt; if microcytic but c normal or high ferritin, check serum iron lvl. If iron lvl low- is anemia of chronic dz. If iron lvl is nl/ high, check serum lead lvl. If lead lvl high- if lead toxicity c basophilic stippling. If lead lvl normal- do hb electrophoresis to check for thalassemia- will have nl RDW.
&lt;/li&gt;&lt;li&gt; tx c po iron- absorbed in stomach so no enteric coated tabs. Poor absrobtion if on antacids, H2 blckrs, caffeine
&lt;/li&gt;&lt;li&gt; if no response to po Fe, give IV
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Anemia_(DDx)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Anemia of Chronic Dz"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Anemia_of_Chronic_Dz"&gt;Anemia of Chronic Dz&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; normal serum transferrin
&lt;/li&gt;&lt;li&gt; can be microcytic
&lt;/li&gt;&lt;li&gt; tx c epo
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Anemia_(DDx)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Normocytic Anemia"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Normocytic_Anemia"&gt;Normocytic Anemia&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; do corrected retic count=
&lt;/li&gt;&lt;li&gt;retic cnt X hct/45
&lt;ol&gt;&lt;li&gt; if retic cnt low or nl- eval for bone marrow failure or anemia of chronic dz.
&lt;/li&gt;&lt;li&gt; if retic cnt high, eval for hypersplenism or hemolysis- will have increased indirect bili and LDH
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Anemia_(DDx)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Macrocytic Anemia"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Macrocytic_Anemia"&gt;Macrocytic Anemia&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; mcv &amp;gt; 100
&lt;/li&gt;&lt;li&gt; megaloblastic- b12 or folate. Has glossitis, gi sxs, leuko/ thrombocytopenia
&lt;/li&gt;&lt;li&gt; b12 def also c neuro sxs. usually failure to absorb- pernicious, crohns, drugs, ilieal resection
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Anemia_(DDx)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Pernicious Anemia"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Pernicious_Anemia"&gt;Pernicious Anemia&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; megaloblastic, b12 def, by intestinal malabsorbtion due atrophy of gastric mucosa and decreaed secretion of intrinsic factor.
&lt;/li&gt;&lt;li&gt; dx by Schilling's test- fail to absorb radiolabelled b12 initially, then absorbed if repeat c coadministered intrinsic factor.
&lt;/li&gt;&lt;li&gt; tx c im b12
&lt;/li&gt;&lt;li&gt; eval for gastric CA c endoscopy
&lt;/li&gt;&lt;/ol&gt;




</content><folder>Heme/Onc</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="anemia_(gen)"><name>Anemia (Gen)</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Anemia_(Gen)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Hb &amp;lt;6 --&amp;gt; almost always transfuse
&lt;/p&gt;&lt;p&gt;Hb &amp;gt;10 --&amp;gt; almost never transfuse
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Anemia_(Gen)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: DDX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX"&gt;DDX &lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Hemorrhage
&lt;/li&gt;&lt;li&gt; Destruction (hemolytic)
&lt;ol&gt;&lt;li&gt; Hereditary
&lt;/li&gt;&lt;li&gt; Acquired
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Impaired Production
&lt;ol&gt;&lt;li&gt; Hypochromic (microcytic)
&lt;ol&gt;&lt;li&gt;Fe deff, chronic disease, thalassemias, sideroblastic
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Aplastic/myelodysplastic (normocytic)
&lt;ol&gt;&lt;li&gt;marrow failure, chemicals (ETOH), radiation, infection (HIV, parvo), RF
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Megaloblastic (macrocytic)
&lt;ol&gt;&lt;li&gt;vit B12/folate def, drugs (chemo), HIV
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Anemia_(Gen)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1/26/06 DONALDSON (adapted from Tintinalli's)
&lt;/p&gt;



</content><folder>Heme/Onc</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="angina_class_(canadian)"><name>Angina Class (Canadian)</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Angina_Class_(Canadian)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Classes (Canadian Cardiovascular Society Classification)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Classes_.28Canadian_Cardiovascular_Society_Classification.29"&gt;Classes (Canadian Cardiovascular Society Classification)&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;I. Sx w/ prolonged exertion
&lt;/p&gt;&lt;p&gt;II. Sx walking &amp;gt;2 blocks
&lt;/p&gt;&lt;p&gt;III. Sx walking &amp;lt;2 blocks
&lt;/p&gt;&lt;p&gt;IV. Sx with minimal activity or at rest
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="anion_gap_(high)"><name>Anion Gap (High)</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Anion_Gap_(High)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;TOXICOLOGICAL
&lt;/p&gt;&lt;p&gt;methanol
&lt;/p&gt;&lt;p&gt;ethanol glycol
&lt;/p&gt;&lt;p&gt;salicylates
&lt;/p&gt;&lt;p&gt;iron
&lt;/p&gt;&lt;p&gt;inh
&lt;/p&gt;&lt;p&gt;paraldehyde
&lt;/p&gt;&lt;p&gt;alcoholic ketoacidosis
&lt;/p&gt;&lt;p&gt;inhalants- CN, CO, H2S
&lt;/p&gt;&lt;p&gt;toluene
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;NONTOX
&lt;/p&gt;&lt;p&gt;lactic acidosis
&lt;/p&gt;&lt;p&gt;dm ketoacidosis
&lt;/p&gt;&lt;p&gt;uremia
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;MUDPILES
&lt;/p&gt;&lt;p&gt;M- methanol
&lt;/p&gt;&lt;p&gt;U- uremia
&lt;/p&gt;&lt;p&gt;D- dka
&lt;/p&gt;&lt;p&gt;P- paraldehyde
&lt;/p&gt;&lt;p&gt;I- iron. inh
&lt;/p&gt;&lt;p&gt;L- lactic acidosis
&lt;/p&gt;&lt;p&gt;E- ethylene glycol
&lt;/p&gt;&lt;p&gt;S- salicylates
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Anion_Gap_(High)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;MISTRY 6/06
&lt;/p&gt;



</content><folder>Tox</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="anion_gap_(low)"><name>Anion Gap (Low)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#DDX"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;DDX&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Anion_Gap_(Low)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;&amp;lt; 7 meq/L
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Anion_Gap_(Low)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: DDX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX"&gt;DDX&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1) Lab error
&lt;/p&gt;&lt;p&gt;2) Decreased "unmeasured" anions
&lt;/p&gt;
&lt;pre&gt;    a) hypoalbuminemia*
&lt;/pre&gt;
&lt;p&gt;3) Increased "unmeasured" cations
&lt;/p&gt;
&lt;pre&gt;    a) hyperkalemia
&lt;/pre&gt;
&lt;pre&gt;    b) hypercalcemia
&lt;/pre&gt;
&lt;pre&gt;    c) hypermagnesemia
&lt;/pre&gt;
&lt;pre&gt;    d) lithium intoxication
&lt;/pre&gt;
&lt;p&gt;4) increased cationic paraprotein
&lt;/p&gt;
&lt;pre&gt;    a) multiple myeloma (do a serum protein electrophoresis to w/o)
&lt;/pre&gt;
&lt;pre&gt;    b) polyclonal IgG gammopathy.
&lt;/pre&gt;
&lt;p&gt;5)  Pseudo
&lt;/p&gt;
&lt;pre&gt;    a) severe hypernatremia (&amp;gt;170 meq/L)
&lt;/pre&gt;
&lt;pre&gt;         -true concentration of sodium is underestimated
&lt;/pre&gt;
&lt;pre&gt;    b) marked hyperlipidemia (marked overestimation of the plasma chloride concentration)
&lt;/pre&gt;
&lt;pre&gt;    c) bromide intoxication (e.g. for myasthenia gravis and some herbal medications)
&lt;/pre&gt;
&lt;ul&gt;&lt;li&gt;AG falls by about 2.5 meq/L for every 1 g/dL (10 g/L) reduction in the plasma albumin concentration
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Anion_Gap_(Low)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: "&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id=""&gt; &lt;/span&gt;&lt;/h2&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Anion_Gap_(Low)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Kaji Questions
&lt;/p&gt;



</content><folder>Tox</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="anion_gap_and_osmolar_gap_(high)"><name>Anion Gap and Osmolar Gap (High)</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Anion_Gap_and_Osmolar_Gap_(High)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;TOXICOLOGICAL
&lt;/p&gt;&lt;p&gt;methanol
&lt;/p&gt;&lt;p&gt;ethanol glycol
&lt;/p&gt;&lt;p&gt;salicylates
&lt;/p&gt;&lt;p&gt;iron
&lt;/p&gt;&lt;p&gt;inh
&lt;/p&gt;&lt;p&gt;paraldehyde
&lt;/p&gt;&lt;p&gt;alcoholic ketoacidosis
&lt;/p&gt;&lt;p&gt;inhalants- CN, CO, H2S
&lt;/p&gt;&lt;p&gt;toluene
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;NONTOX
&lt;/p&gt;&lt;p&gt;lactic acidosis
&lt;/p&gt;&lt;p&gt;dm ketoacidosis
&lt;/p&gt;&lt;p&gt;uremia
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;MUDPILES
&lt;/p&gt;&lt;p&gt;M- methanol
&lt;/p&gt;&lt;p&gt;U- uremia
&lt;/p&gt;&lt;p&gt;D- dka
&lt;/p&gt;&lt;p&gt;P- paraldehyde
&lt;/p&gt;&lt;p&gt;I- iron. inh
&lt;/p&gt;&lt;p&gt;L- lactic acidosis
&lt;/p&gt;&lt;p&gt;E- ethylene glycol
&lt;/p&gt;&lt;p&gt;S- salicylates
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Anion_Gap_and_Osmolar_Gap_(High)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;MISTRY 6/06
&lt;/p&gt;



</content><folder>Tox</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="ankle_(fractures)"><name>Ankle (Fractures)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Malleolar_Fractures"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Malleolar Fractures&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Imaging"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Imaging&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Classification"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Classification&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Danis-Weber_system"&gt;&lt;span class="tocnumber"&gt;3.1&lt;/span&gt; &lt;span class="toctext"&gt;Danis-Weber system&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Fracture_Types"&gt;&lt;span class="tocnumber"&gt;3.2&lt;/span&gt; &lt;span class="toctext"&gt;Fracture Types&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Management"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Management&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Complications"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Complications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ankle_(Fractures)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Malleolar Fractures"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Malleolar_Fractures"&gt;Malleolar Fractures&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Isolated Malleolar
&lt;ol&gt;&lt;li&gt; Stable if displaced &amp;lt;2mm, joint surface involvement &amp;lt;25%, and no contralateral or syndesmotic injury 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Medial Malleolus Fx
&lt;ol&gt;&lt;li&gt; Is it really isolated? (frequently associated with lateral or posterior injuries)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Posterior Malleolus Fx
&lt;ol&gt;&lt;li&gt; Usually occurs in association w/ post. tibiofibular ligament injury / fibular fx
&lt;/li&gt;&lt;li&gt; Rarely occurs in isolation! 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Bimalleolar
&lt;ol&gt;&lt;li&gt;  Lateral + medial malleoli fx
&lt;/li&gt;&lt;li&gt; Unstable
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Trimalleolar
&lt;ol&gt;&lt;li&gt; Lateral + medial + posterior malleoli fx
&lt;/li&gt;&lt;li&gt; Requires surgical stabilization
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ankle_(Fractures)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Imaging"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Imaging"&gt;Imaging&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Ottawa Ankle Rules
&lt;/li&gt;&lt;li&gt; 3 views:
&lt;ol&gt;&lt;li&gt; AP - Best for isolated lateral and medial malleolar fractures
&lt;/li&gt;&lt;li&gt; Oblique (mortise) - Best for evaluating for unstable fracture or soft tissue injury
&lt;ol&gt;&lt;li&gt; at a point 1cm proximal to the articular surface of the tibia the space between the tib/fib should be &#8804;6cm 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Lateral - Best for posterior malleolar fractures
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ankle_(Fractures)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Classification"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Classification"&gt;Classification&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ankle_(Fractures)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Danis-Weber system"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Danis-Weber_system"&gt;Danis-Weber system&lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt;type A-fibular Fx at or below the joint line without syndesmotic involvement.
&lt;/li&gt;&lt;li&gt;type B-fib Fx at joint level with partial syndesmotic ligament injury.
&lt;/li&gt;&lt;li&gt;type C-fibular Fx above the joint level and complete syndesmotic disruption.
&lt;ul&gt;&lt;li&gt;C-diaphyseal (Dupuytren Fx) or proximal fibular Fx (maissoneuve).
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ankle_(Fractures)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Fracture Types"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Fracture_Types"&gt;Fracture Types&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;lateral malleolar-Tx depends on type A, B, or C
&lt;/li&gt;&lt;li&gt;A-splinting in ED, 6-8 weeks in cast.NWB for three weeks.
&lt;/li&gt;&lt;li&gt;B-often requires a surgical repair.
&lt;/li&gt;&lt;li&gt;C-surgery usually required.
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ankle_(Fractures)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Emergent
&lt;ol&gt;&lt;li&gt; Open fracture
&lt;/li&gt;&lt;li&gt; Fx/dislocation with vascular compromise
&lt;/li&gt;&lt;li&gt; Fx/dislocation with significant tenting of the skin
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Recommended (pt often admitted for repair)
&lt;ol&gt;&lt;li&gt; Tillaux/triplane fractures
&lt;/li&gt;&lt;li&gt; Intrarticular fractures with displacement
&lt;/li&gt;&lt;li&gt; Pilon fractures (reduce if ortho unavailable)
&lt;/li&gt;&lt;li&gt; Trimalleolar fractures
&lt;/li&gt;&lt;li&gt; Maisonneuve Fx
&lt;/li&gt;&lt;li&gt; Any Fx with significant disruption of mortise
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Recommended (phone is ok)
&lt;ol&gt;&lt;li&gt; Bimalleolar Fx
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Minimally displaced medial or lateral malleolar Fx
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ankle_(Fractures)&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Management"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Management"&gt;Management&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Lateral malleolar Fx
&lt;ol&gt;&lt;li&gt; Stable - &amp;gt;90% have good clinical result 
&lt;ol&gt;&lt;li&gt; Treat like severe ankle sprain 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Unstable = displacement &amp;gt;2mm, medial fx, or medial ligament disruption
&lt;ol&gt;&lt;li&gt; Medial tenderness indicates need for stress xrays to determine degree of instability 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;  Medial or posterior malleolar Fx
&lt;ol&gt;&lt;li&gt; Must confirm no other injuries!
&lt;/li&gt;&lt;li&gt; If non-displaced, isolated:
&lt;ol&gt;&lt;li&gt; Short-leg posterior splint (ankle at 90o)
&lt;/li&gt;&lt;li&gt; Non-weight bearing
&lt;/li&gt;&lt;li&gt; Refer in 5-7 days
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Lateral malleolar fx with deltoid injury OR bimalleolar OR trimalleolar fx
&lt;ol&gt;&lt;li&gt; Short-leg posterior splint (ankle at 90o)
&lt;/li&gt;&lt;li&gt; Refer within few days for surgical intervention
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ankle_(Fractures)&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Complications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Complications"&gt;Complications&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Nerve damage
&lt;/li&gt;&lt;li&gt; Peroneal nerve (lateral ankle injury)
&lt;/li&gt;&lt;li&gt; Weak foot dorsiflexion
&lt;/li&gt;&lt;li&gt; Tibial nerve (medial ankle injury) 
&lt;/li&gt;&lt;li&gt; Compartment syndrome
&lt;/li&gt;&lt;li&gt; Nonunion or malunion
&lt;/li&gt;&lt;li&gt; Fracture blister/skin necrosis 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ankle_(Fractures)&amp;amp;action=edit&amp;amp;section=9" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;&lt;a href="/wiki/Maisonneuve" title="Maisonneuve"&gt;Maisonneuve&lt;/a&gt;
&lt;/li&gt;&lt;li&gt;&lt;a href="/wiki/Pilon_Fx" title="Pilon Fx"&gt;Pilon Fx&lt;/a&gt;
&lt;/li&gt;&lt;li&gt;&lt;a href="/wiki/Ankle_(Ottowa)" title="Ankle (Ottowa)"&gt;Ankle (Ottowa)&lt;/a&gt;
&lt;/li&gt;&lt;li&gt;&lt;a href="/wiki/Ankle_(Sprain)" title="Ankle (Sprain)"&gt;Ankle (Sprain)&lt;/a&gt;
&lt;/li&gt;&lt;/ul&gt;




</content><folder>Ortho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="ankle_(ottowa)"><name>Ankle (Ottowa)</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ankle_(Ottowa)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Rule"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Rule"&gt;Rule&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Order ankle xrays when:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt; Bony tenderness along the posterior edge or distal 6cm of either malleolus
&lt;ol&gt;&lt;li&gt; pain in the medial malleolar zone 
&lt;/li&gt;&lt;li&gt; pain in lateral malleolar zone 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Inability to bear weight for at least two steps with each foot immediately after the injury and at the time of evaluation
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;&lt;br /&gt;
Order foot xrays when there is any pain in the mid-foot zone and any of these findings:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt; Bony tenderness over the navicular bone
&lt;/li&gt;&lt;li&gt; Bony tenderness over base of the 5th metatarsal
&lt;/li&gt;&lt;li&gt; Inability to bear weight for at least two steps with each foot immediately after the injury and at the time of evaluation
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ankle_(Ottowa)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Exceptions"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Exceptions"&gt;Exceptions&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;?age &amp;lt;18 or &amp;gt;55
&lt;/li&gt;&lt;li&gt;doesn't apply to pediatrics
&lt;/li&gt;&lt;li&gt;only for blunt trauma mechanism
&lt;/li&gt;&lt;li&gt;doesn't apply to subacute/chronic injuries
&lt;/li&gt;&lt;li&gt;doesn't apply to injuries of the hindfoot or forefoot
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;0.5% of pt's not xrayed were found to have minor fractures on follow up xray in 5-7 days.
&lt;/p&gt;&lt;p&gt;Although it doesn't apply to peds, a study of 1500 patients age 1-15 showed a sensitivity of 98% (Journal of Acc/Emerg Med 1999;16:342-344)
&lt;/p&gt;



</content><folder>Ortho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="ankle_(sprain)"><name>Ankle (Sprain)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Classification"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Classification&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Causes_of_Chronic_Pain_after_Healing"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Causes of Chronic Pain after Healing&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Syndesmotic_Sprain"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Syndesmotic Sprain&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;4.1&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-6"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4.2&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ankle_(Sprain)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;stress tests-best done several days after injury.
&lt;/p&gt;&lt;p&gt;anterior drawer- tests the anterior talar fibular ligament (ATFL). knee at 90 degrees, foot in relaxed position. cup heel with one hand and push on tibia posteriorly-positive is 2mm of subluxation relative to the other foot or visible dimpling of the anterior skin.
&lt;/p&gt;&lt;p&gt;Talar tilt- tests ATFL and calcaneofibular ligament (CFL)-in same position as above-forced inversion of foot is applied- positive if there is obvious joint laxity relative to the other side or no passive resistance to forced motion-indicates rupture of ATFL and CFL. can do with forced eversion which tests the stability of the deltiod ligament.
&lt;/p&gt;&lt;p&gt;Fibular compression: tests the tiobiofibular syndesmotic ligament. Same position as before but dorsiflex foot. squeeze tibia and fibula together 6-8 inches below knee. Positive tests if there is pain in the ankle.
&lt;/p&gt;&lt;p&gt;Thompson's tests- prone with knee flexed squeeze gastroc and soleus in midcalf. if no plantarflexion-torn achilles tendon.
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ankle_(Sprain)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Classification"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Classification"&gt;Classification&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Class I
&lt;ol&gt;&lt;li&gt; mild pain,swelling can bear weight, negative stress test-
&lt;/li&gt;&lt;li&gt;Treatment = RICE and f/u in 7 days.
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Class II
&lt;ol&gt;&lt;li&gt;mod pain, swelling, difficulty bearing weight, pos ant drawer (4-14 mm), pos talar tilt (5-15 degrees)
&lt;/li&gt;&lt;li&gt;Treatment: rigid splint, crutches, &amp;lt;7 day f/u.
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Class III
&lt;ol&gt;&lt;li&gt;severe pain, unable to bear weight, lot of swelling. ant drawer &amp;gt;15 mm, talar tilt &amp;gt;15 degrees
&lt;/li&gt;&lt;li&gt;Treatment: rigid splint, crutches, f/u in &amp;lt;7 days.
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;ATFL most common ligament (80% of inversion injuries).
&lt;/p&gt;&lt;p&gt;eversion injuries- deltoid ligament rarely isolated tear-usually avulsion Fx of medial malleolus. syndesmotic sprains more common than deltoid injuries (and more easily missed).
&lt;/p&gt;&lt;p&gt;grade 2 and 3 eversion injuries are often placed in a short leg walking cast for 6-8 weeks.
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ankle_(Sprain)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Causes of Chronic Pain after Healing"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Causes_of_Chronic_Pain_after_Healing"&gt;Causes of Chronic Pain after Healing&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;soft tissue problems
&lt;ol&gt;&lt;li&gt;synovial impingement syndromes
&lt;/li&gt;&lt;li&gt;loose bodies in the joint
&lt;/li&gt;&lt;li&gt;proneal tendon subluxation
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;bony problems
&lt;ol&gt;&lt;li&gt;osteochondral Fx of talar dome
&lt;/li&gt;&lt;li&gt;lateral or posterior fx of talus
&lt;/li&gt;&lt;li&gt;anterior fx of calcaneus
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ankle_(Sprain)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Syndesmotic Sprain"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Syndesmotic_Sprain"&gt;Syndesmotic Sprain&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;(High Ankle)
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ankle_(Sprain)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Positive squeeze test
&lt;/li&gt;&lt;li&gt;TTP distal tibiofibular joint
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ankle_(Sprain)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Treat as sprain, f/u ortho/sports
&lt;/li&gt;&lt;li&gt;possible surgical repair if refractory to conservative management
&lt;/li&gt;&lt;/ol&gt;




</content><folder>Ortho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="ankle_fracture_(peds)"><name>Ankle Fracture (Peds)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Tillaux_Fx"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Tillaux Fx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Triplane_Fx"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Triplane Fx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ankle_Fracture_(Peds)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-more Fx and fewer sprains since immature bone is more fragile than the surrounding ligaments.
&lt;/p&gt;&lt;p&gt;-just always get an x-ray.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ankle_Fracture_(Peds)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Tillaux Fx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Tillaux_Fx"&gt;Tillaux Fx&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-ave age 11-15 yrs.
&lt;/p&gt;&lt;p&gt;-more common in girls
&lt;/p&gt;&lt;p&gt;salter-harris type 3 Fx that avulses the anterolateral tibial epiphysis (distal to the growth plate).
&lt;/p&gt;&lt;p&gt;-caused by ext rotation of the leg with the foot fixed, the ATFL avulses off the distal tibia.
&lt;/p&gt;&lt;p&gt;-oblique films are often necessary to distinguish a tillaux from the more common triplane fx.
&lt;/p&gt;&lt;p&gt;-more than 2mm of displacement after reduction requires surgical intervention.
&lt;/p&gt;&lt;p&gt;-since most of the growth plate has closed at this age, leg length discrepancies and rotational deformities are rare.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ankle_Fracture_(Peds)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Triplane Fx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Triplane_Fx"&gt;Triplane Fx&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-more common and serious than tillaux Fx.
&lt;/p&gt;&lt;p&gt;-10% of all pediatric ankle Fx.
&lt;/p&gt;&lt;p&gt;-mechanism is a combination of external rotation and axial loading in a foot in plantarflexion.
&lt;/p&gt;&lt;p&gt;-occur about one year prior to growth plate closure usually.
&lt;/p&gt;&lt;p&gt;-more common in boys.
&lt;/p&gt;&lt;p&gt;-can be 2 part, 3 part, or 4 part fractures-if the distal tibula is also fractured do not count it as part of the triplane Fx.
&lt;/p&gt;&lt;p&gt;- 2 part Fx is a salter-Harris 4 Fx. One Fx line is transverse through the tibial epiphysis (growth plate). The medial portion of the plate is already closed, so the fracture doesn't extend through the plate. second fracture plane extends up the tibia (coronal plane-up the metaphysis). the third fracture line (sagittal) extends distally into the joint.
&lt;/p&gt;&lt;p&gt;-the three and four part fractures are similar in that there are fractures in all three planes, but the distal tibia is in two or three parts respectively.
&lt;/p&gt;&lt;p&gt;-can be treated with closed reduction if less than 2mm of displacement can be achieved.
&lt;/p&gt;&lt;p&gt;-unfortunately, this Fx has a lot of swelling and if the cast accommodates the swelling then there is enough room for the reduction to slip off when the swelling subsides.
&lt;/p&gt;&lt;p&gt;-most three or four part Fxs are treated with ORIF.
&lt;/p&gt;&lt;p&gt;-growth arrest is uncommon since the growth plate is near closure at the time of injury.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ankle_Fracture_(Peds)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Ortho:  Ankle (Fracture)
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="anorectum"><name>Anorectum</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#Pain_and_Bleeding"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;Pain and Bleeding&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Pain.2C_No_Bleeding"&gt;&lt;span class="tocnumber"&gt;1.2&lt;/span&gt; &lt;span class="toctext"&gt;Pain, No Bleeding&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Bleeding.2C_No_Pain"&gt;&lt;span class="tocnumber"&gt;1.3&lt;/span&gt; &lt;span class="toctext"&gt;Bleeding, No Pain&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Painless_Swelling"&gt;&lt;span class="tocnumber"&gt;1.4&lt;/span&gt; &lt;span class="toctext"&gt;Painless Swelling&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-6"&gt;&lt;a href="#Itching"&gt;&lt;span class="tocnumber"&gt;1.5&lt;/span&gt; &lt;span class="toctext"&gt;Itching&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#External_Hemorroid_Excision"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;External Hemorroid Excision&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Anorectum&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Anorectum&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Pain and Bleeding"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Pain_and_Bleeding"&gt;Pain and Bleeding&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;external hemorrhoids
&lt;ol&gt;&lt;li&gt;swelling
&lt;/li&gt;&lt;li&gt;looks like skin if not thrombosed
&lt;/li&gt;&lt;li&gt;12,7,9 o'clock
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;anal fissure
&lt;ol&gt;&lt;li&gt;no swelling
&lt;/li&gt;&lt;li&gt;off midline = CA, HIV, TB, Crohn's
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;prolapsed internal
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Anorectum&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Pain, No Bleeding"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Pain.2C_No_Bleeding"&gt;Pain, No Bleeding&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;swelling
&lt;ol&gt;&lt;li&gt;abscess
&lt;ol&gt;&lt;li&gt;perirectal
&lt;/li&gt;&lt;li&gt;ischiorectal
&lt;/li&gt;&lt;li&gt;intersphincteric
&lt;/li&gt;&lt;li&gt;supralevator
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;pilonidal (drain off midline)
&lt;/li&gt;&lt;li&gt;fistula (2/2 chronic abscess; don't probe)
&lt;/li&gt;&lt;li&gt;hidradenitis suppurativa
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;no swelling
&lt;ol&gt;&lt;li&gt;proctalgia fugax
&lt;ol&gt;&lt;li&gt;episodic pain (women, pts &amp;lt; 45yo)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;incontinence
&lt;ol&gt;&lt;li&gt;urgency
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Anorectum&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Bleeding, No Pain"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Bleeding.2C_No_Pain"&gt;Bleeding, No Pain&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;CA
&lt;/li&gt;&lt;li&gt;internal hemorrhoids
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Anorectum&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Painless Swelling"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Painless_Swelling"&gt;Painless Swelling&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;itch --&amp;gt; condyloma acuminata (warts 2/2 HPV)
&lt;/li&gt;&lt;li&gt;no itch --&amp;gt; procidentia (rectal prolaps; peds - think CF, malnutrion)
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Anorectum&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Itching"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Itching"&gt;Itching&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;discharge --&amp;gt; proctitis (inflamm changes of rectum within 15cm of dentate line; GC/chlamy, HSV)
&lt;/li&gt;&lt;li&gt;no discharge --&amp;gt; pruritis ani (pinworms)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Anorectum&amp;amp;action=edit&amp;amp;section=7" title="Edit section: External Hemorroid Excision"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="External_Hemorroid_Excision"&gt;External Hemorroid Excision&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;&amp;lt;48 hrs
&lt;/p&gt;&lt;p&gt;All pts presenting with anorectal complaints should be considered for HIV testing
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Anorectum&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Donaldson; adapted from Coates
&lt;/p&gt;



</content><folder>GI</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="anthrax"><name>Anthrax</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Ddx"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Ddx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Imaging"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Imaging&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Anthrax&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background &lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Gm positive rod, tough spores
&lt;/li&gt;&lt;li&gt;Inhalational Anthrax: Russian accident at Sverdlovsk
&lt;/li&gt;&lt;li&gt;Incubation Period is 10 days
&lt;/li&gt;&lt;li&gt;No one &amp;lt; 24 died
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Anthrax&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Ddx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Ddx"&gt;Ddx&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Cutaneous (painless)
&lt;ol&gt;&lt;li&gt;Ecthyma gangrenosum
&lt;/li&gt;&lt;li&gt;Rat-bite fever (Streptobacillus monilifomis and Spirillum minus)
&lt;/li&gt;&lt;li&gt;Ulceroglandular tularemia
&lt;/li&gt;&lt;li&gt;Plague
&lt;/li&gt;&lt;li&gt;Glanders (Pseudomonas peudomallei)
&lt;/li&gt;&lt;li&gt;Rickettsialpox (Rickettsia akari)
&lt;/li&gt;&lt;li&gt;Orf (parapox virus)
&lt;/li&gt;&lt;li&gt;Staph lymphadenitis
&lt;/li&gt;&lt;li&gt;TB
&lt;/li&gt;&lt;li&gt;Leprosy
&lt;/li&gt;&lt;li&gt;Buruli ulcer (Mycobact ulcerans)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Inhalational
&lt;ol&gt;&lt;li&gt;Acute bacterial mediastinitis
&lt;/li&gt;&lt;li&gt;Mycoplasma
&lt;/li&gt;&lt;li&gt;Legionnaire's
&lt;/li&gt;&lt;li&gt;Psittacosis
&lt;/li&gt;&lt;li&gt;Tularemia
&lt;/li&gt;&lt;li&gt;Q fever (Coxiella burnetti)
&lt;/li&gt;&lt;li&gt;Viral pneumonia
&lt;/li&gt;&lt;li&gt;Histoplasmosis
&lt;/li&gt;&lt;li&gt;Coccidiomycosis
&lt;/li&gt;&lt;li&gt;Ruptured aortic aneurysm
&lt;/li&gt;&lt;li&gt;SVC syndrome
&lt;/li&gt;&lt;li&gt;Silicosis
&lt;/li&gt;&lt;li&gt;Sarcoidosis
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Anthrax&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Imaging"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Imaging"&gt;Imaging&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;CXR/CT- Widened mediastinum representing hemorrhagic mediastinitis
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Anthrax&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Cipro 500 mg bid or 30 mg/kg div q12
&lt;/li&gt;&lt;li&gt;Levo 500 mg qd
&lt;/li&gt;&lt;li&gt;Doxycycline 100 mg bid
&lt;/li&gt;&lt;li&gt;x 60 days
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;PLUS vaccine: inactivated, cell-free immediately, 2 wks and then 4 wks
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Anthrax&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;7/2/09 PANI
&lt;/p&gt;



</content><folder>ID</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="antibiotics_(basics)"><name>Antibiotics (Basics)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Beta-Lactams"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Beta-Lactams&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Aminoglycosides"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Aminoglycosides&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Sulfonamides"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Sulfonamides&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Fluoroquinolones"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Fluoroquinolones&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Tetracyclines"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Tetracyclines&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Macrolides"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Macrolides&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Clindamycin"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Clindamycin&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Antibiotics_(Basics)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Beta-Lactams"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Beta-Lactams"&gt;Beta-Lactams&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Penicillin
&lt;ul&gt;&lt;li&gt; Strep Pharyngitis (including scarlet fever) Streptococcal Toxic Shock and Necrotizing Fascitis
&lt;ul&gt;&lt;li&gt; Penicillin &lt;i&gt;plus&lt;/i&gt; clindamycin (to decrease toxin synthesis)
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; Meningococcus Meningitis
&lt;/li&gt;&lt;li&gt; Syphilis (Primary, 2ndary, and latent syphilis &amp;lt; 1 year duration)
&lt;/li&gt;&lt;li&gt; Actinomycosis
&lt;/li&gt;&lt;li&gt; Anthrax
&lt;/li&gt;&lt;li&gt; Clostridial infections
&lt;/li&gt;&lt;li&gt; Listeria
&lt;/li&gt;&lt;li&gt; Pasteurella
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; Penicilinase-Resistant Penicillins
&lt;ul&gt;&lt;li&gt; Nafcillin, oxacillin, dicloxacillin
&lt;ul&gt;&lt;li&gt; Agents of 1st choice for treatment of S. aureus and S. epidermidis that are not methicillin-reistant
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; Expanded-Spectrum Penicillins
&lt;ul&gt;&lt;li&gt; Ampicillin, amoxicillin (+ clavulanate)
&lt;ul&gt;&lt;li&gt; Upper Respiratory Infections (due to S. pyogenes, S. pneumoniae, H. influenzae)
&lt;ul&gt;&lt;li&gt; Sinusitis
&lt;/li&gt;&lt;li&gt; Otitis media
&lt;/li&gt;&lt;li&gt; Acute exacerbation of chronic bronchitis
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; Listeria
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; Antipseudomonal Penicillins
&lt;ul&gt;&lt;li&gt; Piperacillin
&lt;ul&gt;&lt;li&gt; Infection following burns
&lt;/li&gt;&lt;li&gt; Neutropenia
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; 1st Gen Cephalosporins
&lt;ul&gt;&lt;li&gt; Cefazolin, cephalexin
&lt;ul&gt;&lt;li&gt; Skin and soft tissue infections (why is agent of choice before gen sx)
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; Cross-reactivity of PCN allergy 7% to 18% 
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; 2nd Gen Cephalosporins
&lt;ul&gt;&lt;li&gt; Cefuroxime
&lt;ul&gt;&lt;li&gt; Intestinal anaerobes (why is agent of chioce for colorectal sx)
&lt;/li&gt;&lt;li&gt; Largely displaced by 3rd gen agents
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; 3rd Gen Cephalosporins
&lt;ul&gt;&lt;li&gt; Ceftriaxone, Ceftazidime, Cefixime
&lt;ul&gt;&lt;li&gt; Drug of choice for serious infections due to:
&lt;ul&gt;&lt;li&gt; Klebsiella
&lt;/li&gt;&lt;li&gt; Enterobacter
&lt;/li&gt;&lt;li&gt; Proteus
&lt;/li&gt;&lt;li&gt; Haemophilus
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; Gonorrhea
&lt;/li&gt;&lt;li&gt; Lyme disease
&lt;/li&gt;&lt;li&gt; Meningitis (+ vanc and ampicillin)
&lt;/li&gt;&lt;li&gt; Pseudomonas meningitis (+ AG)
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; 4th Gen Cephalosporins
&lt;ul&gt;&lt;li&gt; Cefepime
&lt;ul&gt;&lt;li&gt; Resistant, nosocomial infections
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; Carbapenems
&lt;ul&gt;&lt;li&gt; Imipenem (+ cilastatin), meropenem
&lt;ul&gt;&lt;li&gt; Cephalosporin-resistant nosocomial bacteria
&lt;/li&gt;&lt;li&gt; Empirical treatment of serious infections in patients who recently received other b-lactams 
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; Aztreonam
&lt;ul&gt;&lt;li&gt; Antimicrobial activity more closely resembles AG's (only active against gram -)
&lt;ul&gt;&lt;li&gt; Enterobacter, pseudomonas, H. influenzae, gonococci
&lt;/li&gt;&lt;li&gt; Little allergic cross-reactivity with B-lactam antibiotics
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Antibiotics_(Basics)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Aminoglycosides"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Aminoglycosides"&gt;Aminoglycosides&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Gentamicin, amikacin, streptomycin (either alone or with B-lactam)
&lt;ul&gt;&lt;li&gt; Serious gram-negative bacillary infections
&lt;ul&gt;&lt;li&gt; Ill patient with pyelonephritis
&lt;/li&gt;&lt;li&gt; Meningitis (due to Pseudomonas, Acinetobacter)
&lt;/li&gt;&lt;li&gt; Peritoneal Dialysis&#8211;Associated Peritonitis
&lt;/li&gt;&lt;li&gt; Bacterial endocarditis?
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; Caution: Use in patients with Myasthenia Gravis, can precipitate crisis
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Antibiotics_(Basics)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Sulfonamides"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Sulfonamides"&gt;Sulfonamides&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Trimethoprim-sulfamethoxazole
&lt;ul&gt;&lt;li&gt; 1st line for uncomplicated lower UTI (especially chronic and recurrent infections)
&lt;/li&gt;&lt;li&gt; PCP pneumonia
&lt;/li&gt;&lt;li&gt; Acute exacerbations of chronic bronchitis
&lt;/li&gt;&lt;li&gt; Maxillary sinusitis
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Antibiotics_(Basics)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Fluoroquinolones"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Fluoroquinolones"&gt;Fluoroquinolones&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; UTI (2nd line)
&lt;/li&gt;&lt;li&gt; Prostatitis
&lt;/li&gt;&lt;li&gt; Chlamydia
&lt;/li&gt;&lt;li&gt; PID
&lt;/li&gt;&lt;li&gt; Traveler's diarrhea
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Antibiotics_(Basics)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Tetracyclines"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Tetracyclines"&gt;Tetracyclines&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Mycoplasma
&lt;/li&gt;&lt;li&gt; Chlamydia
&lt;/li&gt;&lt;li&gt; PID (combined with cephalosporin)
&lt;/li&gt;&lt;li&gt; Epididymitis
&lt;/li&gt;&lt;li&gt; Anthrax
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Antibiotics_(Basics)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Macrolides"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Macrolides"&gt;Macrolides&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Erythromycin, Clarithromycin, Azithromycin
&lt;ul&gt;&lt;li&gt; Community-acquired PNA
&lt;/li&gt;&lt;li&gt; Mycoplasma
&lt;/li&gt;&lt;li&gt; Legionnaires' Disease
&lt;/li&gt;&lt;li&gt; Chlamydia (single dose)
&lt;/li&gt;&lt;li&gt; H. Pylori
&lt;/li&gt;&lt;li&gt; Traveler's diarrhea (children and pregnant women) 
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Antibiotics_(Basics)&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Clindamycin"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Clindamycin"&gt;Clindamycin&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Drug of choice for lung abscess and anaerobic lung and pleural space infections
&lt;/li&gt;&lt;li&gt; Toxin-mediated disease, i.e. toxic shock syndrome (TSS)
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Antibiotics_(Basics)&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Goodman &amp;amp; Gilman's Pharmacology
&lt;/p&gt;



</content><folder>ID</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="antibiotics_(initial)"><name>Antibiotics (Initial)</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Antibiotics_(Initial)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Examples of initial antimicrobial therapy for acutely ill"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Examples_of_initial_antimicrobial_therapy_for_acutely_ill"&gt;Examples of initial antimicrobial therapy for acutely ill&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;hospitalized adults pending identification of causative organism
&lt;/p&gt;
&lt;table class="pbSortable" style="width: 535px; height: 880px" cellspacing="1" cellpadding="1" border="1"&gt;
&lt;tr&gt;
&lt;td&gt; Suspected Clinical Diagnosis
&lt;/td&gt;&lt;td&gt; Likely Etiologic Diagnosis
&lt;/td&gt;&lt;td&gt; Drugs of Choice
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Meningitis, bacterial, community-acquired &lt;sup&gt;6&lt;/sup&gt;
&lt;/td&gt;&lt;td&gt; Pneumococcus,&lt;sup&gt;1&lt;/sup&gt; meningococcus
&lt;/td&gt;&lt;td&gt; Cefotaxime,&lt;sup&gt;2&lt;/sup&gt; 2&#8211;3 g IV every 6 hours; &lt;b&gt;or&lt;/b&gt; ceftriaxone, 2 g IV every 12 hours plus vancomycin, 10 mg/kg IV every 8 hours
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Meningitis, bacterial, age &amp;gt; 50, community-acquired &lt;sup&gt;6&lt;/sup&gt;
&lt;/td&gt;&lt;td&gt; Pneumococcus, meningococcus, &lt;i&gt;Listeria monocytogenes,&lt;/i&gt;&lt;sup&gt;3&lt;/sup&gt; gram-negative bacilli
&lt;/td&gt;&lt;td&gt; Ampicillin, 2 g IV every 4 hours, plus Cefotaxime or ceftriaxone and vancomycin
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Meningitis, postoperative (or posttraumatic) &lt;sup&gt;6&lt;/sup&gt;
&lt;/td&gt;&lt;td&gt; &lt;i&gt;S aureus,&lt;/i&gt; gram-negative bacilli (pneumococcus, in posttraumatic)&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; vancomycin, 10 mg/kg IV every 8 hours, plus ceftazidime, 3 g IV every 8 hours
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Brain abscess
&lt;/td&gt;&lt;td&gt; Mixed anaerobes, pneumococci, streptococci
&lt;/td&gt;&lt;td&gt; Penicillin G, 4 million units IV every 4 hours, plus metronidazole, 500 mg orally every 8 hours; &lt;b&gt;or&lt;/b&gt; Cefotaxime or ceftriaxone plus metronidazole, 500 mg orally every 8 hours
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Pneumonia, acute, community-acquired, severe
&lt;/td&gt;&lt;td&gt; Pneumococci, &lt;i&gt;M pneumoniae,'&lt;b&gt;Legionella,'&lt;/b&gt;C pneumoniae&lt;/i&gt;&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Doxycycline, 100 mg IV or orally every 12 hours (or azithromycin), plus Cefotaxime, 2 g IV every 8 hours (or ceftriaxone, 1 g IV every 24 hours); &lt;b&gt;or&lt;/b&gt; a fluoroquinolone&lt;sup&gt;5&lt;/sup&gt; alone
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Pneumonia, postoperative or nosocomial
&lt;/td&gt;&lt;td&gt; &lt;i&gt;S aureus,&lt;/i&gt; mixed anaerobes, gram-negative bacilli&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Cefapime, 2 g IV every 8 hours; &lt;b&gt;or &lt;/b&gt; , 2 g IV every 8 hours; &lt;b&gt;or&lt;/b&gt; piperacillin-tazobactam, 45 g IV every 6 hours; &lt;b&gt;or&lt;/b&gt; imipenem, 500 mg IV every 6 hours; &lt;b&gt;or&lt;/b&gt; meropenem, 1 g IV every 8 hours plus tobramycin, 5 mg/kg IV every 24 hours; &lt;b&gt;or &lt;/b&gt; ciprofloxacin, 400 mg IV every 12 hours; &lt;b&gt;or &lt;/b&gt; levofloxacin, 500 mg IV every 24 hours plus vancomycin, 15 mg/kg IV every 12 hours
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Endocarditis, acute (including injection drug user)
&lt;/td&gt;&lt;td&gt; &lt;i&gt;S aureus, E faecalis,&lt;/i&gt; gram-negative aerobic bacteria, viridans streptococci&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; vancomycin, 15 mg/kg IV every 12 hours, plus gentamicin, 1 mg/kg every 8 hours
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Septic thrombophlebitis (eg, IV tubing, IV shunts)
&lt;/td&gt;&lt;td&gt; &lt;i&gt;S aureus,&lt;/i&gt; gram-negative aerobic bacteria&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Vancomycin, 15 mg/kg IV every 12 hours plus ciprofloxacin, 400 mg IV every 12 hours; &lt;b&gt;or&lt;/b&gt; levofloxacin, 500 mg IV every 24 hours; &lt;b&gt;or&lt;/b&gt; ceftriaxone , 1 g IV every 24 hours
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Osteomyelitis
&lt;/td&gt;&lt;td&gt; &lt;i&gt;S aureus&lt;/i&gt;
&lt;/td&gt;&lt;td&gt; Nafcillin, 2 g IV every 4 hours; &lt;b&gt;or&lt;/b&gt; cefazolin, 2 g IV every 8 hours
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Septic arthritis
&lt;/td&gt;&lt;td&gt; &lt;i&gt;S aureus, N gonorrhoeae&lt;/i&gt;
&lt;/td&gt;&lt;td&gt; Ceftriaxone , 1&#8211;2 g IV every 24 hours
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Pyelonephritis with flank pain and fever (recurrent urinary tract infection)
&lt;/td&gt;&lt;td&gt; &lt;i&gt;E coli, Klebsiella, Enterobacter, Pseudomonas&lt;/i&gt;&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Ceftriaxone, 1g IV every 24 hours; &lt;b&gt;or&lt;/b&gt; ciprofloxacin, 400 mg IV every 12 hours (500 mg orally); &lt;b&gt;or&lt;/b&gt; levofloxacin, 500 mg once daily (IV/PO)
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Fever in neutropenic patient receiving cancer chemotherapy
&lt;/td&gt;&lt;td&gt; &lt;i&gt;S aureus, Pseudomonas, Klebsiella, E coli&lt;/i&gt;&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Ceftazidime, 2 g IV every 8 hours; &lt;b&gt;or&lt;/b&gt; cefepime, 2 g IV every 8 hours
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Intra-abdominal sepsis (eg, postoperative, peritonitis, cholecystitis)
&lt;/td&gt;&lt;td&gt; Gram-negative bacteria, &lt;i&gt;Bacteroides,&lt;/i&gt; anaerobic bacteria, streptococci, clostridia
&lt;/td&gt;&lt;td&gt; Piperacillin-tazobactam or ticarcillin-clavulanate, 3.1 g IV every 6 hours; &lt;b&gt;or&lt;/b&gt; ertapenem, 1 g every 24 hours; &lt;b&gt;or&lt;/b&gt; moxifloxacin, 400 mg IV every 24 hours
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;p&gt;&lt;sup&gt;1&lt;/sup&gt;Some strains may be resistant to penicillin. Vancomycin can be used with or without rifampin.
&lt;/p&gt;&lt;p&gt;&lt;sup&gt;2&lt;/sup&gt;Cefotaxime, ceftriaxone, ceftazidime, or ceftizoxime can be used. Most studies on meningitis
&lt;/p&gt;&lt;p&gt;have been with cefotaxime or ceftriaxone (see text).
&lt;/p&gt;&lt;p&gt;&lt;sup&gt;3&lt;/sup&gt;TMP-SMZ can be used to treat &lt;i&gt;Listeria monocytogenes&lt;/i&gt; in patients allergic to penicillin in a dosage
&lt;/p&gt;&lt;p&gt;of 15&#8211;20 mg/kg of TMP in three or four divided doses.
&lt;/p&gt;&lt;p&gt;&lt;sup&gt;4&lt;/sup&gt;Depending on local drug susceptibility pattern, use tobramycin, 5 mg/kg/d, or amikacin, 15 mg/kg/d,
&lt;/p&gt;&lt;p&gt;in place of gentamicin.
&lt;/p&gt;&lt;p&gt;&lt;sup&gt;5&lt;/sup&gt;Gatifloxacin, levofloxacin, moxifloxacin
&lt;/p&gt;&lt;p&gt;&lt;sup&gt;6&lt;/sup&gt;Remember to give steroids concomitatntly or 15 minutes prior to antibiotics for acute bacterial meningitis
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Antibiotics_(Initial)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;ID: Sepsis (Initial Abx)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Antibiotics_(Initial)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;CURRENT Medical Dx &amp;amp; Tx
&lt;/p&gt;



</content><folder>ID</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="antidotes"><name>Antidotes</name><content>&lt;table width="374" border="1"&gt;

&lt;tr&gt;
&lt;td&gt;
&lt;p&gt;TOXIN
&lt;/p&gt;
&lt;/td&gt;&lt;td&gt; ANTIDOTE&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Acetaminophen&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; N-acetylcysteine&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Antidepressants&lt;br /&gt;
&lt;/td&gt;&lt;td&gt;
&lt;p&gt;Bicarb
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Arsenic&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Dimercaprol (BAL)&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Benzodiazepines
&lt;/td&gt;&lt;td&gt; Flumazenil
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Beta blockers&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Glucagon&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;
&lt;p&gt;Ca channel blockers
&lt;/p&gt;
&lt;/td&gt;&lt;td&gt; Calcium chloride&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;
&lt;p&gt;Clonidine
&lt;/p&gt;
&lt;/td&gt;&lt;td&gt; Yohimbine&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Cyanide&lt;br /&gt;
&lt;/td&gt;&lt;td&gt;
&lt;p&gt;Kit- Hydroxycobalamin, Sodium nitrite, Sodium thiosulfate
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Digoxin&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Dig immune Fab&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Ethylene glycol&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Fomepizole&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Fluoride
&lt;/td&gt;&lt;td&gt; Calcium
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Heparin&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Protamine&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Iron&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Deferoxamine&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Isoniazid (INH)&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Pyridoxine&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Lead&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; EDTA, succimer&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Mercury&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Dimercaprol (BAL)&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Methanol&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Fomepizole&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Methemoglobin&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Methylene blue&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Opiods&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Nalaxone&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Organophosphates&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Atropine+pralidoxime&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Sulfonylurea
&lt;/td&gt;&lt;td&gt; Octreotide
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Valproate&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Carnitine&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Warfarin&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Vit K, FFP&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Antidotes&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;9/09 PANI (Adapted from Donaldson, Mistry, Pharmacopia)
&lt;/p&gt;



</content><folder>Tox</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="aortic_dissection"><name>Aortic Dissection</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#Classification"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;Classification&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#History"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;History&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Physical_Exam"&gt;&lt;span class="tocnumber"&gt;2.2&lt;/span&gt; &lt;span class="toctext"&gt;Physical Exam&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-6"&gt;&lt;a href="#Studies"&gt;&lt;span class="tocnumber"&gt;2.3&lt;/span&gt; &lt;span class="toctext"&gt;Studies&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Complications"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Complications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#Prognosis"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Prognosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-10"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Aortic_Dissection&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt; Background &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;2-3x &amp;gt; men usually 50-70 yrs old
&lt;/p&gt;&lt;p&gt;Predisposing factors: Marfans, Ehlers-Danlos, congenital heart dz, pregnancy (third trimester), bicuspid valve (9x), cocaine, decelerating trauma, aortitis (syphilis, Takayasu, giant cell)
&lt;/p&gt;&lt;p&gt;RISK FACTOR: Hypertension &amp;gt;&amp;gt;&amp;gt; smoking, cocaine, dyslipidemia
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Aortic_Dissection&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Classification"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Classification"&gt; Classification &lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Stanford:
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Type A - involves ascending Aorta, +/- descending Ao (DeBakey I &amp;amp; II)
&lt;/li&gt;&lt;li&gt;Type B - distal to the origin of the L subclavian a (DeBakey III)
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;DeBakey:
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Type I - ascending and descending Ao
&lt;/li&gt;&lt;li&gt;Type II - isolated to ascending Ao
&lt;/li&gt;&lt;li&gt;Type III - isolated to descending Ao
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;Chronic &amp;gt; 2wks otherwise Acute
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Aortic_Dissection&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt; Diagnosis &lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Aortic_Dissection&amp;amp;action=edit&amp;amp;section=4" title="Edit section: History"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="History"&gt; History &lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt;Pain - 90% - abrupt
&lt;/li&gt;&lt;li&gt;VasoVagal - sweat, N\V, lt headed
&lt;/li&gt;&lt;li&gt;Neurologic Deficit - 20-40%
&lt;/li&gt;&lt;li&gt;Syncopy - 5-10%
&lt;/li&gt;&lt;/ul&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Aortic_Dissection&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Physical Exam"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Physical_Exam"&gt; Physical Exam &lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt;Tachycardia
&lt;/li&gt;&lt;li&gt;Pulse Deficits/Discrepencies - (50% of proximal lesions but can be fleeting)
&lt;/li&gt;&lt;li&gt;Aortic Insufficiency
&lt;/li&gt;&lt;li&gt;Tamponade
&lt;/li&gt;&lt;li&gt;Neuro - hemiplegia, parapesia, neuropathy
&lt;/li&gt;&lt;li&gt;Rare - fever unknown origin
&lt;/li&gt;&lt;/ul&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Aortic_Dissection&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Studies"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Studies"&gt; Studies &lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt;D-Dimer always elevated (sensitive but not specific)
&lt;/li&gt;&lt;li&gt;ECG - Vent. hypertrophy from HTN, 10-40% may show ischemia or infarction, 33% normal
&lt;/li&gt;&lt;li&gt;CXR - 60-90% mediastinal widening (S/S 67/70), double shadow, aortic knob, CA+ sign rare but specific, pleural effusions
&lt;/li&gt;&lt;li&gt;Echo (TEE) (S/S 97-100/90-100)
&lt;/li&gt;&lt;li&gt;CT &amp;amp; MRI - 95%
&lt;/li&gt;&lt;li&gt;Aortography (S/S 94/88)
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Aortic_Dissection&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt; Treatment &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Keep BP 100-120sys, HR 60-80
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Nitroprusside (0.5-1.0mcg/kg/min; titrate) &amp;amp; B-blocker eg esmolol (0.5mg/kg loading, 0.05mg/kg/min infusion; titrate)
&lt;/li&gt;&lt;li&gt;Labetalol (10-20mg IV q10mins, or initial infusion rate at 2mg/min; titrate) or
&lt;/li&gt;&lt;li&gt;Verapamil
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;1. Type A - Surgery, unless worsening stroke
&lt;/p&gt;&lt;p&gt;2. Type B - Medical, unless uncontrolled BP, Cont Pain, Rupture.
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Aortic_Dissection&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Complications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Complications"&gt; Complications &lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Rupture
&lt;ul&gt;&lt;li&gt;pericardium --&amp;gt; tamponade
&lt;/li&gt;&lt;li&gt;mediastinum --&amp;gt; hemothorax
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Obstruction of branch vessels
&lt;ul&gt;&lt;li&gt;coronaries --&amp;gt; acute MI
&lt;/li&gt;&lt;li&gt;arch vessels --&amp;gt; stroke
&lt;/li&gt;&lt;li&gt;lumbar --&amp;gt; paraplegia
&lt;/li&gt;&lt;li&gt;mesenteric, renal, or limb ischemia
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;AV Insufficiency
&lt;ul&gt;&lt;li&gt;diastolic murmur and CHF
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Aortic_Dissection&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Prognosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Prognosis"&gt; Prognosis &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Uncomplicated Type B with aggressive medical therapy
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;30 day mortality: 10%
&lt;/li&gt;&lt;li&gt;5 year mortality: 45-60%
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Aortic_Dissection&amp;amp;action=edit&amp;amp;section=10" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt; Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from Donaldson, Bessen, Pani, DeBonis
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="apparent_life-threatening_event_(alte)"><name>Apparent Life-Threatening Event (ALTE)</name><content>&lt;p&gt;Background3% of infants experience ALTEs
&lt;/p&gt;&lt;p&gt;Mean age of ALTE:  8-16 wks
&lt;/p&gt;&lt;p&gt;&amp;lt;6mo-1yr
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Maternal_Risk_Factors"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Maternal Risk Factors&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#DDX"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;DDX&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#DDx_of_Obstructive_Apnea"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;DDx of Obstructive Apnea&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Apparent_Life-Threatening_Event_(ALTE)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Definition - episode, frightening to observer with witnessed apnea, color change, or change in tone, choking or gagging
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;History
&lt;/p&gt;&lt;p&gt;- Central question: did heart/respirations stop?
&lt;/p&gt;&lt;p&gt;- position, activity before, during event, asleep vs. awake
&lt;/p&gt;&lt;p&gt;- previous hx of apnea
&lt;/p&gt;&lt;p&gt;- relation to eating
&lt;/p&gt;&lt;p&gt;- change in color
&lt;/p&gt;&lt;p&gt;- change in tone
&lt;/p&gt;&lt;p&gt;- any intervention done? Duration, CPR? rescue breathes?
&lt;/p&gt;&lt;p&gt;- social history/screen for abuse
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Apparent_Life-Threatening_Event_(ALTE)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;ED
&lt;/p&gt;&lt;p&gt;-CBC, U/A, Lytes
&lt;/p&gt;&lt;p&gt;-CXR, EKG, EEG,
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Inpt
&lt;/p&gt;&lt;p&gt;pH probe, barium swallow
&lt;/p&gt;&lt;p&gt;-CVR monitoring
&lt;/p&gt;&lt;p&gt;-Pneumogram
&lt;/p&gt;&lt;p&gt;-Metabolic studies (Lac/pyruv/NH4, urine AA and OAs)
&lt;/p&gt;&lt;p&gt;-Imaging
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Prognosis is generally excellent--only 10% have repeat events
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Apparent_Life-Threatening_Event_(ALTE)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Maternal Risk Factors"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Maternal_Risk_Factors"&gt;Maternal Risk Factors&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Smoking in pregnancy
&lt;/p&gt;&lt;p&gt;Parity greater than 2
&lt;/p&gt;&lt;p&gt;Mom's age &amp;lt; 20yrs
&lt;/p&gt;&lt;p&gt;Decreased # prenatal visits
&lt;/p&gt;&lt;p&gt;Crowding in home
&lt;/p&gt;&lt;p&gt;Mom not finish High School
&lt;/p&gt;&lt;p&gt;Illicit drugs in pregnancy
&lt;/p&gt;&lt;p&gt;Unmarried
&lt;/p&gt;&lt;p&gt;Anemia in Pregnancy
&lt;/p&gt;&lt;p&gt;&amp;lt; 20lbs wt gain in pregnancy
&lt;/p&gt;&lt;p&gt;UTI in pregnancy
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Apparent_Life-Threatening_Event_(ALTE)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: DDX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX"&gt;DDX&lt;/span&gt;&lt;/h2&gt;
&lt;pre&gt;-idiopathic (50%)... Apnea of infancy
&lt;/pre&gt;
&lt;pre&gt;-infectious... PNA, RSV, Sepsis, Meningitis, encephalitis, botulism, UTI
&lt;/pre&gt;
&lt;pre&gt;-CNS... Sz, ICH
&lt;/pre&gt;
&lt;pre&gt;-Cardiac... CHD, dysrhythmias, CHF
&lt;/pre&gt;
&lt;pre&gt;-GI... GERD, TE Fistula
&lt;/pre&gt;
&lt;pre&gt;-Metabolic... hypoglycemia, hyponatremia, anemia
&lt;/pre&gt;
&lt;pre&gt;-Child abuse
&lt;/pre&gt;
&lt;pre&gt;-Toxic ingestions/fb
&lt;/pre&gt;
&lt;pre&gt;Breath Holding Spell
&lt;/pre&gt;
&lt;p&gt;- usu 6mo to 3-4yr!!
&lt;/p&gt;&lt;p&gt;- in awake pt, begins w/ crying, stops breathing in end expiration, w/resultant cyanosis &amp;amp; LOC
&lt;/p&gt;&lt;p&gt;- resumes breathing spontaneously
&lt;/p&gt;
&lt;pre&gt;Cyanotic Heart Dz
&lt;/pre&gt;
&lt;p&gt;- difficulty feeding w/ diaphoresis &amp;amp; poor wt. gain
&lt;/p&gt;
&lt;pre&gt;Apnea
&lt;/pre&gt;
&lt;p&gt;- central vs obstructive or mixed
&lt;/p&gt;&lt;p&gt;- short (&amp;lt; 15 s) can be normal
&lt;/p&gt;&lt;p&gt;- is pathologic if &amp;gt; 20 sec, or w/ cyanosis, bradycardia, pallor or hypotonia
&lt;/p&gt;
&lt;pre&gt;Periodic Breathing
&lt;/pre&gt;
&lt;p&gt;- 3 or more resp pauses of &amp;gt; 3 sec
&lt;/p&gt;
&lt;pre&gt;Apnea of Prematurity
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Apparent_Life-Threatening_Event_(ALTE)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: DDx of Obstructive Apnea"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx_of_Obstructive_Apnea"&gt;DDx of Obstructive Apnea&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-Stridor - vascular ring, FB, croup, epiglottitis
&lt;/p&gt;&lt;p&gt;- Prematurity - position, laryngomalacia, web, tracheomalacia etc.
&lt;/p&gt;&lt;p&gt;- Airway anatomy abnormalities
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Mixed Apnea
&lt;/p&gt;&lt;p&gt;- shock, dysrhythmias, cong heart dz, prolonged QT
&lt;/p&gt;&lt;p&gt;- sepsis, pertussis, RSV, meningitis, PNA, infant botulism
&lt;/p&gt;&lt;p&gt;- Trauma, anemia, poisoning, NM d/o, metabolic d/o
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;50% have specified etiology:
&lt;/p&gt;&lt;p&gt;-Neuro: Seizure, breath-holding spell
&lt;/p&gt;&lt;p&gt;-GE reflux (Sandifer's sign: arching back to get comfortable), TEF
&lt;/p&gt;&lt;p&gt;-Infection: sepsis, meningitis, PNA, bronchiolits, Apnea of prematurity
&lt;/p&gt;&lt;p&gt;-15% are CNS: sz, ventricular hemorrhage, hydrocephalus
&lt;/p&gt;&lt;p&gt;-Cardiac: Duct-dependent lesion, long QT, arrhythmias
&lt;/p&gt;&lt;p&gt;-Metabolic, electrolytes, abuse
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Apparent_Life-Threatening_Event_(ALTE)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;at least 48 hrs for r/o sepsis
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Apparent_Life-Threatening_Event_(ALTE)&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from Pani
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="appendicitis_(peds)"><name>Appendicitis (Peds)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Pearls"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Pearls&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#History_.26_Physical"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;History &amp;amp; Physical&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Laboratory_Findings"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Laboratory Findings&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Imaging"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Imaging&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Pediatric_Appendicitis_Score"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Pediatric Appendicitis Score&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Management"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Management&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Differential_Diagnosis"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;Differential Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;9&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-10"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;10&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Appendicitis_(Peds)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Pearls"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Pearls"&gt; Pearls &lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Most common between 6-14 yrs (peak 9y-12y)
&lt;/li&gt;&lt;li&gt;Perforation rate up to 92% in children &amp;lt;3 yrs old
&lt;/li&gt;&lt;li&gt;Local tenderness + rigidity at McBurney's point is most reliable clinical sign
&lt;/li&gt;&lt;li&gt;Analgesia does not delay diagnosis!
&lt;/li&gt;&lt;li&gt;NPV of 98% achieved if:
&lt;ul&gt;&lt;li&gt;Lack of nausea (or emesis or anorexia)
&lt;/li&gt;&lt;li&gt;Lack of maximal TTP in the RLQ
&lt;/li&gt;&lt;li&gt;Lack of neutrophil count &amp;gt; 6750
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Appendicitis_(Peds)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt; Diagnosis &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;In children with abdominal pain:
&lt;/p&gt;
&lt;table class="pbNotSortable" cellpadding="1" cellspacing="1" width="200" border="1"&gt;

&lt;tr&gt;
&lt;td&gt; Sx
&lt;/td&gt;&lt;td&gt; +LR
&lt;/td&gt;&lt;td&gt; -LR
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Fever
&lt;/td&gt;&lt;td&gt; 3.4
&lt;/td&gt;&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Rebound
&lt;/td&gt;&lt;td&gt; 3.0
&lt;/td&gt;&lt;td&gt; 0.28
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Migration
&lt;/td&gt;&lt;td&gt; 2.5
&lt;/td&gt;&lt;td&gt; 1.2
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; WBC &amp;lt;10k
&lt;/td&gt;&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 0.22
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; ANC &amp;lt;6,750
&lt;/td&gt;&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 0.06
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Appendicitis_(Peds)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: History &amp;amp; Physical"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="History_.26_Physical"&gt; History &amp;amp; Physical &lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;&lt;b&gt;Neonates (birth - 30 days)&lt;/b&gt;
&lt;ul&gt;&lt;li&gt;History
&lt;ul&gt;&lt;li&gt;Vomiting
&lt;/li&gt;&lt;li&gt;Irritability/lethargy
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Physical
&lt;ul&gt;&lt;li&gt;Abdominal distention
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;&lt;b&gt;Infants (30 days - 2 yrs&lt;/b&gt;)
&lt;ul&gt;&lt;li&gt;History
&lt;ul&gt;&lt;li&gt;Vomiting
&lt;/li&gt;&lt;li&gt;Abdominal pain
&lt;/li&gt;&lt;li&gt;Fever
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Physical
&lt;ul&gt;&lt;li&gt;Diffuse abdominal tenderness
&lt;ul&gt;&lt;li&gt;Localized RLQ TTP occurs &amp;lt;50%
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;&lt;b&gt;Preschool (2 - 5yrs)&lt;/b&gt;
&lt;ul&gt;&lt;li&gt;History
&lt;ul&gt;&lt;li&gt;Vomiting (often precedes pain)
&lt;/li&gt;&lt;li&gt;Abdominal pain
&lt;/li&gt;&lt;li&gt;Fever
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Physical
&lt;ul&gt;&lt;li&gt;RLQ tenderness
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;&lt;b&gt;School-age (6 - 12yrs)&lt;/b&gt;
&lt;ul&gt;&lt;li&gt;History
&lt;ul&gt;&lt;li&gt;Vomiting
&lt;/li&gt;&lt;li&gt;Abdominal pain
&lt;/li&gt;&lt;li&gt;Fever
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Physical
&lt;ul&gt;&lt;li&gt;RLQ tenderness
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;&lt;b&gt;Adolescents ( &amp;gt;12yrs)&lt;/b&gt;
&lt;ul&gt;&lt;li&gt;Present similar to adults
&lt;ul&gt;&lt;li&gt;RLQ pain
&lt;/li&gt;&lt;li&gt;Vomiting (occurs after onset of abdominal pain)
&lt;/li&gt;&lt;li&gt;Anorexia
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Appendicitis_(Peds)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Laboratory Findings"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Laboratory_Findings"&gt; Laboratory Findings &lt;/span&gt;&lt;/h2&gt;
&lt;div&gt;
&lt;ul&gt;&lt;li&gt;WBC or neutrophil&amp;nbsp;% elevation
&lt;ul&gt;&lt;li&gt;Sn/Sp = 79/80%
&lt;/li&gt;&lt;li&gt;May also be seen in gastroenteritis, strep, PNA, PID
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;CRP
&lt;ul&gt;&lt;li&gt;May be more Sn than WBC in identifying perforation
&lt;ul&gt;&lt;li&gt;Consider in pts with a prolonged history
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;UA
&lt;ul&gt;&lt;li&gt;7-25% of pts with appy have sterile pyuria
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Appendicitis_(Peds)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Imaging"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Imaging"&gt; Imaging &lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Consider only in intermediate-risk pts
&lt;/li&gt;&lt;li&gt;Ultrasound
&lt;ul&gt;&lt;li&gt;Sn: 88%, Sp: 94%
&lt;/li&gt;&lt;li&gt;Consider as 1st choice in non-obese children
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;CT (+/- contrast)
&lt;ul&gt;&lt;li&gt;Sn: 94%, Sp: 95%
&lt;/li&gt;&lt;li&gt;Consider if U/S is equivocal OR strong suspicion despite normal U/S
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Appendicitis_(Peds)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Pediatric Appendicitis Score"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Pediatric_Appendicitis_Score"&gt;Pediatric Appendicitis Score&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Anorexia - 1pt
&lt;/li&gt;&lt;li&gt;Nausea or vomiting - 1pt
&lt;/li&gt;&lt;li&gt;Migration of pain - 1pt
&lt;/li&gt;&lt;li&gt;Fever &amp;gt; 100.5 - 1pt
&lt;/li&gt;&lt;li&gt;Pain with cough, percussion, or hopping - 2pt
&lt;/li&gt;&lt;li&gt;RLQ tenderness - 2pt
&lt;/li&gt;&lt;li&gt;WBC &amp;gt; 10K - 1pt
&lt;/li&gt;&lt;li&gt;Neutrophils + bands &amp;gt; 7500- 1pt
&lt;/li&gt;&lt;/ul&gt;
&lt;/div&gt;&lt;div&gt;
&lt;ul&gt;&lt;li&gt;Score &#8804; 2
&lt;ul&gt;&lt;li&gt;Low risk (0-2.5%)
&lt;/li&gt;&lt;li&gt;Consider d/c home with close f/u
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Score &#8805; 7
&lt;ul&gt;&lt;li&gt;High risk
&lt;/li&gt;&lt;li&gt;Consider surgical consultation
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Score 3-6
&lt;ul&gt;&lt;li&gt;Indeterminate risk
&lt;/li&gt;&lt;li&gt;Consider serial exams, consultation, or imaging
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Appendicitis_(Peds)&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Management"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Management"&gt; Management &lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Fluids (20 mL/kg boluses)
&lt;/li&gt;&lt;li&gt;Analgesia
&lt;/li&gt;&lt;li&gt;ABx
&lt;ul&gt;&lt;li&gt;Second gen cephalosporin OR
&lt;/li&gt;&lt;li&gt;Piperacillin/tazobactam OR
&lt;/li&gt;&lt;li&gt;Penicillin allergy?
&lt;ul&gt;&lt;li&gt;Gent + (clinda or metronidazole)
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Appendicitis_(Peds)&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Differential Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Differential_Diagnosis"&gt; Differential Diagnosis &lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Emergent surgical diagnoses
&lt;ul&gt;&lt;li&gt;Bowel obstruction
&lt;/li&gt;&lt;li&gt;Malrotation
&lt;/li&gt;&lt;li&gt;Intussusception
&lt;/li&gt;&lt;li&gt;Ovarian torsion
&lt;/li&gt;&lt;li&gt;Ectopic pregnancy
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Emergent nonsurgical diagnoses
&lt;ul&gt;&lt;li&gt;HUS
&lt;/li&gt;&lt;li&gt;DKA
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Non-emergent diagnoses
&lt;ul&gt;&lt;li&gt;PID
&lt;/li&gt;&lt;li&gt;PNA
&lt;/li&gt;&lt;li&gt;UTI
&lt;/li&gt;&lt;li&gt;Strep throat
&lt;/li&gt;&lt;li&gt;Gastroenteritis (esp yersinia)
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Appendicitis_(Peds)&amp;amp;action=edit&amp;amp;section=9" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Peds: Abdominal Pain
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Appendicitis_(Peds)&amp;amp;action=edit&amp;amp;section=10" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt; Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Bundy DG et al. Does this child have appendicitis? JAMA 2007; 298:438-451, UpToDate
&lt;/p&gt;
&lt;br /&gt;&lt;/div&gt;




</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="arrhythmias_(ddx)"><name>Arrhythmias (DDX)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#I._Supraventricular"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;I. Supraventricular&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#II._Junctional"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;II. Junctional&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#III._Ventricular"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;III. Ventricular&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#IV._Conduction_Disturbances"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;IV. Conduction Disturbances&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#V._Preterminal"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;V. Preterminal&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#VI._Preexcitation_Syndromes"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;VI. Preexcitation Syndromes&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Arrhythmias_(DDX)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: I. Supraventricular"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="I._Supraventricular"&gt; I. Supraventricular &lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Sinus Dysrhythmia
&lt;/li&gt;&lt;li&gt;Sinus Bradycardia
&lt;/li&gt;&lt;li&gt;Sinus Tachycardia (100-160) [Ddx: fever, hypoxia, anemia, hypovolemia, PE]
&lt;/li&gt;&lt;li&gt;Premature Atrial Contractions
&lt;/li&gt;&lt;li&gt;MAT (100-180) [Ddx: COPD, CHF, sepsis, methylxanthine tox]
&lt;/li&gt;&lt;li&gt;A. Flutter (250-350)
&lt;/li&gt;&lt;li&gt;A. Fib [HTN, ACS, rheumatic HD, thyrotoxicosis)
&lt;/li&gt;&lt;li&gt;Supraventricular tachycardia
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Arrhythmias_(DDX)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: II. Junctional"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="II._Junctional"&gt; II. Junctional &lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;(40-60)
&lt;/li&gt;&lt;li&gt;[Ddx: CHF, HF, myocarditis, hyperkalemia, dig tox)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Arrhythmias_(DDX)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: III. Ventricular"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="III._Ventricular"&gt; III. Ventricular &lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;PVCs [Ddx: dig, CHF, hypokalemia, alkalosis, hypoxia, drugs]
&lt;/li&gt;&lt;li&gt;Accelerated Idioventricular Rhythms (AIVR)
&lt;/li&gt;&lt;li&gt;V. Tach
&lt;/li&gt;&lt;li&gt;Torsades de Pointes
&lt;/li&gt;&lt;li&gt;V. Fib
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Arrhythmias_(DDX)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: IV. Conduction Disturbances"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="IV._Conduction_Disturbances"&gt; IV. Conduction Disturbances &lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;A. AV Block
&lt;ol&gt;&lt;li&gt;First Deg
&lt;/li&gt;&lt;li&gt;Second Deg
&lt;ol&gt;&lt;li&gt;Mobitz I (Wenckeback) -progressive prolongation-
&lt;/li&gt;&lt;li&gt;Mobitz II -droped beat(s)-
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Third Deg
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Arrhythmias_(DDX)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: V. Preterminal"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="V._Preterminal"&gt; V. Preterminal &lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;PEA
&lt;/li&gt;&lt;li&gt;Asystole
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Arrhythmias_(DDX)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: VI. Preexcitation Syndromes"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="VI._Preexcitation_Syndromes"&gt; VI. Preexcitation Syndromes &lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;WPW
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Arrhythmias_(DDX)&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt; Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1/1/06 DONALDSON (from Tintinali)
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="arthrocentesis"><name>Arthrocentesis</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Indications"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Indications&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#Relative_Indications"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;Relative Indications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Contraindications"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Contraindications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Equipment_Needed"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Equipment Needed&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Procedure"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Procedure&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Approach"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Approach&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-7"&gt;&lt;a href="#Shoulder"&gt;&lt;span class="tocnumber"&gt;5.1&lt;/span&gt; &lt;span class="toctext"&gt;Shoulder&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-8"&gt;&lt;a href="#Elbow"&gt;&lt;span class="tocnumber"&gt;5.2&lt;/span&gt; &lt;span class="toctext"&gt;Elbow&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-9"&gt;&lt;a href="#Wrist"&gt;&lt;span class="tocnumber"&gt;5.3&lt;/span&gt; &lt;span class="toctext"&gt;Wrist&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-10"&gt;&lt;a href="#Metacarpophalangeal"&gt;&lt;span class="tocnumber"&gt;5.4&lt;/span&gt; &lt;span class="toctext"&gt;Metacarpophalangeal&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-11"&gt;&lt;a href="#Interphalangeal"&gt;&lt;span class="tocnumber"&gt;5.5&lt;/span&gt; &lt;span class="toctext"&gt;Interphalangeal&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-12"&gt;&lt;a href="#Knee"&gt;&lt;span class="tocnumber"&gt;5.6&lt;/span&gt; &lt;span class="toctext"&gt;Knee&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-13"&gt;&lt;a href="#Ankle"&gt;&lt;span class="tocnumber"&gt;5.7&lt;/span&gt; &lt;span class="toctext"&gt;Ankle&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-14"&gt;&lt;a href="#Metatarsophalangeal"&gt;&lt;span class="tocnumber"&gt;5.8&lt;/span&gt; &lt;span class="toctext"&gt;Metatarsophalangeal&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-15"&gt;&lt;a href="#Interphalangeal_2"&gt;&lt;span class="tocnumber"&gt;5.9&lt;/span&gt; &lt;span class="toctext"&gt;Interphalangeal&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-16"&gt;&lt;a href="#Complications"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Complications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-17"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Arthrocentesis&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Indications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Indications"&gt;Indications&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Diagnosis
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;suspicion of septic arthritis, crystal induced arthritis
&lt;/li&gt;&lt;li&gt;evaluation of therapeutic response for septic arthritis
&lt;/li&gt;&lt;li&gt;unexplained arthritis with synovial effusion
&lt;/li&gt;&lt;/ul&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Arthrocentesis&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Relative Indications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Relative_Indications"&gt;Relative Indications&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Therapeutic (decrease intra-articular pressure, injection of anesthetics/steroids)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Arthrocentesis&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Contraindications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Contraindications"&gt;Contraindications&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;No absolute contraindications for diagnostic arthrocentesis
&lt;/li&gt;&lt;li&gt;do not inject steroids into a joint that you suspect or know to be infected 
&lt;/li&gt;&lt;li&gt;Relative Contraindications:
&lt;ol&gt;&lt;li&gt;coagulopathy
&lt;/li&gt;&lt;li&gt;local or systemic infection
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Arthrocentesis&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Equipment Needed"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Equipment_Needed"&gt;Equipment Needed&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Betadine or Chlorhexadine
&lt;/li&gt;&lt;li&gt;Sterile Gloves/drape
&lt;/li&gt;&lt;li&gt;sterile gauze 
&lt;/li&gt;&lt;li&gt;Lidocaine 
&lt;/li&gt;&lt;li&gt;Syringes
&lt;ol&gt;&lt;li&gt;small syringe (6-12cc) for injection of local anesthetic
&lt;/li&gt;&lt;li&gt;Large (one 60cc or 2 30cc) syringe for aspiration 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Needles 
&lt;ol&gt;&lt;li&gt;18 gauges
&lt;/li&gt;&lt;li&gt;27 gauge 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Collection tubes (red tops)
&lt;/li&gt;&lt;li&gt;Culture bottles
&lt;/li&gt;&lt;li&gt;adhesive bandage
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Arthrocentesis&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Procedure"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Procedure"&gt;Procedure&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Position the patient in a way so that they are comfortable and so you have easy access to the joint that you are going to tap (see below for positioning pearls)
&lt;/li&gt;&lt;li&gt;Prep the area with betadine or chlorhexadine using circular motion moving away from the joint x 3. Drape the joint in a sterile fashion
&lt;/li&gt;&lt;li&gt;Inject lidocaine superficially and then into the deeper tissues
&lt;/li&gt;&lt;li&gt;Confirm landmarks and then insert the needle into the joint space while you are simultaneously pulling back on the plunger of the syringe. Stop once you aspirate fluid and aspirate as much fluid as possible (you may need to replace the syringe multiple times to get larger volumes)
&lt;/li&gt;&lt;li&gt;Once fluid is removed, remove the needle and apply adhesive bandage
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Arthrocentesis&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Approach"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Approach"&gt;Approach&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Arthrocentesis&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Shoulder"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Shoulder"&gt;Shoulder&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;anterior approach: have patient sitting with should in external rotation. Insert needle anteriorly below the tip of the coracoid medial to the humeral head directing it posterolaterally
&lt;/li&gt;&lt;li&gt;posterior approach: same as anterior approach except needle is inserted on the posterior side of the shoulder
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Arthrocentesis&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Elbow"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Elbow"&gt;Elbow&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Have patient sitting with elbow in 90 degrees of flexion, forearm pronated, palm facing downward
&lt;/li&gt;&lt;li&gt;insert needle within triangle bounded by radial head, lateral humeral epicondyle, and olecranon directing it toward the medial epichondyle 
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Arthrocentesis&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Wrist"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Wrist"&gt;Wrist&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;3-4 portal approach: have wrist in slight flexion and ulnar deviation. Insert needle dorsally just distal to Lister's tubercle (bony prominence over the dorsum of the distal radius) and ulnar to the extensor pollicus longus 
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Arthrocentesis&amp;amp;action=edit&amp;amp;section=10" title="Edit section: Metacarpophalangeal"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Metacarpophalangeal"&gt;Metacarpophalangeal&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;have palm facing down and apply gentle traction to the affected digit
&lt;/li&gt;&lt;li&gt;insert needle dorsally just medial or lateral to midline and proximal to the base of the proximal phalanx 
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Arthrocentesis&amp;amp;action=edit&amp;amp;section=11" title="Edit section: Interphalangeal"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Interphalangeal"&gt;Interphalangeal&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;have palm facing down and apply gentle traction to the affected digit
&lt;/li&gt;&lt;li&gt;insert needle dorsally medial or lateral to midline and proximal to base of middle or distal phalanx 
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Arthrocentesis&amp;amp;action=edit&amp;amp;section=12" title="Edit section: Knee"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Knee"&gt;Knee&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Inferior-medial approach: knee flexed at 90 degrees and needle inserted between patella tendon, medial femoral condyle, and medial tibial plateau 
&lt;/li&gt;&lt;li&gt;Medial approach: knee extended and needle inserted 1-2cm medial to patella just distal to proximal edge of the patella directing it posteriorly beneath the patella
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Arthrocentesis&amp;amp;action=edit&amp;amp;section=13" title="Edit section: Ankle"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Ankle"&gt;Ankle&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;plantarflex the ankle and locate the medial malleolus and anterior tibialis tendon
&lt;/li&gt;&lt;li&gt;Insert needle 1/2 inch above medial malleolus, 1/2 inch lateral to anterior edge of medial malleolus, and medial to the anterior tibialis tendon advancing it posteriorly  
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Arthrocentesis&amp;amp;action=edit&amp;amp;section=14" title="Edit section: Metatarsophalangeal"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Metatarsophalangeal"&gt;Metatarsophalangeal&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;patient supine with flexion of the MTP joint 15-20 degrees and apply gentle traction
&lt;/li&gt;&lt;li&gt;insert needle dorsally just medial or lateral to midline between the metatarsal head and base of proximal phalanx 
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Arthrocentesis&amp;amp;action=edit&amp;amp;section=15" title="Edit section: Interphalangeal"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Interphalangeal_2"&gt;Interphalangeal&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;patient supine with joint flexed 15-20 degrees with gentle traction
&lt;/li&gt;&lt;li&gt;insert needle dorsally, medial or lateral to midline between head of proximal phalanx and base of more distal phalanx 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Arthrocentesis&amp;amp;action=edit&amp;amp;section=16" title="Edit section: Complications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Complications"&gt;Complications&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;pain
&lt;/li&gt;&lt;li&gt;infection
&lt;/li&gt;&lt;li&gt;reaccumulation of effusion
&lt;/li&gt;&lt;li&gt;damage to tendons, nerves, or blood vessels 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Arthrocentesis&amp;amp;action=edit&amp;amp;section=17" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;&lt;a href="http://emprocedures.com/arthrocentesis/introduction.htm" class="external free" rel="nofollow"&gt;http://emprocedures.com/arthrocentesis/introduction.htm&lt;/a&gt;
&lt;/p&gt;



</content><folder>Procedures</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="asthma"><name>Asthma</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Asthma&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Order CXR if:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Fever
&lt;/li&gt;&lt;li&gt;Worsening sx (return)
&lt;/li&gt;&lt;li&gt;Poor response to Rx
&lt;/li&gt;&lt;li&gt;1st wheeze
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Asthma&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;(In order of severity)
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Albuterol
&lt;ul&gt;&lt;li&gt;continuous = 0.15mg/kg/hr (max 20mg/hr)
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Atrovent
&lt;/li&gt;&lt;li&gt;Steroids (solumedrol/prednisone/prednisolone/dex)
&lt;ul&gt;&lt;li&gt;2mg/kg (inptn = 1mg/kg Q6hrs; outpt burst = 1mg/kg x4dy)
&lt;/li&gt;&lt;li&gt;or dexamethasone PO 0.6mg/kg (max 16kg) 1st dose, 2nd dose 36hrs after
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Magnesium 50mg/kg (max 2gm IV over 20minutes)
&lt;/li&gt;&lt;li&gt;Epi (1:1000) 0.01mg/kg (max 0.5mg) Q20min x 3 SQ
&lt;ul&gt;&lt;li&gt;Terbutaline SQ = same as Epi (max 0.25)
&lt;/li&gt;&lt;li&gt;Caution in elderly/CHF
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Asthma&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Peak Flow = (30 x age-in-yrs) + 30
&lt;/li&gt;&lt;li&gt;Severe = &amp;lt;50% predicted Peak flow
&lt;/li&gt;&lt;li&gt;Severe = &amp;lt;91% SaO2
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Asthma&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from Donaldson, Rosen
&lt;/p&gt;



</content><folder>Pulm</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="asymptomatic_hypertension_(htn)"><name>Asymptomatic Hypertension (HTN)</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Asymptomatic_Hypertension_(HTN)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: JNC-7 Classification"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="JNC-7_Classification"&gt; JNC-7 Classification &lt;/span&gt;&lt;/h2&gt;
&lt;table style="width: 500px" border="1" cellpadding="1" cellspacing="1"&gt;

&lt;tr&gt;
&lt;td&gt; &lt;b&gt;Class&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;&amp;nbsp;Systolic&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Diasolic&lt;/b&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Normal
&lt;/td&gt;&lt;td&gt; &amp;lt;120
&lt;/td&gt;&lt;td&gt; and
&lt;/td&gt;&lt;td&gt; &amp;lt;80
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Pre-hypertension
&lt;/td&gt;&lt;td&gt; 120-130
&lt;/td&gt;&lt;td&gt; or
&lt;/td&gt;&lt;td&gt; 80-89
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Stage 1
&lt;/td&gt;&lt;td&gt; 140-150
&lt;/td&gt;&lt;td&gt; or
&lt;/td&gt;&lt;td&gt; 90-99
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Stage 2
&lt;/td&gt;&lt;td&gt; &#8805;160
&lt;/td&gt;&lt;td&gt; or
&lt;/td&gt;&lt;td&gt; &#8805;100
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Asymptomatic_Hypertension_(HTN)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt; Work-Up &lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Upreg
&lt;/li&gt;&lt;li&gt;&amp;lt;120 diastolic --&amp;gt; home, outpt rx
&lt;/li&gt;&lt;li&gt;&amp;gt;210 systolic or &amp;gt;120-130 diastolic --&amp;gt; search end organ
&lt;ol&gt;&lt;li&gt;Chem 7 (creatinine)
&lt;/li&gt;&lt;li&gt;UA (protein)?
&lt;/li&gt;&lt;li&gt;ECG?
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;Note:
&lt;/p&gt;&lt;p&gt;The Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure recommends an average of 2 or more properly measured, seated blood pressure readings on each of 2 or more office visits to establish the diagnosis
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Asymptomatic_Hypertension_(HTN)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt; Treatment &lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;HCTZ all
&lt;/li&gt;&lt;li&gt;2dary= B-blockers; Ca channel in AA
&lt;/li&gt;&lt;li&gt;also ACE in CHF, DM
&lt;/li&gt;&lt;/ol&gt;




</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="atrial_fibrillation_(general)"><name>Atrial Fibrillation (General)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Cardioversion"&gt;&lt;span class="tocnumber"&gt;4.1&lt;/span&gt; &lt;span class="toctext"&gt;Cardioversion&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-6"&gt;&lt;a href="#Chemical_Cardioversion"&gt;&lt;span class="tocnumber"&gt;4.2&lt;/span&gt; &lt;span class="toctext"&gt;Chemical Cardioversion&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-8"&gt;&lt;a href="#Indications_for_hospitalization"&gt;&lt;span class="tocnumber"&gt;5.1&lt;/span&gt; &lt;span class="toctext"&gt;Indications for hospitalization&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#Complications"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Complications&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-10"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;6.1&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-11"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Atrial_Fibrillation_(General)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Causes:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Cardiac (atrial enlargement)
&lt;ol&gt;&lt;li&gt;HTN, CAD, valvular disease, cardiomyopathy, ACS
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Noncardiac (increased automaticity)
&lt;ol&gt;&lt;li&gt;Hyperthyroidism, PE, hypoxic pulmonary conditions, ethanol ("holiday heart"), drugs (cocaine, TCA) 
&lt;/li&gt;&lt;li&gt;Need to treat underlying cause 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Atrial_Fibrillation_(General)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Presentation
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Asymptomatic - 44%
&lt;/li&gt;&lt;li&gt;Palpitations - 32%
&lt;/li&gt;&lt;li&gt;Dyspnea - 10%
&lt;/li&gt;&lt;li&gt;Stroke - 2%
&lt;/li&gt;&lt;li&gt;Also can present with decompensated heart failure, acute pulmonary edema 
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;History
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;History of afib?
&lt;ul&gt;&lt;li&gt;If yes, on medication?
&lt;/li&gt;&lt;li&gt;If no, was the onset recgonized? 
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;&amp;lt;48hrs duration?
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;Physical Exam
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Evidence of hemodynamic instability, CHF?
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;b&gt;ECG (3 types)&lt;/b&gt;
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Typical
&lt;ol&gt;&lt;li&gt;Irregularly, irregular R waves
&lt;/li&gt;&lt;li&gt;QRS rate 140-160/min
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Large fibrillatory waves
&lt;ol&gt;&lt;li&gt;May look like flutter waves
&lt;ol&gt;&lt;li&gt;Unlike a-flutter, the fibrillatory waves are irregular 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Slow, regular A-fib
&lt;ol&gt;&lt;li&gt;Due to complete AV block with escape rhythm 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;ul&gt;&lt;li&gt;Ischemic changes?
&lt;/li&gt;&lt;li&gt;Rate &amp;gt; 250? (think preexcitation)
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Atrial_Fibrillation_(General)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;ECG
&lt;/li&gt;&lt;li&gt;Digoxin level (if appropriate)
&lt;/li&gt;&lt;li&gt;Chem-10
&lt;/li&gt;&lt;li&gt;TSH
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Atrial_Fibrillation_(General)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;See Atrial Fibrillation (RVR) 
&lt;/p&gt;&lt;p&gt;&lt;b&gt;Anti-thrombotic therapy&lt;/b&gt;
Chronic and paroxysmal a fib are associated with thrombus formation
&lt;/p&gt;&lt;p&gt;Decision based on CHADS2 Score
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Chf (1pt)
&lt;/li&gt;&lt;li&gt;HTN (1pt)
&lt;/li&gt;&lt;li&gt;Age&amp;gt;75 (1pt)
&lt;/li&gt;&lt;li&gt;DM (1pt)
&lt;/li&gt;&lt;li&gt;Stroke/TIA (2pts)
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;Score 0 - consider no treatment or ASA
&lt;/p&gt;&lt;p&gt;Score 1 - consider coumadin or ASAn 
&lt;/p&gt;&lt;p&gt;Score 2-6 - consider coumadin (INR goal = 2-3)
&lt;/p&gt;&lt;p&gt;All patients with valvular disease should be on anticoagulation 
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Atrial_Fibrillation_(General)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Cardioversion"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Cardioversion"&gt;Cardioversion&lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt;If unstable OR low risk for clot (risk still about 1%)
&lt;ul&gt;&lt;li&gt;Low Risk = &amp;lt;48 hrs symptoms, new dx, no hx similar episodes, no cause found by history, no LV dysfunction, no mitral valve dz, no prior thromboembolic event
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Then anticoagulation for 3 weeks afterward
&lt;/li&gt;&lt;/ul&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Atrial_Fibrillation_(General)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Chemical Cardioversion"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Chemical_Cardioversion"&gt;Chemical Cardioversion&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Ibutilide (Class III) 
&lt;ol&gt;&lt;li&gt;1 mg over 10 min in pts &amp;gt;60 kg (or 0.01 mg/kg)
&lt;/li&gt;&lt;li&gt;can repeat dose once if not sinus within 10 min of infusion
&lt;/li&gt;&lt;li&gt;Avoid in hypoK, hypoMg, prolonged QT, torsades
&lt;/li&gt;&lt;li&gt;Efficacy superior at 90 min to IV procainamide /sotalol
&lt;/li&gt;&lt;li&gt;(monitor for few hours for polymorph VT (8% incidence), then d/c home with PO beta/Ca blockers)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;Other Options:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Procainamide up to 1 gm IV (100 mg Q5 min) @ &amp;lt;20 mg/min
&lt;/li&gt;&lt;li&gt;Amiodarone 0.75 mg/kg IV over 15 min.  1200 mg in 24h
&lt;/li&gt;&lt;li&gt;Flecainide 300mg po
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Atrial_Fibrillation_(General)&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;New-Onset Afib (&amp;lt;48hrs)
&lt;ol&gt;&lt;li&gt;In the absence of angina, ECG evidence of MI, or recent infarction, no need to admit to r/o MI! 
&lt;/li&gt;&lt;li&gt;If stable, no history of heart disease, no other indication for admission then most patients can be directly d/c'd from the ED after successful pharmacologic or electrical cardioversion
&lt;/li&gt;&lt;li&gt;Outpatient TTE, cardiology follow-up
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Atrial_Fibrillation_(General)&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Indications for hospitalization"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Indications_for_hospitalization"&gt;Indications for hospitalization&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Hemodynamic instability
&lt;/li&gt;&lt;li&gt;Myocardial ischemia
&lt;/li&gt;&lt;li&gt;CHF exacerbation 2/2 a-fib
&lt;/li&gt;&lt;li&gt;Symptomatic recurrence in the ED
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Atrial_Fibrillation_(General)&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Complications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Complications"&gt;Complications&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Hemodynamic compromise
&lt;ol&gt;&lt;li&gt;Lowers CO by 20-30%
&lt;/li&gt;&lt;li&gt;Impaired coronary blood flow 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Arrhythmogenesis
&lt;/li&gt;&lt;li&gt;Arterial thromboembolism
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Atrial_Fibrillation_(General)&amp;amp;action=edit&amp;amp;section=10" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Atrial Fibrillation (RVR)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Atrial_Fibrillation_(General)&amp;amp;action=edit&amp;amp;section=11" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1/30/06  DONALDSON (adapted from Lampe), UpToDate
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="atrial_fibrillation_(rvr)"><name>Atrial Fibrillation (RVR)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Unstable_.28Cardioversion.29"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Unstable (Cardioversion)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Stable_but_Symptomatic_.28Rate_Control.29"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Stable but Symptomatic (Rate Control)&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Calcium-Channel_Blockers"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;Calcium-Channel Blockers&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-3 tocsection-4"&gt;&lt;a href="#Diltiazem"&gt;&lt;span class="tocnumber"&gt;2.1.1&lt;/span&gt; &lt;span class="toctext"&gt;Diltiazem&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Beta-Blockers"&gt;&lt;span class="tocnumber"&gt;2.2&lt;/span&gt; &lt;span class="toctext"&gt;Beta-Blockers&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-3 tocsection-6"&gt;&lt;a href="#Metoprolol"&gt;&lt;span class="tocnumber"&gt;2.2.1&lt;/span&gt; &lt;span class="toctext"&gt;Metoprolol&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-3 tocsection-7"&gt;&lt;a href="#Esmolol"&gt;&lt;span class="tocnumber"&gt;2.2.2&lt;/span&gt; &lt;span class="toctext"&gt;Esmolol&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-8"&gt;&lt;a href="#Digoxin"&gt;&lt;span class="tocnumber"&gt;2.3&lt;/span&gt; &lt;span class="toctext"&gt;Digoxin&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-9"&gt;&lt;a href="#Amiodarone"&gt;&lt;span class="tocnumber"&gt;2.4&lt;/span&gt; &lt;span class="toctext"&gt;Amiodarone&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-10"&gt;&lt;a href="#Stable_and_Asymptomatic"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Stable and Asymptomatic&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-11"&gt;&lt;a href="#Evidence_of_preexcitation"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Evidence of preexcitation&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-12"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-13"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Atrial_Fibrillation_(RVR)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Unstable (Cardioversion)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Unstable_.28Cardioversion.29"&gt; Unstable (Cardioversion) &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Indications
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Ischemic CP
&lt;/li&gt;&lt;li&gt;SBP &amp;lt; 90
&lt;/li&gt;&lt;li&gt;Acute pulmonary edema
&lt;/li&gt;&lt;li&gt;AMS
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;Above must be 2/2 RVR (i.e. if pulse is &amp;lt;130 look for other cause of above signs)
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Sedate: Versed / Ativan / Fentanyl
&lt;/li&gt;&lt;li&gt;Initial 100J monophasic or 50-70j biphasic synchronized cardioversion
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Atrial_Fibrillation_(RVR)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Stable but Symptomatic (Rate Control)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Stable_but_Symptomatic_.28Rate_Control.29"&gt; Stable but Symptomatic (Rate Control) &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Goal &amp;lt; 110bpm1
&lt;/p&gt;&lt;p&gt;Be careful that you are not slowing down a normal physiologic response!
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;RVR in AF may be an appropriate response to fever, hypovolemia, hemorrhage, hypoxemia, withdrawal
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;No evidence that pharmacological rate control has any adverse influence on LV dysfunction
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Atrial_Fibrillation_(RVR)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Calcium-Channel Blockers"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Calcium-Channel_Blockers"&gt;Calcium-Channel Blockers&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Preferred in pts with chronic lung disease or low EF
&lt;/li&gt;&lt;li&gt;Contraindications
&lt;ol&gt;&lt;li&gt;Decompensated heart failure
&lt;/li&gt;&lt;li&gt;Preexcitation
&lt;/li&gt;&lt;li&gt;Significant hypotension
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h4&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Atrial_Fibrillation_(RVR)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Diltiazem"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diltiazem"&gt;Diltiazem&lt;/span&gt;&lt;/h4&gt;
&lt;ol&gt;&lt;li&gt;Bolus 0.25 mg/kg (average adult dose 20mg) over 2 min
&lt;ol&gt;&lt;li&gt;If, after 15 minutes the first dose is tolerated but inadequate, re-bolus 0.35 mg/kg (average adult dose 25 mg)
&lt;/li&gt;&lt;li&gt;If pt responds to 1st or 2nd bolus start infusion at 5-15mg/hr
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Takes 2-5 minutes to work, last 1-4 hours
&lt;/li&gt;&lt;li&gt;94% responive
&lt;/li&gt;&lt;li&gt;If effective, can start PO dilt at 30mg QID
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Atrial_Fibrillation_(RVR)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Beta-Blockers"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Beta-Blockers"&gt;Beta-Blockers&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Particularly useful with a fib associated with exercise, after an acute MI, or with thyrotoxicosis
&lt;/li&gt;&lt;li&gt;Contraindicated in COPD, low EF CHF
&lt;/li&gt;&lt;li&gt;PO load with MTP 25-50mg following successful rate control with IV
&lt;/li&gt;&lt;/ol&gt;
&lt;h4&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Atrial_Fibrillation_(RVR)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Metoprolol"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Metoprolol"&gt;Metoprolol&lt;/span&gt;&lt;/h4&gt;
&lt;ol&gt;&lt;li&gt;2.5-5mg IVP over 2min q5 min up to 3 doses
&lt;/li&gt;&lt;/ol&gt;
&lt;h4&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Atrial_Fibrillation_(RVR)&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Esmolol"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Esmolol"&gt;Esmolol&lt;/span&gt;&lt;/h4&gt;
&lt;ol&gt;&lt;li&gt;Use if unsure whether pt will tolerate a BB (duration of action is only 10-20min)
&lt;/li&gt;&lt;li&gt;Bolus 0.5 mg/kg over one minute, followed by 50 &#181;g/kg/min
&lt;ol&gt;&lt;li&gt;If, after 4 minutes response is inadequate, re-bolus followed by infusion of 100 &#181;g/kg/min
&lt;/li&gt;&lt;li&gt;If, after 4 minutes response is still inadequate, try final bolus followed by infusion of 150 &#181;g/kg/min
&lt;/li&gt;&lt;li&gt;If necessary, infusion can be increased to maximum of 200 &#181;g/kg/min after another four minutes
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Atrial_Fibrillation_(RVR)&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Digoxin"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Digoxin"&gt;Digoxin&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Consider as initial therapy for pts with LV dysfunction who:
&lt;ol&gt;&lt;li&gt;Do not achieve rate control targets on beta blockers alone
&lt;/li&gt;&lt;li&gt;Cannot tolerate addition of or increased doses of a beta blocker due to acute decompensated HF
&lt;/li&gt;&lt;li&gt;Would have digoxin added anyway to improve CHF symptoms independent of AF
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Consider as initial therapy in pts with severe hypotension
&lt;/li&gt;&lt;li&gt;Consider as 2nd agent in pts in whom IV BB or IV CCB has failed to control their rate
&lt;/li&gt;&lt;li&gt;May take up to 6-8 hours to work
&lt;/li&gt;&lt;li&gt;Dosing
&lt;ol&gt;&lt;li&gt;0.25 mg IV q2hr up to 1.5 mg, then 0.125-0.25 mg PO or IV QD
&lt;/li&gt;&lt;li&gt;Adjust dose in presence of renal failure, amiodarone, etc
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Atrial_Fibrillation_(RVR)&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Amiodarone"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Amiodarone"&gt;Amiodarone&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Consider for use in pts with decompensated heart failure or those with accessory pathways
&lt;/li&gt;&lt;li&gt;2nd-line agent for chronic rate control when BBs and CCBs, alone, combined, or when used with digoxin, are ineffective
&lt;/li&gt;&lt;li&gt;Load 5-7 mg/kg IV over 30 min; then 1200 mg over 24 h via continuous infusion or in divided oral doses
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Atrial_Fibrillation_(RVR)&amp;amp;action=edit&amp;amp;section=10" title="Edit section: Stable and Asymptomatic"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Stable_and_Asymptomatic"&gt;Stable and Asymptomatic&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;If mild or no symptoms and pulse only mildly elevated (&amp;lt;120bpm), ok to manage with PO meds
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Atrial_Fibrillation_(RVR)&amp;amp;action=edit&amp;amp;section=11" title="Edit section: Evidence of preexcitation"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Evidence_of_preexcitation"&gt; Evidence of preexcitation &lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Initial therapy is aimed at reversion to sinus rhythm
&lt;/li&gt;&lt;li&gt;Avoid AV nodal agents
&lt;ol&gt;&lt;li&gt;Unstable -&amp;gt; urgent cardioversion
&lt;ol&gt;&lt;li&gt;DC cardioversion
&lt;/li&gt;&lt;li&gt;Pharmacologic cardioversion
&lt;ol&gt;&lt;li&gt;Procainamide
&lt;ol&gt;&lt;li&gt;20-50 mg/min until arrhythmia is controlled, hypotension occurs, QRS complex widens by 50% of original width, or total of 17 mg/kg is given; followed by continuous infusion of 1-4 mg/min
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Stable -&amp;gt; try to avoid cardioversion without adequate anticoagulation
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Atrial_Fibrillation_(RVR)&amp;amp;action=edit&amp;amp;section=12" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt; See Also &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Atrial Fibrillation (Gen)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Atrial_Fibrillation_(RVR)&amp;amp;action=edit&amp;amp;section=13" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt; Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1/30/06 DONALDSON (adapted from Lampe), UpToDate, Niemann lecture
&lt;/p&gt;&lt;p&gt;1RACE II study
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="auricular_hematoma"><name>Auricular Hematoma</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Auricular_Hematoma&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt; Background &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Auricular_Hematoma&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt; Diagnosis &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Auricular_Hematoma&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Auricular_Hematoma&amp;amp;action=edit&amp;amp;section=4" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Auricular_Hematoma&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Auricular_Hematoma&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Auricular_Hematoma&amp;amp;action=edit&amp;amp;section=7" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt; See Also &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Auricular_Hematoma&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt; Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from ....(insert)
&lt;/p&gt;



</content><folder>ENT</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="avulsion_fx_of_pelvis"><name>Avulsion Fx of Pelvis</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Avulsion_Fx_of_Pelvis&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Fx of pelvis in 14y-25y d/t sports, usu ant sup iliac spine (d/t sartorius) or ant inf iliac spine (d/t rectus femoris w/ kicking w/ groin pain) or ischial tuberosity (d/t hamstrings)
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Avulsion_Fx_of_Pelvis&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;XR showing avulsion Fx
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Avulsion_Fx_of_Pelvis&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;NSAIDS and bed rest x1 week, wbat x6 weeks, return to sports in 6-10 wks
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="bnp"><name>BNP</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=BNP&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Values"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Values"&gt;Values&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;&amp;lt;100 --&amp;gt; CHF R/O
&lt;/p&gt;&lt;p&gt;100-400 Consider ddx
&lt;/p&gt;&lt;p&gt;&amp;gt;400 Certain
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=BNP&amp;amp;action=edit&amp;amp;section=2" title="Edit section: DDX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX"&gt; DDX &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1. CHF/AMI
&lt;/p&gt;&lt;p&gt;2. PE
&lt;/p&gt;&lt;p&gt;3. Pulm HTN
&lt;/p&gt;&lt;p&gt;4. Renal dysfx
&lt;/p&gt;&lt;p&gt;(Slightly lowered with obesity &amp;amp; diastolic dysfx)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=BNP&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;4/19/07 DONALDSON (adapted from Ryu)
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="baby_formulas"><name>Baby Formulas</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Baby_Formulas&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Types"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Types"&gt;Types&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;ENFAMIL
&lt;/p&gt;&lt;p&gt;- milk based, for most babies
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;LACTOSE FREE
&lt;/p&gt;&lt;p&gt;- milk based lactose free for fussy, gas diarrhea due to lactose intolerance
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;PROSOBEE
&lt;/p&gt;&lt;p&gt;- soy based milk free lactose free
&lt;/p&gt;&lt;p&gt;for family hx of allergy or milk sensitivity
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;NUTRAMIGEN
&lt;/p&gt;&lt;p&gt;- protein free, hypoallergenic, lactose free, for colic or other sx due to milk protein allergy
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Baby_Formulas&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;6/06 MISTRY
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="back_pain_(red_flags)"><name>Back Pain (Red Flags)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Traditional_Red_Flags"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Traditional Red Flags&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#History"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;History&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Physical_Exam"&gt;&lt;span class="tocnumber"&gt;1.2&lt;/span&gt; &lt;span class="toctext"&gt;Physical Exam&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Specific_Condition_Red_Flags"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Specific Condition Red Flags&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Cancer_Related"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;Cancer Related&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-6"&gt;&lt;a href="#Infection_Related"&gt;&lt;span class="tocnumber"&gt;2.2&lt;/span&gt; &lt;span class="toctext"&gt;Infection Related&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-7"&gt;&lt;a href="#Cauda_Equina"&gt;&lt;span class="tocnumber"&gt;2.3&lt;/span&gt; &lt;span class="toctext"&gt;Cauda Equina&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-8"&gt;&lt;a href="#Herniated_Disc"&gt;&lt;span class="tocnumber"&gt;2.4&lt;/span&gt; &lt;span class="toctext"&gt;Herniated Disc&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-9"&gt;&lt;a href="#Vertebral_Fracture"&gt;&lt;span class="tocnumber"&gt;2.5&lt;/span&gt; &lt;span class="toctext"&gt;Vertebral Fracture&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-10"&gt;&lt;a href="#AAA"&gt;&lt;span class="tocnumber"&gt;2.6&lt;/span&gt; &lt;span class="toctext"&gt;AAA&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-11"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Back_Pain_(Red_Flags)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Traditional Red Flags"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Traditional_Red_Flags"&gt;Traditional Red Flags&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Back_Pain_(Red_Flags)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: History"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="History"&gt;History&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Pain &amp;gt;6wks
&lt;/li&gt;&lt;li&gt;Age &amp;gt;50&amp;lt;18
&lt;/li&gt;&lt;li&gt;Hx of trauma
&lt;/li&gt;&lt;li&gt;Sciatica
&lt;/li&gt;&lt;li&gt;Neurological complaints (paresthesias, anesthesia, weakness)
&lt;/li&gt;&lt;li&gt;Incontinence of bowel or bladder
&lt;/li&gt;&lt;li&gt;Night pain
&lt;/li&gt;&lt;li&gt;Unrelenting pain despite analgesics
&lt;/li&gt;&lt;li&gt;Fever, chills, night sweats
&lt;/li&gt;&lt;li&gt;Hx of IVDU
&lt;/li&gt;&lt;li&gt;Hx of CA
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Back_Pain_(Red_Flags)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Physical Exam"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Physical_Exam"&gt;Physical Exam&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Fever
&lt;/li&gt;&lt;li&gt;Pt writhing in pain
&lt;/li&gt;&lt;li&gt;Point vertebral tenderness
&lt;/li&gt;&lt;li&gt;Neurological deficits
&lt;/li&gt;&lt;li&gt;Positive SLR
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Back_Pain_(Red_Flags)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Specific Condition Red Flags"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Specific_Condition_Red_Flags"&gt;Specific Condition Red Flags&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Back_Pain_(Red_Flags)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Cancer Related"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Cancer_Related"&gt;Cancer Related&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Hx of back pain
&lt;/li&gt;&lt;li&gt;Weight loss&amp;gt;10kg in 6 months
&lt;/li&gt;&lt;li&gt;Age&amp;gt;50 &amp;lt;18
&lt;/li&gt;&lt;li&gt;No improvement despite therapy
&lt;/li&gt;&lt;li&gt;Pain for 4-6 weeks
&lt;/li&gt;&lt;li&gt;Night pain
&lt;/li&gt;&lt;li&gt;Pain worse at rest
&lt;/li&gt;&lt;li&gt;Vertebral tenderness
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Back_Pain_(Red_Flags)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Infection Related"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Infection_Related"&gt;Infection Related&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Persistent fever
&lt;/li&gt;&lt;li&gt;History of IVDA
&lt;/li&gt;&lt;li&gt;Recent infection
&lt;/li&gt;&lt;li&gt;Immunocompromised state
&lt;ol&gt;&lt;li&gt; Systemic Corticosteroids
&lt;/li&gt;&lt;li&gt; Transplant
&lt;/li&gt;&lt;li&gt; Diabetes
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; HIV
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Back_Pain_(Red_Flags)&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Cauda Equina"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Cauda_Equina"&gt;Cauda Equina&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Incontinence or retention
&lt;/li&gt;&lt;li&gt;Saddle anesthesia
&lt;/li&gt;&lt;li&gt;Decreased anal sphincter tone
&lt;/li&gt;&lt;li&gt;Bilateral lower extremity weakness or numbness
&lt;/li&gt;&lt;li&gt;Neurologic deficit
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Back_Pain_(Red_Flags)&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Herniated Disc"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Herniated_Disc"&gt;Herniated Disc&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Muscle Weakness
&lt;/li&gt;&lt;li&gt;Radiation of pain
&lt;/li&gt;&lt;li&gt;Footdrop
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Back_Pain_(Red_Flags)&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Vertebral Fracture"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Vertebral_Fracture"&gt;Vertebral Fracture&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Prolonged use of corticosteroids
&lt;/li&gt;&lt;li&gt;History of osteoporosis
&lt;/li&gt;&lt;li&gt;Age&amp;gt;70
&lt;/li&gt;&lt;li&gt;Mild trauma in age &amp;gt; 50
&lt;/li&gt;&lt;li&gt;Significant trauma in any age
&lt;/li&gt;&lt;li&gt;Bony tenderness
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Back_Pain_(Red_Flags)&amp;amp;action=edit&amp;amp;section=10" title="Edit section: AAA"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="AAA"&gt;AAA&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Risk factors for PVD
&lt;/li&gt;&lt;li&gt;Pulsating mass
&lt;/li&gt;&lt;li&gt;Pain at rest or at night
&lt;/li&gt;&lt;li&gt;Age &amp;gt; 60 years
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Back_Pain_(Red_Flags)&amp;amp;action=edit&amp;amp;section=11" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Ortho: Lower Back Pain
&lt;/p&gt;



</content><folder>Ortho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="bacterial_conjunctivitis"><name>Bacterial Conjunctivitis</name><content>&lt;p&gt;if hyperacute or purulent look for gonorrhea and tx c ceftriaxone im, ocular lavage, topical e- mycin
&lt;/p&gt;



</content><folder>Ophtho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="bartholin_gland_abscess"><name>Bartholin Gland Abscess</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Complications"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Complications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Bartholin_Gland_Abscess&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Pathogens: E.coli, lesser GC/C
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Bartholin_Gland_Abscess&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Labs: GC/C
&lt;/p&gt;&lt;p&gt;Pts &amp;gt;40 yr/non-healing abscesses - r/o malignancy
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Bartholin_Gland_Abscess&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Anatomy: 4 and 8 o'clock position at vag orifice
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Bartholin_Gland_Abscess&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;I&amp;amp;D, sitz baths, CTX/doxy for GC/C, clinda/metro/augmentin, word catheter (keep &amp;gt;6 wks better)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Bartholin_Gland_Abscess&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Complications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Complications"&gt;Complications&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Reinfection common; keeping Word catheter in &amp;gt;6 wks increases likelihood of epithelializ. of new tract
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Bartholin_Gland_Abscess&amp;amp;action=edit&amp;amp;section=6" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;ID: Abscess
&lt;/p&gt;



</content><folder>ID</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="beer_potomania_syndrome"><name>Beer Potomania Syndrome</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Beer_Potomania_Syndrome&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;The pathophysiology involves the inability to excrete sufficient free water, based on a loss of normal renal urea gradients. Patients may actually be total-body sodium depleted, yet have elevated urinary sodium and fractional sodium excretion due to this disorder of water metabolism. Attention to proper nutrition during the acute illness may obviate the need for potentially hazardous administration of hypertonic saline
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Beer_Potomania_Syndrome&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;a history of chronic alcohol ingestion (in a hypotonic form)
&lt;/li&gt;&lt;li&gt;protein malnutrition
&lt;/li&gt;&lt;li&gt;signs, symptoms and laboratory values consistent with water intoxication, including hyponatraemia, hypochloraemia and, usually, hypokalaemia
&lt;/li&gt;&lt;li&gt;no evidence of another cause of hyponatraemia such as steroid use, diuretic use, hyperlipidaemia, etc. 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Beer_Potomania_Syndrome&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Chem 10 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Beer_Potomania_Syndrome&amp;amp;action=edit&amp;amp;section=4" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Beer_Potomania_Syndrome&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Beer_Potomania_Syndrome&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Beer_Potomania_Syndrome&amp;amp;action=edit&amp;amp;section=7" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Tox: ETOH Intoxication
&lt;/p&gt;&lt;p&gt;Tox: ETOH Withdrawl
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Beer_Potomania_Syndrome&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Va Med. 1989 Jun;116(6):270-1.  Beer potomania syndrome in an alcoholic.  Harrow AS.
&lt;/p&gt;



</content><folder>FEN</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="bells_palsy"><name>Bells Palsy</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Bells_Palsy&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; unilateral, peripheral facial paralysis that is abrupt in onset
&lt;/li&gt;&lt;li&gt; most common neurlogic disorder affecting the cranial nerves 
&lt;/li&gt;&lt;li&gt; thought to be due to inflammation and swelling of the facial nerve but etiology is still unclear (thought to be infectious (viral), genetic, vascular, or immunologic in origin)
&lt;/li&gt;&lt;li&gt; affects 1 person in 65 with a higher incidence in diabetics and those of Japanese descent
&lt;/li&gt;&lt;li&gt; occurs mostly in patients 10-30 years 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Bells_Palsy&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; patients often present with:
&lt;ol&gt;&lt;li&gt; weakness to one side of the face
&lt;/li&gt;&lt;li&gt; may have pain in the mastoid region with hyperacusis
&lt;/li&gt;&lt;li&gt; may present with tear flow or dry eyes 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; physical exam revelas:
&lt;ol&gt;&lt;li&gt; weakness + paralysis of upper and lower face on one side 
&lt;/li&gt;&lt;li&gt; may have difficulty with eye closure
&lt;/li&gt;&lt;li&gt; other cranial nerves are spared
&lt;/li&gt;&lt;li&gt; TM may be inflammed or have vesicles
&lt;/li&gt;&lt;li&gt; look for rash/vesicles in ear canal, pinna, mouth (Ramsey Hunt) 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Bells_Palsy&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;no specific lab tests are done to confirm diangosis of bells palsy. may order tests to rule out other causes of the paralysis. these may include:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt; CBC 
&lt;/li&gt;&lt;li&gt; ESR
&lt;/li&gt;&lt;li&gt; thyroid function studies 
&lt;/li&gt;&lt;li&gt; accucheck
&lt;/li&gt;&lt;li&gt; lyme titer
&lt;/li&gt;&lt;li&gt; RPR
&lt;/li&gt;&lt;li&gt; HIV
&lt;/li&gt;&lt;li&gt; CSF
&lt;/li&gt;&lt;li&gt; CT head/MRI
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Bells_Palsy&amp;amp;action=edit&amp;amp;section=4" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; diabetes
&lt;/li&gt;&lt;li&gt; mandible fracture
&lt;/li&gt;&lt;li&gt; herpes zoster
&lt;/li&gt;&lt;li&gt; multiple sclerosis
&lt;/li&gt;&lt;li&gt; lyme disease
&lt;/li&gt;&lt;li&gt; polyneuritis
&lt;/li&gt;&lt;li&gt; sarcoidosis
&lt;/li&gt;&lt;li&gt; parotid tumor
&lt;/li&gt;&lt;li&gt; mononucleosis
&lt;/li&gt;&lt;li&gt; aneurysm
&lt;/li&gt;&lt;li&gt; meningitis
&lt;/li&gt;&lt;li&gt; leprosy
&lt;/li&gt;&lt;li&gt; osteomyelitis of the skull base
&lt;/li&gt;&lt;li&gt; guillain-barre syndrome 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Bells_Palsy&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Antiviral 
&lt;ol&gt;&lt;li&gt; Acyclovir 2000-4000mg/24hr divided 5 times per day for 7-10days
&lt;/li&gt;&lt;li&gt; Valacyclovir 1000-3000mg/24hrs x 5 days
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Steroids
&lt;ol&gt;&lt;li&gt; start wtihin 72 hours of symptom onset 
&lt;/li&gt;&lt;li&gt; Predinsone 1mg/kg/day (up to 60mg max) for 7-10days 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Eye lubricants/tears/shield 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Bells_Palsy&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;simple bells palsy may be dispo'd home with f/u by pmd
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Bells_Palsy&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from Drakos
&lt;/p&gt;



</content><folder>Neuro</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="benign_positional_vertigo_(bpv)"><name>Benign Positional Vertigo (BPV)</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Benign_Positional_Vertigo_(BPV)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-first decide which ear affected- do Dix Hallpike test w head rotated to R and neck hyperextended and head hanging off bed- if get R sided nystagmus then R ear affected
&lt;/p&gt;&lt;p&gt;- once decide which ear affected- do bedside manuever on that ear
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Benign_Positional_Vertigo_(BPV)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;R Ear Affected
&lt;/p&gt;&lt;p&gt;- place pt recumbant w head turned to right, head hanging off of bed and chin pointing up and wait for sxs to stop
&lt;/p&gt;&lt;p&gt;- then rotate head and body until L ear down
&lt;/p&gt;&lt;p&gt;- then rotate further until face down
&lt;/p&gt;&lt;p&gt;- vertex of head kept down throughout rotation
&lt;/p&gt;&lt;p&gt;- keep face down for 15 sec
&lt;/p&gt;&lt;p&gt;- bring pt back to seated position with head turned to L
&lt;/p&gt;&lt;p&gt;- now keep chin down
&lt;/p&gt;



</content><folder>Neuro</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="beta-blocker_od"><name>Beta-Blocker OD</name><content>&lt;ol&gt;&lt;li&gt;REDIRECT &lt;a href="/wiki/Beta-Blocker_Toxicity" title="Beta-Blocker Toxicity"&gt;Beta-Blocker Toxicity&lt;/a&gt;
&lt;/li&gt;&lt;/ol&gt;




</content><folder></folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="beta-blocker_toxicity"><name>Beta-Blocker Toxicity</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Management"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Management&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Beta-Blocker_Toxicity&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Coingestion with CCB, cyclics, and neuroleptics increases mortality
&lt;/li&gt;&lt;li&gt;Agents with membrane-stabilizing activity are esp lethal
&lt;ul&gt;&lt;li&gt;Prolongs QT &amp;gt; dysrhythmias
&lt;ul&gt;&lt;li&gt;Propranolol
&lt;/li&gt;&lt;li&gt;Sotalol
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Beta-Blocker_Toxicity&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Cardiac
&lt;ul&gt;&lt;li&gt;Bradycardia
&lt;/li&gt;&lt;li&gt;Hypotension
&lt;/li&gt;&lt;li&gt;Ventricular dysrhythmias
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;CNS
&lt;ul&gt;&lt;li&gt;Mental status change
&lt;ul&gt;&lt;li&gt;Delirium, coma
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Seizure (esp w/ propranolol)
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Other
&lt;ul&gt;&lt;li&gt;Hypoglycemia (uncommon in adults)
&lt;/li&gt;&lt;li&gt;Bronchospasm (uncommon)
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Beta-Blocker_Toxicity&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;ECG
&lt;ul&gt;&lt;li&gt;PR prolongation
&lt;/li&gt;&lt;li&gt;Bradycardia
&lt;/li&gt;&lt;li&gt;QT prolongation
&lt;/li&gt;&lt;li&gt;Any bradydysrhythmia
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Glucose
&lt;/li&gt;&lt;li&gt;Chemistry
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Beta-Blocker_Toxicity&amp;amp;action=edit&amp;amp;section=4" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Calcium-channel blockers
&lt;ul&gt;&lt;li&gt;Unlikely to cause CNS changes
&lt;/li&gt;&lt;li&gt;Hyperglycemia is more common
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Digoxin
&lt;ul&gt;&lt;li&gt;Nausea/vomiting is more common
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Clonidine
&lt;ul&gt;&lt;li&gt;Miosis, somnolence
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Cholinergic agents
&lt;ul&gt;&lt;li&gt;SLUDGE
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Beta-Blocker_Toxicity&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Management"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Management"&gt;Management&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Consider charcoal if present within 2 hr of ingestion
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Bradycardia (symptomatic)
&lt;ul&gt;&lt;li&gt; Atropine 0.5-1mg q3-5min up to 0.04mg/kg
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Hypotension
&lt;ul&gt;&lt;li&gt;IV fluids
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Hypoglycemia
&lt;ul&gt;&lt;li&gt;Adult - D50
&lt;/li&gt;&lt;li&gt;Ped - 2.5mL/kg of D10
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
If IV fluid and atropine are not sufficient then consider:
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Glucagon 
&lt;ul&gt;&lt;li&gt;Half-life is 20min
&lt;/li&gt;&lt;li&gt;Consider concurrent administration of ondansetron (causes n/v)
&lt;/li&gt;&lt;li&gt;Adult: 5mg IV bolus over one minute
&lt;/li&gt;&lt;li&gt;Ped: 50mcg/kg
&lt;/li&gt;&lt;li&gt;Rebolus if no response after 10min
&lt;/li&gt;&lt;li&gt;If effective start infusion at:
&lt;ul&gt;&lt;li&gt;Adult: 2-5mg/hr
&lt;/li&gt;&lt;li&gt;Ped: 70mcg/kg/hr
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;High dose insulin and glucose
&lt;ul&gt;&lt;li&gt;Augments myocardial contraction
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Vasopressors
&lt;ul&gt;&lt;li&gt;Consider if all of above has failed
&lt;/li&gt;&lt;li&gt;Epinephrine
&lt;ul&gt;&lt;li&gt;Adult: Start 1 mcg/min and titrate to MAP=60
&lt;/li&gt;&lt;li&gt;Ped: Start 0.1mcg/kg/min
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Hemodialysis
&lt;ul&gt;&lt;li&gt;Only effective for atenolol, sotalol
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Beta-Blocker_Toxicity&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Admit all symptomatic patients
&lt;/li&gt;&lt;li&gt;Admit all sotalol ingestions (long half-life)
&lt;/li&gt;&lt;li&gt;Observe all others for ~ 6hr
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Beta-Blocker_Toxicity&amp;amp;action=edit&amp;amp;section=7" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Beta-Blocker_Toxicity&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Rosen's
&lt;/p&gt;



</content><folder>Tox</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="beta-hcg_levels"><name>Beta-HCG Levels</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Beta-HCG_Levels&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Chart"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Chart"&gt; Chart &lt;/span&gt;&lt;/h2&gt;
&lt;table class="pbNotSortable" border="1" cellpadding="1" cellspacing="1" width="200"&gt;

&lt;tr&gt;
&lt;td&gt; &lt;b&gt;Wk&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Min&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Max&lt;/b&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 3
&lt;/td&gt;&lt;td&gt; 0
&lt;/td&gt;&lt;td&gt; 5
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 4
&lt;/td&gt;&lt;td&gt; 5
&lt;/td&gt;&lt;td&gt; 426
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 5
&lt;/td&gt;&lt;td&gt; 18
&lt;/td&gt;&lt;td&gt; 7,340
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 6
&lt;/td&gt;&lt;td&gt; 1,080
&lt;/td&gt;&lt;td&gt; 56,500
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 7-8
&lt;/td&gt;&lt;td&gt; 7,650
&lt;/td&gt;&lt;td&gt; 229,000
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 9-12
&lt;/td&gt;&lt;td&gt; 25,700
&lt;/td&gt;&lt;td&gt; 288,000
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 13-16
&lt;/td&gt;&lt;td&gt; 13,300
&lt;/td&gt;&lt;td&gt; 254,000
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 17-24
&lt;/td&gt;&lt;td&gt; 4,060
&lt;/td&gt;&lt;td&gt; 165,400
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 25-birth
&lt;/td&gt;&lt;td&gt; 3,640
&lt;/td&gt;&lt;td&gt; 117,000
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 4-6 post
&lt;/td&gt;&lt;td&gt; NA
&lt;/td&gt;&lt;td&gt; &amp;lt;5
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Beta-HCG_Levels&amp;amp;action=edit&amp;amp;section=2" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Beta-HCG_Levels&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert
&lt;/p&gt;



</content><folder>OB/GYN</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="bioterrorism"><name>Bioterrorism</name><content>&lt;p&gt;Top 6 Agents of Concern (CDC)
&lt;/p&gt;&lt;p&gt;1. Anthrax
&lt;/p&gt;&lt;p&gt;2. Smallpox
&lt;/p&gt;&lt;p&gt;3. Plague
&lt;/p&gt;&lt;p&gt;4. Tularemia
&lt;/p&gt;&lt;p&gt;5. Botulinum Toxin
&lt;/p&gt;&lt;p&gt;6. Viral Hem. Fevers
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Treatment:
&lt;/p&gt;&lt;p&gt;1. Anthrax- (Inhalational)
&lt;/p&gt;&lt;p&gt;Cipro (Adult)-400mg IV q 12h
&lt;/p&gt;&lt;p&gt;(Peds)-20-30mg/kg IV q12h
&lt;/p&gt;&lt;p&gt;Doxy (Adult) 100mg IV q 12h
&lt;/p&gt;&lt;p&gt;(Peds) 2.5mg/kg IV q12h
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Prophylaxis
&lt;/p&gt;&lt;p&gt;Cipro (Adult)-500mg PO BID
&lt;/p&gt;&lt;p&gt;(Peds)-20-30mg/kg/d PO BID
&lt;/p&gt;&lt;p&gt;Doxy (Adult) 100mgPO BID
&lt;/p&gt;&lt;p&gt;(Peds) 2.5mg/kg PO BID
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;2. Smallpox
&lt;/p&gt;&lt;p&gt;Supportive care
&lt;/p&gt;&lt;p&gt;Vaccination within 72h=effective
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;6/06 MISTRY
&lt;/p&gt;



</content><folder>Tox</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="bites"><name>Bites</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Table_by_Species"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Table by Species&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#.5EHIGH_RISK"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;^HIGH RISK&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Admission_Criteria_Human_Hand_Bite"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;Admission Criteria Human Hand Bite&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Bites&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Table by Species"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Table_by_Species"&gt; Table by Species&lt;/span&gt;&lt;/h2&gt;
&lt;table style="width: 500px" border="1" cellpadding="1" cellspacing="1"&gt;

&lt;tr&gt;
&lt;td&gt; &lt;b&gt;Species Bite&lt;br /&gt;&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Suturing?&lt;br /&gt;&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Proph Abx?&lt;br /&gt;&lt;/b&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Dog&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Yes (+/- hand/foot)
&lt;/td&gt;&lt;td&gt; High risk^&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Cat&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Face only&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Yes&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Rodent&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Yes&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; No&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Monkey&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; No&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Yes&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Human (hand)&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; No&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Yes&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Human (other)&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Yes&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; High risk^&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Self-bite (mucosa)&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Yes&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; No&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Self-bite (through)&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Yes&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Yes&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Bites&amp;amp;action=edit&amp;amp;section=2" title="Edit section: ^HIGH RISK"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id=".5EHIGH_RISK"&gt; ^HIGH RISK &lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Hand wounds
&lt;/li&gt;&lt;li&gt;Deep punctures
&lt;/li&gt;&lt;li&gt;Heavy contam
&lt;/li&gt;&lt;li&gt;Sig tissue destruct
&lt;/li&gt;&lt;li&gt;&amp;gt;12hrs
&lt;/li&gt;&lt;li&gt;Joint, tendon, bone
&lt;/li&gt;&lt;li&gt;DM; PVD, steroid use, etc
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Bites&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Bites&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Admission Criteria Human Hand Bite"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Admission_Criteria_Human_Hand_Bite"&gt;Admission Criteria Human Hand Bite&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;wound&amp;gt;24hours
&lt;/li&gt;&lt;li&gt;establihed infxn
&lt;/li&gt;&lt;li&gt;penetration joint/tendon
&lt;/li&gt;&lt;li&gt;presence foreign body
&lt;/li&gt;&lt;li&gt;unreliable pt/poor home sit
&lt;/li&gt;&lt;li&gt;diabetic
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Bites&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Abx = Amox/clav
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Bites&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1/22/06 DONALDSON (adapted from Lampe, Rosen)
&lt;/p&gt;



</content><folder>ID</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="bleeding_treatment"><name>Bleeding Treatment</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Treatments"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Treatments&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Warfarin.2FVitamin_K_Def"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Warfarin/Vitamin K Def&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Heparin.2FLovenox"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Heparin/Lovenox&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Liver_Disease"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Liver Disease&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Renal_Disease"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Renal Disease&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#DIC"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;DIC&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Factor_VIII_Inhibitor"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Factor VIII Inhibitor&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Lupus_Anticoagulant"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;Lupus Anticoagulant&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;9&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Bleeding_Treatment&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Treatments"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatments"&gt;Treatments&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; PRBCs
&lt;/li&gt;&lt;li&gt; DDAVP (0.3mirog/kq SQ/IV)
&lt;/li&gt;&lt;li&gt; Platelets
&lt;/li&gt;&lt;li&gt; FFP
&lt;/li&gt;&lt;li&gt; Cryopreticipate
&lt;/li&gt;&lt;li&gt; Vitamin K (10mg SQ/IM)
&lt;/li&gt;&lt;li&gt; Protamine (Heparin)
&lt;/li&gt;&lt;li&gt; Estrogen (Renal)
&lt;/li&gt;&lt;li&gt; PPI/Pepcid/Octreotide (GI)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Bleeding_Treatment&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Warfarin/Vitamin K Def"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Warfarin.2FVitamin_K_Def"&gt;Warfarin/Vitamin K Def&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;(inc PT/INR)
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;FFP
&lt;/li&gt;&lt;li&gt;Vitamin K (+/- takes 24hrs to affect &amp;amp; 2wk to wear off)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Bleeding_Treatment&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Heparin/Lovenox"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Heparin.2FLovenox"&gt;Heparin/Lovenox&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;(inc PTT)
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Protamie (1mg IV Q100 U of heparin in previous 4hrs)
&lt;/li&gt;&lt;li&gt;Massive bleed --&amp;gt; cryoprecipitate (10 U IV), then FFP (&amp;amp; platelets, aminocaproic acid infusion if nec)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Bleeding_Treatment&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Liver Disease"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Liver_Disease"&gt;Liver Disease&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Vitamin K
&lt;/li&gt;&lt;li&gt;PPI/pepcid/octreotide (variceal bleed)
&lt;/li&gt;&lt;li&gt;FFP (&amp;amp; platlets if low)
&lt;/li&gt;&lt;li&gt;DDAVP
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Bleeding_Treatment&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Renal Disease"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Renal_Disease"&gt;Renal Disease&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;PRBCs (&amp;lt;8 Hb)
&lt;/li&gt;&lt;li&gt;Hemodialysis
&lt;/li&gt;&lt;li&gt;DDAVP
&lt;/li&gt;&lt;li&gt;Conjugated estrogens (unknown mechanism)
&lt;/li&gt;&lt;li&gt;Cyroprecipitate &amp;amp; platelets (in life-threatening bleed only)
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Bleeding_Treatment&amp;amp;action=edit&amp;amp;section=6" title="Edit section: DIC"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DIC"&gt;DIC&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;(see also DIC)
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;IVF
&lt;/li&gt;&lt;li&gt;PRBCs
&lt;/li&gt;&lt;li&gt;Vitamin K
&lt;/li&gt;&lt;li&gt;Folate (1mg IV)
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;&lt;br /&gt;
If bleeding predominant DIC:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;FFP (2 U at a time)
&lt;/li&gt;&lt;li&gt;Cryoprecipitate (10 bags at a time)
&lt;/li&gt;&lt;li&gt;(Heparin is contraversial in thrombosis predominant DIC)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Bleeding_Treatment&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Factor VIII Inhibitor"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Factor_VIII_Inhibitor"&gt;Factor VIII Inhibitor&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;(PTT does not correct after mixing)
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;high dose Factor VII, prothrombin, or recombinant factor VIIa
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Bleeding_Treatment&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Lupus Anticoagulant"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Lupus_Anticoagulant"&gt;Lupus Anticoagulant&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;(rare)
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;warfarin or ASA
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Bleeding_Treatment&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1/22/06 DONALDSON (adapted from Tintinalli's)
&lt;/p&gt;



</content><folder>Heme/Onc</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="blood_or_hematology_products"><name>Blood or Hematology Products</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Cryoprecipitate"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Cryoprecipitate&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#Features"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;Features&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Indications"&gt;&lt;span class="tocnumber"&gt;1.2&lt;/span&gt; &lt;span class="toctext"&gt;Indications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Dose"&gt;&lt;span class="tocnumber"&gt;1.3&lt;/span&gt; &lt;span class="toctext"&gt;Dose&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Fresh_Frozen_Plasma"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Fresh Frozen Plasma&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-6"&gt;&lt;a href="#Features_2"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;Features&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-7"&gt;&lt;a href="#Indications_2"&gt;&lt;span class="tocnumber"&gt;2.2&lt;/span&gt; &lt;span class="toctext"&gt;Indications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-8"&gt;&lt;a href="#Dose_2"&gt;&lt;span class="tocnumber"&gt;2.3&lt;/span&gt; &lt;span class="toctext"&gt;Dose&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#Packed_Red_Blood_Cells"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Packed Red Blood Cells&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-10"&gt;&lt;a href="#Features_3"&gt;&lt;span class="tocnumber"&gt;3.1&lt;/span&gt; &lt;span class="toctext"&gt;Features&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-11"&gt;&lt;a href="#Indications_3"&gt;&lt;span class="tocnumber"&gt;3.2&lt;/span&gt; &lt;span class="toctext"&gt;Indications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-12"&gt;&lt;a href="#Dose_3"&gt;&lt;span class="tocnumber"&gt;3.3&lt;/span&gt; &lt;span class="toctext"&gt;Dose&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-13"&gt;&lt;a href="#Platelet_concentrate"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Platelet concentrate&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-14"&gt;&lt;a href="#Features_4"&gt;&lt;span class="tocnumber"&gt;4.1&lt;/span&gt; &lt;span class="toctext"&gt;Features&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-15"&gt;&lt;a href="#Indications_4"&gt;&lt;span class="tocnumber"&gt;4.2&lt;/span&gt; &lt;span class="toctext"&gt;Indications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-16"&gt;&lt;a href="#Dose_4"&gt;&lt;span class="tocnumber"&gt;4.3&lt;/span&gt; &lt;span class="toctext"&gt;Dose&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Blood_or_Hematology_Products&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Cryoprecipitate"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Cryoprecipitate"&gt;Cryoprecipitate&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Blood_or_Hematology_Products&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Features"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Features"&gt;Features&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;1 bag (10ml) has 50-500 units of factor 8 activity
&lt;/li&gt;&lt;li&gt;There are 10 donors per bag
&lt;/li&gt;&lt;li&gt;Contains: fibrinogen, von Willibrand's, factor 8+13
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Blood_or_Hematology_Products&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Indications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Indications"&gt;Indications&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Hypofibrinogemia if fibrinogen &amp;lt;100 mg/dl
&lt;/li&gt;&lt;li&gt;VonWillibrand's disease &amp;amp; active bleeding-if DDAVP is unavailable or
&lt;/li&gt;&lt;li&gt;factor 8 concentrate with vW is unavailable
&lt;/li&gt;&lt;li&gt;Hemophilia A + unavailable monoclonal or viral inactivated factor 8
&lt;/li&gt;&lt;li&gt;Fibronectin replacement for healing in trauma, burns, or sepsis
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Blood_or_Hematology_Products&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Dose"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Dose"&gt;Dose&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;2-4 bags for every 10kg of bodyweight or 10-20 bags at a time
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Blood_or_Hematology_Products&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Fresh Frozen Plasma"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Fresh_Frozen_Plasma"&gt;Fresh Frozen Plasma&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Blood_or_Hematology_Products&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Features"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Features_2"&gt;Features&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Contains all coagulation factors. 40 ml/kg raises any factor by 100%
&lt;/li&gt;&lt;li&gt;May cause fluid overload
&lt;/li&gt;&lt;li&gt;ABO compatibilty a must but crossmatch before transfusing not
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Blood_or_Hematology_Products&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Indications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Indications_2"&gt;Indications&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Coagulation protein deficiency if factor concentrates unavailable
&lt;/li&gt;&lt;li&gt;Reversal of warfarin toxicity or active bleed with liver disease
&lt;/li&gt;&lt;li&gt;Bleeding and coagulapathy with unknown cause
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Blood_or_Hematology_Products&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Dose"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Dose_2"&gt;Dose&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;If bleeding from VitK deficiency (liver disease) 10-25 ml/kg
&lt;/li&gt;&lt;li&gt;10-15 ml/kg will raise factor 8 by 15-20%
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Blood_or_Hematology_Products&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Packed Red Blood Cells"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Packed_Red_Blood_Cells"&gt;Packed Red Blood Cells&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Blood_or_Hematology_Products&amp;amp;action=edit&amp;amp;section=10" title="Edit section: Features"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Features_3"&gt;Features&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Fewer antigens are preent PRBC's compared to whole blood
&lt;/li&gt;&lt;li&gt;Leukocyte poor-use if transplant recipient or candidate
&lt;/li&gt;&lt;li&gt;Washed-use if prior anaphylaxis due to IgA or other proteins
&lt;/li&gt;&lt;li&gt;Frozen deglycerized-purest RBC product use if reaction to washed RBC's
&lt;ol&gt;&lt;li&gt;or a transfusion reactionfrom anti-IgA antibodies
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Blood_or_Hematology_Products&amp;amp;action=edit&amp;amp;section=11" title="Edit section: Indications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Indications_3"&gt;Indications&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Acute hemorrhage or chronic anemia with Hgb &amp;lt; 7-8 g/dl
&lt;/li&gt;&lt;li&gt;Symptomatic anemia or cardiopulmonary disease + Hb &amp;lt; 8-10 g/dl
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Blood_or_Hematology_Products&amp;amp;action=edit&amp;amp;section=12" title="Edit section: Dose"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Dose_3"&gt;Dose&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;One unit raises hemoglobin by 1 g/dl or hematocrit &amp;lt; 3%
&lt;/li&gt;&lt;li&gt;&amp;gt;=2 untis require
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Blood_or_Hematology_Products&amp;amp;action=edit&amp;amp;section=13" title="Edit section: Platelet concentrate"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Platelet_concentrate"&gt;Platelet concentrate&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Blood_or_Hematology_Products&amp;amp;action=edit&amp;amp;section=14" title="Edit section: Features"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Features_4"&gt;Features&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;1 unit (pack)=5-10,000 platelets.  Platelets are not refrigerated &amp;amp; survive 7days
&lt;/li&gt;&lt;li&gt;ABO cross-match is not necessary, but preferred
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Blood_or_Hematology_Products&amp;amp;action=edit&amp;amp;section=15" title="Edit section: Indications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Indications_4"&gt;Indications&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Level &amp;lt;10,000/uL unless anti-platelet anti-bodies
&lt;/li&gt;&lt;li&gt;Level &amp;lt;50,000/uL if major surgery, significant bleed, major trauma
&lt;/li&gt;&lt;li&gt;Level &amp;lt;10-50, 000/uL if concurrent liver or renal disease that is causing platelet dysfunction
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Blood_or_Hematology_Products&amp;amp;action=edit&amp;amp;section=16" title="Edit section: Dose"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Dose_4"&gt;Dose&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;6 platelet packs (250-300 ml) or one plateletpheresis pack should raise platelet count by 50-60,000/uL
&lt;/p&gt;



</content><folder>Drugs</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="botulism"><name>Botulism</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Symptoms"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Symptoms&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Infant_Botulism"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;Infant Botulism&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Wound_Botulism"&gt;&lt;span class="tocnumber"&gt;2.2&lt;/span&gt; &lt;span class="toctext"&gt;Wound Botulism&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Workup"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Workup&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Botulism&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; sporeforming,m obligate anaerobe, gram positive
&lt;/li&gt;&lt;li&gt; lethal dose 1 ng/kg
&lt;/li&gt;&lt;li&gt; 1 gm can kill 1 million people
&lt;/li&gt;&lt;li&gt; blocks release of Ach from presynaptic membrane
&lt;/li&gt;&lt;li&gt; experimental vaccine
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Botulism&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Symptoms"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Symptoms"&gt;Symptoms&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; symmetric, desc. paralysis w/B/L cranial nerve neuropathies (diplopia, dysarthria, ptosis)
&lt;/li&gt;&lt;li&gt; GI sxs: N/V, pain, late constipation
&lt;/li&gt;&lt;li&gt; Respiratory Failure
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Botulism&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Infant Botulism"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Infant_Botulism"&gt;Infant Botulism&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; no honey or corn syrup to &amp;lt; 1 yo
&lt;/li&gt;&lt;li&gt; most cases &amp;lt; 1 y/o, 90% &amp;lt; 6mo
&lt;/li&gt;&lt;li&gt; most common form of botulism
&lt;/li&gt;&lt;li&gt; relative achlorhydia, poorly developed gut flora
&lt;/li&gt;&lt;li&gt; sxs from mild failure to thrive to sudden infant death
&lt;/li&gt;&lt;li&gt; drooling, ptosis, dilated/sluggish pupils, weak cry, feeding difficulties, constipation, resp arrest, poor head control, diminished muscle tone
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Botulism&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Wound Botulism"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Wound_Botulism"&gt;Wound Botulism&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; black tar heroin, dirty wounds, C-section, tooth abscess, sinus infections
&lt;/li&gt;&lt;li&gt; incubation 10 days
&lt;/li&gt;&lt;li&gt; wound may appear benign
&lt;/li&gt;&lt;li&gt; GI sxs absent
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Botulism&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; clinically
&lt;/li&gt;&lt;li&gt; EMG studies: in botulism and Lambert-Eaton, few AcH released and muscle fibers don't reach threshold for contraction. With rapid nerve stim, can get enough AcH buildup in multiple muscle fibers to get "posttetanic facilitation."
&lt;/li&gt;&lt;li&gt; Nerve Conduction - normal in botulism (unlike GBS)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Botulism&amp;amp;action=edit&amp;amp;section=6" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Myasthenia Gravis - EMG findings and antibody studies will differentiate (decremental response to repetitive nerve stimulation). CAN see false positive improvement to Tensilon test in botulism
&lt;/li&gt;&lt;li&gt; Lambert-Eaton - spares resp muscles and primarily affects proximal lower limb muscles EMG findings similar to botulism (post-tetanic facilitation) but not identical
&lt;/li&gt;&lt;li&gt; Guillain -Barre - Miller Fisher variant has prominent ataxia &amp;amp; areflexia that isn't seen in botulism. Nerve conduction tests are also abnormal
&lt;/li&gt;&lt;li&gt; Poliomyelitis - usually have fever and asymmetric weakness. Ascending paralysis and CSF pleocytosis.
&lt;/li&gt;&lt;li&gt; Tick Paralysis - ascending paralysis, abnl nerve cond tests
&lt;/li&gt;&lt;li&gt; Diphtheria - proximal to distal spread of weakness 1-3 mo after fever and pharyngitis
&lt;/li&gt;&lt;li&gt; Hyperthyroidism
&lt;/li&gt;&lt;li&gt; Paralytic fish poisoning - tetrodotoxication (w/in 1 hr of fish eat)
&lt;/li&gt;&lt;li&gt; Mg, mushroom or chemical (arsenic,thallium, anticholinergic) or meds (antichol, aminogly)
&lt;/li&gt;&lt;li&gt; Sepsis
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Botulism&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Workup"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Workup"&gt;Workup&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Anaerobic cxs: emesis, gastric fluid, stool, food, wound, serum
&lt;/li&gt;&lt;li&gt; EPS - EMG shows decr amplitude with post-tetanic facilitation Nerve conduction normal
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Botulism&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Ventilatory support: Intubate when VC &amp;lt; 30% predicted or &amp;lt; 12 cc/kg
&lt;/li&gt;&lt;li&gt; Foodbrone: antitoxin and AC, consider cathartics
&lt;/li&gt;&lt;li&gt; Infant: supportive care only, no benefit from antitoxin or Abx
&lt;/li&gt;&lt;li&gt; Wound: antitoxin, Td, wound irrigation &amp;amp; debridement even if appears well. Pen G 10-20 mill units/day
&lt;/li&gt;&lt;/ol&gt;




</content><folder>ID</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="bouncebacks_(prevention)"><name>Bouncebacks (Prevention)</name><content>&lt;p&gt;STEP 1
&lt;/p&gt;&lt;p&gt;Identify High Risk patients:
&lt;/p&gt;&lt;p&gt;-High risk complaint without definitive diagnosis on d/c (eg A/P, C/P, H/A, F)
&lt;/p&gt;&lt;p&gt;-Abnl VS
&lt;/p&gt;&lt;p&gt;-Condition making it less likely pt will return for worsening symptoms (mental/psych/substance abuse)
&lt;/p&gt;&lt;p&gt;-Chronic dz with decompensation
&lt;/p&gt;&lt;p&gt;-Difficulty obtaining accurate data (language, dementia, inebriation, etc)
&lt;/p&gt;&lt;p&gt;-Advanced age
&lt;/p&gt;&lt;p&gt;-Upset pt
&lt;/p&gt;&lt;p&gt;-Unmet pt expectations
&lt;/p&gt;&lt;p&gt;-Bouncebacks (a pt return, us within 72h)
&lt;/p&gt;&lt;p&gt;-OVERALL: a pt you will worry about after your shift
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;STEP 2
&lt;/p&gt;&lt;p&gt;Review your evaluation prior to d/c:
&lt;/p&gt;&lt;p&gt;-Address ALL documented complaints in H&amp;amp;P
&lt;/p&gt;&lt;p&gt;-Confirm hx is accurate
&lt;/p&gt;&lt;p&gt;-Consider potentially serious dx
&lt;/p&gt;&lt;p&gt;-Explore abnl findings
&lt;/p&gt;&lt;p&gt;-Write a progress note explaining medical decision-making process (if unclear in H&amp;amp;P)
&lt;/p&gt;&lt;p&gt;-Assure that aftercare instructions are specific and f/u is timely and available
&lt;/p&gt;&lt;p&gt;-Confirm that pt understands and is comfortable with the plan
&lt;/p&gt;&lt;p&gt;-OVERALL: Complete a medically and legally defensible eval which is reflected in the documentation on the chart
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Source
&lt;/p&gt;&lt;p&gt;"Bouncebacks" (Weinstock, Longstreth)
&lt;/p&gt;



</content><folder>Policy</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="bradycardia_(wide)"><name>Bradycardia (Wide)</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Bradycardia_(Wide)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: DDX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX"&gt; DDX &lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Hyperkalemia
&lt;ul&gt;&lt;li&gt;normally peaked T-waves
&lt;/li&gt;&lt;li&gt;no U-waves
&lt;/li&gt;&lt;li&gt;See "FEN: HyperK"
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Dig toxicity
&lt;ul&gt;&lt;li&gt;Normally flattented T-waves
&lt;/li&gt;&lt;li&gt;depressed ST segments
&lt;/li&gt;&lt;li&gt;U-waves
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;PEA
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Bradycardia_(Wide)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Empiric Tx (arrest)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Empiric_Tx_.28arrest.29"&gt; Empiric Tx (arrest) &lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Digibind 6 vials (over 30min)
&lt;/li&gt;&lt;li&gt;?CaCl 1 amp IV (can give mult times)*
&lt;ol&gt;&lt;li&gt;Caution in dig-toxic patients!
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Bradycardia_(Wide)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;10/07 DONALDSON
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="brain_death"><name>Brain Death</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Criteria"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Criteria&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Brain_Stem_Reflexes"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Brain Stem Reflexes&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Apnea_Testing"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Apnea Testing&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Brain_Death&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Criteria"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Criteria"&gt;Criteria&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Known proximate cause of condition
&lt;/li&gt;&lt;li&gt; Exclusion of complicating medical conditions (severe electrolyte, acidbase, or endocrine disturbance)
&lt;/li&gt;&lt;li&gt; No drug intoxication/poisoning
&lt;/li&gt;&lt;li&gt; Core temp &amp;gt;32C (90F)
&lt;/li&gt;&lt;li&gt; Cerebral unresponsiveness
&lt;/li&gt;&lt;li&gt; Absence of brain stem relexes (see below)
&lt;/li&gt;&lt;li&gt; Apneic (see below)
&lt;/li&gt;&lt;li&gt; Irreversible condition (+/- repeat exam in 6hrs)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Brain_Death&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Brain Stem Reflexes"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Brain_Stem_Reflexes"&gt;Brain Stem Reflexes&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Pupils
&lt;ol&gt;&lt;li&gt;no response to light (fixed and mid-dialated)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Ocular movement
&lt;ol&gt;&lt;li&gt;no oculocephalic reflex (deviation of eyes to irrigation w/ 50mL cold water to ears - allow 1 min after and 5 min b/t)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Facial motor response/sensation
&lt;ol&gt;&lt;li&gt;jaw reflex (grimacing to deep facial pressure)
&lt;/li&gt;&lt;li&gt;corneal reflex (touch eye w/ swab)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Paryngeal/tracheal
&lt;ol&gt;&lt;li&gt;gag (tounge blade)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Brain_Death&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Apnea Testing"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Apnea_Testing"&gt;Apnea Testing&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Prerequisites:
&lt;ol&gt;&lt;li&gt;Core temp &amp;gt;36.5 C (97 F)
&lt;/li&gt;&lt;li&gt;SBP &amp;gt;90
&lt;/li&gt;&lt;li&gt;Corrected DI
&lt;/li&gt;&lt;li&gt;Nl PCO2 (&amp;gt;40)
&lt;/li&gt;&lt;li&gt;Nl PO2 (preoxiginate &amp;gt;200)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Test:
&lt;ol&gt;&lt;li&gt;Connect pulse ox, disconnect ventilator, place nasal cannula in ET (at carina), observe for resp movements, draw ABG @ 8 min
&lt;/li&gt;&lt;li&gt;Pos test = PCO2 &amp;gt;60 (or 20 increase over baseline)
&lt;/li&gt;&lt;li&gt;reconnect ventilator if SBP &amp;lt;90 or sig O2 desat (can draw ABG @ that time, with same criteria as above)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;One-Legacy 800-338-6112
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Brain_Death&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;2/8/07 DONALDSON (adapted from One-Legacy)
&lt;/p&gt;



</content><folder>Neuro</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="bronchiolitis_(rsv)"><name>Bronchiolitis (RSV)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Epidemiology"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Epidemiology&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#CXR"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;CXR&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Admit"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Admit&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#DDX"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;DDX&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Bronchiolitis_(RSV)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Epidemiology"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Epidemiology"&gt;Epidemiology&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Children &amp;lt; 2years old (peak 2-6mo age)
&lt;/p&gt;&lt;p&gt;-1st episode wheeze
&lt;/p&gt;&lt;p&gt;-seasonal
&lt;/p&gt;&lt;p&gt;-no fam h/o asthma/atopy
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Bronchiolitis_(RSV)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1. O2 (maintain SaO2 &amp;gt;90%)
&lt;/p&gt;&lt;p&gt;2. Racemic Epi neb (or albuterol)
&lt;/p&gt;&lt;p&gt;3. No steroids (for 1st episode wheezing)
&lt;/p&gt;&lt;p&gt;4.&amp;nbsp;?Send RSV
&lt;/p&gt;&lt;p&gt;5. Suction nares
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Bronchiolitis_(RSV)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: CXR"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="CXR"&gt;CXR&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1. Mod-severe
&lt;/p&gt;&lt;p&gt;2. Recurrance
&lt;/p&gt;&lt;p&gt;3. Toxic
&lt;/p&gt;&lt;p&gt;4. Sudden deterioration
&lt;/p&gt;&lt;p&gt;5. Prolonged course
&lt;/p&gt;&lt;p&gt;6. *1st time wheeze
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Bronchiolitis_(RSV)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Admit"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Admit"&gt;Admit&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1. Underlying dz
&lt;/p&gt;&lt;p&gt;2. Toxic
&lt;/p&gt;&lt;p&gt;3. Unalbe PO
&lt;/p&gt;&lt;p&gt;4. Unresponsive to meds
&lt;/p&gt;&lt;p&gt;5. Initial SaO2 &amp;lt;95%
&lt;/p&gt;&lt;p&gt;6. Preterm (&amp;lt;34wks)
&lt;/p&gt;&lt;p&gt;7. RR &amp;gt;70
&lt;/p&gt;&lt;p&gt;8. Atelectasis on CXR
&lt;/p&gt;&lt;p&gt;9. Age &amp;lt;4-6wks
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Bronchiolitis_(RSV)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: DDX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX"&gt;DDX&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1. Asthma
&lt;/p&gt;&lt;p&gt;2. PNA
&lt;/p&gt;&lt;p&gt;3. FB
&lt;/p&gt;&lt;p&gt;4. Pertusis
&lt;/p&gt;&lt;p&gt;5. CHF
&lt;/p&gt;&lt;p&gt;6. Cystic fibrosis
&lt;/p&gt;&lt;p&gt;7. Vascular ring
&lt;/p&gt;&lt;p&gt;8. CA
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Bronchiolitis_(RSV)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from from Rosen, Young, Donaldson
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="bronchitis"><name>Bronchitis</name><content>&lt;p&gt;TX only c COPD &amp;amp; changes (doxy)
&lt;/p&gt;



</content><folder>Pulm</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="brugada_syndrome"><name>Brugada Syndrome</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Pathophysiology"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Pathophysiology&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#EKG_Criteria"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;EKG Criteria&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Brugada_Syndrome&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Pathophysiology"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Pathophysiology"&gt;Pathophysiology&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Genetically-linked sodium channelopathy, characterized by incomplete RBBB with ST elevation in V1 and V2, and an increased risk of sudden cardiac death
&lt;/p&gt;&lt;p&gt;Note - EKG findings can be TRANSIENT 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Brugada_Syndrome&amp;amp;action=edit&amp;amp;section=2" title="Edit section: EKG Criteria"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="EKG_Criteria"&gt;EKG Criteria&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Type 1 - 2 mm J-point elevation a gradually descending ST segment and a negative T-wave
&lt;/li&gt;&lt;li&gt;Type 2 - saddle back pattern with at least 2 mm J-point elevation and at least 1 mm ST elevation with a positive or biphasic T-wave
&lt;/li&gt;&lt;li&gt;Type 3 - saddle back pattern with less than 2 mm J-point elevation and less than 1 mm ST elevation with a positive T-wave
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Brugada_Syndrome&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;a/w polymorphic v tach, v fib. 
&lt;/li&gt;&lt;li&gt;mortality ~10% / yr
&lt;/li&gt;&lt;li&gt;pts need an AICD
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Brugada_Syndrome&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from ....Mattu (lecture)
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="burns"><name>Burns</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#Rule_of_Nines"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;Rule of Nines&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Rule_of_Palms"&gt;&lt;span class="tocnumber"&gt;1.2&lt;/span&gt; &lt;span class="toctext"&gt;Rule of Palms&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Pre-Hospital"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Pre-Hospital&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#ED_W.2FU"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;ED W/U&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Management"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Management&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Intubation_Guidelines"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Intubation Guidelines&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Fluid_Resuscitation"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Fluid Resuscitation&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#Cyanide"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Cyanide&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-10"&gt;&lt;a href="#Escharotomy"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;Escharotomy&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-11"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;9&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-12"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;10&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Burns&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Burn Degrees
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;1st
&lt;ul&gt;&lt;li&gt;red, tender, no blisters
&lt;/li&gt;&lt;li&gt;two point discrimination intact
&lt;/li&gt;&lt;li&gt;heals without scarring
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;2nd
&lt;ul&gt;&lt;li&gt;Partial thickness
&lt;/li&gt;&lt;li&gt;Superficial
&lt;ul&gt;&lt;li&gt;Thin blisters
&lt;/li&gt;&lt;li&gt;Heals without scarring in 2-3 wks
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Deep
&lt;ul&gt;&lt;li&gt;Thick blisters
&lt;/li&gt;&lt;li&gt;2 point discrimination decreased
&lt;/li&gt;&lt;li&gt;Can feel pressure
&lt;/li&gt;&lt;li&gt;Potential for scar/contractions
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;3rd
&lt;ul&gt;&lt;li&gt;Full thickness
&lt;/li&gt;&lt;li&gt;skin is white, leathery and anesthetic
&lt;/li&gt;&lt;li&gt;always needs grafting
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;4th
&lt;ul&gt;&lt;li&gt;3rd degree + involves muscle, bone, or other deep structures
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Burns&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Rule of Nines"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Rule_of_Nines"&gt;Rule of Nines&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;ADULTS
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Each area is 9% BSA:
&lt;ul&gt;&lt;li&gt;Entire head and neck
&lt;/li&gt;&lt;li&gt;Each arm including hand
&lt;/li&gt;&lt;li&gt;Chest
&lt;/li&gt;&lt;li&gt;Abdomen
&lt;/li&gt;&lt;li&gt;Upper back
&lt;/li&gt;&lt;li&gt;Lower back
&lt;/li&gt;&lt;li&gt;Each front of leg
&lt;/li&gt;&lt;li&gt;Each back of leg
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;1%: Genital region
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;CHILDREN
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Each area is 9% BSA:
&lt;ul&gt;&lt;li&gt;Anterior head and neck
&lt;/li&gt;&lt;li&gt;Posterior head an neck
&lt;/li&gt;&lt;li&gt;Each arm including hand
&lt;/li&gt;&lt;li&gt;Chest
&lt;/li&gt;&lt;li&gt;Upper back
&lt;/li&gt;&lt;li&gt;Lower back
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Each area is 13.5%:
&lt;ul&gt;&lt;li&gt;Each leg (not broken up to front or back)
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;1%: Genital Region
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Burns&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Rule of Palms"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Rule_of_Palms"&gt;Rule of Palms&lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt;Pt's palm = 1%
&lt;/li&gt;&lt;li&gt;Use to estimate scatter burns
&lt;/li&gt;&lt;li&gt;Also use for local burns up to 10% BSA
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Burns&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Pre-Hospital"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Pre-Hospital"&gt;Pre-Hospital&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Assess for signs of inhalational injury
&lt;ul&gt;&lt;li&gt;Start humidified O2
&lt;/li&gt;&lt;li&gt;Intubate if necessary (below)
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;IVF (below)
&lt;/li&gt;&lt;li&gt;Remove all burned/burning clothing, jewelry
&lt;/li&gt;&lt;li&gt;Immerse wounds in cold water (1-5&#730;C)
&lt;ul&gt;&lt;li&gt;Only effective within first 30 mins
&lt;/li&gt;&lt;li&gt;No direct ice to wound
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Burns&amp;amp;action=edit&amp;amp;section=5" title="Edit section: ED W/U"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="ED_W.2FU"&gt;ED W/U&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Labs
&lt;/li&gt;&lt;li&gt;CO level
&lt;/li&gt;&lt;li&gt;CN level if suspicious and/or empiric Tx (see below)
&lt;/li&gt;&lt;li&gt;Work-up for associated trauma, if indicated
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Burns&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Management"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Management"&gt;Management&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Airway (Intubation below)
&lt;/li&gt;&lt;li&gt;IVF (below)
&lt;/li&gt;&lt;li&gt;Foley cath
&lt;/li&gt;&lt;li&gt;Dressing (saline/tap/petroleum gauze)
&lt;/li&gt;&lt;li&gt;No PPxIV Abx; topical bacitracin ok
&lt;/li&gt;&lt;li&gt;Escharotomy (below)
&lt;/li&gt;&lt;li&gt;H2 blocker (stress ulcer)
&lt;/li&gt;&lt;li&gt;NG tube (gastroparesis)
&lt;/li&gt;&lt;li&gt;Td
&lt;/li&gt;&lt;li&gt;Analgesia
&lt;/li&gt;&lt;li&gt;Consider Transfer
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Burns&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Intubation Guidelines"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Intubation_Guidelines"&gt;Intubation Guidelines&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Any hard signs:
&lt;ul&gt;&lt;li&gt;Stridor
&lt;/li&gt;&lt;li&gt;Hoarseness
&lt;/li&gt;&lt;li&gt;Pharyngeal burns
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;3 or more soft signs:
&lt;ul&gt;&lt;li&gt;h/o unconciousness
&lt;/li&gt;&lt;li&gt;Noxious fumes at scene
&lt;/li&gt;&lt;li&gt;Burn occurring in closed space
&lt;/li&gt;&lt;li&gt;Facial burns
&lt;/li&gt;&lt;li&gt;Carbonaceous sputum
&lt;/li&gt;&lt;li&gt;CO level &amp;gt;15%
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Burns&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Fluid Resuscitation"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Fluid_Resuscitation"&gt;Fluid Resuscitation&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Indicated if:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;&amp;gt;20% BSA (2nd &amp;amp; 3rd)
&lt;/li&gt;&lt;li&gt;Evidence of shock
&lt;/li&gt;&lt;/ol&gt;
&lt;ul&gt;&lt;li&gt;Total Fluids = Parkland + maint + blood loss
&lt;/li&gt;&lt;li&gt;Parkland:
&lt;ul&gt;&lt;li&gt;4 x kg x&amp;nbsp;%BSA (2nd&amp;amp;3rd)= cc NS (or LR)
&lt;ul&gt;&lt;li&gt;Give 1/2 in first 8hrs, remainder in next 16hrs
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Place Foley cath:
&lt;ul&gt;&lt;li&gt;Goal:
&lt;ul&gt;&lt;li&gt;Adult: UOP&amp;gt;30mL/hr
&lt;/li&gt;&lt;li&gt;Peds: UOP &amp;gt;1mL/kg/hr
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Consider CVP line if h/o cardiopulmonary dz
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Burns&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Cyanide"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Cyanide"&gt;Cyanide&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Consider empiric tx for smoke inhalation victims with (any):
&lt;/li&gt;&lt;/ul&gt;
&lt;ol&gt;&lt;li&gt;Hypotension
&lt;/li&gt;&lt;li&gt;Metabolic acidosis
&lt;/li&gt;&lt;li&gt;CV collapse
&lt;/li&gt;&lt;/ol&gt;
&lt;ul&gt;&lt;li&gt;Give sodium thiosulfate (12.5 mg) alone (given possiblility of CO also)
&lt;/li&gt;&lt;li&gt;See also &lt;a href="/wiki/Cyanide" title="Cyanide"&gt;Cyanide&lt;/a&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Burns&amp;amp;action=edit&amp;amp;section=10" title="Edit section: Escharotomy"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Escharotomy"&gt;Escharotomy&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Restriced ventilation
&lt;ul&gt;&lt;li&gt;Anterior axillary line
&lt;/li&gt;&lt;li&gt;2cm below clavicle to 10th rib
&lt;/li&gt;&lt;li&gt;May connect (square)
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Restricted perfusion (focal)
&lt;ul&gt;&lt;li&gt;Along long axis of hands, forearms, feet, fingers, toes if no pulse by doppler
&lt;/li&gt;&lt;li&gt;Lateral on extremity
&lt;/li&gt;&lt;li&gt;No perfusion, add medial
&lt;/li&gt;&lt;li&gt;Bovie or scalpel
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Burns&amp;amp;action=edit&amp;amp;section=11" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Transfer Criteria (ABA 1994)
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;2-3 deg &amp;gt;10% in pt &amp;lt;10 or &amp;gt;50yo
&lt;/li&gt;&lt;li&gt;2-3 deg &amp;gt;20% anyone
&lt;/li&gt;&lt;li&gt;3 deg &amp;gt;5% anyone
&lt;/li&gt;&lt;li&gt;Complicating factors
&lt;ol&gt;&lt;li&gt;Sig face/hand/feet/perineum/major joint
&lt;/li&gt;&lt;li&gt;Circumferential burns
&lt;/li&gt;&lt;li&gt;Inhalation injury
&lt;/li&gt;&lt;li&gt;Concomitant trauma
&lt;/li&gt;&lt;li&gt;Sig pre-existing dz
&lt;/li&gt;&lt;li&gt;Sig electrical/chemical burn
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;For moderate burns not meeting transfer criteria may admit
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Burns&amp;amp;action=edit&amp;amp;section=12" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;8/07 DONALDSON (adapted from Bessen, Mistry); 3/10 DeBonis
&lt;/p&gt;



</content><folder>Trauma</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="c-spine_x-ray"><name>C-Spine X-Ray</name><content>&lt;p&gt;RULES (normal)
&lt;/p&gt;&lt;p&gt;1. Post vert &amp;gt; ant vert + 3mm
&lt;/p&gt;&lt;p&gt;2. Predental space &amp;lt; 3mm
&lt;/p&gt;
&lt;pre&gt;    (&amp;lt; 5mm in children)
&lt;/pre&gt;
&lt;p&gt;3. Spinal canal narrowest point should be &amp;gt;13mm (lateral)
&lt;/p&gt;&lt;p&gt;4. Anterior Soft tissue
&lt;/p&gt;
&lt;pre&gt;    -at C1-C4 &amp;lt; 7mm
&lt;/pre&gt;
&lt;pre&gt;    -at C5-T1 &amp;lt; 22mm
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;PEDS
&lt;/p&gt;&lt;p&gt;Children &amp;lt;8yo
&lt;/p&gt;&lt;p&gt;~50% SCI have no x-ray changes
&lt;/p&gt;&lt;p&gt;-most higher than C3
&lt;/p&gt;&lt;p&gt;Pseudosubluxation (peds) = C2 on C3 posterior cervical line (nl = &amp;lt;2mm)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;LATERAL
&lt;/p&gt;&lt;p&gt;Alignment: Anterior, posterior, middle arcs
&lt;/p&gt;&lt;p&gt;Bones: Vertebrae and spinous processes uniformity and height
&lt;/p&gt;&lt;p&gt;Cartilage:intervertebral disc space height and length
&lt;/p&gt;&lt;p&gt;Soft tissue: prevertebral soft tissue width
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;AP VIEW
&lt;/p&gt;&lt;p&gt;Aligment of spinous processes
&lt;/p&gt;&lt;p&gt;Distance between spinous processes
&lt;/p&gt;&lt;p&gt;Uniformity and height of vertebrae
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;ODONTOID
&lt;/p&gt;&lt;p&gt;Spacing of dens and lateral masses
&lt;/p&gt;&lt;p&gt;Lateral aligment of C1 and C2
&lt;/p&gt;&lt;p&gt;Uniformity of bones
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;4/11/06 DONALDSON (adapted from Lampe, Rosen)
&lt;/p&gt;



</content><folder>Rads</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="c-spine_(nexus)"><name>C-spine (NEXUS)</name><content>&lt;p&gt;Radiography is Unnecessary if pts satisfy ALL five of the following low risk criteria:
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; No midline cervical tenderness
&lt;/li&gt;&lt;li&gt; No focal neuro deficits
&lt;/li&gt;&lt;li&gt; Normal alertness
&lt;/li&gt;&lt;li&gt; No intoxication
&lt;/li&gt;&lt;li&gt; No painful distracting injury
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=C-spine_(NEXUS)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Radiologically identified c spine inj not clinically significant
&lt;/p&gt;&lt;p&gt;- spinous process fx
&lt;/p&gt;&lt;p&gt;- simple wedge compression fx &amp;lt; 25%
&lt;/p&gt;&lt;p&gt;- isolated avvlsion s lig inj
&lt;/p&gt;&lt;p&gt;- type 1 odontoid fx
&lt;/p&gt;&lt;p&gt;- end plate fx
&lt;/p&gt;&lt;p&gt;- inj to trabecular bone
&lt;/p&gt;&lt;p&gt;- transverse process fx
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=C-spine_(NEXUS)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;UpToDate
&lt;/p&gt;



</content><folder>Trauma</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="chf_meds"><name>CHF Meds</name><content>&lt;table style="width: 500px" border="1" cellpadding="1" cellspacing="1"&gt;

&lt;tr&gt;
&lt;td&gt;&lt;b&gt;Agent&lt;/b&gt;&lt;br /&gt;
&lt;/td&gt;&lt;td&gt;&lt;b&gt;RA&lt;/b&gt;
&lt;/td&gt;&lt;td&gt;&lt;b&gt;RCW&lt;/b&gt;
&lt;/td&gt;&lt;td&gt;&lt;b&gt;SVR&lt;/b&gt;
&lt;/td&gt;&lt;td&gt;&lt;b&gt;BP&lt;/b&gt;
&lt;/td&gt;&lt;td&gt;&lt;b&gt;CO&lt;/b&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Isordil60
&lt;/td&gt;&lt;td&gt; -&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; -&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; (-)&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; -&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; -/+&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; &amp;nbsp;hydral100
&lt;/td&gt;&lt;td&gt; ~&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; ~&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; -&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; +/-&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; ++&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; hy (MR/AI)
&lt;/td&gt;&lt;td&gt; -&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; --&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; ++&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; -/+&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; +/-&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; ACEI
&lt;/td&gt;&lt;td&gt; -&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; -&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; -&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; +/-&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; +&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Minoxidil
&lt;/td&gt;&lt;td&gt; ~&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; ~&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; --&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; +/-&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; ++&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;p&gt;&lt;br /&gt;Carvedilol: decreases mortality 67%
&lt;/p&gt;&lt;p&gt;Digoxin: decrease syx/hospitaliz.
&lt;/p&gt;&lt;p&gt;Aldactone in Class IV dec mortality
&lt;/p&gt;&lt;p&gt;Isordil: cor. VD; +BP if ischemia
&lt;/p&gt;&lt;p&gt;ISDN/HYDRA. decreased mortality in CHF.
&lt;/p&gt;&lt;p&gt;ACEI GREAT mortality benefit.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=CHF_Meds&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Target Doses"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Target_Doses"&gt; Target Doses &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Hydralazine: 100 TID start 25
&lt;/p&gt;&lt;p&gt;Isordil: 60-80 TID
&lt;/p&gt;&lt;p&gt;Captopril: 100 TID start 12.5
&lt;/p&gt;&lt;p&gt;Lisinopril/enalapril: 10 bid class II/III
&lt;/p&gt;&lt;p&gt;20 bid class IV
&lt;/p&gt;&lt;p&gt;Carvedilol 25 BID; 50 BID if &amp;gt;80kg
&lt;/p&gt;&lt;p&gt;Digoxin: varies
&lt;/p&gt;&lt;p&gt;Spironolactone 25-50 qd
&lt;/p&gt;&lt;p&gt;Enalapril 1.25mg IV
&lt;/p&gt;&lt;p&gt;Nitroglycerin (Initial dose 5-10ug/min, increased every 3-5 minute to dose range 10-200ug/min)
&lt;/p&gt;&lt;p&gt;Nitroprusside (Initial dose 5-10ug/min, increased every 3-5 minute to dose range 5-400ug/min)
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Consider when need afterload reduction
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=CHF_Meds&amp;amp;action=edit&amp;amp;section=2" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt; See Also &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Cards: Congestive Heart Failure (CHF)
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="ck-mb"><name>CK-MB</name><content>&lt;p&gt;&amp;lt;5% of Total CK = nl
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=CK-MB&amp;amp;action=edit&amp;amp;section=1" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Cards: Cardiac Enzymes
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="copd"><name>COPD</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Definition"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Definition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Exacerbation"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Exacerbation&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Maintenance"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Maintenance&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=COPD&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Definition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Definition"&gt;Definition&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Airflow obstruction as measured by spirometry isdefined as a  ratio of the postbronchodilator FEV1&amp;nbsp;: FVC &amp;lt; 0.70
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=COPD&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Exacerbation"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Exacerbation"&gt;Exacerbation&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Albuterol
&lt;/li&gt;&lt;li&gt;Atrovent
&lt;/li&gt;&lt;li&gt;Steroids: Prednisone 40mg po qday x 5-10d
&lt;/li&gt;&lt;li&gt;Abx
&lt;ul&gt;&lt;li&gt;Levaquin (sick)
&lt;/li&gt;&lt;li&gt;Doxy (outpt) sputum change
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;CXR
&lt;/li&gt;&lt;li&gt;BiPap/Intubation
&lt;/li&gt;&lt;li&gt;Carefull with O2 &amp;amp; hypoxic drive
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=COPD&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Maintenance"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Maintenance"&gt;Maintenance&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;B-agonist
&lt;ul&gt;&lt;li&gt;Short: albuterol 90&#181;g/inh 1-2 q4-6h prn; neb 2.5mg q4-6h prn
&lt;/li&gt;&lt;li&gt;Long:  Salmeterol 50&#181;g/inh 1 bid
&lt;/li&gt;&lt;li&gt;Formoterol MDI 12&#181;g/INH 1  bid; neb 20&#181;g bid
&lt;/li&gt;&lt;li&gt;Arfomoterol neb 15&#181;g bid
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Anticholinergic
&lt;ul&gt;&lt;li&gt;Short: ipratriopium 17&#181;g/INH 2xINH 4x/d up to 12; neb 0.5mg q6-8h
&lt;/li&gt;&lt;li&gt;Long: tiotropium 18&#181;g/INH 1xINH qam
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Steroids (inhaled)
&lt;ul&gt;&lt;li&gt;Fluticasone (dry powder) 250&#181;g/INH  1-2 bid; (aerosol) 220&#181;g 1-2INH bid
&lt;/li&gt;&lt;li&gt;Budesonide 160&#181;k 2 inh bid
&lt;/li&gt;&lt;li&gt;Beclomethasone 80&#181;g/inh 2INH bid
&lt;/li&gt;&lt;li&gt;Mometasone 220&#181;g/INH 1-2INH bid
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Combination
&lt;ul&gt;&lt;li&gt;Albuterol-Ipratropium 90/18 2INH 4xd up to 12
&lt;/li&gt;&lt;li&gt;Advair Diskus = Fluticasone-salmeterol (dry powder): 250/50 1INH bid
&lt;/li&gt;&lt;li&gt;Budesonide-Formoterol: 160/4.5 2INH bid
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Home O2
&lt;ul&gt;&lt;li&gt;Indicated if PaO2 &amp;lt; 55mmHg or O2 Sat &amp;lt; 88% RA
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;Goal is 18h/day including sleep with flow rate that maintain sat &amp;gt; 90%
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=COPD&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;DONALDSON 1/06, NEJM 4/10
&lt;/p&gt;



</content><folder>Pulm</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="copd_exacerbation"><name>COPD Exacerbation</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Differential_Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Differential Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Work-up"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Work-up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Maintenance"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Maintenance&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=COPD_Exacerbation&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Increase in cough, sputum, or dyspnea
&lt;/li&gt;&lt;li&gt; Precipitants
&lt;/li&gt;&lt;li&gt; Infection: 50%
&lt;/li&gt;&lt;li&gt; Unknown: 30%
&lt;/li&gt;&lt;li&gt; MI, PE, CHF, aspiration 
&lt;/li&gt;&lt;li&gt; Environment: 10%
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=COPD_Exacerbation&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Differential Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Differential_Diagnosis"&gt;Differential Diagnosis &lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; CHF
&lt;/li&gt;&lt;li&gt; PE
&lt;/li&gt;&lt;li&gt; PNA 
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=COPD_Exacerbation&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Work-up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-up"&gt;Work-up&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; CXR
&lt;/li&gt;&lt;li&gt; Often normal
&lt;/li&gt;&lt;li&gt; VBG/ABG 
&lt;/li&gt;&lt;li&gt; Assesses severity of exacerbation and baseline from which to judge improvement
&lt;/li&gt;&lt;li&gt; O2
&lt;/li&gt;&lt;li&gt; Target PaO2 of 60-70, or SpO2 90-94%
&lt;/li&gt;&lt;li&gt; If unable to correct hypoxemia with a low FiO2 consider alternative diagnosis
&lt;/li&gt;&lt;li&gt; Adequate oxygenation is essential, even if it leads to hypercapnia
&lt;/li&gt;&lt;li&gt; If hypercapnia leads to AMS, dysrhythmias, acidemia then consider mechanical ventilation
&lt;/li&gt;&lt;li&gt; Sputum culture
&lt;/li&gt;&lt;li&gt; Consider for for patients with:
&lt;/li&gt;&lt;li&gt; Strong clinical suspicion for bacterial infection yet unresponsive to abx 
&lt;/li&gt;&lt;li&gt; Risk factors for pseudomonas infection
&lt;/li&gt;&lt;li&gt; Recent hospitalization (&amp;gt;2 days within previous 3 months)
&lt;/li&gt;&lt;li&gt; Frequent abx tx (&amp;gt;4 courses w/in past year)
&lt;/li&gt;&lt;li&gt; Severe underlying COPD (FEV1 &amp;lt; 50% predicted)
&lt;/li&gt;&lt;li&gt; Previous isolation of pseudomonas 
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=COPD_Exacerbation&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Albuterol/atrovent
&lt;/li&gt;&lt;li&gt; Steroids (no difference in efficacy between PO and IV)
&lt;/li&gt;&lt;li&gt; Duration = 7-10 days (no tapering required) 
&lt;/li&gt;&lt;li&gt; Oral: Prednisone 40-60mg daily
&lt;/li&gt;&lt;li&gt; IV: Methylprednisolone 60-125mg BID-QID 
&lt;/li&gt;&lt;li&gt; Antibiotics
&lt;/li&gt;&lt;li&gt; Indicated for moderate to severe exacerbations
&lt;/li&gt;&lt;li&gt; Outpatient
&lt;/li&gt;&lt;li&gt; Risk factors (Age &amp;gt;65, cardiac disease, &amp;gt;3 exacerbations per year)
&lt;/li&gt;&lt;li&gt; Levofloxacin/moxifloxacin OR amox/clavulanate  
&lt;/li&gt;&lt;li&gt; No risk factors
&lt;/li&gt;&lt;li&gt; Azithromycin OR doxycline OR TMP/SMX 
&lt;/li&gt;&lt;li&gt; Pseudomonas risk factors (see above)
&lt;/li&gt;&lt;li&gt; Ciprofloxacin 
&lt;/li&gt;&lt;li&gt; Inpatient
&lt;/li&gt;&lt;li&gt; Pseudomonas risk factors
&lt;/li&gt;&lt;li&gt; Levofloxacin PO or IV OR cefepime IV OR Ceftazadine IV OR pip-tazo IV
&lt;/li&gt;&lt;li&gt; No pseudomonas risk factors
&lt;/li&gt;&lt;li&gt; Levo/moxifloxacin PO or IV OR CTX IV OR cefotaxime IV 
&lt;/li&gt;&lt;li&gt; Duration
&lt;/li&gt;&lt;li&gt; 3-5 days 
&lt;/li&gt;&lt;li&gt; Consider oseltamivir during influenza season 
&lt;/li&gt;&lt;li&gt; Noninvasive ventilation (e.g. CPAP, BiPaP) if needed 
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=COPD_Exacerbation&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition &lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Consider hospitalization for the following:
&lt;/li&gt;&lt;li&gt; Inadequate response of symptoms to outpatient management
&lt;/li&gt;&lt;li&gt; Inability to eat or sleep due to symptoms
&lt;/li&gt;&lt;li&gt; Changes in mental status
&lt;/li&gt;&lt;li&gt; Uncertain diagnosis
&lt;/li&gt;&lt;li&gt; High risk comorbidities (e.g. PNA, CHF, renal failure) 
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=COPD_Exacerbation&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Maintenance"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Maintenance"&gt;Maintenance&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1. B-agonist
&lt;/p&gt;
&lt;pre&gt;    Short: albuterol 90&#181;g/inh 1-2 q4-6h prn; neb 2.5mg q4-6h prn
&lt;/pre&gt;
&lt;pre&gt;    Long:  Salmeterol 50&#181;g/inh 1 bid
&lt;/pre&gt;
&lt;pre&gt;              Formoterol MDI 12&#181;g/INH 1 bid; neb 20&#181;g bid
&lt;/pre&gt;
&lt;pre&gt;              Arfomoterol neb 15&#181;g bid
&lt;/pre&gt;
&lt;p&gt;2. Anticholinergic
&lt;/p&gt;
&lt;pre&gt;    Short: ipratriopium 17&#181;g/INH 2xINH 4x/d up to 12; neb 0.5mg q6-8h
&lt;/pre&gt;
&lt;pre&gt;    Long: tiotropium 18&#181;g/INH 1xINH qam
&lt;/pre&gt;
&lt;p&gt;3. Steroids (inhaled)
&lt;/p&gt;
&lt;pre&gt;    Fluticasone (dry powder) 250&#181;g/INH 1-2 bid; (aerosol) 220&#181;g 1-2INH bid
&lt;/pre&gt;
&lt;pre&gt;    Budesonide 160&#181;k 2 inh bid
&lt;/pre&gt;
&lt;pre&gt;    Beclomethasone 80&#181;g/inh 2INH bid
&lt;/pre&gt;
&lt;pre&gt;    Mometasone 220&#181;g/INH 1-2INH bid
&lt;/pre&gt;
&lt;p&gt;4. Combination
&lt;/p&gt;
&lt;pre&gt;    Albuterol-Ipratropium 90/18 2INH 4xd up to 12
&lt;/pre&gt;
&lt;pre&gt;    Advair Diskus = Fluticasone-salmeterol (dry powder): 250/50 1INH bid
&lt;/pre&gt;
&lt;pre&gt;    Budesonide-Formoterol: 160/4.5 2INH bid
&lt;/pre&gt;
&lt;p&gt;5. Home O2
&lt;/p&gt;&lt;p&gt;Indicated if PaO2 &amp;lt; 55mmHg or O2 Sat &amp;lt; 88% RA
&lt;/p&gt;&lt;p&gt;Goal is 18h/day including sleep with flow rate that maintain sat &amp;gt; 90%
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=COPD_Exacerbation&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;DONALDSON 1/06, NEJM 4/10, UpToDate
&lt;/p&gt;



</content><folder>Pulm</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="csf_studies"><name>CSF Studies</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Tests"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Tests&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Correction"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Correction&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#When_to_CT_before_LP"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;When to CT before LP&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#When_to_treat_infants_under_4-6_weeks_empirically_for_herpes_encephalitis:"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;When to treat infants under 4-6 weeks empirically for herpes encephalitis:&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=CSF_Studies&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Tests"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Tests"&gt;Tests&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;&lt;b&gt;Standard&lt;/b&gt;
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;tube 1 gs and culture
&lt;/li&gt;&lt;li&gt;2 protein glc
&lt;/li&gt;&lt;li&gt;3  cell count w diff
&lt;/li&gt;&lt;li&gt;4 hold
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;&lt;b&gt;Additional&lt;/b&gt;
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;cryptoccal ag
&lt;/li&gt;&lt;li&gt;india ink
&lt;/li&gt;&lt;li&gt;afb pcr
&lt;/li&gt;&lt;li&gt;rpr vdrl
&lt;/li&gt;&lt;li&gt;fungal cx
&lt;/li&gt;&lt;li&gt;viral cx
&lt;/li&gt;&lt;li&gt;pcr for herpes viridae
&lt;/li&gt;&lt;li&gt;ldh  &amp;gt;40 suggests bact. Meningitis &amp;lt; 40 viral (neches -pediatrics 1968)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=CSF_Studies&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Correction"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Correction"&gt;Correction&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;for each 1000 rbc dec prot. By 1mg/dl
&lt;/p&gt;&lt;p&gt;actual WBC =counted WBC-RBC csfx (Wbc blood/Rbc blood).
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=CSF_Studies&amp;amp;action=edit&amp;amp;section=3" title="Edit section: When to CT before LP"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="When_to_CT_before_LP"&gt;When to CT before LP&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;AMS
&lt;/li&gt;&lt;li&gt;focal deficit or papilledema
&lt;/li&gt;&lt;li&gt;head trauma (recent or remote)
&lt;/li&gt;&lt;li&gt;new onset seizure (except poss febrile seizure in child)
&lt;/li&gt;&lt;li&gt;HIV+
&lt;/li&gt;&lt;li&gt;IVDA only if other above findings are present.
&lt;/li&gt;&lt;li&gt;age over 60
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=CSF_Studies&amp;amp;action=edit&amp;amp;section=4" title="Edit section: When to treat infants under 4-6 weeks empirically for herpes encephalitis:"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="When_to_treat_infants_under_4-6_weeks_empirically_for_herpes_encephalitis:"&gt;When to treat infants under 4-6 weeks empirically for herpes encephalitis:&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;csf pleocytosis consistent w/ encephalitis + 1 of the following:
&lt;ol&gt;&lt;li&gt;HSV skin eye or mouth manifest.
&lt;/li&gt;&lt;li&gt;focal neuro findings or seizure
&lt;/li&gt;&lt;li&gt;sepsis with pneumonitis or hepatitis
&lt;/li&gt;&lt;li&gt;mother w/ genital HSV at delivery
&lt;/li&gt;&lt;li&gt;consider for very toxic fever &amp;gt;39 EC. 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=CSF_Studies&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;7/2/09 PANI
&lt;/p&gt;



</content><folder>ID</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="ct_before_lp"><name>CT Before LP</name><content>&lt;p&gt;LP without CT is likely safe if:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt; History 
&lt;ol&gt;&lt;li&gt; Age &amp;lt; 60
&lt;/li&gt;&lt;li&gt; Not immunocompromised
&lt;/li&gt;&lt;li&gt; No history of CNS disease
&lt;/li&gt;&lt;li&gt; No seizure within 1 week of presentation
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Physical Exam
&lt;ol&gt;&lt;li&gt; No ALOC
&lt;/li&gt;&lt;li&gt; No inability to answer two consecutive questions successfully
&lt;/li&gt;&lt;li&gt; No inability to follow two consecutive commands successfully
&lt;/li&gt;&lt;li&gt; No gaze palsy
&lt;/li&gt;&lt;li&gt; No abnormal visual fields
&lt;/li&gt;&lt;li&gt; No facial palsy
&lt;/li&gt;&lt;li&gt; No arm drift
&lt;/li&gt;&lt;li&gt; No leg drift
&lt;/li&gt;&lt;li&gt; No abnormal language 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;If none of the above, chance of normal ct is 97%, none of the patients herniated 
&lt;/p&gt;&lt;p&gt;CT before LP often results in longer average delay to abx
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=CT_Before_LP&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;NEJM 2001; 345; 1727-33
&lt;/p&gt;



</content><folder>ID</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="cva_(workup_and_general_rx)"><name>CVA (Workup and General Rx)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#DDX_Ischemic"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;DDX Ischemic&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Ischemic"&gt;&lt;span class="tocnumber"&gt;3.1&lt;/span&gt; &lt;span class="toctext"&gt;Ischemic&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Hemorrhagic"&gt;&lt;span class="tocnumber"&gt;3.2&lt;/span&gt; &lt;span class="toctext"&gt;Hemorrhagic&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=CVA_(Workup_and_General_Rx)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Glucose check
&lt;/li&gt;&lt;li&gt; CBC, chemistry, coags, troponin
&lt;/li&gt;&lt;li&gt; Lipid profile
&lt;/li&gt;&lt;li&gt; Head CT
&lt;/li&gt;&lt;li&gt; ECG (a. fib) 
&lt;/li&gt;&lt;li&gt; Also consider:
&lt;ol&gt;&lt;li&gt; Pregnancy test
&lt;/li&gt;&lt;li&gt; Utox
&lt;/li&gt;&lt;li&gt; TTE with bubble study
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=CVA_(Workup_and_General_Rx)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: DDX Ischemic"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX_Ischemic"&gt;DDX Ischemic&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Thrombosis (atherosclerosis, vasculitis, dissection)
&lt;/li&gt;&lt;li&gt; Embolic (cardiac -a.fib, valve, septic- CAS, hypercoagulable)
&lt;/li&gt;&lt;li&gt; Vasospasm
&lt;/li&gt;&lt;li&gt; Hypotension/watershed 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=CVA_(Workup_and_General_Rx)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=CVA_(Workup_and_General_Rx)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Ischemic"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Ischemic"&gt;Ischemic&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Glycemic control
&lt;ol&gt;&lt;li&gt; Use insulin to maintain blood sugar &amp;lt; 185
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Temperature control
&lt;ol&gt;&lt;li&gt; Treat fever &amp;gt; 37.5 (99.5) 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;If pt is tPA candidate (CVA (tPA criteria and dosing) 
&lt;ol&gt;&lt;li&gt; Consider tPA
&lt;ol&gt;&lt;li&gt; If give tPA DO NOT give antiplatelets/anticoagulants for at least 24 hours 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; BP Control
&lt;ol&gt;&lt;li&gt; If potential candidate for tPA but BP &amp;gt; 185/110:
&lt;ol&gt;&lt;li&gt; Labetalol 10-20mg IV over 1-2min, may repeat x 1, OR
&lt;/li&gt;&lt;li&gt; Nicardipine IV 5mg/hr, titrate up by 2.5mg/hr q5-15min, max 15mg/hr; when desired BP reached lower to 3mg/hr OR
&lt;/li&gt;&lt;li&gt; other agents (hydralazine, enalaprit, etc) may be considered when appropriate
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; If pt is NOT a tPA candidate:
&lt;ol&gt;&lt;li&gt; Aspirin
&lt;/li&gt;&lt;li&gt; BP control 
&lt;ol&gt;&lt;li&gt; Only tx BP if &amp;gt; 220/120 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Anticoagulation
&lt;ol&gt;&lt;li&gt; Heparin only if cardiac embolic source/ a-fib
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=CVA_(Workup_and_General_Rx)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Hemorrhagic"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Hemorrhagic"&gt;Hemorrhagic&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;See Intracranial Hemorrhage (ICH) 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=CVA_(Workup_and_General_Rx)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;8/12/07 DONALDSON (adapted from Smith, Lampe, NEJM '07) 
&lt;/p&gt;&lt;p&gt;UpToDate
&lt;/p&gt;&lt;p&gt;AHA/ASA Acute Stroke Guidelines
&lt;/p&gt;



</content><folder>Neuro</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="cva_(tpa_criteria)"><name>CVA (tPA Criteria)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Inclusion_Criteria"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Inclusion Criteria&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Exclusion_Criteria"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Exclusion Criteria&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Absolute"&gt;&lt;span class="tocnumber"&gt;3.1&lt;/span&gt; &lt;span class="toctext"&gt;Absolute&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Relative"&gt;&lt;span class="tocnumber"&gt;3.2&lt;/span&gt; &lt;span class="toctext"&gt;Relative&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-6"&gt;&lt;a href="#ECASS_III_Exclusion_Criteria_.28if_giving_tPA_between_3-4.5_hours.29"&gt;&lt;span class="tocnumber"&gt;3.3&lt;/span&gt; &lt;span class="toctext"&gt;ECASS III Exclusion Criteria (if giving tPA between 3-4.5 hours)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Studies_Needed"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Studies Needed&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#tPA_Administration"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;tPA Administration&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-10"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=CVA_(tPA_Criteria)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Pros:
&lt;ol&gt;&lt;li&gt; 30% greater chance of good neurologic outcome at 3 months
&lt;/li&gt;&lt;li&gt; Comparable 3-month mortality rate
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Cons 
&lt;ol&gt;&lt;li&gt; Intracranial hemorrhage occurs in ~5% of pts
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; Coag results prior to tx is only required for pts on anticoagulants
&lt;/li&gt;&lt;li&gt; ...but if history unable to be obtained must wait for coag results prior to starting tx 
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=CVA_(tPA_Criteria)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Inclusion Criteria"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Inclusion_Criteria"&gt;Inclusion Criteria&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Diagnosis of ischemic stroke causing measurable neuro deficit
&lt;/li&gt;&lt;li&gt; Clear onset (last witnessed well) &amp;lt;3 hours (see below for extension to &amp;lt;4.5 hours)
&lt;/li&gt;&lt;li&gt; Age &amp;gt;18 yrs
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=CVA_(tPA_Criteria)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Exclusion Criteria"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Exclusion_Criteria"&gt;Exclusion Criteria&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=CVA_(tPA_Criteria)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Absolute"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Absolute"&gt;Absolute&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Head trauma or prior stroke in previous 3 months
&lt;/li&gt;&lt;li&gt; Symptoms suggestive of SAH
&lt;/li&gt;&lt;li&gt; Arterial puncture at noncompressible site in previous 7 days
&lt;/li&gt;&lt;li&gt; History of previous ICH
&lt;/li&gt;&lt;li&gt; Elevated BP (sys &amp;gt; 185 or dia &amp;gt; 110
&lt;/li&gt;&lt;li&gt; Active bleeding on exam
&lt;/li&gt;&lt;li&gt; Acute bleeding diathesis:
&lt;ol&gt;&lt;li&gt; Plt count &amp;lt; 100K
&lt;/li&gt;&lt;li&gt; PTT &amp;gt; upper limit of normal
&lt;/li&gt;&lt;li&gt; INR &amp;gt;1.7
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Blood Glucose &amp;lt;50
&lt;/li&gt;&lt;li&gt; CT demonstrates multilobar infarction (hypodensity &amp;gt; 1/3 cerebral hemisphere)
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=CVA_(tPA_Criteria)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Relative"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Relative"&gt;Relative&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Minor stroke or rapidly improving stroke symptoms
&lt;/li&gt;&lt;li&gt; Seizure at onset with postictal residual neuro impairments
&lt;/li&gt;&lt;li&gt; Major surgery or serious trauma within previous 14 days
&lt;/li&gt;&lt;li&gt; Acute GI or GU hemorrhage (within previous 21 days)
&lt;/li&gt;&lt;li&gt; Acute MI (within previous 3 months)
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=CVA_(tPA_Criteria)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: ECASS III Exclusion Criteria (if giving tPA between 3-4.5 hours)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="ECASS_III_Exclusion_Criteria_.28if_giving_tPA_between_3-4.5_hours.29"&gt;ECASS III Exclusion Criteria (if giving tPA between 3-4.5 hours)&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Age &amp;gt; 80
&lt;/li&gt;&lt;li&gt;Baseline NIHSS &amp;gt; 25
&lt;/li&gt;&lt;li&gt;Any oral anticoagulant use
&lt;/li&gt;&lt;li&gt;History of prior stroke and DM
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=CVA_(tPA_Criteria)&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Studies Needed"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Studies_Needed"&gt;Studies Needed&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Head CT
&lt;/li&gt;&lt;li&gt; CBC
&lt;/li&gt;&lt;li&gt; PT/PTT
&lt;/li&gt;&lt;li&gt; Glu check
&lt;/li&gt;&lt;li&gt; ECG
&lt;/li&gt;&lt;li&gt; Icon
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=CVA_(tPA_Criteria)&amp;amp;action=edit&amp;amp;section=8" title="Edit section: tPA Administration"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="tPA_Administration"&gt;tPA Administration&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Alteplase 0.9mg/kg IV (max 90mg total)
&lt;ol&gt;&lt;li&gt; Load with .09mg/kg (10% of dose) as IV bolus over 1min, followed by 0.81mg/kg (90% of dose) as cont. infusion over 60min
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Neuo check Q15min x 2hrs, Q30min x6hrs, Q1hr x 16hrs
&lt;/li&gt;&lt;li&gt; Keep BP &amp;lt;180/105
&lt;ol&gt;&lt;li&gt; Labetalol 10mg IV followed by continous IV infusion 2-8mg/min OR
&lt;/li&gt;&lt;li&gt; Nicardipine IV 5mg/h, titrate up to desired effect by 2.5mg/hr q 5-15min, maximum 15mg/h
&lt;/li&gt;&lt;li&gt; If BP not controlled or dia &amp;gt; 140 consider nitroprusside
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; No anticoatulation/antiplatelets x 24hrs
&lt;/li&gt;&lt;li&gt; Stop tPA and consider head CT if pt develops:
&lt;ol&gt;&lt;li&gt; Neuro changes
&lt;/li&gt;&lt;li&gt; Acute hypertension
&lt;/li&gt;&lt;li&gt; Nausea/vomiting
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=CVA_(tPA_Criteria)&amp;amp;action=edit&amp;amp;section=9" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Neuro: post-tPA Hemmorhage
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=CVA_(tPA_Criteria)&amp;amp;action=edit&amp;amp;section=10" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1/26/06 DONALDSON (adapted from Lampe, Tintinali)
&lt;/p&gt;&lt;p&gt;2/20/10 PANI (ACEP/AAN Guidelines--class B recommendations)
&lt;/p&gt;&lt;p&gt;AHA/ASA Guidelines
&lt;/p&gt;



</content><folder>Neuro</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="calcium_channel_blocker_toxicity"><name>Calcium Channel Blocker Toxicity</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Calcium_Channel_Blocker_Toxicity&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Hemodialysis is ineffective
&lt;/li&gt;&lt;li&gt;Precipitous deterioration is common (esp w/ verapamil)
&lt;/li&gt;&lt;li&gt;Nifedipine can kill a child with a single pill
&lt;/li&gt;&lt;li&gt;2 Classes:
&lt;ul&gt;&lt;li&gt; 1. Dihydropyridines (nifedipine, amlodipine, nicardipine)
&lt;ul&gt;&lt;li&gt; Systemic vasodilation, mild effect on heart
&lt;/li&gt;&lt;li&gt; Toxicity = Hypotension, reflex tachycardia
&lt;ul&gt;&lt;li&gt;Note: with higher doses peripheral selectivity is lost
&lt;ul&gt;&lt;li&gt;I.e. may see decreased inotrophy, bradycardia
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; 2. Non-dihydropyridines (Verapamil, diltiazem)
&lt;ul&gt;&lt;li&gt; Stronger effect on heart, weak vasodilators
&lt;/li&gt;&lt;li&gt; Toxicity = Bradycardia, decreased inotropy
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Calcium_Channel_Blocker_Toxicity&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Cardiovascular
&lt;ul&gt;&lt;li&gt;Hypotension (any CCB overdose)
&lt;/li&gt;&lt;li&gt;Bradycardia (usually only seen with verapamil/dilt)
&lt;/li&gt;&lt;li&gt;AV/sinus block
&lt;/li&gt;&lt;li&gt;CHF
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Pulmonary
&lt;ul&gt;&lt;li&gt;Respiratory depression
&lt;/li&gt;&lt;li&gt;Pulmonary edema
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;GI
&lt;ul&gt;&lt;li&gt;Nausea/vomiting
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Neurologic
&lt;ul&gt;&lt;li&gt;Lethargy, confusion, coma
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Metabolic
&lt;ul&gt;&lt;li&gt;Hyperglycemia
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Calcium_Channel_Blocker_Toxicity&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;ECG
&lt;ul&gt;&lt;li&gt;PR prolongation
&lt;/li&gt;&lt;li&gt;Bradydysrhythmia
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Glucose
&lt;/li&gt;&lt;li&gt;Chemistry
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Calcium_Channel_Blocker_Toxicity&amp;amp;action=edit&amp;amp;section=4" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Beta blockers
&lt;ul&gt;&lt;li&gt;More likely to cause CNS changes
&lt;/li&gt;&lt;li&gt;Hypoglycemia is more common
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Digoxin
&lt;ul&gt;&lt;li&gt;Nausea/vomiting is more common
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Clonidine
&lt;ul&gt;&lt;li&gt;Miosis, somnolence
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Cholinergic agents
&lt;ul&gt;&lt;li&gt;SLUDGE
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Calcium_Channel_Blocker_Toxicity&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Monotherapy only successful for trivial overdoses
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;Phase 1
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Charcoal 1g/kg (max 50g)
&lt;ul&gt;&lt;li&gt;Consider if present within 1-2hr with delayed-release preparation
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Fluids
&lt;/li&gt;&lt;li&gt;Atropine
&lt;ul&gt;&lt;li&gt;Adult: 0.5-1mg IV q2-3min to max of 3g
&lt;/li&gt;&lt;li&gt;Ped: 0.02mg/kg (minimum is 0.1mg)
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Calcium
&lt;ul&gt;&lt;li&gt;Calcium gluconate 30-60mL of 10% soln
&lt;/li&gt;&lt;li&gt;Calcium chloride 10-20mL of 10% soln (requires central line)
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;Phase 2
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Glucagon
&lt;ul&gt;&lt;li&gt;5mg IV bolus q10min x 2
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Vasopressors
&lt;ul&gt;&lt;li&gt;Norepinephrine is agent of choice
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;High-dose insulin and glucose
&lt;ul&gt;&lt;li&gt;Takes 30-60min for effect
&lt;/li&gt;&lt;li&gt;Glucose:
&lt;ul&gt;&lt;li&gt;Adult: 50mL of D50W
&lt;/li&gt;&lt;li&gt;Ped: 2.5mL/kg of D10
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Insulin bolus 1 Unit/kg followed by 0.5units/kg/hr
&lt;ul&gt;&lt;li&gt;Titrate infusion until hypotension is corrected or max 2u/kg/hr
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Potassium
&lt;ul&gt;&lt;li&gt;If &amp;lt;3 administer 20mEq IV
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Calcium_Channel_Blocker_Toxicity&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Admit all symptomatic pts
&lt;/li&gt;&lt;li&gt;Admit all sustained-release ingestions
&lt;/li&gt;&lt;li&gt;D/C if asymptomatic x 6-8hrs
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Calcium_Channel_Blocker_Toxicity&amp;amp;action=edit&amp;amp;section=7" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Calcium_Channel_Blocker_Toxicity&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Rosen's
&lt;/p&gt;



</content><folder>Tox</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="calcium_channel_blockers"><name>Calcium Channel Blockers</name><content>&lt;table border="1"&gt;

&lt;tr&gt;
&lt;td&gt; &lt;b&gt;Ca Blocker&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;BP/SVR&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;HR&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;SA/AV&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;CF&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;ION&lt;/b&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Nifedipine
&lt;/td&gt;&lt;td&gt; +++
&lt;/td&gt;&lt;td&gt; +
&lt;/td&gt;&lt;td&gt; -
&lt;/td&gt;&lt;td&gt; +
&lt;/td&gt;&lt;td&gt; -
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Diltiazem
&lt;/td&gt;&lt;td&gt; ++
&lt;/td&gt;&lt;td&gt; -
&lt;/td&gt;&lt;td&gt; +
&lt;/td&gt;&lt;td&gt; +
&lt;/td&gt;&lt;td&gt; -
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Verapamil
&lt;/td&gt;&lt;td&gt; ++
&lt;/td&gt;&lt;td&gt; --
&lt;/td&gt;&lt;td&gt; ++
&lt;/td&gt;&lt;td&gt; +
&lt;/td&gt;&lt;td&gt; -
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Bepiridil
&lt;/td&gt;&lt;td&gt; +
&lt;/td&gt;&lt;td&gt; (-)
&lt;/td&gt;&lt;td&gt; min.
&lt;/td&gt;&lt;td&gt; +++
&lt;/td&gt;&lt;td&gt; -
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Amlodipine
&lt;/td&gt;&lt;td&gt; +++
&lt;/td&gt;&lt;td&gt; +
&lt;/td&gt;&lt;td&gt; +
&lt;/td&gt;&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Felodipine
&lt;/td&gt;&lt;td&gt; +++
&lt;/td&gt;&lt;td&gt; +
&lt;/td&gt;&lt;td&gt; +
&lt;/td&gt;&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;p&gt;&lt;i&gt;CF = coronary flow, ION = ionotropy, SA/AV = nodes&lt;/i&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Calcium_Channel_Blockers&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Doses:"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Doses:"&gt; Doses: &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Nif-10-30 tid (Adalat CC: 30-90 qD)
&lt;/p&gt;&lt;p&gt;Dilt.: 60-120 TID ( CD: 180-360 qD)
&lt;/p&gt;&lt;p&gt;Verapamil: 80- 120 TID
&lt;/p&gt;&lt;p&gt;Bepiridil: 200-400 QD
&lt;/p&gt;&lt;p&gt;Amlodipine: 2.5- 20 (10) qD
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="canthotomy"><name>Canthotomy</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Indications"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Indications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Contraindications"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Contraindications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Equipment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Equipment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Procedure"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Procedure&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Complications"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Complications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Canthotomy&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Indications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Indications"&gt;Indications&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Indicated in pt with acute orbital compartment syndromeAbsolute indications: 
&lt;/p&gt;&lt;p&gt;- acute loss of visual acuity
&lt;/p&gt;&lt;p&gt;- increased intraocular pressure (&amp;gt;40 mm Hg)
&lt;/p&gt;&lt;p&gt;- severe proptosis
&lt;/p&gt;&lt;p&gt;- diffuse subconjunctival hemorrhage
&lt;/p&gt;&lt;p&gt;- periorbital edema
&lt;/p&gt;&lt;p&gt;Relative indications:
&lt;/p&gt;&lt;p&gt;- afferent pupillary defect
&lt;/p&gt;&lt;p&gt;- ophthalmoplegia
&lt;/p&gt;&lt;p&gt;- cherry red macula
&lt;/p&gt;&lt;p&gt;- optic nerve pallor
&lt;/p&gt;&lt;p&gt;- severe eye pain
&lt;/p&gt;&lt;p&gt;- periorbital crepitus/edema
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Canthotomy&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Contraindications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Contraindications"&gt;Contraindications &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;globe rupture
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Canthotomy&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Equipment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Equipment"&gt;Equipment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- Lidocaine w/epi
&lt;/p&gt;&lt;p&gt;- sterile gloves, face shield, gown
&lt;/p&gt;&lt;p&gt;- sterile field
&lt;/p&gt;&lt;p&gt;- syringe with 25 gauge needle
&lt;/p&gt;&lt;p&gt;- normal saline for irrigation
&lt;/p&gt;&lt;p&gt;- straight hemostat
&lt;/p&gt;&lt;p&gt;- sterile iris or suture scissors
&lt;/p&gt;&lt;p&gt;- forceps
&lt;/p&gt;&lt;p&gt;- betadine/iodine prep
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Canthotomy&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Procedure"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Procedure"&gt;Procedure&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1) consider sedating patient for procedure
&lt;/p&gt;&lt;p&gt;2) prep and drape the area
&lt;/p&gt;&lt;p&gt;3) inject 1cc of lido with epi into the lateral canthus directing the needle tip toward the lateral orbital rim
&lt;/p&gt;&lt;p&gt;4) irrigate eye to eliminate debris
&lt;/p&gt;&lt;p&gt;5) crimp the skin at the lateral corner of the pts eye using a straight hemostat for ~1-2 minutes (make sure to crimp all the way down to the orbital rim)
&lt;/p&gt;&lt;p&gt;6) lift up the skin around the lateral orbit with forceps and make a 1-2 cm cut with scissors beginning at the lateral corner of the eye and extending laterally
&lt;/p&gt;&lt;p&gt;7) retract the inferior lid and dissect bluntly until you palpate/visualize the lateral canthus tendon
&lt;/p&gt;&lt;p&gt;8) cut the inferior crux of the lateral canthus tendon (point scissors infero-posteriorally toward the lateral orbital rim avoiding the globe)
&lt;/p&gt;&lt;p&gt;9) recheck IOP, if still elevated cut the superior crux of the tendon
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Canthotomy&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Complications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Complications"&gt;Complications&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- iatrogenic globe/tendon/lacrimal duct injury
&lt;/p&gt;&lt;p&gt;- loss of adequate lower lid suspension
&lt;/p&gt;&lt;p&gt;- bleeding
&lt;/p&gt;&lt;p&gt;- infection
&lt;/p&gt;&lt;p&gt;- fibrosis
&lt;/p&gt;&lt;p&gt;- vision loss
&lt;/p&gt;



</content><folder>Procedures</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="carbon_monoxide_(co)"><name>Carbon Monoxide (CO)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Hyperbaric_Tx"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Hyperbaric Tx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Carbon_Monoxide_(CO)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;can co-occur with HCN (cyanide) toxicity in certain fires like industrial fires, (treat HCN with Sodium thiosulfate 12.5grams).
&lt;/p&gt;&lt;p&gt;multiple pts from same building/car. winter months.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;1/2 life of COHb:
&lt;/p&gt;&lt;p&gt;decreases from 5 hrs to 1 hr with 100% FiO2,
&lt;/p&gt;&lt;p&gt;to 20 min 2.5 atm HBO.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Carbon_Monoxide_(CO)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1. Symptoms generally depend on CO level (i.e. carboxyhemoglobin)
&lt;/p&gt;&lt;p&gt;20-40%:
&lt;/p&gt;&lt;p&gt;CNS SX first... Dizziness, Headache, weakness, n/v, disturbed judgment, confusion, decreased visual acuity.
&lt;/p&gt;&lt;p&gt;Often misdiagnosed as 'Flu', 'viral syndrome.'
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;40-60%: CP, DOE, Tachycardia, tachypnea, ataxia, syncope, seizures
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;&amp;gt;60%: arrhythmias, hypotension, coma, death
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;2. To get CO level, ABG with carboxyhemoglobin level (this needs to be specifically requested; done by co-oximetry)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Pulse Ox usually NORMAL.
&lt;/p&gt;&lt;p&gt;Need co-oximetry. Oxygen Sat gap, SpO2-SaO2 increases as COHb increases.
&lt;/p&gt;&lt;p&gt;mortality usually due to ventricular arrhythmias.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Carbon_Monoxide_(CO)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1. Treat with 100% oxygen by tight-fitting mask or endotracheal tube
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;2. Measure CO level q2-4 hours until &amp;lt;10%.
&lt;/p&gt;&lt;p&gt;smokers... COHb level up to 10%.
&lt;/p&gt;&lt;p&gt;&amp;lt;5% is normal.
&lt;/p&gt;&lt;p&gt;levels not predictive of outcome.
&lt;/p&gt;&lt;p&gt;lactate more useful for inferring tissue hypoxia.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Carbon_Monoxide_(CO)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Hyperbaric Tx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Hyperbaric_Tx"&gt;Hyperbaric Tx&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;indications for HBO...
&lt;/p&gt;&lt;p&gt;sz, coma, focal deficit
&lt;/p&gt;&lt;p&gt;COHb &amp;gt; 25%
&lt;/p&gt;&lt;p&gt;COHb &amp;gt; 15% in pregnancy (fetal Hb has greater affinity for CO, and nml intrauterine Mt Everest makes CO poisoning very toxic to fetus)
&lt;/p&gt;&lt;p&gt;myocardial ischemia, arrhythmias
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;recently...double-blind sham controlled study by...
&lt;/p&gt;&lt;p&gt;Scheinkestel, C. Med J Aust. 1999. 170: 2203-2210.
&lt;/p&gt;&lt;p&gt;Questions the HBO benefit\risk for CO. 3 days of 100% FiO2 (NBO) is equivalent to hyperbaric (2-3 atmospheres); severe poisoning.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Carbon_Monoxide_(CO)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;admit
&lt;/p&gt;&lt;p&gt;all symptomatic CO poisonings.
&lt;/p&gt;&lt;p&gt;all &amp;gt; 20%.
&lt;/p&gt;&lt;p&gt;Gas company and Fire Dept will test home/work environments.
&lt;/p&gt;&lt;p&gt;ECG, CXR, CT Head in all pts.
&lt;/p&gt;&lt;p&gt;ICON.
&lt;/p&gt;&lt;p&gt;4 randomized HBO trials. two showed benefit, two showed no benefit. however, only at mild cases.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Carbon_Monoxide_(CO)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Tibbles, PM et al. NEJM. Hyperbaric oxygen Rx. 1996.
&lt;/p&gt;



</content><folder>Tox</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="carbonmonoxide_(co)"><name>Carbonmonoxide (CO)</name><content>&lt;ol&gt;&lt;li&gt;REDIRECT &lt;a href="/wiki/Carbon_Monoxide_(CO)" title="Carbon Monoxide (CO)"&gt;Carbon Monoxide (CO)&lt;/a&gt;
&lt;/li&gt;&lt;/ol&gt;




</content><folder></folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="cardiac_enzymes"><name>Cardiac Enzymes</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Markers"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Markers&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Creatine_Phosphokinase"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Creatine Phosphokinase&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Troponins"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Troponins&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Cardiac_Enzymes&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Markers"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Markers"&gt;Markers&lt;/span&gt;&lt;/h2&gt;
&lt;table class="pbNotSortable" width="300" cellspacing="1" cellpadding="1" border="1"&gt;
&lt;tr&gt;
&lt;td&gt; Name
&lt;/td&gt;&lt;td&gt; INTL
&lt;/td&gt;&lt;td&gt; ELV PEAK
&lt;/td&gt;&lt;td&gt; RETRN
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; myglbn
&lt;/td&gt;&lt;td&gt; 1-4h
&lt;/td&gt;&lt;td&gt; 6-7h
&lt;/td&gt;&lt;td&gt; 18-24h
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; trp I
&lt;/td&gt;&lt;td&gt; 3-12
&lt;/td&gt;&lt;td&gt; 10-24
&lt;/td&gt;&lt;td&gt; 3-10d
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; trp T
&lt;/td&gt;&lt;td&gt; 3-12
&lt;/td&gt;&lt;td&gt; 10-24
&lt;/td&gt;&lt;td&gt; 5-14d
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; ckmb
&lt;/td&gt;&lt;td&gt; 4-12
&lt;/td&gt;&lt;td&gt; 12-24
&lt;/td&gt;&lt;td&gt; 48-72
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; ldh
&lt;/td&gt;&lt;td&gt; 8-12
&lt;/td&gt;&lt;td&gt; 24-48
&lt;/td&gt;&lt;td&gt; 10-14d
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;n I - 2-4 hrs 1st detect
&lt;ul&gt;&lt;li&gt;8-12 hrs w/100% sensitivity
&lt;/li&gt;&lt;li&gt;10-24 peak
&lt;/li&gt;&lt;li&gt;5-10 day duration
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Tn T - above plus 5-14 d duration
&lt;ul&gt;&lt;li&gt;CK-MB&amp;nbsp;: 3-4
&lt;/li&gt;&lt;li&gt;8-12 (100% sensitive)
&lt;/li&gt;&lt;li&gt;10-24 hr peak&amp;lt;/font&amp;gt;&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;MYOGLOBIN&amp;nbsp;: 1-2 hrs detect first
&lt;ul&gt;&lt;li&gt;4-8 100% sens
&lt;/li&gt;&lt;li&gt;4-8 peak
&lt;/li&gt;&lt;li&gt;0.5-1.0 duration
&lt;/li&gt;&lt;li&gt;2-4 day duration&amp;lt;/font&amp;gt;&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Cardiac_Enzymes&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Creatine Phosphokinase"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Creatine_Phosphokinase"&gt;Creatine Phosphokinase&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-can be elevated in trauma, rhabdo, hyperthermia, physical activity, renal or endocrine dz, systemic infections
&lt;/p&gt;&lt;p&gt;-if pt small with small muscle mass to begin with, total ck may not be elevated- so better to use ck index- is ratio of ckmb/ total ck. Elevated if &amp;gt; 3- 5%.
&lt;/p&gt;&lt;p&gt;-CK Mass: with monoclonal antibody techniques, can directly measure ck mb mass as mmcg/L. More sensitive for detection of ami
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Cardiac_Enzymes&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Troponins"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Troponins"&gt;Troponins&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-during contraction of muscle- thick filaments of myosin slide past thin filaments of actin by calcium mediated atp dependent contraction. Released calcium binds to troponin C, T, and I, which regulate muscle contraction.
&lt;/p&gt;&lt;p&gt;-troponins not change in trauma, skeletal muscle dz, exercise, renal failure like ck does.
&lt;/p&gt;&lt;p&gt;-troponin C found in all tissue and is not cardiac marker
&lt;/p&gt;&lt;p&gt;-troponin T is qualitative assay.
&lt;/p&gt;&lt;p&gt;-troponin I is quantitative assay.
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Cardiac_Enzymes&amp;amp;action=edit&amp;amp;section=4" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Cards: CK-MB
&lt;/p&gt;&lt;p&gt;Cards: Troponin
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="central_retinal_artery_occlusion_(crao)"><name>Central Retinal Artery Occlusion (CRAO)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#Etiology"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;Etiology&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Epidemiology"&gt;&lt;span class="tocnumber"&gt;1.2&lt;/span&gt; &lt;span class="toctext"&gt;Epidemiology&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Symptoms"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Symptoms&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Exam"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Exam&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Workup"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Workup&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#Dispo"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Dispo&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-10"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Central_Retinal_Artery_Occlusion_(CRAO)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Central_Retinal_Artery_Occlusion_(CRAO)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Etiology"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Etiology"&gt;Etiology&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Retinal Embolism (20%)
&lt;/li&gt;&lt;li&gt;Atherosclerotic changes
&lt;/li&gt;&lt;li&gt;Angiospasm
&lt;/li&gt;&lt;li&gt;Inflammatory Endarteritis
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Central_Retinal_Artery_Occlusion_(CRAO)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Epidemiology"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Epidemiology"&gt;Epidemiology&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Bilateral 1-2%
&lt;/li&gt;&lt;li&gt;M&amp;gt;F
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Central_Retinal_Artery_Occlusion_(CRAO)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Symptoms"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Symptoms"&gt;Symptoms&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Painless, monocular loss of vision
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Central_Retinal_Artery_Occlusion_(CRAO)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Amaurosis fugax (painless, fleeting; nl exam)
&lt;/li&gt;&lt;li&gt;CRVO (painless, over hours; blood and thunder)
&lt;/li&gt;&lt;li&gt;Temporal Arteritis
&lt;/li&gt;&lt;li&gt;Acute glaucoma (blurry vision, eye pain)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Central_Retinal_Artery_Occlusion_(CRAO)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Exam"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Exam"&gt;Exam&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Pale retina with edema
&lt;/li&gt;&lt;li&gt;Cherry red spot at the macula
&lt;/li&gt;&lt;li&gt;APD
&lt;/li&gt;&lt;li&gt;Boxcar segmentation of blood column
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Central_Retinal_Artery_Occlusion_(CRAO)&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Workup"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Workup"&gt;Workup&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Fundoscopic exam
&lt;/li&gt;&lt;li&gt;CBC, ESR, EKG
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Central_Retinal_Artery_Occlusion_(CRAO)&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Ocular massage
&lt;/li&gt;&lt;li&gt; Anterior chamber paracentesis
&lt;/li&gt;&lt;li&gt; Intraarterial fibrinolysis
&lt;/li&gt;&lt;li&gt; Acetazolamide
&lt;/li&gt;&lt;li&gt; Mannitol
&lt;/li&gt;&lt;li&gt; Timolol
&lt;/li&gt;&lt;li&gt; Steroids
&lt;/li&gt;&lt;li&gt; Hyperbarics (most effective if within 2-12h of presentation)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Central_Retinal_Artery_Occlusion_(CRAO)&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Dispo"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Dispo"&gt;Dispo&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Admit: comorbid disease
&lt;/p&gt;&lt;p&gt;D/C: f/u with ophtho in 1-4 weeks
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Central_Retinal_Artery_Occlusion_(CRAO)&amp;amp;action=edit&amp;amp;section=10" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;H-N
&lt;/p&gt;



</content><folder>Ophtho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="charcoal_lavage"><name>Charcoal Lavage</name><content>&lt;p&gt;if greater than 2 hrs or toxin already in intestine, gastric decontam not helpful
&lt;/p&gt;&lt;p&gt;-    helpful however if delayed emptying or decreased intest motility
&lt;/p&gt;&lt;p&gt;-    always use charcoal asap unless agent/ quantity not toxic, agent not absorbed to charcoal, or delay so long absorption is complete
&lt;/p&gt;&lt;p&gt;-    gastric emptying before charcoal- higher risk of aspiration, intubation, icu- not routinely recommended
&lt;/p&gt;&lt;p&gt;-    gastric emptying helpful if symptomatic within 1 hr, symptomatic with agents that slow gi motility, sustained release meds or massive/ life threatening amount
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Does GI Decont Change Pt Outcome?
&lt;/p&gt;&lt;p&gt;-    effect only if used early- no effect if late
&lt;/p&gt;&lt;p&gt;-    however, no prospective trial has proven charcoal or ipecac- only suggests it
&lt;/p&gt;&lt;p&gt;-    also, gi decont benefit never disproved either
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;What Are Risks of GI Decont?
&lt;/p&gt;&lt;p&gt;-    aspiration- by cns depression, loss of gag reflex, spont or induced emesis, manipulation of airway or gi tract
&lt;/p&gt;&lt;p&gt;-    ipecac assoc with asp if used incorrectly-
&lt;/p&gt;&lt;p&gt;-    charcoal usually not assoc with asp- but can be
&lt;/p&gt;&lt;p&gt;-    charcoal asp worse than gastric content asp because causes granulomatous reaction, tissue reaction to sorbitol or povidone, increased lung microvascular permeability
&lt;/p&gt;&lt;p&gt;-    risk of gastric lavage include unnecessary intubation
&lt;/p&gt;&lt;p&gt;-    intubation for airway protection/ aspiration not 100% protective
&lt;/p&gt;&lt;p&gt;-    lavage can also damage throat, esoph, stomach
&lt;/p&gt;&lt;p&gt;-    all types of decont have risk- small but acceptable
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Which Pt Not Need GI Decon?
&lt;/p&gt;&lt;p&gt;-    most preschool pts do not need decont
&lt;/p&gt;&lt;p&gt;-    no need for decon if nontoxic dose or substance or drug taken so long ago already absorbed.
&lt;/p&gt;&lt;p&gt;-    Gi decon reasonable if all pt and all symptomatic pt unless full absorption already occurred- risks of single dose low. 
&lt;/p&gt;&lt;p&gt;-    However- if low risk pt and uncooperative- may not be worth trauma/ risk to staff or pt
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Benefit of GI Emptying Before Charcoal?
&lt;/p&gt;&lt;p&gt;-    no- especially not if present late, are asymptomatic.
&lt;/p&gt;&lt;p&gt;-    Gastric emptying will not add benefit to charcoal
&lt;/p&gt;&lt;p&gt;-    Benefit of charcoal not even proven but is considered state of the art to give unless full absorption already occurred
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Will Some Pts Benefit From Aggressive GI Decon?
&lt;/p&gt;&lt;p&gt;-    charcoal not useful for iron, lithium alcohol, caustics, hydrocarbons
&lt;/p&gt;&lt;p&gt;-    even with sustained release meds, if most of drug has moved beyond stomach, lavage will only hold up charcoal
&lt;/p&gt;&lt;p&gt;-    if pt given ipecac and vomits long time before ED presentation- probably don't need additional charcoal for pediatric pts
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;ED physician needs to evaluate each ingestions individually and design treatment plan.  If substance poorly aborbed to charcoal- try gastric lavage unless have prolonged delay.  Usually charcoal alone is best choice.  If late presenting pt and asymptomatic- no gi decon needed.  If ealy and symptomatic- personal choice to do gastric lavage followed by charcoal or just charcoal- examine relative risk.
&lt;/p&gt;



</content><folder>Tox</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="cheat_sheet_for_harbor_shifts"><name>Cheat Sheet for Harbor Shifts</name><content>&lt;p&gt;Most of this information can also be located on:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Housestaff Manual
&lt;/li&gt;&lt;li&gt;Forgot your password?
&lt;ol&gt;&lt;li&gt;Novell/Network User Code/Password Help (x5059)
&lt;/li&gt;&lt;li&gt;Affinity User Code/Password Help (x2181)
&lt;/li&gt;&lt;li&gt;Quantim User Code/Password Help (x2181)
&lt;/li&gt;&lt;li&gt;(CW) Clinical Work Station User Code/Password Help (x2181)
&lt;/li&gt;&lt;li&gt;Synapse User Code/Password Help (x5059)
&lt;/li&gt;&lt;li&gt;DHS Internet Proxy Password User Code/Password Help (x5059)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;ECG app
&lt;ol&gt;&lt;li&gt;Need personal username from dhshucla domain to logon&#8212;cannot use rad/rad, not the same as affinity login. Do not need to input &#8220;dhshucla/" as part of log on.
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Intenet log on
&lt;ol&gt;&lt;li&gt;Again, needs personal dhshucla logon. Do not need to input &#8220;dhshucla/" as part of log on.
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Synapse Radiology (generic)
&lt;ol&gt;&lt;li&gt;log on:  dhshucla/rad    passwrd: rad1
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Radiology:
&lt;ol&gt;&lt;li&gt;CTs need 2 orders, i.e. use white (regular) order sheet and yellow form
&lt;/li&gt;&lt;li&gt;Need also consent form for IV contrast and a creatinine on the yellow sheet
&lt;/li&gt;&lt;li&gt;Ultrasounds must first be requested through rads (so tech can be notified)
&lt;/li&gt;&lt;li&gt;Body CT reads - x3079
&lt;/li&gt;&lt;li&gt;Neuro reads - x2808
&lt;/li&gt;&lt;li&gt;Ultrasound request/reads - x2831
&lt;/li&gt;&lt;li&gt;On wknd/after-hours - Page (310) 501- 5814
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Psych ED Call x3144
&lt;/li&gt;&lt;li&gt;Peds ED Call x2316 or -7
&lt;/li&gt;&lt;/ol&gt;
&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Common_PAGERS_.28301.29_501-xxxx"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Common PAGERS (301) 501-xxxx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Suture_Cart"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Suture Cart&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#To_look_up_scanned_ED_documents_.28EDM.29"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;To look up scanned ED documents  (EDM)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#To_look_up_previous_d.2Fc_summaries:"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;To look up previous d/c summaries:&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Family_Medicine_Clinics"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Family Medicine Clinics&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#OSH_Radiology_films:"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;OSH Radiology films:&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Outpatient_Referrals:"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Outpatient Referrals:&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Cheat_Sheet_for_Harbor_Shifts&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Common PAGERS (301) 501-xxxx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Common_PAGERS_.28301.29_501-xxxx"&gt;Common PAGERS (301) 501-xxxx&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Also located on the board along the back wall
Daily list is next to the Admin computer
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Trauma p4291
&lt;/li&gt;&lt;li&gt;Ortho p0345
&lt;/li&gt;&lt;li&gt;Gyn p0545
&lt;/li&gt;&lt;li&gt;Neuro p0771
&lt;/li&gt;&lt;li&gt;Neurosurgery p2701
&lt;/li&gt;&lt;li&gt;Ophtho p3303
&lt;/li&gt;&lt;li&gt;GI p3698
&lt;/li&gt;&lt;li&gt;Urology p3821 or p5815 (check daily list)
&lt;/li&gt;&lt;li&gt;ENT p2665
&lt;/li&gt;&lt;li&gt;Fam Med p3482
&lt;/li&gt;&lt;li&gt;Renal p0500
&lt;/li&gt;&lt;li&gt;Hospitalist p1325
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;&lt;br /&gt;
Amion (online call schedule)
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;www.amion.com
&lt;/li&gt;&lt;li&gt;Login: humc
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;C-team
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Sometimes incorrectly listed (if resident is post-call)
&lt;/li&gt;&lt;li&gt;Try 3rd Call pager p6534 instead
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;Ward Call pager 5018
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Takes overnight ICU admissions&#8212;deals with any boarded patients in the ED after teams go home. Hospitalist does not take any ICU patients.
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Cheat_Sheet_for_Harbor_Shifts&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Suture Cart"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Suture_Cart"&gt;Suture Cart&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;X 35280
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Cheat_Sheet_for_Harbor_Shifts&amp;amp;action=edit&amp;amp;section=3" title="Edit section: To look up scanned ED documents (EDM)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="To_look_up_scanned_ED_documents_.28EDM.29"&gt;To look up scanned ED documents  (EDM)&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Go to Affinity
&lt;/li&gt;&lt;li&gt;&#8220;Patient Charting&#8221; and select patient
&lt;/li&gt;&lt;li&gt;Click on &#8220;Procedures&#8221; up top and drag click &#8220;EDM&#8221;
&lt;ol&gt;&lt;li&gt;If this is your 1st time accessing it, it&#8217;ll ask for login info.
&lt;ol&gt;&lt;li&gt;User id is you affinity id
&lt;/li&gt;&lt;li&gt;Passwrd: password1
&lt;/li&gt;&lt;li&gt;It&#8217;ll ask you to change your password
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;You then need to drag/scroll (upper left) to the specific patient encounter, usually &#8220;ERACC&#8221; or &#8220;ERTX&#8221; or &#8220;ERMSE&#8221;--- &#8220;RO&#8221; are outpt visits and are not scanned
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Cheat_Sheet_for_Harbor_Shifts&amp;amp;action=edit&amp;amp;section=4" title="Edit section: To look up previous d/c summaries:"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="To_look_up_previous_d.2Fc_summaries:"&gt;To look up previous d/c summaries:&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Go to Affinity
&lt;/li&gt;&lt;li&gt;"Patient Charting&#8221; and select patient
&lt;/li&gt;&lt;li&gt;Click on &#8220;Procedures&#8221; up top and drag click &#8220;Health Notes&#8221;  and click on &#8220;All Reports&#8221;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Cheat_Sheet_for_Harbor_Shifts&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Family Medicine Clinics"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Family_Medicine_Clinics"&gt;Family Medicine Clinics&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;To find out if a patient &#8220;Zones&#8221; out anywhere, i.e. if they are eligible to go to a fam med clinic, look at the bottom right hand corner of the Demographic information sheet. For a &#8220;Z: WILM&#8221; or &#8220;Z: FAM&#8221; or &#8220;Z:LB&#8221;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Cheat_Sheet_for_Harbor_Shifts&amp;amp;action=edit&amp;amp;section=6" title="Edit section: OSH Radiology films:"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="OSH_Radiology_films:"&gt;OSH Radiology films:&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;To view an outside hospital CD, you must log off the computer, then logon with your personal dhshucla login/password (See above). Then you can load the disc.
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Cheat_Sheet_for_Harbor_Shifts&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Outpatient Referrals:"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Outpatient_Referrals:"&gt;Outpatient Referrals:&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Ask the clerks if they can book certain clinics, they usually can for:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Gyn Urgent Care, Fam Med, Gen Ortho, Cards
&lt;/li&gt;&lt;li&gt;Otherwise call the consultant to get a direct appt&#8212;the clerks can then fill out a &#8220;schedule reminder&#8221; (white half/sheet) slip for the patient that serves as the appt confirmation.
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;If an appointment can wait, there are special forms that need to be filled for:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Neurology (blue form)
&lt;/li&gt;&lt;li&gt;GI (2 forms)
&lt;ol&gt;&lt;li&gt;Clinic
&lt;/li&gt;&lt;li&gt;Endoscopy
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;All subspecialty surgery need a &#8220;Interfacility&#8221; form filled out (triplicate white/green/yellow form)&#8212;pt will get appts in a few weeks
&lt;ol&gt;&lt;li&gt;Urology, Neurosurgery, Colorectal, GI/ONC
&lt;/li&gt;&lt;li&gt;For gallbladder, hernia repair&#224; patients are designated by birth month for specific clinics (see board in back)
&lt;ol&gt;&lt;li&gt;Vasc    Jan- April
&lt;/li&gt;&lt;li&gt;GI/Onc    May- August
&lt;/li&gt;&lt;li&gt;Colorectal   Sept-Dec
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Heart Station has a new process (do not use the form)
&lt;ol&gt;&lt;li&gt;Log onto Affinity
&lt;/li&gt;&lt;li&gt;Go to Patient Charting and select your patient
&lt;/li&gt;&lt;li&gt;Go to the bottm tab &#8220;Chart Assessment&#8221;
&lt;/li&gt;&lt;li&gt;Click on the &#8220;Record&#8221; button
&lt;/li&gt;&lt;li&gt;Make your selection, e.g inpt vs outpt, stress etc..
&lt;/li&gt;&lt;li&gt;When you are done, select &#8220;Print&#8221; and type in &#8220;HEART&#8221; for the printer
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;N.B. All the computers shut down and restart at 3am.
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Cheat_Sheet_for_Harbor_Shifts&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Rev 9/09 jjh
&lt;/p&gt;



</content><folder>Harbor Admin</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="chemical_burns_(eye)"><name>Chemical Burns (Eye)</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Chemical_Burns_(Eye)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Irrigate!!! until pH 7.0
&lt;/li&gt;&lt;li&gt; Check IOP
&lt;/li&gt;&lt;li&gt; Cycloplegic like atropine
&lt;/li&gt;&lt;/ul&gt;




</content><folder>Ophtho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="chest_pain_(ddx)"><name>Chest Pain (DDx)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Critical"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Critical&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Emergent"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Emergent&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Nonemergent"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Nonemergent&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Chest_Pain_(DDx)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Critical"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Critical"&gt;Critical&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;ACS
&lt;/li&gt;&lt;li&gt;Aortic dissection
&lt;/li&gt;&lt;li&gt;Cardiac tamponade
&lt;/li&gt;&lt;li&gt;PE
&lt;/li&gt;&lt;li&gt;Tension pneumothorax
&lt;/li&gt;&lt;li&gt;Borhaave (esophag rupture)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Chest_Pain_(DDx)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Emergent"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Emergent"&gt;Emergent&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Pericarditis
&lt;/li&gt;&lt;li&gt;Myocarditis
&lt;/li&gt;&lt;li&gt;Pneumothorax
&lt;/li&gt;&lt;li&gt;Mediastinitis
&lt;/li&gt;&lt;li&gt;Mallory-Weiss (esophag tear)
&lt;/li&gt;&lt;li&gt;Cholecystitis
&lt;/li&gt;&lt;li&gt;Pancreatitis
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Chest_Pain_(DDx)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Nonemergent"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Nonemergent"&gt;Nonemergent&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Valvular heart dz
&lt;/li&gt;&lt;li&gt;Aortic stenosis
&lt;/li&gt;&lt;li&gt;Mitral prolaps
&lt;/li&gt;&lt;li&gt;Hypertrophic cardiomeg
&lt;/li&gt;&lt;li&gt;PNA
&lt;/li&gt;&lt;li&gt;Pleuritis
&lt;/li&gt;&lt;li&gt;Tumor
&lt;/li&gt;&lt;li&gt;Pneumomediastinum
&lt;/li&gt;&lt;li&gt;Esophageal spasm
&lt;/li&gt;&lt;li&gt;GERD
&lt;/li&gt;&lt;li&gt;Peptic ulcer
&lt;/li&gt;&lt;li&gt;Biliary colic
&lt;/li&gt;&lt;li&gt;Muscle sprain
&lt;/li&gt;&lt;li&gt;Rib fracture
&lt;/li&gt;&lt;li&gt;Arthritis
&lt;/li&gt;&lt;li&gt;Tumor
&lt;/li&gt;&lt;li&gt;Chostochondirits
&lt;/li&gt;&lt;li&gt;Spinal root compression
&lt;/li&gt;&lt;li&gt;Thoracic outlet
&lt;/li&gt;&lt;li&gt;Herpes zoster
&lt;/li&gt;&lt;li&gt;Postherpetic neuralgia
&lt;/li&gt;&lt;li&gt;Psychologic
&lt;/li&gt;&lt;li&gt;Hyperventilation
&lt;/li&gt;&lt;li&gt;Panic attack
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Chest_Pain_(DDx)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Cards: Cocaine Chest Pain
&lt;/p&gt;&lt;p&gt;Cards: ACS Risk Stratification
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Chest_Pain_(DDx)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;3/12/06 DONALDSON (adapted from Rosen)
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="chest_pain_(peds)"><name>Chest Pain (Peds)</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Chest_Pain_(Peds)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Idiopathic-most common
&lt;/p&gt;
&lt;pre&gt;       Precordial catch: pain w/ deep inspiration, self-resolving
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Musculoskeletal (costochondritis, trauma)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Pulmonary-10%
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;GI (e.g. esophagitis)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Psychosomatic
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Cardiac-1%
&lt;/p&gt;&lt;p&gt;-L-sided obstructive lesions
&lt;/p&gt;&lt;p&gt;-Arrhythmias
&lt;/p&gt;&lt;p&gt;-IHSS
&lt;/p&gt;&lt;p&gt;-Pericarditis
&lt;/p&gt;&lt;p&gt;-Prinzmetal's angina (vasospasm)
&lt;/p&gt;&lt;p&gt;-MI (rare, even post-Kawasaki)
&lt;/p&gt;&lt;p&gt;-Mitral valve prolapse
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Chest_Pain_(Peds)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1) Careful physical exam
&lt;/p&gt;&lt;p&gt;-Listen for murmurs
&lt;/p&gt;&lt;p&gt;-Palpate
&lt;/p&gt;&lt;p&gt;-Compress rib cage
&lt;/p&gt;&lt;p&gt;2) EKG
&lt;/p&gt;&lt;p&gt;3) CXR
&lt;/p&gt;&lt;p&gt;Consider echo
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Chest_Pain_(Peds)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from Pani
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="chest_tube"><name>Chest Tube</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Indications"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Indications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Relative_Indications"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Relative Indications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Contraindications"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Contraindications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Equipment_Needed"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Equipment Needed&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Procedure"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Procedure&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Complications"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Complications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Chest_Tube&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Indications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Indications"&gt;Indications&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; pneumothorax
&lt;/li&gt;&lt;li&gt; hemothorax
&lt;/li&gt;&lt;li&gt; abscess
&lt;/li&gt;&lt;li&gt; empyema  
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Chest_Tube&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Relative Indications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Relative_Indications"&gt;Relative Indications&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; rib fractures and positive pressure ventilation
&lt;/li&gt;&lt;li&gt; profound hypoxia/hypotension in patient with penetrating chest injury
&lt;/li&gt;&lt;li&gt; profound hypoxia/hypotension and signs of hemithorax 
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Chest_Tube&amp;amp;action=edit&amp;amp;section=3" title="Edit section: "&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id=""&gt; &lt;/span&gt;&lt;/h2&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Chest_Tube&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Contraindications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Contraindications"&gt;Contraindications&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; overlying skin infection 
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Chest_Tube&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Equipment Needed"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Equipment_Needed"&gt;Equipment Needed&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Chest Tube Tray
&lt;/li&gt;&lt;li&gt; sterile drapes 
&lt;/li&gt;&lt;li&gt; silk sutures
&lt;/li&gt;&lt;li&gt; curved clamps
&lt;/li&gt;&lt;li&gt; syringes and needles for anesthesia
&lt;/li&gt;&lt;li&gt; scaple 
&lt;/li&gt;&lt;li&gt; Lidocaine
&lt;/li&gt;&lt;li&gt; Betadine
&lt;/li&gt;&lt;li&gt; Sterile gown
&lt;/li&gt;&lt;li&gt; sterile gloves
&lt;/li&gt;&lt;li&gt; face shield
&lt;/li&gt;&lt;li&gt; Chest tube (18-20 French for pneumothorax, 32-26F for hemothorax, 38-40 French for trauma pt)
&lt;/li&gt;&lt;li&gt; Pleura-vac
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Chest_Tube&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Procedure"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Procedure"&gt;Procedure&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1) expose patients lateral thorax by moving the upper extremity above the head on the affected side
&lt;/p&gt;&lt;p&gt;2) note landmarks to help decide where you will be inserting your tube (lateral thorax, midaxillary line at 4th/5th intercostal space (~nipple line in males or 5cm above the sternoxiphoid junction in females)
&lt;/p&gt;&lt;p&gt;3) prep skin with betadine and drape with sterile drapes
&lt;/p&gt;&lt;p&gt;4) confirm the rib space where you are going to insert the tube and anesthetize the area with 10-20cc's of lidocaine w/epinephrine making sure to anesthetize the skin, soft tissues, muscle, periosteum, and pleural space
&lt;/p&gt;&lt;p&gt;5) Make an incision along the upper border of the lower rib below the intercostal space that you are going to use. **make sure the incision is large enough that your finger can easily go through it
&lt;/p&gt;&lt;p&gt;6) Using a curved clamp, create a tract by bluntly dissecting the muscle tissue until you reach the rib
&lt;/p&gt;&lt;p&gt;7) Angle the clamp to go above and over the rib (avoiding intercostal vessels and nerves) and push until you enter the pleural space
&lt;/p&gt;&lt;p&gt;8) Open the clamp and pull it out with the clamp still open creating a larger tract 
&lt;/p&gt;&lt;p&gt;9) Clamp the end of your chest tube and pass it along the tract into the pleural cavity (it helps if you have your finger in the tract in the space and pass the tube along your finger so you know you're in the right space)
&lt;/p&gt;&lt;p&gt;10) Once in the space, remove the clamp and feed the chest tube until all the holes are inside the thoracic cavity aiming it toward the apex
&lt;/p&gt;&lt;p&gt;11) Attach the other end of the chest tube to your pleura-vac and place on suction
&lt;/p&gt;&lt;p&gt;12) Secure the tube with silk suture (in the kit) and cover with gauze and cloth tape
&lt;/p&gt;&lt;p&gt;13) re-examine patient to see if you got a desired effect and get a CXR to confirm placement and position of tube
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Chest_Tube&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Complications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Complications"&gt;Complications&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; bleeding (causing a hemothorax)
&lt;/li&gt;&lt;li&gt; infection
&lt;/li&gt;&lt;li&gt; damage to nerves/vessels/heart/lung/diaphragm/abdomen
&lt;/li&gt;&lt;li&gt; air leak
&lt;/li&gt;&lt;li&gt; improper positioning of the tube
&lt;/li&gt;&lt;li&gt; tension pneumothorax 
&lt;/li&gt;&lt;li&gt; failure to drain 
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Chest_Tube&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;&lt;a href="http://www.trauma.org/archive/thoracic/CHESTdrain.html" class="external free" rel="nofollow"&gt;http://www.trauma.org/archive/thoracic/CHESTdrain.html&lt;/a&gt;
&lt;/p&gt;



</content><folder>Procedures</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="chest_tube_(peds)"><name>Chest Tube (Peds)</name><content>&lt;p&gt;PEDS INDICATIONS
&lt;/p&gt;&lt;p&gt;1. Ventilation
&lt;/p&gt;&lt;p&gt;2. Sy tension PNTX
&lt;/p&gt;&lt;p&gt;3. &amp;gt;20% PNTX
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Chest tube size = 4 x ET
&lt;/p&gt;



</content><folder>Procedures</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="cholesterol"><name>Cholesterol</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Cholesterol&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Ideal:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;LDL- &amp;lt;100mg/dl
&lt;/li&gt;&lt;li&gt;HDL- &amp;gt;35mg/dl
&lt;/li&gt;&lt;li&gt;TRIGLYCERIDES-&amp;lt;200mg/dl
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Cholesterol&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;6/06 MISTRY
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="chronic_cough"><name>Chronic Cough</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Chronic_Cough&amp;amp;action=edit&amp;amp;section=1" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Allergies
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; GERD
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; ACE-I
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; TB
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; Pertussis
&lt;/li&gt;&lt;/ul&gt;




</content><folder>Pulm</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="coagulopathies"><name>Coagulopathies</name><content>&lt;p&gt;Paracentesisno data supporting cutoff values for coags/platelets beyond which paracent should be avoided/prophylactically transfused
&lt;/p&gt;&lt;p&gt;the routine use of fresh frozen plasma and platelet concentrates is not recommended.
&lt;/p&gt;&lt;p&gt;contraindicated only if DIC or fibrinolysis
&lt;/p&gt;&lt;p&gt;incidence of clinically significant bleeding complications low even in liver failure (&amp;lt; 0.2%)
&lt;/p&gt;&lt;p&gt;Greatly increased serum creatinine levels --&amp;gt; consider post-procedure observation
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;ThoracentesisTransfuse if plat &amp;lt;50,000, or PT/PTT twice nl range
&lt;/p&gt;&lt;p&gt;(Mcvay)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Lumbar PunctureTranfuse if plat &amp;lt;50,000, or PT/PTT &amp;gt; 1.5 times nl
&lt;/p&gt;&lt;p&gt;If hemophiliac, replace factor before LP
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Central LineNo benefit FFP if artery isn't hit (Am J Surg '01)
&lt;/p&gt;&lt;p&gt;Consider transfuse if plat &amp;lt;50,000
&lt;/p&gt;&lt;p&gt;Use compressible site if coagulopathic (jury is still out)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;SourcesParacentesis:  Kaji Questions, Thomsen TW. Paracentesis. N Engl J Med 2006; 355: e21.; Roberts, Clin Proc Emer Med 2004; Yu (Clin Liv Dz '01)
&lt;/p&gt;&lt;p&gt;8/14/06 DONALDSON (adapted from Lampe, Charfen)
&lt;/p&gt;



</content><folder>Procedures</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="cocaine_chest_pain"><name>Cocaine Chest Pain</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#Epidemiology"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;Epidemiology&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Workup"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Workup&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-7"&gt;&lt;a href="#Risk_Stratification"&gt;&lt;span class="tocnumber"&gt;5.1&lt;/span&gt; &lt;span class="toctext"&gt;Risk Stratification&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Cocaine_Chest_Pain&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Cocaine is a catalyst for CAD &amp;amp; up to 6% of cocaine related CP develop an MI, however, a  9-12 hour period of ECG's and serial troponins can be safe. Of the 334 pts studied, if both were negative, no deaths from CV events occurred at 30 days. 4 pts did have non-fatal MI's but were using coc at the time (NEJM 2/03).
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Cocaine_Chest_Pain&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Epidemiology"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Epidemiology"&gt;Epidemiology&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;causes vasculitis
&lt;/li&gt;&lt;li&gt;6% incidence of AMI w/ cocaine CP
&lt;/li&gt;&lt;li&gt;Cocaine assoc c 24x risk of MI
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Cocaine_Chest_Pain&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;1- 3hrs onset from last use
&lt;ol&gt;&lt;li&gt;if &amp;gt;3 hrs = lower risk of MI
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Most with characterislnic pain
&lt;/li&gt;&lt;li&gt;Dyspnea, diaploresis, and nausea
&lt;/li&gt;&lt;li&gt;Most have nl vitals
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Cocaine_Chest_Pain&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Workup"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Workup"&gt;Workup&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;nl CP w/o (see disposition)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Cocaine_Chest_Pain&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Benzos
&lt;/li&gt;&lt;li&gt;Labetalol?
&lt;ol&gt;&lt;li&gt;Theoretical contra-indication B-blocker 2nd to unopposed alpha
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Cocaine_Chest_Pain&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;May discharge after: 9-12 hour period of ECG's and serial troponins, if both are negative.
&lt;ol&gt;&lt;li&gt;NEJM 2/03; n=334; outcome of zero events at 30dys if no more cocaine
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Cocaine_Chest_Pain&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Risk Stratification"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Risk_Stratification"&gt;Risk Stratification&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Lower:
&lt;ol&gt;&lt;li&gt;also low risk if ecg normal and without ischemic changes
&lt;/li&gt;&lt;li&gt;cocaine can however cause AMI, dilated cardiomyopathy,/ chf
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Cocaine_Chest_Pain&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;10/07 DONALDSON (adapted from Lampe, Mistry)
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="cocaine_withdrawl"><name>Cocaine Withdrawl</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Cocaine_Withdrawl&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-    pts may have concomitant wd from other drugs also
&lt;/p&gt;&lt;p&gt;-    mech of action of intoxication if to block reuptake of monoaminergic neuroxmtter.
&lt;/p&gt;&lt;p&gt;-    Repeated cocaine reduces number of post synaptic receptors (dopamine type)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Cocaine_Withdrawl&amp;amp;action=edit&amp;amp;section=2" title="Edit section: "&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id=""&gt; &lt;/span&gt;&lt;/h2&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Cocaine_Withdrawl&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Stimulant Withdrawal (Cocaine/ Amphetamine)
&lt;/p&gt;&lt;p&gt;-    stimulant wd can give dysphoria, appetite, motor disturbance- like depression sxs
&lt;/p&gt;&lt;p&gt;-    last 8- 48 hr to as much as 2 weeks
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Cocaine_Withdrawl&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-    no meds really helpful for wd sxs but if psychotic- give neuroleptics or benzos
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Cocaine_Withdrawl&amp;amp;action=edit&amp;amp;section=5" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Cards: Cocaine CP
&lt;/p&gt;



</content><folder>Tox</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="colic"><name>Colic</name><content>&lt;p&gt;&#65279;&#65279;&#65279;&#65279;&amp;gt;3h crying/day for &amp;gt;3x/week for &amp;gt;3wks; usually &amp;lt; 3months old
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="common_probs"><name>Common Probs</name><content>&lt;p&gt;NEONATES- common probs
&lt;/p&gt;&lt;p&gt;- sepsis
&lt;/p&gt;&lt;p&gt;- malrotation midgut volv- green vomit
&lt;/p&gt;&lt;p&gt;- child abuse
&lt;/p&gt;&lt;p&gt;- inborn error metab- AMS- check gluc or ammonia
&lt;/p&gt;&lt;p&gt;- ductal dependent heart lesion- tx c prostaglandin
&lt;/p&gt;&lt;p&gt;- omphalitis- goes to fasciitis- admit for sepsis
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;INFANTS
&lt;/p&gt;&lt;p&gt;- intussusception
&lt;/p&gt;&lt;p&gt;- perf appy
&lt;/p&gt;&lt;p&gt;- DKA
&lt;/p&gt;&lt;p&gt;- ingestions
&lt;/p&gt;&lt;p&gt;- abuse
&lt;/p&gt;&lt;p&gt;- SVT
&lt;/p&gt;&lt;p&gt;- partial status epilepticus- AMS but o/w normal- tx c benzo
&lt;/p&gt;&lt;p&gt;- myocarditis- tachy post inflvenza- worse c ivf- chf
&lt;/p&gt;&lt;p&gt;- ALTE- looks oK but septic workup and admit
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;6/06 MISTRY
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="compartment_syndrome"><name>Compartment Syndrome</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Pathophysiology"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Pathophysiology&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Presentation"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Presentation&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Etiology"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Etiology&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Specific_Syndromes"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Specific Syndromes&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-6"&gt;&lt;a href="#Forearm_.28.3C5.25.29"&gt;&lt;span class="tocnumber"&gt;5.1&lt;/span&gt; &lt;span class="toctext"&gt;Forearm (&amp;lt;5%)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-7"&gt;&lt;a href="#Lower_.28Leg_2-12.25_tibia.29"&gt;&lt;span class="tocnumber"&gt;5.2&lt;/span&gt; &lt;span class="toctext"&gt;Lower (Leg 2-12% tibia)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Compartment_Syndrome&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Pathophysiology"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Pathophysiology"&gt;Pathophysiology&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Cycle: Increased pressure--&amp;gt;impaired perfusion--&amp;gt;disruption of cellular metabolism--&amp;gt;cytolysis with release of osmotically active contents into compartment--&amp;gt;additional fluid drawn into compartment--&amp;gt;increased pressure
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Compartment_Syndrome&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Presentation"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Presentation"&gt;Presentation&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;5 Ps: pain, paresthesias, pallor, poikilothermia, pulselessness
&lt;ol&gt;&lt;li&gt;NB: pain, paresthesias are NOT reliable
&lt;/li&gt;&lt;li&gt;Pain at rest or with passive ROM
&lt;/li&gt;&lt;li&gt;Sensory nerves are first to lose conductive ability
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Compartment_Syndrome&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Etiology"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Etiology"&gt;Etiology&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Most often develops soon after significant trauma  (particularly involving long bone fractures of the lower leg or forearm)
&lt;/li&gt;&lt;li&gt;May also occur following minor trauma or from  nontraumatic causes:
&lt;ol&gt;&lt;li&gt;ischemia-reperfusion  injury
&lt;/li&gt;&lt;li&gt;coagulopathy
&lt;/li&gt;&lt;li&gt;certain  animal envenomations and bites
&lt;/li&gt;&lt;li&gt;extravasation  of IV fluids
&lt;/li&gt;&lt;li&gt;injection of recreational drugs
&lt;/li&gt;&lt;li&gt;prolonged limb compression
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Compartment_Syndrome&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Non-invasive tests are NOT reliable
&lt;/li&gt;&lt;li&gt;Striker
&lt;ol&gt;&lt;li&gt;Normal = 0-8mm Hg
&lt;/li&gt;&lt;li&gt;Capillary blod flow starts to be compromised at 20mmHg
&lt;ol&gt;&lt;li&gt;-Symptoms and signs may develop with pressures above approximately 20  mmHg
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Muscles and nerve fibers at risk at &amp;gt;30-40mmHg
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;interpret in light of SBP
&lt;/li&gt;&lt;li&gt;The pressure necessary for injury varies
&lt;/li&gt;&lt;li&gt;Higher pressures may be necessary with systemic hypertension
&lt;/li&gt;&lt;li&gt;May develop at lower pressures in those with hypotension or peripheral vascular disease
&lt;/li&gt;&lt;li&gt;A single normal compartment pressure reading, early in the course of the disease, does NOT rule out comp sy.
&lt;/li&gt;&lt;li&gt;Serial or continuous measurements are important when patient risk is moderate to high or clinical suspicion exists.
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Compartment_Syndrome&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Specific Syndromes"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Specific_Syndromes"&gt;Specific Syndromes&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Compartment_Syndrome&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Forearm (&amp;amp;lt;5%)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Forearm_.28.3C5.25.29"&gt;Forearm (&amp;lt;5%)&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;(most frequent injuries associated with comp sy in forearm are supracondylar humerus fractures in children and distal radius fractures in adults)
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt; deep volar
&lt;ol&gt;&lt;li&gt;at highest risk for comp sy
&lt;/li&gt;&lt;li&gt;contains the digital flexors
&lt;/li&gt;&lt;li&gt;decreased wrist extension
&lt;/li&gt;&lt;li&gt;includes flexor digitorum profundus (responsible for distal interphalangeal joint flexion) and the flexor pollicis longus (responsible for interphalangeal joint flexion of the thumb) 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; superficial volar
&lt;/li&gt;&lt;li&gt; dorsal
&lt;ol&gt;&lt;li&gt;contains the digital extensors
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; lateral
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Compartment_Syndrome&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Lower (Leg 2-12% tibia)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Lower_.28Leg_2-12.25_tibia.29"&gt;Lower (Leg 2-12% tibia)&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Anterior
&lt;ol&gt;&lt;li&gt;most common site compartment sy
&lt;/li&gt;&lt;li&gt;contains the four extensor muscles of the foot, the anterior tibial artery, and the deep peroneal nerve
&lt;/li&gt;&lt;li&gt;sx include loss of sensation between the 1st and 2nd toes and weakness of foot dorsiflexion
&lt;/li&gt;&lt;li&gt;late sequelae include foot drop, claw foot, and deep peroneal nerve dysfunction
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Lateral
&lt;ol&gt;&lt;li&gt;contains muscles for foot eversion and some plantar flexion (ie, peroneus brevis, peroneus longus), the peroneal artery, the superficial peroneal nerve, and the proximal portion of the deep peroneal nerve
&lt;/li&gt;&lt;li&gt;sx include deep peroneal nerve deficit (weakness in dorsiflexion and inversion of the foot and sensory loss in the web space between the great toe and the adjacent toe)
&lt;/li&gt;&lt;li&gt;superficial peroneal nerve also travels through this compartment and supplies sensation to the lower leg and foot
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Deep posterior
&lt;ol&gt;&lt;li&gt;muscles that aid in foot plantar flexion, as well as the posterior tibial artery, peroneal artery, and the tibial nerve
&lt;/li&gt;&lt;li&gt;sx include plantar hypesthesia, weakness of toe flexion, and pain with passive extension of the toes
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Superficial posterior
&lt;ol&gt;&lt;li&gt;the major muscles of plantar flexion (ie, gastrocnemius, soleus)
&lt;/li&gt;&lt;li&gt;no major arteries or nerves in this compartment.
&lt;/li&gt;&lt;li&gt;least likely to develop ACS in lower leg
&lt;/li&gt;&lt;li&gt;sx include pain and a palpably tense and tender compartment
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Compartment_Syndrome&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Raise limb to level of heart
&lt;/li&gt;&lt;li&gt;AVOID ice (will further compromise microcirculation)
&lt;/li&gt;&lt;li&gt;Bivalve or remove cast if present
&lt;/li&gt;&lt;li&gt;Surgery consult
&lt;/li&gt;&lt;li&gt;Definitive: Fasciotomy
&lt;/li&gt;&lt;li&gt;Goal: &amp;lt; 6hours
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Compartment_Syndrome&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from KajiQuestions and Donaldson; Perron (ACEP '09)
&lt;/p&gt;



</content><folder>Ortho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="concussion"><name>Concussion</name><content>&lt;p&gt;CONCUSSIONS
&lt;/p&gt;&lt;p&gt;-    transient aloc p trauma with neg ct
&lt;/p&gt;&lt;p&gt;-    but neg ct does not r/o diffuse axonal inj or microscopic inj
&lt;/p&gt;&lt;p&gt;-    with concussion can have abnormal neuro fnc for few days
&lt;/p&gt;&lt;p&gt;-    second impact syndrome- irrev brain damage p prior concussion after minor head inj- due to disordered autoregulation
&lt;/p&gt;&lt;p&gt;-    ct not as good as mri but good enough to find lesions requiring medical/ surgical eval
&lt;/p&gt;&lt;p&gt;-    risk of subsequent deterioration p neg initial ct is very low
&lt;/p&gt;&lt;p&gt;-    isolated skull fx and neg ct- few complications
&lt;/p&gt;&lt;p&gt;-    post traumatic sz with neg ct and neg neuro exam- low risk for subsequent sz
&lt;/p&gt;&lt;p&gt;-    theoretical risk for delayed bleeding p initial neg ct but these pts usually have abnormal neuro on presentation
&lt;/p&gt;&lt;p&gt;-    is normal neuro and neg ct, chance of delayed bleeding very rare
&lt;/p&gt;&lt;p&gt;-    minor trauma can give long term neuropsych changes- cognitive fnc, problem solving, attention, concentration- usually resolve p 1 yr
&lt;/p&gt;&lt;p&gt;-    the more concussions, the poorer the score on neuropsych testing
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Return to Sports
&lt;/p&gt;&lt;p&gt;minor- consussion, no LOC, neuro change &amp;lt;15 min- 1 wk no sports
&lt;/p&gt;&lt;p&gt;Grade 2- consussion, no loc, neuro change &amp;gt;15 min- 1- 2 wks no sports
&lt;/p&gt;&lt;p&gt;Grade 3- concussion w LOC- no sports for 2 wks
&lt;/p&gt;&lt;p&gt;if second grade 3, no sport for 1 mo and ct pos- no sports for rest of season and possible for ever!
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="concussions"><name>Concussions</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Concussions&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;minor- consussion, no LOC, neuro change &amp;lt;15 min- 1 wk no sports
&lt;/li&gt;&lt;li&gt;grade 2- consussion, no loc, neuro change &amp;gt;15 min- 1- 2 wks no sports
&lt;/li&gt;&lt;li&gt;grade 3- concussion w LOC- no sports for 2 wks
&lt;/li&gt;&lt;li&gt;is second grade 3, no sport for 1 mo and ct pos- no sports for rest of season and possible for ever!
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Concussions&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;7/2/09 PANI
&lt;/p&gt;



</content><folder>Neuro</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="congestive_heart_failure_(chf)"><name>Congestive Heart Failure (CHF)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#NYHA_Classes"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;NYHA Classes&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Key_Historical_Questions"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;Key Historical Questions&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Studies"&gt;&lt;span class="tocnumber"&gt;2.2&lt;/span&gt; &lt;span class="toctext"&gt;Studies&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#DDX"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;DDX&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-7"&gt;&lt;a href="#Causes_of_Decompensation"&gt;&lt;span class="tocnumber"&gt;3.1&lt;/span&gt; &lt;span class="toctext"&gt;Causes of Decompensation&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-8"&gt;&lt;a href="#Underlying_Etiology"&gt;&lt;span class="tocnumber"&gt;3.2&lt;/span&gt; &lt;span class="toctext"&gt;Underlying Etiology&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-10"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-11"&gt;&lt;a href="#Admission_Criteria_.28AHCPR_.2700.29"&gt;&lt;span class="tocnumber"&gt;5.1&lt;/span&gt; &lt;span class="toctext"&gt;Admission Criteria (AHCPR '00)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-12"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-13"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Congestive_Heart_Failure_(CHF)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Congestive_Heart_Failure_(CHF)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: NYHA Classes"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="NYHA_Classes"&gt;NYHA Classes&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;No Sx
&lt;/li&gt;&lt;li&gt;Sx with every day activity
&lt;/li&gt;&lt;li&gt;Severely limits activity
&lt;/li&gt;&lt;li&gt;Sx at rest
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Congestive_Heart_Failure_(CHF)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Congestive_Heart_Failure_(CHF)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Key Historical Questions"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Key_Historical_Questions"&gt;Key Historical Questions&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;History of heart failure? 
&lt;/li&gt;&lt;li&gt;Have you been taking your meds?
&lt;/li&gt;&lt;li&gt;Any recent changes in medication?
&lt;/li&gt;&lt;li&gt;SOB while: lying flat, walking, middle of night?
&lt;/li&gt;&lt;li&gt;CP?
&lt;/li&gt;&lt;li&gt;Syncope?
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Congestive_Heart_Failure_(CHF)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Studies"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Studies"&gt;Studies&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;CBC (r/o anemia), chemistry
&lt;/li&gt;&lt;li&gt;ECG
&lt;/li&gt;&lt;li&gt;CXR 
&lt;/li&gt;&lt;li&gt;Troponin? 
&lt;/li&gt;&lt;li&gt;BNP?
&lt;ol&gt;&lt;li&gt;&amp;lt;100 (90% Sn)
&lt;/li&gt;&lt;li&gt;&amp;gt; 500 (87% Sp) 
&lt;/li&gt;&lt;li&gt;Elevated in:
&lt;ol&gt;&lt;li&gt;Elderly, kidney failure, PE
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Decreased in:
&lt;ol&gt;&lt;li&gt;Obese
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Congestive_Heart_Failure_(CHF)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: DDX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX"&gt;DDX&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Cardiovascular
&lt;ol&gt;&lt;li&gt;ACS
&lt;/li&gt;&lt;li&gt;Acute valve dysfunction
&lt;/li&gt;&lt;li&gt;Aortic Dissection
&lt;/li&gt;&lt;li&gt;Dysrhthymia
&lt;/li&gt;&lt;li&gt;Endocarditis
&lt;/li&gt;&lt;li&gt;Hypertensive crisis
&lt;/li&gt;&lt;li&gt;Pericardial tamponade
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Pulmonary
&lt;ol&gt;&lt;li&gt;COPD
&lt;/li&gt;&lt;li&gt;PE
&lt;/li&gt;&lt;li&gt;PNA
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Other
&lt;ol&gt;&lt;li&gt;Pure volume overload
&lt;ol&gt;&lt;li&gt;Renal failure
&lt;/li&gt;&lt;li&gt;Post-transfusion
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Sepsis 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Congestive_Heart_Failure_(CHF)&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Causes of Decompensation"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Causes_of_Decompensation"&gt;Causes of Decompensation&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Medical noncompliance
&lt;/li&gt;&lt;li&gt;Dietary noncompliance
&lt;/li&gt;&lt;li&gt;ACS 
&lt;/li&gt;&lt;li&gt;Dysrhythmia
&lt;/li&gt;&lt;li&gt;Uncontrolled HTN 
&lt;/li&gt;&lt;li&gt;Infection
&lt;/li&gt;&lt;li&gt;Anemia
&lt;/li&gt;&lt;li&gt;Thyrotoxicosis
&lt;/li&gt;&lt;li&gt;PE
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Congestive_Heart_Failure_(CHF)&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Underlying Etiology"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Underlying_Etiology"&gt;Underlying Etiology&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;CAD
&lt;/li&gt;&lt;li&gt;HTN
&lt;/li&gt;&lt;li&gt;Cardiomyopathy
&lt;/li&gt;&lt;li&gt;Valvular
&lt;/li&gt;&lt;li&gt;High-output
&lt;/li&gt;&lt;li&gt;Post-partum
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Congestive_Heart_Failure_(CHF)&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;UNLOAD+
&lt;ol&gt;&lt;li&gt;Upright Position
&lt;/li&gt;&lt;li&gt;Nitrates
&lt;ol&gt;&lt;li&gt;Consider nitroprusside if NTG ineffective
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Lasix 
&lt;/li&gt;&lt;li&gt;Oxygen
&lt;/li&gt;&lt;li&gt;ASA
&lt;ol&gt;&lt;li&gt;Digoxin
&lt;ol&gt;&lt;li&gt;Indicated for a fib rate control 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;ACEI
&lt;ol&gt;&lt;li&gt;Enalaprilat 0.004mg/kg as IVB or 1mg gtt over 2hr
&lt;ol&gt;&lt;li&gt;Avoid in pregnancy, hyperK+ 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;BiPAP
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Congestive_Heart_Failure_(CHF)&amp;amp;action=edit&amp;amp;section=10" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Congestive_Heart_Failure_(CHF)&amp;amp;action=edit&amp;amp;section=11" title="Edit section: Admission Criteria (AHCPR '00)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Admission_Criteria_.28AHCPR_.2700.29"&gt;Admission Criteria (AHCPR '00)&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;ACS
&lt;/li&gt;&lt;li&gt;Pulm edema/resp distress
&lt;/li&gt;&lt;li&gt;O2 sat &amp;lt; 90% on room air
&lt;/li&gt;&lt;li&gt;Severe complicating illness
&lt;/li&gt;&lt;li&gt;CHF refractory to outpt therapy
&lt;/li&gt;&lt;li&gt;Anasarca
&lt;/li&gt;&lt;li&gt;Symptomatic hypotension or syncope
&lt;/li&gt;&lt;li&gt;Arrythmia (e.g. new a. fib)
&lt;/li&gt;&lt;li&gt;Inadequate outpt support
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Congestive_Heart_Failure_(CHF)&amp;amp;action=edit&amp;amp;section=12" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt; See Also &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Cards: CHF Meds
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Congestive_Heart_Failure_(CHF)&amp;amp;action=edit&amp;amp;section=13" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;EB Medicine, UpToDate, DONALDSON (adapted from Lampe)
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="constipation"><name>Constipation</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Workup"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Workup&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#Acute"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;Acute&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Chronic"&gt;&lt;span class="tocnumber"&gt;1.2&lt;/span&gt; &lt;span class="toctext"&gt;Chronic&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Differential"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Differential&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-6"&gt;&lt;a href="#Basic"&gt;&lt;span class="tocnumber"&gt;3.1&lt;/span&gt; &lt;span class="toctext"&gt;Basic&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-7"&gt;&lt;a href="#Acute_2"&gt;&lt;span class="tocnumber"&gt;3.2&lt;/span&gt; &lt;span class="toctext"&gt;Acute&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-8"&gt;&lt;a href="#Algorithm"&gt;&lt;span class="tocnumber"&gt;3.3&lt;/span&gt; &lt;span class="toctext"&gt;Algorithm&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Constipation&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Workup"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Workup"&gt;Workup&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Constipation&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Acute"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Acute"&gt;Acute&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;CBC (anemia)
&lt;/li&gt;&lt;li&gt;Chem7 (hypoK or hyperCa)
&lt;/li&gt;&lt;li&gt;TSH
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Constipation&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Chronic"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Chronic"&gt;Chronic&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;outpt
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Constipation&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Differential"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Differential"&gt;Differential&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Acute
&lt;ol&gt;&lt;li&gt;Diet
&lt;ol&gt;&lt;li&gt;Dec fluids
&lt;/li&gt;&lt;li&gt;Dec fiber
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Drugs
&lt;ol&gt;&lt;li&gt;Anticholinergics
&lt;/li&gt;&lt;li&gt;Antacids
&lt;/li&gt;&lt;li&gt;Antihypertensives
&lt;/li&gt;&lt;li&gt;Narcotics
&lt;/li&gt;&lt;li&gt;Symptathomimetics
&lt;/li&gt;&lt;li&gt;Laxative abuse
&lt;/li&gt;&lt;li&gt;NSAIDS
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Daily routine
&lt;ol&gt;&lt;li&gt;Immobility/lack exercis
&lt;/li&gt;&lt;li&gt;Travel
&lt;/li&gt;&lt;li&gt;Stress
&lt;/li&gt;&lt;li&gt;Failure respond to urge
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Disease
&lt;ol&gt;&lt;li&gt;Anatomic
&lt;ol&gt;&lt;li&gt;Painful (hemorrhoids, fissure)
&lt;/li&gt;&lt;li&gt;Intrinsic (diverticulitis, CA, obstruction)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Metabolic
&lt;ol&gt;&lt;li&gt;Hypothyrd/adrenal
&lt;/li&gt;&lt;li&gt;Hypokal/Ca/RF
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Chronic
&lt;ol&gt;&lt;li&gt;Hypertonic
&lt;ol&gt;&lt;li&gt;IBD
&lt;/li&gt;&lt;li&gt;Diverticulosis
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Hypotonic
&lt;ol&gt;&lt;li&gt;Neurogenic
&lt;ol&gt;&lt;li&gt;Dementia/CVA
&lt;/li&gt;&lt;li&gt;DM
&lt;/li&gt;&lt;li&gt;MS/ALS
&lt;/li&gt;&lt;li&gt;Spinal cord lesion
&lt;/li&gt;&lt;li&gt;Parkinson's
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Psychogenic (psychosis)
&lt;/li&gt;&lt;li&gt;Debilitated
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Habit (toilet training)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Constipation&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Constipation&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Basic"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Basic"&gt;Basic&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Do not use colace
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Fiber (bran not rughage)
&lt;/li&gt;&lt;li&gt;Increased fluids
&lt;/li&gt;&lt;li&gt;Bulk agents (Metamucil)
&lt;/li&gt;&lt;li&gt;Exercise
&lt;/li&gt;&lt;li&gt;Respond quickly urge to defecate
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Constipation&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Acute"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Acute_2"&gt;Acute&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Mineral oil (peds)
&lt;ol&gt;&lt;li&gt;15-30mL per yr of age (QD-BIDx3dy)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Milk of Mag
&lt;ol&gt;&lt;li&gt;15-30mL (QD-BID)
&lt;/li&gt;&lt;li&gt;cotraindicated with renal failure
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Mag Citrate
&lt;ol&gt;&lt;li&gt;200mL once
&lt;/li&gt;&lt;li&gt;cotraindicated with renal failure
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Fleets Enema
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Constipation&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Algorithm"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Algorithm"&gt;Algorithm&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Associate pain?
&lt;ol&gt;&lt;li&gt;Pain --&amp;gt; hemorrhoids?
&lt;ol&gt;&lt;li&gt;Yes --&amp;gt; hydrocort, etc
&lt;/li&gt;&lt;li&gt;No --&amp;gt; fissure?
&lt;ol&gt;&lt;li&gt;Yes --&amp;gt; (treat,&amp;nbsp;?IBD)
&lt;/li&gt;&lt;li&gt;No --&amp;gt; (GI ref,&amp;nbsp;?mass lesion)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;No pain --&amp;gt; urge to defecate?
&lt;ol&gt;&lt;li&gt;Yes --&amp;gt; stool in vault?
&lt;ol&gt;&lt;li&gt;Yes --&amp;gt; neuro, chronic dz
&lt;/li&gt;&lt;li&gt;No --&amp;gt; R/O meds, electrolyes, DM, thyroid --&amp;gt; IBS
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;No --&amp;gt; dementia, retardation, DM, myopathy, obstruction
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Constipation&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;3/12/06 DONALDSON (adapted from Rosen)
&lt;/p&gt;



</content><folder>GI</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="contrast_with_renal_dysfx"><name>Contrast with Renal Dysfx</name><content>&lt;p&gt;Indication = Cr &amp;gt; 1.1
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Harbor Cut-off 1.5 for CT
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Most give mucomyst, although in the original study patients received mucomyst much before the CT
&lt;/p&gt;&lt;p&gt;Mucomyst 600mg PO
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;(3 amps NaBicarb in 1L of D5H2O)
&lt;/p&gt;&lt;p&gt;Bolus 3mL/kg 1hr prior to IV contrast,
&lt;/p&gt;&lt;p&gt;then 1mL/kg/hr for 6hrs after
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Merten et al, JAMA 2004
&lt;/p&gt;



</content><folder>Rads</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="cord_compression"><name>Cord Compression</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Cord_Compression&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;MRI, may get CT myelography
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Cord_Compression&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Rad Tx for compressive lesions
&lt;/li&gt;&lt;li&gt;AMERICAN ASSOCIATION OF NEUROLOGICAL SURGEONS GUIDLINES (9/07) NO LONGER RECOMMENDS STEROIDS FOR SPINAL CORD INJURY (Old for Tx &amp;lt;8 hrs = methylprednisolone 30 mg IV, then infusion of 5.4 m/k/h x 23 hrs + GI prophylaxis)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Cord_Compression&amp;amp;action=edit&amp;amp;section=3" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Trauma: Spinal Fractures
&lt;/p&gt;&lt;p&gt;Neuro: Spinal Cord Syndromes
&lt;/p&gt;&lt;p&gt;Neuro: Neurogenic Shock
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Cord_Compression&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;DONALDSON 9/07 (Adapted from Lampe, Hockberger, Brower, and Mistry)
&lt;/p&gt;



</content><folder>Neuro</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="corneal_abrasion"><name>Corneal Abrasion</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Foreign_Body_Removal_Techniques"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Foreign Body Removal Techniques&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Rust_Ring"&gt;&lt;span class="tocnumber"&gt;3.1&lt;/span&gt; &lt;span class="toctext"&gt;Rust Ring&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Corneal_Abrasion&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Visual acuity
&lt;ol&gt;&lt;li&gt;If substantially subnormal evaluate for corneal edema versus infectious infiltrate  
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Pupil shape and reactivity
&lt;ol&gt;&lt;li&gt;Irregular or nonreactive pupil suggests pupillary sphincter injury 
&lt;ol&gt;&lt;li&gt;Evaulate for penetrating injury 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Hyphema or hypopyon?
&lt;ol&gt;&lt;li&gt;If yes then same same-day ophtho consult is required
&lt;/li&gt;&lt;li&gt;Hyphema suggests possible penetrating injury 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Extruded ocular contents?
&lt;ol&gt;&lt;li&gt;If yes then place eye shield and obtain emergent ophtho referral  
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Contact lens wearer?
&lt;ol&gt;&lt;li&gt;If yes and p/w corneal abrasion AND e/o white spot or opacity on exam concerning for infiltrate or ulceration then refer for same day ophtho appt 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Fluorescein Examination
&lt;ol&gt;&lt;li&gt;Seidel sign (streaming of fluorescein caused by leaking aqueous humor)
&lt;ol&gt;&lt;li&gt;Indicates penetrating trauma (globe microperforation)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Branching pattern suggests possible herpes keratitis
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Corneal Ulcer?
&lt;ol&gt;&lt;li&gt;Grayish white
&lt;/li&gt;&lt;li&gt;Worsening symptoms
&lt;/li&gt;&lt;li&gt;&amp;gt; 1day 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Intraocular foreign body?
&lt;ol&gt;&lt;li&gt;If concern for foreign body but none visualized on external exam consider CT orbit
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Corneal_Abrasion&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Foreign Body Removal Techniques"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Foreign_Body_Removal_Techniques"&gt;Foreign Body Removal Techniques&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Irrigation
&lt;/li&gt;&lt;li&gt;Cotton swab
&lt;/li&gt;&lt;li&gt;18-25G needle 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Corneal_Abrasion&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Antibiotics - Indicated for all abrasions 
&lt;ol&gt;&lt;li&gt;Ointment is better than drops due to its lubricant effect
&lt;ol&gt;&lt;li&gt;Erythromycin ointment qid x 3-5 days 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;If treatintg contact lens associated abrasion must cover pseudomonas
&lt;ol&gt;&lt;li&gt;E.g.  Cipro/ofloxacin or tobramycin drops qid x 3-5 days
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Analgesia
&lt;ol&gt;&lt;li&gt;Cycloplegics
&lt;ol&gt;&lt;li&gt;Consider for patients with large abrasions and photophobia
&lt;ol&gt;&lt;li&gt;Cyclopentolate 0.5-1% bid or homatropine 2.5-5% daily for up to 48 hours 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Systemic opiods
&lt;/li&gt;&lt;li&gt;Never give Rx for topical anesthetics 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Tetanus prophylaxis
&lt;ol&gt;&lt;li&gt;Only indicated for penetrating injuries, not for abrasions or foreign bodies
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Corneal_Abrasion&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Rust Ring"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Rust_Ring"&gt;Rust Ring&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Treat just like pts with corneal abrasions
&lt;/li&gt;&lt;li&gt;obtain ophtho f/u in 24-48 hrs for removal of the rust
&lt;/li&gt;&lt;/ol&gt;




</content><folder>Ophtho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="corneal_abrasion_vs_ulcer"><name>Corneal Abrasion vs Ulcer</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Corneal_Abrasion_vs_Ulcer&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Corneal Ulcer"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Corneal_Ulcer"&gt;Corneal Ulcer&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Gray/white area
&lt;/li&gt;&lt;li&gt; Worsening symptoms
&lt;/li&gt;&lt;li&gt; +/- discharge
&lt;/li&gt;&lt;li&gt; &amp;gt;1dy
&lt;/li&gt;&lt;/ol&gt;




</content><folder>Ophtho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="cortisol_stim_test"><name>Cortisol Stim Test</name><content>&lt;p&gt;Cosyntropin
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Before: Draw serum cortisol
&lt;/li&gt;&lt;li&gt;Time 0: ^0.25mg IM/IV over 2min
&lt;/li&gt;&lt;li&gt;Time 30: Draw serum cortisol
&lt;/li&gt;&lt;li&gt;Time 60: Draw serum cortisol &amp;amp; give 100mg hydrodortison IVP
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;^0.125mg if &amp;lt;2yrs old
&lt;/p&gt;&lt;p&gt;Positive:
&lt;/p&gt;&lt;p&gt;Negative:
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Cortisol_Stim_Test&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Then give either
&lt;ol&gt;&lt;li&gt;dexamethasone 6mg IV
&lt;/li&gt;&lt;li&gt;OR
&lt;/li&gt;&lt;li&gt;Hydrocotipn
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Cortisol_Stim_Test&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;2/22/06 DONALDSON (from Pharmacopoeia)
&lt;/p&gt;



</content><folder>Endo</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="coude_catheter"><name>Coude Catheter</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Indications.2FContraindications"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Indications/Contraindications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Procedure"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Procedure&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Complications"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Complications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Coude_Catheter&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Indications/Contraindications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Indications.2FContraindications"&gt;Indications/Contraindications&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-Same as for Foley catheter placement (but typically used after failure of Foley placement) in a man with an enlarged prostate.
&lt;/p&gt;&lt;p&gt;-Almost never used in pediatric patients
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Coude_Catheter&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Procedure"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Procedure"&gt;Procedure&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-insert with curved tip pointing up (cephalad)
&lt;/p&gt;&lt;p&gt;-gentle but continuous pressure past the resistance point
&lt;/p&gt;&lt;p&gt;-advanced until the hub is at the glans (with urine return through catheter)
&lt;/p&gt;&lt;p&gt;-inflate balloon (10 mL of saline)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Coude_Catheter&amp;amp;action=edit&amp;amp;section=3" title="Edit section: "&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id=""&gt; &lt;/span&gt;&lt;/h2&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Coude_Catheter&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Complications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Complications"&gt;Complications&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-creation or extension of false tracts
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Coude_Catheter&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Evaluation and treatment of acute urinary retention. J Emerg Med. 2008:  35:193-198
&lt;/p&gt;



</content><folder>Procedures</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="create_an_account"><name>Create an Account</name><content>&lt;p&gt;Everyone is able to view WikEM on the web and via smart phones, as long as they agree to our disclaimer (see disclaimer page).  &lt;b&gt;You can view all data without creating an account.&lt;/b&gt; 
&lt;/p&gt;&lt;p&gt;We invite medical physicians (senior medical students, residents, and attendings) to create an account on &lt;i&gt;&lt;b&gt;WikEM&lt;/b&gt;&lt;/i&gt; to edit content. By default users are awarded read-only access. If you would like to have write access, please &lt;a href="/wiki/Special:UserLogin" title="Special:UserLogin"&gt;create an account&lt;/a&gt; and provide an email address when you register. You will then receive an email asking to confirm your address.  You must use your real name.
&lt;/p&gt;&lt;p&gt;After confirming your email address you will be granted a trial period of write access for 2 weeks. Please note that we reserve the right to revoke editing privileges in the unlikely event that we perceive inappropriate behavior on the WikEM website.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;



</content><folder>WikEM</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="croup"><name>Croup</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Epidemiology"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Epidemiology&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Spasmodic_Croup"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Spasmodic Croup&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Croup&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Epidemiology"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Epidemiology"&gt;Epidemiology&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- 3 mo - 3 yrs (6-24 mo common)
&lt;/p&gt;&lt;p&gt;- fall &amp;amp; winter
&lt;/p&gt;&lt;p&gt;- Parainfluenza (50%), RSV, adenovirus, influenza, measles, HSV,
&lt;/p&gt;&lt;p&gt;Mycoplasma pneumonia.
&lt;/p&gt;&lt;p&gt;In non-immunized, poss Diphtheria --&amp;gt; give Erythromycin IV &amp;amp; Diphtheria antitoxin
&lt;/p&gt;&lt;p&gt;- 6pm to 6am
&lt;/p&gt;&lt;p&gt;- Spasmodic croup age 1-5yrs
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Croup&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;r/o Foreign Body
&lt;/p&gt;&lt;p&gt;2-3 day hx URI, then abrupt onset barking cough
&lt;/p&gt;&lt;p&gt;Inspiratory Stridor
&lt;/p&gt;&lt;p&gt;low fever 37.7 - 38.8
&lt;/p&gt;&lt;p&gt;NO drooling or dysphagia
&lt;/p&gt;&lt;p&gt;lasts 3 - 5 days, up to 1 wk
&lt;/p&gt;&lt;p&gt;Steeple sign on AP (25% epiglotitis can show this too)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Croup&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Consider CXR
&lt;/p&gt;&lt;p&gt;Consider nasal washings for RSV, parainfluenza, influenza.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Croup&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;CROUP SCORE (also see Med Rules)
&lt;/p&gt;&lt;p&gt;I. STRIDOR
&lt;/p&gt;
&lt;pre&gt;    0 None
&lt;/pre&gt;
&lt;pre&gt;    1 Only c agitation
&lt;/pre&gt;
&lt;pre&gt;    2 Mild @ rest
&lt;/pre&gt;
&lt;pre&gt;    3 Severe at rest
&lt;/pre&gt;
&lt;p&gt;II. RETRACTIONS
&lt;/p&gt;
&lt;pre&gt;    0 None
&lt;/pre&gt;
&lt;pre&gt;    1 Mild
&lt;/pre&gt;
&lt;pre&gt;    2 Moderate
&lt;/pre&gt;
&lt;pre&gt;    3 Severe
&lt;/pre&gt;
&lt;p&gt;III. AIR ENTRY
&lt;/p&gt;
&lt;pre&gt;    0 Normal
&lt;/pre&gt;
&lt;pre&gt;    1 Mild decrease
&lt;/pre&gt;
&lt;pre&gt;    2 Mod decrease
&lt;/pre&gt;
&lt;pre&gt;    3 Marked decrease
&lt;/pre&gt;
&lt;p&gt;IV. COLOR
&lt;/p&gt;
&lt;pre&gt;    0 Normal
&lt;/pre&gt;
&lt;pre&gt;    1
&lt;/pre&gt;
&lt;pre&gt;    2
&lt;/pre&gt;
&lt;pre&gt;    3 Cyanotic at rest
&lt;/pre&gt;
&lt;p&gt;V. LEVEL OF CONSCIOUSNESS
&lt;/p&gt;
&lt;pre&gt;    0 Normal
&lt;/pre&gt;
&lt;pre&gt;    1 Restless when disturbed
&lt;/pre&gt;
&lt;pre&gt;    2 Restless when un-disturbed
&lt;/pre&gt;
&lt;pre&gt;    3 Lethargic
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;MANAGEMENT (Viral)
&lt;/p&gt;&lt;p&gt;&amp;lt;4: Mild
&lt;/p&gt;
&lt;pre&gt;    1. Mist
&lt;/pre&gt;
&lt;pre&gt;    2. Outpt
&lt;/pre&gt;
&lt;p&gt;5-6: Mild-Mod
&lt;/p&gt;
&lt;pre&gt;    1. Mist
&lt;/pre&gt;
&lt;pre&gt;    2. Racemic epi*
&lt;/pre&gt;
&lt;pre&gt;    3. Dexameth**
&lt;/pre&gt;
&lt;pre&gt;    4. Outpt if (after 3hr OPs):
&lt;/pre&gt;
&lt;pre&gt;         a. Improved in ED
&lt;/pre&gt;
&lt;pre&gt;         b. &amp;gt;6 mo old
&lt;/pre&gt;
&lt;pre&gt;         c. Reliable family
&lt;/pre&gt;
&lt;pre&gt;         d. No rest stridor
&lt;/pre&gt;
&lt;pre&gt;         e. Access to F/U
&lt;/pre&gt;
&lt;pre&gt;         f. Benign PMH
&lt;/pre&gt;
&lt;pre&gt;         g. VS nl
&lt;/pre&gt;
&lt;p&gt;7-8: Moderate
&lt;/p&gt;
&lt;pre&gt;    1. Racemic epi*
&lt;/pre&gt;
&lt;pre&gt;    2. Dexameth**
&lt;/pre&gt;
&lt;pre&gt;    3. Admit
&lt;/pre&gt;
&lt;p&gt;&amp;gt;9: Severe
&lt;/p&gt;
&lt;pre&gt;    1. Racemic epi*
&lt;/pre&gt;
&lt;pre&gt;    2. Dexameth**
&lt;/pre&gt;
&lt;pre&gt;    3. Intubtion?
&lt;/pre&gt;
&lt;pre&gt;    4. PICU
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Racemic Epi 0.25-0.75mg in 2.5ml NS
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;if 1:1,000 (L-epi) use 2.5-5.0mL (= 5mg)
&lt;/p&gt;&lt;p&gt;May repeat Q20-30 min x 3
&lt;/p&gt;&lt;p&gt;DON'T USE if Cardiac Muscular Outflow Obstruction or Tetralogy of Fallot.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;&lt;ul&gt;&lt;li&gt;Dexamethasone 0.6 mg/kg IV/IM/PO
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;&lt;ul&gt;&lt;li&gt;&lt;ul&gt;&lt;li&gt;Intubation: Use ET tube 1-2 sizes smaller than usual (swelling)
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Croup&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Spasmodic Croup"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Spasmodic_Croup"&gt;Spasmodic Croup&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-presents suddenly, without URI prodrome
&lt;/p&gt;&lt;p&gt;-often resolve spontaneously before ED c cold night air, shower water vapor.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Treatment
&lt;/p&gt;&lt;p&gt;Outpt
&lt;/p&gt;&lt;p&gt;cool mist / cool air / shower vapor
&lt;/p&gt;&lt;p&gt;2- 4 ml Nebulized NS or
&lt;/p&gt;&lt;p&gt;Racemic Epi 0.25-0.75ml in 2.5ml NS
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Croup&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;4/14/06 DONALDSON (adapted from Lampe, Rosen)
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="crying_infant"><name>Crying Infant</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Crying_Infant&amp;amp;action=edit&amp;amp;section=1" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- occult UTI (consider in excessive crying)
&lt;/p&gt;&lt;p&gt;- DPT (excessive crying &amp;gt; 3 hrs)
&lt;/p&gt;&lt;p&gt;- corneal abrasion
&lt;/p&gt;&lt;p&gt;- strangulation (hair tourniquets on extremities, penis)
&lt;/p&gt;&lt;p&gt;- diaper pin
&lt;/p&gt;&lt;p&gt;- insect bites
&lt;/p&gt;&lt;p&gt;- burns in mouth
&lt;/p&gt;&lt;p&gt;- otitis
&lt;/p&gt;&lt;p&gt;- physical abuse
&lt;/p&gt;&lt;p&gt;- anal fissures
&lt;/p&gt;&lt;p&gt;- intussusception
&lt;/p&gt;&lt;p&gt;- incarcerated hernias
&lt;/p&gt;&lt;p&gt;- testicular torsion
&lt;/p&gt;&lt;p&gt;- cocaine exposure or drug withdrawal
&lt;/p&gt;&lt;p&gt;- meningitis
&lt;/p&gt;&lt;p&gt;- SVT
&lt;/p&gt;&lt;p&gt;- PNA, rib fxs
&lt;/p&gt;&lt;p&gt;- GERD
&lt;/p&gt;&lt;p&gt;- ASA OD
&lt;/p&gt;&lt;p&gt;- colic (rule of 3s - healthy infant cry more than 3 hrs/day, &amp;gt; 3 days/wk, for more than 3 weeks).
&lt;/p&gt;&lt;p&gt;Crying peaks in afternoon &amp;amp; night age 1-3 mo, cows milk allergy? Ends 4-5 mo old
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Crying_Infant&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- rule out badness above including shaken baby
&lt;/p&gt;&lt;p&gt;- flourescein staining to r/o corneal abrasions
&lt;/p&gt;&lt;p&gt;- fundoscopic exam
&lt;/p&gt;&lt;p&gt;- r/o otitis
&lt;/p&gt;&lt;p&gt;- examine all bones/joints to r/o fx, osteo or septic joint
&lt;/p&gt;&lt;p&gt;- inspect GU area
&lt;/p&gt;&lt;p&gt;- Skeletal survey &amp;amp; head CT in suspected child abuse
&lt;/p&gt;&lt;p&gt;- 4% benefit from change to soy formula
&lt;/p&gt;&lt;p&gt;- rocking, warm compresses to belly feeding, frequent burping, diaper changes
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Crying_Infant&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;C. 243 Harwood
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="cyanide"><name>Cyanide</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#CO.2FCN_Combined_Poisoning"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;CO/CN Combined Poisoning&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Cyanide&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Older cyanide kit with potential to cause metHgb which potentially problem as patient may have CO as well
&lt;/p&gt;&lt;p&gt;Newer CyanoKit safer (but very expensive) without significant adverse rxn
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;PATHOPHYSIOLOGY
&lt;/p&gt;&lt;p&gt;-glucose metabolized to pyruvate yields 2 ATP by anaerobic glycolysis.  No O2 needed.
&lt;/p&gt;&lt;p&gt;- pyruvate then enters  Kreb cycle and with O2, yields 36 more ATP.  Requires function of mitochondrial electron xport system, the last step of which transfers electrons to oxygen to form water.
&lt;/p&gt;&lt;p&gt;- cyanide, hydrogen sulfide and carbon monoxide  bind to and inhibit cytochrome part of electron xport chain.
&lt;/p&gt;&lt;p&gt;- if pyruvate blocked from entering Krebs cycle, pyruvate metabolized to lactic acid- leads to lactic acidosis.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Cyanide&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-cn and h2s pts can&#8217;t extract o2 from blood.  Po2 of venous blood similar to arterial blood.  May diagnose cn poisoning by similar mixed venous o2 and arterial o2- get arterial and venous blood gases ana compare O2
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;-  Venous PO2 = Arterial PO2
&lt;/p&gt;&lt;p&gt;-  lactic acidosis
&lt;/p&gt;&lt;p&gt;-  nl SaO2
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Cyanide&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- goal is to remove cn from cytochrome enzyme and bind cn to something else
&lt;/p&gt;&lt;p&gt;- give amyl nitrite inhaler followed by iv sodium nitrite to make MetHb- methb bind to  cn and pulls cn out of tissue into blood to make cyanomethemoglobin.
&lt;/p&gt;&lt;p&gt;- dose of  sodium nitrite is  10cc of 3% soln over  2- 4 min. Ped dose is 0.2cc.kg.  May cause hypotension if given too fast.  Will generate methb level of 8%.
&lt;/p&gt;&lt;p&gt;- if cn present, will rapidlly be converted to cnmethb.  Lack of measurable methb levels p iv Na nitrite confirms cn presence.
&lt;/p&gt;&lt;p&gt;- once cnmethb in blood, give sodium thiosulfate 12.5 gm (50 cc of 25% soln of 5X vol of na nitrite).  Sulfur will bind with cn to make thiocyanate which is nontoxic and renally excreted.
&lt;/p&gt;&lt;p&gt;-consider retreatment of incomplete response or oral cn poisoning with ongoing absorption.
&lt;/p&gt;&lt;p&gt;- can also use vit b12 hydroxycobalamin to make cyanocobalamine
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;TREATMENT
&lt;/p&gt;&lt;p&gt;- amyl nitrite inhaler
&lt;/p&gt;&lt;p&gt;- then iv sodium nitrite
&lt;/p&gt;&lt;p&gt;-&amp;gt;  10cc of 3% over  2- 4 min.(0.2cc/kg in peds)
&lt;/p&gt;&lt;p&gt;- then sodium thiosulfate 12.5 gm (50 cc of 25% soln of 5X vol of na nitrite)
&lt;/p&gt;&lt;p&gt;-follow methemoglobn levels
&lt;/p&gt;&lt;p&gt;- also consider hydroxycobalamin
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Cyanide&amp;amp;action=edit&amp;amp;section=4" title="Edit section: CO/CN Combined Poisoning"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="CO.2FCN_Combined_Poisoning"&gt;CO/CN Combined Poisoning&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-if pt has co poisoning already and is given cn antidote and methb make, two dyshemoglobins cohb and methb will further inhibit o2 carriage.
&lt;/p&gt;&lt;p&gt;- cn poisoning correlated with lactate level &amp;gt; 10mmol/L
&lt;/p&gt;&lt;p&gt;- sodium thiosulfate given alone is safe without alteration of o2 carrying capacity of nitrites.  Consider emperic  tx c 12.5 mg to all smoke inhalation victims with hypotension, acidosis, or CV collapse. 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;CO/CN COMBINED POISONING
&lt;/p&gt;&lt;p&gt;- sodium thiosulfate given alone (no alteration O2 carrying capacity)
&lt;/p&gt;&lt;p&gt;-&amp;gt; consider emperic  tx (12.5 mg) for smoke inhalation victims with
&lt;/p&gt;&lt;p&gt;hypotension, acidosis, or CV collapse
&lt;/p&gt;&lt;p&gt;-&amp;gt; See also Trauma:  Burns (Severe)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Cyanide&amp;amp;action=edit&amp;amp;section=5" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Tox: Hydrogen Sulfide
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Cyanide&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Pani
&lt;/p&gt;&lt;p&gt;8/07  DONLDSON (adapted from Sandness, Mistry)
&lt;/p&gt;



</content><folder>Tox</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="dic"><name>DIC</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Causes"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Causes&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=DIC&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Causes"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Causes"&gt;Causes&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;infection
&lt;/li&gt;&lt;li&gt;carcinoma
&lt;/li&gt;&lt;li&gt;acute leukemia
&lt;/li&gt;&lt;li&gt;trauma (head)
&lt;/li&gt;&lt;li&gt;shock
&lt;/li&gt;&lt;li&gt;liver disease
&lt;/li&gt;&lt;li&gt;pregnancy
&lt;/li&gt;&lt;li&gt;vascular disease
&lt;/li&gt;&lt;li&gt;envenomation
&lt;/li&gt;&lt;li&gt;ARDS
&lt;/li&gt;&lt;li&gt;transfusion reaction
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=DIC&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;PT high
&lt;/li&gt;&lt;li&gt;PTT high
&lt;/li&gt;&lt;li&gt;Platlet low
&lt;/li&gt;&lt;li&gt;Fibrinogen low
&lt;/li&gt;&lt;li&gt;FDP high
&lt;/li&gt;&lt;li&gt;D-dimer high
&lt;/li&gt;&lt;li&gt;RBCs fragmented
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=DIC&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;See Heme: Bleeding Treatment
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=DIC&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1/26/06 DONALDSON (addapted from Tintinalli)
&lt;/p&gt;



</content><folder>Heme/Onc</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="dka_(peds)"><name>DKA (Peds)</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=DKA_(Peds)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1) IV Fluids
&lt;/p&gt;
&lt;pre&gt;    Bolus 20ml/kg NS prn unstable VS
&lt;/pre&gt;
&lt;pre&gt;    NS@10ml/hr/kg for stable VS
&lt;/pre&gt;
&lt;pre&gt;    Replace fluid deficit evenly over
&lt;/pre&gt;
&lt;pre&gt;           48hrs w/NS or &#189;NS
&lt;/pre&gt;
&lt;pre&gt;    When BS &amp;lt; 250, go to #5 below
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;2) Insulin
&lt;/p&gt;
&lt;pre&gt;    IV Infusion 0.1 units/kg/hr
&lt;/pre&gt;
&lt;pre&gt;    Cont until HCO3&amp;gt;p15 and pH&amp;gt;7.3
&lt;/pre&gt;
&lt;pre&gt;    Decrease infusion to 0.05 u/kg/hr
&lt;/pre&gt;
&lt;pre&gt;            until SC insulin initiated
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;3) Potassium
&lt;/p&gt;
&lt;pre&gt;     if &amp;lt; 2.5, hold insulin and give
&lt;/pre&gt;
&lt;pre&gt;           1 meq/kg KCL in IV over 1hr
&lt;/pre&gt;
&lt;pre&gt;           No insulin until K &amp;gt; 2.5
&lt;/pre&gt;
&lt;pre&gt;     if &amp;gt; 2.5 but &amp;lt; 3.5, then give
&lt;/pre&gt;
&lt;pre&gt;           40-60 meq/L in IV until K &amp;gt; 3.5
&lt;/pre&gt;
&lt;pre&gt;     if &amp;gt; 3.5 but &amp;lt; 5.5, then give
&lt;/pre&gt;
&lt;pre&gt;           30-40 meq/L in IV for K=3.5 - 5
&lt;/pre&gt;
&lt;pre&gt;     if &amp;gt;  5.5, then
&lt;/pre&gt;
&lt;pre&gt;           check K q1hr
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;4) Bicarbonate
&lt;/p&gt;
&lt;pre&gt;     if pH &amp;lt; 7.0 after 1hr fluids, then
&lt;/pre&gt;
&lt;pre&gt;     give 2 meq/kg NaHCO3 in NS x1hr
&lt;/pre&gt;
&lt;pre&gt;     (don't exceed 155 meq/L Na)
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;5) When BS &amp;lt; 250:
&lt;/p&gt;
&lt;pre&gt;    Change fluid to D5&#189;NS @ rate to
&lt;/pre&gt;
&lt;pre&gt;           correct fluid deficit in 48hrs
&lt;/pre&gt;
&lt;pre&gt;           and maintain BS 150-250
&lt;/pre&gt;
&lt;pre&gt;           (may require D10 w/lytes)
&lt;/pre&gt;
&lt;pre&gt;    Check chem7 q2hrs until gap closes
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=DKA_(Peds)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from Pani
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="dvt"><name>DVT</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Well.27s_Scoring"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Well's Scoring&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Score"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;Score&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-7"&gt;&lt;a href="#Outpt_Rx_.28Harbor_Protocol.29"&gt;&lt;span class="tocnumber"&gt;5.1&lt;/span&gt; &lt;span class="toctext"&gt;Outpt Rx (Harbor Protocol)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-8"&gt;&lt;a href="#Emergency_Department_Treatment_and_follow-up"&gt;&lt;span class="tocnumber"&gt;5.2&lt;/span&gt; &lt;span class="toctext"&gt;Emergency Department Treatment and follow-up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=DVT&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=DVT&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Well's Scoring"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Well.27s_Scoring"&gt;Well's Scoring&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Clinical characteristics:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt; Active cancer (&amp;lt;6 mo) 1
&lt;/li&gt;&lt;li&gt; Paralysis, paresis, recent immob 1
&lt;/li&gt;&lt;li&gt; Recent bedridden &amp;gt;3 days,
&lt;/li&gt;&lt;li&gt; Major surg past &amp;lt;4 weeks 1
&lt;/li&gt;&lt;li&gt; TTP deep venous system 1
&lt;/li&gt;&lt;li&gt; Entire leg swollen 1
&lt;/li&gt;&lt;li&gt; calf swelling &amp;gt;3cm measured 10cm below tibial tuberosity 1
&lt;/li&gt;&lt;li&gt; Pitting edema &amp;gt; in affected leg 1
&lt;/li&gt;&lt;li&gt; Symptomatic leg 1
&lt;/li&gt;&lt;li&gt; Collateral superficial veins (not varicose) 1
&lt;/li&gt;&lt;li&gt; alternative dx as likely or greater than that of dvt -2
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=DVT&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Score"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Score"&gt;Score&lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt;2 or greater = high
&lt;/li&gt;&lt;li&gt;1 = low
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=DVT&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;High
&lt;ol&gt;&lt;li&gt;D-dimer and UTZ
&lt;ol&gt;&lt;li&gt;If both negative
&lt;ol&gt;&lt;li&gt;Alt diagnosis
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;If pos D-dimer, neg UTZ
&lt;ol&gt;&lt;li&gt;repeat UTZ 1 week
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Low
&lt;ol&gt;&lt;li&gt;D-dimer neg
&lt;ol&gt;&lt;li&gt;Alt diagnosis
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;D-dimer pos
&lt;ol&gt;&lt;li&gt;need UTZ
&lt;ol&gt;&lt;li&gt;UTZ neg = alt diagnosis
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=DVT&amp;amp;action=edit&amp;amp;section=5" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Arterial embolism
&lt;/li&gt;&lt;li&gt;Septic joint
&lt;/li&gt;&lt;li&gt;Osteomyelitis
&lt;/li&gt;&lt;li&gt;Compartment syndrome
&lt;/li&gt;&lt;li&gt;Nec fasc
&lt;/li&gt;&lt;li&gt;Gout
&lt;/li&gt;&lt;li&gt;Neuropathy
&lt;/li&gt;&lt;li&gt;Nerve entrapment
&lt;/li&gt;&lt;li&gt;Sciatica
&lt;/li&gt;&lt;li&gt;Fx
&lt;/li&gt;&lt;li&gt;Reflex sympathetic dystrophy
&lt;/li&gt;&lt;li&gt;Lymphangitis
&lt;/li&gt;&lt;li&gt;Buerger's disease
&lt;/li&gt;&lt;li&gt;Arthritis
&lt;/li&gt;&lt;li&gt;Tendonitis
&lt;/li&gt;&lt;li&gt;Myositis
&lt;/li&gt;&lt;li&gt;Arteritis
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=DVT&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=DVT&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Outpt Rx (Harbor Protocol)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Outpt_Rx_.28Harbor_Protocol.29"&gt;Outpt Rx (Harbor Protocol)&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Outpatient treatment of DVT from the Emergency Department
&lt;/p&gt;&lt;p&gt;The goal of this protocol is to decrease unnecessary hospital admissions for selected patients who can be treated for deep venous thrombosis on an outpatient basis with low molecular weight heparin (LMWH) and coumadin.
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Patient Selection
&lt;ol&gt;&lt;li&gt;All patients diagnosed with DVT should be considered for potential outpatient management with the following exclusion criteria:
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Absolute contraindications to outpatient management:
&lt;ol&gt;&lt;li&gt; Presence of massive DVT (phlegmasia cerulea dolens)
&lt;/li&gt;&lt;li&gt; Presence of concurrent symptoms of pulmonary embolism (PE)
&lt;/li&gt;&lt;li&gt; High-risk of anticoagulation-related bleeding
&lt;/li&gt;&lt;li&gt; Presence of acute co-morbid conditions and other factors that would necessitate hospitalization.
&lt;/li&gt;&lt;li&gt; Recent (within 2 weeks) stroke or transient ischemic attack
&lt;/li&gt;&lt;li&gt; Hypertensive emergencies
&lt;/li&gt;&lt;li&gt; Severe renal dysfunction (creatinine clearance &amp;lt; 30mL/min)
&lt;/li&gt;&lt;li&gt; History of heparin sensitivity or heparin-induced thrombocytopenia
&lt;/li&gt;&lt;li&gt; Weight &amp;gt; 150kg
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Relative contraindications to outpatient management:
&lt;ol&gt;&lt;li&gt; A history of medical noncompliance
&lt;/li&gt;&lt;li&gt; A history of substance abuse
&lt;/li&gt;&lt;li&gt; An inability to pay for LMWH
&lt;/li&gt;&lt;li&gt; Inability to care for self (or no family, friend or nurse to provide care in outpatient setting)
&lt;/li&gt;&lt;li&gt; Language barrier
&lt;/li&gt;&lt;li&gt; Lack of access to a clinic or telephone
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=DVT&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Emergency Department Treatment and follow-up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Emergency_Department_Treatment_and_follow-up"&gt;Emergency Department Treatment and follow-up&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Physicians will:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt; Explain the diagnosis and treatment to the patient, including
&lt;ol&gt;&lt;li&gt; The need to take medication exactly as prescribed
&lt;/li&gt;&lt;li&gt; The risks of anticoagulation including foods to avoid while taking Coumadin
&lt;/li&gt;&lt;li&gt; The need to keep follow-up appointments
&lt;/li&gt;&lt;li&gt; The need to return to the ED immediately for signs or symptoms of PE or worsening leg or arm symptoms
&lt;/li&gt;&lt;li&gt; Print information for all patients, and ask if the patient has any questions
&lt;ol&gt;&lt;li&gt; English: &lt;a href="http://home.mdconsult.com/das/patient/body/0/43/13766.html" class="external free" rel="nofollow"&gt;http://home.mdconsult.com/das/patient/body/0/43/13766.html&lt;/a&gt;
&lt;/li&gt;&lt;li&gt; Spanish: &lt;a href="http://home.mdconsult.com/das/patient/body/0/43/13767.html" class="external free" rel="nofollow"&gt;http://home.mdconsult.com/das/patient/body/0/43/13767.html&lt;/a&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Write the order for:
&lt;ol&gt;&lt;li&gt; Lovenox 0.5 mg/kg subcutaneously X 1 by RN
&lt;/li&gt;&lt;li&gt; Lovenox 0.5 mg/kg subcutaneously X 1 by patient and observed
&lt;/li&gt;&lt;li&gt; Coumadin 5 mg po x 1
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Arrange for 2-3 day follow-up in an anticoagulation clinic to check INR
&lt;ol&gt;&lt;li&gt; See Anticoagulation clinic referral in the follow-up binder for patients who are followed at Harbor-UCLA Medical Center.
&lt;/li&gt;&lt;li&gt; Give appointment at Z: LB for patients without appointments in HIS.
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Confirm or arrange for follow-up with a PMD to continue management.
&lt;/li&gt;&lt;li&gt; Provide referral to home health nurse if the patient is unable to self-inject. This form should be dropped in the box across from scheduled admissions. These referrals are only picked up Monday through Friday!
&lt;/li&gt;&lt;li&gt; Give a prescription for Lovenox 1mg/kg subcutaneously every 12 hours for 5 days (9 doses) and Coumadin 5mg orally daily (give 7 days worth only).
&lt;/li&gt;&lt;li&gt; Provide a Treatment Authorization Request (TAR) to justify prescription for MediCal patients. Please read the instructions for filling out the TAR carefully and make your name and number
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;Nursing will:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt; Provide verbal instruction on how to administer the LMWH injection.
&lt;/li&gt;&lt;li&gt; Demonstrate how to administer Lovenox by giving the initial 0.5mg/kg dose of lovenox.
&lt;/li&gt;&lt;li&gt; Have patients demonstrate self injection giving the second 0.5mg/kg for a total initial dose of 1mg/kg.
&lt;/li&gt;&lt;li&gt; Documenting the ability to self-inject in the chart, or inform the physician that the patient is unable to self-inject.
&lt;/li&gt;&lt;li&gt; Administer the first dose of oral Coumadin
&lt;/li&gt;&lt;li&gt; Provide the usual discharge instructions
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;Pharmacy will:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt; Provide Lovenox at the Harbor-UCLA Medical Center discounted rate to patients without insurance. Patients with MediCal should get prescriptions at outside pharmacies.
&lt;/li&gt;&lt;li&gt; Lovenox can be prescribed by all licensed emergency physicians.
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=DVT&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1/30/06 DONALDSON (adapted from Lampe, Wells [Lancet 12\97])
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="deficits_by_level"><name>Deficits By Level</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Deficits_By_Level&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Deficits"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Deficits"&gt; Deficits &lt;/span&gt;&lt;/h2&gt;
&lt;table style="width: 500px" border="1" cellpadding="1" cellspacing="1"&gt;

&lt;tr&gt;
&lt;td&gt; Level
&lt;/td&gt;&lt;td&gt; motor sensory deficit&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; C3
&lt;/td&gt;&lt;td&gt; lower neck
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; C4
&lt;/td&gt;&lt;td&gt; diaphragm/clavicular
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; C5
&lt;/td&gt;&lt;td&gt; deltoid,biceps/lat upperarm
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; C6
&lt;/td&gt;&lt;td&gt; extensor carpi rad/thumb,lat forearm
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; C7
&lt;/td&gt;&lt;td&gt; triceps,wrist flexors,finger extensors/ middle finger
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; C8
&lt;/td&gt;&lt;td&gt; finger flexors/ little finger
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; T1
&lt;/td&gt;&lt;td&gt; hand intriniscs/ medial forearm
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; T4
&lt;/td&gt;&lt;td&gt; intercostals/nipples
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; T10
&lt;/td&gt;&lt;td&gt; abdominals/ umbilicus
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; T12
&lt;/td&gt;&lt;td&gt; &amp;nbsp;/suprapubic area, inguinal ligament
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; L1
&lt;/td&gt;&lt;td&gt; illiopsoas /upper thigh
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; L2
&lt;/td&gt;&lt;td&gt; "
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; L3
&lt;/td&gt;&lt;td&gt; quadriceps/lower anterior thigh
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; L4
&lt;/td&gt;&lt;td&gt; &amp;nbsp;" /medial calf
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; L5
&lt;/td&gt;&lt;td&gt; extensor hallicus longus/dorsal foot
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; S1
&lt;/td&gt;&lt;td&gt; gastrosoleus, flexor hallicus longus/little toe
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; S2
&lt;/td&gt;&lt;td&gt; anal sphincterbladder/perineum
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; S3
&lt;/td&gt;&lt;td&gt; " / "
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; S4
&lt;/td&gt;&lt;td&gt; " / "
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Deficits_By_Level&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Reflexes"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Reflexes"&gt; Reflexes &lt;/span&gt;&lt;/h2&gt;
&lt;table style="width: 500px" border="1" cellpadding="1" cellspacing="1"&gt;

&lt;tr&gt;
&lt;td&gt; &lt;b&gt;Level&lt;br /&gt;&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Reflex&lt;br /&gt;&lt;/b&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; C5&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; biceps&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; C6&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; brachioradialis
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; C7
&lt;/td&gt;&lt;td&gt; triceps
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; L3
&lt;/td&gt;&lt;td&gt; quadriceps
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; S1
&lt;/td&gt;&lt;td&gt; achilles tendon
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; S2,3,4
&lt;/td&gt;&lt;td&gt; bulbocavernosus, anal wink
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Deficits_By_Level&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt; Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1/30/06 DONALDSON (adapted from Lampe)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;



</content><folder>Neuro</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="dehydration"><name>Dehydration</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Dehydration&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1kg body wt = to 1 liter flluid
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Oral rehydration soln should contain 60- 90 meq of Na and 2% dextrose. Can use pedialyte, rehydralyte or infalyte.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Home made solns:
&lt;/p&gt;&lt;p&gt;- 1 litre water
&lt;/p&gt;&lt;p&gt;- 8 teaspoons sugar
&lt;/p&gt;&lt;p&gt;- 1 tsp salt
&lt;/p&gt;&lt;p&gt;- can add banana or orange juice for potassium
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;- give Xcc q 5min
&lt;/p&gt;&lt;p&gt;- if vomit, wait 10 min and do again
&lt;/p&gt;&lt;p&gt;- try to achieve 50cc/kg over 3- 4 hr for mild- mod dehydration
&lt;/p&gt;&lt;p&gt;- if diarrheal stool, add 10cc/kg extra
&lt;/p&gt;&lt;p&gt;- for mod to severe dehydration, do 100cc/kg over 3- 4hrs
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Can do ngt if refuses to take po's- 150 cc/ hr. If not vomiting can infuse faster at 25cc/kg/hr.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;If fail, do IVF at 30- 40 cc/kg at minimum- replaces 3- 4% body wt
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Lactobacillus from yogurt may decrease diarrhea by one day.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;ABX
&lt;/p&gt;&lt;p&gt;- avoid in entrohemorrhagic e coli
&lt;/p&gt;&lt;p&gt;- may increase carrie state in non typhoid salmonella
&lt;/p&gt;&lt;p&gt;- unless severe or comorbidity or &amp;lt;3 months old, do not tx salmonella, yersinia, aeromonas, campylobacter or c diff.
&lt;/p&gt;&lt;p&gt;- tx shigella or vibrio
&lt;/p&gt;&lt;p&gt;- Continue to breast feed
&lt;/p&gt;&lt;p&gt;- Lactose intolerance rare but if intolerant will have acidic stool with&amp;gt;0.5% reducing substances
&lt;/p&gt;&lt;p&gt;- BRAT ok as is complex carbs and lean meat, fruits, veg.
&lt;/p&gt;&lt;p&gt;- BRAT has low energy and protein
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Dehydration&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;6/06 MISTRY
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="dementia_work-up"><name>Dementia Work-Up</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Dementia_Work-Up&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt; Diagnosis &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Acute onset, fluctuating course, inattention
&lt;/p&gt;&lt;p&gt;Plus either disorganized thinking or altered level of consciousness
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Dementia_Work-Up&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt; Work-Up &lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;CBC
&lt;/li&gt;&lt;li&gt;Chem 10
&lt;/li&gt;&lt;li&gt;UA/Utox
&lt;/li&gt;&lt;li&gt;ECG, CXR
&lt;/li&gt;&lt;li&gt;ETOH
&lt;/li&gt;&lt;li&gt;CT/MRI
&lt;/li&gt;&lt;li&gt;Consider
&lt;ol&gt;&lt;li&gt;LFTs, TSH
&lt;/li&gt;&lt;li&gt;B12, RPR, ESR, ANA, Folate, Thiamine, HIV
&lt;/li&gt;&lt;li&gt;neuropsych eval
&lt;/li&gt;&lt;li&gt;Consider LP, urine heavy metals, EEG
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Dementia_Work-Up&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt; Treatment &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Give MVI, thiamine, folate
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Dementia_Work-Up&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt; Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;7/1/09 PANI (Adapted from Donaldson)
&lt;/p&gt;



</content><folder>Neuro</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="dental_numbers"><name>Dental Numbers</name><content>&lt;p&gt;1: Right upper wisdom
&lt;/p&gt;&lt;p&gt;8&amp;amp;9: Upper incisors
&lt;/p&gt;&lt;p&gt;16: Left upper wisdom
&lt;/p&gt;&lt;p&gt;17: Left lower wisdom
&lt;/p&gt;&lt;p&gt;24&amp;amp;25: Lower incisors
&lt;/p&gt;&lt;p&gt;32: Rightlower wisdom
&lt;/p&gt;&lt;p&gt;^Children's = letter
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Dental_Numbers&amp;amp;action=edit&amp;amp;section=1" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;ENT: Acute Alveolar Osteitis (Dry Socket)
&lt;/p&gt;&lt;p&gt;ENT: Dental Problems
&lt;/p&gt;



</content><folder>ENT</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="dental_problems"><name>Dental Problems</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Dentoalveolar_Injuries"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Dentoalveolar Injuries&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#Fracture"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;Fracture&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Subluxation"&gt;&lt;span class="tocnumber"&gt;1.2&lt;/span&gt; &lt;span class="toctext"&gt;Subluxation&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Avulsion"&gt;&lt;span class="tocnumber"&gt;1.3&lt;/span&gt; &lt;span class="toctext"&gt;Avulsion&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Bleeding_Socket"&gt;&lt;span class="tocnumber"&gt;1.4&lt;/span&gt; &lt;span class="toctext"&gt;Bleeding Socket&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Odontogenic_infections"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Odontogenic infections&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-7"&gt;&lt;a href="#Dental_Carie.2FPulpitis"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;Dental Carie/Pulpitis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-8"&gt;&lt;a href="#Periapical_vs._Periodontal_Abcess"&gt;&lt;span class="tocnumber"&gt;2.2&lt;/span&gt; &lt;span class="toctext"&gt;Periapical vs. Periodontal Abcess&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Dental_Problems&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Dentoalveolar Injuries"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Dentoalveolar_Injuries"&gt;Dentoalveolar Injuries&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Dental_Problems&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Fracture"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Fracture"&gt;Fracture&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Enamel
&lt;ol&gt;&lt;li&gt; Routine f/u
&lt;/li&gt;&lt;li&gt; Nothing to do
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Enamel + dentin (yellowish)
&lt;ol&gt;&lt;li&gt; Adult
&lt;ol&gt;&lt;li&gt; Next day f/u
&lt;/li&gt;&lt;li&gt; Consider placing calcium hydroxide paste over fracture site as needed for comfort
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Child
&lt;ol&gt;&lt;li&gt; Place calcium hydroxide paste
&lt;ol&gt;&lt;li&gt; More important in children than adults because children have less dentin to protect the pulp
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Immediate referral
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Enamel + dentin + pulp (reddish)
&lt;ol&gt;&lt;li&gt; Immediate referral (dental emergency)
&lt;/li&gt;&lt;li&gt; If no dentist is available, place moist cotton over exposed pulp and cover with foil or seal with canal sealant
&lt;/li&gt;&lt;li&gt; Consider antibiotics (penicillin or clindamycin)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Dental_Problems&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Subluxation"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Subluxation"&gt;Subluxation&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Minimally mobile
&lt;ol&gt;&lt;li&gt; Soft diet for 14 days
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Markedly mobile
&lt;ol&gt;&lt;li&gt; Immediate referral for stabilization
&lt;/li&gt;&lt;li&gt; Temporizing measure: Periodontal pack in which tooth is bonded to its two neighboring teeth on both sides
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Dental_Problems&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Avulsion"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Avulsion"&gt;Avulsion&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Dental emergency
&lt;/li&gt;&lt;li&gt; Where is the tooth?
&lt;ol&gt;&lt;li&gt; May be intruded, aspirated, swallowed, or embedded in the oral mucosa
&lt;ol&gt;&lt;li&gt; Consider facial films, CXR
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Adult
&lt;ol&gt;&lt;li&gt; Replace avulsed tooth as soon as possible! (as long as no alveolar ridge fx, no severe socket injury)
&lt;ol&gt;&lt;li&gt; Rinse tooth in saline, socket is suctioned (if necessary), reimplant tooth, bond tooth to neighboring teeth
&lt;/li&gt;&lt;li&gt; Manipulate tooth only by the crown
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Storage solution (in order of efficacy): Hank's balanced salt solution &amp;gt; Milk &amp;gt; saliva &amp;gt; saline&amp;lt;/span&amp;gt;
&lt;/li&gt;&lt;li&gt; Tetanus vaccine if indicated
&lt;/li&gt;&lt;li&gt; Consider antibiotics (penicillin or clindamycin)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Child
&lt;ol&gt;&lt;li&gt; Do not reimplant primary teeth
&lt;ol&gt;&lt;li&gt; Refer to pedodontist for space maintainer
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Dental_Problems&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Bleeding Socket"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Bleeding_Socket"&gt;Bleeding Socket&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Apply pressure by having pt bite on gauze or tea bag
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Dental_Problems&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Odontogenic infections"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Odontogenic_infections"&gt;Odontogenic infections&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Dental_Problems&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Dental Carie/Pulpitis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Dental_Carie.2FPulpitis"&gt;Dental Carie/Pulpitis&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;dental referral only
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Dental_Problems&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Periapical vs. Periodontal Abcess"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Periapical_vs._Periodontal_Abcess"&gt;Periapical vs. Periodontal Abcess&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;drain
&lt;/li&gt;&lt;li&gt;PCN V
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;Exquisite pain to percussion suggests an underlying periapical abscess,
&lt;/p&gt;&lt;p&gt;More commonly, fluctuant abscesses are a result of periodontal abscesses and are best treated with an incision and drainage
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Dental_Problems&amp;amp;action=edit&amp;amp;section=9" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Acute Alveolar Osteitis (Dry Socket)
&lt;/p&gt;&lt;p&gt;Dental Numbers
&lt;/p&gt;



</content><folder>ENT</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="depakote_loading"><name>Depakote loading</name><content>&lt;p&gt;(100-level) .25 times wt
&lt;/p&gt;&lt;p&gt;give over 1 hr
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Depakote_loading&amp;amp;action=edit&amp;amp;section=1" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Neuro: Seizure (Reloading)
&lt;/p&gt;



</content><folder>Drugs</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="developmental_dysplasia_of_hip_(ddh)"><name>Developmental Dysplasia of Hip (DDH)</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Developmental_Dysplasia_of_Hip_(DDH)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-D/t abnormal relationship of fem head to acetabulum, usu in o/w healthy infants prior to or shortly after birth
&lt;/p&gt;&lt;p&gt;-&amp;lt;2% incidence
&lt;/p&gt;&lt;p&gt;-4-6X more common in girls
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Developmental_Dysplasia_of_Hip_(DDH)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Early: see asymm soft tissue folds in groin, buttock &amp;amp; thigh, limb may be pulled prox &amp;amp; short
&lt;/p&gt;&lt;p&gt;Ortolani on ALL young inf in ED, flex hip &amp;amp; knee @ 90 degrees &amp;amp; the thigh is abducted, the lateral aspect of both thighs should touch the table, the dislocated side will be restricted &amp;amp; have "click" as head slips out of acetabulum
&lt;/p&gt;&lt;p&gt;-by 6 wk &amp;lt;30% will have + ortolani or bartlow
&lt;/p&gt;&lt;p&gt;&amp;lt;3mo: Utz hip
&lt;/p&gt;&lt;p&gt;&amp;gt;3mo: AP pelvis with both legs extended in neutral abduction
&lt;/p&gt;&lt;p&gt;-Shenton's line
&lt;/p&gt;&lt;p&gt;-Acetabular angle should be &amp;lt;30'
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Developmental_Dysplasia_of_Hip_(DDH)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-Refer ALL pts to pediatric orthopedist
&lt;/p&gt;&lt;p&gt;-0-6 mo pavlik harness or spica
&lt;/p&gt;&lt;p&gt;-Older=orif
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="developmental_milestones"><name>Developmental Milestones</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Motor"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Motor&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Visual.2FProblem_Solving"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Visual/Problem Solving&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Language"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Language&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Social"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Social&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Developmental_Milestones&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Motor"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Motor"&gt;Motor&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1mo slight head raise
&lt;/p&gt;&lt;p&gt;2mo holds up head
&lt;/p&gt;&lt;p&gt;3mo holds head steady
&lt;/p&gt;&lt;p&gt;4mo rolls front to back
&lt;/p&gt;&lt;p&gt;5mo sits supported
&lt;/p&gt;&lt;p&gt;6mo sits unsupported
&lt;/p&gt;&lt;p&gt;7mo creeps
&lt;/p&gt;&lt;p&gt;8mo crawls
&lt;/p&gt;&lt;p&gt;9mo pulls to stand
&lt;/p&gt;&lt;p&gt;12mo walks alone
&lt;/p&gt;&lt;p&gt;15mo creeps up stairs
&lt;/p&gt;&lt;p&gt;18mo runs, throws from standing
&lt;/p&gt;&lt;p&gt;21mo squats, walks up stairs
&lt;/p&gt;&lt;p&gt;24mo walks up &amp;amp; down steps
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Developmental_Milestones&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Visual/Problem Solving"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Visual.2FProblem_Solving"&gt;Visual/Problem Solving&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1mo visually fixes
&lt;/p&gt;&lt;p&gt;2mo visually follows past midline
&lt;/p&gt;&lt;p&gt;3mo responds to visual threat
&lt;/p&gt;&lt;p&gt;4mo reaches with arms in unison
&lt;/p&gt;&lt;p&gt;5mo transfers objects
&lt;/p&gt;&lt;p&gt;6mo unilateral reach
&lt;/p&gt;&lt;p&gt;7mo inspects objects
&lt;/p&gt;&lt;p&gt;8mo inspects objects
&lt;/p&gt;&lt;p&gt;9mo pincer grasp, holds bottle
&lt;/p&gt;&lt;p&gt;12mo mature pincer grasp
&lt;/p&gt;&lt;p&gt;15mo scribbles, 2-block tower
&lt;/p&gt;&lt;p&gt;18mo 3-block tower
&lt;/p&gt;&lt;p&gt;21mo 5-block tower
&lt;/p&gt;&lt;p&gt;24mo removes shoes, pants, etc
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Developmental_Milestones&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Language"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Language"&gt;Language&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1mo alert to sound
&lt;/p&gt;&lt;p&gt;2mo social smile
&lt;/p&gt;&lt;p&gt;3mo coos
&lt;/p&gt;&lt;p&gt;4mo laughs, orients to voice
&lt;/p&gt;&lt;p&gt;5mo "ah-goo"
&lt;/p&gt;&lt;p&gt;6mo babbles
&lt;/p&gt;&lt;p&gt;7mo orients to bell
&lt;/p&gt;&lt;p&gt;8mo Mama/dada
&lt;/p&gt;&lt;p&gt;9mo Mama/dada descriminately
&lt;/p&gt;&lt;p&gt;12mo 2 additional words
&lt;/p&gt;&lt;p&gt;15mo 4-6 words
&lt;/p&gt;&lt;p&gt;18mo 2 word combinations
&lt;/p&gt;&lt;p&gt;21mo 50 words
&lt;/p&gt;&lt;p&gt;24mo pronouns
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Developmental_Milestones&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Social"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Social"&gt;Social&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1mo regards face
&lt;/p&gt;&lt;p&gt;2mo recognizes parent
&lt;/p&gt;&lt;p&gt;3mo reaches fo objects
&lt;/p&gt;&lt;p&gt;4mo looks around environment
&lt;/p&gt;&lt;p&gt;5mo
&lt;/p&gt;&lt;p&gt;6mo recognizes strangers
&lt;/p&gt;&lt;p&gt;7mo finger-feeds
&lt;/p&gt;&lt;p&gt;8mo
&lt;/p&gt;&lt;p&gt;9mo explores environment
&lt;/p&gt;&lt;p&gt;12mo comes when called
&lt;/p&gt;&lt;p&gt;15mo uses spoon independently
&lt;/p&gt;&lt;p&gt;18mo plays with other children
&lt;/p&gt;&lt;p&gt;21mo asks for food/toilet
&lt;/p&gt;&lt;p&gt;24mo parallel play
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Developmental_Milestones&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;4/13/06 DONALDSON (adapted from Rosen/Harriet Lane)
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="diabetes_(meds)"><name>Diabetes (Meds)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#General"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;General&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Sulfonylureas"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Sulfonylureas&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Biguanides"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Biguanides&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Alpha_Glucosidase_Inhibitors"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Alpha Glucosidase Inhibitors&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Thiazolidinediones"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Thiazolidinediones&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Benzoic_Acid_Derivatives"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Benzoic Acid Derivatives&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Diabetes_(Meds)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Hypoglycemics
&lt;ol&gt;&lt;li&gt;sulfonylureas
&lt;/li&gt;&lt;li&gt;benzoic acid derivatives
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Antihyperglycemics
&lt;ol&gt;&lt;li&gt;biguanides
&lt;/li&gt;&lt;li&gt;alpha glucosidase inhibitors
&lt;/li&gt;&lt;li&gt;thiazolidinediones
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Diabetes_(Meds)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: General"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="General"&gt;General&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;type 2 dm- overproduction and under utilization of glucose
&lt;/li&gt;&lt;li&gt;diet and exercise best
&lt;/li&gt;&lt;li&gt;if sugar not controlled with one agent, add bedtime insulin or second agent
&lt;/li&gt;&lt;li&gt;if still not controlled p 2 meds either do 2 orals + nighttime insulin, or mixed split insulin regimen or third oral agent
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Diabetes_(Meds)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Sulfonylureas"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Sulfonylureas"&gt;Sulfonylureas&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;increase insulin secretion and enhance activity
&lt;/li&gt;&lt;li&gt;second and third gen sulfonyls are lipid soluble so penetrate cell mem better and have selective binding
&lt;/li&gt;&lt;li&gt;stimulate insulin release from panc beta cells by inhibiting atp dependent potassium channel.
&lt;/li&gt;&lt;li&gt;Decrease hepatic insulin clearance= increase insulin conc
&lt;/li&gt;&lt;li&gt;Elevated insulin level feeds back to liver and causes decrease hepatic gluc prod
&lt;/li&gt;&lt;li&gt;Secondary treatment failure from noncompliance, wt gain, desensitized beta cells, and escalating insulin resistance and increased insulin deficiency
&lt;/li&gt;&lt;li&gt;Sulfon has hepatic metab, renal exretion and prolonged activity
&lt;/li&gt;&lt;li&gt;Toxicity related to hypoglycemia
&lt;/li&gt;&lt;li&gt;Risk factors for hypoG- elderly, poor diet, alcohol, renal/ hepatic dz, polypharmacy
&lt;/li&gt;&lt;li&gt;Time to peak effect and duration of effect important in OD
&lt;/li&gt;&lt;li&gt;Chlorpropamide, glyburide and glypizide most likely to cause hypoG
&lt;/li&gt;&lt;li&gt;Do not use glyburide in pt with CRI since renally excreted
&lt;/li&gt;&lt;li&gt;If pt well and young, will not get hypoG during fast due to counterregulatory hormones for glucose homeostasis
&lt;/li&gt;&lt;li&gt;Chlorpropamide can cause hyponatremia regardless of dose- induces ADH secretion- risk increases with elderly and if on thiazide diuretics
&lt;/li&gt;&lt;li&gt;Chlorpropamide can also give cholestatic jaundice, resolves with discontinuation
&lt;/li&gt;&lt;li&gt;Glypizide- enterohepatic recirculation- prolonged action if liver dz. Long duration of action since metabolite still active. All metabolites renally cleared
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Diabetes_(Meds)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Biguanides"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Biguanides"&gt;Biguanides&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;metformin, phenformin and buformin
&lt;/li&gt;&lt;li&gt;phenformin no longer used due to lactic acidosis
&lt;/li&gt;&lt;li&gt;metformin does not cause wt gain like sulfonyls
&lt;/li&gt;&lt;li&gt;effect is to decrease hep glucose prod, inhibit intestinal glucose absorption
&lt;/li&gt;&lt;li&gt;also decreases fatty acid oxidation
&lt;/li&gt;&lt;li&gt;increases insulin sensitivity and decreases insln resis
&lt;/li&gt;&lt;li&gt;decrease sugar of dm pt not normal person- so is antihyperglycemic agent not hypoglycemic agent
&lt;/li&gt;&lt;li&gt;100% renal excretion
&lt;/li&gt;&lt;li&gt;most serious side effect is lactic acidosis- aerobic type by increased lactate production- not tissue hypoxia
&lt;/li&gt;&lt;li&gt;signs of lactic acidosis- nonspecific- nvd, abd pain, sleepy, tachypnia, lethargy- seen mostly if renal/ liver dz, alcohol, heart dz, infection
&lt;/li&gt;&lt;li&gt;metformin exclusion criteria- CRI, cardiac/ pulm insuff, h/o lactosis, profound infc, liver dz, alcohol, iv contrast agents
&lt;/li&gt;&lt;li&gt;fatality from metformn lactosis not related to lactate levels or metformin level but rather to concomitant condition (hypoxia) resulting in elevated lactate
&lt;/li&gt;&lt;li&gt;OD- hypoglycemia rare, can get lactosis- obs for 6-8 hr and tx c bicarb and consider hemodialysis
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Diabetes_(Meds)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Alpha Glucosidase Inhibitors"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Alpha_Glucosidase_Inhibitors"&gt;Alpha Glucosidase Inhibitors&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;acarbose, miglitol, voglibose
&lt;/li&gt;&lt;li&gt;competitively and reversibly inhibit alpha glucosidase brush border hydrolase enzyme- makes postprandial decrease in carbohydrate absorption since complex polysaccharides not broken down into absorbable monosaccharides
&lt;/li&gt;&lt;li&gt;does not affect lactose absorption
&lt;/li&gt;&lt;li&gt;if hypoG- sucrose/ table sugar will not work- use glucose- po or iv
&lt;/li&gt;&lt;li&gt;take these meds with each meal with first bite
&lt;/li&gt;&lt;li&gt;since limited aborption, stays in gut and side effects mostly GI- bloating, gas, diarrhea
&lt;/li&gt;&lt;li&gt;contraindications- cirrhosis, IBD, malabsorption synd
&lt;/li&gt;&lt;li&gt;alpha glucs do not cause hypoG when used as monotx
&lt;/li&gt;&lt;li&gt;acarbose- can cause transaminitis/ liver inj
&lt;/li&gt;&lt;li&gt;since min absorption- systemic tox from OD unlikely
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Diabetes_(Meds)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Thiazolidinediones"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Thiazolidinediones"&gt;Thiazolidinediones&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;rosiglitazone and poiglitazone
&lt;/li&gt;&lt;li&gt;enhance insulin effect on muscle, fat, liver without increasing panc insulin secretion
&lt;/li&gt;&lt;li&gt;protein bound and hep metab- not good if liver dz
&lt;/li&gt;&lt;li&gt;side effects- induce ovulation, increase plasma vol bad if CHF, decrease effectiveness of OCP's
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Diabetes_(Meds)&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Benzoic Acid Derivatives"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Benzoic_Acid_Derivatives"&gt;Benzoic Acid Derivatives&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;repaglinide- mono or combo tx c metformin
&lt;/li&gt;&lt;li&gt;binds to atp dependent potassium channel like sulfonyls but at different site.
&lt;/li&gt;&lt;li&gt;Unlike sulfonyls, it decreases insulin lvls
&lt;/li&gt;&lt;li&gt;Dose 30 min before meal to decrease post prandial hyperglycemia
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Diabetes_(Meds)&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;6/06 MISTRY
&lt;/p&gt;



</content><folder>Drugs</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="diabetes_(new_onset)"><name>Diabetes (New Onset)</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Diabetes_(New_Onset)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;metformin if obese
&lt;/li&gt;&lt;li&gt;glipizide if old/skinny
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Diabetes_(New_Onset)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Endo: DKA
&lt;/p&gt;&lt;p&gt;Endo: Diabetes (Meds)
&lt;/p&gt;&lt;p&gt;Endo: HONC
&lt;/p&gt;&lt;p&gt;Endo: Hypoglycemia
&lt;/p&gt;



</content><folder>Endo</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="diabetic_foot_ulcers"><name>Diabetic Foot Ulcers</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Diabetic_Foot_Ulcers&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Failure of ulcer to heal by 50% or more after 1 month of Rx is a strong predictor that the ulcer is unlikely to heal after 3 mos.
&lt;/li&gt;&lt;li&gt;75% of pts hv polymicrobial inf, usu 70% are g+. Severe limb/life threatening inf are more likely to involve g- aerobic &amp;amp; anaerobic bacteria w/ g+. MRSA is incr in freq.
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Diabetic_Foot_Ulcers&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;1st key factor is to assess extent &amp;amp; depth of ulcer (usu more extensive than they appear). Ulcer depth is imp predictor of healing rate, OM &amp;amp; risk of amputation.
&lt;/li&gt;&lt;li&gt;Gently probe wound w/ sterile probe, if probe hits bone, chance of osteo is 90% higher.
&lt;/li&gt;&lt;li&gt;50% or more of pts w/ SEVERE diabetic foot inf have no s/s of systemic tox (ie fever, tachy, incr wbc or Lt shift)
&lt;/li&gt;&lt;li&gt;Inf of the wound is demonstrated by presence of purulent dc or 2 or more signs of inflammation (ttp, warmth, induration or erythema) around the ulcer.
&lt;/li&gt;&lt;li&gt;Inf is severe if any of the following: abnl vs, rim of erythema around the ulcer is 2 cm or more in diameter, lymphangitic streaking or signs of fasciitis (such as crepitice or bullae), or if probe reaches bone/tendon/joint
&lt;/li&gt;&lt;li&gt;ESR &amp;gt;40 incr chance of OM 12 fold, an ESR &amp;gt;70 makes dx nearly certain.
&lt;/li&gt;&lt;li&gt;Charcot foot can look similar, but foot ulcer is usu absent, erythema &amp;amp; edema partially resolve w/ elevation of goot for 10 min.
&lt;/li&gt;&lt;li&gt;Nd ABI if any of following: absence of DP &amp;amp; PT, claudication sx, isch foot pain.
&lt;/li&gt;&lt;li&gt;Nd vascular surgeon if ABI &amp;lt;.4 (severe obst). .4-.69= mod obst, .7-.9 =mild obst, .9-1.3 =nl, &amp;gt;1.3 = med art ca (can see falsely high/nl ABI d/t medial calcification of the arteries).
&lt;/li&gt;&lt;li&gt;Wound NOT likely to be infected if no systemic sx, no dc &amp;amp; no more than 1 s/s of local inflammation
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Diabetic_Foot_Ulcers&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Abx for mild= keflex or augmentin or diclox or clinda. Abx for severe= unasyn or clinda &amp;amp; quinolone or clinda &amp;amp; ceftaz, add vanco if life threat.
&lt;/li&gt;&lt;li&gt;Focusing Rx on g+ aerobes w/ oral abx (1-2 wk) appears effective for most mild inf. Must eliminate pressure on wound until healed, nd to elminate or decr periph edema. Dress wound w/ warm/moist env after debridement, absorbant drsng if exudate present.
&lt;/li&gt;&lt;li&gt;Recurrence of amp is 50-70% over 3-5 yrs. Overall, 50-80% will heal w/in 6 mos w/ optimal care.
&lt;/li&gt;&lt;li&gt;Goal for best reults is A1c level &amp;lt;7%, BP &amp;lt;130/80, no Etoh or smoking &amp;amp; LDL &amp;lt;100.
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Diabetic_Foot_Ulcers&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;7/2/09 PANI
&lt;/p&gt;



</content><folder>ID</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="diabetic_ketoacidosis_(dka)"><name>Diabetic Ketoacidosis (DKA)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Workup"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Workup&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Classification"&gt;&lt;span class="tocnumber"&gt;3.1&lt;/span&gt; &lt;span class="toctext"&gt;Classification&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Initial"&gt;&lt;span class="tocnumber"&gt;3.2&lt;/span&gt; &lt;span class="toctext"&gt;Initial&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-6"&gt;&lt;a href="#Secondary"&gt;&lt;span class="tocnumber"&gt;3.3&lt;/span&gt; &lt;span class="toctext"&gt;Secondary&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Complications"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Complications&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-8"&gt;&lt;a href="#SLIDING_SCALE"&gt;&lt;span class="tocnumber"&gt;4.1&lt;/span&gt; &lt;span class="toctext"&gt;SLIDING SCALE&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Diabetic_Ketoacidosis_(DKA)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Hyperosmolality and insulin deficiency causes hyperkalemia; as reverses K+ goes back into cell
&lt;/p&gt;&lt;p&gt;Most pts 3-6L depleted
&lt;/p&gt;&lt;p&gt;Look for precipitating causes:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt; Insulin non-compliance
&lt;/li&gt;&lt;li&gt; Infection
&lt;/li&gt;&lt;li&gt; Ischemia
&lt;/li&gt;&lt;li&gt; Intra-abd process
&lt;ol&gt;&lt;li&gt; (Lipase/amylase not specific in pts w/ DKA)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Iatrogenic (steroids)
&lt;/li&gt;&lt;li&gt; Etoh/drug abuse
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Diabetic_Ketoacidosis_(DKA)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Workup"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Workup"&gt;Workup&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;PRECIPITANT
&lt;/p&gt;&lt;p&gt;Fever is rare even in the presence of infection due to peripheral vasoconstriction 2/2 hypovolemia
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;CBC
&lt;/li&gt;&lt;li&gt;Chem 10
&lt;/li&gt;&lt;li&gt;Urine acetone/b-OH
&lt;ol&gt;&lt;li&gt;If urine ketones + then obtain serum ketones
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Plasma osmolality
&lt;/li&gt;&lt;li&gt;hCG
&lt;/li&gt;&lt;li&gt;UA
&lt;/li&gt;&lt;li&gt;ECG
&lt;/li&gt;&lt;li&gt;?VBG
&lt;/li&gt;&lt;li&gt;?CXR
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Diabetic_Ketoacidosis_(DKA)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Diabetic_Ketoacidosis_(DKA)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Classification"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Classification"&gt;Classification&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Mild (ketosis): gap &amp;lt;12
&lt;/li&gt;&lt;li&gt;Mod: gap 12-18
&lt;/li&gt;&lt;li&gt;Severe: gap &amp;gt;18
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Diabetic_Ketoacidosis_(DKA)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Initial"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Initial"&gt;Initial&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Labs
&lt;ol&gt;&lt;li&gt;Glucose check Q1hr
&lt;/li&gt;&lt;li&gt;Chem 10 Q4hr
&lt;/li&gt;&lt;li&gt;Corrected Na+
&lt;ol&gt;&lt;li&gt;Add 1.6mEq for each glucose 100mg/dl &amp;gt;100)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;IV Fluids
&lt;ol&gt;&lt;li&gt;If severe hypovolemia: 1L NS / hr for up to 3 hr
&lt;/li&gt;&lt;li&gt;If mild dehydration then evaluate corrected Na+
&lt;ol&gt;&lt;li&gt;If hypernatremic: 1/2NS @ 250-500ml/hr
&lt;/li&gt;&lt;li&gt;If hyponatremic: NS @ 250-500ml/hr
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;When BS &amp;lt; 200 switch to D5&amp;frac12;NS@ 150-200 ml/hr(+/- KCl)
&lt;/li&gt;&lt;li&gt;Bolus NS as needed for unstable VS
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Insulin
&lt;ol&gt;&lt;li&gt;Check K+ prior to insulin Tx!
&lt;ol&gt;&lt;li&gt;If K &amp;lt; 3.3 do not administer insulin
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;IV Route
&lt;ol&gt;&lt;li&gt;IV gtt 0.14 U/kg/hr =10 U/hr in 70kg pt
&lt;ol&gt;&lt;li&gt;Bolus dose unnecessary
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;If BS does not decrease by 50-70/hr then double infusion rate qhr until achieved
&lt;/li&gt;&lt;li&gt;When BS &amp;lt;200, reduce to 0.02-0.05 U/kg/hr IV OR give subQ 0.1 U/kg q2hr
&lt;ol&gt;&lt;li&gt;Maintain BS between 150 and 200 until resolution of DKA
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;SubQ route (appropriate only for mild DKA)
&lt;ol&gt;&lt;li&gt;Insulin lispro or aspart 0.3 U/kg initially
&lt;ol&gt;&lt;li&gt;0.2 U/kg one hr later
&lt;ol&gt;&lt;li&gt;0.2 U/kg q2hr thereafter
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;If BS does not decrease by 50-70/hr then double dose qhr until achieved
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Potassium (initial)
&lt;ol&gt;&lt;li&gt;&amp;gt;5.5: don't give, but recheck q2hr
&lt;/li&gt;&lt;li&gt;3.3-5.5: give 30 meq/hr in each liter bag
&lt;ol&gt;&lt;li&gt;1/2NS is preferred b/c adding 30meq to NS = hypertonic soln
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;&amp;lt;3.3: hold insulin and give 30 meq/hr until K &amp;gt;3.3
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Bicarb
&lt;ol&gt;&lt;li&gt;if pH &amp;lt;6.9: 100 meq NaHCO3 in 400mL H2O @ 200 mL/hr
&lt;ol&gt;&lt;li&gt;Dose as needed until pH &amp;gt; 7.00
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Phosphate
&lt;ol&gt;&lt;li&gt;Repletion is controversial
&lt;ol&gt;&lt;li&gt;Has not been shown to be beneficial
&lt;/li&gt;&lt;li&gt;Hypophosphatemia following insulin tx usually asymptomatic
&lt;/li&gt;&lt;li&gt;Repletion is associated with hypoCa and hypoMg
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Consider repletion (KPO4 20-30 meq/L)if:
&lt;ol&gt;&lt;li&gt;Phosphate &amp;lt;1.0
&lt;/li&gt;&lt;li&gt;Cardiac dysfunction
&lt;/li&gt;&lt;li&gt;Respiratory dysfunction
&lt;/li&gt;&lt;li&gt;Evidence of hemolysis or rhabdo
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Diabetic_Ketoacidosis_(DKA)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Secondary"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Secondary"&gt;Secondary&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;When gap closes and patient able to eat:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Begin multidose insulin regimen
&lt;/li&gt;&lt;li&gt;Continue IV infusion for 1-2 hr after SC insulin tx is begun
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Diabetic_Ketoacidosis_(DKA)&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Complications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Complications"&gt;Complications&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Cerebral Edema
&lt;ul&gt;&lt;li&gt; Almost all affected pts are &amp;lt;20yrs
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; Noncardiogenic pulmonary edema
&lt;/li&gt;&lt;/ul&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Diabetic_Ketoacidosis_(DKA)&amp;amp;action=edit&amp;amp;section=8" title="Edit section: SLIDING SCALE"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="SLIDING_SCALE"&gt;SLIDING SCALE&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;200- 250- 4u sq
&lt;/p&gt;&lt;p&gt;251- 300- 6
&lt;/p&gt;&lt;p&gt;301- 350- 8
&lt;/p&gt;&lt;p&gt;351- 400- 10
&lt;/p&gt;&lt;p&gt;&amp;gt; 400- call MD
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Diabetic_Ketoacidosis_(DKA)&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from Chavira, Rosen, Mistry, Ip, Donaldson, Pani, UpToDate
&lt;/p&gt;



</content><folder>Endo</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="dialysis_sepsis"><name>Dialysis Sepsis</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Dialysis_Sepsis&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Gent
&lt;/li&gt;&lt;li&gt;Vanco
&lt;/li&gt;&lt;li&gt;Ceftriaxone
&lt;/li&gt;&lt;/ol&gt;




</content><folder>ID</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="diarrhea"><name>Diarrhea</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Definitions"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Definitions&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Emergent_Causes"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;Emergent Causes&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Questions"&gt;&lt;span class="tocnumber"&gt;2.2&lt;/span&gt; &lt;span class="toctext"&gt;Questions&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Toxigenic_v._Infectious"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Toxigenic v. Infectious&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Work_Up"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Work Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-8"&gt;&lt;a href="#Toxigenic"&gt;&lt;span class="tocnumber"&gt;5.1&lt;/span&gt; &lt;span class="toctext"&gt;Toxigenic&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-9"&gt;&lt;a href="#Infectious"&gt;&lt;span class="tocnumber"&gt;5.2&lt;/span&gt; &lt;span class="toctext"&gt;Infectious&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-3 tocsection-10"&gt;&lt;a href="#Empiric_Abx"&gt;&lt;span class="tocnumber"&gt;5.2.1&lt;/span&gt; &lt;span class="toctext"&gt;Empiric Abx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-11"&gt;&lt;a href="#Loperimide_Contraindications"&gt;&lt;span class="tocnumber"&gt;5.3&lt;/span&gt; &lt;span class="toctext"&gt;Loperimide Contraindications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-12"&gt;&lt;a href="#WHO_Oral_Rehydration"&gt;&lt;span class="tocnumber"&gt;5.4&lt;/span&gt; &lt;span class="toctext"&gt;WHO Oral Rehydration&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-13"&gt;&lt;a href="#Other"&gt;&lt;span class="tocnumber"&gt;5.5&lt;/span&gt; &lt;span class="toctext"&gt;Other&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-14"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Diarrhea&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Definitions"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Definitions"&gt; Definitions &lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Diarrhea: 3 or more stools per day; assumes shape of container
&lt;/li&gt;&lt;li&gt;Hyperacute: 1-6 hours
&lt;/li&gt;&lt;li&gt;Acute: less than 2 weeks in duration
&lt;/li&gt;&lt;li&gt;Gastroenteritis: diarrhea with nausea and or vomiting
&lt;/li&gt;&lt;li&gt;Dysentery: Diarrhea with blood/mucus/pus
&lt;/li&gt;&lt;li&gt;Invasive=Infectious
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Diarrhea&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt; Diagnosis &lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Diarrhea&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Emergent Causes"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Emergent_Causes"&gt; Emergent Causes &lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Appendicitis
&lt;/li&gt;&lt;li&gt;Mesenteric ischemia
&lt;/li&gt;&lt;li&gt;Ectopic
&lt;/li&gt;&lt;li&gt;CO poisoning
&lt;/li&gt;&lt;li&gt;SAH
&lt;/li&gt;&lt;li&gt;Diverticultis
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Diarrhea&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Questions"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Questions"&gt; Questions &lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Ingestions
&lt;/li&gt;&lt;li&gt;Abd pain
&lt;/li&gt;&lt;li&gt;Blood/Consistency
&lt;/li&gt;&lt;li&gt;Frequency/Quantity/Odor
&lt;/li&gt;&lt;li&gt;Tenesmus (infxs - shigella)
&lt;/li&gt;&lt;li&gt;HIV/Immunocomp/Sexual hx
&lt;/li&gt;&lt;li&gt;Recent Abx (&amp;lt;30 dys), PPI
&lt;/li&gt;&lt;li&gt;Recent travel
&lt;/li&gt;&lt;li&gt;Timing: Chronic (&amp;gt;1mo) vs. acute (&amp;lt;2wk)
&lt;/li&gt;&lt;li&gt;Chemo
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Diarrhea&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Toxigenic v. Infectious"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Toxigenic_v._Infectious"&gt; Toxigenic v. Infectious &lt;/span&gt;&lt;/h2&gt;
&lt;table class="pbNotSortable" cellpadding="1" cellspacing="1" width="400" border="1"&gt;

&lt;tr&gt;
&lt;td&gt; &lt;b&gt;Characteristic&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Toxic&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;span style="font-weight: bold"&gt;Infectious/Invasive&lt;/span&gt;&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Incubation
&lt;/td&gt;&lt;td&gt; 2-12h
&lt;/td&gt;&lt;td&gt; 1-3d
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Onset
&lt;/td&gt;&lt;td&gt; abrupt
&lt;/td&gt;&lt;td&gt; gradual
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Duration
&lt;/td&gt;&lt;td&gt; &amp;lt;10-24h
&lt;/td&gt;&lt;td&gt; 1-7days
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Fever
&lt;/td&gt;&lt;td&gt; No
&lt;/td&gt;&lt;td&gt; Yes
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Abdominal Pain
&lt;/td&gt;&lt;td&gt; Minimal
&lt;/td&gt;&lt;td&gt; Yes, tenesmus
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Systemic
&lt;/td&gt;&lt;td&gt; No
&lt;/td&gt;&lt;td&gt; Yes, myalgias, N/V
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Physical findings
&lt;/td&gt;&lt;td&gt; Nontoxic
&lt;/td&gt;&lt;td&gt; Toxic
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Abdominal Tenderness
&lt;/td&gt;&lt;td&gt; No
&lt;/td&gt;&lt;td&gt; Yes
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Stool Blood, WBCs
&lt;/td&gt;&lt;td&gt; No
&lt;/td&gt;&lt;td&gt; Yes
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Diarrhea&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Work Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work_Up"&gt;Work Up&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Toxigenic:Nothing
&lt;/li&gt;&lt;li&gt;Invasive:
&lt;ol&gt;&lt;li&gt;Stool Cx
&lt;ol&gt;&lt;li&gt;Additional Cx: E.Coli 0157:H7
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;C. dif toxin
&lt;/li&gt;&lt;li&gt;Sool O&amp;amp;P
&lt;ol&gt;&lt;li&gt;&lt;ol&gt;&lt;li&gt;only if suspect parasitic, recent travel, failed abx, chronic diarrhea, immunocompromised
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Send stool WBCs only if diagnosis is uncertain; Sensitivity: 60-85% (ie unclear if invasive or toxigenic)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Diarrhea&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt; Treatment &lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Diarrhea&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Toxigenic"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Toxigenic"&gt; Toxigenic &lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Rehydrate with fluids containing sugar, salt, fluids po, IV NS
&lt;/li&gt;&lt;li&gt;Avoid high osmolality (gatorade!), caffeine, lactose-containing (lactase removed during infection)
&lt;/li&gt;&lt;li&gt;Eat! - BRAT diet (small amounts banana, rice, apple sauce, toast) - will speed up recovery
&lt;/li&gt;&lt;li&gt;Analgesia as needed
&lt;/li&gt;&lt;li&gt;Anti-diarrheals
&lt;/li&gt;&lt;li&gt;Kaolin-pectin agents
&lt;/li&gt;&lt;li&gt;Bismuth
&lt;/li&gt;&lt;li&gt;Antimotility (avoid &lt;i&gt;alone&lt;/i&gt; in invasive illness)
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Diarrhea&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Infectious"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Infectious"&gt; Infectious &lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;&lt;b&gt;Above plus:&lt;/b&gt;
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Antibiotics
&lt;ol&gt;&lt;li&gt;Ciprofloxacin 500mg po bid or
&lt;/li&gt;&lt;li&gt;Levofloxacin 500mg po qd or
&lt;/li&gt;&lt;li&gt;Bactrim DS 1tab po bid (+/-)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;3-7d treatment
&lt;/li&gt;&lt;/ol&gt;
&lt;h4&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Diarrhea&amp;amp;action=edit&amp;amp;section=10" title="Edit section: Empiric Abx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Empiric_Abx"&gt; Empiric Abx &lt;/span&gt;&lt;/h4&gt;
&lt;ol&gt;&lt;li&gt;Toxic appearance
&lt;/li&gt;&lt;li&gt;Vital abnl
&lt;/li&gt;&lt;li&gt;Fever &amp;gt;39
&lt;/li&gt;&lt;li&gt;Bloody diarrhea
&lt;/li&gt;&lt;li&gt;Severe dehydration
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Diarrhea&amp;amp;action=edit&amp;amp;section=11" title="Edit section: Loperimide Contraindications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Loperimide_Contraindications"&gt; Loperimide Contraindications &lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Pediatric
&lt;/li&gt;&lt;li&gt;IBD
&lt;/li&gt;&lt;li&gt;C. Diff
&lt;/li&gt;&lt;li&gt;Dysentery
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;(always give with abx)
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Diarrhea&amp;amp;action=edit&amp;amp;section=12" title="Edit section: WHO Oral Rehydration"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="WHO_Oral_Rehydration"&gt; WHO Oral Rehydration &lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;1 cup orange juice
&lt;/li&gt;&lt;li&gt;4 tsp sugar
&lt;/li&gt;&lt;li&gt;1 tsp baking powder
&lt;/li&gt;&lt;li&gt;3/4 tsp salt
&lt;/li&gt;&lt;li&gt;in 1 liter of H2O
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Diarrhea&amp;amp;action=edit&amp;amp;section=13" title="Edit section: Other"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Other"&gt; Other &lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Octreotide can be used in AIDS-associated diarrhea unresponsive to loperimide
&lt;/p&gt;&lt;p&gt;Consider Pepto-Bismol for traveler's diarrhea (contraindicated in HIV--&amp;gt;encephalopathy)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Diarrhea&amp;amp;action=edit&amp;amp;section=14" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt; Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;3/12/06 DONALDSON (adapted from Rosen); 09 Birnbaumer
&lt;/p&gt;



</content><folder>GI</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="diarrhea_(peds)"><name>Diarrhea (Peds)</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Diarrhea_(Peds)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;&amp;lt;10yr old
&lt;/p&gt;&lt;p&gt;&amp;lt;3mo --&amp;gt; abx
&lt;/p&gt;&lt;p&gt;&lt;b&gt;Diarrheal Pathogens in Children and Specific Therapy&lt;/b&gt;
&lt;/p&gt;
&lt;table border="1" cellpadding="2"&gt;
&lt;tr&gt;
&lt;th align="left"&gt; AGENT
&lt;/th&gt;&lt;th align="left"&gt; SPECIFIC THERAPY BEYOND SUPPORTIVE CARE
&lt;/th&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td rowspan="2" align="left"&gt; &lt;i&gt;Campylobacter jejuni&lt;/i&gt;
&lt;/td&gt;&lt;td align="left"&gt; Azithromycin 12 mg/kg/day PO for 5 days &lt;i&gt;or&lt;/i&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left"&gt; Erythromycin 30&#8211;50 mg/kg/day, divided, tid PO for 5&#8211;7 days
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left"&gt; &lt;i&gt;Clostridium difficile&lt;/i&gt;
&lt;/td&gt;&lt;td align="left"&gt; Metronidazole 30 mg/kg/day, divided, qid PO for 7&#8211;10 days &lt;i&gt;or&lt;/i&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td rowspan="2" align="left"&gt; &lt;i&gt;Escherichia coli&lt;/i&gt;
&lt;/td&gt;&lt;td align="left"&gt; Azithromycin 12 mg/kg/day PO for 5 days &lt;i&gt;or&lt;/i&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left"&gt; Trimethoprim-sulfamethoxazole 10 mg (TMP)/kg/day PO divided bid for 5&#8211;7 days
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left"&gt; &lt;i&gt;Giardia&lt;/i&gt; lamblia
&lt;/td&gt;&lt;td align="left"&gt; Metronidazole 15 mg/kg/day PO, divided, tid for 5 days
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left"&gt; &lt;i&gt;Salmonella&lt;/i&gt; species
&lt;/td&gt;&lt;td align="left"&gt; &lt;i&gt;In toxic infants &amp;lt;3&lt;/i&gt; &lt;i&gt;mo&lt;/i&gt;:&lt;br /&gt;Ampicillin 200 mg/kg/24 hours q6h for 7&#8211;10 days &lt;i&gt;and&lt;/i&gt;&lt;br /&gt;Gentamicin 5&#8211;7.5 mg/kg/24 hours q8h IV
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td rowspan="2" align="left"&gt; &lt;i&gt;Shigella&lt;/i&gt; species
&lt;/td&gt;&lt;td align="left"&gt; Azithromycin 12 mg/kg/day PO for 5 days &lt;i&gt;or&lt;/i&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left"&gt; Trimethoprim-sulfamethoxazole 10 mg (TMP)/kg/day, divided, bid for 5&#8211;7 days if susceptible
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left"&gt; &lt;i&gt;Yersinia enterocolitica&lt;/i&gt;
&lt;/td&gt;&lt;td align="left"&gt; If patient is immunosuppressed, treat as for presumed sepsis
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left"&gt; &lt;i&gt;Vibrio&lt;/i&gt;
&lt;/td&gt;&lt;td align="left"&gt; None; severe diarrhea or cholera may benefit from antibiotics
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Diarrhea_(Peds)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Peds: Dehydration
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Diarrhea_(Peds)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Sources"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Sources"&gt;Sources&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Rosen's
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="difficult_airway_algorithm"><name>Difficult Airway Algorithm</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#LEMON_Mnemonic"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;LEMON Mnemonic&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#Look"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;Look&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Evaluate"&gt;&lt;span class="tocnumber"&gt;1.2&lt;/span&gt; &lt;span class="toctext"&gt;Evaluate&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#ASA_DIFF_AIRWAY_ALGORITHM"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;ASA DIFF AIRWAY ALGORITHM&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Airway_Adjuncts"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Airway Adjuncts&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-6"&gt;&lt;a href="#Gum_Bougie"&gt;&lt;span class="tocnumber"&gt;3.1&lt;/span&gt; &lt;span class="toctext"&gt;Gum Bougie&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-7"&gt;&lt;a href="#Blind_Naso_Trach_Intub"&gt;&lt;span class="tocnumber"&gt;3.2&lt;/span&gt; &lt;span class="toctext"&gt;Blind Naso Trach Intub&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-8"&gt;&lt;a href="#Lighted_Optical_Stylets"&gt;&lt;span class="tocnumber"&gt;3.3&lt;/span&gt; &lt;span class="toctext"&gt;Lighted Optical Stylets&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-9"&gt;&lt;a href="#LMA"&gt;&lt;span class="tocnumber"&gt;3.4&lt;/span&gt; &lt;span class="toctext"&gt;LMA&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-10"&gt;&lt;a href="#Combitube-_esoph_obturator"&gt;&lt;span class="tocnumber"&gt;3.5&lt;/span&gt; &lt;span class="toctext"&gt;Combitube- esoph obturator&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-11"&gt;&lt;a href="#Trans_Trach_Jet_Vent"&gt;&lt;span class="tocnumber"&gt;3.6&lt;/span&gt; &lt;span class="toctext"&gt;Trans Trach Jet Vent&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-12"&gt;&lt;a href="#Retrograde_Intubation"&gt;&lt;span class="tocnumber"&gt;3.7&lt;/span&gt; &lt;span class="toctext"&gt;Retrograde Intubation&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-13"&gt;&lt;a href="#Fiberoptic_Bronchoscopic_Intubation"&gt;&lt;span class="tocnumber"&gt;3.8&lt;/span&gt; &lt;span class="toctext"&gt;Fiberoptic Bronchoscopic Intubation&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-14"&gt;&lt;a href="#Rigid_Fiberoptic_Laryngoscopes"&gt;&lt;span class="tocnumber"&gt;3.9&lt;/span&gt; &lt;span class="toctext"&gt;Rigid Fiberoptic Laryngoscopes&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-15"&gt;&lt;a href="#Surgical_Airway"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Surgical Airway&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-16"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Difficult_Airway_Algorithm&amp;amp;action=edit&amp;amp;section=1" title="Edit section: LEMON Mnemonic"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="LEMON_Mnemonic"&gt;LEMON Mnemonic&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Look- as in Diff to BVM
&lt;/li&gt;&lt;li&gt;Evaluate 3-2-2
&lt;/li&gt;&lt;li&gt;Mallampati
&lt;/li&gt;&lt;li&gt;Obstruction
&lt;/li&gt;&lt;li&gt;Neck Mobility
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Difficult_Airway_Algorithm&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Look"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Look"&gt;Look&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;trauma
&lt;/li&gt;&lt;li&gt;short neck
&lt;/li&gt;&lt;li&gt;micrognathia
&lt;/li&gt;&lt;li&gt;prior surgery
&lt;/li&gt;&lt;li&gt;may also be difficult to bag
&lt;ol&gt;&lt;li&gt;body mass index
&lt;/li&gt;&lt;li&gt;advanced age
&lt;/li&gt;&lt;li&gt;beard
&lt;/li&gt;&lt;li&gt;no teeth
&lt;/li&gt;&lt;li&gt;snoring
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Difficult_Airway_Algorithm&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Evaluate"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Evaluate"&gt;Evaluate&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;3 finger-breadths mouth opening
&lt;/li&gt;&lt;li&gt;3 fingers from chin to hyoid
&lt;/li&gt;&lt;li&gt;2 from thryroid to sternum
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Difficult_Airway_Algorithm&amp;amp;action=edit&amp;amp;section=4" title="Edit section: ASA DIFF AIRWAY ALGORITHM"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="ASA_DIFF_AIRWAY_ALGORITHM"&gt;ASA DIFF AIRWAY ALGORITHM&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;in OR, can always let pt wake up and cancel case
&lt;/li&gt;&lt;li&gt;if can't do BVM after failed intubation- do cric or transtracheal jet since will desat otherwise
&lt;/li&gt;&lt;li&gt;straight blade- Miller- better for deep glottis, buck teeth
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Difficult_Airway_Algorithm&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Airway Adjuncts"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Airway_Adjuncts"&gt;Airway Adjuncts&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Difficult_Airway_Algorithm&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Gum Bougie"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Gum_Bougie"&gt;Gum Bougie&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Blind orotracheal intubation
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Difficult_Airway_Algorithm&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Blind Naso Trach Intub"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Blind_Naso_Trach_Intub"&gt;Blind Naso Trach Intub&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;not as successful but still an option
&lt;/li&gt;&lt;li&gt;higher complication rate- bleeding, emesis
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Difficult_Airway_Algorithm&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Lighted Optical Stylets"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Lighted_Optical_Stylets"&gt;Lighted Optical Stylets&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;high success rate- esp good for trauma, cspine
&lt;/li&gt;&lt;li&gt;use for both reg and nasotrach
&lt;/li&gt;&lt;li&gt;low complication rate
&lt;/li&gt;&lt;li&gt;limited by fogging, secretion, recognition of anatomy, cost
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Difficult_Airway_Algorithm&amp;amp;action=edit&amp;amp;section=9" title="Edit section: LMA"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="LMA"&gt;LMA&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;can use without muscle relaxants
&lt;/li&gt;&lt;li&gt;better than face mask
&lt;/li&gt;&lt;li&gt;can be used as bridge to fiberoptic intubation
&lt;/li&gt;&lt;li&gt;limited by unreliable seal at peak insp pressure
&lt;/li&gt;&lt;li&gt;asp risk
&lt;/li&gt;&lt;li&gt;mucosal trauma
&lt;/li&gt;&lt;li&gt;LMA better than ett for paramedics
&lt;/li&gt;&lt;li&gt;intubating LMA (ILMA) better for ventilating ED pts but intubating through ILMA more difficult for neophyte
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Difficult_Airway_Algorithm&amp;amp;action=edit&amp;amp;section=10" title="Edit section: Combitube- esoph obturator"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Combitube-_esoph_obturator"&gt;Combitube- esoph obturator&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;good for nurses and paramedics
&lt;/li&gt;&lt;li&gt;indicated if diff airway predicted, can't see glottis with laryngoscope,
&lt;/li&gt;&lt;li&gt;reduced risk for aspiration compared to  face mask or LMA
&lt;/li&gt;&lt;li&gt;can maintain spinal immobilization
&lt;/li&gt;&lt;li&gt;large size predisposes to esoph dilatation, laceration
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Difficult_Airway_Algorithm&amp;amp;action=edit&amp;amp;section=11" title="Edit section: Trans Trach Jet Vent"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Trans_Trach_Jet_Vent"&gt;Trans Trach Jet Vent&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;TTJV
&lt;/li&gt;&lt;li&gt;needle through cric mem, connected to 50 psi 02- can ventilate and oxygenate ok
&lt;/li&gt;&lt;li&gt;need adequate 02 pressure
&lt;/li&gt;&lt;li&gt;1 sec insp and 2- 3 sec exp to avoid breath stacking
&lt;/li&gt;&lt;li&gt;may get ptx or barotrauma
&lt;/li&gt;&lt;li&gt;contraindications- distorted anatomy, bleeding diathesis,  complete airway obstr
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Difficult_Airway_Algorithm&amp;amp;action=edit&amp;amp;section=12" title="Edit section: Retrograde Intubation"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Retrograde_Intubation"&gt;Retrograde Intubation&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;perc guide wire through cric and retrograde intubation over wire
&lt;/li&gt;&lt;li&gt;use guide catheter over wire and then ett
&lt;/li&gt;&lt;li&gt;need time to set up
&lt;/li&gt;&lt;li&gt;risk hematoma, ptx
&lt;/li&gt;&lt;li&gt;contra- bleeding, distorted anatomy
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Difficult_Airway_Algorithm&amp;amp;action=edit&amp;amp;section=13" title="Edit section: Fiberoptic Bronchoscopic Intubation"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Fiberoptic_Bronchoscopic_Intubation"&gt;Fiberoptic Bronchoscopic Intubation&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;takes time to set up
&lt;/li&gt;&lt;li&gt;good for c-spine injury or awake pt with diff airway
&lt;/li&gt;&lt;li&gt;go through nose
&lt;/li&gt;&lt;li&gt;use for all ages, can give 02 during procedure thru fiberscope, immediate confirmation of position
&lt;/li&gt;&lt;li&gt;limited by secretions, bleeding, poor suction,
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Difficult_Airway_Algorithm&amp;amp;action=edit&amp;amp;section=14" title="Edit section: Rigid Fiberoptic Laryngoscopes"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Rigid_Fiberoptic_Laryngoscopes"&gt;Rigid Fiberoptic Laryngoscopes&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;use for diff airway or spinal immob
&lt;/li&gt;&lt;li&gt;not as good and longer time to intubate than flex scope
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Difficult_Airway_Algorithm&amp;amp;action=edit&amp;amp;section=15" title="Edit section: Surgical Airway"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Surgical_Airway"&gt;Surgical Airway&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;can get subglottic stenosis
&lt;/li&gt;&lt;li&gt;rapid 4 step procedure faster but higher compl rate- cric cart fx
&lt;/li&gt;&lt;li&gt;can also do wire guided
&lt;/li&gt;&lt;li&gt;long term morbid, mortality similar to tracheostomy 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Difficult_Airway_Algorithm&amp;amp;action=edit&amp;amp;section=16" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;7/06 MISTRY
&lt;/p&gt;



</content><folder>Airway/Resus</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="digital_epipen_injection"><name>Digital EpiPen Injection</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Digital_EpiPen_Injection&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Accidental digital self-injection of epinephrine from an EpiPen.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Digital_EpiPen_Injection&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Clinical ==Work-Up==
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
None ====
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
Treatment1) Observation for 2 hours after injection2) If continued ischemia sx after 2 hrs, give phentolamine mesylate 1.5mg in 1 mL of lidocaine into the ischemic area ==Disposition==
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
Home
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Digital_EpiPen_Injection&amp;amp;action=edit&amp;amp;section=3" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Tox: Epinephrine
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Digital_EpiPen_Injection&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;"Six Years of Epinephrine Digital injections: Absence of Significant Local or Systemic Effects." Annals of EM.  Sept. 2010.  56(3):p270-274.
&lt;/p&gt;



</content><folder>Tox</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="digoxin"><name>Digoxin</name><content>&lt;ol&gt;&lt;li&gt;REDIRECT &lt;a href="/wiki/Digoxin_Toxicity" title="Digoxin Toxicity"&gt;Digoxin Toxicity&lt;/a&gt;
&lt;/li&gt;&lt;/ol&gt;




</content><folder></folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="digoxin_toxicity"><name>Digoxin Toxicity</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Risk_Factors"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Risk Factors&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Clinical_Manifestations"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Clinical Manifestations&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Digoxin_Toxicity&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt; Background &lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Positive inotropic effect
&lt;ul&gt;&lt;li&gt;Inhibits Na-K pump -&amp;gt; incr extracelluar K, incr intracellular Na -&amp;gt; incr intracellular Ca
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Increases vagal tone
&lt;ul&gt;&lt;li&gt;Can lead to bradyarrhythmias (esp in young)
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Increases automaticity
&lt;ul&gt;&lt;li&gt;Can lead to tachyarrhythmias (esp in elderly)
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Renally cleared
&lt;/li&gt;&lt;li&gt;Hemodialysis does not work
&lt;/li&gt;&lt;li&gt;1 fab vial binds 0.5mg of digoxin
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Digoxin_Toxicity&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Risk Factors"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Risk_Factors"&gt; Risk Factors &lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Electrolyte Imbalance
&lt;ul&gt;&lt;li&gt;Hypokalemia, hypomagnesemia, Hypercalcemia
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Hypovolemia
&lt;/li&gt;&lt;li&gt;Renal insufficiency
&lt;/li&gt;&lt;li&gt;Cardiac ischemia
&lt;/li&gt;&lt;li&gt;Hypothyroidism
&lt;/li&gt;&lt;li&gt;Meds
&lt;ul&gt;&lt;li&gt;CCBs, amiodarone
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Digoxin_Toxicity&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Clinical Manifestations"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Clinical_Manifestations"&gt; Clinical Manifestations &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Cardiac
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Any type of dysrhythmia is possible except for rapidly conducted atrial arrhythmias
&lt;/li&gt;&lt;li&gt;Most common:
&lt;ul&gt;&lt;li&gt;PVCs
&lt;/li&gt;&lt;li&gt;Bradycardia
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Digitalis Effect
&lt;ul&gt;&lt;li&gt;T wave changes
&lt;/li&gt;&lt;li&gt;QT interval shortening
&lt;/li&gt;&lt;li&gt;Scooped ST segments with depression in lateral leads
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;GI
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Nausea/vomiting
&lt;/li&gt;&lt;li&gt;Abdominal pain
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;Neuro
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Confusion
&lt;/li&gt;&lt;li&gt;Weakness
&lt;/li&gt;&lt;li&gt;Visual disturbances
&lt;ul&gt;&lt;li&gt;Yellow halos
&lt;/li&gt;&lt;li&gt;Scotomas
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Delirium
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Digoxin_Toxicity&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt; Work-Up &lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Dig level
&lt;ul&gt;&lt;li&gt;Normal = 0.8-2 ng/mL (ideal = 0.7-1.1)
&lt;ul&gt;&lt;li&gt;May have toxicity even with "therapeutic" levels
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Measure serum level at least 6 hours after acute ingestion (if stable), immediately for chronic ingestion
&lt;ul&gt;&lt;li&gt;If measure before this may be falsely elevated due to incomplete drug distribution
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Chemistry
&lt;ul&gt;&lt;li&gt;Hyperkalemia level correlates with degree of toxicity
&lt;/li&gt;&lt;li&gt;Hypokalemia increases susceptibility in chronic toxicity
&lt;/li&gt;&lt;li&gt;Hypomagnesemia is common
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Cr/BUN
&lt;/li&gt;&lt;li&gt;Urine output
&lt;/li&gt;&lt;li&gt;ECG (serial)
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Digoxin_Toxicity&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt; Treatment &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;&lt;b&gt;Fab Fragment Therapy&lt;/b&gt;
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Indications
&lt;ul&gt;&lt;li&gt;Severe rhythm disturbances refractory to conventional therapy
&lt;/li&gt;&lt;li&gt;End-organ dysfunction
&lt;/li&gt;&lt;li&gt;Hyperkalemia &amp;gt;5 after acute overdose
&lt;/li&gt;&lt;li&gt;Pacemaker (may mask cardiac dysrhythmia)
&lt;/li&gt;&lt;li&gt;Consider for:
&lt;ul&gt;&lt;li&gt;Dig level &amp;gt; 10 in acute ingestion
&lt;/li&gt;&lt;li&gt;Dig level &amp;gt; 4 in chronic ingestion
&lt;/li&gt;&lt;li&gt;If adult acutely ingests &amp;gt; 10mg
&lt;/li&gt;&lt;li&gt;If child acutely ingests &amp;gt; 4mg
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Side effects
&lt;ul&gt;&lt;li&gt;Allergic reaction
&lt;/li&gt;&lt;li&gt;Withdrawal of dig effect:
&lt;ul&gt;&lt;li&gt;CHF, a fib w/ RVR
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Hypokalemia
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Initial response time ~ 20min, peak effect ~ 90min
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;How To Use
&lt;ul&gt;&lt;li&gt;&lt;b&gt;1. Neither amount ingested nor digoxin level are known:&lt;/b&gt;
&lt;ul&gt;&lt;li&gt;Adult dose
&lt;ul&gt;&lt;li&gt;10 vials over 30 min
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Peds dose
&lt;ul&gt;&lt;li&gt;5 vials over 30 min
&lt;/li&gt;&lt;li&gt;Repeat dose if clinical response is inadequate
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;&lt;b&gt;2. Amount ingested is known but digoxin level is unknown&lt;/b&gt;
&lt;/li&gt;&lt;li&gt;Step 1: Calculate total body load (TBL)
&lt;ul&gt;&lt;li&gt;TBL = dose (in mg) ingested
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Step 2: Calculate number of vials needed
&lt;ul&gt;&lt;li&gt;Number of vials = TBL X 2 (round up to nearest whole number)
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;&lt;b&gt;3. Steady state digoxin level is known&lt;/b&gt;
&lt;/li&gt;&lt;li&gt;Number of vials = (dig level(in ng/mL) X pt wt) / 100
&lt;/li&gt;&lt;li&gt;&lt;b&gt;4. Chronic toxicity without severe signs&lt;/b&gt;
&lt;/li&gt;&lt;li&gt;Give half the recommended dose
&lt;ul&gt;&lt;li&gt;Otherwise may unmask the condition for which the pt is taking digoxin
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;&lt;b&gt;5. Cardiac Arrest&lt;/b&gt;
&lt;ul&gt;&lt;li&gt;20 vials administered undiluted by IV bolus
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;b&gt;Activated charcoal&lt;/b&gt;
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Questionable efficacy
&lt;/li&gt;&lt;li&gt;Only an adjunctive tx; NOT an alternative to fab fragment therapy
&lt;/li&gt;&lt;li&gt;Consider only if present within 1 hr of ingestion
&lt;/li&gt;&lt;li&gt;1g/kg (max 50g)
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;b&gt;Rhythm Disturbances&lt;/b&gt;
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Fab fragments is the agent of choice for all dysrhythmias!
&lt;/li&gt;&lt;li&gt;Bradyarrhythmias (symptomatic)
&lt;ul&gt;&lt;li&gt;Atropine 0.5mg IV
&lt;/li&gt;&lt;li&gt;Pacing
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Tachyarrhythmias
&lt;ul&gt;&lt;li&gt;Lidocaine
&lt;ul&gt;&lt;li&gt;1-3mg/kg over several minutes, followed by 1-4mg/min
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Phenytoin
&lt;ul&gt;&lt;li&gt;May enhance AV conduction
&lt;/li&gt;&lt;li&gt;Infuse at 25-50 mg/min to a loading dose of 10-15mg/kg
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Cardioversion
&lt;ul&gt;&lt;li&gt;Consider lower energy settings (25-50J)
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;b&gt;Hyperkalemia&lt;/b&gt;
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Treat with Fab, not with usual meds
&lt;ul&gt;&lt;li&gt;Once fab is given hyperkalemia will rapidly correct
&lt;/li&gt;&lt;li&gt;Aggressive tx with potassium-lowering agents could cause sig hypokalemia following therapy
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;If Fab is not available and hyperkalemia is life-threatening then treat
&lt;/li&gt;&lt;li&gt;Calcium is controversial (some say dangerous, others say not)
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;b&gt;Hypokalemia&lt;/b&gt;
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Chronic intoxication
&lt;ul&gt;&lt;li&gt;Raise level to 3.5-4
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Acute intoxication
&lt;ul&gt;&lt;li&gt;Do not treat (likely that potassium level is rapidly rising)
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;b&gt;Hypomagnesemia&lt;/b&gt;
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Treat with 1-2g over 10-20 min
&lt;ul&gt;&lt;li&gt;Monitor for resp depresion
&lt;/li&gt;&lt;li&gt;Avoid in pts with:
&lt;ul&gt;&lt;li&gt;Renal failure
&lt;/li&gt;&lt;li&gt;Bradydysrhythmias/conduction blocks
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Digoxin_Toxicity&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt; Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Rosen's &lt;br /&gt;
&lt;/p&gt;



</content><folder>Tox</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="dilantin_load"><name>Dilantin Load</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#First_time_load"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;First time load&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Already_On"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Already On&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Correcting"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Correcting&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Dilantin_Load&amp;amp;action=edit&amp;amp;section=1" title="Edit section: First time load"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="First_time_load"&gt;First time load&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;18mg/kg (can be given PO in divided doses or IV)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Dilantin_Load&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Already On"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Already_On"&gt;Already On&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;If patient is already on dilantin but sub-therapeutic use following to calculate dose needed to achieve therapeutic level:
&lt;/p&gt;&lt;p&gt;Concentration adjusted = (concentration desired - concentration measured) x (0.7 x adjusted body weight)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Dilantin_Load&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Correcting"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Correcting"&gt;Correcting&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Sheiner-Tozer Equation may be needed to correct level in patients with low albumin or abnormal creatinine:
&lt;ol&gt;&lt;li&gt; Corrected level = measured level/[(adjustment x albumin) + 0.1]
&lt;/li&gt;&lt;li&gt; adjustment is 0.2 unless patient has Creatinine clearance &amp;lt;20 then it is 0.1
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Dilantin_Load&amp;amp;action=edit&amp;amp;section=4" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Neuro: Seizure (Reloading)
&lt;/p&gt;



</content><folder>Drugs</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="dirty_bomb_(i-131)"><name>Dirty Bomb (I-131)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Disposition.3E"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&amp;gt;&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Dirty_Bomb_(I-131)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;is a non-nuclear normal bomb cased in radioactive material
&lt;/li&gt;&lt;li&gt;can cause exposure to I-131
&lt;/li&gt;&lt;li&gt;administration of potassium iodide (KI) can significantly reduce thyroid I-131 uptake, which can later causes thyroid cancer
&lt;/li&gt;&lt;li&gt;for persons older than 40 years of age, the risk for radiation-induced thyroid cancer is extremely low, while the potential side effects of prophylaxis due to preexisting thyroid disease tend to increase
&lt;/li&gt;&lt;/ul&gt;
&lt;table width="339" border="1"&gt;
&lt;tr&gt;
&lt;td&gt; &lt;b&gt;Time to KI Dose&lt;/b&gt;&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Reduction in Radioactive Uptake&lt;/b&gt;&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; &amp;lt;2hrs&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 90%&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 3hrs&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 50%&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 4hrs&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 10%&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; &amp;gt;4hrs&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; little protection*&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;p&gt;*unless the exposure to I-131 continues
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Dirty_Bomb_(I-131)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Dirty_Bomb_(I-131)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Dirty_Bomb_(I-131)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert&amp;lt;/div&amp;gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Dirty_Bomb_(I-131)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Treatment with stable iodine when the committed dose equivalent to the adult thyroid is expected to exceed 250 milliSieverts (mSv), the equivalent of 25 rem (FDA 2001).
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Under 40 years old
&lt;ol&gt;&lt;li&gt;potassium iodide (KI)
&lt;/li&gt;&lt;li&gt;immediate and Qday x 7-14 days
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Over 40 years old
&lt;ol&gt;&lt;li&gt;no KI treatment
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;ul&gt;&lt;li&gt;contraindication = iodine allergy
&lt;/li&gt;&lt;li&gt;potassium iodate (KIO3) can also be used (more GI irritation)
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Dirty_Bomb_(I-131)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Disposition&amp;amp;gt;"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition.3E"&gt;Disposition&amp;gt;&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Dirty_Bomb_(I-131)&amp;amp;action=edit&amp;amp;section=7" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Dirty_Bomb_(I-131)&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from KajiQuestions
&lt;/p&gt;



</content><folder>Environ</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="disc_disease"><name>Disc Disease</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#SPINAL_STENOSIS"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;SPINAL STENOSIS&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#CHRONIC_LBP"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;CHRONIC LBP&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#PREVENTION"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;PREVENTION&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Disc_Disease&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; if no cauda equina or  progressive neuro deficit- delay surg for a month
&lt;/li&gt;&lt;li&gt; epidural steroids for temporary symptomatic relief
&lt;/li&gt;&lt;li&gt; discetomy gives better pain control over 4 yrs but not past 10
&lt;/li&gt;&lt;li&gt; microdiscectomy similar to standard discectomy but perscutaenour or laser disctmy less effective than standard  surg
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Disc_Disease&amp;amp;action=edit&amp;amp;section=2" title="Edit section: SPINAL STENOSIS"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="SPINAL_STENOSIS"&gt;SPINAL STENOSIS&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; avoid alcohol and strengthen legs to prevent falls
&lt;/li&gt;&lt;li&gt; exercise bike or walking recommened with rest when pain comes
&lt;/li&gt;&lt;li&gt; decompressive laminectomy for severe persistent pain
&lt;/li&gt;&lt;li&gt; adding spinal fusion to decompression improves outcome
&lt;/li&gt;&lt;li&gt; even with surg, sxs may reoccur in a few years
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Disc_Disease&amp;amp;action=edit&amp;amp;section=3" title="Edit section: CHRONIC LBP"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="CHRONIC_LBP"&gt;CHRONIC LBP&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; neural remodeling and neurplasticity may explain chronic pain in absence of ongoing tissue injury- alters perception of pain
&lt;/li&gt;&lt;li&gt; intensive exercise helps
&lt;/li&gt;&lt;li&gt; antidepressants especiallly tricyclics (better than SSRI), also helpful
&lt;/li&gt;&lt;li&gt; no  long term opioids
&lt;/li&gt;&lt;li&gt; goals may need to be refocused
&lt;/li&gt;&lt;li&gt; multiple surgical precedures no helpful
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Disc_Disease&amp;amp;action=edit&amp;amp;section=4" title="Edit section: PREVENTION"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="PREVENTION"&gt;PREVENTION&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; corsets and education not helpful
&lt;/li&gt;&lt;li&gt; wt loss, excersice, stop smoking helpful
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Disc_Disease&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;7/2/09 PANI
&lt;/p&gt;



</content><folder>Neuro</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="distal_radius_(fx)"><name>Distal Radius (Fx)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#Imaging"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;Imaging&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Fracture_Types"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Fracture Types&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Distal_Radius_(Fx)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Mechanism often c/w FOOSH
&lt;/li&gt;&lt;li&gt; Examine for deformity
&lt;ul&gt;&lt;li&gt; "Dinner-fork" deformity common with Colles' fracturs
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; Examine for impaired sensation of thumb, IF
&lt;ul&gt;&lt;li&gt; Median nerve injury is common in displaced fractures
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Distal_Radius_(Fx)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Imaging"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Imaging"&gt;Imaging&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Is there loss of normal anatomy (e.g. fx displacement or angulation, loss of radial height)
&lt;/li&gt;&lt;li&gt; Is there involvement of the radiocarpal or distal radioulnar joint?
&lt;/li&gt;&lt;li&gt; Is there discontinuity of the articular surface or diastasis (separation) of the articular fragments? 
&lt;/li&gt;&lt;li&gt; Are high-risk features present (severe comminution, articular step-off &amp;gt;2 mm, fracture-dislocation)? 
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt; PA
&lt;ol&gt;&lt;li&gt; Radial inclination (angle between line perpendicular to long axis of radius and line between radial styloid and ulnar corner of lunate fossa)
&lt;ol&gt;&lt;li&gt; Normal = 15-25 degrees
&lt;ol&gt;&lt;li&gt; Often smaller with fx
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Radial height (Distance between distal tip of radial styloid and articular surface of the radius)
&lt;ol&gt;&lt;li&gt; Normal ~ 10-17mm
&lt;ol&gt;&lt;li&gt; Often smaller with comminuted or impacted fx  
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Ulnar variance (Distance between ulnar-side articular surface of radius and the ulnar carpal surface)  
&lt;ol&gt;&lt;li&gt; Normally 1-2mm
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Lateral 
&lt;ol&gt;&lt;li&gt; Palmar Tilt (angle between line perpendicular to long axis of radial shaft and line through the apices of the palmar and dorsal rims of the radius
&lt;ol&gt;&lt;li&gt;  Normally 10o-25o
&lt;ol&gt;&lt;li&gt; Often smaller with fx 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Oblique
&lt;ol&gt;&lt;li&gt; May reveal intra-articular involvement not seen on other views
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Distal_Radius_(Fx)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Fracture Types"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Fracture_Types"&gt;Fracture Types&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Colles' Fx
&lt;ol&gt;&lt;li&gt; Dorsal displacement of the distal radius fragment
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Smith's Fx
&lt;ol&gt;&lt;li&gt; Palmar displacement of distal radius fragment
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Hutchinson's Fx
&lt;ol&gt;&lt;li&gt; Radial styloid avulsion +/- lunate or scapholunate dissocation
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Galeazzi Fx
&lt;ol&gt;&lt;li&gt; Radial shaft Fx + dislocation of the distal radioulnar joint (ulna positive variance)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Barton's Fx-dislocation
&lt;ol&gt;&lt;li&gt; Palmar Barton's
&lt;ol&gt;&lt;li&gt; Radial avulsion + palmar displacement of radiocarpal unit
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Dorsal Barton's
&lt;ol&gt;&lt;li&gt; Radial avulsion + dorsal displacement of radiocarpal unit
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Distal_Radius_(Fx)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Immediate reduction only required for neurovascular invovlement
&lt;/li&gt;&lt;li&gt; Nondisplaced extra-articular fx
&lt;ol&gt;&lt;li&gt; Relatively stable
&lt;/li&gt;&lt;li&gt; Sugar tong, reverse sugar tong, or double sugar tong splint
&lt;ol&gt;&lt;li&gt; Elbow flexed to 90o, arm in neutral position
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Displaced fx
&lt;ol&gt;&lt;li&gt; Splint, arrange next-day f/u; reduction by experienced clinician is appropriate, but not required
&lt;ol&gt;&lt;li&gt; Adequate reduction:
&lt;ol&gt;&lt;li&gt; No dorsal tilt of the distal radial articular surface
&lt;/li&gt;&lt;li&gt; Less than 5 mm of radial shortening
&lt;/li&gt;&lt;li&gt; Less than 2 mm of displacement of fracture fragments 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Distal_Radius_(Fx)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Refer all of the following:
&lt;ol&gt;&lt;li&gt; Palmarly displaced fx
&lt;/li&gt;&lt;li&gt; Articular step-off &amp;gt;2mm
&lt;/li&gt;&lt;li&gt; Large ulnar styloid fx with displaced fragments at the styloid base
&lt;/li&gt;&lt;li&gt; Fracture dislocations
&lt;/li&gt;&lt;li&gt; Distal radius fractures associated with scaphoid fractures or scapholunate ligament injuries 
&lt;/li&gt;&lt;li&gt; Fractures with significant displacement or comminution
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Unstable fx
&lt;ol&gt;&lt;li&gt; Greater than 20 degrees of dorsal angulation
&lt;/li&gt;&lt;li&gt; Fracture displacement in any direction greater than two-thirds the width of the radial shaft
&lt;/li&gt;&lt;li&gt; Metaphyseal comminution with more than 5 mm of radial shortening
&lt;/li&gt;&lt;li&gt; Ulnar variance greater than 5 mm compared with the contralateral wrist (normal variance is 0 to -2 mm
&lt;/li&gt;&lt;li&gt; Intraarticular component (especially involving the DRUJ)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Distal_Radius_(Fx)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;UpToDate
&lt;/p&gt;



</content><folder>Ortho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="diverticulitis"><name>Diverticulitis</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Epidemiology"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Epidemiology&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Abx"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;Abx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Dispo"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Dispo&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Diverticulitis&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Epidemiology"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Epidemiology"&gt;Epidemiology&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1/3 affected by age 50
&lt;/p&gt;&lt;p&gt;Occurs in 10-25% of those with diverticulosis
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Diverticulitis&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Clear-liquid diet initially
&lt;/li&gt;&lt;li&gt;High-fiber diet
&lt;/li&gt;&lt;li&gt;Abx
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Diverticulitis&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Abx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Abx"&gt;Abx&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;PO
&lt;ol&gt;&lt;li&gt;Bactrim/Cipro + Flagyl
&lt;/li&gt;&lt;li&gt;Augmentin
&lt;/li&gt;&lt;li&gt;Moxifloxacin
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;IV
&lt;ol&gt;&lt;li&gt;CTX + Flagyl
&lt;/li&gt;&lt;li&gt;Unasyn
&lt;/li&gt;&lt;li&gt;Zosyn
&lt;/li&gt;&lt;li&gt;Imipenem
&lt;/li&gt;&lt;li&gt;Levaquin
&lt;/li&gt;&lt;li&gt;etc.
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Diverticulitis&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Dispo"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Dispo"&gt;Dispo&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Outpt
&lt;ol&gt;&lt;li&gt;Simple diverticulitis
&lt;/li&gt;&lt;li&gt;tol po
&lt;/li&gt;&lt;li&gt;social support
&lt;/li&gt;&lt;li&gt;able to f/u in 48-72h
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Admit
&lt;ol&gt;&lt;li&gt;Comorbidities
&lt;/li&gt;&lt;li&gt;complicated disease
&lt;ol&gt;&lt;li&gt;assoc abscess
&lt;/li&gt;&lt;li&gt;bowel wall &amp;gt;4mm
&lt;/li&gt;&lt;li&gt;obstruction
&lt;/li&gt;&lt;li&gt;ill appearance
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Surgery/IR
&lt;ol&gt;&lt;li&gt;Abscesses &amp;gt;4cm
&lt;/li&gt;&lt;li&gt;fistulas
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;




</content><folder>GI</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="dorsal_slit_(penis)"><name>Dorsal Slit (Penis)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Indications"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Indications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Contraindications"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Contraindications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Equipment_Needed"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Equipment Needed&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Procedure"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Procedure&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Complications"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Complications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Dorsal_Slit_(Penis)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Indications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Indications"&gt;Indications&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; relieve paraphimosis that is strangulating the glans
&lt;/li&gt;&lt;li&gt; phimosis causing urinary retention  
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Dorsal_Slit_(Penis)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Contraindications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Contraindications"&gt;Contraindications&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; no absolute contraindications
&lt;/li&gt;&lt;li&gt; consult urologist prior to procedure if there is evidence of overlying infection, patients who are immunocompromised, or in those with coagulation disorder
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Dorsal_Slit_(Penis)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Equipment Needed"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Equipment_Needed"&gt;Equipment Needed&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; betadine
&lt;/li&gt;&lt;li&gt; sterile gloves/drape 
&lt;/li&gt;&lt;li&gt; local anesthesia
&lt;/li&gt;&lt;li&gt; 27 gauge needle
&lt;/li&gt;&lt;li&gt; 3cc syringe
&lt;/li&gt;&lt;li&gt; straight hemostats or kelly clamp
&lt;/li&gt;&lt;li&gt; iris scissors
&lt;/li&gt;&lt;li&gt; vicryl suture (3-0 or 4-0)
&lt;/li&gt;&lt;li&gt; needle driver
&lt;/li&gt;&lt;li&gt; gauze 
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Dorsal_Slit_(Penis)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Procedure"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Procedure"&gt;Procedure&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1) prep and drape penis in sterile fashion
&lt;/p&gt;&lt;p&gt;2) raise a wheal of anesthesia in the foreskin, just proximal to the glans on the dorsal aspect of the penis (27-gauge needle)
&lt;/p&gt;&lt;p&gt;3) Extend the injection along the longitudinal axis distally to the tip of the foreskin
&lt;/p&gt;&lt;p&gt;4) After 4 min, check to make certain the anesthesia is effective
&lt;/p&gt;&lt;p&gt;5) Slide the hemostats along the space between the foreskin and the glans, and gently open, forming a tract. 
&lt;/p&gt;&lt;p&gt;6) Remove the hemostats, then replace with one tip between the foreskin and glans, and one tip outside the foreskin, straddling the region of anesthesia. Make certain the tip of the hemostats is not in the urethral meatus. 
&lt;/p&gt;&lt;p&gt;7) Close the hemostat over the region of anesthesia and keep clamped for 10 min. 
&lt;/p&gt;&lt;p&gt;8) Remove the hemostat, and cut the serrated clamped tissue with the scissors. 
&lt;/p&gt;&lt;p&gt;(If the skin edges continue to ooze, a running stitch using a vicryl suture can be placed on each side) 
&lt;/p&gt;&lt;p&gt;9) Retract the foreskin and clean the glans 
&lt;/p&gt;&lt;p&gt;(Place a Foley catheter when indicated)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Dorsal_Slit_(Penis)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Complications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Complications"&gt;Complications&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; bleeding
&lt;/li&gt;&lt;li&gt; pain
&lt;/li&gt;&lt;li&gt; infection
&lt;/li&gt;&lt;li&gt; damage to glans or urethra 
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Dorsal_Slit_(Penis)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Emedicine
&lt;/p&gt;&lt;p&gt;adapted from donaldson
&lt;/p&gt;



</content><folder>Procedures</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="downloading_mobile_notes"><name>Downloading Mobile Notes</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Android"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Android&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Blackberry"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Blackberry&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#iPhone_.2F_iPod_Touch"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;iPhone / iPod Touch&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Palm_OS"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Palm OS&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Problems"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Problems&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Downloading_Mobile_Notes&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Android"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Android"&gt; Android &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;We now have Android in beta-version!  If you would like to test the beta software, please email Christopher Kim &amp;lt;christopherkim@ucla.edu&amp;gt;.
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Downloading_Mobile_Notes&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Blackberry"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Blackberry"&gt;Blackberry&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;For every download except the initial, you must first:
&lt;ol&gt;&lt;li&gt;Delete all of the old Wik-EM memos in your home computer; in Outlook: select Notes, right click on the Wik-EM, and delete (do not delete any other memos you may be keeping)
&lt;/li&gt;&lt;li&gt;Sync with your Blackberry and press "Accept" when it asks if you wish to delete all memos on your Blackberry
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Redownload following the steps below
&lt;ol&gt;&lt;li&gt;visit &lt;a href="http://wik-em.sabindang.com/database.csv" class="external free" rel="nofollow"&gt;http://wik-em.sabindang.com/database.csv&lt;/a&gt; via Windows Internet Explorer on your home computer
&lt;/li&gt;&lt;li&gt;you should be asked to open or save database.csv. Select save
&lt;/li&gt;&lt;li&gt;open up Outlook, select file &amp;gt;&amp;gt; import and export
&lt;/li&gt;&lt;li&gt;Select import from another program or file
&lt;/li&gt;&lt;li&gt;Select Comma Separated Values (Windows)
&lt;/li&gt;&lt;li&gt;Select database.csv
&lt;/li&gt;&lt;li&gt;Import the file to your Notes section
&lt;/li&gt;&lt;li&gt;Hit next through the next few screens 
&lt;/li&gt;&lt;li&gt;The Notes should then appear in your Outlook notes section, next you need to Synch your Blackberry with Outlook via your standard manner
&lt;/li&gt;&lt;li&gt;The Notes will appear on your Blackberry under the "MemoPad" icon (sometimes you need to find the icon, which can be moved, in your "Applications" folder)
&lt;/li&gt;&lt;li&gt;For Blackberry users, currently you will have to repeat the above procedure to get new Note updates/improvements.  You may wish to do this every month or so.
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Downloading_Mobile_Notes&amp;amp;action=edit&amp;amp;section=3" title="Edit section: iPhone / iPod Touch"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="iPhone_.2F_iPod_Touch"&gt;iPhone / iPod Touch&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;WikEM is available for iPhone and iPod Touch at the iTunes store. Search for WikEM within the App store. The application is free.
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Downloading_Mobile_Notes&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Palm OS"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Palm_OS"&gt;Palm OS&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Sorry, we are in the middle of working on support for the Palm OS.  If you have a Palm (and know how to Sync it with Outlook on your personal computer), and would like to help us develop the software, please send an email to Sabin Dang &amp;lt;sabin@ucla.edu&amp;gt;.
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Downloading_Mobile_Notes&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Problems"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Problems"&gt;Problems&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Problems? Questions? Please email sabin@ucla.edu.
&lt;/p&gt;



</content><folder>WikEM</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="dyspnea_(sob)"><name>Dyspnea (SOB)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Workup"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Workup&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#DDX"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;DDX&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Dyspnea_(SOB)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Workup"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Workup"&gt;Workup&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; CXR
&lt;/li&gt;&lt;li&gt; ECG
&lt;/li&gt;&lt;li&gt; CBC
&lt;/li&gt;&lt;li&gt; Chem 7
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;Consider:
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; BNP
&lt;/li&gt;&lt;li&gt; D-dimer
&lt;/li&gt;&lt;li&gt; Troponin
&lt;/li&gt;&lt;li&gt; ABG
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Dyspnea_(SOB)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;EMERGENT PATERN RECOGNITION
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Pulmonary edema
&lt;ul&gt;&lt;li&gt;lungs: bilat rales
&lt;/li&gt;&lt;li&gt;CXR: interstitial fluid
&lt;/li&gt;&lt;li&gt;Tx: ECG (R/O AMI), lasix, nitrates, ACE, BIPAP
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Bronchoconstriction
&lt;ul&gt;&lt;li&gt;lungs: wheezes
&lt;/li&gt;&lt;li&gt;CXR: neg/hyperinflated
&lt;/li&gt;&lt;li&gt;Tx: albuterol, atrovent, steroids, consider anaphylaxis (antihistamines, epi)
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Pneumonia
&lt;ul&gt;&lt;li&gt;lungs: focal ronchi/dec BS
&lt;/li&gt;&lt;li&gt;CXR: infiltrate/effusion
&lt;/li&gt;&lt;li&gt;Tx: abx, goal directed,
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;PE
&lt;ul&gt;&lt;li&gt;lungs: clear
&lt;/li&gt;&lt;li&gt;CXR: clear/Westrmrk/Hmptn
&lt;/li&gt;&lt;li&gt;Tx: ECG, D-dimer and/or spiral CT; anticoagulate/thrombolise
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Pneumo/Hemo-Thorax
&lt;ul&gt;&lt;li&gt;lungs: unequal
&lt;/li&gt;&lt;li&gt;CXR: pneumo/hemo
&lt;/li&gt;&lt;li&gt;Tx: needle/chest-tube
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Dysrythmia
&lt;ul&gt;&lt;li&gt;lungs: clear/pulm edema
&lt;/li&gt;&lt;li&gt;CXR: clear/pulm edema
&lt;/li&gt;&lt;li&gt;ECG: abnl
&lt;/li&gt;&lt;li&gt;Tx: rate dependent
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Cardiac Ischemia
&lt;ul&gt;&lt;li&gt;lungs: clear/pulm edema
&lt;/li&gt;&lt;li&gt;CXR: clear/pulm edema
&lt;/li&gt;&lt;li&gt;ECG: nl/abnl
&lt;/li&gt;&lt;li&gt;Tx: B-block, nitrates, anticoag, +/- thrombolitics
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;Consider ABG
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Dyspnea_(SOB)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: DDX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX"&gt;DDX&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;&lt;b&gt;EMERGENT&lt;/b&gt;
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Pulmonary
&lt;ol&gt;&lt;li&gt;Airway obstruction
&lt;/li&gt;&lt;li&gt;PE
&lt;/li&gt;&lt;li&gt;Noncardiogenic edema
&lt;/li&gt;&lt;li&gt;Anaphylaxis
&lt;/li&gt;&lt;li&gt;Spont pneumothorax
&lt;/li&gt;&lt;li&gt;Asthma
&lt;/li&gt;&lt;li&gt;Cor pulmonale
&lt;/li&gt;&lt;li&gt;Aspiration
&lt;/li&gt;&lt;li&gt;PNA
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Cardiac
&lt;ol&gt;&lt;li&gt;Pulmonary edema (CHF)
&lt;/li&gt;&lt;li&gt;MI
&lt;/li&gt;&lt;li&gt;Cardiac tamponade
&lt;/li&gt;&lt;li&gt;Pericarditis
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Other Associated with Nl/Increased Resp Effort
&lt;ol&gt;&lt;li&gt;Toxic ingestion
&lt;/li&gt;&lt;li&gt;DKA
&lt;/li&gt;&lt;li&gt;Epiglotitis
&lt;/li&gt;&lt;li&gt;Tension PNTX
&lt;/li&gt;&lt;li&gt;Cardiac tamponade
&lt;/li&gt;&lt;li&gt;Flail chest
&lt;/li&gt;&lt;li&gt;CO poisoning
&lt;/li&gt;&lt;li&gt;Abd distension
&lt;/li&gt;&lt;li&gt;Sepsis
&lt;/li&gt;&lt;li&gt;Hypotension
&lt;/li&gt;&lt;li&gt;Renal failure
&lt;/li&gt;&lt;li&gt;Electrolyte abnl
&lt;/li&gt;&lt;li&gt;Metabolic acidosis
&lt;/li&gt;&lt;li&gt;PNA
&lt;/li&gt;&lt;li&gt;Pneumo/hemo-thorax
&lt;/li&gt;&lt;li&gt;Diaphragmatic rupture
&lt;/li&gt;&lt;li&gt;Anemia
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Other Associated with Decreased Resp Effort
&lt;ol&gt;&lt;li&gt;CVA
&lt;/li&gt;&lt;li&gt;Organophosphate poisoning
&lt;/li&gt;&lt;li&gt;MS
&lt;/li&gt;&lt;li&gt;Guillian-Barre
&lt;/li&gt;&lt;li&gt;Tick paralysis
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;b&gt;Non-Emergent&lt;/b&gt;
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Pleural effusion
&lt;/li&gt;&lt;li&gt;Neoplam
&lt;/li&gt;&lt;li&gt;PNA
&lt;/li&gt;&lt;li&gt;COPD
&lt;/li&gt;&lt;li&gt;Congenital heart dz
&lt;/li&gt;&lt;li&gt;Pregnancy
&lt;/li&gt;&lt;li&gt;Ascites
&lt;/li&gt;&lt;li&gt;Obesity
&lt;/li&gt;&lt;li&gt;Hypterventilation
&lt;/li&gt;&lt;li&gt;Panic attack
&lt;/li&gt;&lt;li&gt;Fever
&lt;/li&gt;&lt;li&gt;Thyroid dz
&lt;/li&gt;&lt;li&gt;Rib fx
&lt;/li&gt;&lt;li&gt;ALS
&lt;/li&gt;&lt;li&gt;Polymyositis
&lt;/li&gt;&lt;li&gt;Porphyria
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Dyspnea_(SOB)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;3/7/06 DONALDSON (adapted from Rosen)
&lt;/p&gt;



</content><folder>Pulm</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="dystonic_reaction"><name>Dystonic Reaction</name><content>&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Dystonic_Reaction&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; adverse extrapyramidal effect (intermittent spasmodic or sustained involuntary contractions of muscles) that occurs shortly after initiation of new drugs 
&lt;/li&gt;&lt;li&gt; rarely life threatening but patient is in distress from pain and discomfort
&lt;/li&gt;&lt;li&gt; men are affected more frequently than women 
&lt;/li&gt;&lt;li&gt; predisposing factors:
&lt;/li&gt;&lt;li&gt; young age
&lt;/li&gt;&lt;li&gt; family history of dystonic reaction
&lt;/li&gt;&lt;li&gt; history of EtOH or drug use 
&lt;/li&gt;&lt;li&gt; associated with administration of antiemetics or antipsychotic medications 
&lt;/li&gt;&lt;li&gt; 25% of patients treated with Haldol have been known to develop this reaction
&lt;/li&gt;&lt;li&gt; reaction usually occurs within 48 hrs of drug treatment but can occur up to 5 days after starting therapy 
&lt;/li&gt;&lt;li&gt; severity and onset of reaction depends on an individual, no association with dose, drug type, potency of drug, or duration of treatment 
&lt;/li&gt;&lt;li&gt; many theories on what causes the reaction
&lt;/li&gt;&lt;li&gt; direct blockade of central dopaminergic receptors
&lt;/li&gt;&lt;li&gt; imbalance of neurotransmitters (dopamine and acetylcholine) causing excessive cholinergic activity
&lt;/li&gt;&lt;li&gt; combination of dopamine blockade initially by the offending agent and later dopamine activation in nigrostriatal system 
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Dystonic_Reaction&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; History of recent drug exposure or increase in drug dosage
&lt;/li&gt;&lt;li&gt; Thorough drug history (prescription, over the counter, herbals, illegal) 
&lt;/li&gt;&lt;li&gt; Physical exam is usually normal except for dystonia of any striated muscle group. Some common presentations include:
&lt;/li&gt;&lt;li&gt; torticollar reaction
&lt;/li&gt;&lt;li&gt; buccolingual reaction 
&lt;/li&gt;&lt;li&gt; oculogyric crisis
&lt;/li&gt;&lt;li&gt; oromandibular dystonia
&lt;/li&gt;&lt;li&gt; lingual dystonia
&lt;/li&gt;&lt;li&gt; kyphosis/lordosis/scoliosis 
&lt;/li&gt;&lt;li&gt; trismus
&lt;/li&gt;&lt;li&gt; facial grimacing
&lt;/li&gt;&lt;li&gt; tortipelvic crisis 
&lt;/li&gt;&lt;/ul&gt;
&lt;pre&gt;==Medications Associated with Dystonic Reaction==
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; Amitriptyline
&lt;/li&gt;&lt;li&gt; Amoxaine
&lt;/li&gt;&lt;li&gt; Azatadine
&lt;/li&gt;&lt;li&gt; Buproprion
&lt;/li&gt;&lt;li&gt; Chlorpromazine
&lt;/li&gt;&lt;li&gt; Chlorprothixene
&lt;/li&gt;&lt;li&gt; Cimetiddine
&lt;/li&gt;&lt;li&gt; Cisapride
&lt;/li&gt;&lt;li&gt; Cocaine
&lt;/li&gt;&lt;li&gt; Clomipramine
&lt;/li&gt;&lt;li&gt; Clozapine
&lt;/li&gt;&lt;li&gt; Cyclizine
&lt;/li&gt;&lt;li&gt; Dexgtromethorphan
&lt;/li&gt;&lt;li&gt; Diazepam
&lt;/li&gt;&lt;li&gt; Diphenhydramine
&lt;/li&gt;&lt;li&gt; Doxepin
&lt;/li&gt;&lt;li&gt; Etomidate
&lt;/li&gt;&lt;li&gt; Fluoxetine
&lt;/li&gt;&lt;li&gt; Fluphenazine
&lt;/li&gt;&lt;li&gt; Fluvoxamine
&lt;/li&gt;&lt;li&gt; Haloperidol
&lt;/li&gt;&lt;li&gt; Imipramine
&lt;/li&gt;&lt;li&gt; Ketamine
&lt;/li&gt;&lt;li&gt; Lozapine
&lt;/li&gt;&lt;li&gt; Mesoridazine
&lt;/li&gt;&lt;li&gt; Methohexital
&lt;/li&gt;&lt;li&gt; Metoclopraminde
&lt;/li&gt;&lt;li&gt; Olanzpine
&lt;/li&gt;&lt;li&gt; Paroxetine
&lt;/li&gt;&lt;li&gt; Perphenazine
&lt;/li&gt;&lt;li&gt; Phenelzine
&lt;/li&gt;&lt;li&gt; Pheyntoin
&lt;/li&gt;&lt;li&gt; Pimozide
&lt;/li&gt;&lt;li&gt; Prochlorperazine
&lt;/li&gt;&lt;li&gt; Promazine
&lt;/li&gt;&lt;li&gt; Promethazine
&lt;/li&gt;&lt;li&gt; Propofol
&lt;/li&gt;&lt;li&gt; Quietiapine
&lt;/li&gt;&lt;li&gt; ranitidine
&lt;/li&gt;&lt;li&gt; Risperidone
&lt;/li&gt;&lt;li&gt; Sertraline
&lt;/li&gt;&lt;li&gt; Thiethylperazine
&lt;/li&gt;&lt;li&gt; Thiopental
&lt;/li&gt;&lt;li&gt; Thioridazine
&lt;/li&gt;&lt;li&gt; Thiothixene
&lt;/li&gt;&lt;li&gt; Tigabine
&lt;/li&gt;&lt;li&gt; tranylcypromine
&lt;/li&gt;&lt;li&gt; Trifluoperazine
&lt;/li&gt;&lt;li&gt; Triflupromazine
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Dystonic_Reaction&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; consider Utox if no offending agent given by history
&lt;/li&gt;&lt;/ul&gt;
&lt;pre&gt;==DDx==
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; tetanus
&lt;/li&gt;&lt;li&gt; hysterical conversion disorder
&lt;/li&gt;&lt;li&gt; dislocation of mandible
&lt;/li&gt;&lt;li&gt; electrolyte abnormality (Calcium, magnesium)
&lt;/li&gt;&lt;li&gt; meningitis 
&lt;/li&gt;&lt;li&gt; seizure disorder
&lt;/li&gt;&lt;li&gt; strychnine poisoning
&lt;/li&gt;&lt;li&gt; akathisia
&lt;/li&gt;&lt;li&gt; stroke
&lt;/li&gt;&lt;li&gt; drug toxicity (anticholinergic, phenytoin, valproate, carbamazepine)
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;pre&gt;==Treatment==
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; Anticholinergic medication: 
&lt;/li&gt;&lt;li&gt; Diphenhydramine: 50-100mg over 2 minutes
&lt;/li&gt;&lt;li&gt; Benztropine: 1-2 mg in adults over 2 minutes
&lt;/li&gt;&lt;li&gt; Biperiden
&lt;/li&gt;&lt;li&gt; Trihexyphenidyl 2mg PO BID
&lt;/li&gt;&lt;li&gt; IV &amp;gt; IM &amp;gt; PO
&lt;/li&gt;&lt;li&gt; symptoms will typically begin resolving in 2-15 minutes  but may take up to 90 minutes to completely abate (depends on route in which medication was given)
&lt;/li&gt;&lt;li&gt; patients may require more than one dose of IV medication before symptoms resolve completely
&lt;/li&gt;&lt;li&gt; Benzodiazepines 
&lt;/li&gt;&lt;li&gt; Airway Management
&lt;/li&gt;&lt;li&gt; rare, but may be indicated in patients with severe respiratory distress from laryngeal or pharyngeal dystoni 
&lt;/li&gt;&lt;/ul&gt;
&lt;pre&gt;==Disposition==
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; stop the offending agent (if antipsychotic, speak with patients psychiatrist before just stopping the medication)
&lt;/li&gt;&lt;li&gt; continue to treat with PO anticholinergic to prevent relapse of symptoms 
&lt;/li&gt;&lt;li&gt; Diphenhydramine: 12.5-50mg PO TID-QID
&lt;/li&gt;&lt;li&gt; Benztropine: 1-2mg PO BID 
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Dystonic_Reaction&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from Harwood-Nuss
&lt;/p&gt;&lt;p&gt;emedicine
&lt;/p&gt;



</content><folder>Tox</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="ebq_medical_treatment_for_nephrolithiasis"><name>EBQ Medical Treatment for Nephrolithiasis</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=EBQ_Medical_Treatment_for_Nephrolithiasis&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Answer"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Answer"&gt;Answer&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Use an &#945;-antagonist (preferably) or calcium channel  blocker for  moderately sized distal ureteral stones
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=EBQ_Medical_Treatment_for_Nephrolithiasis&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Summary"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Summary"&gt;Summary&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;A pooled analysis of 16 studies using an &#945;-antagonist and 9 studies using a calcium channel blocker suggested that the addition of these agents compared to standard therapy significantly improved spontaneous stone expulsion (&#945;-antagonist RR 1.59; 95% CI 1.44 to 1.75; number needed to treat 3.3 [95% CI 2.1 to 4.5]; calcium channel blocker RR 1.50; 95% CI 1.34 to 1.68; number needed to treat 3.9 [95% CI 3.2 to 4.6]) in patients with distal ureteral stones. Subgroup analysis of trials using concomitant medications (ie, low-dose steroids, antibiotics, and elimination of trials using an anticholinergic agent) yielded a similar improvement in stone expulsion rate. Adverse effects were noted in 4% of patients receiving &#945;-antagonist and in 15.2% of patients receiving calcium channel blockers.
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=EBQ_Medical_Treatment_for_Nephrolithiasis&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Singh A et al. A systematic review of medical therapy to facilitate the  passage of ureteral calculi. Annals of Emerg Med 2007; 552-563.
&lt;/p&gt;



</content><folder>GU</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="ecg_(basics)"><name>ECG (Basics)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#General"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;General&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Intervals"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Intervals&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Axis"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Axis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Q_waves"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Q waves&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#T_waves"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;T waves&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#RAE"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;RAE&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#LAE"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;LAE&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#LVH"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;LVH&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#RVH"&gt;&lt;span class="tocnumber"&gt;9&lt;/span&gt; &lt;span class="toctext"&gt;RVH&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-10"&gt;&lt;a href="#RBBB"&gt;&lt;span class="tocnumber"&gt;10&lt;/span&gt; &lt;span class="toctext"&gt;RBBB&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-11"&gt;&lt;a href="#LBB"&gt;&lt;span class="tocnumber"&gt;11&lt;/span&gt; &lt;span class="toctext"&gt;LBB&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-12"&gt;&lt;a href="#LASH"&gt;&lt;span class="tocnumber"&gt;12&lt;/span&gt; &lt;span class="toctext"&gt;LASH&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-13"&gt;&lt;a href="#L_Post_Inf_Hemiblock"&gt;&lt;span class="tocnumber"&gt;13&lt;/span&gt; &lt;span class="toctext"&gt;L Post Inf Hemiblock&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-14"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;14&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ECG_(Basics)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: General"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="General"&gt;General&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;1 small box = 1mm = 0.04 sec = 40 mili-seconds
&lt;/li&gt;&lt;li&gt;5 small boxes = 1 big box = 5mm = 0.2 sec = 200 mili-seconds
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ECG_(Basics)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Intervals"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Intervals"&gt;Intervals&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;ECG Seconds mm (sm boxes)
&lt;/p&gt;&lt;p&gt;P 0.10 2.5
&lt;/p&gt;&lt;p&gt;PR 0.12-0.20 3-5
&lt;/p&gt;&lt;p&gt;QRS 0.06-0.10 1.5-2.5
&lt;/p&gt;&lt;p&gt;Q &amp;lt;0.04 1
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;QT 0.33-0.42 8.25-10.5
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;QTc &amp;lt;0.44 NA
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ECG_(Basics)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Axis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Axis"&gt;Axis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;axis and ventricular hypertrophy cannot be measured correctly in presence of BBBs....
&lt;/li&gt;&lt;li&gt;Anterior hemiblock-left axis deviationgreater than-45 to -60. and small q in 1 and avl. RS in 2,3, avf. Intrinsicoid deflection in avl greater than .045.
&lt;/li&gt;&lt;li&gt;posterior hemiblock-right axis deviation and S1Q3.
&lt;/li&gt;&lt;li&gt;Axis-check lead 1 and AVF..If both are positive then axis is normal .
&lt;/li&gt;&lt;li&gt;Find isoelectric lead. Axis is perpendicular.
&lt;/li&gt;&lt;li&gt;Horizontal axis-find isoeletric chest lead. If shifted to V1 or V2 then counterclockwise rotation. If shifted to V5 or V6 then clockwise rotation.
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ECG_(Basics)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Q waves"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Q_waves"&gt;Q waves&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;sig Q waves are @ least 1 mm (1 box) wide or @ least 1/3 of the entire QRS amplitude.
&lt;/li&gt;&lt;li&gt;Early Repolarization:
&lt;ol&gt;&lt;li&gt;STE most prominent in lat precord leads (V4-6) but no reciprocal chngs. T waves here usu broad, tall (usu &amp;gt; 5mm) &amp;amp; upright.
&lt;/li&gt;&lt;li&gt;limb leads may also have ste, rarely &amp;gt;2 mm
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ECG_(Basics)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: T waves"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="T_waves"&gt;T waves&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;T waves are normally upright in 1,2,V3 to V6. Negative in AVR.
&lt;ol&gt;&lt;li&gt;if T wave is greater than 2/3 height of R wave it is abnormal.
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ECG_(Basics)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: RAE"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="RAE"&gt;RAE&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;P amplitude &amp;gt;2.5 mm in II.
&lt;/li&gt;&lt;li&gt;Rarely isolated finding (usu rvh/rad too).
&lt;/li&gt;&lt;li&gt;large diphasic p wave in V1. Right atrial hyper.-initial component is larger in V1 than V6&amp;nbsp;:tall p wave, bigger than 2.5 boxes in limb leads.
&lt;/li&gt;&lt;li&gt;p-mitrale-m notched p wave in leads 1 and 2. Greater than .12 seconds.
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ECG_(Basics)&amp;amp;action=edit&amp;amp;section=7" title="Edit section: LAE"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="LAE"&gt;LAE&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Biphasic P in V1 w/ wide, deep terminal component, &amp;gt;1mm depth &amp;amp; wide.
&lt;/li&gt;&lt;li&gt;Left atrial hyper.-terminal component is larger than .04 sec.
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ECG_(Basics)&amp;amp;action=edit&amp;amp;section=8" title="Edit section: LVH"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="LVH"&gt;LVH&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Sum of S in V1 or V2 &amp;amp; R in V5 or V6 is &amp;gt;35mm.
&lt;/li&gt;&lt;li&gt;Sum of highest R &amp;amp; deepest S in precord is &amp;gt;45mm
&lt;/li&gt;&lt;li&gt;R wave in V6 &amp;gt; 18mm
&lt;/li&gt;&lt;li&gt;R in AVL of &amp;gt;12mm
&lt;/li&gt;&lt;li&gt;L precordial leads may show ST depression &amp;amp; twi= LV strain pattern
&lt;/li&gt;&lt;li&gt;LVH-s wave in V1 or V2 (biggest) plus R in V5 or V6 (biggest) is greater than 35mm. LAD-with slightly wide QRS.  Or r in avl greater than 11mm, r in 1 is greater than 12mm, or R in AVf is greater than 20mm.
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ECG_(Basics)&amp;amp;action=edit&amp;amp;section=9" title="Edit section: RVH"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="RVH"&gt;RVH&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Dominant R in V1 &amp;gt;7mm (also seen in WPW, RBBB, post MI, &amp;amp; nml var.)
&lt;/li&gt;&lt;li&gt;RSR in V1 w/ QRS &amp;lt; 0.12
&lt;/li&gt;&lt;li&gt;This dx usu also w/ RAE or strain (ST dep w/ twi in V1-V3).
&lt;/li&gt;&lt;li&gt;Less sens. &amp;amp; spec. than LVH, usu nl ecg
&lt;/li&gt;&lt;li&gt;RVH-R wave greater than S in V1, but gets progressively smaller from V1 to V6. S wave persists in V5 and V6. RAD with slightly wide QRS.
&lt;/li&gt;&lt;li&gt;(note: R&amp;nbsp;:S ratio greater than 1 also in: 1.RBBB 2.WPW type A. 3. Post. Wall MI. 4.kids.)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ECG_(Basics)&amp;amp;action=edit&amp;amp;section=10" title="Edit section: RBBB"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="RBBB"&gt;RBBB&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;QRS &amp;gt; 0.12 in limb leads (all qrs intervals should be measured in limb leads)
&lt;/li&gt;&lt;li&gt;triphasic QRS (RSR') in ant precord leads (V1-V3), often w/ st dep &amp;amp; twi in these leads
&lt;/li&gt;&lt;li&gt;assoc w/ org heart dz (cant cause rad on own)
&lt;/li&gt;&lt;/ol&gt;
&lt;ol&gt;&lt;li&gt;QRS greater than .12.
&lt;/li&gt;&lt;li&gt;slurred s in 1 and V6.
&lt;/li&gt;&lt;li&gt;RSR' in V1 with R' taller than R.
&lt;/li&gt;&lt;li&gt;V1 must have a positive complex.
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ECG_(Basics)&amp;amp;action=edit&amp;amp;section=11" title="Edit section: LBB"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="LBB"&gt;LBB&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;QRS &amp;gt; 0.12 in limb leads, w/ lg, broad , notched or slurred R waves in lat precord leads (V5-V6) &amp;amp; lead I &amp;amp; avL, the st seg is usu depressed &amp;amp; twi in these leads!
&lt;/li&gt;&lt;li&gt;can cause lad, ste seen in ant leads but can call ant mi in rbb!
&lt;/li&gt;&lt;/ol&gt;
&lt;ol&gt;&lt;li&gt;duration equals .12sec
&lt;/li&gt;&lt;li&gt;broad monomorphic R waves in 1 and V6 without Q waves.
&lt;/li&gt;&lt;li&gt;broad monomorphic S waves in V1, may have a small r wave.
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ECG_(Basics)&amp;amp;action=edit&amp;amp;section=12" title="Edit section: LASH"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="LASH"&gt;LASH&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;(caused by CAD, valv. dis., cong. dis., cardiomyop., myocard.)
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Axis &amp;lt; -45 (L axis) w/QRS &amp;lt;0.10s
&lt;/li&gt;&lt;li&gt;deep S in II, III, and AVF
&lt;/li&gt;&lt;li&gt;exclude other cause of L axis (habitus, Inf. MI, hyperK, Vent. pre-excitation)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ECG_(Basics)&amp;amp;action=edit&amp;amp;section=13" title="Edit section: L Post Inf Hemiblock"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="L_Post_Inf_Hemiblock"&gt;L Post Inf Hemiblock&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;(USU. organic heart dis.)
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;R axis (&amp;gt;110) w/ QRS &amp;lt; 0.10s
&lt;/li&gt;&lt;li&gt;R waves in II, III, AVF.
&lt;/li&gt;&lt;li&gt;Exclude other causes (COPD, RVH, Lat MI)
&lt;/li&gt;&lt;li&gt;(-w/ combined blocks cons. pacing only if sxs w/ bradyarrhythmias)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ECG_(Basics)&amp;amp;action=edit&amp;amp;section=14" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;9/09 DONALDSON (adapted from Niemann, Lampe, Pani)
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="ecg_(diagnosis)"><name>ECG (Diagnosis)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Arrythmias"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Arrythmias&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#MI"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;MI&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Infarct_notes"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;Infarct notes&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Pericarditis"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Pericarditis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Electrolyte_Disorders"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Electrolyte Disorders&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-6"&gt;&lt;a href="#HyperK"&gt;&lt;span class="tocnumber"&gt;4.1&lt;/span&gt; &lt;span class="toctext"&gt;HyperK&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-7"&gt;&lt;a href="#HypoK"&gt;&lt;span class="tocnumber"&gt;4.2&lt;/span&gt; &lt;span class="toctext"&gt;HypoK&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-8"&gt;&lt;a href="#HyperCa"&gt;&lt;span class="tocnumber"&gt;4.3&lt;/span&gt; &lt;span class="toctext"&gt;HyperCa&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-9"&gt;&lt;a href="#HypoCa"&gt;&lt;span class="tocnumber"&gt;4.4&lt;/span&gt; &lt;span class="toctext"&gt;HypoCa&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-10"&gt;&lt;a href="#CNS"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;CNS&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-11"&gt;&lt;a href="#Pacemakers"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Pacemakers&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-12"&gt;&lt;a href="#PE"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;PE&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-13"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ECG_(Diagnosis)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Arrythmias"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Arrythmias"&gt;Arrythmias&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;See Cards: Arrythmias (DDX)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ECG_(Diagnosis)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: MI"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="MI"&gt;MI&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;T wave usu tracks w/ the QRS, thus if QRS primarily negative, twi is not necessarily abnl (nl twi in V1).
&lt;/li&gt;&lt;li&gt;ST elevation non-specific, also w/ LVH &amp;amp; strain, LBBB, CA spasm, pericarditis, "early repol", hyperK, dig/TCA's, CVA, Vent. aneurysm, hypothermia.
&lt;/li&gt;&lt;li&gt;Non-transmural: ST dep at least 1.0mm, twi.
&lt;/li&gt;&lt;li&gt;II, II, AVF for inf. MI
&lt;/li&gt;&lt;li&gt;V1-3 for anteroseptal inf.
&lt;/li&gt;&lt;li&gt;I, AVL, V4-6 for lat. wall inf.
&lt;/li&gt;&lt;li&gt;V1 or V2-6 anterolat.
&lt;/li&gt;&lt;li&gt;Large R and ST depression in V1-V2= POST. INFARCT! Post MI usu seen w/ inf MI b/c RCA supplies both in 90% of pts!
&lt;/li&gt;&lt;li&gt;Pts w/ inf. infarction +/or post wall mi often also have RV mi, need R sided leads!!
&lt;/li&gt;&lt;li&gt;STE &amp;gt;/= 1mm in V3R or V4R suggest RV MI!
&lt;/li&gt;&lt;li&gt;STE &amp;gt; 2wks= poss vent aneurysm!
&lt;/li&gt;&lt;li&gt;STE in avR and avL = LMA stenosis
&lt;/li&gt;&lt;li&gt;STE in avR and V1 = LAD or LMA stenosis
&lt;/li&gt;&lt;li&gt;if STE &amp;gt; 1.5 mm in avR pt has 75% mortality from AMI  --&amp;gt; activate cath lab (unless pt is in SVT, then STE is allowed)
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ECG_(Diagnosis)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Infarct notes"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Infarct_notes"&gt;Infarct notes&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;inf wall: recip. In 1 and AVl. Downward sloping ST in AVl is often first sign.
&lt;/li&gt;&lt;li&gt;Any ST depression in V1 to V3 in a LBBB is pathological and suggestive of a post. Wall MI.
&lt;/li&gt;&lt;li&gt;Poor r waves progression-no r's by V4
&lt;/li&gt;&lt;li&gt;persistent t-wave elevation 6 wks post mi-vent. Anyeursm.anteroseptal with biphasic/inverted t wave
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ECG_(Diagnosis)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Pericarditis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Pericarditis"&gt;Pericarditis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Stage I: ST elevated in precordial leads, esp. V5-6 &amp;amp; I-II. Isoelectric or depressed ST in V1. PR depression in II, AVF, V4-6.
&lt;/li&gt;&lt;li&gt;Stage II: ST returning to baseline. T wave amplitude decreases.
&lt;/li&gt;&lt;li&gt;Stage III: ST isoelectric. TWI where prior STE.
&lt;/li&gt;&lt;li&gt;Stage IV: Resolution of T wave changes.
&lt;/li&gt;&lt;li&gt;Also ST:T ratio &amp;gt;0.25 in V6
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;(Depressed PR, Diffuse ST elevation, Scooping upwardly concave ST segments, Notching at the end of the QRS)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ECG_(Diagnosis)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Electrolyte Disorders"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Electrolyte_Disorders"&gt;Electrolyte Disorders&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ECG_(Diagnosis)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: HyperK"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="HyperK"&gt;HyperK&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;5.5-6.6 -&amp;gt; tall peaked T, deep S in I and V6, QRS nml
&lt;/li&gt;&lt;li&gt;7.0-8.0 -&amp;gt; QRS widens, slurred initial and term QRS, ST elevation, low wide P's, AV blocks, SA arrest, bradycardia.
&lt;/li&gt;&lt;li&gt;&amp;gt;8.0 -&amp;gt; widened QRS, Vfib, asystole.
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ECG_(Diagnosis)&amp;amp;action=edit&amp;amp;section=7" title="Edit section: HypoK"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="HypoK"&gt;HypoK&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;3.0-3.5 no change or flat T' sand U's in V2-3, QT interval and QRS nml.
&lt;/li&gt;&lt;li&gt;2.7-3.0 U taller, T smaller, esp. V2-3
&lt;/li&gt;&lt;li&gt;&amp;lt;2.6 ECG change includes tall U's, QT and QRS wnl.
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ECG_(Diagnosis)&amp;amp;action=edit&amp;amp;section=8" title="Edit section: HyperCa"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="HyperCa"&gt;HyperCa&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Increased QRS duration (slight)
&lt;/li&gt;&lt;li&gt;ST short or absent
&lt;/li&gt;&lt;li&gt;Short corrected QT.
&lt;/li&gt;&lt;li&gt;PR long
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ECG_(Diagnosis)&amp;amp;action=edit&amp;amp;section=9" title="Edit section: HypoCa"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="HypoCa"&gt;HypoCa&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;slight decrease in QRS.
&lt;/li&gt;&lt;li&gt;ST and corrected QT long
&lt;/li&gt;&lt;li&gt;PR short.
&lt;/li&gt;&lt;li&gt;T's flat to inverted.
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ECG_(Diagnosis)&amp;amp;action=edit&amp;amp;section=10" title="Edit section: CNS"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="CNS"&gt;CNS&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;SAH, IC bleed, stroke, can see diffuse wide deep, blunted inverted T's. and QT prolonged
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ECG_(Diagnosis)&amp;amp;action=edit&amp;amp;section=11" title="Edit section: Pacemakers"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Pacemakers"&gt;Pacemakers&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Should be in the apex of R vent.
&lt;/li&gt;&lt;li&gt;ECG should mimic LBBB, w/ L axis.
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ECG_(Diagnosis)&amp;amp;action=edit&amp;amp;section=12" title="Edit section: PE"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="PE"&gt;PE&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;S1Q3T3
&lt;ol&gt;&lt;li&gt;(good specificity, poor sensitiviy)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ECG_(Diagnosis)&amp;amp;action=edit&amp;amp;section=13" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;DONALDSON 17/09 (Adapted from Niemann/Lampe)
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="etoh_intoxication"><name>ETOH Intoxication</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#ETOH_Metabloism"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;ETOH Metabloism&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ETOH_Intoxication&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;CAGE
&lt;/p&gt;&lt;p&gt;C- can you cut down
&lt;/p&gt;&lt;p&gt;A- anyone annoyed
&lt;/p&gt;&lt;p&gt;G- Guilty about drinking
&lt;/p&gt;&lt;p&gt;E- Eye opener in am?
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ETOH_Intoxication&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-    withdrawals sxs- dysphoria, insomnia, anxiety, irritable, nause, agitation, tachy, HTN- all same for all three classes of drugs but complications and tx different
&lt;/p&gt;&lt;p&gt;-    substance abuse tx- detox, abstinence, reduce withdrawal sxs, retain pt in tx
&lt;/p&gt;&lt;p&gt;-    ongoing tx needed to maintain tx
&lt;/p&gt;&lt;p&gt;-    substitute long acting agent for abused drug and then taper- med should be oral, low potential for abuse/ overdose and low side effects
&lt;/p&gt;&lt;p&gt;-    out pt  is mild to moderate
&lt;/p&gt;&lt;p&gt;-     inpt if DT's, psychotic, depressed
&lt;/p&gt;&lt;p&gt;-    behavioral interventions- contingency management, motivation, cognitive therapy
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ETOH_Intoxication&amp;amp;action=edit&amp;amp;section=3" title="Edit section: ETOH Metabloism"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="ETOH_Metabloism"&gt;ETOH Metabloism&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;20-40 per hour
&lt;/p&gt;&lt;p&gt;May D/C at &amp;lt;200 (Harbor)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ETOH_Intoxication&amp;amp;action=edit&amp;amp;section=4" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;FEN: Beer Potomania Syndrome
&lt;/p&gt;&lt;p&gt;Tox: ETOH Withdrawl
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ETOH_Intoxication&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;PANI 9/09
&lt;/p&gt;



</content><folder>Tox</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="etoh_withdrawl"><name>ETOH Withdrawl</name><content>&lt;ol&gt;&lt;li&gt;REDIRECT &lt;a href="/wiki/Alcohol_Withdrawl" title="Alcohol Withdrawl"&gt;Alcohol Withdrawl&lt;/a&gt;
&lt;/li&gt;&lt;/ol&gt;




</content><folder></folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="ectopic"><name>Ectopic</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#General"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;General&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Risk_Factors"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Risk Factors&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Workup"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Workup&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Persistent_EP"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Persistent EP&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Sources"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Sources&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ectopic&amp;amp;action=edit&amp;amp;section=1" title="Edit section: General"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="General"&gt;General&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;EP incidence increasing
&lt;/li&gt;&lt;li&gt;Ectopic embryo grows at slower rate since is implanted in tissue not designed to support its growth.
&lt;/li&gt;&lt;li&gt;HCG levels rise slower or not at all.
&lt;/li&gt;&lt;li&gt;Embryo can implant ectopically at ovary, fimbria, ampulla, tube, isthmus, cornua/ interstitial of uterus, or cervix
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ectopic&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Risk Factors"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Risk_Factors"&gt;Risk Factors&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Prev pelvic/abd surg, smoking, douching, age of 1st 
&lt;/li&gt;&lt;li&gt;sex &amp;lt;18, PID, in vitro fertilization, multiple sex partners, prev EP,
&lt;/li&gt;&lt;li&gt;prev tubal surg or sterilization, diethystilbesterol exposure in utero, documented tubal pathology, use of IUD
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ectopic&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;HCG Levels
&lt;ol&gt;&lt;li&gt;Should double q2days until 10000 mIU/ml
&lt;/li&gt;&lt;li&gt;If EP, hcg levels fall, plateau or fail to reach predicted slope before 9- 10 wks gestation.
&lt;/li&gt;&lt;li&gt;1500 mIU/ml should see IUP by transvag utz
&lt;/li&gt;&lt;li&gt;6500 = transabd utz
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;UTZ
&lt;ol&gt;&lt;li&gt;By 2- 3 wks see gest sac followed by yolk sac, then fetal pole and finally cardiac motion (5-6wks)
&lt;/li&gt;&lt;li&gt;Consider EP if complex adnexal mass,  or gest sac in fallopian tube
&lt;/li&gt;&lt;li&gt;If HCG &amp;gt; 1500 and no IUP - assume EP
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ectopic&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Workup"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Workup"&gt;Workup&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;CBC or Hemaccu
&lt;/li&gt;&lt;li&gt;T&amp;amp;S
&lt;/li&gt;&lt;li&gt;B-HCG
&lt;/li&gt;&lt;li&gt;UA, UCx
&lt;/li&gt;&lt;li&gt;Pelvic UTZ
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ectopic&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Surgery
&lt;/li&gt;&lt;li&gt;Medical management: Methotrexate
&lt;ol&gt;&lt;li&gt;Pt must be hemodynamicallys stable, be reliable, and be  amenable to the treatment regimen
&lt;/li&gt;&lt;li&gt;Methotrexate 50 mg/m2 IM  on day 1 and on day 7 if the beta decreases by less than 15% between  days 4 and 7
&lt;/li&gt;&lt;li&gt;Contraindications:
&lt;ol&gt;&lt;li&gt;Adnexal mass &amp;gt;3- 4cm,
&lt;/li&gt;&lt;li&gt;Hcg &amp;gt; 5000
&lt;/li&gt;&lt;li&gt;Cardiac activity
&lt;/li&gt;&lt;li&gt;Suspected twin
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;MTX inhibits synthesis of purines and pyrimidines and prevents DNA synthesis and cell division.  Can also cause bone marrow suppression, hepatotoxicity (get LFTs), stomatitis, pulm fibrosis, photosensitivity.  Side effects minimized by leucovorin
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ectopic&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Persistent EP"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Persistent_EP"&gt;Persistent EP&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Complication of surg.
&lt;/li&gt;&lt;li&gt;Trophoblastic tissue retained.
&lt;/li&gt;&lt;li&gt;Diagnosed by hcg level not less than 50% of pre op value on 1st post-op day.  Tx with single dose MTX
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ectopic&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Sources"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Sources"&gt;Sources&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Donaldson, KajiQuestions
&lt;/p&gt;



</content><folder>OB/GYN</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="elbow_(fractures)"><name>Elbow (Fractures)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Four_Questions"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Four Questions&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#ADULT_INJURIES"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;ADULT INJURIES&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Radial_Head.2FNeck_Fractures"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;Radial Head/Neck Fractures&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Olecranon_Fx"&gt;&lt;span class="tocnumber"&gt;2.2&lt;/span&gt; &lt;span class="toctext"&gt;Olecranon Fx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Elbow_D.2FL"&gt;&lt;span class="tocnumber"&gt;2.3&lt;/span&gt; &lt;span class="toctext"&gt;Elbow D/L&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-6"&gt;&lt;a href="#Monteggia_Fx.2FD.2FL"&gt;&lt;span class="tocnumber"&gt;2.4&lt;/span&gt; &lt;span class="toctext"&gt;Monteggia Fx/D/L&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Elbow_(Fractures)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Four Questions"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Four_Questions"&gt;Four Questions&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Are the fat pads normal?
&lt;ol&gt;&lt;li&gt; A visible ant. fat pad is normal but if displaced anteriorly (Sail sign) it is abnormal
&lt;/li&gt;&lt;li&gt; A visible post. fat pad is always abnormal
&lt;/li&gt;&lt;li&gt; What if have fat pad displacement but no fx or displacement is identified?
&lt;ol&gt;&lt;li&gt; Adults: Treat as radial head fx
&lt;/li&gt;&lt;li&gt; Peds: Be certain that neither an undisplaced supracondylar fx nor a displaced internal epicondyle fx is overlooked! 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Is the radiocapitellar line normal?
&lt;ol&gt;&lt;li&gt; A line drawn along the longitudinal axis of the radial head and neck should pass through the capitellum
&lt;ol&gt;&lt;li&gt; If line does not pass through capitellum than dislocation of radial head is probable
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Whenver there is a fx of the ulnar shaft must evaluate the radiocapitellar line for poss  radial head dislocation (Monteggia fx dislocation)
&lt;/li&gt;&lt;li&gt; This rule is always valid on a true lateral film
&lt;ol&gt;&lt;li&gt; In peds cases the AP view may be misleading
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Is the anterior humeral line normal?
&lt;ol&gt;&lt;li&gt; A line drawn along the ant cortex of the humerus will have at leats 1/3 of the capitellum anterior to it
&lt;ol&gt;&lt;li&gt; If less than 1/3 then strong probability of supracondylar fx w/ distal fragment displaced posteriorly 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Are the ossification centers normal?
&lt;ol&gt;&lt;li&gt; CRITOE (Capitellum, Radial head, Internal epicondyle, Trochlea, Olecranon, Lateral Epicondyle)
&lt;ol&gt;&lt;li&gt; Dislocated elbow may result in avulsion of internal epicondyle 
&lt;ol&gt;&lt;li&gt; Because the trochlea ossifies after the internal epicondyle if you see the trochlea you must find the epicondyle! 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Elbow_(Fractures)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: ADULT INJURIES"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="ADULT_INJURIES"&gt;ADULT INJURIES&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Elbow_(Fractures)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Radial Head/Neck Fractures"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Radial_Head.2FNeck_Fractures"&gt;Radial Head/Neck Fractures&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; 50% of elbow injury in adults
&lt;/li&gt;&lt;li&gt; see Elbow Fx lect
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Elbow_(Fractures)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Olecranon Fx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Olecranon_Fx"&gt;Olecranon Fx&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; 2nd most common
&lt;/li&gt;&lt;li&gt; 20%
&lt;/li&gt;&lt;li&gt; direct blow
&lt;/li&gt;&lt;li&gt; pain,swelling, can't extend elbow
&lt;/li&gt;&lt;li&gt; OR if &amp;gt; 2 mm stepoff
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Elbow_(Fractures)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Elbow D/L"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Elbow_D.2FL"&gt;Elbow D/L&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; 3rd most common jt D/L
&lt;/li&gt;&lt;li&gt; 90% post or postlateral
&lt;/li&gt;&lt;li&gt; 50% have assoc injuries, most common is med epicondylar fx that can often get entrapped
&lt;/li&gt;&lt;li&gt; prox radius &amp;amp; coronoid also Fxed
&lt;/li&gt;&lt;li&gt; ulnar injury - 8-21% in post D/L
&lt;/li&gt;&lt;li&gt; higher rate of neurovasc injury in anterior D/L
&lt;/li&gt;&lt;li&gt; Long arm post splint
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Elbow_(Fractures)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Monteggia Fx/D/L"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Monteggia_Fx.2FD.2FL"&gt;Monteggia Fx/D/L&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Type I - prox 1/3 of ulna, ant displ of distal ulna &amp;amp; ant disl of radial head
&lt;ol&gt;&lt;li&gt;80%
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Type II - post displ of distal ulna &amp;amp; post D/L or radial head (20%)
&lt;/li&gt;&lt;li&gt; Dislocation of radial head requires ORIF
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Elbow_(Fractures)&amp;amp;action=edit&amp;amp;section=7" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;&lt;a href="/w/index.php?title=Elbow_Fracture&amp;amp;action=edit&amp;amp;redlink=1" class="new" title="Elbow Fracture (page does not exist)"&gt;Elbow Fracture&lt;/a&gt;
&lt;/p&gt;&lt;p&gt;&lt;a href="/wiki/Elbow_(Minor)" title="Elbow (Minor)"&gt;Elbow (Minor)&lt;/a&gt;
&lt;/p&gt;&lt;p&gt;&lt;a href="/w/index.php?title=Supracondylar&amp;amp;action=edit&amp;amp;redlink=1" class="new" title="Supracondylar (page does not exist)"&gt;Supracondylar&lt;/a&gt;
&lt;/p&gt;&lt;p&gt;&lt;a href="/wiki/Elbow_Xray_Peds" title="Elbow Xray Peds"&gt;Elbow Xray Peds&lt;/a&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Elbow_(Fractures)&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Whiting lect 2001- By Lampe
&lt;/p&gt;



</content><folder>Ortho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="elbow_(minor)"><name>Elbow (Minor)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Lateral_Epicondylitis_.28Tennis.29"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Lateral Epicondylitis (Tennis)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Medial_Epicondylitis_.28Golf.29"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Medial Epicondylitis (Golf)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Olecranon_Bursitis"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Olecranon Bursitis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Elbow_(Minor)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Lateral Epicondylitis (Tennis)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Lateral_Epicondylitis_.28Tennis.29"&gt;Lateral Epicondylitis (Tennis)&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Injury: Repetitive wrst flex
&lt;/p&gt;&lt;p&gt;Diag: TTP lat epicondy/wrist flex
&lt;/p&gt;&lt;p&gt;Rx: RICE, stop motion,&amp;nbsp;?wrist imob
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Elbow_(Minor)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Medial Epicondylitis (Golf)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Medial_Epicondylitis_.28Golf.29"&gt;Medial Epicondylitis (Golf)&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Injury: Repet wrist extension
&lt;/p&gt;&lt;p&gt;Diag: TTP med epicondy/wrist exten
&lt;/p&gt;&lt;p&gt;Rx: RICE, stop motion,&amp;nbsp;?wrist immob
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Elbow_(Minor)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Olecranon Bursitis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Olecranon_Bursitis"&gt;Olecranon Bursitis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Injury:
&lt;/p&gt;&lt;p&gt;Diag: Swelling; FROM;&amp;nbsp;?aspirate
&lt;/p&gt;&lt;p&gt;Rx: Avoid trauma and excessive pressure; chronic = surg
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Elbow_(Minor)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Ortho:  &lt;a href="/w/index.php?title=Elbow_Fracture&amp;amp;action=edit&amp;amp;redlink=1" class="new" title="Elbow Fracture (page does not exist)"&gt;Elbow Fracture&lt;/a&gt;
&lt;/p&gt;&lt;p&gt;Ortho:  &lt;strong class="selflink"&gt;Elbow (Minor)&lt;/strong&gt;
&lt;/p&gt;&lt;p&gt;Peds: &lt;a href="/w/index.php?title=Supracondylar&amp;amp;action=edit&amp;amp;redlink=1" class="new" title="Supracondylar (page does not exist)"&gt;Supracondylar&lt;/a&gt;
&lt;/p&gt;&lt;p&gt;Rads: &lt;a href="/wiki/Elbow_Xray_Peds" title="Elbow Xray Peds"&gt;Elbow Xray Peds&lt;/a&gt;
&lt;/p&gt;&lt;p&gt;Peds: &lt;a href="/wiki/Elbow_Fracture_(Peds)" title="Elbow Fracture (Peds)"&gt;Elbow Fracture (Peds)&lt;/a&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Elbow_(Minor)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;5/4/06 DONALDSON (adapted from Miller)
&lt;/p&gt;



</content><folder>Ortho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="elbow_fracture_(peds)"><name>Elbow Fracture (Peds)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#1._Supracondylar_Fracture"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;1. Supracondylar Fracture&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#2._Lateral_Condylar_Fracture"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;2. Lateral Condylar Fracture&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#3._Medial_Epicondylar_Fractures"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;3. Medial Epicondylar Fractures&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Elbow_Fracture_(Peds)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: 1. Supracondylar Fracture"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="1._Supracondylar_Fracture"&gt;1. Supracondylar Fracture&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; 7% have nerve injury (median &amp;amp; radial most common)
&lt;/li&gt;&lt;li&gt; Can get ischemia due to brachial artery compression from increased compartment pressure
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
Diagnosis
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; Anterior humeral line does NOT intersect middle third of capitellum
&lt;/li&gt;&lt;li&gt; Small anterior fat pad sometimes normal, posterior fat pad always abnormal 
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
Classificiation
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; Type I - Nondisplaced
&lt;/li&gt;&lt;li&gt; Type II - Displaced w/ intact posterior cortex
&lt;/li&gt;&lt;li&gt; Type III - no cortical contact
&lt;/li&gt;&lt;li&gt;On XR look @ development of secondary ossification centers (must occur in following order, age not as important, ie if see ossification of trochlea you MUST also see CRI as well!)
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Treatment
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; Type I 
&lt;/li&gt;&lt;li&gt; Immobilize using a posterior splint and sling (extend from wrist to axilla) 
&lt;/li&gt;&lt;li&gt; Refer to ortho within 1 week  
&lt;/li&gt;&lt;li&gt; Type II &amp;amp; III  
&lt;/li&gt;&lt;li&gt; Orthopedic consultation regarding closed versus open reduction w/ percutaneous pinning 
&lt;/li&gt;&lt;li&gt; Admit 
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Elbow_Fracture_(Peds)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: 2. Lateral Condylar Fracture"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="2._Lateral_Condylar_Fracture"&gt;2. Lateral Condylar Fracture&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Diagnosis
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; Radiocapitellar line does NOT intersect the middle of the capitelum in all views 
&lt;/li&gt;&lt;li&gt; May be only sign if fracture is entirely through the growth plate
&lt;/li&gt;&lt;li&gt; Fat Pad Sign 
&lt;/li&gt;&lt;li&gt; May be only sign of nondisplaced fx
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Elbow_Fracture_(Peds)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: 3. Medial Epicondylar Fractures"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="3._Medial_Epicondylar_Fractures"&gt;3. Medial Epicondylar Fractures&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Diagnosis
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; Displacement of medial epicondyle ossification center 
&lt;/li&gt;&lt;li&gt; May become entrapped w/in elbow joint
&lt;/li&gt;&lt;li&gt; Use CRITOE to determine if bone in joint is medial epicondyle vs. normal trochlear oss center 
&lt;/li&gt;&lt;li&gt; If think is trochlear but cannot see medial epicondyle, fragment is medial epicondyle 
&lt;/li&gt;&lt;li&gt; (Medial epicondyle normally ossifies before the trochlea)
&lt;/li&gt;&lt;li&gt; Fat pad sign not usually present because most injuries are extra-articular
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Elbow_Fracture_(Peds)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Ortho:  Elbow Fracture
&lt;/p&gt;&lt;p&gt;Ortho:  Elbow (Minor)
&lt;/p&gt;&lt;p&gt;Peds: Supracondylar
&lt;/p&gt;&lt;p&gt;Rads: Elbow Xray Peds
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Source: UpToDate
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="elbow_xray_peds"><name>Elbow Xray Peds</name><content>&lt;p&gt;CRITOE: 1,3,5,7,9,11
&lt;/p&gt;&lt;p&gt;Capitellum 2
&lt;/p&gt;&lt;p&gt;Radial Head 4
&lt;/p&gt;&lt;p&gt;Internal (medial) epicondyle 6
&lt;/p&gt;&lt;p&gt;Trochlea 8
&lt;/p&gt;&lt;p&gt;Olecranon 10
&lt;/p&gt;&lt;p&gt;External (lateral) epicondyle 12
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Elbow_Xray_Peds&amp;amp;action=edit&amp;amp;section=1" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Ortho:  Elbow Fracture
&lt;/p&gt;&lt;p&gt;Ortho:  Elbow (Minor)
&lt;/p&gt;&lt;p&gt;Peds: Supracondylar
&lt;/p&gt;&lt;p&gt;Peds:  Elbow Fracture (Peds)
&lt;/p&gt;



</content><folder>Rads</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="electrocution"><name>Electrocution</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Electrocution&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;End Organ Effects
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; Brain-lack of concentration
&lt;/li&gt;&lt;li&gt; Eyes-cataracts
&lt;/li&gt;&lt;li&gt; Ears-Ruptured TMs
&lt;/li&gt;&lt;li&gt; Cardiac-Arrhythmia
&lt;/li&gt;&lt;li&gt; Renal: ARI
&lt;/li&gt;&lt;li&gt; Rhabdomyolysis
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Electrocution&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Cardiac Monitoring Indications:
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; cardiac arrest
&lt;/li&gt;&lt;li&gt; loss of consciousness
&lt;/li&gt;&lt;li&gt; abnormal ECG
&lt;/li&gt;&lt;li&gt; dysrhythmias (prehospital or ED)
&lt;/li&gt;&lt;li&gt; suspicion of conductive injury
&lt;/li&gt;&lt;li&gt; hypoxia
&lt;/li&gt;&lt;li&gt; chest pain
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Electrocution&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Rosen
&lt;/p&gt;



</content><folder>Environ</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="electrolytes_(general)"><name>Electrolytes (General)</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Electrolytes_(General)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Diagnosis (Ranges)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis_.28Ranges.29"&gt; Diagnosis (Ranges) &lt;/span&gt;&lt;/h2&gt;
&lt;table class="pbNotSortable" border="1" cellpadding="1" cellspacing="1" width="200"&gt;

&lt;tr&gt;
&lt;td&gt; &lt;b&gt;Ion&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Low!&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Low&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;High&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;High!&lt;/b&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; K
&lt;/td&gt;&lt;td&gt; 2.5
&lt;/td&gt;&lt;td&gt; 3.5
&lt;/td&gt;&lt;td&gt; 5.5
&lt;/td&gt;&lt;td&gt; 6.5
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Ca
&lt;/td&gt;&lt;td&gt; 6.5
&lt;/td&gt;&lt;td&gt; 8.5
&lt;/td&gt;&lt;td&gt; 10.5
&lt;/td&gt;&lt;td&gt; 12.0
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Na
&lt;/td&gt;&lt;td&gt; 120
&lt;/td&gt;&lt;td&gt; 135
&lt;/td&gt;&lt;td&gt; 150
&lt;/td&gt;&lt;td&gt; (Osm &amp;gt;350)
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Mg
&lt;/td&gt;&lt;td&gt; Clinical
&lt;/td&gt;&lt;td&gt; 3.5
&lt;/td&gt;&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Electrolytes_(General)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Correct in the following order:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Volume
&lt;/li&gt;&lt;li&gt;pH
&lt;/li&gt;&lt;li&gt;K, Ca, Mg
&lt;/li&gt;&lt;li&gt;Na, Cl
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Electrolytes_(General)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;2/4/06 DONALDSON (adapted from Tintinalli)
&lt;/p&gt;



</content><folder>FEN</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="emergency_contraception"><name>Emergency Contraception</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#Progestin-Only_Regimen"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;Progestin-Only Regimen&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Yuzpe_Regimen"&gt;&lt;span class="tocnumber"&gt;1.2&lt;/span&gt; &lt;span class="toctext"&gt;Yuzpe Regimen&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Emergency_Contraception&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Emergency_Contraception&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Progestin-Only Regimen"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Progestin-Only_Regimen"&gt;Progestin-Only Regimen&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; First dose within 48 hours after unprotected intercourse followed by second dose 12 hours later
&lt;ol&gt;&lt;li&gt;may take both at once
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Relative risk redction of pregnancy = 89% (1% with  vs 8% without)
&lt;/li&gt;&lt;li&gt; Side effects
&lt;ol&gt;&lt;li&gt; Nausea (23%)
&lt;/li&gt;&lt;li&gt; Vomiting (6%)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;no teratogenisis
&lt;/li&gt;&lt;li&gt; FDA approved regimens:
&lt;ol&gt;&lt;li&gt; Plan B (marketed specifically for emergency contraception) - 1 pill (0.75 mg levonorgestrel) per dose
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Emergency_Contraception&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Yuzpe Regimen"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Yuzpe_Regimen"&gt;Yuzpe Regimen&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;(combination OCPs)
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt; First dose within 72 hours after unprotected intercourse followed by second dose 12 hours later
&lt;/li&gt;&lt;li&gt; May be given up to 120 hours later (but efficacy reduced)
&lt;/li&gt;&lt;li&gt; Reduces risk of pregnancy by 75% (2% with vs 8% without)
&lt;/li&gt;&lt;li&gt; Side effects
&lt;ol&gt;&lt;li&gt; Nausea (50%)
&lt;/li&gt;&lt;li&gt; Vomiting (20%)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Safety
&lt;ol&gt;&lt;li&gt;  No teratogenic effect
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Contraindications
&lt;ol&gt;&lt;li&gt; Pregnancy
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; FDA approved regimens:
&lt;ol&gt;&lt;li&gt; Ovral, Ogestrel - 2 pills (100 ug ethiny estradiol/0.5 mg levonorgestrel) per dose
&lt;/li&gt;&lt;li&gt; Alesse, Aviane, Levlite - 5 pills (100 ug ethiny estradiol/0.5 mg levonorgestrel) per dose
&lt;/li&gt;&lt;li&gt; Levlen, Levora, Lo/Ovral, Low-Ogestrel - 4 pills (120 ug ethiny estradiol/0.6 mg levonorgestrel) per dose
&lt;/li&gt;&lt;li&gt; Triphasil, Tri-Levlen, Trivora - 4 pills (120 ug ethiny estradiol/0.5 mg levonorgestrel) per dose
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Emergency_Contraception&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;7/09 PANI
&lt;/p&gt;



</content><folder>OB/GYN</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="endocarditis"><name>Endocarditis</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Risk_Factors"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Risk Factors&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Complications"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Complications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Endocarditis&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Risk Factors"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Risk_Factors"&gt;Risk Factors&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; IVDA
&lt;ol&gt;&lt;li&gt; Most significant risk factor for right-sided disease
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Prosthetic heart valve
&lt;/li&gt;&lt;li&gt; Structural heart disease
&lt;/li&gt;&lt;li&gt; Hemodialysis
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Endocarditis&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; History
&lt;ol&gt;&lt;li&gt; Recent source of bacteremia?
&lt;ol&gt;&lt;li&gt; Indwelling catheters, IVDA
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Physical Exam
&lt;ol&gt;&lt;li&gt; Cardiac, fundi, conjunctivae, skin, digits,
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Labs
&lt;ol&gt;&lt;li&gt; Blood Cx
&lt;ol&gt;&lt;li&gt; All patients with S. aureus bacteremia should be evaluated for IE
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; CBC
&lt;ol&gt;&lt;li&gt; Staphylococcal endocarditis: Leukocytosis +/- thrombocytopenia
&lt;/li&gt;&lt;li&gt; Subacute endocarditis: WBC may be normal or elevated
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; UA
&lt;ol&gt;&lt;li&gt; C/w glomerulonephritis
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; ECG
&lt;ol&gt;&lt;li&gt; Evidence of ischemia, heart block
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; CXR
&lt;ol&gt;&lt;li&gt; Septic pulmonary emboli
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; TTE
&lt;ol&gt;&lt;li&gt; Low Sn, high Sp
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Endocarditis&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Duke Criteria
&lt;ol&gt;&lt;li&gt; 2 major criteria OR
&lt;/li&gt;&lt;li&gt; 1 major and 3 minor criteria OR
&lt;/li&gt;&lt;li&gt; 5 minor criteria
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Major Criteria
&lt;ol&gt;&lt;li&gt; Positive blood culture for infective endocarditis
&lt;ol&gt;&lt;li&gt; S. aureus, S. viridans, S. bovis, Enterococci, HACEK
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Evidence of endocardial involvement
&lt;ol&gt;&lt;li&gt; TEE + or &lt;i&gt;new &lt;/i&gt;valvular regurgitation
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Minor Criteria
&lt;ol&gt;&lt;li&gt; Predisposition - predisposing heart condition or IVDA
&lt;/li&gt;&lt;li&gt; Fever - 38.0 C (100.4 F)
&lt;/li&gt;&lt;li&gt; Vascular phenomena
&lt;ol&gt;&lt;li&gt; Arterial emboli, pulmonary infarcts, mycotic aneurysm, ICH, conjunctival hemorrhage, Janeway lesions
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Immunologic phenomena - glomerulonephritis, Osler's nodes, Roth spots, rheumatoid factor
&lt;/li&gt;&lt;li&gt; Microbiologic evidence - positive blood culture but not meeting major criterion as noted previously
&lt;/li&gt;&lt;li&gt; Echo findings: consistent with IE but do not meet a major criterion as noted above
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Endocarditis&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Antibiotics
&lt;ol&gt;&lt;li&gt; Only bactericidal agents are effective in treating endocarditis
&lt;ol&gt;&lt;li&gt; Vancomycin
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Endocarditis&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Complications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Complications"&gt;Complications&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Cardiac
&lt;ol&gt;&lt;li&gt; Heart Failure
&lt;ol&gt;&lt;li&gt; Most common cause of death due to IE
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Perivalvular Abscess
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Embolic
&lt;ol&gt;&lt;li&gt; CVA
&lt;/li&gt;&lt;li&gt; Blindness
&lt;/li&gt;&lt;li&gt; Painful, ischemic extremities
&lt;/li&gt;&lt;li&gt; Unusual pain sydromes (due to splenic or renal infarction)
&lt;/li&gt;&lt;li&gt; Hypoxia
&lt;/li&gt;&lt;li&gt; Paralysis
&lt;/li&gt;&lt;li&gt; MI
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Neurologic
&lt;ol&gt;&lt;li&gt; Embolic stroke
&lt;/li&gt;&lt;li&gt; Acute encephalopathy
&lt;/li&gt;&lt;li&gt; Meningoencephalitis
&lt;/li&gt;&lt;li&gt; Purulent or aseptic meningitis
&lt;/li&gt;&lt;li&gt; Cerebral hemorrhage
&lt;/li&gt;&lt;li&gt; Seizure
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Renal
&lt;ol&gt;&lt;li&gt; Infarction
&lt;/li&gt;&lt;li&gt; Glomerulonephritis
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Musculoskeletal
&lt;ol&gt;&lt;li&gt; Vertebral osteomyelitis
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Endocarditis&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;UpToDate
&lt;/p&gt;



</content><folder>ID</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="endometritis_(postpartum)"><name>Endometritis (Postpartum)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#Risk_Factors"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;Risk Factors&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Evidence_Based_Questions"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Evidence Based Questions&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-10"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;9&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Endometritis_(Postpartum)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;table width="200" cellspacing="1" border="1"&gt;
&lt;tr&gt;
&lt;td&gt; &lt;b&gt;RF (+no abx prophy)&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Rate&lt;/b&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Nonelective cesarean
&lt;/td&gt;&lt;td&gt; 30%
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Elective cesarean
&lt;/td&gt;&lt;td&gt; 7%
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Vaginal delivery
&lt;/td&gt;&lt;td&gt; 3%
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Endometritis_(Postpartum)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Risk Factors"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Risk_Factors"&gt;Risk Factors&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Cesarean delivery (most important)***
&lt;/li&gt;&lt;li&gt;Prolonged labor
&lt;/li&gt;&lt;li&gt;Prolonged rupture of membranes
&lt;/li&gt;&lt;li&gt;Multiple cervical examinations
&lt;/li&gt;&lt;li&gt;Internal fetal or uterine monitoring
&lt;/li&gt;&lt;li&gt;Large amount of meconium in amniotic fluid
&lt;/li&gt;&lt;li&gt;Manual removal of the placenta
&lt;/li&gt;&lt;li&gt;Low socioeconomic status
&lt;/li&gt;&lt;li&gt;Maternal diabetes mellitus or severe anemia
&lt;/li&gt;&lt;li&gt;Preterm birth
&lt;/li&gt;&lt;li&gt;Bacterial vaginosis
&lt;/li&gt;&lt;li&gt;Operative vaginal delivery
&lt;/li&gt;&lt;li&gt;Postterm pregnancy
&lt;/li&gt;&lt;li&gt;HIV infection
&lt;/li&gt;&lt;li&gt;Colonization with group B streptococcus
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Endometritis_(Postpartum)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt; Diagnosis &lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;fever
&lt;/li&gt;&lt;li&gt;uterine tenderness
&lt;/li&gt;&lt;li&gt;foul lochia
&lt;/li&gt;&lt;li&gt;mild vaginal bleeding 
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Endometritis_(Postpartum)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Endometritis_(Postpartum)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Endometritis_(Postpartum)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Endometritis_(Postpartum)&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Endometritis_(Postpartum)&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Evidence Based Questions"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Evidence_Based_Questions"&gt; Evidence Based Questions &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Endometritis_(Postpartum)&amp;amp;action=edit&amp;amp;section=9" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt; See Also &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Endometritis_(Postpartum)&amp;amp;action=edit&amp;amp;section=10" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt; Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from ....(insert)
&lt;/p&gt;



</content><folder>ID</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="epididymitis"><name>Epididymitis</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Epididymitis&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;acute scrotal pain is a common reason for ER visit
&lt;/li&gt;&lt;li&gt;epididymitis is entity most often confused with testicular torsion
&lt;/li&gt;&lt;li&gt;sexually active men &amp;lt;35yo: Chlamydia trachomatis, Neisseria gonorrhea
&lt;/li&gt;&lt;li&gt;men engaging in anal intercourse, non sexually active and/or &amp;gt;35, also consider: E. Coli, Pseudomonas, Enterobacteraciaceae, TB, syphilis
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Epididymitis&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;pain of gradual onset, peak at 24 hours
&lt;/li&gt;&lt;li&gt;cremasteric reflex intact
&lt;/li&gt;&lt;li&gt;pain relieved with elevation of testicle (positive Prehn sign)
&lt;/li&gt;&lt;li&gt;US shows scrotal wall thickening and hyperemia, possible reactive hydrocele or pyocele
&lt;/li&gt;&lt;li&gt;UA may show pyuria but absence does not rule out disease
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Epididymitis&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;UA, Urine culture
&lt;/li&gt;&lt;li&gt;urethral gram stain, culture, chlamydia, gonorrhea
&lt;/li&gt;&lt;li&gt;testicular US
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Epididymitis&amp;amp;action=edit&amp;amp;section=4" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;testicular torsion
&lt;/li&gt;&lt;li&gt;torsion of testicular appendage
&lt;/li&gt;&lt;li&gt;testicular tumor
&lt;/li&gt;&lt;li&gt;orchitis
&lt;/li&gt;&lt;li&gt;scrotal abscess
&lt;/li&gt;&lt;li&gt;indirect inguinal hernia
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Epididymitis&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;scrotal elevation
&lt;/li&gt;&lt;li&gt;analgesia
&lt;/li&gt;&lt;li&gt;antibiotics:
&lt;ol&gt;&lt;li&gt;sexually transmitted (&amp;lt;35yo):
&lt;ol&gt;&lt;li&gt;ceftriaxone 250mg IM x1 or cipro 500mg PO x1 for gonorrhea
&lt;/li&gt;&lt;li&gt;doxycycline 100mg PO BID x 14 days for chlamydia
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;anal intercourse, nonsexually active, instrumentation and/or &amp;gt;35yo:
&lt;ol&gt;&lt;li&gt;cipro 500mg PO BID x 14 days OR Ofloxacin 200mg PO BID x 14 days
&lt;/li&gt;&lt;li&gt;IV: piperacillin/taxobactam 3.375g IV q6 or ampicillin/sulbactam 3g IV q6
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;treat sexual partner
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Epididymitis&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;admit for systemic signs of toxicity (fever, chills, nausea, vomiting)
&lt;/li&gt;&lt;li&gt;discharge home with follow up in one week if non toxic
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Epididymitis&amp;amp;action=edit&amp;amp;section=7" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;testicular torsion
&lt;/p&gt;&lt;p&gt;torsion of the testicular appendage
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Epididymitis&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Anatomical Approach to Scrotal Emergencies: A New Paradigm for the Diagnosis and Treatment of the Acute Scrotum. The Internet Journal of Urology 2010&amp;nbsp;: Volume 6 Number 2. Sardar Ali. KhanRosens
&lt;/p&gt;



</content><folder>GU</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="epidural_abscess_(spinal)"><name>Epidural Abscess (Spinal)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Risk_Factors"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Risk Factors&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Differential_Diagnosis"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Differential Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Epidural_Abscess_(Spinal)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Risk Factors"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Risk_Factors"&gt;Risk Factors&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Diabetes mellitus 
&lt;/li&gt;&lt;li&gt; Alcoholism 
&lt;/li&gt;&lt;li&gt; AIDS
&lt;/li&gt;&lt;li&gt; Trauma 
&lt;/li&gt;&lt;li&gt; Tattooing 
&lt;/li&gt;&lt;li&gt; Acupuncture 
&lt;/li&gt;&lt;li&gt; Contiguous bony or soft tissue infection
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Epidural_Abscess_(Spinal)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis &lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Classic triad of fever, back pain, and neuro deficits is rare 
&lt;/li&gt;&lt;li&gt; Fever is only present in ~50% of cases
&lt;/li&gt;&lt;li&gt; Fever + localized back pain = epidural abscess until proven otherwise
&lt;/li&gt;&lt;li&gt; Routine lab tests are rarely helpful
&lt;/li&gt;&lt;li&gt; Only 60% have leukocytosis
&lt;/li&gt;&lt;li&gt; CT with IV contrast is acceptable (MRI is preferred)
&lt;/li&gt;&lt;li&gt; Blood cultures are indicated to identify the source organism (Staph in 2/3 of cases)
&lt;/li&gt;&lt;li&gt; CSF studies are rarely useful (only positive in 20% of cases)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Epidural_Abscess_(Spinal)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Differential Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Differential_Diagnosis"&gt;Differential Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Disc and bony disease
&lt;/li&gt;&lt;li&gt; Vertebral discitis and osteomyelitis  
&lt;/li&gt;&lt;li&gt; Metastatic tumors 
&lt;/li&gt;&lt;li&gt; Meningitis 
&lt;/li&gt;&lt;li&gt; Herpes zoster, prior to appearance of skin lesions
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Epidural_Abscess_(Spinal)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment &lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Early surgical decompression and drainage
&lt;/li&gt;&lt;li&gt; Aspiration (for diagnosis) and Abx may be sufficient for pts w/o neuro deficits 
&lt;/li&gt;&lt;li&gt; Antibiotics
&lt;ol&gt;&lt;li&gt; Vanco + metronidazole + either cefotaxime or ceftriaxone or ceftazadine
&lt;ol&gt;&lt;li&gt; (Ceftazidine is preferred if pseudomonas is considered likely)
&lt;/li&gt;&lt;li&gt; Can substitute nafcillin or oxacillin for vanco if not MRSA 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Treat for 6-8 weeks 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Epidural_Abscess_(Spinal)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;UpToDate
&lt;/p&gt;



</content><folder>ID</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="epinephrine"><name>Epinephrine</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Concentration"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Concentration&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Anaphlylaxis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Anaphlylaxis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Anaphylactic_Shock"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Anaphylactic Shock&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Cardiac_Arrest"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Cardiac Arrest&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Epinephrine&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Concentration"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Concentration"&gt;Concentration&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Amount of solution in mL used to dilute 1,000mg of epinephrine
&lt;ol&gt;&lt;li&gt;eg 1:10,000 = 1,000mg/10,000mL = 0.1mg/mL
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Epinephrine&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Anaphlylaxis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Anaphlylaxis"&gt;Anaphlylaxis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;0.3-0.5mg of 1:1,000 IM
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Epinephrine&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Anaphylactic Shock"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Anaphylactic_Shock"&gt;Anaphylactic Shock&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;0.1mg of 1:10,000 slow IV during 5 min
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Epinephrine&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Cardiac Arrest"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Cardiac_Arrest"&gt;Cardiac Arrest&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1mg of 1:10,000 IVP
&lt;/p&gt;



</content><folder>Airway/Resus</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="epistaxis"><name>Epistaxis</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#Pathophysiology"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;Pathophysiology&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Misc"&gt;&lt;span class="tocnumber"&gt;1.2&lt;/span&gt; &lt;span class="toctext"&gt;Misc&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#ANTERIOR_NB"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;ANTERIOR NB&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-6"&gt;&lt;a href="#POSTERIOR_NB"&gt;&lt;span class="tocnumber"&gt;2.2&lt;/span&gt; &lt;span class="toctext"&gt;POSTERIOR NB&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Aftercare.2FDisposition"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Aftercare/Disposition&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-8"&gt;&lt;a href="#Admission"&gt;&lt;span class="tocnumber"&gt;3.1&lt;/span&gt; &lt;span class="toctext"&gt;Admission&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Epistaxis&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Epistaxis&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Pathophysiology"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Pathophysiology"&gt;Pathophysiology&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;90% anterior
&lt;/li&gt;&lt;li&gt;Kiesselbach plexus or Little area
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Epistaxis&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Misc"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Misc"&gt;Misc&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Hypertension does not cause NBs but may prlong bleed; rx with analgesia and mild sedation
&lt;/li&gt;&lt;li&gt;For severe or recurrent NBs or pts on Coumadin, have hepatic or renal dysfxn, consider CBC, Coags, T&amp;amp;S
&lt;/li&gt;&lt;li&gt;Posterior packing complications: hypoxia, hypercarbia, exacerbation of OSA, aspiration, hypertension, bradycardia, arrhythmias, MI, death
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Epistaxis&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment &lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Apply anterior pressure
&lt;/li&gt;&lt;li&gt;Start with 4 tongue blades and tape
&lt;/li&gt;&lt;li&gt;Ice pack
&lt;/li&gt;&lt;li&gt;Gown up and gown the patient
&lt;/li&gt;&lt;li&gt;Kidney basin
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;Stepwise approach - if successful do not proceed to next step...
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Epistaxis&amp;amp;action=edit&amp;amp;section=5" title="Edit section: ANTERIOR NB"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="ANTERIOR_NB"&gt;ANTERIOR NB&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Step 1: Clear nose of blood with suction or have pt blow nose
&lt;ol&gt;&lt;li&gt;Identify bleeding source with good light and speculum 
&lt;/li&gt;&lt;li&gt;Open speculum vertically; rest index finger of speculum hand on bridge of pts nose
&lt;/li&gt;&lt;li&gt;If bleeding point cannot be localized, approx depth of bleeding can be localized using small Frazier suction catheter 
&lt;/li&gt;&lt;li&gt;Place at nares and tilt pts head forward so that the sxn captures all bleeding
&lt;/li&gt;&lt;li&gt;Advance catheter posteriorly along the floor of the nose until blood returns from the nares and note depth
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Step 2:
&lt;ol&gt;&lt;li&gt;Afrin spray (topical oxymetazoline): alapha agonist
&lt;/li&gt;&lt;li&gt;LET (lido 4%, epi 0.1%, tetracaine 0.4%) applied to cotton ball or gauze and remain in nares for 10-15mins
&lt;/li&gt;&lt;li&gt;Lidocaine 4% spray
&lt;/li&gt;&lt;li&gt;Topical cocaine HCL 4% or 10%
&lt;/li&gt;&lt;li&gt;Inject 0.5-1.0cc 1% lido in epi 1:100,000 with 27 gauge needle
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Step 3: Cautery
&lt;ol&gt;&lt;li&gt;Chemical cautery: silver nitrate for mild active bleeding or after bleeding has stopped (only one side of septum) cauterize on surrounding tissues first then upon source.
&lt;/li&gt;&lt;li&gt;If dry wet silver nitrate tip first
&lt;/li&gt;&lt;li&gt;Roll over area for 5-10s until grey eschar forms
&lt;/li&gt;&lt;li&gt;NosebleedQR: nonprescription powder of hydrophilic polymer and potassium salts &#8211; forms a crust.  Load onto an applicator swab and apply firmly to site b/g pinching nose for 15-20s
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Step 4: Nasal packing (if Step 3 fails)
&lt;ol&gt;&lt;li&gt;Merocel: (insert after adequate analgesia)
&lt;/li&gt;&lt;li&gt;Lubricate the TIP with antibiotic ointment (bacitracin) or surgical lubricant
&lt;ol&gt;&lt;li&gt;Insert with vertical orientation into nose at 45&#730; 1-2cm then grasp merocel with bayonet forceps and rotate to horizontal plane and push all the way
&lt;/li&gt;&lt;li&gt;If the pack doesn&#8217;t rehydrate with blood may inject with NS or lido with epi or other vasoconstrictor
&lt;/li&gt;&lt;li&gt;Trim as necessary
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Epistaxis ballons: after checking balloon integrity lubricate copiously with viscous lidocaine or or water-based lubricant and insert
&lt;ol&gt;&lt;li&gt;Inflate balloons slowly; use NS if in place for duration &amp;gt;hours
&lt;/li&gt;&lt;li&gt;Rapid Rhino (inflatable balloon covered in carboxymethylcellulose hydrocolloid) that acts as a platelet aggregator and also forms a lubricant upon contact with water
&lt;ol&gt;&lt;li&gt;Soak in basin of sterile water for 30 seconds
&lt;/li&gt;&lt;li&gt;Inserted along septal floor and parallel to hard palate until fabric ring is well within the naris
&lt;/li&gt;&lt;li&gt;Inflate with 20cc syringe with air or NS
&lt;/li&gt;&lt;li&gt;Leave in place for 72h
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Surgicel or Oxycel (oxidized regenerated cellulose) and Gelfoam (absorbable gelatin foam) encourage platelet formation
&lt;ol&gt;&lt;li&gt;Place directly over bleeding site
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;FloSeal is a biodegradable hemostasis sealant
&lt;ol&gt;&lt;li&gt;Works in anticoagulated patients &#8211; doesn&#8217;t require platelet aggregation
&lt;/li&gt;&lt;li&gt;Using forceps, place a moistened piece of gauze over FloSeal matrix for 1-2 minutes to ensure material remains in contact with bleeding tissue
&lt;/li&gt;&lt;li&gt;Begins to break down after 3-5days
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Thrombin-JMI Epistaxis Kit bovine derived topical thrombin
&lt;ol&gt;&lt;li&gt;Tradional packing: Sterile petroleum ribbon 0.5-1cm ribbon. 
&lt;/li&gt;&lt;li&gt;Cover with abx ointment
&lt;/li&gt;&lt;li&gt;Grasp ribbon about 6cm from end with bayonet forceps and insert along floor of nose
&lt;/li&gt;&lt;li&gt;Remove speculum and place on top of ribbon and press down
&lt;/li&gt;&lt;li&gt;Grab ribbon 4-5cm from nasal alae and place in nose
&lt;/li&gt;&lt;li&gt;Once finished make sure both ends are protruding from nose
&lt;/li&gt;&lt;li&gt;Cover with gauze and secure with tape
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Epistaxis&amp;amp;action=edit&amp;amp;section=6" title="Edit section: POSTERIOR NB"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="POSTERIOR_NB"&gt;POSTERIOR NB&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Foley catheter (12 or 14F with 30cc balloon) lubricate then advance until tip and balloon are entirely in nasopharynx
&lt;ol&gt;&lt;li&gt;Fill the balloon with sterile saline (us 5-10cc) to allow it to be pulled snugly against the posterior nasal choana with anterior traction
&lt;/li&gt;&lt;li&gt;Secure in place with umbilical or c-clamp on the catheter
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Epistat has posterior balloon and anterior Merocel nasal tampon
&lt;/li&gt;&lt;li&gt;Storz T3100 nasal catheter has separate anterior and posterior balloons
&lt;ol&gt;&lt;li&gt;Insert then inflate posterior balloon with 5-10cc NS then pull forward gently until snug; inflate anterior balloon with 15-30cc NS
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Epistaxis&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Aftercare/Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Aftercare.2FDisposition"&gt;Aftercare/Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Observe for 1 hour after control of bleed no matter which treatment; encourage the pt to walk or perform other things that they would do at home
&lt;/li&gt;&lt;li&gt;F/U: stop ASA and NSAIDs for a few days
&lt;/li&gt;&lt;li&gt;If rx with cautery, Vaseline or a similar moisturizing agent should be applied liberally in the nose 3x/day for 7-10d to promote healing of friable mucosa and superficial vessels
&lt;/li&gt;&lt;li&gt;If nasal pack, prescribe analgesics, abx (Bactrim, Keflex or Augmentin) and f/u with ENT in 3days
&lt;/li&gt;&lt;li&gt;Avoid nose blowing, straingig, bending over, sports; nseeeze with mouth open
&lt;/li&gt;&lt;li&gt;Home humidifiers and saline nasal spray in drier, colder months
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Epistaxis&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Admission"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Admission"&gt;Admission&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Posterior packing: risk of airway obstrxn and subsequent hypoxemia and dysrhythmias 
&lt;ol&gt;&lt;li&gt;Significant blood loss
&lt;/li&gt;&lt;li&gt;Abnormal vital signs
&lt;/li&gt;&lt;li&gt;Coagulopathies
&lt;/li&gt;&lt;li&gt;Refractory epistaxis
&lt;/li&gt;&lt;li&gt;Anterior packing with CHF, COPD
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Epistaxis&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;DeBonis 7/09
&lt;/p&gt;



</content><folder>ENT</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="esophageal_foreign_body"><name>Esophageal Foreign Body</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Esophageal_Foreign_Body&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adults = food bolus (usually meat) lodged above a peptic stricture or ring.  &amp;gt;12 hours = risk of pulmonary aspiration.
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Esophageal_Foreign_Body&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;dysphagia
&lt;/li&gt;&lt;li&gt;odynophagia
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Esophageal_Foreign_Body&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Consider soft tissue lateral 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Esophageal_Foreign_Body&amp;amp;action=edit&amp;amp;section=4" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;stricture/ring
&lt;/li&gt;&lt;li&gt;cancer
&lt;/li&gt;&lt;li&gt;eosinophilic esophagitis
&lt;/li&gt;&lt;li&gt;achalasia 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Esophageal_Foreign_Body&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Coke-Cola PO
&lt;/li&gt;&lt;li&gt; Nitro spray SL
&lt;/li&gt;&lt;li&gt; Glucagon (1.0 mg IV/IM) 
&lt;/li&gt;&lt;li&gt; Endoscopy 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Esophageal_Foreign_Body&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; resolved (spontaneously or after medical Tx) --&amp;gt; outpt GI referal
&lt;/li&gt;&lt;li&gt; not resolved --&amp;gt; GI consult
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Esophageal_Foreign_Body&amp;amp;action=edit&amp;amp;section=7" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Peds:  Esophageal Foreign Body (Peds)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Esophageal_Foreign_Body&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;KajiQuestions
&lt;/p&gt;



</content><folder>ENT</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="esophageal_foreign_body_(peds)"><name>Esophageal Foreign Body (Peds)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Esophageal_Foreign_Body_(Peds)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Most common site in upper 1/3 of esophagous
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;5% of FB are more than 1 FB
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Disk batteries can cause esophageal burns 4hrs &amp;amp; perf in 6hrs
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Esophageal_Foreign_Body_(Peds)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: "&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id=""&gt; &lt;/span&gt;&lt;/h2&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Esophageal_Foreign_Body_(Peds)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Clinical
&lt;/p&gt;&lt;p&gt;Consider CXR and/or soft tissue lateral x-ray
&lt;/p&gt;&lt;p&gt;(soft tissue lateral of neck, cxr, kub), if no FB on xr (radiolucent, ie plastic, button), but child w/ sx or strong hx of recent FB ingestion, then endoscopy is indicated.
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Coins in the esoph are in coronal plane &amp;amp; coins in trachea in the sagital plane
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Esophageal_Foreign_Body_(Peds)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Tracheal/lung aspiration
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Esophageal_Foreign_Body_(Peds)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;STABLE
&lt;/p&gt;&lt;p&gt;1) Food bolus (soft; ie. no bones)
&lt;/p&gt;
&lt;pre&gt;    -glucagon (caution causes vomiting)
&lt;/pre&gt;
&lt;pre&gt;    -fails --&amp;gt; endosopic removal
&lt;/pre&gt;
&lt;p&gt;2) Coin (or similar round/smooth FB)
&lt;/p&gt;
&lt;pre&gt;    a. Below diaphram
&lt;/pre&gt;
&lt;pre&gt;         i. asymptomatic
&lt;/pre&gt;
&lt;pre&gt;              -d/c home, check stool x 1 wk, repeak KUB if not passed as outpt
&lt;/pre&gt;
&lt;pre&gt;         ii. sx obstruction or perf
&lt;/pre&gt;
&lt;pre&gt;              -surgery
&lt;/pre&gt;
&lt;pre&gt;    b. Above diaphram
&lt;/pre&gt;
&lt;pre&gt;         i. asymptomatic
&lt;/pre&gt;
&lt;pre&gt;              -Obs + repeat XR x 6hrs
&lt;/pre&gt;
&lt;pre&gt;              -Consider "Foley manuver" if fails Obs
&lt;/pre&gt;
&lt;p&gt;3) Disk or button battery
&lt;/p&gt;
&lt;pre&gt;    a. Esophagus --&amp;gt; immediate removal (endoscopy)
&lt;/pre&gt;
&lt;pre&gt;    b. Below diaphram
&lt;/pre&gt;
&lt;pre&gt;         i. asymptomatic
&lt;/pre&gt;
&lt;pre&gt;              -Outpt obs with close f/u
&lt;/pre&gt;
&lt;pre&gt;              -needs to be removed if still in stomach after 24-48hr
&lt;/pre&gt;
&lt;pre&gt;         ii. Sypmtomatic
&lt;/pre&gt;
&lt;pre&gt;              -immediate removal (endoscopy)
&lt;/pre&gt;
&lt;p&gt;4) Sharp (ie bone, pin, etc) or long (&amp;gt;3-6cm)
&lt;/p&gt;
&lt;pre&gt;    a. Esophagous, stomach, and/or symptomatic
&lt;/pre&gt;
&lt;pre&gt;         --&amp;gt; Immediate removal (endoscopy)
&lt;/pre&gt;
&lt;pre&gt;    b. Below stomach and asymptomatic
&lt;/pre&gt;
&lt;pre&gt;         --&amp;gt;Outpt obs with close F/U
&lt;/pre&gt;
&lt;pre&gt;              -perf rare (&amp;lt;1-2%)
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Esophageal_Foreign_Body_(Peds)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;GI: Esophageal Foreign Body
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Esophageal_Foreign_Body_(Peds)&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;6/04 EM Reports- By Lampe
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="ethylene_glycol_poisoning"><name>Ethylene Glycol Poisoning</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Pathophysiology"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Pathophysiology&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Clinical_Manifestations"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Clinical Manifestations&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ethylene_Glycol_Poisoning&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt; Background &lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Component of antifreeze
&lt;/li&gt;&lt;li&gt;Toxic dose = 0.2mL/kg
&lt;/li&gt;&lt;li&gt;Lethal dose = 1.4mL/kg
&lt;/li&gt;&lt;li&gt;Sweet taste
&lt;/li&gt;&lt;li&gt;Fluoresces yellow/green under Wood's lamp
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ethylene_Glycol_Poisoning&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Pathophysiology"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Pathophysiology"&gt; Pathophysiology &lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Ethylene glycol + alcohol/aldehyde dehydrogenase &amp;gt; oxalate + glycolic acid
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ethylene_Glycol_Poisoning&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt; Work-Up &lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Chemistry
&lt;ul&gt;&lt;li&gt;Anion gap acidosis
&lt;/li&gt;&lt;li&gt;Renal failure
&lt;/li&gt;&lt;li&gt;Osm gap
&lt;ul&gt;&lt;li&gt;Calculated serum osm = 2Na + BUN/2.8 + glucose/18 + ethanol/4.2)
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Serum Osm
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Glucose
&lt;/li&gt;&lt;li&gt;Ethanol level
&lt;/li&gt;&lt;li&gt;UA
&lt;ul&gt;&lt;li&gt;Hematuria, proteinuria, pyuria
&lt;/li&gt;&lt;li&gt;Calcium oxalate crystals (late finding, only seen in 50%)
&lt;/li&gt;&lt;li&gt;Urinary fluorescence (may be seen 6 hours after ingestion)
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Total CK
&lt;/li&gt;&lt;li&gt;VBG
&lt;/li&gt;&lt;li&gt;ECG
&lt;ul&gt;&lt;li&gt;QT prolongation ~ hypocalcemia
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;Note:
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Cannot rule out toxic ingestion with a "normal" osmol gap
&lt;ul&gt;&lt;li&gt;Only parent alcohol is osmotically active
&lt;ul&gt;&lt;li&gt;Delayed presentation may mean that much of it is already metabolized
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ethylene_Glycol_Poisoning&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Clinical Manifestations"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Clinical_Manifestations"&gt; Clinical Manifestations &lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Patients may die in any stage!
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Stage 1 - CNS
&lt;ul&gt;&lt;li&gt; 30min to 12h
&lt;/li&gt;&lt;li&gt; Pt appears intoxicated (slurred speech, ataxia, stupor, sz, coma)
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Stage 2 - Cardiopulmonary
&lt;ul&gt;&lt;li&gt; 12- 24h
&lt;/li&gt;&lt;li&gt; Hypertension, tachycardia, CHF
&lt;/li&gt;&lt;li&gt; ARDS, pulmonary infiltrates
&lt;/li&gt;&lt;li&gt; Hypocalcemia (chelation by oxalate)
&lt;/li&gt;&lt;li&gt; Myositis &amp;amp; CK elevation
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Stage 3 - Renal
&lt;ul&gt;&lt;li&gt; 24- 72h
&lt;/li&gt;&lt;li&gt; Flank pain, CVAT
&lt;/li&gt;&lt;li&gt; Hematuria, proteinuria, calcium oxalate crystals (50%)
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Stage 4 - Delayed CNS
&lt;ul&gt;&lt;li&gt; 6-12days
&lt;/li&gt;&lt;li&gt; Cranial neuropathy
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ethylene_Glycol_Poisoning&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt; Treatment &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1. Correction of metabolic acidosis with bicarbonate
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; Bicarbonate 1-2mEq/kg IV bolus to attain pH = 7.45-7.50
&lt;ul&gt;&lt;li&gt; Follow by infusion of 150mEq/L in D5 @ 1.5-2 times maintenance fluid rate
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; Monitor for worsening hypocalcemia
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
2. ADH enzyme blockade
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Fomepizole (4-MP)
&lt;ul&gt;&lt;li&gt; 15mg/kg followed by 10mg/kg q12hr x 4 doses
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Ethyl alcohol
&lt;ul&gt;&lt;li&gt;BAL of 100-150 completely saturates alcohol dehydrogenase
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
3. Removal of parent alcohol and metabolites via dialysis
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Indications (controversial):
&lt;ul&gt;&lt;li&gt; Severe acidosis (pH &amp;lt;7.30)
&lt;/li&gt;&lt;li&gt; Renal compromise
&lt;/li&gt;&lt;li&gt; Electrolyte imbalances unreponsive to conventional therapy
&lt;/li&gt;&lt;li&gt; Anion gap &amp;gt; 20
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;4. Other
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; Thiamine 100mg IV q6hr and Pyridoxine 50mg q6hr
&lt;ul&gt;&lt;li&gt;Theoretically decreases oxalate production
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; Replace Magnesium
&lt;/li&gt;&lt;li&gt;Hypercalcemia
&lt;ul&gt;&lt;li&gt; Symptomatic - treat cautiously (avoid further precipitation)
&lt;/li&gt;&lt;li&gt; Asymptomatic - do not treat
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ethylene_Glycol_Poisoning&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt; Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Rosen's
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; &lt;br /&gt;&lt;br /&gt;
&lt;/p&gt;



</content><folder>Tox</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="exotic_pet_infections"><name>Exotic Pet Infections</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Exotic_Pet_Infections&amp;amp;action=edit&amp;amp;section=1" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-Hedgehogs: T. Mentagrophtes, saliva-induced urticaria, salmonella, mycobacteria
&lt;/p&gt;&lt;p&gt;-Iguanas: Salmonella, serratia (resistant strains: use quinolone)
&lt;/p&gt;&lt;p&gt;-Flying Squirrels: Rickettsia prowazeki (typhus fever), staph
&lt;/p&gt;&lt;p&gt;-Gerbils: Leishmania, giardia, staph aureus, avian mites
&lt;/p&gt;&lt;p&gt;-Praire dogs: Monkeypox,Yersinia, tularemia
&lt;/p&gt;&lt;p&gt;-Cockatoos and macaws: Cryptococcus neoformans
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Exotic_Pet_Infections&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;7/2/09  PANI
&lt;/p&gt;



</content><folder>ID</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="eye_exam"><name>Eye Exam</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Visual_Acuity"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Visual Acuity&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Slit_Lamp"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Slit Lamp&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Slit_Lamp_Abreviations"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Slit Lamp Abreviations&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Fundoscopic"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Fundoscopic&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Other"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Other&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Eye_Exam&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Visual Acuity"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Visual_Acuity"&gt;Visual Acuity &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;(OD (R)/ OS (L))
&lt;/p&gt;&lt;p&gt;best possible
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
NPL No perception of light
&lt;/p&gt;&lt;p&gt;HM Hand movements only
&lt;/p&gt;&lt;p&gt;CF Count fingers
&lt;/p&gt;&lt;p&gt;20/X
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Eye_Exam&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Slit Lamp"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Slit_Lamp"&gt; Slit Lamp &lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Lids and Lashes
&lt;ol&gt;&lt;li&gt;eversion
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Conjunctiva and Sclera
&lt;ol&gt;&lt;li&gt;injection, hemorrhage, discharge
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Cornea
&lt;ol&gt;&lt;li&gt;fluorescein for abrasions, foreign bodies,&amp;nbsp;&amp;nbsp;
&lt;/li&gt;&lt;li&gt;perforation (staining or pooling)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Ant Chamber
&lt;ol&gt;&lt;li&gt;cell and flare
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Iris
&lt;/li&gt;&lt;li&gt;Lens
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;Florecine: pooling or staining (don't say uptake)
&lt;/p&gt;&lt;p&gt;Sidel's sign
&lt;/p&gt;&lt;p&gt;APD (afferent pupillary defect): affected pupil enlarges in response to light (2/2 optic nerve dysfunction-neuritis vs retinal damage)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Eye_Exam&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Slit Lamp Abreviations"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Slit_Lamp_Abreviations"&gt;Slit Lamp Abreviations&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;L/L (lids/lashes) = nl
&lt;/li&gt;&lt;li&gt;C (conjunctiva) = cl
&lt;/li&gt;&lt;li&gt;K (cornea) = cl
&lt;/li&gt;&lt;li&gt;A/C (anterior chamber) = D/Q (dark/quiet)
&lt;/li&gt;&lt;li&gt;I (iris) = R/R (round/reactive)
&lt;/li&gt;&lt;li&gt;L (lens) = cl
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;(cl = clear; nl = normal)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Eye_Exam&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Fundoscopic"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Fundoscopic"&gt;Fundoscopic&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;optic disc for cupping/pallor/swelling/hemorr
&lt;/li&gt;&lt;li&gt;central retina for hemor/pallor
&lt;/li&gt;&lt;li&gt;periph retina for vessel appearance/hemorr/detach
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Eye_Exam&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Other"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Other"&gt;Other&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;T Tono/Applinator/Schiotz
&lt;/li&gt;&lt;li&gt;EOM
&lt;/li&gt;&lt;li&gt;Visual fields
&lt;/li&gt;&lt;li&gt;Xray with concerns of metal/glass/stone
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Eye_Exam&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from Pani, Donaldson
&lt;/p&gt;



</content><folder>Ophtho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="fuo"><name>FUO</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#DDX"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;DDX&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Workup"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Workup&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Phase_1"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;Phase 1&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Phase_2"&gt;&lt;span class="tocnumber"&gt;2.2&lt;/span&gt; &lt;span class="toctext"&gt;Phase 2&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Phase_3"&gt;&lt;span class="tocnumber"&gt;2.3&lt;/span&gt; &lt;span class="toctext"&gt;Phase 3&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=FUO&amp;amp;action=edit&amp;amp;section=1" title="Edit section: DDX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX"&gt;DDX&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Infectious disease (22%)
&lt;ol&gt;&lt;li&gt;EBV
&lt;/li&gt;&lt;li&gt;UTI
&lt;/li&gt;&lt;li&gt;Enterovirus
&lt;/li&gt;&lt;li&gt;Lyme
&lt;/li&gt;&lt;li&gt;Cat-scratch
&lt;/li&gt;&lt;li&gt;Osteomyelitis
&lt;/li&gt;&lt;li&gt;Psittacosis
&lt;/li&gt;&lt;li&gt;Rheumatic fever
&lt;/li&gt;&lt;li&gt;Crohn's
&lt;/li&gt;&lt;li&gt;Bacterial meningitis
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Autoimmune (6%)
&lt;ol&gt;&lt;li&gt;JRA
&lt;/li&gt;&lt;li&gt;SLE
&lt;/li&gt;&lt;li&gt;PAN
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Malignancy (2%)
&lt;ol&gt;&lt;li&gt;Leukemia
&lt;/li&gt;&lt;li&gt;Lymphoma
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Drug-induced fever (2%)
&lt;/li&gt;&lt;li&gt;Factitious (2%)
&lt;/li&gt;&lt;li&gt;No Etiology  (67%)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=FUO&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Workup"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Workup"&gt;Workup&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=FUO&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Phase 1"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Phase_1"&gt;Phase 1&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;CBC
&lt;/li&gt;&lt;li&gt;ESR
&lt;/li&gt;&lt;li&gt;TB test
&lt;/li&gt;&lt;li&gt;MonoSpot
&lt;/li&gt;&lt;li&gt;CXR
&lt;/li&gt;&lt;li&gt;BCx
&lt;/li&gt;&lt;li&gt;ASLO
&lt;/li&gt;&lt;li&gt;ANA
&lt;/li&gt;&lt;li&gt;HIV
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=FUO&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Phase 2"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Phase_2"&gt;Phase 2&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;LP
&lt;/li&gt;&lt;li&gt;BCx again
&lt;/li&gt;&lt;li&gt;Sinus/mastoid x-ray
&lt;/li&gt;&lt;li&gt;Ophtho exam for iridocyclits
&lt;/li&gt;&lt;li&gt;CMV, Toxo, Hep A/B, Tularemia, Brucellosis, Leptospirosis, Salmonellosis
&lt;/li&gt;&lt;li&gt;LFTs
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=FUO&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Phase 3"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Phase_3"&gt;Phase 3&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Abd U/S
&lt;/li&gt;&lt;li&gt;Abd CT
&lt;/li&gt;&lt;li&gt;Gallium/Indium scanning
&lt;/li&gt;&lt;li&gt;UGI series c sbft
&lt;/li&gt;&lt;li&gt;Bone marrow
&lt;/li&gt;&lt;li&gt;Technetium bone scan
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=FUO&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;7/2/09 PANI
&lt;/p&gt;



</content><folder>ID</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="fuo_(peds)"><name>FUO (Peds)</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=FUO_(Peds)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Febrile &amp;gt;14dys (without clear source)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=FUO_(Peds)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;I. INFECTION
&lt;/p&gt;
&lt;pre&gt;    1. Bacterial
&lt;/pre&gt;
&lt;pre&gt;         a. Adenitis
&lt;/pre&gt;
&lt;pre&gt;         b. Endocarditis
&lt;/pre&gt;
&lt;pre&gt;         c. Mastoiditis
&lt;/pre&gt;
&lt;pre&gt;         d. Occult abcess
&lt;/pre&gt;
&lt;pre&gt;         e. Pyelonephritis
&lt;/pre&gt;
&lt;pre&gt;         f. Sinusitis
&lt;/pre&gt;
&lt;pre&gt;         g. Tb
&lt;/pre&gt;
&lt;pre&gt;    2. Viral
&lt;/pre&gt;
&lt;pre&gt;         a. CMV
&lt;/pre&gt;
&lt;pre&gt;         b. Hep A,B, C
&lt;/pre&gt;
&lt;pre&gt;         c. Mono
&lt;/pre&gt;
&lt;pre&gt;    3. Chlamydial
&lt;/pre&gt;
&lt;pre&gt;         a. Lymphogranuloma venereum
&lt;/pre&gt;
&lt;pre&gt;         b. Psittacosis
&lt;/pre&gt;
&lt;pre&gt;    4. Mycoplasmal
&lt;/pre&gt;
&lt;pre&gt;    5. Fungal
&lt;/pre&gt;
&lt;pre&gt;         a. Blastomycosis
&lt;/pre&gt;
&lt;pre&gt;         b. Cysticercosis
&lt;/pre&gt;
&lt;pre&gt;         c. Histoplasmosis
&lt;/pre&gt;
&lt;pre&gt;    6. Rickettsial
&lt;/pre&gt;
&lt;pre&gt;         a. Q fever
&lt;/pre&gt;
&lt;pre&gt;         b. Rocky Mt
&lt;/pre&gt;
&lt;pre&gt;    7. Parasitic
&lt;/pre&gt;
&lt;pre&gt;         a. Malaria
&lt;/pre&gt;
&lt;pre&gt;         b. Toxo
&lt;/pre&gt;
&lt;p&gt;II. COLLAGEN VASCULAR
&lt;/p&gt;
&lt;pre&gt;    a. JRA
&lt;/pre&gt;
&lt;pre&gt;    b. LSE
&lt;/pre&gt;
&lt;pre&gt;    c. Regional enteritis
&lt;/pre&gt;
&lt;pre&gt;    d. Rheumatic fever
&lt;/pre&gt;
&lt;pre&gt;    e. Ulcerative colitis
&lt;/pre&gt;
&lt;pre&gt;    f. Vasculitis
&lt;/pre&gt;
&lt;p&gt;III. MALIGNANCY
&lt;/p&gt;
&lt;pre&gt;    a. Leukemia
&lt;/pre&gt;
&lt;pre&gt;    b. Lymphoma
&lt;/pre&gt;
&lt;pre&gt;    c. Neuroblastoma
&lt;/pre&gt;
&lt;pre&gt;    d. Wilm's tumor
&lt;/pre&gt;
&lt;p&gt;IV. DRUG INDUCED
&lt;/p&gt;
&lt;pre&gt;    a. Abx
&lt;/pre&gt;
&lt;pre&gt;    b. Anticonvulsants
&lt;/pre&gt;
&lt;pre&gt;    c. Anti TB
&lt;/pre&gt;
&lt;pre&gt;    d. Procainamide
&lt;/pre&gt;
&lt;pre&gt;    e. Quinidine
&lt;/pre&gt;
&lt;pre&gt;    f. Serum sickness
&lt;/pre&gt;
&lt;p&gt;V. MISC
&lt;/p&gt;
&lt;pre&gt;    a. AIDS
&lt;/pre&gt;
&lt;pre&gt;    b. CNS
&lt;/pre&gt;
&lt;pre&gt;    c. Environmental
&lt;/pre&gt;
&lt;pre&gt;    d. Factitious
&lt;/pre&gt;
&lt;pre&gt;    e. Familial dysautonomia
&lt;/pre&gt;
&lt;pre&gt;    f. Kawasaki
&lt;/pre&gt;
&lt;pre&gt;    g. PE
&lt;/pre&gt;
&lt;pre&gt;    h. Serial infections
&lt;/pre&gt;
&lt;pre&gt;    i. Thyrotoxicosis
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=FUO_(Peds)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;4/13/06 DONALDSON (adapted from Rosen)
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="fascia_iliaca_compartment_nb"><name>Fascia Iliaca Compartment NB</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Fascia_Iliaca_Compartment_NB&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Indication"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Indication"&gt;Indication&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Indicated for isolated femur fractures, etc.
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;Use:
&lt;/p&gt;&lt;p&gt;1) Ropivacain (Natropin) 0.5%
&lt;/p&gt;&lt;p&gt;&amp;lt;20kg = 0.75mL/kg
&lt;/p&gt;&lt;p&gt;&amp;gt;20kg = 0.5 ML/kg
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;max - 30mL
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;OR
&lt;/p&gt;&lt;p&gt;2) Bupivicaine
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Risk of cardiac depression if injected intravascularly
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Fascia_Iliaca_Compartment_NB&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Procedure"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Procedure"&gt;Procedure&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1) Point = 2/3 laterally along line between ant/sup iliac spine and pubis
&lt;/p&gt;&lt;p&gt;-i.e. sig lateral to nerve
&lt;/p&gt;&lt;p&gt;2) 90 deg angle with 22Ga needle
&lt;/p&gt;&lt;p&gt;3) 2 "pops" through facial plains (1 inch max)
&lt;/p&gt;&lt;p&gt;4) Withdraw to check not in vessel
&lt;/p&gt;&lt;p&gt;5) Apply pressure 1 inch caudally accross thigh
&lt;/p&gt;&lt;p&gt;6) Infuse drug
&lt;/p&gt;&lt;p&gt;7) Hold pressure on thigh for 2 minutes
&lt;/p&gt;&lt;p&gt;-to encourage cephalad spread
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Should see effect in &amp;lt;10 min
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Fascia_Iliaca_Compartment_NB&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;8/07 DONALDSON (adapted from EM Annals 8/07)
&lt;/p&gt;



</content><folder>Procedures</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="febrile_seizure"><name>Febrile Seizure</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis.2FWork-Up"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis/Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Febrile_Seizure&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Criteria:  Seizure + temp &amp;gt;38 in pt age 6 mo - 6 yr without previous afebrile seizure 
&lt;/li&gt;&lt;li&gt; Simple versus complex:
&lt;/li&gt;&lt;li&gt; Simple 
&lt;/li&gt;&lt;li&gt; &amp;lt;15 min in duration
&lt;/li&gt;&lt;li&gt; No focal features 
&lt;/li&gt;&lt;li&gt; Only a single episode in 24 hours
&lt;/li&gt;&lt;li&gt; Complex
&lt;/li&gt;&lt;li&gt; Any exception to above 
&lt;/li&gt;&lt;li&gt; Risk Factors
&lt;/li&gt;&lt;li&gt; Family history (2-4x higher)
&lt;/li&gt;&lt;li&gt; Infection (viral and bacterial)
&lt;/li&gt;&lt;li&gt; Recent vaccinations 
&lt;/li&gt;&lt;li&gt; Recurrence
&lt;/li&gt;&lt;li&gt; Risk of recurrence:
&lt;/li&gt;&lt;li&gt; If first seizure occurs in age &amp;lt;1yr  = 50%
&lt;/li&gt;&lt;li&gt; If first seizure occurs in age 1-3yr = 25%
&lt;/li&gt;&lt;li&gt; If first seizure occurs in age &amp;gt;3yr = 12% 
&lt;/li&gt;&lt;li&gt; Majority of recurrences occur within 1st year; almost all occur within 2 years 
&lt;/li&gt;&lt;li&gt; Risk factors for recurrence include:
&lt;/li&gt;&lt;li&gt; Young age at onset
&lt;/li&gt;&lt;li&gt; Family history of febrile seizures
&lt;/li&gt;&lt;li&gt; Low-degree of fever in the ED
&lt;/li&gt;&lt;li&gt; Brief duration between onset of fever and initial seizure
&lt;/li&gt;&lt;li&gt; Complex febrile seizure does not increase risk of recurrent seizures
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Febrile_Seizure&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis/Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis.2FWork-Up"&gt;Diagnosis/Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Consider trauma, toxidromes, infection/ petechiae
&lt;/li&gt;&lt;li&gt; Glucose check
&lt;/li&gt;&lt;li&gt; if sz &amp;gt;5 min tx with IM, IV, IN Versed  
&lt;/li&gt;&lt;li&gt; Consider trauma or toxic cause
&lt;/li&gt;&lt;li&gt; Classifly as simple or comple 
&lt;/li&gt;&lt;li&gt; Search for devel delay, fam hx,
&lt;/li&gt;&lt;li&gt; Physical exam should focus on source of fever 
&lt;/li&gt;&lt;li&gt; Routine lab tests other than blood glucose not needed unless searching for cause of fever (UA, CBC, CXR, etc)
&lt;/li&gt;&lt;li&gt; Consider LP if:
&lt;/li&gt;&lt;li&gt; Age &amp;lt;12 mo (AAP guidelines)
&lt;/li&gt;&lt;li&gt; However, bacterial meningitis is rarely the diagnosis if it not clinically suspected
&lt;/li&gt;&lt;li&gt; Seizure occurs after the second day of illness
&lt;/li&gt;&lt;li&gt; Concern for CNS infection
&lt;/li&gt;&lt;li&gt; Febrile status epilepticus
&lt;/li&gt;&lt;li&gt; Pmd visit w/ in 48 hrs
&lt;/li&gt;&lt;li&gt; Sz in ED
&lt;/li&gt;&lt;li&gt; Focal sz
&lt;/li&gt;&lt;li&gt; Abnormal neuro/ phys exam
&lt;/li&gt;&lt;li&gt; Irritable, poor feeding
&lt;/li&gt;&lt;li&gt; Complex features
&lt;/li&gt;&lt;li&gt; Slow postictal clearance
&lt;/li&gt;&lt;li&gt; Pretreated with abx (consider partially tx meningitis if already on abx)
&lt;/li&gt;&lt;li&gt; CT if: 
&lt;/li&gt;&lt;li&gt; Persistently abnormal neuro exam (especially with focal features)
&lt;/li&gt;&lt;li&gt; Signs/symptoms of increased ICP
&lt;/li&gt;&lt;li&gt; Consider for presence of VP shunt
&lt;/li&gt;&lt;li&gt; Routine EEG not indicated
&lt;/li&gt;&lt;li&gt; Consider only if developmental delay or for focal symptoms
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Febrile_Seizure&amp;amp;action=edit&amp;amp;section=3" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Meningitis
&lt;/li&gt;&lt;li&gt; More likely in patients with status epilepticus
&lt;/li&gt;&lt;li&gt; Seizure due to identifiable cause (e.g. intracranial mass, trauma)
&lt;/li&gt;&lt;li&gt; Epidural/subdural infection or hematoma
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Febrile_Seizure&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Treat if initial seizure persists &amp;gt;5 min or for subsequent seizures
&lt;/li&gt;&lt;li&gt; Benzodiapazines
&lt;/li&gt;&lt;li&gt; Lorazepam (0.05 - 0.1mg/kg)
&lt;/li&gt;&lt;li&gt; If seizure persists try one additional dose (risk of resp. depression incr if &amp;gt;2 doses)
&lt;/li&gt;&lt;li&gt; Effective duration of action is up to 4-6 hours 
&lt;/li&gt;&lt;li&gt; Midazolam (0.1-0.3mg/kg)
&lt;/li&gt;&lt;li&gt; Diazepam
&lt;/li&gt;&lt;li&gt; Compared to lorazepam, less effective and more respiratory depression 
&lt;/li&gt;&lt;li&gt; Fosphenytoin (15-20 mg/kg)
&lt;/li&gt;&lt;li&gt; Treat if seizure persists despite benzo tx
&lt;/li&gt;&lt;li&gt; Onset of action may take as long as 30 minutes
&lt;/li&gt;&lt;li&gt; Can cause hypotension and dysrhythmias
&lt;/li&gt;&lt;li&gt; Barbituates
&lt;/li&gt;&lt;li&gt; Consider only if benzos and phenytoin have failed 
&lt;/li&gt;&lt;li&gt; May lead to respiratory depression, especially when preceded by a benzo 
&lt;/li&gt;&lt;li&gt; Valproic acid
&lt;/li&gt;&lt;li&gt; Has been shown to be effective when benzos, phenytoin, and barbituates have failed 
&lt;/li&gt;&lt;li&gt; Can be used as 2nd or 3rd-line treatment 
&lt;/li&gt;&lt;li&gt; Propofol 
&lt;/li&gt;&lt;li&gt; Treat underlying infection
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Febrile_Seizure&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Home:  Simple febrile seizure and patient back at baseline with follow up in 1-2 days
&lt;/li&gt;&lt;li&gt; Admit: Complex febrile seizures, lethargy beyond postictal period, uncertain home situation
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Febrile_Seizure&amp;amp;action=edit&amp;amp;section=6" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Seizure (Peds)
&lt;/p&gt;&lt;p&gt;Fever (Peds)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Febrile_Seizure&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from Gausche, Mistry, Donaldson, Pani, UpToDate
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="fetal_maternal_hemorrhage_(rhogam)"><name>Fetal Maternal Hemorrhage (RhoGAM)</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Fetal_Maternal_Hemorrhage_(RhoGAM)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Risk = &amp;gt;4-12wks
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Fetal_Maternal_Hemorrhage_(RhoGAM)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;1st Trimester
&lt;ol&gt;&lt;li&gt;--&amp;gt; give 50 microgm
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;2nd &amp;amp; 3rd Trimester
&lt;ol&gt;&lt;li&gt;--&amp;gt; give 300 microgm once and send Kleihauer-Betke test
&lt;/li&gt;&lt;li&gt;--&amp;gt; within 72hrs give additional 300 microgm/15 ml Rh-positive  blood
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Fetal_Maternal_Hemorrhage_(RhoGAM)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Exceptions"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Exceptions"&gt;Exceptions&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; prior sensitization of mother
&lt;/li&gt;&lt;li&gt; known  Rh-negative father
&lt;/li&gt;&lt;li&gt; known Rh-negative fetus (from cord blood)
&lt;/li&gt;&lt;/ol&gt;




</content><folder>OB/GYN</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="fever"><name>Fever</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#General"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;General&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Fever_Sources"&gt;&lt;span class="tocnumber"&gt;1.2&lt;/span&gt; &lt;span class="toctext"&gt;Fever Sources&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Guidelines"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Guidelines&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#.3C1_Month"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;&amp;lt;1 Month&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-6"&gt;&lt;a href="#1-3_Month"&gt;&lt;span class="tocnumber"&gt;2.2&lt;/span&gt; &lt;span class="toctext"&gt;1-3 Month&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-7"&gt;&lt;a href="#3-36_Month"&gt;&lt;span class="tocnumber"&gt;2.3&lt;/span&gt; &lt;span class="toctext"&gt;3-36 Month&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-8"&gt;&lt;a href="#Abnormal_Host"&gt;&lt;span class="tocnumber"&gt;2.4&lt;/span&gt; &lt;span class="toctext"&gt;Abnormal Host&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#Work-Ups"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Work-Ups&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-10"&gt;&lt;a href="#Definitions"&gt;&lt;span class="tocnumber"&gt;3.1&lt;/span&gt; &lt;span class="toctext"&gt;Definitions&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-11"&gt;&lt;a href="#Positive_Workup_Definitions"&gt;&lt;span class="tocnumber"&gt;3.2&lt;/span&gt; &lt;span class="toctext"&gt;Positive Workup Definitions&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-12"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-13"&gt;&lt;a href="#Medication_Doses"&gt;&lt;span class="tocnumber"&gt;4.1&lt;/span&gt; &lt;span class="toctext"&gt;Medication Doses&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-14"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-15"&gt;&lt;a href="#Outpatient_Tx_.281-3_Month.29"&gt;&lt;span class="tocnumber"&gt;5.1&lt;/span&gt; &lt;span class="toctext"&gt;Outpatient Tx (1-3 Month)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-16"&gt;&lt;a href="#Outpatient_Tx_.283-36_Month.29"&gt;&lt;span class="tocnumber"&gt;5.2&lt;/span&gt; &lt;span class="toctext"&gt;Outpatient Tx (3-36 Month)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-17"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Fever&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Fever&amp;amp;action=edit&amp;amp;section=2" title="Edit section: General"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="General"&gt;General&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Fever = rectal &amp;gt;38.0 (100.4)
&lt;/p&gt;&lt;p&gt;Petechiae = toxic
&lt;/p&gt;&lt;p&gt;+RSV or +influenza = low risk of bacterial illness, but still some risk UTI
&lt;/p&gt;&lt;p&gt;B/f pneumococcal vac, 1/1000 well-looking children &amp;lt;3 mos without source had SBI
&lt;/p&gt;&lt;p&gt;~2% of nontoxic children with T &amp;gt; 39 and no source will have occult bacteremia, 3% of these will go on to have Serious Bacterial Infections (PNA, bone, joint, meningitis)
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Fever&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Fever Sources"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Fever_Sources"&gt;Fever Sources&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Recent vaccination (can cause fever)
&lt;/li&gt;&lt;li&gt;Oral vesicles (viral)
&lt;/li&gt;&lt;li&gt;?OM
&lt;/li&gt;&lt;li&gt;Other
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;If have a source, do not use below flowsheet!
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Fever&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Guidelines"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Guidelines"&gt; Guidelines &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Only for those without a source (see Background)!
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Fever&amp;amp;action=edit&amp;amp;section=5" title="Edit section: &amp;amp;lt;1 Month"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id=".3C1_Month"&gt;&amp;lt;1 Month&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Well/toxic --&amp;gt; Full Flog
&lt;ol&gt;&lt;li&gt;Gent 3.5 or Cefotax + Amp
&lt;/li&gt;&lt;li&gt;Acyclovir 20 if CSF pleocytosis and HSV infxn in baby/mom
&lt;/li&gt;&lt;li&gt;Admit
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Fever&amp;amp;action=edit&amp;amp;section=6" title="Edit section: 1-3 Month"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="1-3_Month"&gt;1-3 Month&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Toxic --&amp;gt; Full Flog
&lt;ol&gt;&lt;li&gt;Ceftriaxone*100 + Amp
&lt;/li&gt;&lt;li&gt;Acyclovir 20 if CSF pleocytosis and HSV infxn in baby/mom
&lt;/li&gt;&lt;li&gt;Admit
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Well --&amp;gt;
&lt;ol&gt;&lt;li&gt;Modified Flog + Ceftriaxone*50
&lt;ol&gt;&lt;li&gt;Pos --&amp;gt; admit
&lt;/li&gt;&lt;li&gt;Neg --&amp;gt; F/U w/i 24 hrs
&lt;/li&gt;&lt;li&gt;Any Cx pos --&amp;gt; admit
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Less conservative --&amp;gt; Basic W/U
&lt;ol&gt;&lt;li&gt;Pos --&amp;gt; admit
&lt;/li&gt;&lt;li&gt;Neg --&amp;gt; F/U w/i 24 hrs
&lt;ol&gt;&lt;li&gt;Any Cx pos with fever--&amp;gt; admit
&lt;/li&gt;&lt;li&gt;UCx pos, no fever --&amp;gt; outpt abx
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Fever&amp;amp;action=edit&amp;amp;section=7" title="Edit section: 3-36 Month"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="3-36_Month"&gt;3-36 Month&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Toxic --&amp;gt; Full Flog
&lt;ol&gt;&lt;li&gt;Ceftriaxone*100
&lt;/li&gt;&lt;li&gt;Vanco (if bact meningitis on LP)
&lt;/li&gt;&lt;li&gt;Admit
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Well (T =39 (39.5 older than 24mo))--&amp;gt; Prevnar?
&lt;ol&gt;&lt;li&gt;No --&amp;gt; CBC, Urine
&lt;ol&gt;&lt;li&gt;Pos --&amp;gt;
&lt;ol&gt;&lt;li&gt;Ceftriaxone*50
&lt;/li&gt;&lt;li&gt;Send BC
&lt;/li&gt;&lt;li&gt;Outpt
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Neg --&amp;gt; Home (antipyretics)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Yes --&amp;gt; Urine W/O
&lt;ol&gt;&lt;li&gt;Pos --&amp;gt;
&lt;ol&gt;&lt;li&gt;Oral Abx
&lt;/li&gt;&lt;li&gt;Outpt
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Well (T =38 &amp;amp; &amp;lt; above) --&amp;gt; Home (antipyretics)
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Fever&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Abnormal Host"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Abnormal_Host"&gt;Abnormal Host&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Preterm
&lt;/li&gt;&lt;li&gt;Poor feeding
&lt;/li&gt;&lt;li&gt;Pos PMH
&lt;/li&gt;&lt;li&gt;Abnl VS (except fever)
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;table border="1" width="504"&gt;

&lt;tr&gt;
&lt;td&gt; &lt;b&gt;Age&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;How Child Looks&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Options&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;W/U&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Tx&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Dispo&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;F/U&lt;/b&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;
&lt;p&gt;29-90 days
&lt;/p&gt;&lt;p&gt;T &amp;gt; 38
&lt;/p&gt;
&lt;/td&gt;&lt;td&gt; Either well or toxic
&lt;/td&gt;&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;
&lt;p&gt;90d-36mo
&lt;/p&gt;&lt;p&gt;T &amp;gt; 39 3-24 mo
&lt;/p&gt;&lt;p&gt;T &amp;gt; 39.5 24-36 mo
&lt;/p&gt;&lt;p&gt;No source for fever
&lt;/p&gt;
&lt;/td&gt;&lt;td&gt; Toxic
&lt;/td&gt;&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;
&lt;p&gt;3-36 mo
&lt;/p&gt;&lt;p&gt;(T 38-38.9)
&lt;/p&gt;
&lt;/td&gt;&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Fever&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Work-Ups"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Ups"&gt;Work-Ups&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Fever&amp;amp;action=edit&amp;amp;section=10" title="Edit section: Definitions"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Definitions"&gt;Definitions&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;See Guidelines for indications
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Full Flog: CBC, BC, UA, UCx, UGm, LP, CXR
&lt;/li&gt;&lt;li&gt;Modified Flog: #1 minus CXR
&lt;/li&gt;&lt;li&gt;Basic^: CBC, BC, UA, UCx, UGm
&lt;/li&gt;&lt;li&gt;Urine^: UA, UCx, UGm
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;Add CXR to any of the above if resp sx or admitting
&lt;/p&gt;&lt;p&gt;^Circumcised males &amp;gt;6mo do not need urine studies; uncirc &amp;gt;12mo
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Fever&amp;amp;action=edit&amp;amp;section=11" title="Edit section: Positive Workup Definitions"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Positive_Workup_Definitions"&gt;Positive Workup Definitions&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;WBC &amp;gt;15k or &amp;lt;5k
&lt;/li&gt;&lt;li&gt;&amp;lt;1,500 bands or ANC &amp;gt;10k
&lt;/li&gt;&lt;li&gt;Positive urine Gm/leuk/nit or =5 WBC
&lt;/li&gt;&lt;li&gt;CXR infiltrate
&lt;/li&gt;&lt;li&gt;CSF =8 WBC
&lt;/li&gt;&lt;li&gt;Stool =5 WBC
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Fever&amp;amp;action=edit&amp;amp;section=12" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;See Guidelines for indications
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Fever&amp;amp;action=edit&amp;amp;section=13" title="Edit section: Medication Doses"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Medication_Doses"&gt;Medication Doses&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Cefotax (50mg/kg)
&lt;/li&gt;&lt;li&gt;Amp (100-200mg/kg)
&lt;/li&gt;&lt;li&gt;Ceftriaxone (50-100 mg/kg IM/IV) *[&amp;gt;6wks]
&lt;/li&gt;&lt;li&gt;Vancomycin 15mg/kg IV
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Fever&amp;amp;action=edit&amp;amp;section=14" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-See Guidelines for indications
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Fever&amp;amp;action=edit&amp;amp;section=15" title="Edit section: Outpatient Tx (1-3 Month)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Outpatient_Tx_.281-3_Month.29"&gt;Outpatient Tx (1-3 Month)&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;F/U within 24hrs
&lt;/p&gt;&lt;p&gt;Positive culture --&amp;gt; admit for sepsis W/O
&lt;/p&gt;&lt;p&gt;Negative --&amp;gt; outpt fever W/O
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Fever&amp;amp;action=edit&amp;amp;section=16" title="Edit section: Outpatient Tx (3-36 Month)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Outpatient_Tx_.283-36_Month.29"&gt;Outpatient Tx (3-36 Month)&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;RTED fever persist &amp;gt;48hrs
&lt;/p&gt;&lt;p&gt;Pos BC or UCx cont treatment outpt except if:
&lt;/p&gt;&lt;p&gt;1. Febrile
&lt;/p&gt;&lt;p&gt;2. Ill-appearing
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Fever&amp;amp;action=edit&amp;amp;section=17" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from Newell, Young, Donaldson, Pani
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="fever_and_rash"><name>Fever and Rash</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Petechial"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Petechial&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Maculopapular"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Maculopapular&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Vesico-Bullous"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Vesico-Bullous&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Erythematous"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Erythematous&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Urticarial"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Urticarial&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Fever_and_Rash&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Petechial"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Petechial"&gt;Petechial&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Infectious
&lt;ol&gt;&lt;li&gt;Endocarditis
&lt;/li&gt;&lt;li&gt;Meningococcemia
&lt;/li&gt;&lt;li&gt;Gonococcemia
&lt;/li&gt;&lt;li&gt;Gram neg bacteria
&lt;/li&gt;&lt;li&gt;Enteric bacteria
&lt;/li&gt;&lt;li&gt;RMSF
&lt;/li&gt;&lt;li&gt;Enterovirus
&lt;/li&gt;&lt;li&gt;Dengue fever
&lt;/li&gt;&lt;li&gt;Hepatitis B
&lt;/li&gt;&lt;li&gt;Rubella
&lt;/li&gt;&lt;li&gt;EBV
&lt;/li&gt;&lt;li&gt;Rat bite fever
&lt;/li&gt;&lt;li&gt;Epidemic typhus 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Noninfectious
&lt;ol&gt;&lt;li&gt;Allergy
&lt;/li&gt;&lt;li&gt;Thrombocytopenia
&lt;/li&gt;&lt;li&gt;Scurvy
&lt;/li&gt;&lt;li&gt;Lupus
&lt;/li&gt;&lt;li&gt;HSP
&lt;/li&gt;&lt;li&gt;Hypersensitivity vasculitis
&lt;/li&gt;&lt;li&gt;Rhumatic fever
&lt;/li&gt;&lt;li&gt;Amyloidosis
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Fever_and_Rash&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Maculopapular"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Maculopapular"&gt;Maculopapular&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Infectious 
&lt;ol&gt;&lt;li&gt;Typhoid fever/typhus
&lt;/li&gt;&lt;li&gt;Secondary syphilis
&lt;/li&gt;&lt;li&gt;Lyme
&lt;/li&gt;&lt;li&gt;Meningococcemia
&lt;/li&gt;&lt;li&gt;Mycoplasma
&lt;/li&gt;&lt;li&gt;Psittacosis
&lt;/li&gt;&lt;li&gt;Rickettsia
&lt;/li&gt;&lt;li&gt;Leptospiroisis
&lt;/li&gt;&lt;li&gt;Ehrlichiosis
&lt;/li&gt;&lt;li&gt;Enterovirus
&lt;/li&gt;&lt;li&gt;Parvovirus (B19)
&lt;/li&gt;&lt;li&gt;5th Dz
&lt;/li&gt;&lt;li&gt;HSV 6
&lt;/li&gt;&lt;li&gt;Rubeola
&lt;/li&gt;&lt;li&gt;Rubella
&lt;/li&gt;&lt;li&gt;Arbovirus
&lt;/li&gt;&lt;li&gt;EBV
&lt;/li&gt;&lt;li&gt;Adenovirus
&lt;/li&gt;&lt;li&gt;Primary HIV
&lt;/li&gt;&lt;li&gt;Streptobacillus moniliformis
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Noninfectious
&lt;ol&gt;&lt;li&gt;Allergy
&lt;/li&gt;&lt;li&gt;Serum sickness
&lt;/li&gt;&lt;li&gt;Erythema multiforme
&lt;/li&gt;&lt;li&gt;Erythema marginatum
&lt;/li&gt;&lt;li&gt;Lupus
&lt;/li&gt;&lt;li&gt;Dermatomyositis
&lt;/li&gt;&lt;li&gt;Sweet's syndrome
&lt;/li&gt;&lt;li&gt;Acroderm enteropathica
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Fever_and_Rash&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Vesico-Bullous"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Vesico-Bullous"&gt;Vesico-Bullous&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Infectious
&lt;ol&gt;&lt;li&gt;Staph
&lt;/li&gt;&lt;li&gt;GC
&lt;/li&gt;&lt;li&gt;Rickettsia
&lt;/li&gt;&lt;li&gt;HSV
&lt;/li&gt;&lt;li&gt;Varicella
&lt;/li&gt;&lt;li&gt;Vibrio vulnificans
&lt;/li&gt;&lt;li&gt;Folliculitis (Staph, Candida, Pseudomonas)
&lt;/li&gt;&lt;li&gt;Enterovirus
&lt;/li&gt;&lt;li&gt;5th Dz
&lt;/li&gt;&lt;li&gt;Parvovirus B19
&lt;/li&gt;&lt;li&gt;HIV
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Noninfectious
&lt;ol&gt;&lt;li&gt;Allergy
&lt;/li&gt;&lt;li&gt;Plant dermatitis
&lt;/li&gt;&lt;li&gt;Eczema vaccinatum
&lt;/li&gt;&lt;li&gt;Erythema multiforme bullosum
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Fever_and_Rash&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Erythematous"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Erythematous"&gt;Erythematous&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Infectious
&lt;ol&gt;&lt;li&gt;Staph/strep (toxic shock, scarlet fever)
&lt;/li&gt;&lt;li&gt;Ehrlichiosis
&lt;/li&gt;&lt;li&gt;Strep viridans
&lt;/li&gt;&lt;li&gt;C. haemolyticum
&lt;/li&gt;&lt;li&gt;Kawasaki's 
&lt;/li&gt;&lt;li&gt;Enterovirus
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Noninfectious
&lt;ol&gt;&lt;li&gt;Allergy
&lt;/li&gt;&lt;li&gt;Vasodilation
&lt;/li&gt;&lt;li&gt;Eczema
&lt;/li&gt;&lt;li&gt;Psoriasis
&lt;/li&gt;&lt;li&gt;Lymphoma
&lt;/li&gt;&lt;li&gt;Pityriasis rubra
&lt;/li&gt;&lt;li&gt;Sezary syndrome
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Fever_and_Rash&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Urticarial"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Urticarial"&gt;Urticarial&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Infectious
&lt;ol&gt;&lt;li&gt;Mycoplasma
&lt;/li&gt;&lt;li&gt;Lyme
&lt;/li&gt;&lt;li&gt;Enterovirus
&lt;/li&gt;&lt;li&gt;HIV
&lt;/li&gt;&lt;li&gt;Hep B
&lt;/li&gt;&lt;li&gt;Adenovirus
&lt;/li&gt;&lt;li&gt;EBV
&lt;/li&gt;&lt;li&gt;Strongyloides
&lt;/li&gt;&lt;li&gt;Trichinosis
&lt;/li&gt;&lt;li&gt;Schistosomiasis
&lt;/li&gt;&lt;li&gt;Onchocerciasis
&lt;/li&gt;&lt;li&gt;Loiasis
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Noninfectious
&lt;ol&gt;&lt;li&gt;Allergy
&lt;/li&gt;&lt;li&gt;Vasculitis
&lt;/li&gt;&lt;li&gt;Malignancy
&lt;/li&gt;&lt;li&gt;Idiopathic
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Fever_and_Rash&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Donaldson 9/09  (Adapted from Tarascon Adult Emergency Pocketbook)
&lt;/p&gt;



</content><folder>Derm</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="finger_(fx)"><name>Finger (Fx)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Pearls"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Pearls&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Proximal_Phalanx_Fx"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Proximal Phalanx Fx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Middle_Phalanx_Fx"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Middle Phalanx Fx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Distal_Phalanx_Fx"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Distal Phalanx Fx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Finger_(Fx)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Pearls"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Pearls"&gt;Pearls&lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt; Be wary of avulsion fx of base of phalanx
&lt;/li&gt;&lt;li&gt; Lateral or medial fracture fragment = collateral ligament avulsion
&lt;/li&gt;&lt;li&gt; Dorsal fracture fragment = extensor tendon avulsion
&lt;/li&gt;&lt;li&gt; Palmar fracture fragment = volar plate avulsion
&lt;/li&gt;&lt;li&gt; Flexion deformity of distal phalanx (mallet/baseball finger) = avulsion fx or extensor tendon rupture 
&lt;/li&gt;&lt;/ul&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Finger_(Fx)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: "&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id=""&gt; &lt;/span&gt;&lt;/h3&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Finger_(Fx)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Proximal Phalanx Fx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Proximal_Phalanx_Fx"&gt;Proximal Phalanx Fx&lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt; Examination
&lt;/li&gt;&lt;li&gt; Examine the phalanx with the fingers in full extension and flexion 
&lt;/li&gt;&lt;li&gt; Assess for malrotation 
&lt;/li&gt;&lt;li&gt; Imaging
&lt;/li&gt;&lt;li&gt; AP, lateral, oblique
&lt;/li&gt;&lt;li&gt; Examine for rotation, shortening, angulation
&lt;/li&gt;&lt;li&gt; Treatment
&lt;/li&gt;&lt;li&gt; If requires ortho referral: Radial or ulnar gutter splint
&lt;/li&gt;&lt;li&gt; Nondisplaced, stable:  Consider buddy taping the injured finger to an adjacent finger
&lt;/li&gt;&lt;li&gt; If the ring finger is involved it should be buddy taped to the little finger 
&lt;/li&gt;&lt;li&gt; Displaced or angulated fx
&lt;/li&gt;&lt;li&gt; Consider closed reduction
&lt;/li&gt;&lt;li&gt; After reduction ensure that PIP joint is in extension, MCP is in flexion (to avoid contracture) 
&lt;/li&gt;&lt;li&gt; Disposition
&lt;/li&gt;&lt;li&gt; Refer for:
&lt;/li&gt;&lt;li&gt; Intraarticular
&lt;/li&gt;&lt;li&gt; Unstable
&lt;/li&gt;&lt;li&gt; Spiral or oblique fx
&lt;/li&gt;&lt;li&gt; Condylar fx 
&lt;/li&gt;&lt;li&gt; Neck fx 
&lt;/li&gt;&lt;li&gt; Large avulsion fx 
&lt;/li&gt;&lt;li&gt; Rotated
&lt;/li&gt;&lt;li&gt; NO degree of rotation is acceptable following a reduction 
&lt;/li&gt;&lt;li&gt; Shortened
&lt;/li&gt;&lt;li&gt; Significantly angulated
&lt;/li&gt;&lt;li&gt; Less than 10&#186; may be tolerated 
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Finger_(Fx)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Middle Phalanx Fx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Middle_Phalanx_Fx"&gt;Middle Phalanx Fx&lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt; Commonly associated with tendon injuries!
&lt;/li&gt;&lt;li&gt; Examination
&lt;/li&gt;&lt;li&gt; Assess PIP, DIP flexion/extension 
&lt;/li&gt;&lt;li&gt; Assess PIP, DIP collateral ligaments (varus/valgus stress)
&lt;/li&gt;&lt;li&gt; Images
&lt;/li&gt;&lt;li&gt; AP, lateral, oblique
&lt;/li&gt;&lt;li&gt; Oblique and spiral fractures: evaluate for shortening/malrotation
&lt;/li&gt;&lt;li&gt; Treatment
&lt;/li&gt;&lt;li&gt; Nondisplaced without angulation:
&lt;/li&gt;&lt;li&gt; Buddy tape to adjacent finger
&lt;/li&gt;&lt;li&gt; Buddy tape ring finger to little finger
&lt;/li&gt;&lt;li&gt; Dorsal or volar finger splint if desire added protection  
&lt;/li&gt;&lt;li&gt; Displaced or angulated fx
&lt;/li&gt;&lt;li&gt; Closed reduction
&lt;/li&gt;&lt;li&gt; Adequate reduction:
&lt;/li&gt;&lt;li&gt; &amp;lt;1-2mm displacement or shortening
&lt;/li&gt;&lt;li&gt; Up to 10&#186; of angulation
&lt;/li&gt;&lt;li&gt; No amount rotation 
&lt;/li&gt;&lt;li&gt; Followed by ulnar or radial gutter splint
&lt;/li&gt;&lt;li&gt; Wrist in 20-30&#186; of extension
&lt;/li&gt;&lt;li&gt; MCP joints in 70-90&#186; of flexion
&lt;/li&gt;&lt;li&gt; PIP and DIP joints flexed 5-10&#186; 
&lt;/li&gt;&lt;li&gt; Decreases the force exerted by the FDS 
&lt;/li&gt;&lt;li&gt; Dispo 
&lt;/li&gt;&lt;li&gt; Refer for:
&lt;/li&gt;&lt;li&gt; Comminution
&lt;/li&gt;&lt;li&gt; Malrotation
&lt;/li&gt;&lt;li&gt; Intraarticular fx
&lt;/li&gt;&lt;li&gt; Displaced or angulated fractures that cannot maintain their reduction
&lt;/li&gt;&lt;li&gt; Most spiral and oblique fx (usually involve rotation or shortening and are unstable)
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Finger_(Fx)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Distal Phalanx Fx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Distal_Phalanx_Fx"&gt;Distal Phalanx Fx&lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt; Examination
&lt;/li&gt;&lt;li&gt; Evaluate for tendon damage
&lt;/li&gt;&lt;li&gt; Imaging
&lt;/li&gt;&lt;li&gt; Comminuted tuft fx
&lt;/li&gt;&lt;li&gt; Stable 
&lt;/li&gt;&lt;li&gt; Longitudinal fx
&lt;/li&gt;&lt;li&gt; Usually non-displaced and stable 
&lt;/li&gt;&lt;li&gt; Transverse fx
&lt;/li&gt;&lt;li&gt; Evaluate for angulation/displacement
&lt;/li&gt;&lt;li&gt; Intraarticular fx 
&lt;/li&gt;&lt;li&gt; Treatment
&lt;/li&gt;&lt;li&gt; Nondisplaced: Splint with the DIP joint in extension (splint should extend past the tip of the distal phalanx(
&lt;/li&gt;&lt;li&gt; Do not attempt to reduce comminuted tuft fx 
&lt;/li&gt;&lt;li&gt; Dispo
&lt;/li&gt;&lt;li&gt; Refer for:
&lt;/li&gt;&lt;li&gt; Tendon dysfunction
&lt;/li&gt;&lt;li&gt; Nerve dysfunction
&lt;/li&gt;&lt;li&gt; Displacement or angulation
&lt;/li&gt;&lt;li&gt; Intraarticular fx
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Finger_(Fx)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;UpToDate
&lt;/p&gt;



</content><folder>Ortho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="fluid_repletion_(ivf)"><name>Fluid Repletion (IVF)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#TBW"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;TBW&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Maintenance"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Maintenance&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Electrolytes"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Electrolytes&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Fluid_Repletion_(IVF)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: TBW"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="TBW"&gt;TBW&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;TBW = 0.6 x weight (kg); 2/3 intra, 1/3 extracellular.  1/4 of extracellular is vascular.
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Fluid_Repletion_(IVF)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Maintenance"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Maintenance"&gt;Maintenance&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Calculation 1
&lt;ol&gt;&lt;li&gt;100 cc/kg/d (4cc/kg/h) 1st 10 kg
&lt;/li&gt;&lt;li&gt;50 cc/kg/d   (2cc/kg/h) 2nd 10 kg
&lt;/li&gt;&lt;li&gt;20 cc/kg/d   (1cc/kg/h) each kg &amp;gt; 20
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Calculation 2
&lt;ol&gt;&lt;li&gt;1500 cc/m2/d (bsa (m2) = sqr rt [wt (kg) x ht (cm)]/3600
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;Insensible losses = 300-400 cc/m2/d
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
Adult Standard: D5 0.45%NS @ 75-125 mL/hr + 20meq/L of KCl
&lt;/p&gt;&lt;p&gt;Deficit:&amp;nbsp;% dehydration x baseline weight
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
Daily volume needed = maintenance + deficit - fluid already given (i.e. boluses)
&lt;/p&gt;&lt;p&gt;Hourly rate  daily vol/24 hr
&lt;/p&gt;&lt;p&gt;(or correct 1/2 of deficit in first 8 hr, remainder in next 16)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Fluid_Repletion_(IVF)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Electrolytes"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Electrolytes"&gt;Electrolytes&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Maintenance Na = 3 mEq/kg/d; K = 2 mEq/kg/d
&lt;/p&gt;&lt;p&gt;Deficit = [desired - measured mEq/L] x fD x wt (kg)
&lt;/p&gt;&lt;p&gt;fD (distribution factor) Na = 0.6, K = 0.6, Cl = 0.2-0.3, HCO3 = 0.5
&lt;/p&gt;&lt;p&gt;(Maintenance + deficit)/daily volume = concentration of electrolyte in fluid to be given
&lt;/p&gt;&lt;p&gt;4mL/kg of H2O lost, ups Na by 1meq
&lt;/p&gt;&lt;p&gt;NS = 154 mEq Na/L, 1/2 NS = 77 mEq/L, 1/4NS = 38 mEq/L
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Fluid_Repletion_(IVF)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;7/2/09  PANI
&lt;/p&gt;



</content><folder>FEN</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="foot_bones"><name>Foot Bones</name><content>&lt;p&gt;Lat
&lt;/p&gt;&lt;p&gt;toes
&lt;/p&gt;&lt;p&gt;heel
&lt;/p&gt;&lt;p&gt;talus
&lt;/p&gt;&lt;p&gt;navicular
&lt;/p&gt;&lt;p&gt;123 cuneiform
&lt;/p&gt;&lt;p&gt;calcaneus
&lt;/p&gt;&lt;p&gt;cuboid
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;AP VIEW
&lt;/p&gt;&lt;p&gt;sm toe
&lt;/p&gt;&lt;p&gt;big toe
&lt;/p&gt;&lt;p&gt;metatarsals
&lt;/p&gt;&lt;p&gt;cuboid
&lt;/p&gt;&lt;p&gt;cuneiforms
&lt;/p&gt;&lt;p&gt;navicular
&lt;/p&gt;&lt;p&gt;talus
&lt;/p&gt;&lt;p&gt;calcaneus
&lt;/p&gt;



</content><folder>Rads</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="gcs"><name>GCS</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=GCS&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Score"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Score"&gt;Score&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;EYES
&lt;/p&gt;&lt;p&gt;4 Spontaneous
&lt;/p&gt;&lt;p&gt;3 To verbal
&lt;/p&gt;&lt;p&gt;2 To pain
&lt;/p&gt;&lt;p&gt;1 No reponse
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;MOTOR
&lt;/p&gt;&lt;p&gt;6 Obeys
&lt;/p&gt;&lt;p&gt;5 Localizes
&lt;/p&gt;&lt;p&gt;4 Withdraws (semi-purposeful)
&lt;/p&gt;&lt;p&gt;3 Decorticate
&lt;/p&gt;&lt;p&gt;2 Decerebrate
&lt;/p&gt;&lt;p&gt;1 No response
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;VERBAL
&lt;/p&gt;&lt;p&gt;5 A&amp;amp;O x 3
&lt;/p&gt;&lt;p&gt;4 Disoriented
&lt;/p&gt;&lt;p&gt;3 Inappropriate words
&lt;/p&gt;&lt;p&gt;2 Incomprehensible sounds
&lt;/p&gt;&lt;p&gt;1 No response
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=GCS&amp;amp;action=edit&amp;amp;section=2" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Peds: GCS (Peds)
&lt;/p&gt;



</content><folder>Trauma</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="gcs_(peds)"><name>GCS (Peds)</name><content>&lt;p&gt;EYES
&lt;/p&gt;&lt;p&gt;4 Spontaneous
&lt;/p&gt;&lt;p&gt;3 To verbal
&lt;/p&gt;&lt;p&gt;2 To pain
&lt;/p&gt;&lt;p&gt;1 No reponse
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;MOTOR
&lt;/p&gt;&lt;p&gt;6 Normal spontaneous movement
&lt;/p&gt;&lt;p&gt;5 Withdraws to touch
&lt;/p&gt;&lt;p&gt;4 Withdraws to pain
&lt;/p&gt;&lt;p&gt;3 Decorticate/ abnl flexion
&lt;/p&gt;&lt;p&gt;2 Decerebrate/ abnl extension
&lt;/p&gt;&lt;p&gt;1 No response
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;VERBAL
&lt;/p&gt;&lt;p&gt;5 Coos, babbles
&lt;/p&gt;&lt;p&gt;4 Irritable, cries
&lt;/p&gt;&lt;p&gt;3 Cries to pain
&lt;/p&gt;&lt;p&gt;2 Moans to pain
&lt;/p&gt;&lt;p&gt;1 No response
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="ghb"><name>GHB</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#_2"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#GHB_Withdrawal"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;GHB Withdrawal&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=GHB&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- ghb is natural analog of gaba
&lt;/p&gt;&lt;p&gt;- used as dietary supplement, recreational drug
&lt;/p&gt;&lt;p&gt;- gives ams, resp depression, recover in 6 hrs
&lt;/p&gt;&lt;p&gt;- ghb withdrawal like sedative/ hypnotic/ alcohol wd
&lt;/p&gt;&lt;p&gt;- gaba is cns inhibitor neuroxmtter
&lt;/p&gt;&lt;p&gt;- ghb can be used for absence sz model
&lt;/p&gt;&lt;p&gt;- ghb has tissue protective effects for MI, cva,
&lt;/p&gt;&lt;p&gt;sepsis, bowel ischemia, shock, radiation, o2 free
&lt;/p&gt;&lt;p&gt;radicals, general anesthetic
&lt;/p&gt;&lt;p&gt;- ghb like benzos for etoh wd
&lt;/p&gt;&lt;p&gt;- ghb fda approved for narcolepsy tx
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Metabolism
&lt;/p&gt;&lt;p&gt;- exists naturally in brain- also heart, liver,
&lt;/p&gt;&lt;p&gt;kidney, muscle, brown fat
&lt;/p&gt;&lt;p&gt;- ghb eliminated by Krebs cycle and expired as co2,
&lt;/p&gt;&lt;p&gt;also by liver and very little by urine
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Pharmacokinetics
&lt;/p&gt;&lt;p&gt;- effect starts 15- 20min, peaks in 30- 60 min,
&lt;/p&gt;&lt;p&gt;- lipid soluble, no protein binding so crosses BBB
&lt;/p&gt;&lt;p&gt;readily
&lt;/p&gt;&lt;p&gt;- elimination is dose dependant with half life of 20-
&lt;/p&gt;&lt;p&gt;50 min
&lt;/p&gt;&lt;p&gt;Pharmacology
&lt;/p&gt;&lt;p&gt;- cns depression is main effect
&lt;/p&gt;&lt;p&gt;- novel ghb receptor exists in brain- as synaptosomal
&lt;/p&gt;&lt;p&gt;membrane
&lt;/p&gt;&lt;p&gt;- at pons and hippocampus as well as cortex and
&lt;/p&gt;&lt;p&gt;caudate
&lt;/p&gt;&lt;p&gt;- ghb also binds to gaba receptor but with lower
&lt;/p&gt;&lt;p&gt;affinity
&lt;/p&gt;&lt;p&gt;- ghb receptor assoc with dopaminergic neurons
&lt;/p&gt;&lt;p&gt;- increases formation and release of dopamine
&lt;/p&gt;&lt;p&gt;- also affects acetylcholine and 5- hydroxytryptamine
&lt;/p&gt;&lt;p&gt;and cns opiods
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Drug of Abuse
&lt;/p&gt;&lt;p&gt;- touted for body building or sleep enhancement
&lt;/p&gt;&lt;p&gt;- date rape drug
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=GHB&amp;amp;action=edit&amp;amp;section=2" title="Edit section: "&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id=""&gt; &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Prodrugs of GHB
&lt;/p&gt;&lt;p&gt;- gbl like ghb
&lt;/p&gt;&lt;p&gt;- also 1,4 butanediol
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=GHB&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=GHB&amp;amp;action=edit&amp;amp;section=4" title="Edit section: "&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="_2"&gt; &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- cns and resp depression
&lt;/p&gt;&lt;p&gt;- also cardioa and gi sxs
&lt;/p&gt;&lt;p&gt;- many times have cointoxicants
&lt;/p&gt;&lt;p&gt;- usually young white male from nightclub
&lt;/p&gt;&lt;p&gt;- can have n/v, resp deprsn, bradycardia, sz
&lt;/p&gt;&lt;p&gt;- get euphoria s hang over
&lt;/p&gt;&lt;p&gt;- can also get ataxia, nystagmus, somnolence and
&lt;/p&gt;&lt;p&gt;aggression
&lt;/p&gt;&lt;p&gt;- resp/ cns deprrsion resolves abruptly
&lt;/p&gt;&lt;p&gt;- resp depression worse with other cns depressants-
&lt;/p&gt;&lt;p&gt;alcohol
&lt;/p&gt;&lt;p&gt;- periods of apnea and hyperventilation- is periodic
&lt;/p&gt;&lt;p&gt;breathing
&lt;/p&gt;&lt;p&gt;- decreases resp rate but tidal vol increases so
&lt;/p&gt;&lt;p&gt;minute vol stable
&lt;/p&gt;&lt;p&gt;- can also have sz but eeg shows no epileptiform
&lt;/p&gt;&lt;p&gt;changes
&lt;/p&gt;&lt;p&gt;- bradycardia, hypotension- ekg change occasionally
&lt;/p&gt;&lt;p&gt;but rare
&lt;/p&gt;&lt;p&gt;- also get vomitting, hypothermia
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Clinical Course
&lt;/p&gt;&lt;p&gt;- recover 2- 6 hrs
&lt;/p&gt;&lt;p&gt;- may be extubated and sent home
&lt;/p&gt;&lt;p&gt;- if longer than 6hr, look for other cause
&lt;/p&gt;&lt;p&gt;- can have cross tolerance with other drugs- alcohol
&lt;/p&gt;&lt;p&gt;and others that effect liver p450 cytochome oxidase
&lt;/p&gt;&lt;p&gt;system
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=GHB&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- supportive
&lt;/p&gt;&lt;p&gt;- look for coingestants and occult trauma
&lt;/p&gt;&lt;p&gt;- charcoal not helpful since rapidly absorbed and
&lt;/p&gt;&lt;p&gt;since can vomit and aspirate
&lt;/p&gt;&lt;p&gt;- protein bound so can use dialysis- but so short
&lt;/p&gt;&lt;p&gt;course usually don't need.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Antidotes
&lt;/p&gt;&lt;p&gt;- flumazenil/ narcan helps in animals but not in
&lt;/p&gt;&lt;p&gt;humans
&lt;/p&gt;&lt;p&gt;- physostigmine may reverse coma but if have
&lt;/p&gt;&lt;p&gt;coingestant is dangerous- may lower sz threshold
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=GHB&amp;amp;action=edit&amp;amp;section=6" title="Edit section: GHB Withdrawal"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="GHB_Withdrawal"&gt;GHB Withdrawal&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- like alcohol
&lt;/p&gt;&lt;p&gt;- tremor, agitation, hallucinations, tachy, htn,
&lt;/p&gt;&lt;p&gt;- wd only if have long term use, not episodic binging
&lt;/p&gt;&lt;p&gt;- tx c benzos, neuroleptics, bb, chloral hydrate,
&lt;/p&gt;&lt;p&gt;barbs
&lt;/p&gt;&lt;p&gt;- need v large dose of benzos
&lt;/p&gt;&lt;p&gt;- wd sxs occur few hours p ghb
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=GHB&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Mistry
&lt;/p&gt;



</content><folder>Tox</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="gi_bleed"><name>GI Bleed</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Workup"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Workup&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#ER"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;ER&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Consider"&gt;&lt;span class="tocnumber"&gt;1.2&lt;/span&gt; &lt;span class="toctext"&gt;Consider&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#DDX"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;DDX&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Adult"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;Adult&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-6"&gt;&lt;a href="#Peds"&gt;&lt;span class="tocnumber"&gt;2.2&lt;/span&gt; &lt;span class="toctext"&gt;Peds&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-8"&gt;&lt;a href="#Home_.28very_low_risk.29"&gt;&lt;span class="tocnumber"&gt;3.1&lt;/span&gt; &lt;span class="toctext"&gt;Home (very low risk)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-9"&gt;&lt;a href="#Ward.2FStable_.28low_risk.29"&gt;&lt;span class="tocnumber"&gt;3.2&lt;/span&gt; &lt;span class="toctext"&gt;Ward/Stable (low risk)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-10"&gt;&lt;a href="#ICU"&gt;&lt;span class="tocnumber"&gt;3.3&lt;/span&gt; &lt;span class="toctext"&gt;ICU&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-11"&gt;&lt;a href="#False_Positive_Guaiac"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;False Positive Guaiac&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-12"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=GI_Bleed&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Workup"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Workup"&gt;Workup&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=GI_Bleed&amp;amp;action=edit&amp;amp;section=2" title="Edit section: ER"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="ER"&gt;ER&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; 2 large bore IV
&lt;/li&gt;&lt;li&gt; Icon
&lt;/li&gt;&lt;li&gt; CBC &amp;amp; serial Hb
&lt;/li&gt;&lt;li&gt; Chem 7 (BUN/Cr &amp;gt;35 suggests UGI if no hx of RF)
&lt;/li&gt;&lt;li&gt; T&amp;amp;S/T&amp;amp;C
&lt;/li&gt;&lt;li&gt; Coags (if INR &amp;gt; 1.5 transfuse FFP)
&lt;/li&gt;&lt;li&gt;&amp;nbsp;?Guiac
&lt;/li&gt;&lt;li&gt; LFTs/lipase
&lt;/li&gt;&lt;li&gt;&amp;nbsp;?CXR if sx perf (diff TTP abd)
&lt;/li&gt;&lt;li&gt;&amp;nbsp;?ECG (if &amp;gt;50 yo or if suspicious for silent MI)
&lt;/li&gt;&lt;li&gt; NG lavage (controversial)
&lt;/li&gt;&lt;li&gt; IVF/blood
&lt;/li&gt;&lt;li&gt; IV PPI (Protonix 40-80mg x 1, then 8mg/hr)
&lt;/li&gt;&lt;li&gt; Octreotide (suspected varices: 50mcg bolus, then 25mcg/hr)
&lt;/li&gt;&lt;li&gt; Ceftriaxone (if e/o ascites; decreases mortality)
&lt;/li&gt;&lt;li&gt;&amp;nbsp;?Consider vasopressin/sengstaken-blakemore tube if no access to endoscopy
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;If aortic graft --&amp;gt; immed surg consult
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=GI_Bleed&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Consider"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Consider"&gt;Consider&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Proctoscopy (22cm from anal verge)
&lt;/li&gt;&lt;li&gt;Sigmoidoscopy (60cm from anal verge)
&lt;/li&gt;&lt;li&gt;Angiography (requries arterial bledding &amp;gt;0.5cc/min)
&lt;/li&gt;&lt;li&gt;CT angio
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=GI_Bleed&amp;amp;action=edit&amp;amp;section=4" title="Edit section: DDX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX"&gt;DDX&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=GI_Bleed&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Adult"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Adult"&gt;Adult&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;UGIB
&lt;ol&gt;&lt;li&gt;PUD (Gastric 21%, Duodenal 24%)
&lt;/li&gt;&lt;li&gt;Gastritis 23%
&lt;/li&gt;&lt;li&gt;Esophagitis/Duodenitis 6%
&lt;/li&gt;&lt;li&gt;Varicies
&lt;/li&gt;&lt;li&gt;Mallory-Weiss &amp;lt;15%
&lt;/li&gt;&lt;li&gt;Boerhaave's
&lt;/li&gt;&lt;li&gt;Dieulafoy lesion
&lt;/li&gt;&lt;li&gt;Angiodysplasia
&lt;/li&gt;&lt;li&gt;Hemobilia
&lt;/li&gt;&lt;li&gt;Aortoenteric fistula
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;LGIB
&lt;/li&gt;&lt;li&gt;Upper GI bleed
&lt;/li&gt;&lt;li&gt;Diverticulosis (painless, voluminous)
&lt;/li&gt;&lt;li&gt;Infectious (virus, bacteria, parasites, C. dif)
&lt;/li&gt;&lt;li&gt;Ischemic Colitis 3-12% (acute onset; 90% &amp;gt; 70yo)
&lt;/li&gt;&lt;li&gt;IBD (fistula-in-ano)
&lt;/li&gt;&lt;li&gt;Mesenteric Vascular Insufficiency (abd pain out of proportion to PE)
&lt;/li&gt;&lt;li&gt;Angiodysplasia
&lt;/li&gt;&lt;li&gt;Cancer/polyps
&lt;/li&gt;&lt;li&gt;Rectal dz
&lt;/li&gt;&lt;li&gt;Hemorrhoids
&lt;ol&gt;&lt;li&gt;External (below pectinate); Internal (above)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Ulcer (HIV, syphilis, STDs)
&lt;/li&gt;&lt;li&gt;Fissures (painful defecation)
&lt;/li&gt;&lt;li&gt;Abscess, prolapse, proctitis, impaction
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=GI_Bleed&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Peds"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Peds"&gt;Peds&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;UGIB
&lt;ol&gt;&lt;li&gt;Esophagitis
&lt;/li&gt;&lt;li&gt;Gastritis
&lt;/li&gt;&lt;li&gt;Ulcer
&lt;/li&gt;&lt;li&gt;Esophageal varices
&lt;/li&gt;&lt;li&gt;Mallory-Weiss
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;LGIB
&lt;ol&gt;&lt;li&gt;Anal fissure
&lt;/li&gt;&lt;li&gt;Infectious colitis
&lt;/li&gt;&lt;li&gt;IBD
&lt;/li&gt;&lt;li&gt;Polyps
&lt;/li&gt;&lt;li&gt;Intussusception
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=GI_Bleed&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Blatchford score
&lt;/p&gt;&lt;p&gt;Rockall score
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=GI_Bleed&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Home (very low risk)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Home_.28very_low_risk.29"&gt;Home (very low risk)&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;No comorbid dz
&lt;/li&gt;&lt;li&gt;Normal vitals
&lt;/li&gt;&lt;li&gt;Norma/trace pos guiac
&lt;/li&gt;&lt;li&gt;Normal/near-normal Hb
&lt;/li&gt;&lt;li&gt;Home support
&lt;/li&gt;&lt;li&gt;F/U within 24hrs
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=GI_Bleed&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Ward/Stable (low risk)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Ward.2FStable_.28low_risk.29"&gt;Ward/Stable (low risk)&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Age &amp;lt;60
&lt;/li&gt;&lt;li&gt;Initial SBP &amp;gt;100
&lt;/li&gt;&lt;li&gt;Normal vitals x 1hr
&lt;/li&gt;&lt;li&gt;No transfusion req
&lt;/li&gt;&lt;li&gt;No major comorbid
&lt;/li&gt;&lt;li&gt;No liver dz
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=GI_Bleed&amp;amp;action=edit&amp;amp;section=10" title="Edit section: ICU"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="ICU"&gt;ICU&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Normal or dec Hct
&lt;/li&gt;&lt;li&gt;Blood in NG doesn't clear
&lt;/li&gt;&lt;li&gt;SBP&amp;lt;100, HR&amp;gt;100
&lt;/li&gt;&lt;li&gt;Gauaic +/- stool
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=GI_Bleed&amp;amp;action=edit&amp;amp;section=11" title="Edit section: False Positive Guaiac"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="False_Positive_Guaiac"&gt;False Positive Guaiac&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Red fruits and meats
&lt;ol&gt;&lt;li&gt;(Bananas, turnips, broccoli)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Methylene blue
&lt;/li&gt;&lt;li&gt;Chlorophyll
&lt;/li&gt;&lt;li&gt;Iodide
&lt;/li&gt;&lt;li&gt;Cupric sulfate
&lt;/li&gt;&lt;li&gt;Bromide
&lt;/li&gt;&lt;li&gt;Iron (causes GI bleed by irritation)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=GI_Bleed&amp;amp;action=edit&amp;amp;section=12" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;3/12/06 DONALDSON (adapted from Rosen), Kaji
&lt;/p&gt;



</content><folder>GI</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="gu_trauma"><name>GU Trauma</name><content>&lt;p&gt;Upper Tract Injuries (kidney + ureter)
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; Majority of blunt trauma injuries present w/ hematuria
&lt;/li&gt;&lt;li&gt; Renal pedicle injuries and penetrating injuries to ureter
&lt;/li&gt;&lt;/ul&gt;
&lt;pre&gt;                  may not cause hematuria!
&lt;/pre&gt;
&lt;ul&gt;&lt;li&gt; AAST Grading System for renal injuries
&lt;/li&gt;&lt;li&gt; Non-operative management
&lt;/li&gt;&lt;li&gt; Grade I: Cortex contusion
&lt;/li&gt;&lt;li&gt; Grade II: Cortex laceration
&lt;/li&gt;&lt;li&gt; Possible operative management
&lt;/li&gt;&lt;li&gt; Grade III: Corticomedullary junction laceration
&lt;/li&gt;&lt;li&gt; Grade IV: Collecting system laceration
&lt;/li&gt;&lt;li&gt; Operative management
&lt;/li&gt;&lt;li&gt; Grade V: Shattered kidney, thrombosis of renal artery, avulsion of hilum
&lt;/li&gt;&lt;li&gt; Who to image?
&lt;/li&gt;&lt;li&gt; Penetrating trauma
&lt;/li&gt;&lt;li&gt; Blunt trauma with gross hematuria
&lt;/li&gt;&lt;li&gt; Blunt trauma with microscopic hematuria (&amp;gt;5 rbc/HPF) and hemodynamic instability
&lt;/li&gt;&lt;li&gt; High-energy deceleration mechanism or suspected associated intra-abdominal injuries 
&lt;/li&gt;&lt;li&gt; Disposition
&lt;/li&gt;&lt;li&gt; Majority of blunt renal injuries and all penetrating renal injuries require admission 
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
Lower Tract Injuries (bladder + urethra + genitalia)
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; Often accompany pelvic fracture
&lt;/li&gt;&lt;li&gt; Urethral Injuries
&lt;/li&gt;&lt;li&gt; Anterior: Self-instrumentation, falls, straddle injuries 
&lt;/li&gt;&lt;li&gt; Posterior: Accompany pelvic fx
&lt;/li&gt;&lt;li&gt; Perform pelvic exam in all women with pelvic fractures! 
&lt;/li&gt;&lt;li&gt; Signs: Blood at meatus, high prostate, difficulty voiding
&lt;/li&gt;&lt;li&gt; Management
&lt;/li&gt;&lt;li&gt; Presence of urethral injury should be ruled out prior to foley insertion!
&lt;/li&gt;&lt;li&gt; Retrograde urethogram 
&lt;/li&gt;&lt;li&gt; Suprapubic cystotomy to allow drainage of bladder 
&lt;/li&gt;&lt;li&gt; Bladder Rupture
&lt;/li&gt;&lt;li&gt; Extraperitoneal
&lt;/li&gt;&lt;li&gt; Assoc w/ pelvic fx and laceration by bony fragments
&lt;/li&gt;&lt;li&gt; Leakage of urine into perivesicular space
&lt;/li&gt;&lt;li&gt; Intraperitoneal
&lt;/li&gt;&lt;li&gt; Assoc w/ compresive force in presence of full bladder 
&lt;/li&gt;&lt;li&gt; Pelvic fracture + gross hematuria = bladder rupture!
&lt;/li&gt;&lt;li&gt; Fewer than 1% of all blunt bladder injuries present with urinalysis w/ &amp;lt;25 RBCs/HPF
&lt;/li&gt;&lt;li&gt; Signs: blood at meatus, inability to void, suprapubic pain 
&lt;/li&gt;&lt;li&gt; Management
&lt;/li&gt;&lt;li&gt; Bladder drainage via foley cather 
&lt;/li&gt;&lt;li&gt; Diagnosic w/u indicated for patients with:
&lt;/li&gt;&lt;li&gt; Gross hematuria
&lt;/li&gt;&lt;li&gt; Inability to void
&lt;/li&gt;&lt;li&gt; Pelvic ring fx in assoc w/ microscopic hematuria
&lt;/li&gt;&lt;li&gt; Retrograde cystography
&lt;/li&gt;&lt;li&gt; A "tear drop" shape suggests extraperitoneal bladder rupture 
&lt;/li&gt;&lt;li&gt; A routine abd/pelvis CT is not sensitive for bladder rupture!
&lt;/li&gt;&lt;li&gt; Need retrograde contrast
&lt;/li&gt;&lt;li&gt; Extraperitoneal rupture - nonoperative management with simple urinary drainage 
&lt;/li&gt;&lt;li&gt; Intraperitoneal rupture - primary surgical repair 
&lt;/li&gt;&lt;li&gt; External Genitalia Injury 
&lt;/li&gt;&lt;li&gt; If suspect testicular injury obtain ultrasound
&lt;/li&gt;&lt;li&gt; Any pt with external genitialia trauma w/ hematuria, urinary retention
&lt;/li&gt;&lt;/ul&gt;
&lt;pre&gt;                  or dysuria requires a retrograde urethrogram
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Reference: Harwood-Nuss
&lt;/p&gt;



</content><folder>Trauma</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="gallbladder_disease"><name>Gallbladder Disease</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#DDX"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;DDX&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Acute_Cholecystitis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Acute Cholecystitis&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;2.2&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Complications"&gt;&lt;span class="tocnumber"&gt;2.3&lt;/span&gt; &lt;span class="toctext"&gt;Complications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Cholangitis"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Cholangitis&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-7"&gt;&lt;a href="#Diagnosis_2"&gt;&lt;span class="tocnumber"&gt;3.1&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-8"&gt;&lt;a href="#Treatment_2"&gt;&lt;span class="tocnumber"&gt;3.2&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#Symptomatic_Cholelithiasis"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Symptomatic Cholelithiasis&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-10"&gt;&lt;a href="#Diagnosis_3"&gt;&lt;span class="tocnumber"&gt;4.1&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-11"&gt;&lt;a href="#Treatment_3"&gt;&lt;span class="tocnumber"&gt;4.2&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-12"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Gallbladder_Disease&amp;amp;action=edit&amp;amp;section=1" title="Edit section: DDX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX"&gt;DDX&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Cholecystitis 
&lt;/li&gt;&lt;li&gt;Cholangitis
&lt;/li&gt;&lt;li&gt;Symptomatic Cholelithiasis
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Gallbladder_Disease&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Acute Cholecystitis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Acute_Cholecystitis"&gt;Acute Cholecystitis&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Gallbladder_Disease&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; RUQ pain + fever + leukocytosis associated with gallbladder inflammation
&lt;/li&gt;&lt;li&gt; Ultrasound
&lt;ol&gt;&lt;li&gt; GB wall thickening (greater than 4-5mm) or edema (double wall sign)
&lt;/li&gt;&lt;li&gt; Sonographic Murphy's Sign
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Gallbladder_Disease&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Antibiotics
&lt;ol&gt;&lt;li&gt; Although clear evidence is lacking, assoc/ w/ decreased wnd infection and bacteremia
&lt;/li&gt;&lt;li&gt; CTX + metronidazole OR piperacillin/tazobactam (Zosyn) OR ampicillin-sulbactam (Unasyn)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Admit
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Gallbladder_Disease&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Complications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Complications"&gt;Complications&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Gangrene
&lt;ol&gt;&lt;li&gt; Occurs in 20% if untreated (esp. diabetics, elderly, delay in seeking care)
&lt;/li&gt;&lt;li&gt; Consider if pt presents with sepsis in addition to cholecystitis
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Perforation
&lt;ol&gt;&lt;li&gt; Occurs in 2% after development of gangrene  
&lt;/li&gt;&lt;li&gt; Usually localized, leading to pericholecystic abscess
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Gallstone Ileus
&lt;ol&gt;&lt;li&gt; Due to cholecystoenteric fistula
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Emphysematous cholecystitis
&lt;ol&gt;&lt;li&gt; Due to secondary infection of GB by gas-forming organisms
&lt;/li&gt;&lt;li&gt; Presents like cholecystitis (crepitus in abdominal wall may rarely be detected)
&lt;/li&gt;&lt;li&gt; IV abx and cholecystectomy are essential
&lt;/li&gt;&lt;li&gt; Ultrasound report may mistake GB wall gas for bowel gas 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Gallbladder_Disease&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Cholangitis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Cholangitis"&gt;Cholangitis&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Gallbladder_Disease&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis_2"&gt;Diagnosis&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Charcot's Triad: Fever + jaundice + RUQ pain
&lt;ol&gt;&lt;li&gt; Occurs in 50-75%
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Reynold's Pentad: The triad + AMS + hypotension
&lt;ol&gt;&lt;li&gt; Hypotension may be the only presenting sign in elderly pts 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Labs
&lt;ol&gt;&lt;li&gt; Leukocytosis with neutrophil predominance
&lt;/li&gt;&lt;li&gt; Elevated alk phos, conj. bilirubin
&lt;/li&gt;&lt;li&gt; Blood culture is indicated
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Imaging
&lt;ol&gt;&lt;li&gt; Ultrasound
&lt;ol&gt;&lt;li&gt; Dilatation of CBD ( &amp;gt; 6mm) and presence of choledocholithiasis
&lt;/li&gt;&lt;li&gt; May miss small CBD stones and in acute cases CBD may not have had time to dilate
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; ERCP
&lt;ol&gt;&lt;li&gt; Should be obtained to confirm the diagnosis and to intervene
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Gallbladder_Disease&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment_2"&gt;Treatment &lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Broad-spectrum parenteral Abx covering gram - and anerobes
&lt;ol&gt;&lt;li&gt; CTX + metronidazole OR piperacillin/tazobactam (Zosyn) OR ampicillin-sulbactam (Unasyn) 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Gallbladder_Disease&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Symptomatic Cholelithiasis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Symptomatic_Cholelithiasis"&gt;Symptomatic Cholelithiasis&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Gallbladder_Disease&amp;amp;action=edit&amp;amp;section=10" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis_3"&gt;Diagnosis&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; History
&lt;ol&gt;&lt;li&gt; RUQ pain that is usually constant, not colicky
&lt;/li&gt;&lt;li&gt; Usually does not occur during fasting
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Physical Exam
&lt;ol&gt;&lt;li&gt; Often benign; as compared to cholecystitis, usually negative Murphy's Sign
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Labs
&lt;ol&gt;&lt;li&gt; LFT, CBC normal 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Ultrasound
&lt;ol&gt;&lt;li&gt; Sensitivity 84%, Specificity 99% 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Gallbladder_Disease&amp;amp;action=edit&amp;amp;section=11" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment_3"&gt;Treatment&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; IV/IM Ketorolac (as effective as meperidine) with Rx for Ibuprofen
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Gallbladder_Disease&amp;amp;action=edit&amp;amp;section=12" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;UpToDate
&lt;/p&gt;



</content><folder>GI</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="general_psych_workup"><name>General Psych Workup</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=General_Psych_Workup&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Workup"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Workup"&gt;Workup&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1) CBC
&lt;/p&gt;&lt;p&gt;2) Chem 7
&lt;/p&gt;&lt;p&gt;3) LFTs + lipase
&lt;/p&gt;&lt;p&gt;4) PT/PTT
&lt;/p&gt;&lt;p&gt;5) ASA level
&lt;/p&gt;&lt;p&gt;6) Tylenol level
&lt;/p&gt;&lt;p&gt;7) Utox/Drugs of abuse
&lt;/p&gt;&lt;p&gt;8) ETOH
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;8)&amp;nbsp;?ECG (eval tox)
&lt;/p&gt;&lt;p&gt;9)&amp;nbsp;?UA (r/o delerium older pts)
&lt;/p&gt;&lt;p&gt;10)&amp;nbsp;?CXR (r/o delerium older pts)
&lt;/p&gt;&lt;p&gt;11)&amp;nbsp;?HCT (r/o bleed AMS pts)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=General_Psych_Workup&amp;amp;action=edit&amp;amp;section=2" title="Edit section: DDX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX"&gt;DDX&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1) Delerium
&lt;/p&gt;&lt;p&gt;2) Dementia
&lt;/p&gt;&lt;p&gt;3) Overdose
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=General_Psych_Workup&amp;amp;action=edit&amp;amp;section=3" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Psych: Sad Person's Score
&lt;/p&gt;



</content><folder>Psych</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="gout"><name>Gout</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Pathophysiology"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Pathophysiology&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Clinical"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Clinical&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Acute"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;Acute&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Chronic"&gt;&lt;span class="tocnumber"&gt;2.2&lt;/span&gt; &lt;span class="toctext"&gt;Chronic&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Gout&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Pathophysiology"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Pathophysiology"&gt;Pathophysiology&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Monosodium urate (MSU) crystals - needle shaped negative birefringence
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Gout&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Clinical"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Clinical"&gt;Clinical&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Swelling, redness, warmth evolving RAPIDLY over &amp;lt;12 hours (to days)
&lt;/p&gt;&lt;p&gt;First MTP (podagra) 60% &amp;gt; ankle &amp;gt; midfoot &amp;gt; knee &amp;gt; wrist
&lt;/p&gt;&lt;p&gt;May have constitutional complaints
&lt;/p&gt;&lt;p&gt;Precipitants: purine-rich food, EtOH, trauma, chemo, diuretic use,  RI
&lt;/p&gt;
&lt;pre&gt;==Diagnosis==
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt;
Synovial fluid aspiration (above)
&lt;/p&gt;&lt;p&gt;Note: serum uric acid levels unhelpful; ESR/CRP may be elevated
&lt;/p&gt;
&lt;pre&gt;==Treatment==
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Gout&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Acute"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Acute"&gt;Acute&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;-Prednisone 50mg po qd for 3-4d and/or triamcinolone 60mg IM x1
&lt;/p&gt;&lt;p&gt;-Indomethacin 50mg po TID for 2d, tapered to 25mg po TID until flare is over OR Naproxen 500mg po bid x 3d and taper over 4-7d (Cr &amp;lt; 1.8mg/dL)
&lt;/p&gt;&lt;p&gt;-Colchicine 1.2mg po x 1 OR 0.6mg po qh x 3 or 1mg PO f/b 0.5mg q1h until relif, GI  upset, or 8mg  max
&lt;/p&gt;&lt;p&gt;-Intraarticular: Methylprednisolone acetate or triamcinolone 40-60mg x1 +/- Bupivicaine +/- Morphine 2-4mg
&lt;/p&gt;&lt;p&gt;-STOP thiazide diuretics
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Gout&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Chronic"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Chronic"&gt;Chronic&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Allopurinol for urate overexcretors
&lt;/p&gt;&lt;p&gt;Probenecid for urate underexcretors
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Gout&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;H-N; EMP
&lt;/p&gt;



</content><folder>Rheum</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="guillian-barre_syndrome"><name>Guillian-Barre Syndrome</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Work-up"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Work-up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Guillian-Barre_Syndrome&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; acute idiopathic inflammatory demyelinating polyneuropathy characterized by progressive muscle weakness and areflexia usually associated with sponatneous remission 
&lt;/li&gt;&lt;li&gt; Post-infectious autoimmune destruction of peripheral nerves
&lt;ol&gt;&lt;li&gt; may be associated with hx of antecedent respiratory tract or GI infection (camphylobacter) 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Characterized by:
&lt;ol&gt;&lt;li&gt; Ascending paralysis; symmetric in legs. rapid onset.
&lt;/li&gt;&lt;li&gt; Autonomic dysfunction: 50%
&lt;/li&gt;&lt;li&gt; arrhythmias, brady/tachy, hypotension, sweating, urinary retention, respiratory failure
&lt;/li&gt;&lt;li&gt; symptoms progress and peak ~2-4 weeks after onset, plateau for 2-4 weeks then remit from weeks to months 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Intubation in 25% of pts. 
&lt;/li&gt;&lt;li&gt; 90% full recovery in months with 5% Mortality 
&lt;/li&gt;&lt;li&gt; Forms:
&lt;ol&gt;&lt;li&gt; Acute Inflammatory Demyelinating Polyneuropathy (AIDP)
&lt;ol&gt;&lt;li&gt; demyelination is immunologically mediated 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Acute Motor Axonal Neuropathy (AMAN)
&lt;ol&gt;&lt;li&gt; pure motor form
&lt;/li&gt;&lt;li&gt; seasonal incidence, associated with Camphylobacter infection
&lt;/li&gt;&lt;li&gt; pts with this form tend to require ventilatory assistance
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Acute Motor Sensory Axonal Neuropathy (AMSAN) 
&lt;ol&gt;&lt;li&gt; motor and sensory symptoms 
&lt;/li&gt;&lt;li&gt; Miller-Fisher (4%) variant is descending: ophthalmoplegia, ataxia, mainly affects CN's
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Guillian-Barre_Syndrome&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Physical Exam:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt; symmetric weakness with diminished/absent reflexes
&lt;/li&gt;&lt;li&gt; minimal loss of sensation
&lt;/li&gt;&lt;li&gt; signs of autonomic dysfunction: dysarrythmias, orthostatic hypotension, transient/persistent hypertension, paralytic ileus, bladder dysfunction, abnormal sweating 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Guillian-Barre_Syndrome&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Work-up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-up"&gt;Work-up&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; nerve conduction study: slowed nerve conduction velocities, partial motor conduction block, abnormal temporal dispersion, prolonged distal latencies
&lt;/li&gt;&lt;li&gt; LP: normal pressure, few cells (mononuclear), elevated protein (&amp;gt;50mg/dL)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Guillian-Barre_Syndrome&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Admit to neuro / ICU
&lt;/li&gt;&lt;li&gt; Intubation (if indicated)
&lt;ol&gt;&lt;li&gt; 20/30/40 rule: patient with vital capacity &amp;lt;20mL/kg, max inspiratory pressure &amp;lt;30 cmH20, or max expiratory &amp;lt;40 cm H20 will generally progress to require mechanical ventilation 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Supportive care, ABC's, close monitoring 
&lt;/li&gt;&lt;li&gt; Steroids iv (no proven benefit)
&lt;/li&gt;&lt;li&gt; plasmaphoresis vs IVIG
&lt;/li&gt;&lt;li&gt; DVT Prophylaxis (subQ heparin and SCDs)
&lt;/li&gt;&lt;/ol&gt;




</content><folder>Neuro</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="h1n1_(swine)_flu"><name>H1N1 (Swine) Flu</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#High-risk_groups"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;High-risk groups&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Screening"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Screening&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Post-exposure_chemoprophylaxis"&gt;&lt;span class="tocnumber"&gt;4.1&lt;/span&gt; &lt;span class="toctext"&gt;Post-exposure chemoprophylaxis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=H1N1_(Swine)_Flu&amp;amp;action=edit&amp;amp;section=1" title="Edit section: High-risk groups"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="High-risk_groups"&gt;High-risk groups&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Pregnant- incr rates of SAB, preterm labor
&lt;/li&gt;&lt;li&gt;Chronic lung disease
&lt;/li&gt;&lt;li&gt;Immunosuppressed
&lt;/li&gt;&lt;li&gt;Cardiac
&lt;/li&gt;&lt;li&gt;DM
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=H1N1_(Swine)_Flu&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Screening"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Screening"&gt;Screening&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Individuals with an acute febrile respiratory illness (a measured temperature of 100&#186;F or higher and recent onset of at least one of the following: rhinorrhea, nasal congestion, sore throat, or cough) or sepsis-like syndrome- HIGH PRIORITY for hospitalized patients and those at high-risk for severe disease.
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=H1N1_(Swine)_Flu&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Rapid Flu nasal swab 60-80% sensitive in detecting influenza A
&lt;/li&gt;&lt;li&gt;If patient is negative, severely ill and will be hospitalized, send viral culture
&lt;/li&gt;&lt;li&gt;PCR is the recommended confirmatory test
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=H1N1_(Swine)_Flu&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;All hospitalized patients with confirmed, probable or suspected novel influenza (H1N1)
&lt;/li&gt;&lt;li&gt;Patients who are at higher risk for seasonal influenza complications
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;Most effective when started within 48 hours of illness onset.
&lt;/p&gt;&lt;p&gt;Adult: 75-mg capsule twice per day for 5 days
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=H1N1_(Swine)_Flu&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Post-exposure chemoprophylaxis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Post-exposure_chemoprophylaxis"&gt;Post-exposure chemoprophylaxis&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Tamiflu 75mg po daily x 10 days (10 days after the last known exposure to novel (H1N1) influenza.)
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;If the contact occurred with a patient after 7 days of symtpom onset, then chemoprophylaxis is not necessary. This is the presumed post-infectious period.
&lt;/p&gt;



</content><folder>ID</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="hiv_(alc)"><name>HIV (ALC)</name><content>&lt;p&gt;Absolute lymphocyte nl &amp;gt;2,500
&lt;/p&gt;&lt;p&gt;?1.2
&lt;/p&gt;



</content><folder>ID</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="hiv_(cd4)"><name>HIV (CD4)</name><content>&lt;table style="width: 500px" border="1" cellpadding="1" cellspacing="1"&gt;

&lt;tr&gt;
&lt;td&gt; &lt;b&gt;CD4 Count&lt;/b&gt;&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Disease&lt;/b&gt;&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; &amp;gt;500&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Early diease&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 200-500&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Intermediate disease&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; &amp;lt;200&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Late disease: PCP, toxo&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; &amp;lt;100&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Cryptococcus&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; &amp;lt;50&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; CMV retinitis, MA
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;p&gt;Viral load more important for med compliance
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=HIV_(CD4)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt; Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;6/06 MISTRY
&lt;/p&gt;



</content><folder>ID</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="hiv_(disposition)"><name>HIV (Disposition)</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=HIV_(Disposition)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Suggested Admission"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Suggested_Admission"&gt;Suggested Admission&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;New presentation of fever of unknown origin
&lt;/li&gt;&lt;li&gt;Hypoxemia (worse than baselin) (PaO2 &amp;lt;60)
&lt;/li&gt;&lt;li&gt;Suspected PCP
&lt;/li&gt;&lt;li&gt;Suspected TB
&lt;/li&gt;&lt;li&gt;New CNS symptoms
&lt;/li&gt;&lt;li&gt;Intractable diarrhea
&lt;/li&gt;&lt;li&gt;Suicidal
&lt;/li&gt;&lt;li&gt;Suspected CMV retinitis
&lt;/li&gt;&lt;li&gt;Ophthalmicus zoster
&lt;/li&gt;&lt;li&gt;Cachexia or weakness
&lt;/li&gt;&lt;li&gt;Unable to care for self/receive care
&lt;/li&gt;&lt;li&gt;Unable to assure F/U
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=HIV_(Disposition)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Suggested Discharge"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Suggested_Discharge"&gt;Suggested Discharge&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Normal or baseline vitals
&lt;/li&gt;&lt;li&gt;Stable medical condition
&lt;/li&gt;&lt;li&gt;Able to tol POs/not orthostatic
&lt;/li&gt;&lt;li&gt;F/U arranged
&lt;/li&gt;&lt;li&gt;Able to comply with D/C instructions
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=HIV_(Disposition)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;DONALDSON 3/07 (adapted from Rosen)
&lt;/p&gt;



</content><folder>ID</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="hiv_(transmission_risk)"><name>HIV (Transmission Risk)</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=HIV_(Transmission_Risk)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Exposure Estimated Risk"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Exposure_Estimated_Risk"&gt; Exposure Estimated Risk &lt;/span&gt;&lt;/h2&gt;
&lt;table style="width: 500px" border="1" cellpadding="1" cellspacing="1"&gt;

&lt;tr&gt;
&lt;td&gt; &lt;b&gt;Exposure^&lt;/b&gt;&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Risk&lt;/b&gt;&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Percutaneous
&lt;/td&gt;&lt;td&gt; 0.3%
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Mucocutaneous
&lt;/td&gt;&lt;td&gt; 0.09%
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Needle-sharing injection drug
&lt;/td&gt;&lt;td&gt; 0.7%
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Receptive anal intercourse
&lt;/td&gt;&lt;td&gt; 0.5%
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Receptive penile-vaginal intercourse
&lt;/td&gt;&lt;td&gt; 0.1%
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Insertive anal intercourse
&lt;/td&gt;&lt;td&gt; 0.07%
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Insertive penile-vaginal intercourse
&lt;/td&gt;&lt;td&gt; 0.05%
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Receptive oral (male) intercourse
&lt;/td&gt;&lt;td&gt; 0.01%
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Insertive oral (male) intercourse
&lt;/td&gt;&lt;td&gt; 0.005%
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;p&gt;^assumes no condom use
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=HIV_(Transmission_Risk)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt; Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;8/07 DONALDSON
&lt;/p&gt;



</content><folder>ID</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="hiv_prophylaxis_(non-occupational)"><name>HIV Prophylaxis (Non-Occupational)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Workup"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Workup&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Negligible_Risk"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;Negligible Risk&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Substantial_Risk"&gt;&lt;span class="tocnumber"&gt;2.2&lt;/span&gt; &lt;span class="toctext"&gt;Substantial Risk&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=HIV_Prophylaxis_(Non-Occupational)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Workup"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Workup"&gt;Workup&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Icon
&lt;/li&gt;&lt;li&gt;Consider Plan B
&lt;/li&gt;&lt;li&gt;Td
&lt;/li&gt;&lt;li&gt;Hepatitis B PEP for non-vaccinated
&lt;ol&gt;&lt;li&gt;Hepatitis B immunoglobulin and/or vaccine
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Labs
&lt;ol&gt;&lt;li&gt;Rapid HIV, hep pannel, RPR?
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Consider HIV PEP
&lt;ol&gt;&lt;li&gt;Basic labs, LFTs, if considering HIV PEP
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;PD notification
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;^Currently no PEP for Hep C
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=HIV_Prophylaxis_(Non-Occupational)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=HIV_Prophylaxis_(Non-Occupational)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Negligible Risk"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Negligible_Risk"&gt;Negligible Risk&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Urine, nasal secretions, saliva, sweat or tears not visibly contaminated with blood
&lt;/li&gt;&lt;li&gt;HIV Post-Exposure Prophylaxis not recommended
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=HIV_Prophylaxis_(Non-Occupational)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Substantial Risk"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Substantial_Risk"&gt;Substantial Risk&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Exposure of vagina, rectum, eye, mouth or other mucous membrane, non-intact skin, or percutaneous contact
&lt;/li&gt;&lt;li&gt;With blood, semen, vaginal secretions, rectal secretions, breast milk, or any body fluid visibly contaminated with blood
&lt;ol&gt;&lt;li&gt;&amp;lt;72 Hours
&lt;ol&gt;&lt;li&gt;Source = Unknown HIV
&lt;ol&gt;&lt;li&gt;--&amp;gt;Case-by-case determination
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Source = Known HIV+
&lt;ol&gt;&lt;li&gt;--&amp;gt;28-day course of HAART
&lt;ol&gt;&lt;li&gt;(three-drug regimen), start ASAP
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;&amp;gt;72 Hours
&lt;ol&gt;&lt;li&gt;--&amp;gt;No HAART recommended
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=HIV_Prophylaxis_(Non-Occupational)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;HIV (Transmission Risk)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=HIV_Prophylaxis_(Non-Occupational)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;8/07 DONALDSON
&lt;/p&gt;



</content><folder>ID</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="hiv_prophylaxis_(occupational)"><name>HIV Prophylaxis (Occupational)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Workup"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Workup&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#HIV_PEP"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;HIV PEP&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Specific_Regimens_.28CDC.29"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;Specific Regimens (CDC)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#High_Risk"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;High Risk&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=HIV_Prophylaxis_(Occupational)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Workup"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Workup"&gt;Workup&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Td
&lt;/li&gt;&lt;li&gt;Hepatitis B PEP for non-vaccinated
&lt;ol&gt;&lt;li&gt;Hepatitis B immunoglobulin and/or vaccine
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Source labs
&lt;ol&gt;&lt;li&gt;Rapid HIV, hep pannel, RPR?
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Exposed labs
&lt;ol&gt;&lt;li&gt;Rapid HIV, hep pannel, RPR?
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Consider HIV PEP
&lt;ol&gt;&lt;li&gt;CBC, C7, LFTs, Icon if considering HIV PEP
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;^Currently no PEP for Hep C
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=HIV_Prophylaxis_(Occupational)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: HIV PEP"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="HIV_PEP"&gt;HIV PEP&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;~79% transmission reduction
&lt;/li&gt;&lt;li&gt;Initiate ASAP (goal = 1-2 hours)
&lt;/li&gt;&lt;li&gt;&amp;gt;36 hours: normally deferred, unless particularly high risk
&lt;/li&gt;&lt;li&gt;Common side-effects = constitutional, gastrointestinal
&lt;/li&gt;&lt;/ul&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=HIV_Prophylaxis_(Occupational)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Specific Regimens (CDC)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Specific_Regimens_.28CDC.29"&gt;Specific Regimens (CDC)&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Basic
&lt;ol&gt;&lt;li&gt;Exposures for which there is a recognized transmission risk
&lt;/li&gt;&lt;li&gt;4 week, 2 drug regimen (normally zidovudine and lamivudine)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Expanded
&lt;ol&gt;&lt;li&gt;High risk exposures
&lt;/li&gt;&lt;li&gt;Basic regimen + protease inhibitor (e.g. indinavir or nelfinavir)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=HIV_Prophylaxis_(Occupational)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: High Risk"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="High_Risk"&gt;High Risk&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;&lt;b&gt;Source&lt;/b&gt;
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Symptomatic HIV/AIDS
&lt;/li&gt;&lt;li&gt;Acute seroconversion
&lt;/li&gt;&lt;li&gt;High viral load
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;&lt;b&gt;Exposure&lt;/b&gt;
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Deep injuries
&lt;/li&gt;&lt;li&gt;Visible blood on device
&lt;/li&gt;&lt;li&gt;Injuries sustained placing a catheter in a vein/artery
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=HIV_Prophylaxis_(Occupational)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;8/07 DONALDSON
&lt;/p&gt;



</content><folder>ID</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="honc_(redirect)"><name>HONC (Redirect)</name><content>&lt;p&gt;See Endo: Hyperosmolar Hyperglycemic Nonketotic State (HHS)
&lt;/p&gt;



</content><folder>Endo</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="hsv_ophthalmic"><name>HSV Ophthalmic</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=HSV_Ophthalmic&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;corneal dedrite that stains or hazy edematous patch in cornea.
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=HSV_Ophthalmic&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Tx c topical trifluridine 8X/d for 7 d
&lt;/li&gt;&lt;li&gt;debridement of dendrite may hasten recovery
&lt;/li&gt;&lt;/ol&gt;




</content><folder>ID</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="hand_(fx)"><name>Hand (Fx)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Thumb_metacarpal_Fx"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Thumb metacarpal Fx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#_2"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Non-Thumb_Metacarpal_Head_Fx"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Non-Thumb Metacarpal Head Fx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Non-Thumb_Metacarpal_Neck_Fx"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Non-Thumb Metacarpal Neck Fx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Non-Thumb_Metacarpal_Shaft_Fx"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Non-Thumb Metacarpal Shaft Fx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Non-Thumb_Metacarpal_Base_Fx"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;Non-Thumb Metacarpal Base Fx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;9&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hand_(Fx)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt; Splinting is used in the initial immobilization of, and often is the definitive treatment for, metacarpal fractures
&lt;/li&gt;&lt;li&gt; Maintenance of the MCP joint in flexion is important to avoid immobility contractures of the collateral ligaments
&lt;/li&gt;&lt;/ul&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hand_(Fx)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: "&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id=""&gt; &lt;/span&gt;&lt;/h3&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hand_(Fx)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Thumb metacarpal Fx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Thumb_metacarpal_Fx"&gt;Thumb metacarpal Fx&lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt; Classification
&lt;/li&gt;&lt;li&gt; Type I (Bennett's Fx)
&lt;/li&gt;&lt;li&gt; Fx-dislocation of the base of the metacarpal (intraarticular)
&lt;/li&gt;&lt;li&gt; Type II (Rolando's Fx)
&lt;/li&gt;&lt;li&gt; Comminuted version of a Bennett's fracture (intraarticular)
&lt;/li&gt;&lt;li&gt; Type III
&lt;/li&gt;&lt;li&gt; Extraarticular (transverse or oblique)
&lt;/li&gt;&lt;li&gt; Type IV
&lt;/li&gt;&lt;li&gt; Extraarticular pediatric fx involving the proximal physis 
&lt;/li&gt;&lt;li&gt; Examination
&lt;/li&gt;&lt;li&gt; Important to distinguish tenderness at base of 1st MC from injury to scaphoid, trapezium, or distal radius 
&lt;/li&gt;&lt;li&gt; If pain or ecchymosis occurs more distally at the MCP (particularly on the ulnar side) consider ulnar collateral ligament injury (Game Keeper's Thumb)
&lt;/li&gt;&lt;li&gt; Imaging
&lt;/li&gt;&lt;li&gt; AP, lateral, oblique 
&lt;/li&gt;&lt;li&gt; Treatment
&lt;/li&gt;&lt;li&gt; Splinting
&lt;/li&gt;&lt;li&gt; Type I, II - Thumb-spica with the IP joint free and wrist in 30&#186; of extension
&lt;/li&gt;&lt;li&gt; Type III - Short arm thumb-spica extening to the IP joint and wrist in 30&#186; of extension
&lt;/li&gt;&lt;li&gt; RICE
&lt;/li&gt;&lt;li&gt; Significant swelling or overly aggressive icing to radial side of thumb may result in temporary palsy to the superficial radial nerve (numbness over the dorsum of the thumb)
&lt;/li&gt;&lt;li&gt; Reduction
&lt;/li&gt;&lt;li&gt; Indicated for:
&lt;/li&gt;&lt;li&gt; Angulated extraarticular fx if clinician is comfortable with the procedure  
&lt;/li&gt;&lt;li&gt; Dispo
&lt;/li&gt;&lt;li&gt; Refer within 3-5 days:
&lt;/li&gt;&lt;li&gt; All intraarticular fractures warrant referral (most require sx) 
&lt;/li&gt;&lt;li&gt; Extraarticular fractures that cannot be adequately reduced 
&lt;/li&gt;&lt;/ul&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hand_(Fx)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: "&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="_2"&gt; &lt;/span&gt;&lt;/h3&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hand_(Fx)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Non-Thumb Metacarpal Head Fx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Non-Thumb_Metacarpal_Head_Fx"&gt;Non-Thumb Metacarpal Head Fx&lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt; Intra-articular Fx
&lt;/li&gt;&lt;li&gt; Examination
&lt;/li&gt;&lt;li&gt; Swelling, decreased ROM, and TTP of MCP joint
&lt;/li&gt;&lt;li&gt; Assess for rotational alignment (rotational malalignment is not tolerated)
&lt;/li&gt;&lt;li&gt; Assess for skin integrity (r/o fight bite) 
&lt;/li&gt;&lt;li&gt; Imaging
&lt;/li&gt;&lt;li&gt; AP, lateral, oblique
&lt;/li&gt;&lt;li&gt; Angulation assessed on lateral view 
&lt;/li&gt;&lt;li&gt; Consider "Brewerton" view if collateral ligament avulsion fx suspected
&lt;/li&gt;&lt;li&gt; Treatment
&lt;/li&gt;&lt;li&gt; Ulnar or radial gutter splint
&lt;/li&gt;&lt;li&gt; MCP joints in 70-90&#186; flexion, wrist in 20-30&#186; extension, PIP and DIP joints in 5-10&#186; of flexion 
&lt;/li&gt;&lt;li&gt; Dispo
&lt;/li&gt;&lt;li&gt; Almost always refer b/c are intraarticular and typically comminuted
&lt;/li&gt;&lt;li&gt; Non-displaced fx can be splinted for 2-3 weeks followed by ROM exercises
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hand_(Fx)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Non-Thumb Metacarpal Neck Fx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Non-Thumb_Metacarpal_Neck_Fx"&gt;Non-Thumb Metacarpal Neck Fx&lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt; Examination
&lt;/li&gt;&lt;li&gt; TTP or ecchymosis on the palmar bony surface is highly suggestive of fracture 
&lt;/li&gt;&lt;li&gt; Loss of the normal knuckle contour
&lt;/li&gt;&lt;li&gt; Due to dorsal angulation of fracture apex due to pull of the interosseous muscles 
&lt;/li&gt;&lt;li&gt; Assess angulation
&lt;/li&gt;&lt;li&gt; Head-to-neck angle of the metacarpals is normally 15 degrees 
&lt;/li&gt;&lt;li&gt; Fracture angulation = measured angle minus 15&#186;
&lt;/li&gt;&lt;li&gt; Angle toleration (below which there is no adverse functional outcome)
&lt;/li&gt;&lt;li&gt; 2nd MC &amp;lt; 10&#186; 
&lt;/li&gt;&lt;li&gt; 3rd MC &amp;lt; 20&#186;
&lt;/li&gt;&lt;li&gt; 4th MC &amp;lt; 30&#186;
&lt;/li&gt;&lt;li&gt; 5th MC &amp;lt; 30&#186; 
&lt;/li&gt;&lt;li&gt; Assess rotational alignment 
&lt;/li&gt;&lt;li&gt; Assess extensor apparatus
&lt;/li&gt;&lt;li&gt; Assess skin integrity 
&lt;/li&gt;&lt;li&gt; Treatment
&lt;/li&gt;&lt;li&gt; Gutter splint
&lt;/li&gt;&lt;li&gt; MCP joints in 70-90&#186; flexion, wrist in 20-30&#186; extension, PIP and DIP joints in 5-10&#186; of flexion 
&lt;/li&gt;&lt;li&gt; Acute reduction indicated:
&lt;/li&gt;&lt;li&gt; Pseudoclawing 
&lt;/li&gt;&lt;li&gt; Significantly angulated 4th or 5th MC fx 
&lt;/li&gt;&lt;li&gt; Dispo
&lt;/li&gt;&lt;li&gt; Refer for:
&lt;/li&gt;&lt;li&gt; Comminution
&lt;/li&gt;&lt;li&gt; Rotational malalignment 
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hand_(Fx)&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Non-Thumb Metacarpal Shaft Fx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Non-Thumb_Metacarpal_Shaft_Fx"&gt;Non-Thumb Metacarpal Shaft Fx&lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt; Examination
&lt;/li&gt;&lt;li&gt; TTP along affected metacarpal
&lt;/li&gt;&lt;li&gt; Flexion at MCP is difficult
&lt;/li&gt;&lt;li&gt; Assess for extensor dysfunction; pt may exhibit "pseudo-clawing" during attempts at finger extension
&lt;/li&gt;&lt;li&gt; Assess angulation
&lt;/li&gt;&lt;li&gt; &amp;gt;10&#186; in 2nd and 3rd and &amp;gt;20&#186; in 4th and 5th metacarpal shaft fractures requires reduction 
&lt;/li&gt;&lt;li&gt; Assess rotational alignment
&lt;/li&gt;&lt;li&gt; Imaging
&lt;/li&gt;&lt;li&gt; Oblique fx are more prone to shorten and rotate
&lt;/li&gt;&lt;li&gt; Transverse fx generally stable (particularly isolated 3rd or 4th MC shaft fx)
&lt;/li&gt;&lt;li&gt; Treatment
&lt;/li&gt;&lt;li&gt; Gutter splint
&lt;/li&gt;&lt;li&gt; Acute reduction indicated if there is pseudo-clawing or significant angulation
&lt;/li&gt;&lt;li&gt; Closed reduction generally corrects angulation but typically does not restore length 
&lt;/li&gt;&lt;li&gt; Dispo
&lt;/li&gt;&lt;li&gt; Refer:
&lt;/li&gt;&lt;li&gt; Malrotation
&lt;/li&gt;&lt;li&gt; Comminution
&lt;/li&gt;&lt;li&gt; Shortening &amp;gt; 5mm (refer all shortening if not familiar with fx management)
&lt;/li&gt;&lt;li&gt; 2 or more metacarpal fractures
&lt;/li&gt;&lt;li&gt; Unacceptable angulation
&lt;/li&gt;&lt;li&gt; Long oblique fractres
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hand_(Fx)&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Non-Thumb Metacarpal Base Fx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Non-Thumb_Metacarpal_Base_Fx"&gt;Non-Thumb Metacarpal Base Fx&lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt; Examination
&lt;/li&gt;&lt;li&gt; Movement at the wrist elicits pain 
&lt;/li&gt;&lt;li&gt; Assess for ulnar deficits (finger abduction/adduction)
&lt;/li&gt;&lt;li&gt; Assess for rotational alignment
&lt;/li&gt;&lt;li&gt; Imaging
&lt;/li&gt;&lt;li&gt; AP, lateral, oblique 
&lt;/li&gt;&lt;li&gt; 30&#186; obliques pronated and supinated if usual films unable to visualize the MC bases 
&lt;/li&gt;&lt;li&gt; Consider CT if index of suspicion high for occult fx despite "negative" plain films 
&lt;/li&gt;&lt;li&gt; Treatment
&lt;/li&gt;&lt;li&gt; Dorsal and volar splints with the wrist in 30&#186; of extension and MCP joints free 
&lt;/li&gt;&lt;li&gt; Dispo
&lt;/li&gt;&lt;li&gt; Refer for:
&lt;/li&gt;&lt;li&gt; Intraarticular fx
&lt;/li&gt;&lt;li&gt; Etraarticular fx with malrotation
&lt;/li&gt;&lt;li&gt; Dislocation of metacarpal base CMC joint;
&lt;/li&gt;&lt;li&gt; Ulnar nerve injury
&lt;/li&gt;&lt;li&gt; 5th metacarpal base fx (typically require sx)
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hand_(Fx)&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;UpToDate
&lt;/p&gt;



</content><folder>Ortho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="hand_(minor)"><name>Hand (Minor)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#1._Gamekeepers_Thumb"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;1. Gamekeepers Thumb&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#2._De_Quervians_Tenosynovitis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;2. De Quervians Tenosynovitis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#3._Trigger_Finger"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;3. Trigger Finger&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#4._Mallet_Finger"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;4. Mallet Finger&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#5._Jersey_Finger"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;5. Jersey Finger&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#6._Jammed_Finger"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;6. Jammed Finger&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hand_(Minor)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: 1. Gamekeepers Thumb"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="1._Gamekeepers_Thumb"&gt;1. Gamekeepers Thumb&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Injury: forced extension/abduction
&lt;/p&gt;&lt;p&gt;Diag: TTP/laxity ulnar part MCP
&lt;/p&gt;&lt;p&gt;RX: Thumb spica &amp;amp; Ortho x 1 wk
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hand_(Minor)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: 2. De Quervians Tenosynovitis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="2._De_Quervians_Tenosynovitis"&gt;2. De Quervians Tenosynovitis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Injury: Repetitive grasping
&lt;/p&gt;&lt;p&gt;Diag: TTP radial styloid; +Finklestein test (thumb in hand -&amp;gt; ulnar deviate)
&lt;/p&gt;&lt;p&gt;Rx: Thumb spica
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hand_(Minor)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: 3. Trigger Finger"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="3._Trigger_Finger"&gt;3. Trigger Finger&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Rx: Lidocaine/steroid injection
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hand_(Minor)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: 4. Mallet Finger"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="4._Mallet_Finger"&gt;4. Mallet Finger&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Injury: Forced flexion DP on extensn
&lt;/p&gt;&lt;p&gt;Diag: Unable extend DIP
&lt;/p&gt;&lt;p&gt;Rx: Extension splint x 6 wk
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hand_(Minor)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: 5. Jersey Finger"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="5._Jersey_Finger"&gt;5. Jersey Finger&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Injury: Forced extensn of flexed DIP
&lt;/p&gt;&lt;p&gt;Diag: Loss FDS
&lt;/p&gt;&lt;p&gt;Rx: Outpt surg; POF splint
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hand_(Minor)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: 6. Jammed Finger"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="6._Jammed_Finger"&gt;6. Jammed Finger&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Injury: Axial load PIP
&lt;/p&gt;&lt;p&gt;Diag:
&lt;/p&gt;
&lt;pre&gt;    A. Volar plate sprain
&lt;/pre&gt;
&lt;pre&gt;    -no weakness
&lt;/pre&gt;
&lt;pre&gt;    -Rx: buddy tape
&lt;/pre&gt;
&lt;pre&gt;    B. Central slip injury
&lt;/pre&gt;
&lt;pre&gt;    -mild extensor weakness
&lt;/pre&gt;
&lt;pre&gt;    -may become Boutonniere
&lt;/pre&gt;
&lt;pre&gt;    -Rx: Dorsal splint extension
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hand_(Minor)&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;5/4/06 DONALDSON (adapted from Miller)
&lt;/p&gt;



</content><folder>Ortho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="harbor_disaster"><name>Harbor Disaster</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Disaster_Binder"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Disaster Binder&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Chempack"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Chempack&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Decontamination_Trailer"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Decontamination Trailer&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Disaster_Closet"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Disaster Closet&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Decontamination_Shower"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Decontamination Shower&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Harbor_Disaster&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Disaster Binder"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disaster_Binder"&gt;Disaster Binder&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;There is a disaster binder in the Doctor's Room in the AED, which outlines your specific roles
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Harbor_Disaster&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Chempack"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Chempack"&gt;Chempack&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Re: the CHEMPACK&amp;nbsp;: Just as a reminder, Harbor is one of the recipients of the CDC sponsored CHEMPACK, which is a stockpile of medications designed to treat victims of a nerve agent exposure (e.g, in a terrorist attack). Basically, the CHEMPACK contains Mark-1 Autoinjectors, Diazepam Autoinjectors, Pralidoxime, Atropine Autoinjectors, Atropine and Diazepam multi-dose vials, and sterile water for injection vials. It is stored in the basement in the central pharmacy under strict surveillance via cameras and a phone that is directly connected to the CDC.
&lt;/li&gt;&lt;li&gt;There are 2 CONDITIONS that must be met before deployment of a CHEMPACK:
&lt;ol&gt;&lt;li&gt;The incident must be a true mass casualty incident, with AT LEAST 50 victims.
&lt;/li&gt;&lt;li&gt; A NERVE AGENT must be responsible for the casualties.
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;The ED Attending will probably be the one who initiates deployment of the CHEMPACK in a mass casualty incident. If you think a situation meets the above two criteria, then you would simultaneously notify the CENTRAL PHARMACY (Ext. 2363) and the EMS Agency that a mass casualty incident has occurred and at least fifty victims of a nerve agent exposure are anticipated. The pharmacy staff will access the CHEMPACK, which will automatically alert the CDC (and thereby the FBI) that we have deployed the CHEMPACK. We may also be asked to deploy the CHEMPACK to an outside facility (although it may be futile to do so, by that time).
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Harbor_Disaster&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Decontamination Trailer"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Decontamination_Trailer"&gt;Decontamination Trailer&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Re: the need to have the decontamination trailer set up: If you need the decontamination trailer set up, please do the following:
&lt;/li&gt;&lt;li&gt;Before 5pm, call X3301, and tell the secretary that we are expecting contaminated victims in the ED and will need them to deploy the decontamination trailer.
&lt;/li&gt;&lt;li&gt;After 5pm, you will need to page the one mechanical staff person on-call, and his pager number is 501-2848. This person is supposed to be stationed in the Power Station at all times, and so he can also be reached by calling him at extensions X3324 or X3228.
&lt;/li&gt;&lt;li&gt;(At this time, in addition to all of the graduating senior residents, there are a few nurses (Gideon, Ria, Grace, Essence), as well as mechanical and clerical personnel that are&amp;nbsp;?certified? to don the PPE. During R2 orientation, the second years were also taught how to don and doff the PPE).
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Harbor_Disaster&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Disaster Closet"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disaster_Closet"&gt;Disaster Closet&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;The key to the disaster closet with the PPE (outside the ambulance bay) is with the charge nurse and in the Pyxis.
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Harbor_Disaster&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Decontamination Shower"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Decontamination_Shower"&gt;Decontamination Shower&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;The key to the small decontamination shower outside the ED is with the security guard who sits there 24 hours a day. I would recommend using this decontamination shower for incidents that only involve one or two people, and before the large decontamination trailer can be set up. Note that simple soap and water is what is recommended for decontamination.
&lt;/p&gt;



</content><folder>Harbor Admin</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="harbor_drip_card"><name>Harbor Drip Card</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Harbor_Drip_Card&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Adult IV Concentrations"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Adult_IV_Concentrations"&gt;Adult IV Concentrations&lt;/span&gt;&lt;/h2&gt;
&lt;table style="border: medium none" align="left" border="1"&gt;

&lt;tr&gt;
&lt;td style="width: 36px; background-color: rgb(217, 217, 217); height: 5px; border: 1pt solid" valign="top" width="43"&gt;
&lt;p&gt;&lt;b&gt;&lt;font face="Arial"&gt;Medication&lt;/font&gt;&lt;/b&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 60px; background-color: rgb(217, 217, 217); height: 5px" valign="top" width="60"&gt;
&lt;p&gt;&lt;b&gt;&lt;font face="Arial"&gt;Indications&lt;/font&gt;&lt;/b&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 40px; background-color: rgb(217, 217, 217); height: 5px" valign="top" width="48"&gt; &lt;center&gt;&lt;b&gt;&lt;font face="Arial"&gt;Concentration&lt;/font&gt;&lt;/b&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 40px; background-color: rgb(217, 217, 217); height: 5px" valign="top" width="48"&gt; &lt;center&gt;&lt;b&gt;&lt;font face="Arial"&gt;Start&lt;/font&gt;&lt;font face="Arial"&gt;Range&lt;/font&gt;&lt;/b&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 36px; background-color: rgb(217, 217, 217); height: 5px" valign="top" width="36"&gt; &lt;center&gt;&lt;b&gt;&lt;font face="Arial"&gt;Maximum&lt;/font&gt;&lt;/b&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 60px; background-color: rgb(217, 217, 217); height: 5px" valign="top" width="72"&gt;
&lt;p&gt;&lt;b&gt;&lt;font face="Arial"&gt;Comments&lt;/font&gt;&lt;/b&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="width: 36px; height: 20px" valign="top" width="43"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;Amiodarone&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 60px; height: 20px" valign="top" width="60"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;SVT, &lt;/font&gt;&lt;font face="Arial"&gt;Unstable&lt;/font&gt;&lt;font face="Arial"&gt;VT&lt;/font&gt;&lt;font face="Arial"&gt;, V-fib, Convert Afib to NSR&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 40px; height: 20px" valign="top" width="48"&gt; &lt;center&gt;&lt;span lang="de"&gt;&lt;font face="Arial"&gt;900mg/500mL D5Ws (1.8mg/ml)&lt;/font&gt;&lt;/span&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 40px; height: 20px" valign="top" width="48"&gt; &lt;center&gt;&lt;span lang="de"&gt;&lt;font face="Arial"&gt;150mg x10min&lt;/font&gt;&lt;/span&gt;&lt;font face="Wingdings"&gt;&#224;&lt;/font&gt;&lt;font face="Arial"&gt;1mg/min x6hrs&lt;/font&gt;&lt;font face="Wingdings"&gt;&#224;&lt;/font&gt;&lt;font face="Arial"&gt;0.5mg/min x18hr&lt;/font&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 36px; height: 20px" valign="top" width="36"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;2.2 gm/day&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 60px; height: 20px" valign="top" width="72"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;Watch for &#8595;BP,&lt;/font&gt;&lt;font face="Arial"&gt;worsened/new arrythmias&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="width: 36px; height: 11px" valign="top" width="43"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;Diltiazem&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 60px; height: 11px" valign="top" width="60"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;SVT, Afib/flutter&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 40px; height: 11px" valign="top" width="48"&gt; &lt;center&gt;&lt;font face="Arial"&gt;125mg/125mL D5W (1mg/ml)&lt;/font&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 40px; height: 11px" valign="top" width="48"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;Load 0.25mg/kg &lt;/font&gt;&lt;span lang="de"&gt;&lt;font face="Wingdings"&gt;&#224;&lt;/font&gt;&lt;/span&gt;&lt;font face="Arial"&gt;5-15mg/hr&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 36px; height: 11px" valign="top" width="36"&gt; &lt;center&gt;&lt;font face="Arial"&gt;15mg/hr x 24hrs&lt;/font&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 60px; height: 11px" valign="top" width="72"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;Monitor BP, HR, EKG, SVR&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="width: 36px; height: 11px" valign="top" width="43"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;Dobutamine&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 60px; height: 11px" valign="top" width="60"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;Refractory CHF, Cardiogenic Shock, use Dopamine first if BP low&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 40px; height: 11px" valign="top" width="48"&gt; &lt;center&gt;&lt;font face="Arial"&gt;500 mg/250mL D5W (2mg/ml)&lt;/font&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 40px; height: 11px" valign="top" width="48"&gt;
&lt;p&gt;&lt;span lang="de"&gt;&lt;font face="Arial"&gt;Initial 1 &lt;/font&gt;&lt;/span&gt;
&lt;/p&gt;&lt;p&gt;&lt;span lang="de"&gt;&lt;font face="Arial"&gt;mcg/kg/min&lt;/font&gt;&lt;/span&gt;
&lt;/p&gt;
&lt;center&gt;&lt;font face="Wingdings"&gt;&#224;&lt;/font&gt;&lt;span lang="de"&gt;&lt;font face="Arial"&gt; 2mcg/kg/min&lt;/font&gt;&lt;/span&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 36px; height: 11px" valign="top" width="36"&gt; &lt;center&gt;&lt;font face="Arial"&gt;20 mcg/kg/min&lt;/font&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 60px; height: 11px" valign="top" width="72"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;monitor BP, EKG, UOP&lt;/font&gt;
&lt;/p&gt;&lt;p&gt;&lt;font face="Arial"&gt;Tachydysrhythmias&lt;/font&gt;
&lt;/p&gt;&lt;p&gt;&lt;font face="Arial"&gt;caution AMI, incr O2 req&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="width: 36px; height: 14px" valign="top" width="43"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;Dopamine&lt;/font&gt;
&lt;/p&gt;&lt;p&gt;&lt;font face="Arial"&gt;D&amp;gt;B&amp;gt;B/A&amp;gt;A&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 60px; height: 14px" valign="top" width="60"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;HypoTN p volume resus, cardiog shock, bradycard&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 40px; height: 14px" valign="top" width="48"&gt; &lt;center&gt;&lt;font face="Arial"&gt;800 mg/250mL D5W&lt;/font&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 40px; height: 14px" valign="top" width="48"&gt; &lt;center&gt;&lt;font face="Arial"&gt;1-5 mcg/kg/min (renal 0.5-2)&lt;/font&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 36px; height: 14px" valign="top" width="36"&gt; &lt;center&gt;&lt;font face="Arial"&gt;20 mcg/kg/min&lt;/font&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 60px; height: 14px" valign="top" width="72"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;Monitor BP, EKG, UOP&lt;/font&gt;
&lt;/p&gt;&lt;p&gt;&lt;font face="Arial"&gt;tachydysrthm when d/c&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="width: 36px; height: 11px" valign="top" width="43"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;Epinephrine&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 60px; height: 11px" valign="top" width="60"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;VF or pulseless VT, Asystole, PEA, decr SVR&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 40px; height: 11px" valign="top" width="48"&gt; &lt;center&gt;&lt;font face="Arial"&gt;8 mg/250mL D5W&lt;/font&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 40px; height: 11px" valign="top" width="48"&gt; &lt;center&gt;&lt;font face="Arial"&gt;1-10 mcg/min&lt;/font&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 36px; height: 11px" valign="top" width="36"&gt; &lt;center&gt;&lt;font face="Arial"&gt;20 mcg/min&lt;/font&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 60px; height: 11px" valign="top" width="72"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;Tachydysrhythmias&lt;/font&gt;
&lt;/p&gt;&lt;p&gt;&lt;font face="Arial"&gt;increase O2 demand&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="width: 36px; height: 20px" valign="top" width="43"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;Esmolol&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 60px; height: 20px" valign="top" width="60"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;Reduce VF in post MI, convert SVT/Afib/flut, decr AMI ischem&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 40px; height: 20px" valign="top" width="48"&gt; &lt;center&gt;&lt;font face="Arial"&gt;2.5gm/250mL&lt;/font&gt;&lt;/center&gt;&lt;center&gt;&lt;font face="Arial"&gt;NS&lt;/font&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 40px; height: 20px" valign="top" width="48"&gt; &lt;center&gt;&lt;font face="Arial"&gt;Load 500 mcg/kg x1min &lt;/font&gt;&lt;font face="Wingdings"&gt;&#224;&lt;/font&gt;&lt;font face="Arial"&gt;50 mcg/kg/min&lt;/font&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 36px; height: 20px" valign="top" width="36"&gt; &lt;center&gt;&lt;font face="Arial"&gt;300 mcg/kg/min&lt;/font&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 60px; height: 20px" valign="top" width="72"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;Careful: bradycardia, AV block, dec BP, reactive airway, no mix c Ca Ch Blk&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="width: 36px; height: 8px" valign="top" width="43"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;Fentanyl&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 60px; height: 8px" valign="top" width="60"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;Sedation, pain&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 40px; height: 8px" valign="top" width="48"&gt; &lt;center&gt;&lt;font face="Arial"&gt;1mg/100mL NS&lt;/font&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 40px; height: 8px" valign="top" width="48"&gt; &lt;center&gt;&lt;font face="Arial"&gt;0.5-1mcg/kg/hr&lt;/font&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 36px; height: 8px" valign="top" width="36"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;5 mcg/kg/hr&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 60px; height: 8px" valign="top" width="72"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;Resp depression&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="width: 36px; height: 8px" valign="top" width="43"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;Furosemide&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 60px; height: 8px" valign="top" width="60"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;Diuresis&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 40px; height: 8px" valign="top" width="48"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;500mg/100mLD5&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 40px; height: 8px" valign="top" width="48"&gt; &lt;center&gt;&lt;font face="Arial"&gt;10mg/hr&lt;/font&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 36px; height: 8px" valign="top" width="36"&gt; &lt;center&gt;&lt;font face="Arial"&gt;100 mg/hr&lt;/font&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 60px; height: 8px" valign="top" width="72"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;Monitor UOP, Cr, lytes&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="width: 36px; height: 8px" valign="top" width="43"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;Insulin (reg)&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 60px; height: 8px" valign="top" width="60"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;BS control&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 40px; height: 8px" valign="top" width="48"&gt; &lt;center&gt;&lt;font face="Arial"&gt;100units/100mL NS&lt;/font&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 40px; height: 8px" valign="top" width="48"&gt; &lt;center&gt;&lt;font face="Arial"&gt;Load 0.1units/kg &lt;/font&gt;&lt;font face="Wingdings"&gt;&#224;&lt;/font&gt;&lt;font face="Arial"&gt;0.1-0.7units/hr&lt;/font&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 36px; height: 8px" valign="top" width="36"&gt; &lt;center&gt;&lt;font face="Arial"&gt;10&lt;/font&gt;&lt;/center&gt;&lt;center&gt;&lt;font face="Arial"&gt;units/hr&lt;/font&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 60px; height: 8px" valign="top" width="72"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;Use Insulin protocol form&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="width: 36px; height: 8px" valign="top" width="43"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;Labetalol&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 60px; height: 8px" valign="top" width="60"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;HTN urg/emerg&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 40px; height: 8px" valign="top" width="48"&gt; &lt;center&gt;&lt;font face="Arial"&gt;200mg/300mL D5W&lt;/font&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 40px; height: 8px" valign="top" width="48"&gt; &lt;center&gt;&lt;font face="Arial"&gt;2mg/min&lt;/font&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 36px; height: 8px" valign="top" width="36"&gt; &lt;center&gt;&lt;font face="Arial"&gt;4mg/min&lt;/font&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 60px; height: 8px" valign="top" width="72"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;hypotension&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="width: 36px; height: 8px" valign="top" width="43"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;Midazolam&lt;/font&gt;
&lt;/p&gt;&lt;p&gt;&lt;font face="Arial"&gt;(Versed)&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 60px; height: 8px" valign="top" width="60"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;Sedation intubated pt&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 40px; height: 8px" valign="top" width="48"&gt; &lt;center&gt;&lt;font face="Arial"&gt;100mg/100mL D5W&lt;/font&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 40px; height: 8px" valign="top" width="48"&gt; &lt;center&gt;&lt;font face="Arial"&gt;Load 10- 50 mcg/kg&lt;/font&gt;&lt;font face="Wingdings"&gt;&#224;&lt;/font&gt;&lt;font face="Arial"&gt;20-100&lt;/font&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 36px; height: 8px" valign="top" width="36"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td style="width: 60px; height: 8px" valign="top" width="72"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;hypotension&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="width: 36px; height: 8px" valign="top" width="43"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;Neo-syneph (phenyleph)&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 60px; height: 8px" valign="top" width="60"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;Hypotension, vascular failure in shock, SVT&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 40px; height: 8px" valign="top" width="48"&gt; &lt;center&gt;&lt;font face="Arial"&gt;80 mg/250mL D5W&lt;/font&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 40px; height: 8px" valign="top" width="48"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;Load 100 mcg&lt;/font&gt;&lt;font face="Wingdings"&gt;&#224;&lt;/font&gt;
&lt;/p&gt;
&lt;center&gt;&lt;font face="Arial"&gt;40-60 mcg/min&lt;/font&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 36px; height: 8px" valign="top" width="36"&gt; &lt;center&gt;&lt;font face="Arial"&gt;200 mcg/min&lt;/font&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 60px; height: 8px" valign="top" width="72"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;Monitor BP, HR, SVR&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="width: 36px; height: 8px" valign="top" width="43"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;NTG&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 60px; height: 8px" valign="top" width="60"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;AMI and Ischemia/Infarction&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 40px; height: 8px" valign="top" width="48"&gt; &lt;center&gt;&lt;font face="Arial"&gt;100 mg/250mL D5W&lt;/font&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 40px; height: 8px" valign="top" width="48"&gt; &lt;center&gt;&lt;font face="Arial"&gt;0.1 mcg/kg/min&lt;/font&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 36px; height: 8px" valign="top" width="36"&gt; &lt;center&gt;&lt;font face="Arial"&gt;5 mcg/kg/min&lt;/font&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 60px; height: 8px" valign="top" width="72"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;Hypotension, HA&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="width: 36px; height: 8px" valign="top" width="43"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;Nitroprussid&lt;/font&gt;
&lt;/p&gt;&lt;p&gt;&lt;font face="Arial"&gt;(Nipride)&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 60px; height: 8px" valign="top" width="60"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;Hypertensive crisis&lt;/font&gt;
&lt;/p&gt;&lt;p&gt;&lt;font face="Arial"&gt;Heart failure&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 40px; height: 8px" valign="top" width="48"&gt; &lt;center&gt;&lt;font face="Arial"&gt;100 mg/250mL D5W&lt;/font&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 40px; height: 8px" valign="top" width="48"&gt; &lt;center&gt;&lt;font face="Arial"&gt;0.5 mcg/kg/min&lt;/font&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 36px; height: 8px" valign="top" width="36"&gt; &lt;center&gt;&lt;font face="Arial"&gt;10 mcg/kg/min&lt;/font&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 60px; height: 8px" valign="top" width="72"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;Watch BP, thiocynate tox, tinnitus, delirium, CP,vision&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="width: 36px; height: 14px" valign="top" width="43"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;Norepineph&lt;/font&gt;
&lt;/p&gt;&lt;p&gt;&lt;font face="Arial"&gt;(levophed)&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 60px; height: 14px" valign="top" width="60"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;Cardiogenic shock, Sig hypoTN w/ SBP &amp;lt;70&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 40px; height: 14px" valign="top" width="48"&gt; &lt;center&gt;&lt;font face="Arial"&gt;8 mg/250mL D5W&lt;/font&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 40px; height: 14px" valign="top" width="48"&gt; &lt;center&gt;&lt;font face="Arial"&gt;2 mcg/min&lt;/font&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 36px; height: 14px" valign="top" width="36"&gt; &lt;center&gt;&lt;font face="Arial"&gt;20&lt;/font&gt;&lt;/center&gt;&lt;center&gt;&lt;font face="Arial"&gt;mcg/min&lt;/font&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 60px; height: 14px" valign="top" width="72"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;Monitor BP, EKG, UO caution in AMI&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="width: 36px; height: 6px" valign="top" width="43"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;Octreotide&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 60px; height: 6px" valign="top" width="60"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;GI Bleed&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 40px; height: 6px" valign="top" width="48"&gt; &lt;center&gt;&lt;font face="Arial"&gt;1250mcg/250mL D5W&lt;/font&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 40px; height: 6px" valign="top" width="48"&gt; &lt;center&gt;&lt;font face="Arial"&gt;50 mcg bolus&lt;/font&gt;&lt;/center&gt;&lt;center&gt;&lt;font face="Wingdings"&gt;&#224;&lt;/font&gt;&lt;font face="Arial"&gt;25 mcg/hr&lt;/font&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 36px; height: 6px" valign="top" width="36"&gt; &lt;center&gt;&lt;font face="Arial"&gt;50mcg/hr&lt;/font&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 60px; height: 6px" valign="top" width="72"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;Dysglycemia, bradycardia, hypothyroidism&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="width: 36px; height: 6px" valign="top" width="43"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;Protonix&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 60px; height: 6px" valign="top" width="60"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;GI Bleed&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 40px; height: 6px" valign="top" width="48"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td style="width: 40px; height: 6px" valign="top" width="48"&gt; &lt;center&gt;&lt;font face="Arial"&gt;80mg bolus &lt;/font&gt;&lt;font face="Wingdings"&gt;&#224;&lt;/font&gt;&lt;font face="Arial"&gt;8mg/hr&lt;/font&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 36px; height: 6px" valign="top" width="36"&gt; &lt;center&gt;&lt;font face="Arial"&gt;8mg/hr&lt;/font&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 60px; height: 6px" valign="top" width="72"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="width: 36px; height: 6px" valign="top" width="43"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;Vasopressn&lt;/font&gt;
&lt;/p&gt;&lt;p&gt;&lt;font face="Arial"&gt;(Pitressin)&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 60px; height: 6px" valign="top" width="60"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;vasodilatory shock, pulseless VF/VT, DI, GIB&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 40px; height: 6px" valign="top" width="48"&gt; &lt;center&gt;&lt;font face="Arial"&gt;100 units&lt;/font&gt;&lt;/center&gt;&lt;center&gt;&lt;font face="Arial"&gt;/250mL D5W&lt;/font&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 40px; height: 6px" valign="top" width="48"&gt; &lt;center&gt;&lt;font face="Arial"&gt;0.04 units/min&lt;/font&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 36px; height: 6px" valign="top" width="36"&gt; &lt;center&gt;&lt;font face="Arial"&gt;1.0 unit/min&lt;/font&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 60px; height: 6px" valign="top" width="72"&gt;
&lt;p&gt;&lt;font face="Arial"&gt;Inc SVR ++periph vasoconstr, bad in AMI; do not titrate for vasodilatory shock&lt;/font&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;



</content><folder>Drugs</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="head_ct"><name>Head CT</name><content>&lt;p&gt;1. Brain density-grey vs white matter
&lt;/p&gt;&lt;p&gt;2. midline shift
&lt;/p&gt;&lt;p&gt;3. Subarach space-syl fissure - look for sulci
&lt;/p&gt;&lt;p&gt;4.vent system - look at temp horns
&lt;/p&gt;&lt;p&gt;5. Corner shots - eyes / bones
&lt;/p&gt;&lt;p&gt;trigone
&lt;/p&gt;&lt;p&gt;Ethmoid/ sphenoid
&lt;/p&gt;&lt;p&gt;Foramen ovale -cn
&lt;/p&gt;&lt;p&gt;5 -maxillary div
&lt;/p&gt;&lt;p&gt;spinosum- middle meningeal
&lt;/p&gt;&lt;p&gt;foramen rotundum / pterygoid
&lt;/p&gt;&lt;p&gt;Clinoid- medial is orbital canal
&lt;/p&gt;&lt;p&gt;-sup/inf orb fissure lateral
&lt;/p&gt;&lt;p&gt;Look for central sulcus- parietal/ frontal div
&lt;/p&gt;&lt;p&gt;Hypoglossal canal off magnum
&lt;/p&gt;&lt;p&gt;Cn 7 up cn 8 coke down ( cochlear)
&lt;/p&gt;&lt;p&gt;jugular foramen 9, 10,11
&lt;/p&gt;&lt;p&gt;pars marginalis/ central sulcus- division parietal/frontal
&lt;/p&gt;&lt;p&gt;Sylvian fissure atrophy = temporal lobe atrophy( alzh)
&lt;/p&gt;&lt;p&gt;Supracellar cistern- circle willis - meningioma/ pit tumors/ craniopharnygioma/ aneurysm
&lt;/p&gt;&lt;p&gt;Comm hydro - arachnoid
&lt;/p&gt;&lt;p&gt;Pineal gland - usually calcified- below third vent,
&lt;/p&gt;&lt;p&gt;Sphenoid - vert vs ethmoid -horizontal
&lt;/p&gt;&lt;p&gt;Occipital - sagital sinus enhancement
&lt;/p&gt;&lt;p&gt;Lens/ epidural- dont cross suture lines- cornonal
&lt;/p&gt;&lt;p&gt;Ex vacuo dilatation- large vent from atrophy vs aids encephalopathy
&lt;/p&gt;&lt;p&gt;Subdural empyema- meningitis-- stroke
&lt;/p&gt;&lt;p&gt;Mesenchyme makes up tentorium
&lt;/p&gt;&lt;p&gt;Vasogenic edema- tumors/infectious vs cytotoxic edema- stroke
&lt;/p&gt;&lt;p&gt;Ring enh lesions- toxo vs lymphoma in immunocomp pt
&lt;/p&gt;&lt;p&gt;If thickened near outside. - abcess vs Irreg - ca
&lt;/p&gt;&lt;p&gt;Avm- atrophy/ calcification
&lt;/p&gt;&lt;p&gt;Post fossa-cerebellum / pons/ medulla
&lt;/p&gt;



</content><folder>Rads</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="head_ct_(peds)"><name>Head CT (Peds)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#.3C_2_yr_old-_no_CT_if_all_below_negative"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;&amp;lt; 2 yr old- no CT if all below negative&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#.3E_2_yr_old-_no_CT_if_all_below_negative"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;&amp;gt; 2 yr old- no CT if all below negative&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Head_CT_(Peds)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: &amp;amp;lt; 2 yr old- no CT if all below negative"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id=".3C_2_yr_old-_no_CT_if_all_below_negative"&gt;&amp;lt; 2 yr old- no CT if all below negative&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;AMS
&lt;/p&gt;&lt;p&gt;Scalp hematoma (parietal, occipital, temporal, excluding frontal)
&lt;/p&gt;&lt;p&gt;LOC &amp;gt; 5sec
&lt;/p&gt;&lt;p&gt;Severe mechanism of injury
&lt;/p&gt;&lt;p&gt;Palpable or unclear skull fracture
&lt;/p&gt;&lt;p&gt;Acting normal per parent
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Head_CT_(Peds)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: &amp;amp;gt; 2 yr old- no CT if all below negative"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id=".3E_2_yr_old-_no_CT_if_all_below_negative"&gt;&amp;gt; 2 yr old- no CT if all below negative&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;AMS
&lt;/p&gt;&lt;p&gt;LOC
&lt;/p&gt;&lt;p&gt;History of vomiting
&lt;/p&gt;&lt;p&gt;Severe mechanism of injury
&lt;/p&gt;&lt;p&gt;Clinical signs of basilar skull fracture
&lt;/p&gt;&lt;p&gt;Severe headache
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;NPV &amp;gt; 99%  PPV &amp;gt; 99%
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;If any (except AMS or e/o fracture) are positive, may consider period of observation vs CT depending on:
&lt;/p&gt;&lt;p&gt;Physician experience
&lt;/p&gt;&lt;p&gt;Parental preference
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Head_CT_(Peds)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: "&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id=""&gt; &lt;/span&gt;&lt;/h2&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Head_CT_(Peds)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Peds: Head Trauma (Peds)
&lt;/p&gt;&lt;p&gt;Peds: GCS (Peds)
&lt;/p&gt;&lt;p&gt;Peds: Concussion
&lt;/p&gt;&lt;p&gt;Peds: Skull Fracture
&lt;/p&gt;&lt;p&gt;Peds: Abuse (Nonaccidental Trauma)
&lt;/p&gt;&lt;p&gt;Trauma: Head Trauma (Adult)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Head_CT_(Peds)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;PECARN- Kupperman 2009
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="head_mri"><name>Head MRI</name><content>&lt;p&gt;T1- bright-methemoglobin/ fat/ protein- like ct
&lt;/p&gt;&lt;p&gt;T2- fluid bright
&lt;/p&gt;&lt;p&gt;FLAIR- fluid attenuation inversion recovery - like t2 without
&lt;/p&gt;&lt;p&gt;csf ( ms)
&lt;/p&gt;&lt;p&gt;Diffusion- restriction free water motion
&lt;/p&gt;&lt;p&gt;blood T1 T2
&lt;/p&gt;&lt;p&gt;hyperacute dark, iso bright (oxyhemo)
&lt;/p&gt;&lt;p&gt;acute bright dark (deoxyhemo)
&lt;/p&gt;&lt;p&gt;1-3 days bright dark (methgb/intracellular)
&lt;/p&gt;&lt;p&gt;1-2 wks bright bright ( extracelluar)
&lt;/p&gt;&lt;p&gt;2-3 wks dark dark
&lt;/p&gt;



</content><folder>Rads</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="head_trauma"><name>Head Trauma</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#_2"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Head_Trauma&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;See Peds: Head CT (Peds)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Head_Trauma&amp;amp;action=edit&amp;amp;section=2" title="Edit section: "&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id=""&gt; &lt;/span&gt;&lt;/h2&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Head_Trauma&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; sedate &amp;amp; paralize prn (barbiturate coma can decr metabolism &amp;amp; ICP)
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;pCO2 (target = 30-35)
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;HOB @ 30 degrees,
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;prevent jugular venous compression w/ c-collar
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Goal= maintain CPP (MAP-ICP), cpp of 40-65 is goal, better survival if 40-50
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Prevent hypotension
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Keep Hgb &amp;gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Mannitol .25-1g/kg in boluses
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Dilantin
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Must operate on sig depressed skull fx
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Head_Trauma&amp;amp;action=edit&amp;amp;section=4" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Peds: Head Trauma (Peds)
&lt;/p&gt;&lt;p&gt;Peds: GCS (Peds)
&lt;/p&gt;&lt;p&gt;Peds: Concussion
&lt;/p&gt;&lt;p&gt;Peds: Skull Fracture
&lt;/p&gt;&lt;p&gt;Peds: Abuse (Nonaccidental Trauma)
&lt;/p&gt;&lt;p&gt;Trauma: Head Trauma (Adult)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Head_Trauma&amp;amp;action=edit&amp;amp;section=5" title="Edit section: "&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="_2"&gt; &lt;/span&gt;&lt;/h2&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Head_Trauma&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from Rosen, Lampe, Gausche, Mistry, Donaldson
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="head_trauma_(adult)"><name>Head Trauma (Adult)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Head_Trauma_(Adult)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;CT Guidelines
&lt;/p&gt;&lt;p&gt;Inclusion = 'minor head trauma'
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;AMERICAN HEAD CT RULE
&lt;/p&gt;&lt;p&gt;Minor head trauma = brief LOC after event, then GCS of 15
&lt;/p&gt;&lt;p&gt;CT indicated for (if any present):
&lt;/p&gt;&lt;p&gt;1) Short term memory deficit ( &amp;gt;amnesia to the event; i.e. persistent anterograde amnesia)
&lt;/p&gt;&lt;p&gt;2) Evidence of trauma above clavicles (signs of linear, basilar, depressed skull fracture, scalp hematoma, soft-tissue injury)
&lt;/p&gt;&lt;p&gt;3) Headache
&lt;/p&gt;&lt;p&gt;4) Vomiting
&lt;/p&gt;&lt;p&gt;5) Age &amp;gt;60yrs
&lt;/p&gt;&lt;p&gt;6) Drug or EtOH intoxication (by suspicion, not nec lab tests)
&lt;/p&gt;&lt;p&gt;7) Seizure post trauma
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Coagulopathy (including coumadin)
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;(NEJM 7/00, Haydel)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;CANADIAN HEAD CT RULE
&lt;/p&gt;&lt;p&gt;Minor head trauma = witnessed LOC, definite amnesia, witnessed disorientation w/ GCS 13-15
&lt;/p&gt;&lt;p&gt;CT indicated for (if any present):
&lt;/p&gt;&lt;p&gt;A. High Risk (for neurological intervention)
&lt;/p&gt;
&lt;pre&gt;    1) GCS &amp;lt;15 2hrs post accident
&lt;/pre&gt;
&lt;pre&gt;    2) Suspected open/depressed skull fx
&lt;/pre&gt;
&lt;pre&gt;    3) Any sign of basal skull fracture (hemotympanum, racoon eyes, CSF otorrhea/ rhinnorrhea, Battle's sign)
&lt;/pre&gt;
&lt;pre&gt;    4) Vomiting &amp;gt;2 episodes
&lt;/pre&gt;
&lt;pre&gt;    5) Age &amp;gt;=65
&lt;/pre&gt;
&lt;p&gt;B. Medium risk (for brain injury on CT)
&lt;/p&gt;
&lt;pre&gt;    6) Amnesia &amp;gt;30 mins pror to impact
&lt;/pre&gt;
&lt;pre&gt;    7) Dangerous mechanism (struck by MVA, ejected from MV, fall from height &amp;gt; 3ft or 5 stairs.)
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Head_Trauma_(Adult)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1. DAI
&lt;/p&gt;&lt;p&gt;2. Contusion
&lt;/p&gt;&lt;p&gt;3. Epidural
&lt;/p&gt;&lt;p&gt;4. Subdural
&lt;/p&gt;&lt;p&gt;5. Traumatic SAH
&lt;/p&gt;
&lt;pre&gt;    -Rx w/ Ca-blockers
&lt;/pre&gt;
&lt;p&gt;6. Intracerebral
&lt;/p&gt;&lt;p&gt;7. Concussion
&lt;/p&gt;
&lt;pre&gt;    -return to sports 1 wk after asympt
&lt;/pre&gt;
&lt;pre&gt;    -1 mo if LOC/prolonged amnesia
&lt;/pre&gt;
&lt;pre&gt;    -postconcussive synd (50% chance HA/irritability/seep/depression if HA/nausea/dizziness)
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Head_Trauma_(Adult)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1. ABCs
&lt;/p&gt;&lt;p&gt;2. HOB Elevated
&lt;/p&gt;&lt;p&gt;3. Sx Prophy (see other)
&lt;/p&gt;
&lt;pre&gt;    Dilantin 13-18mg/kg IV over 20min
&lt;/pre&gt;
&lt;p&gt;4. CO2
&lt;/p&gt;
&lt;pre&gt;    (PCo2 30-35 if sx herniation)
&lt;/pre&gt;
&lt;p&gt;5. Prevent
&lt;/p&gt;
&lt;pre&gt;    -Hypotension
&lt;/pre&gt;
&lt;pre&gt;    -Hypoxia
&lt;/pre&gt;
&lt;pre&gt;    -Anemia
&lt;/pre&gt;
&lt;pre&gt;    -Hyperthermia
&lt;/pre&gt;
&lt;pre&gt;    -Coagulopathy
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Head_Trauma_(Adult)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Peds: Head Trauma (Peds)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Head_Trauma_(Adult)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;(Lancet 5/01, Stiell)
&lt;/p&gt;&lt;p&gt;2/6/06 DONALDSON (adapted from Lampe)
&lt;/p&gt;



</content><folder>Trauma</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="head_trauma_(anticoagulated)"><name>Head Trauma (Anticoagulated)</name><content>



</content><folder>Trauma</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="headache"><name>Headache</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#History"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;History&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Physical_Exam"&gt;&lt;span class="tocnumber"&gt;2.2&lt;/span&gt; &lt;span class="toctext"&gt;Physical Exam&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Laboratory_Tests"&gt;&lt;span class="tocnumber"&gt;2.3&lt;/span&gt; &lt;span class="toctext"&gt;Laboratory Tests&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-6"&gt;&lt;a href="#Imaging"&gt;&lt;span class="tocnumber"&gt;2.4&lt;/span&gt; &lt;span class="toctext"&gt;Imaging&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-8"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;3.1&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Headache&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Opening pressure useful for SAH, cerebral venous thrombosis
&lt;/li&gt;&lt;li&gt; LP is required if suspect SAH
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Headache&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Headache&amp;amp;action=edit&amp;amp;section=3" title="Edit section: History"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="History"&gt;History&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Time to maximal onset
&lt;/li&gt;&lt;li&gt; Location
&lt;ol&gt;&lt;li&gt; Occipital - Cerebellar lesion, muscle spasm, cervical radiculopathy
&lt;/li&gt;&lt;li&gt; Orbital - Optic neuritis, cavernous sinus thrombosis
&lt;/li&gt;&lt;li&gt; Facial - Sinusitis, carotid artery dissection
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Prior headache history
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Headache&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Physical Exam"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Physical_Exam"&gt;Physical Exam&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Scalp and temporal artery palpation
&lt;/li&gt;&lt;li&gt; Sinus tap / transillumination
&lt;/li&gt;&lt;li&gt; Jolt test (have pt rapidly shake head side to side)
&lt;ol&gt;&lt;li&gt; 100% sensitive for meningitis
&lt;/li&gt;&lt;li&gt; "Most useful adjunctive maneuver for evaluating headache in the presence of fever"
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Neuro exam 
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Headache&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Laboratory Tests"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Laboratory_Tests"&gt;Laboratory Tests&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; If suspect temporal arteritis -&amp;gt; ESR
&lt;/li&gt;&lt;li&gt; If suspect meningitis -&amp;gt; CSF studies
&lt;ol&gt;&lt;li&gt; Cannot use CBC to rule-out meningitis!
&lt;/li&gt;&lt;li&gt; Add India Ink, cryptococcal antigen if suspect AIDS-related infection
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; If suspect CO poisoning -&amp;gt; carboxyhemoglobin level
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Headache&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Imaging"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Imaging"&gt;Imaging&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Consider non-contrast head CT in patients with:
&lt;ol&gt;&lt;li&gt; Thunderclap headache 
&lt;/li&gt;&lt;li&gt; Worst headache
&lt;/li&gt;&lt;li&gt; Different headache from usual 
&lt;/li&gt;&lt;li&gt; Meningeal signs
&lt;/li&gt;&lt;li&gt; Headache + intractable vomiting
&lt;/li&gt;&lt;li&gt; New-onset headache in pts with:
&lt;ol&gt;&lt;li&gt; Age &amp;gt; 50yrs
&lt;/li&gt;&lt;li&gt; Malignancy
&lt;/li&gt;&lt;li&gt; HIV
&lt;/li&gt;&lt;li&gt; Neurological deficits (other than migraine with aura)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Consider CXR
&lt;ol&gt;&lt;li&gt; 50% of pts w/ pneumococcal meningitis have e/o PNA on CXR 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Headache&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Migraine
&lt;ol&gt;&lt;li&gt; 1st line: Prochlorperazine (compazine) 10mg IV (+/- benadryl)
&lt;ol&gt;&lt;li&gt; Most effective therapy 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; 2nd line:
&lt;ol&gt;&lt;li&gt; Metoclopramide (reglan) 10mg IV 
&lt;/li&gt;&lt;li&gt; DHE 1mg IV (often used with an antiemetic)
&lt;ol&gt;&lt;li&gt; Contraindications: pregnancy, cardiovascular disease, HTN 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Triptans
&lt;ol&gt;&lt;li&gt; Contraindications: cardiovascular disease 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Ketorolac 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Cluster
&lt;ol&gt;&lt;li&gt; Oxygen
&lt;/li&gt;&lt;li&gt; Triptans
&lt;/li&gt;&lt;li&gt; DHE
&lt;/li&gt;&lt;li&gt; Corticosteroids
&lt;/li&gt;&lt;li&gt; Verapemil
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Tension
&lt;ol&gt;&lt;li&gt; NSAIDs
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Headache&amp;amp;action=edit&amp;amp;section=8" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Headache DDX
&lt;/p&gt;&lt;p&gt;Headache Red Flags
&lt;/p&gt;&lt;p&gt;CT Before LP
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Headache&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;EB Medicine, 06/01, vol 3, number 6
&lt;/p&gt;&lt;p&gt;Annals 2008:52
&lt;/p&gt;



</content><folder>Neuro</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="headache_ddx"><name>Headache DDX</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Common"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Common&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Killers"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;Killers&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Maimers"&gt;&lt;span class="tocnumber"&gt;2.2&lt;/span&gt; &lt;span class="toctext"&gt;Maimers&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Others"&gt;&lt;span class="tocnumber"&gt;2.3&lt;/span&gt; &lt;span class="toctext"&gt;Others&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Headache_DDX&amp;amp;action=edit&amp;amp;section=1" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Headache_DDX&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Common"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Common"&gt;Common&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Migraine
&lt;/li&gt;&lt;li&gt; Tension 
&lt;/li&gt;&lt;li&gt; Cluster
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Headache_DDX&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Killers"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Killers"&gt;Killers&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Meningitis/encephalitis
&lt;/li&gt;&lt;li&gt; SAH / sentinel bleed
&lt;/li&gt;&lt;li&gt; ICH (subdura/epidural)
&lt;/li&gt;&lt;li&gt; Acute obstructive hydrocephalus
&lt;/li&gt;&lt;li&gt; Space occupying lesions
&lt;/li&gt;&lt;li&gt; Stroke
&lt;/li&gt;&lt;li&gt; Carbon monoxide poisoning
&lt;/li&gt;&lt;li&gt; Basilar artery dissection
&lt;/li&gt;&lt;li&gt; Preeclampsia
&lt;/li&gt;&lt;li&gt; Cerebral Venous Thrombosis (pregnancy/post-partum)
&lt;/li&gt;&lt;li&gt; Hypertensive Emergency
&lt;/li&gt;&lt;li&gt; Depression
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Headache_DDX&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Maimers"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Maimers"&gt;Maimers&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Temporal Arteritis (&amp;gt;50yrs &amp;amp; ESR)
&lt;/li&gt;&lt;li&gt; Idiopathic intracranial hypertension
&lt;/li&gt;&lt;li&gt; Acute glaucoma
&lt;/li&gt;&lt;li&gt; Acute sinusitis
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Headache_DDX&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Others"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Others"&gt;Others&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Trigeminal neuralgia
&lt;/li&gt;&lt;li&gt; Temporomandibular
&lt;/li&gt;&lt;li&gt; Post LP/ low CSF
&lt;/li&gt;&lt;li&gt; Dehydration
&lt;/li&gt;&lt;li&gt; Analgesia abuse
&lt;/li&gt;&lt;li&gt; Eye, dental, or derm cause
&lt;/li&gt;&lt;li&gt; Febrile HA
&lt;/li&gt;&lt;/ol&gt;




</content><folder>Neuro</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="headache_red_flags"><name>Headache Red Flags</name><content>&lt;ol&gt;&lt;li&gt;Sudden onset or accelerating pattern
&lt;/li&gt;&lt;li&gt;No similar headache in past
&lt;/li&gt;&lt;li&gt;Age &amp;gt; 50 years
&lt;/li&gt;&lt;li&gt;Occipitonuchal HA
&lt;/li&gt;&lt;li&gt;Visual disturbances
&lt;/li&gt;&lt;li&gt;Exertional
&lt;/li&gt;&lt;li&gt;Family history of SAH
&lt;/li&gt;&lt;li&gt;Focal neurologic signs
&lt;/li&gt;&lt;li&gt;Diastolic BP &amp;gt; 120
&lt;/li&gt;&lt;li&gt;Papilledema
&lt;/li&gt;&lt;li&gt;Jaw claudication
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;&lt;br /&gt;
Headache in setting of:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt; Infection
&lt;/li&gt;&lt;li&gt; Cancer
&lt;/li&gt;&lt;li&gt; Immunosuppression
&lt;/li&gt;&lt;li&gt; Syncope
&lt;/li&gt;&lt;li&gt; Trauma
&lt;/li&gt;&lt;li&gt; Altered mental status
&lt;/li&gt;&lt;li&gt; Systemic illness (fever, stiff neck, rash)
&lt;/li&gt;&lt;li&gt; Nausea/vomiting
&lt;/li&gt;&lt;li&gt; Patient on anticoagulation, steroids, NSAIDs
&lt;/li&gt;&lt;/ol&gt;




</content><folder>Neuro</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="heart_disease_(congenital)"><name>Heart Disease (Congenital)</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Heart_Disease_(Congenital)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1) Pulse Ox non-responsive to O2
&lt;/p&gt;&lt;p&gt;2) Hepatomegaly
&lt;/p&gt;&lt;p&gt;3) High pulse pressure (also sepsis)
&lt;/p&gt;&lt;p&gt;4) Murmur
&lt;/p&gt;&lt;p&gt;5) Blood pressure in 3 limbs
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Heart_Disease_(Congenital)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Treatment (by presentation)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment_.28by_presentation.29"&gt;Treatment (by presentation)&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1) Cyanosis (shunt)
&lt;/p&gt;
&lt;pre&gt;    -PGE1* (0.01mg/kg; may repeat at double dose x 3)
&lt;/pre&gt;
&lt;pre&gt;    -pressors
&lt;/pre&gt;
&lt;p&gt;2) Tet spells
&lt;/p&gt;
&lt;pre&gt;    -knee chest position
&lt;/pre&gt;
&lt;pre&gt;    -O2
&lt;/pre&gt;
&lt;p&gt;3) CHF
&lt;/p&gt;
&lt;pre&gt;    -diuretis, NTG, inotrops
&lt;/pre&gt;
&lt;p&gt;4) Shock (resrictive lesion)
&lt;/p&gt;
&lt;pre&gt;    -Dobutamine
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;PGE1 Side Effects
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;-Apnea (intubate)
&lt;/p&gt;&lt;p&gt;-Hypotension
&lt;/p&gt;&lt;p&gt;-Bradycardia
&lt;/p&gt;&lt;p&gt;-Hyperexia
&lt;/p&gt;&lt;p&gt;-Flushing
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="heart_murmur_maneuvers"><name>Heart Murmur Maneuvers</name><content>&lt;ol&gt;&lt;li&gt;Valsalva
&lt;ol&gt;&lt;li&gt;increase-&amp;gt;MP &amp;amp; HCM; MOST decrease. c RELEASE: R heart murmurs return first. Increases thoracic pressure c lower preload-- then decreased CO and afterload.
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Hand grip
&lt;ol&gt;&lt;li&gt;increase-&amp;gt; MR, MS, AR, 3rd &amp;amp; 4th sounds; c increased L ventricular volume. Decreased AS and HCM. Increase in HR + C.O. may inc ischemia.
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Squatting
&lt;ol&gt;&lt;li&gt;acute inc. in venous return thus LV size and DELAYS MP click, standing decreases VR thus earlier click. Can distinguish ejection sound (murmur component) which does NOT change c manuever.
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Standing
&lt;ol&gt;&lt;li&gt;dec in both R &amp;amp; L venous return &amp;amp; SV. Thus: dec in murmur of PS, AS, AR, TR, VSD. INCREASE in HOCM b/c of dec in LV outflow size.
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Vasodilator
&lt;ol&gt;&lt;li&gt;amyl nitrate: dec. Diastolic component of AR to-fro murmur by dec. vascular resistance favoring forward flow. Also dec. Austin Flint bec depenant on magnitude of AR vs. MS murmur.
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Inspiration: (ideally sitting or standing)
&lt;ol&gt;&lt;li&gt;Inc. R sided venous return while dec. L sided. Thus inc. in S2 splitting c P2 further from A2/
&lt;/li&gt;&lt;li&gt;Inc. in R sided S3 &amp;amp; S4/ Inc. TS opening snap &amp;amp; murmur/ Dec.in MS opening snap/ Dec. in MVP murmur and click/ Inc. PR/ Inc. TR murmur (Carvallo's sx).
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Heart_Murmur_Maneuvers&amp;amp;action=edit&amp;amp;section=1" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Cards: Heart Murmurs
&lt;/p&gt;&lt;p&gt;Cards: Valvular Emergencies (Valve)
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="heart_murmurs"><name>Heart Murmurs</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Heart_Murmurs&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Aortic stenosis
&lt;ol&gt;&lt;li&gt;Systolic murmur heard best in the aortic area; rarely at apex. Crescendo-decrescendo, transmitted to carotids. A2 decreased. Paradoxical splitting of S2; narrow pulse pressure. Pulsus parvus et tardus.
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Aortic insufficiency
&lt;ol&gt;&lt;li&gt;Diastolic blowing murmur heard at left sternal border in 3rd and 4th interspace. Wide pulse pressure. Quincke's sign (capillary pulsations at fingertips), DeMusset's sign (bobbing head), Muller's sign (pulsing uvula), Corrigan's pulse (water hammer). Pistol shot sounds.
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Pulmonic stenosis
&lt;ol&gt;&lt;li&gt;systolic murmur heard in pulmonic area, transmitted to back and neck. A2 is decreased, P2 is delayed, RVH with parasternal lift.
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Pulmonic insufficiency
&lt;ol&gt;&lt;li&gt;High pitched diastolic murmur; heard in pulmonic area; decrescendo; RVH
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Mitral stenosis
&lt;ol&gt;&lt;li&gt;low rumbling diastolic murmur heard best at apex c bell. Opening snap sometimes present worse c closer to S2. Loud S1. (associad c L atrium dilation)
&lt;/li&gt;&lt;li&gt;Can hear presystolic sound confused c systolic murmur.
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Mitral insufficiency
&lt;ol&gt;&lt;li&gt;loud, holosystolic, high-pitched, heard best at apex and transmitted to axilla. Soft S1. Severity gauged by s3, rumble.
&lt;/li&gt;&lt;li&gt;paradoxical splitting:
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;ol&gt;&lt;li&gt;Gallavardin Effect
&lt;ol&gt;&lt;li&gt;AS sounds like MR--high frequency vibrations to the apex through a calcific AV
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Austin-Flint
&lt;ol&gt;&lt;li&gt;MS sounds like AR--Soft, rumbling murmur, likely due to functional mitral valve stenosis as the backflow of blood from the aorta presses on anterior leaflet of MV.
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Heart_Murmurs&amp;amp;action=edit&amp;amp;section=2" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Cards: Heart Murmur Manuvers
&lt;/p&gt;&lt;p&gt;Cards: Valvular Emergencies (Valve)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Heart_Murmurs&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;7/2/09 PANI
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="heat_exhaustion"><name>Heat Exhaustion</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Definition"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Definition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Risk_Factors"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Risk Factors&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Symptoms"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Symptoms&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Heat_Exhaustion&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Definition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Definition"&gt;Definition&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Acute heat-related injury due to volume depletion; Temp can be low, high or normal (&amp;gt;37 but  &amp;lt;40)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Heat_Exhaustion&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Risk Factors"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Risk_Factors"&gt;Risk Factors&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Underlying factors (poor fluid intake, hot environment, inappropriate clothing)
&lt;/p&gt;&lt;p&gt;Underlying illness (endocrine disorders, cardiac disease, burns)
&lt;/p&gt;&lt;p&gt;Poorly adaptive thermoregulatory mechanisms
&lt;/p&gt;&lt;p&gt;Medication use (anticholinergics, B-blockers, alcohol, diuretics)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Heat_Exhaustion&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Symptoms"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Symptoms"&gt;Symptoms&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Thirst, cephalgia, dizziness, weakness, n/v, myalgia, anxiety
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Heat_Exhaustion&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Volume replacement
&lt;/p&gt;&lt;p&gt;Balanced salt solutions
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Heat_Exhaustion&amp;amp;action=edit&amp;amp;section=5" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Environ: &lt;a href="/wiki/Heat_Stroke" title="Heat Stroke"&gt;Heat Stroke&lt;/a&gt;
&lt;/p&gt;



</content><folder>Environ</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="heat_stroke"><name>Heat Stroke</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Signs_.26_Symptoms"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Signs &amp;amp; Symptoms&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#General"&gt;&lt;span class="tocnumber"&gt;4.1&lt;/span&gt; &lt;span class="toctext"&gt;General&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-6"&gt;&lt;a href="#Specific_Co-Symptom"&gt;&lt;span class="tocnumber"&gt;4.2&lt;/span&gt; &lt;span class="toctext"&gt;Specific Co-Symptom&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Prognosis"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Prognosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Heat_Stroke&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;often fatal, if survive probable brain damage
&lt;/li&gt;&lt;li&gt;usually v young or elderly, poor or socially isolated, no access to air conditioning
&lt;/li&gt;&lt;li&gt;heat stroke has microvasc thrombosis and endothelial cell damage- like  DIC
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Heat_Stroke&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Heat Stroke- temp &amp;gt;40 and CNS dz
&lt;/li&gt;&lt;li&gt;Heat Exhaustion- thirst, weakness, anxiety, dizzy, HA due to temp and water and salt depletion. Temp can be low, high or normal. (&amp;gt;37 but &amp;lt;40)
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Heat_Stroke&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Signs &amp;amp; Symptoms"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Signs_.26_Symptoms"&gt;Signs &amp;amp; Symptoms&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;heat stroke- hot and altered
&lt;/li&gt;&lt;li&gt;tachy and hyperventilation
&lt;/li&gt;&lt;li&gt;may have hypotn
&lt;/li&gt;&lt;li&gt;nonexertional heat stroke- have resp alk
&lt;/li&gt;&lt;li&gt;exertional- resp alk and lactic acidosis, also rhabdo and electrolyte abnormalities
&lt;/li&gt;&lt;li&gt;may have muscular rigidity
&lt;/li&gt;&lt;li&gt;hypoglycemia rare
&lt;/li&gt;&lt;li&gt;can progress to multiorgan faillure
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Heat_Stroke&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Heat_Stroke&amp;amp;action=edit&amp;amp;section=5" title="Edit section: General"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="General"&gt;General&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Rapid Cooling
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;by conduction, evaporaton, convection
&lt;/li&gt;&lt;li&gt;continue only until the temperature drops to 38.5 or 39 C to avoid  overshoot hypothermia
&lt;/li&gt;&lt;li&gt;evaporative cooling and iced gastric lavage recommended
&lt;ol&gt;&lt;li&gt;e.g. luke-warm water or wet towels + blowing air with a fan
&lt;/li&gt;&lt;li&gt;ay consider peritoneal and thoracic lavage
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;cooling blankets may be effective for mild  heatstroke
&lt;/li&gt;&lt;li&gt;immersing or covering the patient in ice NOT recommended  (causes vasoconstriction and shivering)
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;^no drugs helpful (dantrolene not effective; antipyretics not studied)
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Heat_Stroke&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Specific Co-Symptom"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Specific_Co-Symptom"&gt;Specific Co-Symptom&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Shivering: Treat with chlorpromazine, benzodiazepines, or thiopental
&lt;/li&gt;&lt;li&gt; Seizure: Treated with diazepam or thiopental (dilantin is ineffective)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Heat_Stroke&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Prognosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Prognosis"&gt;Prognosis&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;cns recovery is a favorable sign- but 20% will have resid damage
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Heat_Stroke&amp;amp;action=edit&amp;amp;section=8" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Environ: &lt;a href="/wiki/Heat_Exhaustion" title="Heat Exhaustion"&gt;Heat Exhaustion&lt;/a&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Heat_Stroke&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Mistry, KajiQuestions, Donaldson
&lt;/p&gt;



</content><folder>Environ</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="hemophilia"><name>Hemophilia</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Factor_8"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Factor 8&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#Standard_Calculation"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;Standard Calculation&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Factor_8_Tx_for_Specific_Problems_in_Hemophilia"&gt;&lt;span class="tocnumber"&gt;1.2&lt;/span&gt; &lt;span class="toctext"&gt;Factor 8 Tx for Specific Problems in Hemophilia&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#.C2.A0Dosage_of_Factor_VIII_.28Antihemophilic_Factor.29"&gt;&lt;span class="tocnumber"&gt;1.3&lt;/span&gt; &lt;span class="toctext"&gt;&amp;nbsp;Dosage of Factor VIII (Antihemophilic Factor)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Factor_9"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Factor 9&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hemophilia&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Factor 8"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Factor_8"&gt;Factor 8&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hemophilia&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Standard Calculation"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Standard_Calculation"&gt;Standard Calculation&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;(weight in kg) x (50ml plasma/kg) x (desired F8 level - native F8 level) = number of units for initial dose
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;In emergency therapy, the present level of factor VIII is assumed to be zero.
&lt;/li&gt;&lt;li&gt;One unit is the activity of the coagulation factor present in 1 mL of normal human plasma.
&lt;/li&gt;&lt;li&gt;Because the half-life of factor VIII is 8&#8211;12 hr, the desired level is maintained by giving half the initial dose every 8&#8211;12 hr.
&lt;/li&gt;&lt;li&gt;Cryoprecipitate is assumed to have 80&#8211;100 U of factor VIII:C per bag; factor VIII:C concentrates list the units per bottle on the label.
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hemophilia&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Factor 8 Tx for Specific Problems in Hemophilia"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Factor_8_Tx_for_Specific_Problems_in_Hemophilia"&gt;Factor 8 Tx for Specific Problems in Hemophilia&lt;/span&gt;&lt;/h3&gt;
&lt;table border="1" cellpadding="2"&gt;

&lt;tr&gt;
&lt;th align="left"&gt; TYPE OF BLEEDING
&lt;/th&gt;&lt;th align="left"&gt; INITIAL DOSAGE
&lt;/th&gt;&lt;th align="left"&gt; DURATION
&lt;/th&gt;&lt;th align="left"&gt; COMMENT
&lt;/th&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td colspan="4" align="left"&gt; &lt;b&gt;Skin&lt;/b&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left"&gt; Abrasion
&lt;/td&gt;&lt;td align="left"&gt; None
&lt;/td&gt;&lt;td align="left"&gt; None
&lt;/td&gt;&lt;td align="left"&gt; Treat with local pressure and topical thrombin
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left"&gt; Laceration
&lt;/td&gt;&lt;td align="left"&gt; Usually none; if necessary, treat as minor
&lt;/td&gt;&lt;td align="left"&gt; None
&lt;/td&gt;&lt;td align="left"&gt; Local pressure and anesthetic with epinephrine may benefit; watch 4 hours after suturing; reexamine in 24 hours
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left"&gt; Superficial
&lt;/td&gt;&lt;td align="left"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td align="left"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td align="left"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left"&gt; Deep
&lt;/td&gt;&lt;td align="left"&gt; Minor bleeding (12.5 mg/kg)
&lt;/td&gt;&lt;td align="left"&gt; Single-dose coverage
&lt;/td&gt;&lt;td align="left"&gt; May need hospitalization for observation; repeat may be necessary for suture removal
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left"&gt; Nasal epistaxis
&lt;/td&gt;&lt;td align="left"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td align="left"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td align="left"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left"&gt; Spontaneous
&lt;/td&gt;&lt;td align="left"&gt; Usually none; may need to be treated as mild bleeding
&lt;/td&gt;&lt;td align="left"&gt; None
&lt;/td&gt;&lt;td align="left"&gt; Uncommon; consider platelet inhibition; treat in usual manner
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left"&gt; Traumatic
&lt;/td&gt;&lt;td align="left"&gt; Moderate bleeding (25 mg/kg)
&lt;/td&gt;&lt;td align="left"&gt; Up to 5&#8211;7 days
&lt;/td&gt;&lt;td align="left"&gt; Trauma-related bleeding can be significant
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td colspan="4" align="left"&gt; &lt;b&gt;Oral&lt;/b&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left"&gt; Mucosa or tongue bites
&lt;/td&gt;&lt;td align="left"&gt; Usually none; treat as minor if persists
&lt;/td&gt;&lt;td align="left"&gt; Single dose
&lt;/td&gt;&lt;td align="left"&gt; Commonly seen
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left"&gt; Traumatic (laceration) or dental extraction
&lt;/td&gt;&lt;td align="left"&gt; Moderate (25 U/kg) to severe (50 U/kg)
&lt;/td&gt;&lt;td align="left"&gt; Single dose; may need more
&lt;/td&gt;&lt;td align="left"&gt; Saliva rich in fibrin lytic activity; oral &#949;-aminocaproic acid (Amicar) may be given at 100 mg every 6 hr for 7 days to block fibrinolysis; check contraindications; hospitalize patients with severe bleeding
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left"&gt; &lt;b&gt;Soft tissue/muscle hematomas&lt;/b&gt;
&lt;/td&gt;&lt;td align="left"&gt; Moderate (25 U/kg) to severe (50 U/kg)
&lt;/td&gt;&lt;td align="left"&gt; 2&#8211;5 days
&lt;/td&gt;&lt;td align="left"&gt; May be complicated by local pressure on nerves or vessels (e.g., iliopsoas, forearm, calf)
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td colspan="4" align="left"&gt; &lt;b&gt;Hemarthrosis&lt;/b&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left"&gt; Early
&lt;/td&gt;&lt;td align="left"&gt; Mild (12.5 U/kg)
&lt;/td&gt;&lt;td align="left"&gt; Single dose
&lt;/td&gt;&lt;td align="left"&gt; Treat as earliest symptom (pain); knee, elbow, ankle more common
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left"&gt; Late or unresponsive cases of early hemarthrosis
&lt;/td&gt;&lt;td align="left"&gt; Mild to moderate (25 U/kg)
&lt;/td&gt;&lt;td align="left"&gt; 3&#8211;4 days
&lt;/td&gt;&lt;td align="left"&gt; Arthrocentesis rarely necessary and only with 50% level coverage; immobilization is critical point of therapy
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left"&gt; &lt;b&gt;Hematuria&lt;/b&gt;
&lt;/td&gt;&lt;td align="left"&gt; Mild (12.5 U/kg)
&lt;/td&gt;&lt;td align="left"&gt; 2&#8211;3 days
&lt;/td&gt;&lt;td align="left"&gt; Urokinase, the fibrinolytic enzyme, is in urine; with persistent hematuria an organic cause should be ruled out
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left"&gt; Major bleeding
&lt;/td&gt;&lt;td align="left"&gt; Major bleeding (50 U/kg)
&lt;/td&gt;&lt;td align="left"&gt; 7&#8211;10 days or 3&#8211;5 days after bleeding ceases
&lt;/td&gt;&lt;td align="left"&gt; In head trauma, therapy should be given prophylactically; early CT scan of head recommended for all
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left"&gt; Gastrointestinal severe bleeding
&lt;/td&gt;&lt;td align="left"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td align="left"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td align="left"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left"&gt; Neck/sublingual
&lt;/td&gt;&lt;td align="left"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td align="left"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td align="left"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left"&gt; Retroperitoneal
&lt;/td&gt;&lt;td align="left"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td align="left"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td align="left"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left"&gt; Intra-abdominal
&lt;/td&gt;&lt;td align="left"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td align="left"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td align="left"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left"&gt; Major trauma
&lt;/td&gt;&lt;td align="left"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td align="left"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td align="left"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left"&gt; Head injury (see text)
&lt;/td&gt;&lt;td align="left"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td align="left"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td align="left"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left"&gt; Central nervous system bleeding (see text)
&lt;/td&gt;&lt;td align="left"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td align="left"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td align="left"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left"&gt; Surgical procedure
&lt;/td&gt;&lt;td align="left"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td align="left"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td align="left"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left"&gt; CT, computed tomography
&lt;/td&gt;&lt;td align="left"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td align="left"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td align="left"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hemophilia&amp;amp;action=edit&amp;amp;section=4" title="Edit section: &amp;amp;nbsp;Dosage of Factor VIII (Antihemophilic Factor)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id=".C2.A0Dosage_of_Factor_VIII_.28Antihemophilic_Factor.29"&gt;&amp;nbsp;Dosage of Factor VIII (Antihemophilic Factor)&lt;/span&gt;&lt;/h3&gt;
&lt;table border="1" cellpadding="2"&gt;

&lt;tr&gt;
&lt;th align="left"&gt; BLEEDING RISK
&lt;/th&gt;&lt;th align="left"&gt; DESIRED FACTOR VIII LEVEL (%)
&lt;/th&gt;&lt;th align="left"&gt; INITIAL DOSE (U/KG)
&lt;/th&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left"&gt; Mild
&lt;/td&gt;&lt;td align="left"&gt; 5&#8211;10
&lt;/td&gt;&lt;td align="left"&gt; 12.5
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left"&gt; Moderate
&lt;/td&gt;&lt;td align="left"&gt; 20&#8211;30
&lt;/td&gt;&lt;td align="left"&gt; 25
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left"&gt; Severe
&lt;/td&gt;&lt;td align="left"&gt; 50 or greater
&lt;/td&gt;&lt;td align="left"&gt; 50
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table width="100%"&gt;

&lt;tr&gt;
&lt;td align="left"&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hemophilia&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Factor 9"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Factor_9"&gt; Factor 9 &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;(weight in kg) x (100ml plasma/kg) x (desired F9 level - native F9 level) = total units^
&lt;/p&gt;&lt;p&gt;^half this dose should be readministered in 24 hours
&lt;/p&gt;&lt;p&gt;^^DDAVP is not helpful in F9 deficiency
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hemophilia&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt; Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;DONALDSON 10/08 (From "Kaji Questions"), Rosen's
&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;




</content><folder>Heme/Onc</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="hemoptysis"><name>Hemoptysis</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Workup"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Workup&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hemoptysis&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Workup"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Workup"&gt;Workup&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;0) Icon
&lt;/p&gt;&lt;p&gt;1) CBC
&lt;/p&gt;&lt;p&gt;2) Chem 7
&lt;/p&gt;&lt;p&gt;3) Coags
&lt;/p&gt;&lt;p&gt;4) T&amp;amp;S/T&amp;amp;C
&lt;/p&gt;&lt;p&gt;5) UA (autoimune)
&lt;/p&gt;&lt;p&gt;6) ECG (pulm HTN/PE)
&lt;/p&gt;&lt;p&gt;7) CXR (30% will be nl)
&lt;/p&gt;&lt;p&gt;8) Consider D-Dimer/Spiral CT
&lt;/p&gt;&lt;p&gt;9) IVF/blood/correct coagulop as nec
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hemoptysis&amp;amp;action=edit&amp;amp;section=2" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;I. Airway
&lt;/p&gt;
&lt;pre&gt;    A. Bronchitis (acute/chronic)
&lt;/pre&gt;
&lt;pre&gt;    B. Bronchietctasis
&lt;/pre&gt;
&lt;pre&gt;    C. Neoplasm (primary/met)
&lt;/pre&gt;
&lt;pre&gt;    D. Trauma
&lt;/pre&gt;
&lt;pre&gt;    E. Foreign body
&lt;/pre&gt;
&lt;p&gt;II. Parenchymal Dz
&lt;/p&gt;
&lt;pre&gt;    A. Infectious
&lt;/pre&gt;
&lt;pre&gt;         1. TB
&lt;/pre&gt;
&lt;pre&gt;         2. PNA
&lt;/pre&gt;
&lt;pre&gt;         3. Fungal
&lt;/pre&gt;
&lt;pre&gt;         4. Abcess
&lt;/pre&gt;
&lt;pre&gt;    B. Autoimmune
&lt;/pre&gt;
&lt;pre&gt;         1. Goodpasture's
&lt;/pre&gt;
&lt;pre&gt;         2. SLE
&lt;/pre&gt;
&lt;pre&gt;         3. Wegener's
&lt;/pre&gt;
&lt;pre&gt;         4. Pulmonary Hemosiderosis
&lt;/pre&gt;
&lt;p&gt;III. Vascular
&lt;/p&gt;
&lt;pre&gt;    A. PE
&lt;/pre&gt;
&lt;pre&gt;    B. AV malformation
&lt;/pre&gt;
&lt;pre&gt;    C. Pulm HTN
&lt;/pre&gt;
&lt;pre&gt;    D. Aortic dissection
&lt;/pre&gt;
&lt;p&gt;IV. Hematologic Dz
&lt;/p&gt;
&lt;pre&gt;    A. Coagulopathy
&lt;/pre&gt;
&lt;pre&gt;    B. DIC
&lt;/pre&gt;
&lt;pre&gt;    C. Platelet dysfx
&lt;/pre&gt;
&lt;pre&gt;    D. Thrombocytopenia
&lt;/pre&gt;
&lt;p&gt;V. Cardiac
&lt;/p&gt;
&lt;pre&gt;    A. Mitral stenosis
&lt;/pre&gt;
&lt;pre&gt;    B. Tricuspid endocarditis
&lt;/pre&gt;
&lt;p&gt;VI. Misc
&lt;/p&gt;
&lt;pre&gt;    A. Cack cocaine
&lt;/pre&gt;
&lt;pre&gt;    B. Iatrogenic
&lt;/pre&gt;
&lt;pre&gt;    C. Tracheal-arterial fistula
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Bold: Most common in US
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hemoptysis&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;MASSIVE = &amp;gt;100-500cc/day
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;angle head down with affected lung low
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;consider angio embolization
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;intubate with &amp;gt;8.0 (for bronch)
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hemoptysis&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;ADMISSION
&lt;/p&gt;&lt;p&gt;1) Massive
&lt;/p&gt;&lt;p&gt;2) Minor + high risk of massive bleed
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hemoptysis&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;3/19/06 DONALDSON (adapted from Rosen)
&lt;/p&gt;



</content><folder>Pulm</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="hemorrhoids"><name>Hemorrhoids</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#External"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;External&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Internal"&gt;&lt;span class="tocnumber"&gt;2.2&lt;/span&gt; &lt;span class="toctext"&gt;Internal&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hemorrhoids&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; most common cause of anal pathology
&lt;/li&gt;&lt;li&gt; pt may present with mild symptoms (pruritis) or concerning symptoms (pain, bleeding)
&lt;/li&gt;&lt;li&gt; 2 classifications:
&lt;ol&gt;&lt;li&gt; internal: above pectinate line (usuallypainless)
&lt;/li&gt;&lt;li&gt; external: below pectinate line (usually painful)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; typically affects Caucasians from higher socioeconomic classes and rural areas, as well as pregnant females
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hemorrhoids&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hemorrhoids&amp;amp;action=edit&amp;amp;section=3" title="Edit section: External"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="External"&gt;External&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; physical may reveal redundant tissue, skin tags from old thrombosed external hemorrhoids, fissures or fistulas, rectal or hemorrhoidal prolapse 
&lt;/li&gt;&lt;li&gt; Thrombosed hemorrhoids: painful mass at rectum that peaks at 48-72 hours and will start declining by day 4 as thrombus organizes
&lt;/li&gt;&lt;li&gt; be aware of concominant anal fissure  
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hemorrhoids&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Internal"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Internal"&gt;Internal&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Grade I: may protrude with defecation only
&lt;/li&gt;&lt;li&gt; Grade II: prolapses and spontaneously reduces
&lt;/li&gt;&lt;li&gt; Grade III: prolapses and requires manual reduction
&lt;/li&gt;&lt;li&gt; Grade IV: prolapsed and unable to reduce
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hemorrhoids&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; cbc to look at hemoglobin, wbc as marker for infection
&lt;/li&gt;&lt;li&gt; anoscopy/proctoscopy 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hemorrhoids&amp;amp;action=edit&amp;amp;section=6" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; condyloma acuminata
&lt;/li&gt;&lt;li&gt; proctitis
&lt;/li&gt;&lt;li&gt; rectal prolapse
&lt;/li&gt;&lt;li&gt; anal cancer, fissure, fistula
&lt;/li&gt;&lt;li&gt; pedunculated polyp
&lt;/li&gt;&lt;li&gt; perianal abscess
&lt;/li&gt;&lt;li&gt; pruritis ani
&lt;/li&gt;&lt;li&gt; colorectal tumor 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hemorrhoids&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Nonsurgical
&lt;ol&gt;&lt;li&gt; Stool softener
&lt;/li&gt;&lt;li&gt; No straining 
&lt;/li&gt;&lt;li&gt; Sitz baths x15min tid
&lt;/li&gt;&lt;li&gt; Steroid/Abx/Anusol cream
&lt;/li&gt;&lt;li&gt; increased fiber and fluid intake
&lt;/li&gt;&lt;li&gt; anal hygiene  
&lt;/li&gt;&lt;li&gt; if there is prolapse that you cannot manually reduce, try placing some sugar on the area of prolapse and see if it will reduce spontaneously  
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Surgical 
&lt;ol&gt;&lt;li&gt; Thrombosed external
&lt;ol&gt;&lt;li&gt; Excision (elliptical) is usually necessary only for severe pain
&lt;ol&gt;&lt;li&gt; Contraindications:
&lt;ol&gt;&lt;li&gt; &amp;gt;72 hours
&lt;/li&gt;&lt;li&gt; Crohn&#8217;s disease
&lt;/li&gt;&lt;li&gt; minimal pain
&lt;/li&gt;&lt;li&gt; uncooperative patient
&lt;/li&gt;&lt;li&gt; pregnant women
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Grade III/IV internal hemorrhoid 
&lt;ol&gt;&lt;li&gt; surgical hemorrhoidectomy is best treatment
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hemorrhoids&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from Donaldson
&lt;/p&gt;



</content><folder>GI</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="henoch-schonlein_purpura"><name>Henoch-Schonlein Purpura</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Henoch-Schonlein_Purpura&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-HSP, aka anaphylactoid purpura
&lt;/p&gt;&lt;p&gt;-systemic vasculitis associated with abdominal pain and rash
&lt;/p&gt;&lt;p&gt;-usually age 4-11, may occur in adults
&lt;/p&gt;&lt;p&gt;-commonly occurs in springtime after viral URI
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Henoch-Schonlein_Purpura&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-clinical diagnosis based on presence of abdominal pain, classic rash, microscopic hematuria, arthralgias in otherwise well appearing child
&lt;/p&gt;&lt;p&gt;-symptoms: abdominal pain, nausea, vomiting, diarrhea, rash, mild arthralgias
&lt;/p&gt;&lt;p&gt;-rash: palpable purpura on buttocks and lower extremities
&lt;/p&gt;&lt;p&gt;-intussusception: ileoileal more common than ileocolic inpatients with HSP
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Henoch-Schonlein_Purpura&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-CBC, Chem7
&lt;/p&gt;&lt;p&gt;-UA
&lt;/p&gt;&lt;p&gt;-Blood cx
&lt;/p&gt;&lt;p&gt;-ESR
&lt;/p&gt;&lt;p&gt;-consider CT abdomen (ileoileal intussusception difficult to detect by US)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Henoch-Schonlein_Purpura&amp;amp;action=edit&amp;amp;section=4" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-meningococcemia (febrile, ill appearing)
&lt;/p&gt;&lt;p&gt;-erythema nodosum
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Henoch-Schonlein_Purpura&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-dz self limited: 94% recover completely
&lt;/p&gt;&lt;p&gt;-consider corticosteroids for severe disease (abdominal pain, hematuria, arthralgias)
&lt;/p&gt;
&lt;pre&gt;    -prednisone 1mg/kg/day
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Henoch-Schonlein_Purpura&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-most patients managed safely as outpatient
&lt;/p&gt;&lt;p&gt;-consider admission for:
&lt;/p&gt;
&lt;pre&gt;    -uncertain diagnosis to exclude possibility of meningococcemia
&lt;/pre&gt;
&lt;pre&gt;    -severe abdominal pain and vomiting
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Henoch-Schonlein_Purpura&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from Rosens 7th edition
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="heparin"><name>Heparin</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Common_Indications"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Common Indications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Bleeding_Risk_Factors"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Bleeding Risk Factors&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Heparin&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Common Indications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Common_Indications"&gt;Common Indications&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;DVT, PE, AFIB, ACS
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Heparin&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Bleeding Risk Factors"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Bleeding_Risk_Factors"&gt;Bleeding Risk Factors&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Surgery, trauma, or stroke within the previous 14 days.
&lt;/li&gt;&lt;li&gt; History of peptic ulcer disease, GI bleeding or GU bleeding.
&lt;/li&gt;&lt;li&gt; Platelet count less than 150K
&lt;/li&gt;&lt;li&gt; Age &amp;gt; 70 yrs.
&lt;/li&gt;&lt;li&gt; Hepatic failure, uremia, bleeding diathesis, brain metastases.
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;Draw extra blue top prior to starting if concerned about a hypercoaguable state (heparin will interfere with assays)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Heparin&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment &lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Bolus - 150 u/kg for PE, and 80-100 u/kg for all other conditions.
&lt;/li&gt;&lt;li&gt; Infuse - 15-25 u/kg/hr (high risk --&amp;gt; 15-18 u/kg/hr; low risk --&amp;gt; 22-25 u/kg/hr)
&lt;/li&gt;&lt;li&gt; Sliding scale - PTT in 60-80 range..
&lt;ol&gt;&lt;li&gt;PTT Bolus/Hold Adjust Heparin
&lt;/li&gt;&lt;li&gt;&amp;lt;50 70 u/kg 0 Increase 200 u/hr
&lt;/li&gt;&lt;li&gt;50-59 0 0 Increase 100 u/hr
&lt;/li&gt;&lt;li&gt;60-80 0 0 No change
&lt;/li&gt;&lt;li&gt;81-99 0 0 Decrease 100u/hr
&lt;/li&gt;&lt;li&gt;&amp;gt;100 0 60min Decrease 200 u/hr
&lt;ol&gt;&lt;li&gt;If 1st PTT after loading dose is &amp;gt; 100 sec do NOT change the infusion rate unless evidence of bleeding
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; The PTT should be checked 4-6 hrs after a new bolus or any change in the infusion dose.
&lt;/li&gt;&lt;li&gt; Other LABS to check include stool GUIAC qd and CBC (platelets) qd
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;Duration: DVT or PE --&amp;gt; 5 days of heparin (even if the INR is therapeutic earlier in hospital course)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Heparin&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1/22/06; DONALDSON (addapted from Lampe)
&lt;/p&gt;



</content><folder>Heme/Onc</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="hepatorenal_syndrome"><name>Hepatorenal Syndrome</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Pathophysiology"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Pathophysiology&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hepatorenal_Syndrome&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Pathophysiology"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Pathophysiology"&gt;Pathophysiology&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Functional renal vasoconstriction leading to severe redxn in GFR with minimal renal histologic abnormalities
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hepatorenal_Syndrome&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Type 1: doubling of serum Cr to &amp;gt; 2.5mg/dl in &amp;lt; 2wk
&lt;/li&gt;&lt;li&gt;Type 2: stable or less rapidly progressive course than Type 1
&lt;/li&gt;&lt;li&gt;Type 1 &amp;amp; 2 both require^:
&lt;ol&gt;&lt;li&gt;Cr &amp;gt;1.5mg/dl
&lt;/li&gt;&lt;li&gt;Cr NOT reduced below 1.5mg/dl with administration of albumin (1g/kg) and after a minimum of 2 days off diuretics 
&lt;/li&gt;&lt;li&gt;Abscence of current or recent rx with potentially nephrotoxic drugs
&lt;/li&gt;&lt;li&gt;Abscence of shock
&lt;/li&gt;&lt;li&gt;Abscence of renal parenchymal disease (urinary excretion of &amp;gt;500mg protein/d, &amp;gt;50 RBC/hpf, abnl kidneys on U/S)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hepatorenal_Syndrome&amp;amp;action=edit&amp;amp;section=3" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Hypovolemia-induced renal failure (GI bleed or fluid losses 2/2 diuretics, diarrhea most common)
&lt;/li&gt;&lt;li&gt;Parenchymal renal disease (proteinuria &amp;gt;500mg protein/d, &amp;gt;50 RBC/hpf or both; confirmed with renal biopsy)
&lt;/li&gt;&lt;li&gt;Drug-induced renal failure (current NSAIDs, aminoglycosides)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hepatorenal_Syndrome&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Vasoconstrictors
&lt;ol&gt;&lt;li&gt;Terlipressin: 0.5-1mg q 4-6 IV us 5-15d
&lt;/li&gt;&lt;li&gt;Norepi: 0.5-3mg/hr to increase MAP by 10mmHg
&lt;/li&gt;&lt;li&gt;Midrodrine: 7.5mg PO tid with Octreotide 100mcg sq
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Albumin: 1-1.5g/kg with one of above
&lt;/li&gt;&lt;li&gt;Other: TIPS, renal replacement therapy
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hepatorenal_Syndrome&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;1-month survival: 50%
&lt;/li&gt;&lt;li&gt;6-month survival: 20%
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hepatorenal_Syndrome&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from NEJM vol 361 no 13 P. Gines
&lt;/p&gt;&lt;p&gt;^International Ascites Club criteria
&lt;/p&gt;



</content><folder>GI</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="herniation_syndromes"><name>Herniation Syndromes</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Herniation_Syndromes&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Types"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Types"&gt;Types&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Uncal
&lt;ol&gt;&lt;li&gt;blown pupil
&lt;/li&gt;&lt;li&gt;hemiparesis/babinski (75% contralat)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Central Transtentorial
&lt;ol&gt;&lt;li&gt;B pinpoint --&amp;gt; nonresponsive midpoint
&lt;/li&gt;&lt;li&gt;B motor weakness/inc tone
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Cerebellotonsilar
&lt;ol&gt;&lt;li&gt;B pinpoint
&lt;/li&gt;&lt;li&gt;sudden cario/resp colapse
&lt;/li&gt;&lt;li&gt;flacid quadraplegia
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Upward Transtentorial
&lt;ol&gt;&lt;li&gt;B pinpoint
&lt;/li&gt;&lt;li&gt;downward conjugate gaze
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Herniation_Syndromes&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;5/15/06 DONALDSON (adapted from Rosen)
&lt;/p&gt;



</content><folder>Neuro</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="hiccups"><name>Hiccups</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hiccups&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Also known as Singultus
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hiccups&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Workup"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Workup"&gt;Workup&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;CBC
&lt;/li&gt;&lt;li&gt;Chem 10
&lt;/li&gt;&lt;li&gt;CXR (?CT diaphram)
&lt;/li&gt;&lt;li&gt;LFTs
&lt;/li&gt;&lt;li&gt;Lipase
&lt;/li&gt;&lt;li&gt;?Head-CT
&lt;/li&gt;&lt;li&gt;ECG
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hiccups&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment &lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Vagal maneuvers
&lt;/li&gt;&lt;li&gt;Thorazine
&lt;/li&gt;&lt;li&gt;Reglan
&lt;/li&gt;&lt;li&gt;Haldol
&lt;/li&gt;&lt;/ol&gt;




</content><folder>GI</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="high_altitude"><name>High Altitude</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Acute_Mountain_Sickness_.28AMS.29"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Acute Mountain Sickness (AMS)&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#High_Altitude_Pulmonary_Edema_.28HAPE.29"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;High Altitude Pulmonary Edema (HAPE)&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Prevention"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;Prevention&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Treatment_2"&gt;&lt;span class="tocnumber"&gt;2.2&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#High_Altitude_Cerebral_Edema_.28HACE.29"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;High Altitude Cerebral Edema (HACE)&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-7"&gt;&lt;a href="#Treatment_3"&gt;&lt;span class="tocnumber"&gt;3.1&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=High_Altitude&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Acute Mountain Sickness (AMS)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Acute_Mountain_Sickness_.28AMS.29"&gt;Acute Mountain Sickness (AMS)&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;acetazolamide
&lt;ol&gt;&lt;li&gt;Start day before ascent 125- 150 mg BID or qhs for 2- 3 days while at altitude and then stop. Peds dose is 5mg/kg/day. Watch for sulfa allergy, paresthesias, diuresis.
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Dexamethasone
&lt;ol&gt;&lt;li&gt;prevents as well as treats cerebral edema. 4mg BID- QID, day of ascent and taper off over several days. Can combine with acetazolamide.
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=High_Altitude&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;rest, descend 500- 1000m, acetazolamide 250- 500mg, dex 4mg with taper, Gamow bag (portable hyperbaric chamber)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=High_Altitude&amp;amp;action=edit&amp;amp;section=3" title="Edit section: High Altitude Pulmonary Edema (HAPE)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="High_Altitude_Pulmonary_Edema_.28HAPE.29"&gt;High Altitude Pulmonary Edema (HAPE)&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;definition: two symptoms: dyspnea at rest, cough, weakness, chest tightness or congestion.
&lt;/li&gt;&lt;li&gt;And
&lt;/li&gt;&lt;li&gt;two signs: central cyanosis, crackles or wheezes, tachypnea, tachycardia.
&lt;/li&gt;&lt;li&gt;most common medical cause of altitude related death.
&lt;/li&gt;&lt;li&gt;&amp;gt;2500m, young males, usually second night of altitude or after 3- 4 days ascent.
&lt;/li&gt;&lt;li&gt;recent URI predisposes
&lt;/li&gt;&lt;li&gt;highest risk in mountain dweller who descends to sea level and then reascends- possibly due to pulm art muscle remodeling.
&lt;/li&gt;&lt;li&gt;is noncardiogenic pulmonary edema with pulm hypertension and inflammation of capillaries and transepithelial water and sodium transport. Caused by combination of both pulm hypertension and increased cap permeability.
&lt;/li&gt;&lt;li&gt;Nitric oxide (NO) inhalation decreases pulm art pressures and can improve oxygenation. Dz possibly due to NO deficiency?
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=High_Altitude&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Prevention"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Prevention"&gt;Prevention&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;limit exercise for first 1- 2 days. Also limit ascent when over 2500m to 300- 350m/day.
&lt;/li&gt;&lt;li&gt;Nifedipine 20mg TID or 30- 6- mg extended release qd- prevents HAPE but not pulm edema of exercise of AMS or HACE.
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=High_Altitude&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment_2"&gt;Treatment&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;descend, oxygen, nifedipine 10 mg po, CPAP mask, diuretics, GAMOW bag.
&lt;/li&gt;&lt;li&gt;Can reascend in 2- 3days in needed but at increased risk for reoccurence.
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=High_Altitude&amp;amp;action=edit&amp;amp;section=6" title="Edit section: High Altitude Cerebral Edema (HACE)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="High_Altitude_Cerebral_Edema_.28HACE.29"&gt;High Altitude Cerebral Edema (HACE)&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Acute Mountain Sickness plus altered mental status or ataxia. Of if mountain sickness not present, is ataxia with mental status changes.
&lt;/li&gt;&lt;li&gt;occurs &amp;gt;4000m
&lt;/li&gt;&lt;li&gt;due to increased brain water, not just volume. Get increased intracranial pressure.
&lt;/li&gt;&lt;li&gt;initially get vasogenic edema- fluid and protein crosses BBB, Get reversible changes in white matter, especially corpus callosum.. Later get cytotoxic edema by toxins and ischemia. Mostly of gray matter and has poorer px.
&lt;/li&gt;&lt;li&gt;Theories: angiogenesis model- hypoxemia causes macrophages to release cytokines and vascular endothelium growth factor. Basement membranes of capillaries are dissolved causing leaks and petechial hemorrhages. Inhibited by dexamethasone.
&lt;/li&gt;&lt;li&gt;Other theory is due to unexpandable cranial vault. As brain volume increases buffering ability of CSF overcome and brain swells in closed nonexpanding space.
&lt;/li&gt;&lt;li&gt;Prevent as with AMS
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=High_Altitude&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment_3"&gt;Treatment&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;descend, oxygen, dex 4- 8mg IV, then 4mg q6hr. If GAMOW bag available- 4-8 hr recompression may allow pt to walk down mountain (big help).
&lt;/li&gt;&lt;/ol&gt;




</content><folder>Environ</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="high_risk_orthopedic_injuries"><name>High Risk Orthopedic Injuries</name><content>&lt;p&gt;Hip Dislocation
&lt;/p&gt;&lt;p&gt;Knee Dislocation
&lt;/p&gt;&lt;p&gt;Compartment Syndrome
&lt;/p&gt;&lt;p&gt;Supracondylar Fx
&lt;/p&gt;&lt;p&gt;Sternoclavicular Dislocation
&lt;/p&gt;



</content><folder>Ortho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="hip_dislocation"><name>Hip Dislocation</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Epidemiology"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Epidemiology&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Presentation"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Presentation&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#W.2FU"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;W/U&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Reduction"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Reduction&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Consequences"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Consequences&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hip_Dislocation&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Trauma is primary mechanism. In adults, requires substantial force vectors (MVC, fall from a height)
&lt;/p&gt;&lt;p&gt;Because of force required, 50% will have other fractures or significant injuries
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hip_Dislocation&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Epidemiology"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Epidemiology"&gt;Epidemiology&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;90% posterior (10% central or anterior)
&lt;/p&gt;&lt;p&gt;Posterior = force applied to flexed knee and hip (e.g. dashboard)
&lt;/p&gt;&lt;p&gt;Anterior = direct blow to posterior hip or posterior force to abducted leg
&lt;/p&gt;&lt;p&gt;Central = direct impact to lateral aspect.
&lt;/p&gt;&lt;p&gt;Mortality primarily due to associated injuries
&lt;/p&gt;&lt;p&gt;Head, thorax &amp;amp; pelvis
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hip_Dislocation&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Presentation"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Presentation"&gt;Presentation&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Shortened, adducted &amp;amp; internally rotated. Hip and knee in slight flexion
&lt;/p&gt;&lt;p&gt;NB: not true if there is associated femoral fx
&lt;/p&gt;&lt;p&gt;Look for:
&lt;/p&gt;&lt;p&gt;-Loss of sensat posterior leg/foot (sciatic nerve)
&lt;/p&gt;&lt;p&gt;-Loss of dorsiflexion (peroneal branch) or plantar flexion (tibial branch)
&lt;/p&gt;&lt;p&gt;-LE pale / cool to touch (femoral art)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hip_Dislocation&amp;amp;action=edit&amp;amp;section=4" title="Edit section: W/U"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="W.2FU"&gt;W/U&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Usually obvious, but can be subtle on single AP view
&lt;/p&gt;&lt;p&gt;Typically femoral head is seen lateral and superior to acetabulum
&lt;/p&gt;&lt;p&gt;CT very accurate, and helps especially in delineating acetabular injury (where plain films are notoriously poor)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hip_Dislocation&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Reduction"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Reduction"&gt;Reduction&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Multiple techniques described (Allis/Stimson)
&lt;/p&gt;&lt;p&gt;All involve longitudinal traction to unlock the femoral head, with gentle internal/external rotation to seat it in the acetabulum
&lt;/p&gt;&lt;p&gt;ED success rate for native hip dislocation/reduction unclear
&lt;/p&gt;&lt;p&gt;(10% reported, but not a pure series)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hip_Dislocation&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Consequences"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Consequences"&gt;Consequences&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Other injuries/life threats aside, the primary pathophysiology associated with hip dislocation is Avascular necrosis (AVN)
&lt;/p&gt;&lt;p&gt;-Occurs in 10-20% of cases
&lt;/p&gt;&lt;p&gt;-Time-dependant phenomenon
&lt;/p&gt;&lt;p&gt;-6-hours is the cut-off
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Sciatic Nerve injury: 10-15%
&lt;/p&gt;&lt;p&gt;-Usually neuropraxia with eventual recovery expected
&lt;/p&gt;&lt;p&gt;-Incidence of this 2.5X with delay &amp;gt; 6 hours for reduction
&lt;/p&gt;&lt;p&gt;-Osteoarthritis: 10%-35%  30-70% after open-reduction
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hip_Dislocation&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;ACEP ('09)
&lt;/p&gt;



</content><folder>Ortho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="hip_fracture"><name>Hip Fracture</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hip_Fracture&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Overview"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Overview"&gt;Overview&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Imaging
&lt;/li&gt;&lt;li&gt; Consider AP pelvis in addition to standard AP and lateral views to compare to contralateral side
&lt;/li&gt;&lt;li&gt; Consider MRI if strong clinical suspicion but negative xray
&lt;/li&gt;&lt;li&gt; Most fractures, including all displaced fx, are treated with ORIF
&lt;/li&gt;&lt;li&gt; Isolated trochanteric fx often does not require surgery 
&lt;/li&gt;&lt;li&gt; Skeletal traction is not beneficial 
&lt;/li&gt;&lt;li&gt; Type and cross/screen for pts at higher risk of hemorrhage
&lt;/li&gt;&lt;li&gt; Age &amp;gt; 75 yrs
&lt;/li&gt;&lt;li&gt; Initial hemoglobin &amp;lt; 12
&lt;/li&gt;&lt;li&gt; Peritrochanteric fx 
&lt;/li&gt;&lt;li&gt; Adolescent + knee or hip pain = rule-out SCFE 
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hip_Fracture&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Intracapsular"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Intracapsular"&gt;Intracapsular&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Femoral Head
&lt;/li&gt;&lt;li&gt; Usually occurs along with dislocation
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; Posterior dislocation - Fracture of inf aspect of femoral head; concomitant sciatic nerve injury
&lt;/li&gt;&lt;li&gt; Anterior dislocation - Fracture of anterior femoral head; concomitant vascular injury
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; Femoral neck
&lt;/li&gt;&lt;li&gt; Typically minimal bruising (intracapsular)
&lt;/li&gt;&lt;li&gt; If fractured and displaced:
&lt;/li&gt;&lt;li&gt; Externally rotated and shortened
&lt;/li&gt;&lt;li&gt; Garden Classification
&lt;/li&gt;&lt;li&gt; Type 1: Impaction Fx
&lt;/li&gt;&lt;li&gt; Type 2: Nondisplaced Fx 
&lt;/li&gt;&lt;li&gt; Type 3: Displacement of the femoral head
&lt;/li&gt;&lt;li&gt; Type 4: Complete loss of continuity between fragments 
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hip_Fracture&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Extracapsular"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Extracapsular"&gt;Extracapsular&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Intertrochanteric
&lt;/li&gt;&lt;li&gt; Typically pain, swelling, ecchymosis
&lt;/li&gt;&lt;li&gt; May lose 1-2L of blood 
&lt;/li&gt;&lt;li&gt; Unable to bear weight 
&lt;/li&gt;&lt;li&gt; Shortening and external rotation if fracture is significantly displaced 
&lt;/li&gt;&lt;li&gt; Types
&lt;/li&gt;&lt;li&gt; Stable - Lesser trochanter is not displaced, no comminution, medial cortices of prox and dist. fragments are aligned
&lt;/li&gt;&lt;li&gt; Unstable - Displacement occurs, comminution is present, or multiple fracture lines exist
&lt;/li&gt;&lt;li&gt; Trochanteric
&lt;/li&gt;&lt;li&gt; Lesser Trochanter
&lt;/li&gt;&lt;li&gt; Pain in groin or may present with knee or posterior thigh pain worse with hip flexion and rotation
&lt;/li&gt;&lt;li&gt; Most common in the young (due to forceful contraction of iliopsoas muscle) 
&lt;/li&gt;&lt;li&gt; If occurs in elderly pt with lack of trauma history consider lytic lesion   
&lt;/li&gt;&lt;li&gt; Greater Trochanter
&lt;/li&gt;&lt;li&gt; Hip pain that increases with abduction and tenderness over the greater trochanter
&lt;/li&gt;&lt;li&gt; Imaging
&lt;/li&gt;&lt;li&gt; Lessor trochanter -  AP view with the leg in supported external rotation
&lt;/li&gt;&lt;li&gt; Greater trochanter - Standard AP view
&lt;/li&gt;&lt;li&gt; Treatment 
&lt;/li&gt;&lt;li&gt; NWB for 3-4 weeks for non-displaced fx
&lt;/li&gt;&lt;li&gt; If displaced (&amp;gt; 1cm) refer to orthopedic surgeon for ORIF
&lt;/li&gt;&lt;li&gt; Subtrochanteric (including mid-shaft)
&lt;/li&gt;&lt;li&gt; Occur with severe trauma or in association with pathological bone
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; Blood loss can be substantial (average loss = 1L)
&lt;/li&gt;&lt;li&gt; Clinical presentation is similar to intertrochanteric fracture
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
Source: UpToDate, Harwood-Nuss
&lt;/p&gt;



</content><folder>Ortho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="hip_pain"><name>Hip Pain</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hip_Pain&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1)  Xray knee-hip
&lt;/p&gt;&lt;p&gt;2)  Consider CBC, Sed rate
&lt;/p&gt;&lt;p&gt;3)  Consider US (vs. CT)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hip_Pain&amp;amp;action=edit&amp;amp;section=2" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;SEPTIC ARTHRITIS
&lt;/p&gt;&lt;p&gt;Age - 6 mo to 8 yrs
&lt;/p&gt;&lt;p&gt;Pres - Pain, Pseudoparalysis
&lt;/p&gt;&lt;p&gt;Labs - ESR &amp;gt; 20 after 1-2 d, WBC &amp;gt;
&lt;/p&gt;&lt;p&gt;Xrays - possible effusion
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;SLIPPED CAPITAL FEMORAL EPIPHYSIS (SCFE)
&lt;/p&gt;&lt;p&gt;Age - 9 to 16 yrs
&lt;/p&gt;&lt;p&gt;Present - mild to severe pain, limp
&lt;/p&gt;&lt;p&gt;Labs - normal
&lt;/p&gt;&lt;p&gt;Xray - Anterior displacement of femoral neck to head
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;LEGG-CALVE-PERTHES DISEASE
&lt;/p&gt;&lt;p&gt;Age - 4 to 9 yrs
&lt;/p&gt;&lt;p&gt;Present - Painless Limp
&lt;/p&gt;&lt;p&gt;Labs - normal
&lt;/p&gt;&lt;p&gt;Xrays - Compression, collapse, fragmentation
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;ACUTE TRANSIENT SYNOVITIS
&lt;/p&gt;&lt;p&gt;Diagnosis of Exclusion
&lt;/p&gt;&lt;p&gt;- Age 3 to 8 yrs
&lt;/p&gt;&lt;p&gt;- Present - Pain. Limp, refusal to bear weight
&lt;/p&gt;&lt;p&gt;- Labs nl
&lt;/p&gt;&lt;p&gt;- Xray normal
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hip_Pain&amp;amp;action=edit&amp;amp;section=3" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Peds: Acute Transient Synovitis
&lt;/p&gt;&lt;p&gt;Peds: Legg Calve Perthes Disease
&lt;/p&gt;&lt;p&gt;Peds: Slipped Capital Femoral Epiphysis (SCFE)
&lt;/p&gt;&lt;p&gt;Peds: Septic Arthritis
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hip_Pain&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Resident &amp;amp; Staff Physician, July 02
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="humerus_shaft_fracture"><name>Humerus shaft fracture</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Complications"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Complications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Humerus_shaft_fracture&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;X-ray ==Work-Up==
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
-skin inspection (r/o open fx)-neurovascular function-Flat films     -shoulder x-ray with at least one view (axillary or scapular-Y) to r/o humeral head dislocation 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Humerus_shaft_fracture&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1) Open --&amp;gt; to OR2) Neurovascular dysfx --&amp;gt; ortho3) Closed, DNVI     - Coaptation (sugar-tong) splint &amp;amp; outpt f/u     -(oblique or spiral fractures requiring traction, a collar and cuff sling is used instead)     - 70-80% closed treated without surgical intervention 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Humerus_shaft_fracture&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Outpt Except
&lt;/p&gt;&lt;p&gt;1) Open fx
&lt;/p&gt;&lt;p&gt;2) NVascular injuries
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Consider:
&lt;/p&gt;&lt;p&gt;1) Arrticular injuries
&lt;/p&gt;&lt;p&gt;2)  Ipsilateral forearm fractures (floating elbow injuries)
&lt;/p&gt;&lt;p&gt;3)  Pathologic fractures
&lt;/p&gt;&lt;p&gt;4)  Concomitant traumatic fractures
&lt;/p&gt;&lt;p&gt;5) Distal spiral shaft fractures (Holstein Lewis fractures) - high association with radial nerve injuries (consider surgical exploration and repair)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Humerus_shaft_fracture&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Complications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Complications"&gt;Complications &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1) radial nerve injury
&lt;/p&gt;
&lt;pre&gt;    -10-18% of midshaft; more common in distal
&lt;/pre&gt;
&lt;pre&gt;    -75-90% temporary neurapraxias (resolve 3-4 mo; all should be seen by ortho)
&lt;/pre&gt;
&lt;p&gt;1)  Nonunion (2-5%)
&lt;/p&gt;
&lt;pre&gt;    -no union at 3-4 months 
&lt;/pre&gt;
&lt;pre&gt;    -more common in transverse and severely comminuted fractures
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Humerus_shaft_fracture&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;KajiQuestions
&lt;/p&gt;



</content><folder>Ortho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="hydrogen_sulfide"><name>Hydrogen Sulfide</name><content>&lt;p&gt;HYDROGEN SULFIDE
&lt;/p&gt;&lt;p&gt;n pathophys identicle to cn except bond of h2s to cytochrome more rapidly reversible than cn.  Therefore, just need to remove pt from source and use standard resus measures to reverse h2s toxicity.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;HYDROGEN SULFIDE (septic tank)
&lt;/p&gt;&lt;p&gt;remove pt from source and use standard resus measures
&lt;/p&gt;



</content><folder>Tox</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="hypercalcemia"><name>Hypercalcemia</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#DDX"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;DDX&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Causes"&gt;&lt;span class="tocnumber"&gt;4.1&lt;/span&gt; &lt;span class="toctext"&gt;Causes&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-7"&gt;&lt;a href="#Indications"&gt;&lt;span class="tocnumber"&gt;5.1&lt;/span&gt; &lt;span class="toctext"&gt;Indications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-8"&gt;&lt;a href="#Treatment_2"&gt;&lt;span class="tocnumber"&gt;5.2&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-10"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypercalcemia&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;High &amp;gt;10.5 meq/L (&amp;gt;2.7 ionized)
&lt;/p&gt;&lt;p&gt;High! &amp;gt;12.0 meq/L
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypercalcemia&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;stones (renal calculi)
&lt;/li&gt;&lt;li&gt;bones (bone destruction)
&lt;/li&gt;&lt;li&gt;psychic moanes (lethargy/confusion)
&lt;/li&gt;&lt;li&gt;abd groans (abd pain, constipation, polyuria, polydipsia)
&lt;/li&gt;&lt;li&gt;cardiac arrest (&amp;gt;20meq/L)
&lt;/li&gt;&lt;li&gt;ECG: shortened QT; heart block; depressed STs
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypercalcemia&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;check phosphate, amylase, ua
&lt;/li&gt;&lt;li&gt;ekg for prolonged PR &amp;amp; QRS, decreased QT interval, heart block
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypercalcemia&amp;amp;action=edit&amp;amp;section=4" title="Edit section: DDX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX"&gt;DDX&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypercalcemia&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Causes"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Causes"&gt;Causes&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Hypothyroid
&lt;/li&gt;&lt;li&gt;Malignancy (mult myeloma, breast, lung, renal, leukemia, pancreatic)
&lt;/li&gt;&lt;li&gt;Addison's
&lt;/li&gt;&lt;li&gt;Paget's
&lt;/li&gt;&lt;li&gt;Sarcoid
&lt;/li&gt;&lt;li&gt;Hyperthyroid
&lt;/li&gt;&lt;li&gt;Milk-alkali synd
&lt;/li&gt;&lt;li&gt;Excess vit D
&lt;/li&gt;&lt;li&gt;Thiazides
&lt;/li&gt;&lt;li&gt;Inc parathyroid
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypercalcemia&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypercalcemia&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Indications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Indications"&gt;Indications&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;&amp;gt;12.0 meq/L
&lt;/li&gt;&lt;li&gt;symptomatic
&lt;/li&gt;&lt;li&gt;unalbe to tolerated POs
&lt;/li&gt;&lt;li&gt;abnl renal fx
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypercalcemia&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment_2"&gt;Treatment&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Correct dehydration (NS 5-10L)
&lt;ol&gt;&lt;li&gt;aim UOP = 500cc/hr
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Lasix (40-200mg IV Q1-2hr PRN dec UOP)
&lt;/li&gt;&lt;li&gt;Correct hypokalemia/hypomagnesemia
&lt;/li&gt;&lt;li&gt;^Calcitonin 0.5-4 IU/kg IV over 24hrs
&lt;/li&gt;&lt;li&gt;^Hydrocortisone 25-100mg IV Q6
&lt;/li&gt;&lt;li&gt;^Dialysis if anuric, RF, or CHF
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;^if Rxs 1-3 unsuccsessful
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypercalcemia&amp;amp;action=edit&amp;amp;section=9" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Hem/Onc: Hypercalcemia of Malignancy
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypercalcemia&amp;amp;action=edit&amp;amp;section=10" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;2/12/06 DONALDSON (adapted from Tintinalli, Mistry)
&lt;/p&gt;



</content><folder>FEN</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="hypercalcemia_of_malignancy"><name>Hypercalcemia of Malignancy</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Categorization"&gt;&lt;span class="tocnumber"&gt;3.1&lt;/span&gt; &lt;span class="toctext"&gt;Categorization&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-6"&gt;&lt;a href="#Calcium_level_.3C_12_mg.2FdL_.28mild_or_chronic.29"&gt;&lt;span class="tocnumber"&gt;4.1&lt;/span&gt; &lt;span class="toctext"&gt;Calcium level &amp;lt; 12 mg/dL (mild or chronic)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-7"&gt;&lt;a href="#Calcium_level_.E2.89.A5_12_mg.2FdL_.28severe_or_symptomatic.29"&gt;&lt;span class="tocnumber"&gt;4.2&lt;/span&gt; &lt;span class="toctext"&gt;Calcium level &#8805; 12 mg/dL (severe or symptomatic)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-10"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypercalcemia_of_Malignancy&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;In the setting of cancer, hypercalcemia falls into the following 4 categories:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt; Local osteolysis associated primarily with bone metastasis (20%)
&lt;ol&gt;&lt;li&gt;breast, MM, lymphoma
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Humoral hypercalcemia of malignancy (HHM) associated with PTHrP
&lt;ol&gt;&lt;li&gt;Squamous cell carcinoma (particularly of the head and neck); renal, endometrial, and breast cancers, HTLV-lymphoma
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Lymphoma-associated secretion of calcitriol, which increases intestinal calcium absorption and bone resorption by osteoclasts (1%)
&lt;ol&gt;&lt;li&gt;Hodgkin-associated hypercalcemia and 30% to 40% of non-Hodgkin lymphoma&#8211;associated hypercalcemia 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Ectopic secretion of PTH, which is extremely rare (usually with parathyroid carcinomas)
&lt;ol&gt;&lt;li&gt;ovary, lung, and primitive neuroectoderm
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypercalcemia_of_Malignancy&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Signs &amp;amp; Symptoms
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Consistent with degree of hypercalcemia and rate of increase (see Hypercalcemia)
&lt;/li&gt;&lt;li&gt;Polydipsia, polyuria
&lt;/li&gt;&lt;li&gt;Bone pain
&lt;/li&gt;&lt;li&gt;Gastrointestinal symptoms (anorexia, nausea, vomiting, and constipation)
&lt;/li&gt;&lt;li&gt;Psychiatric symptoms (memory loss, apathy)
&lt;/li&gt;&lt;li&gt;Lethargy, and fatigue
&lt;/li&gt;&lt;li&gt;Bony tenderness over sites of osteolysis
&lt;/li&gt;&lt;li&gt;Dehydration
&lt;/li&gt;&lt;li&gt;Look for signs of CHF, renal failure to avoid vol overload
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypercalcemia_of_Malignancy&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Chem10
&lt;/li&gt;&lt;li&gt;ionized Ca
&lt;/li&gt;&lt;li&gt;CBC
&lt;/li&gt;&lt;li&gt;LFTs (alk phos, albumin)
&lt;/li&gt;&lt;li&gt;PTH
&lt;/li&gt;&lt;li&gt;PTH-rP (non emergent)
&lt;/li&gt;&lt;li&gt;EKG (prolonged PR interval, widened QRS complex, shortened QT interval, bundle branch block, or bradydysrhythmia and even cardiac arrest (typically with calcium levels &amp;gt; 15 mg/dL)
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypercalcemia_of_Malignancy&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Categorization"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Categorization"&gt;Categorization&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Mild (total calcium level, 10.5-11.9 mg/dL)
&lt;/li&gt;&lt;li&gt;Moderate (total calcium level, 12.0-13.9 mg/dL)
&lt;/li&gt;&lt;li&gt;Severe (total calcium level &#8805; 14.0 mg/dL)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypercalcemia_of_Malignancy&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Address volume losses and reduce bone resorption
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypercalcemia_of_Malignancy&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Calcium level &amp;amp;lt; 12 mg/dL (mild or chronic)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Calcium_level_.3C_12_mg.2FdL_.28mild_or_chronic.29"&gt;Calcium level &amp;lt; 12 mg/dL (mild or chronic)&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Oral hydration
&lt;/li&gt;&lt;li&gt;High-salt diet
&lt;/li&gt;&lt;li&gt;Avoid medications that cause hypercalcemia
&lt;/li&gt;&lt;li&gt;No treatment at all may be an option
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypercalcemia_of_Malignancy&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Calcium level &#8805; 12 mg/dL (severe or symptomatic)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Calcium_level_.E2.89.A5_12_mg.2FdL_.28severe_or_symptomatic.29"&gt;Calcium level &#8805; 12 mg/dL (severe or symptomatic)&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Normal saline
&lt;ol&gt;&lt;li&gt;initially 200-300 mL/h until patient is euvolemic
&lt;/li&gt;&lt;li&gt;then adjust to maintain urine output of 100-150 mL/h
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;IV Bisphosphonate (pyrophosphate analogues bind to hydroxyapatite and inhibit bone crystal dissolution and therefore osteoclastic resorption)
&lt;ol&gt;&lt;li&gt;Zoledronic acid: 4 mg over 15 minutes; 8 mg if second dose is required (not FDA approved)
&lt;/li&gt;&lt;li&gt;Pamidronate: given over 2-24 hours, either as 60 mg (calcium level, 12-13.5 mg/dL) or 90 mg (calcium level &amp;gt;13.5 mg/dL)
&lt;/li&gt;&lt;li&gt;Calcium levels begin to decrease 2 to 4 days after administration of IV bisphosphonates, reach a nadir between 4 and 7 days, and typically remain within the reference range for 1 to 4 weeks
&lt;/li&gt;&lt;li&gt;In a head-to-head comparison of zoledronate (4 mg) versus pamidronate (90 mg), zoledronate had the benefit of a shorter administration time (15 minutes vs 2 hours, respectively) and a statistically significant difference (p 0.001) of 0.7 mg/dL in the calcium level at its nadir (9.8 mg/dL vs 10.5 mg/dL, respectively)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Calcitonin 4 IU/kg SQ or IM; repeat every 6-12 hours only if patient is responsive
&lt;ol&gt;&lt;li&gt;Calcitonin exerts this effect by inhibiting osteoclastic resorption and inducing calciuresis
&lt;/li&gt;&lt;li&gt;peak activity within 12-24h
&lt;/li&gt;&lt;li&gt;lowers Ca ~1.0mg/dL
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Loop diuretics only after volume repletion in patients with congestive heart failure or chronic kidney disease
&lt;/li&gt;&lt;li&gt;Hemodialysis for patients with any of the following:
&lt;ol&gt;&lt;li&gt;Neurologic symptoms
&lt;/li&gt;&lt;li&gt;Calcium level &#8805; 18 mg/dL
&lt;/li&gt;&lt;li&gt;Acute or chronic kidney disease (GFR &amp;lt; 10-20 mL/min)
&lt;/li&gt;&lt;li&gt;Congestive heart failure
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypercalcemia_of_Malignancy&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Ca &amp;lt;12: home with f/u after d/w onc
&lt;/li&gt;&lt;li&gt;Ca&amp;gt;12: admit ward
&lt;/li&gt;&lt;li&gt;EKG changes: tele
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypercalcemia_of_Malignancy&amp;amp;action=edit&amp;amp;section=9" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Hypercalcemia
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypercalcemia_of_Malignancy&amp;amp;action=edit&amp;amp;section=10" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;EM Practice 3/10
&lt;/p&gt;



</content><folder>FEN</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="hyperkalemia"><name>Hyperkalemia</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#ECG"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;ECG&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Differential_Diagnosis"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Differential Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hyperkalemia&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;High = &amp;gt;5.5meq/L
&lt;/p&gt;&lt;p&gt;High! = &amp;gt;6.5meq/L 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hyperkalemia&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Always consider pseudohyperkalemia (e.g. from hemolysis)
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hyperkalemia&amp;amp;action=edit&amp;amp;section=3" title="Edit section: ECG"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="ECG"&gt;ECG&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;6.5 - peaked Ts, inc PR, dec QT
&lt;/p&gt;&lt;p&gt;7.5 - QRS widening, P flattening
&lt;/p&gt;&lt;p&gt;8 - sine wave, v-fib, heart block
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hyperkalemia&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Differential Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Differential_Diagnosis"&gt;Differential Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Redistribution
&lt;ol&gt;&lt;li&gt;Acidosis drives potassium out of the cells
&lt;ol&gt;&lt;li&gt;DKA
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Cellular breakdown
&lt;ol&gt;&lt;li&gt;Rhabdomyolysis
&lt;/li&gt;&lt;li&gt;Hemolysis
&lt;/li&gt;&lt;li&gt;Tumor lysis syndrome
&lt;/li&gt;&lt;li&gt;Crush
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Increased total body potassium
&lt;ol&gt;&lt;li&gt;Inadequate excretion
&lt;ol&gt;&lt;li&gt;Renal caused (acute or chronic renal failure-must have GFR&amp;lt;10)
&lt;/li&gt;&lt;li&gt;Mineralocorticoid deficiency or Addison's disease
&lt;/li&gt;&lt;li&gt;Drug-induced (potassium sparing diuretics [e.g., spironolactone] and ACE-inhibitors)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Excessive intake
&lt;ol&gt;&lt;li&gt;Diet, meds
&lt;/li&gt;&lt;li&gt;Blood transfusion
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Pseudohyperkalemia
&lt;ol&gt;&lt;li&gt;Hemolysis of the specimen
&lt;/li&gt;&lt;li&gt;Prolonged period of tourniquets occlusion prior to blood draw
&lt;/li&gt;&lt;li&gt;Thrombocytosis/leukocytosis
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Misc
&lt;ol&gt;&lt;li&gt;Succs, dib, B-blockers
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hyperkalemia&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Calcium gluconate 1 amp IV (if ECG changes/hypotension/or &amp;gt;7; can give mult times)
&lt;ol&gt;&lt;li&gt;Caution in dig-toxic patients!
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Albuterol neb 2.5mg x 3
&lt;/li&gt;&lt;li&gt;10 U reg insulin IV with 1 amp D50W IV now, and 1 amp in 15 min
&lt;/li&gt;&lt;li&gt;1 amp NaBicarb IV (over 5 min)
&lt;/li&gt;&lt;li&gt;Kayexalate 30g PO (may cause volume overload; +/- 50mL sorbitol)
&lt;/li&gt;&lt;li&gt;Consider dialyisis &amp;amp;&amp;nbsp;?lasix
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hyperkalemia&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;7/2/09 Adapted from Tintinalli, Donaldson, Pani
&lt;/p&gt;



</content><folder>FEN</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="hypermagnesemia"><name>Hypermagnesemia</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#DDX"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;DDX&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypermagnesemia&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;High &amp;gt;3.5
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypermagnesemia&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;3.5 dec DTRs
&lt;/p&gt;&lt;p&gt;4 muscl weakness
&lt;/p&gt;&lt;p&gt;5 hypotension
&lt;/p&gt;&lt;p&gt;8 resp paralysis
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypermagnesemia&amp;amp;action=edit&amp;amp;section=3" title="Edit section: DDX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX"&gt;DDX&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Renal failure
&lt;/li&gt;&lt;li&gt;Lithium
&lt;/li&gt;&lt;li&gt;Iatrogenic
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypermagnesemia&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;IVF (NS)
&lt;/li&gt;&lt;li&gt;Lasix 20-40mg IVP
&lt;/li&gt;&lt;li&gt;Correct acidosis (NaBicarb iv nec)
&lt;/li&gt;&lt;li&gt;CaCl
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypermagnesemia&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;2/12/06 DONALDSON (adapted from Tintinalli)
&lt;/p&gt;



</content><folder>FEN</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="hypernatremia"><name>Hypernatremia</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#DDX"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;DDX&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Water_Deficit"&gt;&lt;span class="tocnumber"&gt;4.1&lt;/span&gt; &lt;span class="toctext"&gt;Water Deficit&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypernatremia&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;High = &amp;gt;150meq/L
&lt;/p&gt;&lt;p&gt;High! = (Osm &amp;gt;350)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypernatremia&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;SYMPTOMS
&lt;/p&gt;&lt;p&gt;&amp;gt;350 = begin sx
&lt;/p&gt;&lt;p&gt;&amp;gt;375 = irritability, ataxia
&lt;/p&gt;&lt;p&gt;&amp;gt;400 = lethargy, coma
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypernatremia&amp;amp;action=edit&amp;amp;section=3" title="Edit section: DDX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX"&gt;DDX&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;H2O loss
&lt;ol&gt;&lt;li&gt;Decreased Intake
&lt;/li&gt;&lt;li&gt;H2O loss &amp;gt; Na loss
&lt;ol&gt;&lt;li&gt;vomit
&lt;/li&gt;&lt;li&gt;diarrhea
&lt;/li&gt;&lt;li&gt;sweating
&lt;/li&gt;&lt;li&gt;dialysis,
&lt;/li&gt;&lt;li&gt;osmotic diuresis
&lt;/li&gt;&lt;li&gt;Central DI
&lt;ol&gt;&lt;li&gt;Head trauma
&lt;/li&gt;&lt;li&gt;CVA
&lt;/li&gt;&lt;li&gt;Tumor
&lt;/li&gt;&lt;li&gt;Infect
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Nephrogenic DI
&lt;/li&gt;&lt;li&gt;Thyroidtoxicosis
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Na gain
&lt;ol&gt;&lt;li&gt;Increased Intake
&lt;ol&gt;&lt;li&gt;Na intake
&lt;/li&gt;&lt;li&gt;NaBicarb
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Renal Na retention
&lt;ol&gt;&lt;li&gt;(2nd poor perfusion)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypernatremia&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Tx perfusion deficits with NS
&lt;/li&gt;&lt;li&gt;Then, switch to 4.5% NS after UOP = &amp;gt;0.5 mL/kg/hr
&lt;/li&gt;&lt;li&gt;if no UOP after rehydration, use lasix (20-40mg IV)
&lt;/li&gt;&lt;/ol&gt;
&lt;ul&gt;&lt;li&gt;Avoid lowering Na more than 10meq/L/day (chronic)!
&lt;/li&gt;&lt;li&gt;Around 120mL/kg/hr D5W
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypernatremia&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Water Deficit"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Water_Deficit"&gt;Water Deficit&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;H2O Deficit = TBW (1 - (measured Na/desired Na))
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Each liter H2O Deficit increases measured Na by 3-5 meq/L
&lt;/li&gt;&lt;li&gt;Central DI --&amp;gt; Tx with DDAVP
&lt;/li&gt;&lt;li&gt;In Peds &amp;gt;180meq/L consider peritoneal dialysis
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypernatremia&amp;amp;action=edit&amp;amp;section=6" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;MDCalc: www.mdcalc.com/free-water-deficit-in-hypernatremia
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypernatremia&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;2/4/06 DONALDSON (adapted from Tintinalli)
&lt;/p&gt;



</content><folder>FEN</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="hyperosmolar_hyperglycemic_nonketotic_state_(hhs)"><name>Hyperosmolar Hyperglycemic Nonketotic State (HHS)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#Precipitants"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;Precipitants&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#History"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;History&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Physical_Exam"&gt;&lt;span class="tocnumber"&gt;2.2&lt;/span&gt; &lt;span class="toctext"&gt;Physical Exam&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Work_Up"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Work Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hyperosmolar_Hyperglycemic_Nonketotic_State_(HHS)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hyperosmolar_Hyperglycemic_Nonketotic_State_(HHS)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Precipitants"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Precipitants"&gt;Precipitants&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Renal failure 
&lt;/li&gt;&lt;li&gt; Pneumonia, Sepsis
&lt;/li&gt;&lt;li&gt; GI bleed
&lt;/li&gt;&lt;li&gt; MI
&lt;/li&gt;&lt;li&gt; CVA, bleed/ischemic
&lt;/li&gt;&lt;li&gt; PE
&lt;/li&gt;&lt;li&gt; Pancreatitis 
&lt;/li&gt;&lt;li&gt; Burns
&lt;/li&gt;&lt;li&gt; Heat Stroke
&lt;/li&gt;&lt;li&gt; Dialysis
&lt;/li&gt;&lt;li&gt; Recent Surgery
&lt;/li&gt;&lt;li&gt; Drugs, Meds: CCBs, Beta-blockers, carbamezapines, cimetidine, cocaine/alcohol, steroids, etc..
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hyperosmolar_Hyperglycemic_Nonketotic_State_(HHS)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hyperosmolar_Hyperglycemic_Nonketotic_State_(HHS)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: History"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="History"&gt;History&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Fever
&lt;/li&gt;&lt;li&gt; Thirst 
&lt;/li&gt;&lt;li&gt; Polyuria or Oliguria or Polydipsia
&lt;/li&gt;&lt;li&gt; Confusion
&lt;/li&gt;&lt;li&gt; Seizures (focal)
&lt;/li&gt;&lt;li&gt; Hallucinations
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hyperosmolar_Hyperglycemic_Nonketotic_State_(HHS)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Physical Exam"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Physical_Exam"&gt;Physical Exam&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; decrease consciousness
&lt;/li&gt;&lt;li&gt; tachy, hypotension
&lt;/li&gt;&lt;li&gt; fever
&lt;/li&gt;&lt;li&gt; focal seizures
&lt;/li&gt;&lt;li&gt; hemiparesis
&lt;/li&gt;&lt;li&gt; myoclonus
&lt;/li&gt;&lt;li&gt; quadriplegia
&lt;/li&gt;&lt;li&gt; nystagmus
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hyperosmolar_Hyperglycemic_Nonketotic_State_(HHS)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Work Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work_Up"&gt;Work Up&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; CBC
&lt;/li&gt;&lt;li&gt; UA
&lt;/li&gt;&lt;li&gt; CXR
&lt;/li&gt;&lt;li&gt; EKG
&lt;/li&gt;&lt;li&gt; cultures
&lt;/li&gt;&lt;li&gt; Head CT, LP if suspecting intracranial process
&lt;/li&gt;&lt;/ol&gt;
&lt;ul&gt;&lt;li&gt; 50-65% have no history of diabetes
&lt;/li&gt;&lt;li&gt; Chem-10: Glucose&amp;gt; 600mg/dl (often &amp;gt; 1000), BUN/Cr ratio  &amp;gt;30
&lt;/li&gt;&lt;li&gt; Acetone:  no ketosis (lactic acidosis +/- present)
&lt;/li&gt;&lt;li&gt; Serum, Urine osmolarity: serum osmolarity &amp;gt; 320-350 mOsm/L
&lt;/li&gt;&lt;li&gt; Creatinine Kinase: often elevated due to rhabdo
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hyperosmolar_Hyperglycemic_Nonketotic_State_(HHS)&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Fluids- mean deficit is 9L. Start IV NS until BP and UOP OK.  Then, change to 1/2 NS &amp;amp; replace 50% deficit over 12h, &amp;amp; 50% over next 12-24h 
&lt;ol&gt;&lt;li&gt; ADA guidelines: 1/2 NS at 4-14 ml/kg/hr if corrected sodium normal or elevated
&lt;/li&gt;&lt;li&gt; ADA guidelines: NS at 4-14 ml/kg/hr if low corrected sodium
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Add dextrose once glucose fall &amp;lt;=300 mg/dl
&lt;/li&gt;&lt;li&gt; Replace potassium (5-10 meq per h) when level available and OK UOP
&lt;ol&gt;&lt;li&gt; if serum K &amp;lt;3.3 mEq/L add 40 mEq/L/hr
&lt;/li&gt;&lt;li&gt; if serum K &amp;lt;5 mEq/L add 20 mEq to each liter of fluids
&lt;/li&gt;&lt;li&gt; chemistry q1hr for first 4-6hrs of treatment
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Insulin: may be unnecessary in ED.  Consider starting once hemodynamically stable and UOP is adequate
&lt;ol&gt;&lt;li&gt; consider 0.1 Unit/kg/hr IV and modify rate to lower glucose 50-75 dL/hour
&lt;/li&gt;&lt;li&gt; once glucose is &amp;lt;=300 mg/dL, add D5 and decrease insulin to &amp;lt;= 0.5 Units/kg/hr
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Empiric phosphate repletion, SC Heparin, Broad Spectrum PPx ABx may be needed
&lt;/li&gt;&lt;li&gt; Avoid phenytoin for seizures since this agent inhibits the release of exogenous insulin and is associated with HHS  
&lt;/li&gt;&lt;li&gt; Admit ICU, consider central line if underlying cardiac, or renal disease
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hyperosmolar_Hyperglycemic_Nonketotic_State_(HHS)&amp;amp;action=edit&amp;amp;section=8" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Endo: DKA
&lt;/p&gt;&lt;p&gt;Endo: Diabetes (Meds)
&lt;/p&gt;&lt;p&gt;Endo: Hypoglycemia
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hyperosmolar_Hyperglycemic_Nonketotic_State_(HHS)&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Sotelo 11/3/2009
&lt;/p&gt;



</content><folder>Endo</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="hypertensive_emergency"><name>Hypertensive Emergency</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Etiology"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Etiology&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Disease_Specific"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Disease Specific&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#HTN_Encephalopathy"&gt;&lt;span class="tocnumber"&gt;4.1&lt;/span&gt; &lt;span class="toctext"&gt;HTN Encephalopathy&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-6"&gt;&lt;a href="#Stroke"&gt;&lt;span class="tocnumber"&gt;4.2&lt;/span&gt; &lt;span class="toctext"&gt;Stroke&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-7"&gt;&lt;a href="#Acute_Aortic_Dissection"&gt;&lt;span class="tocnumber"&gt;4.3&lt;/span&gt; &lt;span class="toctext"&gt;Acute Aortic Dissection&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-8"&gt;&lt;a href="#ACS_and_Pulmonary_Edema"&gt;&lt;span class="tocnumber"&gt;4.4&lt;/span&gt; &lt;span class="toctext"&gt;ACS and Pulmonary Edema&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-9"&gt;&lt;a href="#Pheochromocytoma"&gt;&lt;span class="tocnumber"&gt;4.5&lt;/span&gt; &lt;span class="toctext"&gt;Pheochromocytoma&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-10"&gt;&lt;a href="#ARF"&gt;&lt;span class="tocnumber"&gt;4.6&lt;/span&gt; &lt;span class="toctext"&gt;ARF&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-11"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypertensive_Emergency&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; End-organ damage 2/2 increased BP (generally &amp;gt;180/120, usually &amp;gt; 220/130)
&lt;ul&gt;&lt;li&gt; Brain - Encephelopathy, seizure, ICH, ischemic stroke
&lt;/li&gt;&lt;li&gt; Eyes - Retinal hemorrhage, exudate, papilledema
&lt;/li&gt;&lt;li&gt; CV - MI, CHF/LV failure/pulm edema, aortic dissection
&lt;/li&gt;&lt;li&gt; Renal - Acute failure, hematuria, proteinuria
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; Ancillary Tests
&lt;ul&gt;&lt;li&gt; Chemistry - assess renal failure
&lt;/li&gt;&lt;li&gt; UA - Assess renal failure, glomerulo nephritis, preeclampsia
&lt;/li&gt;&lt;li&gt; Troponin
&lt;/li&gt;&lt;li&gt; CXR - Evidenceo failure, dissection
&lt;/li&gt;&lt;li&gt; ECG
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypertensive_Emergency&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Etiology"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Etiology"&gt;Etiology&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Idiopathic
&lt;/li&gt;&lt;li&gt; Sympathomimetic drug use
&lt;/li&gt;&lt;li&gt; Preeclampsia
&lt;/li&gt;&lt;li&gt; Acute glomerulonephritis
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypertensive_Emergency&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Goal: Lower diastolic pressure to 105mmHg within 2-6 hours
&lt;ul&gt;&lt;li&gt; Maximum initial fall in BP should not exceed 25% of presenting value
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; Be careful of lowering BP in pts with CVA!
&lt;/li&gt;&lt;/ul&gt;
&lt;table style="width: 100%" border="1"&gt;
&lt;tr&gt;
&lt;td&gt; Drug
&lt;/td&gt;&lt;td&gt; Dose
&lt;/td&gt;&lt;td&gt; Mechanism
&lt;/td&gt;&lt;td&gt; Pros
&lt;/td&gt;&lt;td&gt; Cons
&lt;/td&gt;&lt;td&gt; Notes
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Nitroprusside
&lt;/td&gt;&lt;td&gt;
&lt;p&gt;0.25-8&amp;nbsp;?g/kg/min
&lt;/p&gt;&lt;p&gt;(start at 0.25)
&lt;/p&gt;
&lt;/td&gt;&lt;td&gt; Arterial and veno-dilator
&lt;/td&gt;&lt;td&gt;
&lt;p&gt;1. Very effective
&lt;/p&gt;&lt;p&gt;2. Immediate onset/offset
&lt;/p&gt;
&lt;/td&gt;&lt;td&gt;
&lt;p&gt;1. Cyanide Toxicity
&lt;/p&gt;&lt;p&gt;2. Coronary steal?
&lt;/p&gt;&lt;p&gt;3. Incr HR
&lt;/p&gt;
&lt;/td&gt;&lt;td&gt;
&lt;p&gt;1. Avoid in liver/renal failure
&lt;/p&gt;&lt;p&gt;2. Avoid with incr ICP
&lt;/p&gt;&lt;p&gt;3. Avoid in pregnancy
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Nitgroglycerin
&lt;/td&gt;&lt;td&gt; 5-100&amp;nbsp;?g/min
&lt;/td&gt;&lt;td&gt; Veno&amp;gt;arteriodilation
&lt;/td&gt;&lt;td&gt;
&lt;p&gt;1. Rapid on/offset
&lt;/p&gt;&lt;p&gt;2. Increases coronary flow
&lt;/p&gt;
&lt;/td&gt;&lt;td&gt; Causes Tachycardia
&lt;/td&gt;&lt;td&gt;
&lt;p&gt;Drug of choice in pts w/ cardiac ischemia,
&lt;/p&gt;&lt;p&gt;LV dysfunction, and pulm edema
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Labetalol
&lt;/td&gt;&lt;td&gt;
&lt;p&gt;20-80mg IV bolus q10min OR
&lt;/p&gt;&lt;p&gt;0.5-2mg/min IV
&lt;/p&gt;
&lt;/td&gt;&lt;td&gt; Beta&amp;gt;alpha blocker
&lt;/td&gt;&lt;td&gt;
&lt;p&gt;1. No change in HR, cerebral flow
&lt;/p&gt;&lt;p&gt;2. Rapid onset
&lt;/p&gt;
&lt;/td&gt;&lt;td&gt;
&lt;p&gt;Avoid in COPD, CHF
&lt;/p&gt;&lt;p&gt;heart block
&lt;/p&gt;
&lt;/td&gt;&lt;td&gt;
&lt;p&gt;1. Consider in ACS
&lt;/p&gt;&lt;p&gt;2. Consider in ischemic CVA
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Esmolol
&lt;/td&gt;&lt;td&gt;
&lt;p&gt;250-500&amp;nbsp;?g/kg/min;
&lt;/p&gt;&lt;p&gt;may repeat bolus after
&lt;/p&gt;&lt;p&gt;5min or incr to 300&amp;nbsp;?g/min
&lt;/p&gt;
&lt;/td&gt;&lt;td&gt; Beta selective
&lt;/td&gt;&lt;td&gt; 1. Rapid on/offset
&lt;/td&gt;&lt;td&gt;
&lt;p&gt;Avoid in COPD, CHF
&lt;/p&gt;&lt;p&gt;bradycardia
&lt;/p&gt;
&lt;/td&gt;&lt;td&gt;
&lt;p&gt;Consider in ACS
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Nicardipine
&lt;/td&gt;&lt;td&gt; 5-15mg/h&lt;br /&gt;&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Decreases PVR&lt;br /&gt;&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Good for intracranial pathology
&lt;/td&gt;&lt;td&gt; Slower onset/offset
&lt;/td&gt;&lt;td&gt; Avoid in CHF, ACS
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Hydralazine
&lt;/td&gt;&lt;td&gt; 5-10mg IV bolus, max dose 20mg OR 0.5-1mg/min IV infusion
&lt;/td&gt;&lt;td&gt; Arteriolar vasodilator
&lt;/td&gt;&lt;td&gt; Rarely causes hypotension
&lt;/td&gt;&lt;td&gt; Avoid in CAD
&lt;/td&gt;&lt;td&gt; Primarily used in pregancy
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Phentolamine
&lt;/td&gt;&lt;td&gt;
&lt;p&gt;5-10mg IV bolus q5-15min OR
&lt;/p&gt;&lt;p&gt;0.2-5mg/min IV infusion
&lt;/p&gt;
&lt;/td&gt;&lt;td&gt; Alpha blocker
&lt;/td&gt;&lt;td&gt;
&lt;/td&gt;&lt;td&gt;
&lt;/td&gt;&lt;td&gt; Used for catecholamine-induced HTN
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Enalapril
&lt;/td&gt;&lt;td&gt; 1.25mg over 5min q6hr
&lt;/td&gt;&lt;td&gt; Decreases HR, SV, systemic arterial pressure
&lt;/td&gt;&lt;td&gt; Does not impair cerebral flow
&lt;/td&gt;&lt;td&gt; Variable response
&lt;/td&gt;&lt;td&gt;
&lt;p&gt;1. Used in pts at risk for cerebral hypotension, CHF
&lt;/p&gt;&lt;p&gt;2. Avoid in pregnancy
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypertensive_Emergency&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Disease Specific"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disease_Specific"&gt;Disease Specific&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypertensive_Emergency&amp;amp;action=edit&amp;amp;section=5" title="Edit section: HTN Encephalopathy"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="HTN_Encephalopathy"&gt;HTN Encephalopathy&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Controlled redxn of BP over 1h; never &amp;lt; 110 diastolic
&lt;/p&gt;&lt;p&gt;Labetolol, nicardipine, fenoldopam; nitroprusside of diastolic &amp;gt; 140
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypertensive_Emergency&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Stroke"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Stroke"&gt;Stroke&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;10-15% reduction of MAP; diastolic not &amp;lt; 110
&lt;/p&gt;&lt;p&gt;lower to 185/110 in ischemic stroke to meet t-PA criteria
&lt;/p&gt;&lt;p&gt;Labetolol, nicardipine, nitroprusside as above
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypertensive_Emergency&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Acute Aortic Dissection"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Acute_Aortic_Dissection"&gt;Acute Aortic Dissection&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Rapid redxn of BP, systolic bp 100-120; HR 60-80 &lt;i&gt;within&lt;/i&gt; 20mins
&lt;/p&gt;&lt;p&gt;Prevent reflex tachycardia
&lt;/p&gt;&lt;p&gt;Nitroprusside, fenoldopam, nicardipine &lt;i&gt;with&lt;/i&gt; metoprolol or esmolol; labetolol alone
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypertensive_Emergency&amp;amp;action=edit&amp;amp;section=8" title="Edit section: ACS and Pulmonary Edema"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="ACS_and_Pulmonary_Edema"&gt;ACS and Pulmonary Edema&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Nitroglycerin
&lt;/p&gt;&lt;p&gt;Eslampsia/Pre-eclampsia
&lt;/p&gt;&lt;p&gt;Labetolol, nicardipine or IV hydralazine
&lt;/p&gt;&lt;p&gt;Magnesium
&lt;/p&gt;&lt;p&gt;Cocaine and Amphetamine Toxicitiy
&lt;/p&gt;&lt;p&gt;BDZs
&lt;/p&gt;&lt;p&gt;Mixed alpha + B blockade: phentolamine or nitroprusside &lt;i&gt;plus&lt;/i&gt; beta blocker
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypertensive_Emergency&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Pheochromocytoma"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Pheochromocytoma"&gt;Pheochromocytoma&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Phentolamine or nitroprusside &lt;i&gt;plus&lt;/i&gt; beta blocker
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypertensive_Emergency&amp;amp;action=edit&amp;amp;section=10" title="Edit section: ARF"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="ARF"&gt;ARF&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Fenoldopam, nicardipine; nitroprusside risk cyanide toxicity (renal metabolism)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypertensive_Emergency&amp;amp;action=edit&amp;amp;section=11" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from Bessen, Bresler (ACEP '09), UpToDate
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="hypertensive_urgency"><name>Hypertensive Urgency</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Definition"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Definition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#ED_RX"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;ED RX&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Post_ED_RX"&gt;&lt;span class="tocnumber"&gt;2.2&lt;/span&gt; &lt;span class="toctext"&gt;Post ED RX&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;2.3&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypertensive_Urgency&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Definition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Definition"&gt;Definition&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Major elevation in BP, roughly in range of &amp;gt;220/&amp;gt;120, but
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;without evidence of acute organ failure
&lt;/li&gt;&lt;li&gt;no acute symptoms directly attributable to elevated BP
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypertensive_Urgency&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Unnecessary in ED, but if you must...
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypertensive_Urgency&amp;amp;action=edit&amp;amp;section=3" title="Edit section: ED RX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="ED_RX"&gt;ED RX&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Clonidine 0.1 - 0.2mg PO to start
&lt;ol&gt;&lt;li&gt;Goal: 20% reduction of MAP or to diastolic 110
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypertensive_Urgency&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Post ED RX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Post_ED_RX"&gt;Post ED RX&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Consider in:
&lt;/li&gt;&lt;li&gt;Consistantly &amp;gt; 100 diastolic
&lt;/li&gt;&lt;li&gt;Chronic CHF
&lt;/li&gt;&lt;li&gt;CAD
&lt;/li&gt;&lt;li&gt;CRF
&lt;/li&gt;&lt;li&gt;DM
&lt;/li&gt;&lt;/ol&gt;
&lt;ol&gt;&lt;li&gt;Hydrochlorothiazide 12.5-25mg PO qday
&lt;ol&gt;&lt;li&gt;If on other antiHTN, add 6.25-12.5mg PO qday
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;If already on diuretic:
&lt;ol&gt;&lt;li&gt;CAD - Beta blocker
&lt;/li&gt;&lt;li&gt;CHF - ACEi or ARB
&lt;/li&gt;&lt;li&gt;RF - ACEi or ARB
&lt;/li&gt;&lt;li&gt;DM - ACEi or ARB
&lt;/li&gt;&lt;li&gt;Isolated systolic htn: lonag acting CCB or ACEi/ARB
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypertensive_Urgency&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Bresler (ACEP '09)
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="hyperthyroidism"><name>Hyperthyroidism</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#Precipitants"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;Precipitants&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#DDX"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;DDX&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Grave.27s_Disease"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;Grave's Disease&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hyperthyroidism&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hyperthyroidism&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Precipitants"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Precipitants"&gt;Precipitants&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;infc
&lt;/li&gt;&lt;li&gt;surg
&lt;/li&gt;&lt;li&gt;trauma
&lt;/li&gt;&lt;li&gt;dka
&lt;/li&gt;&lt;li&gt;hypoglycemia
&lt;/li&gt;&lt;li&gt;palpation of gland
&lt;/li&gt;&lt;li&gt;withdrawal of meds
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hyperthyroidism&amp;amp;action=edit&amp;amp;section=3" title="Edit section: DDX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX"&gt;DDX&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hyperthyroidism&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Grave's Disease"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Grave.27s_Disease"&gt;Grave's Disease&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;exophthalmos, increased metabolism, pretib myxedema
&lt;/li&gt;&lt;li&gt;ab stim tsh receptor
&lt;/li&gt;&lt;li&gt;decreased tsh conc
&lt;/li&gt;&lt;li&gt;increased radioactive iodine uptake RAI
&lt;/li&gt;&lt;li&gt;tx first with propylthiouracil or methimazole, then either albation, surg or more meds. Meds I organfication of I2
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hyperthyroidism&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;If no CHF, hydrate with D5NS
&lt;/li&gt;&lt;li&gt;Prograffin 3 gms qd (stops conversion and release)
&lt;/li&gt;&lt;li&gt;Propranolol 1-2 mg IV up to 0.1 mg/kg q 1- 2 h. or 40- 80 mg q6h. for conv &amp;amp; betablock. not if chf or brochospasm
&lt;/li&gt;&lt;li&gt;Iodide 30 ggts KI/d in divided doses or 0.5- 1.0 gm KaI in 1L ns q 12h. or sski 5 ggts q 6h. (stops release from gland)
&lt;/li&gt;&lt;li&gt;Dexamethasone 2mg q6 or hydrocortisone 100mg iv qh (stops conversion)
&lt;/li&gt;&lt;li&gt;Dopamine if hypotensive
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hyperthyroidism&amp;amp;action=edit&amp;amp;section=6" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Endo: Thyroid Storm
&lt;/p&gt;&lt;p&gt;Endo: Thyroid (General)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hyperthyroidism&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;6/06 MISTRY
&lt;/p&gt;



</content><folder>Endo</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="hypertrophic_cardiomyopathy"><name>Hypertrophic Cardiomyopathy</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Decompensated.21"&gt;&lt;span class="tocnumber"&gt;4.1&lt;/span&gt; &lt;span class="toctext"&gt;Decompensated!&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypertrophic_Cardiomyopathy&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Genetically-linked (AD) hypertrophy of cardiac muscle - can but does not always cause outflow obstruction
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypertrophic_Cardiomyopathy&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Sx: Syncope or sudden death most common.  Also CP, SOB, dizzyness, palpitations, or CHF
&lt;/li&gt;&lt;li&gt;PE: if + syst murmur, will increase with valsalva
&lt;/li&gt;&lt;li&gt;EKG: Nonspecific/normal.  Or, high voltage/LVH, deep narrow Q waves in 1, avL, V5, V6  = "daggers of death" 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypertrophic_Cardiomyopathy&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;EKG
&lt;/li&gt;&lt;li&gt;CXR
&lt;/li&gt;&lt;li&gt;ECHO 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypertrophic_Cardiomyopathy&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Myomectomy
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypertrophic_Cardiomyopathy&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Decompensated!"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Decompensated.21"&gt;Decompensated!&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Presents as hypotensive CHF
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Preserve preload
&lt;ol&gt;&lt;li&gt;careful hydration
&lt;/li&gt;&lt;li&gt;avoid high airway pressures with mechanical ventilation (small TV with high RR)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Limit tachycardia
&lt;ol&gt;&lt;li&gt;beta blockers
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Avoid vasodilators (no nitrates)
&lt;/li&gt;&lt;li&gt;Maintain sinus rythm (i.e. cardiovert A. fib)
&lt;/li&gt;&lt;li&gt;Increase afterload (hypotenisve only)     
&lt;ol&gt;&lt;li&gt;phenlephrine
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypertrophic_Cardiomyopathy&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from ....Rosen, Mattu (lecture)
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="hypocalcemia"><name>Hypocalcemia</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#DDX"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;DDX&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypocalcemia&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Low &amp;lt;8.5 (&amp;lt;2.0 ionized)
&lt;/p&gt;&lt;p&gt;Low! &amp;lt;6.5 (&amp;lt;1.5 ionized)
&lt;/p&gt;&lt;p&gt;Correct for hypoalbumimia
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypocalcemia&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Symptoms
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;paresthesias
&lt;/li&gt;&lt;li&gt;inc DTRs
&lt;/li&gt;&lt;li&gt;cramps
&lt;/li&gt;&lt;li&gt;weakness
&lt;/li&gt;&lt;li&gt;confusion
&lt;/li&gt;&lt;li&gt;sz
&lt;/li&gt;&lt;li&gt;Chvostek's/Trouseau's
&lt;/li&gt;&lt;li&gt;prolonged QT
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypocalcemia&amp;amp;action=edit&amp;amp;section=3" title="Edit section: DDX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX"&gt;DDX&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Shock
&lt;/li&gt;&lt;li&gt;sepsis
&lt;/li&gt;&lt;li&gt;renal failure
&lt;/li&gt;&lt;li&gt;cimetidine
&lt;/li&gt;&lt;li&gt;hypoparathyroid
&lt;/li&gt;&lt;li&gt;inc phos
&lt;/li&gt;&lt;li&gt;vit D def
&lt;/li&gt;&lt;li&gt;fat embolism
&lt;/li&gt;&lt;li&gt;strychnine
&lt;/li&gt;&lt;li&gt;hypomag
&lt;/li&gt;&lt;li&gt;tetanus
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypocalcemia&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Asymptomatic
&lt;ol&gt;&lt;li&gt;calcium gluconate 1 gm PO Q6hrs
&lt;/li&gt;&lt;li&gt;vitamin D (calcitriol) 0.2 mcg BID
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Symptomatic
&lt;ol&gt;&lt;li&gt;calcium gluconate/chloride 10mL of 10% sol over 10min IV
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypocalcemia&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;2/12/06 DONALDSON (adapted from Tintinalli)
&lt;/p&gt;



</content><folder>FEN</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="hypoglycemia"><name>Hypoglycemia</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypoglycemia&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Glucose &amp;lt; 50 there are 28% with disorder
&lt;/p&gt;&lt;p&gt;Send lytes: if Glucose &amp;lt; 50:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;U/A: Ketones and Urine organic acids
&lt;/li&gt;&lt;li&gt;Add cortisol to lytes
&lt;/li&gt;&lt;li&gt;Insulin if no ketones in urine
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;9,000 glucoses sent--only 40 kids &amp;lt; 50 glucose
&lt;/p&gt;&lt;p&gt;40 kids: 6 w/ fatty acid oxidation defect
&lt;/p&gt;&lt;p&gt;3 pts w/ endocrine causes of hypoglycemia
&lt;/p&gt;&lt;p&gt;BUN is often elevated in FAOD
&lt;/p&gt;&lt;p&gt;History is key:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Difficulty weaning bottle
&lt;/li&gt;&lt;li&gt;Longest fast
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;Full labs include (if very low sugar)
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;LFTs/Hepatomegaly--Glycogen storage
&lt;/li&gt;&lt;li&gt;GH/Cortisol: 'accelerated starvation'/ketotic hypoglycemia or glycogen synthase disorder
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;If no ketones:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Exogenous insulin
&lt;/li&gt;&lt;li&gt;insulinoma
&lt;/li&gt;&lt;li&gt;nesidioblastosis
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;Critical labs: VBG, Lytes, lactate, NH3, Serum AAs, carnitine, Urine AAs, acylcarnitine, pyruvate.
&lt;/p&gt;&lt;p&gt;If glucose &amp;lt; 50:
&lt;/p&gt;&lt;p&gt;Plasma glucose, Insulin, GH, Cortisol, free fatty acids, total and free carnitine, U/A for ketones, acyl-carnitine, acyl-glycines.
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypoglycemia&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment &lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;hypoG from sulfonylureas
&lt;/li&gt;&lt;li&gt;not expected if taking just metformin or thiazolidinedione- but if these are added to sulfonyl regimen, may get hypoG
&lt;/li&gt;&lt;li&gt;repaglinide can potentially cause hypoG but if skip next dose, should revere
&lt;/li&gt;&lt;li&gt;mostly from sulfonylureas
&lt;/li&gt;&lt;li&gt;ABC's
&lt;/li&gt;&lt;li&gt;Charcoal
&lt;/li&gt;&lt;li&gt;No emetic agents as airway problem as pt get depressed with hypoG
&lt;/li&gt;&lt;li&gt;Consid admit for obs because of long duration of action and delayed clearance- even if pt euglycemic at presentation
&lt;/li&gt;&lt;li&gt;Admit for obs even if only one tablet OD
&lt;/li&gt;&lt;li&gt;Octreotide- inhibits secretion of insulin among others and can be used for sulfonylurea OD with hypoG
&lt;/li&gt;&lt;li&gt;Dextrose itself is an insulin stimulator paradoxically
&lt;/li&gt;&lt;li&gt;Octreotide will treat hyperinsulinism caused by both sulfonyls and dextrose
&lt;/li&gt;&lt;li&gt;Diazoxide- nondiuretic vasodilator used for HTN emergency.  Does not suppress insulin lvls like octreotide and therefore is second line to octreotd
&lt;/li&gt;&lt;li&gt;Glucagon- hormone that stimulates hepatic gluconeogenesis- efficacy dependent on hepatic glycogen stores.  Not as fast as iv dextrose.  Used if can't get iv established- give im
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypoglycemia&amp;amp;action=edit&amp;amp;section=3" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Endo: Diabetic Meds
&lt;/p&gt;&lt;p&gt;Peds: Hypoglycemia (Peds)
&lt;/p&gt;&lt;p&gt;Peds: Hypoglycemia (Neonatal)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypoglycemia&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;7/2/09 PANI
&lt;/p&gt;



</content><folder>Endo</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="hypoglycemia_(neonatal)"><name>Hypoglycemia (Neonatal)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#DDX"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;DDX&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypoglycemia_(Neonatal)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;3 births per 1000 w/ hypoglycemia
&lt;/p&gt;&lt;p&gt;Risks:
&lt;/p&gt;&lt;p&gt;DM mothers (hyperinsulin)
&lt;/p&gt;&lt;p&gt;Premies (can't store glycogen)
&lt;/p&gt;&lt;p&gt;Sick kids (depleted glycogen)
&lt;/p&gt;&lt;p&gt;Growth restricted babies (depleted glycogen)
&lt;/p&gt;&lt;p&gt;Macrosomic kids
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypoglycemia_(Neonatal)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;blood glucose &amp;lt;40 mg/dL (preterm infants repeated levels below &amp;lt;50)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Signs &amp;amp; sx:
&lt;/p&gt;&lt;p&gt;Jitteriness and irritability
&lt;/p&gt;&lt;p&gt;Apnea and cyanosis
&lt;/p&gt;&lt;p&gt;Hypotonia
&lt;/p&gt;&lt;p&gt;Convulsions
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;There is nl. fall in glucose @ 2-4hr
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypoglycemia_(Neonatal)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: DDX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX"&gt;DDX&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1. Decreased substrate availability:
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; Intra-uterine growth retardation
&lt;/li&gt;&lt;li&gt; Glycogen storage disease
&lt;/li&gt;&lt;li&gt; Inborn errors (e.g., fructose intolerance)
&lt;/li&gt;&lt;li&gt; Prematurity
&lt;/li&gt;&lt;li&gt; Prolonged fasting without IV glucose
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;2. Hyperinsulinemia:
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; Infant of diabetic mother
&lt;/li&gt;&lt;li&gt; Islet cell hyperplasia
&lt;/li&gt;&lt;li&gt; Erythroblastosis fetalis
&lt;/li&gt;&lt;li&gt; Exchange transfusion
&lt;/li&gt;&lt;li&gt; Beckwith-Wiedemann Syndrome
&lt;/li&gt;&lt;li&gt; Maternal &#65533;-mimetic tocolytic agents
&lt;/li&gt;&lt;li&gt;&amp;nbsp;?High? umbilical arterial catheter
&lt;/li&gt;&lt;li&gt; Abrupt cessation of IV glucose
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;3. Other endocrine abnormalities:
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; Pan-hypopituitarism
&lt;/li&gt;&lt;li&gt; Hypothyroidism
&lt;/li&gt;&lt;li&gt; Adrenal insufficiency
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;4. Increased glucose utilization:
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; Cold stress
&lt;/li&gt;&lt;li&gt; Increased work of breathing
&lt;/li&gt;&lt;li&gt; Sepsis
&lt;/li&gt;&lt;li&gt; Perinatal asphyxia
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;5. Miscellaneous conditions:
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; Polycythemia
&lt;/li&gt;&lt;li&gt; Congenital heart disease
&lt;/li&gt;&lt;li&gt; CNS abnormalities
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
Ddx persistent:
&lt;/p&gt;&lt;p&gt;Too much insulin:
&lt;/p&gt;&lt;p&gt;-idiopathic, asphyxia, rhesus dx, Beckwith-Weiderman, Nesiodoblastosis (autosomal recessive hyperinsulinism)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Not enough anti-insulin:
&lt;/p&gt;&lt;p&gt;-hypopit, adrenal hyperplasia
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Inborn errors of metabolism:
&lt;/p&gt;&lt;p&gt;-glycogen storage dz, fatty oxidation errors
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypoglycemia_(Neonatal)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1) Glucometer reading 20-40 mg/dL, infant is term and is able to feed:
&lt;/p&gt;&lt;p&gt;-Draw blood for stat blood glucose.
&lt;/p&gt;&lt;p&gt;-Feed 5 mL/kg of D5W.
&lt;/p&gt;&lt;p&gt;-Repeat blood glucose or Glucometer 20 min after feeding.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;2) Glucometer reading:
&lt;/p&gt;
&lt;pre&gt;    (a) &amp;lt;20 mg/dL or
&lt;/pre&gt;
&lt;pre&gt;    (b) &amp;lt;40 mg/dL and NPO or preterm or
&lt;/pre&gt;
&lt;pre&gt;    (c) &amp;lt;40 mg/dL after feeding or
&lt;/pre&gt;
&lt;pre&gt;    (d) &amp;lt;40 mg/dL and symptomatic
&lt;/pre&gt;
&lt;p&gt;-Draw blood for stat glucose measurement.
&lt;/p&gt;&lt;p&gt;-Give IV bolus of 2-3 mL/kg of D10W.
&lt;/p&gt;&lt;p&gt;-Begin continuous infusion of D10W at 4-6 mg/kg/min.
&lt;/p&gt;&lt;p&gt;-If infant of diabetic mother, begin D10W at 8-10 mg/kg/min (100-125 cc/kg/d).
&lt;/p&gt;&lt;p&gt;-Repeat blood glucose in 20 min and pursue treatment until blood sugar &amp;gt;40 mg/dL.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;3) For persistent hypoglycemia despite above measures:
&lt;/p&gt;&lt;p&gt;-Increase rate of glucose infusion stepwise in 2 mg/kg/min* increments up to 12-15
&lt;/p&gt;&lt;p&gt;mg/kg/min glucose. Use increased volume with caution in infants where volume
&lt;/p&gt;&lt;p&gt;overload is a concern. Maximal concentration of glucose in peripheral IV is D12.5.
&lt;/p&gt;&lt;p&gt;-If infant requires IV dextrose concentrations &amp;gt;12.5%, insert central venous catheter.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Do not use D25W or D50W IV or large IV volume boluses as this creates rebound
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;hypoglycemia in infants who are hyperinsulinemic. In addition, administration of D25W or
&lt;/p&gt;&lt;p&gt;D50W can cause dangerous increase in plasma osmolarity.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;4) If hypoglycemia is not controlled with above measures: Obtain Endocrine Consult to guide
&lt;/p&gt;&lt;p&gt;further diagnostic evaluation and management. While awaiting consult, send blood (while blood
&lt;/p&gt;&lt;p&gt;sugar is low) for glucose, plasma cortisol, growth hormone and insulin concentrations. Further
&lt;/p&gt;&lt;p&gt;management may include glucocorticoids, diazoxide, somatostatin or pancreatectomy.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;5) Weaning IV dextrose infusion: When blood glucose has been stable for 12-24 h, begin
&lt;/p&gt;&lt;p&gt;decreasing IV infusion by 1-2 mL/hr q3-4 hours if blood glucose remains &#65533;60 mg/dL.
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; To calculate rate of glucose administration, use either of the following formulas:
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;(% glucose x mL/kg/d)/144 = glucose infusion rate (mg/kg/min)
&lt;/p&gt;&lt;p&gt;or
&lt;/p&gt;&lt;p&gt;(% glucose x mL/h)/(6 x body weight in kg) = glucose infusion rate (mg/kg/min)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Mgmt:
&lt;/p&gt;&lt;p&gt;31-44: PO feed, check in 1 &amp;amp; 2 hr
&lt;/p&gt;&lt;p&gt;31-44 x 2: D10W 2cc/kg bolus
&lt;/p&gt;&lt;p&gt;&amp;gt; 45 PO feed @ 1st and 3rd hr
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Mgmt of persistent hypoglycemia:
&lt;/p&gt;&lt;p&gt;-Check insulin, GH, cortisol
&lt;/p&gt;&lt;p&gt;-Increase volume by 30cc/kg/d
&lt;/p&gt;&lt;p&gt;-Increase glucose to 12.5%
&lt;/p&gt;&lt;p&gt;-Glucagon infusion
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;If continues for &amp;gt;7 d: send insulin, cortisol, growth hormone
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypoglycemia_(Neonatal)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from Pani
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="hypoglycemia_(peds)"><name>Hypoglycemia (Peds)</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypoglycemia_(Peds)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: DDX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX"&gt;DDX&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1)  Ingestions (e.g. ETOH)
&lt;/p&gt;&lt;p&gt;2)  Metabolic dz^
&lt;/p&gt;&lt;p&gt;3)  Sepsis
&lt;/p&gt;&lt;p&gt;^Save blood tubes b/f treatment
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypoglycemia_(Peds)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;table class="pbNotSortable" width="200" cellspacing="1" cellpadding="1" border="1"&gt;
&lt;tr&gt;
&lt;td&gt; Age
&lt;/td&gt;&lt;td&gt; Tx
&lt;/td&gt;&lt;td&gt; Def
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; &amp;lt;2mo
&lt;/td&gt;&lt;td&gt; D10W
&lt;/td&gt;&lt;td&gt; (glu &amp;lt;40)
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 2mo-8yrs
&lt;/td&gt;&lt;td&gt; D25W
&lt;/td&gt;&lt;td&gt; (glu &amp;lt;60)
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; &amp;gt;8yrs
&lt;/td&gt;&lt;td&gt; D50W
&lt;/td&gt;&lt;td&gt; (glu &amp;lt;70)
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;p&gt;Dose all = 2mL/kg IV  (may use 4mL/kg for D10W)
&lt;/p&gt;&lt;p&gt;^recheck in all Q5min and repeat dose if low
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypoglycemia_(Peds)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Peds: Hypoglycemia (Neonatal)
&lt;/p&gt;&lt;p&gt;Endo: Hypoglycemia
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="hypokalemia"><name>Hypokalemia</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#DDX"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;DDX&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypokalemia&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Low = &amp;lt;3.5meq/L
&lt;/p&gt;&lt;p&gt;Low! = &amp;lt;2.5meq/L
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypokalemia&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Symptoms:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;CNS (weakness, cramps, hyporeflexia)
&lt;/li&gt;&lt;li&gt;GI (ileus)
&lt;/li&gt;&lt;li&gt;CV (dysrhythmia, dig tox, U waves, ST depression, prolonged QT)
&lt;/li&gt;&lt;li&gt;Renal (met alkalosis)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypokalemia&amp;amp;action=edit&amp;amp;section=3" title="Edit section: DDX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX"&gt; DDX &lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Shift
&lt;ul&gt;&lt;li&gt;Increased pH
&lt;/li&gt;&lt;li&gt;B-agonist, inuslin
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Reduced intake
&lt;/li&gt;&lt;li&gt;Increased loss
&lt;ul&gt;&lt;li&gt;Renal
&lt;ul&gt;&lt;li&gt;Primary (hyperaldos, osmotic diuresis)
&lt;/li&gt;&lt;li&gt;Secondary (diuretics, malignant HTN, renal art stenosis)
&lt;/li&gt;&lt;li&gt;Misc
&lt;ul&gt;&lt;li&gt;Licorice
&lt;/li&gt;&lt;li&gt;HyperCa
&lt;/li&gt;&lt;li&gt;HypoMg
&lt;/li&gt;&lt;li&gt;RTA
&lt;/li&gt;&lt;li&gt;Leukemia
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Drugs
&lt;ul&gt;&lt;li&gt;PCN
&lt;/li&gt;&lt;li&gt;Lithium
&lt;/li&gt;&lt;li&gt;L-dopa
&lt;/li&gt;&lt;li&gt;Theophyline
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;GI Loss (v/d/fistula)
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypokalemia&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;20meq/h KCl IV or PO
&lt;/p&gt;&lt;p&gt;every 10meq should inc serum by ~0.1meq/L)
&lt;/p&gt;&lt;p&gt;treat hypomag if present
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypokalemia&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;2/7/06 DONALDSON (adapted from Tintinalli)
&lt;/p&gt;



</content><folder>FEN</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="hypomagnesemia"><name>Hypomagnesemia</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#DDX"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;DDX&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypomagnesemia&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Low! Clinical
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypomagnesemia&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Symptoms:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;CNS (depression, vertigo, ataxia, seizures, inc DTR, tetany
&lt;/li&gt;&lt;li&gt;Anemia
&lt;/li&gt;&lt;li&gt;Hypotension
&lt;/li&gt;&lt;li&gt;Hypothermia
&lt;/li&gt;&lt;li&gt;Dysphagia
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypomagnesemia&amp;amp;action=edit&amp;amp;section=3" title="Edit section: DDX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX"&gt;DDX&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;ETOH
&lt;/li&gt;&lt;li&gt;poor nutrition
&lt;/li&gt;&lt;li&gt;Cirrhosis
&lt;/li&gt;&lt;li&gt;Pancreatitis
&lt;/li&gt;&lt;li&gt;S/P DKA
&lt;/li&gt;&lt;li&gt;Excessive GI loss
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypomagnesemia&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Repleat 2gm IV over 2hrs (universal)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypomagnesemia&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;2/12/06 DONALDSON (adapted from Tintinalli)
&lt;/p&gt;



</content><folder>FEN</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="hyponatremia"><name>Hyponatremia</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#DDX"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;DDX&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#NA_DEFICIT"&gt;&lt;span class="tocnumber"&gt;4.1&lt;/span&gt; &lt;span class="toctext"&gt;NA DEFICIT&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-6"&gt;&lt;a href="#EXAMPLE"&gt;&lt;span class="tocnumber"&gt;4.2&lt;/span&gt; &lt;span class="toctext"&gt;EXAMPLE&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hyponatremia&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Low = &amp;lt;135meq/L
&lt;/p&gt;&lt;p&gt;Symptomatic = &amp;lt;120meq/L (or higher than this if drop occurs abruptly)
&lt;/p&gt;&lt;p&gt;Rapid correction can cause CHF &amp;amp; CPM (AMS, dysphagia, dysarthria, paresis)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hyponatremia&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Correct for glu/lipid/protein
&lt;/li&gt;&lt;li&gt;see med calc 'Change in plasma Na'
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hyponatremia&amp;amp;action=edit&amp;amp;section=3" title="Edit section: DDX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX"&gt;DDX&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Hypovolemic
&lt;ol&gt;&lt;li&gt;Extrarenal losses (UNa &amp;lt;20)
&lt;ol&gt;&lt;li&gt;Sweating
&lt;/li&gt;&lt;li&gt;Vomiting
&lt;/li&gt;&lt;li&gt;Diarrhea
&lt;/li&gt;&lt;li&gt;Third-spacing
&lt;ol&gt;&lt;li&gt;Burns
&lt;/li&gt;&lt;li&gt;Peritonitis
&lt;/li&gt;&lt;li&gt;Pancreatitis
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Renal losses (UNa &amp;gt;20)
&lt;ol&gt;&lt;li&gt;Diruetics
&lt;/li&gt;&lt;li&gt;Addison's
&lt;/li&gt;&lt;li&gt;Ketonuria
&lt;/li&gt;&lt;li&gt;RTA
&lt;/li&gt;&lt;li&gt;Osmotic diruresis
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Euvolemic (UNa &amp;gt;20 meq/L)
&lt;ol&gt;&lt;li&gt;SIADH
&lt;ol&gt;&lt;li&gt;CNS
&lt;/li&gt;&lt;li&gt;Lung
&lt;/li&gt;&lt;li&gt;CA
&lt;/li&gt;&lt;li&gt;Pain
&lt;/li&gt;&lt;li&gt;Drugs
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;H2O intoxication
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Hypervolemic
&lt;ol&gt;&lt;li&gt;Renal failure (UNa &amp;gt;20)
&lt;/li&gt;&lt;li&gt;Cirrhosis, CHF, RF (UNa &amp;lt; 20)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Pseudo
&lt;ol&gt;&lt;li&gt;Hyperprotein
&lt;/li&gt;&lt;li&gt;Hyperlipid
&lt;/li&gt;&lt;li&gt;Hyperglyc
&lt;/li&gt;&lt;li&gt;Mannitol
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hyponatremia&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Correct volume deficit (NS)
&lt;/li&gt;&lt;li&gt; For severe (&amp;lt;120 with CNS changes):
&lt;ol&gt;&lt;li&gt; 3% NS @ 100 cc/hr x 3 hrs (70kg person)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; For non-70kg person:
&lt;ol&gt;&lt;li&gt; (kg X 0.6)/513 = cc/hr 3% 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; For seizure, benzos + bolus 1.5cc/kg of 3% over 10min; repeat Q10min until sz stops (max total = 6cc/kg)
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hyponatremia&amp;amp;action=edit&amp;amp;section=5" title="Edit section: NA DEFICIT"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="NA_DEFICIT"&gt;NA DEFICIT&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Na Deficit (meq) = kg x 0.6 x (140 - Na)
&lt;/li&gt;&lt;li&gt;Give 1/3 total def rapidly in severe sx
&lt;/li&gt;&lt;li&gt;OR (Desired Na - Measured Na)(0.6)(wt in kg)= mEq Na administered
&lt;/li&gt;&lt;/ol&gt;
&lt;ul&gt;&lt;li&gt;NS = 154 meq/L
&lt;/li&gt;&lt;li&gt;3% = 513 meq/L
&lt;/li&gt;&lt;/ul&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hyponatremia&amp;amp;action=edit&amp;amp;section=6" title="Edit section: EXAMPLE"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="EXAMPLE"&gt;EXAMPLE&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;desired Na- 120
&lt;/p&gt;&lt;p&gt;measure Na- 100
&lt;/p&gt;&lt;p&gt;(120-100)(.6)(70kg)=840 meq
&lt;/p&gt;&lt;p&gt;^if 513meq in 1L, then 840 meq in 1.6L. Correct over 24hr, so 68cc hypertonic Na/ hr for 24 hrs
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;&lt;p&gt;Asympt = max inc 0.5meq/L/hr (12meq/L/dy)
&lt;/p&gt;&lt;p&gt;Sympt = 1-2 meq/L/hr
&lt;/p&gt;&lt;p&gt;^Do not correct to &amp;gt;120 meq/l or &amp;gt;20 meq/l in 24 hr
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hyponatremia&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Admit Na &amp;lt; 125
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hyponatremia&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;2/4/06 DONALDSON (adapted from Tintinalli, Mistry)
&lt;/p&gt;



</content><folder>FEN</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="hypophosphatemia"><name>Hypophosphatemia</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypophosphatemia&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;2.5-2.8 Mild
&lt;/p&gt;&lt;p&gt;1.0-2.5 Mod
&lt;/p&gt;&lt;p&gt;&amp;lt;1.0 Severe
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypophosphatemia&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment &lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Mild-mod --&amp;gt; PO
&lt;ol&gt;&lt;li&gt;KPhos /neutra phos
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Severe --&amp;gt; IV* (same)
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;10-20meq normally
&lt;/p&gt;



</content><folder>FEN</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="hypotension"><name>Hypotension</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypotension&amp;amp;action=edit&amp;amp;section=1" title="Edit section: General Approach"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="General_Approach"&gt;General Approach&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;HR
&lt;ol&gt;&lt;li&gt;too high - likely &amp;gt;180; or too low. tx with cardiovert/defib or pace 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;volume
&lt;ol&gt;&lt;li&gt;plasma vs. RBC loss. evaluate CVP, IVC, UOP, etc. Check for GI, intraperitoneal, lung, retroperitoneal loss/sequestration 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;contractility
&lt;ol&gt;&lt;li&gt;poor pump. Dx with ultrasound. Pt will have high afterload, may be due to STEMI, CHF, etc. 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;forward flow
&lt;ol&gt;&lt;li&gt;valvular dysfunction (MR) or obstruction. Evaluate via auscultation, ultrasound. Consider PE, HOCM 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;SVR
&lt;ol&gt;&lt;li&gt;pathologic vasodilation - warm extremities, bounding pulse. Consider sympathetic  dysregulation/neurogenic shock. In a pt with cool extremities and a "normal"  BP, consider vasoconstriction and treat as hypotension from the top.
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypotension&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Morchi 2010
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="hypothermia"><name>Hypothermia</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypothermia&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Definition: Core Temp &amp;lt; 35&#176;C (95 &#176;F)
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Mild hypothermia (32-35&#176;C) (90-95)
&lt;/li&gt;&lt;li&gt;Moderate hypothermia (28-32&#176;C) 
&lt;/li&gt;&lt;li&gt;Severe hypothermia (&amp;lt;28&#176;C)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypothermia&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;ECG: Osborne J wave "camel hump" 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypothermia&amp;amp;action=edit&amp;amp;section=3" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Accidental/environmental
&lt;/li&gt;&lt;li&gt;Sepsis
&lt;/li&gt;&lt;li&gt;Hypoendocrine states (e.g. hypothyroidism, hypoadrenalism, hypopituitarism)
&lt;/li&gt;&lt;li&gt;Hypoglycemia (-&amp;gt; impaired hypothalmus)
&lt;/li&gt;&lt;li&gt;CNS dysfunction, hypothalmic, e.g Wernickes
&lt;/li&gt;&lt;li&gt;Head trauma , stroke, tumor 
&lt;/li&gt;&lt;li&gt;Drug-induced ETOH (vasodilator, CNS depressant)
&lt;/li&gt;&lt;li&gt;Skin disorder - burns, exfoliative dermatitis 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypothermia&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Passive RewarmingActive External RewarmingActive Core Rewarming 2005 AHA guidelinesVfib--&amp;gt; Attempt defib ONCE; no meds until &amp;gt;30&#176;C (86&#176;F)Repeat defib once &amp;gt;30&#176;C (&#176;86F)  
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypothermia&amp;amp;action=edit&amp;amp;section=5" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypothermia&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from Bessen
&lt;/p&gt;



</content><folder>Environ</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="hypothyroidism"><name>Hypothyroidism</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Types"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Types&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Etiology"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Etiology&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Complications"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Complications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;9&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-10"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;10&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypothyroidism&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Affects ~4% US
&lt;/li&gt;&lt;li&gt;3-10x more common in F
&lt;/li&gt;&lt;li&gt;Peak incidence at age &amp;gt;60
&lt;/li&gt;&lt;li&gt;More common among Caucasians, Latinos than AA
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypothyroidism&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Types"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Types"&gt;Types&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Primary: failure of thyroid
&lt;ol&gt;&lt;li&gt;elevated TSH, low FT4
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Secondary: failure of pituitary
&lt;ol&gt;&lt;li&gt;low TSH, low FT4
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Tertiary: failure of hypothalamus
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypothyroidism&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Etiology"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Etiology"&gt;Etiology&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Primary
&lt;ol&gt;&lt;li&gt; Autoimmune
&lt;/li&gt;&lt;li&gt; Idiopathic
&lt;/li&gt;&lt;li&gt; Postsurgical thyroidectomy
&lt;/li&gt;&lt;li&gt; External radiation therapy
&lt;/li&gt;&lt;li&gt; Radioiodine therapy
&lt;/li&gt;&lt;li&gt; Inherited enzymatic defect
&lt;/li&gt;&lt;li&gt; Iodine deficiency
&lt;/li&gt;&lt;li&gt; Antithyroid drugs
&lt;/li&gt;&lt;li&gt; Lithium, phyenylbutazone
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Secondary
&lt;ol&gt;&lt;li&gt; Pituitary tumor
&lt;/li&gt;&lt;li&gt; Infiltrative Dz (eg Sarcoid) 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypothyroidism&amp;amp;action=edit&amp;amp;section=4" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Addisons disease
&lt;/li&gt;&lt;li&gt; anovulation
&lt;/li&gt;&lt;li&gt; autoimmune thyroid disease
&lt;/li&gt;&lt;li&gt; chronic fatigue syndrome
&lt;/li&gt;&lt;li&gt; craniopharyngiomas
&lt;/li&gt;&lt;li&gt; De Qeurvain Thyroiditis
&lt;/li&gt;&lt;li&gt; Depression
&lt;/li&gt;&lt;li&gt; Esoinophilia
&lt;/li&gt;&lt;li&gt; euthyroid sick syndrome
&lt;/li&gt;&lt;li&gt; fibromyalgia
&lt;/li&gt;&lt;li&gt; goiter
&lt;/li&gt;&lt;li&gt; hypochondriasis
&lt;/li&gt;&lt;li&gt; hypopituitarism
&lt;/li&gt;&lt;li&gt; hypothermia
&lt;/li&gt;&lt;li&gt; infectious mononucleosis
&lt;/li&gt;&lt;li&gt; iodine deficiency
&lt;/li&gt;&lt;li&gt; lithium nephropathy
&lt;/li&gt;&lt;li&gt; lymphoma
&lt;/li&gt;&lt;li&gt; ovarian insufficiency
&lt;/li&gt;&lt;li&gt; myxedema
&lt;/li&gt;&lt;li&gt; pituitary macroadenoma 
&lt;/li&gt;&lt;li&gt; Prolactin deficiency
&lt;/li&gt;&lt;li&gt; SIADH 
&lt;/li&gt;&lt;li&gt; thyroiditis
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypothyroidism&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; TSH
&lt;/li&gt;&lt;li&gt; Total and Free T4
&lt;/li&gt;&lt;li&gt; T3
&lt;/li&gt;&lt;li&gt; Thyroid Binding Globulin (TBG)
&lt;/li&gt;&lt;li&gt; auto-antibodies (anti-TPO, anti-microsomal, anti-Tg)
&lt;/li&gt;&lt;li&gt; Ultrasound to look for nodules 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypothyroidism&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Complications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Complications"&gt;Complications&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Myxedema Coma 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypothyroidism&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Depends on etiology, consider starting Levothyroxine daily but be aware that doses too high may lead to thyroid storm
&lt;/li&gt;&lt;li&gt;see Myxedema Coma 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypothyroidism&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; most hypothyroidism is treated as an outpatient followed in ambulatory clinic
&lt;/li&gt;&lt;li&gt; admit and treat sever hypothyroidism or myxedema coma 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypothyroidism&amp;amp;action=edit&amp;amp;section=9" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Endo: Myxedema Coma
&lt;/p&gt;&lt;p&gt;Endo: Thyroid (General)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypothyroidism&amp;amp;action=edit&amp;amp;section=10" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Emedicine
&lt;/p&gt;&lt;p&gt;Adapted from DeBonis
&lt;/p&gt;



</content><folder>Endo</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="hypoxia"><name>Hypoxia</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypoxia&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;PAO2 = (PB - PH2O) x FiO2 - PaCO2/RQ
&lt;/p&gt;
&lt;pre&gt;        = 760 - 47 x 0.21 - 40/0.8
&lt;/pre&gt;
&lt;pre&gt;        = 100
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Hypoxia&amp;amp;action=edit&amp;amp;section=2" title="Edit section: DDX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX"&gt;DDX&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-V/Q mismatch
&lt;/p&gt;&lt;p&gt;-Diffusion
&lt;/p&gt;&lt;p&gt;-Hypercarbia
&lt;/p&gt;&lt;p&gt;-Altitude
&lt;/p&gt;&lt;p&gt;-Cardiac Shunt
&lt;/p&gt;



</content><folder>Pulm</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="inh"><name>INH</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=INH&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- inh causes luw pyridoxine b6 stores
&lt;/p&gt;&lt;p&gt;- b6 used tu make gaba- an inhibitory neuroxmitter
&lt;/p&gt;&lt;p&gt;- also inh inhibits lactate to pyruvate conversion
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=INH&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- 1g inh per gm pyridoxime. 1gm q 1/2 hr
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=INH&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;6/06 MISTRY
&lt;/p&gt;



</content><folder>Tox</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="itp"><name>ITP</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#GENERAL"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;GENERAL&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#PATHOPHYS"&gt;&lt;span class="tocnumber"&gt;1.2&lt;/span&gt; &lt;span class="toctext"&gt;PATHOPHYS&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#GENETICS"&gt;&lt;span class="tocnumber"&gt;1.3&lt;/span&gt; &lt;span class="toctext"&gt;GENETICS&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Initial_Management"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Initial Management&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-7"&gt;&lt;a href="#ADULTS"&gt;&lt;span class="tocnumber"&gt;3.1&lt;/span&gt; &lt;span class="toctext"&gt;ADULTS&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-8"&gt;&lt;a href="#KIDS"&gt;&lt;span class="tocnumber"&gt;3.2&lt;/span&gt; &lt;span class="toctext"&gt;KIDS&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#Management_of_First_Relapse"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Management of First Relapse&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-10"&gt;&lt;a href="#ADULTS_2"&gt;&lt;span class="tocnumber"&gt;4.1&lt;/span&gt; &lt;span class="toctext"&gt;ADULTS&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-11"&gt;&lt;a href="#KIDS_2"&gt;&lt;span class="tocnumber"&gt;4.2&lt;/span&gt; &lt;span class="toctext"&gt;KIDS&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-12"&gt;&lt;a href="#SPLENECTOMY"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;SPLENECTOMY&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-13"&gt;&lt;a href="#Chronic_Refractory_ITP"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Chronic Refractory ITP&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-14"&gt;&lt;a href="#Children"&gt;&lt;span class="tocnumber"&gt;6.1&lt;/span&gt; &lt;span class="toctext"&gt;Children&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-15"&gt;&lt;a href="#Complications"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Complications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-16"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ITP&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ITP&amp;amp;action=edit&amp;amp;section=2" title="Edit section: GENERAL"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="GENERAL"&gt;GENERAL&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; low platelets and mucocutaneous bleeding
&lt;/li&gt;&lt;li&gt; half occur in kids
&lt;/li&gt;&lt;li&gt; either primary or secondary to other disorder
&lt;/li&gt;&lt;li&gt; either acute or chronic &amp;gt; 6mo
&lt;/li&gt;&lt;li&gt; usually presents days to weeks after infection
&lt;/li&gt;&lt;li&gt; in kids, 70% resolve in 6 mo regardless of tx or not
&lt;/li&gt;&lt;li&gt; adults usually chronic, insidous onset and more likely in women than men
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ITP&amp;amp;action=edit&amp;amp;section=3" title="Edit section: PATHOPHYS"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="PATHOPHYS"&gt;PATHOPHYS&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; mediated by autoantibodies- platelets coated with igg antibodies undergo accelerated clearance in spleen and liver
&lt;/li&gt;&lt;li&gt; can get compensatory increase in platelet production in some pts
&lt;/li&gt;&lt;li&gt; in other pts, get abnormal production destruction of intermedullary antibody coated platelets
&lt;/li&gt;&lt;li&gt; level of thrombopoietin not increased
&lt;/li&gt;&lt;li&gt; methods to tx are directed at 1- antibody prodctn, 2- platelet sensitization, 3- clearance, 4- production.
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ITP&amp;amp;action=edit&amp;amp;section=4" title="Edit section: GENETICS"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="GENETICS"&gt;GENETICS&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; can be seen in certain families and twins
&lt;/li&gt;&lt;li&gt; HLA type may predict response to different tx's
&lt;/li&gt;&lt;li&gt; no consistent assoc btwn HLA types and ITP however
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ITP&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; is dx of exclusion
&lt;/li&gt;&lt;li&gt;can get secondary ITP in SLE, antiphospholid syn, immune deficiency states, leukemia, lymphoma, HIV, Hep C, heparin and quinidine.
&lt;/li&gt;&lt;li&gt; duration of bleeding tells acute from chronic
&lt;/li&gt;&lt;li&gt;absence of systemic symptoms helps rule out secondary forms and other dxs
&lt;/li&gt;&lt;li&gt; family hx usually negative.
&lt;/li&gt;&lt;li&gt; physical exam shows platelet type bleeding-petechia, purpura, conj hem,
&lt;/li&gt;&lt;li&gt; if spleen very big, consider other dx
&lt;/li&gt;&lt;li&gt; can see anemia if have lots of blood loss
&lt;/li&gt;&lt;li&gt; can see large young plateltets on perif smear
&lt;/li&gt;&lt;li&gt; bone marrow bx- debatetable- but need it if atypical case, fever, pain, neutropenia, unexplained macrocytosis.
&lt;/li&gt;&lt;li&gt; dx by measuring platelet assoc antibodies- fair sensitivity, specificity and predictive value
&lt;/li&gt;&lt;li&gt; neg test does not rule it out
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ITP&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Initial Management"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Initial_Management"&gt;Initial Management&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ITP&amp;amp;action=edit&amp;amp;section=7" title="Edit section: ADULTS"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="ADULTS"&gt;ADULTS&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; if plts above 50k- will dx incidentally
&lt;/li&gt;&lt;li&gt; plts 30k- 50k- will get easy bruising
&lt;/li&gt;&lt;li&gt; petechia and purpura at 1-k- 30k
&lt;/li&gt;&lt;li&gt;&amp;lt;10k at risk for internal bleeding
&lt;/li&gt;&lt;li&gt; adults usually require tx with prednsone at tme of presentation
&lt;/li&gt;&lt;li&gt; can also use Anti- D immune globulin in Rh + pt
&lt;/li&gt;&lt;li&gt; IV IG used for internal bleeding
&lt;/li&gt;&lt;li&gt; splenectomy within 3- 6mo if more than 10- 20 mg prednisone per day.
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ITP&amp;amp;action=edit&amp;amp;section=8" title="Edit section: KIDS"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="KIDS"&gt;KIDS&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;outcome so good usually dont need to tx unless risk of intracranial hem- plts &amp;lt;10k- 20k
&lt;/li&gt;&lt;li&gt; usually observe and avoid sports, ASA..
&lt;/li&gt;&lt;li&gt; if severe thrombocytopenia- can tx with IV IG or anti D IG. or prednisone.
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;Urgent Tx in Kids
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt; neuro sxs, internal bleeding, surgery- tx with iv solumedrol and iv ig and platelet infusion
&lt;/li&gt;&lt;li&gt; consider vincristine
&lt;/li&gt;&lt;li&gt; consider splenectomy
&lt;/li&gt;&lt;li&gt; plasmapharesis not helpful
&lt;/li&gt;&lt;li&gt; consider antifibrinolytic/ aminocaproic acid fo mucosal bleeding
&lt;/li&gt;&lt;li&gt; for severe bleeding- iv ig and iv platelets
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ITP&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Management of First Relapse"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Management_of_First_Relapse"&gt;Management of First Relapse&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ITP&amp;amp;action=edit&amp;amp;section=10" title="Edit section: ADULTS"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="ADULTS_2"&gt;ADULTS&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;no tx if asymptomatic with plt 30k
&lt;/li&gt;&lt;li&gt; splenectomy if relapse or not response to steroids, iv ig or iv anti D ig
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ITP&amp;amp;action=edit&amp;amp;section=11" title="Edit section: KIDS"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="KIDS_2"&gt;KIDS&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; delay splenectomy as long as possible- or if symptomatic &amp;gt; 1yr or severe thrombocytopenia
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ITP&amp;amp;action=edit&amp;amp;section=12" title="Edit section: SPLENECTOMY"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="SPLENECTOMY"&gt;SPLENECTOMY&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; immunize against H flu, pneumoccus, and give daily prophylactic penicilin for 1 yr
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ITP&amp;amp;action=edit&amp;amp;section=13" title="Edit section: Chronic Refractory ITP"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Chronic_Refractory_ITP"&gt;Chronic Refractory ITP&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;30- 40% adults do not respond to splenectomy or have relapse p splenectomy
&lt;/li&gt;&lt;li&gt; hunt for accessory splene
&lt;/li&gt;&lt;li&gt; tx with prednisone, iv ig
&lt;/li&gt;&lt;li&gt; next step is medicine that impedes platelet clearance- Danazol, Dapsone, vinca alkaloids.
&lt;/li&gt;&lt;li&gt; if splenectomized, do not give ig anti D ig.
&lt;/li&gt;&lt;li&gt; immunesuppression if platelet &amp;lt;20k and no response to above tx- use azathioprine or cyclophosphamide
&lt;/li&gt;&lt;li&gt; Azathioprine watch LFT's- is also carcinogenic
&lt;/li&gt;&lt;li&gt; Cyclophoshamide- marrow suppression, hem cystitis, bladder fibrosis, alopecia, infertility, leukemia and teratogenic.
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ITP&amp;amp;action=edit&amp;amp;section=14" title="Edit section: Children"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Children"&gt;Children&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; azathioprine alone or in combination with cyclophosphamide.
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ITP&amp;amp;action=edit&amp;amp;section=15" title="Edit section: Complications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Complications"&gt;Complications&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; fatal bleeding from ICH- risk greatest in elderly or recurrent bleeding or no response to tx
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ITP&amp;amp;action=edit&amp;amp;section=16" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;6/06 MISTRY
&lt;/p&gt;



</content><folder>Heme/Onc</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="itp_in_pregnancy"><name>ITP in Pregnancy</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ITP_in_Pregnancy&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; marked diff btwn maternal and fetal platelet counts
&lt;/li&gt;&lt;li&gt; no antenatal measures predict fetal status
&lt;/li&gt;&lt;li&gt; maternal response to medicine does not guarantee a favorable outcome for baby
&lt;/li&gt;&lt;li&gt; only previous neonatal outcomes provide predictor of neonatal platelet counts.
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ITP_in_Pregnancy&amp;amp;action=edit&amp;amp;section=2" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;(low platelets during pregnancy)
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;preg induced HTN
&lt;/li&gt;&lt;li&gt;HELLP
&lt;/li&gt;&lt;li&gt;microangiopathic hemolytic anemia
&lt;/li&gt;&lt;li&gt;hereditary
&lt;/li&gt;&lt;li&gt;thrombocytopenias
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ITP_in_Pregnancy&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; usually mild thrombocytopenia (&amp;gt;70k) and
&lt;/li&gt;&lt;li&gt; platelet count normalizes p delivery
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ITP_in_Pregnancy&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; most meds teratogenic or  with pred- worsens gest diabtetes- so use iv ig mostly
&lt;/li&gt;&lt;li&gt; baby with v low risk of ICH- but higher of normal baby.
&lt;/li&gt;&lt;li&gt; risk of ICH not change with cesarean
&lt;/li&gt;&lt;li&gt; if baby with platelets &amp;lt;30k, try iv ig and or prednisone
&lt;/li&gt;&lt;li&gt; exchange xfusion only if severe.
&lt;/li&gt;&lt;li&gt; no problem for breast feeding.
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ITP_in_Pregnancy&amp;amp;action=edit&amp;amp;section=5" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;HEME:  ITP
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=ITP_in_Pregnancy&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;6/06  MISTRY
&lt;/p&gt;



</content><folder>Heme/Onc</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="ivf_maintenance"><name>IVF Maintenance</name><content>&lt;table width="335" border="1"&gt;
&lt;tr&gt;
&lt;td&gt;
&lt;p&gt;&lt;b&gt;Weight (kg) &lt;/b&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Fluid Rate &lt;/b&gt;&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Example &lt;/b&gt;&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; &amp;lt;10 &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 4 mL/kg per hour &lt;br /&gt;
&lt;/td&gt;&lt;td&gt;
&lt;p&gt;8 kg infant:
&lt;/p&gt;&lt;p&gt;4mL/kg per hour x 8 kg
&lt;/p&gt;&lt;p&gt;= 32 mL/h
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 10 to 20 &lt;br /&gt;
&lt;/td&gt;&lt;td&gt;
&lt;p&gt;40 mL/h +
&lt;/p&gt;&lt;p&gt;2 mL/kg per hour per each add kg
&lt;/p&gt;
&lt;/td&gt;&lt;td&gt;
&lt;p&gt;15 kg child:
&lt;/p&gt;&lt;p&gt;40 mL/h +
&lt;/p&gt;&lt;p&gt;2 mL/kg per hour x 5 kg
&lt;/p&gt;&lt;p&gt;= 50 mL/h
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; &amp;gt;20 &lt;br /&gt;
&lt;/td&gt;&lt;td&gt;
&lt;p&gt;60 mL/h +
&lt;/p&gt;&lt;p&gt;1 mL/kg per hour per each add kg
&lt;/p&gt;
&lt;/td&gt;&lt;td&gt;
&lt;p&gt;30 kg child:
&lt;/p&gt;&lt;p&gt;60 mL/h +
&lt;/p&gt;&lt;p&gt;1 mL/kg per hour x 10 kg
&lt;/p&gt;&lt;p&gt;= 70 mL/h
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;p&gt;4-2-1 Rule (above)
&lt;/p&gt;&lt;p&gt;(4*first10kg, 2* second 10kg, 1*every kg after)
&lt;/p&gt;&lt;p&gt;AGE-pm-nb-2-4- 6-9-12-15-2- 3- 5
&lt;/p&gt;&lt;p&gt;WT- 2 3.5- 5 6.5 8 9 10 11 13 15 19
&lt;/p&gt;&lt;p&gt;IVF- 8 14 20 26 32.36.40.42.46 50 58
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=IVF_Maintenance&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;6/06 MISTRY, PALS 06
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="impetigo"><name>Impetigo</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Impetigo&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; --&amp;gt; bacitracin
&lt;/li&gt;&lt;li&gt; --&amp;gt; Bactroban
&lt;/li&gt;&lt;li&gt; spread or immunomp --&amp;gt; keflex
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;--&amp;gt; cover MRSA if RF
&lt;/p&gt;



</content><folder>Derm</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="inborn_errors"><name>Inborn Errors</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Inborn_Errors&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Over hundreds of diseases
&lt;/p&gt;&lt;p&gt;Suspect in any sick neonate
&lt;/p&gt;&lt;p&gt;Newborn screening varies by states, California tests for 29 major diseases
&lt;/p&gt;&lt;p&gt;May present as late as early childhood
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Inborn_Errors&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Exam and history:
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; Lethargic (2/2 hyperammonia encephelopathy)
&lt;/li&gt;&lt;li&gt; Nausea/vomiting
&lt;/li&gt;&lt;li&gt; Difficulty feeding
&lt;/li&gt;&lt;li&gt; Seizure 
&lt;/li&gt;&lt;li&gt; Strange odors 
&lt;/li&gt;&lt;li&gt; Hypotonia 
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Inborn_Errors&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Elevated Ammonia
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; Key to suspect diagnosis, however there are a few diseases where  ammonia may be normal
&lt;/li&gt;&lt;li&gt; +/- Hypoglycemia, metabolic acidosis, anion gate, elevated  lactate, ketones 
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;Sepsis work up usually concomitant, if patient is ill as these children are prone to infections
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Inborn_Errors&amp;amp;action=edit&amp;amp;section=4" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;in neonates: THE MISFITS
&lt;/p&gt;&lt;p&gt;see Neonatal Resuscitation
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Inborn_Errors&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Must stop catabolism and acculmulation of toxins/ammonia
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; IVF with Dextrose at 1-1.5x maintenace
&lt;/li&gt;&lt;li&gt; Don't feed 
&lt;/li&gt;&lt;li&gt; Dialysis (ammonia &amp;gt;500)
&lt;/li&gt;&lt;li&gt; NaBicarb if acidotic
&lt;/li&gt;&lt;li&gt; Consider L-carnitine in conjuction with specialist, as some diseases may respond (but has side effects)
&lt;/li&gt;&lt;li&gt; Antibiotics-- assume sepsis
&lt;/li&gt;&lt;li&gt; if seizing-- consider Vit B6/pyroxidine 
&lt;/li&gt;&lt;li&gt;  
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Inborn_Errors&amp;amp;action=edit&amp;amp;section=6" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;see Neonatal Resuscitation
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="infectious_tenosynovitis"><name>Infectious Tenosynovitis</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Etiology"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Etiology&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Clinical_Manifestations"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Clinical Manifestations&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Infectious_Tenosynovitis&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Infection of extensor tendons rarely result in loculated infections
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Infectious_Tenosynovitis&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Etiology"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Etiology"&gt;Etiology &lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Trauma with direct inoculation
&lt;/li&gt;&lt;li&gt; Microbiology
&lt;/li&gt;&lt;li&gt; "Clean trauma" - skin flora
&lt;/li&gt;&lt;li&gt; DM, bites - Polymicrobial (gram -, anerobes)
&lt;/li&gt;&lt;li&gt; Puncture from plants - Fungal (sporotrichosis)  
&lt;/li&gt;&lt;li&gt; Hematogenous spread 
&lt;/li&gt;&lt;li&gt; Microbiology
&lt;/li&gt;&lt;li&gt; Gonorrhea
&lt;/li&gt;&lt;li&gt; Look for vesiculopustular skin lesion, polyarthralgia 
&lt;/li&gt;&lt;li&gt; Mycobacteria 
&lt;/li&gt;&lt;li&gt; Contiguous spread 
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Infectious_Tenosynovitis&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Clinical Manifestations"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Clinical_Manifestations"&gt;Clinical Manifestations&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Pain along the tendon with passive extension (early sign)  
&lt;/li&gt;&lt;li&gt; Tenderness along the course of the flexor sheath (late sign)
&lt;/li&gt;&lt;li&gt; Symmetric enlargement of the affected digit
&lt;/li&gt;&lt;li&gt; Slightly flexed finger at rest
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Infectious_Tenosynovitis&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Xray
&lt;/li&gt;&lt;li&gt; Usually normal but helpful to r/o bony involvement, FB
&lt;/li&gt;&lt;li&gt; Blood culture
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Infectious_Tenosynovitis&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Surgery consult for wash-out versus debridement
&lt;/li&gt;&lt;li&gt;  IV Abx (appropriate to the likely organism)
&lt;/li&gt;&lt;/ul&gt;




</content><folder>Ortho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="influenza"><name>Influenza</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#Epidemiology"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;Epidemiology&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Complications"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Complications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Influenza&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;3 types, 2 of which cause dz in humans
&lt;ol&gt;&lt;li&gt;type A- most common and causes world pandemics- also found in pigs, horses, seals, whales and birds
&lt;/li&gt;&lt;li&gt;type B- only found in humans- causes regional epidemics, not global
&lt;/li&gt;&lt;li&gt;type C- no human dz
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Influenza&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Epidemiology"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Epidemiology"&gt;Epidemiology&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;transmitted by resp secretions or hand to hand. Infection limited to resp epithelium and ciliated columnar cells involved initially. Viremia rare.
&lt;/li&gt;&lt;li&gt;symptoms start within 18 hrs, pt contagious for 2- 5 days. Usually involve sudden onset fever, malaise, headache. Later get sore throat, myalgia, cough and sputum. Cough can last for 2 wks. Can have vomiting and diarrhea in kids or even present as croup, bronchiolitis or febrile seizures.
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Influenza&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;generally supportive but can use antivirals
&lt;ol&gt;&lt;li&gt;Amantadine- reduces fever and symptoms by 1- 2d. Targets M2 membrane protein of influ A. Has neurologic side effects (lightheadedness, nervous, confusion, insomnia) and resistance developing and not useful against Type B.
&lt;/li&gt;&lt;li&gt;Flumadine- like amantadine but fewer side effects. Not for kids
&lt;/li&gt;&lt;li&gt;Neuraminidase Inhibitors- Relenza and Tamiflu. Inhibition of neuraminidase activity prevents spread and aborts infection. Works with all strains. Limited resistance.
&lt;/li&gt;&lt;li&gt;Relenza- decreases symptoms by 1.5- 2.5 days. Use if age 7 or older and within 48 hrs of sxs.
&lt;/li&gt;&lt;li&gt;Tamiflu- reduces duration of dz by 1.5 days but better yet, reduces by 50% sequela like otitis media, sinusitis, bronchitis, pneumonia
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Influenza&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Complications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Complications"&gt;Complications&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;post influenza asthenia- elderly can have malaise and lassitude requiring prolonged convelescence.
&lt;/li&gt;&lt;li&gt;viral pneumonia-
&lt;/li&gt;&lt;li&gt;secondary bacterial pneumonia- seen during recovery phase- staph, strep, hemophilus
&lt;/li&gt;&lt;li&gt;myositis- calf muscle pain with elevated CPK seen in kids with influ B
&lt;/li&gt;&lt;li&gt;Reyes Syndrome- fatty liver degeneration seen in viral syndrome tx?ed with ASA. Get liver failure, hepatic encephalopathy and brain edema
&lt;/li&gt;&lt;li&gt;can also see encephalitis, Guillain Barre, transverse myelitis, myocarditis, pericarditis
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Influenza&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;6/06 MISTRY
&lt;/p&gt;



</content><folder>ID</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="inguinal_hernia_(peds)"><name>Inguinal Hernia (Peds)</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Inguinal_Hernia_(Peds)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Inguinal Hernia"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Inguinal_Hernia"&gt;Inguinal Hernia&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; 1-2% of children hve these, 10% become incarcerated, 70% of incarceration occurs ininfants (usu &amp;lt;6 mo), M:F 6:1, 21% of F w/ inguinal hernia contain an ovary!
&lt;/li&gt;&lt;li&gt; S/S: parents usu report bulge in scrotum or groin that incr w/ crying, lack of transillumination indicates incarcerated hernia vs hydrocele (usu no chng w/ crying), must distinguish btwn hydrocele, torsion, inguinal lymph node, UTZ can help!
&lt;/li&gt;&lt;li&gt; Rx: 95% can be reduced w/o surgery using gentle FIRM CONTINUOUS pressure, trendelenberg, &amp;amp; analgesics
&lt;/li&gt;&lt;li&gt; Surgery consult or f/u if can't reduce. Ensure no obstruction
&lt;/li&gt;&lt;/ul&gt;




</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="innocent_murmurs"><name>Innocent Murmurs</name><content>&lt;p&gt;&#65533; 72% of all school-age children have innocent murmurs.
&lt;/p&gt;&lt;p&gt;&#65533; Congenital heart disease 0.8% of live births
&lt;/p&gt;&lt;p&gt;&#65533; Still's- mid-Systolic, best at LLSB, likely from harmonic vibrations of LV outflow tract (chordae tindinae). All ages, particularly young school age. Low pitch, musical. Decr. with inspiration, sitting, standing. Not a VSD- not regurgitant or w/ thrill. VSD - HSM
&lt;/p&gt;&lt;p&gt;&#65533; Innocent Pulmonary Flow Murmur- systolic best at LUSB, minor turbulence in RV outflow tract &amp;amp; main pulm. a. Often infants and preschool age. Higher pitched than still's, less musical. Not PS- no ejection click, no incr. RV impulse. no wide s2 split. Not Pulm M of ASD, no fixed splitting, no diastolic tricuspid flow rumble, no incr. RV impulse. Decr. on inspiration/sitting/standing.
&lt;/p&gt;&lt;p&gt;&#65533; Innocent Pulmonary Branch Murmur of Infancy- SEM from turbulence in Pulm. A. branches (one or both). Med pitch. Physiologic in neonates, becoming audible at L,R,B USB btwn 0-2wks; transmits well to back and axilla. Common in premature; disappears early in infancy. Not PS- no eject click, no incr. RV impulse.
&lt;/p&gt;&lt;p&gt;&#65533; Supraclavicular Bruit- SEM of med pitch from physiologic turbulence of carotid/subclavian and heard at base of neck. Can be palpable. Disappears on hyperextension of shoulders. Not AS which is loudest at URSB with systolic thrill, sometimes with click.
&lt;/p&gt;&lt;p&gt;&#65533; Venous Hum - Continuous murmur from turb.flow in SVC heard at L,R,or B infraclavicular position while sitting/standing. Not PDA (bounding pulse, systolic&amp;gt;diastolic sound) or AV malformation. Disappears in recumbent position, rotation of head, by pressure at jugular.
&lt;/p&gt;&lt;p&gt;&#65533; Mammary Souffle- Blood flow in A and V to engorged breast. - systolic or continuous, disappears with stethoscope pressure.
&lt;/p&gt;&lt;p&gt;&#65533; Cardiorespiratory murmur- high pitched cooing, anywhere, but esp apex. Breath sound so not timed to heart, disappear when holding breath.
&lt;/p&gt;&lt;p&gt;&#65533;
&lt;/p&gt;&lt;p&gt;&#65533; Check height and weight- L-to-R can cause decr., but are usually symptomatic.
&lt;/p&gt;&lt;p&gt;&#65533; Color- so, so but cynanosis of hands,feet,perioral on exertion.
&lt;/p&gt;&lt;p&gt;&#65533; Feeding- fatigue or short feeding times for infants- perspiring, grunting, coughing, tachycardia while feeding. Severe CHF may show at rest deep breathing with dyspnea w/ distress.
&lt;/p&gt;&lt;p&gt;&#65533; Enlarged heart (ie ASD) can cause bulging of chest
&lt;/p&gt;&lt;p&gt;&#65533; Older kids- activity causing dyspnea/cyanosis- keeping up with peers, grunting, coughing, tired from stairs. Syncopal/presyncopal, incr fatigue, palpitations/angina can occur with IHSS
&lt;/p&gt;&lt;p&gt;&#65533; Yet older- Aortic valve with rheumatic fever,myocarditis (h/o URI), endocarditis (IV drug use)
&lt;/p&gt;&lt;p&gt;&#65533;
&lt;/p&gt;&lt;p&gt;&#65533; Preg Hx- Diabetes M (ASD, coarctation of aorta, cardiomyopathies), CMV, Coxsackie B5, warfarin, antiseizure, EtOH (ASD,VSD), prematurity (PDA)
&lt;/p&gt;&lt;p&gt;&#65533;
&lt;/p&gt;&lt;p&gt;&#65533; Worry when- fam hx of IHSS/sudden death &amp;amp; prominent apical thrust indicates LVH
&lt;/p&gt;&lt;p&gt;&#65533; S1 &amp;amp; S2 are not normal or are obscured
&lt;/p&gt;&lt;p&gt;&#65533; Murmur is not musical or vibratory
&lt;/p&gt;&lt;p&gt;&#65533; most innocent murmurs are
&lt;/p&gt;&lt;p&gt;- not holo or diastolic
&lt;/p&gt;&lt;p&gt;- not &amp;gt;grade III
&lt;/p&gt;&lt;p&gt;- hockey stick dist
&lt;/p&gt;&lt;p&gt;- normal S1 &amp;amp; S2
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="intracranial_hemorrhage_(ich)"><name>Intracranial Hemorrhage (ICH)</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Intracranial_Hemorrhage_(ICH)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: AHA Guidlines"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="AHA_Guidlines"&gt;AHA Guidlines&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Keep MAP &amp;lt;130 during acute phase
&lt;/li&gt;&lt;li&gt;When patient is anticoagulated on warfarin with INR &amp;gt; 2.0 should consider reversal with following:
&lt;ol&gt;&lt;li&gt;Vitamin K 10mg IV (small risk of anaphylaxis, takes up to 6 hours to work)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;FFP (generally need up to 6 units to bring INR to 1.2; careful about volume overload in the elderly)
&lt;/li&gt;&lt;li&gt;Prothrombin Complex Concentrate (25-50mg/kg IV)
&lt;ol&gt;&lt;li&gt;very expensive with limited data but trends are moving towards using this in life threatening bleeding.  can decrease hematoma expansion.
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Desmopressin: can increase activity of platelets via vWF
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Intracranial_Hemorrhage_(ICH)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Arabinda Pani, MD
&lt;/p&gt;&lt;p&gt;2/20/2010
&lt;/p&gt;



</content><folder>Neuro</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="intubation"><name>Intubation</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Indications"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Indications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Premedication"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Premedication&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Difficult_BVM_.28MOANS.29"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Difficult BVM (MOANS)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Difficult_Intubation"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Difficult Intubation&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Laryngoscopy_Grades_.28Cormack_.26_Lehane.29"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Laryngoscopy Grades (Cormack &amp;amp; Lehane)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Nasal_Intubation"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Nasal Intubation&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Intubation&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Indications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Indications"&gt;Indications&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Failure to ventilate
&lt;/li&gt;&lt;li&gt;Failure to oxygenate
&lt;/li&gt;&lt;li&gt;Inability to protect airway (gag unhelpful)
&lt;/li&gt;&lt;li&gt;Anticipated clinical course (anticipated deterioration, transport, or impending airway compromise)
&lt;/li&gt;&lt;li&gt;Increased ICP (for hyperventilation)
&lt;/li&gt;&lt;li&gt;Combative, needing imaging
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Intubation&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Premedication"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Premedication"&gt;Premedication&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Lidocaine (1.5mg/kg): inc ICP, severe asthma
&lt;/li&gt;&lt;li&gt;Fentanyl (3mcg/kg): ischemic CAD, inc ICP, aortic dissect
&lt;/li&gt;&lt;li&gt;Atropine (0.02mg/kg): children &amp;lt;10 yrs
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;^consider ketamine (1.5mg/kg) in place of etomidate for induction in asthma
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Intubation&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Difficult BVM (MOANS)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Difficult_BVM_.28MOANS.29"&gt;Difficult BVM (MOANS)&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Mask seal
&lt;/li&gt;&lt;li&gt;Obesity
&lt;/li&gt;&lt;li&gt;Aged
&lt;/li&gt;&lt;li&gt;No teeth
&lt;/li&gt;&lt;li&gt;Stiffness (resistance to ventilation)
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;"Remove dentures to intubate; keep them in to bag/mask ventilate"
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Intubation&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Difficult Intubation"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Difficult_Intubation"&gt;Difficult Intubation&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Look externally (gestalt)
&lt;/li&gt;&lt;li&gt;Evaluate 3-3-2 rule
&lt;/li&gt;&lt;li&gt;Mallampati
&lt;/li&gt;&lt;li&gt;Obstruction
&lt;/li&gt;&lt;li&gt;Neck mobility
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Intubation&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Laryngoscopy Grades (Cormack &amp;amp; Lehane)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Laryngoscopy_Grades_.28Cormack_.26_Lehane.29"&gt; Laryngoscopy Grades (Cormack &amp;amp; Lehane) &lt;/span&gt;&lt;/h2&gt;
&lt;table style="width: 500px" border="1" cellpadding="1" cellspacing="1"&gt;

&lt;tr&gt;
&lt;td&gt; Grade&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; View&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Failure Rate&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; I&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; whole aperture
&lt;/td&gt;&lt;td&gt; 0%&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; IIa&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; ayretenoids +partial cords
&lt;/td&gt;&lt;td&gt; 4%&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; IIb&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; ayretenoids only
&lt;/td&gt;&lt;td&gt; 67%&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; III&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; epiglottis only
&lt;/td&gt;&lt;td&gt; &amp;gt;67%&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; IV&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; no epiglottis
&lt;/td&gt;&lt;td&gt;&amp;nbsp;?%&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Intubation&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Nasal Intubation"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Nasal_Intubation"&gt;Nasal Intubation&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;sniffing position (like oral ET)
&lt;/li&gt;&lt;li&gt;pretreat with lido, hurricaine, or 4cc nebulized lidocaine for 5 minutes
&lt;/li&gt;&lt;li&gt;Tube size = 1.0 mm smaller
&lt;/li&gt;&lt;li&gt;listen with stethoscope  at end of tube (breath sounds become louder as tube approaches cords)
&lt;/li&gt;&lt;li&gt;when tube hits cords patient will cough, back up 1 or 2 cm.  wait for beginning of inspiration, as patient begins inspiration advance 3-4 cm (tube should be 22-26cm in women, 23-28cm in men)
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;tips: occlude other nostril to hear better, cricoid pressure when advancing, use a small suciton catheter as a seldinger guide, precurve tube before insertion. 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Intubation&amp;amp;action=edit&amp;amp;section=7" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Air/Resus: Airway (RSI)
&lt;/p&gt;&lt;p&gt;Air/Resus: Rapid Sequence Intubation (RSI)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Intubation&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;2/06  DONALDSON (Adapted from Rosen, Lampe)
&lt;/p&gt;



</content><folder>Airway/Resus</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="intussusception"><name>Intussusception</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Intussusception&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; d/t prolapse of part of intestine into the other
&lt;/li&gt;&lt;li&gt; 90% occurs in childhood (ileocolic, ileocecal, or ileoileocolic), adults can occur (50% are small bowel)
&lt;/li&gt;&lt;li&gt; Most common cause of intestinal obstruction in &amp;lt;2 y/o group (2nd cause in infants behind hernia)
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Intussusception&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Usually btwn 3-12 mos, peak at 10mos (range is 3mo- 2 yr)
&lt;/li&gt;&lt;li&gt; Classic triad (3 Sx in 21%, 2Sx in 70%): colicky abdominal pain 80%, vomiting (bilious), bloody stools (currant jelly like) 50%. Intermittent pain= child pulls up knees, then relief.
&lt;/li&gt;&lt;li&gt; "Dance's sign"= sausage like RUQ mass with no bowel in RLQ 85%
&lt;/li&gt;&lt;li&gt; All labs nonspecific
&lt;/li&gt;&lt;li&gt; AXR= signs of obst w/ AFL &amp;amp; no gas distal to obst. U/s gd screening: sensitivity 100% spec.93%
&lt;/li&gt;&lt;li&gt; Air contrast enema (replaced barium) can Dx &amp;amp; Rx (do NOT use if pt has peritonitis and/or shock). See coiled spring appearance/cervix lke mass.
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Intussusception&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Rx= npo, NGT, IVF, surgery consult, Air-Contrast enema reduces 80%!
&lt;/li&gt;&lt;/ul&gt;




</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="iron_(fe)"><name>Iron (Fe)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Iron_(Fe)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- in blood fe bound to protein called transferrin. Reticuloendothelial sys removes xferrin from blood and stores fe as ferritin or hemosiderin
&lt;/p&gt;&lt;p&gt;- ferum fe lvls- 50- 150 mcg/dl
&lt;/p&gt;&lt;p&gt;- TIBC or xferrin lvl 300- 400 mcg/dl
&lt;/p&gt;&lt;p&gt;- xferrin saturation 35% +/- 15%
&lt;/p&gt;&lt;p&gt;- sys tox due to free Fe- free fe exists once total fe lvl exceeds fe binding capacity of xferrin
&lt;/p&gt;&lt;p&gt;- fe normally lost thru bile, sweat, dermal and GI turnover
&lt;/p&gt;&lt;p&gt;- causes vomitting, gi bleeds and deposits in liver- can cause coagulopathy and hypoglycemia later on
&lt;/p&gt;&lt;p&gt;- can cause sz
&lt;/p&gt;&lt;p&gt;- free fe and xferrin are vasodilators and neg inotrope
&lt;/p&gt;&lt;p&gt;- can get met acidosis
&lt;/p&gt;&lt;p&gt;- free fe goes intracellularly and uncouples mitochondrial electron xport from ox phosphorylation so get cellular asphyxiation.
&lt;/p&gt;&lt;p&gt;also may increase lipid peroxidation and get free radicals to cause dysfnction of krebs cycle and e- xprt- theoretically free radical scavenger like vit E may be useful
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Iron_(Fe)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;PHASES
&lt;/p&gt;&lt;p&gt;1- corrosive effect on gut- abd pain, n/v/d,
&lt;/p&gt;&lt;p&gt;2- 2- 48 hr- apparent recovery and response to fluids
&lt;/p&gt;&lt;p&gt;3- 6- 48 hr- recurrence of gi sys, CV collapse, acidosis, leukocytosis, coagulopathy,
&lt;/p&gt;&lt;p&gt;4- 2- 5d, hepatic failure and hypoglycemia
&lt;/p&gt;&lt;p&gt;5- delayed sequelae of gi scarring
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;EVAL OF TOXICITY
&lt;/p&gt;&lt;p&gt;- elemental fe determines toxicity, not amount of salt
&lt;/p&gt;&lt;p&gt;liquid- 1- 20 mg fe/cc
&lt;/p&gt;&lt;p&gt;chewable- 15 mg/tab
&lt;/p&gt;&lt;p&gt;fe gluc- 12% elemental fe
&lt;/p&gt;&lt;p&gt;fe sulf- 20%
&lt;/p&gt;&lt;p&gt;fe fumrt- 33%
&lt;/p&gt;&lt;p&gt;Elemental Fe Load=
&lt;/p&gt;&lt;p&gt;(#tabs x (mg Fe salt/tab)x(%elemental Fe))/ pt wt
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Predicted Tox
&lt;/p&gt;&lt;p&gt;&amp;lt; 20mg/kg- nontox
&lt;/p&gt;&lt;p&gt;20- 60- mild to mod
&lt;/p&gt;&lt;p&gt;&amp;gt; 60- severe
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Labs
&lt;/p&gt;&lt;p&gt;- get serum fe at 3- 5 hr and repeat @ 6- 8 hr
&lt;/p&gt;&lt;p&gt;if less than 350mcg/dl min tox. &amp;gt; 500 mcg/dl- severe
&lt;/p&gt;&lt;p&gt;- increased wbc. 15K and gluc &amp;gt;150 early on. If have this, then do defuroxime challenge test- if + admit
&lt;/p&gt;&lt;p&gt;- kub with pills. 50mg/kg up to 1 gm im or 10 mg/kg iv and wait for 2 urinations for vin rose color change.
&lt;/p&gt;&lt;p&gt;- met acidosis since neg inotrope and have lactic acidosis
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Iron_(Fe)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- lavage
&lt;/p&gt;&lt;p&gt;- whole bowel irrigation c golytly
&lt;/p&gt;&lt;p&gt;- charcoal ineffective
&lt;/p&gt;&lt;p&gt;- defuroxamine- chelates c fe to make ferrioxamine- water soluble and peed out. makes brown/ orange urine
&lt;/p&gt;&lt;p&gt;90 mg/kg im up to 1 gm in kids or 2 gms in adults- repeat q 4- 6hrs with daily max of 6 gms
&lt;/p&gt;&lt;p&gt;if severe tox, 15 mg/kg/hr
&lt;/p&gt;&lt;p&gt;- no compazine since can cause coma in combination c def
&lt;/p&gt;&lt;p&gt;- can also dialyze the ferrioxamine
&lt;/p&gt;&lt;p&gt;- if asymp for 6 hrs and neg labs, home
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Iron_(Fe)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;6/06 MISTRY
&lt;/p&gt;



</content><folder>Tox</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="irritable_bowel_syndrome_(ibs)"><name>Irritable Bowel Syndrome (IBS)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#General"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;General&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Criteria"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;Criteria&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Irritable_Bowel_Syndrome_(IBS)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: General"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="General"&gt;General&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;psychosocial factors
&lt;/li&gt;&lt;li&gt;altered gut motility
&lt;/li&gt;&lt;li&gt;hypersensitive intestinal pain perseption
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Irritable_Bowel_Syndrome_(IBS)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Irritable_Bowel_Syndrome_(IBS)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Criteria"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Criteria"&gt;Criteria&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;3 months of pain:
&lt;ol&gt;&lt;li&gt;relieved by defecation
&lt;/li&gt;&lt;li&gt;assoc with change of stool freq
&lt;/li&gt;&lt;li&gt;related to a change in stool consistency
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;AND, 2 or more sx for quarter of the days
&lt;ol&gt;&lt;li&gt; &amp;gt;3 bm per day or &amp;lt; 3 bm per wk
&lt;/li&gt;&lt;li&gt; altered stool form
&lt;/li&gt;&lt;li&gt; altered stool passage
&lt;/li&gt;&lt;li&gt; passage of mucous
&lt;/li&gt;&lt;li&gt; bloating
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Irritable_Bowel_Syndrome_(IBS)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;6/06 MISTRY
&lt;/p&gt;



</content><folder>GI</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="jaundice"><name>Jaundice</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Workup"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Workup&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#DDX"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;DDX&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Pregnancy_Related"&gt;&lt;span class="tocnumber"&gt;4.1&lt;/span&gt; &lt;span class="toctext"&gt;Pregnancy Related&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-6"&gt;&lt;a href="#Transplant_Related"&gt;&lt;span class="tocnumber"&gt;4.2&lt;/span&gt; &lt;span class="toctext"&gt;Transplant Related&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-7"&gt;&lt;a href="#Peds_Related"&gt;&lt;span class="tocnumber"&gt;4.3&lt;/span&gt; &lt;span class="toctext"&gt;Peds Related&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-8"&gt;&lt;a href="#Additional_DDX"&gt;&lt;span class="tocnumber"&gt;4.4&lt;/span&gt; &lt;span class="toctext"&gt;Additional DDX&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-10"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-11"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Jaundice&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;One end product of heme metabolism; remainder from myoglobin
&lt;/li&gt;&lt;li&gt;All bilirubin products in the body are initially UNconjugated
&lt;/li&gt;&lt;li&gt;Transported from albumin into liver cells; combined with glucuronic acid into conjugated bilirubin
&lt;/li&gt;&lt;li&gt;Excreted into the biliary tract in conjugated form
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Jaundice&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Workup"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Workup"&gt;Workup&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Icon
&lt;/li&gt;&lt;li&gt;CBC
&lt;/li&gt;&lt;li&gt;Chem 7
&lt;/li&gt;&lt;li&gt;LFTs
&lt;/li&gt;&lt;li&gt;Lipase
&lt;/li&gt;&lt;li&gt;UA
&lt;/li&gt;&lt;li&gt;Coags
&lt;/li&gt;&lt;li&gt;?Ammonia
&lt;/li&gt;&lt;li&gt;?US vs. CT
&lt;/li&gt;&lt;li&gt;?Retic count
&lt;/li&gt;&lt;li&gt;?Haptoglobin/LDH
&lt;/li&gt;&lt;li&gt;?Tylenol/ASA/Utox/ETOH
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Jaundice&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Masqueraders:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Carotenemia
&lt;/li&gt;&lt;li&gt;Quinacrine ingestion
&lt;/li&gt;&lt;li&gt;Dinitrophenol, teryl (explosive chemicals)
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;NB: Only bilirubin stains the sclera
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Jaundice&amp;amp;action=edit&amp;amp;section=4" title="Edit section: DDX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX"&gt;DDX&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Indirect &amp;gt;&amp;gt; direct (Hematologic) [near nl AST/ALT/Alk P/PT/PTT]
&lt;ol&gt;&lt;li&gt;Hemolytic
&lt;ol&gt;&lt;li&gt;G6PD
&lt;/li&gt;&lt;li&gt;Drug related
&lt;/li&gt;&lt;li&gt;Autoimmune
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Hematoma resorption
&lt;/li&gt;&lt;li&gt;Infective erythropoiesis
&lt;/li&gt;&lt;li&gt;Gilbert's
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Direct &amp;gt;&amp;gt; indirect
&lt;ol&gt;&lt;li&gt;Increased Alk P (Obstructive)  [nl to mild inc AST/ALT]
&lt;/li&gt;&lt;li&gt;Choledocholithiasis
&lt;/li&gt;&lt;li&gt;Cholecystitis
&lt;/li&gt;&lt;li&gt;Cholangitis (Ascending)
&lt;/li&gt;&lt;li&gt;AIDS cholangiopathy
&lt;/li&gt;&lt;li&gt;Stricture
&lt;/li&gt;&lt;li&gt;Neoplasm
&lt;ol&gt;&lt;li&gt;Panc head
&lt;/li&gt;&lt;li&gt;Gallbladder
&lt;/li&gt;&lt;li&gt;Primary liver
&lt;/li&gt;&lt;li&gt;Metastatic
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Obstructing AAA
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Nl Alk P (Hepatocellular/cholestatic) [greatly elevated AST/ALT]
&lt;ol&gt;&lt;li&gt;Viral hepatitis
&lt;/li&gt;&lt;li&gt;Fulminant hepatic failure
&lt;/li&gt;&lt;li&gt;ETOH hepatitis
&lt;/li&gt;&lt;li&gt;Ischemia
&lt;/li&gt;&lt;li&gt;Toxins
&lt;ol&gt;&lt;li&gt;isoniazide
&lt;/li&gt;&lt;li&gt;phenytoin
&lt;/li&gt;&lt;li&gt;acetaminophen
&lt;/li&gt;&lt;li&gt;ritonavir
&lt;/li&gt;&lt;li&gt;halothane
&lt;/li&gt;&lt;li&gt;sulronamide
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Autoimmune hepatitis
&lt;ol&gt;&lt;li&gt;1 biliary cirhosis
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;HELLP syndrome
&lt;/li&gt;&lt;li&gt;Congestive
&lt;ol&gt;&lt;li&gt;CHF
&lt;/li&gt;&lt;li&gt;Sepsis
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Jaundice&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Pregnancy Related"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Pregnancy_Related"&gt;Pregnancy Related&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;HELP
&lt;/li&gt;&lt;li&gt;Acute fatty liver
&lt;/li&gt;&lt;li&gt;Hyperemesis gravidarum
&lt;/li&gt;&lt;li&gt;Cholestasis of pregnancy
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Jaundice&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Transplant Related"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Transplant_Related"&gt;Transplant Related&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Transplant regection
&lt;/li&gt;&lt;li&gt;Graft-vs-host
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Jaundice&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Peds Related"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Peds_Related"&gt;Peds Related&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Inborn error of metabolism
&lt;/li&gt;&lt;li&gt;Physiologic neonatal
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Jaundice&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Additional DDX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Additional_DDX"&gt;Additional DDX&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Reye's syndrome
&lt;/li&gt;&lt;li&gt;TPN
&lt;/li&gt;&lt;li&gt;Heatstroke
&lt;/li&gt;&lt;li&gt;Budd-Chiari (with acute ascites)
&lt;/li&gt;&lt;li&gt;Wilson's
&lt;/li&gt;&lt;li&gt;Sarcoidosis
&lt;/li&gt;&lt;li&gt;Amyloidosis
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Jaundice&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;NEW ONSET JAUNDICE ADMIT CRITERIA
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Transaminase &amp;gt;1000IU/L
&lt;/li&gt;&lt;li&gt;Tbil &amp;gt;10mg/dL
&lt;/li&gt;&lt;li&gt;Evidence coagulopathy
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Jaundice&amp;amp;action=edit&amp;amp;section=10" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Peds: Neonatal Jaundice
&lt;/p&gt;&lt;p&gt;GI: Viral Hepatis
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Jaundice&amp;amp;action=edit&amp;amp;section=11" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;3/14/06 DONALDSON (adapted from Rosen), H-N
&lt;/p&gt;



</content><folder>GI</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="joint_rom_(table)"><name>Joint ROM (Table)</name><content>&lt;h2&gt; &lt;span class="mw-headline" id="Average_ROMs.C2.A0"&gt;Average ROMs&amp;nbsp;&lt;/span&gt;&lt;/h2&gt;
&lt;table border="1" cellspacing="0" cellpadding="3"&gt;
&lt;tr&gt;
&lt;td width="121" align="center"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;strong&gt;&lt;span style="font-family:Arial;"&gt;Joint/Segment&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;
&lt;/td&gt;&lt;td width="169" align="center"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;strong&gt;&lt;span style="font-family:Arial;"&gt;Movement&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;
&lt;/td&gt;&lt;td width="69" align="center"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;strong&gt;&lt;span style="font-family:Arial;"&gt;Degrees&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td rowspan="2" width="121"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;Elbow&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;td width="169"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;Flexion&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;td width="69" align="center"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;140&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td width="169"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;Hyperextension&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;td width="69" align="center"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;0&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td rowspan="2" width="121"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;Forearm&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;td width="169"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;Pronation&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;td width="69" align="center"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;80&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td width="169"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;Supination&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;td width="69" align="center"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;80&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td rowspan="4" width="121"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;Wrist&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;td width="169"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;Extension (Dorsiflexion)&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;td width="69" align="center"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;60&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td width="169"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;Flexion (Palmar flexion)&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;td width="69" align="center"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;60&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td width="169"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;Radial Deviation&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;td width="69" align="center"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;20&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td width="169"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;Ulnar Deviation&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;td width="69" align="center"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;30&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td rowspan="4" width="121"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;Shoulder&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;td width="169"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;Flexion&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;td width="69" align="center"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;180&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td width="169"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;Hyperextension&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;td width="69" align="center"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;50&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td width="169"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;Abduction&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;td width="69" align="center"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;180&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td width="169"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;Adduction&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;td width="69" align="center"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;50&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td rowspan="4" width="121"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;Shoulder&lt;br /&gt; w/ Abducted Arm&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;td width="169"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;Internal Rotation&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;td width="69" align="center"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;90&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td width="169"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;External Rotation&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;td width="69" align="center"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;90&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td width="169"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;Horizontal Adduction&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;td width="69" align="center"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;-&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td width="169"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;Horizontal Adduction&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;td width="69" align="center"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;-&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td rowspan="4" width="121"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;Hip&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;td width="169"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;Flexion&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;td width="69" align="center"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;100&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td width="169"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;Hyperextension&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;td width="69" align="center"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;30&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td width="169"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;Abduction&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;td width="69" align="center"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;40&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td width="169"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;Adduction&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;td width="69" align="center"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;20&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td rowspan="2" width="121"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;Extended Hip&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;td width="169"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;Internal Rotation&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;td width="69" align="center"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;40&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td width="169"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;External Rotation&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;td width="69" align="center"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;50&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td width="121"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;Knee&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;td width="169"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;Flexion&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;td width="69" align="center"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;150&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td rowspan="2" width="121"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;Ankle&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;td width="169"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;Plantar flexion&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;td width="69" align="center"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;20&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td width="169"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;Dorsiflexion&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;td width="69" align="center"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;30&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td rowspan="4" width="121"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;Cervical Spine&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;td width="169"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;Flexion&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;td width="69" align="center"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;60&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td width="169"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;Hyperextension&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;td width="69" align="center"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;75&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td width="169"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;Lateral Flexion&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;td width="69" align="center"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;45&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td width="169"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;Rotation&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;td width="69" align="center"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;80&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td rowspan="4" width="121"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;Lumbar-thoracic Spine&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;td width="169"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;Flexion&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;td width="69" align="center"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;45-50&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td width="169"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;Hyperextension&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;td width="69" align="center"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;25&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td width="169"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;Lateral Flexion&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;td width="69" align="center"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;25&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td width="169"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;Rotation&lt;/span&gt;&lt;/span&gt;
&lt;/td&gt;&lt;td width="69" align="center"&gt; &lt;span style="font-family:Arial, Arial, Helvetica;"&gt;&lt;span style="font-family:Arial;"&gt;30&lt;/span&gt;&lt;/span&gt;&amp;lt;/tbody&amp;gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;h2&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;&lt;p&gt;Luttgens &amp;amp; Hamilton, 1997&lt;/p&gt;




</content><folder>Ortho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="kawasaki's"><name>Kawasaki's</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Kawasaki%27s&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;A. Fever &amp;gt;38.5 (101.3) x &amp;gt;4dys
&lt;/p&gt;&lt;p&gt;AND
&lt;/p&gt;&lt;p&gt;B. 4 of the following:
&lt;/p&gt;
&lt;pre&gt;    1. Extremity edema/erythema/desquamation
&lt;/pre&gt;
&lt;pre&gt;    2. Polymophous exanthem
&lt;/pre&gt;
&lt;pre&gt;    3. Bilat conjunctival injection
&lt;/pre&gt;
&lt;pre&gt;    4. Lip/oral chages (red lips, straberry tongue)
&lt;/pre&gt;
&lt;pre&gt;    5. Cervical LAD (&amp;gt;1.5cm diam, usually unilat)
&lt;/pre&gt;
&lt;ul&gt;&lt;li&gt;Also associated with platlets &amp;gt;1k
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;CDC Dx criteria:
&lt;/p&gt;&lt;p&gt;Fever &amp;gt;5 days and 4/5 of:
&lt;/p&gt;&lt;p&gt;Bilateral conjunctival injection
&lt;/p&gt;
&lt;pre&gt; limbic sparing
&lt;/pre&gt;
&lt;p&gt;Oral mucosa changes
&lt;/p&gt;
&lt;pre&gt; erythema of lips or OR
&lt;/pre&gt;
&lt;pre&gt; strawberry tongue
&lt;/pre&gt;
&lt;pre&gt; dry cracked lips
&lt;/pre&gt;
&lt;p&gt;Peripheral extremity changes
&lt;/p&gt;
&lt;pre&gt; edema
&lt;/pre&gt;
&lt;pre&gt; erythema
&lt;/pre&gt;
&lt;pre&gt; periungual desquamation
&lt;/pre&gt;
&lt;p&gt;Rash
&lt;/p&gt;&lt;p&gt;Cervical LAD &amp;gt;1.5cm
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;C- conjunctivitis
&lt;/p&gt;&lt;p&gt;R- rash
&lt;/p&gt;&lt;p&gt;A- aneurysm
&lt;/p&gt;&lt;p&gt;S- strawberry tongue
&lt;/p&gt;&lt;p&gt;H- hands feet changes
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Associated Sx:
&lt;/p&gt;
&lt;pre&gt; High ESR/WBC/LFTs/Plts
&lt;/pre&gt;
&lt;pre&gt; Aseptic meningitis
&lt;/pre&gt;
&lt;pre&gt; Urethritis, Anemia
&lt;/pre&gt;
&lt;pre&gt; RUQ pain, big GB (hydrops)
&lt;/pre&gt;
&lt;pre&gt; Irritability, N/V/D
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Kawasaki%27s&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Labs:
&lt;/p&gt;
&lt;pre&gt; CBC/Diff/SPA/ALT/TBili
&lt;/pre&gt;
&lt;pre&gt; Blood Cx and UA
&lt;/pre&gt;
&lt;pre&gt; ECG
&lt;/pre&gt;
&lt;pre&gt; Echo (Coronaries, LV, Valves)
&lt;/pre&gt;
&lt;pre&gt; Red Top "Kawasaki Serum to CBR"
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Kawasaki%27s&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Orders:
&lt;/p&gt;
&lt;pre&gt; Vitals:
&lt;/pre&gt;
&lt;pre&gt;   q6h pre ASA doses
&lt;/pre&gt;
&lt;pre&gt;   During IVIG/ Steroid Rx:
&lt;/pre&gt;
&lt;pre&gt;     q15min x1h
&lt;/pre&gt;
&lt;pre&gt;     q30min x1h
&lt;/pre&gt;
&lt;pre&gt;     q1h for remainder
&lt;/pre&gt;
&lt;pre&gt;     cardiac monitor during infsn
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Consults:
&lt;/p&gt;
&lt;pre&gt; Full cardio
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Meds:
&lt;/p&gt;
&lt;pre&gt; ASA 20mg/kg q6h until afebrile
&lt;/pre&gt;
&lt;pre&gt; Benadryl 1mg/kg IV pre IVIG
&lt;/pre&gt;
&lt;pre&gt; IVIG 2G/kg IV over 8-12h
&lt;/pre&gt;
&lt;pre&gt; IV methylprednisolone 30mg/kg [max 1.5gm] over 3 hrs before IVIG
&lt;/pre&gt;
&lt;pre&gt;   pulse (shorter duration of fever, shorter hospital stay, lower ESR at 6 weeks.  Sundel et al, J Peds 142 June 2003)
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Kawasaki%27s&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;pre&gt; F/U w/ cardio
&lt;/pre&gt;
&lt;pre&gt; Cont ASA at high dose, switch to ASA 3-5mg/kg/day once afebrile for 48h
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Kawasaki%27s&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from Donaldson, Pani
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="ketamine"><name>Ketamine</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Contraindications"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Contraindications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Preparation"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Preparation&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Conscious_Sedation"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Conscious Sedation&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#O2_ready_vs_on"&gt;&lt;span class="tocnumber"&gt;3.1&lt;/span&gt; &lt;span class="toctext"&gt;O2 ready vs on&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Side_Effects"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Side Effects&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Overdose"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Overdose&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ketamine&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Contraindications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Contraindications"&gt;Contraindications&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;&amp;lt;3-6 mo old
&lt;/li&gt;&lt;li&gt;Increased ICP
&lt;/li&gt;&lt;li&gt;Glaucoma/acute globe (increased IOP)
&lt;/li&gt;&lt;li&gt;CAD, HTN, CHF (? &amp;gt;40 yr old )
&lt;/li&gt;&lt;li&gt;URI or active asthma (unless for induction)
&lt;/li&gt;&lt;li&gt;Procedures stimulating gag
&lt;/li&gt;&lt;li&gt;Porphyria/thyroid (theoretical)
&lt;/li&gt;&lt;li&gt;?Increased intra-abd pressure
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ketamine&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Preparation"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Preparation"&gt;Preparation&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;NPO (&amp;gt;3hrs = rec; no evidence of need)
&lt;/li&gt;&lt;li&gt;Consent
&lt;/li&gt;&lt;li&gt;Monitor
&lt;/li&gt;&lt;li&gt;BVM/O2 mask
&lt;/li&gt;&lt;li&gt;Suction
&lt;/li&gt;&lt;li&gt;Ketamine (drawn up)
&lt;/li&gt;&lt;li&gt;Atropine (ready) [0.01 mg/kg IVP; min 0.1mg, max 0.5mg]
&lt;/li&gt;&lt;li&gt;Versed (ready) [0.05mg/kg IVP]
&lt;/li&gt;&lt;li&gt;"Happy Place"
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ketamine&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Conscious Sedation"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Conscious_Sedation"&gt;Conscious Sedation&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Give initial bolus 2 mg/kg SLOW IV* (over 1 min)
&lt;ol&gt;&lt;li&gt;Nystagmus = effect
&lt;/li&gt;&lt;li&gt;?maximal dose = 6mg/kg at one time
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;May repeat boluses at 1 mg/kg increments
&lt;/li&gt;&lt;li&gt;prefered by most over IM 4 mg/kg
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ketamine&amp;amp;action=edit&amp;amp;section=4" title="Edit section: O2 ready vs on"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="O2_ready_vs_on"&gt;O2 ready vs on&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;No data
&lt;/li&gt;&lt;li&gt;Most don't give atropine prophy (some &amp;lt;5yrs; no evidence)
&lt;/li&gt;&lt;li&gt;Most don't give versed prophy (evidence against)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ketamine&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Side Effects"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Side_Effects"&gt;Side Effects&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Transient rash (common)
&lt;ol&gt;&lt;li&gt;not harmful
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Hypersalvation (1.7%)
&lt;ol&gt;&lt;li&gt;may give atropine
&lt;/li&gt;&lt;li&gt;suction sides only
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Laryngospasm (&amp;lt;0.4%)
&lt;ol&gt;&lt;li&gt;not dose-dependent
&lt;/li&gt;&lt;li&gt;assoc with fast IVP
&lt;/li&gt;&lt;li&gt;assoc with procedures stimulating gag
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Transient apnea (&amp;lt;0.3%)
&lt;ol&gt;&lt;li&gt;around 2min after IVP
&lt;/li&gt;&lt;li&gt;normally BVM needed only
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Emergence Rx (~2% mod-severe)
&lt;ol&gt;&lt;li&gt;give benzo
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Emesis/persistent ataxia
&lt;ol&gt;&lt;li&gt;typically during recovery
&lt;/li&gt;&lt;li&gt;no cases of aspiration (airway reflex maintained)
&lt;/li&gt;&lt;li&gt;no driving!
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ketamine&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Overdose"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Overdose"&gt;Overdose&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Prolonged sedation --&amp;gt; full recovery 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ketamine&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;3/06  DONALDSON (Adapted from Young)
&lt;/p&gt;



</content><folder>Drugs</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="kidney_stone_(nephrolithiasis)"><name>Kidney Stone (Nephrolithiasis)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Pass_Rates"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Pass Rates&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#Size"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;Size&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Location_in_Ureter"&gt;&lt;span class="tocnumber"&gt;1.2&lt;/span&gt; &lt;span class="toctext"&gt;Location in Ureter&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Recurrence_Rates"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Recurrence Rates&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Kidney_Stone_(Nephrolithiasis)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Pass Rates"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Pass_Rates"&gt;Pass Rates&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Kidney_Stone_(Nephrolithiasis)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Size"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Size"&gt;Size&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;4mm ~75%
&lt;/p&gt;&lt;p&gt;4-6mm ~50%
&lt;/p&gt;&lt;p&gt;&amp;gt;6mm ~10%
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Kidney_Stone_(Nephrolithiasis)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Location in Ureter"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Location_in_Ureter"&gt;Location in Ureter&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Distal ~70%
&lt;/li&gt;&lt;li&gt;Middle ~50%
&lt;/li&gt;&lt;li&gt;Proximal ~20%
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Kidney_Stone_(Nephrolithiasis)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Recurrence Rates"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Recurrence_Rates"&gt;Recurrence Rates&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1 yr ~33%
&lt;/p&gt;&lt;p&gt;5yr ~50%
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Incresing H2O intake decreases rate
&lt;/li&gt;&lt;li&gt;Protease inhibitors and diuretics increases rate
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Kidney_Stone_(Nephrolithiasis)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Kidney_Stone_(Nephrolithiasis)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;10/07 DONALDSON (adapted from Tintinalli)
&lt;/p&gt;



</content><folder>GU</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="knee_(meniscus_vs_ligament)"><name>Knee (Meniscus vs Ligament)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#General"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;General&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#MECHANISMS_OF_INJ"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;MECHANISMS OF INJ&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#RESULTS"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;RESULTS&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Knee_(Meniscus_vs_Ligament)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: General"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="General"&gt;General&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- torn menis or lig can cause sig disability- so expeditious repair needed
&lt;/p&gt;&lt;p&gt;- knee largest articulating joint in body- is modified hing with extensive ROM
&lt;/p&gt;&lt;p&gt;- stability provided by sof tissue- cruciate ligs and  collateral
&lt;/p&gt;&lt;p&gt;ligs, menisci, capsule and muscles
&lt;/p&gt;&lt;p&gt;- acl and pcl add stability and proprioception
&lt;/p&gt;&lt;p&gt;- ligs passively limit motion therfore providing stability
&lt;/p&gt;&lt;p&gt;- acl- pcl limit  ant and post desplacement of tibia on femur respectivelly
&lt;/p&gt;&lt;p&gt;- acl limits ant motion of tibia on femur- if tibial plateau keeps
&lt;/p&gt;&lt;p&gt;going forward get relative int rotation of tibia at terminal extention
&lt;/p&gt;&lt;p&gt;and can result in sensation knee is buckling or giving out- most
&lt;/p&gt;&lt;p&gt;common during pivoting.
&lt;/p&gt;&lt;p&gt;- acl inj also gives "loss of confidence" due to lack of proprioception input.
&lt;/p&gt;&lt;p&gt;- pcl provides stability  regardless of position of knee- if
&lt;/p&gt;&lt;p&gt;disrupted, tibia goes posteriorly- may get hyperextension of knee,
&lt;/p&gt;&lt;p&gt;post displacement of tibial during flexing and varus and valgus
&lt;/p&gt;&lt;p&gt;angulation with knee extenstion.
&lt;/p&gt;&lt;p&gt;- symptomatic pcl inj more common in pt with chronic tear or acute
&lt;/p&gt;&lt;p&gt;tear with other lig inj
&lt;/p&gt;&lt;p&gt;- Meniscus- increase joint stability, nutrition, lubrication, shock
&lt;/p&gt;&lt;p&gt;absorption or articular cartilage.
&lt;/p&gt;&lt;p&gt;- lat meniscus larger and less firmly attached- more mobile
&lt;/p&gt;&lt;p&gt;- medial menis immobilie and attached to MCL and capsule
&lt;/p&gt;&lt;p&gt;- med menis greater chance of inj since bears more weight and immobile
&lt;/p&gt;&lt;p&gt;- knee flexion pushes menisc posteriorly
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Knee_(Meniscus_vs_Ligament)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: MECHANISMS OF INJ"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="MECHANISMS_OF_INJ"&gt;MECHANISMS OF INJ&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- position of knee at time of inj dictates which structures inj
&lt;/p&gt;&lt;p&gt;- acl- inj during traumatic twisting with valgus stress- may hear pop
&lt;/p&gt;&lt;p&gt;- pcl- foot planted, twist with force directed posteriorly against
&lt;/p&gt;&lt;p&gt;tibia with knee flexed
&lt;/p&gt;&lt;p&gt;- col lig- from abduction and ext rotation
&lt;/p&gt;&lt;p&gt;- with age menisc tissure degenerates and splits and get horizontal
&lt;/p&gt;&lt;p&gt;tears- this leads to more loads on articular cartilage and arthritis.
&lt;/p&gt;&lt;p&gt;- menisc are without pain fibres so pain from tearing and bleeding
&lt;/p&gt;&lt;p&gt;into perif attachments and capsule that causes pain.
&lt;/p&gt;&lt;p&gt;- locked knee in flexed position by bucket handle tear in mcl- more
&lt;/p&gt;&lt;p&gt;common in youger pt
&lt;/p&gt;&lt;p&gt;- lcl more mobile so less locking when torn- may get clicking
&lt;/p&gt;&lt;p&gt;- women have more acl inj than men
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Knee_(Meniscus_vs_Ligament)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- examine healthy knee first- relaxes pt and ensures trust.  also
&lt;/p&gt;&lt;p&gt;needed for comparison
&lt;/p&gt;&lt;p&gt;- inspection- gait- effusion
&lt;/p&gt;&lt;p&gt;- palpation- warmth, eff, swelling, crepitance
&lt;/p&gt;&lt;p&gt;- function- ACL tests- lachman, ant drawer and lat pivot shift- should
&lt;/p&gt;&lt;p&gt;not cause pain in subacute setting
&lt;/p&gt;&lt;p&gt;Lachman- pt supine, knee 20- 30' extended- hold dista femur with one
&lt;/p&gt;&lt;p&gt;hand and prox tibia with other and pull up- should feed discreet stop-
&lt;/p&gt;&lt;p&gt;is positive test if no stop felt or too much motion
&lt;/p&gt;&lt;p&gt;Ant Drawer- pt supine, knee flexed 90', pull up on prox tibia
&lt;/p&gt;&lt;p&gt;Lateral Pivot Shift- valgus stress to knee with twisting force while
&lt;/p&gt;&lt;p&gt;flexing knee. one hand on lat part of knee pushing in.  other hand on
&lt;/p&gt;&lt;p&gt;foot with lateral force.  As start to extend knee, will get thud or
&lt;/p&gt;&lt;p&gt;jerk at 10- 20' representing ant subluxation of tibia on femur
&lt;/p&gt;&lt;p&gt;- pcl stability assessed by  post drawer test- pt supine, both knees
&lt;/p&gt;&lt;p&gt;flexed 90'.  In knee with pcl tear tibia will sag posteriorly.  If
&lt;/p&gt;&lt;p&gt;putting force on  post calf corrects sag is positive test.
&lt;/p&gt;&lt;p&gt;Meniscal integrity- mcmurray, apley, med- lat gring
&lt;/p&gt;&lt;p&gt;McMurray- pt supine, one hand on foot, other gives valgus force to
&lt;/p&gt;&lt;p&gt;knee- extend knee and int  and ext rotating tibia.  Positive if  get
&lt;/p&gt;&lt;p&gt;popping, sensation of symptoms along joint line and inablity to extend
&lt;/p&gt;&lt;p&gt;knee fully.
&lt;/p&gt;&lt;p&gt;Apley Compression test- pt prone, put your knee on pts thigh and flex
&lt;/p&gt;&lt;p&gt;knee and  ext rotate tibia- then compress tibia downward- if more pain
&lt;/p&gt;&lt;p&gt;is postive
&lt;/p&gt;&lt;p&gt;Medial Lateral Grind- supine, cradle calf in one hand. other on tibial
&lt;/p&gt;&lt;p&gt;joint line- apply varus and valgus stresses during flex and extending
&lt;/p&gt;&lt;p&gt;knee. if get grinding sensaiton from hand on joint line if positive
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Knee_(Meniscus_vs_Ligament)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: "&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id=""&gt; &lt;/span&gt;&lt;/h2&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Knee_(Meniscus_vs_Ligament)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: RESULTS"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="RESULTS"&gt;RESULTS&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- composite test of acl, pcl meniscus reasonable sens and specific.
&lt;/p&gt;&lt;p&gt;acl/ pcl test better predictors than menisc tests.
&lt;/p&gt;&lt;p&gt;- no data to judge test for mcl/ lcl inj
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Knee_(Meniscus_vs_Ligament)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;6/06  MISTRY
&lt;/p&gt;



</content><folder>Ortho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="knee_(minor)"><name>Knee (Minor)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#1._Bakers_Cyst"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;1. Bakers Cyst&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#2._Achilles_Tendon_Rupture"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;2. Achilles Tendon Rupture&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#3._Plantaris_Tendon_Rupture"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;3. Plantaris Tendon Rupture&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#4._Prepatellar_Bursitis"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;4. Prepatellar Bursitis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#5._Pes_Anserine_Bursitis"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;5. Pes Anserine Bursitis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#6._Patellofemoral_Sy_.28Runner.27s_Knee.29"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;6. Patellofemoral Sy (Runner's Knee)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#7._Patelar_tendonitis_.28Jumpers_knee.29"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;7. Patelar tendonitis (Jumpers knee)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Knee_(Minor)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: 1. Bakers Cyst"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="1._Bakers_Cyst"&gt;1. Bakers Cyst&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Injury: H/o joint dz,&amp;nbsp;?sudden rupture into calf
&lt;/p&gt;&lt;p&gt;Diag: Clinical
&lt;/p&gt;&lt;p&gt;Rx: cane/walker
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Knee_(Minor)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: 2. Achilles Tendon Rupture"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="2._Achilles_Tendon_Rupture"&gt;2. Achilles Tendon Rupture&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Injury: Calf pain/pop w/ sudden flex
&lt;/p&gt;&lt;p&gt;Diag: Pos Thompsons
&lt;/p&gt;&lt;p&gt;Rx: Ortho
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Knee_(Minor)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: 3. Plantaris Tendon Rupture"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="3._Plantaris_Tendon_Rupture"&gt;3. Plantaris Tendon Rupture&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;(Tennis Calf)
&lt;/p&gt;&lt;p&gt;Injury: Same as Achilles
&lt;/p&gt;&lt;p&gt;Diag: Neg Thompsons
&lt;/p&gt;&lt;p&gt;Rx: Immobilize
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Knee_(Minor)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: 4. Prepatellar Bursitis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="4._Prepatellar_Bursitis"&gt;4. Prepatellar Bursitis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Injury:
&lt;/p&gt;&lt;p&gt;Diag: Swelling above pattela; aspirate
&lt;/p&gt;&lt;p&gt;Rx: RICE
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Knee_(Minor)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: 5. Pes Anserine Bursitis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="5._Pes_Anserine_Bursitis"&gt;5. Pes Anserine Bursitis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Injury: knee stress, DM
&lt;/p&gt;&lt;p&gt;Diag: TTP medial tib/inf to joint
&lt;/p&gt;&lt;p&gt;Rx: steroid inject
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Knee_(Minor)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: 6. Patellofemoral Sy (Runner's Knee)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="6._Patellofemoral_Sy_.28Runner.27s_Knee.29"&gt;6. Patellofemoral Sy (Runner's Knee)&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Injury: Overuse
&lt;/p&gt;&lt;p&gt;Diag:
&lt;/p&gt;&lt;p&gt;-pain w/exertion/sitting
&lt;/p&gt;&lt;p&gt;-diffuse pain w/ patella rocking
&lt;/p&gt;&lt;p&gt;-xx =&amp;nbsp;?patella sublux
&lt;/p&gt;&lt;p&gt;Rx: PT = straight leg raises in extension/external rotation
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Knee_(Minor)&amp;amp;action=edit&amp;amp;section=7" title="Edit section: 7. Patelar tendonitis (Jumpers knee)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="7._Patelar_tendonitis_.28Jumpers_knee.29"&gt;7. Patelar tendonitis (Jumpers knee)&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Diag: Focal TTP inf patella
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Knee_(Minor)&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;5/4/06 DONALDSON (adapted from Miller)
&lt;/p&gt;



</content><folder>Ortho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="knee_(ottawa)"><name>Knee (Ottawa)</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Knee_(Ottawa)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Rule"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Rule"&gt;Rule&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1) Age &amp;gt;55
&lt;/p&gt;&lt;p&gt;2) TTP fibula head
&lt;/p&gt;&lt;p&gt;3) TTP patella
&lt;/p&gt;&lt;p&gt;4) Inability flex &amp;gt;90 deg
&lt;/p&gt;&lt;p&gt;5) Inability to walk 4 steps
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Knee_(Ottawa)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;2/8/05 DONALDSON (from 'the board')
&lt;/p&gt;



</content><folder>Ortho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="knee_dislocation"><name>Knee Dislocation</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Pathophysiology"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Pathophysiology&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Physical_Exam"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Physical Exam&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#W.2FU"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;W/U&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Consequences"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Consequences&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Knee_Dislocation&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Can result from high- or low-velocity injuries (MVC, martial arts, water-skiing)
&lt;/p&gt;&lt;p&gt;Anterior, posterior, medial, lateral, or rotatory dislocations all possible
&lt;/p&gt;&lt;p&gt;Anterior requires 30o of hyperextension before joint failure
&lt;/p&gt;&lt;p&gt;Posterior usually a dashboard injury
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Knee_Dislocation&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Pathophysiology"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Pathophysiology"&gt;Pathophysiology&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Requires failure of three ligaments
&lt;/p&gt;&lt;p&gt;Popliteal artery injured in 20-30%; if high-velocity then 40%
&lt;/p&gt;&lt;p&gt;8 hour window...
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Knee_Dislocation&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Physical Exam"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Physical_Exam"&gt;Physical Exam&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;If dislocation is still present, joint injury is easy to diagnose
&lt;/p&gt;&lt;p&gt;-Reduce if dislocated!
&lt;/p&gt;&lt;p&gt;-Search for hard and soft vascular signs
&lt;/p&gt;&lt;p&gt;-If hard vascular signs are present, popliteal artery injury is easy to diagnose
&lt;/p&gt;&lt;p&gt;--Hard signs = Pulse deficits, ischemic limb, active hemorrhage, expanding/pulsatile hematoma
&lt;/p&gt;&lt;p&gt;--Soft signs = Small/stable hematoma, injury to anatomically related nerve, history of hemorrhage
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Considerations:-Knee may present already reduced
&lt;/p&gt;&lt;p&gt;-Finding of significant ligament laxity
&lt;/p&gt;&lt;p&gt;-NB: Rate of arterial injury is the SAME, regardless
&lt;/p&gt;&lt;p&gt;-Knee swelling is NOT universal
&lt;/p&gt;&lt;p&gt;--Knee capsule is frequently disrupted, allowing hemarthrosis to leak into surrounding tissues
&lt;/p&gt;&lt;p&gt;-Normal pulses do NOT rule-out a vascular injury
&lt;/p&gt;&lt;p&gt;--10% of vascular injuries have normal palpated pulses
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Knee_Dislocation&amp;amp;action=edit&amp;amp;section=4" title="Edit section: W/U"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="W.2FU"&gt;W/U&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-Xray
&lt;/p&gt;&lt;p&gt;SOFT SIGNS
&lt;/p&gt;&lt;p&gt;Requires further evaluation/studies
&lt;/p&gt;&lt;p&gt;-ABI's
&lt;/p&gt;&lt;p&gt;-Duplex Doppler Ultrasonography
&lt;/p&gt;&lt;p&gt;--Reported sensitivity of 95% and specificity of 99%
&lt;/p&gt;&lt;p&gt;--Can miss intimal tears (intimal tears &amp;gt; 30% ofvessel lumen are felt to be &#8220;significant&#8221;). 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;HARD SIGNS
&lt;/p&gt;&lt;p&gt;OR +/- CT Angiogram prior
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Knee_Dislocation&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Reduction, ortho, vascular consult if necessary
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Knee_Dislocation&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Consequences"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Consequences"&gt;Consequences&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Amputation rate:
&lt;/p&gt;&lt;p&gt;&amp;gt;8h = 80%
&lt;/p&gt;&lt;p&gt;&amp;lt;8h = 15%
&lt;/p&gt;



</content><folder>Ortho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="la_area_hospital_numbers"><name>LA Area Hospital Numbers</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=LA_Area_Hospital_Numbers&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Emergency Departments"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Emergency_Departments"&gt; Emergency Departments &lt;br /&gt; &lt;/span&gt;&lt;/h2&gt;
&lt;table style="width: 500px" border="1" cellpadding="1" cellspacing="1"&gt;

&lt;tr&gt;
&lt;td&gt; &lt;b&gt;ED&lt;br /&gt;&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Phone Number&lt;br /&gt;&lt;/b&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Centinela
&lt;/td&gt;&lt;td&gt; 310-673-4660
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Kaiser
&lt;/td&gt;&lt;td&gt; 800-447-3777 (transfer)
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Kaiser
&lt;/td&gt;&lt;td&gt; 800-823-2020 (general)
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; LBM
&lt;/td&gt;&lt;td&gt; 562-933-2000
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; LCM
&lt;/td&gt;&lt;td&gt; 310-303-5600
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; MLK
&lt;/td&gt;&lt;td&gt; 310-668-4426
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Pacific Care &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 800-762-8456
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Santa Monica
&lt;/td&gt;&lt;td&gt; 310-319-4765
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; St. Mary's
&lt;/td&gt;&lt;td&gt; 562-491-9090
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; St. Francis
&lt;/td&gt;&lt;td&gt; 310-900-4525
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Torrance
&lt;/td&gt;&lt;td&gt; 310-325-9110
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; USC
&lt;/td&gt;&lt;td&gt; 310-226-2622
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=LA_Area_Hospital_Numbers&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from Donaldson
&lt;/p&gt;



</content><folder>Harbor Admin</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="labs_checklist"><name>Labs Checklist</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#General_Labs.2FOrders"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;General Labs/Orders&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Case_Specific"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Case Specific&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#AMS"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;AMS&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Anemia"&gt;&lt;span class="tocnumber"&gt;2.2&lt;/span&gt; &lt;span class="toctext"&gt;Anemia&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#DIC"&gt;&lt;span class="tocnumber"&gt;2.3&lt;/span&gt; &lt;span class="toctext"&gt;DIC&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-6"&gt;&lt;a href="#GYN"&gt;&lt;span class="tocnumber"&gt;2.4&lt;/span&gt; &lt;span class="toctext"&gt;GYN&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-7"&gt;&lt;a href="#Abruption"&gt;&lt;span class="tocnumber"&gt;2.5&lt;/span&gt; &lt;span class="toctext"&gt;Abruption&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-8"&gt;&lt;a href="#Preeclampsia"&gt;&lt;span class="tocnumber"&gt;2.6&lt;/span&gt; &lt;span class="toctext"&gt;Preeclampsia&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#Procedure_.2F_Fluid"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Procedure / Fluid&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-10"&gt;&lt;a href="#Lumbar_Puncture"&gt;&lt;span class="tocnumber"&gt;3.1&lt;/span&gt; &lt;span class="toctext"&gt;Lumbar Puncture&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-11"&gt;&lt;a href="#Synovial_Fluid"&gt;&lt;span class="tocnumber"&gt;3.2&lt;/span&gt; &lt;span class="toctext"&gt;Synovial Fluid&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-12"&gt;&lt;a href="#Peritoneal_Fluid"&gt;&lt;span class="tocnumber"&gt;3.3&lt;/span&gt; &lt;span class="toctext"&gt;Peritoneal Fluid&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-13"&gt;&lt;a href="#Pleural_Fluid"&gt;&lt;span class="tocnumber"&gt;3.4&lt;/span&gt; &lt;span class="toctext"&gt;Pleural Fluid&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-14"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Labs_Checklist&amp;amp;action=edit&amp;amp;section=1" title="Edit section: General Labs/Orders"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="General_Labs.2FOrders"&gt; General Labs/Orders &lt;/span&gt;&lt;/h2&gt;
&lt;table border="1" width="723"&gt;

&lt;tr&gt;
&lt;td&gt;
&lt;p&gt;&lt;b&gt;Serum&lt;/b&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Other&lt;/b&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;
&lt;p&gt;CBC
&lt;/p&gt;&lt;p&gt;Chem10
&lt;/p&gt;&lt;p&gt;LFTs
&lt;/p&gt;&lt;p&gt;Lipase
&lt;/p&gt;&lt;p&gt;Coags
&lt;/p&gt;&lt;p&gt;T&amp;amp;S/T&amp;amp;C
&lt;/p&gt;&lt;p&gt;BCx x2, catheters
&lt;/p&gt;&lt;p&gt;D-dimer
&lt;/p&gt;&lt;p&gt;BNP
&lt;/p&gt;&lt;p&gt;ESR/CRP
&lt;/p&gt;&lt;p&gt;Fungal Cx
&lt;/p&gt;&lt;p&gt;VBG
&lt;/p&gt;&lt;p&gt;ABG
&lt;/p&gt;&lt;p&gt;Lactate
&lt;/p&gt;&lt;p&gt;B-OH, Acetone qX
&lt;/p&gt;&lt;p&gt;CKMB, TnI qX
&lt;/p&gt;&lt;p&gt;Total CK q
&lt;/p&gt;&lt;p&gt;Rapid HIV
&lt;/p&gt;&lt;p&gt;LDH
&lt;/p&gt;
&lt;/td&gt;&lt;td&gt;
&lt;p&gt;Accu-check
&lt;/p&gt;&lt;p&gt;HemoCue
&lt;/p&gt;&lt;p&gt;Icon
&lt;/p&gt;&lt;p&gt;UA, UCx, grm stain
&lt;/p&gt;&lt;p&gt;Flu
&lt;/p&gt;&lt;p&gt;Strep
&lt;/p&gt;&lt;p&gt;Thick &amp;amp; thin
&lt;/p&gt;&lt;p&gt;Sputum Cx
&lt;/p&gt;&lt;p&gt;CXR (PA/lat v portable)
&lt;/p&gt;&lt;p&gt;EKG qX
&lt;/p&gt;&lt;p&gt;CT/CTA
&lt;/p&gt;&lt;p&gt;U/S
&lt;/p&gt;&lt;p&gt;Angio
&lt;/p&gt;&lt;p&gt;MRI/MRA
&lt;/p&gt;&lt;p&gt;Foley/NG/OG/CT
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Labs_Checklist&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Case Specific"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Case_Specific"&gt;Case Specific&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Labs_Checklist&amp;amp;action=edit&amp;amp;section=3" title="Edit section: AMS"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="AMS"&gt;AMS&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;UA
&lt;/p&gt;&lt;p&gt;Utox
&lt;/p&gt;&lt;p&gt;Serum EtOH
&lt;/p&gt;&lt;p&gt;Tylenol/Salicylate
&lt;/p&gt;&lt;p&gt;TSH
&lt;/p&gt;&lt;p&gt;ABG/CO level
&lt;/p&gt;&lt;p&gt;Ammonia
&lt;/p&gt;&lt;p&gt;Rapid HIV
&lt;/p&gt;&lt;p&gt;EKG/CXR
&lt;/p&gt;&lt;p&gt;Lactate
&lt;/p&gt;&lt;p&gt;Dilantin/Phenobarb
&lt;/p&gt;&lt;p&gt;B12, Folate, RPR
&lt;/p&gt;&lt;p&gt;non-con Head CT
&lt;/p&gt;&lt;p&gt;LP
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Labs_Checklist&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Anemia"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Anemia"&gt;Anemia&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Consent for transfusion
&lt;/p&gt;&lt;p&gt;Retic
&lt;/p&gt;&lt;p&gt;Fe
&lt;/p&gt;&lt;p&gt;TIBC
&lt;/p&gt;&lt;p&gt;Ferritin
&lt;/p&gt;&lt;p&gt;Coombs (Direct/Indirect)
&lt;/p&gt;&lt;p&gt;B12
&lt;/p&gt;&lt;p&gt;Folate
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Labs_Checklist&amp;amp;action=edit&amp;amp;section=5" title="Edit section: DIC"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DIC"&gt;DIC&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;CBC (platelets)
&lt;/p&gt;&lt;p&gt;D-Dimer
&lt;/p&gt;&lt;p&gt;Fibrinogen
&lt;/p&gt;&lt;p&gt;FDP
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Labs_Checklist&amp;amp;action=edit&amp;amp;section=6" title="Edit section: GYN"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="GYN"&gt;GYN&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;GC/Chlam Cx v Urine
&lt;/p&gt;&lt;p&gt;Wet mount, Grm stain
&lt;/p&gt;&lt;p&gt;T&amp;amp;S
&lt;/p&gt;&lt;p&gt;B-HCG; serum progesterone
&lt;/p&gt;&lt;p&gt;U/S
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Labs_Checklist&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Abruption"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Abruption"&gt; Abruption &lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;CBC
&lt;/p&gt;&lt;p&gt;Coags
&lt;/p&gt;&lt;p&gt;FDP
&lt;/p&gt;&lt;p&gt;Fibrinogen
&lt;/p&gt;&lt;p&gt;D-dimer
&lt;/p&gt;&lt;p&gt;T&amp;amp;S
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Labs_Checklist&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Preeclampsia"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Preeclampsia"&gt;Preeclampsia&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;&lt;br /&gt;BUN/Cr
&lt;/p&gt;&lt;p&gt;CBC
&lt;/p&gt;&lt;p&gt;AST/ALT
&lt;/p&gt;&lt;p&gt;Uric Acid if RI
&lt;/p&gt;&lt;p&gt;LDH
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Labs_Checklist&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Procedure / Fluid"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Procedure_.2F_Fluid"&gt;Procedure / Fluid&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Labs_Checklist&amp;amp;action=edit&amp;amp;section=10" title="Edit section: Lumbar Puncture"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Lumbar_Puncture"&gt; Lumbar Puncture &lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;consent/1-2ccProt/Gluc
&lt;/p&gt;&lt;p&gt;Cx/Grm stain
&lt;/p&gt;&lt;p&gt;Cell count with dif
&lt;/p&gt;&lt;p&gt;Hold
&lt;/p&gt;&lt;p&gt;HSV PCR
&lt;/p&gt;&lt;p&gt;Fungal Cx
&lt;/p&gt;&lt;p&gt;India ink/Cryptococcal Ag
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Labs_Checklist&amp;amp;action=edit&amp;amp;section=11" title="Edit section: Synovial Fluid"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Synovial_Fluid"&gt; Synovial Fluid &lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;&#8211; consent/1-2ccCell count with dif
&lt;/p&gt;&lt;p&gt;Cx and Grm stain
&lt;/p&gt;&lt;p&gt;Crystals
&lt;/p&gt;&lt;p&gt;Protein/Glucose
&lt;/p&gt;&lt;p&gt;Cytology
&lt;/p&gt;&lt;p&gt;Test for string sign (nl 5-10cm)
&lt;/p&gt;&lt;p&gt;If only one test: Cx
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Labs_Checklist&amp;amp;action=edit&amp;amp;section=12" title="Edit section: Peritoneal Fluid"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Peritoneal_Fluid"&gt; Peritoneal Fluid &lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;- consentCell count with dif
&lt;/p&gt;&lt;p&gt;Cx (BCx bottles) and Grm stain
&lt;/p&gt;&lt;p&gt;Albumin and SERUM albumin
&lt;/p&gt;&lt;p&gt;Protein/glucose
&lt;/p&gt;&lt;p&gt;LDH and SERUM LDH at same time
&lt;/p&gt;&lt;p&gt;Amylase
&lt;/p&gt;&lt;p&gt;Specific circumstances:
&lt;/p&gt;&lt;p&gt;TB smear and Cx
&lt;/p&gt;&lt;p&gt;Cytology
&lt;/p&gt;&lt;p&gt;TG
&lt;/p&gt;&lt;p&gt;Billirubin
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Labs_Checklist&amp;amp;action=edit&amp;amp;section=13" title="Edit section: Pleural Fluid"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Pleural_Fluid"&gt; Pleural Fluid &lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;- consentProtein/Glucose
&lt;/p&gt;&lt;p&gt;Cx and Grm stain
&lt;/p&gt;&lt;p&gt;Cell count with dif
&lt;/p&gt;&lt;p&gt;LDH and SERUM LDH
&lt;/p&gt;&lt;p&gt;pH
&lt;/p&gt;&lt;p&gt;Specific circumstances:
&lt;/p&gt;&lt;p&gt;TB smear and Cx
&lt;/p&gt;&lt;p&gt;Cytology
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Labs_Checklist&amp;amp;action=edit&amp;amp;section=14" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt; Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;DeBonis 11/1/08
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;



</content><folder>Misc/General</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="laceration_repair"><name>Laceration Repair</name><content>&lt;p&gt;Anesthesia
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; Lidocaine (1% solution (10mg/mL) 
&lt;/li&gt;&lt;li&gt; Maximum safe dose = 300mg
&lt;/li&gt;&lt;li&gt; Lidocaine + epinephrine 
&lt;/li&gt;&lt;li&gt; Maximum safe dose = 500mg
&lt;/li&gt;&lt;li&gt; Delays healing, increases infection risk?
&lt;/li&gt;&lt;li&gt; Bupivicaine (0.25%) 
&lt;/li&gt;&lt;li&gt; Maximum safe dose = 175mg
&lt;/li&gt;&lt;li&gt; Bupivicaine + epinephrine 
&lt;/li&gt;&lt;li&gt; Maximum safe dose = 225mg
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; To decrease pain of injection: 
&lt;/li&gt;&lt;li&gt; Buffer lidocaine with bicarbonate (1mL bicarb: 10mL lidocaine)
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
Skin Preparation
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; Avoid betadine/chlorhexadine in wound
&lt;/li&gt;&lt;li&gt; Not necessary to remove hair (if do, avoid using razor)
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
Wound Preparation
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; Debridement is most important step in reducing infection/ promoting healing
&lt;/li&gt;&lt;li&gt; High pressure irrigation (can be achieved with 19 gauge syringe)
&lt;/li&gt;&lt;li&gt; Tap water is as effective as sterile water/ normal saline
&lt;/li&gt;&lt;li&gt; Irrigation optional for face/scalp wound as long as:
&lt;/li&gt;&lt;li&gt; Not a bite wound
&lt;/li&gt;&lt;li&gt; Not a contaminated wound
&lt;/li&gt;&lt;li&gt; Not older than 6 hours 
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Laceration_Repair&amp;amp;action=edit&amp;amp;section=1" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Trauma: Wound Management
&lt;/p&gt;&lt;p&gt;Trauma: Sutures
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Laceration_Repair&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;UpToDate
&lt;/p&gt;



</content><folder>Trauma</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="lactic_acidosis"><name>Lactic acidosis</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Lactic_acidosis&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt; Background &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Most common cause of metabolic acidosis in hospitalized patients
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Lactic_acidosis&amp;amp;action=edit&amp;amp;section=2" title="Edit section: DDX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX"&gt;DDX&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Type A
&lt;ol&gt;&lt;li&gt; Impaired tissue oxygenation
&lt;ol&gt;&lt;li&gt; Hypovolemia
&lt;/li&gt;&lt;li&gt; Cardiac failure
&lt;/li&gt;&lt;li&gt; Sepsis
&lt;/li&gt;&lt;li&gt; CO poisoning
&lt;/li&gt;&lt;li&gt; CN poisoning
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Type B
&lt;ol&gt;&lt;li&gt; No impaired tissue oxygenation
&lt;ol&gt;&lt;li&gt; Alcoholism
&lt;ol&gt;&lt;li&gt; Lactate utilization is impaired 2/2 impaired hepatic gluconeogenesis  
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Liver disease
&lt;/li&gt;&lt;li&gt; Metformin
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;




</content><folder>FEN</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="laryngeal_mask_airway_(lma)"><name>Laryngeal Mask Airway (LMA)</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Laryngeal_Mask_Airway_(LMA)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Chart"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Chart"&gt;Chart&lt;/span&gt;&lt;/h2&gt;
&lt;table width="264" border="1"&gt;
&lt;tr&gt;
&lt;td&gt; &lt;b&gt;Mask Size &lt;/b&gt;&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Weight (kg)&lt;/b&gt;&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Age (yr)&lt;/b&gt;&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;LMA length (cm) &lt;/b&gt;&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;LMA Cuff Vol (mL) &lt;/b&gt;&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Largest ETT^ (mm)&lt;/b&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 1
&lt;/td&gt;&lt;td&gt; &amp;lt;5&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &amp;lt;0.5&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 10 &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 4 &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 3.5 &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 1.5 &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 5-10 &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &amp;lt;1 &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 10 &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 5-7 &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 4 &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 2 &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 6.5-20 &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 1-5 &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 11.5 &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 7-10 &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 4.5 &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 2.5 &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 20-30 &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 5-10 &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 12.5 &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 14 &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 5 &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 3 &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 30-60 &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 10-15 &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 19 &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 15-20 &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 6 &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 4 &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 60-80 &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &amp;gt;15 &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 19 &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 25-30 &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 6.5 &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 5 &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &amp;gt;80 &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &amp;gt;15 &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 19 &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 30-40 &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 7 &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;p&gt;^Largest ETT that can pass thorough LMA
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Laryngeal_Mask_Airway_(LMA)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Tarascon Adult Emergency Pocketbook
&lt;/p&gt;



</content><folder>Airway/Resus</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="legg_calve_perthes_disease"><name>Legg Calve Perthes Disease</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Legg_Calve_Perthes_Disease&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- ischemic necrosis of femoral head
&lt;/p&gt;&lt;p&gt;- exact mech unknown
&lt;/p&gt;&lt;p&gt;- more common in boys
&lt;/p&gt;&lt;p&gt;- 10% of cases occur bilaterally
&lt;/p&gt;&lt;p&gt;- inc 1 per 1200 - 12,000
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Legg_Calve_Perthes_Disease&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Age - 4 to 9 yrs
&lt;/p&gt;&lt;p&gt;Present - Painless Limp
&lt;/p&gt;&lt;p&gt;Labs - normal
&lt;/p&gt;&lt;p&gt;Xrays - Compression, collapse, frag-
&lt;/p&gt;&lt;p&gt;mentation
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Presentation
&lt;/p&gt;&lt;p&gt;- classically a painless limp
&lt;/p&gt;&lt;p&gt;- may have mild, intermittent pain in hip, groi, thigh or knee
&lt;/p&gt;&lt;p&gt;- pain often activiity related &amp;amp; relieveed by rest.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Physical Exam
&lt;/p&gt;&lt;p&gt;- decr range of motion, esp internal rotation and abduction.
&lt;/p&gt;&lt;p&gt;- may have leg length discrepancy Xrays
&lt;/p&gt;&lt;p&gt;- initially show increase in articular space or compression of bone
&lt;/p&gt;&lt;p&gt;- as necrosis progresses, epiphysis will collapse and fragment
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Legg_Calve_Perthes_Disease&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- "Containment" by external orthoses, for up to 18 mo or surgery
&lt;/p&gt;&lt;p&gt;- 50% of untreated get disabling arthritis
&lt;/p&gt;&lt;p&gt;- younger diagnosed, better prog
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Legg_Calve_Perthes_Disease&amp;amp;action=edit&amp;amp;section=4" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Peds:  Hip Pain
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="lidocaine"><name>Lidocaine</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Lidocaine&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Theraputic Doses"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Theraputic_Doses"&gt; Theraputic Doses &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;MAX DOSE (mg/kg)
&lt;/p&gt;
&lt;table class="pbNotSortable" border="1" cellpadding="1" cellspacing="1" width="200"&gt;

&lt;tr&gt;
&lt;td&gt; &lt;b&gt;Agent&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;With Epi&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Without Epi&lt;/b&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Lidocaine
&lt;/td&gt;&lt;td&gt; 7
&lt;/td&gt;&lt;td&gt; 3-5
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Mevipicaine
&lt;/td&gt;&lt;td&gt; 8
&lt;/td&gt;&lt;td&gt; 7
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Bupivicaine
&lt;/td&gt;&lt;td&gt; 3
&lt;/td&gt;&lt;td&gt; 1.5
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Lidocaine&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt; Diagnosis &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Symptoms:
&lt;/p&gt;&lt;p&gt;1. CV (brady/arrest)
&lt;/p&gt;&lt;p&gt;-Tx w/ epi per ACLS
&lt;/p&gt;&lt;p&gt;2. CNS (lightheaded, pathesia)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;



</content><folder>Tox</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="limp"><name>Limp</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Limp&amp;amp;action=edit&amp;amp;section=1" title="Edit section: DDx (Serious)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx_.28Serious.29"&gt;DDx (Serious)&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Developmental dysplasia
&lt;/p&gt;&lt;p&gt;Fracture
&lt;/p&gt;&lt;p&gt;Neoplasm:
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; Leukemia
&lt;/li&gt;&lt;li&gt; Ewings
&lt;/li&gt;&lt;li&gt; Osteogenic sarcoma
&lt;/li&gt;&lt;li&gt; Metastatic neuroblastoma
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;Osteomyelitis
&lt;/p&gt;&lt;p&gt;SCFE
&lt;/p&gt;&lt;p&gt;Septic arthritis
&lt;/p&gt;&lt;p&gt;Other:
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; Appy
&lt;/li&gt;&lt;li&gt; Meningitis
&lt;/li&gt;&lt;li&gt; Epidural abscess (spine)
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Limp&amp;amp;action=edit&amp;amp;section=2" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Peds: Hip Pain
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="lisfranc_injury"><name>Lisfranc Injury</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Definition"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Definition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Epidemiology"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Epidemiology&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Pathophysiology"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Pathophysiology&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Dx"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Dx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Lisfranc_Injury&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Definition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Definition"&gt;Definition&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;...any fracture or dislocation of the TMT joint.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Lisfranc_Injury&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Epidemiology"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Epidemiology"&gt;Epidemiology&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;20% are missed on first presentation to the ER.
&lt;/p&gt;&lt;p&gt;&amp;lt;1% of all orthopedic trauma cases
&lt;/p&gt;&lt;p&gt;Up to one third of all lisfranc inuries are from minor slip and fall cases...
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Lisfranc_Injury&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Pathophysiology"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Pathophysiology"&gt;Pathophysiology&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;The Lisfranc ligament attaches the second metatarsal to the medial cuboid.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Lisfranc_Injury&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Clinical presentation is variable, includes severe midfoot pain, inability to bear weight, pain with pronation and passive abduction of the midfoot.
&lt;/p&gt;&lt;p&gt;Ecchymosis of the plantar section of the midfoot is highly suggestive of Lissfrank injury...
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Lisfranc_Injury&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Dx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Dx"&gt;Dx&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Radiographic criteria:
&lt;/p&gt;&lt;p&gt;Fracture of the base of the second metatarsal is pathonognmonic.
&lt;/p&gt;&lt;p&gt;Stein's Criteria for Lisfranc injury:
&lt;/p&gt;&lt;p&gt;1)The medial border of the fourth metatarsal does not form a continuous line with the medial border of the cuboid.
&lt;/p&gt;&lt;p&gt;2)The lateral border of the third metatarsal does not form a straight line with the lateral border of the lateral cuneiform.
&lt;/p&gt;&lt;p&gt;3)On AP view the medial border of the second metatarsal does not form a continuous straight line with the medial border of the middle cuneiform.
&lt;/p&gt;&lt;p&gt;4)The first metatarsal does not align itself medially and laterally with the medial cuneifom.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Have suspicion whenever there is any widening of the spaces between the first and second or second and third matarsal bases.
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Lisfranc_Injury&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Other than Lisfranc sprains (clinical findings but normal radiographs) which are treated ith 6 weeks of casting, all Lisfranc injuries require operative repair...
&lt;/p&gt;



</content><folder>Ortho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="lithium_od"><name>Lithium OD</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Lithium_OD&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;hemodialysis, whole bowel irrigation, kayexalate
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Lithium_OD&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;9/09  PANI (Adapted from Donaldson, Mistry, Pharmacopia)
&lt;/p&gt;



</content><folder>Tox</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="lovenox"><name>Lovenox</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Lovenox&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;DOSE = 1mg/kg sq bid
&lt;/li&gt;&lt;li&gt;No need to monitor PTT and adjust dosages.
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Lovenox&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Uses/Benefits"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Uses.2FBenefits"&gt;Uses/Benefits&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; DVT/PE - equal efficacy
&lt;/li&gt;&lt;li&gt; Unstable Angina (better than heparin)
&lt;/li&gt;&lt;li&gt; Ischemic Stroke - (LMWH benefit at 6 months)
&lt;/li&gt;&lt;li&gt; Prevent prolonged hospitalization
&lt;/li&gt;&lt;li&gt; Rapid neutralization with protamine possible
&lt;/li&gt;&lt;li&gt;1:1 mg upto 50 for lovenox in last 8hours
&lt;/li&gt;&lt;li&gt; Renal insufficiency (creatinine &amp;gt;2), liver disease, pregnancy, or obesity
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Lovenox&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;7/2/09 PANI
&lt;/p&gt;



</content><folder>Drugs</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="lower_back_pain"><name>Lower Back Pain</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Causes"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Causes&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Red_Flags"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Red Flags&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#DDX"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;DDX&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Cord_Compression"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Cord Compression&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Treatment_.28Pain.29"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Treatment (Pain)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Lower_Back_Pain&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Causes"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Causes"&gt; Causes &lt;/span&gt;&lt;/h2&gt;
&lt;table style="width: 479px; height: 436px" border="1" cellpadding="1"&gt;

&lt;tr&gt;
&lt;td&gt; &lt;b&gt;Cause&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Patient&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Onset&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Radiation&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Exam&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Evaluation&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Treatment&lt;/b&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Fracture
&lt;/td&gt;&lt;td&gt;
&lt;p&gt;Malignancy
&lt;/p&gt;&lt;p&gt;Osteoporosis
&lt;/p&gt;
&lt;/td&gt;&lt;td&gt; Acute-subacute
&lt;/td&gt;&lt;td&gt; Rare
&lt;/td&gt;&lt;td&gt; Localized pain
&lt;/td&gt;&lt;td&gt; xray
&lt;/td&gt;&lt;td&gt;
&lt;p&gt;Pain meds
&lt;/p&gt;&lt;p&gt;Refer/admit
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Malignancy
&lt;/td&gt;&lt;td&gt;
&lt;p&gt;Hx of cancer
&lt;/p&gt;&lt;p&gt;Age &amp;gt; 50
&lt;/p&gt;&lt;p&gt;Pain &amp;gt; 1 mo
&lt;/p&gt;&lt;p&gt;Incr. severity
&lt;/p&gt;
&lt;/td&gt;&lt;td&gt; Subacute
&lt;/td&gt;&lt;td&gt; Yes with epidural mets
&lt;/td&gt;&lt;td&gt; +/- decr neuro
&lt;/td&gt;&lt;td&gt;
&lt;p&gt;xray
&lt;/p&gt;&lt;p&gt;ESR
&lt;/p&gt;&lt;p&gt;MRI/CT-M
&lt;/p&gt;
&lt;/td&gt;&lt;td&gt;
&lt;p&gt;Steroids
&lt;/p&gt;&lt;p&gt;Admit
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Infection
&lt;/td&gt;&lt;td&gt;
&lt;p&gt;Immunocomp
&lt;/p&gt;&lt;p&gt;IVDA
&lt;/p&gt;&lt;p&gt;Children
&lt;/p&gt;
&lt;/td&gt;&lt;td&gt; Subacute
&lt;/td&gt;&lt;td&gt; Yes with epidural abscess
&lt;/td&gt;&lt;td&gt;
&lt;p&gt;+/- decr neuro
&lt;/p&gt;&lt;p&gt;Localized pain
&lt;/p&gt;&lt;p&gt;Fever in 50%
&lt;/p&gt;
&lt;/td&gt;&lt;td&gt;
&lt;p&gt;xray
&lt;/p&gt;&lt;p&gt;ESR
&lt;/p&gt;&lt;p&gt;MRI/CT-M
&lt;/p&gt;
&lt;/td&gt;&lt;td&gt;
&lt;p&gt;Abx
&lt;/p&gt;&lt;p&gt;Neurosx consult
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Musc/skel
&lt;/td&gt;&lt;td&gt; Adults
&lt;/td&gt;&lt;td&gt;
&lt;p&gt;Acute-subacute
&lt;/p&gt;
&lt;/td&gt;&lt;td&gt; Yes if herniated disc
&lt;/td&gt;&lt;td&gt;
&lt;p&gt;+/- decr neuro
&lt;/p&gt;&lt;p&gt;+ SLR
&lt;/p&gt;
&lt;/td&gt;&lt;td&gt;
&lt;p&gt;Nothing
&lt;/p&gt;&lt;p&gt;xrays?
&lt;/p&gt;&lt;p&gt;CT/MRI?
&lt;/p&gt;
&lt;/td&gt;&lt;td&gt;
&lt;p&gt;Pain meds
&lt;/p&gt;&lt;p&gt;Modified activity
&lt;/p&gt;&lt;p&gt;Referral
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Cauda Equ
&lt;/td&gt;&lt;td&gt; Adults-elderly
&lt;/td&gt;&lt;td&gt; Acute-subacute
&lt;/td&gt;&lt;td colspan="2"&gt;
&lt;p&gt;Bilateral S/S
&lt;/p&gt;&lt;p&gt;Urine/fecal changes
&lt;/p&gt;&lt;p&gt;Decr rectal tone
&lt;/p&gt;&lt;p&gt;Saddle anesthesia
&lt;/p&gt;
&lt;/td&gt;&lt;td&gt; MRI/CT-M
&lt;/td&gt;&lt;td&gt; Neurosx
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Lower_Back_Pain&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt; Work-Up &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;0) Icon
&lt;/p&gt;&lt;p&gt;1) X-rays* (if have red flag)
&lt;/p&gt;&lt;p&gt;2) CBC/ESR/Chem 7/UA (if &amp;gt;50 yo)
&lt;/p&gt;&lt;p&gt;3) Abd aorta US (if susp AAA &amp;gt;60 yo)
&lt;/p&gt;&lt;p&gt;4) Pain treatment
&lt;/p&gt;&lt;p&gt;Adults: AP &amp;amp; lateral of lumbar spine
&lt;/p&gt;&lt;p&gt;Children: add oblique views (to evaluate for spondolithesis)
&lt;/p&gt;&lt;p&gt;CT/MRI INDICATIONS
&lt;/p&gt;&lt;p&gt;1) Suspect disc dis. w. severe motor impairment,
&lt;/p&gt;&lt;p&gt;2) Suspect abcess or mets w/ neuro involv.
&lt;/p&gt;&lt;p&gt;3) Cauda equina syndrome.
&lt;/p&gt;&lt;p&gt;4) Elevated ESR
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Lower_Back_Pain&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Red Flags"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Red_Flags"&gt; Red Flags &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;History
&lt;/p&gt;&lt;p&gt;-Pain &amp;gt;4 weeks
&lt;/p&gt;&lt;p&gt;-Age &amp;gt;50 or &amp;lt;18
&lt;/p&gt;&lt;p&gt;-History of trauma
&lt;/p&gt;&lt;p&gt;-Bilateral sciatica (or LBP w/ new sciatica)
&lt;/p&gt;&lt;p&gt;-Neurologic complaints
&lt;/p&gt;&lt;p&gt;-Bladder/bowel incontinence
&lt;/p&gt;&lt;p&gt;-Night pain
&lt;/p&gt;&lt;p&gt;-Unrelenting pain despite rest and analgesics
&lt;/p&gt;&lt;p&gt;-Fevers/chills/nightsweats
&lt;/p&gt;&lt;p&gt;-IVDA history
&lt;/p&gt;&lt;p&gt;-Hx of cancer
&lt;/p&gt;&lt;p&gt;-Prolonged steriod use
&lt;/p&gt;&lt;p&gt;-Unexplained weight loss
&lt;/p&gt;&lt;p&gt;Physical Exam
&lt;/p&gt;&lt;p&gt;-Fever
&lt;/p&gt;&lt;p&gt;-Point vertebral tenderness
&lt;/p&gt;&lt;p&gt;-Neurologic deficits
&lt;/p&gt;&lt;p&gt;-?Patient writhing in pain
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Lower_Back_Pain&amp;amp;action=edit&amp;amp;section=4" title="Edit section: DDX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX"&gt; DDX &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;AAA
&lt;/p&gt;&lt;p&gt;Cauda equina sy
&lt;/p&gt;&lt;p&gt;Epidural abcess/hematoma
&lt;/p&gt;&lt;p&gt;Spinal fracture with cord/nerve impingement
&lt;/p&gt;&lt;p&gt;Back pain with neurologic def
&lt;/p&gt;&lt;p&gt;Intervetebral disk herniation
&lt;/p&gt;&lt;p&gt;CA
&lt;/p&gt;&lt;p&gt;Meningitis
&lt;/p&gt;&lt;p&gt;Siatica
&lt;/p&gt;&lt;p&gt;Spinal fracture
&lt;/p&gt;&lt;p&gt;Spinal stenosis
&lt;/p&gt;&lt;p&gt;Transverse myelitis
&lt;/p&gt;&lt;p&gt;Vertebral osteo
&lt;/p&gt;&lt;p&gt;Acute ligamentous injury
&lt;/p&gt;&lt;p&gt;Acute muscle strain
&lt;/p&gt;&lt;p&gt;Ankylosing spondylitis
&lt;/p&gt;&lt;p&gt;Degeverative joint disease
&lt;/p&gt;&lt;p&gt;Intervetebral disk disase
&lt;/p&gt;&lt;p&gt;Pathologic fracture
&lt;/p&gt;&lt;p&gt;Seropositive arthritis
&lt;/p&gt;&lt;p&gt;Spondylolithesis
&lt;/p&gt;&lt;p&gt;Cholecystitis
&lt;/p&gt;&lt;p&gt;Esophageal dz
&lt;/p&gt;&lt;p&gt;Pleural effusion
&lt;/p&gt;&lt;p&gt;Pancreatic dis.
&lt;/p&gt;&lt;p&gt;Perffed ulcer
&lt;/p&gt;&lt;p&gt;Retrocecal appy
&lt;/p&gt;&lt;p&gt;Large bowel obstr.
&lt;/p&gt;&lt;p&gt;Renal dz
&lt;/p&gt;&lt;p&gt;Pelvic dz
&lt;/p&gt;&lt;p&gt;PID
&lt;/p&gt;&lt;p&gt;Nephrolithiasis
&lt;/p&gt;&lt;p&gt;PNA
&lt;/p&gt;&lt;p&gt;PE
&lt;/p&gt;&lt;p&gt;Pyelonephritis
&lt;/p&gt;&lt;p&gt;Retroperitoneal hemorrhage/mass
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Lower_Back_Pain&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Cord Compression"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Cord_Compression"&gt; Cord Compression &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;L4: pain frnt leg, weak knee ext., sens. loss knee/medial foot, lose knee jerk.
&lt;/p&gt;&lt;p&gt;L5: pain side leg, wk dorsiflex, sens. loss lat lo leg &amp;amp; web big toe, reflex intact.
&lt;/p&gt;&lt;p&gt;S1: pain back leg, weak plantarflex, sens. loss calf/lat foot, ankle jerk gone.
&lt;/p&gt;&lt;p&gt;-Straight leg raise most sens., crossed most specific.
&lt;/p&gt;&lt;p&gt;-Hypertrophic spur formation behind vert. is most likely non-disc cause of + SLR.
&lt;/p&gt;&lt;p&gt;-Sciatica: impinged or irritated nerve. radicular distr., sharp, NO paresthesias/pain distal to knee/neuro impairment.
&lt;/p&gt;&lt;p&gt;-Stenosis: back pain w/ walking, usually old person radiation to legs: Pseudo claudication. Usu. will curl after walking to get relief.
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Lower_Back_Pain&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Treatment (Pain)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment_.28Pain.29"&gt; Treatment (Pain) &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Mild to mod:
&lt;/p&gt;&lt;p&gt;-NSAIDs
&lt;/p&gt;&lt;p&gt;Mod to Severe
&lt;/p&gt;&lt;p&gt;-non-narcotic(toradol/norflex), then 2-10 of MSO4 PRN
&lt;/p&gt;&lt;p&gt;-OPIOD (vicodin or percocet) &amp;amp; nonsteroidal for 2-3 dy, then NSAID alone.
&lt;/p&gt;&lt;p&gt;-#1 NSAIDs: ibuprofen, naprosyn; #2 Valium first choice for spasm as muscle relaxant. #3 Narcotics w/ oxycodone (percocet) 10-15 tabs. (don't use flexoril)
&lt;/p&gt;&lt;p&gt;-Bedrest 2-3 days
&lt;/p&gt;&lt;p&gt;-Referral
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Lower_Back_Pain&amp;amp;action=edit&amp;amp;section=7" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt; See Also &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Back Pain (Red Flags)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Lower_Back_Pain&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt; Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1/26/06 DONALDSON (adapted from Rosen, Lampe, Hock)
&lt;/p&gt;



</content><folder>Ortho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="lumbar_puncture"><name>Lumbar Puncture</name><content>&lt;p&gt;Correction for bloody tap
&lt;/p&gt;&lt;p&gt;Nl Ratio: 700 RBCs to 1 WBC
&lt;/p&gt;&lt;p&gt;Protein subtract 1mg/dL per 1000 RBCs
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;General Contraindications:
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;A. Infection at LP site
&lt;/p&gt;&lt;p&gt;B. Severe thrombocytopenia (platelets &amp;lt;50) or bleeding diathesis or INR &amp;gt;1.5
&lt;/p&gt;&lt;p&gt;C. Mass lesion suspected (do CT or MRI first)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;CT findings that prohibit LP
&lt;/p&gt;&lt;p&gt;A. Midline shift
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; Look for unequal pressures between the 3 cerebral compartments (left/right supretentorial compartments, posterior fossa)
&lt;/li&gt;&lt;li&gt; Look for intracerebral masses not causing midline shift
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;B. Obsutrictive hydrocephalus
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; Look for enlargement of ventricles prox to lesions and normal ventricles distal (especially 4th ventricle)
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;C. Basilar cisterns compressed
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; Look for lateral/3rd ventricles may be small due to diffuse cerebral edema or enlarged due to obstr. hydroceph. +/- shift
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;D. Posterior fossa mass
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; Look for displacement/compression of 4th ventricle
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
Consider contrast CT/MRI
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;(source: Emergency Radiology: Case Studies Schwartz)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;CT Head indicated before LP in pts with suspected meningitis with:
&lt;/p&gt;&lt;p&gt;1) AMS
&lt;/p&gt;&lt;p&gt;2) Focal Neurologic deficit
&lt;/p&gt;&lt;p&gt;3) Papilledema
&lt;/p&gt;&lt;p&gt;4) Head Trauma or h/o CNS disease (recent or remote)
&lt;/p&gt;&lt;p&gt;5) New Onset Sz (&amp;lt;1 wk prior to ED visit)
&lt;/p&gt;&lt;p&gt;6) HIV + / AIDS or any immunocompromised (transplant pt, steroids, cancer) patient
&lt;/p&gt;&lt;p&gt;7) Age &amp;gt; 60.
&lt;/p&gt;&lt;p&gt;-Hasbun, R. et al, (Yale), NEJM, Dec 13, 2001. (prospective, 301 pts)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;PEDIATRICS (Marianne)
&lt;/p&gt;&lt;p&gt;1) VP shunt
&lt;/p&gt;&lt;p&gt;2) Febrile sx&amp;nbsp;?counts
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;NORMAL WBC
&lt;/p&gt;&lt;p&gt;Preterm: &amp;lt;25
&lt;/p&gt;&lt;p&gt;Term: &amp;lt;22
&lt;/p&gt;&lt;p&gt;Child: &amp;lt;7
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;May also order: cytology, VDRL, AFB stain/culture (often requires lab medicine approval), fungal stain (fungal cultures often require lab medicine approval), Cryptococcal antigen (CrAg), India Ink, oligoclonal bands, MBP, Lyme titers, HSV PCR.
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;NORMAL
&lt;/p&gt;&lt;p&gt;Appearance Clear
&lt;/p&gt;&lt;p&gt;Glucose (mg/dl) 50-75% serum
&lt;/p&gt;&lt;p&gt;Protein (mg/dl) 15-45
&lt;/p&gt;&lt;p&gt;Cell Count WBC 0-5
&lt;/p&gt;&lt;p&gt;Differential 100% lymph, no PMN
&lt;/p&gt;&lt;p&gt;Pressure (cm H2O) 5-20
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Traumatic LP:
&lt;/p&gt;&lt;p&gt;1000 RBC for 1mg/dL protein
&lt;/p&gt;&lt;p&gt;700 -1000 RBC gives 1 WBC
&lt;/p&gt;&lt;p&gt;Xanthrochromia tube 4; results from RBC lysis and hemoglobin breakdown.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;HEMORRHAGE
&lt;/p&gt;&lt;p&gt;Appearance Bloody or xantho
&lt;/p&gt;&lt;p&gt;Glucose (mg/dl) N or D
&lt;/p&gt;&lt;p&gt;Protein (mg/dl) Inc but &amp;lt;1000
&lt;/p&gt;&lt;p&gt;Cell Count RBC (&amp;lt;~50 okay)
&lt;/p&gt;&lt;p&gt;(50-600 = gray zone)
&lt;/p&gt;&lt;p&gt;(&amp;gt;600 c/w SAH)
&lt;/p&gt;&lt;p&gt;Differential Same as blood
&lt;/p&gt;&lt;p&gt;Pressure (cm H2O) Usually Inc
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;BACTERIAL MENINGITIS
&lt;/p&gt;&lt;p&gt;Appearance Cloudy or purulent
&lt;/p&gt;&lt;p&gt;Glucose (mg/dl) &amp;lt;40 or &amp;lt;40% serum
&lt;/p&gt;&lt;p&gt;Protein (mg/dl) &amp;gt;100-500
&lt;/p&gt;&lt;p&gt;Cell Count 100-100,000 (&amp;gt;5)
&lt;/p&gt;&lt;p&gt;Differential &amp;gt;80% PMN
&lt;/p&gt;&lt;p&gt;Pressure (cm H2O) Usually Inc
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;FUNGAL MENINGITiS
&lt;/p&gt;&lt;p&gt;Appearance Clear or cloudy
&lt;/p&gt;&lt;p&gt;Glucose (mg/dl) 20-40
&lt;/p&gt;&lt;p&gt;Protein (mg/dl) 25-500
&lt;/p&gt;&lt;p&gt;Cell Count 25-1000
&lt;/p&gt;&lt;p&gt;Differential mono&amp;amp; lymph
&lt;/p&gt;&lt;p&gt;Pressure (cm H2O) N or I
&lt;/p&gt;&lt;p&gt;India ink 50% sensitivity
&lt;/p&gt;&lt;p&gt;LA assay for crypto antigen 80%.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;ASEPTIC/VIRAL MENINGITIS
&lt;/p&gt;&lt;p&gt;Appearance Clear
&lt;/p&gt;&lt;p&gt;Glucose (mg/dl) N or D
&lt;/p&gt;&lt;p&gt;Protein (mg/dl) 50-200
&lt;/p&gt;&lt;p&gt;Cell Count WBC 10-100
&lt;/p&gt;&lt;p&gt;Differential Inc mono &amp;amp; PMN early, then lymph.
&lt;/p&gt;&lt;p&gt;Pressure (cm H2O) N or I
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;TB MENINGITIS
&lt;/p&gt;&lt;p&gt;Appearance Cloudy
&lt;/p&gt;&lt;p&gt;Glucose (mg/dl) &amp;lt;40
&lt;/p&gt;&lt;p&gt;Protein (mg/dl) 100-2000
&lt;/p&gt;&lt;p&gt;Cell Count 50-500
&lt;/p&gt;&lt;p&gt;Differential Most lymph, some PMN
&lt;/p&gt;&lt;p&gt;Pressure (cm H2O) Usually I
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;HERPES ENCEPHALITIS
&lt;/p&gt;&lt;p&gt;Appearance Bloody or xantho
&lt;/p&gt;&lt;p&gt;Glucose (mg/dl) N or D
&lt;/p&gt;&lt;p&gt;Protein (mg/dl) 50-100
&lt;/p&gt;&lt;p&gt;Cell Count 20-500
&lt;/p&gt;&lt;p&gt;Differential Mostly lymph
&lt;/p&gt;&lt;p&gt;Pressure (cm H2O) N or I
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;NEOPLASM
&lt;/p&gt;&lt;p&gt;Appearance Clear or xantho
&lt;/p&gt;&lt;p&gt;Glucose (mg/dl) 40-80
&lt;/p&gt;&lt;p&gt;Protein (mg/dl) 50-1000
&lt;/p&gt;&lt;p&gt;Cell Count &amp;lt;100
&lt;/p&gt;&lt;p&gt;Differential Mostly lymph
&lt;/p&gt;&lt;p&gt;Pressure (cm H2O) Usually I
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;GUILLAIN-BARR
&lt;/p&gt;&lt;p&gt;Appearance Clear or cloudy
&lt;/p&gt;&lt;p&gt;Glucose (mg/dl) Normal
&lt;/p&gt;&lt;p&gt;Protein (mg/dl) slight Inc
&lt;/p&gt;&lt;p&gt;Cell Count &amp;lt;100
&lt;/p&gt;&lt;p&gt;Differential Mostly lymph
&lt;/p&gt;&lt;p&gt;Pressure (cm H2O) Normal
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;NEUROSYPHILIS
&lt;/p&gt;&lt;p&gt;Appearance Clear &amp;amp; cloudy
&lt;/p&gt;&lt;p&gt;Glucose (mg/dl) Normal
&lt;/p&gt;&lt;p&gt;Protein (mg/dl) 40-200
&lt;/p&gt;&lt;p&gt;Cell Count 200-500
&lt;/p&gt;&lt;p&gt;Differential Mostly lymph &amp;amp; mono
&lt;/p&gt;&lt;p&gt;Pressure (cm H2O) N or I
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Lumbar Puncture Note (LP)
&lt;/p&gt;&lt;p&gt;Consent
&lt;/p&gt;&lt;p&gt;Indication
&lt;/p&gt;&lt;p&gt;Pressure
&lt;/p&gt;&lt;p&gt;Color
&lt;/p&gt;&lt;p&gt;Amount
&lt;/p&gt;&lt;p&gt;Tests
&lt;/p&gt;&lt;p&gt;Interspace
&lt;/p&gt;&lt;p&gt;Anesthesia
&lt;/p&gt;&lt;p&gt;Position
&lt;/p&gt;&lt;p&gt;Pt. tolerance
&lt;/p&gt;



</content><folder>Procedures</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="lyme"><name>Lyme</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Lyme&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Lyme&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Prophylaxis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Prophylaxis"&gt;Prophylaxis&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Tick Bite Propylaxis = 200mg PO x 1
&lt;/p&gt;&lt;p&gt;&lt;b&gt;High Risk&lt;/b&gt;
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Tick on for &amp;gt;48 hrs
&lt;/li&gt;&lt;li&gt;Engorged tick
&lt;/li&gt;&lt;li&gt;Endenic area (east coast, )
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;^Old vaccine has little to no efficacy after 1 year
&lt;/p&gt;



</content><folder>ID</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="mrsa"><name>MRSA</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Prevention"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Prevention&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=MRSA&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Suspect MRSA infection/carrier in patients who present with:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;multiple skin sites
&lt;/li&gt;&lt;li&gt;recurrent infection
&lt;/li&gt;&lt;li&gt;pt who has been in close contact of person with Hx of MRSA
&lt;/li&gt;&lt;li&gt;infection showing early necrosis
&lt;/li&gt;&lt;li&gt;two kinds: hospital acquired and community acquired 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=MRSA&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Prevention"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Prevention"&gt;Prevention&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; good hand hygiene
&lt;/li&gt;&lt;li&gt; avoid sharing personal items with carriers
&lt;/li&gt;&lt;li&gt; wash common household items with bleach and hot water 
&lt;/li&gt;&lt;li&gt; wash soiled sheets, towels, clothes in hot water with bleach and dry in hot dryer
&lt;/li&gt;&lt;li&gt; Eradicate carriers:
&lt;/li&gt;&lt;li&gt; mupirocin 2%: apply to each nostril TID x 5days
&lt;/li&gt;&lt;li&gt; Hibiclens wash daily x 5 days
&lt;/li&gt;&lt;li&gt; consider oral antibiotics  
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=MRSA&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Antibiotics
&lt;ol&gt;&lt;li&gt; Keflex + Bactrim DS 
&lt;/li&gt;&lt;li&gt; clindamycin 
&lt;/li&gt;&lt;li&gt; doxycycline
&lt;/li&gt;&lt;li&gt; Vancomycin IV if severe infection/sepsis 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; I&amp;amp;D if abscess 
&lt;ol&gt;&lt;li&gt;(antibiotics not needed if no e/o cellulitis) 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=MRSA&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from Donaldson
&lt;/p&gt;



</content><folder>ID</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="magic_mouthwash"><name>Magic Mouthwash</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Magic_Mouthwash&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Equal parts:
&lt;/p&gt;&lt;p&gt;-Viscous lido 2%
&lt;/p&gt;&lt;p&gt;-Benadryl
&lt;/p&gt;&lt;p&gt;-Maalox
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;0.5-1cc before feeds
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;DO NOT EXCEED  dosing limits especially for lidocaine.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;1 cc Viscous 2% lidocaine = 20 mg lidocaine
&lt;/p&gt;&lt;p&gt;Max dose = 5mg/kg
&lt;/p&gt;&lt;p&gt;For a 10 kg child = 50 mg lidocaine = 2.5 cc
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Benadryl 6.25mg/5cc or 12.5mg/5cc
&lt;/p&gt;&lt;p&gt;Max dose = 5mg/kg/day
&lt;/p&gt;&lt;p&gt;For a 10 kg child = 50 mg benadryl =20 cc of 12.5mg/5cc
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Never give a family an amount that can be toxic if unintetionally swallowed in its entirety.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Magic_Mouthwash&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;DONALDSON (6/04)
&lt;/p&gt;&lt;p&gt;Hsiao 7/6/09
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="main_page"><name>Main Page</name><content>&lt;h2&gt; &lt;span class="mw-headline" id="WikEM:_The_Emergency_Medicine_Wiki"&gt;WikEM: The Emergency Medicine Wiki&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;&lt;b&gt;Overview&lt;/b&gt;
&lt;/p&gt;&lt;p&gt;&lt;i&gt;&lt;b&gt;WikEM&lt;/b&gt;&lt;/i&gt; is a database of quick emergency medicine notes to assist physicians with their daily practice.  Via wiki-software, it features a continually updated set of notes and checklists that allow for rapid reference of key information.  WikEM is intended for clinicians only and not directly for patients.  &lt;b&gt;See the left navigation bar on how to use the site and its downloadable software.&lt;/b&gt;
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
&lt;b&gt;Disclaimer&lt;/b&gt;
&lt;/p&gt;&lt;p&gt;The information on this site and the related mobile software has been, and continues to be, compiled from multiple sources and multiple authors. It is intended for clinicians only and not directly for patients. It can be edited by numerous individuals given access to the site, which produces constantly changing content. &lt;u&gt;&lt;i&gt;&lt;b&gt;  As such, the accuracy and completeness of this work cannot be guaranteed.&lt;/b&gt;&lt;/i&gt;&lt;/u&gt;  The information contained herein is intended as a quick and convenient reminder of information you have already learned elsewhere. The contents are to be used as a guide only; health care professionals should always use sound clinical judgment and individualize patient care. This information is not meant to be a replacement for training, experience, continuing medical education, or studying the latest literature and medical information. The site managers, editors, contributing authors, the Harbor-UCLA EM residency program, and other people and organizations related to this site make this information available without warranties of any kind, express or implied. We disclaim any liability, loss, or damage caused by the contents. &lt;b&gt;If you do not wish to be bound by the foregoing cautions and conditions, please do not use this site or downloaded mobile software.&lt;/b&gt;
&lt;/p&gt;



</content><folder>WikEM</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="maisonneuve"><name>Maisonneuve</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Maisonneuve&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- medial malleolar Fx or complete deltoid ligament tear,syndesmotic ligament tear, and proximal fibular Fx.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Maisonneuve&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-prox fibular Fx can also damage the common peroneal nerve which supplies tibialis anterior and sensation to the first web space.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Maisonneuve&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-can be treated without surgery if mortise is intact, but usually requires a syndesmotic screw. diastasis on plain films indicates an unstable mortise and surgical repair required.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Maisonneuve&amp;amp;action=edit&amp;amp;section=4" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;




</content><folder>Ortho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="mandible_fx"><name>Mandible Fx</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Mandible_Fx&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-bite most sensitive (or tongue blade braking)
&lt;/p&gt;&lt;p&gt;-check Stenson's duct for bleeding
&lt;/p&gt;&lt;p&gt;-if suspicious:
&lt;/p&gt;&lt;p&gt;flat films (adult) --&amp;gt; panorex if neg
&lt;/p&gt;&lt;p&gt;CT with recontruct (children)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Sublingual hematoma is suggestive of an occult jaw fracture.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Tongue blade test-havept bite down on tongue blade and twist it, if a mandibular Fx is present then the pt should reflexively openmouth...95% sensitive and 65% specific.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Mandible_Fx&amp;amp;action=edit&amp;amp;section=2" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Trauma: Maxilofacial
&lt;/p&gt;



</content><folder>Trauma</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="maternal_vitals_and_labs_in_pregnancy"><name>Maternal Vitals and Labs in Pregnancy</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Maternal_Vitals_and_Labs_in_Pregnancy&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Vitals"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Vitals"&gt;Vitals&lt;/span&gt;&lt;/h2&gt;
&lt;table border="1" cellpadding="1" cellspacing="1" width="200"&gt;

&lt;tr&gt;
&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Nonpreg&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;T1&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;T2&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;T3&lt;/b&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; HR
&lt;/td&gt;&lt;td&gt; 70
&lt;/td&gt;&lt;td&gt; 78
&lt;/td&gt;&lt;td&gt; 82
&lt;/td&gt;&lt;td&gt; 85
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; SBP
&lt;/td&gt;&lt;td&gt; 115
&lt;/td&gt;&lt;td&gt; 112
&lt;/td&gt;&lt;td&gt; 112
&lt;/td&gt;&lt;td&gt; 114
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; DBP
&lt;/td&gt;&lt;td&gt; 70
&lt;/td&gt;&lt;td&gt; 60
&lt;/td&gt;&lt;td&gt; 63
&lt;/td&gt;&lt;td&gt; 70
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Hcrt
&lt;/td&gt;&lt;td&gt; 40
&lt;/td&gt;&lt;td&gt; 36
&lt;/td&gt;&lt;td&gt; 33
&lt;/td&gt;&lt;td&gt; 34
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; WBC
&lt;/td&gt;&lt;td&gt; 7.2k
&lt;/td&gt;&lt;td&gt; 9.1k
&lt;/td&gt;&lt;td&gt; 9.7k
&lt;/td&gt;&lt;td&gt; 9.8k
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Maternal_Vitals_and_Labs_in_Pregnancy&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Labs"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Labs"&gt;Labs&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Other:
&lt;/p&gt;&lt;p&gt;Increased ESR ~78
&lt;/p&gt;&lt;p&gt;Decreased PaCO2 ~30
&lt;/p&gt;&lt;p&gt;ECG w/ Qs in III &amp;amp; aVF, L axis
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Maternal_Vitals_and_Labs_in_Pregnancy&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;3/29/09 DONALDSON (adapted from Rosen)
&lt;/p&gt;



</content><folder>OB/GYN</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="maxillofacial"><name>Maxillofacial</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Maxillofacial&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;ALWAYS ASK ABOUT VISION.
&lt;/p&gt;&lt;p&gt;facial numbness, misalignment o teeth, and diploplia (monocular vs binocular)
&lt;/p&gt;&lt;p&gt;anesthesia of upper lip and/or maxillary teethmay be due to infraorbital nerve injury fromorbital blowout or orbital rimFx.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Exam (finer points): jaw deviation-the chin will point away from a dislocation and towards a fracture.
&lt;/p&gt;&lt;p&gt;The best way to palpate the mandibular condyles is to place a finger in the external auditory canal and press down while pt opens and closes mouth.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Radiology-
&lt;/p&gt;&lt;p&gt;If high suspicion of midface Fx then o directly to facial CT. Orbital floor Fx can be seen w/ orbital CT.
&lt;/p&gt;&lt;p&gt;Water's view- can see orbital rims, floors, zygmatic arch, as well as maxillary sinus and maxilla.
&lt;/p&gt;&lt;p&gt;Bucket handle view to examine zygomatic arches.
&lt;/p&gt;&lt;p&gt;Panorex or mandibular series for mndibular Fx. Fractures throughthe mandibular body are best seen on the oblique view. Fractures through theangle and symphysis are best seen on th PA view. Fx through themandibular condyles are best seen through the AP axial(Towne's) view
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Maxillofacial&amp;amp;action=edit&amp;amp;section=2" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Frontal sinus fractures: ant wall isthick and the posterior wall is thin. Only 18% of frontal sinus fractures are anterior wall only. If ant wall Fx-need CT t evaluate posterior wall. (75% have both walls Fx). Need neurosurg or ENT for post wall since many need surgery and IVABx.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Naso-ethmoid fractures- diffuse tearing and increased intercanthal distance are suggestive. intranasal palpation w/ hemostat while palpating along bonyrim for crepitus useful.
&lt;/p&gt;&lt;p&gt;complications include lacrimal disruption, medial cathal ligament rupture, and dural tears. intracranial injury seen in up to 70%. can develop malignant periorbital emphysema and blinndness. cover w/ABx and have pt see maxillofacial surgeon.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Nasal Fx-clincal diagnosis (no xrays) drain septal hematomas and f/u with ENTin 7-10 days
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Zygomatic arch fractures- unlikely isolated
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Tripod Fractures-
&lt;/p&gt;&lt;p&gt;Fx through 1)inf orbital rim, 2) lateral orbital wall, 3) fx/disocation of zygomatic arch.
&lt;/p&gt;&lt;p&gt;-must rule out associated ocular injuries. usually requires admission and surgical repair.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Maxillofacial&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;bedside consult is necessary for:
&lt;/p&gt;&lt;p&gt;decreased vision, tripod fractures, Lefort fractures, openmandibular fractures, frontal sinus fractures with intracranial involvement, NEO injuries.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Maxillofacial&amp;amp;action=edit&amp;amp;section=4" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Trauma: Mandible Fx
&lt;/p&gt;&lt;p&gt;Optho: Orbital Blowout Fx
&lt;/p&gt;



</content><folder>Trauma</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="meckel's_diverticulum"><name>Meckel's Diverticulum</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Meckel%27s_Diverticulum&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; most common cause of sig LGIB in kids, rule of 2's (2% of pop, 2 ft from ileocecal valve, 45% are 2 years of age, 2 cm long), d/t vitelline duct not disappearing by 7 wks
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Meckel%27s_Diverticulum&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; s/s: rectal bleeding (+/- pain) is the most common presentation in &amp;lt;5 y/o &amp;amp; may be intermittent or massive, obstruction (can cause intuss.), diverticulitis, umbilical fistula, 1/3 perf!
&lt;/li&gt;&lt;li&gt; CT may show, xr nl, Meckel's scan is test of choice
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Meckel%27s_Diverticulum&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; NGT, IVF, PRBCs prn, surgery consult
&lt;/li&gt;&lt;/ul&gt;




</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="meningitis"><name>Meningitis</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Classification"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Classification&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Risk_Factors"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Risk Factors&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Signs.2FSymptoms"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Signs/Symptoms&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Physical_Exam_Findings"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Physical Exam Findings&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Differential_Diagnosis"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Differential Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Orders.2FWorkup"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Orders/Workup&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Interpreting_CSF"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Interpreting CSF&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-9"&gt;&lt;a href="#Antibiotics"&gt;&lt;span class="tocnumber"&gt;8.1&lt;/span&gt; &lt;span class="toctext"&gt;Antibiotics&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-10"&gt;&lt;a href="#Steroids"&gt;&lt;span class="tocnumber"&gt;8.2&lt;/span&gt; &lt;span class="toctext"&gt;Steroids&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-11"&gt;&lt;a href="#Prophylaxis"&gt;&lt;span class="tocnumber"&gt;9&lt;/span&gt; &lt;span class="toctext"&gt;Prophylaxis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Meningitis&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Classification"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Classification"&gt;Classification&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; &lt;span style="line-height: 20px"&gt;Acute (&amp;lt;24 hrs): usually bacterial in origin (25%)&lt;/span&gt;
&lt;/li&gt;&lt;li&gt; Subacute (1-7 days): viral or bacterial
&lt;/li&gt;&lt;li&gt; Chronic (&amp;gt;7 days): viral, TB, syphilis, fungi, carcinomatous
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Meningitis&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Risk Factors"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Risk_Factors"&gt;Risk Factors&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Age &amp;gt;60 or &amp;lt;5
&lt;/li&gt;&lt;li&gt;Immunosuppressed/Immunocompromised (DM, adrenal insufficiency, HIV, cystic fibrosis, pts on steroids, Sickle Cell, etc)
&lt;/li&gt;&lt;li&gt;Crowding (military, dormitory)
&lt;/li&gt;&lt;li&gt;Alcoholism/cirrhosis
&lt;/li&gt;&lt;li&gt;Recent exposure to someone with meningitis
&lt;/li&gt;&lt;li&gt;Contiguous infection/ dural defect (traumatic, surgical (VP shunt))
&lt;/li&gt;&lt;li&gt;IVDA/endocarditis
&lt;/li&gt;&lt;li&gt;Malignancy
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Meningitis&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Signs/Symptoms"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Signs.2FSymptoms"&gt;Signs/Symptoms&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Headache
&lt;/li&gt;&lt;li&gt;Nuchal rigidity (may not be present in those with AMS)
&lt;/li&gt;&lt;li&gt;Fevers/chills
&lt;/li&gt;&lt;li&gt;Photophobia
&lt;/li&gt;&lt;li&gt;Vomiting
&lt;/li&gt;&lt;li&gt;Prodromal URI
&lt;/li&gt;&lt;li&gt;Focal neuro sx (ie seizure)
&lt;/li&gt;&lt;li&gt;AMS (may be the only complaint esp in elderly) 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Meningitis&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Physical Exam Findings"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Physical_Exam_Findings"&gt;Physical Exam Findings&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Signs of Meningeal Irritation
&lt;ol&gt;&lt;li&gt;&lt;i&gt;Kernigs&lt;/i&gt;: passive knee extension while pt is supine causes neck pain and hamstring resistance
&lt;/li&gt;&lt;li&gt;&lt;i&gt;Brudzinski:&lt;/i&gt; when you flex pts neck you see involuntary flexion of b/l lower ext
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Fever
&lt;/li&gt;&lt;li&gt;Rash
&lt;/li&gt;&lt;li&gt;Abnl Neuro exam (altered, focal cranial nerve defect)
&lt;/li&gt;&lt;li&gt;papilledema  
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Meningitis&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Differential Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Differential_Diagnosis"&gt;Differential Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;encephalitis
&lt;/li&gt;&lt;li&gt;brain mass
&lt;/li&gt;&lt;li&gt;brain abscess
&lt;/li&gt;&lt;li&gt;subarachnoid hemorrhage
&lt;/li&gt;&lt;li&gt;migraine
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Meningitis&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Orders/Workup"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Orders.2FWorkup"&gt;Orders/Workup&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;isolation of patient (if suspect bacterial meningitis)
&lt;/li&gt;&lt;li&gt;cbc
&lt;/li&gt;&lt;li&gt;blood cultures
&lt;/li&gt;&lt;li&gt;coags
&lt;/li&gt;&lt;li&gt;chem panel
&lt;/li&gt;&lt;li&gt;CT head 
&lt;/li&gt;&lt;li&gt;CXR (50% of pts w/pneumoccocal meningitis have e/o pna on CXR) 
&lt;/li&gt;&lt;li&gt;CSF studies
&lt;ol&gt;&lt;li&gt;Glucose and protein (Tube 1) 
&lt;/li&gt;&lt;li&gt;Gram stain and culture (Tube 2)
&lt;/li&gt;&lt;li&gt;Cell count and differential (Tube 3)
&lt;/li&gt;&lt;li&gt;Special studies if indicated (e.g. HSV PCR or india ink in HIV pt) - Tube 2 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Meningitis&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Interpreting CSF"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Interpreting_CSF"&gt; Interpreting CSF &lt;/span&gt;&lt;/h2&gt;
&lt;table style="width: 500px" border="1" cellpadding="1" cellspacing="1"&gt;

&lt;tr&gt;
&lt;td&gt; &lt;b&gt;Measure&lt;br /&gt;&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Bacterial&lt;br /&gt;&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Viral&lt;br /&gt;&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Fungal&lt;br /&gt;&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Neoplastic&lt;br /&gt;&lt;/b&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Opening Pressure&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &lt;span lang="en-us"&gt;&lt;font face="&amp;#39;&#23435;&#20307;&amp;#39;"&gt;&#8593;&lt;/font&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;font face="&amp;#39;&#23435;&#20307;&amp;#39;"&gt;&#8593;&lt;/font&gt;&lt;/span&gt;
&lt;/td&gt;&lt;td&gt; Normal, mild &lt;span lang="en-us"&gt;&lt;font face="&amp;#39;&#23435;&#20307;&amp;#39;"&gt;&#8593;&lt;/font&gt;&lt;/span&gt;
&lt;/td&gt;&lt;td&gt; Normal, mild &lt;span lang="en-us"&gt;&lt;font face="&amp;#39;&#23435;&#20307;&amp;#39;"&gt;&#8593;&lt;/font&gt;&lt;/span&gt;
&lt;/td&gt;&lt;td&gt; Normal, mild &lt;span lang="en-us"&gt;&lt;font face="&amp;#39;&#23435;&#20307;&amp;#39;"&gt;&#8593;&lt;/font&gt;&lt;/span&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Cell Count&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &amp;gt;1000&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &amp;lt;1000&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &amp;lt;500&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &amp;lt;500&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;&amp;nbsp;% PMNs&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &amp;gt;80%&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 1-50%&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 1-50%&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 1-50%&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Glucose&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &amp;lt;40&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &amp;gt;40&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &amp;lt;40&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &amp;lt;40&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Protein&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &amp;gt;200&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &amp;lt;200&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &amp;gt;200&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &amp;gt;200&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Gram Stain&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; + (80% effective)&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; neg&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; AFB, India ink&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Meningitis&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;&lt;i&gt;Goal is to initiate treatment within 30 minutes of presentation (if pt is acutely ill). Abx given 2 hr prior to LP will NOT decrease the sensitivity of CSF culture&lt;/i&gt;
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Meningitis&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Antibiotics"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Antibiotics"&gt;Antibiotics&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Ampicillin + cefotaxime or amp +gent 
&lt;/li&gt;&lt;li&gt;Ampicillin + Cefotax or Ceftriaxone 
&lt;/li&gt;&lt;li&gt;Cefotax or Ceftriaxone &amp;lt;/nowiki&amp;gt;&amp;lt;/font&amp;gt;&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;
&lt;/li&gt;&lt;li&gt;&lt;i&gt;Adults&lt;/i&gt;: Cefotaxime or ceftriaxone + vanco; Add Ampicillin if Listeria suspected 
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Meningitis&amp;amp;action=edit&amp;amp;section=10" title="Edit section: Steroids"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Steroids"&gt;Steroids&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;(Dexamethasone 0.15mg/kg Q6hrsx4dys; 10mg max) --give 15-20 minutes before antibiotics
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Neonates (&amp;lt;6wks) --&amp;gt; No
&lt;/li&gt;&lt;li&gt;Infants/child --&amp;gt; Yes
&lt;/li&gt;&lt;li&gt;Adults --&amp;gt; Yes
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;^prior to or with abx = only group w/ benefit
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Meningitis&amp;amp;action=edit&amp;amp;section=11" title="Edit section: Prophylaxis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Prophylaxis"&gt;Prophylaxis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Cipro 500mg PO x 1 or rifampin x 4 doses or ceftriaxone x1
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;For N. meningitis
&lt;/li&gt;&lt;li&gt;Rx primary caregivers (those in close contact to  nasopharyngeal secretions or those who were with the patient at least 4 hours during week before onset of symptoms)
&lt;/li&gt;&lt;/ul&gt;




</content><folder>ID</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="mesenteric_ischemia"><name>Mesenteric Ischemia</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Pathophysiology"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Pathophysiology&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Epidemiology"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Epidemiology&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Risk_Factors"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Risk Factors&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Signs.2FSymptoms"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Signs/Symptoms&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Work_Up"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Work Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-7"&gt;&lt;a href="#Acute_arterial_embolus"&gt;&lt;span class="tocnumber"&gt;6.1&lt;/span&gt; &lt;span class="toctext"&gt;Acute arterial embolus&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-8"&gt;&lt;a href="#Nonocclusive_mesenteric_ischemia"&gt;&lt;span class="tocnumber"&gt;6.2&lt;/span&gt; &lt;span class="toctext"&gt;Nonocclusive mesenteric ischemia&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-9"&gt;&lt;a href="#Mesenteric_venous_thrombosis"&gt;&lt;span class="tocnumber"&gt;6.3&lt;/span&gt; &lt;span class="toctext"&gt;Mesenteric venous thrombosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-10"&gt;&lt;a href="#Chronic_mesenteric_ischemia"&gt;&lt;span class="tocnumber"&gt;6.4&lt;/span&gt; &lt;span class="toctext"&gt;Chronic mesenteric ischemia&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-11"&gt;&lt;a href="#Consultation"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Consultation&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-12"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Mesenteric_Ischemia&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Pathophysiology"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Pathophysiology"&gt; Pathophysiology &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;4 distinct entities:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Mesenteric arterial embolism
&lt;/li&gt;&lt;li&gt;Mesenteric arterial thrombosis
&lt;/li&gt;&lt;li&gt;Nonocclusive mesenteric ischemia
&lt;/li&gt;&lt;li&gt;Mesenteric venous thrombosis
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Mesenteric_Ischemia&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Epidemiology"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Epidemiology"&gt; Epidemiology &lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Mean age: 70yo
&lt;/li&gt;&lt;li&gt;2/3 women
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Mesenteric_Ischemia&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Risk Factors"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Risk_Factors"&gt; Risk Factors &lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;CAD
&lt;/li&gt;&lt;li&gt;Valvular heart disease
&lt;/li&gt;&lt;li&gt;Dysrhythmia
&lt;/li&gt;&lt;li&gt;Hypovolemia / hypotension
&lt;/li&gt;&lt;li&gt;Meds
&lt;ol&gt;&lt;li&gt; Diuretics
&lt;/li&gt;&lt;li&gt; Vasoconstrictive
&lt;/li&gt;&lt;li&gt; Digoxin
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Dialysis
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Mesenteric_Ischemia&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Signs/Symptoms"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Signs.2FSymptoms"&gt; Signs/Symptoms &lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Pain out of proportion to exam
&lt;/li&gt;&lt;li&gt; Severe, poorly localized, colicky
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Mesenteric_Ischemia&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Work Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work_Up"&gt;Work Up&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Lactate (higher later)
&lt;/li&gt;&lt;li&gt; CTA
&lt;/li&gt;&lt;li&gt; Angiography
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Mesenteric_Ischemia&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt; Treatment &lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; IVF
&lt;/li&gt;&lt;li&gt; IV Abx
&lt;/li&gt;&lt;li&gt; Narcotic analgesia
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Mesenteric_Ischemia&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Acute arterial embolus"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Acute_arterial_embolus"&gt;Acute arterial embolus&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Papaverine infusion (30-60 mg/h IV) OR
&lt;/li&gt;&lt;li&gt; surgical embolectomy OR
&lt;/li&gt;&lt;li&gt; intra-arterial thrombolysis
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Mesenteric_Ischemia&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Nonocclusive mesenteric ischemia"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Nonocclusive_mesenteric_ischemia"&gt;Nonocclusive mesenteric ischemia&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Papaverine infusion
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Mesenteric_Ischemia&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Mesenteric venous thrombosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Mesenteric_venous_thrombosis"&gt;Mesenteric venous thrombosis&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Heparin/warfarin either alone or in combination with surgery
&lt;/li&gt;&lt;li&gt; Immediate heparinization should be started even when surgical intervention is indicated
&lt;ol&gt;&lt;li&gt; Decreases progression of thrombosis and improves survival
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Mesenteric_Ischemia&amp;amp;action=edit&amp;amp;section=10" title="Edit section: Chronic mesenteric ischemia"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Chronic_mesenteric_ischemia"&gt;Chronic mesenteric ischemia&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Angioplasty with or without stent placement or surgical revascularization
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Mesenteric_Ischemia&amp;amp;action=edit&amp;amp;section=11" title="Edit section: Consultation"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Consultation"&gt; Consultation &lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; IR
&lt;/li&gt;&lt;li&gt; Vascular
&lt;/li&gt;&lt;li&gt; Surgery
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Mesenteric_Ischemia&amp;amp;action=edit&amp;amp;section=12" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt; Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;6/06 MISTRY, Rosen's, Tintinalli
&lt;/p&gt;



</content><folder>GI</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="metabolic_acidosis"><name>Metabolic Acidosis</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#DDX"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;DDX&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#Gap"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;Gap&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Non-gap"&gt;&lt;span class="tocnumber"&gt;1.2&lt;/span&gt; &lt;span class="toctext"&gt;Non-gap&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Bicarbonate_Indications"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;Bicarbonate Indications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Metabolic_Acidosis&amp;amp;action=edit&amp;amp;section=1" title="Edit section: DDX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX"&gt;DDX&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Metabolic_Acidosis&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Gap"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Gap"&gt;Gap&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Lactic acidosis
&lt;/li&gt;&lt;li&gt;Renal failure
&lt;/li&gt;&lt;li&gt;Ketoacidosis
&lt;ol&gt;&lt;li&gt;DM
&lt;/li&gt;&lt;li&gt;ETOH
&lt;/li&gt;&lt;li&gt;Starvation
&lt;/li&gt;&lt;li&gt;High fat diet
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Tox ingestion
&lt;ol&gt;&lt;li&gt;Inc osm gap
&lt;ol&gt;&lt;li&gt;Methanol
&lt;/li&gt;&lt;li&gt;Ethylene glycol
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Nl osm gap
&lt;ol&gt;&lt;li&gt; Salicylate
&lt;/li&gt;&lt;li&gt;Paraldehyde
&lt;/li&gt;&lt;li&gt;Cyanide
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Metabolic_Acidosis&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Non-gap"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Non-gap"&gt;Non-gap&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Hyperkalemia
&lt;ol&gt;&lt;li&gt; Resolving DKA
&lt;/li&gt;&lt;li&gt; Early uremic acidosis
&lt;/li&gt;&lt;li&gt; Early obstructive
&lt;/li&gt;&lt;li&gt; RTA Type IV
&lt;/li&gt;&lt;li&gt; Hypoaldo
&lt;/li&gt;&lt;li&gt; K-sparing diuretics
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Hypokalemia
&lt;ol&gt;&lt;li&gt; RTA Type I
&lt;/li&gt;&lt;li&gt; RTA Type II
&lt;/li&gt;&lt;li&gt; Acetazolamide
&lt;/li&gt;&lt;li&gt; Acute diarrhea
&lt;ol&gt;&lt;li&gt; (May be assoc with gap if hypoperfusion -&amp;gt; lactic acidosis)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Metabolic_Acidosis&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Treat source
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Metabolic_Acidosis&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Bicarbonate Indications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Bicarbonate_Indications"&gt;Bicarbonate Indications&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Bicarb &amp;lt;4
&lt;/li&gt;&lt;li&gt;pH &amp;lt;7.20 + Sx shock/myocardial irritability
&lt;/li&gt;&lt;li&gt;Severe hyperchloremic acidemia + Sx shock/myocardial irritability
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Metabolic_Acidosis&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;2/21/06 DONALDSON (adapted from Tintinalli)
&lt;/p&gt;



</content><folder>FEN</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="metabolic_alkalosis"><name>Metabolic Alkalosis</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Metabolic_Alkalosis&amp;amp;action=edit&amp;amp;section=1" title="Edit section: DDX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX"&gt;DDX&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Chloride-responsive (urine Cl &amp;lt; 20 mEq/L)
&lt;ol&gt;&lt;li&gt;Loss of gastric secretions
&lt;ol&gt;&lt;li&gt;vomiting
&lt;/li&gt;&lt;li&gt;NG suction
&lt;/li&gt;&lt;li&gt;bulemia
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Loss of colonic secretions
&lt;ol&gt;&lt;li&gt;congenital chloridorrhea
&lt;/li&gt;&lt;li&gt;villous adenoma
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Thiazides/loop after D/C
&lt;/li&gt;&lt;li&gt;Post hypercapnia
&lt;/li&gt;&lt;li&gt;Cystic fibrosis
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Chloride-resistant (urine Cl &amp;gt; 20 mEq/L)
&lt;ol&gt;&lt;li&gt;With HTN
&lt;ol&gt;&lt;li&gt;Primary hyperaldo
&lt;ol&gt;&lt;li&gt;adrenal adenoma
&lt;/li&gt;&lt;li&gt;bilateral adrenal
&lt;/li&gt;&lt;li&gt;hyperplasia
&lt;/li&gt;&lt;li&gt;adrenal carcinoma
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;11B-HSD2
&lt;ol&gt;&lt;li&gt;genetic, licorice
&lt;/li&gt;&lt;li&gt;chewing tobacco
&lt;/li&gt;&lt;li&gt;carbenoxolone
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;CAH (11-Hydroxylase or 17-hydroxylase deficiency)
&lt;/li&gt;&lt;li&gt;Current diuretics + HTN
&lt;/li&gt;&lt;li&gt;Cushing syndrome
&lt;/li&gt;&lt;li&gt;Exogenous steroids
&lt;/li&gt;&lt;li&gt;Liddle syndrome
&lt;/li&gt;&lt;li&gt;Renovascular HTN
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Without HTN
&lt;ol&gt;&lt;li&gt;Bartter syndrome^
&lt;/li&gt;&lt;li&gt;Gitelman syndrome^
&lt;/li&gt;&lt;li&gt;Severe K+ depletion
&lt;/li&gt;&lt;li&gt;Current thiazides/loop
&lt;/li&gt;&lt;li&gt;Hypomagnesemia
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Other causes
&lt;ol&gt;&lt;li&gt;Exogenous alkali (Nabicarb + renal failure, metabolism of lactic acid, or ketoacids)
&lt;/li&gt;&lt;li&gt;Milk alkali syndrome
&lt;/li&gt;&lt;li&gt;Hypercalcemia
&lt;/li&gt;&lt;li&gt;Intravenous penicillin
&lt;/li&gt;&lt;li&gt;Refeeding alkalosis
&lt;/li&gt;&lt;li&gt;Massive blood transfusion
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;^ln children
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Metabolic_Alkalosis&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;2/21/06 DONALDSON (adapted from emedicine)
&lt;/p&gt;



</content><folder>FEN</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="methanol_poisoning"><name>Methanol Poisoning</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Pathophysiology"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Pathophysiology&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Clinical_Manifestations"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Clinical Manifestations&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Methanol_Poisoning&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt; Background &lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Found in antifreeze, windshield washer fluid
&lt;/li&gt;&lt;li&gt;Volatile (as opposed to ethylene glycol)
&lt;ul&gt;&lt;li&gt;Respiratory tract absorption can result in toxicity, esp. in infants
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Sweet-tasting
&lt;/li&gt;&lt;li&gt;Lethal dose:
&lt;ul&gt;&lt;li&gt; Adult ~ 15mL of 40% methanol (lowest lethal dose reported)
&lt;/li&gt;&lt;li&gt; Ped ~ 1.5mL of 100% methanol
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Blinding dose ~ 4mL of 100% methanol
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Methanol_Poisoning&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Pathophysiology"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Pathophysiology"&gt; Pathophysiology &lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Methanol + alcohol/aldehyde dehydrogenase &amp;gt; formic acid
&lt;ul&gt;&lt;li&gt; Optic neuropathy + putaminal necrosis (parkinsonism)
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Methanol_Poisoning&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt; Work-Up &lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Chemistry
&lt;ul&gt;&lt;li&gt;Anion gap acidosis
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Serum Osm
&lt;ul&gt;&lt;li&gt;Osm gap (measured - calculated)
&lt;ul&gt;&lt;li&gt;Calculated serum osm = 2Na + BUN/2.8 + glucose/18 + ethanol/4.6
&lt;/li&gt;&lt;li&gt;Normal is &amp;lt; 10
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Ethanol level
&lt;/li&gt;&lt;li&gt;VBG
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;Note:
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Cannot rule out toxic ingestion with a "normal" osmol gap
&lt;ul&gt;&lt;li&gt;Only parent alcohol is osmotically active
&lt;ul&gt;&lt;li&gt;Delayed presentation may mean that much of it is already metabolized
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Methanol_Poisoning&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Clinical Manifestations"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Clinical_Manifestations"&gt; Clinical Manifestations &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Symptoms begin typically 12-24hr after ingestion
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;May occur later if ethanol is co-ingested
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;1. Intoxication signs (confusion, ataxia, depressed mental status, sz, coma)
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;&lt;ul&gt;&lt;li&gt; Less inebriating than ethanol and ethylene glycol)
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;2. Visual disturbances (50% of pts)
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; Development may precede or parallel that of other clinical symptoms
&lt;ul&gt;&lt;li&gt; Cloudy or blurry vision ("stepping out into a snowstorm)
&lt;/li&gt;&lt;li&gt; Central scotoma, complete vision loss
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;3. Anion-gap acidosis
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; May be severe (bicarb &amp;lt; 5, pH &amp;lt; 7)
&lt;/li&gt;&lt;li&gt; Compensatory tachypnea
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Methanol_Poisoning&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt; Treatment &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1. Correction of metabolic acidosis with bicarbonate
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; Bicarbonate 1-2mEq/kg IV bolus to attain pH = 7.45-7.50
&lt;ul&gt;&lt;li&gt; Follow by infusion of 150mEq/L in D5 @ 1.5-2 times maintenance fluid rate
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; Monitor for worsening hypocalcemia
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
2. ADH enzyme blockade
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Fomepizole (4-MP)
&lt;ul&gt;&lt;li&gt; 15mg/kg followed by 10mg/kg q12hr x 4 doses
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Ethyl alcohol
&lt;ul&gt;&lt;li&gt;BAL of 100-150 completely saturates alcohol dehydrogenase
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
3. Removal of parent alcohol and metabolites via dialysis
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Indications (controversial):
&lt;ul&gt;&lt;li&gt; Severe acidosis (pH &amp;lt;7.30)
&lt;/li&gt;&lt;li&gt; Visual symptoms
&lt;/li&gt;&lt;li&gt; Electrolyte imbalances unreponsive to conventional therapy
&lt;/li&gt;&lt;li&gt; Anion gap &amp;gt; 20
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;4. Other
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; Folinic acid 50mg IV q4hr
&lt;ul&gt;&lt;li&gt; Enhances formic acid metabolism
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Methanol_Poisoning&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt; Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Rosen's
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; &lt;br /&gt;&lt;br /&gt;
&lt;/p&gt;



</content><folder>Tox</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="microbiology_basics"><name>Microbiology Basics</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Gram_Negatives"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Gram Negatives&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#Lactose_Fermenters"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;Lactose Fermenters&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Non-Lactose_Fermenters"&gt;&lt;span class="tocnumber"&gt;1.2&lt;/span&gt; &lt;span class="toctext"&gt;Non-Lactose Fermenters&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Gram_Positives"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Gram Positives&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Rods"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;Rods&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Anaerobes"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Anaerobes&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Microbiology_Basics&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Gram Negatives"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Gram_Negatives"&gt; Gram Negatives &lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Cocci
&lt;ol&gt;&lt;li&gt;Neisseria sp. meningococcus
&lt;/li&gt;&lt;li&gt;Moraxella
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Rods
&lt;ol&gt;&lt;li&gt;Lactose Fermenters
&lt;/li&gt;&lt;li&gt;Non-Lactose Fermenters
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Microbiology_Basics&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Lactose Fermenters"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Lactose_Fermenters"&gt;Lactose Fermenters&lt;/span&gt;&lt;/h3&gt;
&lt;table border="1" width="327"&gt;

&lt;tr&gt;
&lt;td&gt; &lt;b&gt;Lactose Fermenters&lt;br /&gt;&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Indole&lt;br /&gt;&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;morphology&lt;br /&gt;&lt;/b&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;
&lt;p&gt;E. Coli
&lt;/p&gt;
&lt;/td&gt;&lt;td&gt; +&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; flat
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Klebsiella
&lt;/td&gt;&lt;td&gt; -
&lt;/td&gt;&lt;td&gt; muccoid&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Enterobacter
&lt;/td&gt;&lt;td&gt; -&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; muccoid
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Citrobacter
&lt;/td&gt;&lt;td&gt; -
&lt;/td&gt;&lt;td&gt; flat
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Arizona
&lt;/td&gt;&lt;td&gt; -
&lt;/td&gt;&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Microbiology_Basics&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Non-Lactose Fermenters"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Non-Lactose_Fermenters"&gt;Non-Lactose Fermenters&lt;/span&gt;&lt;/h3&gt;
&lt;table border="1" width="342"&gt;

&lt;tr&gt;
&lt;td&gt; &lt;b&gt;Non-Lactose Fermenters&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Characteristics&lt;br /&gt;&lt;/b&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;
&lt;p&gt;Pseudomonas
&lt;/p&gt;
&lt;/td&gt;&lt;td&gt; usually strict aerobes, oxidase +, small
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Salmonella, Shigella
&lt;/td&gt;&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Acinetobacter
&lt;/td&gt;&lt;td&gt; coccobac
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Proteus&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; swarming
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; H. Flu&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; tiny, chocolate agar
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Pasteurella
&lt;/td&gt;&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Microbiology_Basics&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Gram Positives"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Gram_Positives"&gt; Gram Positives &lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Cocci
&lt;ol&gt;&lt;li&gt;Clusters
&lt;ol&gt;&lt;li&gt;catalase + Staph sp
&lt;/li&gt;&lt;li&gt;coagulase + S. aureus
&lt;/li&gt;&lt;li&gt;coagulase - S. epidermidis
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Pairs/chains -
&lt;ol&gt;&lt;li&gt;catalase - Strep sp.
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Rods
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Microbiology_Basics&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Rods"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Rods"&gt;Rods&lt;/span&gt;&lt;/h3&gt;
&lt;table border="1" width="453"&gt;

&lt;tr&gt;
&lt;td&gt; &lt;b&gt;Rods &lt;br /&gt;&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;&lt;br /&gt;&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Cult&lt;br /&gt;&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Morphology&lt;br /&gt;&lt;/b&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;
&lt;p&gt;Listeria
&lt;/p&gt;
&lt;/td&gt;&lt;td&gt;
&lt;p&gt;Small
&lt;/p&gt;
&lt;/td&gt;&lt;td&gt; Aero&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; tumbling&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Diphtheroids&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Small
&lt;/td&gt;&lt;td&gt; Anaero&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; pallisades&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Actinomyces&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Small
&lt;/td&gt;&lt;td&gt; Anaero&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Branching&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Propionibac&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Small
&lt;/td&gt;&lt;td&gt; Anaero&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; clumps/pleo&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Lactobacillus&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Variable
&lt;/td&gt;&lt;td&gt; Both&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; may chain&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Clostridium&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Large
&lt;/td&gt;&lt;td&gt; Anaero&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Spores&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Bacillus
&lt;/td&gt;&lt;td&gt; Large
&lt;/td&gt;&lt;td&gt; Aero
&lt;/td&gt;&lt;td&gt; Spores
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Microbiology_Basics&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Anaerobes"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Anaerobes"&gt; Anaerobes &lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Origin - gut, mouth, head/neck (50% of chronic sinusitis), lung, female gu tract
&lt;/li&gt;&lt;li&gt;Cant grow unless culture specifically asked. 3% of bacteremia, &amp;lt;1% of cystitis
&lt;/li&gt;&lt;li&gt;Bacteroides (B.frag GNR) (Peptostreptococus GPC) (P. Acnes GPR), Clostridium GPR)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Microbiology_Basics&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt; Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;7/2/09 PANI
&lt;/p&gt;



</content><folder>ID</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="migraine"><name>Migraine</name><content>&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Migraine&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Migraine Likely?"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Migraine_Likely.3F"&gt;Migraine Likely?&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;POUNDing
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt; Pulsatile
&lt;/li&gt;&lt;li&gt; Duration of 4-72 hOurs
&lt;/li&gt;&lt;li&gt; Unilateral
&lt;/li&gt;&lt;li&gt; Nausea or vomiting
&lt;/li&gt;&lt;li&gt; Disabling in quality
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;Yes to 4 or more: LR 24 (definite or possible migraine)
&lt;/p&gt;&lt;p&gt;3 criteria: LR 3.5
&lt;/p&gt;&lt;p&gt;1-2: LR 0.41
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Migraine&amp;amp;action=edit&amp;amp;section=2" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Neuro: Headache
&lt;/p&gt;&lt;p&gt;Neuro: Headache DDX
&lt;/p&gt;&lt;p&gt;Neuro: Headache Red Flags
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Migraine&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Detsky et. al, JAMA  '06 Does this Patient with a Headache have a Migraine or need Neuroimaging?
&lt;/p&gt;



</content><folder>Neuro</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="missed_and_delayed_diagnosis"><name>Missed and Delayed Diagnosis</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Missed_and_Delayed_Diagnosis&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Missed or delayed diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Missed_or_delayed_diagnosis"&gt; Missed or delayed diagnosis &lt;/span&gt;&lt;/h2&gt;
&lt;table border="1"&gt;

&lt;tr&gt;
&lt;td&gt; &lt;b&gt;Cause &lt;/b&gt;&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;%&lt;/b&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Fracture
&lt;/td&gt;&lt;td&gt; 19
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Infection
&lt;/td&gt;&lt;td&gt; 15
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Myocardial infarction
&lt;/td&gt;&lt;td&gt; 10
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Cancer
&lt;/td&gt;&lt;td&gt; 9
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Cerebral vascular disease
&lt;/td&gt;&lt;td&gt; 8
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Embolism
&lt;/td&gt;&lt;td&gt; 5
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Appendicitis
&lt;/td&gt;&lt;td&gt; 5
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Other abdominal disease
&lt;/td&gt;&lt;td&gt; 5
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Peripheral vascular disease
&lt;/td&gt;&lt;td&gt; 4
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Aneurysm
&lt;/td&gt;&lt;td&gt; 3
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Other cardiac disease
&lt;/td&gt;&lt;td&gt; 3
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;
&lt;p&gt;Other
&lt;/p&gt;
&lt;/td&gt;&lt;td&gt; 15
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Missed_and_Delayed_Diagnosis&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt; Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Missed and Delayed Diagnoses in the Emergency Department: A Study of Closed Malpractice Claims From 4 Liability Insurers. Annals of Emergency Medicine - Volume 49, Issue 2 (February 2007)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;



</content><folder>Misc/General</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="monoarticular_arthritis"><name>Monoarticular Arthritis</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Septic_Arthritis"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Septic Arthritis&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#Gonococcal_Arthritis"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;Gonococcal Arthritis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Nongonococcal_Arthritis"&gt;&lt;span class="tocnumber"&gt;1.2&lt;/span&gt; &lt;span class="toctext"&gt;Nongonococcal Arthritis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Crystal-Induced_Monoarthritis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Crystal-Induced Monoarthritis&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Gout"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;Gout&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-6"&gt;&lt;a href="#Pseudogout"&gt;&lt;span class="tocnumber"&gt;2.2&lt;/span&gt; &lt;span class="toctext"&gt;Pseudogout&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Traumatic"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Traumatic&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Ischemic"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Ischemic&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#Hemorrhagic"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Hemorrhagic&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-10"&gt;&lt;a href="#Neoplastic"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Neoplastic&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-11"&gt;&lt;a href="#Systemic_Disease"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Systemic Disease&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-12"&gt;&lt;a href="#Periarticular"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;Periarticular&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-13"&gt;&lt;a href="#Peds"&gt;&lt;span class="tocnumber"&gt;9&lt;/span&gt; &lt;span class="toctext"&gt;Peds&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-14"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;10&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Monoarticular_Arthritis&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Septic Arthritis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Septic_Arthritis"&gt;Septic Arthritis&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Monoarticular_Arthritis&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Gonococcal Arthritis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Gonococcal_Arthritis"&gt;Gonococcal Arthritis&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Healthy, young sexually active adults
&lt;/p&gt;&lt;p&gt;Women &amp;gt; men
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Suppurative monoarthritis (may be preceded by polyarthralgias)
&lt;/p&gt;&lt;p&gt;Knee, wrist, ankle
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Arthritis-Dermatitis Syndrome
&lt;/p&gt;&lt;p&gt;-Triad: dermatitis, tenosynovitis, migratory polyarthritis (hematogenous spread of bacteria and immune complexes)
&lt;/p&gt;&lt;p&gt;-Skin lesions: scattered small painless erythematous macules or petechiae--&amp;gt;pustular --&amp;gt;necrotic lesions
&lt;/p&gt;&lt;p&gt;-Transient painful extensor tenosynovitis (writs, hands, ankles)
&lt;/p&gt;&lt;p&gt;-Asymmtric polyarthralgia of extremity joints
&lt;/p&gt;&lt;p&gt;DiagnosisCx everything - jt, mucosal surfaces, lesions
&lt;/p&gt;&lt;p&gt;TreatmentCTX 1gIV qd OR
&lt;/p&gt;&lt;p&gt;Cefotax 1g q8
&lt;/p&gt;&lt;p&gt;Empirically treat Chlamydia
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Monoarticular_Arthritis&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Nongonococcal Arthritis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Nongonococcal_Arthritis"&gt;Nongonococcal Arthritis&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Fulminant presentation (abrupt, swelling, toxicity and fever) unless elderly
&lt;/p&gt;&lt;p&gt;-Hematogenous
&lt;/p&gt;&lt;p&gt;-Contiguous
&lt;/p&gt;&lt;p&gt;-Direct traumatic implantation
&lt;/p&gt;&lt;p&gt;-Postop
&lt;/p&gt;&lt;p&gt;CausesBacterial
&lt;/p&gt;&lt;p&gt;Mycobacterial
&lt;/p&gt;&lt;p&gt;Spirochete (lyme, syphilis)
&lt;/p&gt;&lt;p&gt;Fungal
&lt;/p&gt;&lt;p&gt;VIral (HIV, Hep B, Rubella, etc)
&lt;/p&gt;&lt;p&gt;Postinfectious
&lt;/p&gt;&lt;p&gt;DiagnosisSynovial fluid aspiration
&lt;/p&gt;&lt;p&gt;Cx - if only one test, use BCx bottles (may enhance yield)
&lt;/p&gt;&lt;p&gt;Grm stain - 80% positive in gram-positive infxn; less sens in gram-negative
&lt;/p&gt;&lt;p&gt;Cell count with dif - &amp;gt;50,000-150,000; PMN &amp;gt; 90%
&lt;/p&gt;&lt;p&gt;TreatmentPCN-ase resistant synthetic PCN:
&lt;/p&gt;&lt;p&gt;Nafcillin 1-2g
&lt;/p&gt;&lt;p&gt;Cefazolin 1-2g
&lt;/p&gt;&lt;p&gt;AND
&lt;/p&gt;&lt;p&gt;3rd gen ceph
&lt;/p&gt;&lt;p&gt;OR
&lt;/p&gt;&lt;p&gt;Vanc*
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;new evidence suggests significantly increased rate of MRSA septic arthritis
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;&lt;ul&gt;&lt;li&gt;cell counts are as low as 20,000 in MRSA Cx + synovial fluid
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Monoarticular_Arthritis&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Crystal-Induced Monoarthritis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Crystal-Induced_Monoarthritis"&gt;Crystal-Induced Monoarthritis&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Monoarticular_Arthritis&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Gout"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Gout"&gt;Gout&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Monosodium urate crystals - needle shaped negative birefringence
&lt;/p&gt;&lt;p&gt;Swelling, redness, warmth evolving rapidly over hours todays
&lt;/p&gt;&lt;p&gt;First MTP (podagra) 60% &amp;gt; ankle &amp;gt; midfoot &amp;gt; knee
&lt;/p&gt;&lt;p&gt;May have constitutional complaints
&lt;/p&gt;&lt;p&gt;Precipitants: purine-rich food, EtOH, trauma, chemo, diueretic use, RI
&lt;/p&gt;&lt;p&gt;DiagnosisSynovial fluid aspiration (above)
&lt;/p&gt;&lt;p&gt;Note: serum uric acid levels unhelpful; ESR/CRP may be elevated
&lt;/p&gt;&lt;p&gt;TreatmentNSAIDS eg Naproxen 500mg po bid x 3d and taper over 4-7d
&lt;/p&gt;&lt;p&gt;Colchicine 0.6mg po qh x 3 or 1mg PO f/b 0.5mg q1h until relif, GI upset, or 8mg max
&lt;/p&gt;&lt;p&gt;Can give 1-2mg IV over 30mins
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;No further doses after initial load
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;&lt;ul&gt;&lt;li&gt;avoid NSAIDS, Colchicine in RF
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;Steroids
&lt;/p&gt;&lt;p&gt;-Prednisone 40-60mg po qd x 3d f/b 7d taper
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Monoarticular_Arthritis&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Pseudogout"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Pseudogout"&gt;Pseudogout&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Calcium pyrophosphate dihydrate (CPPD) - rhomboid shaped positive birefringence
&lt;/p&gt;&lt;p&gt;chondrocalcinosis
&lt;/p&gt;&lt;p&gt;acute attacks of mono or oligoarticular inlammatory arthritis
&lt;/p&gt;&lt;p&gt;progressive joint deenerative changes similar to OA
&lt;/p&gt;&lt;p&gt;Evolves over days
&lt;/p&gt;&lt;p&gt;Age &amp;gt; 50
&lt;/p&gt;&lt;p&gt;Knee, wrists, ankles, elbows
&lt;/p&gt;&lt;p&gt;Systemic illness, surgery, trauma triggers
&lt;/p&gt;&lt;p&gt;Assoc with hyperparathyroidism and hemochromatosis
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Monoarticular_Arthritis&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Traumatic"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Traumatic"&gt;Traumatic&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Fracture
&lt;/p&gt;&lt;p&gt;ligamentous
&lt;/p&gt;&lt;p&gt;Overuse
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Monoarticular_Arthritis&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Ischemic"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Ischemic"&gt;Ischemic&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Avascular necrosis
&lt;/p&gt;&lt;p&gt;Decompression illness
&lt;/p&gt;&lt;p&gt;Spontaneous osteonecrosis
&lt;/p&gt;&lt;p&gt;pain in abscence of trauma
&lt;/p&gt;&lt;p&gt;femoral head, medial conyle of knee
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Monoarticular_Arthritis&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Hemorrhagic"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Hemorrhagic"&gt;Hemorrhagic&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Posttraumatic
&lt;/p&gt;&lt;p&gt;-Joint aspiration if tense
&lt;/p&gt;&lt;p&gt;-RICE
&lt;/p&gt;&lt;p&gt;Hemophilia
&lt;/p&gt;&lt;p&gt;Systemic anticoagulation
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Monoarticular_Arthritis&amp;amp;action=edit&amp;amp;section=10" title="Edit section: Neoplastic"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Neoplastic"&gt;Neoplastic&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Mets
&lt;/p&gt;&lt;p&gt;Osteochondroma
&lt;/p&gt;&lt;p&gt;Osteoid osteoma
&lt;/p&gt;&lt;p&gt;Pigmented villonodular synovitis
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Monoarticular_Arthritis&amp;amp;action=edit&amp;amp;section=11" title="Edit section: Systemic Disease"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Systemic_Disease"&gt;Systemic Disease&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Remote infxn, infectious endocarditis
&lt;/p&gt;&lt;p&gt;Rheumatic fever
&lt;/p&gt;&lt;p&gt;Seronegative (no RF) spondyloarthropathies (AS, IBS, psoriatic, reactive or Reiter's)
&lt;/p&gt;&lt;p&gt;Rheumatoid arthritis, SLE
&lt;/p&gt;&lt;p&gt;Sarcoidosis, amyloidosis
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Monoarticular_Arthritis&amp;amp;action=edit&amp;amp;section=12" title="Edit section: Periarticular"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Periarticular"&gt;Periarticular&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;these conditions mimic joint involvement...
&lt;/p&gt;&lt;p&gt;Cellulitis
&lt;/p&gt;&lt;p&gt;Tendonitis
&lt;/p&gt;&lt;p&gt;Bursitis
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Monoarticular_Arthritis&amp;amp;action=edit&amp;amp;section=13" title="Edit section: Peds"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Peds"&gt;Peds&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;don't forget about...
&lt;/p&gt;&lt;p&gt;Acute Transient Synovitis
&lt;/p&gt;&lt;p&gt;-Children 3-10yo
&lt;/p&gt;&lt;p&gt;-1-3 wks after viral illness
&lt;/p&gt;&lt;p&gt;Self-limited
&lt;/p&gt;&lt;p&gt;SCFE (portly pubescent)
&lt;/p&gt;&lt;p&gt;Leff-Calve-Perthes (young school-age children)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Monoarticular_Arthritis&amp;amp;action=edit&amp;amp;section=14" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;H-N
&lt;/p&gt;



</content><folder>Rheum</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="mucormycosis"><name>Mucormycosis</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Workup"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Workup&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Prognosis"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Prognosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Mucormycosis&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Infection of fungal hyphae in immunocompromised hosts
&lt;ol&gt;&lt;li&gt;DM
&lt;/li&gt;&lt;li&gt;HIV
&lt;/li&gt;&lt;li&gt;Neutropenic
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;&lt;b&gt;Locations&lt;/b&gt;
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Most commonly affects paranasal sinuses (rhinocerebral mucormycosis)
&lt;/li&gt;&lt;li&gt;Pulmonary
&lt;/li&gt;&lt;li&gt;GI
&lt;/li&gt;&lt;li&gt;CNS
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Mucormycosis&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Rhinocerebral: mimics acute bacterial sinusitis, however a much more rapid, extensive expansion of the fungus to the surrounding anatomy is classic
&lt;/p&gt;&lt;p&gt;Can spread to orbits, oropharynx, nasopharynx, brain, nearby vasculature leading to:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Vision changes
&lt;/li&gt;&lt;li&gt;Nasopharyngeal and oropharyngeal ulceration or eschars
&lt;/li&gt;&lt;li&gt;Facial edema, pain
&lt;/li&gt;&lt;li&gt;Cranial nerve deficits
&lt;/li&gt;&lt;li&gt;Headache
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Mucormycosis&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Workup"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Workup"&gt;Workup&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;CT scan of sinuses
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Mucormycosis&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Adjunctive: Amphotericin B (1mgkg/d IV)
&lt;/li&gt;&lt;li&gt;Definitive: Prompt surgical consultation --&amp;gt; debridement
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Mucormycosis&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Prognosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Prognosis"&gt;Prognosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Mortality 30-90%
&lt;/p&gt;



</content><folder>ID</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="multiple_sclerosis_(ms)"><name>Multiple Sclerosis (MS)</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Multiple_Sclerosis_(MS)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Neuro Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Neuro_Work-Up"&gt;Neuro Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; LP
&lt;ol&gt;&lt;li&gt;IgG
&lt;/li&gt;&lt;li&gt;albumin
&lt;/li&gt;&lt;li&gt;IgG synthesis rate
&lt;/li&gt;&lt;li&gt;oligoclonal bands
&lt;/li&gt;&lt;li&gt;myelin basic protein
&lt;/li&gt;&lt;li&gt;cell count
&lt;/li&gt;&lt;li&gt;glucose
&lt;/li&gt;&lt;li&gt;protein
&lt;/li&gt;&lt;li&gt;gm stain
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; CBC, Chem 7, UA
&lt;/li&gt;&lt;li&gt; ECG, CXR
&lt;/li&gt;&lt;li&gt; MRI w/ GAD of brain (+/- affected spine)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Multiple_Sclerosis_(MS)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Optho: Optic Neuritis
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Multiple_Sclerosis_(MS)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;2/26/06 DONALDSON
&lt;/p&gt;



</content><folder>Neuro</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="mushroom"><name>Mushroom</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Mushroom&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Amatoxin
&lt;/p&gt;&lt;p&gt;- inhibits rna polymerase and interfers c dna rna transcriptn. -
&lt;/p&gt;&lt;p&gt;- Disruption of protein synthesis causes fatal intestinal hepatic renal dz.
&lt;/p&gt;&lt;p&gt;- Is heat stable- not affected by cooking
&lt;/p&gt;&lt;p&gt;- delayed tox- 6-24 hrs
&lt;/p&gt;&lt;p&gt;- liver and kidney failure
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Gyromitrins
&lt;/p&gt;&lt;p&gt;- oxidizes hemoglobin- can cause methemoglobinemia
&lt;/p&gt;&lt;p&gt;- inhibits glutamic acid decarboxylase- leads to low GABA level - neuro sxs
&lt;/p&gt;&lt;p&gt;-delayed 6-8 hrs -
&lt;/p&gt;&lt;p&gt;- hepatitis
&lt;/p&gt;&lt;p&gt;- cns changes
&lt;/p&gt;&lt;p&gt;- hemolysis
&lt;/p&gt;&lt;p&gt;- metHb
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Orellanine and orelline
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Coprine
&lt;/p&gt;&lt;p&gt;- if ingested c etoh can lead to Beta adrenergic stimulation like disulfiram rxn
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Ibotenic acid and muscimol
&lt;/p&gt;&lt;p&gt;- anticholinergic activity and hallucinatns,
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Muscarine
&lt;/p&gt;&lt;p&gt;- cholinergic stimulatn- blurred vision, sweating, HA, lacrimation, salivation, urinary freq
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Psilocybin and psilocin
&lt;/p&gt;&lt;p&gt;- nv, hallucination, flashbacks
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Mushroom&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- if &amp;gt; 6h from ingestion to sxs suggests amatoxin, gyromitrin, orellenine, oreline. Do LFT, PT
&lt;/p&gt;&lt;p&gt;- if &amp;lt; 3h is ibotenic acid, muscimol, muscarine, psilocin
&lt;/p&gt;&lt;p&gt;- temporal assoc c etoh and sxs suggest coprine poisoning
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Mushroom&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- charcoal
&lt;/p&gt;&lt;p&gt;- no antiemetic or imodium since will cause increased toxin absorption
&lt;/p&gt;&lt;p&gt;- golightly whole bowel irrigation
&lt;/p&gt;&lt;p&gt;- if amatoxn, gyromitrin, orellanine admit for observatn
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;TOXIN SPECIFIC TX-
&lt;/p&gt;&lt;p&gt;Amatoxn-
&lt;/p&gt;&lt;p&gt;- forced diuresis
&lt;/p&gt;&lt;p&gt;- charcoal hemoperfusion
&lt;/p&gt;&lt;p&gt;- high dose penicilin- inhibits amatoxn uptake by hepatocytes. One million units/kg in divided doses per day for 2- 3 days. Sz is complicatn.
&lt;/p&gt;&lt;p&gt;- high dose cimetidine- inhibits P450 enzyme. 2 gms q 4h iv
&lt;/p&gt;&lt;p&gt;- liver xplant
&lt;/p&gt;&lt;p&gt;- hyperbaric O2
&lt;/p&gt;&lt;p&gt;- high dose ascorbic acid
&lt;/p&gt;&lt;p&gt;- N- acetylcysteine
&lt;/p&gt;&lt;p&gt;Gyromitrin poisoning-
&lt;/p&gt;&lt;p&gt;- pyridoxin 25mg/kg iv over 30min. Repeat up to 4 times in 24 hrs if sxs persist.
&lt;/p&gt;&lt;p&gt;- benzos
&lt;/p&gt;&lt;p&gt;- diuresis
&lt;/p&gt;&lt;p&gt;- blood xfusion
&lt;/p&gt;&lt;p&gt;- methylene blue
&lt;/p&gt;&lt;p&gt;Orellanine
&lt;/p&gt;&lt;p&gt;- fluids
&lt;/p&gt;&lt;p&gt;Coprine- etoh
&lt;/p&gt;&lt;p&gt;- dopamine for hypotn
&lt;/p&gt;&lt;p&gt;Ibotenil- muscimol
&lt;/p&gt;&lt;p&gt;- control neuromuscular hyperactivity- benzos. Consider physostigmine if refractory agitation and tachy and perif anticholinergic findings
&lt;/p&gt;&lt;p&gt;Muscarine poisoning
&lt;/p&gt;&lt;p&gt;- atropine
&lt;/p&gt;&lt;p&gt;- albuterol
&lt;/p&gt;&lt;p&gt;- anti histamines,
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Mushroom&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;6/06 MISTRY
&lt;/p&gt;



</content><folder>Tox</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="myasthenia_gravis"><name>Myasthenia Gravis</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#Pathophys"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;Pathophys&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Epi"&gt;&lt;span class="tocnumber"&gt;1.2&lt;/span&gt; &lt;span class="toctext"&gt;Epi&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#DDX"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;DDX&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Botulism"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;Botulism&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-6"&gt;&lt;a href="#Eaton_Lambert"&gt;&lt;span class="tocnumber"&gt;2.2&lt;/span&gt; &lt;span class="toctext"&gt;Eaton Lambert&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-7"&gt;&lt;a href="#Tick_Paralysis"&gt;&lt;span class="tocnumber"&gt;2.3&lt;/span&gt; &lt;span class="toctext"&gt;Tick Paralysis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-9"&gt;&lt;a href="#History"&gt;&lt;span class="tocnumber"&gt;3.1&lt;/span&gt; &lt;span class="toctext"&gt;History&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-10"&gt;&lt;a href="#Symptoms"&gt;&lt;span class="tocnumber"&gt;3.2&lt;/span&gt; &lt;span class="toctext"&gt;Symptoms&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-11"&gt;&lt;a href="#Physical_Exam"&gt;&lt;span class="tocnumber"&gt;3.3&lt;/span&gt; &lt;span class="toctext"&gt;Physical Exam&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-12"&gt;&lt;a href="#Testing"&gt;&lt;span class="tocnumber"&gt;3.4&lt;/span&gt; &lt;span class="toctext"&gt;Testing&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-13"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-14"&gt;&lt;a href="#Myasthenic_Crisis_vs._Cholinergic"&gt;&lt;span class="tocnumber"&gt;4.1&lt;/span&gt; &lt;span class="toctext"&gt;Myasthenic Crisis vs. Cholinergic&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-15"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Myasthenia_Gravis&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Myasthenia_Gravis&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Pathophys"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Pathophys"&gt;Pathophys&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;thymus abnl in most - thymoma, thymitis, B cells sensitized to Ach receptors here.
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Myasthenia_Gravis&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Epi"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Epi"&gt;Epi&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; mostly women in 20s
&lt;/li&gt;&lt;li&gt; peak incid in men is 60-70s
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Myasthenia_Gravis&amp;amp;action=edit&amp;amp;section=4" title="Edit section: DDX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX"&gt;DDX&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Toxin Induced
&lt;ol&gt;&lt;li&gt; Botulism
&lt;/li&gt;&lt;li&gt; Tick Paralysis
&lt;/li&gt;&lt;li&gt; Envenomation (coral snake, black widow spider), paralytic shellfish
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Autoimmune - Eaton Lambert
&lt;/li&gt;&lt;li&gt; Drug-Induced - aminogly, dilantin, procainamide, chloroquine
&lt;/li&gt;&lt;li&gt; Poisoning - Organophosphates, Carbamates
&lt;/li&gt;&lt;li&gt; Miller Fisher Variant Guillen Barre
&lt;/li&gt;&lt;li&gt; Causes of oculomotor palsy - DM, MS, aneurysm
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Myasthenia_Gravis&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Botulism"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Botulism"&gt;Botulism&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; toxin binds to presyn prevents AcH release. Wound may be benign in appearance 
&lt;/li&gt;&lt;li&gt;GI source - neuro sxs w/in 72 hrs of ingestion usually. Aticholinergic effects include dry mouth, mydriasis, ileus, urine retention then fluctuating but rapidly progressive weakness
&lt;/li&gt;&lt;li&gt;send cx blood, food, stool or wound
&lt;/li&gt;&lt;li&gt; only 33% of food borne source have positive blood cx
&lt;/li&gt;&lt;li&gt; may actually see pos Tensilon test in botulism.
&lt;/li&gt;&lt;li&gt;Wound Botulism - high dose PCN &amp;amp; debridement.
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Myasthenia_Gravis&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Eaton Lambert"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Eaton_Lambert"&gt;Eaton Lambert&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;rare, defect in release of AcH from presynapse
&lt;/li&gt;&lt;li&gt;Usually paraneoplastic (part. small cell Ca of lung)
&lt;/li&gt;&lt;li&gt; Clinically proximal weakness of limb muscles, hyporeflexia, dry mouth, impotence.
&lt;/li&gt;&lt;li&gt; Extraocular &amp;amp; facial muscles usually spared.
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Myasthenia_Gravis&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Tick Paralysis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Tick_Paralysis"&gt;Tick Paralysis&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;acsending flaccid paralysis caused by neurotoxin block acH release
&lt;/li&gt;&lt;li&gt; late spring, summer in Rockies &amp;amp; NW
&lt;/li&gt;&lt;li&gt; female wood tick or common dog tick
&lt;/li&gt;&lt;li&gt; paralysis progresses over 1-2 days to involve bulbar, extraocular muscles.
&lt;/li&gt;&lt;li&gt; Resp paralysis can follow
&lt;/li&gt;&lt;li&gt; Ataxia may be early finding
&lt;/li&gt;&lt;li&gt; normal sens exam usually
&lt;/li&gt;&lt;li&gt; DTRs decreased markedly as in GB
&lt;/li&gt;&lt;li&gt; fatal in 10% if tick not removed
&lt;/li&gt;&lt;li&gt; CHECK for ticks in someone you think has Guillen Barre
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Myasthenia_Gravis&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Myasthenia_Gravis&amp;amp;action=edit&amp;amp;section=9" title="Edit section: History"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="History"&gt;History&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; pts report worse sxs as day progresses.
&lt;/li&gt;&lt;li&gt; insidious onset, can develop over wks to months.
&lt;/li&gt;&lt;li&gt; precipitated by stress, preg, infec
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Myasthenia_Gravis&amp;amp;action=edit&amp;amp;section=10" title="Edit section: Symptoms"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Symptoms"&gt;Symptoms&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; diplopia, ptosis (later in day)
&lt;/li&gt;&lt;li&gt; weakness in eye closure, swallowing muscles of facial expression, difficulty chewing, dysarthria, dysphagia.
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Myasthenia_Gravis&amp;amp;action=edit&amp;amp;section=11" title="Edit section: Physical Exam"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Physical_Exam"&gt;Physical Exam&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Provocative tests - ptosis with prolonged upward gaze, hold arms up, clench tongue blade, dysarthria w/ loud counting
&lt;/li&gt;&lt;li&gt; sensation, reflexes usually normal
&lt;/li&gt;&lt;li&gt; always eval tidal volume, FEV &amp;amp; ability to handle secretions
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Myasthenia_Gravis&amp;amp;action=edit&amp;amp;section=12" title="Edit section: Testing"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Testing"&gt;Testing&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Always test FEV, consider ABG, Look for infections (resp) or meds, electrolyte problems that may have induced problem.
&lt;/li&gt;&lt;li&gt; Edrophonium - use caution in trying to test for crisis vs. cholinergic crisis
&lt;/li&gt;&lt;li&gt; Ach receptor antibodies - found 90%
&lt;/li&gt;&lt;li&gt; CT of thymus, TFTs, search for other immun dz
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Myasthenia_Gravis&amp;amp;action=edit&amp;amp;section=13" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Plasmapherisis or plasma exchenge in acute setting
&lt;/li&gt;&lt;li&gt; Anticholinesterase agent such as Pyridostigmine 60 mg tid
&lt;/li&gt;&lt;li&gt; Corticosteroids produce good results in &amp;gt;80% but are reserved for those who don't respond to anti-cholinesterases and thymectomy due to adverse effects. Decreases levels of antiAch receptor Ab. Also may initially aggravate muscle weakness so usually begun in hosp &amp;amp; at low doses
&lt;/li&gt;&lt;/ol&gt;
&lt;ol&gt;&lt;li&gt;don't treat Myasthenic with meds that may exacerbate weakness
&lt;/li&gt;&lt;li&gt; search for source of infection or electrolyte problem w/ weakness
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Myasthenia_Gravis&amp;amp;action=edit&amp;amp;section=14" title="Edit section: Myasthenic Crisis vs. Cholinergic"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Myasthenic_Crisis_vs._Cholinergic"&gt;Myasthenic Crisis vs. Cholinergic&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Cholinergic - usually present w/ signs of cholinergic overactivity (miosis, sweats, salivation, GI distress-musc) &amp;amp; cramps, fasciculations (nicotinic)
&lt;/li&gt;&lt;li&gt; Myasthenic - more common, caused by noncompliance, drug interaction, infection, stress
&lt;ol&gt;&lt;li&gt; aminoglycosides, flouroquinolones, clinda, sulfas, erythro, ampicillin, Dilantin, phenobarb, B blockers, Ca channel Blk, procainamide, steroids, lithium, phenothiazines, MSO4, benzos, antihistamines
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;VERY DANGEROUS &amp;amp; UNRELIABLE to use Tensilon Test to distinguish between the two.
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Myasthenia_Gravis&amp;amp;action=edit&amp;amp;section=15" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Harwood Nuss p.1002
&lt;/p&gt;



</content><folder>Neuro</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="myxedema_coma"><name>Myxedema Coma</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Precipitants"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Precipitants&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;9&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Myxedema_Coma&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Myxedema: thick, nonpitting edematous changes to skin and soft tissues
&lt;/li&gt;&lt;li&gt; occurs in 0.1% of patients with hypothyroid
&lt;/li&gt;&lt;li&gt; 80% mortality 
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Myxedema_Coma&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Precipitants"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Precipitants"&gt;Precipitants&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Exposure to Cold
&lt;/li&gt;&lt;li&gt;Infection (esp pulmonary)
&lt;/li&gt;&lt;li&gt;CHF
&lt;/li&gt;&lt;li&gt;Trauma
&lt;/li&gt;&lt;li&gt;Drugs: phenothiazines, pheobarbitol, narcotics, anesthetics, bdzs, lithium
&lt;/li&gt;&lt;li&gt;Iodides
&lt;/li&gt;&lt;li&gt;CVA
&lt;/li&gt;&lt;li&gt;Hemorrhage (GI)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Myxedema_Coma&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;AMS
&lt;/li&gt;&lt;li&gt;unsteady gait 
&lt;/li&gt;&lt;li&gt;Skin findings (cool, dry, coarse, pale)
&lt;/li&gt;&lt;li&gt;soft tissues with nonpitting, waxy, dry edema (periorbital edema)
&lt;/li&gt;&lt;li&gt;loss of axillary and pubic hair 
&lt;/li&gt;&lt;li&gt;Hypothermia (core temp &amp;lt;37C)
&lt;/li&gt;&lt;li&gt;Cardiovascular alterations (bradycardia)
&lt;/li&gt;&lt;li&gt;Hypoventilation --&amp;gt; respiratory collapse
&lt;/li&gt;&lt;li&gt;abdominal distension 
&lt;/li&gt;&lt;li&gt;Delayed DTRs
&lt;/li&gt;&lt;li&gt;Precipitant
&lt;/li&gt;&lt;li&gt;Hypoglycemia
&lt;/li&gt;&lt;li&gt;Hyponatremia
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Myxedema_Coma&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Chem panel (shows hyponatremia)
&lt;/li&gt;&lt;li&gt;serum osms 
&lt;/li&gt;&lt;li&gt;accucheck (may be normal or low)
&lt;/li&gt;&lt;li&gt;CBC
&lt;/li&gt;&lt;li&gt;cultures 
&lt;/li&gt;&lt;li&gt;total CK
&lt;/li&gt;&lt;li&gt;LFTS
&lt;/li&gt;&lt;li&gt;LDH
&lt;/li&gt;&lt;li&gt;TSH, FT4, FT3
&lt;/li&gt;&lt;li&gt;cortisol level 
&lt;/li&gt;&lt;li&gt;ABG
&lt;/li&gt;&lt;li&gt;ECHO
&lt;/li&gt;&lt;li&gt;CXR 
&lt;/li&gt;&lt;li&gt;EKG 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Myxedema_Coma&amp;amp;action=edit&amp;amp;section=5" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;CHF
&lt;/li&gt;&lt;li&gt;Pulmonary Edema
&lt;/li&gt;&lt;li&gt;hypoventilation syndromes 
&lt;/li&gt;&lt;li&gt;hypothermia 
&lt;/li&gt;&lt;li&gt;Depression/SI
&lt;/li&gt;&lt;li&gt;hepatic encephalopathy
&lt;/li&gt;&lt;li&gt;shock 
&lt;/li&gt;&lt;li&gt;CVA 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Myxedema_Coma&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Intubation and mechanical ventilation if pt has significant respiratory acidosis, hypercapnia, or hypoxia
&lt;/li&gt;&lt;li&gt;IV thyroid replacement
&lt;ol&gt;&lt;li&gt;500-800 mcg  of Levothyroxine then 50-100mcg IV qday 
&lt;/li&gt;&lt;li&gt;consider 10-20mcg q12hrs IV of T3 in younger patients with low cardiovascular risk
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Steroid Replacement 
&lt;ol&gt;&lt;li&gt;5-10mg/hr IV hydrocortisone 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;treat associated infections
&lt;/li&gt;&lt;li&gt;correct severe hyponatremia and hypoglycemia 
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;passive external rewarming  
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Myxedema_Coma&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Admit to ICU
&lt;/li&gt;&lt;li&gt;get endocrine consult 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Myxedema_Coma&amp;amp;action=edit&amp;amp;section=8" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Hypothyroidism
&lt;/p&gt;&lt;p&gt;Thyroid (General)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Myxedema_Coma&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Emedicine
&lt;/p&gt;&lt;p&gt;Adapted from PANI, Clarke
&lt;/p&gt;



</content><folder>Endo</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="nausea_vomiting_in_pregnancy"><name>Nausea Vomiting in Pregnancy</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Nausea_Vomiting_in_Pregnancy&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;  vit b6 10-25 mg tid or qid
&lt;/li&gt;&lt;li&gt;  Add unisom (doxylamine) 12.5 mg tid or qid (1/2 tab)
&lt;/li&gt;&lt;li&gt; Add phenergan 12.5-25 mg q 4 hr po/pr or dramamine 50-100 mg q 4-6
&lt;ol&gt;&lt;li&gt;hr po/pr (not to exceed 400 mg/dy or 200 mg/dy if also taking unisom
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; No dehydration-add reglan 5-10 mg im/po q 8hr or zofran 8 mg im/po q 12 hr.  
&lt;ol&gt;&lt;li&gt;q 3-4 hr or 25 mg pr bid or phenergan 12,5 - 25 mg im/po/pr q4 hr
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; If dehydration,iv fluids, mvi, dimenhydrinate 50 mg in 50 ml saline over 20 min iv q 4-6 hr.  add reglan, compazine, phenergan, zofran.
&lt;ol&gt;&lt;li&gt;if needed, solumedrol 16 mg q8h iv/po x 3 days, taper over 2weeks toowest effective dose. limit to 6 wks duration
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Nausea_Vomiting_in_Pregnancy&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;admission criteria - acetone in blood
&lt;/p&gt;



</content><folder>OB/GYN</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="nausea_and_vomiting"><name>Nausea and Vomiting</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Complications"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Complications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#DDX"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;DDX&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Critical"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;Critical&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Emergent"&gt;&lt;span class="tocnumber"&gt;2.2&lt;/span&gt; &lt;span class="toctext"&gt;Emergent&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Nonemergent"&gt;&lt;span class="tocnumber"&gt;2.3&lt;/span&gt; &lt;span class="toctext"&gt;Nonemergent&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Nausea_and_Vomiting&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Complications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Complications"&gt;Complications&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Hypovolemia
&lt;/li&gt;&lt;li&gt; Metabolic alkalosis
&lt;/li&gt;&lt;li&gt; Hypokalemia
&lt;/li&gt;&lt;li&gt; Mallory-Weiss (tear)
&lt;/li&gt;&lt;li&gt; Boerhaave (rupture)
&lt;/li&gt;&lt;li&gt; Aspiration
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Nausea_and_Vomiting&amp;amp;action=edit&amp;amp;section=2" title="Edit section: DDX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX"&gt;DDX&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Nausea_and_Vomiting&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Critical"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Critical"&gt;Critical&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Boerhaave
&lt;/li&gt;&lt;li&gt;Ischemic bowel
&lt;/li&gt;&lt;li&gt;ICH
&lt;/li&gt;&lt;li&gt;Meningitis
&lt;/li&gt;&lt;li&gt;DKA
&lt;/li&gt;&lt;li&gt;AMI
&lt;/li&gt;&lt;li&gt;Sepsis
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Nausea_and_Vomiting&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Emergent"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Emergent"&gt;Emergent&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Gastric outlet obstruction
&lt;/li&gt;&lt;li&gt;Pancreatitis
&lt;/li&gt;&lt;li&gt;Cholecystitis
&lt;/li&gt;&lt;li&gt;Bowel obstruction/ileus
&lt;/li&gt;&lt;li&gt;Ruptured viscus
&lt;/li&gt;&lt;li&gt;Appendicitis
&lt;/li&gt;&lt;li&gt;Peritonitis
&lt;/li&gt;&lt;li&gt;Migraine
&lt;/li&gt;&lt;li&gt;CNS tumor
&lt;/li&gt;&lt;li&gt;raised ICP
&lt;/li&gt;&lt;li&gt;Adrenal insuffciency
&lt;/li&gt;&lt;li&gt;Hyperemesis gravidarum
&lt;/li&gt;&lt;li&gt;Tylenol
&lt;/li&gt;&lt;li&gt;Digoxin
&lt;/li&gt;&lt;li&gt;ASA
&lt;/li&gt;&lt;li&gt;Theophyline
&lt;/li&gt;&lt;li&gt;Gonadal torsion
&lt;/li&gt;&lt;li&gt;CO
&lt;/li&gt;&lt;li&gt;Electrolyte disorder
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Nausea_and_Vomiting&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Nonemergent"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Nonemergent"&gt;Nonemergent&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Gastritis
&lt;/li&gt;&lt;li&gt;Gastroparesis
&lt;/li&gt;&lt;li&gt;PUD
&lt;/li&gt;&lt;li&gt;Gastroenteritis
&lt;/li&gt;&lt;li&gt;Biliary colic
&lt;/li&gt;&lt;li&gt;Hepatitis
&lt;/li&gt;&lt;li&gt;Thyroid
&lt;/li&gt;&lt;li&gt;Pregnancy
&lt;/li&gt;&lt;li&gt;Erythromycin
&lt;/li&gt;&lt;li&gt;Ibuprofen
&lt;/li&gt;&lt;li&gt;Chemotherapy
&lt;/li&gt;&lt;li&gt;Narcotics/wdwl from
&lt;/li&gt;&lt;li&gt;ETOH
&lt;/li&gt;&lt;li&gt;UTI
&lt;/li&gt;&lt;li&gt;Renal colic
&lt;/li&gt;&lt;li&gt;Motion sickness
&lt;/li&gt;&lt;li&gt;Labyrinthitis
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Nausea_and_Vomiting&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;12/06 DONALDSON (adapted from Rosen)
&lt;/p&gt;



</content><folder>GI</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="necrotizing_enterocolitis_(nec)"><name>Necrotizing Enterocolitis (NEC)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Necrotizing_Enterocolitis_(NEC)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; usu 24-48 hr of life/neonates &amp;amp; premature infants
&lt;/li&gt;&lt;li&gt; It is d/t intestinal wall necrosis
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Necrotizing_Enterocolitis_(NEC)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; S/S: feeding intolerance, jaundice, abdominal distension, change in stooling pattern, heme + stools
&lt;/li&gt;&lt;li&gt; radiology= pneumotosis intestinalis, pneumobilia, pneumoperitoneum, air in portal vein, gasless abdomen
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
Clinical triad&amp;nbsp;: Abdominal. Distension + GI bleeding + Pneumatosis intestinalis
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Signs of functional Intestinal obstruction&amp;nbsp;: Abdominal distension, progressive decreased Peristalsis, Bilious vomiting, hematemesis and blood in stools
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Signs of peritonitis &amp;amp; perforation: Ascites, erythema &amp;amp; edema of abdominal wall, localized mass or rigidity
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Systemic signs&amp;nbsp;: respiratory distress, Apnea / bradycardia, Lethargy, thermal instability, irritability, poor feeding, hypotension (shock), oliguria, bleeding diathesis, sclerema
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Triad of:
&lt;/p&gt;&lt;p&gt;Thrombocytopenia
&lt;/p&gt;&lt;p&gt;Metabolic acidosis
&lt;/p&gt;&lt;p&gt;Hyponatremia
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Stools are heme +
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Radiography
&lt;/p&gt;&lt;p&gt;-Pneumotosis is hallmark
&lt;/p&gt;&lt;p&gt;Get KUB and left lat decubital
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Necrotizing_Enterocolitis_(NEC)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Sepsis, pneumonia, malro/volvulus, intuss, feeding intolerance (exclusion)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Necrotizing_Enterocolitis_(NEC)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Rx= 80% nd only medical mgt (bowel rest, ngt, fluids, abx to cover bowel flora), 20% need bowel surgery (if perf etc)
&lt;/li&gt;&lt;li&gt; 15% mortality
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
Management
&lt;/p&gt;&lt;p&gt;-NPO
&lt;/p&gt;&lt;p&gt;-CBC, lytes, BCx, x-ray
&lt;/p&gt;&lt;p&gt;-Abx x 48 hrs
&lt;/p&gt;&lt;p&gt;-Serial CBC, lytes, x-ray (q6)
&lt;/p&gt;&lt;p&gt;Treatment:
&lt;/p&gt;&lt;p&gt;NG to suction
&lt;/p&gt;&lt;p&gt;NPO
&lt;/p&gt;&lt;p&gt;Amp/gent/clinda
&lt;/p&gt;&lt;p&gt;Volume replacement
&lt;/p&gt;&lt;p&gt;Support
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Surgery indications
&lt;/p&gt;&lt;p&gt;-Perforation, portal/biliary air, rapidly deteriorating
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Necrotizing_Enterocolitis_(NEC)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from Pani
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="necrotizing_fasciitis"><name>Necrotizing Fasciitis</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#Fasciitis"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;Fasciitis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Myositis"&gt;&lt;span class="tocnumber"&gt;1.2&lt;/span&gt; &lt;span class="toctext"&gt;Myositis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Necrotizing_Fasciitis"&gt;&lt;span class="tocnumber"&gt;1.3&lt;/span&gt; &lt;span class="toctext"&gt;Necrotizing Fasciitis&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-3 tocsection-5"&gt;&lt;a href="#Microorganisms"&gt;&lt;span class="tocnumber"&gt;1.3.1&lt;/span&gt; &lt;span class="toctext"&gt;Microorganisms&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-7"&gt;&lt;a href="#Labs"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;Labs&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-8"&gt;&lt;a href="#Imaging"&gt;&lt;span class="tocnumber"&gt;2.2&lt;/span&gt; &lt;span class="toctext"&gt;Imaging&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-10"&gt;&lt;a href="#Antibiotic_Regimens"&gt;&lt;span class="tocnumber"&gt;3.1&lt;/span&gt; &lt;span class="toctext"&gt;Antibiotic Regimens&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-11"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Necrotizing_Fasciitis&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Necrotizing_Fasciitis&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Fasciitis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Fasciitis"&gt;Fasciitis&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; does not involve muscle- but can spread to muscle
&lt;/li&gt;&lt;li&gt; syst toxicity
&lt;/li&gt;&lt;li&gt; skin c blebs, crepitus, necrosis
&lt;/li&gt;&lt;li&gt; risks- dm, pvd, trauma or recent surg
&lt;/li&gt;&lt;li&gt; pain varies since nerve endings damaged- cessation or absence of pain may indicate worsening sxs
&lt;/li&gt;&lt;li&gt; necrosis of fat can lead to soapanification and hypocalemia
&lt;/li&gt;&lt;li&gt; pcn/gent/clinda
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Necrotizing_Fasciitis&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Myositis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Myositis"&gt;Myositis&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; myonecrosis- deep soft- tissue infection with  death of muscle
&lt;/li&gt;&lt;li&gt; often with little skin changes but does have gas  formation
&lt;/li&gt;&lt;li&gt; result of trauma or surgical wounds
&lt;/li&gt;&lt;li&gt; exotoxin of clostridia damages and kills muscle,  setting up anaerobic environment that promotes further bacterial growth
&lt;/li&gt;&lt;li&gt; odor described as "sickly sweet:
&lt;/li&gt;&lt;li&gt; pt usually anuric
&lt;/li&gt;&lt;li&gt; muscle appears cooked or dead, does not bleed  when cut or retract when pinched
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Necrotizing_Fasciitis&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Necrotizing Fasciitis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Necrotizing_Fasciitis"&gt;Necrotizing Fasciitis&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; can occur p minor trauma
&lt;/li&gt;&lt;li&gt; mortality 20- 50%
&lt;/li&gt;&lt;/ol&gt;
&lt;h4&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Necrotizing_Fasciitis&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Microorganisms"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Microorganisms"&gt;Microorganisms&lt;/span&gt;&lt;/h4&gt;
&lt;ol&gt;&lt;li&gt; Type I Polymicrobrial- Anaerboic (mixed) staph, proteus, pseudomonas
&lt;/li&gt;&lt;li&gt; Type 2 Streptococcal (toxin-generating)
&lt;/li&gt;&lt;li&gt; Type 3 (?) Clostridium (gas gangrene)
&lt;/li&gt;&lt;li&gt; Grp A beta hemolytic strep pyogenes releases substance in cell wall that causes separation of the dermal connective tissue resulting in continued inflammation and necrosis
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Necrotizing_Fasciitis&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;"Hard Signs"
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt; Hypotension
&lt;/li&gt;&lt;li&gt; Gas on XR
&lt;/li&gt;&lt;li&gt; Skin necrosis
&lt;/li&gt;&lt;li&gt; Bullae
&lt;/li&gt;&lt;li&gt; Crepitance
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;Other common signs/symptoms
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt; Systemic toxicity
&lt;/li&gt;&lt;li&gt; Numbness or deep pain out of proportion to exam
&lt;/li&gt;&lt;li&gt; Violaceous or hemorrhagic appearance
&lt;/li&gt;&lt;li&gt; Pain beyond margins of cellulitis
&lt;/li&gt;&lt;li&gt; Skip lesions
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;Other
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt; Meleney's synergistic gangrene- (progressive bacterial synergistic gangrene) involves superficial and deep fascial planes with thrombosis of subQ vessels and gangrene of tissue
&lt;/li&gt;&lt;li&gt; Clostridial cellulitis- healthy muscle not invovled
&lt;/li&gt;&lt;li&gt; Fournier's syndrome- necrotizing subq infection of perineum- risk factors include infection or trauma to the perineal area,, anal intercourse, scratches, chemical or thermal burns or diabetes.  Obliteration of small branches of pudendal arteries results in dermal gangrene of perineal and scrotal skin.
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Necrotizing_Fasciitis&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Labs"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Labs"&gt;Labs&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Hyponatremia, Na&amp;lt;135
&lt;/li&gt;&lt;li&gt;Leukocytosis
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Necrotizing_Fasciitis&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Imaging"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Imaging"&gt;Imaging&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;XR- gas
&lt;/li&gt;&lt;li&gt;CT- most commonly used, up to 80% sensitive
&lt;/li&gt;&lt;li&gt;UTZ- operator dependent
&lt;/li&gt;&lt;li&gt;MRI- overly sensitive
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Necrotizing_Fasciitis&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; wide surgical debridement and excision
&lt;/li&gt;&lt;li&gt; IV ABX
&lt;/li&gt;&lt;li&gt; Resuscitate as in sepsis
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;Unclear benefit
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt; hyperbaric O2
&lt;/li&gt;&lt;li&gt; IVIG
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Necrotizing_Fasciitis&amp;amp;action=edit&amp;amp;section=10" title="Edit section: Antibiotic Regimens"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Antibiotic_Regimens"&gt;Antibiotic Regimens&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Harbor:
&lt;ol&gt;&lt;li&gt; community-acquired- Ceftriaxone/vanc/clinda +/- gent
&lt;/li&gt;&lt;li&gt; hospital-acquired- Zosyn/vanc/clinda
&lt;/li&gt;&lt;li&gt; pcn allergic- Cipro/vanc/clinda/gent
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Other common regimens:
&lt;ol&gt;&lt;li&gt; pen/ ox/ gent/ clinda- and also use vanco
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Necrotizing_Fasciitis&amp;amp;action=edit&amp;amp;section=11" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;6/06 PANI
&lt;/p&gt;



</content><folder>ID</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="needle_stick"><name>Needle Stick</name><content>&lt;p&gt;See "Occupational Exposure"
&lt;/p&gt;



</content><folder>ID</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="neonatal_jaundice"><name>Neonatal Jaundice</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Risk_Factors"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Risk Factors&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Phototherapy_Guidelines"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Phototherapy Guidelines&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Neonatal_Jaundice&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Risk Factors"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Risk_Factors"&gt;Risk Factors&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Isoimmune hemolytic disease
&lt;/li&gt;&lt;li&gt;G6PD deficiency
&lt;/li&gt;&lt;li&gt;Asphyxia
&lt;/li&gt;&lt;li&gt;Significant lethargy
&lt;/li&gt;&lt;li&gt;Temperature instability
&lt;/li&gt;&lt;li&gt;Sepsis
&lt;/li&gt;&lt;li&gt;Acidosis
&lt;/li&gt;&lt;li&gt;Albumin &amp;lt;3 g/d (if measured)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Neonatal_Jaundice&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt; Diagnosis &lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Direct (conjugated, post- liver obstructive)
&lt;ol&gt;&lt;li&gt;congenital biliary atresia
&lt;/li&gt;&lt;li&gt;neuroblastoma
&lt;/li&gt;&lt;li&gt;cholesterol cysts
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Cellular
&lt;ol&gt;&lt;li&gt;hepatitis
&lt;/li&gt;&lt;li&gt;galactosemia
&lt;/li&gt;&lt;li&gt;sepsis
&lt;/li&gt;&lt;li&gt;TORCHS
&lt;/li&gt;&lt;li&gt;tyrosinemia
&lt;/li&gt;&lt;li&gt;alpha 1 antitrypsis deficiency
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Iindirect (unconjugated, pre-liver)
&lt;ol&gt;&lt;li&gt;sepsis
&lt;/li&gt;&lt;li&gt;hypotension
&lt;/li&gt;&lt;li&gt;rH/ ABO incompatibility
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Neonatal_Jaundice&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Tbil
&lt;/li&gt;&lt;li&gt;Dbil
&lt;/li&gt;&lt;li&gt;CBC (for hemolytic anemia)
&lt;/li&gt;&lt;li&gt;Coombs or T&amp;amp;S (mom &amp;amp; baby)
&lt;/li&gt;&lt;li&gt;?blood resorption
&lt;/li&gt;&lt;li&gt;?septic
&lt;/li&gt;&lt;li&gt;Decreased gastric motility
&lt;/li&gt;&lt;li&gt;Physiologic/breast milk (none @ birth presents 1st week)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Neonatal_Jaundice&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Phototherapy Guidelines"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Phototherapy_Guidelines"&gt;Phototherapy Guidelines&lt;/span&gt;&lt;/h2&gt;
&lt;table cellpadding="1" cellspacing="1" width="200" border="1"&gt;

&lt;tr&gt;
&lt;td&gt; Age
&lt;/td&gt;&lt;td&gt; Low
&lt;/td&gt;&lt;td&gt; Med
&lt;/td&gt;&lt;td&gt; High
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Birth
&lt;/td&gt;&lt;td&gt; 7.0
&lt;/td&gt;&lt;td&gt; 5.0
&lt;/td&gt;&lt;td&gt; 4.0
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 24h
&lt;/td&gt;&lt;td&gt; 11.5
&lt;/td&gt;&lt;td&gt; 9.0
&lt;/td&gt;&lt;td&gt; 8.0
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 48h
&lt;/td&gt;&lt;td&gt; 15
&lt;/td&gt;&lt;td&gt; 14
&lt;/td&gt;&lt;td&gt; 10
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 72h
&lt;/td&gt;&lt;td&gt; 17.5
&lt;/td&gt;&lt;td&gt; 15
&lt;/td&gt;&lt;td&gt; 14
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 96h
&lt;/td&gt;&lt;td&gt; 20
&lt;/td&gt;&lt;td&gt; 17.5
&lt;/td&gt;&lt;td&gt;
&lt;p&gt;14.5
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 5+day
&lt;/td&gt;&lt;td&gt; 21
&lt;/td&gt;&lt;td&gt; 17.5
&lt;/td&gt;&lt;td&gt; 15
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;p&gt;Low Risk: &amp;gt;=38wk + no risk factors
&lt;/p&gt;&lt;p&gt;Med Risk: (&amp;gt;=38wk + risk factors) or (35-37 wk and no risk factors)
&lt;/p&gt;&lt;p&gt;High Risk: 35-37wk + risk factors
&lt;/p&gt;&lt;p&gt;see &lt;a href="http://bilitool.org/" class="external text" rel="nofollow"&gt;&lt;font color="#14456e"&gt;http://bilitool.org/&lt;/font&gt;&lt;/a&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Neonatal_Jaundice&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt; Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;DONALDSON 10/07 (from UpToDate), Mistry, DeBonis
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="neonatal_resuscitation"><name>Neonatal Resuscitation</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Neonatal_Resuscitation&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;See Newborn Resuscitation for after-delivery issues
&lt;/p&gt;
&lt;pre&gt;==Diagnosis==
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt;
Neonate in shock
&lt;/p&gt;&lt;p&gt;Neonate &amp;lt;1mo age
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Neonatal_Resuscitation&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Blood glucose (stat)
&lt;/p&gt;&lt;p&gt;Sepsis workup
&lt;/p&gt;&lt;p&gt;ECGAmmonia to  rule in Inborn Errors* Need to look up values for neonate. Ammonia is high as liver is immature (i.e. that's why neonates are jaundice)
If hypoxic or evidence of CHF assume CHD* CHF in neonate = hepatomegaly, wheezing, gallop
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; if unclear do Hyperoxia test
&lt;/li&gt;&lt;li&gt; place infant on 100% O2 for 10 minutes
&lt;/li&gt;&lt;li&gt; check ABG, if O2&amp;lt;100 torr, highly predictive of CHD
&lt;/li&gt;&lt;li&gt; some use Pulse Ox &amp;lt;95%, less sensitive 
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;Abdominal xrays* may help rule in intestinal disaster early 
&lt;/p&gt;
&lt;pre&gt;==DDx==
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt;
THE MISFITS
&lt;/p&gt;&lt;p&gt;1) Trauma
&lt;/p&gt;&lt;p&gt;2) Heart (Congenital Heart Disease) or Hypovolemia
&lt;/p&gt;&lt;p&gt;3) Endocrine- hypothyroidism, congenital adrenal hyperplasia
&lt;/p&gt;&lt;p&gt;4) Metabolic- sodium, calcium
&lt;/p&gt;&lt;p&gt;5) Inborn Errors of Metabolism
&lt;/p&gt;&lt;p&gt;6) Seizure-  can be 2/2 trauma, metaboli
&lt;/p&gt;
&lt;pre&gt;7) Formula Problems- hyponatremia, hypocalcemia
&lt;/pre&gt;
&lt;p&gt;8) Intestinal Disasters- duodenal atresia, midgut volvulus, necrotizing enterocolitis, intussussception
&lt;/p&gt;&lt;p&gt;9) Toxin 
&lt;/p&gt;&lt;p&gt;10) Sepsis
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Neonatal_Resuscitation&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Full Sepsis work-up- IV Abx and fluids, pressorsif CHD suspected- Intubate and give PGE- Sides effects of PGE include apnea (10%)if Inborn errors suspected- IV dextrose at 1.5 maintenance- dialysis if ammonia &amp;gt;500 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Neonatal_Resuscitation&amp;amp;action=edit&amp;amp;section=4" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Peds: Newborn Resuscitation
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="nerve_block:_infraorbital"><name>Nerve Block: Infraorbital</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Indications"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Indications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Contraindications"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Contraindications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Equipment_Needed"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Equipment Needed&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Procedure"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Procedure&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Intraoral_approach"&gt;&lt;span class="tocnumber"&gt;4.1&lt;/span&gt; &lt;span class="toctext"&gt;Intraoral approach&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-6"&gt;&lt;a href="#Extraoral_Approach"&gt;&lt;span class="tocnumber"&gt;4.2&lt;/span&gt; &lt;span class="toctext"&gt;Extraoral Approach&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-7"&gt;&lt;a href="#Field_Block"&gt;&lt;span class="tocnumber"&gt;4.3&lt;/span&gt; &lt;span class="toctext"&gt;Field Block&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Complications"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Complications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Nerve_Block:_Infraorbital&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Indications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Indications"&gt;Indications&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Infraorbital block provides facial anesthesia to the lower eyelid, side of the nose, and upper lip for procedures (closer of lacerations, debridement) without distorting the soft tissues as seen with local infiltration  
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Nerve_Block:_Infraorbital&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Contraindications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Contraindications"&gt;Contraindications&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;allergic reaction to the type of anesthesia you are going to administer
&lt;/li&gt;&lt;li&gt;non-cooperative patient
&lt;/li&gt;&lt;li&gt;overlying skin infection 
&lt;/li&gt;&lt;li&gt;distortion of anatomical landmarks 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Nerve_Block:_Infraorbital&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Equipment Needed"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Equipment_Needed"&gt;Equipment Needed&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;local anesthesia
&lt;ol&gt;&lt;li&gt;lidocaine 1% (lasts 30-60 minutes or longer if given with epi, rapid onset of 4-6 minutes) 
&lt;/li&gt;&lt;li&gt;Bupivacaine 0.5% (lasts 2-4 hours, slowest in onset)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;18 gauge needle to draw up anesthetic
&lt;/li&gt;&lt;li&gt;1.5 inch 25 or 27 gauge needle 
&lt;/li&gt;&lt;li&gt;6cc syringe
&lt;/li&gt;&lt;li&gt;gauze pads
&lt;/li&gt;&lt;li&gt;gloves
&lt;/li&gt;&lt;li&gt;q-tip 
&lt;/li&gt;&lt;li&gt;betadine 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Nerve_Block:_Infraorbital&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Procedure"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Procedure"&gt;Procedure&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Nerve_Block:_Infraorbital&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Intraoral approach"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Intraoral_approach"&gt;Intraoral approach&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Place patient in supine position or seated
&lt;/li&gt;&lt;li&gt;Obtain informed consent 
&lt;/li&gt;&lt;li&gt;draw up 2-5cc of anesthetic into syringe
&lt;/li&gt;&lt;li&gt;apply anesthetic soaked q-tip to the mucosa opposite the upper second premolar (bicuspid) for 1 minute allowing for topical anesthesia
&lt;/li&gt;&lt;li&gt;palpate the infraorbital foramen by having the patient look straight ahead and draw an imaginary line vertically from the pupil toward the inferior border of the infraorbital ridge, keep your finger on the foramen
&lt;/li&gt;&lt;li&gt;retract the cheek and introduce the needle into the mucosa ~ 0.5cm from the buccal surface 
&lt;/li&gt;&lt;li&gt;advance the needle, keeping it parallel to the long axis of the bicuspid) until it is near the foramen (~1.5-2.5 cm)... do not advance too far as you may enter the orbit
&lt;/li&gt;&lt;li&gt;aspirate, and if no blood, inject 4-5 cc of anesthetic slowly 
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Nerve_Block:_Infraorbital&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Extraoral Approach"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Extraoral_Approach"&gt;Extraoral Approach&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Place patient in supine position or seated
&lt;/li&gt;&lt;li&gt;Obtain informed consent 
&lt;/li&gt;&lt;li&gt;draw up 2-5cc of anesthetic into syringe (avoid epinephrine as you are very close to the facial artery while doing the block via this approach)
&lt;/li&gt;&lt;li&gt;palpate the infraorbital foramen (step 5 above)
&lt;/li&gt;&lt;li&gt;prep the overlying skin with betadine
&lt;/li&gt;&lt;li&gt;insert the needle through the skin, subcutaneous tissue, and muscle
&lt;/li&gt;&lt;li&gt;aspirate, if no blood, inject anesthetic slowly (the tissue will swell)
&lt;/li&gt;&lt;li&gt;remove the needle and massage the area for 10-15 seconds 
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Nerve_Block:_Infraorbital&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Field Block"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Field_Block"&gt;Field Block&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;if the nerve block does not work you can do a field block which will generally achieve the same effect
&lt;/li&gt;&lt;li&gt;inject 5 cc of local anesthetic into the upper buccal fold in an arc like distribution and then massage into the area for a few seconds 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Nerve_Block:_Infraorbital&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Complications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Complications"&gt;Complications&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;bleeding
&lt;/li&gt;&lt;li&gt;infection
&lt;/li&gt;&lt;li&gt;pain
&lt;/li&gt;&lt;li&gt;needle fracture
&lt;/li&gt;&lt;li&gt;swelling of face/eyelid
&lt;/li&gt;&lt;li&gt;hematoma
&lt;/li&gt;&lt;li&gt;allergic reaction to anesthetic
&lt;/li&gt;&lt;li&gt;damage to nerves/vessels
&lt;/li&gt;&lt;li&gt;failure to achieve anesthesia 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Nerve_Block:_Infraorbital&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;emedicine
&lt;/p&gt;



</content><folder>Procedures</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="nerve_block:_mental"><name>Nerve Block: Mental</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Indications"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Indications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Contraindications"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Contraindications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Equipment_Needed"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Equipment Needed&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Procedure"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Procedure&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Complications"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Complications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Nerve_Block:_Mental&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Indications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Indications"&gt;Indications&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;The mental nerve innervates the skin of the chin and mucous membranes of the lower lip, by blocking this nerve you can have adequate anesthesia for complicated laceration closures
&lt;ol&gt;&lt;li&gt;NOTE this block does NOT anesthetize the teeth or mandibular soft tissue 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Use block to repair laceration of lower lip or soft tissues of the chin that extend from lip anteriorly to alveolar process and to the mid body of the mandible
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Nerve_Block:_Mental&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Contraindications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Contraindications"&gt;Contraindications&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;allergic reaction to the type of anesthesia you are going to administer
&lt;/li&gt;&lt;li&gt;non-cooperative patient
&lt;/li&gt;&lt;li&gt;overlying skin infection 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Nerve_Block:_Mental&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Equipment Needed"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Equipment_Needed"&gt;Equipment Needed&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;topical anesthesia
&lt;ol&gt;&lt;li&gt;viscous lidocaine
&lt;/li&gt;&lt;li&gt;LET 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;local anesthesia
&lt;ol&gt;&lt;li&gt;lidocaine 1% (lasts 30-60 minutes or longer if given with epi, rapid onset)
&lt;/li&gt;&lt;li&gt;Mepivacaine 3% (lasts 45-90 minutes, slower onset) 
&lt;/li&gt;&lt;li&gt;Bupivacaine 0.5% (lasts 2-4 hours, slowest in onset)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;18 gauge needle to draw up anesthetic
&lt;/li&gt;&lt;li&gt;25 or 27 gauge needle 
&lt;/li&gt;&lt;li&gt;6 cc syringe
&lt;/li&gt;&lt;li&gt;gauze pads
&lt;/li&gt;&lt;li&gt;good light source 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Nerve_Block:_Mental&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Procedure"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Procedure"&gt;Procedure&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Place patient in semi-recumbent position
&lt;/li&gt;&lt;li&gt;apply topical anesthesia 
&lt;/li&gt;&lt;li&gt;draw up 2-5cc of anesthetic into syringe
&lt;/li&gt;&lt;li&gt;locate the mental foramen by retracting the cheek laterally and palpating between the 2 lower premolar teeth 
&lt;/li&gt;&lt;li&gt;insert the needle along the lower gum into the buccal fold between the premolar teeth without placing the needle directly into the foramen
&lt;/li&gt;&lt;li&gt;aspirate; if no blood inject a few cc's of anesthetic slowly (avoid injecting directly into the foramen as to prevent damage to the neurovascular bundle) 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Nerve_Block:_Mental&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Complications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Complications"&gt;Complications&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;bleeding
&lt;/li&gt;&lt;li&gt;infection
&lt;/li&gt;&lt;li&gt;pain
&lt;/li&gt;&lt;li&gt;needle fracture
&lt;/li&gt;&lt;li&gt;neurapraxia 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Nerve_Block:_Mental&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;emedicine
&lt;/p&gt;



</content><folder>Procedures</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="nerve_block:_upper_extremity"><name>Nerve Block: Upper Extremity</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Indications"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Indications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Contraindications"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Contraindications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Equipment_Needed"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Equipment Needed&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Procedure"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Procedure&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#For_Median_Nerve_block"&gt;&lt;span class="tocnumber"&gt;4.1&lt;/span&gt; &lt;span class="toctext"&gt;For Median Nerve block&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-6"&gt;&lt;a href="#For_Radial_Nerve_Block"&gt;&lt;span class="tocnumber"&gt;4.2&lt;/span&gt; &lt;span class="toctext"&gt;For Radial Nerve Block&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Complications"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Complications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Nerve_Block:_Upper_Extremity&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Indications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Indications"&gt;Indications&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Greater pain relief in a larger area for wound exploration, irrigation, and repair without distoring local anatomy
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Nerve_Block:_Upper_Extremity&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Contraindications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Contraindications"&gt;Contraindications&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;allergic reaction to anesthetic 
&lt;/li&gt;&lt;li&gt;patients with proximal vascular grafts or AV fistulas
&lt;/li&gt;&lt;li&gt;overlying skin infection 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Nerve_Block:_Upper_Extremity&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Equipment Needed"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Equipment_Needed"&gt;Equipment Needed&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Syringe
&lt;/li&gt;&lt;li&gt;18 gauge needle
&lt;/li&gt;&lt;li&gt;25-27 gauge needle
&lt;/li&gt;&lt;li&gt;chlorhexadine
&lt;/li&gt;&lt;li&gt;sterile gloves 
&lt;/li&gt;&lt;li&gt;Local Anesthetic (lidocaine without epi, bupivacaine) 
&lt;/li&gt;&lt;li&gt;sterile drapes 
&lt;/li&gt;&lt;li&gt;gauze
&lt;/li&gt;&lt;li&gt;bandage 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Nerve_Block:_Upper_Extremity&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Procedure"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Procedure"&gt;Procedure&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Obtain informed consent
&lt;/li&gt;&lt;li&gt;Perform and document a thorough neurovascular examination of the extremity 
&lt;/li&gt;&lt;li&gt;Draw up your anesthetic and load a 25-27 gauge needle 
&lt;/li&gt;&lt;li&gt;position the patient so that they are comfortable, placing the patients arm on a Mayo stand to help, you may also want a small towel roll to help extend the wrist 
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Nerve_Block:_Upper_Extremity&amp;amp;action=edit&amp;amp;section=5" title="Edit section: For Median Nerve block"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="For_Median_Nerve_block"&gt;For Median Nerve block&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Locate the palmaris longus (PL) and the flexor carpi radialis (FCR) tendons  
&lt;/li&gt;&lt;li&gt;you can have the patient flex the middle finger against resistance or pinch their thump and pinky together to help highlight these tendons
&lt;/li&gt;&lt;li&gt;some patients do not have PL but you can estimate its general location by going 5 mm medially to the FCR (~midpoint of the wrist)
&lt;/li&gt;&lt;li&gt;Prep the skin and drape it in sterile fashion 
&lt;/li&gt;&lt;li&gt;Insert the needle perpendicular to the skin between the PL and FCR tendons 2-3 cm proximal to the distal crease of the wrist to a depth of 1-2cm
&lt;/li&gt;&lt;li&gt;aspirate and then inject 3-5cc of anesthetic then remove needle
&lt;/li&gt;&lt;li&gt;allow anesthetic to sit ~10 minutes prior to performing procedure 
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Nerve_Block:_Upper_Extremity&amp;amp;action=edit&amp;amp;section=6" title="Edit section: For Radial Nerve Block"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="For_Radial_Nerve_Block"&gt;For Radial Nerve Block&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;locate the radial styloid and prep and drape area sterily
&lt;/li&gt;&lt;li&gt;inject 5cc of anethetic just above the radial styloid aiming medially
&lt;/li&gt;&lt;li&gt;extend infiltration laterally using an aditional 5cc of anesthetic
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Nerve_Block:_Upper_Extremity&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Complications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Complications"&gt;Complications&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;infection
&lt;/li&gt;&lt;li&gt;hematoma
&lt;/li&gt;&lt;li&gt;nerve injury
&lt;/li&gt;&lt;li&gt;vascular injury 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Nerve_Block:_Upper_Extremity&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;emedicine
&lt;/p&gt;



</content><folder>Procedures</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="neuro_exam_(physical)"><name>Neuro Exam (Physical)</name><content>&lt;ol&gt;&lt;li&gt;MS A&amp;amp;O vs. MMSE
&lt;ol&gt;&lt;li&gt;Dysarthria (mech) vs. Aphasia
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;CNs II-XII
&lt;/li&gt;&lt;li&gt;Motor Tone (hyper/hypo)
&lt;ol&gt;&lt;li&gt;Strength (0-none; 1-trace contraction; 2-moves w/o gravity; 3-moves against gravity; 4-moves against some resistance; 5-full)
&lt;/li&gt;&lt;li&gt;Atrophy
&lt;/li&gt;&lt;li&gt;Delts (C5), wrists (C6-8), biceps (C5-6), triceps (C6-8), iliopsoa (L1-2), quads (L3-4), hamstrings (S1), TA (L4), G/S (S1-2)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Cerebel Finger-to-nose (dysmetira)
&lt;ol&gt;&lt;li&gt;Rapid alternating (dysdidokinesis)
&lt;/li&gt;&lt;li&gt;Heel-to-shin
&lt;/li&gt;&lt;li&gt;Pronator drift
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Reflex Clonus (+4)
&lt;ol&gt;&lt;li&gt;Cross adductor (+3)
&lt;/li&gt;&lt;li&gt;Hoffman's sign
&lt;/li&gt;&lt;li&gt;DTRs
&lt;/li&gt;&lt;li&gt;Babinski
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Sens Dorsal comumns (vibratory/proprio)
&lt;ol&gt;&lt;li&gt;Spinothalamic (PP/LT)
&lt;/li&gt;&lt;li&gt;Romberg
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Gait Wide-based, sway
&lt;ol&gt;&lt;li&gt;Heel &amp;amp; toe
&lt;/li&gt;&lt;li&gt;Tandem
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Neuro_Exam_(Physical)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;2/26/06 DONALDSON
&lt;/p&gt;



</content><folder>Neuro</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="neurogenic_shock"><name>Neurogenic Shock</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#Sympathetic_Disruption"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;Sympathetic Disruption&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Prognosis"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Prognosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Neurogenic_Shock&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Hypotension &amp;amp; bradycardia
&lt;/p&gt;&lt;p&gt;Results from disrupted sympathetic flow w/ overriding vagal tone
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Neurogenic_Shock&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Sympathetic Disruption"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Sympathetic_Disruption"&gt;Sympathetic Disruption&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Above T1:  full
&lt;/li&gt;&lt;li&gt;T1-L3:  Partial (higher=more)
&lt;/li&gt;&lt;li&gt;Below L4:  none
&lt;/li&gt;&lt;li&gt;Lasts = 1-3 wks
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;^beware of hypothermia
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Neurogenic_Shock&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;(high thoracic or cervical injury)
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;mild hypotension
&lt;/li&gt;&lt;li&gt;bradycardia
&lt;/li&gt;&lt;li&gt;warm periferal extremities
&lt;/li&gt;&lt;li&gt;loss of neuro func below injury level
&lt;/li&gt;&lt;li&gt;Flaccid paralysis/Areflexia
&lt;/li&gt;&lt;li&gt;priapism, Horner's, &amp;amp; abd breathing
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Neurogenic_Shock&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; EXCLUDE other causes of shock (i.e. hemorrhage, PNTX, tampand)
&lt;/li&gt;&lt;li&gt; IVF (SBP goal &amp;gt;70)
&lt;ol&gt;&lt;li&gt;use neosynephrine/ Levophed
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Atropine (if sypm brady)
&lt;/li&gt;&lt;li&gt; Keep warm
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Neurogenic_Shock&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Prognosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Prognosis"&gt;Prognosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;If cord is contused and not transected, bulbocavernosus refex should return w/in 24-48 hrs
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Neurogenic_Shock&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;2/06 DONALDSON (Adapted from Tintinalli)
&lt;/p&gt;



</content><folder>Neuro</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="neuroleptic_malignant_syndrome"><name>Neuroleptic Malignant Syndrome</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#Potential_Pitfalls"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;Potential Pitfalls&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Clinical_History"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;Clinical History&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Diagnostic_Criteria"&gt;&lt;span class="tocnumber"&gt;2.2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnostic Criteria&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Woodbury_Stages"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Woodbury Stages&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#Complications"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Complications&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-10"&gt;&lt;a href="#Prognosis"&gt;&lt;span class="tocnumber"&gt;6.1&lt;/span&gt; &lt;span class="toctext"&gt;Prognosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-11"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Neuroleptic_Malignant_Syndrome&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Related to Dopamine Blockade in:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Anterior Hypothalamus --&amp;gt; Hyperthermia
&lt;/li&gt;&lt;li&gt;Frontal Lobe --&amp;gt; AMS
&lt;/li&gt;&lt;li&gt;Nigrostriatal Pathways --&amp;gt; Rigidity
&lt;/li&gt;&lt;li&gt;Sympathetic Nervous System --&amp;gt; Autonomic Instability
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Neuroleptic_Malignant_Syndrome&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Potential Pitfalls"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Potential_Pitfalls"&gt;Potential Pitfalls&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Overlooking the AMS in a &#8220;psych pt&#8221;
&lt;/li&gt;&lt;li&gt;Delay in obtaining rectal temp
&lt;/li&gt;&lt;li&gt;Use of physical restraints
&lt;/li&gt;&lt;li&gt;Isometric contractions leads increased metabolism, worsening rhabdo and hyperthermia
&lt;/li&gt;&lt;li&gt;Use of high potency antipsychotics in the ER
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Neuroleptic_Malignant_Syndrome&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Classic Tetrad of Symptoms:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt; Altered Mental Status
&lt;/li&gt;&lt;li&gt; Muscular Rigidity
&lt;/li&gt;&lt;li&gt; Fever
&lt;/li&gt;&lt;li&gt; Autonomic Instability
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Neuroleptic_Malignant_Syndrome&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Clinical History"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Clinical_History"&gt;Clinical History&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Drug Exposure:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Typical high potency antipsychotics (haloperidol)
&lt;/li&gt;&lt;li&gt;Atypical neuroleptics (risperidone, olanzapine, clozapine)
&lt;/li&gt;&lt;li&gt;Antiemetics (metochlopromide, promethazine)
&lt;/li&gt;&lt;li&gt;Withdrawal of anti-Parkinson medication
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;&lt;br /&gt;
Timing:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Symptoms typically occur within 4-14d following initiation of med or an increase in dosing; can occur years after initiating therapy
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;&lt;br /&gt;
Laboratory Examination (non-specific):
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Total CK &amp;gt; 1000
&lt;/li&gt;&lt;li&gt;WBC &amp;gt; 10K
&lt;/li&gt;&lt;li&gt;Mildly elevated LDH, LFTs
&lt;/li&gt;&lt;li&gt;Renal Insufficiency
&lt;/li&gt;&lt;li&gt;CSF with mildly elevated Protein
&lt;/li&gt;&lt;li&gt;Low Serum Iron
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Neuroleptic_Malignant_Syndrome&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Diagnostic Criteria"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnostic_Criteria"&gt;Diagnostic Criteria&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;DSM-IV:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Recent administration of antipsychotic
&lt;/li&gt;&lt;li&gt;Elevated Temp (&amp;gt; 40C)
&lt;/li&gt;&lt;li&gt;Muscle Rigidity
&lt;/li&gt;&lt;li&gt;At least 2 other signs/symptoms or lab findings c/w NMS
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Neuroleptic_Malignant_Syndrome&amp;amp;action=edit&amp;amp;section=6" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Delirium tremens
&lt;/li&gt;&lt;li&gt;Heat Stroke (altered CNS, temp &amp;gt;40)
&lt;/li&gt;&lt;li&gt;Meningitis
&lt;/li&gt;&lt;li&gt;Malignant Hyperthermia (genetic d/o; 1h post general anesthetic; hyperthermia up to 45deg C, rigidity, tachy, skin cyanosis with mottling)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Neuroleptic_Malignant_Syndrome&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;ABCs
&lt;/li&gt;&lt;li&gt;Stop the Offending Agent
&lt;/li&gt;&lt;li&gt;Aggressive Cooling Measures
&lt;/li&gt;&lt;li&gt;Fluid Resuscitation
&lt;/li&gt;&lt;li&gt;Supportive Care
&lt;/li&gt;&lt;li&gt;Benzos: for agitation
&lt;/li&gt;&lt;li&gt;Dantrolene:
&lt;ol&gt;&lt;li&gt;direct skeletal muscle relaxant
&lt;/li&gt;&lt;li&gt;(Showed improvement in 80% cases)
&lt;/li&gt;&lt;li&gt;Dosage: 10mg/kg per day
&lt;/li&gt;&lt;li&gt;Relative Contraindication in pts on CCB (can lead to cardiovascular collapse)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Bromocriptine:
&lt;ol&gt;&lt;li&gt;dopamine agonist to counteract central blockade
&lt;/li&gt;&lt;li&gt;Max: 40mg/day
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Amantadine:
&lt;ol&gt;&lt;li&gt;dopamine agonist and anticholinergic agent
&lt;/li&gt;&lt;li&gt;Max 400mg/day
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Consider ECT
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;Retrospective analysis: suggests pts on dantrolene +/- bromocriptine have a faster recovery (9days vs 12Days)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Neuroleptic_Malignant_Syndrome&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Woodbury Stages"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Woodbury_Stages"&gt;Woodbury Stages&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Incorporates severity of disease with treatment
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;(I-III: supportive care +/- benzos)
&lt;/li&gt;&lt;li&gt;Stage IV (Moderate NMS): All four features present
&lt;ol&gt;&lt;li&gt;TX: benzos, bromocriptine
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Stage V (Severe NMS) Tetrad with more severe hyperthermia
&lt;ol&gt;&lt;li&gt;TX: benzos, dantrolene, bromocriptine, consider ECT
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Neuroleptic_Malignant_Syndrome&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Complications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Complications"&gt;Complications&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;arrhthmias, renal failure, seizures, pneumonia, DIC, death
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Neuroleptic_Malignant_Syndrome&amp;amp;action=edit&amp;amp;section=10" title="Edit section: Prognosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Prognosis"&gt;Prognosis&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Most resolve within 2 weeks, without long term sequelae
&lt;/p&gt;&lt;p&gt;Poorer prognosis in those with high peak and/or long duration of hyperthermia
&lt;/p&gt;&lt;p&gt;Mortality of 10-20%
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Neuroleptic_Malignant_Syndrome&amp;amp;action=edit&amp;amp;section=11" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Pani 6/2009 based on Rosen's
&lt;/p&gt;



</content><folder>Airway/Resus</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="neutropenic_enterocolitis_(typhlitis)"><name>Neutropenic Enterocolitis (Typhlitis)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Definition"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Definition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Pathophysiology"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Pathophysiology&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Workup"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Workup&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Prognosis"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Prognosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Neutropenic_Enterocolitis_(Typhlitis)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Definition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Definition"&gt;Definition&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Necrosis of bowel wall 2/2  microbial invasion
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Neutropenic_Enterocolitis_(Typhlitis)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Pathophysiology"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Pathophysiology"&gt;Pathophysiology&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Usually involves the CECUM
&lt;/li&gt;&lt;li&gt;Typically occurs 10-14d after cytotoxic therapy
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Neutropenic_Enterocolitis_(Typhlitis)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Fever
&lt;/li&gt;&lt;li&gt;RLQ pain
&lt;/li&gt;&lt;li&gt;Nausea
&lt;/li&gt;&lt;li&gt;Vomiting
&lt;/li&gt;&lt;li&gt;(mimics appy)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Neutropenic_Enterocolitis_(Typhlitis)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Workup"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Workup"&gt;Workup&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;CT A/P: cecal distention and wall thickening
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Neutropenic_Enterocolitis_(Typhlitis)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Bowel rest
&lt;/li&gt;&lt;li&gt;NG suction
&lt;/li&gt;&lt;li&gt;IVF
&lt;/li&gt;&lt;li&gt;Broad spec abx
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Neutropenic_Enterocolitis_(Typhlitis)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Surgical consultation (right hemicolectomy)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Neutropenic_Enterocolitis_(Typhlitis)&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Prognosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Prognosis"&gt;Prognosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Mortality 50%
&lt;/p&gt;



</content><folder>GI</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="neutropenic_fever"><name>Neutropenic Fever</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#Definition"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;Definition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Pathophysiology"&gt;&lt;span class="tocnumber"&gt;1.2&lt;/span&gt; &lt;span class="toctext"&gt;Pathophysiology&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Common_Causes"&gt;&lt;span class="tocnumber"&gt;1.3&lt;/span&gt; &lt;span class="toctext"&gt;Common Causes&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-8"&gt;&lt;a href="#High-Risk.2FSpecial_Infections"&gt;&lt;span class="tocnumber"&gt;4.1&lt;/span&gt; &lt;span class="toctext"&gt;High-Risk/Special Infections&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-10"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-11"&gt;&lt;a href="#Patient_Clinical_Factor_Score"&gt;&lt;span class="tocnumber"&gt;6.1&lt;/span&gt; &lt;span class="toctext"&gt;Patient Clinical Factor Score&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-12"&gt;&lt;a href="#Out_Patient"&gt;&lt;span class="tocnumber"&gt;6.2&lt;/span&gt; &lt;span class="toctext"&gt;Out Patient&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-13"&gt;&lt;a href="#In_Patient"&gt;&lt;span class="tocnumber"&gt;6.3&lt;/span&gt; &lt;span class="toctext"&gt;In Patient&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-14"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Neutropenic_Fever&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Neutropenic_Fever&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Definition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Definition"&gt;Definition&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;ANC
&lt;ol&gt;&lt;li&gt;&amp;lt; 500 cells/&#181;L (severe)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;OR, &amp;lt;1000 cells/&#181;L (moderate) with a predicted nadir of ANC &amp;lt; 500 cells/&#181;L in 48h
&lt;/li&gt;&lt;li&gt;AND
&lt;ol&gt;&lt;li&gt;Fever &#8805; 38.3&#730;C (101&#730;F) once
&lt;/li&gt;&lt;li&gt;OR, Sustained temp &#8805; 38&#730;C (100.4&#730;F) for &amp;gt; 1h
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Neutropenic_Fever&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Pathophysiology"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Pathophysiology"&gt;Pathophysiology&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Nadir usually occurs 7-10d after chemo
&lt;/li&gt;&lt;li&gt;Duration of neutropenia depends on type of cancer treatment
&lt;ol&gt;&lt;li&gt;Solid tumor Rx: ~&amp;lt;5d
&lt;/li&gt;&lt;li&gt;Hematologic malignancies: ~14d or longer
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Leukemias, lymphomas + chemo most commonly associated with neutropenia
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Neutropenic_Fever&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Common Causes"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Common_Causes"&gt;Common Causes&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Definitive cause only found in 30%
&lt;/li&gt;&lt;li&gt;Endogenous Flora 80%
&lt;ol&gt;&lt;li&gt;E Coli, Enterobacter, anaerobes
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Skin
&lt;ol&gt;&lt;li&gt;Staph, strep
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Respiratory tract
&lt;ol&gt;&lt;li&gt;Step pneumo, Klebsiella, Corynebacterium, Pseudomonas
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Other
&lt;ol&gt;&lt;li&gt;C dif, Mycobacterium, Candida, Aspergillus
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Neutropenic_Fever&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Classic manifestations of infxn NOT seen
&lt;/li&gt;&lt;li&gt;Check skin, mucosa, sinuses, indwelling cath sites CAREFULLY
&lt;ol&gt;&lt;li&gt;mild erythema, slight erosion in oropharynx or perianal area
&lt;/li&gt;&lt;li&gt;AVOID DRE
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Neutropenic_Fever&amp;amp;action=edit&amp;amp;section=6" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Transfusion reaction
&lt;/li&gt;&lt;li&gt;Medication allergies and toxicities
&lt;/li&gt;&lt;li&gt;Tumor-related fever
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Neutropenic_Fever&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;AVOID rectal temp
&lt;/li&gt;&lt;li&gt;CBC with dif
&lt;/li&gt;&lt;li&gt;Chem 10
&lt;/li&gt;&lt;li&gt;LFTs
&lt;/li&gt;&lt;li&gt;UA (may not show WBCs or leuk esterase given neutropenia), UCx
&lt;/li&gt;&lt;li&gt;Sputum gram stain and Cx
&lt;/li&gt;&lt;li&gt;BCx x 2 (20-30cc blood (adult) or 1-5cc (child); may take both samples from central venous catheter)
&lt;/li&gt;&lt;li&gt;Cx any indwelling catheters
&lt;/li&gt;&lt;li&gt;LP (if neuro abnl or suspicious)
&lt;/li&gt;&lt;li&gt;Site-specific specimens
&lt;ol&gt;&lt;li&gt;nasopharyngeal wash in pts with UR (RSV, influenza)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Stool (if indicated)
&lt;ol&gt;&lt;li&gt;C dif
&lt;/li&gt;&lt;li&gt;O&amp;amp;P
&lt;/li&gt;&lt;li&gt;Cx
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;CXR
&lt;/li&gt;&lt;li&gt;CT if necessary
&lt;ol&gt;&lt;li&gt;Sinuses
&lt;/li&gt;&lt;li&gt;Chest
&lt;/li&gt;&lt;li&gt;A/P
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Neutropenic_Fever&amp;amp;action=edit&amp;amp;section=8" title="Edit section: High-Risk/Special Infections"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="High-Risk.2FSpecial_Infections"&gt;High-Risk/Special Infections&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Neutropenic Enterocolitis (Typhlitis) 
&lt;/li&gt;&lt;li&gt;Zygomycosis (see Mucormycosis)
&lt;/li&gt;&lt;li&gt;Hepatosplenocandidiasis
&lt;ol&gt;&lt;li&gt;after neutropenic fever resolves and ANC has come up allowing abcess formation
&lt;/li&gt;&lt;li&gt;Rx ampho b
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Neutropenic_Fever&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Even if afebrile, if si/sy of infxn, TREAT
&lt;/p&gt;&lt;p&gt;3rd or 4th gen cephalosporin (cefepime 2g or ceftazidime 2g)
&lt;/p&gt;&lt;p&gt;OR
&lt;/p&gt;&lt;p&gt;Carbapenem (imipenem 500mg or meropenem 1g)
&lt;/p&gt;&lt;p&gt;OR
&lt;/p&gt;&lt;p&gt;Zosyn 4.5g
&lt;/p&gt;&lt;p&gt;+/-
&lt;/p&gt;&lt;p&gt;Aminoglycoside (gent 2-5mg/kg, amikacin)
&lt;/p&gt;&lt;p&gt;OR
&lt;/p&gt;&lt;p&gt;Antipseudomonal fluoroquinolone (moxi, levo, cipro)
&lt;/p&gt;&lt;p&gt;+/-
&lt;/p&gt;&lt;p&gt;Vancomycin 1g (alternative: quinupristin/dalfopristin, daptomycin, linezolid)
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;hypotension
&lt;/li&gt;&lt;li&gt;Grm + Bcx
&lt;/li&gt;&lt;li&gt;Hx of MRSA or Bactrim resistant pneumococci
&lt;/li&gt;&lt;li&gt;Prior ppx with fluoroquinolone or Bactrim
&lt;/li&gt;&lt;li&gt;Catheter related infxn
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;Add Amphotericin B 0.5-1 mg/kg qd if fever &amp;gt;72 h or candida in esophagus, urine or stool
&lt;/p&gt;&lt;p&gt;Add anaerobic coverage (clindamycin, flagyl) if peritonitis or abdominal symptomatology occurs
&lt;/p&gt;&lt;p&gt;If PMNs expected to be &#8804; 100/mm3 for one week, consider G-CSF/GM-CSF
&lt;/p&gt;&lt;p&gt;-Unless pt has hx of leukemia, in which case G-CSF is generally contraindicated
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
^No current evidence supports antifungals or antivirals if fever alone; after 4-7 days may need to start either/both
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Neutropenic_Fever&amp;amp;action=edit&amp;amp;section=10" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Low Risk patients can be safely d/c'd home using the Multinational Association for Supportive Care in Cancer (MASCC) risk index:
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Neutropenic_Fever&amp;amp;action=edit&amp;amp;section=11" title="Edit section: Patient Clinical Factor Score"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Patient_Clinical_Factor_Score"&gt;Patient Clinical Factor Score&lt;/span&gt;&lt;/h3&gt;
&lt;table width="340" border="1"&gt;
&lt;tr&gt;
&lt;td&gt; Patient Clinical Factor
&lt;/td&gt;&lt;td&gt;Score
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;
&lt;p&gt;Severity of illness:
&lt;/p&gt;&lt;p&gt;no symptoms or mild symptoms
&lt;/p&gt;&lt;p&gt;moderate symptoms
&lt;/p&gt;
&lt;/td&gt;&lt;td&gt;
&lt;p&gt;5
&lt;/p&gt;&lt;p&gt;3
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; No hypotension&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 5&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; No chronic obstructive pulmonary disease&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 4&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Solid tumor or no fungal infxn&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 4&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; No dehydration&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 3&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Outpt at onset of fever&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 3&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Age &amp;lt; 60yo&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 2&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;p&gt;&#8805;21 pt = low risk for SBI
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Neutropenic_Fever&amp;amp;action=edit&amp;amp;section=12" title="Edit section: Out Patient"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Out_Patient"&gt;Out Patient&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Home with close onc f/u and abx:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Cipro 500 Q8H
&lt;/li&gt;&lt;li&gt;AND, Augmentin 500 Q8H
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Neutropenic_Fever&amp;amp;action=edit&amp;amp;section=13" title="Edit section: In Patient"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="In_Patient"&gt;In Patient&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;ADMIT all other patients (majority) 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Neutropenic_Fever&amp;amp;action=edit&amp;amp;section=14" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Pani 6/09, DeBonis 3/10
&lt;/p&gt;&lt;p&gt;Reference: LLSA 2009; Halfdanarson Onc Emergencies Mayo Clin Proc June 2006; EMP
&lt;/p&gt;



</content><folder>Heme/Onc</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="newborn_resuscitation"><name>Newborn Resuscitation</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Consider_DDx_.28esp_if_older_neonate.29"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Consider DDx (esp if older neonate)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Equipment"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Equipment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Newborn_Resuscitation&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;NEWBORN VITAL SIGNS
&lt;/p&gt;&lt;p&gt;HR RR SBP*
&lt;/p&gt;&lt;p&gt;&amp;gt;100 40-80 60-70
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;&amp;lt;3kg (premature) SBP = 40-60
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Newborn_Resuscitation&amp;amp;action=edit&amp;amp;section=2" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;COMMON NEWBORN PROBLEMS
&lt;/p&gt;&lt;p&gt;1) Hypoxia
&lt;/p&gt;
&lt;pre&gt;    a) Primary apnea
&lt;/pre&gt;
&lt;pre&gt;    b) Secondary apnea
&lt;/pre&gt;
&lt;p&gt;2) Hypothermia
&lt;/p&gt;&lt;p&gt;3) Hypoglycemia
&lt;/p&gt;&lt;p&gt;4) Meconium asp
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Newborn_Resuscitation&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Consider DDx (esp if older neonate)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Consider_DDx_.28esp_if_older_neonate.29"&gt;Consider DDx (esp if older neonate)&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1)  Sepsis
&lt;/p&gt;&lt;p&gt;2)   Congenital Heart Dz (PGE)
&lt;/p&gt;&lt;p&gt;3)  Inborn  Error of Metabolism (lactate) 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Newborn_Resuscitation&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;ASSESSMENT TRIAD
&lt;/p&gt;&lt;p&gt;1) Respiration- adequacy, difficulty
&lt;/p&gt;&lt;p&gt;2) HR &amp;gt;100, umbilical
&lt;/p&gt;&lt;p&gt;3) Color
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Newborn_Resuscitation&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;RESUSCITATION INVERSE PYRAMID
&lt;/p&gt;&lt;p&gt;1) Dry, warm, position, suction, stimulate
&lt;/p&gt;
&lt;pre&gt;    a) position: neutral
&lt;/pre&gt;
&lt;pre&gt;    (towel --&amp;gt; thorax)
&lt;/pre&gt;
&lt;pre&gt;    b) suction: oral then nasal
&lt;/pre&gt;
&lt;pre&gt;    c) stim: along spine or feet
&lt;/pre&gt;
&lt;pre&gt;    d) check glucose*
&lt;/pre&gt;
&lt;p&gt;2) Oxygen (use liberally)
&lt;/p&gt;&lt;p&gt;3) Ventilate (40-60 breaths/min @ 20-25 cmH20)
&lt;/p&gt;
&lt;pre&gt;    a) BVM (indications)
&lt;/pre&gt;
&lt;pre&gt;         i) Apnea/gasping
&lt;/pre&gt;
&lt;pre&gt;         ii) HR &amp;lt;100/min
&lt;/pre&gt;
&lt;pre&gt;         iii) Persistent cyanosis
&lt;/pre&gt;
&lt;pre&gt;    b) ET** (indications)
&lt;/pre&gt;
&lt;pre&gt;    ETT size = Gest age (wks) / 10
&lt;/pre&gt;
&lt;pre&gt;         i) BVM ineffect after 30s
&lt;/pre&gt;
&lt;pre&gt;         ii) Suction meconium**
&lt;/pre&gt;
&lt;p&gt;4) Chest compressions (indications)
&lt;/p&gt;
&lt;pre&gt;    a) HR &amp;lt;60 after above x 30 sec
&lt;/pre&gt;
&lt;pre&gt;         i) 120/min (resp 3:1)
&lt;/pre&gt;
&lt;pre&gt;         ii) Stop when HR &amp;gt; 60
&lt;/pre&gt;
&lt;p&gt;5) Medications****
&lt;/p&gt;&lt;p&gt;(if HR &amp;lt;60 despite above)
&lt;/p&gt;
&lt;pre&gt;    a) Epi (0.01-0.03 mg/kg)
&lt;/pre&gt;
&lt;pre&gt;    b) D10W (4 mL/kg = 0.2gm/kg)
&lt;/pre&gt;
&lt;pre&gt;    c) Nalaxone (0.4 mg/kg)
&lt;/pre&gt;
&lt;pre&gt;         i) For opiod use &amp;lt;4hrs
&lt;/pre&gt;
&lt;pre&gt;    d) NS (10 mL/kg boluses)
&lt;/pre&gt;
&lt;pre&gt;    e) Dopamine gtt
&lt;/pre&gt;
&lt;pre&gt;    (5-20 mcg/kg/min)
&lt;/pre&gt;
&lt;pre&gt;    f) NaHCO3 - prolonged resus
&lt;/pre&gt;
&lt;pre&gt;    (1-2 meQ/kg)
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;HYPOGLYCEMIA (give D10W)
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&amp;gt;2.5 kg = &amp;lt;40 mg/dL
&lt;/p&gt;&lt;p&gt;&amp;lt;2.5 kg = &amp;lt;30 mg/dL
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;&lt;ul&gt;&lt;li&gt;MECONIUM SUCTIONING INDICATIONS
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;Meconium + --&amp;gt;
&lt;/p&gt;&lt;p&gt;1) absent/depressed resp
&lt;/p&gt;&lt;p&gt;2) poor muscle tone
&lt;/p&gt;&lt;p&gt;3) HR &amp;lt;100
&lt;/p&gt;&lt;p&gt;(2 passes w/ ET + suction)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;&lt;ul&gt;&lt;li&gt;&lt;ul&gt;&lt;li&gt;NEWBORN VENT SETTINGS
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;Pressure Cycled: RR 30+, PIP 20/2 (Preemie 15/2)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;&lt;ul&gt;&lt;li&gt;&lt;ul&gt;&lt;li&gt;&lt;ul&gt;&lt;li&gt;UMBILICAL VEIN ACCESS
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;1) Cut cord 1 &amp;amp; 1/2 inch
&lt;/p&gt;&lt;p&gt;2) 5F cath, 3-way stopcock
&lt;/p&gt;&lt;p&gt;3) Feed the 'mouth'
&lt;/p&gt;&lt;p&gt;3) Place until get blood flow (-4 cm)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;DETERIORATION AFTER INTUBATION
&lt;/p&gt;&lt;p&gt;D - Displacement (flexion pushes in, exten pulls it out)
&lt;/p&gt;&lt;p&gt;O - Obstruction of tube
&lt;/p&gt;&lt;p&gt;P - PTX
&lt;/p&gt;&lt;p&gt;E - Equipment failure
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;PREEMIE (&amp;lt;23-24 wks or 500 gms)
&lt;/p&gt;&lt;p&gt;1) rapid volume may inc risk of IVH
&lt;/p&gt;&lt;p&gt;2) usually ETT immed
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;GROUP B SEPSIS
&lt;/p&gt;&lt;p&gt;1) Early (1dy-1wk)
&lt;/p&gt;
&lt;pre&gt;    a) p/w PNA, meningitis, sepsis
&lt;/pre&gt;
&lt;pre&gt;    b) risk factors
&lt;/pre&gt;
&lt;pre&gt;         i) premature
&lt;/pre&gt;
&lt;pre&gt;         ii) maternal fever
&lt;/pre&gt;
&lt;pre&gt;         iii) PROM&amp;gt; 18 hrs
&lt;/pre&gt;
&lt;pre&gt;         iv) low wt.
&lt;/pre&gt;
&lt;p&gt;2) Late (2-4 wks)
&lt;/p&gt;
&lt;pre&gt;    a) p/w meningitis
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;APGAR: 0 1 2
&lt;/p&gt;&lt;p&gt;HR absent &amp;lt;100 &amp;gt;100
&lt;/p&gt;&lt;p&gt;Resp absent slow,irr good
&lt;/p&gt;&lt;p&gt;Tone limp some flex active
&lt;/p&gt;&lt;p&gt;Color blue,pale blue ext pink
&lt;/p&gt;&lt;p&gt;Reflex no resp grimace cough
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Newborn_Resuscitation&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Equipment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Equipment"&gt;Equipment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- blankets, warmer, umbilical clamps
&lt;/p&gt;&lt;p&gt;- Bulb suction or wall suction
&lt;/p&gt;&lt;p&gt;- Catheters (5F,8F,10F)
&lt;/p&gt;&lt;p&gt;- Meconium aspirators
&lt;/p&gt;&lt;p&gt;- BVM
&lt;/p&gt;&lt;p&gt;- ETT 2.5-4.0 w/ stylets
&lt;/p&gt;&lt;p&gt;- Blades 0 &amp;amp; 1
&lt;/p&gt;&lt;p&gt;- IV catheters (22 &amp;amp; 24 g)
&lt;/p&gt;&lt;p&gt;- Umbilical caths (3.5 F &amp;amp; 5F)
&lt;/p&gt;&lt;p&gt;- syringes, 3 way stop cocks
&lt;/p&gt;&lt;p&gt;- Epi 1:10,000
&lt;/p&gt;&lt;p&gt;- Naloxone 0.4 mg/ml or 1 mg/ml
&lt;/p&gt;&lt;p&gt;- NaHCO3 4.2% or 8.4%
&lt;/p&gt;&lt;p&gt;- NS &amp;amp; D10W
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Newborn_Resuscitation&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;2/26/05 DONALDSON (adapted from Rosen, Lampe, Young)
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="normal_labor_and_delivery"><name>Normal Labor and Delivery</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Normal_Labor_and_Delivery&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Physical Examination"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Physical_Examination"&gt;Physical Examination &lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Normal_Labor_and_Delivery&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Digital Examination of the Vagina"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Digital_Examination_of_the_Vagina"&gt;Digital Examination of the Vagina&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Cervical Dilatation
&lt;ol&gt;&lt;li&gt; 0 cm (closed/fingertip) to 10 cm (complete/fully dilated)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Effacement
&lt;ol&gt;&lt;li&gt; assessment of the cervical length
&lt;/li&gt;&lt;li&gt; percentage of normal 3-4 cm long cervix 
&lt;/li&gt;&lt;li&gt; 4cm cervix = 0%; 0cm (thin) cervix = 100%
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Station (-5 to +5)
&lt;ol&gt;&lt;li&gt; (distance of the presenting body relative to the maternal ischial spines)
&lt;ol&gt;&lt;li&gt; -3 = beginning of second stage of labor
&lt;/li&gt;&lt;li&gt; 0 = in line with the plane of the maternal ischial spines
&lt;/li&gt;&lt;li&gt; +3 = impending delivery
&lt;/li&gt;&lt;li&gt; +4 to +5 = crowning
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;




</content><folder>OB/GYN</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="nursemaid's_elbow"><name>Nursemaid's Elbow</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Pathophysiology"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Pathophysiology&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Diagnosis.2FPresentation"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis/Presentation&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Nursemaid%27s_Elbow&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Pathophysiology"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Pathophysiology"&gt;Pathophysiology&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Transverse tear in annular ligament with entrapment of annular ligament between radial head and capitellum
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Nursemaid%27s_Elbow&amp;amp;action=edit&amp;amp;section=2" title="Edit section: "&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id=""&gt; &lt;/span&gt;&lt;/h2&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Nursemaid%27s_Elbow&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Diagnosis/Presentation"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis.2FPresentation"&gt;Diagnosis/Presentation&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-Age 1y-5y (peak 2y-3y) d/t swinging pt by arm
&lt;/p&gt;&lt;p&gt;-Sudden onset
&lt;/p&gt;&lt;p&gt;-Absence of edema, focal tenderness, or bruising
&lt;/p&gt;&lt;p&gt;-ANY swelling/bruising NOT typical so XR!
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Nursemaid%27s_Elbow&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-Pronation alone (93% successful)
&lt;/p&gt;&lt;p&gt;-Extend elbow then quickly supinate &amp;amp; flex (84%)
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;if back in child will move arm again in &amp;lt;30 min
&lt;/li&gt;&lt;/ul&gt;




</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="nutritional_needs"><name>Nutritional Needs</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#IBW"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;IBW&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Kcal_Needs.28kcal.2Fkg.29:"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Kcal Needs(kcal/kg):&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Protein_Needs_.28g.2Fkg.29"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Protein Needs (g/kg)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Fluid_Needs"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Fluid Needs&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Sedated_Patients"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Sedated Patients&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Nutritional_Needs&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Nutritional_Needs&amp;amp;action=edit&amp;amp;section=2" title="Edit section: IBW"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="IBW"&gt;IBW&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;male= 106 lbs + 6lbs for each inch over 60 +/- 10%.
&lt;/li&gt;&lt;li&gt;female=100 plus 5 lbs for each inch over 60 +/- 10%
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;adjusted body wt.=(actual-IBW) x.25 + IBW. Use for people whose abw is greater than 120 percent ibw ...or BMI greater than 25.
&lt;/p&gt;&lt;p&gt;Kcal needs is based on adjusted body weight, but protein needs is based on ideal body weight.
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Nutritional_Needs&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Kcal Needs(kcal/kg):"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Kcal_Needs.28kcal.2Fkg.29:"&gt;Kcal Needs(kcal/kg):&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;basal m25 f20
&lt;/li&gt;&lt;li&gt;normal weight maintenance: m30 f25.
&lt;/li&gt;&lt;li&gt;Ventilated m25-30 f same.
&lt;/li&gt;&lt;li&gt;Stress m30-35 f same.
&lt;/li&gt;&lt;li&gt;trauma/sepsis m35-40 f same
&lt;/li&gt;&lt;li&gt;extremely catabolic 40-45
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Nutritional_Needs&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Protein Needs (g/kg)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Protein_Needs_.28g.2Fkg.29"&gt;Protein Needs (g/kg)&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;maintenance .8
&lt;/li&gt;&lt;li&gt;hospitalized 1-1.5
&lt;/li&gt;&lt;li&gt;trauma/stress/sepsis 1.2-2
&lt;/li&gt;&lt;li&gt;closed head injury 1.4-2.2
&lt;/li&gt;&lt;li&gt;renal failure (without dialysis) .8^
&lt;/li&gt;&lt;li&gt;renal failure (with dialysis) 1.2-1.5
&lt;/li&gt;&lt;li&gt;liver disease w/o encephalopathy 1.2-2.0
&lt;/li&gt;&lt;li&gt;hepatic encephalopathy .6-.8^
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;^ may be greater with compounding medical conditions
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Nutritional_Needs&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Fluid Needs"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Fluid_Needs"&gt;Fluid Needs&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;adults 30 cc/kg
&lt;/li&gt;&lt;li&gt;elderly 25cc/kg
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Nutritional_Needs&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Sedated Patients"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Sedated_Patients"&gt;Sedated Patients&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;reduction in metabolic rate by as much as 30%.
&lt;/li&gt;&lt;li&gt;propofol gives 1.1Kcal/cc
&lt;/li&gt;&lt;li&gt;patients getting po dilantin should have their tube feeds held 1 hour prior to and 1 hour after it is administered.
&lt;/li&gt;&lt;/ol&gt;




</content><folder>FEN</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="observation_care_documents"><name>Observation Care Documents</name><content>&lt;p&gt;- obs performed to determine need for admit
&lt;/p&gt;&lt;p&gt;- discharge note to summarize obs findings
&lt;/p&gt;&lt;p&gt;- need past-social-and- FAMILY Hx
&lt;/p&gt;&lt;p&gt;- need start and stop time for obs
&lt;/p&gt;&lt;p&gt;- obs start before and end p MN has highest payment
&lt;/p&gt;



</content><folder>Policy</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="occupational_exposure"><name>Occupational Exposure</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#HIV"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;HIV&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Hep_B"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Hep B&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Hep_C"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Hep C&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Occupational_Exposure&amp;amp;action=edit&amp;amp;section=1" title="Edit section: HIV"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="HIV"&gt;HIV&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;See "HIV (Occupational)"
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Occupational_Exposure&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Hep B"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Hep_B"&gt;Hep B&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; risk of infc 2- 30% after needle stick
&lt;/li&gt;&lt;li&gt; can survive on dried blood for 1 wk
&lt;/li&gt;&lt;li&gt; found in all fluids but highest conc in blood and therefore highest risk with blood
&lt;/li&gt;&lt;li&gt; hep b surface antibodies confers life long immunity
&lt;/li&gt;&lt;li&gt; don't need to test pt or source if pt certain fully/ successfully immunized- antibodies &amp;gt; 10 IU at some time
&lt;/li&gt;&lt;li&gt; if pt not successfully immunized, give hep b immune globulin
&lt;/li&gt;&lt;li&gt; failed 3 shots/ 1 series- give hep booster and immune globulin x 2 doses over 1 mo
&lt;/li&gt;&lt;li&gt; failed 6 shots/ 2 series- give sequential immune globulin
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;Patient Unvaccinated, Source Pos
--&amp;gt; HBIG + vaccine
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Occupational_Exposure&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Hep C"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Hep_C"&gt;Hep C&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; no prophylaxsis
&lt;/li&gt;&lt;li&gt; no interferon, no antivirals, no globulin
&lt;/li&gt;&lt;li&gt; not xmitted efficiently through needle stick- 2% rate
&lt;/li&gt;&lt;li&gt; get basline hcv test and ALT
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;Post Exp Viral Hep Counseling
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt; can still breast feed
&lt;/li&gt;&lt;li&gt; no organ/ blood donation
&lt;/li&gt;&lt;li&gt; no worry about modifiying sex pattern or becoming preg
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;www.needlestick.mednet.ucla.edu
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Occupational_Exposure&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;6/06 MISTRY
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Occupational_Exposure&amp;amp;action=edit&amp;amp;section=5" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;See "HIV (Occupational)"
&lt;/p&gt;



</content><folder>ID</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="opiod_od"><name>Opiod OD</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Opiod_OD&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Narcan (initial Dose 0.4 to 2mg) 
&lt;/p&gt;&lt;p&gt;Caution in chronic users, who are otherwise hemodynamically stable
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Narcan gtt started at 2/3 the dose first required to awaken the patient per hour
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Opiod_OD&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;PANI 9/09 (Adapted from Donaldson, Katz, EP Monthly)
&lt;/p&gt;



</content><folder>Tox</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="opiod_withdrawl"><name>Opiod Withdrawl</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Opiod_Withdrawl&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Opiod_Withdrawl&amp;amp;action=edit&amp;amp;section=2" title="Edit section: "&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id=""&gt; &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Opiod substitute meds
&lt;/p&gt;&lt;p&gt;-    methadone or buprenorphine- better than clonidine
&lt;/p&gt;&lt;p&gt;-    methadone wd worse and lasts longer than buprenorphine wd
&lt;/p&gt;&lt;p&gt;-    reduce methadone dose by 3% each week- less dropout but still only 40% achieve abstinence
&lt;/p&gt;&lt;p&gt;-    long taper vs short taper has no better success
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Non Opiod Meds
&lt;/p&gt;&lt;p&gt;-    opioids agonistic to mu opioids receptor where it inhibits cyclic amp
&lt;/p&gt;&lt;p&gt;-    in wd, adrenergic system revved up
&lt;/p&gt;&lt;p&gt;-    clonidine or lofexidine suppress autonimic stimulation and sxs
&lt;/p&gt;&lt;p&gt;-    if insomnia or muscle cramps give benzo instead of clonidine
&lt;/p&gt;&lt;p&gt;-    lofexidine is alternative to clonidine- less hypotnsin, less drop out, faster resolution of wd sxs than clonidine
&lt;/p&gt;&lt;p&gt;-    Optimal heroin withdrawal- buprenorphine taper than stop and then lofexidine or clonidine for 5 days
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Opiod_Withdrawl&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-    like bad flu
&lt;/p&gt;&lt;p&gt;-    dilated pupils, tearing, yawning, sneezing, A/n/v,d,
&lt;/p&gt;&lt;p&gt;-    not sz or dt
&lt;/p&gt;&lt;p&gt;-    heroin- peak 36- 72 hr and last 7- 10d
&lt;/p&gt;&lt;p&gt;-    methadone- peak 2-96 hrs and last 14 days or longer
&lt;/p&gt;



</content><folder>Tox</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="optic_neuritis"><name>Optic Neuritis</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Optic_Neuritis&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;an inflammatory, demyelinating condition highly associated with multiple sclerosis (MS)
&lt;/li&gt;&lt;li&gt;presenting feature of MS in 15 to 20 percent of patients and occurs in 50 percent at some time during the course of their illness
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Optic_Neuritis&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;acute, usually monocular, visual loss-usually monocular (90%)
&lt;/li&gt;&lt;li&gt;vision loss (over hours to days; peaking within 1-2 wks)
&lt;/li&gt;&lt;li&gt;eye pain (92%), often worsened with eye movement
&lt;/li&gt;&lt;li&gt;afferent pupillary defect
&lt;/li&gt;&lt;li&gt;visual field defect (typically central scotoma)
&lt;/li&gt;&lt;li&gt;papillitis (33%) with hyperemia and swelling of the disk, blurring of disk margins, and distended veins
&lt;/li&gt;&lt;li&gt;photopsias (30%) (flickering or flashes of light) often precipitated with eye movement
&lt;/li&gt;&lt;li&gt;loss of color of vision out of proportion to the loss of visual acuity is specific 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Optic_Neuritis&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Optic_Neuritis&amp;amp;action=edit&amp;amp;section=4" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Optic_Neuritis&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Optic_Neuritis&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Optic_Neuritis&amp;amp;action=edit&amp;amp;section=7" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Neuro: Multiple Scleritis
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Optic_Neuritis&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;KajiQuestions
&lt;/p&gt;



</content><folder>Neuro</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="orbital_blowout_fx"><name>Orbital Blowout Fx</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Initial_Assessment"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Initial Assessment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#DDX"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;DDX&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Orbital_CT_indicated_for"&gt;&lt;span class="tocnumber"&gt;3.1&lt;/span&gt; &lt;span class="toctext"&gt;Orbital CT indicated for&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Orbital_Blowout_Fx&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Initial Assessment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Initial_Assessment"&gt;Initial Assessment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Eye
&lt;ol&gt;&lt;li&gt; Acuity, extraocular movements
&lt;/li&gt;&lt;li&gt; Blurry, double, or decreased vision?
&lt;/li&gt;&lt;li&gt; Pain with EOM?
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Pupil
&lt;ol&gt;&lt;li&gt; Reactivity, size, shape
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Globe
&lt;ol&gt;&lt;li&gt; Proptosis or enophthalmos?
&lt;/li&gt;&lt;li&gt; Increased intercanthal distance?
&lt;/li&gt;&lt;li&gt; Extrusion of intraocular contents?
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Orbit
&lt;ol&gt;&lt;li&gt; Crepitus from fracture into sinuses?
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Orbital_Blowout_Fx&amp;amp;action=edit&amp;amp;section=2" title="Edit section: DDX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX"&gt;DDX&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Orbital Hematoma
&lt;ol&gt;&lt;li&gt; Proptosis, diffuse pain
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Ruptured Globe
&lt;ol&gt;&lt;li&gt; Tear-shaped pupil
&lt;/li&gt;&lt;li&gt; Extrusion of intraocular content
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Orbital zygomatic fracture
&lt;ol&gt;&lt;li&gt; Most common
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Nasoethmoid fracture
&lt;ol&gt;&lt;li&gt; Inspect for:
&lt;ol&gt;&lt;li&gt; Damage to medial canthal ligament
&lt;/li&gt;&lt;li&gt; Damage to lacrimal duct
&lt;/li&gt;&lt;li&gt; Medial rectus entrapment
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Orbial Floor fracture
&lt;ol&gt;&lt;li&gt; Inspect for:
&lt;ol&gt;&lt;li&gt; Entrapment of inferior rectus
&lt;/li&gt;&lt;li&gt; Enophthalmos
&lt;/li&gt;&lt;li&gt; Damage to infraorbital nerve
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Retinal Detachment
&lt;/li&gt;&lt;/ol&gt;
&lt;ul&gt;&lt;li&gt; Hyphema
&lt;/li&gt;&lt;li&gt; Optic Nerve Shealth Hematoma
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Orbital_Blowout_Fx&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Orbital_Blowout_Fx&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Orbital CT indicated for"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Orbital_CT_indicated_for"&gt;Orbital CT indicated for&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Evidence of fracture on exam
&lt;/li&gt;&lt;li&gt; Decreased extraocular mobility
&lt;/li&gt;&lt;li&gt; Decreased visual acuity
&lt;/li&gt;&lt;li&gt; Severe pain
&lt;/li&gt;&lt;li&gt; Unable to perform adequate exam
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;===Globe Injury
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;&lt;ol&gt;&lt;li&gt; Eye covering
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;ul&gt;&lt;li&gt; Elevate head of bed
&lt;/li&gt;&lt;li&gt; Prevent nausea/vomiting
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;Orbital Hematoma
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; Consider lateral canthotomy
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;Orbital fracture into sinus
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; Azithromycin or augmentin
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;Extraocular muscle entrapment
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; May result in oculocardiac reflex -&amp;gt; vagal symptoms* Consider release of entrapped muscle
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;Decreased extraocular movement not due to entrapment
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; Consider corticosteroids
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;Orbital blowout fractures-Water's view is 83% sensitive at detecting these. If present needs CT to eval soft tissue structures (retrobulbar hemmorhage). Surgical indications include greater tha 2mm enopthalmos and/or persistent diploplia.
&lt;/p&gt;&lt;p&gt;10-20% have ocular injury. binocular diploplia from direct muscle injury resolves in 82%, but diploplia from entrapment requires surgical repair.Malignant emphysema and/or retrobulbar hemmorhage are emergencies requiring a lateral canthotomy.
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Orbital_Blowout_Fx&amp;amp;action=edit&amp;amp;section=5" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Trauma: Maxilofacial
&lt;/p&gt;



</content><folder>Ophtho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="orbital_cellulitis"><name>Orbital Cellulitis</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#Epidemiology"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;Epidemiology&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Symptoms"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;Symptoms&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Imaging"&gt;&lt;span class="tocnumber"&gt;2.2&lt;/span&gt; &lt;span class="toctext"&gt;Imaging&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Complications"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Complications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Orbital_Cellulitis&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Orbital_Cellulitis&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Epidemiology"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Epidemiology"&gt;Epidemiology&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Sinus infection
&lt;/li&gt;&lt;li&gt;Facial skin
&lt;/li&gt;&lt;li&gt;Dental infection
&lt;/li&gt;&lt;li&gt;HIB
&lt;/li&gt;&lt;li&gt;Children
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Orbital_Cellulitis&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Orbital_Cellulitis&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Symptoms"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Symptoms"&gt;Symptoms&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Fever
&lt;/li&gt;&lt;li&gt; Ill appearance
&lt;/li&gt;&lt;li&gt; Blurred vision
&lt;/li&gt;&lt;li&gt; Proptosis
&lt;/li&gt;&lt;li&gt; Painful/limited EOM
&lt;/li&gt;&lt;li&gt; Diplopia
&lt;/li&gt;&lt;li&gt; Edema of optic disk
&lt;/li&gt;&lt;li&gt; Venous engorgement of retina
&lt;/li&gt;&lt;li&gt; Afferent Pupillary defect
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Orbital_Cellulitis&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Imaging"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Imaging"&gt;Imaging&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;CT to r/o sinusitis, subperiosteal abscess
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Orbital_Cellulitis&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Complications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Complications"&gt;Complications&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Meningitis
&lt;/li&gt;&lt;li&gt;Cavernous Venous Thrombosis
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Orbital_Cellulitis&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;IV clindamycin and ceftazidime
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Orbital_Cellulitis&amp;amp;action=edit&amp;amp;section=8" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Ophtho:  Periorbital Swelling
&lt;/p&gt;



</content><folder>ID</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="orchitis"><name>Orchitis</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Orchitis&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;rare acute infection of testis
&lt;/li&gt;&lt;li&gt;most common in prepubertal boys with viral infections (20% of patients with mumps)
&lt;ol&gt;&lt;li&gt;arises several days after onset of flu-like symptoms and parotitis in mumps patients
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;bacterial orchitis typically due to spread from epididymis: epididymo-orchitis
&lt;ol&gt;&lt;li&gt;bacterial pathogens: N. gonorrhea, c. trachomatis, E. Coli, Klebsiella, P. aeruginosa
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;presents with fever and scrotal pain
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Orchitis&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;affected testicle/scrotum: swollen, tender, erythematous
&lt;/li&gt;&lt;li&gt;testicular US shows testicular inflammation, rules out torsion, epididymitis
&lt;/li&gt;&lt;li&gt;UA: positive in epididymo-orchitis
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Orchitis&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;testicular US
&lt;/li&gt;&lt;li&gt;UA, Urine Culture, gonorrhea, chlamydia screen
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Orchitis&amp;amp;action=edit&amp;amp;section=4" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;tesicular torsion
&lt;/li&gt;&lt;li&gt;epididymitis
&lt;/li&gt;&lt;li&gt;testicular tumor
&lt;/li&gt;&lt;li&gt;mumps (or other viral) orchitis
&lt;/li&gt;&lt;li&gt;bacterial orchitis (epididymo-orchitis)
&lt;/li&gt;&lt;li&gt;lupus orchitis
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Orchitis&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;viral orchitis (mumps): supportive care, ice, elevation, analgesia. 
&lt;/li&gt;&lt;li&gt;bacterial orchitis (epididymo-orchitis):
&lt;ol&gt;&lt;li&gt;sexually transmitted (&amp;lt;35yo):
&lt;ol&gt;&lt;li&gt;ceftriaxone 250mg IM x1 or cipro 500mg PO x1 for gonorrhea
&lt;/li&gt;&lt;li&gt;doxycycline 100mg PO BID x 14 days for chlamydia
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;anal intercourse, nonsexually active, instrumentation and/or &amp;gt;35yo:
&lt;ol&gt;&lt;li&gt;cipro 500mg PO BID x 14 days OR Ofloxacin 200mg PO BID x 14 days
&lt;/li&gt;&lt;li&gt;IV: piperacillin/taxobactam 3.375g IV q6 or ampicillin/sulbactam 3g IV q6
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;treat sexual partner
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Orchitis&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;admit for signs of systemic toxicity 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Orchitis&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from Rosen's
&lt;/p&gt;



</content><folder>GU</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="organophosphates"><name>Organophosphates</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Organophosphates&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1. High dose atropine
&lt;/p&gt;
&lt;pre&gt;    -titrate to secretions
&lt;/pre&gt;
&lt;p&gt;2. Pralidoxime
&lt;/p&gt;



</content><folder>Tox</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="osmolal_or_osmolar_gap"><name>Osmolal or Osmolar Gap</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Definitions"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Definitions&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Calculations"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Calculations&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Calculated_Osm"&gt;&lt;span class="tocnumber"&gt;3.1&lt;/span&gt; &lt;span class="toctext"&gt;Calculated Osm&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Osmolal_Gap"&gt;&lt;span class="tocnumber"&gt;3.2&lt;/span&gt; &lt;span class="toctext"&gt;Osmolal Gap&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-6"&gt;&lt;a href="#Estimating_Toxic_Alcohol_Concentration"&gt;&lt;span class="tocnumber"&gt;3.3&lt;/span&gt; &lt;span class="toctext"&gt;Estimating Toxic Alcohol Concentration&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#DDX"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;DDX&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-8"&gt;&lt;a href="#Increased.29"&gt;&lt;span class="tocnumber"&gt;4.1&lt;/span&gt; &lt;span class="toctext"&gt;Increased)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Osmolal_or_Osmolar_Gap&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Definitions"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Definitions"&gt;Definitions&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Osmolarity = the total number of particles in solution per liter
&lt;/p&gt;&lt;p&gt;Osmolality = the number of particles per kilogram of solvent
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Osmolal_or_Osmolar_Gap&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Serum osmolality should be measured by the freezing-point depression method rather than by the vapor pressure method, since the latter technique will underestimate the concentrations of volatile alcohols (methanol, ethylene glycol, and isopropanol).
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Osmolal_or_Osmolar_Gap&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Calculations"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Calculations"&gt;Calculations&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Osmolal_or_Osmolar_Gap&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Calculated Osm"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Calculated_Osm"&gt;Calculated Osm&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Calculated Osm = 2 x Na = (glu/18) + (BUN/2.8) + (ethanol/4.6) + (methanol/2.6) + (ethylene glycol/5) + (acetone/5.5) + (isopropanol/5.9)
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Osmolal_or_Osmolar_Gap&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Osmolal Gap"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Osmolal_Gap"&gt;Osmolal Gap&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Osmolal Gap = measured osm - calculated osm
&lt;/p&gt;&lt;p&gt;(Normal = (-)14-10 mOsm/L)
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Osmolal_or_Osmolar_Gap&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Estimating Toxic Alcohol Concentration"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Estimating_Toxic_Alcohol_Concentration"&gt;Estimating Toxic Alcohol Concentration&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Toxic alcohol (mg/dL) = Osmolal gap x Conversion Factor
&lt;/p&gt;&lt;p&gt;^Parent compounds are responsible for the osmolar gap while their metabolites are responsible for anion gap changes
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Osmolal_or_Osmolar_Gap&amp;amp;action=edit&amp;amp;section=7" title="Edit section: DDX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX"&gt;DDX&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Osmolal_or_Osmolar_Gap&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Increased)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Increased.29"&gt;Increased)&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Alcohols
&lt;ol&gt;&lt;li&gt;methanol
&lt;/li&gt;&lt;li&gt;ethylene glycol
&lt;/li&gt;&lt;li&gt;isopropanol
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Sugar
&lt;ol&gt;&lt;li&gt;glycerol
&lt;/li&gt;&lt;li&gt;manitol
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Ketones
&lt;ol&gt;&lt;li&gt;acetone
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;




</content><folder>FEN</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="osteomyelitis"><name>Osteomyelitis</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Osteomyelitis&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;usu hematogenous spread starting @ metaphysis b/c wbc cannot exit there, minor trauma= osteo in rabbits post staph inj(x).
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;age &amp;gt;2, immunecompetent Rx for staph strep, only need bone if &amp;lt;2 b/c other causes ie e. coli
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Osteomyelitis&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;usu rubor, dolor etc at about 3-5 days, no xr changes until 10 days
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Bcx alone= org 50% of time, w/ bone &amp;amp; bcx get 70% of org!
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Order xr, cbc, crp, bcx,
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Osteomyelitis&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Rx= ancef or ox
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="otitis_externa"><name>Otitis Externa</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#Microbiology"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;Microbiology&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Risk_Factors"&gt;&lt;span class="tocnumber"&gt;1.2&lt;/span&gt; &lt;span class="toctext"&gt;Risk Factors&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Differential_Diagnosis"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Differential Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Otitis_Externa&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Otitis_Externa&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Microbiology"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Microbiology"&gt;Microbiology&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Pseudomonas
&lt;/li&gt;&lt;li&gt;staph
&lt;/li&gt;&lt;li&gt;strep
&lt;/li&gt;&lt;li&gt;anerobes
&lt;/li&gt;&lt;li&gt;Fungal infection may present after Abx tx
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Otitis_Externa&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Risk Factors"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Risk_Factors"&gt;Risk Factors&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Swimming
&lt;/li&gt;&lt;li&gt;excessive Q-tip use
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Otitis_Externa&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Otalgia
&lt;ol&gt;&lt;li&gt;Elicited by tragal pressure, pulling the auricle superiorly
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Pruritis
&lt;/li&gt;&lt;li&gt;Discharge
&lt;/li&gt;&lt;li&gt;Hearing loss-pain on gentle traction of the external ear structures 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Otitis_Externa&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Differential Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Differential_Diagnosis"&gt;Differential Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Necrotizing otitis externa
&lt;ol&gt;&lt;li&gt;Spread of infection to soft tissue, cartilage, bone of temporal region
&lt;/li&gt;&lt;li&gt;Most common in elderly, diabetic patients
&lt;/li&gt;&lt;li&gt;Granulation tissue often seen in the ear canal floor
&lt;/li&gt;&lt;li&gt;Prompt referral to ENT; treat with anti-pseudomonal agents 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Otomycosis
&lt;ol&gt;&lt;li&gt;Pts complain more of itching than pain
&lt;/li&gt;&lt;li&gt;Characteristic apperance on exam; like mold growing on spoiled food
&lt;/li&gt;&lt;li&gt;Treatment
&lt;ol&gt;&lt;li&gt;Cleaning of ear canal
&lt;/li&gt;&lt;li&gt;Topical antifungal
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Contact dermatitis
&lt;/li&gt;&lt;li&gt;Chronic suppurative otitis media
&lt;ol&gt;&lt;li&gt;Ear canal findings are usually mild compared with bacterial external otitis
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Otitis_Externa&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Clean the ear canal
&lt;ol&gt;&lt;li&gt;Cerumen wire loop or cotton swab
&lt;/li&gt;&lt;li&gt;1:1 dilution of 3% hydrogen peroxide if TM is visible and intact
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Topical antibiotic therapy
&lt;ol&gt;&lt;li&gt;Floxin Otic: 5 drops in affected ear BID x 7 days
&lt;/li&gt;&lt;li&gt;Cipro HC Otic: 3 drops in affected ear BID x 7 days 
&lt;ol&gt;&lt;li&gt;Contains hydrocortisone = faster healing
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Cortisporin Otic suspension: 4 drops TID x 7 days
&lt;ol&gt;&lt;li&gt;Avoid in pts with perforated TM 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Analgesia
&lt;ol&gt;&lt;li&gt;NSAIDs
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Avoiding promoting factors
&lt;ol&gt;&lt;li&gt;Keep ear canal dry
&lt;/li&gt;&lt;li&gt;Abstain from water sports for 7-10 days 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Follow-up
&lt;ol&gt;&lt;li&gt;1-2 weeks for pts with moderate disease 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Otitis_Externa&amp;amp;action=edit&amp;amp;section=7" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;ENT: Otitis media
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Otitis_Externa&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;UpToDate
&lt;/p&gt;



</content><folder>ENT</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="otitis_media_(peds)"><name>Otitis Media (Peds)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#_2"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Antibiotic_Choices"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Antibiotic Choices&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#_3"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Treatment_Failures"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;Treatment Failures&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;9&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-10"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;10&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Otitis_Media_(Peds)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;35-50% are caused by nontypable H inluenza
&lt;/p&gt;&lt;p&gt;25-40% are caused Streptococcus pneumonae
&lt;/p&gt;&lt;p&gt;5-10% Moraxella caterallis
&lt;/p&gt;&lt;p&gt;5-15% viruses
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Otitis_Media_(Peds)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; acute onset &amp;lt;48 hours, chronic cases should be followed by PMD as may represent differnet diagnostic entity
&lt;/li&gt;&lt;li&gt; Middle Ear Effusion: bulging TM, otorrhea, anair/fluid level behind TM, or limited or absent TM mobility
&lt;/li&gt;&lt;li&gt; Middle Ear inflammation: erythema, of the TM or otalgia, but also need above symptoms
&lt;/li&gt;&lt;li&gt; Note: Please clean ear of cerumen with 1:1 solution peroxide and water and curette
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Otitis_Media_(Peds)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: "&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id=""&gt; &lt;/span&gt;&lt;/h2&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Otitis_Media_(Peds)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Treat Pain! Acetaminophen and topical Benzocaine
&lt;/li&gt;&lt;li&gt; Narcotics not recommended because risk or respiratory depression ad altered mental status and generally not indicated unless SEVERE pain
&lt;/li&gt;&lt;li&gt; Some may be observed WITHOUT antibiotics  (meta-analysis showed 7-20 children need to be treated with abx to see benefit)
&lt;/li&gt;&lt;li&gt; Infant &amp;lt;6months: treat with abx even if uncertain of diagnosis
&lt;/li&gt;&lt;li&gt; 6 months to 2 years: only if traid present or temp 39 or above and severe otalgia
&lt;/li&gt;&lt;li&gt; Well appearing kids may be treated symptomatically if do not meet triad (this assumes reliable caregiver and prompt Peds follow up
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;if concern for perforated tympanic membrane, avoid using otic aminoglycoside solution (risk of ototoxicity). In this setting, suspension drops are safer to use. 
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Otitis_Media_(Peds)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: "&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="_2"&gt; &lt;/span&gt;&lt;/h2&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Otitis_Media_(Peds)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Antibiotic Choices"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Antibiotic_Choices"&gt;Antibiotic Choices&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Duration should be 10 days for children under 6yo
&lt;/p&gt;&lt;p&gt;Duration should be 5-7 days for older children
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; "high-dose" amoxicillin 80-90 mg/kg/day for most children
&lt;/li&gt;&lt;li&gt; If pcn allergy and not type 1 reaction may use cefdinir, cefuroxime, or cefpodoxime
&lt;/li&gt;&lt;li&gt; If pcn allergy anaphlaxis or uticaria use azithromyin, clarithromycin, ot trimethorpin-sulfamethoxazole
&lt;/li&gt;&lt;li&gt; ceftriaxone if cannot tolerate POs
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Otitis_Media_(Peds)&amp;amp;action=edit&amp;amp;section=7" title="Edit section: "&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="_3"&gt; &lt;/span&gt;&lt;/h2&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Otitis_Media_(Peds)&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Treatment Failures"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment_Failures"&gt;Treatment Failures&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; for fever and sxs &amp;gt; 72 hours after Tx begun (10%) - switch to Augmentin, Ceftriaxone IM x 3 d, Cefuroxime, Clinda.
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Otitis_Media_(Peds)&amp;amp;action=edit&amp;amp;section=9" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;ENT: Otitis Externa
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Otitis_Media_(Peds)&amp;amp;action=edit&amp;amp;section=10" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Recommendations 2004 by AAP/AAFP (apply to 2 month to 12 years)
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="p450"><name>P450</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=P450&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Coumadin
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=P450&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Avoid"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Avoid"&gt;Avoid&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Quinolones, esp levoflox
&lt;/li&gt;&lt;li&gt;Macrolides, esp erythromycin
&lt;/li&gt;&lt;li&gt;Bactrim
&lt;/li&gt;&lt;li&gt;Flagyl
&lt;/li&gt;&lt;li&gt;Nafcillin, oxacillin
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=P450&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Use"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Use"&gt;Use&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Azithro
&lt;/li&gt;&lt;li&gt;Gentamicin
&lt;/li&gt;&lt;li&gt;Cephalosporin, aminopenicillins
&lt;/li&gt;&lt;li&gt;Nitrofurantoin
&lt;/li&gt;&lt;li&gt;Clinda
&lt;/li&gt;&lt;li&gt;Vanc
&lt;/li&gt;&lt;/ol&gt;




</content><folder>Drugs</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="perc_rule"><name>PERC Rule</name><content>&lt;p&gt;Pulmonary Embolism Rule Out (PERC) Criteria
&lt;/p&gt;&lt;p&gt;If all BREATHS are present AND low suspicion for PE, no D-dimer needed:
&lt;/p&gt;&lt;p&gt;B- No blood in sputum
&lt;/p&gt;&lt;p&gt;R- room air sat &amp;gt; 95%
&lt;/p&gt;&lt;p&gt;E- No estrogen or hormone use
&lt;/p&gt;&lt;p&gt;A- Age &amp;lt; 50
&lt;/p&gt;&lt;p&gt;T- No  prior DVT or PE
&lt;/p&gt;&lt;p&gt;H- Heart rate &amp;lt; 100bpm 
&lt;/p&gt;&lt;p&gt;S- No surgery/trauma requiring hospitalization in past 4 weeks
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Note: Inclusion Criteria
&lt;/p&gt;&lt;p&gt;Use this criteria if confident in excluding PE with negative D-dimer
&lt;/p&gt;&lt;p&gt;Patient with dyspnea and PE was not felt to be the most likely Dx:
&lt;/p&gt;
&lt;pre&gt;    -very low risk group ~2% overall PE risk
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Note: Exclusion
&lt;/p&gt;&lt;p&gt;DO NOT use if negative D-dimer does not r/o PE
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Validated on 7527 patients found 96% sensitive in detecting PE
&lt;/p&gt;&lt;p&gt;0.9% had PE, 0 died when all BREATHS present
&lt;/p&gt;



</content><folder>Pulm</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="painful_eyes_with_normal_exam"><name>Painful Eyes with Normal Exam</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Painful_Eyes_with_Normal_Exam&amp;amp;action=edit&amp;amp;section=1" title="Edit section: DDX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX"&gt;DDX&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Ocular Ischemia: 2/2 carotid dz, carotid bruits, retinal hemorrhages, give ASA
&lt;/li&gt;&lt;li&gt;Optic Neuritis: APD, reduced color vision
&lt;/li&gt;&lt;li&gt;Temporal Arteritis:check esr/crp
&lt;/li&gt;&lt;li&gt;Sinusitis
&lt;/li&gt;&lt;li&gt;Neuralgia: shingles
&lt;/li&gt;&lt;li&gt;Migraine
&lt;/li&gt;&lt;li&gt;DM: CN 3/4/6 palsy
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;^CN 3 palsy: dilated pupil, ptosis (droopy eyelid) w/ HA, must consider cerebral aneurysm
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Painful_Eyes_with_Normal_Exam&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from Pani
&lt;/p&gt;



</content><folder>Ophtho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="palpitations"><name>Palpitations</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Palpitations&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Palpitations&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Palpitations&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;CBC
&lt;/li&gt;&lt;li&gt;Chem
&lt;/li&gt;&lt;li&gt;ECG
&lt;/li&gt;&lt;li&gt;CXR
&lt;/li&gt;&lt;li&gt;?Trop 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Palpitations&amp;amp;action=edit&amp;amp;section=4" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Palpitations&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Palpitations&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Palpitations&amp;amp;action=edit&amp;amp;section=7" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Cards: Atrial Fibrilation
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="pancreatitis"><name>Pancreatitis</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#Etiology"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;Etiology&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Complications"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Complications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Prognosis"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Prognosis&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-7"&gt;&lt;a href="#RANSON_CRITERIA"&gt;&lt;span class="tocnumber"&gt;5.1&lt;/span&gt; &lt;span class="toctext"&gt;RANSON CRITERIA&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-8"&gt;&lt;a href="#APACHE-II"&gt;&lt;span class="tocnumber"&gt;5.2&lt;/span&gt; &lt;span class="toctext"&gt;APACHE-II&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-10"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pancreatitis&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pancreatitis&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Etiology"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Etiology"&gt;Etiology&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; alcohol
&lt;/li&gt;&lt;li&gt; gallstone
&lt;/li&gt;&lt;li&gt; drugs- azathioprine, cisplatin, lasix, tetracycline, thiazides, sulfa
&lt;/li&gt;&lt;li&gt; hypercalcemia
&lt;/li&gt;&lt;li&gt; hyperlipidemia
&lt;/li&gt;&lt;li&gt; infection
&lt;/li&gt;&lt;li&gt; pregnancy
&lt;/li&gt;&lt;li&gt; scorpion bite
&lt;/li&gt;&lt;li&gt; trauma
&lt;/li&gt;&lt;li&gt; tumor
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pancreatitis&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Elevated lipase (more specific and sensitive than amylase)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pancreatitis&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;"Place the pancreas at rest"
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt; NPO (clears is probably ok for mild/moderate cases)
&lt;/li&gt;&lt;li&gt; IV fluids!
&lt;/li&gt;&lt;li&gt; Electrolyte repletion as needed
&lt;/li&gt;&lt;li&gt; NGT if ileus is present
&lt;/li&gt;&lt;li&gt; Consider antibiotics for established infection/ severe cases 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pancreatitis&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Complications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Complications"&gt;Complications&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Local
&lt;ol&gt;&lt;li&gt; Pseudocyst, abscess
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Systemic
&lt;ol&gt;&lt;li&gt; Cardiac dysfunction
&lt;/li&gt;&lt;li&gt; Renal failure
&lt;/li&gt;&lt;li&gt; Respiratory failure (due to phospholipase damage to surfactant/ increased cap permeability)
&lt;/li&gt;&lt;li&gt; Shock 
&lt;/li&gt;&lt;li&gt; Hypocalcemia (due to sequestration in necrotic fat)
&lt;/li&gt;&lt;li&gt; Hyperglycemia
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pancreatitis&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Prognosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Prognosis"&gt;Prognosis&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pancreatitis&amp;amp;action=edit&amp;amp;section=7" title="Edit section: RANSON CRITERIA"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="RANSON_CRITERIA"&gt;RANSON CRITERIA&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; age &amp;gt;55
&lt;/li&gt;&lt;li&gt; WBC &amp;gt; 16k
&lt;/li&gt;&lt;li&gt; glucose &amp;gt; 200
&lt;/li&gt;&lt;li&gt; LDH &amp;gt; 350
&lt;/li&gt;&lt;li&gt; AST&amp;gt; 250
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;WITHIN 48 HRS
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt; hct fall of &amp;gt; 10%
&lt;/li&gt;&lt;li&gt; bun increase &amp;gt; 5
&lt;/li&gt;&lt;li&gt; Ca++ &amp;lt; 8
&lt;/li&gt;&lt;li&gt; PO2 &amp;lt; 60
&lt;/li&gt;&lt;li&gt; base deficit &amp;gt; 4
&lt;/li&gt;&lt;li&gt; fluid seqeustration &amp;gt; 6L
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;0-2= 1% mortallity, 15% for 3-4, 40% for 5-6, 100% for 7 or more signs
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pancreatitis&amp;amp;action=edit&amp;amp;section=8" title="Edit section: APACHE-II"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="APACHE-II"&gt;APACHE-II&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Highest sensitivity and specificity in distinguishing mild from severe pancreatitis
&lt;/li&gt;&lt;li&gt; Can be used to estimate risk of hospital death at admission 
&lt;/li&gt;&lt;li&gt; &lt;a href="http://www.globalrph.com/apacheii.htm" class="external free" rel="nofollow"&gt;http://www.globalrph.com/apacheii.htm&lt;/a&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pancreatitis&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; If mild case + tolerating clears + no e/o gallbladder etiology then consider d/c home
&lt;/li&gt;&lt;li&gt; All other patients should be admitted 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pancreatitis&amp;amp;action=edit&amp;amp;section=10" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;6/06 MISTRY
&lt;/p&gt;&lt;p&gt;Harwood-Nuss
&lt;/p&gt;



</content><folder>GI</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="paracentesis"><name>Paracentesis</name><content>&lt;p&gt;SBP
&lt;/p&gt;&lt;p&gt;1) &amp;gt;500 WBC or &amp;gt;250 PMNs
&lt;/p&gt;&lt;p&gt;or
&lt;/p&gt;&lt;p&gt;2) Positive gm stain (single microbe)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;CONSIDER PERITONITIS (eg. perf appy, chole)
&lt;/p&gt;&lt;p&gt;Any:
&lt;/p&gt;&lt;p&gt;1) &amp;gt;10,000 WBC
&lt;/p&gt;&lt;p&gt;2) Polymicrobial gm stain
&lt;/p&gt;&lt;p&gt;3) Total protein &amp;gt;1g/dL
&lt;/p&gt;&lt;p&gt;4) Glu &amp;lt;50
&lt;/p&gt;&lt;p&gt;5) Increased LDH
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;IF PERITONEAL DIALYSIS (SBP)
&lt;/p&gt;&lt;p&gt;1) &amp;gt;100WBC OR &amp;gt;50% NEUT
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;IF NIGHTLY (APD)
&lt;/p&gt;&lt;p&gt;1) &amp;gt;50%NEUT
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Send Amyase (&amp;gt;100 suggestive of intra-abd process)
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;&lt;ul&gt;&lt;li&gt;Placing Cx in BCx tube increases yield
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;12/06 DONALDSON
&lt;/p&gt;



</content><folder>Procedures</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="paraphimosis_reduction"><name>Paraphimosis Reduction</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Indications"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Indications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Contraindications"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Contraindications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Equipment_Needed"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Equipment Needed&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Procedure"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Procedure&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Complications"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Complications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Paraphimosis_Reduction&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Indications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Indications"&gt;Indications&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Paraphimosis 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Paraphimosis_Reduction&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Contraindications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Contraindications"&gt;Contraindications&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;None
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Paraphimosis_Reduction&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Equipment Needed"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Equipment_Needed"&gt;Equipment Needed&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; lubricant
&lt;/li&gt;&lt;li&gt; gloves 
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Paraphimosis_Reduction&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Procedure"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Procedure"&gt;Procedure&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1) Remove the Foley catheter if one is in place.
&lt;/p&gt;&lt;p&gt;2) Place a small amount of lubricant on the proximal aspect of the glans and inner surface of the foreskin
&lt;/p&gt;&lt;p&gt;3) Grasp the swollen foreskin with the non-dominant hand and apply slow gentle pressure for several minutes while elevating to reduce edema
&lt;/p&gt;&lt;p&gt;4) With the non-dominant hand, securely hold the proximal aspect of the swollen ring of foreskin with a ring formed by the thumb and the index and middle finger
&lt;/p&gt;&lt;p&gt;5) Slowly begin pushing the glans into the foreskin with the dominant thumb that is placed over the urethral meatus
&lt;/p&gt;&lt;p&gt;6) Continue until the foreskin is replaced over the glans
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Paraphimosis_Reduction&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Complications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Complications"&gt;Complications&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;failure of reduction requiring Dorsal Slit (Penis)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Paraphimosis_Reduction&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Vilke GM et al. Evaluation and treatment of acute urinary retention. J Emerg Med. 2008: 35:193-198.
&lt;/p&gt;



</content><folder>Procedures</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="parasites"><name>Parasites</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Chagas_disease"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Chagas disease&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#African_sleeping_sickness"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;African sleeping sickness&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Swimmer.27s_itch"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Swimmer's itch&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Seabather.27s_eruption"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Seabather's eruption&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Cysticercosis"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Cysticercosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Enterobius_vermicularis"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Enterobius vermicularis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Larva_Currens"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Larva Currens&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Dracunculosis"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;Dracunculosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#Loa_loa"&gt;&lt;span class="tocnumber"&gt;9&lt;/span&gt; &lt;span class="toctext"&gt;Loa loa&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-10"&gt;&lt;a href="#Onchocerciasis_.28River_blindness.29"&gt;&lt;span class="tocnumber"&gt;10&lt;/span&gt; &lt;span class="toctext"&gt;Onchocerciasis (River blindness)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-11"&gt;&lt;a href="#Trichinosis"&gt;&lt;span class="tocnumber"&gt;11&lt;/span&gt; &lt;span class="toctext"&gt;Trichinosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-12"&gt;&lt;a href="#M._Opercularis"&gt;&lt;span class="tocnumber"&gt;12&lt;/span&gt; &lt;span class="toctext"&gt;M. Opercularis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-13"&gt;&lt;a href="#Cimex_lenticularis"&gt;&lt;span class="tocnumber"&gt;13&lt;/span&gt; &lt;span class="toctext"&gt;Cimex lenticularis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-14"&gt;&lt;a href="#Body_lice"&gt;&lt;span class="tocnumber"&gt;14&lt;/span&gt; &lt;span class="toctext"&gt;Body lice&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-15"&gt;&lt;a href="#Myiasis"&gt;&lt;span class="tocnumber"&gt;15&lt;/span&gt; &lt;span class="toctext"&gt;Myiasis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-16"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;16&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Parasites&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Chagas disease"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Chagas_disease"&gt;Chagas disease&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;T. Cruzi
&lt;/p&gt;&lt;p&gt;Reduvid bug
&lt;/p&gt;&lt;p&gt;Transmitted by fecal material
&lt;/p&gt;&lt;p&gt;Romana's sign: eye swelling
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Parasites&amp;amp;action=edit&amp;amp;section=2" title="Edit section: African sleeping sickness"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="African_sleeping_sickness"&gt;African sleeping sickness&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Tsetse fly
&lt;/p&gt;&lt;p&gt;Winterbottom's sign: posterior cervical LAD (Gambiense)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Parasites&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Swimmer's itch"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Swimmer.27s_itch"&gt;Swimmer's itch&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Cercaria (non-human schistisomes)
&lt;/p&gt;&lt;p&gt;Exposed areas
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Parasites&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Seabather's eruption"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Seabather.27s_eruption"&gt;Seabather's eruption&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Under bathing suit
&lt;/p&gt;&lt;p&gt;-Nematocysts of the larval forms of sea anemones: Edwardsiella lineata 
&lt;/p&gt;&lt;p&gt;Thimble jellyfishe: Linuche unguiculata
&lt;/p&gt;&lt;p&gt;Cnidaria larve get trapped, release toxin
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Parasites&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Cysticercosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Cysticercosis"&gt;Cysticercosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Humans can become intermediate host and then get invasive disease
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Parasites&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Enterobius vermicularis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Enterobius_vermicularis"&gt;Enterobius vermicularis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Nocturnal perianal itch (pinworm)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Parasites&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Larva Currens"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Larva_Currens"&gt;Larva Currens&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Thumbprint sign: periumbilical purpura
&lt;/p&gt;&lt;p&gt;Strongyloides stercoralis
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Parasites&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Dracunculosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Dracunculosis"&gt;Dracunculosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Copepods (Cyclops spp)
&lt;/p&gt;&lt;p&gt;Metro and excision
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Parasites&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Loa loa"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Loa_loa"&gt;Loa loa&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Calabar swelling: localized angioedema
&lt;/p&gt;&lt;p&gt;Mature worm migrates across eye
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Parasites&amp;amp;action=edit&amp;amp;section=10" title="Edit section: Onchocerciasis (River blindness)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Onchocerciasis_.28River_blindness.29"&gt;Onchocerciasis (River blindness)&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Elephant skin
&lt;/p&gt;&lt;p&gt;Lizard skin
&lt;/p&gt;&lt;p&gt;Leopard skin
&lt;/p&gt;&lt;p&gt;Skin snip
&lt;/p&gt;&lt;p&gt;Mazotti test: give DEC 50 mg, get reaction in patient
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Parasites&amp;amp;action=edit&amp;amp;section=11" title="Edit section: Trichinosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Trichinosis"&gt;Trichinosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Trichinella spiralis
&lt;/p&gt;&lt;p&gt;Splinter hemorrhages
&lt;/p&gt;&lt;p&gt;Pork, polar bear, walrus
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Parasites&amp;amp;action=edit&amp;amp;section=12" title="Edit section: M. Opercularis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="M._Opercularis"&gt;M. Opercularis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Wolly caterpillar
&lt;/p&gt;&lt;p&gt;Train-track hemorrages
&lt;/p&gt;&lt;p&gt;-'Erucism' inflammation around hairs, can be chronic, can cause systemic effects
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Parasites&amp;amp;action=edit&amp;amp;section=13" title="Edit section: Cimex lenticularis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Cimex_lenticularis"&gt;Cimex lenticularis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Bedbugs
&lt;/p&gt;&lt;p&gt;Hep B carrier's
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Parasites&amp;amp;action=edit&amp;amp;section=14" title="Edit section: Body lice"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Body_lice"&gt;Body lice&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Only seen in seams of clothing
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Parasites&amp;amp;action=edit&amp;amp;section=15" title="Edit section: Myiasis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Myiasis"&gt;Myiasis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Dermatobia hominis
&lt;/p&gt;&lt;p&gt;Odd question of Collembola (Springtail) implicated in one case series (J NY Entomol Soc, 2004)
&lt;/p&gt;&lt;p&gt;-Pimozide (diphenylbutylpiperidine class antipsychotic) at 1&#8211;12 mg daily
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Parasites&amp;amp;action=edit&amp;amp;section=16" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;7/2/09 PANI
&lt;/p&gt;



</content><folder>ID</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="pedal_edema"><name>Pedal Edema</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pedal_Edema&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;CBC
&lt;/li&gt;&lt;li&gt;Chem 7
&lt;/li&gt;&lt;li&gt;PT vs albumin (liver)
&lt;/li&gt;&lt;li&gt;ECG
&lt;/li&gt;&lt;li&gt;CXR
&lt;/li&gt;&lt;li&gt;UA (nephrotic)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pedal_Edema&amp;amp;action=edit&amp;amp;section=2" title="Edit section: DDX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX"&gt;DDX&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Gravitational
&lt;/li&gt;&lt;li&gt;Venous insuf/thrombophlebitis
&lt;/li&gt;&lt;li&gt;Drugs
&lt;ol&gt;&lt;li&gt;NSAIDS
&lt;/li&gt;&lt;li&gt;OCP
&lt;/li&gt;&lt;li&gt;Steroids
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;CHF
&lt;/li&gt;&lt;li&gt;Lymphedema
&lt;/li&gt;&lt;li&gt;Pretibial myxedema
&lt;/li&gt;&lt;/ol&gt;




</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="peds_quick_drug_card"><name>Peds Quick Drug Card</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Intubation"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Intubation&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Cards"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Cards&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#AMS.2FSZ"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;AMS/SZ&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Peds_Quick_Drug_Card&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Intubation"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Intubation"&gt;Intubation&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Atropine 0.02 mg/kg
&lt;/p&gt;&lt;p&gt;Lidocaine 1 mg/kg
&lt;/p&gt;&lt;p&gt;Succ 1.5-2 mg/kg
&lt;/p&gt;&lt;p&gt;Vec 0.1 mg/kg
&lt;/p&gt;&lt;p&gt;Rox 1 mg/kg
&lt;/p&gt;&lt;p&gt;Etomidate 0.3 mg/kg
&lt;/p&gt;&lt;p&gt;Versed 0.05-0.1 mg/kg
&lt;/p&gt;&lt;p&gt;Ketamine 2 mg/kg
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Peds_Quick_Drug_Card&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Cards"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Cards"&gt;Cards&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Epi 0.1 cc/kg
&lt;/p&gt;&lt;p&gt;Atropine 0.02 mg/kg
&lt;/p&gt;&lt;p&gt;Adenosine 0.1-0.2 mg/kg
&lt;/p&gt;&lt;p&gt;Defib 2J/4J/4J per kg
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Peds_Quick_Drug_Card&amp;amp;action=edit&amp;amp;section=3" title="Edit section: AMS/SZ"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="AMS.2FSZ"&gt;AMS/SZ&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;D25W 2 cc/kg
&lt;/p&gt;&lt;p&gt;Ativan 0.05-0.1 mg/kg
&lt;/p&gt;&lt;p&gt;Dilantin 18 mg/kg
&lt;/p&gt;&lt;p&gt;Phenobarb 10-20 mg/kg
&lt;/p&gt;&lt;p&gt;Valium rectal 0.5 mg/kg
&lt;/p&gt;&lt;p&gt;Mannitol 1 gm/kg
&lt;/p&gt;&lt;p&gt;ET = (age-in-years/4) + 4
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Peds_Quick_Drug_Card&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;2/8/06 DONALDSON (from 'Peds board')
&lt;/p&gt;



</content><folder>Airway/Resus</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="peds_vitals"><name>Peds Vitals</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Peds_Vitals&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Chart"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Chart"&gt;Chart&lt;/span&gt;&lt;/h2&gt;
&lt;table border="1"&gt;

&lt;tr&gt;
&lt;td&gt; &lt;b&gt;AGE&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;RR&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;HR&lt;/b&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; &amp;lt;1
&lt;/td&gt;&lt;td&gt; 30-60
&lt;/td&gt;&lt;td&gt; 100-160
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 1-2
&lt;/td&gt;&lt;td&gt; 24-40
&lt;/td&gt;&lt;td&gt; 90-150
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 2-5
&lt;/td&gt;&lt;td&gt; 22-34
&lt;/td&gt;&lt;td&gt; 80-140
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 6-12
&lt;/td&gt;&lt;td&gt; 18-30
&lt;/td&gt;&lt;td&gt; 70-120
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; &amp;gt;12
&lt;/td&gt;&lt;td&gt; 12-16
&lt;/td&gt;&lt;td&gt; 60-100
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Peds_Vitals&amp;amp;action=edit&amp;amp;section=2" title="Edit section: SBP"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="SBP"&gt;SBP&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;0-28dy &amp;gt;60
&lt;/p&gt;&lt;p&gt;1-12mo &amp;gt;70
&lt;/p&gt;&lt;p&gt;1-10yrs SBP = 70 + (Age x 2)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Peds_Vitals&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;4/13/06 DONALDSON (adapted from Rosen/Gausche)
&lt;/p&gt;



</content><folder>Airway/Resus</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="pelvic_fractures"><name>Pelvic Fractures</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Pearls"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Pearls&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Fracture_Types"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Fracture Types&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Pelvic_Ring_Disruptions"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;Pelvic Ring Disruptions&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Other_Pelvic_Fractures"&gt;&lt;span class="tocnumber"&gt;2.2&lt;/span&gt; &lt;span class="toctext"&gt;Other Pelvic Fractures&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Imaging"&gt;&lt;span class="tocnumber"&gt;2.3&lt;/span&gt; &lt;span class="toctext"&gt;Imaging&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-6"&gt;&lt;a href="#Management"&gt;&lt;span class="tocnumber"&gt;2.4&lt;/span&gt; &lt;span class="toctext"&gt;Management&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-7"&gt;&lt;a href="#Reference"&gt;&lt;span class="tocnumber"&gt;2.5&lt;/span&gt; &lt;span class="toctext"&gt;Reference&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pelvic_Fractures&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Pearls"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Pearls"&gt;Pearls&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Pelvic fractures are associated with:
&lt;/li&gt;&lt;li&gt; Hemorrhage requiring transfusion - 35%
&lt;/li&gt;&lt;li&gt; Especially with sacroiliac joint disruption
&lt;/li&gt;&lt;li&gt; Intraabdominal injury - 16%
&lt;/li&gt;&lt;li&gt; Bladder/urethra injury - 6%
&lt;/li&gt;&lt;li&gt; Nerve deficits - 15%
&lt;/li&gt;&lt;li&gt; Especially with post. ring fx, upper sacral fracture
&lt;/li&gt;&lt;li&gt; Thoracic aorta rupture - 1.5%
&lt;/li&gt;&lt;li&gt; If pelvic ring is disrupted there are usually two fractures
&lt;/li&gt;&lt;li&gt; Exception to this is in the elderly (isolated pubic ramus) and athletes (isolated avulsion)
&lt;/li&gt;&lt;li&gt; Extension of fracture into the rectum or vagina = open fx 
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pelvic_Fractures&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Fracture Types"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Fracture_Types"&gt;Fracture Types&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pelvic_Fractures&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Pelvic Ring Disruptions"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Pelvic_Ring_Disruptions"&gt;Pelvic Ring Disruptions&lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt; Lateral Compression
&lt;/li&gt;&lt;li&gt; Usually stable as affected hemipelvis is crushed inward, reducing pelvic volume
&lt;/li&gt;&lt;li&gt; Anteroposterior Compression
&lt;/li&gt;&lt;li&gt; Usually unstable as the iliac wings are forced outward, increasing pelvic volume
&lt;/li&gt;&lt;li&gt; Often assocciated with pelvic and retroperitoneal hemorrhage 
&lt;/li&gt;&lt;li&gt; Coincident injuries of the thorax and the abdomen are the rule
&lt;/li&gt;&lt;li&gt; Vertical Shear
&lt;/li&gt;&lt;li&gt; Result from vertically oriented force delivered to the pelvis via the extended femurs
&lt;/li&gt;&lt;li&gt; Unstable; pelvic volume is increased 
&lt;/li&gt;&lt;li&gt; Malgaigne Fracture
&lt;/li&gt;&lt;li&gt; Ipsilateral anterior and posterior ring fractures
&lt;/li&gt;&lt;li&gt; High rate of neurovascular injury
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pelvic_Fractures&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Other Pelvic Fractures"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Other_Pelvic_Fractures"&gt;Other Pelvic Fractures&lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt; Straddle Injury
&lt;/li&gt;&lt;li&gt; Unstable
&lt;/li&gt;&lt;li&gt; Both rami fractured on both sides or both rami on one side and pubic symphysis diastasis
&lt;/li&gt;&lt;li&gt; High rate of urinary tract and bowel injury
&lt;/li&gt;&lt;li&gt; Avulsion Fracture
&lt;/li&gt;&lt;li&gt; Stable; occur usually in skeletally immature athletes aged 14-17 yrs
&lt;/li&gt;&lt;li&gt; Can rarely occur in association with trauma in adults; if lack of trauma pathological until proven otherwise 
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pelvic_Fractures&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Imaging"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Imaging"&gt;Imaging&lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt; Plain films
&lt;/li&gt;&lt;li&gt; AP - Obtain in all unconscious blunt trauma patients
&lt;/li&gt;&lt;li&gt; Inlet - Better defines the pelvic brim
&lt;/li&gt;&lt;li&gt; Outlet - Better defines the sacrum and SI joints
&lt;/li&gt;&lt;li&gt; Judet - Better defines the acetabulum 
&lt;/li&gt;&lt;li&gt; CT
&lt;/li&gt;&lt;li&gt; Obtain in all hemodynamically stable blunt trauma pts with pelvic fx on xray
&lt;/li&gt;&lt;li&gt; Exceptions include isolated pubic rami fx, avulsion fx
&lt;/li&gt;&lt;li&gt; Retrograde cystourethrogram
&lt;/li&gt;&lt;li&gt; Obtain (before foley!) if blood at the meatus, high riding prostate, or gross hematuria
&lt;/li&gt;&lt;li&gt; US
&lt;/li&gt;&lt;li&gt; May confuse hemoperitoneum for uroperitoneum
&lt;/li&gt;&lt;li&gt; If FAST negative but pt is persistently hypotensive consider DPA (aspirate) 
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pelvic_Fractures&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Management"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Management"&gt;Management&lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt; Anticipate hypotension
&lt;/li&gt;&lt;li&gt; Rapidly detect hemoperitoneum
&lt;/li&gt;&lt;li&gt; Classify fx pattern as "stable" or "unstable"
&lt;/li&gt;&lt;li&gt; If unstable wrap with sheet or pelvic binder
&lt;/li&gt;&lt;li&gt; Be careful not to over-reduce a lateral compression fx (places increased strain on the post. pelvis)
&lt;/li&gt;&lt;li&gt; Pt's legs, greater trochanters, and patellae should always lie in an anatomical position 
&lt;/li&gt;&lt;li&gt; In lateral compression injury the goal is stabilization, not compression 
&lt;/li&gt;&lt;li&gt; Assess for associated injuries
&lt;/li&gt;&lt;li&gt; Neurological
&lt;/li&gt;&lt;li&gt; Distal motor weakness (impaired dorsi/plantar flexion of great toe)
&lt;/li&gt;&lt;li&gt; Distal numbness (dorsal and lateral aspects of foot)
&lt;/li&gt;&lt;li&gt; Cauda equina syndrome (perianal anesthesia, loss of sphincter tone)  
&lt;/li&gt;&lt;li&gt; Open Fx
&lt;/li&gt;&lt;li&gt; Vaginal bleeding
&lt;/li&gt;&lt;li&gt; Rectal bleeding
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pelvic_Fractures&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Reference"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Reference"&gt;Reference&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;UpToDate, Harwood-Nuss
&lt;/p&gt;



</content><folder>Ortho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="pelvic_inflmatory_disease_(pid)"><name>Pelvic Inflmatory Disease (PID)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#CDC_Criteria.5E.5E"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;CDC Criteria^^&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-6"&gt;&lt;a href="#Outpatient"&gt;&lt;span class="tocnumber"&gt;4.1&lt;/span&gt; &lt;span class="toctext"&gt;Outpatient&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-7"&gt;&lt;a href="#Inpatient"&gt;&lt;span class="tocnumber"&gt;4.2&lt;/span&gt; &lt;span class="toctext"&gt;Inpatient&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#Complications"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Complications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-10"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pelvic_Inflmatory_Disease_(PID)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Commonly begins as cervical infection (cervicitis) with gonorrhea or chlamydia
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pelvic_Inflmatory_Disease_(PID)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Pelvic pain (90%)
&lt;/li&gt;&lt;li&gt;Constitutional sx-Vaginal discharge (75%)
&lt;/li&gt;&lt;li&gt;Abnl pelvic exam (60%)
&lt;/li&gt;&lt;li&gt;Vaginal bleeding (40%) 
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pelvic_Inflmatory_Disease_(PID)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: CDC Criteria^^"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="CDC_Criteria.5E.5E"&gt;CDC Criteria^^&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Cervical motion tenderness (CMT)
&lt;/li&gt;&lt;li&gt;OR, B. Pelvic/adenexal TTP (in pt with no other identifiable cause) 
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;Additional Criteria
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt; Fever
&lt;/li&gt;&lt;li&gt; WBC &amp;gt;10k
&lt;/li&gt;&lt;li&gt; Abnl cervical discharge (50%)
&lt;/li&gt;&lt;li&gt; WBC on wet mounte) GC/Chlamy 
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;^^CDC Criteria are sensitive, but not specific (i.e. many intr-abominal processes have CMT) 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pelvic_Inflmatory_Disease_(PID)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Upreg (negative)
&lt;/li&gt;&lt;li&gt; Pelvic exam (send GC/Chlamy, wet mount)
&lt;/li&gt;&lt;li&gt; Pelvic US if toxic (r/o TOA)
&lt;/li&gt;&lt;li&gt; R/O other intra-abd pathology (consider CT, UA, labs) 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pelvic_Inflmatory_Disease_(PID)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pelvic_Inflmatory_Disease_(PID)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Outpatient"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Outpatient"&gt;Outpatient&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;1) Ceftriaxone (250 mg IM x 1)
&lt;/p&gt;&lt;p&gt;+ doxycycline (100mg PO BID x 14 days)
&lt;/p&gt;&lt;p&gt;+/- metronidazole (500mg PO BID x 14 days)
&lt;/p&gt;&lt;p&gt;OR
&lt;/p&gt;&lt;p&gt;2) Cefoxitin (2g IM x 1)
&lt;/p&gt;&lt;p&gt;+ probebenecid (1gm PO x 1)
&lt;/p&gt;&lt;p&gt;+ doxycycline (100mg PO BID x 14 days)
&lt;/p&gt;&lt;p&gt;+/- metronidazole (500mg PO BID x 14 days)
&lt;/p&gt;&lt;p&gt;OR
&lt;/p&gt;&lt;p&gt;3) 3-gen cephalosporin [cefotaxime (1gm IM x1) OR ceftizoxime (1gm IM x 1)
&lt;/p&gt;&lt;p&gt;+ doxycycline (100mg PO BID x 14 days)
&lt;/p&gt;&lt;p&gt;+/- metronidazole (500mg PO BID x 14 days) 
&lt;/p&gt;&lt;p&gt;^Metronidazole based upon assessment of risk for anaerobs.  Consider in:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt; Pelvic abscess
&lt;/li&gt;&lt;li&gt; Proven or suspected infection Trichomonas vaginalis or bacterial vaginosis
&lt;/li&gt;&lt;li&gt; History of gynecological instrumentation in the preceding two to three weeks. 
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pelvic_Inflmatory_Disease_(PID)&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Inpatient"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Inpatient"&gt;Inpatient&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;1) Cefotetan 2gm IV q12h OR cefoxitin 2mg IV q6h     
&lt;/p&gt;&lt;p&gt;+ doxy 100mg IV/PO q12hOR2) Clinda 900mg IV q8h     
&lt;/p&gt;&lt;p&gt;+ 4.5 mg/kg QD     
&lt;/p&gt;&lt;p&gt;+ (after) doxy 100mg PO BID x 14dy 
&lt;/p&gt;&lt;p&gt;^Rising levels of fluoroquinolone resistance, use them only where prevalence of resistant GC &amp;lt;5%.
&lt;/p&gt;&lt;p&gt;^^Treat all partners that had sexual contact with the patient during the previous 60 days prior to the patient's onset of symptoms (advise to avoid sex until treated)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pelvic_Inflmatory_Disease_(PID)&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Admit for:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt; TOA, Fitz-Hugh-Curtis
&lt;/li&gt;&lt;li&gt; Sepsis/peritonitis
&lt;/li&gt;&lt;li&gt; Unable to tol POs
&lt;/li&gt;&lt;li&gt; Failed outpt Rx
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pelvic_Inflmatory_Disease_(PID)&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Complications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Complications"&gt;Complications&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;TOA/sepsis
&lt;/li&gt;&lt;li&gt;Infertility
&lt;/li&gt;&lt;li&gt;Ectopic
&lt;/li&gt;&lt;li&gt;Chronic pelvic pain
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pelvic_Inflmatory_Disease_(PID)&amp;amp;action=edit&amp;amp;section=10" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;CDC, KajiQuestions
&lt;/p&gt;



</content><folder>ID</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="pelvic_x-ray"><name>Pelvic X-ray</name><content>&lt;p&gt;pubic symphysis: up to 5mm in width, up to 2mm offset, no overlap
&lt;/p&gt;&lt;p&gt;SI joints: 2-4 mm in width
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;checklist-
&lt;/p&gt;&lt;p&gt;1)obturator foramina for symmetry-clue for rotation of film
&lt;/p&gt;&lt;p&gt;2)diastasis of pubic symphysis and both SI joints
&lt;/p&gt;&lt;p&gt;3)assymetry of illiac wings (rotation or deformity)
&lt;/p&gt;&lt;p&gt;4)sacral foramina-especially the superior cortical margins
&lt;/p&gt;&lt;p&gt;5)transverse processes of L5
&lt;/p&gt;&lt;p&gt;6)integrity of all cortical lines, especially around acetabulum.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Outlet views-sacral fxs, SI joint abnormalities
&lt;/p&gt;&lt;p&gt;Inlet view-displacement of ant. Fragments into pelvis..
&lt;/p&gt;&lt;p&gt;(posterior abnormalities usually need CT )
&lt;/p&gt;



</content><folder>Rads</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="penetrating_neck_injury"><name>Penetrating Neck Injury</name><content>&lt;p&gt;Penetrating Neck Injury (PNI)
&lt;/p&gt;&lt;p&gt;- accounts for 5-10% of traumatic injuries in adults
&lt;/p&gt;&lt;p&gt;- 2-6% mortality (can be as high as 65% fatal if major blood vessel is damaged)
&lt;/p&gt;&lt;p&gt;- multiple structures are injured in 30% of patients with PNI (especially if there is a breach in the platysma)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Zones of the Neck
&lt;/p&gt;&lt;p&gt;Zone 1: region between clavicles and inferior aspect of the cricoid cartilage
&lt;/p&gt;&lt;p&gt;Zone 2: from cricoid cartilage superiorly to the angle of the mandible
&lt;/p&gt;&lt;p&gt;Zone 3: angle of the mandible to base of skull
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Anatomical Structures at Risk:
&lt;/p&gt;&lt;p&gt;- carotid (common, internal external)
&lt;/p&gt;&lt;p&gt;- vertebral arteries
&lt;/p&gt;&lt;p&gt;- subclavian vessels
&lt;/p&gt;&lt;p&gt;- jugular vein
&lt;/p&gt;&lt;p&gt;- brachiocephalic vein
&lt;/p&gt;&lt;p&gt;- aortic arch
&lt;/p&gt;&lt;p&gt;- lung apices
&lt;/p&gt;&lt;p&gt;- cervical spine/cord
&lt;/p&gt;&lt;p&gt;- thoracic duct
&lt;/p&gt;&lt;p&gt;- brachial plexus
&lt;/p&gt;&lt;p&gt;- phrenic nerve
&lt;/p&gt;&lt;p&gt;- vagus nerve
&lt;/p&gt;&lt;p&gt;- recurrent laryngeal nerve
&lt;/p&gt;&lt;p&gt;- esophagus
&lt;/p&gt;&lt;p&gt;- trachea
&lt;/p&gt;&lt;p&gt;- larynx
&lt;/p&gt;&lt;p&gt;- partoid/salivary glands
&lt;/p&gt;&lt;p&gt;- cranial nerves 9-12
&lt;/p&gt;&lt;p&gt;- floor of mouth/skull
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Management
&lt;/p&gt;&lt;p&gt;Airway 
&lt;/p&gt;&lt;p&gt;- consider early airway stabilization especially in those with respiratory distress, subq emphysema, expanding hematoma, AMS, or in those with direct laryngotracheal trauma
&lt;/p&gt;&lt;p&gt;- RSI  has been proven safe and effective
&lt;/p&gt;&lt;p&gt;- minimize BVM as positive pressure generated can cause air to dissect into the neck and worsen injuries
&lt;/p&gt;&lt;p&gt;- Orotracheal intubation usually successful but always have backup plan (fiberoptic, nasal intubation, surgical airway)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Surgical Management
&lt;/p&gt;&lt;p&gt;Immediate Exploration if:
&lt;/p&gt;&lt;p&gt;- hard signs of vascular injury (expanding hematoma, severe active/pulsatile bleeding, bruit, palpable thrill)
&lt;/p&gt;&lt;p&gt;- HD unstable
&lt;/p&gt;&lt;p&gt;- airway compromise
&lt;/p&gt;&lt;p&gt;Can delay surgical management for further evaluation/imaging if not
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Imaging/Other studies
&lt;/p&gt;&lt;p&gt;Plain Films
&lt;/p&gt;&lt;p&gt;- not helpful in visualizing soft tissues/vacular structures
&lt;/p&gt;&lt;p&gt;- can show foreign bodies, fractures, tracheal displacement, hemo/penumothorax, widened mediastinum, apical hematoma, etc
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Angiography
&lt;/p&gt;&lt;p&gt;- gold standard for evaluating vasculature
&lt;/p&gt;&lt;p&gt;- more important for Zone 1 and 3 injuries, especially for surgical planning
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;CT Angio
&lt;/p&gt;&lt;p&gt;- shows soft tissue, bone, and vascular injury
&lt;/p&gt;&lt;p&gt;- similar results as traditional angiography
&lt;/p&gt;&lt;p&gt;- if normal, may consider eliminating surgical exploration in zone 2 PNI in a HD stable patient
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Bronchoscopy
&lt;/p&gt;&lt;p&gt;Esophagraphy/Esophagoscopy
&lt;/p&gt;



</content><folder>Trauma</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="pericardial_effusion_and_tamponade"><name>Pericardial Effusion and Tamponade</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Pathophysiology"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Pathophysiology&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Signs_.26_Symptoms"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Signs &amp;amp; Symptoms&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Causes"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Causes&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;9&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pericardial_Effusion_and_Tamponade&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Pathophysiology"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Pathophysiology"&gt;Pathophysiology&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;see pericarditis
&lt;/li&gt;&lt;li&gt;hemodynamic compromise from inc pericardial fluid
&lt;ol&gt;&lt;li&gt;incr pericardial pressures
&lt;/li&gt;&lt;li&gt;decr diastolic filling, venous return, collapse of RA
&lt;/li&gt;&lt;li&gt;inhalation sequesters fluid in pulm vasc, not LV
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pericardial_Effusion_and_Tamponade&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Signs &amp;amp; Symptoms"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Signs_.26_Symptoms"&gt;Signs &amp;amp; Symptoms&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Rapidity of fluid accumulation determines clinical effects
&lt;/li&gt;&lt;li&gt;Rapid accumulation: as little as 150cc may decr cardiac output
&lt;/li&gt;&lt;li&gt;Slow accumulation: as much as 2L may have little effect
&lt;/li&gt;&lt;li&gt;Pts may c/o CP, dyspnea, fatigue, anorexia, wt loss, MS changes, shock
&lt;/li&gt;&lt;li&gt;Overall: looks a lot like CHF with JVD, SOB, hepatomegaly, etc...
&lt;/li&gt;&lt;li&gt;Narrow pulse pressure
&lt;/li&gt;&lt;li&gt;Friction rub
&lt;/li&gt;&lt;li&gt;Beck's Triad
&lt;ol&gt;&lt;li&gt;hypotension, muffled heart sounds, JVD
&lt;/li&gt;&lt;li&gt;present in only 30% of pts
&lt;/li&gt;&lt;li&gt;90% will have at least one of the three findings
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Pulsus paradoxus
&lt;ol&gt;&lt;li&gt;&amp;gt;10mmHg change in sys BP on inspiration
&lt;/li&gt;&lt;li&gt;decreased intrathoracic P on inspiration causes increased return to R heart --&amp;gt; R septum bows into L given constriction by surrounding pericardial effusion --&amp;gt; decreased LVEDV and concomitant decreased CO
&lt;/li&gt;&lt;li&gt;can see in many right heart dz states as well
&lt;/li&gt;&lt;li&gt;may NOT see in acute trauma
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Ewart's sign (compressive atelectasis causes pulmonary auscultatory changes)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pericardial_Effusion_and_Tamponade&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Pulsus paradoxus (old school)
&lt;/li&gt;&lt;li&gt;EKG 
&lt;ol&gt;&lt;li&gt;nl or diffuse low QRS
&lt;/li&gt;&lt;li&gt;electrical alternans (beat to beat QRS amp vary)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;CXR: CM, obliteration of costophrenic angles
&lt;/li&gt;&lt;li&gt;TTE -modality of choice: effusion, diffuse hypokinesis, RA and RV collapse
&lt;/li&gt;&lt;li&gt;labs: CBC, chem 10, coags, enzymes
&lt;/li&gt;&lt;li&gt;consider: HIV, ANA, ESR, RF, PPD
&lt;/li&gt;&lt;li&gt;pericardial fluid for viral/bact Cx, cell count, cytology
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pericardial_Effusion_and_Tamponade&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Causes"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Causes"&gt;Causes&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;As in pericarditis
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;idiopathic
&lt;/li&gt;&lt;li&gt;infectious, including AIDS related, TB
&lt;/li&gt;&lt;li&gt;malignancy: heme, lung, breast
&lt;/li&gt;&lt;li&gt;uremia
&lt;/li&gt;&lt;li&gt;post radiation
&lt;/li&gt;&lt;li&gt;connective tissue dz
&lt;/li&gt;&lt;li&gt;drugs: procainamide, hydralaine, methyldopa, anticoagulants
&lt;/li&gt;&lt;li&gt;cardiac injury (can see up to weeks later): post MI, trauma, aortic  dissection
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pericardial_Effusion_and_Tamponade&amp;amp;action=edit&amp;amp;section=5" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Tension PTX
&lt;/li&gt;&lt;li&gt;PE
&lt;/li&gt;&lt;li&gt;SVC syndrome
&lt;/li&gt;&lt;li&gt;large pleural effusion
&lt;/li&gt;&lt;li&gt;Tension pneumocardium
&lt;/li&gt;&lt;li&gt;Constrictive pericarditis
&lt;/li&gt;&lt;li&gt;Cardiogenic shock
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pericardial_Effusion_and_Tamponade&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;EMERGENCY
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;ABCs, IV, O2, monitor
&lt;/li&gt;&lt;li&gt;IV fluids to incr RV vol
&lt;/li&gt;&lt;li&gt;Pressors (temporizing)
&lt;/li&gt;&lt;li&gt;AVOID preload reducing meds eg Nitrates, diuretics
&lt;/li&gt;&lt;li&gt;Procedures: see Pericardiocentesis
&lt;/li&gt;&lt;li&gt;Pericardial window (OR)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pericardial_Effusion_and_Tamponade&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;likely ICU
&lt;/li&gt;&lt;li&gt;Cards, CT surg consults
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pericardial_Effusion_and_Tamponade&amp;amp;action=edit&amp;amp;section=8" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Cards: Pericarditis
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pericardial_Effusion_and_Tamponade&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from Donaldson
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="pericardiocentesis"><name>Pericardiocentesis</name><content>&lt;p&gt;Indications==
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
-Cardiac Tamponade
&lt;/p&gt;&lt;p&gt;-Diagnose etiology of pericardial effusion
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Contraindications==
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
-Unstable: none
&lt;/p&gt;&lt;p&gt;-Stable: coagulopathy, traumatic tamponade, s/p CABG, effusion &amp;lt;200cc, overlying cellulitis
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Equipment==
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
-Pericardiocentesis kit
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Prep==
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
-30-45&#730; or supine
&lt;/p&gt;&lt;p&gt;-NGT (decompress stomach)
&lt;/p&gt;&lt;p&gt;-Subxiphoid prep
&lt;/p&gt;&lt;p&gt;-Consider atropine
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Technique==
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
-1cm inf, 1cm lat to subxiphoid
&lt;/p&gt;&lt;p&gt;-35cc syringe attached to 18g spinal needle
&lt;/p&gt;&lt;p&gt;-attach V1 to needle base or use US
&lt;/p&gt;&lt;p&gt;-11 blade incision
&lt;/p&gt;&lt;p&gt;-45&#730; to abdomen, 45&#730; to midline pointed towards L shoulder
&lt;/p&gt;&lt;p&gt;-Insert and w/d until flash - stop if STE, cardiac pulsations     
&lt;/p&gt;&lt;p&gt;-NB: Pericardial blood won't clot, intracadiac blood will
&lt;/p&gt;&lt;p&gt;-Can place 3-way stopcock
&lt;/p&gt;&lt;p&gt;-Use seldinger to place indwelling cath if necessary
&lt;/p&gt;&lt;p&gt;-Post CXR
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Labs==
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
-Hct, cell count, Cx/grm stain, cytology
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Complications===
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
-Arrhythmia
&lt;/p&gt;&lt;p&gt;-Ventric free wall
&lt;/p&gt;&lt;p&gt;-Coronary Artery Injury
&lt;/p&gt;&lt;p&gt;-Hemo/PTX
&lt;/p&gt;&lt;p&gt;-LIMA injury
&lt;/p&gt;&lt;p&gt;-Reaccumulation
&lt;/p&gt;&lt;p&gt;-False neg (clotted pericardial blood)
&lt;/p&gt;&lt;p&gt;-False pos (intracardiac)
&lt;/p&gt;



</content><folder>Procedures</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="pericarditis"><name>Pericarditis</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Workup"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Workup&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Differential_Diagnosis"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Differential Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Complications"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Complications&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-8"&gt;&lt;a href="#Recurrence"&gt;&lt;span class="tocnumber"&gt;7.1&lt;/span&gt; &lt;span class="toctext"&gt;Recurrence&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-9"&gt;&lt;a href="#Contrictive_Pericarditis"&gt;&lt;span class="tocnumber"&gt;7.2&lt;/span&gt; &lt;span class="toctext"&gt;Contrictive Pericarditis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-10"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pericarditis&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt; Background &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Causes:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;idiopathic
&lt;/li&gt;&lt;li&gt;infectious, including AIDS related
&lt;/li&gt;&lt;li&gt;malignancy: heme, lung, breast
&lt;/li&gt;&lt;li&gt;uremia
&lt;/li&gt;&lt;li&gt;post radiation
&lt;/li&gt;&lt;li&gt;connective tissue dz
&lt;/li&gt;&lt;li&gt;drugs: procainamide, hydralaine, methyldopa, anticoagulants
&lt;/li&gt;&lt;li&gt;cardiac injury (can see up to weeks later): post MI, trauma, aortic dissection
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pericarditis&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt; Diagnosis &lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;usually sharp pleuritic chest pain, but can be anything
&lt;/li&gt;&lt;li&gt;radiates to chest, back, trapezius ridge
&lt;/li&gt;&lt;li&gt;diminish with sitting up/lean forward
&lt;/li&gt;&lt;li&gt;SOB, esp if concommitant pleural effusion
&lt;/li&gt;&lt;li&gt;hypotension/extremis if tamponade
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pericarditis&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Workup"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Workup"&gt; Workup &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;EKG is virtually diagnostic
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;less reliable in post MI patients and others with baseline EKG abnormalities
&lt;/li&gt;&lt;li&gt;if pt. has early repol.confounding interpretation, check (ST elev)/(T height) in V6; if &amp;gt;0.25 likely pericarditis
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;EKG progression:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;global concave up ST elev, +/- PR depression
&lt;/li&gt;&lt;li&gt;ST to baseline, big T's, PR dep
&lt;/li&gt;&lt;li&gt;T wave flatten then inversion
&lt;/li&gt;&lt;li&gt;return to baseline EKG
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;CXR, WBC, ESR, CK-MB, TN all nonspecific.
&lt;/p&gt;&lt;p&gt;Echo will show NL wall motion
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;also useful to monitor progress
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;Friction rub
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pericarditis&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Differential Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Differential_Diagnosis"&gt; Differential Diagnosis &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;MI is the big confounder
&lt;/p&gt;
&lt;table border="1"&gt;

&lt;tr&gt;
&lt;td&gt; &lt;b&gt;MI&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Pericarditis&lt;/b&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; no fever
&lt;/td&gt;&lt;td&gt;
&lt;p&gt;fever
&lt;/p&gt;&lt;p&gt;pain varries w/motion
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; focal ST chgs
&lt;/td&gt;&lt;td&gt; diffuse ST elev
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; reciprocal chgs
&lt;/td&gt;&lt;td&gt; no reciprocal chgs
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Q waves
&lt;/td&gt;&lt;td&gt; no Q wave
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; +/- pulm edema
&lt;/td&gt;&lt;td&gt; clear lungs
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; wall motion abn
&lt;/td&gt;&lt;td&gt; nl wall motion
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;p&gt;also on DDx:
&lt;/p&gt;&lt;p&gt;CHF, PE, PTX, aortic dissection, pneumomediastinum, pleuritis
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pericarditis&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt; Treatment &lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Mostly supportive
&lt;/li&gt;&lt;li&gt;NSAIDS for viral/idiopathic
&lt;/li&gt;&lt;li&gt;Recurrent - colchicine
&lt;/li&gt;&lt;li&gt;Uremic - dialysis
&lt;/li&gt;&lt;li&gt;"buy time" with fluid boluses
&lt;/li&gt;&lt;li&gt;Tamponade --&amp;gt; pericardiocentesis
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;(See Procedures: Pericardiocentesis)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pericarditis&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt; Disposition &lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Most need admission, but if young and healthy can echo, and D/C with close f/u
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;Risk Stratification
&lt;/p&gt;&lt;p&gt;HIGH RISK (admit)
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Subacute sx (several dys-wks)
&lt;/li&gt;&lt;li&gt;Fever &amp;gt;100.4
&lt;/li&gt;&lt;li&gt;Evidence of tamponade
&lt;/li&gt;&lt;li&gt;Large effusion (&amp;gt;20mm)
&lt;/li&gt;&lt;li&gt;Immunosupressed
&lt;/li&gt;&lt;li&gt;On anticoagulant
&lt;/li&gt;&lt;li&gt;Acute trauma
&lt;/li&gt;&lt;li&gt;Failure to respond to NSAID Rx (&amp;gt;7dy)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pericarditis&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Complications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Complications"&gt; Complications &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Tamponade/Effusion-see Pericardial Effusion and Tamponade
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pericarditis&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Recurrence"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Recurrence"&gt;Recurrence&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;usually weeks to months after initial episode
&lt;/li&gt;&lt;li&gt;management is same
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pericarditis&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Contrictive Pericarditis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Contrictive_Pericarditis"&gt;Contrictive Pericarditis&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;restrictive picture with pericardial calcific on CXR and thicken on ECHO
&lt;/li&gt;&lt;li&gt;Rx window
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pericarditis&amp;amp;action=edit&amp;amp;section=10" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt; Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from Pani, Donaldson, and UpToDate
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="perimortum_c-section"><name>Perimortum C-Section</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Perimortum_C-Section&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1. Fundus higher than umbilicus
&lt;/p&gt;&lt;p&gt;2. Fetal heart tones present
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;70% success at &amp;lt;5min loss vitals of mother
&lt;/li&gt;&lt;/ul&gt;




</content><folder>Procedures</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="periorbital_swelling"><name>Periorbital Swelling</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#PERIORBITAL"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;PERIORBITAL&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#LID"&gt;&lt;span class="tocnumber"&gt;1.2&lt;/span&gt; &lt;span class="toctext"&gt;LID&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#ORBITAL_CELLULITIS_.28vs._Periorbital.29"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;ORBITAL CELLULITIS (vs. Periorbital)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Periorbital_Swelling&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Periorbital_Swelling&amp;amp;action=edit&amp;amp;section=2" title="Edit section: PERIORBITAL"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="PERIORBITAL"&gt;PERIORBITAL&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Proptosis
&lt;ol&gt;&lt;li&gt; Nl IOP
&lt;ol&gt;&lt;li&gt; Orbital cellulitis^
&lt;/li&gt;&lt;li&gt; Pseudotumor^
&lt;/li&gt;&lt;li&gt; Orbital tumor^
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Inc IOP
&lt;ol&gt;&lt;li&gt; Retrobulbar abcess^
&lt;ol&gt;&lt;li&gt;(worsened orbital cellulitis)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Retrobulb emphysema^
&lt;ol&gt;&lt;li&gt;(worsened pseudotumor)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Retrobulbar hematoma^
&lt;/li&gt;&lt;li&gt; Orbital tumor^
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; No proptosis
&lt;ol&gt;&lt;li&gt; Periorbital cellulitis/erysipelas
&lt;/li&gt;&lt;li&gt; Dacryocystitis (lacrimal duct)
&lt;/li&gt;&lt;li&gt; Allergic Rx
&lt;/li&gt;&lt;li&gt; Nephrotic Syndrome (pediatrics)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Periorbital_Swelling&amp;amp;action=edit&amp;amp;section=3" title="Edit section: LID"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="LID"&gt;LID&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Blepharitis (crusts)
&lt;/li&gt;&lt;li&gt; Chalazion (meibomian gland)
&lt;/li&gt;&lt;li&gt; Hordeolum (eyelash folicle)
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;^Emergent diagnoses
&lt;/p&gt;&lt;p&gt;^^Critical diagnoses
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Periorbital_Swelling&amp;amp;action=edit&amp;amp;section=4" title="Edit section: ORBITAL CELLULITIS (vs. Periorbital)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="ORBITAL_CELLULITIS_.28vs._Periorbital.29"&gt;ORBITAL CELLULITIS (vs. Periorbital)&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Any of the following:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt; Fever
&lt;/li&gt;&lt;li&gt; Ill appearance
&lt;/li&gt;&lt;li&gt; Blurred vision
&lt;/li&gt;&lt;li&gt; Proptosis
&lt;/li&gt;&lt;li&gt; Painful/limited EOM
&lt;/li&gt;&lt;li&gt; Diplopia
&lt;/li&gt;&lt;li&gt; Edema of optic disk
&lt;/li&gt;&lt;li&gt; Venous engorgement of retina
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Periorbital_Swelling&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;3/20/06 DONALDSON (adapted from Rosen, WMS Practic Guidelines 2000)
&lt;/p&gt;



</content><folder>Ophtho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="periorbital_and_orbital_cellulitis"><name>Periorbital and Orbital Cellulitis</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Signs.2FSymptoms"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;Signs/Symptoms&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Imaging"&gt;&lt;span class="tocnumber"&gt;2.2&lt;/span&gt; &lt;span class="toctext"&gt;Imaging&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Complications"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Complications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Periorbital_and_Orbital_Cellulitis&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt; Important to distinguish between these two conditions
&lt;/li&gt;&lt;li&gt; Orbital cellulitis may mimic periorbital cellulitis early in its course! 
&lt;/li&gt;&lt;li&gt; Orbital cellulitis most often 2/2 ethmoid sinusitis
&lt;/li&gt;&lt;li&gt; May also be 2/2 orbital trauma, endophthalmitis, infectious infection from teeth / middle ear 
&lt;/li&gt;&lt;li&gt; Periorbital cellulitis most often 2/2 contiguous infection of soft tissues of face and eyelids
&lt;/li&gt;&lt;li&gt; Periorbital cellulitis does not lead to orbital cellulitis
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Periorbital_and_Orbital_Cellulitis&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Periorbital_and_Orbital_Cellulitis&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Signs/Symptoms"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Signs.2FSymptoms"&gt;Signs/Symptoms&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Periorbital Cellulitis
&lt;ol&gt;&lt;li&gt; Swelling and erythema of tissues surrounding the orbit
&lt;/li&gt;&lt;li&gt; +/- pain with eye movement 
&lt;/li&gt;&lt;li&gt; +/- fever
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Orbital Cellulitis
&lt;ol&gt;&lt;li&gt; All of the above plus:
&lt;ol&gt;&lt;li&gt; Proptosis
&lt;/li&gt;&lt;li&gt; Chemosis (conj. swelling) 
&lt;/li&gt;&lt;li&gt; Globe displacement
&lt;/li&gt;&lt;li&gt; Limitation of eye movements
&lt;/li&gt;&lt;li&gt; Double vision
&lt;/li&gt;&lt;li&gt; Vision loss (indicates orbital apex involvement)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Periorbital_and_Orbital_Cellulitis&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Imaging"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Imaging"&gt;Imaging&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; CT Orbit with IV contrast
&lt;ol&gt;&lt;li&gt; Indicated for suspected orbital cellulitis or in pts who cannot accurately assess vision (e.g. age &amp;lt;1yr)
&lt;/li&gt;&lt;li&gt; Findings c/w orbital cellulitis:
&lt;ol&gt;&lt;li&gt; Proptosis
&lt;/li&gt;&lt;li&gt; Inflammation of ocular muscles
&lt;/li&gt;&lt;li&gt; Subperiosteal or orbital abscess
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Periorbital_and_Orbital_Cellulitis&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Complications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Complications"&gt;Complications&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Subperiosteal Abscess
&lt;ol&gt;&lt;li&gt; Must be distinguished from orbital cellulitis based on CT
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Orbital Abscess
&lt;ol&gt;&lt;li&gt; Pts tend to have severe proptosis, globe displacement, and appear systemically ill
&lt;/li&gt;&lt;li&gt; May be clinically indistinguishable from orbital cellulitis; requires CT 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Meningitis
&lt;/li&gt;&lt;li&gt; Cavernous sinus thrombosis 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Periorbital_and_Orbital_Cellulitis&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Periorbital Cellulitis
&lt;ol&gt;&lt;li&gt; Most cases (except for pts &amp;lt; 1yr) can be managed as outpatient w/ oral abx and daily f/u
&lt;/li&gt;&lt;li&gt; Treatment (7-10 days)
&lt;ol&gt;&lt;li&gt; Augmentin 875mg BID OR
&lt;/li&gt;&lt;li&gt; Cefpodoxime 200mg BID OR
&lt;/li&gt;&lt;li&gt; Cefdinir 600mg qd
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Orbital Cellulitis
&lt;ol&gt;&lt;li&gt; Vancomycin +
&lt;ol&gt;&lt;li&gt; Ampicillin-sulbactam 3 g IV q6hr OR
&lt;/li&gt;&lt;li&gt; Ticarcillin-clavulanate 3.1 g IV q4h OR
&lt;/li&gt;&lt;li&gt; Piperacillin-tazobactam 4.5 g IV q6h OR
&lt;/li&gt;&lt;li&gt; Ceftriaxone 2 g IV q12hr OR
&lt;/li&gt;&lt;li&gt; Cefotaxime 2 g IV q4h
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Periorbital_and_Orbital_Cellulitis&amp;amp;action=edit&amp;amp;section=7" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Ophtho:  Periorbital Swelling
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Periorbital_and_Orbital_Cellulitis&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;UpToDate
&lt;/p&gt;



</content><folder>ID</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="peritonsillar_abscess_(pta)"><name>Peritonsillar Abscess (PTA)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Presentation"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;Presentation&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Imaging_Studies"&gt;&lt;span class="tocnumber"&gt;2.2&lt;/span&gt; &lt;span class="toctext"&gt;Imaging Studies&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;2.3&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Antibiotics"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Antibiotics&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-8"&gt;&lt;a href="#Outpatient"&gt;&lt;span class="tocnumber"&gt;4.1&lt;/span&gt; &lt;span class="toctext"&gt;Outpatient&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-9"&gt;&lt;a href="#Inpatient"&gt;&lt;span class="tocnumber"&gt;4.2&lt;/span&gt; &lt;span class="toctext"&gt;Inpatient&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-10"&gt;&lt;a href="#Steroids"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Steroids&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Peritonsillar_Abscess_(PTA)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Common Organisms: Streptococcus spp, Anaerobes, Eikenella Corrodens, Haemophilis spp, S. Aureus
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Peritonsillar_Abscess_(PTA)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Peritonsillar_Abscess_(PTA)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Presentation"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Presentation"&gt;Presentation&lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt; Fever, hot-potato voice, trismus, exudate and uvular devation (away from abscess)
&lt;/li&gt;&lt;li&gt; If unclear, can attempt to digitally palpate posterior oropharynx for fluctuance
&lt;/li&gt;&lt;/ul&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Peritonsillar_Abscess_(PTA)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Imaging Studies"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Imaging_Studies"&gt;Imaging Studies&lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt; Radiography: Lateral soft tissue neck radiographs may help rule out other causes. The anteroposterior (AP) view of the neck may demonstrate distortion of soft tissue.
&lt;/li&gt;&lt;li&gt; CT scan: Head and neck scan with intravenous (IV) contrast is useful if incision and drainage (I&amp;amp;D) is failed, if the patient cannot open his or her mouth, or if the patient is young (&amp;lt;7 y). A hypodense fluid collection with rim enhancement may be seen in the affected tonsil. Foreign bodies such as fish or chicken bones may also be found as an inciting factor.
&lt;/li&gt;&lt;li&gt; Ultrasonography: Intraoral ultrasonography (use vaginal probe with condom!) has a sensitivity of 95.2% and specificity of 78.5%. Transcutaneous ultrasonography has a sensitivity of 80% and specificity of 92.8%. This method is cost-effective and fast.
&lt;/li&gt;&lt;/ul&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Peritonsillar_Abscess_(PTA)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt; Needle aspiration is used for symptom relief and is the criterion standard for diagnosis 
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Peritonsillar_Abscess_(PTA)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Needle aspiration
&lt;/li&gt;&lt;li&gt;Abscess I&amp;amp;D: After lidocaine with epinephrine local infiltration, a No. 11 blade scalpel may be used to incise a very large PTA, allowing the purulent drainage to flow freely as the abscess cavity decompresses. Allow the patient to hold the Yankauer catheter tip and to suction the pus, rather than swallow it.
&lt;/li&gt;&lt;li&gt;Tonsillectomy: for recurrent or emergent PTA (i.e. not protecting airway)
&lt;/li&gt;&lt;li&gt;Hydrate as most patients often not tolerating adequate amount of fluid
&lt;/li&gt;&lt;li&gt;Pain and antipyretics prn
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Peritonsillar_Abscess_(PTA)&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Antibiotics"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Antibiotics"&gt;Antibiotics&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Peritonsillar_Abscess_(PTA)&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Outpatient"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Outpatient"&gt;Outpatient&lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt; Amoxicillin/Clavulanate 875 mg PO BID for 7-10 days
&lt;/li&gt;&lt;li&gt; Clindamycin 600-900 mg IV/PO TID (7.5 mg/kg IV QID) for 7-10 days
&lt;/li&gt;&lt;li&gt; Penicillin G 4 million units IV/PO (50,00 units/kg) four times daily AND Metronidazole 500 mg IV/PO (7.5 mg/kg) four time daily 7-10 days
&lt;/li&gt;&lt;/ul&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Peritonsillar_Abscess_(PTA)&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Inpatient"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Inpatient"&gt;Inpatient&lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt; Ampicillin/Sulbactam 3 gm (75mg/kg) IV four times daily
&lt;/li&gt;&lt;li&gt; Pipericillin/Tazobactam 4.5 gm IV three times daily
&lt;/li&gt;&lt;li&gt; Ticarcillin/Clavulanate 3.1 g IV four time daily
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Peritonsillar_Abscess_(PTA)&amp;amp;action=edit&amp;amp;section=10" title="Edit section: Steroids"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Steroids"&gt;Steroids&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;The addition of a single dose of intravenous dexamethasone to parenteral antibiotics has been found to significantly lessen the variables of hours hospitalized, throat pain, fever, and trismus compared with a group of patients who were only treated with parenteral antibiotics.
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; Dexamethasone 10mg PO/IM once
&lt;/li&gt;&lt;/ul&gt;




</content><folder>ENT</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="pharyngitis_(centor)"><name>Pharyngitis (Centor)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#CENTOR_CRITERIA"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;CENTOR CRITERIA&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-6"&gt;&lt;a href="#Antibiotics"&gt;&lt;span class="tocnumber"&gt;4.1&lt;/span&gt; &lt;span class="toctext"&gt;Antibiotics&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pharyngitis_(Centor)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Most common in children aged 4-7 years
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pharyngitis_(Centor)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pharyngitis_(Centor)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: CENTOR CRITERIA"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="CENTOR_CRITERIA"&gt;CENTOR CRITERIA&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;History of fever
&lt;/li&gt;&lt;li&gt;Absence of cough
&lt;/li&gt;&lt;li&gt;LAD
&lt;/li&gt;&lt;li&gt;Tonsillar exudate
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pharyngitis_(Centor)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;viral pharyngitis
&lt;/li&gt;&lt;li&gt;PTA
&lt;/li&gt;&lt;li&gt;retropharyngeal abscess
&lt;/li&gt;&lt;li&gt;GC pharyngitis
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pharyngitis_(Centor)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt; Treatment &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;&lt;b&gt;CENTOR: CDC Guidelines for adults &amp;gt;15yrs old&lt;/b&gt;
&lt;/p&gt;
&lt;table style="width: 500px" border="1" cellpadding="1" cellspacing="1"&gt;

&lt;tr&gt;
&lt;td&gt; &lt;b&gt;Points&lt;/b&gt;&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Treatment&lt;/b&gt;&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 4&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Rx presumptive
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 3&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Rx Presumptive
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 2&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Rapid Strep Test^
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 1&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Do not test/treat
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 0&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Do not test/treat
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;p&gt;3 criteria = 40% PPV
&lt;/p&gt;&lt;p&gt;4 criteria = 50% PPV
&lt;/p&gt;&lt;p&gt;^No need for cultures after neg rapid test
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pharyngitis_(Centor)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Antibiotics"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Antibiotics"&gt; Antibiotics &lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;PCN (erythro if allergic)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pharyngitis_(Centor)&amp;amp;action=edit&amp;amp;section=7" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;See Peritonsilar Abscess
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pharyngitis_(Centor)&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;3/19/06 DONALDSON (Adapted from Rosen)
&lt;/p&gt;



</content><folder>ENT</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="pilon_fx"><name>Pilon Fx</name><content>&lt;p&gt;Ankle
&lt;/p&gt;&lt;p&gt;axial loading injury-suspect other Fx as well (calcaneal,talar dome, tibial plateau, femoral neck,acetabular,L spine)
&lt;/p&gt;&lt;p&gt;-watch for compartment syndrome
&lt;/p&gt;&lt;p&gt;bad Fracture common to have poor outcomes
&lt;/p&gt;&lt;p&gt;-up to 10-55% complication rate
&lt;/p&gt;&lt;p&gt;-non-union rates from 25 up to 100% with severe Fx
&lt;/p&gt;&lt;p&gt;-malunion rates up to 42% in some series.
&lt;/p&gt;&lt;p&gt;-post-traumatic arthritis extremely common.
&lt;/p&gt;



</content><folder>Ortho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="placenta_previa"><name>Placenta Previa</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Risk_Factors"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Risk Factors&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Placenta_Previa&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; placenta improperly positioned between cervic and baby. can be total, partial or marginal
&lt;/li&gt;&lt;li&gt; tx c c section
&lt;/li&gt;&lt;li&gt; hem from early separation of placenta from ut- due to gradual thinning of cervix in anticipation of delivery.  can also be by physical exertion, labor, local trauma (intercourse, speculum exam)
&lt;/li&gt;&lt;li&gt; assoc with intrauterine growth retardation, congenital abnormalities, and placenta prev.
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Placenta_Previa&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Risk Factors"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Risk_Factors"&gt;Risk Factors&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; c section
&lt;/li&gt;&lt;li&gt; previous pl previa
&lt;/li&gt;&lt;li&gt; twins
&lt;/li&gt;&lt;li&gt; D&amp;amp;C
&lt;/li&gt;&lt;li&gt; muliparous
&lt;/li&gt;&lt;li&gt; scarring of uterus with no place for placenta to attach except at botton near cervix
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Placenta_Previa&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; painless bright red blood
&lt;/li&gt;&lt;li&gt; exam only with double set up in OR by obstetrician
&lt;/li&gt;&lt;li&gt; in ER use abd utz
&lt;/li&gt;&lt;li&gt; 90% of prev dx before 20 wks will have placnta that migrates away from cervix or lower ut  segmnt will grow more
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Placenta_Previa&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; c section
&lt;/li&gt;&lt;li&gt; if fetus not viable, tx in hospital until viable then c section
&lt;/li&gt;&lt;/ol&gt;




</content><folder>OB/GYN</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="plantar_fasciitis"><name>Plantar Fasciitis</name><content>&lt;p&gt;Insert
&lt;/p&gt;



</content><folder>Ortho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="pleural_effusions"><name>Pleural Effusions</name><content>&lt;p&gt;(court. Giancarlo Dimassa) based on NEJM 6/20/02 by Richard Light
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Signs: Dullness to perc., absence of fremitus, diminished or absent breath sounds, tracheal deviation, intercostal retractions, displaced apical pulse.
&lt;/p&gt;&lt;p&gt;...assoc. signs clue in to disease process.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;radiologic eval: 250 CC needed to see effusion.
&lt;/p&gt;&lt;p&gt;-ultrasosund and/or lat decub often used_Ct scan allows lung parenchyma, and mediastinum imaging.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Indications for Thoracentesis-
&lt;/p&gt;&lt;p&gt;Presence of clinically significant effusion (greater than 10mm thick on U/S or lat decub) with no known cause.
&lt;/p&gt;&lt;p&gt;-if pt has CHF and effusion persists for more than three days despite treatment and/or diueresis, or is unilateral.
&lt;/p&gt;&lt;p&gt;-up to 1500cc can be removed for therapeutic purposes. Removing greater than this increases chance of developing post expansion pulmonary edema (20% mortality).
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Repeat the CXR after? Not necessary unless:
&lt;/p&gt;&lt;p&gt;-air is obtained during thoracentesis
&lt;/p&gt;&lt;p&gt;-coughing, chest pain, or dypnea develops
&lt;/p&gt;&lt;p&gt;-tactile fremitus is lost over the superior part of the aspirated hemithorax.
&lt;/p&gt;&lt;p&gt;(based on ALeman,Alegre, Armadans-The value of CXR in the Dx of PTX after Thoracentesis AM J Med 1999;107:340-3...they looked at 506 pleural taps of 18 with these symptoms, 13 had PTX, of the other 488 without these symptoms only five had PTX)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Fluid Analysis:
&lt;/p&gt;&lt;p&gt;possibilities:
&lt;/p&gt;&lt;p&gt;Protein, LDH, Specific Grav, PH, Culture, Gram's stain, Red COunt, White Count, diff, Wright's stain, glc, triglycerides, amylase, lipase, interferon gamma, adenosine deaminase, cholesterol, cytology, cytometry, AFB cultures, ANA, PCR for myco etc...
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;per Dr. Light- examine the fluid...if it looks like a transudate only need to send protein, and LDH (extra tests in this group often not only are low yield, but give misleading results..)
&lt;/p&gt;&lt;p&gt;-if fluid is exudative then need to send cell count with diff, smears and cultures, glucose, LDH, cyotlogy, and pleural mrkers for TB.
&lt;/p&gt;&lt;p&gt;the clinical picture sdhould decide whether to send the obscure lab tests...
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;TB:
&lt;/p&gt;&lt;p&gt;For TB &amp;lt; 40% of patients with TB have positive cultures, so alternates like Adenosine Deaminase, interferon-gamma, and PCR should be used.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Trans vs. Exudate:
&lt;/p&gt;&lt;p&gt;Light's Criteria: (one or more of the following three- sens 98% spec 83%)
&lt;/p&gt;&lt;p&gt;pleural fluid protein to serum protein &amp;gt;.5 (sem 86% spec 84%)
&lt;/p&gt;&lt;p&gt;pleural fluid LDH to serum LDH &amp;gt;.6 (sen 90% spec 83%)
&lt;/p&gt;&lt;p&gt;pleural fluid LDH level greater than 2/3 upper limit of normal for serum ldh level. (sen 82% spec 89%)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;other tests you can do:
&lt;/p&gt;&lt;p&gt;pleural fluid cholesterol &amp;gt;60 mg/dl (sens 54% spec 92%)
&lt;/p&gt;&lt;p&gt;pleurla fluid chol &amp;gt; 43 mg/dl (sens 75% spec 80%)
&lt;/p&gt;&lt;p&gt;pleural fluid chol/serum chol &amp;gt;.3 (sens 89% spec 81%)
&lt;/p&gt;&lt;p&gt;seru malbumin level-pleural fluid albumin level &amp;lt; 1.2 g/dl (sens 87% spec 92%)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;If appearance of fluid turbid supernatant-send Triglyceride level:
&lt;/p&gt;&lt;p&gt;&amp;gt;110 mg/dl=chylothorax
&lt;/p&gt;&lt;p&gt;&amp;gt;50 mg/dl but &amp;lt;110 mg/dl-obtain lipoprotein analysis---&amp;gt;if chylomicrons present=chylothorax.
&lt;/p&gt;&lt;p&gt;If &amp;lt;50 mg/dl and cholesterol is grteater than 250 mg/dl---&amp;gt;pseudochylothorax.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;...last bits...
&lt;/p&gt;&lt;p&gt;If the above workup fails to yield a diagnosis than you need to rule out a PE as the casue of the effusion.
&lt;/p&gt;&lt;p&gt;Empyema Criteria (Light's)
&lt;/p&gt;&lt;p&gt;pH less than 7.2 (old 7.0)
&lt;/p&gt;&lt;p&gt;glucose &amp;lt;40 mg/dl
&lt;/p&gt;&lt;p&gt;LDH &amp;gt; 1000 IU/L
&lt;/p&gt;&lt;p&gt;-if there is purulence, pos. gram stain, loculated effusion or if LDH is 3x upper limit of normal than a chest tube should be placed.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;causes of transudates:
&lt;/p&gt;&lt;p&gt;-CHF
&lt;/p&gt;&lt;p&gt;-Nephrotic Syndrome
&lt;/p&gt;&lt;p&gt;-Cirrhosis
&lt;/p&gt;&lt;p&gt;-hypoalbuminemia
&lt;/p&gt;&lt;p&gt;-urinothorax
&lt;/p&gt;&lt;p&gt;-Peritoneal Dialysis
&lt;/p&gt;&lt;p&gt;-early Atelectasis
&lt;/p&gt;&lt;p&gt;-PE
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;causes of Exudates:
&lt;/p&gt;&lt;p&gt;-Infection
&lt;/p&gt;&lt;p&gt;Malignancy
&lt;/p&gt;&lt;p&gt;-Connective Tissue disease
&lt;/p&gt;&lt;p&gt;-Chylkothorax
&lt;/p&gt;&lt;p&gt;-hemothorax
&lt;/p&gt;&lt;p&gt;-Pancreatitis
&lt;/p&gt;&lt;p&gt;-Post cardiotomoy syndrome
&lt;/p&gt;&lt;p&gt;-Drug induced (amiodarone)
&lt;/p&gt;&lt;p&gt;-Esophageal rupture
&lt;/p&gt;&lt;p&gt;-Uremia
&lt;/p&gt;&lt;p&gt;-subdiaphragmatic abscess
&lt;/p&gt;&lt;p&gt;-pulmonary embolism
&lt;/p&gt;&lt;p&gt;-Asbestos exposure
&lt;/p&gt;&lt;p&gt;-chronic Atelectasis.
&lt;/p&gt;



</content><folder>Pulm</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="pneumonia_(cap)"><name>Pneumonia (CAP)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Clinical_Presentation"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Clinical Presentation&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pneumonia_(CAP)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; 3 questions:
&lt;/li&gt;&lt;li&gt; Does this pt have pneumonia
&lt;/li&gt;&lt;li&gt; If yes, does this pt need to be admitted
&lt;/li&gt;&lt;li&gt; If yes, admit to the ward or ICU? 
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pneumonia_(CAP)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Clinical Presentation"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Clinical_Presentation"&gt;Clinical Presentation&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Fever, chills, pleuritic CP, productive cough
&lt;/li&gt;&lt;li&gt; Fever is seen in 80%
&lt;/li&gt;&lt;li&gt; Tachypnea
&lt;/li&gt;&lt;li&gt; Most sensitive sign in elderly 
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pneumonia_(CAP)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; CXR
&lt;/li&gt;&lt;li&gt; CBC
&lt;/li&gt;&lt;li&gt; Chemistry 
&lt;/li&gt;&lt;li&gt; If pt to be admitted:
&lt;/li&gt;&lt;li&gt; Blood cultures (required if pt may require ICU during their course)
&lt;/li&gt;&lt;li&gt; Sputum staining
&lt;/li&gt;&lt;li&gt; If concern for particular organism
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pneumonia_(CAP)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Abx within 6 hours
&lt;/li&gt;&lt;li&gt; 10-14 days 
&lt;/li&gt;&lt;li&gt; Outpatient, healthy 
&lt;/li&gt;&lt;li&gt; Macrolide OR doxycycline
&lt;/li&gt;&lt;li&gt; Outpatient, unhealthy
&lt;/li&gt;&lt;li&gt; Respiratory fluoroquinolone alone OR macrolide + beta-lactam 
&lt;/li&gt;&lt;li&gt; History of cardiopulmonary disease
&lt;/li&gt;&lt;li&gt; Some high risk factors
&lt;/li&gt;&lt;li&gt; Abx w/in 3 months
&lt;/li&gt;&lt;li&gt; Port Class 1 or 2 
&lt;/li&gt;&lt;li&gt; Inpatient, ward
&lt;/li&gt;&lt;li&gt; Respiratory fluoroquinolone alone OR macrolide + beta-lactam 
&lt;/li&gt;&lt;li&gt; Inpatient, ICU, risk of pseudomonas
&lt;/li&gt;&lt;li&gt; Cefipime, imipenem, OR piperacillin-tazobactam + IV cipro/levo
&lt;/li&gt;&lt;li&gt; OR
&lt;/li&gt;&lt;li&gt; Cefipime, imipenem, OR piperacillin-tazobactam + gent + azithromycin 
&lt;/li&gt;&lt;li&gt; OR
&lt;/li&gt;&lt;li&gt; Cefipime, imipenem, OR piperacillin-tazobactam + gent + cipro/levo 
&lt;/li&gt;&lt;li&gt; Inpatient, ICU, low risk of pseudomonas
&lt;/li&gt;&lt;li&gt; Beta-lactam + (macrolide OR respiratory fluoroquinolone)
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
Pseudomonas risk factors:
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; Alcoholism
&lt;/li&gt;&lt;li&gt; Immunosuppression (incl. steroids)
&lt;/li&gt;&lt;li&gt; Structural lung disease
&lt;/li&gt;&lt;li&gt; Malnutrition
&lt;/li&gt;&lt;li&gt; Recent abx
&lt;/li&gt;&lt;li&gt; Recent hospital stay 
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pneumonia_(CAP)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;See Pneumonia (Port Score)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pneumonia_(CAP)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Pneumonia (Pathogens)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pneumonia_(CAP)&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;UpToDate
&lt;/p&gt;



</content><folder>Pulm</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="pneumonia_(pathogens)"><name>Pneumonia (Pathogens)</name><content>&lt;table border="1"&gt;

&lt;tr&gt;
&lt;td&gt; &lt;b&gt;Conditions&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Commonly Encountered Pathogens&lt;/b&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td height="13"&gt; Alcoholism
&lt;/td&gt;&lt;td rowspan="3"&gt;
&lt;p&gt;Streptococcus pneumoniae
&lt;/p&gt;&lt;p&gt;Anaerobes, e.g. Klebsiella pneumoniae
&lt;/p&gt;&lt;p&gt;Mycobacterium tuberculosis
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td height="13"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td height="13"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td height="13"&gt; COPD and/or Smoking
&lt;/td&gt;&lt;td rowspan="4"&gt;
&lt;p&gt;S pneumoniae
&lt;/p&gt;&lt;p&gt;Haemophilus influenzae
&lt;/p&gt;&lt;p&gt;Moraxella
&lt;/p&gt;&lt;p&gt;Legionella
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td height="13"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td height="13"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td height="13"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td height="13"&gt; Nursing Home
&lt;/td&gt;&lt;td rowspan="3"&gt;
&lt;p&gt;S pneumoniae
&lt;/p&gt;&lt;p&gt;Gram-negative bacilli
&lt;/p&gt;&lt;p&gt;H influenzae
&lt;/p&gt;&lt;p&gt;Staphylococcus aureus
&lt;/p&gt;&lt;p&gt;Anaerobes
&lt;/p&gt;&lt;p&gt;Chlamydia pneumoniae
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td height="13"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td height="13"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td height="13"&gt; Exposure to: Bird droppings
&lt;/td&gt;&lt;td&gt; Histoplasma capsulatum
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td height="13"&gt; Birds
&lt;/td&gt;&lt;td&gt; Chlamydia psittaci
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td height="13"&gt; Rabbits
&lt;/td&gt;&lt;td&gt; Francisella tularensis
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td height="13"&gt; Farm animals
&lt;/td&gt;&lt;td&gt; Coxiella burnetii (Q fever)
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td height="13"&gt; SW US
&lt;/td&gt;&lt;td&gt; Coccidiomycosis (Valley fever)&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td height="13"&gt; HIV
&lt;/td&gt;&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td height="13"&gt; Early
&lt;/td&gt;&lt;td&gt;
&lt;p&gt;S pneumoniae
&lt;/p&gt;&lt;p&gt;H influenzae
&lt;/p&gt;&lt;p&gt;M tuberculosis
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td height="13"&gt; Late
&lt;/td&gt;&lt;td rowspan="2"&gt;
&lt;p&gt;As above, plus:
&lt;/p&gt;&lt;p&gt;Pneumocystis jiroveci (formerly Pneumocystis carinii)
&lt;/p&gt;&lt;p&gt;Cryptococcus
&lt;/p&gt;&lt;p&gt;Histoplasma species
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td height="13"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td height="13"&gt; Aspiration
&lt;/td&gt;&lt;td&gt; Anaerobes
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td height="13"&gt;
&lt;p&gt;Structural Lung Disease
&lt;/p&gt;&lt;p&gt;(CF, bronchiectasis)
&lt;/p&gt;
&lt;/td&gt;&lt;td&gt;
&lt;p&gt;Pseudomonas aeruginosa
&lt;/p&gt;&lt;p&gt;Burkholderia (Pseudomonas) cepacia
&lt;/p&gt;&lt;p&gt;S aureus
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td height="13"&gt; Injection Drug Use
&lt;/td&gt;&lt;td rowspan="3"&gt;
&lt;p&gt;S aureus
&lt;/p&gt;&lt;p&gt;Anaerobes
&lt;/p&gt;&lt;p&gt;M tuberculosis
&lt;/p&gt;&lt;p&gt;S Pneumo
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td height="13"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td height="13"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td height="13"&gt; Influenza
&lt;/td&gt;&lt;td rowspan="2"&gt;
&lt;p&gt;Influenza
&lt;/p&gt;&lt;p&gt;S pneumoniae
&lt;/p&gt;&lt;p&gt;S aureus
&lt;/p&gt;&lt;p&gt;H influenzae
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td height="13"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pneumonia_(Pathogens)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt; See Also &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Pulm: Pneumonia (Port Score)
&lt;/p&gt;&lt;p&gt;Pulm: Pneumonia (CAP)
&lt;/p&gt;



</content><folder>Pulm</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="pneumonia_(peds)"><name>Pneumonia (Peds)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Causes"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Causes&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Sources"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Sources&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pneumonia_(Peds)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- fever and tachypnea have high degree of sens but not specific
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pneumonia_(Peds)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Causes"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Causes"&gt;Causes&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Common Causes
&lt;/p&gt;&lt;p&gt;- viruses- rsv, influenza, parainflu, adeno, rhino, measles
&lt;/p&gt;&lt;p&gt;- mycoplasma
&lt;/p&gt;&lt;p&gt;- chlamydia- pneumoniae and trachomatis
&lt;/p&gt;&lt;p&gt;- bacteria- strep, tb, staph, hflu, nontypable hflu
&lt;/p&gt;&lt;p&gt;- measles and nontypable hflu common in undeveloped world
&lt;/p&gt;&lt;p&gt;- c. pneumonia frequently recovered from asymptomatic subjects
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Uncommon Causes
&lt;/p&gt;&lt;p&gt;- viruses- varicella zoster, corona, entero, coxsackie, echo, cmv, ebv, mumps, hsv- newborns, hanta is animal exp,
&lt;/p&gt;&lt;p&gt;- chlamydia psittaci
&lt;/p&gt;&lt;p&gt;- coxiella
&lt;/p&gt;&lt;p&gt;- bacteria- strep pyogenes, anaerobic mouth, hflu, pertussis, klebsiella, ecoli, listeria, nesseria, legionella, pseudomonas, tularremia, brucella, leptospira,
&lt;/p&gt;&lt;p&gt;- Fungi- cocci, histo, blasto
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pneumonia_(Peds)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- cxr cannot differentiate between viral and bact pna (but lobar infiltrate more often bacterial)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;WHO Criteria
&lt;/p&gt;&lt;p&gt;1. Tachypnea
&lt;/p&gt;&lt;p&gt;RR &amp;gt;50 (&amp;lt;1 yr old)
&lt;/p&gt;&lt;p&gt;RR &amp;gt;40 (&amp;gt;1 yr old)
&lt;/p&gt;&lt;p&gt;2. Retractions
&lt;/p&gt;&lt;p&gt;Pneumonia: admit if &amp;lt;2 months, tx with azithromycin or clarithromycin after 3 months
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pneumonia_(Peds)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pneumonia_(Peds)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;ADMIT
&lt;/p&gt;&lt;p&gt;-&amp;lt; 3months
&lt;/p&gt;&lt;p&gt;-SaO2 &amp;lt;91%
&lt;/p&gt;&lt;p&gt;-severe dehydration
&lt;/p&gt;&lt;p&gt;-moderate dehydration and unable to hydrate themselves orally after intravenous (IV) hydration
&lt;/p&gt;&lt;p&gt;-moderate or severe respiratory distress
&lt;/p&gt;&lt;p&gt;-failed outpatient antibiotic treatment, or
&lt;/p&gt;&lt;p&gt;-unsafe to send home
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pneumonia_(Peds)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Sources"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Sources"&gt;Sources&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from Donaldson, Pani
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="pneumonia_(port_score)"><name>Pneumonia (Port Score)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Port_Score"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Port Score&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#Scoring"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;Scoring&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Classification"&gt;&lt;span class="tocnumber"&gt;1.2&lt;/span&gt; &lt;span class="toctext"&gt;Classification&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pneumonia_(Port_Score)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Port Score"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Port_Score"&gt; Port Score &lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pneumonia_(Port_Score)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Scoring"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Scoring"&gt; Scoring &lt;/span&gt;&lt;/h3&gt;
&lt;table border="1"&gt;

&lt;tr&gt;
&lt;td&gt;
&lt;p&gt;&lt;u&gt;&lt;b&gt;Risk Factors&lt;/b&gt;&lt;/u&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td&gt; &lt;u&gt;&lt;b&gt;Points&lt;br /&gt;&lt;/b&gt;&lt;/u&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td colspan="2"&gt; &lt;b&gt;Demographic Factors &lt;/b&gt;&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Age for men&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Age&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Age for women&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Age -10&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Nursing home resident&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; +10&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; &lt;b&gt;Coexisting Illnesses &lt;/b&gt;&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Neoplastic disease (active)&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; +30&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Chronic liver disease&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; +20&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Heart Failure&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; +10&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Cerebrovascular disease&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; +10&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Chronic renal disease&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; +10&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; &lt;b&gt;Physical Exam &lt;/b&gt;&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; AMS&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; +20&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; RR &amp;gt; 30/min&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; +20&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Sys BP &amp;lt; 90&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; +20&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Temp &amp;lt;35 or &amp;gt;40&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; +15&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Pulse &amp;gt; 125&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; +10&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; &lt;b&gt;Lab and xray findings&lt;/b&gt;&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Arterial pH &amp;lt; 7.35&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; +30&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; BUN &amp;gt; 30&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; +20&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Na &amp;lt;130&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; +20&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Glucose &amp;gt; 250&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; +10&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Hematocrit &amp;lt;30%&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; +10&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; PaO2 &amp;lt; 60 or SpO2 &amp;lt; 90%&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; +10&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Pleural effusion&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; +10&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pneumonia_(Port_Score)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Classification"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Classification"&gt; Classification &lt;/span&gt;&lt;/h3&gt;
&lt;table border="1" width="172"&gt;

&lt;tr&gt;
&lt;td&gt; &lt;b&gt;Class &lt;/b&gt;&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Points &lt;/b&gt;&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Mortality &lt;/b&gt;&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; I&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; ^^^
&lt;/td&gt;&lt;td&gt; 0.1%&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; II&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &amp;lt;71&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 0.6%&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; III&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 71-90&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 2.8%&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; IV&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 91-130&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 8.2%&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; V&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &amp;gt;130&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 29.2%&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;p&gt;^^^Less than age 55 with no other points
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pneumonia_(Port_Score)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt; See Also &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Pulm: Pneumonia (Pathogens)
&lt;/p&gt;&lt;p&gt;Pulm: Pneumonia (CAP)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pneumonia_(Port_Score)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt; Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;2/8/06 DONALDSON (from 'the board')
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;



</content><folder>Pulm</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="pneumothorax_(traumatic)"><name>Pneumothorax (Traumatic)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pneumothorax_(Traumatic)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;present in 15-50% blunt (usu d/t lung lac w/ air leak, but 6.7% w/o rib fx), 100% penetrating trauma (75%=htx too)
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;htx from lung stops bleeding easily b/c low pressure &amp;amp; thromboplastin in lung, intercostals &amp;amp; int mamm &amp;amp; great vessels bleed much more
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;air reabsorbs @ 1.25% of lung volume/day
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pneumothorax_(Traumatic)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Upright insp cxr best 1st film b/c can see blood &amp;amp; mediastinum but miss 1/3 ptx, upright exp cxr incr sens for ptx but decr sens for htx
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;if neg, repeat in 3hr, 12%= delay presentation
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;supine cxr can hide up to 1 L of blood &amp;amp; ptx, for ptx look @ cpa for deep sulcus sign (b/c air rises ant &amp;amp; tracts above diaphragm exagerating cpa), ct scan is gold standard
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pneumothorax_(Traumatic)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;80% of bleeding stops post c-tube placed
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Can obs ptx if minimal (&amp;lt;25% collapse), which is CXR w/ &amp;lt;4cm collapse of lung @ apex, or &amp;lt;1cm collapse from lat cw margin), some say if see on CXR nd tube, but NEED tube IF: ANYsx, + pressure vent, to OR, transport, any htx or aloc/sedated!
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;nd @ least 200-300 cc blood to see on upright cxr, nd c-tube b/c blood= fibrous tissue &amp;amp; eventual nd for thoracotomy if not removed!
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;always put ct on wall suction 15 cm (look @ level of H2O, NOT wall device to set 15cm)
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;never clamp c-tube, or put in farther if not in all way (contaminated), replace!
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Tension PTX can needle, but ONLY needle if HD compromised! needle only relieves pressure, does not re-expand lung &amp;amp; can be a 2nd source of tension to develop if only simple ptx exists, thus, in field decr bs but stable= NO needle!
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;sucking ptx nds 3 side drsg; if large piece of cw missing, pt cannot generate pressure to breathe so intubate &amp;amp; + pressure ventilate!
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;c-tube= ANCEF!!
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pneumothorax_(Traumatic)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;(Burbulys 2004/Trauma Reports 4/04 /A-Digest 7/04) -by Lampe
&lt;/p&gt;



</content><folder>Trauma</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="poison_control"><name>Poison Control</name><content>&lt;p&gt;1-800-876-4766
&lt;/p&gt;&lt;p&gt;1-800-222-1222
&lt;/p&gt;



</content><folder>Tox</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="poison_oak,_ivy,_sumac"><name>Poison Oak, Ivy, Sumac</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Poison_Oak,_Ivy,_Sumac&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- ivy found east coast- 3 leaf structure
&lt;/p&gt;&lt;p&gt;- oak- along Pacific Coast can be tree bush or vine- jet black stain on leaf, 3 leaf structure
&lt;/p&gt;&lt;p&gt;- sumac- in swamps- 2 opposing leaflets single terminal leaf
&lt;/p&gt;&lt;p&gt;-Mango and Cashews can cross react
&lt;/p&gt;&lt;p&gt;- toxicodendron- antigen is urushiole
&lt;/p&gt;&lt;p&gt;- T- cell mediated delayed hypersensitivity
&lt;/p&gt;&lt;p&gt;- resin carried by smoke of burning leaves
&lt;/p&gt;&lt;p&gt;- resin found in leaves and stems- not surface
&lt;/p&gt;&lt;p&gt;- must break or crush to release resin
&lt;/p&gt;&lt;p&gt;- resin binds in 30sec. After binds cannot wash off
&lt;/p&gt;&lt;p&gt;- lesions start in 48hrs
&lt;/p&gt;&lt;p&gt;- linear array of vesicles
&lt;/p&gt;&lt;p&gt;- vesicle fluid not antigenic
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Poison_Oak,_Ivy,_Sumac&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;PREXPOSURE PROPHYLAXIS-
&lt;/p&gt;&lt;p&gt;-Ivy Shield, Stokogard, Organoclay, IvyBlock
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;POSTEXPOSURE PROPHYLAXIS-
&lt;/p&gt;&lt;p&gt;-Technu Poison Cleanser- may solubilize bound resin several hours post exposure
&lt;/p&gt;&lt;p&gt;-Dr Wests Ivy Detox Cleanser chelates urushiol- decreases itching even if have rash
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;SYMPTOMATIC TX
&lt;/p&gt;&lt;p&gt;- if small can use topical Temovate 0.05%
&lt;/p&gt;&lt;p&gt;- topical anesthetic- menthol or pramoxine
&lt;/p&gt;&lt;p&gt;- single IM dose of Triamcinolone or Prednisone taper over 15-20 days- 60mg x 4d then 50mg x 4d then 40 30 20....Use oral steroid for 3wks until skin turns over
&lt;/p&gt;&lt;p&gt;- systemic antihistamines
&lt;/p&gt;&lt;p&gt;- cooling soothing baths
&lt;/p&gt;&lt;p&gt;- Pentoxifylline- blocks formation of TNF alpha- suppresses allergic patch testing
&lt;/p&gt;&lt;p&gt;Put sunscreen first, then prexposure ivy cream, then mosquito repellant
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Poison_Oak,_Ivy,_Sumac&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;6/06 MISTRY
&lt;/p&gt;



</content><folder>Tox</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="post-partum_hemorrhage"><name>Post-Partum Hemorrhage</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Post-Partum_Hemorrhage&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Causes"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Causes"&gt;Causes&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Uterine atony
&lt;/li&gt;&lt;li&gt; Retained POC
&lt;/li&gt;&lt;li&gt; Laceration of vagina/cervix
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Post-Partum_Hemorrhage&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Pitocin
&lt;/li&gt;&lt;li&gt; More Pit
&lt;/li&gt;&lt;li&gt; Methergine IM
&lt;/li&gt;&lt;li&gt; Hemabate (PGF 2 alpha)
&lt;/li&gt;&lt;li&gt; Cytotec PR (PGE1) (Misoprostol)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Post-Partum_Hemorrhage&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;7/09 PANI
&lt;/p&gt;



</content><folder>OB/GYN</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="post-streptococcal_glomerular_nephritis_(psgn)"><name>Post-streptococcal glomerular nephritis (PSGN)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Post-streptococcal_glomerular_nephritis_(PSGN)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;most common cause of acute nephritis worldwide
&lt;/li&gt;&lt;li&gt;risk greatest in children 5-12 years old and adults &amp;gt;60
&lt;/li&gt;&lt;li&gt;caused by glomerular immune complex disease induced by specific nephritogenic strains of group A beta-hemolytic streptococcus (GAS)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Post-streptococcal_glomerular_nephritis_(PSGN)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Most common:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;edema
&lt;/li&gt;&lt;li&gt;gross hematuria
&lt;/li&gt;&lt;li&gt;hypertension
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;Varies from asymptomatic to microscopic hematuria to acute nephritic syndrome (gross hematuria, proteinuria, edema, hypertension, and acute kidney injury)
&lt;/p&gt;&lt;p&gt;Typically diagnosed by acute nephritis + recent GAS infection
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Post-streptococcal_glomerular_nephritis_(PSGN)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;CBC
&lt;/li&gt;&lt;li&gt;Chem 7
&lt;/li&gt;&lt;li&gt;UA (dysmorphic red blood cells, varying degrees of proteinuria, red blood cell casts, and pyuria)
&lt;/li&gt;&lt;li&gt;Strep antigen serology 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Post-streptococcal_glomerular_nephritis_(PSGN)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Post-streptococcal_glomerular_nephritis_(PSGN)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Supportive management (treat volume overload)
&lt;ol&gt;&lt;li&gt; sodium and water restriction
&lt;/li&gt;&lt;li&gt; lasix (also controls HTN)
&lt;/li&gt;&lt;li&gt; consider dialysis (for acute renal failure) 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Post-streptococcal_glomerular_nephritis_(PSGN)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;most have complete recovery, particularly children
&lt;/li&gt;&lt;li&gt;resolution begins within the first two weeks
&lt;/li&gt;&lt;li&gt;small subset have late renal complications (ie, hypertension, increasing proteinuria, and renal insufficiency)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Post-streptococcal_glomerular_nephritis_(PSGN)&amp;amp;action=edit&amp;amp;section=7" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Post-streptococcal_glomerular_nephritis_(PSGN)&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;KajiQuestions
&lt;/p&gt;



</content><folder>GU</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="post-tpa_hemorrhage"><name>Post-tPA Hemorrhage</name><content>&lt;p&gt;Consider bleeding if decreased LOC, increased weakness, new headache, sudden rise in blood pressure
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
If bleeding occurs after tPA:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt; Stop tpa infusion
&lt;/li&gt;&lt;li&gt; Stat head CT
&lt;ol&gt;&lt;li&gt; if no bleeding resume tpa
&lt;/li&gt;&lt;li&gt; If bleeding check labs, consider fibrinogen replacement 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Recheck pt/ptt, platelets, fibrinogen levels
&lt;/li&gt;&lt;li&gt; Prepare 6- 8 units cryoprecipitate
&lt;/li&gt;&lt;li&gt; Prepare 6- 8 units platelets
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Post-tPA_Hemorrhage&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;6/06 MISTRY
&lt;/p&gt;



</content><folder>Heme/Onc</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="post_cardiac_arrest"><name>Post Cardiac Arrest</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Post_Cardiac_Arrest&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Maintain perfusion (cerebral)
&lt;ol&gt;&lt;li&gt;Tx hypotension
&lt;/li&gt;&lt;li&gt;ignore HTN
&lt;/li&gt;&lt;li&gt;normal PaCO2 (~40)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Normoxia
&lt;ol&gt;&lt;li&gt;PaO2 80-120
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Mild Hypothermia (except in trauma)
&lt;ol&gt;&lt;li&gt;32-34 deg C for 12-24 hrs
&lt;/li&gt;&lt;li&gt;aggresivly Tx hyperthermia (acetamin)
&lt;/li&gt;&lt;li&gt;prevent shivering (meperidine, buspirone, and/or dexmetomidine)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Aggressively Tx hyperglycemia
&lt;ol&gt;&lt;li&gt;no IVFs with glucose
&lt;/li&gt;&lt;li&gt;RISS
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Aggressive Seizure Tx
&lt;ol&gt;&lt;li&gt;prophylaxis unproven
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Minimize Irritation
&lt;ol&gt;&lt;li&gt;sedatives +/- paralytics
&lt;/li&gt;&lt;li&gt;supine flat
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Post_Cardiac_Arrest&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;2/17/06   DONALDSON (adapted from Rosen)
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="postpartum_emergencies"><name>Postpartum Emergencies</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Late_Postpartum_Eclampsia"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Late Postpartum Eclampsia&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;1.2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;1.3&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;1.4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#HELLP_Syndrome"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;HELLP Syndrome&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-7"&gt;&lt;a href="#Background_2"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-8"&gt;&lt;a href="#Diagnosis_2"&gt;&lt;span class="tocnumber"&gt;2.2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-9"&gt;&lt;a href="#Work-Up_2"&gt;&lt;span class="tocnumber"&gt;2.3&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-10"&gt;&lt;a href="#Treatment_2"&gt;&lt;span class="tocnumber"&gt;2.4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-11"&gt;&lt;a href="#Complications"&gt;&lt;span class="tocnumber"&gt;2.5&lt;/span&gt; &lt;span class="toctext"&gt;Complications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-12"&gt;&lt;a href="#Peripartum_Cardiomyopathy"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Peripartum Cardiomyopathy&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-13"&gt;&lt;a href="#Background_3"&gt;&lt;span class="tocnumber"&gt;3.1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-14"&gt;&lt;a href="#Diagnosis_3"&gt;&lt;span class="tocnumber"&gt;3.2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-15"&gt;&lt;a href="#DDX"&gt;&lt;span class="tocnumber"&gt;3.3&lt;/span&gt; &lt;span class="toctext"&gt;DDX&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-16"&gt;&lt;a href="#Treatment_3"&gt;&lt;span class="tocnumber"&gt;3.4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-17"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Postpartum_Emergencies&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Late Postpartum Eclampsia"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Late_Postpartum_Eclampsia"&gt;Late Postpartum Eclampsia&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Postpartum_Emergencies&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt; Background &lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt;15% of all cases of eclampsia
&lt;/li&gt;&lt;li&gt;40% have no history of HTN or proteinuria
&lt;/li&gt;&lt;/ul&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Postpartum_Emergencies&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt; Diagnosis &lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Hypertension
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Sys &amp;gt;140 or dia &amp;gt; 90 AND
&lt;/li&gt;&lt;li&gt; Proteinuria &amp;gt; 0.3g in 24-hr
&lt;ul&gt;&lt;li&gt;Urine dipstick of 1+ is suggestive
&lt;ul&gt;&lt;li&gt;Lack of proteinuria is not rule-out!
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;History
&lt;ul&gt;&lt;li&gt;Headache
&lt;/li&gt;&lt;li&gt;Confusion
&lt;/li&gt;&lt;li&gt;Visual disturbances
&lt;/li&gt;&lt;li&gt;Nausea/vomiting
&lt;/li&gt;&lt;li&gt;Epigastric pain
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Physical
&lt;ul&gt;&lt;li&gt;AMS
&lt;/li&gt;&lt;li&gt;Focal neurologic deficits
&lt;/li&gt;&lt;li&gt;Visual symptoms
&lt;/li&gt;&lt;li&gt;Hyperreflexia
&lt;/li&gt;&lt;li&gt;RUQ or diffuse abdominal tenderness
&lt;/li&gt;&lt;li&gt;Peripheral edema
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Postpartum_Emergencies&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt; Work-Up &lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt;UA
&lt;/li&gt;&lt;/ul&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Postpartum_Emergencies&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt; Treatment &lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt;Control blood pressure
&lt;ul&gt;&lt;li&gt;Lower to Sys 130-150, dia 80-100
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Labetalol
&lt;ul&gt;&lt;li&gt;Option 1: Initial 20mg; then doses of 20-80mg q10min to total of 300mg 
&lt;/li&gt;&lt;li&gt;Option 2: Initial 20mg; then IV infusion of 1-2mg/min 
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Hydralazine
&lt;ul&gt;&lt;li&gt; 5mg IV over 1-2min; repeat bolus of 5-10mg q20min PRN to total of 30mg
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Prevent eclampsia
&lt;ul&gt;&lt;li&gt; Magnesium: Load 4-6g IV over 15min followed by 2-3g per hr
&lt;ul&gt;&lt;li&gt;Observe for loss of reflexes, respiratory depression
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;If seizures recur:
&lt;ul&gt;&lt;li&gt;Consider other anticonvulsant drugs
&lt;/li&gt;&lt;li&gt;Consider alternative diagnosis
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Postpartum_Emergencies&amp;amp;action=edit&amp;amp;section=6" title="Edit section: HELLP Syndrome"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="HELLP_Syndrome"&gt; HELLP Syndrome &lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Postpartum_Emergencies&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background_2"&gt; Background &lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt;Presents in postpartum period in 30%
&lt;ul&gt;&lt;li&gt;Usually within 48 hr of delivery
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;80% had no evidence of preeclampsia before delivery
&lt;/li&gt;&lt;/ul&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Postpartum_Emergencies&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis_2"&gt; Diagnosis &lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt;Signs/Symptoms
&lt;ul&gt;&lt;li&gt;RUQ or epigastric pain - 40-90%
&lt;/li&gt;&lt;li&gt;Proteinuria - 86-100%
&lt;/li&gt;&lt;li&gt;Hypertension - 82-88%
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Labs
&lt;ul&gt;&lt;li&gt;CBC w/ diff
&lt;ul&gt;&lt;li&gt;Microangiopathic hemolytic anemia
&lt;/li&gt;&lt;li&gt;Plt count &amp;lt;100
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;LFT
&lt;ul&gt;&lt;li&gt;AST &amp;gt; 70, bilirubin &amp;gt; 1.2
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;LDH &amp;gt; 600
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Postpartum_Emergencies&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up_2"&gt; Work-Up &lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt;CBC w/ diff
&lt;/li&gt;&lt;li&gt;Chemistry
&lt;/li&gt;&lt;li&gt;LFT
&lt;/li&gt;&lt;li&gt;LDH
&lt;/li&gt;&lt;li&gt;PT/PTT/INR
&lt;/li&gt;&lt;li&gt;FDP, fibrinogen, D-Dimer
&lt;/li&gt;&lt;li&gt;CT to evaluate for hepatic hematoma (if needed)
&lt;/li&gt;&lt;/ul&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Postpartum_Emergencies&amp;amp;action=edit&amp;amp;section=10" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment_2"&gt; Treatment &lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt;Same as for eclampsia
&lt;/li&gt;&lt;/ul&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Postpartum_Emergencies&amp;amp;action=edit&amp;amp;section=11" title="Edit section: Complications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Complications"&gt; Complications &lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt; DIC
&lt;/li&gt;&lt;li&gt; Acute renal failure
&lt;/li&gt;&lt;li&gt; Subcapsular liver hematoma
&lt;ul&gt;&lt;li&gt;Abdominal distention
&lt;/li&gt;&lt;li&gt;Mainttain adequate intravascular volume
&lt;ul&gt;&lt;li&gt;If unstable consider embolization vs surgery
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Postpartum_Emergencies&amp;amp;action=edit&amp;amp;section=12" title="Edit section: Peripartum Cardiomyopathy"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Peripartum_Cardiomyopathy"&gt; Peripartum Cardiomyopathy &lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Postpartum_Emergencies&amp;amp;action=edit&amp;amp;section=13" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background_3"&gt; Background &lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt;Presentation similar to typical CHF
&lt;/li&gt;&lt;/ul&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Postpartum_Emergencies&amp;amp;action=edit&amp;amp;section=14" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis_3"&gt; Diagnosis &lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt;Development of heart failure in ast month of pregnancy or w/in 5 months of delivery
&lt;/li&gt;&lt;li&gt;Absence of an identifiable cause for the heart failure
&lt;/li&gt;&lt;li&gt;Absence of recognizable heart disease prior to the last month of
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;pregnancy
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Left ventricular systolic dysfunction
&lt;/li&gt;&lt;/ul&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Postpartum_Emergencies&amp;amp;action=edit&amp;amp;section=15" title="Edit section: DDX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX"&gt; DDX &lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt;Respiratory tract infection
&lt;/li&gt;&lt;li&gt;PE
&lt;/li&gt;&lt;li&gt;MI
&lt;/li&gt;&lt;li&gt;Postpartum fluid overload
&lt;/li&gt;&lt;/ul&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Postpartum_Emergencies&amp;amp;action=edit&amp;amp;section=16" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment_3"&gt; Treatment &lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt;Treat like usual heart failure
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Postpartum_Emergencies&amp;amp;action=edit&amp;amp;section=17" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt; Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;EBM, Volume 12, Number 8, Aug 2010. Postpartum Emergencies
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; &lt;br /&gt;&lt;br /&gt;
&lt;/p&gt;



</content><folder>OB/GYN</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="preeclampsia_and_eclampsia"><name>Preeclampsia and Eclampsia</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Preeclampsia"&gt;&lt;span class="tocnumber"&gt;3.1&lt;/span&gt; &lt;span class="toctext"&gt;Preeclampsia&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Eclampsia"&gt;&lt;span class="tocnumber"&gt;3.2&lt;/span&gt; &lt;span class="toctext"&gt;Eclampsia&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Preeclampsia_and_Eclampsia&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;10% pregnancies complicated by hypertension
&lt;/li&gt;&lt;li&gt;After 20 wks gestation
&lt;/li&gt;&lt;li&gt;Common complaints:
&lt;ol&gt;&lt;li&gt;Headache, visual changes, edema, abdominal pain
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Preeclampsia_and_Eclampsia&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;(National High Blood Pressure Education Program (NHBPEP) Working Group)
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Preeclampsia
&lt;ol&gt;&lt;li&gt; SBP&amp;gt;140 and DBP&amp;gt;90 in previously normotensive patient and with proteinuria &amp;gt; 0.3 gm in 24 hr
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Eclampsia^
&lt;ol&gt;&lt;li&gt;+ Seizure
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;HELLP^ 
&lt;ol&gt;&lt;li&gt;Hemolysis, Elevated LFTS, Low Platelets
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Preeclampsia_and_Eclampsia&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Antihypertensives
&lt;ol&gt;&lt;li&gt;Labetalol or Hydralazine
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Preeclampsia_and_Eclampsia&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Preeclampsia"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Preeclampsia"&gt;Preeclampsia&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;If SBP&amp;gt;160 or DBP&amp;gt;110
&lt;ol&gt;&lt;li&gt;&lt;ol&gt;&lt;li&gt;treat  with magnesium (even without seizure)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Preeclampsia_and_Eclampsia&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Eclampsia"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Eclampsia"&gt;Eclampsia&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Magnesium, load at 4 to 6gm (in 15-20min) then 2gm/hr
&lt;ol&gt;&lt;li&gt;titrate to hyporeflexia and respiratory depression
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Definitive treatment is delivery
&lt;/li&gt;&lt;/ol&gt;




</content><folder>GU</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="pressors"><name>Pressors</name><content>&lt;table border="1"&gt;
&lt;tr&gt;
&lt;td&gt; &lt;b&gt;Agent&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;SVR&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;BP&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;PCW&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;CO&lt;/b&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Dopa &amp;gt;5
&lt;/td&gt;&lt;td&gt; ++
&lt;/td&gt;&lt;td&gt; ++
&lt;/td&gt;&lt;td&gt; +
&lt;/td&gt;&lt;td&gt; -
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Dopa &amp;lt;5
&lt;/td&gt;&lt;td&gt; --
&lt;/td&gt;&lt;td&gt; -
&lt;/td&gt;&lt;td&gt;
&lt;/td&gt;&lt;td&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Dobuta
&lt;/td&gt;&lt;td&gt; --
&lt;/td&gt;&lt;td&gt; +/-
&lt;/td&gt;&lt;td&gt; -
&lt;/td&gt;&lt;td&gt; +
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; D+D (7.5/2.5-5)
&lt;/td&gt;&lt;td&gt; +
&lt;/td&gt;&lt;td&gt; +/-
&lt;/td&gt;&lt;td&gt; +
&lt;/td&gt;&lt;td&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Levo
&lt;/td&gt;&lt;td&gt; ++++
&lt;/td&gt;&lt;td&gt; ++
&lt;/td&gt;&lt;td&gt; ++
&lt;/td&gt;&lt;td&gt; --
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;p&gt;DOPA &amp;gt;5 watch for inc HR/PVC
&lt;/p&gt;&lt;p&gt;DOPA&amp;lt;5 coronary vasodilator
&lt;/p&gt;&lt;p&gt;Dobutamine = 2.5-5; for RV infarct; develop tachyphylaxis
&lt;/p&gt;&lt;p&gt;Levophed- large bore IV; Inc HR
&lt;/p&gt;&lt;p&gt;Milrinone= similar to dobutamine
&lt;/p&gt;&lt;p&gt;Sepsis: Levophed or Dopamine
&lt;/p&gt;&lt;p&gt;Cardiogenic: Dobutamine
&lt;/p&gt;&lt;p&gt;Kids: usually prefer Dopamine, then Epi
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pressors&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;7/1/09 Pani
&lt;/p&gt;



</content><folder>Airway/Resus</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="priapism"><name>Priapism</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Priapism&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; priapism = presence of a persistent, usually painful, erection of penis unrelated to sexual stimulation or desire as a result of persistent engorgment of the corpora cavernosa
&lt;/li&gt;&lt;li&gt; may lead to permanent erectile dysfunction and penile necrosis if untreated
&lt;/li&gt;&lt;li&gt; 2 types:
&lt;ol&gt;&lt;li&gt; arterial high flow: usually due to rupture of cavernous artery (rare, not usually painful) from trauma or blunt injury
&lt;/li&gt;&lt;li&gt; low flow: due to veno-occlusion causing pooling of deoxygenated blood in the cavernous tissue
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; associated with sickle cell disease, trauma, neoplasm, infection, fabry disease, spinal cord injury/cauda equina, and certain medications (phenothiazines,sed-hypnotics,SSRIs,BP meds (guanethidine), Phentolamine
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Priapism&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; cbc (in sickle cell patients and to look for leukemia if pt is without other predisposing factors)
&lt;/li&gt;&lt;li&gt; coags
&lt;/li&gt;&lt;li&gt; platelet count
&lt;/li&gt;&lt;li&gt; UA
&lt;/li&gt;&lt;li&gt; Doppler to differentiate between high-flow and low-flow priapism
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Priapism&amp;amp;action=edit&amp;amp;section=3" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Peyroine disease
&lt;/li&gt;&lt;li&gt; urethral foreing body
&lt;/li&gt;&lt;li&gt; penile surgical implant
&lt;/li&gt;&lt;li&gt; erection from sexual arousal
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Priapism&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; saline hydration
&lt;/li&gt;&lt;li&gt; morphine
&lt;/li&gt;&lt;li&gt; oxygen (if secondary to sickle cell)
&lt;/li&gt;&lt;li&gt; transfusion (if secondary to sickle cell, goal Hg of &amp;gt;10)
&lt;/li&gt;&lt;li&gt; pseudoephedrine 60-120mg orally
&lt;/li&gt;&lt;li&gt; terbutaline 0.5 mg sq
&lt;/li&gt;&lt;li&gt; aspiration/injection of corpus cavernosum
&lt;ol&gt;&lt;li&gt; penile nerve block
&lt;/li&gt;&lt;li&gt; puncture corpus cavernosum through the shaft of the penis with a 19 gauge needle attached to a large syringe
&lt;/li&gt;&lt;li&gt; aspirate blood from either 2 or 10 o'clock position while milking the shaft or inject phenylephrine, epinephrine, or methylene blue
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Priapism&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; admit if refractory to treatment
&lt;/li&gt;&lt;li&gt; may dispo home if treatment is successful with:
&lt;ol&gt;&lt;li&gt; close follow up by urology
&lt;/li&gt;&lt;li&gt; PO alpha-adrednergic agonist for 3-5 days to prevent recurrence
&lt;/li&gt;&lt;li&gt; consider giving terbutaline (PO or SubQ) to patient for self administration at home in those who have recurrent episodes
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Priapism&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from Donaldson
&lt;/p&gt;



</content><folder>GU</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="prolonged_qt"><name>Prolonged QT</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#DDX"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;DDX&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Drug_List"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Drug List&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Prolonged_QT&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;QTc &amp;gt;440 (male) &amp;amp; &amp;gt;460 (female)
&lt;/p&gt;&lt;p&gt;&amp;gt;500 = real concern
&lt;/p&gt;&lt;p&gt;^May result in torsades!
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Prolonged_QT&amp;amp;action=edit&amp;amp;section=2" title="Edit section: DDX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX"&gt;DDX&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Pause Dependent (Aquired)
&lt;ol&gt;&lt;li&gt;Drug induced*
&lt;ol&gt;&lt;li&gt;antidyrhythmics
&lt;/li&gt;&lt;li&gt;phenothiazines
&lt;/li&gt;&lt;li&gt;TCAs
&lt;/li&gt;&lt;li&gt;organophosphates
&lt;/li&gt;&lt;li&gt;antihistamines
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Electrolyte abnl (hypoKalemia, hypoMag, hypoCa)
&lt;/li&gt;&lt;li&gt;Diet related (starvation, low protein)
&lt;/li&gt;&lt;li&gt;Severe bradycardia/AV block
&lt;/li&gt;&lt;li&gt;Hypothyroid
&lt;/li&gt;&lt;li&gt;Contrast injection
&lt;/li&gt;&lt;li&gt;CVA (intraparenchymal)
&lt;/li&gt;&lt;li&gt;MI
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Adrenergic Dependent
&lt;ol&gt;&lt;li&gt;Congenital
&lt;ol&gt;&lt;li&gt;Jarvel/Lange-Nielsen
&lt;ol&gt;&lt;li&gt;(+deafness; AR)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Romano-Ward synd
&lt;ol&gt;&lt;li&gt;(nl hearing; AD)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Sporatic
&lt;/li&gt;&lt;li&gt;Mitral valve prolapse
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Acquired
&lt;ol&gt;&lt;li&gt;CVA (subarachnoid)
&lt;/li&gt;&lt;li&gt;Autonomic surg (catechol excess: neck dissection, carotid endarterect, truncal vagotomy)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Prolonged_QT&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Pause Dependent (precipitated by bradycard)
&lt;ol&gt;&lt;li&gt;Unstable/sustained torsades--&amp;gt; unsynch countershock
&lt;/li&gt;&lt;li&gt;Stable
&lt;ol&gt;&lt;li&gt;treat underlying prob
&lt;/li&gt;&lt;li&gt;increase HR (isoproterenol or overdrive pacing ~100-120bt/min)
&lt;/li&gt;&lt;li&gt;magnesium sulfated IV
&lt;/li&gt;&lt;li&gt;may consider amiodarone
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Adrenergic Dependent (precipited by tachycardia)
&lt;ol&gt;&lt;li&gt;Unstable/sustained torsades--&amp;gt; unsynch countershock
&lt;/li&gt;&lt;li&gt;Stable
&lt;ol&gt;&lt;li&gt;slow HR (B-blockers)
&lt;/li&gt;&lt;li&gt;may consider magnesium
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Prolonged_QT&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Drug List"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Drug_List"&gt;Drug List&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;amiodarone
&lt;/p&gt;&lt;p&gt;aresenic trioxide
&lt;/p&gt;&lt;p&gt;bepridil
&lt;/p&gt;&lt;p&gt;beta agonists
&lt;/p&gt;&lt;p&gt;chloroquine
&lt;/p&gt;&lt;p&gt;cisapride
&lt;/p&gt;&lt;p&gt;clarithromycin
&lt;/p&gt;&lt;p&gt;disopyramide
&lt;/p&gt;&lt;p&gt;dofetilde
&lt;/p&gt;&lt;p&gt;dolasetron
&lt;/p&gt;&lt;p&gt;droperidol
&lt;/p&gt;&lt;p&gt;erythromycin
&lt;/p&gt;&lt;p&gt;flecainide
&lt;/p&gt;&lt;p&gt;fluoxetine
&lt;/p&gt;&lt;p&gt;foscarnet
&lt;/p&gt;&lt;p&gt;fosphenytoin
&lt;/p&gt;&lt;p&gt;gatifloxacin
&lt;/p&gt;&lt;p&gt;haloperidol
&lt;/p&gt;&lt;p&gt;ibutilide
&lt;/p&gt;&lt;p&gt;indapamide
&lt;/p&gt;&lt;p&gt;isradipine
&lt;/p&gt;&lt;p&gt;levofloxacin
&lt;/p&gt;&lt;p&gt;levomethadyl
&lt;/p&gt;&lt;p&gt;mefloquine
&lt;/p&gt;&lt;p&gt;moexipril
&lt;/p&gt;&lt;p&gt;moxifloxacin
&lt;/p&gt;&lt;p&gt;naratriptan
&lt;/p&gt;&lt;p&gt;nicardipine
&lt;/p&gt;&lt;p&gt;octreaotide
&lt;/p&gt;&lt;p&gt;pentamidine
&lt;/p&gt;&lt;p&gt;phenothiazines
&lt;/p&gt;&lt;p&gt;pimozide
&lt;/p&gt;&lt;p&gt;procainamide
&lt;/p&gt;&lt;p&gt;quetiapine
&lt;/p&gt;&lt;p&gt;quinidine
&lt;/p&gt;&lt;p&gt;quinine
&lt;/p&gt;&lt;p&gt;reisperidone
&lt;/p&gt;&lt;p&gt;sertraline
&lt;/p&gt;&lt;p&gt;sotalol
&lt;/p&gt;&lt;p&gt;sparfloxacin
&lt;/p&gt;&lt;p&gt;sumatriptan
&lt;/p&gt;&lt;p&gt;tamoxifen
&lt;/p&gt;&lt;p&gt;tizanidine
&lt;/p&gt;&lt;p&gt;TCAs
&lt;/p&gt;&lt;p&gt;venlafazine
&lt;/p&gt;&lt;p&gt;ziprasidone
&lt;/p&gt;&lt;p&gt;thioridazine&amp;gt;ziprasidone&amp;gt;risperidone&amp;gt;haloperidol
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Prolonged_QT&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;2/14/06 DONALDSON (adapted from Rosen, Pharmacopia, qtdugs.org)
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="prophylactic_abx"><name>Prophylactic Abx</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Prophylactic_Abx&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Indications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Indications"&gt;Indications&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Contaminated Exposure
&lt;ol&gt;&lt;li&gt; Bite (See Wounds: Bites)
&lt;/li&gt;&lt;li&gt; Delayed closure &amp;gt;12-24hours
&lt;/li&gt;&lt;li&gt; Extensive contamination (e.g fecal)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; High Risk Area
&lt;ol&gt;&lt;li&gt; Exposed tendons, bones (incl open fx), or joints
&lt;/li&gt;&lt;li&gt; Through buccal mucosal (PCN)
&lt;/li&gt;&lt;li&gt; Cartilage (ear/nose)
&lt;/li&gt;&lt;li&gt; Sinus fx (HD amox)
&lt;/li&gt;&lt;li&gt; CSF leak?
&lt;/li&gt;&lt;li&gt; Penetrating head injury
&lt;/li&gt;&lt;li&gt; Punctures
&lt;ol&gt;&lt;li&gt; Uncomplicated &amp;lt;6hrs = no prophy
&lt;/li&gt;&lt;li&gt; Immpunocomt = yes
&lt;/li&gt;&lt;li&gt; Plantar (sesp through shoe) = yes
&lt;ol&gt;&lt;li&gt; cipro (adults)
&lt;/li&gt;&lt;li&gt; keflex (peds)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Poor Host
&lt;ol&gt;&lt;li&gt; Immunocompromised (DM, PVD, etc)
&lt;/li&gt;&lt;li&gt; Devascularized
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Prophylactic_Abx&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;10/07 DONALDSON (adapted from Lampe, Rosen)
&lt;/p&gt;



</content><folder>ID</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="propofol"><name>Propofol</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Contraindications"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Contraindications&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Higher_Risk"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;Higher Risk&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Side_Effects"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Side Effects&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Dose"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Dose&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-6"&gt;&lt;a href="#Adjunctive_medications"&gt;&lt;span class="tocnumber"&gt;4.1&lt;/span&gt; &lt;span class="toctext"&gt;Adjunctive medications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Pediatric_Population"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Pediatric Population&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Propofol&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;an ultrashort-acting sedative alkylphenol derivative that induces deep sedation
&lt;/li&gt;&lt;li&gt;rapid onset (90-100 seconds) and short duration (2-8 minute half-life)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Propofol&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Contraindications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Contraindications"&gt;Contraindications&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;allergy to soy or eggs
&lt;/li&gt;&lt;li&gt;hypotension
&lt;/li&gt;&lt;li&gt;aortic stenosis
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Propofol&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Higher Risk"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Higher_Risk"&gt;Higher Risk&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Patients &amp;gt;55 years old
&lt;/li&gt;&lt;li&gt;Debilitated patients
&lt;/li&gt;&lt;li&gt;Patients with significant underlying illness (i.e. ASA physical status score III or IV)
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;^Optimize volume status before administration 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Propofol&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Side Effects"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Side_Effects"&gt;Side Effects&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Respiratory depression
&lt;/li&gt;&lt;li&gt;Transient hypotension
&lt;/li&gt;&lt;li&gt;Pain at injection site (inject lidocaine IV first)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Propofol&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Dose"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Dose"&gt;Dose&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;induction = 1mg/kg IV, followed by 0.5mg/kg every 2-3 minutes as needed
&lt;/li&gt;&lt;li&gt;Small incremental doses (10-30mg) can slowly be administered to effect
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Propofol&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Adjunctive medications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Adjunctive_medications"&gt;Adjunctive medications&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;fentanyl or morphine (propofol does not provide analgesia)
&lt;/li&gt;&lt;li&gt;NS for transient hypotension
&lt;/li&gt;&lt;li&gt;Lidocaine flush (to reduce injection pain)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Propofol&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Pediatric Population"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Pediatric_Population"&gt;Pediatric Population&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Safe for procedural sedation in pediatric patients.  Same dosing.
&lt;/li&gt;&lt;/ol&gt;




</content><folder>Drugs</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="prostatitis"><name>Prostatitis</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#Acute_Prostatitis"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;Acute Prostatitis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Chronic_Prostatitis"&gt;&lt;span class="tocnumber"&gt;1.2&lt;/span&gt; &lt;span class="toctext"&gt;Chronic Prostatitis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Prostatitis&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Infection of the prostate caused by gram negative organisms, 80% E. coli.
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Prostatitis&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Acute Prostatitis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Acute_Prostatitis"&gt;Acute Prostatitis&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Symptoms: dysuria/urgency/frequency, perineal pain, low back pain, fever, chills
&lt;/li&gt;&lt;li&gt;Rectal exam (mandatory in men with symptoms of cystitis): exquisitely tender and boggy prostate, warm to touch
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Prostatitis&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Chronic Prostatitis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Chronic_Prostatitis"&gt;Chronic Prostatitis&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Relapsing UTI caused by the same organism, may have history of acute prostatitis
&lt;/li&gt;&lt;li&gt;Symptoms: same as acute with exception of fever/chills
&lt;/li&gt;&lt;li&gt;Rectal exam: often unremarkable
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Prostatitis&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;UA: typically accompanied by cystitis
&lt;/li&gt;&lt;li&gt;Urine Culture: reveals responsible bacteria
&lt;/li&gt;&lt;li&gt;rectal exam: tender prostate gland (acute)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Prostatitis&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;UA, Urine culture
&lt;/li&gt;&lt;li&gt;Prostate exam
&lt;/li&gt;&lt;li&gt;Chemistry for renal function
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Prostatitis&amp;amp;action=edit&amp;amp;section=6" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;cystitis
&lt;/li&gt;&lt;li&gt;pyelonephritis
&lt;/li&gt;&lt;li&gt;chronic bacterial prostatitis   
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Prostatitis&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Antibiotics: 4-6 week course
&lt;ol&gt;&lt;li&gt;Cipro 500mg PO BID
&lt;/li&gt;&lt;li&gt;OR Bactrim DS 1 tab PO BID
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;IV antibiotics (toxic prostatitis)
&lt;ol&gt;&lt;li&gt;Cipro 400mg IV q12 OR Levofloxacin 500mg IV q24
&lt;/li&gt;&lt;li&gt;OR Ceftriaxone 2g IV q24 +/- Gentamycin 3-5mg/kg/day
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Prostatitis&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Admit toxic patients or patients with urinary retention
&lt;/li&gt;&lt;li&gt; Urology follow, chronic prostatitis may require 16 weeks of therapy
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Prostatitis&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from Rosens 7th Edition
&lt;/p&gt;



</content><folder>GU</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="pseudotumor_cerebri"><name>Pseudotumor Cerebri</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pseudotumor_Cerebri&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Impaired arachnoid villi absorption
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pseudotumor_Cerebri&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Young, obese females
&lt;/li&gt;&lt;li&gt;Headache (worse in AM/ with manuvers increasing ICP)
&lt;/li&gt;&lt;li&gt;Papilledema (optic atrophy/vision loss)
&lt;/li&gt;&lt;li&gt;Neuro exam frequently normal 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pseudotumor_Cerebri&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; CT scan (negative)
&lt;/li&gt;&lt;li&gt; LP (CSF pressure 25-40) 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pseudotumor_Cerebri&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Repeate LPs (decrease CSF pressure)
&lt;/li&gt;&lt;li&gt; Diamox
&lt;/li&gt;&lt;li&gt; Weight loss
&lt;/li&gt;&lt;li&gt; Shunt
&lt;/li&gt;&lt;li&gt; Optic nerve sheath fenestration 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pseudotumor_Cerebri&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Admit for:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt; Severe pain
&lt;/li&gt;&lt;li&gt; Focal findings
&lt;/li&gt;&lt;li&gt; Vision changes
&lt;/li&gt;&lt;/ol&gt;




</content><folder>Neuro</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="pulm_htn_decomp"><name>Pulm HTN Decomp</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pulm_HTN_Decomp&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;0. No fluids
&lt;/p&gt;&lt;p&gt;1. Treat relative bradycardia
&lt;/p&gt;
&lt;pre&gt;    -atropine, pace, dobutamine
&lt;/pre&gt;
&lt;p&gt;2. Pulm vasodialate
&lt;/p&gt;
&lt;pre&gt;    -sildenafil, bostantan
&lt;/pre&gt;
&lt;p&gt;3.&amp;nbsp;?anticoagulate (freq PEs)
&lt;/p&gt;&lt;p&gt;4. Empiric abx
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pulm_HTN_Decomp&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;4/07 DONALDSON (adapted from Sarver)
&lt;/p&gt;



</content><folder>Pulm</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="pulmonary_contusion"><name>Pulmonary Contusion</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pulmonary_Contusion&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;direct damage to lung causing alveolar hemor &amp;amp; edema &amp;amp; mucus/debris accumulation
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pulmonary_Contusion&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;pts= sob, tachy, cyanosis, low bp, rales, hypoxia, wide a-A
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;cxr= patchy irregular infiltrates, always see by 4-6 hr, always worse than 1st xr shows!
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;CXR does NOT give clues to physiologic effects of contusion (ie, Rx pt &amp;amp; sx NOT CXR, even small contusion can be bad, watch pt sats &amp;amp; abg!!)
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;flail chest= 2 or more rib fx @ 2 or more points, problem w/ this is the underlying contusion almost 100% hve!
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pulmonary_Contusion&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Rx= peep b/c response to O2 is poor, intubate prn &amp;amp; low TV &amp;amp; high PEEP vent setting has become standard practice!
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;if possible intubate each side b/c peep can blow out lung + may need diff settings for ea lung.
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;steroids improve cxr but NOT outcome, abx iff aspiration o/w no chng in outcome
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pulmonary_Contusion&amp;amp;action=edit&amp;amp;section=4" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;(Burbulys 2004/Trauma Reports 4/04 /A-Digest 7/04) -by Lampe
&lt;/p&gt;



</content><folder>Trauma</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="pulmonary_embolism_(pe)"><name>Pulmonary Embolism (PE)</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pulmonary_Embolism_(PE)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: DIAGNOSIS"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DIAGNOSIS"&gt;DIAGNOSIS&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;What is the clinical probability of PE? 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Pulmonary Embolism Wells Score
&lt;/p&gt;&lt;p&gt;- Symptoms of DVT (3 points)
&lt;/p&gt;&lt;p&gt;- No alternative diagnosis better explains the illness (3 points)
&lt;/p&gt;&lt;p&gt;- Pulse &amp;gt; 100 (1.5 points) 
&lt;/p&gt;&lt;p&gt;- Immobilization (&amp;gt;= 3 days) or surgery in the previous four weeks (1.5 points)
&lt;/p&gt;&lt;p&gt;- Prior history of DVT or pulmonary embolism (1.5 points)
&lt;/p&gt;&lt;p&gt;- Presence of hemoptysis (1 point)
&lt;/p&gt;&lt;p&gt;- Presence of malignancy (1 point) 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Wells Criteria:
&lt;/p&gt;&lt;p&gt;0-1 point: Low probability
&lt;/p&gt;&lt;p&gt;2-6 points: Moderate probability
&lt;/p&gt;&lt;p&gt;7-12 points: High probability
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Modified Wells criteria:
&lt;/p&gt;&lt;p&gt;0-4 points: PE unlikely
&lt;/p&gt;&lt;p&gt;4-12 points: PE likely
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Do I need imaging?
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;PE unlikely + negative D-dimer = no imaging
&lt;/p&gt;&lt;p&gt;PE unlikely + positive D-dimer = imaging required
&lt;/p&gt;&lt;p&gt;PE likely = imaging required (even if D-dimer is negative)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pulmonary_Embolism_(PE)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: TREATMENT"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="TREATMENT"&gt;TREATMENT&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; 1. Hemodynamic support as needed
&lt;/li&gt;&lt;li&gt; Oxygen 
&lt;/li&gt;&lt;li&gt;  IVF (give cautiously as incr. RV wall stress may lead to ischemia)
&lt;/li&gt;&lt;li&gt; Pressors (norepi, epi, or dopa if 1L NS fails to raise BP)  
&lt;/li&gt;&lt;li&gt;  2. Anticoagulation
&lt;/li&gt;&lt;li&gt; Indicated for all patients with confirmed PE or high clinical suspicion
&lt;/li&gt;&lt;li&gt; Risk-benefit: (untreated PE = 30% mortality, major bleeding &amp;lt;3%)
&lt;/li&gt;&lt;li&gt; Treatment options:
&lt;/li&gt;&lt;li&gt; SC LMWH - First-line agent for most hemodynamically stable patients
&lt;/li&gt;&lt;li&gt; IV/SC UFH - Consider only in pts with:
&lt;/li&gt;&lt;li&gt; Persistent hypotension
&lt;/li&gt;&lt;li&gt; Increased risk of bleeding
&lt;/li&gt;&lt;li&gt; Recent sx/trauma
&lt;/li&gt;&lt;li&gt; Age &amp;gt; 70yrs
&lt;/li&gt;&lt;li&gt; Concurrent ASA use
&lt;/li&gt;&lt;li&gt; Renal failure 
&lt;/li&gt;&lt;li&gt; Morbid obesity or anasarca
&lt;/li&gt;&lt;li&gt; Thrombolysis is being considered 
&lt;/li&gt;&lt;li&gt; Cr clearance &amp;lt; 30ml/min 
&lt;/li&gt;&lt;li&gt; 3. Thrombolysis
&lt;/li&gt;&lt;li&gt; Consider for patients with confirmed PE and shock
&lt;/li&gt;&lt;li&gt; Can also consider, although controversial, for: 
&lt;/li&gt;&lt;li&gt; Severe hypoxemia
&lt;/li&gt;&lt;li&gt; Massive embolic burden on CT
&lt;/li&gt;&lt;li&gt; RV dysfunction
&lt;/li&gt;&lt;li&gt; Free-floating RA or RV thrombus
&lt;/li&gt;&lt;li&gt; Patent foramen ovale
&lt;/li&gt;&lt;li&gt; Absolute contraindications:
&lt;/li&gt;&lt;li&gt; History of hemorrhagic stroke
&lt;/li&gt;&lt;li&gt; Active intracranial neoplasm
&lt;/li&gt;&lt;li&gt; Recent (&amp;lt;2 months) intracranial sx or trauma
&lt;/li&gt;&lt;li&gt; Active or recent internal bleeding in prior 6 months 
&lt;/li&gt;&lt;li&gt; Relative contraindications:
&lt;/li&gt;&lt;li&gt; Bleeding diathesis
&lt;/li&gt;&lt;li&gt; Uncontrolled severe HTN (sys BP &amp;gt;200 or dia BP &amp;gt;110)
&lt;/li&gt;&lt;li&gt; Nonhemorrhagic stroke within prior 2 months
&lt;/li&gt;&lt;li&gt; Surgery within the previous 10 days
&lt;/li&gt;&lt;li&gt; Plt &amp;lt; 100K
&lt;/li&gt;&lt;li&gt; Associated with intracranial hemorrhage in 3% of patients
&lt;/li&gt;&lt;li&gt; Mortality benefit has never been shown
&lt;/li&gt;&lt;li&gt; Consider embolectomy if thrombolytics are contraindicated
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
PROB DETERMINATION (BY SX)
&lt;/p&gt;&lt;p&gt;1) Atypical
&lt;/p&gt;
&lt;pre&gt;    A. Alt diag as/more likely--&amp;gt;low
&lt;/pre&gt;
&lt;pre&gt;    B. Alt diag less likely
&lt;/pre&gt;
&lt;pre&gt;         i. No RF --&amp;gt; low
&lt;/pre&gt;
&lt;pre&gt;         ii. +RF --&amp;gt; intrmte
&lt;/pre&gt;
&lt;p&gt;2) Typical
&lt;/p&gt;
&lt;pre&gt;    A. Alt diag as/more likely
&lt;/pre&gt;
&lt;pre&gt;         i. No RF --&amp;gt; low
&lt;/pre&gt;
&lt;pre&gt;         ii. +RF --&amp;gt; mod
&lt;/pre&gt;
&lt;pre&gt;    B. Alt diag less likely
&lt;/pre&gt;
&lt;pre&gt;         i. No RF --&amp;gt; mod
&lt;/pre&gt;
&lt;pre&gt;         ii. +RF --&amp;gt; high
&lt;/pre&gt;
&lt;p&gt;3) Severe
&lt;/p&gt;
&lt;pre&gt;    A. Alt diag as/more likely-&amp;gt;mod
&lt;/pre&gt;
&lt;pre&gt;    B. Alt diag less likely --&amp;gt; high
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;PROBABILITY --&amp;gt; W/O
&lt;/p&gt;&lt;p&gt;I. Low
&lt;/p&gt;
&lt;pre&gt;    1) No sx DVT --&amp;gt; d-dimer
&lt;/pre&gt;
&lt;pre&gt;         A. neg --&amp;gt; R/O
&lt;/pre&gt;
&lt;pre&gt;         B. pos --&amp;gt; spiral CT
&lt;/pre&gt;
&lt;pre&gt;    2) sx DVT --&amp;gt; US
&lt;/pre&gt;
&lt;pre&gt;         A. neg --&amp;gt; go to I.1
&lt;/pre&gt;
&lt;pre&gt;         B. pos --&amp;gt; R/I
&lt;/pre&gt;
&lt;p&gt;II. Mod/high
&lt;/p&gt;
&lt;pre&gt;    1) no sx DVT --&amp;gt; spiral CT
&lt;/pre&gt;
&lt;pre&gt;    2) sx DVT --&amp;gt; US
&lt;/pre&gt;
&lt;pre&gt;         A. neg --&amp;gt; go to II.1
&lt;/pre&gt;
&lt;pre&gt;         B. pos --&amp;gt; R/I
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;RISK FACTORS
&lt;/p&gt;&lt;p&gt;1. Prior DVT/PE (or FHx &amp;gt;2 people)
&lt;/p&gt;&lt;p&gt;2. CA (within 6mo)
&lt;/p&gt;&lt;p&gt;3. Paralyisis
&lt;/p&gt;&lt;p&gt;4. Bed rest (3dys in last mo)
&lt;/p&gt;&lt;p&gt;5. Plaster imob (&amp;lt;12wk)
&lt;/p&gt;&lt;p&gt;6. Surg (&amp;lt;12wk)
&lt;/p&gt;&lt;p&gt;7. OB deivery (&amp;lt;12wk)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;SEVERE (DEFINITION)
&lt;/p&gt;&lt;p&gt;1) Syncope
&lt;/p&gt;&lt;p&gt;2) BP &amp;lt;90 with HR &amp;gt;100
&lt;/p&gt;&lt;p&gt;3) Requires O2
&lt;/p&gt;&lt;p&gt;4) New onet R heart failue
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;TYPICAL (DEFINITION)
&lt;/p&gt;&lt;p&gt;(&amp;gt;=2 of A plus &amp;gt;=1 of B)
&lt;/p&gt;&lt;p&gt;A
&lt;/p&gt;
&lt;pre&gt;    1. dyspnea
&lt;/pre&gt;
&lt;pre&gt;    2. pleuritic CP
&lt;/pre&gt;
&lt;pre&gt;    3. hemoptysis
&lt;/pre&gt;
&lt;pre&gt;    4. rub
&lt;/pre&gt;
&lt;pre&gt;    5. PaO2 &amp;lt;92%
&lt;/pre&gt;
&lt;p&gt;B
&lt;/p&gt;
&lt;pre&gt;    1. HR &amp;gt;90
&lt;/pre&gt;
&lt;pre&gt;    2. low grade fever (&amp;lt;101)
&lt;/pre&gt;
&lt;pre&gt;    3. leg sx
&lt;/pre&gt;
&lt;pre&gt;    4. CXR c/w PE
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Does not apply to pregnant women*
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;S1Q3T3
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pulmonary_Embolism_(PE)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;UpToDate
&lt;/p&gt;&lt;p&gt;2/8/06 DONALDSON (from 'the board')
&lt;/p&gt;



</content><folder>Pulm</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="pyloric_stenosis"><name>Pyloric Stenosis</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Differential_Diagnosis"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Differential Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pyloric_Stenosis&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; More common in males (5:1) &amp;amp; firstborn children (30%)
&lt;/li&gt;&lt;li&gt; Symptoms usually begin between 3-6 weeks of age, rarely after 12 weeks 
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pyloric_Stenosis&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Immediate post-prandial, non-bilious, often projectile vomiting, but desires to feed ("hungry vomiter")
&lt;/li&gt;&lt;li&gt; Palpable mass in in RUQ to epigastric region, occassionally may see peristaltic waves
&lt;/li&gt;&lt;li&gt; Labs might show a low K, Low Cl, &amp;amp; hypo-Cl alkolosis
&lt;/li&gt;&lt;li&gt; Imaging
&lt;/li&gt;&lt;li&gt; Abdominal xray: May show large stomach bubble
&lt;/li&gt;&lt;li&gt; U/S: ~ 95% Sn/Sp
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pyloric_Stenosis&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Differential Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Differential_Diagnosis"&gt;Differential Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Adrenal crisis may mimic pyloric stenosis
&lt;/li&gt;&lt;li&gt; However, adrenal crisis: hyperkalemic acidosis; pyloric stenosis: hypokalemic alkalosis 
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Pyloric_Stenosis&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; IVF
&lt;/li&gt;&lt;li&gt; Normal electrolytes and no e/o dehydration
&lt;/li&gt;&lt;li&gt; 5% dextrose w/ 0.25% NaCl and 2 meq KCl per 100 mL
&lt;/li&gt;&lt;li&gt; Moderate or severe dehydration
&lt;/li&gt;&lt;li&gt; Higher NaCl concentrations (0.5% to normal saline) and higher rates of administration (1.5 to 2 times maintenance)
&lt;/li&gt;&lt;li&gt; Ensure that kidneys are functional prior to giving potassium 
&lt;/li&gt;&lt;li&gt; Do not give LR
&lt;/li&gt;&lt;li&gt; May lead to worsening alkalosis --&amp;gt; apnea in infants
&lt;/li&gt;&lt;li&gt; NGT
&lt;/li&gt;&lt;li&gt; Surgery
&lt;/li&gt;&lt;li&gt; Can be delayed 24-36 hr to rehydrate infant
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
Source: UpToDate
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="r-wave_in_v1"><name>R-wave in V1</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=R-wave_in_V1&amp;amp;action=edit&amp;amp;section=1" title="Edit section: DDX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX"&gt;DDX&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Posterior MI
&lt;/li&gt;&lt;li&gt;RBBB
&lt;/li&gt;&lt;li&gt;WPW
&lt;/li&gt;&lt;li&gt;RVH w/ strain
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=R-wave_in_V1&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;DONALDSON (12/1/06)
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="rv_mi"><name>RV MI</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=RV_MI&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Inferior STEMI"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Inferior_STEMI"&gt;Inferior STEMI&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Suspect RV MI if 1mm or more ST elevation in V1 or V4R
&lt;/li&gt;&lt;/ol&gt;




</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="rabies"><name>Rabies</name><content>&lt;p&gt;Indication for Prophylaxis
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; Bite or salivary exposure from bat, or mammalian carnivore
&lt;/li&gt;&lt;li&gt; Inhalation counts (e.g. dead bat in room)
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;^Not needed if non-salivary exposure, or if bird, reptile, or rodent (rare cases)
&lt;/p&gt;&lt;p&gt;^Call CDC if questions
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Rabies&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Workup"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Workup"&gt;Workup&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Was animal captured?
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Yes
&lt;ol&gt;&lt;li&gt;Is animal dog or cat?
&lt;ol&gt;&lt;li&gt;Yes: Observe 10 days, if abnormal, sacrifice and treat with vacc and RIG
&lt;ol&gt;&lt;li&gt;discontinue if animal negative path for rabies
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;No: Sacrifice animal and begin RIG and vaccine
&lt;ol&gt;&lt;li&gt;discontinue if animal negative path for rabies
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;No
&lt;ol&gt;&lt;li&gt;Is Animal dog or cat?
&lt;ol&gt;&lt;li&gt;Yes: Give vacc and RIG only if rabies risk for species in area
&lt;/li&gt;&lt;li&gt;No: Treat with  full course vacc and RIG 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Rabies&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Clean wound
&lt;/li&gt;&lt;li&gt; Rabies vaccine: human diploid cell vaccine (HDCV): 1ml IM* Day 0, 3, 7, 14,and 28
&lt;ol&gt;&lt;li&gt; Give in deltoid not buttock (since Ab not created in fat cells)
&lt;/li&gt;&lt;li&gt; If previously immunized: HDCV on day 0, 3; no RIG                   
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; RIG (rabies immune globulin): 20 IU/kg (infiltrated SC around wound) if possible
&lt;ol&gt;&lt;li&gt;place remainder opposite arm of vaccine
&lt;/li&gt;&lt;li&gt;can administer up to 7 days after the first vaccine dose
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;




</content><folder>ID</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="radiation_exposure_(clinical)"><name>Radiation Exposure (Clinical)</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Radiation_Exposure_(Clinical)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Tests and Radiation Amounts"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Tests_and_Radiation_Amounts"&gt;Tests and Radiation Amounts&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;FLAT FILMS (mrad)
&lt;/p&gt;&lt;p&gt;Low-dose
&lt;/p&gt;&lt;p&gt;Head &amp;lt;1
&lt;/p&gt;&lt;p&gt;C-spine &amp;lt;1
&lt;/p&gt;&lt;p&gt;Thracic spine &amp;lt;1
&lt;/p&gt;&lt;p&gt;CXR &amp;lt;1
&lt;/p&gt;&lt;p&gt;Extrem &amp;lt;1
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;High-dose
&lt;/p&gt;&lt;p&gt;L-spine &amp;lt;1250
&lt;/p&gt;&lt;p&gt;Pelvis &amp;lt;350
&lt;/p&gt;&lt;p&gt;Hip &amp;lt;450
&lt;/p&gt;&lt;p&gt;IVP &amp;lt;900
&lt;/p&gt;&lt;p&gt;Urethrocyst &amp;lt;1500
&lt;/p&gt;&lt;p&gt;KUB &amp;lt;500
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;CT (1cm slices)
&lt;/p&gt;&lt;p&gt;Head &amp;lt;50
&lt;/p&gt;&lt;p&gt;Chest &amp;lt;1000
&lt;/p&gt;&lt;p&gt;Upper abd &amp;lt;3000
&lt;/p&gt;&lt;p&gt;Lower abd &amp;lt;9000
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;ANGIO
&lt;/p&gt;&lt;p&gt;Cerebral &amp;lt;100
&lt;/p&gt;&lt;p&gt;Cardiac cath &amp;lt;500
&lt;/p&gt;&lt;p&gt;Aortography &amp;lt;100
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;V/Q scan &amp;lt;215
&lt;/p&gt;&lt;p&gt;(class C injectable technetium, xenon even safer)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Radiation_Exposure_(Clinical)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Pregnancy"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Pregnancy"&gt;Pregnancy&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Greatest risk during organogenesis (8-12wk)
&lt;/p&gt;&lt;p&gt;IV contrast not teratogenic (class B)
&lt;/p&gt;&lt;p&gt;PO contrast not absorbed
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;EXPOSURE RISK (mrads)
&lt;/p&gt;&lt;p&gt;&amp;lt;5,000 = safe
&lt;/p&gt;&lt;p&gt;~10,000 = small risk childhood CA
&lt;/p&gt;&lt;p&gt;~15,000* = 6% chance mental retard
&lt;/p&gt;&lt;p&gt;&amp;lt;3% chance childhood CA
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Considered max
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Always use sheild when possible
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Radiation_Exposure_(Clinical)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;3/29/06 DONALDSON (adapted from Rosen)
&lt;/p&gt;



</content><folder>Rads</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="radiation_exposure_(disaster)"><name>Radiation Exposure (Disaster)</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Radiation_Exposure_(Disaster)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;General
&lt;/p&gt;&lt;p&gt;- potentially easy to deal with since lots of people deal with radiation daily- univ, hosp, military
&lt;/p&gt;&lt;p&gt;- easy to detect with geiger counters
&lt;/p&gt;&lt;p&gt;- immediate effects well known and easy to assess with blood counts
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Possible Scenarios
&lt;/p&gt;&lt;p&gt;- we assume terrorists will only use one source of radiation at a time- combination sources unlikely
&lt;/p&gt;&lt;p&gt;- synergism between radiation and chemicals unlikely- manage chemical exp first, radiation second
&lt;/p&gt;&lt;p&gt;- only nuclear weapon will expose many people. all other types hard to expose many people
&lt;/p&gt;&lt;p&gt;- small radiation dose do not affect people for many years
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Dispersal of Radiation without use of Explosives
&lt;/p&gt;&lt;p&gt;- minimally radioactive sources maybe used to create fear and panic- ex- exempt low level radioisotopes from nuc medicine, research. no immediate effects and probability of long term effects low
&lt;/p&gt;&lt;p&gt;-highly radioactive substances- cobalt, cesium, iridium- used in radiotherapy and radiographic machines have penetrating radiation so easy to detect at check points
&lt;/p&gt;&lt;p&gt;- if souce is metallic- there will be radiation exposure but no contamination. if powder get both exposure and contamination
&lt;/p&gt;&lt;p&gt;- if handle it, will get local skin injury and are risk for acute radiation syndrome
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Dispersal of Radiation with use of Conventional Explosives
&lt;/p&gt;&lt;p&gt;- is greater concern since will be able to spread to more people and assoc traumatic injuries- will also cause additional fear, panic
&lt;/p&gt;&lt;p&gt;- extent of dispersal depends on physical form of source- solid or powder, explosive type, atmospheric conditions
&lt;/p&gt;&lt;p&gt;- health hazard only a few city blocks- goal of response to monitor and contain.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Nuclear Reactor Attack
&lt;/p&gt;&lt;p&gt;- reactor if steel vessel in concrete building. if damaged, is designed to slow down stop reaction
&lt;/p&gt;&lt;p&gt;- if cooling system damaged, may get some radiation leak- radioactive iodine and noble gases
&lt;/p&gt;&lt;p&gt;- gas escape for reactor core will have immediate nearby health effects and rad iodine can have thyroid CA in kids long term at great diistances
&lt;/p&gt;&lt;p&gt;- many nuclear engineering dept at univ have small reactors and are easy targets
&lt;/p&gt;&lt;p&gt;- spent radioactive fuel rods stored in less secure places but hard to expose large population to this solid source
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Nuclear Weapon Detonation
&lt;/p&gt;&lt;p&gt;- unlikely use by terrorists since needs high level of expertise- but low yield weapon can be made or higher yield weapon could be stolen and used
&lt;/p&gt;&lt;p&gt;- even if nuc weapon fizzled- will still be big blast
&lt;/p&gt;&lt;p&gt;- destruction due to airblast and thermal radiation
&lt;/p&gt;&lt;p&gt;- 1 psi increase breaks glass
&lt;/p&gt;&lt;p&gt;- 12 psi 50% mortality
&lt;/p&gt;&lt;p&gt;- fire ball -&amp;gt; flash/ flame burns, blindness
&lt;/p&gt;&lt;p&gt;- inonizing radiation released in first minute as intense pulse- is initial radiation
&lt;/p&gt;&lt;p&gt;- residual radiation, after first minute is fission and activation products
&lt;/p&gt;&lt;p&gt;- ground burst causes radioactive soil into atmsphre and fallout of hundreds of miles- fallout can be lethal at greater ranges than at the blast or fireball
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;BASIC PRINCIPLES
&lt;/p&gt;&lt;p&gt;Physical Properties
&lt;/p&gt;&lt;p&gt;- gamma and xrays- deep penetration
&lt;/p&gt;&lt;p&gt;- alpha- hazard only if ingested/ inoculated since penetration &amp;lt;0.1mm
&lt;/p&gt;&lt;p&gt;- beta/ electrons- penetrate a few centimeters
&lt;/p&gt;&lt;p&gt;- Rads- is dose absorbed by specific tissue. internation unit for absorbed dose is "gray" Gy. 1 gy = 100 rads
&lt;/p&gt;&lt;p&gt;- different radioactive particles have diff effects at same absorbed dose- so use effective dose for comparison
&lt;/p&gt;&lt;p&gt;- effective dose is "REM". 100 rem = 1 sievert
&lt;/p&gt;&lt;p&gt;- one gray = one sievert when dealing with gamma and beta rays
&lt;/p&gt;&lt;p&gt;- effect of radiation based on time of exp, distance and shielding
&lt;/p&gt;&lt;p&gt;- dose decreases rapidly with square of distance and decreases on 1/9th if triple distance
&lt;/p&gt;&lt;p&gt;- shield with lead or stay indoors
&lt;/p&gt;&lt;p&gt;- radiation decays with time
&lt;/p&gt;&lt;p&gt;- short lived- iodines
&lt;/p&gt;&lt;p&gt;- long- cesium, stontium, cobalt
&lt;/p&gt;&lt;p&gt;- rate of decay also effects dose of exposure and may effect management decisions
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Biological Principles
&lt;/p&gt;&lt;p&gt;- some cells may die but if cells role not critical for survival, may not see effect
&lt;/p&gt;&lt;p&gt;- rapidly dividing cells- gi and bone marrow, most vulnerable
&lt;/p&gt;&lt;p&gt;- dose &amp;lt;1gy, cells survive but get CA later
&lt;/p&gt;&lt;p&gt;- radiation induced CA dose related
&lt;/p&gt;&lt;p&gt;- leukemia within 2 yrs, solid tumors 5-10 or more yrs
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Radiation_Exposure_(Disaster)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Type of Radiation Exposure &amp;amp; ED Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Type_of_Radiation_Exposure_.26_ED_Treatment"&gt;Type of Radiation Exposure &amp;amp; ED Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- can be localized or whole body, internal or external deposition and contamination
&lt;/p&gt;&lt;p&gt;- mostly not emergency, just tx sxs and supportive care
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Localized Exposure
&lt;/p&gt;&lt;p&gt;- by direct handling. pt survives eventhough dose high since exposure drops rapidly with distance
&lt;/p&gt;&lt;p&gt;- rad burn like thermal burn- but signs can occur after a few days, vasc insuff after several months and causing necrosis of previously healed skin
&lt;/p&gt;&lt;p&gt;- tx c pain control, infc prophylaxsis, vasodilator tx, surg, skin graft,
&lt;/p&gt;&lt;p&gt;- extent of penetration important factor in outcome
&lt;/p&gt;&lt;p&gt;- beta rays from fallout only burn exposed skin
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Whole Body Exp
&lt;/p&gt;&lt;p&gt;- acute radiation syndrome- within 12 hrs, nv for 48 hrs
&lt;/p&gt;&lt;p&gt;- dose &amp;gt;30 gy, CV and cns effects- hypotn, cerebral edema, sz, nv, ataxia, death
&lt;/p&gt;&lt;p&gt;- dose 10- 30 gy, gi syndrome- nvd- then latent for 1 wk then recurrent nvd this time with sepsis and death
&lt;/p&gt;&lt;p&gt;- hematopoetic syn- dose 2gy or higher- lymphocyte reduction within 48 hrs is indicator for rad exposure. get leukopenia and thrombocytopenia- bleeding and infc- may enhance recovery by hematopoetic factors
&lt;/p&gt;&lt;p&gt;- cutaneous syn- damaged skin may interact with other organ damage
&lt;/p&gt;&lt;p&gt;- amifostine- prophylactic radiation drug- causes hypotn as side effect unfortunately
&lt;/p&gt;&lt;p&gt;- androstenediol- boosts immune system
&lt;/p&gt;&lt;p&gt;- bone marrow xplant not helpful
&lt;/p&gt;&lt;p&gt;- even if tx and survive hematopoetic syn, still die from radiation pneumonitis, denuded gi tract, hepatic and renal dysfunction
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Internal Contamination
&lt;/p&gt;&lt;p&gt;- may enter thru burns, wounds, inhale, ingest
&lt;/p&gt;&lt;p&gt;- need to know type of radionuclide and chemical form
&lt;/p&gt;&lt;p&gt;- need to tx quickly to be effective
&lt;/p&gt;&lt;p&gt;- reduce absorption, dilute, blockage, displacement by non radioactive materials, mobilization, chelation
&lt;/p&gt;&lt;p&gt;- potassium iodine for nuc weapon detonation or reactor breach- prevents radioiodine from accumulating in thyroid. take shortly after exp to be effective- if give too much get iodism
&lt;/p&gt;&lt;p&gt;- dose- 130 mg adults, 65 mg 3- 18ys, 32 mg 1mo- 3yr, 16 mg for age&amp;lt; 1mo
&lt;/p&gt;&lt;p&gt;- chelators- calcium, zinc, only for plutonium or americium
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;External Contamination
&lt;/p&gt;&lt;p&gt;- clothes and exp skin- just clean up and prevent spread
&lt;/p&gt;&lt;p&gt;- clean with soap and water
&lt;/p&gt;&lt;p&gt;- if extremis- stabilize first, then decontam
&lt;/p&gt;&lt;p&gt;- do not abraid skin while cleaning
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Contaminated Burns and Wounds
&lt;/p&gt;&lt;p&gt;- irrigate
&lt;/p&gt;&lt;p&gt;- excise only if long acting radionuclides
&lt;/p&gt;&lt;p&gt;- if whole body dose &amp;gt;1gy, close wound asap to prevent portal of infc
&lt;/p&gt;&lt;p&gt;- in burns, radioactivity comes off with eschar and exudate
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Radiation_Exposure_(Disaster)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Disaster Management"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disaster_Management"&gt;Disaster Management&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- preparation, crisis management, consequences
&lt;/p&gt;&lt;p&gt;- FBI is lead agency in terrorist incident
&lt;/p&gt;&lt;p&gt;- during consequence management, FEMA fed emerg management agency takes over
&lt;/p&gt;&lt;p&gt;- intervention- action to reduce exp and dose of radtn
&lt;/p&gt;&lt;p&gt;- if dose 1 rem- stay in doors up to 2 days- evacuate for 1 wk if dose of 5 rem or more
&lt;/p&gt;&lt;p&gt;- temp relocation if dose 3 rem in first month or 1 rem in subsequent month
&lt;/p&gt;&lt;p&gt;- permanent resettlement if lifetime dose 100 rem
&lt;/p&gt;&lt;p&gt;- pot iodine only if thyroid dose 100 mgy or more
&lt;/p&gt;&lt;p&gt;- EMS occupational dose of 5 rem per yr dose not apply- allowable dose goes up for life saving event
&lt;/p&gt;&lt;p&gt;- at dose of 0.1 gy/hr- ems may go in for short time but dose maybe life threatening
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Early Management
&lt;/p&gt;&lt;p&gt;- evacuate upwind if possible
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Psychosocial Sxs
&lt;/p&gt;&lt;p&gt;- insomnia, anxiety, impaired concentration, social withdrawal
&lt;/p&gt;



</content><folder>Rads</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="rapid_sequence_intubation_(rsi)"><name>Rapid Sequence Intubation (RSI)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Agents"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Agents&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#Premed"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;Premed&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Induction"&gt;&lt;span class="tocnumber"&gt;1.2&lt;/span&gt; &lt;span class="toctext"&gt;Induction&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Paralytics"&gt;&lt;span class="tocnumber"&gt;1.3&lt;/span&gt; &lt;span class="toctext"&gt;Paralytics&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Ron_Wall.27s_7_Ps_of_RSI"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Ron Wall's 7 Ps of RSI&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Rapid_Sequence_Intubation_(RSI)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Agents"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Agents"&gt;Agents&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Rapid_Sequence_Intubation_(RSI)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Premed"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Premed"&gt;Premed&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Atropine 
&lt;ol&gt;&lt;li&gt;0.02 mg/kg
&lt;/li&gt;&lt;li&gt;prevent bradycardia &amp;amp; dries secretions give in &amp;lt; 5 y/o or &amp;lt; 20 kg 
&lt;/li&gt;&lt;li&gt;(possibly 5-10y , but def not if &amp;gt;10y)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Lidocaine
&lt;ol&gt;&lt;li&gt;1.5 mg/kg
&lt;/li&gt;&lt;li&gt;lowers ICP
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Rapid_Sequence_Intubation_(RSI)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Induction"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Induction"&gt;Induction&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Etomidate 0.2 to 0.4 mg/kg
&lt;ol&gt;&lt;li&gt;Onset - 1 min
&lt;/li&gt;&lt;li&gt;Dur - 30-60 min
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Versed 0.2 mg/kg (max 5 mg)
&lt;ol&gt;&lt;li&gt;Onset - 1 to 2 min
&lt;/li&gt;&lt;li&gt;Dur - 30-60 min
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Propofol 1 to 2.o mg/kg
&lt;ol&gt;&lt;li&gt;Dur - 10-15 min
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Rapid_Sequence_Intubation_(RSI)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Paralytics"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Paralytics"&gt;Paralytics&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Succinylcholine
&lt;ol&gt;&lt;li&gt;1.5 mg/kg (&amp;gt;10 y/o)
&lt;/li&gt;&lt;li&gt;2.0 mg/kg (&amp;lt; 10 y/o)
&lt;/li&gt;&lt;li&gt;4mg/kg IM if no line
&lt;/li&gt;&lt;li&gt;30-60 s, 10-15 min
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Vecuronium 
&lt;ol&gt;&lt;li&gt;0.3 mg/kg (intubate)
&lt;/li&gt;&lt;li&gt;0.1mg/kg (paralyze)
&lt;/li&gt;&lt;li&gt;60-90 s, 90 min
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Rocuronium 
&lt;ol&gt;&lt;li&gt;1.0 mg/kg (intubate)
&lt;/li&gt;&lt;li&gt;0.6mg/kg (paralyze)
&lt;/li&gt;&lt;li&gt;30-60 s, 25-60 min
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Pancuronium 
&lt;ol&gt;&lt;li&gt;0.1 mg/kg
&lt;/li&gt;&lt;li&gt;2-5 min, 45-90 min
&lt;/li&gt;&lt;li&gt;Onset - 30-60 s
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Rapid_Sequence_Intubation_(RSI)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Ron Wall's 7 Ps of RSI"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Ron_Wall.27s_7_Ps_of_RSI"&gt;Ron Wall's 7 Ps of RSI&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Preparation
&lt;ol&gt;&lt;li&gt;SOAPME (Suction, oxygen, airway, pharmacology, monitoring, equipment)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Preoxygenate
&lt;ol&gt;&lt;li&gt;Nitrogen wash-out
&lt;ol&gt;&lt;li&gt;100% NRB for 3-5min or 8 vital capacity breaths (BVM) w/ high-flow O2 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Pretreatment
&lt;ol&gt;&lt;li&gt;Incr ICP: Fentanyl 3-5mcg/kg (+- Lidocaine 1.5mg/kg (some think drop in MAP not worth it)
&lt;/li&gt;&lt;li&gt;Ischemic heart dz/dissection: Fentanyl 3-5mcg/kg
&lt;/li&gt;&lt;li&gt;Reactive Airway Dz:  Lidocaine 1.5mg/kg (suppresses cough reflex)
&lt;ol&gt;&lt;li&gt;Peds (age &amp;lt;10): Atropine .01-.02mg/kg (max 0.5)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Paralysis with induction
&lt;ol&gt;&lt;li&gt;INDUCTION
&lt;ol&gt;&lt;li&gt;Etomidate (0.3mg/kg)
&lt;ol&gt;&lt;li&gt;Especially good for hypotensive/trauma patients 
&lt;ol&gt;&lt;li&gt;Hemodynamically neutral, decreases ICP
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Lowers seizure threshold in patients with known seizure disorder 
&lt;/li&gt;&lt;li&gt;Does not blunt sympathetic reaction to intubation (no analgesic effect)
&lt;/li&gt;&lt;li&gt;Adrenal suppression is irrelevant with one-time dose
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Ketamine (1.5mg/kg)
&lt;ol&gt;&lt;li&gt;Agent of choice for asthmatics
&lt;/li&gt;&lt;li&gt;Sympathomimetic
&lt;ol&gt;&lt;li&gt;Avoid in pt with incr. ICP AND HTN 
&lt;/li&gt;&lt;li&gt;Consider in pt with incr. ICP AND hypotension
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Midazolam (0.2 mg/kg)
&lt;ol&gt;&lt;li&gt;Consider in pt with CHF (nitro-life effect --&amp;gt; decr. vent filling pressure)
&lt;/li&gt;&lt;li&gt;Consider in pt in status epilepticus (anti-seizure effect) 
&lt;/li&gt;&lt;li&gt;May decrease MAP, especially if pt hypovolemic
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Propofol (1.5 to 3 mg/kg)
&lt;ol&gt;&lt;li&gt;Consider in pt with bronchospasm
&lt;/li&gt;&lt;li&gt;Causes decrease in MAP, CPP
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;PARALYSIS
&lt;ol&gt;&lt;li&gt;Succinylcholine
&lt;ol&gt;&lt;li&gt;Dosing
&lt;/li&gt;&lt;li&gt;1.5 mg/kg - better to overdose than to underdose
&lt;/li&gt;&lt;li&gt;2mg/kg - neonates/infants
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Contraindications
&lt;ol&gt;&lt;li&gt;Stroke less than 6 months old, MS, muscular dystrophies
&lt;/li&gt;&lt;li&gt;ECG changes c/w hyperkalemia 
&lt;/li&gt;&lt;li&gt;OK to use in crush injury, acute stroke as long as within 3 days of occurrence
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Rocuronium
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Protection and positioning:
&lt;ol&gt;&lt;li&gt;cricoid pressure until placement confirmed
&lt;/li&gt;&lt;li&gt;sniffing position
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Pass Tube
&lt;ol&gt;&lt;li&gt;End-tidal CO2 detection is primary means of ETT placement confirmation
&lt;/li&gt;&lt;li&gt;Cola-complication: need CO2 detection for at least 6 ventilations
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Postintubation management
&lt;ol&gt;&lt;li&gt;CXR
&lt;/li&gt;&lt;li&gt;Long-active sedative (Midazolam 0.5mg/kg, Fentanyl 3mcg/kg)
&lt;/li&gt;&lt;li&gt;Resp Arrest pts: consider esophageal detector device to confirm placement
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Rapid_Sequence_Intubation_(RSI)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Air/Resus: Airway (RSI)
&lt;/p&gt;&lt;p&gt;Air/Resus: Intubation
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Rapid_Sequence_Intubation_(RSI)&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;7/1/09 Pani (Adapted from Harwood Nuss/Chp 1), UpToDate
&lt;/p&gt;



</content><folder>Airway/Resus</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="rashes"><name>Rashes</name><content>&lt;p&gt;Measles-1st disease
&lt;/p&gt;&lt;p&gt;Scarlet fever- 2nd
&lt;/p&gt;&lt;p&gt;Rubella-3rd
&lt;/p&gt;&lt;p&gt;Dukes-4th
&lt;/p&gt;&lt;p&gt;Erythema infectiosom- 5th
&lt;/p&gt;&lt;p&gt;Exanthem subitum (roseola)- 6th
&lt;/p&gt;
&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Measels_.28Rubeola.29"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Measels (Rubeola)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Scarlet_Fever"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Scarlet Fever&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Rubella_.28German_Measles.29"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Rubella (German Measles)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Erythema_Infectiosum_.28Fifth_disease.29"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Erythema Infectiosum (Fifth disease)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Exanthem_Subitum_.28Roseola.29"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Exanthem Subitum (Roseola)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Enteroviral_Infections"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Enteroviral Infections&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Hand_Foot_Mouth_Disease"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;Hand Foot Mouth Disease&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#Varicella"&gt;&lt;span class="tocnumber"&gt;9&lt;/span&gt; &lt;span class="toctext"&gt;Varicella&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-10"&gt;&lt;a href="#HSP"&gt;&lt;span class="tocnumber"&gt;10&lt;/span&gt; &lt;span class="toctext"&gt;HSP&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-11"&gt;&lt;a href="#Drug_Rash"&gt;&lt;span class="tocnumber"&gt;11&lt;/span&gt; &lt;span class="toctext"&gt;Drug Rash&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-12"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;12&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Rashes&amp;amp;action=edit&amp;amp;section=1" title="Edit section: "&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id=""&gt; &lt;/span&gt;&lt;/h2&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Rashes&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Measels (Rubeola)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Measels_.28Rubeola.29"&gt;Measels (Rubeola)&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-10-14days of incubation.
&lt;/p&gt;&lt;p&gt;-Fever, Cough, Conjunctivitis(non-purulent), Coryza, usu. before rash
&lt;/p&gt;&lt;p&gt;-Koplick spot's= pathognomonic, grains of salt on red background on buccal mucousa
&lt;/p&gt;&lt;p&gt;-Rash is "bucket of paint dumped on head"
&lt;/p&gt;&lt;p&gt;-Reddish brown on face &amp;amp; neck rather confluent spreads down trunk &amp;amp; extrems (less confluent) &amp;amp; generalized on 3rd day.
&lt;/p&gt;&lt;p&gt;-Fades on 5-6 day w/ brownish staining then desquamation.
&lt;/p&gt;&lt;p&gt;-Etiology: Rubeola virus
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Rashes&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Scarlet Fever"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Scarlet_Fever"&gt;Scarlet Fever&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-Incubation of 2-5days then...
&lt;/p&gt;&lt;p&gt;-fever, HA, sore thrt, vomiting prodrome 12hrs before rash
&lt;/p&gt;&lt;p&gt;-Erythematous, punctiform that blanches w/ pressure, starts on flexor areas then spreads to generalized in 24hrs.
&lt;/p&gt;&lt;p&gt;-Forehead &amp;amp; cheeks smooth red flushed but circumoral pallor.
&lt;/p&gt;&lt;p&gt;-See lesions most on neck, axilla, inguinal area, popliteal folds
&lt;/p&gt;&lt;p&gt;-INVOLVES HANDS &amp;amp; FEET unlike measles
&lt;/p&gt;&lt;p&gt;-Desquamation follows
&lt;/p&gt;&lt;p&gt;-STRAWBERRY TONGUE IS PATHOGN.
&lt;/p&gt;&lt;p&gt;-Etiol: Grp A strep.
&lt;/p&gt;&lt;p&gt;-Rx= pcn for 10 days or bicillin IM x1
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Rashes&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Rubella (German Measles)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Rubella_.28German_Measles.29"&gt;Rubella (German Measles)&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-Incubation 2-3wks.
&lt;/p&gt;&lt;p&gt;-NO PRODROME
&lt;/p&gt;&lt;p&gt;-Rash often first, LYMPHADENOPATHY often asymptomatic in kids.
&lt;/p&gt;&lt;p&gt;-Rash is pink starting on face/neck down to trunk &amp;amp; extrems faster than w/ measles, general in 24-48hrs.
&lt;/p&gt;&lt;p&gt;-lesions discrete not confluent.
&lt;/p&gt;&lt;p&gt;-By third day face clear only extrems. are involved (first to form, first to fade.
&lt;/p&gt;&lt;p&gt;-NO desquamation.
&lt;/p&gt;&lt;p&gt;-In contrast to measles will see confluent vs discreet.
&lt;/p&gt;&lt;p&gt;-LYMPHAD. is PATHOGN. post-auricular, occipital, but can see in other diseases
&lt;/p&gt;&lt;p&gt;-Etiology is Rubella virus.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Rashes&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Erythema Infectiosum (Fifth disease)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Erythema_Infectiosum_.28Fifth_disease.29"&gt;Erythema Infectiosum (Fifth disease)&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-incubation 6-14days
&lt;/p&gt;&lt;p&gt;-No prodrome often starts w/ rash.
&lt;/p&gt;&lt;p&gt;-Starts w/ "slapped cheeks", then urticarial/morbilliform rash on extrems &amp;amp; trunk, w/ pruritis sometimes
&lt;/p&gt;&lt;p&gt;-As rash fades gets reticular or lacey appearance. Can see this for one week or 8wks.
&lt;/p&gt;&lt;p&gt;-Pathognomic is slapped cheeks in well-appearing child.
&lt;/p&gt;&lt;p&gt;-Etiology is parvovirus B19
&lt;/p&gt;&lt;p&gt;-if pregnant bad, can =fetal hydrops &amp;amp; death (2-6%), risk greatest 1st 1/2 of preg
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Rashes&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Exanthem Subitum (Roseola)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Exanthem_Subitum_.28Roseola.29"&gt;Exanthem Subitum (Roseola)&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-Incubation of 5-15days
&lt;/p&gt;&lt;p&gt;-Prodrome of 3-4 days of high fever &amp;amp; irritability, then rash as temp falls to normal
&lt;/p&gt;&lt;p&gt;-Rash is rose-red maculopapules often appearing on chest &amp;amp; trunk first then face &amp;amp; extremities
&lt;/p&gt;&lt;p&gt;-Eruption fades in 2 days/ several hrs
&lt;/p&gt;&lt;p&gt;-Pathogen is rash as fever fades
&lt;/p&gt;&lt;p&gt;-Etiology is HSV 6,7
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Rashes&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Enteroviral Infections"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Enteroviral_Infections"&gt;Enteroviral Infections&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-ECHO virus &amp;amp; Coxsackie are common examples
&lt;/p&gt;&lt;p&gt;-Incubation about 3-6d but variable in ECHO
&lt;/p&gt;&lt;p&gt;-ECHO can see prodrome w/ fever but lower than roseola
&lt;/p&gt;&lt;p&gt;-Rubella-like appearance of rash, w/ discrete maculopapular nonpruritic rash that is generalized.
&lt;/p&gt;&lt;p&gt;-No desquamation, rarely w/ petechial lesions in ECHO &amp;amp; COXSACKIE A9 or B5
&lt;/p&gt;&lt;p&gt;-Coxsackie A16 gives hand/foot/mouth disease.
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;&lt;ul&gt;&lt;li&gt;all rash ask is it discrete or confluent
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Rashes&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Hand Foot Mouth Disease"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Hand_Foot_Mouth_Disease"&gt;Hand Foot Mouth Disease&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-brief prodrome w/ low fever, anorexia &amp;amp; ap
&lt;/p&gt;&lt;p&gt;-oral lesions (macules to vesicles on red base to ulcers)
&lt;/p&gt;&lt;p&gt;-lesions on soft &amp;amp; hard palate, gingiva
&lt;/p&gt;&lt;p&gt;-usu on dorsal hands &amp;amp; lateral feet, frequently on buttocks
&lt;/p&gt;&lt;p&gt;-pathognomonic= hand, feet &amp;amp; mouth
&lt;/p&gt;&lt;p&gt;-d/t cox A16 &amp;amp; enterovirus 71
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Rashes&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Varicella"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Varicella"&gt;Varicella&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-Incubation 10-21 days (usu 14-16)
&lt;/p&gt;&lt;p&gt;-vesicular eruption, 1st on trunk, scalp or face, later to ext, lesions in various stages of development, very pruritic
&lt;/p&gt;&lt;p&gt;-pathognomonic= macules, papules, vesicles &amp;amp; crusts of diff stages
&lt;/p&gt;&lt;p&gt;-d/t varicella zoster virus
&lt;/p&gt;&lt;p&gt;-Contagious until the last lesion crusts over which is usually about 7-10 days into dz!!
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;&lt;ul&gt;&lt;li&gt;Infectious Mononucleosis**
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;-abrupt or insidious, ha, fever &amp;amp; malaise common w/ st &amp;amp; lad to follow
&lt;/p&gt;&lt;p&gt;-rash in 10-15% usu btwn 4th-6th day of illness
&lt;/p&gt;&lt;p&gt;-red macular or maculopapular morbilliform rash of trunk &amp;amp; upper arms
&lt;/p&gt;&lt;p&gt;-occ involves face, thigh &amp;amp; legs, periorbital &amp;amp; eyelid edema in 50% of cases
&lt;/p&gt;&lt;p&gt;-pathognomonic= st, lad, splenomegaly, d/t EBV
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Rashes&amp;amp;action=edit&amp;amp;section=10" title="Edit section: HSP"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="HSP"&gt;HSP&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-palpable purpura in lower ext and buttocks
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Rashes&amp;amp;action=edit&amp;amp;section=11" title="Edit section: Drug Rash"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Drug_Rash"&gt;Drug Rash&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-sudden, usus morbilliform, often starts on face &amp;amp; trunk &amp;amp; spreads
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Rashes&amp;amp;action=edit&amp;amp;section=12" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Inkelis 7/04- By Lampe
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="red_eye_(bilateral)"><name>Red Eye (Bilateral)</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Red_Eye_(Bilateral)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Painful"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Painful"&gt;Painful&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Chemical Injury
&lt;/li&gt;&lt;li&gt;Foreign Body
&lt;ol&gt;&lt;li&gt;welder's flash/grinding
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Trauma
&lt;/li&gt;&lt;li&gt;Contact Lens
&lt;/li&gt;&lt;li&gt;Conjunctivitis (rarely painful, more irritated)
&lt;ol&gt;&lt;li&gt;watery viral/discharge bacterial/consider chlamydia
&lt;/li&gt;&lt;li&gt;viral keratoconjucitivis assoc with URI and adeno
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Blepharitis (sore/itchy, may also have ulcers)
&lt;/li&gt;&lt;li&gt;Allergic Reaction (to eye drops w/ periorbital excoriation)
&lt;/li&gt;&lt;li&gt;Dysthyroid Dz (proptotic, may have visual loss)
&lt;ol&gt;&lt;li&gt;gross chemosis (swelling of conjunctiva), diploplia
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Carotico-cavernous fistula
&lt;ol&gt;&lt;li&gt;fistula b/n carotid and cavernous sinus p/w bilat conjunctival edema and pulsatile exophthalmos (spont in elderly, 2/2 trauma in young)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Red_Eye_(Bilateral)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Painless"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Painless"&gt;Painless&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Conjunctivitis
&lt;/li&gt;&lt;li&gt;Blepharitis: inflammation of lid margin w/ ocular irritation, matted lashes
&lt;/li&gt;&lt;li&gt;Allergic Reaction
&lt;/li&gt;&lt;li&gt;Thyroid Dz (optic nerve compression/APD)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Red_Eye_(Bilateral)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from Pani
&lt;/p&gt;



</content><folder>Ophtho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="red_eye_(peds)"><name>Red Eye (Peds)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Red_Eye_(Peds)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;corneal abrasion
&lt;/p&gt;&lt;p&gt;corneal infection (consider herpes/chlamydia)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Red_Eye_(Peds)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;EXAM: Fluorescein to id abrasions and herpes keratitis
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Red_Eye_(Peds)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Infxn: oral erythromycin + CTX (for N. gonorrhoea)
&lt;/p&gt;&lt;p&gt;Conjunctivitis + Resp Sx/Abnl CXR or Otitis Media: (if younger than 3 mos) oral macrolide
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Red_Eye_(Peds)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from Pani
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="red_eye_(unilateral)_1"><name>Red Eye (Unilateral) 1</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Trauma"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Trauma&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Nontraumatic"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Nontraumatic&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Red_Eye_(Unilateral)_1&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Trauma"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Trauma"&gt;Trauma&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Obvious open globe^
&lt;/li&gt;&lt;li&gt; No obvious open globe
&lt;ol&gt;&lt;li&gt; Epithelial defect
&lt;ol&gt;&lt;li&gt; Corneal abrasion
&lt;/li&gt;&lt;li&gt; Corneal ulcer^
&lt;/li&gt;&lt;li&gt; Caustic keratoconjunctivitis^^
&lt;/li&gt;&lt;li&gt; Occult open globe^
&lt;ol&gt;&lt;li&gt;(positive Sidel's)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; No defect
&lt;ol&gt;&lt;li&gt; Subconjunct hem
&lt;/li&gt;&lt;li&gt; Traumatic iritis
&lt;/li&gt;&lt;li&gt; Hypema^
&lt;ol&gt;&lt;li&gt;(?occult open globe)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Endophthalmitis^
&lt;ol&gt;&lt;li&gt; (old occult open globe)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Red_Eye_(Unilateral)_1&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Nontraumatic"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Nontraumatic"&gt;Nontraumatic&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Epithelial defect
&lt;ol&gt;&lt;li&gt; Corneal abrasion
&lt;/li&gt;&lt;li&gt; Corneal ulcer^ (above)
&lt;/li&gt;&lt;li&gt; HSV conjunct (dendrite)
&lt;/li&gt;&lt;li&gt; Corneal erosion
&lt;ol&gt;&lt;li&gt;(morning pain)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; UV/welders keratitis
&lt;ol&gt;&lt;li&gt; (SPK)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Scleral penetration^
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; No defect
&lt;ol&gt;&lt;li&gt; No pain relief w/ tropicamide
&lt;ol&gt;&lt;li&gt; Acute angle glaucoma^
&lt;ol&gt;&lt;li&gt;dilated
&lt;/li&gt;&lt;li&gt;closed angle
&lt;/li&gt;&lt;li&gt;inc pressure
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Nontraumatic Iritis
&lt;/li&gt;&lt;li&gt; Scleritis^
&lt;ol&gt;&lt;li&gt;(localized; no move Q-tip)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Anterior uveitis
&lt;ol&gt;&lt;li&gt;(hypopyon, cilliary flush)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; No pain/pain relief w/ tropicamide
&lt;ol&gt;&lt;li&gt; Foreign body
&lt;/li&gt;&lt;li&gt; Conjunctivitis
&lt;ol&gt;&lt;li&gt; Viral
&lt;/li&gt;&lt;li&gt; Bacterial^
&lt;ol&gt;&lt;li&gt;(purulent--&amp;gt;?GC)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Allergic
&lt;/li&gt;&lt;li&gt; Contact
&lt;/li&gt;&lt;li&gt; Toxic
&lt;/li&gt;&lt;li&gt; Chlamydial
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Keratoconjunctivits
&lt;/li&gt;&lt;li&gt; Episcleritis
&lt;ol&gt;&lt;li&gt;(localized; move w/ Q-tip)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Non-uptake finding (no pain/pain relief w/ tropicamd)
&lt;ol&gt;&lt;li&gt; Subconjunct hemorr
&lt;/li&gt;&lt;li&gt; Inflamed pingueculum
&lt;/li&gt;&lt;li&gt; Inflamed pterygium
&lt;/li&gt;&lt;li&gt; Keratoconus (protrude)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;^Emergent diagnosises
&lt;/p&gt;&lt;p&gt;^^Critical diagnosises
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Red_Eye_(Unilateral)_1&amp;amp;action=edit&amp;amp;section=3" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Optho:  Corneal Abrasion vs Ulcer
&lt;/p&gt;&lt;p&gt;Optho:  Red Eye (Unilateral) 2
&lt;/p&gt;&lt;p&gt;Optho:  Red Eye (Bilateral)
&lt;/p&gt;&lt;p&gt;Optho:  Red Eye (by Sx)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Red_Eye_(Unilateral)_1&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;3/20/06 DONALDSON (adapted from Rosen, WMS Practic Guidelines 2000)
&lt;/p&gt;



</content><folder>Ophtho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="red_eye_(unilateral)_2"><name>Red Eye (Unilateral) 2</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#DDX"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;DDX&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Painful"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;Painful&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-3 tocsection-4"&gt;&lt;a href="#Less_Common"&gt;&lt;span class="tocnumber"&gt;2.1.1&lt;/span&gt; &lt;span class="toctext"&gt;Less Common&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Painless"&gt;&lt;span class="tocnumber"&gt;2.2&lt;/span&gt; &lt;span class="toctext"&gt;Painless&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Red_Eye_(Unilateral)_2&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Evert lens and look for foreign body
&lt;/li&gt;&lt;li&gt;Remove contacts
&lt;/li&gt;&lt;li&gt;Photophobia suggests inflammation i.e. uveitis and abrasions
&lt;/li&gt;&lt;li&gt;Pupil: irregular with positive sidel's suggests penetrating injury
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Red_Eye_(Unilateral)_2&amp;amp;action=edit&amp;amp;section=2" title="Edit section: DDX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX"&gt;DDX&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Red_Eye_(Unilateral)_2&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Painful"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Painful"&gt;Painful&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Corneal Abrasion
&lt;/li&gt;&lt;li&gt;Corneal Ulcer
&lt;/li&gt;&lt;li&gt;Foreign Body
&lt;/li&gt;&lt;li&gt;Trauma
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;Endophthalmitis following prior surgery, with Hypopyon or pus in anterior chamber
&lt;/p&gt;
&lt;h4&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Red_Eye_(Unilateral)_2&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Less Common"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Less_Common"&gt;Less Common&lt;/span&gt;&lt;/h4&gt;
&lt;ol&gt;&lt;li&gt;Periorbital/orbital Cellulitis
&lt;/li&gt;&lt;li&gt;Acute Glaucoma: corneal clouding
&lt;/li&gt;&lt;li&gt;Scleritis
&lt;/li&gt;&lt;li&gt;Uveitis (recurrent in AS): keratic precipitates
&lt;ol&gt;&lt;li&gt;photophobia, perilimbal injection
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Hyphema/Hypopyon
&lt;/li&gt;&lt;li&gt;Shingles (look for concurrent skin findings)
&lt;/li&gt;&lt;li&gt;Thyroid Eye Dz
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Red_Eye_(Unilateral)_2&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Painless"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Painless"&gt;Painless&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Conjunctivitis
&lt;/li&gt;&lt;li&gt;Subconjunctival Hemorrhage: h/o trauma or valsalva, DM, HTN
&lt;/li&gt;&lt;li&gt;Episcleritis
&lt;/li&gt;&lt;li&gt;Allergic Reaction
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Red_Eye_(Unilateral)_2&amp;amp;action=edit&amp;amp;section=6" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Optho:  Red Eye (Unilateral) 1
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Red_Eye_(Unilateral)_2&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from Pani
&lt;/p&gt;



</content><folder>Ophtho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="red_eye_(by_sx)"><name>Red Eye (by Sx)</name><content>&lt;p&gt;CAUSTIC CONTAMINATION:
&lt;/p&gt;&lt;p&gt;-caustic keratoconjunctivitis**
&lt;/p&gt;&lt;p&gt;[anesth/irrigation until ph 7/optho]
&lt;/p&gt;&lt;p&gt;...alkaline exp requires min 4L over 40min
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;PROPTOSIS or EXT SWELLING:
&lt;/p&gt;&lt;p&gt;-blepharitis
&lt;/p&gt;&lt;p&gt;[warm compresses 15min 4x/day, scrub w/ mild shampoo BID, outpt optho]
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;-chalazion
&lt;/p&gt;&lt;p&gt;-stye (hordeolum)
&lt;/p&gt;&lt;p&gt;[warm compress 15min 4xday, massage, optho if fails]
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;-dacrocystitis:inflammation lower eyelid near punctum
&lt;/p&gt;&lt;p&gt;[oral analgesia, abx, optho]
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;-inflam pseudotumor: retrobulbar inflamm
&lt;/p&gt;&lt;p&gt;[iop, systemic w/u, CT, steroids and optho]
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;-peri/orbital cellulitis*: orbital w/ systemic sx
&lt;/p&gt;&lt;p&gt;[CTX/Vanco, cx, CT, admit]
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;-retrobulbar abscess/emphysema/hematoma**
&lt;/p&gt;&lt;p&gt;[iop, abx, correct coagulopathy, admit]
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;-orbital tumor*
&lt;/p&gt;&lt;p&gt;[iop, ct, optho]
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;SEVERE PAIN or FB SENSATION:
&lt;/p&gt;&lt;p&gt;-keratitis*
&lt;/p&gt;&lt;p&gt;[r/o penetration, tetanus, topical abx, optho referral]
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;-keratoconjunctivitis
&lt;/p&gt;&lt;p&gt;-epi/scleritis
&lt;/p&gt;&lt;p&gt;-anterior uveitis*
&lt;/p&gt;&lt;p&gt;[optho recs]
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;-acute angle-closure glaucoma**
&lt;/p&gt;&lt;p&gt;[iop, timolol, apraclonidine, prednisolone, pilocarpine, mannitol 2g/kg IV]
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;-hyphema*
&lt;/p&gt;&lt;p&gt;[r/o rupture, head elevation, optho]
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;-endophthalmitis*
&lt;/p&gt;&lt;p&gt;[CTX, vanco; admit to optho]
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;FOCAL REDNESS or BULBAR CONJUNCTIVA
&lt;/p&gt;&lt;p&gt;-inflamed pterygium
&lt;/p&gt;&lt;p&gt;[naphazoline/ketorolac drops, outpt referral]
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;-scleral penetration**
&lt;/p&gt;&lt;p&gt;[pain relief, antiemetic, tetanus, admit optho]
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;-subconjunctival hemorrhage
&lt;/p&gt;&lt;p&gt;[hx re coagulopathy, reassure will resolve 2-3 wks]
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;PURULENT DISCHARGE
&lt;/p&gt;&lt;p&gt;-bacterial conjunctivitis*
&lt;/p&gt;&lt;p&gt;[peds: polymyxin B + trimethoprim ointment 10Ds OU]
&lt;/p&gt;&lt;p&gt;[adults: sulfacetamide or gent; cipro if pseudomonas; drops 10D OU]
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;ITCHING SENSATION
&lt;/p&gt;&lt;p&gt;-allergic conjunctivitis
&lt;/p&gt;&lt;p&gt;[naphazoline drops, oral antihistamines, outpt optho]
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;TOPICAL MEDS or COSMETICS
&lt;/p&gt;&lt;p&gt;-contact dermatoconjunctivitis
&lt;/p&gt;&lt;p&gt;-toxic conjunctivitis
&lt;/p&gt;&lt;p&gt;[irrigate, naphazoline drops, outpt for tx failure]
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;IF NONE OF ABOVE: (consider)
&lt;/p&gt;&lt;p&gt;-Chlamydia conjunctivitis
&lt;/p&gt;&lt;p&gt;[PO erythromycin x 14D; CTX for gonorrhea]
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;-viral conjunctivitis
&lt;/p&gt;&lt;p&gt;[naphazoline or ketorolac drops]
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Red_Eye_(by_Sx)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from Pani
&lt;/p&gt;



</content><folder>Ophtho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="redypaque"><name>Redypaque</name><content>&lt;table border="1"&gt;

&lt;tr&gt;
&lt;td style="width: 98px; border: 1pt solid" valign="top" width="98"&gt;
&lt;p&gt;&lt;b&gt;Weight&lt;/b&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 98px" valign="top" width="98"&gt;
&lt;p&gt;&lt;b&gt;Give 1 hour prior to scan&lt;/b&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 146px" valign="top" width="146"&gt;
&lt;p&gt;&lt;b&gt;Give 30 minutes prior to scan&lt;/b&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 120px" valign="top" width="144"&gt;
&lt;p&gt;&lt;b&gt;Give immediately upon arrival to CT&lt;/b&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="width: 98px" valign="top" width="98"&gt;
&lt;p&gt;&lt;u&gt;&amp;lt;&lt;/u&gt; 2 kg
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 98px" valign="top" width="98"&gt;
&lt;p&gt;None or as ordered by physician
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 146px" valign="top" width="146"&gt;
&lt;p&gt;None or as ordered by physician
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 120px" valign="top" width="144"&gt;
&lt;p&gt;None or as ordered by physician
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="width: 98px" valign="top" width="98"&gt;
&lt;p&gt;2-5 kg
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 98px" valign="top" width="98"&gt;
&lt;p&gt;30 mL
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 146px" valign="top" width="146"&gt;
&lt;p&gt;30 mL
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 120px" valign="top" width="144"&gt;
&lt;p&gt;30 mL
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="width: 98px" valign="top" width="98"&gt;
&lt;p&gt;&amp;gt;5-20 kg
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 98px" valign="top" width="98"&gt;
&lt;p&gt;90 mL
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 146px" valign="top" width="146"&gt;
&lt;p&gt;90 mL
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 120px" valign="top" width="144"&gt;
&lt;p&gt;90 mL
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="width: 98px" valign="top" width="98"&gt;
&lt;p&gt;&amp;gt;20-50 kg
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 98px" valign="top" width="98"&gt;
&lt;p&gt;150 mL
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 146px" valign="top" width="146"&gt;
&lt;p&gt;150 mL
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 120px" valign="top" width="144"&gt;
&lt;p&gt;150 mL
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="width: 98px" valign="top" width="98"&gt;
&lt;p&gt;&amp;gt;50 kg
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 98px" valign="top" width="98"&gt;
&lt;p&gt;300 mL
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 146px" valign="top" width="146"&gt;
&lt;p&gt;300 mL
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 120px" valign="top" width="144"&gt;
&lt;p&gt;300 mL
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;p&gt;(100cc/age)/3 = dose x 3
&lt;/p&gt;&lt;p&gt;Max = 300cc
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Redypaque&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt; Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;adapted from Mink 7/2010
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="refeeding_syndrome"><name>Refeeding Syndrome</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Refeeding_Syndrome&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Mostly an issue c TPN, risk of death
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Fluid overload
&lt;ol&gt;&lt;li&gt;Insulin secretion
&lt;/li&gt;&lt;li&gt;Loss of myocardium
&lt;/li&gt;&lt;li&gt;Na absorption
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Mineral Depletion:
&lt;ol&gt;&lt;li&gt;Phosphorus
&lt;/li&gt;&lt;li&gt;K
&lt;/li&gt;&lt;li&gt;Na
&lt;/li&gt;&lt;li&gt;Mg
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Glucose Intoleraence
&lt;/li&gt;&lt;li&gt;Cardiac Arrhythmas
&lt;ol&gt;&lt;li&gt;1st wk
&lt;/li&gt;&lt;li&gt;Long QT
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Refeeding_Syndrome&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;7/2/09  PANI
&lt;/p&gt;



</content><folder>FEN</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="respiratory_acidosis"><name>Respiratory Acidosis</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Respiratory_Acidosis&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Cause = Hypoventilation
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Respiratory_Acidosis&amp;amp;action=edit&amp;amp;section=2" title="Edit section: DDX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX"&gt;DDX&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;COPD
&lt;/li&gt;&lt;li&gt;Drugs (opiods)
&lt;/li&gt;&lt;li&gt;Chest wall dz
&lt;/li&gt;&lt;li&gt;Pleural dz
&lt;/li&gt;&lt;li&gt;Trauma 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Respiratory_Acidosis&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;2/21/06 DONALDSON (adapted from Tintinalli)
&lt;/p&gt;



</content><folder>FEN</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="respiratory_alkalosis"><name>Respiratory Alkalosis</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Respiratory_Alkalosis&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Cause = hyperventilation
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Respiratory_Alkalosis&amp;amp;action=edit&amp;amp;section=2" title="Edit section: DDX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX"&gt;DDX&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Asthma
&lt;/li&gt;&lt;li&gt;PE
&lt;/li&gt;&lt;li&gt;DKA
&lt;/li&gt;&lt;li&gt;Anxiety
&lt;/li&gt;&lt;li&gt;Hypoxia
&lt;/li&gt;&lt;li&gt;Fever
&lt;/li&gt;&lt;li&gt;Hyperthyroid
&lt;/li&gt;&lt;li&gt;Sympathomimetics
&lt;/li&gt;&lt;li&gt;ASA OD
&lt;/li&gt;&lt;li&gt;Progesterone
&lt;/li&gt;&lt;li&gt;Liver dz
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Respiratory_Alkalosis&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;2/21/06 DONALDSON (adapted from Tintinalli)
&lt;/p&gt;



</content><folder>FEN</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="retinal_detachment"><name>Retinal Detachment</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Retinal_Detachment&amp;amp;action=edit&amp;amp;section=1" title="Edit section: History"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="History"&gt;History &lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Abrupt onset of new "floaters" or flashes of light
&lt;/li&gt;&lt;li&gt; Visual acuity loss (filmy, cloudy, or curtain-like) or visual field loss 
&lt;ol&gt;&lt;li&gt; May be mild or dramatic 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Retinal_Detachment&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Examination 
&lt;ol&gt;&lt;li&gt; Visual acuity and visual fields 
&lt;/li&gt;&lt;li&gt; Intraocular pressure
&lt;ol&gt;&lt;li&gt; Hypotony of &amp;gt; 4-5 mmHg is common in the affected eye
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Fundoscopic exam with dilation
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Ultrasound 
&lt;ol&gt;&lt;li&gt; Linear probe (7.5-10-MHz) is preferred
&lt;/li&gt;&lt;li&gt; Have pt lightly close their eye; avoid excessive pressure on globe
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Retinal_Detachment&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Urgent ophtho referral
&lt;/p&gt;



</content><folder>Ophtho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="rhabdomyolysis"><name>Rhabdomyolysis</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Clinical"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;Clinical&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Laboratory"&gt;&lt;span class="tocnumber"&gt;2.2&lt;/span&gt; &lt;span class="toctext"&gt;Laboratory&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Evidence_Based_Questions"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Evidence Based Questions&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Rhabdomyolysis&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background &lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Muscle necrosis and the release of intracellular muscle constituents into the circulation
&lt;/li&gt;&lt;li&gt; Causes
&lt;ol&gt;&lt;li&gt; Traumatic or muscle compression
&lt;ol&gt;&lt;li&gt; Crush injury
&lt;/li&gt;&lt;li&gt; Immobilization
&lt;/li&gt;&lt;li&gt;. Compartment syndrome
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Nontraumatic exertional
&lt;ol&gt;&lt;li&gt; Exercise + hot weather
&lt;/li&gt;&lt;li&gt; Exercise + sickle cell
&lt;/li&gt;&lt;li&gt; Exercise + hypokalemia
&lt;/li&gt;&lt;li&gt; Hyperkinetic states
&lt;ol&gt;&lt;li&gt; Seizure
&lt;/li&gt;&lt;li&gt; DTs
&lt;/li&gt;&lt;li&gt; Stimulant overdose
&lt;/li&gt;&lt;li&gt; Malignant hyperthermia
&lt;/li&gt;&lt;li&gt; NMS
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Nontraumatic nonexertional
&lt;ol&gt;&lt;li&gt; Drugs and toxins
&lt;ol&gt;&lt;li&gt; Coma induced by sedatives
&lt;/li&gt;&lt;li&gt; Statins
&lt;/li&gt;&lt;li&gt; Colchicine  
&lt;/li&gt;&lt;li&gt; CO poisoning
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Infection
&lt;ol&gt;&lt;li&gt; Viral myositis - Influenza, Coxsackie, EBV, HSV, HIV, CMV
&lt;/li&gt;&lt;li&gt; Bacterial pyomyositis
&lt;/li&gt;&lt;li&gt; Septicemia
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Endocrine
&lt;ol&gt;&lt;li&gt; Hypothyroidism
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Inflammatory myopathies
&lt;ol&gt;&lt;li&gt; Moderate CK elevations only (rhabdo only described in case reports)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Miscellaneous
&lt;ol&gt;&lt;li&gt; Status asthmaticus
&lt;/li&gt;&lt;li&gt; TSS
&lt;/li&gt;&lt;li&gt; Mushroom ingestion
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Rhabdomyolysis&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Rhabdomyolysis&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Clinical"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Clinical"&gt;Clinical&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Myalgias
&lt;ol&gt;&lt;li&gt; May progress to weakness
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Red/brown urine
&lt;/li&gt;&lt;li&gt; Renal failure
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Rhabdomyolysis&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Laboratory"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Laboratory"&gt;Laboratory&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Elevated total CK (typically &amp;gt; 10K)
&lt;ol&gt;&lt;li&gt; CK-MB may be entirely normal or may be mildly elevated (reflects small amount found in skeletal tissue)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Myoglobinuria
&lt;ol&gt;&lt;li&gt; Is cleared much faster than CK (may see elevated CK with no myoglobinuria)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Transaminitis
&lt;/li&gt;&lt;li&gt; Creatinine increase (if renal failure)
&lt;/li&gt;&lt;li&gt; Electrolyte Abnormalities
&lt;ol&gt;&lt;li&gt; Hyperkalemia
&lt;/li&gt;&lt;li&gt; Hyperphosphatemia
&lt;/li&gt;&lt;li&gt; Hypocalcemia
&lt;/li&gt;&lt;li&gt; Hyperuricemia
&lt;/li&gt;&lt;li&gt; Metabolic acidosis
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Rhabdomyolysis&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Aggressive IVF
&lt;ol&gt;&lt;li&gt; Start with 1-2 L/hr
&lt;/li&gt;&lt;li&gt; Once diuresis occurs maintain urine output of 200-300 mL/hr
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Bicarb?
&lt;ol&gt;&lt;li&gt; If IVF establishes diuresis consider adding 75 mmol of NaHCO3 to 1L of 1/2NS
&lt;ol&gt;&lt;li&gt; Goal urine pH is &amp;gt; 6.5
&lt;/li&gt;&lt;li&gt; Monitor for hypocalcemia closely! 
&lt;/li&gt;&lt;li&gt; If urine pH is not &amp;gt; 6.5 after 3-4 hrs or symptomatic hypocalcemia results d/c
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Mannitol?
&lt;ol&gt;&lt;li&gt; Consider if unable to establish diuresis with volume repletion
&lt;ol&gt;&lt;li&gt; Must check plasma osmolaity and plasma osmolal gap q4-6hr
&lt;/li&gt;&lt;li&gt; D/c if osmolal gap &amp;gt; 55 mosmol/kg
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; If mannitol establishes diuresis continue until urine discoloration clears and CK decreases to &amp;lt;10K
&lt;/li&gt;&lt;li&gt; Hypocalcemia
&lt;ol&gt;&lt;li&gt; Only treat if symptomatic or severely hyperkalemic! (pts often have rebound hypercalcemia)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Rhabdomyolysis&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Evidence Based Questions"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Evidence_Based_Questions"&gt;Evidence Based Questions&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;No randomized, controlled trial has supported the evidence-based use of mannitol, and some clinical studies suggest no beneficial effects. In addition, high accumulated doses of mannitol (&amp;gt;200 g per day or accumulated doses of &amp;gt;800 g) have been associated with acute kidney injury due to renal vasoconstriction and tubular toxicity, a condition known as osmotic nephrosis. However, many experts continue to suggest that mannitol should be used to prevent and treat rhabdomyolysis-induced acute kidney injury and relieve compartmental pressure. During the time mannitol is being administered, plasma osmolality and the osmolal gap (i.e., the difference between the measured and calculated serum osmolality) should be monitored frequently and therapy discontinued if adequate diuresis is not achieved or if the osmolal gap rises above 55 mOsm per kilogram.
&lt;/p&gt;&lt;p&gt;A. Bozch X et al. Rhabdomyolysis and Acute Kidney Injury. NEJM 2009; 361: 62-72
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Rhabdomyolysis&amp;amp;action=edit&amp;amp;section=7" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Rhabdomyolysis&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;KajQuestions
&lt;/p&gt;



</content><folder>GU</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="rib_fracture"><name>Rib Fracture</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Rib_Fracture&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;kids &amp;lt;2y w/ &amp;gt;2 rib fx have almost 50% mort b/c ribs in kids rarely break &amp;amp; fx= xtreme force!
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;elderly have 2 X mortality w/ rib fx as younger pts
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Rib_Fracture&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;PA CXR highest yield for rib fx, but clinical dx
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;1st &amp;amp; 2nd Rib Fx hallmark of severe chest trauma, can injure brach plexus, great vessels &amp;amp; lung, ONLY nd angio if evidence of neurological or vascular injury, studies have shown no incr risk if nv intact &amp;amp; fx pattern &amp;amp; amt of displacement does NOT predict vascular inj
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;costochondral seperation have nl cxr w/ similar s/s of rib fx, takes wks to mos to heal d/t decr vasc
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Rib_Fracture&amp;amp;action=edit&amp;amp;section=3" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;(Burbulys 2004/Trauma Reports 4/04 /A-Digest 7/04) -by Lampe
&lt;/p&gt;



</content><folder>Trauma</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="ruptured_globe"><name>Ruptured Globe</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ruptured_Globe&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Be careful not to apply pressure to eye
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ruptured_Globe&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Ceftaz 1gm
&lt;/p&gt;&lt;p&gt;+
&lt;/p&gt;&lt;p&gt;Vanco 1 gm
&lt;/p&gt;&lt;p&gt;PCN allergy
&lt;/p&gt;&lt;p&gt;Cipro + vanc
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ruptured_Globe&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Donaldson 5/08 (trauma reports)
&lt;/p&gt;



</content><folder>Ophtho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="stemi"><name>STEMI</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Adjunctive"&gt;&lt;span class="tocnumber"&gt;3.1&lt;/span&gt; &lt;span class="toctext"&gt;Adjunctive&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Anticoagulants"&gt;&lt;span class="tocnumber"&gt;3.2&lt;/span&gt; &lt;span class="toctext"&gt;Anticoagulants&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-6"&gt;&lt;a href="#Antiplatelet"&gt;&lt;span class="tocnumber"&gt;3.3&lt;/span&gt; &lt;span class="toctext"&gt;Antiplatelet&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-7"&gt;&lt;a href="#Definitive"&gt;&lt;span class="tocnumber"&gt;3.4&lt;/span&gt; &lt;span class="toctext"&gt;Definitive&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Fibrinolysis"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Fibrinolysis&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-9"&gt;&lt;a href="#Inclusion"&gt;&lt;span class="tocnumber"&gt;4.1&lt;/span&gt; &lt;span class="toctext"&gt;Inclusion&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-10"&gt;&lt;a href="#Exclusion"&gt;&lt;span class="tocnumber"&gt;4.2&lt;/span&gt; &lt;span class="toctext"&gt;Exclusion&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-11"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=STEMI&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;&#8805; 1-mm (0.1mV) ST-segment elevation in at least 2 anatomically contiguous limb leads (aVL to III, including -aVR)
&lt;/li&gt;&lt;li&gt;&#8805; 1-mm ST-segment elevation in a precordial lead V4 through V6
&lt;/li&gt;&lt;li&gt;&#8805; 2-mm (0.2mV) ST-segment elevation in V1 through V3
&lt;/li&gt;&lt;li&gt;a new left bundle branch block
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;ACC/AHA, ESC
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=STEMI&amp;amp;action=edit&amp;amp;section=2" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Myocardial ischemia or infarction 
&lt;/li&gt;&lt;li&gt;Noninfarction, transmural ischemia (Prinzmetal's angina pattern or acute takotsubo cardiomyopathy)
&lt;/li&gt;&lt;li&gt;Acute myocardial infarction (MI)
&lt;/li&gt;&lt;li&gt;Post-MI (ventricular aneurysm pattern)-Previous MI with recurrent ischemia in the same area-Acute pericarditis-Normal "early repolarization variants"
&lt;/li&gt;&lt;li&gt;Left ventricular hypertrophy or left bundle branch block (only V1-V2 or V3)-Myocarditis (may look like myocardial infarction or pericarditis)
&lt;/li&gt;&lt;li&gt;Brugada patterns (V1-V3 with right bundle branch block-appearing morphology) 
&lt;/li&gt;&lt;li&gt;Myocardial tumor 
&lt;/li&gt;&lt;li&gt;Myocardial trauma 
&lt;/li&gt;&lt;li&gt;Hyperkalemia (only leads V1 and V2) 
&lt;/li&gt;&lt;li&gt;Hypothermia (J wave/Osborn wave)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=STEMI&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=STEMI&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Adjunctive"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Adjunctive"&gt;Adjunctive&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;O2
&lt;/li&gt;&lt;li&gt;ASA 162, 325chewable PO or 600mg PR; Plavix 300 or 600mg if ASA allergy
&lt;/li&gt;&lt;li&gt;NTG
&lt;/li&gt;&lt;li&gt;Morphine
&lt;/li&gt;&lt;li&gt;BBlocker:
&lt;ol&gt;&lt;li&gt;PO within 24 hours
&lt;/li&gt;&lt;li&gt;IV beta-blocker is reasonable for patients who are hypertensive in the absence of:
&lt;ol&gt;&lt;li&gt;signs of heart failure
&lt;/li&gt;&lt;li&gt;evidence of a low cardiac output state
&lt;/li&gt;&lt;li&gt;post beta-blocker cardiogenic shock risk factors (age &amp;gt; 70 years, systolic blood pressure &amp;lt; 120 mm Hg, sinus tachycardia &amp;gt; 110 bpm or heart rate &amp;lt; 60 bpm, increased time since onset of symptoms of STEMI)
&lt;/li&gt;&lt;li&gt;other relative contraindications to beta blockade (PR interval &amp;gt; 0.24 s, second- or third-degree heart block, active asthma, or reactive airway disease)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=STEMI&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Anticoagulants"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Anticoagulants"&gt;Anticoagulants&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Heparin (UFH)
&lt;ol&gt;&lt;li&gt;Bolus 60U/kg (max: 4000U)
&lt;/li&gt;&lt;li&gt;12U/kg/h (max: 1000U/h)
&lt;/li&gt;&lt;li&gt;NB: monitor PTT: 50-70s
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;LMWH
&lt;ol&gt;&lt;li&gt;&amp;lt;75yo with serum Cr &amp;lt; 2.5 mg/dL (men) or &amp;lt; 2.0 mg/dL (women):
&lt;ol&gt;&lt;li&gt;30mg IV bolus, followed by 1mg/kg SC q12h
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;&#8805; 75yo: 0.75-mg/kg SC q12h
&lt;/li&gt;&lt;li&gt;CrCl &amp;lt; 30 mL/min: 1mg/kg SC qd
&lt;/li&gt;&lt;li&gt;NB: note renal clearance
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Fondaparinux
&lt;ol&gt;&lt;li&gt;Cr &amp;lt; 3.0 mg/dL: 2.5mg IV bolus, then 2.5-mg SC qd, started 24 hr after bolus
&lt;/li&gt;&lt;li&gt;NB: monitor anti-Xa levels
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Bivalirudin
&lt;ol&gt;&lt;li&gt;0.75-mg/kg IV bolus, followed by 1.75 mg/kg/h
&lt;/li&gt;&lt;li&gt;CrCl &amp;lt; 30 mL/min: 0.75-mg/kg IV bolus, followed by 1.0 mg/kg/h
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=STEMI&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Antiplatelet"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Antiplatelet"&gt;Antiplatelet&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;GPIIB/IIIa Inhibitors: Abciximab (ReoPro&#174;), Eptifibatide (Integrilin&#174;), Tirofiban (Aggrastat&#174;)
&lt;ol&gt;&lt;li&gt;Given right before PCI
&lt;/li&gt;&lt;li&gt;Defer to cardiologist
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Clopidogrel (Plavix&#174;)
&lt;ol&gt;&lt;li&gt;300mg po x1 (onset 2h, peak 6-15h)
&lt;/li&gt;&lt;li&gt;600mg po x1 (faster onset)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=STEMI&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Definitive"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Definitive"&gt;Definitive&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Fibrinolytics within 30mins
&lt;/li&gt;&lt;li&gt;PCI within 90mins
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=STEMI&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Fibrinolysis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Fibrinolysis"&gt;Fibrinolysis&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=STEMI&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Inclusion"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Inclusion"&gt;Inclusion&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;&amp;lt;12 hours from the onset of chest pain (lasting 30 minutes) and:
&lt;/li&gt;&lt;li&gt;ST elevation of &#8805;1mm in 2 contiguous limb or precordial leads
&lt;/li&gt;&lt;li&gt;New left bundle branch block
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=STEMI&amp;amp;action=edit&amp;amp;section=10" title="Edit section: Exclusion"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Exclusion"&gt;Exclusion&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;ABSOLUTE
&lt;ol&gt;&lt;li&gt;Any prior ICH
&lt;/li&gt;&lt;li&gt;Known structural CNS lesion (e.g. AV malformation,  intracranial neoplasm)
&lt;/li&gt;&lt;li&gt;Ischemic stroke &amp;lt;3 months (excluding acute ischemic stroke  within last 3h)
&lt;/li&gt;&lt;li&gt;Suspected aortic dissection
&lt;/li&gt;&lt;li&gt;Active bleeding or bleeding diathesis (excluding menses)
&lt;/li&gt;&lt;li&gt;Significant closed-head/facial trauma &amp;lt; 3months
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;RELATIVE
&lt;ol&gt;&lt;li&gt;SBP &amp;gt;180 mmHg
&lt;/li&gt;&lt;li&gt;DBP &amp;gt;110 mmHg
&lt;/li&gt;&lt;li&gt;CPR &amp;gt;10min
&lt;/li&gt;&lt;li&gt;&amp;lt;4wk from major trauma/surgery or GI/GU bleed
&lt;/li&gt;&lt;li&gt;Current use of anticoagulants
&lt;/li&gt;&lt;li&gt;Pregnancy
&lt;/li&gt;&lt;li&gt;Active peptic ulcer (guaiac positive)
&lt;/li&gt;&lt;li&gt;Ischemic  stroke in past 3 months
&lt;/li&gt;&lt;li&gt;Dementia or other known  intracranial pathology not noted above
&lt;/li&gt;&lt;li&gt;Noncompressible  vascular punctures w/in past 3 weeks
&lt;/li&gt;&lt;li&gt;Prior exposure (&amp;gt;  5 days) or prior allergic reaction to streptokinase or anistreplase (if  taking these agents)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=STEMI&amp;amp;action=edit&amp;amp;section=11" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;DONALDSON (adapted from ACC/AHA Practice Guidelines 2004/5), EBM 6/09
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="svt"><name>SVT</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=SVT&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;table border="1"&gt;
&lt;tr&gt;
&lt;td&gt; &lt;b&gt;Sx&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Sinus Tach&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;SVT&lt;/b&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Hx
&lt;/td&gt;&lt;td&gt; volume loss
&lt;/td&gt;&lt;td&gt; sudden onset
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; PE
&lt;/td&gt;&lt;td&gt; dehydated
&lt;/td&gt;&lt;td&gt; CHF-like
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; *HR
&lt;/td&gt;&lt;td&gt; &amp;lt;180
&lt;/td&gt;&lt;td&gt; &amp;gt;180
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Variability
&lt;/td&gt;&lt;td&gt; Yes
&lt;/td&gt;&lt;td&gt; No
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;p&gt;*In infants HR cuttoff = 220
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=SVT&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Skip to cardioversion if unstable!
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Vagal manuvers
&lt;/li&gt;&lt;li&gt;Adenosine
&lt;ol&gt;&lt;li&gt;6mg IVP (fast)
&lt;/li&gt;&lt;li&gt;12mg IVP(fast)
&lt;/li&gt;&lt;li&gt;12mg IVP (fast)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;CCB (Verapamil or dilt) or BB (metoprolol or esmolol)
&lt;/li&gt;&lt;li&gt;Cardioversion (sync) 0.5-1.0 J/kg
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=SVT&amp;amp;action=edit&amp;amp;section=3" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Cards: VTach vs Abberant SVT
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=SVT&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;2/23/06 DONALDSON (adapted from Rosen), UpToDate
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="sad_persons_score"><name>Sad Persons Score</name><content>&lt;p&gt;SCORE (points)
&lt;/p&gt;&lt;p&gt;Sex = male (1)
&lt;/p&gt;&lt;p&gt;Age &amp;lt;19 or &amp;gt;45 (1)
&lt;/p&gt;&lt;p&gt;Depressed S/S (2)
&lt;/p&gt;&lt;p&gt;Past psych hx (1)
&lt;/p&gt;&lt;p&gt;Etoh/drug use hx (1)
&lt;/p&gt;&lt;p&gt;Rational thought loss (2)
&lt;/p&gt;&lt;p&gt;Sep/div./wid (1)
&lt;/p&gt;&lt;p&gt;Organized /serious attempt (2)
&lt;/p&gt;&lt;p&gt;No social support (1)
&lt;/p&gt;&lt;p&gt;Stated intent (or ambivilance) (2)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;assessment must be without ETOH/drugs on board
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;DISPOSITION (by point total)
&lt;/p&gt;&lt;p&gt;&amp;lt;6: May d/c home if have someone to care for them, follow x 1dy, call f/u MD, contract
&lt;/p&gt;&lt;p&gt;6-8: 50% admission rate (consult psych)
&lt;/p&gt;&lt;p&gt;&amp;gt;8: Admit
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;2/6/06 DONALDSON (adapted from Lampe, Hockberger)
&lt;/p&gt;



</content><folder>Psych</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="salicylate_(asa)"><name>Salicylate (ASA)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Dialysis"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Dialysis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Salicylate_(ASA)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;therapeutic: 15mg/kg, 15-30mg/dL, peak level 2-4 h
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;large ingestion- peak levels 18-24h (2/2 bezoar/pylorospasm), enteric or SR peak lev up to 60hr
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;1/2 life longer if toxic: 2-4 hr (therapeutic), up to 20hr (toxic)
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;decr protein bind: 90% therap, 75% toxic, increases apparent Vd
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Pathophys
&lt;/p&gt;&lt;p&gt;1.mixed acid-base: primry resp alkalosis &amp;amp; merab acidosis. if have resp acidosis consider a. pulm edema, b. resp depressing co-ingestant, c. resp fatigue
&lt;/p&gt;&lt;p&gt;2. fluid loss, lytes off: emesis, tachypnea, kidneys excrete bicarb/K,nonolig RF vs oligur (SIADH)
&lt;/p&gt;&lt;p&gt;3. abnml gluc metabolism
&lt;/p&gt;&lt;p&gt;4. non-cards pulm &amp;amp; cerebral edema
&lt;/p&gt;&lt;p&gt;5. plt dysfxn, anemia (chronic tox)
&lt;/p&gt;&lt;p&gt;6. n/v/gastritis/decr gastric motility
&lt;/p&gt;&lt;p&gt;7.tinnitus/hear loss (&amp;gt;20-45mg/dL)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Salicylate_(ASA)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;ASA level, tyl, etoh, utox, UA, icon, ABG, cbc, chem 7, lfts, coag
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;ekg
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;level &amp;gt;30mg/dL s/s of tox
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;or, &amp;gt;35 at any time
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Salicylate_(ASA)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1. sdac 1-2 gm/kg, in right context
&lt;/p&gt;&lt;p&gt;2. WBI- consider if enteric/SR
&lt;/p&gt;&lt;p&gt;3. IVFs: NS boluses for uop 1-2cc/k/h
&lt;/p&gt;&lt;p&gt;4. lytes: consider 40mEq KCl/L, hypoK will prevent urine alkaliniz
&lt;/p&gt;&lt;p&gt;5. urine alkaliniz-fxn of flow &amp;amp; pH, consider bicarb if ASA&amp;gt;35 or suspect serious toxicity. 1-2mEq/kg IV bolus then D5W c 3amps bicarb/L @1.5-2x maintenance adjust for goal urine pH&amp;gt;7.5
&lt;/p&gt;&lt;p&gt;6. HD: consider if elderly, chronic, AMS, acidemia, severe comorbid
&lt;/p&gt;&lt;p&gt;-renal failure
&lt;/p&gt;&lt;p&gt;-CHF(relative)
&lt;/p&gt;&lt;p&gt;-NCPE, ARDS
&lt;/p&gt;&lt;p&gt;-unstable VS
&lt;/p&gt;&lt;p&gt;-acid-base/lyte problem p rx
&lt;/p&gt;&lt;p&gt;-failed urine alkaliniz
&lt;/p&gt;&lt;p&gt;-hepatic failure c coagulopathy
&lt;/p&gt;&lt;p&gt;-acute&amp;gt;100, chronic&amp;gt;60 (relative)
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;&lt;ul&gt;&lt;li&gt;maintain hypervent if intubated
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Salicylate_(ASA)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Dialysis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Dialysis"&gt;Dialysis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;If-
&lt;/p&gt;&lt;p&gt;- severely AMS
&lt;/p&gt;&lt;p&gt;- coma
&lt;/p&gt;&lt;p&gt;- sz
&lt;/p&gt;&lt;p&gt;- refractory acidosis
&lt;/p&gt;&lt;p&gt;- pulm edema, chf
&lt;/p&gt;&lt;p&gt;- renal failure, anuric
&lt;/p&gt;&lt;p&gt;- 6hr lvl &amp;gt; 100- 120 in acute OD
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Salicylate_(ASA)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Casillas '05
&lt;/p&gt;



</content><folder>Tox</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="salter_harris"><name>Salter Harris</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Types"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Types&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Salter_Harris&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;S 1- Slipped (thru epiphysis)
&lt;/p&gt;&lt;p&gt;A 2- Above (epiphysis c metaphysis fx)
&lt;/p&gt;&lt;p&gt;L 3- Lower (thru epiphysis)
&lt;/p&gt;&lt;p&gt;T 4- Through (epi and meta)
&lt;/p&gt;&lt;p&gt;R 5- Rammed (growth plate crushed)
&lt;/p&gt;&lt;p&gt;(*reference joint is below*)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;- most significant diff btwn adult and child bones is presenece of physis/ growth plate
&lt;/p&gt;&lt;p&gt;- is composed of proliferating cartilage cells and lacks inherent strength and therfore easily damaged.
&lt;/p&gt;&lt;p&gt;- injury can happen at any age but most common during period of rapid growth
&lt;/p&gt;&lt;p&gt;- if missed- prematume closure and bone growth arrest
&lt;/p&gt;&lt;p&gt;- most common after age 10
&lt;/p&gt;&lt;p&gt;- more in boys- more active and later skeletal maturity than girls
&lt;/p&gt;&lt;p&gt;- funtion of physis is for rapid longitudinal bone growth
&lt;/p&gt;&lt;p&gt;- distal radius most common site
&lt;/p&gt;&lt;p&gt;- ligaments stronger than bones in kids- more likely to fx than sprain
&lt;/p&gt;&lt;p&gt;- repetitive stress injury can also cause it
&lt;/p&gt;&lt;p&gt;- suspect if point tenderness over physis and neg xray
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Physis zones- epiphysis to metaphys. Blood supply from epiphysis
&lt;/p&gt;&lt;p&gt;1- resting cells
&lt;/p&gt;&lt;p&gt;2- proliferating cells
&lt;/p&gt;&lt;p&gt;3- hypertophic/ maturing cells- weakest link were fx occurs
&lt;/p&gt;&lt;p&gt;4- zone of provisional calcification
&lt;/p&gt;&lt;p&gt;- higher the salter #, the more physeal arrest and joint incongruity because of injury to vascular supply to physis
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Salter_Harris&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Types"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Types"&gt;Types&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Type 1- slip
&lt;/p&gt;&lt;p&gt;- slip through epiphysis
&lt;/p&gt;&lt;p&gt;- mostly in infants and todlers
&lt;/p&gt;&lt;p&gt;- by shearing torsion avulsion
&lt;/p&gt;&lt;p&gt;- fx thru hypertrophic zone with growing cells remaining on the epiphysis in continuity with blood supply
&lt;/p&gt;&lt;p&gt;- no osseous fx
&lt;/p&gt;&lt;p&gt;- good prognosis
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Type 2- above
&lt;/p&gt;&lt;p&gt;- fx thru\above metaphysis. fx thru hypertrophic zone of physis and then above thru metaphysis.
&lt;/p&gt;&lt;p&gt;- most common type of fx
&lt;/p&gt;&lt;p&gt;- segment of metaphyseal bone called Thurston Holland fragment
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Type 3- below
&lt;/p&gt;&lt;p&gt;- intraarticular fx
&lt;/p&gt;&lt;p&gt;- relatively rare
&lt;/p&gt;&lt;p&gt;- the greater displacement, greater chance of vasc supply compromise and greater chance of growth disturbance
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Type 4- both
&lt;/p&gt;&lt;p&gt;- starts at articular surface thru epiphysis thru physisi thru metaphys
&lt;/p&gt;&lt;p&gt;- mostly at distal humerus
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Type 5- crush
&lt;/p&gt;&lt;p&gt;- most rare type
&lt;/p&gt;&lt;p&gt;- highest chance of growth arrest
&lt;/p&gt;&lt;p&gt;- compression crushes cells of zone of reserve and proliferation
&lt;/p&gt;&lt;p&gt;- minimal or no displacement of epiphysis
&lt;/p&gt;&lt;p&gt;- usually at knee or ankle by severe adduction abductn
&lt;/p&gt;&lt;p&gt;- usually dx in retrospect once bone growth abnormality already seen
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Salter_Harris&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;X rays
&lt;/p&gt;&lt;p&gt;- can have acute fx ang neg x ray- look for point tenderness over physis
&lt;/p&gt;&lt;p&gt;- type 2-3-4 can see on xray
&lt;/p&gt;&lt;p&gt;- type 1 - 5 can be occult
&lt;/p&gt;&lt;p&gt;- type 5 may have effusion
&lt;/p&gt;&lt;p&gt;- can also use stress radiography
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Salter_Harris&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- type 1 2- splint
&lt;/p&gt;&lt;p&gt;- type 3-4- surg, probably ORIF
&lt;/p&gt;&lt;p&gt;- type 5- ortho, casting and nonwt bearing
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="scapular_fx"><name>Scapular Fx</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Scapular_Fx&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- result from high speed mva, fall from height or crush
&lt;/p&gt;&lt;p&gt;- high incidence of assoc lung, chest injury- rib, clavicle fx, pneumothorax, hemo, pulm contusion- may present 2-3 days p injury. Can also have brachial plexus, subclavian vessel inj.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Scapular_Fx&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Types"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Types"&gt;Types&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1- body and spine
&lt;/p&gt;&lt;p&gt;2- acromion and coracoid process
&lt;/p&gt;&lt;p&gt;3- scapular neck and glenoid fossa
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Scapular_Fx&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- conservative with analgesics, splinting- for 2- 4 wks.
&lt;/p&gt;&lt;p&gt;- start pendular shoulder exercises to avoid adhesive capsulitis.
&lt;/p&gt;&lt;p&gt;- type 1 fx need no further tx
&lt;/p&gt;&lt;p&gt;- type 2- surgical only if severly displaced
&lt;/p&gt;&lt;p&gt;- type 3- same as #2
&lt;/p&gt;



</content><folder>Ortho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="scleritis_and_episcleritis"><name>Scleritis and Episcleritis</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Imaging"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Imaging&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Dispo"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Dispo&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Complications"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Complications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Episcleritis"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Episcleritis&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-8"&gt;&lt;a href="#Background_2"&gt;&lt;span class="tocnumber"&gt;7.1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#Diagnosis_2"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-10"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;9&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-11"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;10&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-12"&gt;&lt;a href="#Treatment_2"&gt;&lt;span class="tocnumber"&gt;11&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-13"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;12&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-14"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;13&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Scleritis_and_Episcleritis&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt; Potentially blinding disorder
&lt;/li&gt;&lt;li&gt; 50% of cases associated with an underlying disorder
&lt;ul&gt;&lt;li&gt; RA
&lt;/li&gt;&lt;li&gt; Wgener's
&lt;/li&gt;&lt;li&gt; IBD
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; Sclera fuses with the dura mater and arachnoid sheath of the opic nerve
&lt;ul&gt;&lt;li&gt; Explains why optic nerve edema and visual compromise are common complications
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Scleritis_and_Episcleritis&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt; History
&lt;ul&gt;&lt;li&gt; Intense ocular pain that radiates to the face
&lt;/li&gt;&lt;li&gt; Pain with EOM (the extraocular muscles insert into the sclera)
&lt;/li&gt;&lt;li&gt; Photophobia
&lt;/li&gt;&lt;li&gt; Deep-red or purplish scleral hue
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; Physical
&lt;ul&gt;&lt;li&gt; Essential sign is scleral edema, usually accompanied by violaceous discoloration of the globe
&lt;/li&gt;&lt;li&gt; The globe is tender to palpation
&lt;/li&gt;&lt;li&gt; Episcleral vessel dilation
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; Labs (to assess possible associated disease)
&lt;ul&gt;&lt;li&gt; CBC
&lt;/li&gt;&lt;li&gt; Chemistry
&lt;/li&gt;&lt;li&gt; UA
&lt;ul&gt;&lt;li&gt; Rule-out glomerulonephritis
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; ESR, CRP
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt; Posterior Scleritis (posterior to the insertion of the extraocular muscles)
&lt;ul&gt;&lt;li&gt; Physical exam often benign
&lt;ul&gt;&lt;li&gt; Inflammation may sometimes be seen at the extremes of gaze
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; Pt c/o pain, pain upon EOM
&lt;/li&gt;&lt;li&gt; Involvement of the optic nerve and retina is common
&lt;ul&gt;&lt;li&gt; Retinal detachment, optic disc edema
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Scleritis_and_Episcleritis&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Imaging"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Imaging"&gt;Imaging&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Ultrasound and CT can show thickening of the sclera
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Scleritis_and_Episcleritis&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt; Systemic therapy with NSAIDs, glucocorticoids, or other immunosuppressive drugs
&lt;/li&gt;&lt;li&gt; NSAIDs
&lt;ul&gt;&lt;li&gt; Indomethacin 25-75mg PO TID
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Scleritis_and_Episcleritis&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Dispo"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Dispo"&gt;Dispo&lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt; Urgent ophto consult
&lt;/li&gt;&lt;/ul&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Scleritis_and_Episcleritis&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Complications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Complications"&gt;Complications&lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt; Cornea
&lt;ul&gt;&lt;li&gt; Peripheral ulcerative keratitis &amp;gt; irreversible loss of vision
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; Uveal tract
&lt;ul&gt;&lt;li&gt; Anterior uveitis seen in 40%
&lt;ul&gt;&lt;li&gt; Spillover of inflammation from the sclera
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; Posterior segment
&lt;ul&gt;&lt;li&gt; Retinal detachment, optic disc edema
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Scleritis_and_Episcleritis&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Episcleritis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Episcleritis"&gt;Episcleritis&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Scleritis_and_Episcleritis&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background_2"&gt;Background&lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt; Abrupt onset of inflammation in the episclera
&lt;/li&gt;&lt;li&gt; 70% of cases occurs in women (usually young and middle-aged)
&lt;/li&gt;&lt;li&gt; Usually a benign, self-limited condition
&lt;/li&gt;&lt;li&gt; Usually not associated with an underlying disease
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Scleritis_and_Episcleritis&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis_2"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; History
&lt;ul&gt;&lt;li&gt; Abrupt onset of redness, irritation, and watering of the eye
&lt;/li&gt;&lt;li&gt; Pain is unusual
&lt;/li&gt;&lt;li&gt; Vision unaffected
&lt;/li&gt;&lt;li&gt; 50% of cases are bilateral
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; Physical
&lt;ul&gt;&lt;li&gt; Vasodilatation of the superficial episcleral vessels
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Scleritis_and_Episcleritis&amp;amp;action=edit&amp;amp;section=10" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Must distinguish from scleritis
&lt;ul&gt;&lt;li&gt; Phenylephrine drops lead to transient resolution of episcleral redness permitting evaluation of the sclera
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; Must distinguish from conjunctivitis
&lt;ul&gt;&lt;li&gt; If the conjunctival injection is localized rather than diffuse, episcleritis is more likely
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Scleritis_and_Episcleritis&amp;amp;action=edit&amp;amp;section=11" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Scleritis
&lt;/li&gt;&lt;li&gt;Conjunctivitis
&lt;/li&gt;&lt;li&gt;Herpes Keratitis
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Scleritis_and_Episcleritis&amp;amp;action=edit&amp;amp;section=12" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment_2"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Topical lubricants
&lt;ol&gt;&lt;li&gt; Artificial tears q4-6hr
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Scleritis_and_Episcleritis&amp;amp;action=edit&amp;amp;section=13" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Refer to ophtho to reduce chance of misdiagnosis
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Scleritis_and_Episcleritis&amp;amp;action=edit&amp;amp;section=14" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;UpToDate
&lt;/p&gt;



</content><folder>Ophtho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="search"><name>Search</name><content>&lt;p&gt;Use the Search Box in the upper right corner to search for notes, or click on the "Notes by Category" link on the left navigation pane to browse by category.
&lt;/p&gt;



</content><folder>WikEM</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="sedation"><name>Sedation</name><content>&lt;p&gt;TRAUMA
&lt;/p&gt;&lt;p&gt;5mg haldol + benadryl 50mg IV/IM
&lt;/p&gt;&lt;p&gt;5mg haldol
&lt;/p&gt;&lt;p&gt;5mg haldol
&lt;/p&gt;&lt;p&gt;then ativan
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;PSYCH
&lt;/p&gt;&lt;p&gt;2mg cogentin, 50mg benadryl, 2mg ativan
&lt;/p&gt;



</content><folder>Psych</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="seizure"><name>Seizure</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#DDX"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;DDX&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Workup"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Workup&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Typical_with_Known_Sz_Hx"&gt;&lt;span class="tocnumber"&gt;4.1&lt;/span&gt; &lt;span class="toctext"&gt;Typical with Known Sz Hx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-6"&gt;&lt;a href="#New_Onset"&gt;&lt;span class="tocnumber"&gt;4.2&lt;/span&gt; &lt;span class="toctext"&gt;New Onset&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-8"&gt;&lt;a href="#NO_IV"&gt;&lt;span class="tocnumber"&gt;5.1&lt;/span&gt; &lt;span class="toctext"&gt;NO IV&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-9"&gt;&lt;a href="#Refractory_Seizure"&gt;&lt;span class="tocnumber"&gt;5.2&lt;/span&gt; &lt;span class="toctext"&gt;Refractory Seizure&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-10"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-11"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-12"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Seizure&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;SYNCOPE VS. SEIZURE
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;twitches vs more sig movements
&lt;/li&gt;&lt;li&gt;quick return baseline vs postictal
&lt;/li&gt;&lt;li&gt;none vs retrograde amnesia
&lt;/li&gt;&lt;li&gt;none vs loss of continence
&lt;/li&gt;&lt;li&gt;tongue biting (tip) vs tongue biting (sides)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Seizure&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Abrupt onset
&lt;/li&gt;&lt;li&gt; Brief duratoin (typically &amp;lt;1.5min)
&lt;/li&gt;&lt;li&gt; AMS
&lt;/li&gt;&lt;li&gt; Purposeless activity
&lt;/li&gt;&lt;li&gt; Unprovoked
&lt;/li&gt;&lt;li&gt; Postictal state
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Seizure&amp;amp;action=edit&amp;amp;section=3" title="Edit section: DDX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX"&gt;DDX&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Syncope
&lt;/li&gt;&lt;li&gt; Hyperventilation
&lt;/li&gt;&lt;li&gt; Breath-holding (children)
&lt;/li&gt;&lt;li&gt; Toxic/metabolic
&lt;ol&gt;&lt;li&gt; ETOH
&lt;/li&gt;&lt;li&gt; Hypoglycemia
&lt;/li&gt;&lt;li&gt; Tetanus
&lt;/li&gt;&lt;li&gt; Strychnine/camphos
&lt;/li&gt;&lt;li&gt; Extrapyramidal reaction
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; CNS event
&lt;ol&gt;&lt;li&gt; TIA
&lt;/li&gt;&lt;li&gt; Narcolepsy
&lt;/li&gt;&lt;li&gt; Carotid sinus hypersens
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Movement disorder
&lt;ol&gt;&lt;li&gt; Hemiballismus
&lt;/li&gt;&lt;li&gt; Tic
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Psych
&lt;ol&gt;&lt;li&gt; Pseudoseizure
&lt;/li&gt;&lt;li&gt; Fugue
&lt;/li&gt;&lt;li&gt; Panic attack
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Seizure
&lt;ol&gt;&lt;li&gt; Primary (epilepsy)
&lt;ol&gt;&lt;li&gt; Subtheraputic level
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Secondary
&lt;ol&gt;&lt;li&gt; Encephalitis
&lt;/li&gt;&lt;li&gt; Poisoning
&lt;/li&gt;&lt;li&gt; Encephalopathy
&lt;/li&gt;&lt;li&gt; Metabolic disorder
&lt;/li&gt;&lt;li&gt; Pregnancy (eclampsia)
&lt;/li&gt;&lt;li&gt; CNS infection
&lt;/li&gt;&lt;li&gt; CNS tumor
&lt;/li&gt;&lt;li&gt; Supratheraputic levels
&lt;/li&gt;&lt;li&gt; Febrile
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Seizure&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Workup"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Workup"&gt;Workup&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Seizure&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Typical with Known Sz Hx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Typical_with_Known_Sz_Hx"&gt; Typical with Known Sz Hx&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Icon
&lt;/li&gt;&lt;li&gt; Glucose check
&lt;/li&gt;&lt;li&gt; Anticonvulsant levels
&lt;/li&gt;&lt;li&gt; +/- CBC &amp;amp; Chem 10
&lt;/li&gt;&lt;li&gt; +/- Utox
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Seizure&amp;amp;action=edit&amp;amp;section=6" title="Edit section: New Onset"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="New_Onset"&gt;New Onset&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Icon/Glu check
&lt;/li&gt;&lt;li&gt; Head CT (*ED or short F/U if return nl)
&lt;/li&gt;&lt;li&gt; ECG
&lt;/li&gt;&lt;li&gt; CXR
&lt;/li&gt;&lt;li&gt; UA/Utox
&lt;/li&gt;&lt;li&gt; ETOH
&lt;/li&gt;&lt;li&gt; CBC, Chem 10, LFTs
&lt;/li&gt;&lt;li&gt; Anticonvulsant levels
&lt;/li&gt;&lt;li&gt; DMV form/driving instructions
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;-neuro-
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt; LP
&lt;/li&gt;&lt;li&gt; HIV, ESR, RPR, ANA
&lt;/li&gt;&lt;li&gt; EEG
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Seizure&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Status  =   Sz &amp;gt;10min or intermittent without recovery &amp;gt;10min
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt; O2/airway/protection
&lt;/li&gt;&lt;li&gt; Glu &amp;amp; Icon check (consider D50W)
&lt;/li&gt;&lt;li&gt; Ativan 2mg IVP (or Valium 5-10mg IVP)
&lt;/li&gt;&lt;li&gt; Ativan 2mg IVP
&lt;/li&gt;&lt;li&gt; Dilantin (phenytoin) 1gm over 20min
&lt;ol&gt;&lt;li&gt;(20mg/kg no faster than 50mg/min)
&lt;/li&gt;&lt;li&gt;contraindicatd in heart block
&lt;/li&gt;&lt;li&gt;monitor BP/rythm strip
&lt;/li&gt;&lt;li&gt;follow with dilantin 300mg PO QHS
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; If continued, give Phenobarb 1gm over 20min
&lt;ol&gt;&lt;li&gt;(20mg/kg no faster than 50mg/min)
&lt;/li&gt;&lt;li&gt;prepare to intubate
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Seizure&amp;amp;action=edit&amp;amp;section=8" title="Edit section: NO IV"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="NO_IV"&gt;NO IV&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;versed (midazolam) IM (0.2mg/kg)
&lt;/li&gt;&lt;li&gt;valium (diazepam) PR (0.5-1.0mg/kg up to 20mg)
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Seizure&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Refractory Seizure"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Refractory_Seizure"&gt;Refractory Seizure&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;hyponatremia (infants, psych, etc) --&amp;gt; 3%NS
&lt;/li&gt;&lt;li&gt;isoniazide overdose --&amp;gt; pyridoxine
&lt;/li&gt;&lt;li&gt;ecclampsia?
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;Refractory Status Epilepticus, can also consider one of the   following:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;High Dose Phenytoin (30mg/kg)
&lt;/li&gt;&lt;li&gt;Valproic Acid
&lt;/li&gt;&lt;li&gt;Propofol
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Seizure&amp;amp;action=edit&amp;amp;section=10" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Negative workup:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt; Typical with known seizure history --&amp;gt; home after reload
&lt;/li&gt;&lt;li&gt; New onset --&amp;gt; home with neuro follow up (admit to Neuro at Harbor for expedited MRI)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Seizure&amp;amp;action=edit&amp;amp;section=11" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Neuro: Seizure Levels and Reloading
&lt;/p&gt;&lt;p&gt;Peds: Seizure (Peds)
&lt;/p&gt;&lt;p&gt;Peds: Febrile Seizure
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Seizure&amp;amp;action=edit&amp;amp;section=12" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;2/27/06 DONALDSON
&lt;/p&gt;&lt;p&gt;2/20/10 PANI
&lt;/p&gt;



</content><folder>Neuro</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="seizure_(peds)"><name>Seizure (Peds)</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Seizure_(Peds)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: General"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="General"&gt;General&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;immed after trauma = impact sz (no antieleptics)
&lt;/p&gt;&lt;p&gt;&amp;gt;20min after = TBI (antieleptic)
&lt;/p&gt;&lt;p&gt;INH --&amp;gt; pyridoxine
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Seizure_(Peds)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Peds:  Febrile Sz
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="seizure_levels_and_reloading"><name>Seizure Levels and Reloading</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#Dose"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;Dose&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Volume_of_Distribution"&gt;&lt;span class="tocnumber"&gt;1.2&lt;/span&gt; &lt;span class="toctext"&gt;Volume of Distribution&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Desired_Level"&gt;&lt;span class="tocnumber"&gt;1.3&lt;/span&gt; &lt;span class="toctext"&gt;Desired Level&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Seizure_Levels_and_Reloading&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt; Background &lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Seizure_Levels_and_Reloading&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Dose"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Dose"&gt; Dose &lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Dose (mg) = weight^ (kg) X volume of distribution X [desired level - current level (mcg/mL)]
&lt;/p&gt;&lt;p&gt;^Ideal body weight
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Seizure_Levels_and_Reloading&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Volume of Distribution"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Volume_of_Distribution"&gt; Volume of Distribution &lt;/span&gt;&lt;/h3&gt;
&lt;table style="width: 500px" border="1" cellpadding="1" cellspacing="1"&gt;

&lt;tr&gt;
&lt;td&gt; &lt;b&gt;Agent&lt;br /&gt;&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Volume of Distribution&lt;br /&gt;&lt;/b&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Phenytoin (dilantin)
&lt;/td&gt;&lt;td&gt; 0.8
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Carbamazepine (tegretol)
&lt;/td&gt;&lt;td&gt; 0.8
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Phenobarbital
&lt;/td&gt;&lt;td&gt; 0.6
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Valproate (depakote)
&lt;/td&gt;&lt;td&gt; 0.2
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Seizure_Levels_and_Reloading&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Desired Level"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Desired_Level"&gt; Desired Level &lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;If patient's optimal levels known = desired level
&lt;/li&gt;&lt;li&gt;If not, target upper end of therapeutic range:
&lt;ol&gt;&lt;li&gt;Phenytoin = 20 mcg/mL
&lt;/li&gt;&lt;li&gt;Phenobarbital = 40 mcg/mL
&lt;/li&gt;&lt;li&gt;Valproate = 100 mcg/mL
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Seizure_Levels_and_Reloading&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Iv load can be performed with phenobarbital, phenytoin/fosphenytoin, valproate, or levetiracetam.
&lt;/li&gt;&lt;li&gt;Oral loading often limited by neurotoxic adverse effects (n/v) , but can spread dose out over a day or more if necessary.
&lt;ol&gt;&lt;li&gt;(e.g. phenytoin PO 400 mg Q4 to reach the final dosage)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Seizure_Levels_and_Reloading&amp;amp;action=edit&amp;amp;section=6" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Neuro: Seizure Levels and Reloading
&lt;/p&gt;&lt;p&gt;Peds: Seizure (Peds)
&lt;/p&gt;&lt;p&gt;Peds: Febrile Seizure 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Seizure_Levels_and_Reloading&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;DONALDSON 3/08 (from emedicine; Treiman 1997; Bourgeois, 1996)
&lt;/p&gt;



</content><folder>Drugs</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="seizure_prophylaxis_(trauma)"><name>Seizure Prophylaxis (Trauma)</name><content>&lt;p&gt;HEAD TRAUMA
&lt;/p&gt;&lt;p&gt;1. Depressed fx
&lt;/p&gt;&lt;p&gt;2. Paralyzed/intubated
&lt;/p&gt;&lt;p&gt;3. Siezure (after injury/in ED)
&lt;/p&gt;&lt;p&gt;4. Penetrating brian injury
&lt;/p&gt;&lt;p&gt;5. GCS &amp;lt;9
&lt;/p&gt;&lt;p&gt;6. ICH
&lt;/p&gt;&lt;p&gt;7. Hx of Sz? (check level)
&lt;/p&gt;



</content><folder>Trauma</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="sepsis_(goal_directed_tx)"><name>Sepsis (Goal Directed Tx)</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sepsis_(Goal_Directed_Tx)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Indication"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Indication"&gt;Indication&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Indication = Severe Sepsis
&lt;/p&gt;&lt;p&gt;Presumed infection with SBP &amp;lt;90 and two or more SIRS criteria (below):
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;temp &amp;gt;38 or &amp;lt;36
&lt;/li&gt;&lt;li&gt;RR &amp;gt;20 or PaCO2 &amp;lt;32mmHg
&lt;/li&gt;&lt;li&gt;HR &amp;gt;90
&lt;/li&gt;&lt;li&gt;WBC &amp;gt;12k, &amp;lt;4k, or &amp;gt;10% bands
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sepsis_(Goal_Directed_Tx)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Airway/O2/ET
&lt;/li&gt;&lt;li&gt; Fluid resucitation (avg 5L in first 6hrs) (CVP 8-12mmHg or 12-16 intubated) (UOP 0.5-1mL/kg/hr)
&lt;/li&gt;&lt;li&gt; Vasopressors (SBP &amp;lt;70)
&lt;ol&gt;&lt;li&gt;Norepinephrine (5-20mcg/min)
&lt;ol&gt;&lt;li&gt;(consider 0.01 units/min gtt adjunct)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Dopamine (5-20mcg/kg/min)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Abx
&lt;/li&gt;&lt;li&gt; Steroids
&lt;ol&gt;&lt;li&gt;corticotropin stim
&lt;ol&gt;&lt;li&gt;(give 50mg hydrocortisone IV +&amp;nbsp;?fludrocortisone if &amp;lt;9cg/dL increase, or 4mg dexamethasone empirically)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Keep Hb &amp;gt; 10 (consider FFP if INR &amp;gt;1.5; platelets if &amp;lt;50,000)
&lt;/li&gt;&lt;li&gt; Tight glycemic control
&lt;/li&gt;&lt;li&gt; Central O2 &amp;gt;70 (ABG)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sepsis_(Goal_Directed_Tx)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;2/17/06 DONALDSON (adapted from Rosen)
&lt;/p&gt;



</content><folder>Airway/Resus</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="sepsis_(initial_abx)"><name>Sepsis (Initial Abx)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Unknown_Source"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Unknown Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Pneumonia_.28Community.29"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Pneumonia (Community)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Pneumonia_.28Healthcare_Assoc.2FPseudomonas_Risk.29"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Pneumonia (Healthcare Assoc/Pseudomonas Risk)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Abdominal.2FPelvic"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Abdominal/Pelvic&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Urosepsis"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Urosepsis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Meningitis_.28Nl.2FCommunity.29"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Meningitis (Nl/Community)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Meningitis_.28Nl.2FPost_neurosurgical.29"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Meningitis (Nl/Post neurosurgical)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Meningitis_.28Immunocomp.29"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;Meningitis (Immunocomp)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#Necrotizing_Soft-tissue_Infection"&gt;&lt;span class="tocnumber"&gt;9&lt;/span&gt; &lt;span class="toctext"&gt;Necrotizing Soft-tissue Infection&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-10"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;10&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sepsis_(Initial_Abx)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Unknown Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Unknown_Source"&gt;Unknown Source&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Comm. Acquired          
&lt;ol&gt;&lt;li&gt;Vanco 1 g IV
&lt;/li&gt;&lt;li&gt;Ceftriaxone 1 g IV
&lt;/li&gt;&lt;li&gt;Metronidazole 1.5 g IV
&lt;/li&gt;&lt;li&gt;Gentamicin 5mg/kg
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Healthcare Assoc.          
&lt;ol&gt;&lt;li&gt;Vanco 1 gm IV
&lt;/li&gt;&lt;li&gt;Cefepime 2g gm IV
&lt;/li&gt;&lt;li&gt;Metronidazole 1.5 g IV
&lt;/li&gt;&lt;li&gt;Gentamicin 5-7 mg/kg
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Cephalosporin allergy          
&lt;ol&gt;&lt;li&gt;Vanco 1 gm IV
&lt;/li&gt;&lt;li&gt;Metronidazole 1.5 g IV
&lt;/li&gt;&lt;li&gt;Gentamicin 5-7 mg/kg IV
&lt;/li&gt;&lt;li&gt;Levofloxacin 750mg IV
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sepsis_(Initial_Abx)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Pneumonia (Community)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Pneumonia_.28Community.29"&gt;Pneumonia (Community)&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Comm. Acquired          
&lt;ol&gt;&lt;li&gt;Ceftriaxone 1 gm IV
&lt;/li&gt;&lt;li&gt;Azithromycin 500 mg IV  OR  Doxycycline 100mg IV
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Cephalosporin allergy
&lt;ol&gt;&lt;li&gt;Moxifloxacin 400 mg IV  OR  Levofloxacin 750mg IV
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sepsis_(Initial_Abx)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Pneumonia (Healthcare Assoc/Pseudomonas Risk)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Pneumonia_.28Healthcare_Assoc.2FPseudomonas_Risk.29"&gt;Pneumonia (Healthcare Assoc/Pseudomonas Risk)&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Healthcare Assoc.          
&lt;ol&gt;&lt;li&gt;Cefipime 2 g IV
&lt;/li&gt;&lt;li&gt;Cipro 400 mg IV
&lt;/li&gt;&lt;li&gt;Clinda 600 mg IV
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Cephalosporin allergy          
&lt;ol&gt;&lt;li&gt;Clinda 600 mg IV
&lt;/li&gt;&lt;li&gt;Cipro 400 mg IV
&lt;/li&gt;&lt;li&gt;Gentamicin 5-7 mg/kg IV
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sepsis_(Initial_Abx)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Abdominal/Pelvic"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Abdominal.2FPelvic"&gt;Abdominal/Pelvic&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Comm. Acquired          
&lt;ol&gt;&lt;li&gt;Ceftriaxone 1 g IV
&lt;/li&gt;&lt;li&gt;Metronidazole 1.5 g IV
&lt;/li&gt;&lt;li&gt;Gentamicin 5-7 mg/kg IV
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Healthcare Assoc.          
&lt;ol&gt;&lt;li&gt;Ceftazidime 2 g IV
&lt;/li&gt;&lt;li&gt;Gentamicin 5 mg/kg IV
&lt;/li&gt;&lt;li&gt;Metronidazole 1.5 mg IV
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Cephalosporin allergy          
&lt;ol&gt;&lt;li&gt;Cipro 400 mg IV
&lt;/li&gt;&lt;li&gt;Metronidazole 1.5 g IV
&lt;/li&gt;&lt;li&gt;Gentamicin 5-7 mg/kg IV
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sepsis_(Initial_Abx)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Urosepsis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Urosepsis"&gt;Urosepsis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Comm. Acquired          
&lt;ol&gt;&lt;li&gt;Ceftriaxone 1 g IV
&lt;/li&gt;&lt;li&gt;Gentamicin 5-7 mg/kg IV
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Healthcare Assoc.          
&lt;ol&gt;&lt;li&gt;Vancomycin 1 g IV
&lt;/li&gt;&lt;li&gt;Ceftazidime 1g IV
&lt;/li&gt;&lt;li&gt;Gentamicin 5-7 mg/kg IV
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Cephalosporin allergy          
&lt;ol&gt;&lt;li&gt;Vancomycin 1g IV
&lt;/li&gt;&lt;li&gt;Cipro 400 mg IV
&lt;/li&gt;&lt;li&gt;Gentamicin 5 mg/kg IV
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sepsis_(Initial_Abx)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Meningitis (Nl/Community)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Meningitis_.28Nl.2FCommunity.29"&gt;Meningitis (Nl/Community)&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Comm. Acquired          
&lt;ol&gt;&lt;li&gt;Ceftriaxone 2 g IV
&lt;/li&gt;&lt;li&gt;Vancomycin 1.5 g IV
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Cephalosporin allergy          
&lt;ol&gt;&lt;li&gt;Chloramphenicol 1 g IV
&lt;/li&gt;&lt;li&gt;Vancomycin 1.5g IV
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sepsis_(Initial_Abx)&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Meningitis (Nl/Post neurosurgical)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Meningitis_.28Nl.2FPost_neurosurgical.29"&gt;Meningitis (Nl/Post neurosurgical)&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Healthcare Assoc.          
&lt;ol&gt;&lt;li&gt;Vanco 1.5 g IV
&lt;/li&gt;&lt;li&gt;Cefepime 2 g IV
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Cephalosporin allergy          
&lt;ol&gt;&lt;li&gt;Vanco 1.5g IV
&lt;/li&gt;&lt;li&gt;Cipro 400mg IV
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sepsis_(Initial_Abx)&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Meningitis (Immunocomp)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Meningitis_.28Immunocomp.29"&gt;Meningitis (Immunocomp)&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;(Cirrhosis, EtoH, age &amp;gt; 65, steroids, HIV)
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt; Comm. Acquired          
&lt;ol&gt;&lt;li&gt;Penicillin G 4M Units IV
&lt;/li&gt;&lt;li&gt;Ceftriaxone 2 g IV
&lt;/li&gt;&lt;li&gt;Vancomycin 1g IV
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Cephalosporin allergy          
&lt;ol&gt;&lt;li&gt;Chloramphenicol 1g IV
&lt;/li&gt;&lt;li&gt;Trim/sulfa 10mg/kg IV
&lt;/li&gt;&lt;li&gt;Vancomycin 1.5g IV
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sepsis_(Initial_Abx)&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Necrotizing Soft-tissue Infection"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Necrotizing_Soft-tissue_Infection"&gt;Necrotizing Soft-tissue Infection&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Comm. Acquired/Healthcare Assoc.          
&lt;ol&gt;&lt;li&gt;Vanco 1 gm IV
&lt;/li&gt;&lt;li&gt;Ceftriaxone 1 gm IV
&lt;/li&gt;&lt;li&gt;Clinda 600 mg IV
&lt;/li&gt;&lt;li&gt;Consider: Gent 5-7mg/k IV
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Healthcare Assoc.          
&lt;ol&gt;&lt;li&gt;Vancomycin 1g IV
&lt;/li&gt;&lt;li&gt;Piperacillin/Tazobactam 3.375g IV
&lt;/li&gt;&lt;li&gt;Clindamycin 600mg IV
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Cephalosporin allergy          
&lt;ol&gt;&lt;li&gt;Vanco 1 gm IV
&lt;/li&gt;&lt;li&gt;Clinda 600 mg IV
&lt;/li&gt;&lt;li&gt;Cipro 400 mg IV
&lt;/li&gt;&lt;li&gt;Gentamicin 5-7mg/kg
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sepsis_(Initial_Abx)&amp;amp;action=edit&amp;amp;section=10" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted by DONALDSON from Harbor-UCLA Abx-Review Committee (Rev. 07/27/06)
&lt;/p&gt;



</content><folder>Airway/Resus</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="septic_arthritis_(hip)"><name>Septic Arthritis (Hip)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Septic_Arthritis_(Hip)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- hematogenous spread or local inf.
&lt;/p&gt;&lt;p&gt;- wt. bearing joints most common
&lt;/p&gt;&lt;p&gt;- knee (40-50%)
&lt;/p&gt;&lt;p&gt;- hip (20- 25%)
&lt;/p&gt;&lt;p&gt;- staph, S. Pneumo, group A strep
&lt;/p&gt;&lt;p&gt;- in neonates also Groub B strep&amp;nbsp;% gram neg.
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Septic_Arthritis_(Hip)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: "&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id=""&gt; &lt;/span&gt;&lt;/h2&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Septic_Arthritis_(Hip)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Age - 6 mo to 8 yrs
&lt;/p&gt;&lt;p&gt;Pres - Pain, Pseudoparalysis
&lt;/p&gt;&lt;p&gt;Labs - ESR &amp;gt; 20 after 1-2 d, WBC &amp;gt;
&lt;/p&gt;&lt;p&gt;Xrays - possible effusion
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;- may present w/ referred knee or thigh pain
&lt;/p&gt;&lt;p&gt;- usually hold jt in flexion, ext rotat &amp;amp; slt abduction.
&lt;/p&gt;&lt;p&gt;- get Bld Cxs (40-50% grow out)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;- Xrays useful to exclude other cause of joint pain (AP &amp;amp; Frog leg)
&lt;/p&gt;&lt;p&gt;- CT may be useful to look for abscess, UTZ for effusion.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Septic_Arthritis_(Hip)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- drainage
&lt;/p&gt;&lt;p&gt;- Oxacillin, Nafcillin or Clinda in pen all
&lt;/p&gt;&lt;p&gt;- cover H. inf as needed w/ 3rd gen
&lt;/p&gt;&lt;p&gt;ceph.
&lt;/p&gt;&lt;p&gt;- IV abx for 10-14 days before po
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Septic_Arthritis_(Hip)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Peds: Hip Pain
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;&lt;ul&gt;&lt;li&gt;SEPTIC JOINT***
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;usu acute, same mech as OM, usu similar org w/ s. aureus most common (think gc if older).
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Rx= aspirate sufficient for all xcept hip, must go to OR/IR w/ hip b/c incr pressure can cause avn of hip! o/w tap okay, usu OR if reaccumulates. send for (in order) 1) cx 2) count 3) gs.
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;CBC &amp;gt;15 in 50%, ESR &amp;gt;60mm/hr in &amp;gt;90% of cases, CRP &amp;gt;20mg/L in 94%, Bcx 50%, fluid usu &amp;gt;50,000 WBC
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;(in gc arthritis: +blood cx: ~0%, +fluid cx/gs: 25-50%, urethral/rectal/throat swab may incr cx yield)
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;xr for septic hip usu w/ joint space wide of &amp;gt;1-2 mm vs other side
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Rx= neonate ox &amp;amp; gent, 2mo-5yr cefotax &amp;amp; ox, 5y-12y ox (vanco?), &amp;gt;12 ox &amp;amp; ctx
&lt;/li&gt;&lt;/ul&gt;




</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="septic_joint"><name>Septic Joint</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Septic_Joint&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Def: inflammation of a synovial membrane with purulent effusion into the joint capsule
&lt;/li&gt;&lt;li&gt; usually affects monoarticular joints (the knee is most commonly affected in adults and the hip in children)
&lt;/li&gt;&lt;li&gt; Relatively rare disease however because it can quickly destroy the joint or lead to osteomyelitis, fibrous ankylosis, sepsis, or even death it is important to catch and treat promptly
&lt;/li&gt;&lt;li&gt; Frequency is ~20,000 cases in USA/year (may be higher in pts with immunologic disorders (RA, SLE))
&lt;/li&gt;&lt;li&gt; M&amp;gt;F predominance, usually in patients &amp;gt;65 years
&lt;/li&gt;&lt;li&gt; Etiology is usually bacterial, divided into gonococcal or nongonococcal groups
&lt;/li&gt;&lt;li&gt; staph and strep are most common nongonococcal causes
&lt;/li&gt;&lt;li&gt; consider different organisms in children, IV drug users, and those with prosthetic joints
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Septic_Joint&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; may be difficult to diagnose in early stages
&lt;/li&gt;&lt;li&gt; patient typically presents with fever and a warm, red, painful, swollen joint with decreased range of motion even passively 
&lt;/li&gt;&lt;li&gt; confirm diagnosis with work up 
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Septic_Joint&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; CBC
&lt;/li&gt;&lt;li&gt; ESR
&lt;/li&gt;&lt;li&gt; Blood Cultures
&lt;/li&gt;&lt;li&gt; Gonorrhea culture (urethral/cervical/pharyngeal/rectal) 
&lt;/li&gt;&lt;li&gt; Arthrocentesis with synovial fluid analysis
&lt;/li&gt;&lt;li&gt; infected fluid characteristics:
&lt;/li&gt;&lt;li&gt; large amount (&amp;gt;3.5 mL)
&lt;/li&gt;&lt;li&gt; turbid in appearance
&lt;/li&gt;&lt;li&gt; decreased viscosity 
&lt;/li&gt;&lt;li&gt; 15,000-&amp;gt;200,000 leukocytes/cubic cm
&lt;/li&gt;&lt;li&gt; 50-100% PMNs
&lt;/li&gt;&lt;li&gt; Poor mucin clot
&lt;/li&gt;&lt;li&gt; glucose &amp;gt;40mg/100mL less than plasma glucose 
&lt;/li&gt;&lt;li&gt; Positive culture
&lt;/li&gt;&lt;li&gt; Plain films (often normal but may show widening of joint space or evidence of osteomyelitis)
&lt;/li&gt;&lt;li&gt; Ultrasound (can show joint effusion, extent of disease, and may help differentiate from other conditions) 
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Septic_Joint&amp;amp;action=edit&amp;amp;section=4" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; toxic synovitis
&lt;/li&gt;&lt;li&gt; abscess
&lt;/li&gt;&lt;li&gt; cellulitis 
&lt;/li&gt;&lt;li&gt; primary rheumatologic disorder (i.e. vasculitis)
&lt;/li&gt;&lt;li&gt; iatrogenic
&lt;/li&gt;&lt;li&gt; reactive arthritis (post infectious) 
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Septic_Joint&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; drainage of the joint
&lt;/li&gt;&lt;li&gt; IV Antibiotics
&lt;/li&gt;&lt;li&gt; generally Oxacillin or Nafcillin with a cephalosporin (ceftriaxone, feotaxme, ceftizoxime) will cover
&lt;/li&gt;&lt;li&gt; add vancomycin if you suspect MRSA
&lt;/li&gt;&lt;li&gt; in IVDA patients use IV aminoglycoside + antipseudomonal cephalosporin
&lt;/li&gt;&lt;li&gt; patients with prosthetic joints are at higher risk of MRSA, MRSE, Enterobacteriaceae, and Pseudomonas
&lt;/li&gt;&lt;li&gt; consider gonococcal infection in young sexually active patients (treat with ceftriaxone) 
&lt;/li&gt;&lt;li&gt; Open drainage and lavage in the OR 
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Septic_Joint&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; All patients should be admitted with Ortho consult and continued on IV antibiotics 
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Septic_Joint&amp;amp;action=edit&amp;amp;section=7" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Arthrocentesis
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Septic_Joint&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;&lt;a href="http://emprocedures.com/arthrocentesis/analysis.htmEmedicine" class="external free" rel="nofollow"&gt;http://emprocedures.com/arthrocentesis/analysis.htmEmedicine&lt;/a&gt;
&lt;/p&gt;



</content><folder>Ortho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="serotonin_syndrome"><name>Serotonin Syndrome</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Serotonin_Syndrome&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Serotonin works centrally to modulate attention, behavior, thermoregulation
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Serotonin_Syndrome&amp;amp;action=edit&amp;amp;section=2" title="Edit section: "&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id=""&gt; &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;dx when serotinergic agent/ SSRI recently added to med list
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Offending Agents:
&lt;/p&gt;&lt;p&gt;SSRIs
&lt;/p&gt;&lt;p&gt;MAOIs
&lt;/p&gt;&lt;p&gt;TCAs
&lt;/p&gt;&lt;p&gt;Drugs of Abuse: Cocaine, Ecstasy, Marijuana
&lt;/p&gt;&lt;p&gt;Analgesics: demerol, fentanyl
&lt;/p&gt;&lt;p&gt;Antiemetics
&lt;/p&gt;&lt;p&gt;OTC: Cough meds, herbal products, St John&#8217;s Wort
&lt;/p&gt;&lt;p&gt;Triptans
&lt;/p&gt;&lt;p&gt;Bromocriptine
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Serotonin_Syndrome&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Clinical Triad:
&lt;/p&gt;&lt;p&gt;1) Altered Mental Status: Agitated delirium
&lt;/p&gt;&lt;p&gt;2) Autonomic Instability: Hyperthermia, Tachycardia
&lt;/p&gt;&lt;p&gt;3) Neuromuscular Abnormalities: Clonus, hyperreflexia
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Physical Exam
&lt;/p&gt;&lt;p&gt;Clonus is most defining feature: Spontaneous or inducible
&lt;/p&gt;&lt;p&gt;Ocular clonus (horizontal)
&lt;/p&gt;&lt;p&gt;Shivering
&lt;/p&gt;&lt;p&gt;Hyperreflexia
&lt;/p&gt;&lt;p&gt;Diaphoresis
&lt;/p&gt;&lt;p&gt;Nausea
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Diagnostic Criteria
&lt;/p&gt;&lt;p&gt;Hunter Criteria Decision Rules
&lt;/p&gt;&lt;p&gt;(84% Sensitivity; 97% Specificity)
&lt;/p&gt;&lt;p&gt;Serotonergic Agent plus 1 of following:
&lt;/p&gt;&lt;p&gt;Spontaneous Clonus
&lt;/p&gt;&lt;p&gt;Inducible Clonus plus Agitation
&lt;/p&gt;&lt;p&gt;Ocular Clonus plus Agitation
&lt;/p&gt;&lt;p&gt;Clonus plus Hyperthermia
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;OR
&lt;/p&gt;&lt;p&gt;need 3 of 6
&lt;/p&gt;&lt;p&gt;- mental status change
&lt;/p&gt;&lt;p&gt;- agitation
&lt;/p&gt;&lt;p&gt;- myoclonus
&lt;/p&gt;&lt;p&gt;- hyperreflexia
&lt;/p&gt;&lt;p&gt;- diaphoresis
&lt;/p&gt;&lt;p&gt;- shivering
&lt;/p&gt;&lt;p&gt;- tremor
&lt;/p&gt;&lt;p&gt;- diarrhea
&lt;/p&gt;&lt;p&gt;- incoordination
&lt;/p&gt;&lt;p&gt;- fever
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Serotonin_Syndrome&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;ABCs
&lt;/p&gt;&lt;p&gt;Discontinue offending agent
&lt;/p&gt;&lt;p&gt;Supportive Care
&lt;/p&gt;&lt;p&gt;Benzos for agitation
&lt;/p&gt;&lt;p&gt;Avoid physical restraints
&lt;/p&gt;&lt;p&gt;Consider paralysis with non-depolarizing agent
&lt;/p&gt;&lt;p&gt;Cyproheptadine
&lt;/p&gt;&lt;p&gt;serotonin antagonist (works centrally and peripherally)
&lt;/p&gt;&lt;p&gt;An animal model showed that an initial dose (12mg) blocked 85-95% of serotonin receptors
&lt;/p&gt;&lt;p&gt;Dose: 8mg PO/NG, then 4mg Q2H;
&lt;/p&gt;&lt;p&gt;Max 32mg/day
&lt;/p&gt;&lt;p&gt;Clinical Course
&lt;/p&gt;&lt;p&gt;Serotonin Syndrome generally presents within 6-24H of exposure to offending agent Resolves within 24H
&lt;/p&gt;&lt;p&gt;Mortality &amp;lt; 1%
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Serotonin_Syndrome&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;PANI 6/2009 based on Rosen's
&lt;/p&gt;



</content><folder>Tox</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="sexual_assault"><name>Sexual Assault</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Workup"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Workup&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Risk_Factors"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Risk Factors&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Workup_2"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Workup&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Pregnancy"&gt;&lt;span class="tocnumber"&gt;4.1&lt;/span&gt; &lt;span class="toctext"&gt;Pregnancy&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-6"&gt;&lt;a href="#STD"&gt;&lt;span class="tocnumber"&gt;4.2&lt;/span&gt; &lt;span class="toctext"&gt;STD&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-7"&gt;&lt;a href="#Hepatitis_B"&gt;&lt;span class="tocnumber"&gt;4.3&lt;/span&gt; &lt;span class="toctext"&gt;Hepatitis B&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-8"&gt;&lt;a href="#HIV"&gt;&lt;span class="tocnumber"&gt;4.4&lt;/span&gt; &lt;span class="toctext"&gt;HIV&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-10"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sexual_Assault&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Workup"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Workup"&gt;Workup&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Check life threats
&lt;/li&gt;&lt;li&gt;Don&#8217;t change, shower, etc. pt
&lt;/li&gt;&lt;li&gt;Consent obtained
&lt;/li&gt;&lt;li&gt;Contact SANE (sexual assault nurse examiner)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sexual_Assault&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Risk Factors"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Risk_Factors"&gt;Risk Factors&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Risk of pregnancy without contraception 1-5%; if mid-cycle (days 14-16) risk is higher
&lt;/li&gt;&lt;li&gt;Risk of STD 5-10%
&lt;/li&gt;&lt;li&gt;Risk of HIV: consensual vaginal intercourse 0.1-0.2%; receptive anal intercourse 0.5-3%
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sexual_Assault&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Workup"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Workup_2"&gt;Workup&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;ABO, RPR, Hep B, HIV, EtOH, icon, Utox, G&amp;amp;C/wet mount
&lt;/li&gt;&lt;li&gt;HIV test now, 6wk, 3months, 6months
&lt;/li&gt;&lt;li&gt;CBC, Chem 10 if HIV PPx
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sexual_Assault&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sexual_Assault&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Pregnancy"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Pregnancy"&gt;Pregnancy&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Yuzpe ethinyl estradiol 100macg po plus levonorgestral 0.5mg po; repeat in 12h
&lt;/p&gt;&lt;p&gt;OR
&lt;/p&gt;&lt;p&gt;Plan B levonorgestrel 0.75mg po q12h x2
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sexual_Assault&amp;amp;action=edit&amp;amp;section=6" title="Edit section: STD"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="STD"&gt;STD&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Gonorrhea: Ceftriaxone 125mg IM or Cipro 500mg po x1 or Ofloxacin 400mg po x1
&lt;/p&gt;&lt;p&gt;PLUS
&lt;/p&gt;&lt;p&gt;Chlaymdia: Azithromycin 1g PO x1 or Doxycyclin 100mg po bid x7d
&lt;/p&gt;&lt;p&gt;PLUS
&lt;/p&gt;&lt;p&gt;Trich: Metronidazole 2g PO x1 or 500mg po bid x 7d
&lt;/p&gt;&lt;p&gt;Syphilis: Pen G benzathine 2.4million U IM x1
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sexual_Assault&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Hepatitis B"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Hepatitis_B"&gt;Hepatitis B&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Virus vaccine 1.0mL IM now, 1-2 months and in 4-6months if pt unimmunized
&lt;/p&gt;&lt;p&gt;Hep B Immune Globulin for high-risk exposure (IV drug user or multiple assailants)
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sexual_Assault&amp;amp;action=edit&amp;amp;section=8" title="Edit section: HIV"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="HIV"&gt;HIV&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Initiate within 72h (best within 36h) x 28d
&lt;/p&gt;&lt;p&gt;Zidovudine 300mg bid or 200mg tid
&lt;/p&gt;&lt;p&gt;PLUS
&lt;/p&gt;&lt;p&gt;Lamivudine 150mg bid;
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
OR
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
Tenofovir
&lt;/p&gt;&lt;p&gt;PLUS
&lt;/p&gt;&lt;p&gt;Emtricitabine
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sexual_Assault&amp;amp;action=edit&amp;amp;section=9" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;ID:  HIV Prophylaxis (Non-Occupational)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sexual_Assault&amp;amp;action=edit&amp;amp;section=10" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;DeBonis 12/1/08 adapted from the CDC 2006 guidelines
&lt;/p&gt;



</content><folder>ID</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="sexually_transmitted_diseases_(std)"><name>Sexually Transmitted Diseases (STD)</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sexually_Transmitted_Diseases_(STD)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Chart"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Chart"&gt; Chart &lt;/span&gt;&lt;/h2&gt;
&lt;table style="border: medium none; border-collapse: collapse" border="1"&gt;

&lt;tr&gt;
&lt;td style="border: 0.5pt solid windowtext; padding: 0in 5.4pt; width: 81.9pt" valign="top" width="82"&gt;
&lt;p&gt;&lt;b&gt;Disorder&lt;/b&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: solid solid solid none; border-color: windowtext windowtext windowtext -moz-use-text-color; border-width: 0.5pt 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" valign="top" width="108"&gt;
&lt;p&gt;&lt;b&gt;Clinical&lt;/b&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: solid solid solid none; border-color: windowtext windowtext windowtext -moz-use-text-color; border-width: 0.5pt 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 2.25in" valign="top" width="162"&gt;
&lt;p&gt;&lt;b&gt;1&lt;sup&gt;st&lt;/sup&gt; line&lt;/b&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: solid solid solid none; border-color: windowtext windowtext windowtext -moz-use-text-color; border-width: 0.5pt 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 175.5pt" valign="top" width="176"&gt;
&lt;p&gt;&lt;b&gt;Alternative&lt;/b&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: solid solid solid none; border-color: windowtext windowtext windowtext -moz-use-text-color; border-width: 0.5pt 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.25in" valign="top" width="90"&gt;
&lt;p&gt;&lt;b&gt;Partner&lt;/b&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: solid solid solid none; border-color: windowtext windowtext windowtext -moz-use-text-color; border-width: 0.5pt 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" valign="top" width="108"&gt;
&lt;p&gt;&lt;b&gt;In Pregnancy&lt;/b&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; border-width: medium 0.5pt 0.5pt; padding: 0in 5.4pt; width: 81.9pt" valign="top" width="82"&gt;
&lt;p&gt;&lt;i&gt;N. Gonorrhea&lt;/i&gt;
&lt;/p&gt;&lt;p&gt;Urethritis/
&lt;/p&gt;&lt;p&gt;Cervicitis
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" valign="top" width="108"&gt;
&lt;p&gt;M: urethritis with d/c or simply dysuria;can be asymptomatic
&lt;/p&gt;&lt;p&gt;F: purulent discharge; can be asymptomatic
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 2.25in" valign="top" width="162"&gt;
&lt;p&gt;Ceftriaxone 125mg IM
&lt;/p&gt;&lt;p&gt;OR
&lt;/p&gt;&lt;p&gt;Cefixime (Suprax) 400mg po x1
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 175.5pt" valign="top" width="176"&gt;
&lt;p&gt;Cipro 500po x 1 &#8211; not acceptable in MSM, travel, California, Hawaii
&lt;/p&gt;&lt;p&gt;OR
&lt;/p&gt;&lt;p&gt;Spectinomycin 2g IM x 1 OR
&lt;/p&gt;&lt;p&gt;Azithromycin 2g po x 1
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.25in" valign="top" width="90"&gt;
&lt;p&gt;Treat and abstinence x 7d after both treated
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" valign="top" width="108"&gt;
&lt;p&gt;CTX 125mg IM x 1
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; border-width: medium 0.5pt 0.5pt; padding: 0in 5.4pt; width: 81.9pt" valign="top" width="82"&gt;
&lt;p&gt;&lt;i&gt;N. Gonorrhea&lt;/i&gt;
&lt;/p&gt;&lt;p&gt;Conjunctivitis
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" valign="top" width="108"&gt;
&lt;p&gt;2-5d after birth
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 2.25in" valign="top" width="162"&gt;
&lt;p&gt;Erythromycin ophthalmic 0.5% x1
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 175.5pt" valign="top" width="176"&gt;
&lt;p&gt;Tetracycline ophthalmic 1% x1
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.25in" valign="top" width="90"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" valign="top" width="108"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; border-width: medium 0.5pt 0.5pt; padding: 0in 5.4pt; width: 81.9pt" valign="top" width="82"&gt;
&lt;p&gt;&lt;i&gt;N. Gonorrhea&lt;/i&gt;
&lt;/p&gt;&lt;p&gt;Disseminated
&lt;/p&gt;&lt;p&gt;(DGI)
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" valign="top" width="108"&gt;
&lt;p&gt;Petechial, pustular acral skin lesions,
&lt;/p&gt;&lt;p&gt;Asymmetrical arthralgias, tenosynovitis,
&lt;/p&gt;&lt;p&gt;Septic arthritis
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 2.25in" valign="top" width="162"&gt;
&lt;p&gt;CTX 1g IM/IV q24
&lt;/p&gt;&lt;p&gt;-continue x24-48h until improvement
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 175.5pt" valign="top" width="176"&gt;
&lt;p&gt;Cefotax 1g IV q8
&lt;/p&gt;&lt;p&gt;Spectinomycin 2g IV q12
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.25in" valign="top" width="90"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" valign="top" width="108"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; border-width: medium 0.5pt 0.5pt; padding: 0in 5.4pt; width: 81.9pt" valign="top" width="82"&gt;
&lt;p&gt;&lt;i&gt;Chlamydia Trachomatis&lt;/i&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" valign="top" width="108"&gt;
&lt;p&gt;M: urethritis with d/c or simply dysuria; can be asymptomatic
&lt;/p&gt;&lt;p&gt;F: purulent discharge or cervical bleeding; can be asymptomatic
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 2.25in" valign="top" width="162"&gt;
&lt;p&gt;Azithromycin 1g po x1
&lt;/p&gt;&lt;p&gt;OR
&lt;/p&gt;&lt;p&gt;Doxycycline 100mg po bid x 7d
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 175.5pt" valign="top" width="176"&gt;
&lt;p&gt;Erythromycin base 500mg po qid x 7d OR
&lt;/p&gt;&lt;p&gt;Oflox 300mg po bid x 7d
&lt;/p&gt;&lt;p&gt;OR
&lt;/p&gt;&lt;p&gt;Levoflox 500mg po qd x 7days
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.25in" valign="top" width="90"&gt;
&lt;p&gt;Treat and abstinence x 7d after both treated
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" valign="top" width="108"&gt;
&lt;p&gt;Azithromycin 1g po x1 or
&lt;/p&gt;&lt;p&gt;Amoxicillin 500mg po tid x 7d
&lt;/p&gt;&lt;p&gt;Or
&lt;/p&gt;&lt;p&gt;Erythro
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; border-width: medium 0.5pt 0.5pt; padding: 0in 5.4pt; width: 81.9pt" valign="top" width="82"&gt;
&lt;p&gt;&lt;i&gt;Chlamydia&lt;/i&gt;
&lt;/p&gt;&lt;p&gt;&lt;i&gt;Trachomatis&lt;/i&gt;
&lt;/p&gt;&lt;p&gt;Conjunctivitis
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" valign="top" width="108"&gt;
&lt;p&gt;5-12d after birth; silver nitrate ophthalmic only rx gonorrhea
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 2.25in" valign="top" width="162"&gt;
&lt;p&gt;Erythromycin base 50mg/kg/day PO / 4 doses x14days
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 175.5pt" valign="top" width="176"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.25in" valign="top" width="90"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" valign="top" width="108"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; border-width: medium 0.5pt 0.5pt; padding: 0in 5.4pt; width: 81.9pt" valign="top" width="82"&gt;
&lt;p&gt;&lt;i&gt;Chlamydia Trachomatis&lt;/i&gt;
&lt;/p&gt;&lt;p&gt;Pneumonia
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" valign="top" width="108"&gt;
&lt;p&gt;1-3months; afebrile, staccato cough with diffuse infiltrates on CXR; peripheral eosinophilia
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 2.25in" valign="top" width="162"&gt;
&lt;p&gt;Erythromycin base 50mg/kg/day po / 4 doses x14days
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 175.5pt" valign="top" width="176"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.25in" valign="top" width="90"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" valign="top" width="108"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; border-width: medium 0.5pt 0.5pt; padding: 0in 5.4pt; width: 81.9pt" valign="top" width="82"&gt;
&lt;p&gt;&lt;i&gt;Trichamonas vaginalis&lt;/i&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" valign="top" width="108"&gt;
&lt;p&gt;White, thick discharge
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 2.25in" valign="top" width="162"&gt;
&lt;p&gt;Metronidazole 2g po x 1
&lt;/p&gt;&lt;p&gt;OR
&lt;/p&gt;&lt;p&gt;Tinidazole 2g po x 1
&lt;/p&gt;&lt;p&gt;PLUS
&lt;/p&gt;&lt;p&gt;Azithro 1g po x 1
&lt;/p&gt;&lt;p&gt;-intravag cream not recommended
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 175.5pt" valign="top" width="176"&gt;
&lt;p&gt;Metronidazole 500mg bid for 7days; 1-2g po qday x 7d if recurrence
&lt;/p&gt;&lt;p&gt;OR
&lt;/p&gt;&lt;p&gt;Topical clotrimazole for metronidazole allergy&#8211; not as effective
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.25in" valign="top" width="90"&gt;
&lt;p&gt;Metronidazole 2g po x 1
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" valign="top" width="108"&gt;
&lt;p&gt;Rx only if symptomatic but rx partner
&lt;/p&gt;&lt;p&gt;1&lt;sup&gt;st&lt;/sup&gt; trimester, Clotrimazole 100mg hs for 7days
&lt;/p&gt;&lt;p&gt;After 1&lt;sup&gt;st&lt;/sup&gt; trimester,&lt;span&gt; &lt;/span&gt; Metronidazole 2g po x 1
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; border-width: medium 0.5pt 0.5pt; padding: 0in 5.4pt; width: 81.9pt" valign="top" width="82"&gt;
&lt;p&gt;Bacterial Vaginosis
&lt;/p&gt;&lt;p&gt;&lt;i&gt;Lactobacillus&lt;/i&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" valign="top" width="108"&gt;
&lt;p&gt;White, fishy discharge
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 2.25in" valign="top" width="162"&gt;
&lt;p&gt;Metronidazole 500mg po bid for 7d
&lt;/p&gt;&lt;p&gt;OR
&lt;/p&gt;&lt;p&gt;0.75% Metronidazole gel (one full applicator 5g) intravaginal qd for 5d
&lt;/p&gt;&lt;p&gt;OR
&lt;/p&gt;&lt;p&gt;2% Clindamycin cream 5g qd for 5d
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 175.5pt" valign="top" width="176"&gt;
&lt;p&gt;Clindamycin 300mg po bid for 7d (recurrence)
&lt;/p&gt;&lt;p&gt;OR
&lt;/p&gt;&lt;p&gt;Clindamycin ovules 100mg intravaginally qhs x 3d
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.25in" valign="top" width="90"&gt;
&lt;p&gt;Exam for STD
&lt;/p&gt;&lt;p&gt;No rx if nl
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" valign="top" width="108"&gt;
&lt;p&gt;1&lt;sup&gt;st&lt;/sup&gt; trimester, metronidazole 250mg po tid x7d
&lt;/p&gt;&lt;p&gt;After 1&lt;sup&gt;st&lt;/sup&gt; trimester, 500mg po bid for 7days or 250mg po tid x7d or Clinda 300mg po bid x 7d
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; border-width: medium 0.5pt 0.5pt; padding: 0in 5.4pt; width: 81.9pt" valign="top" width="82"&gt;
&lt;p&gt;Candidiasis
&lt;/p&gt;&lt;p&gt;(&lt;i&gt;Candida albicans&lt;/i&gt;&lt;span style="font-style: normal"&gt;)&lt;/span&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" valign="top" width="108"&gt;
&lt;p&gt;Cottage cheese;
&lt;/p&gt;&lt;p&gt;DM or immunocompromised
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 2.25in" valign="top" width="162"&gt;
&lt;p&gt;Butoconazole 2% cream 5g intravaginally for 3d
&lt;/p&gt;&lt;p&gt;OR
&lt;/p&gt;&lt;p&gt;Butaconazole-sustained 2% intravag x1
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 175.5pt" valign="top" width="176"&gt;
&lt;p&gt;Clotrimazole 1%&lt;span&gt; &lt;/span&gt; 5g cream intravaginally for 7-14d (OTC)
&lt;/p&gt;&lt;p&gt;OR
&lt;/p&gt;&lt;p&gt;Clotrimazole 100mg intravag tablet x 7d
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.25in" valign="top" width="90"&gt;
&lt;p&gt;Candicidal cream if dermatitis present
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" valign="top" width="108"&gt;
&lt;p&gt;Avoid fluconazole and ketoconazole.
&lt;/p&gt;&lt;p&gt;Rx with cream for 7d
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; border-width: medium 0.5pt 0.5pt; padding: 0in 5.4pt; width: 81.9pt" valign="top" width="82"&gt;
&lt;p&gt;Chancroid
&lt;/p&gt;&lt;p&gt;(&lt;i&gt;H. ducreyi&lt;/i&gt;&lt;span style="font-style: normal"&gt;)&lt;/span&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" valign="top" width="108"&gt;
&lt;p&gt;Painful ulcers with suppurative LAD
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 2.25in" valign="top" width="162"&gt;
&lt;p&gt;Azithromycin 1g PO x 1
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 175.5pt" valign="top" width="176"&gt;
&lt;p&gt;CTX 250mg IM x1
&lt;/p&gt;&lt;p&gt;Cipro 500mg PO bid x 3days
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.25in" valign="top" width="90"&gt;
&lt;p&gt;See CDC
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" valign="top" width="108"&gt;
&lt;p&gt;CTX
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; border-width: medium 0.5pt 0.5pt; padding: 0in 5.4pt; width: 81.9pt" valign="top" width="82"&gt;
&lt;p&gt;Granuloma Inguinale&lt;span&gt; &lt;/span&gt; (Donvanosis)
&lt;/p&gt;&lt;p&gt;&lt;i&gt;Klebsiella granulomatis&lt;/i&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" valign="top" width="108"&gt;
&lt;p&gt;Painless lesions without LAD
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 2.25in" valign="top" width="162"&gt;
&lt;p&gt;Doxycycline 100mg PO BID x 3wks and until all lesions heald
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 175.5pt" valign="top" width="176"&gt;
&lt;p&gt;Aizthromycin 1g po q week
&lt;/p&gt;&lt;p&gt;Ciproflox 750mg PO bid x 3 weeks
&lt;/p&gt;&lt;p&gt;Bactrim DS 1tab PO BID x 3 wks
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.25in" valign="top" width="90"&gt;
&lt;p&gt;same
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" valign="top" width="108"&gt;
&lt;p&gt;Erythromycin base 500mg po qid x 3wks
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; border-width: medium 0.5pt 0.5pt; padding: 0in 5.4pt; width: 81.9pt" valign="top" width="82"&gt;
&lt;p&gt;Lymphogranuloma Venereum (LGV)
&lt;/p&gt;&lt;p&gt;&lt;i&gt;C. trach&lt;/i&gt; &lt;span style="font-style: normal"&gt;serovars L1-L3&lt;/span&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" valign="top" width="108"&gt;
&lt;p&gt;Tender, unilateral LAD; can lead to proctitis, fistulas
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 2.25in" valign="top" width="162"&gt;
&lt;p&gt;Doxycycline 100mg po bid x 3 weeks
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 175.5pt" valign="top" width="176"&gt;
&lt;p&gt;Erythromycin base 500mg po qid x 3wks
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.25in" valign="top" width="90"&gt;
&lt;p&gt;Treat within 60days of exposure with standard Chlamydia Rx
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" valign="top" width="108"&gt;
&lt;p&gt;Erythromycin base 500mg po qid x 3wks
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; border-width: medium 0.5pt 0.5pt; padding: 0in 5.4pt; width: 81.9pt" valign="top" width="82"&gt;
&lt;p&gt;Chancre-
&lt;/p&gt;&lt;p&gt;Primary
&lt;/p&gt;&lt;p&gt;Syphilis
&lt;/p&gt;&lt;p&gt;(&lt;i&gt;T. pallidum&lt;/i&gt;&lt;span style="font-style: normal"&gt;)&lt;/span&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" valign="top" width="108"&gt;
&lt;p&gt;Painless ulcer, chancre
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 2.25in" valign="top" width="162"&gt;
&lt;p&gt;Benzathine Penicillin G 1.2million U IM x1
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 175.5pt" valign="top" width="176"&gt;
&lt;p&gt;Doxycycline 100mg po bid x 14d
&lt;/p&gt;&lt;p&gt;Tetracycline 500mg po qid x 14d
&lt;/p&gt;&lt;p&gt;CTX 1g IM/IV x 8-10d
&lt;/p&gt;&lt;p&gt;Azithromycin 2g po x 1?
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.25in" valign="top" width="90"&gt;
&lt;p&gt;See CDC
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" valign="top" width="108"&gt;
&lt;p&gt;Penicillin; if allergic desensitize
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; border-width: medium 0.5pt 0.5pt; padding: 0in 5.4pt; width: 81.9pt" valign="top" width="82"&gt;
&lt;p&gt;Secondary Syphilis
&lt;/p&gt;&lt;p&gt;(&lt;i&gt;T. pallidum&lt;/i&gt;&lt;span style="font-style: normal"&gt;)&lt;/span&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" valign="top" width="108"&gt;
&lt;p&gt;Skin rash, mucocutaneous lesions, LAD
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 2.25in" valign="top" width="162"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 175.5pt" valign="top" width="176"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.25in" valign="top" width="90"&gt;
&lt;p&gt;See CDC
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" valign="top" width="108"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; border-width: medium 0.5pt 0.5pt; padding: 0in 5.4pt; width: 81.9pt" valign="top" width="82"&gt;
&lt;p&gt;Latent Syphilis
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" valign="top" width="108"&gt;
&lt;p&gt;Seroreactivity without other evidence of disease
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 2.25in" valign="top" width="162"&gt;
&lt;p&gt;&lt;i&gt;Early&lt;/i&gt;
&lt;/p&gt;&lt;p&gt;&lt;i&gt;Late&lt;/i&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 175.5pt" valign="top" width="176"&gt;
&lt;p&gt;Doxycycline 100mg po bid x 28d
&lt;/p&gt;&lt;p&gt;Tetracycline 500mg po qid x 28d
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.25in" valign="top" width="90"&gt;
&lt;p&gt;See CDC
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" valign="top" width="108"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; border-width: medium 0.5pt 0.5pt; padding: 0in 5.4pt; width: 81.9pt" valign="top" width="82"&gt;
&lt;p&gt;Tertiary Syphilis
&lt;/p&gt;&lt;p&gt;(&lt;i&gt;T. pallidum&lt;/i&gt;&lt;span style="font-style: normal"&gt;)&lt;/span&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" valign="top" width="108"&gt;
&lt;p&gt;Cardiac (aortitis), ophtho (iritis, uveitis), gumma
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 2.25in" valign="top" width="162"&gt;
&lt;p&gt;Benzathine&lt;span&gt; &lt;/span&gt; Penicillin G 2.4million U IM qweek x 3
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 175.5pt" valign="top" width="176"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.25in" valign="top" width="90"&gt;
&lt;p&gt;See CDC
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" valign="top" width="108"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; border-width: medium 0.5pt 0.5pt; padding: 0in 5.4pt; width: 81.9pt" valign="top" width="82"&gt;
&lt;p&gt;Neurosyphilis
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" valign="top" width="108"&gt;
&lt;p&gt;Meningitis, syphilitic eye disease
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 2.25in" valign="top" width="162"&gt;
&lt;p&gt;Aqueous crystalline penicillin G 18-24million units/d administered as 3-4million units IV q4h or continuous infusion x 10-14days
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 175.5pt" valign="top" width="176"&gt;
&lt;p&gt;Procaine penicillin 2.4million units IM qday + Probenecid 500mg po qid&lt;span&gt; &lt;/span&gt;
&lt;/p&gt;&lt;p&gt;BOTH for 10-14d
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.25in" valign="top" width="90"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" valign="top" width="108"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; border-width: medium 0.5pt 0.5pt; padding: 0in 5.4pt; width: 81.9pt" valign="top" width="82"&gt;
&lt;p&gt;HSV (1&lt;sup&gt;st&lt;/sup&gt; episode)
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" valign="top" width="108"&gt;
&lt;p&gt;Vesilcular rash
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 2.25in" valign="top" width="162"&gt;
&lt;p&gt;Acyclovir 400mg po TID x 7-10day
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 175.5pt" valign="top" width="176"&gt;
&lt;p&gt;Famciclovir 250mg po TID x 7-10d
&lt;/p&gt;&lt;p&gt;Valacyclovir 1g PO BID x 7-10d
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.25in" valign="top" width="90"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" valign="top" width="108"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; border-width: medium 0.5pt 0.5pt; padding: 0in 5.4pt; width: 81.9pt" valign="top" width="82"&gt;
&lt;p&gt;HSV (suppressive)
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" valign="top" width="108"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 2.25in" valign="top" width="162"&gt;
&lt;p&gt;Acyclovir 400mg PO BID
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 175.5pt" valign="top" width="176"&gt;
&lt;p&gt;Famciclovir 250mg po BID
&lt;/p&gt;&lt;p&gt;Valacyclovir 500mg PO qday
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.25in" valign="top" width="90"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" valign="top" width="108"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; border-width: medium 0.5pt 0.5pt; padding: 0in 5.4pt; width: 81.9pt" valign="top" width="82"&gt;
&lt;p&gt;Epididymitis
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" valign="top" width="108"&gt;
&lt;p&gt;Pain, swelling, inflammation of the epididymis
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 2.25in" valign="top" width="162"&gt;
&lt;p&gt;CTX 250mg IM + Doxycyline 100mg po bid x 10d
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 175.5pt" valign="top" width="176"&gt;
&lt;p&gt;Oflox 300mg&lt;span&gt; &lt;/span&gt; po bid x 10d + levoflox 500mg po qday x 10d
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.25in" valign="top" width="90"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" valign="top" width="108"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; border-width: medium 0.5pt 0.5pt; padding: 0in 5.4pt; width: 81.9pt" valign="top" width="82"&gt;
&lt;p&gt;Epididymorchitis
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" valign="top" width="108"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 2.25in" valign="top" width="162"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 175.5pt" valign="top" width="176"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.25in" valign="top" width="90"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" valign="top" width="108"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; border-width: medium 0.5pt 0.5pt; padding: 0in 5.4pt; width: 81.9pt" valign="top" width="82"&gt;
&lt;p&gt;Proctitis
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" valign="top" width="108"&gt;
&lt;p&gt;Inflammation of the rectum (distal 10-12cm)
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 2.25in" valign="top" width="162"&gt;
&lt;p&gt;CTX 125mg IM x1 + Doxy 100mg po bid x 7d
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 175.5pt" valign="top" width="176"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.25in" valign="top" width="90"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" valign="top" width="108"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; border-width: medium 0.5pt 0.5pt; padding: 0in 5.4pt; width: 81.9pt" valign="top" width="82"&gt;
&lt;p&gt;PID
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" valign="top" width="108"&gt;
&lt;p&gt;Sexually active, no other sources and: CMT OR uterine OR adnexal TTP
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 2.25in" valign="top" width="162"&gt;
&lt;p&gt;Outpt:
&lt;/p&gt;&lt;p&gt;Ceftriaxone 250mg IM x1
&lt;/p&gt;&lt;p&gt;OR
&lt;/p&gt;&lt;p&gt;Cefoxitin 2g IM in a single dose and probenecid 1g orally administered concurrently in single dose
&lt;/p&gt;&lt;p&gt;OR
&lt;/p&gt;&lt;p&gt;Other parenteral 3&lt;sup&gt;rd&lt;/sup&gt; gen cephalosporin eg ceftizoxime or cefotaxime
&lt;/p&gt;&lt;p&gt;PLUS
&lt;/p&gt;&lt;p&gt;Doxy 100mg po bid x14d
&lt;/p&gt;&lt;p&gt;+/-
&lt;/p&gt;&lt;p&gt;Metronidazole 500mg po bid x 14d
&lt;/p&gt;&lt;p&gt;Parenteral:
&lt;/p&gt;&lt;p&gt;Cefotetan 2g IV q12h
&lt;/p&gt;&lt;p&gt;OR
&lt;/p&gt;&lt;p&gt;Cefoxitin 2g IV q6h
&lt;/p&gt;&lt;p&gt;PLUS
&lt;/p&gt;&lt;p&gt;Doxycyline 100mg IV or PO q12
&lt;/p&gt;&lt;p&gt;(&lt;i&gt;similar bioavailability)&lt;/i&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 175.5pt" valign="top" width="176"&gt;
&lt;p&gt;Outpt:
&lt;/p&gt;&lt;p&gt;Oflox 400mg po bid x 14d
&lt;/p&gt;&lt;p&gt;OR
&lt;/p&gt;&lt;p&gt;Levofloxacin 500mg po qday x 14d
&lt;/p&gt;&lt;p&gt;+/-
&lt;/p&gt;&lt;p&gt;Metronidazole 500mg po bid x 14d
&lt;/p&gt;&lt;p&gt;Parenteral:
&lt;/p&gt;&lt;p&gt;Clinda 900mg IV q8h
&lt;/p&gt;&lt;p&gt;PLUS
&lt;/p&gt;&lt;p&gt;Gent load 2mgkg IV; maintenance 1.5mg/kg q8h; single daily dosing may be substituted
&lt;/p&gt;&lt;p&gt;Oflox 400mg IV q12h
&lt;/p&gt;&lt;p&gt;OR
&lt;/p&gt;&lt;p&gt;Levoflox 500mg IV qday
&lt;/p&gt;&lt;p&gt;+/-
&lt;/p&gt;&lt;p&gt;Metro 500mg IVq8h
&lt;/p&gt;&lt;p&gt;OR
&lt;/p&gt;&lt;p&gt;Unasyn 3g IV q6h
&lt;/p&gt;&lt;p&gt;PLUS
&lt;/p&gt;&lt;p&gt;Doxy 100mg IV or PO q12h
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.25in" valign="top" width="90"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" valign="top" width="108"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; border-width: medium 0.5pt 0.5pt; padding: 0in 5.4pt; width: 81.9pt" valign="top" width="82"&gt;
&lt;p&gt;Scabies
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" valign="top" width="108"&gt;
&lt;p&gt;Crusted rash, intertiginous areas
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 2.25in" valign="top" width="162"&gt;
&lt;p&gt;Permethrin 5% cream applied to all areas of body from neck down and rinsed off after 8-14h
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 175.5pt" valign="top" width="176"&gt;
&lt;p&gt;Ivermectin 200mcg/kg PO, repeated in 2weeks
&lt;/p&gt;&lt;p&gt;Lindane (1%) 1 ounce of lotion of 30g of cream applied in thin layer all over from neck down x 8 hours then rinse
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.25in" valign="top" width="90"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" valign="top" width="108"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; border-width: medium 0.5pt 0.5pt; padding: 0in 5.4pt; width: 81.9pt" valign="top" width="82"&gt;
&lt;p&gt;Pediculosis Pubis
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" valign="top" width="108"&gt;
&lt;p&gt;Puritic genitalia
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 2.25in" valign="top" width="162"&gt;
&lt;p&gt;Permethrin 1% cream: apply to affected areas x 10mins then wash off
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 175.5pt" valign="top" width="176"&gt;
&lt;p&gt;Malathion lotion 0.5% apply x 8-12h then rinse
&lt;/p&gt;&lt;p&gt;OR
&lt;/p&gt;&lt;p&gt;Ivermectin&lt;span&gt; &lt;/span&gt; 250mcg/kg PO repeated in 2 weeks
&lt;/p&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.25in" valign="top" width="90"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;td style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" valign="top" width="108"&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;p&gt;&#8224;Test for HIV, syphilis
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sexually_Transmitted_Diseases_(STD)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt; Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;DeBonis
&lt;/p&gt;&lt;p&gt;Adapted from CDC 2006
&lt;/p&gt;



</content><folder>GU</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="shock_(pressors)"><name>Shock (Pressors)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#FLUIDS"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;FLUIDS&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#PRESSORS"&gt;&lt;span class="tocnumber"&gt;1.2&lt;/span&gt; &lt;span class="toctext"&gt;PRESSORS&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Shock_(Pressors)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt; Treatment &lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Shock_(Pressors)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: FLUIDS"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="FLUIDS"&gt; FLUIDS &lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;NS 20-40 mL/kg bolus Q10-30min (1.5-3L)
&lt;/li&gt;&lt;li&gt;Consider FFP if INR &amp;gt;1.5
&lt;/li&gt;&lt;li&gt;Consider platelets if &amp;lt;50,000
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Shock_(Pressors)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: PRESSORS"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="PRESSORS"&gt; PRESSORS &lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;(low SBP despite fluid, or develop pulm edema)
&lt;/p&gt;
&lt;table style="width: 500px" border="1" cellpadding="1" cellspacing="1"&gt;

&lt;tr&gt;
&lt;td&gt; &lt;b&gt;SBP&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Pressor&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Rate&lt;/b&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; &amp;gt;80
&lt;/td&gt;&lt;td&gt; DoBUtamine
&lt;/td&gt;&lt;td&gt; (2-20mcg/kg/min)
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 70-80&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; DoPAmine
&lt;/td&gt;&lt;td&gt; (2.5-20mcg/kg/min)
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; &amp;lt;70&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Norepi
&lt;/td&gt;&lt;td&gt; (0.5-30mcg/min)
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;p&gt;^AHA has DoPAmine to SPB 70-100; consider DoBUtamine for cardiogenic shock 
&lt;/p&gt;&lt;p&gt;^^normaly start epinephrine gtt first in peds
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Shock_(Pressors)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt; Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;2/2/06 DONALDSON (adapted from Lampe, &amp;amp; Ann of Int Med 1999, Hollenberg)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; &lt;br /&gt;
&lt;/p&gt;



</content><folder>Airway/Resus</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="shock_and_hypotension"><name>Shock and Hypotension</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Definition"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Definition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Types"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Types&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Undifferentiated_Hypotension_Algorithm"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Undifferentiated Hypotension Algorithm&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Lack_of_Response_to_Normal_Tx_.28DDX.29"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Lack of Response to Normal Tx (DDX)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Shock_and_Hypotension&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Definition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Definition"&gt; Definition &lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;SBP &amp;lt;90 in nl pt
&lt;/li&gt;&lt;li&gt;SBP&amp;lt;100 with h/o HTN or age &amp;gt;60
&lt;/li&gt;&lt;li&gt;ABG = lactate &amp;gt; 4 or base def &amp;lt; -4
&lt;/li&gt;&lt;li&gt;MAP = SVR x CO
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Shock_and_Hypotension&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Types"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Types"&gt; Types &lt;/span&gt;&lt;/h2&gt;
&lt;table border="1"&gt;

&lt;tr&gt;
&lt;td&gt; &lt;b&gt;Type&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Skin&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;HR&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Oth&lt;/b&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Hypovolemic
&lt;/td&gt;&lt;td&gt; cold
&lt;/td&gt;&lt;td&gt; inc
&lt;/td&gt;&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Obstructive
&lt;/td&gt;&lt;td&gt; cold
&lt;/td&gt;&lt;td&gt; inc
&lt;/td&gt;&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Cardiogenic
&lt;/td&gt;&lt;td&gt; cold
&lt;/td&gt;&lt;td&gt; inc/dec
&lt;/td&gt;&lt;td&gt; &amp;nbsp;?dysth
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Anaphylactic
&lt;/td&gt;&lt;td&gt; warm
&lt;/td&gt;&lt;td&gt; inc
&lt;/td&gt;&lt;td&gt; hives
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Neurogenic
&lt;/td&gt;&lt;td&gt; warm
&lt;/td&gt;&lt;td&gt; dec
&lt;/td&gt;&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Shock_and_Hypotension&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Undifferentiated Hypotension Algorithm"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Undifferentiated_Hypotension_Algorithm"&gt; Undifferentiated Hypotension Algorithm &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Check:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;HR (age appropriate)
&lt;ol&gt;&lt;li&gt;&amp;lt;40 and &amp;gt;150-180 --&amp;gt; likely HR = Primary etiology
&lt;/li&gt;&lt;li&gt;Pace or Shock
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Volume Status - LVEDP (approx by CVP, IVC, etc.)
&lt;ol&gt;&lt;li&gt;History of volume loss
&lt;/li&gt;&lt;li&gt;Lung Exam
&lt;/li&gt;&lt;li&gt;Mucous membrane
&lt;/li&gt;&lt;li&gt;Ultrasound IVC (RUQ window or AAA)
&lt;/li&gt;&lt;li&gt;Hemeacuu, Guaic
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Contractility (weak heart)
&lt;ol&gt;&lt;li&gt;Bounding/thready pulse, hyperdynamic precordium
&lt;/li&gt;&lt;li&gt;Cardiac Ultrasound
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Low SVR - Vasodilation is the final answer, if all else is negative expect bounding pulse
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Shock_and_Hypotension&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Lack of Response to Normal Tx (DDX)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Lack_of_Response_to_Normal_Tx_.28DDX.29"&gt; Lack of Response to Normal Tx (DDX) &lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Cardiac tamponade
&lt;/li&gt;&lt;li&gt;Tension PNTX
&lt;/li&gt;&lt;li&gt;Adrenal insuffic
&lt;/li&gt;&lt;li&gt;Toxin
&lt;/li&gt;&lt;li&gt;Allergic Rx
&lt;/li&gt;&lt;li&gt;Occult bleeding (ectopic, A/P)
&lt;/li&gt;&lt;li&gt;PE
&lt;/li&gt;&lt;li&gt;DIC
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Shock_and_Hypotension&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt; Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;2/06 DONALDSON (Adapted from Tintinalli)
&lt;/p&gt;&lt;p&gt;Morchi 2010
&lt;/p&gt;



</content><folder>Airway/Resus</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="shoulder_(acute_-_trauma)"><name>Shoulder (Acute - Trauma)</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Shoulder_(Acute_-_Trauma)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: X-ray Positive"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="X-ray_Positive"&gt;X-ray Positive&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;0.  Dislocation
&lt;/p&gt;&lt;p&gt;1.  Fracture
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;2.  AC Injury
&lt;/p&gt;&lt;p&gt;Injury:  Direct trauma, chronic
&lt;/p&gt;&lt;p&gt;Diag:  Superior pain; pain adduction
&lt;/p&gt;
&lt;pre&gt;    TypexxExam
&lt;/pre&gt;
&lt;pre&gt;    1negFROM
&lt;/pre&gt;
&lt;pre&gt;    2slight displace
&lt;/pre&gt;
&lt;pre&gt;    3100% displaceclinc deform
&lt;/pre&gt;
&lt;p&gt;Rx:
&lt;/p&gt;
&lt;pre&gt;    1&amp;amp;2 --&amp;gt; sling, PMD, ROM ex after 2wks
&lt;/pre&gt;
&lt;pre&gt;    3 --&amp;gt; sling, ortho x 2 dys,&amp;nbsp;?surg
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Shoulder_(Acute_-_Trauma)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: X-ray Negativie"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="X-ray_Negativie"&gt;X-ray Negativie&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1.  AC Injury, type 1 (see above)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;2.  Glenohumeral Instability
&lt;/p&gt;&lt;p&gt;-subluxation (separation) or dislocation (now reduced)
&lt;/p&gt;&lt;p&gt;-PE: pt holds arm close to body with unaffected hand
&lt;/p&gt;&lt;p&gt;Rx:  F/U ortho
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;3.  Rotator Cuff
&lt;/p&gt;&lt;p&gt;Injury: 90% chronic arms overhead
&lt;/p&gt;&lt;p&gt;Diag:
&lt;/p&gt;
&lt;pre&gt;    -result of extreme overuse in young adults (e.g. pitchers) or minor trauma in older adults
&lt;/pre&gt;
&lt;pre&gt;    -sudden "pop" while lifting overhead
&lt;/pre&gt;
&lt;pre&gt;    -lateral pain
&lt;/pre&gt;
&lt;pre&gt;    -worse at night
&lt;/pre&gt;
&lt;pre&gt;    -abduct arm pain after 20deg
&lt;/pre&gt;
&lt;pre&gt;    -relief of pain w/ lido inject
&lt;/pre&gt;
&lt;pre&gt;    (pain free weakness = full tear)
&lt;/pre&gt;
&lt;p&gt;PE: -loss of active BUT NOT passive ROM (due to pain)
&lt;/p&gt;&lt;p&gt;-positive impingement signs
&lt;/p&gt;&lt;p&gt;-weakness with drop arm test
&lt;/p&gt;&lt;p&gt;Rx:  Acute --&amp;gt; sling, PT,  ortho f/u
&lt;/p&gt;&lt;p&gt;Chronic --&amp;gt; PT, ortho
&lt;/p&gt;&lt;p&gt;Next: MRI, surgery for younger pts with big tear, rehab
&lt;/p&gt;&lt;p&gt;PT:  arm dangle at side, circle 5-10wt
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;4.  Biceps Tendon Rupture
&lt;/p&gt;&lt;p&gt;-bulge in distal humerus (Popeye muscle), usually result of injury
&lt;/p&gt;&lt;p&gt;-PE: 20% loss of strength of supinators, 8% loss of strength of elbow flexors
&lt;/p&gt;&lt;p&gt;-next: surgery for younger pts, rehab
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Shoulder_(Acute_-_Trauma)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;8/07  DONALDSON (adapted from Miller, Mistry)
&lt;/p&gt;



</content><folder>Ortho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="shoulder_(chronic_-_non-trauma)"><name>Shoulder (Chronic - Non-Trauma)</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Shoulder_(Chronic_-_Non-Trauma)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: I. Normal Shoulder Exam"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="I._Normal_Shoulder_Exam"&gt;I.  Normal Shoulder Exam&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;A.  Referred Pain
&lt;/p&gt;&lt;p&gt;i.  Cervical radiculopathy
&lt;/p&gt;&lt;p&gt;-Suggested by pain radiating below shoulder or to upper back
&lt;/p&gt;&lt;p&gt;-decreased range of motion in neck due to pain,
&lt;/p&gt;&lt;p&gt;-positive Spurling's test (radicular pain with head compression)
&lt;/p&gt;&lt;p&gt;-normal shoulder exam
&lt;/p&gt;&lt;p&gt;ii.  Lung (apical lung tumor, pleural disease)
&lt;/p&gt;&lt;p&gt;iii.  Heart (MI)
&lt;/p&gt;&lt;p&gt;iv.  Subdiaphragmatic (gallbladder disease)
&lt;/p&gt;&lt;p&gt;v.  Vascular (Thoracic Outlet Sy)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Shoulder_(Chronic_-_Non-Trauma)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: II. Point Tenderness"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="II._Point_Tenderness"&gt;II.  Point Tenderness&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1.  Rotator Cuff
&lt;/p&gt;&lt;p&gt;Injury: 90% chronic arms overhead
&lt;/p&gt;&lt;p&gt;Diag:
&lt;/p&gt;&lt;p&gt;-result of extreme overuse in young adults (e.g. pitchers) or minor
&lt;/p&gt;&lt;p&gt;trauma in older adults
&lt;/p&gt;&lt;p&gt;-sudden "pop" while lifting overhead
&lt;/p&gt;&lt;p&gt;-lateral pain
&lt;/p&gt;&lt;p&gt;-worse at night
&lt;/p&gt;&lt;p&gt;-abduct arm pain after 20deg
&lt;/p&gt;&lt;p&gt;-relief of pain w/ lido inject
&lt;/p&gt;&lt;p&gt;(pain free weakness = full tear)
&lt;/p&gt;&lt;p&gt;PE: -loss of active BUT NOT passive ROM (due to pain)
&lt;/p&gt;&lt;p&gt;-positive impingement signs
&lt;/p&gt;&lt;p&gt;-weakness with drop arm test
&lt;/p&gt;&lt;p&gt;Rx:  Acute --&amp;gt; sling, PT,  ortho f/u
&lt;/p&gt;&lt;p&gt;Chronic --&amp;gt; PT, ortho
&lt;/p&gt;&lt;p&gt;Next: MRI, surgery for younger pts with big tear, rehab
&lt;/p&gt;&lt;p&gt;PT:  arm dangle at side, circle 5-10wt
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;2.  Adhesive Capulitis (Frozen Shoulder)
&lt;/p&gt;&lt;p&gt;Diag:
&lt;/p&gt;&lt;p&gt;-diffuse/dull ache
&lt;/p&gt;&lt;p&gt;-result of prolonged immobilization of shoulder
&lt;/p&gt;&lt;p&gt;-loss of active AND passive ROM
&lt;/p&gt;&lt;p&gt;-pain at extremes of motion
&lt;/p&gt;&lt;p&gt;Rx:  PT, ortho f/u
&lt;/p&gt;&lt;p&gt;-rehab for 18 mo, manipulation under anesthesia if no improvement
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;3.  Bicipital Tendinitis
&lt;/p&gt;&lt;p&gt;-result of repetitive flexion-extension or pronation-supination of elbow
&lt;/p&gt;&lt;p&gt;-PE: anterior shoulder pain with flexion at elbow (curling) or
&lt;/p&gt;&lt;p&gt;resisted forearm supination, tenderness over bicipital groove
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;4.  Subacromial Bursitis and Supraspinatus Tendinitis
&lt;/p&gt;&lt;p&gt;-result from repetitive overhead arm movement (e.g. serving in tennis
&lt;/p&gt;&lt;p&gt;or throwing baseball), gradual onset
&lt;/p&gt;&lt;p&gt;-PE: positive impingement signs, pain but no weakness with drop arm test
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;5.  Impingement Syndrome
&lt;/p&gt;&lt;p&gt;-definition: narrowing of impingement interval (space between superior
&lt;/p&gt;&lt;p&gt;aspect of humeral head and inferior aspect of acromion)
&lt;/p&gt;&lt;p&gt;(supraspinatus tendon runs through this space, also subacromial and
&lt;/p&gt;&lt;p&gt;subdeltoid bursae are there)
&lt;/p&gt;&lt;p&gt;Diag:
&lt;/p&gt;&lt;p&gt;-pain exacerbated by overhead arm movements
&lt;/p&gt;&lt;p&gt;-nocturnal pain exacerbated by sleeping on affected shoulder
&lt;/p&gt;&lt;p&gt;-weakness
&lt;/p&gt;&lt;p&gt;-loss of motion
&lt;/p&gt;&lt;p&gt;PE:
&lt;/p&gt;&lt;p&gt;-positive impingement signs
&lt;/p&gt;&lt;p&gt;-pain with elevation of arm with elbow flexed (like military salute)
&lt;/p&gt;&lt;p&gt;against resistance
&lt;/p&gt;&lt;p&gt;-positive drop arm test
&lt;/p&gt;&lt;p&gt;-point tenderness at impingement interval
&lt;/p&gt;&lt;p&gt;causes: abduction of arm (normal), structural variations of acromion
&lt;/p&gt;&lt;p&gt;(types II and III), osteoarthritic spurs of acromioclavicular (AC)
&lt;/p&gt;&lt;p&gt;joint, calcification and thickening of coracoacromial ligament, loss
&lt;/p&gt;&lt;p&gt;of rotator cuff strength resulting in superior migration of humerus,
&lt;/p&gt;&lt;p&gt;among others
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Other
&lt;/p&gt;&lt;p&gt;-osteoarthritis (usually acromioclavicular joint), rheumatoid
&lt;/p&gt;&lt;p&gt;arthritis, septic arthritis, gout, lyme disease, SLE,
&lt;/p&gt;&lt;p&gt;spondyloarthropathy
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Shoulder_(Chronic_-_Non-Trauma)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;8/07  DONALDSON (adapted from Miller, Mistry)
&lt;/p&gt;



</content><folder>Ortho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="shoulder_(tests)"><name>Shoulder (Tests)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Impingement_signs"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Impingement signs&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Positive_drop_arm_test"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Positive drop arm test&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Shoulder_(Tests)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;With arms out to side at 90 deg:
&lt;/p&gt;&lt;p&gt;Internal rotation --&amp;gt; drops hand forward
&lt;/p&gt;&lt;p&gt;External rotation --&amp;gt; raises hand up (like testifying in court)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Shoulder_(Tests)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Impingement signs"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Impingement_signs"&gt;Impingement signs&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;(pain with)
&lt;/p&gt;&lt;p&gt;-passive forward elevation
&lt;/p&gt;&lt;p&gt;-internal rotation with arm abducted 90 degrees
&lt;/p&gt;&lt;p&gt;-external rotation with arm abducted at 90 degrees,
&lt;/p&gt;&lt;p&gt;-adduction
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Shoulder_(Tests)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Positive drop arm test"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Positive_drop_arm_test"&gt;Positive drop arm test&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-pt holds outstretched arm at 90 degrees of abduction, doc pushes down at wrist
&lt;/p&gt;&lt;p&gt;-arm drop signifies weakness secondary to rotator cuff tear
&lt;/p&gt;&lt;p&gt;-pain without weakness suggests subacromial bursitis or supraspinatus tendinitis
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Shoulder_(Tests)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;8/07 DONALDSON (adapted from Miller, Mistry)
&lt;/p&gt;



</content><folder>Ortho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="shoulder_dystocia"><name>Shoulder Dystocia</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Shoulder_Dystocia&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;HELPER
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;H call for help
&lt;/li&gt;&lt;li&gt;E episiotomy (or episioproctotomy) to increase the anetroposterior diameter of passage
&lt;/li&gt;&lt;li&gt;L Legs flex (McRoberts maneuver)
&lt;/li&gt;&lt;li&gt;P Pressure- suprapubic pressure and Rubin&#8217;s maneuver (applying shoulder pressure to the fetus to decreases the bisacromial diameter)
&lt;/li&gt;&lt;li&gt;E Enter the vagina and attempt Wood&#8217;s corkscrew maneuver by pushing the most accessible shoulder toward the chest to corkscrew the shoulders through
&lt;/li&gt;&lt;li&gt;R Remove posterior arm by sweeping it across the chest and bring fetal hand to the chin, grasp and pull out of the birth canal and across the face
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Shoulder_Dystocia&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;6/30/09  DONALDSON (from "Kaji Questions")
&lt;/p&gt;



</content><folder>OB/GYN</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="sickle_cell_crisis"><name>Sickle Cell Crisis</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Precipitating_Factors"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Precipitating Factors&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;9&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sickle_Cell_Crisis&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Sickle cell disease is the most common monogenetic disorder worldwisde affecting 30 million people
&lt;/li&gt;&lt;li&gt; Disease can manifest with vaso-occlusion(pain), acute chest syndrome, stroke, aplastic anemia, priapism
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sickle_Cell_Crisis&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Precipitating Factors"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Precipitating_Factors"&gt;Precipitating Factors&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; For vaso-occlusion:
&lt;ol&gt;&lt;li&gt; cold weather
&lt;/li&gt;&lt;li&gt; hypoxia
&lt;/li&gt;&lt;li&gt; infection
&lt;/li&gt;&lt;li&gt; dehydration
&lt;/li&gt;&lt;li&gt; acidosis
&lt;/li&gt;&lt;li&gt; alcohol intoxication
&lt;/li&gt;&lt;li&gt; emotional stress
&lt;/li&gt;&lt;li&gt; pregnancy
&lt;/li&gt;&lt;li&gt; exertional stress
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; For aplastic crisis:
&lt;ol&gt;&lt;li&gt; parvovirus B19 infection
&lt;/li&gt;&lt;li&gt; folic acid deficiency
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; For acute chest syndrome:
&lt;ol&gt;&lt;li&gt; fat embolus
&lt;/li&gt;&lt;li&gt; infection
&lt;/li&gt;&lt;li&gt; pain crisis
&lt;/li&gt;&lt;li&gt; asthma
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sickle_Cell_Crisis&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sickle_Cell_Crisis&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; CBC / stat hemaglobin
&lt;ol&gt;&lt;li&gt; Assess change in anemia
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Chemistry / LFT / lipase
&lt;ol&gt;&lt;li&gt; If abd pain, may develop cholecystitis, mesenteric ischemia, or perforation
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Reticulocyte count (if aplastic crisis considered) -rare in adults
&lt;/li&gt;&lt;li&gt; CXR
&lt;ol&gt;&lt;li&gt; If cough, sob, or febrile
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; O2
&lt;ol&gt;&lt;li&gt; If pain crisis or hypoxic; otherwise may inhibit erythopoesis
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; ECG
&lt;/li&gt;&lt;li&gt; T&amp;amp;S/T&amp;amp;C
&lt;/li&gt;&lt;li&gt; BCx2
&lt;/li&gt;&lt;li&gt; VBG
&lt;/li&gt;&lt;li&gt; UA
&lt;/li&gt;&lt;li&gt; Urine pregnancy
&lt;/li&gt;&lt;li&gt; Head CT/MRI if symptoms of stroke
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sickle_Cell_Crisis&amp;amp;action=edit&amp;amp;section=5" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; ACS
&lt;/li&gt;&lt;li&gt; anemia (acute, chronic)
&lt;/li&gt;&lt;li&gt; appendicitis
&lt;/li&gt;&lt;li&gt; cholecystitis
&lt;/li&gt;&lt;li&gt; gout
&lt;/li&gt;&lt;li&gt; hepatitis
&lt;/li&gt;&lt;li&gt; meningitis
&lt;/li&gt;&lt;li&gt; osteomyelitis
&lt;/li&gt;&lt;li&gt; pancreatitis
&lt;/li&gt;&lt;li&gt; PID
&lt;/li&gt;&lt;li&gt; pneumonia
&lt;/li&gt;&lt;li&gt; priapism
&lt;/li&gt;&lt;li&gt; pulmonary embolism/infarction
&lt;/li&gt;&lt;li&gt; rheumatic fever
&lt;/li&gt;&lt;li&gt; sepsis
&lt;/li&gt;&lt;li&gt; stroke (ischemic or hemorrhagic)
&lt;/li&gt;&lt;li&gt; UTI
&lt;/li&gt;&lt;li&gt; URI
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sickle_Cell_Crisis&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Abd Pain
&lt;ol&gt;&lt;li&gt; Surgery if abdominal injury
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Aplastic Anemia
&lt;ol&gt;&lt;li&gt; Exculde reverible causes and tranfuse for severe anemia (Hb &amp;lt;6-7)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Pain crisis
&lt;ol&gt;&lt;li&gt; IVF, pain meds, O2 if hypoxic
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Priapism
&lt;ol&gt;&lt;li&gt; Pain meds, exchange tranfusion before surgery, urology consult
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Acute chest syndrome
&lt;ol&gt;&lt;li&gt; Admit if infiltrate, treat pain, give IV Abx
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Stroke
&lt;ol&gt;&lt;li&gt; Head CT +/- LP, IVF, keep HbS &amp;lt;30% total blood vol
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sickle_Cell_Crisis&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Admission if:
&lt;ol&gt;&lt;li&gt; Acute Chest Syndrome - pain/pulmonary infiltrates from infection or pulm infarct
&lt;/li&gt;&lt;li&gt; Stroke, priapism, serious bacterial infection, aplastic crisis, hypoxia, acidosis
&lt;/li&gt;&lt;li&gt; Unable to tolerate PO or inadequate pain control, abnormal vital signs
&lt;/li&gt;&lt;li&gt; Consider if pregnant (in crisis), or uncertain dx of SCD
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sickle_Cell_Crisis&amp;amp;action=edit&amp;amp;section=8" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Acute Chest Syndrome
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sickle_Cell_Crisis&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;DONALDSON 6/07
SOTELO 10/09
&lt;/p&gt;&lt;p&gt;TUNG 7/10
&lt;/p&gt;



</content><folder>Heme/Onc</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="sinus_tachycardia"><name>Sinus Tachycardia</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sinus_Tachycardia&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Workup"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Workup"&gt;Workup&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;CBC
&lt;/li&gt;&lt;li&gt;Chem 7
&lt;/li&gt;&lt;li&gt;Utox
&lt;/li&gt;&lt;li&gt;Orthostatics?
&lt;/li&gt;&lt;li&gt;Consider IVF
&lt;/li&gt;&lt;li&gt;Consider pain meds
&lt;/li&gt;&lt;li&gt;Consider DDX
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sinus_Tachycardia&amp;amp;action=edit&amp;amp;section=2" title="Edit section: DDX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX"&gt;DDX&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;anemia
&lt;/li&gt;&lt;li&gt;dehydration
&lt;/li&gt;&lt;li&gt;drug intox
&lt;/li&gt;&lt;li&gt;drug withdrawal
&lt;/li&gt;&lt;li&gt;pain
&lt;/li&gt;&lt;li&gt;infection
&lt;/li&gt;&lt;li&gt;sepsis
&lt;/li&gt;&lt;li&gt;thyroid
&lt;/li&gt;&lt;li&gt;fever
&lt;/li&gt;&lt;li&gt;psych anger fear
&lt;/li&gt;&lt;li&gt;arrhythmia
&lt;/li&gt;&lt;li&gt;pulm emb
&lt;/li&gt;&lt;li&gt;chf
&lt;/li&gt;&lt;li&gt;tamponade
&lt;/li&gt;&lt;li&gt;myocardial contusion
&lt;/li&gt;&lt;li&gt;cardiac valvular dz
&lt;/li&gt;&lt;li&gt;high low sugar
&lt;/li&gt;&lt;li&gt;ami
&lt;/li&gt;&lt;li&gt;asa od
&lt;/li&gt;&lt;li&gt;tca od
&lt;/li&gt;&lt;li&gt;anticholinergics atopine benedryl
&lt;/li&gt;&lt;li&gt;theophylline od
&lt;/li&gt;&lt;li&gt;sudafed
&lt;/li&gt;&lt;li&gt;anion gap acidosis
&lt;/li&gt;&lt;li&gt;pheochromocytoma 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sinus_Tachycardia&amp;amp;action=edit&amp;amp;section=3" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Cards: SVT
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="sinusitis"><name>Sinusitis</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagonsis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagonsis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Antibiotics"&gt;&lt;span class="tocnumber"&gt;3.1&lt;/span&gt; &lt;span class="toctext"&gt;Antibiotics&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Antibiotic_Failure"&gt;&lt;span class="tocnumber"&gt;3.2&lt;/span&gt; &lt;span class="toctext"&gt;Antibiotic Failure&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sinusitis&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Rhinosinusitis - Inflammation of the lining of the paranasal sinuses
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Acute (&amp;lt; 4 weeks)
&lt;ol&gt;&lt;li&gt;Acute viral
&lt;/li&gt;&lt;li&gt;Acute bacterial (0.5-2% of cases) 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Subacute (4-12 weeks)
&lt;/li&gt;&lt;li&gt;Chronic (&amp;gt;12 weeks)
&lt;/li&gt;&lt;li&gt;Other causes
&lt;ol&gt;&lt;li&gt;Fungal infections
&lt;/li&gt;&lt;li&gt;Allergies
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sinusitis&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagonsis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagonsis"&gt;Diagonsis&lt;/span&gt;&lt;/h2&gt;
&lt;table width="437" border="1"&gt;
&lt;tr&gt;
&lt;td style="width: 581px; height: 14px" colspan="3" width="437" valign="top"&gt;
&lt;p&gt;&lt;b&gt;Classic History &amp;amp; Physical&lt;/b&gt;
&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="width: 156px; height: 15px" width="117"&gt;
&lt;center&gt;&lt;b&gt;Feature&lt;/b&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 87px; height: 15px" width="66"&gt;
&lt;center&gt;&lt;b&gt;Viral&lt;/b&gt;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 338px; height: 15px" width="254"&gt;
&lt;center&gt;&lt;b&gt;Bacterial&lt;/b&gt;&lt;/center&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="width: 156px; height: 15px" width="117"&gt;
&lt;p&gt;Duration (symptoms)
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 87px; height: 15px" width="66"&gt;
&lt;center&gt;&amp;lt;10&lt;span style="display: none; line-height: 0"&gt;&#65279;&lt;/span&gt;days&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 338px; height: 15px" width="254"&gt;
&lt;center&gt;Usually &amp;gt;10 days OR worsening symptoms within 10 days after initial improvement&lt;/center&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="width: 156px; height: 29px" width="117"&gt;
&lt;p&gt;Color change (nasal discharge)
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 87px; height: 29px" rowspan="5" width="66"&gt;
&lt;center&gt;+/&#8722;&lt;/center&gt;
&lt;/td&gt;&lt;td style="width: 338px; height: 29px" width="254"&gt;
&lt;center&gt;+++, quality usually yellow-green and thick&lt;/center&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="width: 156px; height: 14px" width="117"&gt;
&lt;p&gt;Maxillary dental pain
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 338px; height: 14px" width="254"&gt;
&lt;center&gt;+++, often unilateral and associated with a particular sinus&lt;/center&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="width: 156px; height: 14px" width="117"&gt;
&lt;p&gt;Postnasal drip
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 338px; height: 14px" width="254"&gt;
&lt;center&gt;More common&lt;/center&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="width: 156px; height: 15px" width="117"&gt;
&lt;p&gt;Fever, cough, fatigue
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 338px; height: 15px" width="254"&gt;
&lt;center&gt;More common&lt;/center&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="width: 156px; height: 14px" width="117"&gt;
&lt;p&gt;Hyposmia/anosmia
&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 338px; height: 14px" width="254"&gt;
&lt;center&gt;More common&lt;/center&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sinusitis&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;&amp;lt; 10 days symptomatic treatment b/c most likely viral
&lt;ol&gt;&lt;li&gt;Analgesia
&lt;/li&gt;&lt;li&gt;Mechanical irrigation with buffered, hypertonic saline
&lt;/li&gt;&lt;li&gt;Topical glucocorticoids
&lt;/li&gt;&lt;li&gt;Topical decongestants (e.g., oxymetazoline for no more than three days)
&lt;/li&gt;&lt;li&gt;Antihistamines
&lt;/li&gt;&lt;li&gt;Mucolytics
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;10 days or if pt gets better and then worse again (&#8220;double sickening&#8221;)
&lt;ol&gt;&lt;li&gt;Mild bacterial sinusitis when pain is mild and temperature &amp;lt; 38.3&#730;C
&lt;/li&gt;&lt;li&gt;Another seven days of observation
&lt;/li&gt;&lt;li&gt;Severe bacterial sinusitis when pain is moderate-severe or temperature &#8805;38.3&#730;C
&lt;/li&gt;&lt;li&gt;Consider antibiotics
&lt;/li&gt;&lt;li&gt;If the patient is immunocompromised, has an underlying or complicating condition, or patient fails observation, antibiotics are indicated
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sinusitis&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Antibiotics"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Antibiotics"&gt;Antibiotics&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Choice of antibiotic depends on recent antibiotic therapy (past 4-6 weeks).
&lt;ol&gt;&lt;li&gt;Amoxicillin (500mg PO TID for 10 days)
&lt;/li&gt;&lt;li&gt;TMP-SMX
&lt;/li&gt;&lt;li&gt;Erythromycin
&lt;/li&gt;&lt;li&gt;Azithromycin
&lt;/li&gt;&lt;li&gt;&#65279;&#65279;&#65279;&#65279;Cefpodoxime&#65279;
&lt;/li&gt;&lt;li&gt;Cefdinir
&lt;/li&gt;&lt;li&gt;Cefuroxime
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sinusitis&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Antibiotic Failure"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Antibiotic_Failure"&gt;Antibiotic Failure&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;&#65279;If initial antibiotic failure occurs consider further workup (e.g. CT) and/or further tx with either amoxicillin-clavulanate or respiratory fluoroquinolone
&lt;/li&gt;&lt;li&gt;Nosocomial acute bacterial rhinosinusitis can occur (e.g., after prolonged nasotracheal intubation) and often is associated with gram-negatives; remove foreign bodies and use culture-directed antibiotic therapy
&lt;/li&gt;&lt;li&gt;Immunocompromised patients at risk for acute fulminant fungal rhinosinusitis
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sinusitis&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt; Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;DeBonis, Kaji&#65279;,&#65279; &#65279;&#65279;U&#65279;p&#65279;&#65279;T&#65279;o&#65279;&#65279;&#65279;&#65279;&#65279;&#65279;&#65279;D&#65279;a&#65279;t&#65279;e "Rhinosinusitis"
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;



</content><folder>ID</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="six_item_screen"><name>Six Item Screen</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Six_Item_Screen&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Six Item Screen"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Six_Item_Screen"&gt;Six Item Screen&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;for cognitive impairment
&lt;/li&gt;&lt;li&gt;Tests attention, short-term memory, and orientation
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Name Items (3), ask patient to repeat
&lt;/li&gt;&lt;li&gt;ask orientation (3)
&lt;/li&gt;&lt;li&gt;ask to recall items (3)
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;score &amp;lt; 5  94% sensitive and 86% for cognitive impairment
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Six_Item_Screen&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;7/09 PANI
&lt;/p&gt;



</content><folder>Neuro</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="skull_fracture"><name>Skull Fracture</name><content>&lt;p&gt;&lt;br /&gt;
SKULL FRACTURES
&lt;/p&gt;&lt;p&gt;-    fxs are predictors of intracranial inj
&lt;/p&gt;&lt;p&gt;-    fx can lead to complications
&lt;/p&gt;&lt;p&gt;-    infants higher risk for fx since
&lt;/p&gt;&lt;p&gt;o    thinner bones- fx parietal first, then occ, frontal, temp
&lt;/p&gt;&lt;p&gt;o    linear fx most common- then depressed and basilar
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;-    most fxs have hematomas
&lt;/p&gt;&lt;p&gt;-    larger hematoma more likely to have fx
&lt;/p&gt;&lt;p&gt;-    basilar skull fx usually have hemotympanum, battle sign, csf leak, CN palsy
&lt;/p&gt;&lt;p&gt;-    30% of linear skull fx have intracranial inj but 40- 100% of intracranial inj assoc with fx
&lt;/p&gt;&lt;p&gt;-    linear fx heal without complication except growing skull fx
&lt;/p&gt;&lt;p&gt;-    growing skull fx- enlarge overtime producing cranial defect- from tear in dura.  CSF pulsation or meninges herniation and bone remodeling.   Usually &amp;gt;3mm separation and present 18 mo after initial injury. Most need surg
&lt;/p&gt;&lt;p&gt;-    depressed skull fx- complications include intracranial hem, dural laceration, sz, focal neuro,
&lt;/p&gt;&lt;p&gt;-    basilar skull fx- bleed into middle ear, mastoid air cells, csf leak  and meningitis,, hearing loss, CN 6-7-8 defect- transient or permanent
&lt;/p&gt;&lt;p&gt;-    no prophylactic abx- leaks usually stop in 1 wk
&lt;/p&gt;&lt;p&gt;-    plain xrays better than ct to dx skull fx but still need ct to eval brain
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="slipped_capital_femoral_epiphysis_(scfe)"><name>Slipped Capital Femoral Epiphysis (SCFE)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Slipped_Capital_Femoral_Epiphysis_(SCFE)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- head of femur displaces from epiphysis due to loss of mechanical integrity at the growth plate
&lt;/p&gt;&lt;p&gt;- head of femur remains in acetabulum &amp;amp; femoral neck rotates anter
&lt;/p&gt;&lt;p&gt;- may be seen in under 9, although uncommon (must investigate endocrinopathies in this subset)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Slipped_Capital_Femoral_Epiphysis_(SCFE)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: "&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id=""&gt; &lt;/span&gt;&lt;/h2&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Slipped_Capital_Femoral_Epiphysis_(SCFE)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Age - 9 to 16 yrs
&lt;/p&gt;&lt;p&gt;Present - mild to severe pain, limp
&lt;/p&gt;&lt;p&gt;Labs - normal
&lt;/p&gt;&lt;p&gt;Xray - Anterior displacement of femoral neck to head
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Presentation
&lt;/p&gt;&lt;p&gt;- acute, chronic or acute on chronic slippage.
&lt;/p&gt;&lt;p&gt;- pts tend to be overweight
&lt;/p&gt;&lt;p&gt;- limited range of motion on int rot Xrays
&lt;/p&gt;&lt;p&gt;- widened epiphyseal plate &amp;amp; displacement of femoral neck to head.
&lt;/p&gt;&lt;p&gt;- complications include jt space narrowing, arthritis &amp;amp; avascular necrosis of hip.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Slipped_Capital_Femoral_Epiphysis_(SCFE)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;See Peds: Hip Pain
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Slipped_Capital_Femoral_Epiphysis_(SCFE)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Internal fixation
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;&lt;ul&gt;&lt;li&gt;&lt;ul&gt;&lt;li&gt;SCFE****
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;d/t slip of proximal femoral epiphysis post &amp;amp; inf on the metaphysis thru physeal plate during growth spurt
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;20% - 25% rate of opp hip involvement - 2/3 present at same time
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Loenstein (frog leg) view &amp;amp; AP views
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Kleines Line - line from sup cortex of femoral neck parallel to greater trochanter, nl= should cross thru 1/3 of fem head, scfe does'nt.
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;X - ray - early - widened physis (B4 actual slip) if not sure -) do bone scan
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;(33% - mild, 34-50&amp;nbsp;% mod. )50%-sev
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;RF= obesity , AA, male - female 2- 1 (during growth spurt) m=13y f=11y
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;PE= rest - foot ext rotated, hip abducted &amp;amp; sl flexed to decr press. hip= decr int. Rotation, abduction, flexion on PE, waddling gate. Whitman's sign= get abduction &amp;amp; ext. Rotation of hip w/ flexion of knee.
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Rx= non wt bearing &amp;amp; admit for Ortho to pin b/c of risk of avascular necrosis w/o rx.
&lt;/li&gt;&lt;/ul&gt;




</content><folder>Ortho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="small_bowel_obstruction_(sbo)"><name>Small Bowel Obstruction (SBO)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Pearls"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Pearls&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Causes"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Causes&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Clinical_Manifestations"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Clinical Manifestations&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Laboratory_Diagnosis"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Laboratory Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Imaging"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Imaging&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Management"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Management&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Small_Bowel_Obstruction_(SBO)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Pearls"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Pearls"&gt;Pearls&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;SBO without hx of sx, no hernia = malignancy until proven otherwise
&lt;/li&gt;&lt;li&gt;"Never let the sun rise or set on a small bowel obstruction"
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Small_Bowel_Obstruction_(SBO)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Causes"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Causes"&gt;Causes&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Postoperative adhesions
&lt;/li&gt;&lt;li&gt;Malignancy
&lt;/li&gt;&lt;li&gt;Hernias
&lt;/li&gt;&lt;li&gt;Intraluminal strictures
&lt;ol&gt;&lt;li&gt;Crohn's disease
&lt;/li&gt;&lt;li&gt;Radiation therapy
&lt;/li&gt;&lt;li&gt;Mesenteric ischemia
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Trauma (particularly to the duodenum)
&lt;/li&gt;&lt;li&gt;Gallstone ileus
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Small_Bowel_Obstruction_(SBO)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Clinical Manifestations"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Clinical_Manifestations"&gt;Clinical Manifestations&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Nausea/vomiting
&lt;ol&gt;&lt;li&gt;Seen more in proximal than distal obstruction
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Abdominal distention
&lt;ol&gt;&lt;li&gt;Seen more in distal than proximal obstruction
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Abdominal pain
&lt;ol&gt;&lt;li&gt;Typically crampy, periumbilical
&lt;/li&gt;&lt;li&gt;Paroxysms of pain occur q5min
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Inability to pass flatus
&lt;ol&gt;&lt;li&gt;Pts may pass flatus/stool initially
&lt;ol&gt;&lt;li&gt;Takes 12-24hrs for colon to empty
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Dehydration
&lt;/li&gt;&lt;li&gt;Anorexia
&lt;/li&gt;&lt;li&gt;Metabolic alkalosis
&lt;/li&gt;&lt;li&gt;Strangulation may occur
&lt;ol&gt;&lt;li&gt;Fever
&lt;/li&gt;&lt;li&gt;Leukocytosis
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Small_Bowel_Obstruction_(SBO)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Laboratory Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Laboratory_Diagnosis"&gt;Laboratory Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;CBC - evidence of strangulation?
&lt;/li&gt;&lt;li&gt;Chem - degree of dehydration, evidence of ischemia (acidosis)
&lt;/li&gt;&lt;li&gt;Lactate -Sensitive (90-100%), though not specific, marker of strangulation
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Small_Bowel_Obstruction_(SBO)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Imaging"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Imaging"&gt;Imaging&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Acute abdominal series
&lt;ol&gt;&lt;li&gt;Films
&lt;ol&gt;&lt;li&gt;Upright chest film: r/o free air
&lt;/li&gt;&lt;li&gt;Upright abd film: air-fluid levels
&lt;/li&gt;&lt;li&gt;Supine abd film: width of loops of bowel most visible (estimate of amount of distention)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Presence of air in colon or rectum makes complete obstruction less likely (esp of symptoms &amp;gt; 24hr)
&lt;/li&gt;&lt;li&gt;If pt cannot be placed in upright position a left lateral decub abd film can substitute
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;CT A/P with PO and IV contrast
&lt;ol&gt;&lt;li&gt;Consider if plain films are non-diagnostic
&lt;/li&gt;&lt;li&gt;Can show closed-loop obstruction, evidence of ischemia
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Small_Bowel_Obstruction_(SBO)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Management"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Management"&gt;Management&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;IV fluid resuscitation with electrolyte repletion
&lt;/li&gt;&lt;li&gt;Assessment of need for operative vs nonoperative management
&lt;ol&gt;&lt;li&gt;&lt;span style="line-height: 20px"&gt;Nonoperative Management&lt;/span&gt;
&lt;ol&gt;&lt;li&gt;Sometimes successful in patients with partial SBO (must rule-out strangulation first!)
&lt;/li&gt;&lt;li&gt;IV fluid resuscitation with electrolyte repletion
&lt;/li&gt;&lt;li&gt;NG tube
&lt;ol&gt;&lt;li&gt;14 French
&lt;/li&gt;&lt;li&gt;Intermittent low wall suction
&lt;/li&gt;&lt;li&gt;Nasogastric fluid losses can be replaced w/ NS + KCL (30-40 meq)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Contrast
&lt;ol&gt;&lt;li&gt;Both diagnostic and therapeutic (draws water into the bowel stimulating peristalsis)
&lt;/li&gt;&lt;li&gt;Associated with decreased hospital stay, more rapid resolution of symptoms
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;&lt;span style="line-height: 20px"&gt;If increasing pain, distention, or peristent high NGT output, consider operative intervention&lt;/span&gt;
&lt;/li&gt;&lt;li&gt;Repeat CT scan may be helpful to detect early signs of bowel ischemia
&lt;ol&gt;&lt;li&gt;Repeat plain films are not helpful (only detect perforation)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Operative Management
&lt;ol&gt;&lt;li&gt; 25% of pts admitted for SBO require surgery
&lt;/li&gt;&lt;li&gt;Indicated for pts with:
&lt;ol&gt;&lt;li&gt;Complete SBO
&lt;/li&gt;&lt;li&gt;Closed-loop obstruction
&lt;/li&gt;&lt;li&gt;Fever, leukocytosis, peritonitis
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Small_Bowel_Obstruction_(SBO)&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;UpToDate
&lt;/p&gt;



</content><folder>GI</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="snakebite"><name>Snakebite</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Snakebite&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;cbc
&lt;/p&gt;&lt;p&gt;chem
&lt;/p&gt;&lt;p&gt;coags
&lt;/p&gt;&lt;p&gt;fibrinogen split products
&lt;/p&gt;&lt;p&gt;t&amp;amp;s
&lt;/p&gt;&lt;p&gt;total ck
&lt;/p&gt;&lt;p&gt;ua
&lt;/p&gt;&lt;p&gt;xray
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;send labs 15 min after 1st dose in.
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Snakebite&amp;amp;action=edit&amp;amp;section=2" title="Edit section: "&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id=""&gt; &lt;/span&gt;&lt;/h2&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Snakebite&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;CroFab for pitviper
&lt;/p&gt;&lt;p&gt;4-6 vials in 1L
&lt;/p&gt;&lt;p&gt;start slow and check for rxn if ok give 1L over the hour. repeat as needed until progression stops.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;-do not suck, cut, ice or tournicet
&lt;/p&gt;&lt;p&gt;-Treat rxn w benadryl, H2, sq epi
&lt;/p&gt;&lt;p&gt;-give 2 more vials Q6H x 3
&lt;/p&gt;&lt;p&gt;-Only give if clinical sx of envenomation
&lt;/p&gt;&lt;p&gt;-delayed serum sickness. Tx w benadryl and steroids
&lt;/p&gt;&lt;p&gt;-encourage surgeons to AVOID fasciotomy...almost never indicated, symptoms will resolve with antivenom.
&lt;/p&gt;



</content><folder>Tox</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="spinal_column_injuries_(cervical)"><name>Spinal Column Injuries (Cervical)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Pearls"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Pearls&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#Atlanto-occipital_dislocation"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;Atlanto-occipital dislocation&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Atlanto-axial_dislocation"&gt;&lt;span class="tocnumber"&gt;1.2&lt;/span&gt; &lt;span class="toctext"&gt;Atlanto-axial dislocation&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#C1_Fractures"&gt;&lt;span class="tocnumber"&gt;1.3&lt;/span&gt; &lt;span class="toctext"&gt;C1 Fractures&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#C2_Fractures"&gt;&lt;span class="tocnumber"&gt;1.4&lt;/span&gt; &lt;span class="toctext"&gt;C2 Fractures&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-6"&gt;&lt;a href="#Cervical_Fractures"&gt;&lt;span class="tocnumber"&gt;1.5&lt;/span&gt; &lt;span class="toctext"&gt;Cervical Fractures&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-7"&gt;&lt;a href="#Facet_Dislocations"&gt;&lt;span class="tocnumber"&gt;1.6&lt;/span&gt; &lt;span class="toctext"&gt;Facet Dislocations&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Spinal_Column_Injuries_(Cervical)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Pearls"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Pearls"&gt;Pearls&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Suspect vascular damage to the cord if discrepancy between neuro deficit and level of spinal column injury
&lt;/li&gt;&lt;li&gt; Down syndome predisposes to atlanto-occipital dislocation; RA predisposes to C2 transverse ligament rupture
&lt;/li&gt;&lt;li&gt; Cord injury is more likely if both the anterior (vertebral bodies) and posterior (spinal canal) columns are disrupted 
&lt;/li&gt;&lt;/ul&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Spinal_Column_Injuries_(Cervical)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Atlanto-occipital dislocation"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Atlanto-occipital_dislocation"&gt;Atlanto-occipital dislocation&lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt; Evaluate with the Powers ratio
&lt;ul&gt;&lt;li&gt; Ratio of BC:OA &amp;gt; 1 suggests anterior subluxation
&lt;/li&gt;&lt;li&gt; BC = distance between basion and midpoint of C2 post laminar line
&lt;/li&gt;&lt;li&gt; OA = Distance between opisthion and ant arch of C2
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Spinal_Column_Injuries_(Cervical)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Atlanto-axial dislocation"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Atlanto-axial_dislocation"&gt;Atlanto-axial dislocation&lt;/span&gt;&lt;/h3&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Spinal_Column_Injuries_(Cervical)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: C1 Fractures"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="C1_Fractures"&gt;C1 Fractures&lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt; Burst (Jefferson)
&lt;ul&gt;&lt;li&gt; Highly unstable
&lt;/li&gt;&lt;li&gt; Axial loading transmitted through occipital condyles to the lateral masses 
&lt;ul&gt;&lt;li&gt; Results in fx of the ant and post arches
&lt;/li&gt;&lt;li&gt; Stability is determined by whether or not the transverse ligament is disrupted 
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; Suspect if:
&lt;ul&gt;&lt;li&gt; Lateral xray: Increase in the predental space between C1 and the dens
&lt;ul&gt;&lt;li&gt; Predental space greater than 3 mm in adults or 5 mm in children is abnormal
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; Odontoid xray: Masses of C1 to lie lateral to the outer margins of the articular pillars of C2
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; If either of the above findings on xray then obtain CT c-spine
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; Posterior Arch
&lt;ul&gt;&lt;li&gt; Must ensure that you are not confusing this with a burst fx!
&lt;ul&gt;&lt;li&gt; Odontoid view must be normal 
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; Due to forced neck extension
&lt;/li&gt;&lt;li&gt; Vertical fx line through posterior arch seen on lateral xray
&lt;/li&gt;&lt;li&gt; Stable (b/c anterior arch and transverse ligament are unaffected)
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Spinal_Column_Injuries_(Cervical)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: C2 Fractures"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="C2_Fractures"&gt;C2 Fractures&lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt; Traumatic spondylolysis ("Hangman's Fx")
&lt;ul&gt;&lt;li&gt; Unstable
&lt;/li&gt;&lt;li&gt; Forced extension of an already extended neck 
&lt;/li&gt;&lt;li&gt; Spinal cord damage is often minimal (the AP diamter of the neural canal is greatest at C2) 
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; Odontoid Fracture
&lt;ul&gt;&lt;li&gt; Type I
&lt;ul&gt;&lt;li&gt; Above the transverse ligament
&lt;/li&gt;&lt;li&gt; Stable 
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; Type II
&lt;ul&gt;&lt;li&gt; At the base where it attaches to C2
&lt;/li&gt;&lt;li&gt; Unstable
&lt;/li&gt;&lt;li&gt; Most common 
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; Type III
&lt;ul&gt;&lt;li&gt; Extension of the fracture through the upper portion of C2
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Spinal_Column_Injuries_(Cervical)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Cervical Fractures"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Cervical_Fractures"&gt;Cervical Fractures&lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt; Anterior Wedge Fracture
&lt;ul&gt;&lt;li&gt; Unstable if:
&lt;ul&gt;&lt;li&gt; Loss of over half of vertebral height OR
&lt;/li&gt;&lt;li&gt; Multiple adjacent wedge fractures
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; Flexion Teardrop Fracture
&lt;ul&gt;&lt;li&gt; Unstable
&lt;/li&gt;&lt;li&gt; Associated with acute anterior cervical cord syndrome 
&lt;/li&gt;&lt;li&gt; Displacement of a teardrop shaped fragment of the antero-interior portion of the superior vertebra
&lt;ul&gt;&lt;li&gt; Severe flexion &amp;gt; vertebral body collides with the one below
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; Extension Teardrop Fracture 
&lt;ul&gt;&lt;li&gt; Unstable
&lt;/li&gt;&lt;li&gt; Abrupt neck extension &amp;gt; anterior longitudinal ligament avulses anteroinferior corner
&lt;ul&gt;&lt;li&gt; Avulsed fragment is greater in height than width (contrast with flexion teardrop) 
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; Often occurs at C5-C7 associated with diving accidents
&lt;ul&gt;&lt;li&gt; Associated with central cord syndrome
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; Spinous Process Fracture (Clay Shoveler's)
&lt;ul&gt;&lt;li&gt; Stable
&lt;/li&gt;&lt;li&gt; Isolated fracture of one of the spinous processes of the lower cervical vertebrae
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; Burst Fracture
&lt;ul&gt;&lt;li&gt; Posteriorly displaced fracture fragment may impinge on the cord 
&lt;/li&gt;&lt;li&gt; Axial compression &amp;gt; nucleus pulposus forced into vertebral body
&lt;/li&gt;&lt;li&gt; Imaging
&lt;ul&gt;&lt;li&gt; Lateral xray - Comminuted body and loss of vertebral height
&lt;/li&gt;&lt;li&gt; AP xray - Vertical fracture of the body
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Spinal_Column_Injuries_(Cervical)&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Facet Dislocations"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Facet_Dislocations"&gt;Facet Dislocations&lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt; Bilateral
&lt;ul&gt;&lt;li&gt; Unstable
&lt;/li&gt;&lt;li&gt; Complete spinal cord injury most often results 
&lt;/li&gt;&lt;li&gt; Disruption of the annulus fibrosus and the ant longitudinal ligament &amp;gt; ant displacement of the spine 
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; Unilateral
&lt;ul&gt;&lt;li&gt; Stable
&lt;/li&gt;&lt;li&gt; Spinal cord injury rarely occurs
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Spinal_Column_Injuries_(Cervical)&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;UpToDate
&lt;/p&gt;



</content><folder>Trauma</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="spinal_column_injuries_(thoracolumbar)"><name>Spinal Column Injuries (Thoracolumbar)</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Spinal_Column_Injuries_(Thoracolumbar)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Pearls"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Pearls"&gt;Pearls&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Stable if two or more of the spinal columns are intact:
&lt;ul&gt;&lt;li&gt; Anterior (anterior longitudinal ligament, annulus fibrosus, ant. half of the vertebral body)
&lt;/li&gt;&lt;li&gt; Middle (posterior longitudinal ligament, posterior annulus fibrous, and post. half of vertebral body
&lt;/li&gt;&lt;li&gt; Posterior (supraspinous and interspinous ligaments, facet joint capsule)
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; Unstable if:
&lt;ul&gt;&lt;li&gt; 50% loss of vertebral height
&lt;/li&gt;&lt;li&gt; Kyphotic angulation around the fx:
&lt;ul&gt;&lt;li&gt; &amp;gt;30o for compression fx
&lt;/li&gt;&lt;li&gt; &amp;gt; 25o for burst fx 
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; Neurologic deficit
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Spinal_Column_Injuries_(Thoracolumbar)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Classification"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Classification"&gt;Classification&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; &lt;b&gt;Wedge compression fracture&lt;/b&gt;
&lt;ul&gt;&lt;li&gt; Only unstable if posterior ligament complex ruptures (requires a rotational force)
&lt;/li&gt;&lt;li&gt; Suspect instability and obtain CT if:
&lt;ul&gt;&lt;li&gt; Severe compression (&amp;gt;50% loss of vertebral height)
&lt;/li&gt;&lt;li&gt; Kyphosis &amp;gt;30o
&lt;/li&gt;&lt;li&gt; Rotational component to the injury
&lt;/li&gt;&lt;li&gt; Compression fx at multiple sites
&lt;/li&gt;&lt;li&gt; Posterior cortex abnormality
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; &lt;b&gt;Burst fracture&lt;/b&gt;
&lt;ul&gt;&lt;li&gt; Unstable 
&lt;/li&gt;&lt;li&gt; Can occur with or without injury to posterior elements (posterior involvement increases risk for neuro deficits)
&lt;/li&gt;&lt;li&gt; Be certain not to mistakenly call a burst fracture a wedge fracture
&lt;ul&gt;&lt;li&gt; Obtain CT if unsure 
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; &lt;b&gt;Flexion-distraction Injuries (lap belt)&lt;/b&gt;
&lt;ul&gt;&lt;li&gt; Obtain sagittally reconstructed CT if suspect lap-belt mechanism or flexion-distraction 
&lt;/li&gt;&lt;li&gt; Unstable 
&lt;/li&gt;&lt;li&gt; Intra-abdominal injuries more commonly  associated than neuro deficits
&lt;/li&gt;&lt;li&gt; Chance Fx
&lt;ul&gt;&lt;li&gt; Lap belt worn above the pelvic bones without a shoulder harness
&lt;ul&gt;&lt;li&gt; Forceful flexion at the lap belt &amp;gt; compressive failure of the ant and middle columns 
&lt;ul&gt;&lt;li&gt; One or both articular processes fx &amp;gt; upper vertebrae anteriorly dislocates
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; Imaging
&lt;ul&gt;&lt;li&gt; Compression fx + increased posterior interspinous spaces caused by distraction
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; &lt;b&gt;Translational&lt;/b&gt;
&lt;ul&gt;&lt;li&gt; Massive direct trauma to the back &amp;gt; failure of all 3 columns
&lt;/li&gt;&lt;li&gt; Almost invariably demonstrate neuro deficits 
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Spinal_Column_Injuries_(Thoracolumbar)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;UpToDate
&lt;/p&gt;



</content><folder>Trauma</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="spinal_cord_syndromes"><name>Spinal Cord Syndromes</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Spinal_Cord_Syndromes"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Spinal Cord Syndromes&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#COMPLETE_TRANSECTION"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;COMPLETE TRANSECTION&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#ANTERIOR_CORD"&gt;&lt;span class="tocnumber"&gt;2.2&lt;/span&gt; &lt;span class="toctext"&gt;ANTERIOR CORD&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#CENTRAL_CORD"&gt;&lt;span class="tocnumber"&gt;2.3&lt;/span&gt; &lt;span class="toctext"&gt;CENTRAL CORD&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-6"&gt;&lt;a href="#BROWN-SEQUARD"&gt;&lt;span class="tocnumber"&gt;2.4&lt;/span&gt; &lt;span class="toctext"&gt;BROWN-SEQUARD&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-7"&gt;&lt;a href="#CONUS_MEDULLARIS.2FCAUDA_EQUINA"&gt;&lt;span class="tocnumber"&gt;2.5&lt;/span&gt; &lt;span class="toctext"&gt;CONUS MEDULLARIS/CAUDA EQUINA&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Spinal_Cord_Syndromes&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;ANATOMY
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt; Doral column: proprioception, vibration and touch and decussate @ medulla
&lt;/li&gt;&lt;li&gt; Lat corticospinal: voluntary motor and cross @ medulla. Upper extremity fibres more centrally, lower extremity fibres more lateral
&lt;/li&gt;&lt;li&gt; Ant spinothalamic: pain, temp. and light touch. Cross just one level above entry point to spinal cord.
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Spinal_Cord_Syndromes&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Spinal Cord Syndromes"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Spinal_Cord_Syndromes"&gt;Spinal Cord Syndromes&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Spinal_Cord_Syndromes&amp;amp;action=edit&amp;amp;section=3" title="Edit section: COMPLETE TRANSECTION"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="COMPLETE_TRANSECTION"&gt;COMPLETE TRANSECTION&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;higher lesions assoc w/ spinal shock &amp;amp;autonomic dysfunction
&lt;/li&gt;&lt;li&gt;sacral sparing (perianal sens, rectal tone, or toe flexor) excludes complete transection
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Spinal_Cord_Syndromes&amp;amp;action=edit&amp;amp;section=4" title="Edit section: ANTERIOR CORD"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="ANTERIOR_CORD"&gt;ANTERIOR CORD&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;hyperflexion injury or blood supply prob (hypotension or aortic dissection)
&lt;/li&gt;&lt;li&gt;loss of motor (variable) and pain/temp
&lt;/li&gt;&lt;li&gt;proprioception, vibration and touch spared (Doral column)
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Spinal_Cord_Syndromes&amp;amp;action=edit&amp;amp;section=5" title="Edit section: CENTRAL CORD"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="CENTRAL_CORD"&gt;CENTRAL CORD&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; hyperext of neck
&lt;/li&gt;&lt;li&gt;neuro deficit more pronounced in upper than lowe extremites
&lt;/li&gt;&lt;li&gt;Loss of distal upper extremity pain, tem and strength
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Spinal_Cord_Syndromes&amp;amp;action=edit&amp;amp;section=6" title="Edit section: BROWN-SEQUARD"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="BROWN-SEQUARD"&gt;BROWN-SEQUARD&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;ipsilateral loss strength, vibration, position
&lt;/li&gt;&lt;li&gt;contralteral loss pain and temp
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Spinal_Cord_Syndromes&amp;amp;action=edit&amp;amp;section=7" title="Edit section: CONUS MEDULLARIS/CAUDA EQUINA"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="CONUS_MEDULLARIS.2FCAUDA_EQUINA"&gt;CONUS MEDULLARIS/CAUDA EQUINA&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Difficulty w/ urination (retention or incont) and sphincter control
&lt;/li&gt;&lt;li&gt;sexual dysf
&lt;/li&gt;&lt;li&gt;distal motor weakness
&lt;/li&gt;&lt;li&gt;saddle anesthesia
&lt;/li&gt;&lt;li&gt;(Conus Medullaris usually B/L sxs; Cauda Equina is usually unilateral)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Spinal_Cord_Syndromes&amp;amp;action=edit&amp;amp;section=8" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Trauma: Spinal Fractures
&lt;/p&gt;&lt;p&gt;Neuro: Neurogenic Shock
&lt;/p&gt;&lt;p&gt;Neuro: Cord Compression
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Spinal_Cord_Syndromes&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;DONALDSON 9/07 (Adapted from Lampe, Hockberger, Brower, and Mistry)
&lt;/p&gt;



</content><folder>Neuro</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="spinal_fractures"><name>Spinal Fractures</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#A._Flexion"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;A. Flexion&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#B._Flexion-Rotation"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;B. Flexion-Rotation&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#C._Extension"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;C. Extension&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#D._Vertical_Compression"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;D. Vertical Compression&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Spinal_Fractures&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1. If you find an injury, you should CT the C-spine and Xray entire spine.
&lt;/p&gt;&lt;p&gt;2. Injuries invovlving only on column are stable.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;SPINAL COLUMNS
&lt;/p&gt;&lt;p&gt;I. Anterior spinal column: bodies, 
&lt;/p&gt;&lt;p&gt;discs &amp;amp; ant, long ligaments
&lt;/p&gt;&lt;p&gt;II. Posterior spinal column(s): pedicles, 
&lt;/p&gt;&lt;p&gt;transverse processes, facet jts,
&lt;/p&gt;&lt;p&gt;laminae, spinous proc, post ligament,
&lt;/p&gt;&lt;p&gt;and ligamntum flavum
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Spinal_Fractures&amp;amp;action=edit&amp;amp;section=2" title="Edit section: A. Flexion"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="A._Flexion"&gt;A. Flexion&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1. Wedge fx (S)
&lt;/p&gt;&lt;p&gt;2. Flexion teardrop (US!)
&lt;/p&gt;
&lt;pre&gt;    -anterior, inf. vert body
&lt;/pre&gt;
&lt;pre&gt;    -oblique lucency
&lt;/pre&gt;
&lt;p&gt;3. Clay shoveler's (S)
&lt;/p&gt;
&lt;pre&gt;    -lucency through tip C6 or C7
&lt;/pre&gt;
&lt;p&gt;4. Subluxation (US?)
&lt;/p&gt;&lt;p&gt;-look for widening at base of spinous processes
&lt;/p&gt;&lt;p&gt;5. Bilateral facet disloc (US)
&lt;/p&gt;&lt;p&gt;-usually have ant. cord syndrome or spinal shock
&lt;/p&gt;&lt;p&gt;6. Atlanto-occipital disloc (US)
&lt;/p&gt;&lt;p&gt;7. Ant atlantoaxial disloc +/- fx (US)
&lt;/p&gt;&lt;p&gt;8. Odontoid fx w/ lat displace (US)
&lt;/p&gt;&lt;p&gt;9. Transverse process fx (S)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Spinal_Fractures&amp;amp;action=edit&amp;amp;section=3" title="Edit section: B. Flexion-Rotation"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="B._Flexion-Rotation"&gt;B. Flexion-Rotation&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1. Unilateral Facet Dislocation (S)
&lt;/p&gt;
&lt;pre&gt;    -mech of looking to side then flex
&lt;/pre&gt;
&lt;pre&gt;    extend as in car accident
&lt;/pre&gt;
&lt;pre&gt;    -look for bow tie sign on vertebra
&lt;/pre&gt;
&lt;pre&gt;    above
&lt;/pre&gt;
&lt;p&gt;2. Rotary AtlantoAxial D/L (US)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Spinal_Fractures&amp;amp;action=edit&amp;amp;section=4" title="Edit section: C. Extension"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="C._Extension"&gt;C. Extension&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1. Posterior Neural Arch Fx (US)
&lt;/p&gt;
&lt;pre&gt;    -C1
&lt;/pre&gt;
&lt;pre&gt;    -may not see fx and only see
&lt;/pre&gt;
&lt;pre&gt;    ant. soft tissue widened
&lt;/pre&gt;
&lt;p&gt;2. Hangman's Fracture (US)
&lt;/p&gt;
&lt;pre&gt;    -fx through pedicle of
&lt;/pre&gt;
&lt;pre&gt;    C2 (crack thru C2 base)
&lt;/pre&gt;
&lt;pre&gt;    -can have nl or bad neuro exam
&lt;/pre&gt;
&lt;p&gt;3. Extension Teardrop Fracture (S vs. US)
&lt;/p&gt;
&lt;pre&gt;    -usually stable in flexion
&lt;/pre&gt;
&lt;pre&gt;    -UNSTABLE in extension
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Spinal_Fractures&amp;amp;action=edit&amp;amp;section=5" title="Edit section: D. Vertical Compression"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="D._Vertical_Compression"&gt;D. Vertical Compression&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1. Burst Fx of Vertebral Body (S)
&lt;/p&gt;&lt;p&gt;2. Jefferson Fracture (US!)
&lt;/p&gt;
&lt;pre&gt;    -post arch of C1
&lt;/pre&gt;
&lt;pre&gt;    -lateral masses on odontoid
&lt;/pre&gt;
&lt;pre&gt;    splayed laterally
&lt;/pre&gt;
&lt;pre&gt;    -atlantodental lig widening.
&lt;/pre&gt;
&lt;p&gt;3. Isolated Fx of Pillar or Vert Body (S)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;S = Stable
&lt;/p&gt;&lt;p&gt;US = Unstable
&lt;/p&gt;&lt;p&gt;US? = Questionably Unstable
&lt;/p&gt;&lt;p&gt;US! = Extremely Unstable
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Spinal_Fractures&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;DONALDSON 9/07 (Adapted from Lampe, Hockberger, Brower)
&lt;/p&gt;



</content><folder>Trauma</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="splinting"><name>Splinting</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Splinting&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;roximal humerus Fx-S&amp;amp;S
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Humeral shaft Fx-LAPS or stable-coaptation splint/unstable-elephant ear
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Supracondylar humeral Fx-LAPS (ortho consult for type2 or 3)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Humeral condyle Fx-LAPS and ortho for ORIF if displaced
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Olecranon Fx-nondisplaced S&amp;amp;S, displaced LAPS or emerg. ORIF
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Radial Head Fx-nondisplaced S&amp;amp;S,displaced-LAPS or emerg. ORIF
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Monteggia (ulnar shaft w/prox radioulnar disloc)-Emergent ortho for ORIF
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Galeazzi Fx (distal radius w/distal ulnar disloc)-Emerg. ortho for ORIF
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Elbow dislocation-LAPS after reduction (if assoc. Fx-emerg. ortho)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Forearm Fx-sugar tong
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Flexor tendon injury-finger splint/hand specialist ref.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Extensor tendon injury-poss ED repair/finger splint to hand specialist.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Mallet finger-finger splint to DIP (DIP in slight hyperextension)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Gamekeeper's thumb-thumb spica with ortho f/u
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Scaphoid Fx-Thumb spica splint with ortho f/u
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Carpal Fx-volar splint with ortho f/u
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Colle's Fx (distal radius with dist dorsal angulation)-sugar tong and ortho f/u
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Smith Fx (reverse colles w/ volar angulation)-sugar tong and ortho f/u
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Bennet's Fx (intrarticular Fx at base of 1st MCP)-thumb spica and ortho f/u
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Rolando Fx (comminuted base of 1st MCP-thumb spica and ortho f/u
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Boxer's Fx-ulnar gutter splint
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;MCP Fx-gutter splint (4th and 5th-ulnar, 2nd and 3rd-radial)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Phalynx Fx-finger splints with buddy tape.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;S&amp;amp;S= sling and swathe
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Splinting&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;(Ayana Herbert 10/03)
&lt;/p&gt;



</content><folder>Ortho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="spontaneous_bacterial_peritonitis_(sbp)"><name>Spontaneous Bacterial Peritonitis (SBP)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Clinical_Manifestations"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Clinical Manifestations&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Distinction_of_spontaneous_from_secondary_bacterial_peritonitis"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Distinction of spontaneous from secondary bacterial peritonitis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Spontaneous_Bacterial_Peritonitis_(SBP)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Clinical Manifestations"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Clinical_Manifestations"&gt;Clinical Manifestations&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Develops in large, clinically obvious ascites 2/2 cirrhosis
&lt;/li&gt;&lt;li&gt; Fever - 70%
&lt;/li&gt;&lt;li&gt; Abdominal pain (diffuse) - 60%
&lt;/li&gt;&lt;li&gt; Altered mental status - 55% 
&lt;/li&gt;&lt;li&gt; ~15% of patients have no signs/symptoms!
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Spontaneous_Bacterial_Peritonitis_(SBP)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Paracentesis results supporting a diagnosis of SBP:
&lt;ol&gt;&lt;li&gt; Absolute neutrophil count &amp;gt; 250PMNs/microL
&lt;/li&gt;&lt;li&gt; SAAG &amp;gt; 1.1
&lt;/li&gt;&lt;li&gt; Total protein &amp;lt; 1 and Glucose &amp;gt; 50 (otherwise concern for 2&lt;sup&gt;o&lt;/sup&gt; bacterial peritonitis)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; There is no platelet count or INR that is a contraindication to paracentesis
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Spontaneous_Bacterial_Peritonitis_(SBP)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Distinction of spontaneous from secondary bacterial peritonitis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Distinction_of_spontaneous_from_secondary_bacterial_peritonitis"&gt;Distinction of spontaneous from secondary bacterial peritonitis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Importance
&lt;ol&gt;&lt;li&gt; Mortality of 2&lt;sup&gt;o&lt;/sup&gt; bacterial peritonitis approaches 100 percent if tx is only antibiotics without sx
&lt;/li&gt;&lt;li&gt; Mortality of unncessary ex lap in patient w/ SBP and wrongly suspected 2&lt;sup&gt;o&lt;/sup&gt; bacterial peritonitis ~80%
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Laboratory findings
&lt;ol&gt;&lt;li&gt; Neutrocytic fluid (PMN &#8805;250) with two or more of following = strong evidence of 2&lt;sup&gt;o &lt;/sup&gt;bacterial peritonitis:
&lt;ol&gt;&lt;li&gt; 1. Total protein concentration &amp;gt;1 g/dL (10 g/L)
&lt;/li&gt;&lt;li&gt; 2. Glucose concentration &amp;lt;50 mg/dL (2.8 mmol/L) 
&lt;/li&gt;&lt;li&gt; 3. LDH greater than upper limit of normal for serum
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Should strongly suspect if ascitic alk phos &amp;gt;240  
&lt;/li&gt;&lt;li&gt; Gram Stain
&lt;ol&gt;&lt;li&gt; Large numbers of different bacterial forms 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Imaging
&lt;ol&gt;&lt;li&gt; If evidence of 2&lt;sup&gt;o&lt;/sup&gt; bacterial peritonitis obtain abdominal imaging
&lt;ol&gt;&lt;li&gt; If no evidence of free air or contrast extravasation then surgery is not indicated 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Spontaneous_Bacterial_Peritonitis_(SBP)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Antibiotics
&lt;ol&gt;&lt;li&gt; SBP
&lt;ol&gt;&lt;li&gt; Broad-spectrum covering gram + and gram -
&lt;ol&gt;&lt;li&gt; 3rd-generation cephalosporin is agent of choice:
&lt;ol&gt;&lt;li&gt; Cefotaxime 2g IV q8hr or Ceftriaxone 1-2g IV q12-24hr
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; If beta-lactam allergy consider ciprofloxacin 400mg IV q12hr&amp;gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; 2ndary bacterial peritonitis 
&lt;ol&gt;&lt;li&gt; 3rd-generation cephalosporin + metronidazole 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Albumin
&lt;ol&gt;&lt;li&gt; Decreases incidence of renal failure
&lt;/li&gt;&lt;li&gt; 1.5g/kg at time of diagnosis and 1g/kg on day 3
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Spontaneous_Bacterial_Peritonitis_(SBP)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Rosen's, UpToDate, &lt;font face="Arial"&gt;Thomsen TW. Paracentesis. N Engl J Med 2006; 355&lt;/font&gt;
&lt;/p&gt;



</content><folder>GI</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="sternoclavicular_dislocation"><name>Sternoclavicular Dislocation</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Mechanism"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Mechanism&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Presentation"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Presentation&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Imaging"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Imaging&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sternoclavicular_Dislocation&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;SC joint is freely movable synovial joint
&lt;/p&gt;&lt;p&gt;Allows movement in nearly all planes
&lt;/p&gt;&lt;p&gt;Very strong/stable due to connective tissue stabilizers - dislocation is UNCOMMON
&lt;/p&gt;&lt;p&gt;Requires substantial force to dislocate
&lt;/p&gt;&lt;p&gt;Anterior dislocation:posterior ratio 9:1
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sternoclavicular_Dislocation&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Mechanism"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Mechanism"&gt;Mechanism&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Anterior: anterior blow to lateral shoulder levers medial clavicle out
&lt;/p&gt;&lt;p&gt;Poster: usually direct blow to medial clavicle
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sternoclavicular_Dislocation&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Presentation"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Presentation"&gt;Presentation&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Anterior
&lt;/p&gt;&lt;p&gt;-usually not subtle
&lt;/p&gt;&lt;p&gt;-can happen in elderly without significant trauma
&lt;/p&gt;&lt;p&gt;-minimal potential for resultant morbidity
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Posterior
&lt;/p&gt;&lt;p&gt;Associated with sig force
&lt;/p&gt;&lt;p&gt;25% incidence of mediastinal injury
&lt;/p&gt;&lt;p&gt;-tracheal rupture
&lt;/p&gt;&lt;p&gt;-PTX
&lt;/p&gt;&lt;p&gt;-SVC lac
&lt;/p&gt;&lt;p&gt;-Subclavian occlusion
&lt;/p&gt;&lt;p&gt;-Vocal cord palsy
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sternoclavicular_Dislocation&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Imaging"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Imaging"&gt;Imaging&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Rountine Xray may appear nl
&lt;/p&gt;&lt;p&gt;Serendipity View: 40&#730; from vertical, direct cephalad
&lt;/p&gt;&lt;p&gt;CT modality of choice
&lt;/p&gt;&lt;p&gt;-can demonstrate co-injuries
&lt;/p&gt;&lt;p&gt;MRI/MRA if necessary
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sternoclavicular_Dislocation&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Anterior
&lt;/p&gt;&lt;p&gt;-Reduction if you desire
&lt;/p&gt;&lt;p&gt;-Bolster between shoulder blades, abduct arm to 90&#730;, press medial clavicle posteriorly and inferiorly
&lt;/p&gt;&lt;p&gt;-May not reduce 2/2 interposed ligaments
&lt;/p&gt;&lt;p&gt;-May not stay reduced 2/2 loss of ligament support
&lt;/p&gt;&lt;p&gt;-Sling
&lt;/p&gt;&lt;p&gt;-Ortho f/u
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Posterior
&lt;/p&gt;&lt;p&gt;-Difficult to reduce
&lt;/p&gt;&lt;p&gt;-Prep, place towel clips, pull anteriorly while (assistant) placing traction and abduction to ipsilateral arm
&lt;/p&gt;&lt;p&gt;-Sling
&lt;/p&gt;&lt;p&gt;-Ortho f/u
&lt;/p&gt;&lt;p&gt;-Admit if other mediastinal injury
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sternoclavicular_Dislocation&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Perron (ACEP '09)
&lt;/p&gt;



</content><folder>Ortho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="stress_testing_(cad)"><name>Stress Testing (CAD)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Sensitivities.2FSpecificities"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Sensitivities/Specificities&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Def_of_a_positive_treadmill:"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Def of a positive treadmill:&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Utility_of_past_tests"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Utility of past tests&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#ECG_Stress_Testing"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;ECG Stress Testing&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Protocol"&gt;&lt;span class="tocnumber"&gt;4.1&lt;/span&gt; &lt;span class="toctext"&gt;Protocol&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Stress_Testing_(CAD)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Sensitivities/Specificities"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Sensitivities.2FSpecificities"&gt;Sensitivities/Specificities&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;TREADMILL: sens spec
&lt;/p&gt;&lt;p&gt;Overall 68% 77%
&lt;/p&gt;&lt;p&gt;ED 90% 50%
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;SPECT
&lt;/p&gt;&lt;p&gt;Overall 88% 77%
&lt;/p&gt;&lt;p&gt;ED 86% 74%
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;ECHO
&lt;/p&gt;&lt;p&gt;Overall 76% 88%
&lt;/p&gt;&lt;p&gt;ED 47% 99%
&lt;/p&gt;&lt;p&gt;which test to use?
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;ETT- no baseline ST segment abnormalities (no LBBB LVH w/strain), no digoxin use, Beta blockers and CCB ok...and if a negative result will just meant the person is going to get the next test...
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Stress_Testing_(CAD)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Def of a positive treadmill:"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Def_of_a_positive_treadmill:"&gt;Def of a positive treadmill:&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;&amp;gt;1mm horizontal or downsloping ST segment depression or elevation at 80ms after J point
&lt;/li&gt;&lt;li&gt;significant arrythmias
&lt;/li&gt;&lt;li&gt;decreased systolic BP of &amp;gt; 10 mmHg
&lt;/li&gt;&lt;li&gt;significant symptoms
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;a negative stress test has @ 98% negative predictive value.
&lt;/p&gt;&lt;p&gt;does a postive stress mandate admission? not necessarily (yes at Harbor), the following are predictive of L main disease or severe multi vessel disease:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;ST depression &amp;gt; 2.5mm
&lt;/li&gt;&lt;li&gt;serious ventricular arrythmias
&lt;/li&gt;&lt;li&gt;ST depression within 3 minutes of beginning
&lt;/li&gt;&lt;li&gt;prolonged &amp;gt;8 minute ST segment recovery
&lt;/li&gt;&lt;li&gt;hypotension &amp;gt;10mmHb during test or diastolic HTN &amp;gt;110 during test.
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;these either need admission or at least a discussion with a cardiologist.
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Stress_Testing_(CAD)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Utility of past tests"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Utility_of_past_tests"&gt;Utility of past tests&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Angiography- if normal, progrssion to greater than 50% occlusion is unlikely within five years.
&lt;/p&gt;&lt;p&gt;if &amp;lt;50% occlusion, about 30% progress to &amp;gt;50% obstruction at 3 years.
&lt;/p&gt;&lt;p&gt;the change in chest pain and risk factors is predictive of progression (a diabetic with BS OOC not taking his/her lipid meds can accelerate much faster than your ordinary guy that does everything he should be doing...)
&lt;/p&gt;&lt;p&gt;SPECT or EST-
&lt;/p&gt;&lt;p&gt;&amp;lt;1% cardiac event rate at one year in patients with normal tests.
&lt;/p&gt;&lt;p&gt;Bottom line:some low risk patients (10%) will have an adverse event within 31 months of initial evaluation, these are most likely the "higher risk" segment of the low risk population and therefore are quite likely to have some outpatient testing done within the next 31 months.
&lt;/p&gt;&lt;p&gt;10 mets good 10 yr prognosis
&lt;/p&gt;&lt;p&gt;85% max hr is adequate est
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Stress_Testing_(CAD)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: ECG Stress Testing"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="ECG_Stress_Testing"&gt;ECG Stress Testing&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Stress_Testing_(CAD)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Protocol"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Protocol"&gt;Protocol&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;need to reach 85- 100% maximum heart rate
&lt;/li&gt;&lt;li&gt;max heart rate is 220- age
&lt;/li&gt;&lt;li&gt;exercise capacity reported in minutes or met eq of ox consumption
&lt;/li&gt;&lt;li&gt;test is adequate if &amp;gt;6 METs reported
&lt;/li&gt;&lt;li&gt;test stopped when target heart rate reached
&lt;/li&gt;&lt;li&gt;test also stopped if BP decrease more than 10mm, sustained v- tach, st elevation &amp;gt;1mm, chest pain, dizziness.
&lt;/li&gt;&lt;li&gt;relative stop indications- st depression &amp;gt;2mm, arr, BP&amp;gt;250/115, claudication, SOB, BBB
&lt;/li&gt;&lt;li&gt;Positive test if horizontal or downsloping st depression &amp;gt;1mm for 60 - 80ms, inappr slow heart rate, decrease in BP, sust V tach, st elevation
&lt;ol&gt;&lt;li&gt;if positive then need angio
&lt;/li&gt;&lt;li&gt;if equivocal- do stress echg or nuclear scan
&lt;/li&gt;&lt;li&gt;no beta blockers, ca channel blockers or nitrates
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Stress_Testing_(CAD)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;6/06 MISTRY
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="stridor"><name>Stridor</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Stridor&amp;amp;action=edit&amp;amp;section=1" title="Edit section: DDX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX"&gt;DDX&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Trauma
&lt;ol&gt;&lt;li&gt;Larynx fracture
&lt;/li&gt;&lt;li&gt;Tracheobronchial tear/injury
&lt;/li&gt;&lt;li&gt;Thyroid gland injury/trauma
&lt;/li&gt;&lt;li&gt;Trachea injury
&lt;/li&gt;&lt;li&gt;Electromagnetic, Physics, trauma, Radiation Causes
&lt;/li&gt;&lt;li&gt;Burn, inhalation
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Iatrogenic, Self Induced Disorders
&lt;ol&gt;&lt;li&gt;Mechanical ventilation status
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Infectious Disorders (Specific Agent)
&lt;ol&gt;&lt;li&gt;Bacterial tracheitis
&lt;/li&gt;&lt;li&gt;Diphtheria
&lt;/li&gt;&lt;li&gt;Tetanus
&lt;/li&gt;&lt;li&gt;Tracheobronchial tuberculosis
&lt;/li&gt;&lt;li&gt;Poliomyelitis, paralytic, bulbar
&lt;/li&gt;&lt;li&gt;Poliomyelitis, acute
&lt;/li&gt;&lt;li&gt;Fungal Laryngitis
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Infected organ, Abscesses
&lt;ol&gt;&lt;li&gt;Abscess, parapharyngeal
&lt;/li&gt;&lt;li&gt;Epiglottitis, acute
&lt;/li&gt;&lt;li&gt;Peritonsillar abscess
&lt;/li&gt;&lt;li&gt;Laryngotracheobronchitis, acute
&lt;/li&gt;&lt;li&gt;Abscess, retropharyngeal
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Neoplastic Disorders
&lt;ol&gt;&lt;li&gt;Neoplasms/tumors
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Allergic, Collagen, Auto-Immune Disorders
&lt;ol&gt;&lt;li&gt;Croup, spasmodic/tracheobronchitis
&lt;/li&gt;&lt;li&gt;Angioedema/Angioneurotic edema
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Metabolic, Storage Disorders
&lt;ol&gt;&lt;li&gt;Cerebral Gaucher's of infants (acute)
&lt;/li&gt;&lt;li&gt;Tracheobronchial amyloidosis
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Biochemical Disorders
&lt;ol&gt;&lt;li&gt;Tetany
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Congenital, Developmental Disorders
&lt;/li&gt;&lt;li&gt;Hereditary, Familial, Genetic Disorders
&lt;ol&gt;&lt;li&gt;Angioedema/Angioneurotic edema, hereditary
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Relational, Mental, Psychiatric Disorders
&lt;ol&gt;&lt;li&gt;Somatization disorder
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Anatomic, Foreign Body, Structural Disorders
&lt;ol&gt;&lt;li&gt;Acute gastric acid/aspiration syndrome
&lt;/li&gt;&lt;li&gt;Airway obstruction
&lt;/li&gt;&lt;li&gt;Neck compartment hemorrhage/hematoma
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Vegetative, Autonomic, Endocrine Disorders
&lt;ol&gt;&lt;li&gt;Esophageal free reflux/GERD syndrome
&lt;/li&gt;&lt;li&gt;Laryngospasm, acute
&lt;/li&gt;&lt;li&gt;Bilateral vocal cord paralysis
&lt;/li&gt;&lt;li&gt;Hypoparathyroidism
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Poisoning (Specific Agent)
&lt;ol&gt;&lt;li&gt;Smoke inhalation
&lt;/li&gt;&lt;li&gt;Chemical burn/esophagus
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Stridor&amp;amp;action=edit&amp;amp;section=2" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Peds: Stridor
&lt;/p&gt;



</content><folder>Airway/Resus</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="stridor_(peds)"><name>Stridor (Peds)</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Stridor_(Peds)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: DDX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX"&gt;DDX&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Supraglotic Expiratory Gurgling
&lt;/p&gt;&lt;p&gt;Glottic Biphasic (larynx-vocal cords)
&lt;/p&gt;&lt;p&gt;Subglottic Inspiratory High-pitched
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;I. Supraglottic
&lt;/p&gt;
&lt;pre&gt;    A. Congenital
&lt;/pre&gt;
&lt;pre&gt;         1. Pierre Robin sy
&lt;/pre&gt;
&lt;pre&gt;         2. Treacher Collins sy
&lt;/pre&gt;
&lt;pre&gt;         3. Macroglossia
&lt;/pre&gt;
&lt;pre&gt;         4. Down sy
&lt;/pre&gt;
&lt;pre&gt;         5. Storage dz
&lt;/pre&gt;
&lt;pre&gt;         6. Choanal atresia
&lt;/pre&gt;
&lt;pre&gt;         7. Lingual thyroid
&lt;/pre&gt;
&lt;pre&gt;         8. Thyroglossal cyst
&lt;/pre&gt;
&lt;pre&gt;         9. Adenopathy
&lt;/pre&gt;
&lt;pre&gt;    B. Acquired
&lt;/pre&gt;
&lt;pre&gt;         1. Tonsillar hypertorphy - uncommon at birth; associated with snoring or sleep related
&lt;/pre&gt;
&lt;pre&gt;         2. Foreign body
&lt;/pre&gt;
&lt;pre&gt;         3. Pharyngeal abcess - older age, muffled voice, fever, etc.
&lt;/pre&gt;
&lt;pre&gt;         4. Epiglottitis
&lt;/pre&gt;
&lt;p&gt;II. Glottic
&lt;/p&gt;
&lt;pre&gt;    A. Congenital
&lt;/pre&gt;
&lt;pre&gt;         1. Laryngomalacia
&lt;/pre&gt;
&lt;pre&gt;         2. Vocal cord paralysis - weak cry
&lt;/pre&gt;
&lt;pre&gt;         3. Laryngeal web
&lt;/pre&gt;
&lt;pre&gt;         4. Laryngocele
&lt;/pre&gt;
&lt;pre&gt;    B. Aquired
&lt;/pre&gt;
&lt;pre&gt;         1. Papillomas
&lt;/pre&gt;
&lt;pre&gt;         2. Foreign body
&lt;/pre&gt;
&lt;p&gt;III. Subglotic
&lt;/p&gt;
&lt;pre&gt;    A. Congenital
&lt;/pre&gt;
&lt;pre&gt;         1. Tracheomalacia
&lt;/pre&gt;
&lt;pre&gt;         2. Trachal stenosis
&lt;/pre&gt;
&lt;pre&gt;         3. Vascular ring
&lt;/pre&gt;
&lt;pre&gt;         4. Hemangioma cyst
&lt;/pre&gt;
&lt;pre&gt;    B. Aquired
&lt;/pre&gt;
&lt;pre&gt;         1. Croup
&lt;/pre&gt;
&lt;pre&gt;         2. Bacterial tracheitis
&lt;/pre&gt;
&lt;pre&gt;         3. Subglottic stenosis - previous endotracheal intubation; worsens with infections; often requires surgical repair
&lt;/pre&gt;
&lt;pre&gt;         4. Foreign body - sudden onset; asymmetric PE or CXR
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Stridor_(Peds)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;5/2/06 DONALDSON (adapted from Rosen)
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="stye_(hordeolum)"><name>Stye (Hordeolum)</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Stye_(Hordeolum)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Staphylococcus aureus is the infectious agent in 90-95% of cases of hordeolum.
&lt;/p&gt;&lt;p&gt;An external hordeolum arises from a blockage and infection of Zeiss or Moll sebaceous glands. An internal hordeolum is a secondary infection of meibomian glands in the tarsal plate. Both types can arise as a secondary complication of blepharitis.
&lt;/p&gt;&lt;p&gt;Untreated, the disease may spontaneously resolve or it may progress to chronic granulation with formation of a painless mass known as a chalazion. Chalazia can be quite large and can cause visual disturbance by deforming the cornea. Generalized cellulitis of the eyelid may occur if an internal hordeolum is untreated.
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Stye_(Hordeolum)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Risk Factors"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Risk_Factors"&gt;Risk Factors&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Hordeola are found more frequently in persons who have the following:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt; Diabetes
&lt;/li&gt;&lt;li&gt; Other debilitating illness
&lt;/li&gt;&lt;li&gt; Chronic blepharitis
&lt;/li&gt;&lt;li&gt; Seborrhea
&lt;/li&gt;&lt;li&gt; High serum lipids (High lipid levels increase the blockage rate of sebaceous glands, but lowering of serum lipid levels in these patients has not decreased frequency of recurrence.)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Stye_(Hordeolum)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from Pani
&lt;/p&gt;



</content><folder>Ophtho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="subarachnoid_hemorrhage_(sah)"><name>Subarachnoid Hemorrhage (SAH)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#Epidemiology"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;Epidemiology&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Risk_Factors"&gt;&lt;span class="tocnumber"&gt;1.2&lt;/span&gt; &lt;span class="toctext"&gt;Risk Factors&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Clinical_Manifestations"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Clinical Manifestations&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Complications"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Complications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Grading_.28Hunt_and_Hess.29"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Grading (Hunt and Hess)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-10"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Subarachnoid_Hemorrhage_(SAH)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Subarachnoid_Hemorrhage_(SAH)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Epidemiology"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Epidemiology"&gt;Epidemiology&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Of All pts in ED with c/o HA:
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; 1% will have SAH
&lt;/li&gt;&lt;li&gt; 12% will have SAH if c/o worst HA of life
&lt;/li&gt;&lt;li&gt; 25% will have SAH if c/o worst HA of life + any neuro deficit
&lt;/li&gt;&lt;/ul&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Subarachnoid_Hemorrhage_(SAH)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Risk Factors"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Risk_Factors"&gt;Risk Factors&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;(in order of relative risk)
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt; Genetics (polycystic kidney disease, Ehler-Danlos, family hx) 
&lt;/li&gt;&lt;li&gt; Hypertension
&lt;/li&gt;&lt;li&gt; Atherosclerosis
&lt;/li&gt;&lt;li&gt; Cigarette smoking 
&lt;/li&gt;&lt;li&gt; Alcohol
&lt;/li&gt;&lt;li&gt; Age &amp;gt; 85
&lt;/li&gt;&lt;li&gt; Cocaine use
&lt;/li&gt;&lt;li&gt; Estrogen deficiency 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Subarachnoid_Hemorrhage_(SAH)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Clinical Manifestations"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Clinical_Manifestations"&gt;Clinical Manifestations&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Sudden, severe headache (97% of cases) 
&lt;ol&gt;&lt;li&gt; Sudden onset is more important finding than worst HA
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; May be associated with syncope, seizure, nausea/vomiting, and meningismus 
&lt;ol&gt;&lt;li&gt; Meningismus may not develop until several hours after bleed (caused by blood breakdown &amp;gt; aseptic meningitis)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Retinal hemorrhages
&lt;ol&gt;&lt;li&gt;  May be the only clue in comatose patients 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Approximately 30-50% will have sentinel bleed/HA 6-20 days before SAH 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Subarachnoid_Hemorrhage_(SAH)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Non-Contrast Head CT 
&lt;ol&gt;&lt;li&gt; 92% specific if performed w/in 24 hours of bleed
&lt;/li&gt;&lt;li&gt; ~100% sensitive if performed w/in 12 hours of bleed
&lt;/li&gt;&lt;li&gt; 91% sensitive in patients w/ normal neuro exam 
&lt;ol&gt;&lt;li&gt; Decreases to ~50% sensitive by day 5
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Not as sensitive/specific for minor bleeds
&lt;/li&gt;&lt;li&gt; SAH 2/2 aneurysm (90%) - look in cisterns (especially suprasellar cistern)
&lt;/li&gt;&lt;li&gt; SAH 2/2 trauma - Look at convexities of frontal &amp;amp; temporal cortices
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Lumbar Puncture 
&lt;ol&gt;&lt;li&gt; Mandatory if there is a strong suspicion of SAH despite a normal head CT
&lt;/li&gt;&lt;li&gt; Findings:
&lt;ol&gt;&lt;li&gt; Elevated RBC count that doesn't decrease from tube one to four 
&lt;ol&gt;&lt;li&gt; (Decreasing RBCs in later tubes can occur in SAH; only reliable if RBC count in final tube is nl) 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Opening pressure &amp;gt; 20 in 60% of patients with SAH
&lt;ol&gt;&lt;li&gt; Can help differentiate from a traumatic tap (opening pressure expected to be normal)
&lt;/li&gt;&lt;li&gt; Elevated opening pressure also seen in cerebral venous thrombosis, IIH 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Xanthrochromia
&lt;ol&gt;&lt;li&gt; May help differentiate between SAH and a traumatic tap
&lt;/li&gt;&lt;li&gt; Takes at least 2 hours after the bleed to develop (beware of false negatives)
&lt;/li&gt;&lt;li&gt; Sensitivity (93%) / specificity (95%) highest after 12 hours
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; If unable to obtain CSF consider CTA
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Subarachnoid_Hemorrhage_(SAH)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment &lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Nimodipine
&lt;ol&gt;&lt;li&gt; Associated with improved neuro outcomes and decreased cerebral infarction
&lt;/li&gt;&lt;li&gt; Must be given 60mg q4hr PO or NGT only! (never IV)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; BP control
&lt;ol&gt;&lt;li&gt; No consensus on HTN (incr BP may maintain CPP but may also increase rate of bleeding)
&lt;ol&gt;&lt;li&gt; If pt is alert this means CPP is adequate so can try lowering sbp to &amp;lt; 140
&lt;/li&gt;&lt;li&gt; If pt is ALOC consider leaving BP alone, as the ALOC may be 2/2 reduced CPP
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; If BP control is necessary, LABETALOL, ESMOLOL or NICARDIPINE is preferred
&lt;ol&gt;&lt;li&gt; Avoid vasodilators such as nitroprusside or NTG (increase cerebral blood volume --&amp;gt; increased ICP)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Discontinue/reverse all anticoagulation! 
&lt;/li&gt;&lt;li&gt; Seizure prophylaxis
&lt;ol&gt;&lt;li&gt; Controversial; some evidence suggests anti-epileptic drugs may worsen outcomes; 3 day course may be preferable
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Glucocorticoid therapy
&lt;ol&gt;&lt;li&gt; Controversial; available evidence suggests is neither beneficial nor harmful
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Glycemic control
&lt;ol&gt;&lt;li&gt; Controversial; consider sliding scale if long pt stay in ED while awaiting ICU bed
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Avoid hypovolemia 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Subarachnoid_Hemorrhage_(SAH)&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Complications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Complications"&gt;Complications&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Rebleeding
&lt;ol&gt;&lt;li&gt; Risk is highest within first 24 hours (2.5-4%), particularly within first 6 hours
&lt;/li&gt;&lt;li&gt; Usually diagnosed by CT after acute deterioration in neuro status
&lt;/li&gt;&lt;li&gt; Only aneurysm treatment is effective in preventing rebleeding 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Vasospasm
&lt;ol&gt;&lt;li&gt; Leading cause of death and disability after rupture
&lt;/li&gt;&lt;li&gt; Typically begins no earlier than day three after hemorrhage
&lt;/li&gt;&lt;li&gt; Characterized by decline in neuro status
&lt;/li&gt;&lt;li&gt; Aggressive treatment can only be initiated after the aneurysm has been treated (sx or intraluminal tx)
&lt;ol&gt;&lt;li&gt; Triple-H therapy (hemodilution + induced hypertension (pressors) + hypervolemia)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Cardiac abnormalities (?2/2 release of catecholamines due to hypoperfusion of hypothalamus)
&lt;ol&gt;&lt;li&gt; Ischemia
&lt;ol&gt;&lt;li&gt; Elevated troponin (20-40% of cases)
&lt;/li&gt;&lt;li&gt; ST segment depression 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Rhythm disturbances
&lt;ol&gt;&lt;li&gt; Torsades, a fib, a flutter 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; QT prolongation
&lt;/li&gt;&lt;li&gt; Deep, symmetric TWI
&lt;/li&gt;&lt;li&gt; Prominent U waves
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Hydrocephalus
&lt;ol&gt;&lt;li&gt; Consider ventricular drain placement for deteriorating LOC + no improvement within 24 hours 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Hyponatremia
&lt;ol&gt;&lt;li&gt; Usually due to SIADH
&lt;ol&gt;&lt;li&gt; Treat via isotonic, or if necessary, hypertonic saline (do not treat via water restriction!) 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Subarachnoid_Hemorrhage_(SAH)&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Grading (Hunt and Hess)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Grading_.28Hunt_and_Hess.29"&gt;Grading (Hunt and Hess)&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Grade 0:  Unruptured aneurysm
&lt;/p&gt;&lt;p&gt;Grade 1:  Asymptomatic or mild HA and slight nuchal rigidity
&lt;/p&gt;&lt;p&gt;Grade 1a:  No acute meningeal/brain reaction, with fixed neurological def
&lt;/p&gt;&lt;p&gt;Grade 2:  Moderate to severe headache, stiff neck, no neurologic deficit except cranial nerve palsy
&lt;/p&gt;&lt;p&gt;Grade 3: Mild mental status change (drowsy or confused), mild focal neurologic deficit
&lt;/p&gt;&lt;p&gt;Grade 4: Stupor or moderate to severe hemiparesis
&lt;/p&gt;&lt;p&gt;Grade 5:  Coma or decerebrate rigidity
&lt;/p&gt;&lt;p&gt;^Grade 1 or 2 have curable dz, if dx missed pts return w/ higher grade (ie 3 or 4), 2/3 will be dead or vegetative at 6 mos if grade 3 or 4!
&lt;/p&gt;&lt;p&gt;^Add one grade for serious sytemic dz (HTN, DM, severe stherosclerosis, COPD)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Subarachnoid_Hemorrhage_(SAH)&amp;amp;action=edit&amp;amp;section=9" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Neuro: Intracranial Hemorrhage
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Subarachnoid_Hemorrhage_(SAH)&amp;amp;action=edit&amp;amp;section=10" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;7/09 PANI (Adapted from Lampe, Birnbaumer), UpToDate, EB Emergency Medicine, July 2009
&lt;/p&gt;



</content><folder>Neuro</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="subungual_hematoma"><name>Subungual Hematoma</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Subungual_Hematoma&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;A subungual hematoma is a painful condition that results from a collection of blood under the fingernail
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Subungual_Hematoma&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Clinical ==Work-Up==
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
None (may consider x-rays if possibility of underlying phalange fracture) ==DDx==
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
Insert ==Treatment==
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
Simple nail trephination(Nail removal reserved for those with associated with disruption of the nail or surrounding nail folds) ==Disposition==
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
Home
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Subungual_Hematoma&amp;amp;action=edit&amp;amp;section=3" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Subungual_Hematoma&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from KajiQuestions
&lt;/p&gt;&lt;p&gt;Singer AJ. Current Management of Acute Cutaneous Wounds. N Engl J Med 2008; 359:1037-1046
&lt;/p&gt;



</content><folder>Ortho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="succinylcholine"><name>Succinylcholine</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Succinylcholine&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Contraindications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Contraindications"&gt; Contraindications &lt;/span&gt;&lt;/h2&gt;
&lt;table style="width: 500px" border="1" cellpadding="1" cellspacing="1"&gt;

&lt;tr&gt;
&lt;td&gt; &lt;b&gt;Contraindication&lt;br /&gt;&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;From-To&lt;/b&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Known hyperK
&lt;/td&gt;&lt;td&gt; current
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Massive burns &amp;gt;10% BSA
&lt;/td&gt;&lt;td&gt; &amp;gt;4dys-healed
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Massive crush injuries
&lt;/td&gt;&lt;td&gt; &amp;gt;4dys-healed
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Denervation^
&lt;/td&gt;&lt;td&gt; &amp;gt;4dys-6mo
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Neuromuscular dz^^
&lt;/td&gt;&lt;td&gt; indefinite
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Intra-abdominal sepsis
&lt;/td&gt;&lt;td&gt; &amp;gt;5dys-resolution
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Increased ICP
&lt;/td&gt;&lt;td&gt; may use w/ defacic dose
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;p&gt;^CVA (in particular those with residual deficits), spinal cord injury
&lt;/p&gt;&lt;p&gt;^^ALS, MS, skeletal muscle myopathies, cholinesterase def, h/o malignant hyperthermia
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;No evidence to support contraindication in penetrating eye injuries
&lt;/li&gt;&lt;li&gt;N.B. Myasthenia Gravis- theoretically need more succ to induce vs nondepolarizing agents which have a prolonged effect.
&lt;/li&gt;&lt;li&gt;This is 2/2 to lack of post-synaptic receptors, i.e. succ cannot potentiate a reaction 2/2 too few receptors.
&lt;/li&gt;&lt;li&gt;Vs. it takes few "molecules" of roc/vec to block the few remaining functioning receptors.
&lt;/li&gt;&lt;li&gt;Overall, most practitioners tend to avoid succ in all patients with possible neuromuscular disease.
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Succinylcholine&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt; Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;2/06 DONALDSON (Adapted from Rosen)
&lt;/p&gt;&lt;p&gt;Levitan, R. Annals of EM. Vol 45, Issue 2. Safety of succinylcholine in myasthenia gravis.&lt;br /&gt; &lt;br /&gt;
&lt;/p&gt;



</content><folder>Airway/Resus</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="suggest_a_new_note"><name>Suggest a New Note</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Suggest_a_New_Note&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Enter Suggestions Below or Make the Page Yourself!"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Enter_Suggestions_Below_or_Make_the_Page_Yourself.21"&gt; Enter Suggestions Below or Make the Page Yourself! &lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Hypothyroidism
&lt;/li&gt;&lt;li&gt;Thyroid Coma
&lt;/li&gt;&lt;li&gt;Methotrexate level
&lt;/li&gt;&lt;li&gt;us pelvic
&lt;/li&gt;&lt;/ul&gt;




</content><folder>WikEM</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="suggest_a_software_improvement"><name>Suggest a Software Improvement</name><content>&lt;p&gt;Q: Any possibility of downloading to an android smartphone?
&lt;/p&gt;&lt;p&gt;A: See new link under "WikEM on Smart Phone"
&lt;/p&gt;



</content><folder>WikEM</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="sulfonylurea_toxicity"><name>Sulfonylurea Toxicity</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sulfonylurea_Toxicity&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- d50
&lt;/p&gt;&lt;p&gt;- glucagon- relies on pts own glycogen stores
&lt;/p&gt;&lt;p&gt;octreotide- 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sulfonylurea_Toxicity&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;9/09  PANI (Adapted from Donaldson, Mistry, Pharmacopia)
&lt;/p&gt;



</content><folder>Tox</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="sulfonyulreal_(od)"><name>Sulfonyulreal (OD)</name><content>&lt;ol&gt;&lt;li&gt;REDIRECT &lt;a href="/wiki/Sulfonylurea_Toxicity" title="Sulfonylurea Toxicity"&gt;Sulfonylurea Toxicity&lt;/a&gt;
&lt;/li&gt;&lt;/ol&gt;




</content><folder></folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="superior_vena_cava_syndrome"><name>Superior Vena Cava Syndrome</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Pathophysiology"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Pathophysiology&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Clinical_features"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Clinical features&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Management"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Management&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4.1&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Superior_Vena_Cava_Syndrome&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Pathophysiology"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Pathophysiology"&gt;Pathophysiology&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Occurs in 3-8%  with lung cancer and lymphoma
&lt;/li&gt;&lt;li&gt;Symptoms due to venous hypertension in areas drained by SVC
&lt;/li&gt;&lt;li&gt;Deaths occurs from cerebral edema, airway compromise, or cardiac compromise
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Superior_Vena_Cava_Syndrome&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Clinical features"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Clinical_features"&gt;Clinical features&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Thoracic or neck vein distention - 65%
&lt;/li&gt;&lt;li&gt;Shortness of breath - 50%
&lt;/li&gt;&lt;li&gt;Tachypnea - 40%
&lt;/li&gt;&lt;li&gt;Upper trunk or extremity edema - 40%
&lt;/li&gt;&lt;li&gt;Cough/dysphagia/chest pain - 20%
&lt;/li&gt;&lt;li&gt;Peri-orbital or facial edema -&amp;nbsp;?
&lt;/li&gt;&lt;li&gt;Stroke's sign (tight shirt collar) -&amp;nbsp;?
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Superior_Vena_Cava_Syndrome&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;CXR shows mediastinal mass or paranchymal lung mass in 10%
&lt;/li&gt;&lt;li&gt;CT is diagnostic
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Superior_Vena_Cava_Syndrome&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Management"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Management"&gt;Management&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Furosemide 40mg IV
&lt;/li&gt;&lt;li&gt;Methylprednisolone 1-2 mg/kg IV
&lt;/li&gt;&lt;li&gt;Mediastinal radiation
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Superior_Vena_Cava_Syndrome&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Sotelo 10/09
&lt;/p&gt;



</content><folder>Heme/Onc</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="supraclavicular_line"><name>Supraclavicular Line</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Supraclavicular_Line&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Supraclavicular"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Supraclavicular"&gt;Supraclavicular&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- 1cm lat to scm head
&lt;/p&gt;&lt;p&gt;- 1cm post to clavicular head
&lt;/p&gt;&lt;p&gt;- bisect angle btwn scm &amp;amp; clavicle
&lt;/p&gt;&lt;p&gt;- 10' angle inf to horizontal plane
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Supraclavicular_Line&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;6/06 MISTRY
&lt;/p&gt;



</content><folder>Procedures</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="supracondylar_fracture"><name>Supracondylar Fracture</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Mechanism_of_Injury"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Mechanism of Injury&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Physical_Findings"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Physical Findings&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Gartland_Classification"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Gartland Classification&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Complications"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Complications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Supracondylar_Fracture&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Mechanism of Injury"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Mechanism_of_Injury"&gt;Mechanism of Injury&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Extension-type fractures
&lt;/li&gt;&lt;li&gt; 95% of suprcondylar fractures
&lt;/li&gt;&lt;li&gt; Due to FOOSH
&lt;/li&gt;&lt;li&gt; Flexion-type fractures
&lt;/li&gt;&lt;li&gt; 5% of supracondylar fractures
&lt;/li&gt;&lt;li&gt; Due to direct trauma to posterior aspect of flexed elbow  
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Supracondylar_Fracture&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Physical Findings"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Physical_Findings"&gt;Physical Findings&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Do not encourage active/passive elbow movement until displaced fx has been ruled-out! 
&lt;/li&gt;&lt;li&gt; Pain, swelling, very limited to no range of motion at the elbow
&lt;/li&gt;&lt;li&gt; Nondisplaced fx may have limited swelling, but child will refuse to move arm
&lt;/li&gt;&lt;li&gt; Posterior distal humerus TTP usually found in these patients
&lt;/li&gt;&lt;li&gt; If evidence of S-shape configuration or skin dimpling, spint before xray 
&lt;/li&gt;&lt;li&gt; Forearm/wrist injuries
&lt;/li&gt;&lt;li&gt; Occur frequently enough with supracondylar fx that imaging should be performed
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Supracondylar_Fracture&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Gartland Classification"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Gartland_Classification"&gt;Gartland Classification&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Type I: Nondisplaced with evidence of elbow effusion (ant. sail and/or post. fat pad)
&lt;/p&gt;&lt;p&gt;Type II: Displaced w/ intact posterior periosteum (ant. humeral line is displaced anteriorly rel. to capitellum)
&lt;/p&gt;&lt;p&gt;Type III: Displaced w/ disruption of anterior and posterior periosteum
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; No continuity between the proximal and distal fracture fragments
&lt;/li&gt;&lt;li&gt; Direction of displacement is important in predicting neurovascular injury 
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Supracondylar_Fracture&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Type I
&lt;/li&gt;&lt;li&gt; Immobilize using a posterior splint and sling (extend from wrist to axilla)
&lt;/li&gt;&lt;li&gt; Refer to ortho within 1 week 
&lt;/li&gt;&lt;li&gt; Type II &amp;amp; III 
&lt;/li&gt;&lt;li&gt; Orthopedic consultation regarding closed versus open reduction w/ percutaneous pinning
&lt;/li&gt;&lt;li&gt; Admit
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Supracondylar_Fracture&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Complications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Complications"&gt;Complications&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- Vascular
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; Absenst radial pulse in 10-20% of cases
&lt;/li&gt;&lt;li&gt; Need to rule-out compartment syndrome 
&lt;/li&gt;&lt;li&gt; Occurs more commonly when forearm is also fractured 
&lt;/li&gt;&lt;li&gt; Ecchymosis over anteromedial aspect of forearm suggests brachial artery injury
&lt;/li&gt;&lt;li&gt; Rare with type I fx 
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;- Neurologic
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; Median nerve injury
&lt;/li&gt;&lt;li&gt; Weakness of hand flexors
&lt;/li&gt;&lt;li&gt; Loss of two-point sensation on palmar surface of thumb, IF, MF
&lt;/li&gt;&lt;li&gt; Anterior interosseous nerve is branch of median nerve most often affected
&lt;/li&gt;&lt;li&gt; Forearm pain + difficulty making "ok" sign 
&lt;/li&gt;&lt;li&gt; Radial nerve injury
&lt;/li&gt;&lt;li&gt; Weakness of wrist extension, hand supination, and thumb extension (thumbs up) 
&lt;/li&gt;&lt;li&gt; Altered sensation in dorsal web space between thumb and index finger 
&lt;/li&gt;&lt;li&gt; Ulnar nerve injury
&lt;/li&gt;&lt;li&gt; May occur with flexion type fractures
&lt;/li&gt;&lt;li&gt; Weakness of wrist flexion and adduction, finger spread, flexion of pinky DIP
&lt;/li&gt;&lt;li&gt; Altered sensation of ulnar side of ring/pinky  
&lt;/li&gt;&lt;li&gt; Majority of nerve injuries are neurpraxias without long-term sequelae 
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Supracondylar_Fracture&amp;amp;action=edit&amp;amp;section=6" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Ortho: Elbow (Fracture)
&lt;/p&gt;&lt;p&gt;Ortho: Elbow (Minor)
&lt;/p&gt;&lt;p&gt;Peds: Elbow Fracture (Peds)
&lt;/p&gt;&lt;p&gt;Rads: Elbow Xray Peds
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Source: UpToDate
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="sutures"><name>Sutures</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Chart"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Chart&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Technique"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Technique&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sutures&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Chart"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Chart"&gt;Chart&lt;/span&gt;&lt;/h2&gt;
&lt;table border="1"&gt;

&lt;tr&gt;
&lt;td&gt; &lt;b&gt;Area&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Size&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Removal&lt;/b&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; scalp
&lt;/td&gt;&lt;td&gt; 4o,5o
&lt;/td&gt;&lt;td&gt; 5-8 days
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; face
&lt;/td&gt;&lt;td&gt; 5o,6o
&lt;/td&gt;&lt;td&gt; 3-5 days
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; chest/abd
&lt;/td&gt;&lt;td&gt; 3o,4o
&lt;/td&gt;&lt;td&gt; 7-10 days
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; back
&lt;/td&gt;&lt;td&gt; 3o,4o
&lt;/td&gt;&lt;td&gt; 12-14 days
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; upper extrem
&lt;/td&gt;&lt;td&gt; 4o,5o
&lt;/td&gt;&lt;td&gt; 8-10 days
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; lower extrem
&lt;/td&gt;&lt;td&gt; 3o,4o
&lt;/td&gt;&lt;td&gt; 8-12 days
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; foot
&lt;/td&gt;&lt;td&gt; 3o,4o
&lt;/td&gt;&lt;td&gt; 10-12 days
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; joint/extensor surface
&lt;/td&gt;&lt;td&gt; 3o,4o
&lt;/td&gt;&lt;td&gt; 10-14 days
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; joint/felxor surface
&lt;/td&gt;&lt;td&gt; 4o,5o
&lt;/td&gt;&lt;td&gt; 8-10 days
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;p&gt;+2-3 days for elderly
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sutures&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Technique"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Technique"&gt;Technique&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Horizontal: excess tention, mult parallel lacs
&lt;/p&gt;&lt;p&gt;Vertical: contraindication to deeps
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sutures&amp;amp;action=edit&amp;amp;section=3" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt; See Also &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Trauma:Wound Management
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Sutures&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt; Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Lampe
&lt;/p&gt;



</content><folder>Trauma</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="syncope"><name>Syncope</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Pearls"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Pearls&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Differential_Diagnosis"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Differential Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#San_Francisco_Syncope_Rule_.28Annals_5.2F06.29"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;San Francisco Syncope Rule (Annals 5/06)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Syncope_Rule:_Pts_.3E_60yo_.28Annals_12.2F09.29"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Syncope Rule: Pts &amp;gt; 60yo (Annals 12/09)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#F.2FU"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;F/U&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-8"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;7.1&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Syncope&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Pearls"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Pearls"&gt;Pearls&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;3 questions
&lt;ol&gt;&lt;li&gt;Is this true syncope or something else (eg, stroke, seizure, head injury)?
&lt;/li&gt;&lt;li&gt;If this is true syncope, is there a clear life-threatening cause?
&lt;/li&gt;&lt;li&gt;If this is true syncope and the cause is not clear, is the pt at high risk? 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Syncope&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;ECG 
&lt;/li&gt;&lt;li&gt;Urine pregnancy
&lt;/li&gt;&lt;li&gt;Consider:
&lt;ol&gt;&lt;li&gt;Hemoglobin
&lt;/li&gt;&lt;li&gt;Chemistry
&lt;/li&gt;&lt;li&gt;Orthostatics
&lt;/li&gt;&lt;li&gt;CXR (dissection)
&lt;/li&gt;&lt;li&gt;Troponin
&lt;/li&gt;&lt;li&gt;Guaiac 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Syncope&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Differential Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Differential_Diagnosis"&gt;Differential Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Cardiac syncope
&lt;/li&gt;&lt;li&gt;Blood loss
&lt;/li&gt;&lt;li&gt;Pulmonary embolism
&lt;/li&gt;&lt;li&gt;Subarachnoid hemorrhage
&lt;/li&gt;&lt;li&gt;Syncope (DDx)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Syncope&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition &lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Admit (ACEP Clinical Policy 2007)* Abnormal ECG
&lt;ol&gt;&lt;li&gt;Ischemia, dysrhythmias, conduction abnormalities 
&lt;/li&gt;&lt;li&gt;History, or presence of heart failure, CAD, or structural heart disease
&lt;/li&gt;&lt;li&gt;Older age and associated comorbidities
&lt;/li&gt;&lt;li&gt;Hematocrit &amp;lt;30 (if obtained)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Consider Admitting (Hockberger 2003)
&lt;ol&gt;&lt;li&gt;Age&amp;gt;60
&lt;/li&gt;&lt;li&gt;H/O cardiovasc dz
&lt;/li&gt;&lt;li&gt;Frequent syncope
&lt;/li&gt;&lt;li&gt;Meds that cause vent arrythmia
&lt;/li&gt;&lt;li&gt;FHx of sudden death or arrythmia
&lt;/li&gt;&lt;li&gt;Injuries d/t fall
&lt;/li&gt;&lt;li&gt;Mod-severe orthostatics
&lt;/li&gt;&lt;li&gt;Social situation
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;ul&gt;&lt;li&gt;Orthostatics = lie flat, wait 5 minutes, measure, then stand 3 minute and measure, HR rise by 20, or SBP drop by 20 with Sx should be worked up
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;-unless sig neuro signs and sx before and/or after TIA unlikely (need b/l cortex, or brainstem tia for LOC)
&lt;/p&gt;&lt;p&gt;-elderly and sy think MI, 50% in this group are silent
&lt;/p&gt;&lt;p&gt;-even if pacer looks nl could be loose
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Syncope&amp;amp;action=edit&amp;amp;section=5" title="Edit section: San Francisco Syncope Rule (Annals 5/06)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="San_Francisco_Syncope_Rule_.28Annals_5.2F06.29"&gt;San Francisco Syncope Rule (Annals 5/06)&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;SBP &amp;lt;90 ever
&lt;/li&gt;&lt;li&gt;C/O SOB
&lt;/li&gt;&lt;li&gt;H/O CHF
&lt;/li&gt;&lt;li&gt;Non-sinus EKG
&lt;/li&gt;&lt;li&gt;New change on EKG
&lt;/li&gt;&lt;li&gt;HCT &amp;lt; 30
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;7d serious outcome
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Syncope&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Syncope Rule: Pts &amp;amp;gt; 60yo (Annals 12/09)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Syncope_Rule:_Pts_.3E_60yo_.28Annals_12.2F09.29"&gt;Syncope Rule: Pts &amp;gt; 60yo (Annals 12/09)&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Age &amp;gt; 90 
&lt;/li&gt;&lt;li&gt;Male
&lt;/li&gt;&lt;li&gt;Hx of arrhythmia
&lt;/li&gt;&lt;li&gt;Triage Sys BP &amp;gt;160
&lt;/li&gt;&lt;li&gt;Abnl EKG
&lt;/li&gt;&lt;li&gt;Abnl TnI
&lt;/li&gt;&lt;li&gt;Near-Syncope
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;Add 1 point for each, subtract 1 for near-syncope
&lt;/p&gt;&lt;p&gt;Statification (30 day serious event rate):
&lt;/p&gt;&lt;p&gt;Low Risk: -1, 0 (2.5%)
&lt;/p&gt;&lt;p&gt;Medium: 1, 2 (6.3%)
&lt;/p&gt;&lt;p&gt;High: &amp;gt;3 (20%)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Syncope&amp;amp;action=edit&amp;amp;section=7" title="Edit section: F/U"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="F.2FU"&gt;F/U&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Holter (heart disease suspected) vs tilt-test (heart disease not suspected)
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Syncope&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;UpToDate, ACEP Clinical Policy
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="syncope_(ddx)"><name>Syncope (DDx)</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Syncope_(DDx)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Life Threatening Causes"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Life_Threatening_Causes"&gt;Life Threatening Causes&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Cardiovascular syncope
&lt;/li&gt;&lt;li&gt;Dysrhythmia
&lt;/li&gt;&lt;li&gt;V-tach
&lt;/li&gt;&lt;li&gt;Long QT
&lt;/li&gt;&lt;li&gt;Brugada
&lt;/li&gt;&lt;li&gt;Bradycardia (heart block)
&lt;/li&gt;&lt;li&gt;Sinus pause 
&lt;/li&gt;&lt;li&gt;Ischemia
&lt;/li&gt;&lt;li&gt;ACS
&lt;/li&gt;&lt;li&gt;Structural Abnormalities
&lt;/li&gt;&lt;li&gt;Valvular disease (AS, MS) 
&lt;/li&gt;&lt;li&gt;Cardiomyopathy 
&lt;/li&gt;&lt;li&gt;Tamponade
&lt;/li&gt;&lt;li&gt;Aortic dissection 
&lt;/li&gt;&lt;li&gt;Hemorrhage
&lt;/li&gt;&lt;li&gt;Trauma with significant blood loss
&lt;/li&gt;&lt;li&gt;GI bleed
&lt;/li&gt;&lt;li&gt;Tissue rupture (ectopic, spleen, aortic aneurysm)
&lt;/li&gt;&lt;li&gt;Pulmonary Embolism
&lt;/li&gt;&lt;li&gt;Subarachnoid hemorrhage 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Syncope_(DDx)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Common Causes"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Common_Causes"&gt;Common Causes&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Neurocardiogenic syncope (vasovagal)
&lt;/li&gt;&lt;li&gt;Micturion, defecation, cough, swallowing, situational
&lt;/li&gt;&lt;li&gt;Carotid sinus hypersensitivity
&lt;/li&gt;&lt;li&gt;Orthostatic hypotension
&lt;/li&gt;&lt;li&gt;Medication-related
&lt;/li&gt;&lt;li&gt;Vasoactive Medications
&lt;/li&gt;&lt;li&gt;Alpha/beta blockers, CCB, nitrates, antihypertensives, diuretics, ED meds
&lt;/li&gt;&lt;li&gt;Medications affecting conduction
&lt;/li&gt;&lt;li&gt;Antiarrhythmics, CCB, BB, digoxin
&lt;/li&gt;&lt;li&gt;Medications affecting QT interval
&lt;/li&gt;&lt;li&gt;Antiarrhythmics, antiemetics, antipsychotics/depressants
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Syncope_(DDx)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;UpToDate
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="tnk_criteria_(redirect)"><name>TNK Criteria (Redirect)</name><content>&lt;p&gt;See Cards: STEMI
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="ttp"><name>TTP</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=TTP&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;THROMBOTIC THROMBOCYTOPENIC PURPURA
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=TTP&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Pentad"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Pentad"&gt;Pentad&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; CNS changes
&lt;/li&gt;&lt;li&gt; Renal changes
&lt;/li&gt;&lt;li&gt; Microangiopathic hemolytic anemia
&lt;/li&gt;&lt;li&gt; Thrombocytopenia
&lt;/li&gt;&lt;li&gt; Fever
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=TTP&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;8/07 DONALDSON
&lt;/p&gt;



</content><folder>Heme/Onc</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="tachycardia_(narrow)"><name>Tachycardia (Narrow)</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tachycardia_(Narrow)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;table border="1"&gt;

&lt;tr&gt;
&lt;td&gt; &lt;b&gt;Differential&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;A.Rhythm&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;A.rate&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;A.morphology&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Vagal/adenosine&lt;/b&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; A Fib
&lt;/td&gt;&lt;td&gt; Irregular
&lt;/td&gt;&lt;td&gt; &amp;gt;350
&lt;/td&gt;&lt;td&gt; Fibrillatory (V1)
&lt;/td&gt;&lt;td&gt; Incr. AV block
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; A Flutter
&lt;/td&gt;&lt;td&gt; Regular
&lt;/td&gt;&lt;td&gt; &amp;gt;250, &amp;lt;350
&lt;/td&gt;&lt;td&gt; Sawtooth (II, III, AVF)
&lt;/td&gt;&lt;td&gt; Incr. AV block
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; A Tach
&lt;/td&gt;&lt;td&gt; Regular
&lt;/td&gt;&lt;td&gt; &amp;gt;100
&lt;/td&gt;&lt;td&gt; Neg in II, III, AVF
&lt;/td&gt;&lt;td&gt; Nothing
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; AVNRT
&lt;/td&gt;&lt;td&gt; Regular
&lt;/td&gt;&lt;td&gt; &amp;gt;160
&lt;/td&gt;&lt;td&gt; No p's
&lt;/td&gt;&lt;td&gt; --&amp;gt; NSR
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Junctional
&lt;/td&gt;&lt;td&gt; Regular
&lt;/td&gt;&lt;td&gt; &amp;gt;100, &amp;lt;150
&lt;/td&gt;&lt;td&gt; No p's or retrograde p's
&lt;/td&gt;&lt;td&gt; Nothing
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; MAT
&lt;/td&gt;&lt;td&gt; Irregular
&lt;/td&gt;&lt;td&gt; &amp;gt;100
&lt;/td&gt;&lt;td&gt; &amp;gt;3 p shapes
&lt;/td&gt;&lt;td&gt; Transient slowing
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Sinus
&lt;/td&gt;&lt;td&gt; Regular
&lt;/td&gt;&lt;td&gt;
&lt;p&gt;&amp;gt;100 &amp;lt;180
&lt;/p&gt;
&lt;/td&gt;&lt;td&gt; Normal
&lt;/td&gt;&lt;td&gt; Transient slowing
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;p&gt;Flutter vs coarse AFib: determine atrial regularity by taking big bites
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tachycardia_(Narrow)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Digoxin usually only helpful when already c a block (i.e. AF c 2:1 block) NOT c an SVT c 1:1 conduction.
&lt;/p&gt;&lt;p&gt;AFib: IV Beta-block&amp;gt; IV digoxin &amp;gt; CCB (diltiazem) &amp;gt; Type IA to covert to SR
&lt;/p&gt;&lt;p&gt;AFlutter: same as AFib
&lt;/p&gt;&lt;p&gt;AT: same as AFib
&lt;/p&gt;&lt;p&gt;AVNRT: CSM &amp;gt; adenosine &amp;gt; then Beta blockers &amp;gt; CCB &amp;gt; Digoxin PO. Consider eCV (not if low LVEF),&amp;nbsp;?procanamide , amio, sotalol.
&lt;/p&gt;&lt;p&gt;Junctional: remove the cause, Amiodarone(, Beta-blocker, CCB).
&lt;/p&gt;&lt;p&gt;ST: B blocker &amp;gt; CCB &amp;gt; Digoxin
&lt;/p&gt;&lt;p&gt;MAT: Verapamil/ Diltiazem. CAREFUL of Beta-blockers b/c usually in pts with pulmonary dz. Amiodarone
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="tachycardia_(wide)"><name>Tachycardia (Wide)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#TREATMENT_.28WIDE.29"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;TREATMENT (WIDE)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#.5EDDx_Regular"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;^DDx Regular&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#V-TACH_.28BRUGADA_CRITERIA.29"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;V-TACH (BRUGADA CRITERIA)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#.5E.5EDDX_Irregular"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;^^DDX Irregular&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#REFRACTORY_V-TACH"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;REFRACTORY V-TACH&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#See_also"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;See also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tachycardia_(Wide)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Consider hyperkalemia &amp;amp; dig OD!
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tachycardia_(Wide)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: TREATMENT (WIDE)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="TREATMENT_.28WIDE.29"&gt;TREATMENT (WIDE)&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Pulseless --&amp;gt; shock (sync 360J)
&lt;/li&gt;&lt;li&gt;Unstable --&amp;gt; shock (sync 100J -200J monophasic, or 50-100J biphasic)
&lt;/li&gt;&lt;li&gt;Stable
&lt;ol&gt;&lt;li&gt;Regular^
&lt;ol&gt;&lt;li&gt;Tx as presum V.Tach
&lt;ol&gt;&lt;li&gt;Amiodarone (150mg over 10min, then 1mg/min gtt x 6hrs)
&lt;/li&gt;&lt;li&gt;Procainamide (15-18mg/kg over 30 min) 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;May cardiovert
&lt;/li&gt;&lt;li&gt;See Refractory
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Irregular^^
&lt;ol&gt;&lt;li&gt;HR &amp;lt;200
&lt;ol&gt;&lt;li&gt;Presum aberrant a. fib^^
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;HR 200-250
&lt;/li&gt;&lt;li&gt;HR &amp;gt;250
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tachycardia_(Wide)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: ^DDx Regular"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id=".5EDDx_Regular"&gt;^DDx Regular&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;V. tach
&lt;/li&gt;&lt;li&gt;Tachycardia + BBB
&lt;/li&gt;&lt;li&gt;Tachycardia + rate related BBB
&lt;/li&gt;&lt;li&gt;Hyperkalemia, meds (e.g. procainamide, flecainide, TCAs, dig)
&lt;/li&gt;&lt;li&gt;Pacemaker
&lt;/li&gt;&lt;li&gt;Tachycardia + Accessory pathway
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tachycardia_(Wide)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: V-TACH (BRUGADA CRITERIA)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="V-TACH_.28BRUGADA_CRITERIA.29"&gt;V-TACH (BRUGADA CRITERIA)&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Regular rhythms only
&lt;/p&gt;&lt;p&gt;Any 1 of the following = Vtach:
&lt;/p&gt;&lt;p&gt;(matters only if stable, for drug choice)
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Absence of RS complex in all precordial leads
&lt;/li&gt;&lt;li&gt;RS &amp;gt;100ms (&amp;gt;2.5mm) in any precordial
&lt;/li&gt;&lt;li&gt;AV dissociation (fusion beats)
&lt;/li&gt;&lt;li&gt;Morphology criteria for VT in V1 or V6 (clear R/L-BB pattern)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tachycardia_(Wide)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: ^^DDX Irregular"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id=".5E.5EDDX_Irregular"&gt;^^DDX Irregular&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;A.fib + BBB
&lt;/li&gt;&lt;li&gt;A.fib + rate related BBB
&lt;ol&gt;&lt;li&gt;(QRS widest with shortest R-R)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;V. tach (see Brugada Criteria)
&lt;/li&gt;&lt;li&gt;A.fib + hyperkalemia or meds
&lt;/li&gt;&lt;li&gt;Accessory pathway***
&lt;/li&gt;&lt;/ol&gt;
&lt;ol&gt;&lt;li&gt;The danger = A.fib + aberrant pathway (in WPW)
&lt;ol&gt;&lt;li&gt;do not use adenosine, beta blockers, dilt, or dig
&lt;/li&gt;&lt;li&gt;changing morphology of QRS = inc poss
&lt;/li&gt;&lt;li&gt;consider procainamide or ibutilide (amiodarone?)
&lt;/li&gt;&lt;li&gt;shock if becomes unstable
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tachycardia_(Wide)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: REFRACTORY V-TACH"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="REFRACTORY_V-TACH"&gt;REFRACTORY V-TACH&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Overdrive pacing
&lt;/li&gt;&lt;li&gt;Lidocaine
&lt;/li&gt;&lt;li&gt;Magnesium
&lt;/li&gt;&lt;li&gt;Electrolytes
&lt;/li&gt;&lt;li&gt;?dilantin
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tachycardia_(Wide)&amp;amp;action=edit&amp;amp;section=7" title="Edit section: See also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_also"&gt;See also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Cards: V TACH Vs. Aberrant SVT
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tachycardia_(Wide)&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;8/07 DONALDSON (adapted from EM, Rosen)
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="tdap_(pertussis_vaccine)"><name>Tdap (Pertussis Vaccine)</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tdap_(Pertussis_Vaccine)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: ED Tetanus Containing Vaccine Selection Guide"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="ED_Tetanus_Containing_Vaccine_Selection_Guide"&gt; ED Tetanus Containing Vaccine Selection Guide &lt;/span&gt;&lt;/h2&gt;
&lt;table border="1"&gt;

&lt;tr&gt;
&lt;td&gt; &lt;b&gt;Age&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;If No Pertussis Contraindications&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;If Pertussis Contraindicated&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Comments&lt;/b&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 2mo - 7yrs
&lt;/td&gt;&lt;td&gt; DTaP
&lt;/td&gt;&lt;td&gt; DT
&lt;/td&gt;&lt;td&gt; DT available from pharmacy
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 7yrs - 10yrs
&lt;/td&gt;&lt;td&gt; Td
&lt;/td&gt;&lt;td&gt; Td
&lt;/td&gt;&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 10yrs
&lt;/td&gt;&lt;td&gt; Tdap(Adacel)^
&lt;/td&gt;&lt;td&gt; Td
&lt;/td&gt;&lt;td&gt; ^Off label use but appears safe and immunogenic
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 11yrs - 16yrs
&lt;/td&gt;&lt;td&gt; Tdap(Adacel)
&lt;/td&gt;&lt;td&gt; Td
&lt;/td&gt;&lt;td&gt; &lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 16yrs - 65
&lt;/td&gt;&lt;td&gt; Tdap(Adacel)^^
&lt;/td&gt;&lt;td&gt; Td
&lt;/td&gt;&lt;td&gt; ^^Use Td if patient is known to have received prior Tdap
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 65yrs +
&lt;/td&gt;&lt;td&gt; Td&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Td&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Consider TIG for tetanus prone wound plus Td(tetanus immune globulin)
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tdap_(Pertussis_Vaccine)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Caveats"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Caveats"&gt; Caveats &lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Adolescents who have already gotten a booster dose of Td are encouraged to get a dose of Tdap as well. Waiting 5 years after their last Td is encouraged but not required. A period of at least 2 years between Td and Tdap is recommended in these cases.
&lt;/li&gt;&lt;li&gt;Pregnancy is not a contraindication to Tdap.
&lt;/li&gt;&lt;li&gt;Stable neurologic disorders and family history of vaccine reactions are not contraindications to receiving these vaccines.
&lt;/li&gt;&lt;li&gt;No vaccine has ever been shown to play any role in the development of autism or autism spectrum disorders.
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tdap_(Pertussis_Vaccine)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt; See Also &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;ID: Tetanus (Prophylaxis)
&lt;/p&gt;&lt;p&gt;ID: Tetanus (Acute)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;



</content><folder>ID</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="temp_conversion"><name>Temp Conversion</name><content>&lt;p&gt;36= 96.8
&lt;/p&gt;&lt;p&gt;37= 98.6
&lt;/p&gt;&lt;p&gt;38= 100.4
&lt;/p&gt;&lt;p&gt;39= 102.2
&lt;/p&gt;&lt;p&gt;40= 104
&lt;/p&gt;&lt;p&gt;41= 105.8
&lt;/p&gt;&lt;p&gt;42= 107.6
&lt;/p&gt;



</content><folder>Environ</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="template_1_(general)"><name>Template 1 (General)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Template_1_(General)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Template_1_(General)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Template_1_(General)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Template_1_(General)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Template_1_(General)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Template_1_(General)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Template_1_(General)&amp;amp;action=edit&amp;amp;section=7" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Template_1_(General)&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;




</content><folder>WikEM</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="template_2_(drug)"><name>Template 2 (Drug)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Adult_Dosing"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Adult Dosing&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Pediatric_Dosing"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Pediatric Dosing&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Contraindications"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Contraindications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Indications"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Indications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Mechanism_of_Action"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Mechanism of Action&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Adverse_Drug_Rxns"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Adverse Drug Rxns&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Kinetics"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Kinetics&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Pregnancy.2FLactation"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;Pregnancy/Lactation&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#Overdose_Mgmt"&gt;&lt;span class="tocnumber"&gt;9&lt;/span&gt; &lt;span class="toctext"&gt;Overdose Mgmt&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-10"&gt;&lt;a href="#Interactions"&gt;&lt;span class="tocnumber"&gt;10&lt;/span&gt; &lt;span class="toctext"&gt;Interactions&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-11"&gt;&lt;a href="#Trades.2FCosts"&gt;&lt;span class="tocnumber"&gt;11&lt;/span&gt; &lt;span class="toctext"&gt;Trades/Costs&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-12"&gt;&lt;a href="#IV_Info"&gt;&lt;span class="tocnumber"&gt;12&lt;/span&gt; &lt;span class="toctext"&gt;IV Info&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-13"&gt;&lt;a href="#Other"&gt;&lt;span class="tocnumber"&gt;13&lt;/span&gt; &lt;span class="toctext"&gt;Other&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-14"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;14&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Template_2_(Drug)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Adult Dosing"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Adult_Dosing"&gt;Adult Dosing&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Template_2_(Drug)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Pediatric Dosing"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Pediatric_Dosing"&gt;Pediatric Dosing&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Template_2_(Drug)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Contraindications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Contraindications"&gt;Contraindications&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Template_2_(Drug)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Indications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Indications"&gt;Indications&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Template_2_(Drug)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Mechanism of Action"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Mechanism_of_Action"&gt;Mechanism of Action&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Template_2_(Drug)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Adverse Drug Rxns"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Adverse_Drug_Rxns"&gt;Adverse Drug Rxns&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Template_2_(Drug)&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Kinetics"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Kinetics"&gt;Kinetics&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Template_2_(Drug)&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Pregnancy/Lactation"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Pregnancy.2FLactation"&gt;Pregnancy/Lactation&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Template_2_(Drug)&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Overdose Mgmt"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Overdose_Mgmt"&gt;Overdose Mgmt&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Template_2_(Drug)&amp;amp;action=edit&amp;amp;section=10" title="Edit section: Interactions"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Interactions"&gt;Interactions&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Template_2_(Drug)&amp;amp;action=edit&amp;amp;section=11" title="Edit section: Trades/Costs"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Trades.2FCosts"&gt;Trades/Costs&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Template_2_(Drug)&amp;amp;action=edit&amp;amp;section=12" title="Edit section: IV Info"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="IV_Info"&gt;IV Info&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Template_2_(Drug)&amp;amp;action=edit&amp;amp;section=13" title="Edit section: Other"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Other"&gt;Other &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Template_2_(Drug)&amp;amp;action=edit&amp;amp;section=14" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from...
&lt;/p&gt;



</content><folder>WikEM</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="template_3_(list)"><name>Template 3 (List)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#I._Catagory_One"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;I.  Catagory One&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#II._Catagory_Two"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;II.  Catagory Two&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Template_3_(List)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: I. Catagory One"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="I._Catagory_One"&gt;I.  Catagory One&lt;/span&gt;&lt;/h2&gt;
&lt;pre&gt;    A.  Section One
&lt;/pre&gt;
&lt;pre&gt;         1)  Subsection One
&lt;/pre&gt;
&lt;pre&gt;              i.  List One
&lt;/pre&gt;
&lt;pre&gt;                   -Item One
&lt;/pre&gt;
&lt;pre&gt;                   -Item Two
&lt;/pre&gt;
&lt;pre&gt;              i.  List Two
&lt;/pre&gt;
&lt;pre&gt;         2)  Subsection Two 
&lt;/pre&gt;
&lt;pre&gt;    B.  Section Two
&lt;/pre&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Template_3_(List)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: II. Catagory Two"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="II._Catagory_Two"&gt;II.  Catagory Two&lt;/span&gt;&lt;/h2&gt;
&lt;pre&gt;    A.  Section One
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;pre&gt;         1)  Subsection One
&lt;/pre&gt;
&lt;pre&gt;              i.  List One
&lt;/pre&gt;
&lt;pre&gt;                   -Item One
&lt;/pre&gt;
&lt;pre&gt;                   -Item Two
&lt;/pre&gt;
&lt;pre&gt;              i.  List Two
&lt;/pre&gt;
&lt;pre&gt;         2)  Subsection Two 
&lt;/pre&gt;
&lt;pre&gt;    B.  Section Two
&lt;/pre&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Template_3_(List)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: "&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id=""&gt; &lt;/span&gt;&lt;/h2&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Template_3_(List)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from...
&lt;/p&gt;



</content><folder>WikEM</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="template_4_(ddx)"><name>Template 4 (Ddx)</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Template_4_(Ddx)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Item 1
&lt;/li&gt;&lt;li&gt; Item 2
&lt;/li&gt;&lt;li&gt; Item 3
&lt;/li&gt;&lt;li&gt; Item 4
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Template_4_(Ddx)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from...
&lt;/p&gt;



</content><folder>WikEM</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="template_5_(evidence_based_question)"><name>Template 5 (Evidence Based Question)</name><content>



</content><folder>WikEM</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="template_6_(procedure)"><name>Template 6 (Procedure)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Indications"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Indications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Contraindications"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Contraindications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Equipment_Needed"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Equipment Needed&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Procedure"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Procedure&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Complications"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Complications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Template_6_(Procedure)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Indications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Indications"&gt;Indications&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Template_6_(Procedure)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Contraindications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Contraindications"&gt;Contraindications&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Template_6_(Procedure)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Equipment Needed"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Equipment_Needed"&gt;Equipment Needed&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Template_6_(Procedure)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Procedure"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Procedure"&gt;Procedure&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Template_6_(Procedure)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Complications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Complications"&gt;Complications&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Template_6_(Procedure)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Template_6_(Procedure)&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert
&lt;/p&gt;



</content><folder>WikEM</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="tendons_(extremity)"><name>Tendons (Extremity)</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tendons_(Extremity)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Upper"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Upper"&gt;Upper&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;A. Fingers
&lt;/p&gt;
&lt;pre&gt;    i. FDP (DIP flexion)
&lt;/pre&gt;
&lt;pre&gt;    ii. FDS (PIP flexion)
&lt;/pre&gt;
&lt;pre&gt;    iii. Extensor dig communis (extension)
&lt;/pre&gt;
&lt;pre&gt;         -Mallet = DIP
&lt;/pre&gt;
&lt;pre&gt;         -Boutonniere = PIP
&lt;/pre&gt;
&lt;p&gt;B. Thumb
&lt;/p&gt;
&lt;pre&gt;    i. Flx pollicis longus (flexion)
&lt;/pre&gt;
&lt;pre&gt;    ii. Ex poll longus (DIP ext)
&lt;/pre&gt;
&lt;pre&gt;    iii. Ex poll brevis (MCP ext)
&lt;/pre&gt;
&lt;pre&gt;    iv. Abductor poll longus (abduction)
&lt;/pre&gt;
&lt;p&gt;C. Wrist
&lt;/p&gt;
&lt;pre&gt;    i. Flexor carpi ulnaris (flx + ulnar deviation)
&lt;/pre&gt;
&lt;pre&gt;    ii. Flexor carpi radialis (flx + radial dev)
&lt;/pre&gt;
&lt;pre&gt;    iii. Extensor carpi ulnaris (ext + ulnar dev)
&lt;/pre&gt;
&lt;pre&gt;    iv. Extensor carpi radialis (ext + radial dev)
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tendons_(Extremity)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Lower"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Lower"&gt;Lower&lt;/span&gt;&lt;/h2&gt;
&lt;pre&gt;    i. Extensor hallicis longus
&lt;/pre&gt;
&lt;pre&gt;         -Great to ext + ankle inversion
&lt;/pre&gt;
&lt;pre&gt;    ii. Tibialis anterior
&lt;/pre&gt;
&lt;pre&gt;         -Ankle dorsiflex + inversion
&lt;/pre&gt;
&lt;pre&gt;    iii. Achilles tendon
&lt;/pre&gt;
&lt;pre&gt;         -Ankle plantarflex + inversion
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tendons_(Extremity)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;10/07 DONALDSON (adapted from Tintinalli)
&lt;/p&gt;



</content><folder>Ortho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="testicular_torsion"><name>Testicular Torsion</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-6"&gt;&lt;a href="#Manual_Detorsion"&gt;&lt;span class="tocnumber"&gt;5.1&lt;/span&gt; &lt;span class="toctext"&gt;Manual Detorsion&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-3 tocsection-7"&gt;&lt;a href="#For_Right_Testicle"&gt;&lt;span class="tocnumber"&gt;5.1.1&lt;/span&gt; &lt;span class="toctext"&gt;For Right Testicle&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-3 tocsection-8"&gt;&lt;a href="#For_Left_Testicle"&gt;&lt;span class="tocnumber"&gt;5.1.2&lt;/span&gt; &lt;span class="toctext"&gt;For Left Testicle&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-10"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-11"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Testicular_Torsion&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt; Background &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;&lt;b&gt;Salvage Rates for Detorsion Times&lt;/b&gt;
&lt;/p&gt;
&lt;table style="width: 500px" border="1" cellpadding="1" cellspacing="1"&gt;

&lt;tr&gt;
&lt;td&gt; &lt;b&gt;Rate&lt;/b&gt;&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Time&lt;/b&gt;&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 90-100%
&lt;/td&gt;&lt;td&gt; &amp;lt;6 hrs&amp;nbsp;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 20-50%
&lt;/td&gt;&lt;td&gt; 6-12 hrs&amp;nbsp;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 0-10%
&lt;/td&gt;&lt;td&gt; &amp;gt;24 hrs
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;ul&gt;&lt;li&gt;peak incidence in first year of life, 2nd peak incidence at puberty
&lt;/li&gt;&lt;li&gt;scrotal trauma associated with torsion, consider if persistent scrotal pain &amp;gt; 1 hour
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Testicular_Torsion&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt; Diagnosis &lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Absent cremasteric reflex on affected side (~100%)
&lt;/li&gt;&lt;li&gt;Ultrasound (Doppler) = unilateral abscence of flow (specific)
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;Note:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;UA = usually normal (~70%), but the WBC presence can not be relied upon to exclude the diagnosis (30%)
&lt;/li&gt;&lt;li&gt;Ultrasound 88-100% sensitive, 90% specific
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Testicular_Torsion&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;UA
&lt;/li&gt;&lt;li&gt;Ultrasound
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Testicular_Torsion&amp;amp;action=edit&amp;amp;section=4" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;torsion of testicular appendage
&lt;/li&gt;&lt;li&gt;epididymitis
&lt;/li&gt;&lt;li&gt;tumor of testicle
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Testicular_Torsion&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Emergent detorsion manual: (ER) vs. surgical (urology) 
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Testicular_Torsion&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Manual Detorsion"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Manual_Detorsion"&gt;Manual Detorsion&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;"Open the book" = twist outward and laterally
&lt;/p&gt;&lt;p&gt;26% success rate 
&lt;/p&gt;
&lt;h4&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Testicular_Torsion&amp;amp;action=edit&amp;amp;section=7" title="Edit section: For Right Testicle"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="For_Right_Testicle"&gt;For Right Testicle&lt;/span&gt;&lt;/h4&gt;
&lt;ol&gt;&lt;li&gt;stand in front of standing or supine patient
&lt;/li&gt;&lt;li&gt;hold right testicle with left thumb and forefinger
&lt;/li&gt;&lt;li&gt;rotate the right testicle outward 180&#176; in a medial to lateral direction
&lt;/li&gt;&lt;li&gt;rotation may need to be repeated 2-3 times for complete detorsion/pain relief 
&lt;/li&gt;&lt;/ol&gt;
&lt;h4&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Testicular_Torsion&amp;amp;action=edit&amp;amp;section=8" title="Edit section: For Left Testicle"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="For_Left_Testicle"&gt;For Left Testicle&lt;/span&gt;&lt;/h4&gt;
&lt;ol&gt;&lt;li&gt;stand in front of standing or supine patient
&lt;/li&gt;&lt;li&gt;hold left testicle with right thumb and forefinger
&lt;/li&gt;&lt;li&gt;rotate the left testicle outward 180&#176; in a medial to lateral direction
&lt;/li&gt;&lt;li&gt;rotation may need to be repeated 2-3 times for complete detorsion/pain relief
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Testicular_Torsion&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;To OR or Urology
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Testicular_Torsion&amp;amp;action=edit&amp;amp;section=10" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt; See Also &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Testicular_Torsion&amp;amp;action=edit&amp;amp;section=11" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt; Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;KajiQuestions
&lt;/p&gt;&lt;p&gt;Rosens
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;



</content><folder>GU</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="testicular_tumors"><name>Testicular Tumors</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Testicular_Tumors&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;most common malignancy in young men, 1% all cancers in men
&lt;/li&gt;&lt;li&gt;increased frequency in: infertile patients, whites, undescended testis, history of cryptorchidism
&lt;/li&gt;&lt;li&gt;95% germ cell tumors: half seminomas, half mixed types (teratomas, choriocarcinomas, yolk sac tumors)
&lt;/li&gt;&lt;li&gt;5% sex cord stromal tumors
&lt;/li&gt;&lt;li&gt;typically present with painless scrotal mass
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Testicular_Tumors&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;testicular US
&lt;/li&gt;&lt;li&gt;if pain must rule out epididymitis, torsion
&lt;/li&gt;&lt;li&gt;may present with mets at time of diagnosis
&lt;ol&gt;&lt;li&gt;15% present with mets to regional lymph nodes
&lt;/li&gt;&lt;li&gt;5% present with mets to abdomen or pelvis
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Testicular_Tumors&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;testicular US
&lt;/li&gt;&lt;li&gt;UA
&lt;/li&gt;&lt;li&gt;CT of chest/abdomen/pelvis helpful for staging, only necessary in ED if patient has complaints related to this part of body
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Testicular_Tumors&amp;amp;action=edit&amp;amp;section=4" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;hydrocele
&lt;/li&gt;&lt;li&gt;torsion
&lt;/li&gt;&lt;li&gt;epididymitis
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Testicular_Tumors&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;urgent urology referral
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Testicular_Tumors&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Testicular_Tumors&amp;amp;action=edit&amp;amp;section=7" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Testicular_Tumors&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from ....(insert)
&lt;/p&gt;



</content><folder>GU</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="tetanus_(acute)"><name>Tetanus (Acute)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Types"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Types&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Neonatal"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;Neonatal&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Local"&gt;&lt;span class="tocnumber"&gt;2.2&lt;/span&gt; &lt;span class="toctext"&gt;Local&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Generalized"&gt;&lt;span class="tocnumber"&gt;2.3&lt;/span&gt; &lt;span class="toctext"&gt;Generalized&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-6"&gt;&lt;a href="#Cephalic"&gt;&lt;span class="tocnumber"&gt;2.4&lt;/span&gt; &lt;span class="toctext"&gt;Cephalic&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tetanus_(Acute)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; 45% mortality
&lt;/li&gt;&lt;li&gt; 2 to 56d incubation period
&lt;/li&gt;&lt;li&gt; if pt survives, no residual sequealae
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tetanus_(Acute)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Types"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Types"&gt;Types&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tetanus_(Acute)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Neonatal"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Neonatal"&gt;Neonatal&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; from umbilical stump infection. Usually protected by passive maternal Abs
&lt;/li&gt;&lt;li&gt; sx- poor suck, irritability, crying, grimacing
&lt;/li&gt;&lt;li&gt; usually with in 10 d of birth
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tetanus_(Acute)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Local"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Local"&gt;Local&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;rigidity of muscles near wound- may progress to generalized
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tetanus_(Acute)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Generalized"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Generalized"&gt;Generalized&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; most common form
&lt;/li&gt;&lt;li&gt; pts are conscious and alert
&lt;/li&gt;&lt;li&gt; hypersympathetic state c sweating, HTN, tachycardia, fever
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tetanus_(Acute)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Cephalic"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Cephalic"&gt;Cephalic&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; follow injuries to head or otitis media
&lt;/li&gt;&lt;li&gt; get CN dysfunction- usually CN 7
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tetanus_(Acute)&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; sxs for 2 wks- pain &amp;amp; stiffness of jaw, abd, back, diff swallowing, hyperactive DTRs, labile HTN,
&lt;/li&gt;&lt;li&gt; DX = clinical
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tetanus_(Acute)&amp;amp;action=edit&amp;amp;section=8" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;dystonic rxn
&lt;/li&gt;&lt;li&gt;strychnine
&lt;/li&gt;&lt;li&gt;hypocalcemic tetany
&lt;/li&gt;&lt;li&gt;PTA
&lt;/li&gt;&lt;li&gt;teritonitis. SAN
&lt;/li&gt;&lt;li&gt;meningitis
&lt;/li&gt;&lt;li&gt;rabies
&lt;/li&gt;&lt;li&gt;TMJ
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tetanus_(Acute)&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; wound debridement
&lt;/li&gt;&lt;li&gt; TIG- 3000- 10K IM- prevents additional dz but does not reverse toxin already fixed to CNS. Binds circulating toxin
&lt;/li&gt;&lt;li&gt; IVF/ hyperal
&lt;/li&gt;&lt;li&gt; quiet room
&lt;/li&gt;&lt;li&gt; sedation with phenobarb, valium or paralytics
&lt;/li&gt;&lt;li&gt; ABx- pen G or flagyl- not 100% proven
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;steroids &amp;amp; hyperbaric O2 = no evidence
&lt;/p&gt;



</content><folder>ID</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="tetanus_(prophylaxis)"><name>Tetanus (Prophylaxis)</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tetanus_(Prophylaxis)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Incubation Period: 1dy - 2 mo
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tetanus_(Prophylaxis)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Prophylaxis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Prophylaxis"&gt;Prophylaxis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Past vac unknown or &amp;lt;3 total
&lt;ol&gt;&lt;li&gt; Clean wound --&amp;gt; Td
&lt;/li&gt;&lt;li&gt; Dirty wound --&amp;gt; Td &amp;amp; TIG
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Past vac 3 or more total
&lt;ol&gt;&lt;li&gt; Clean wound --&amp;gt; Td Q10yrs
&lt;/li&gt;&lt;li&gt; Dirty wound --&amp;gt; Td Q5yrs
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;Td 0.5cc IM
&lt;/p&gt;&lt;p&gt;TIG (tetanus immunoglobulin)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tetanus_(Prophylaxis)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;"Tdap (Pertussis Vaccine)" for new recommendations from CDC
&lt;/p&gt;&lt;p&gt;ID: Tetanus (Acute)
&lt;/p&gt;



</content><folder>ID</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="thoracentesis"><name>Thoracentesis</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Indications"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Indications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Contraindications"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Contraindications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Equipment_Needed"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Equipment Needed&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Procedure"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Procedure&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Complications"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Complications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Thoracentesis&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Indications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Indications"&gt;Indications&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Thoracentesis&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Contraindications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Contraindications"&gt;Contraindications&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Thoracentesis&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Equipment Needed"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Equipment_Needed"&gt;Equipment Needed&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Thoracentesis&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Procedure"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Procedure"&gt;Procedure&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Thoracentesis&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Complications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Complications"&gt;Complications&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-pneumothorax
&lt;/p&gt;&lt;p&gt;-cough (9%)
&lt;/p&gt;&lt;p&gt;-unilateral pulmonary edema
&lt;/p&gt;&lt;p&gt;-reexpansion hypotension
&lt;/p&gt;&lt;p&gt;-transient hypoxia from V-Q mismatch
&lt;/p&gt;&lt;p&gt;-hemothorax
&lt;/p&gt;&lt;p&gt;-infection (2%)
&lt;/p&gt;&lt;p&gt;-hemoperitoneum
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Thoracentesis&amp;amp;action=edit&amp;amp;section=6" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Insert
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Thoracentesis&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Robert and Hedges, p.145 (130-147)
&lt;/p&gt;



</content><folder>Procedures</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="thoracic_aortic_aneurysm"><name>Thoracic Aortic Aneurysm</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Definition"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Definition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Causes"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Causes&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Risk_Factors"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Risk Factors&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Prognosis"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Prognosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Thoracic_Aortic_Aneurysm&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Definition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Definition"&gt;Definition&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Diameter &amp;gt; 6cm
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Thoracic_Aortic_Aneurysm&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Causes"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Causes"&gt;Causes&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Atherosclerosis
&lt;/li&gt;&lt;li&gt;Cystic medial necrosis
&lt;/li&gt;&lt;li&gt;Giant cell arteritis
&lt;/li&gt;&lt;li&gt;Marfan
&lt;/li&gt;&lt;li&gt;Mycotic aneurysm
&lt;/li&gt;&lt;li&gt;Seronegative spondyloarthropathies
&lt;/li&gt;&lt;li&gt;Syphilis
&lt;/li&gt;&lt;li&gt;TB
&lt;/li&gt;&lt;li&gt;Takayasu arteritis
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Thoracic_Aortic_Aneurysm&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Risk Factors"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Risk_Factors"&gt;Risk Factors&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;HTN
&lt;/li&gt;&lt;li&gt;Advanced atherosclerotic dz
&lt;/li&gt;&lt;li&gt;Smoking
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Thoracic_Aortic_Aneurysm&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Often incidental finding on CXR
&lt;/li&gt;&lt;li&gt;CT
&lt;/li&gt;&lt;li&gt;TEE
&lt;/li&gt;&lt;li&gt;Aortography
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Thoracic_Aortic_Aneurysm&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment &lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Consult Cardiothoracic Surg
&lt;/li&gt;&lt;li&gt;If suspected rupture, see AAA Treatment
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Thoracic_Aortic_Aneurysm&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Prognosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Prognosis"&gt;Prognosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Rupture risk increases 31%  for ascending diameters &amp;gt; 6.0cm and 43% for descending &amp;gt;7cm
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Thoracic_Aortic_Aneurysm&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Harwood-Nuss
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="thoracic_trauma_(general)"><name>Thoracic Trauma (General)</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Thoracic_Trauma_(General)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: General"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="General"&gt;General&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;sternal fx in 8% of thoracic injuries, seen on pa/lat cxr, many recent studies prove most, if no comorbidities, can be d/c home safely (mort= .8%), chk ekg
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;traumatic asphyxia in kids= benign, have discolored upper torso from compression &amp;amp; incr pressure tmitted to valveless veins
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;most tracheobronchial inj are within 2cm of carina, although rare, suspect if constant air leak in c-tube, 90% have sx but hard dx, needs or
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;card tamponade usu from penetrating, do not rely on becks triad, echo is study of choice but 5% false - rate, usu b/c pericardium decompressing into L chest, so be suspicious if L pulm effussion! nd OR, buy time w/ IVF &amp;amp; needle!
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Blunt cardiac inj is dx soley w/ ekg &amp;amp; pe, do NOT need enzymes. most common abnl ekg in order= st, pvc, af. dx valve prob w/ pe. rx arrythmia prn but NOT prophylacticly (incr mort!), no tnk for mi here (incr mort), nd angio! severity depends on underlying cad b/c inflamm chngs= redistribute coronary flow that may= ischemic cp. any abnl pe or ekg admit to tele. pts w/ no arrythmia &amp;amp; no hypotension after 6 hr of obs have NO sig blunt cardiac injury!!
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;w/ pnetrating chest inj neuro defecit should incr suspicion of vasc inj b/c nv bundle run together
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Aortic transection: pt often asx, but die w/o warning, 80% die at scene, hypotension NOT from ruptured aorta (just die). see wide sup mediastinum on cxr (&amp;gt;8cm on supine film), nd high suspicion to dx! ct gd for aorta not branch vessels, if high suspicion nd aortography, the gold stndrd, but 1/4 hve complications ie inf &amp;amp; hematoma. Rx= keep sbp &amp;lt;120 w/ a &amp;amp; b blockers.
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;commotio cordis is most common cause of cardiac death in athlete. sudden death w/o abnl heart from trauma to cw at vent depolarization= vf &amp;amp; death.
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;esophageal inj is rare but bad &amp;amp; hard dx to make. rx=controversial if no sx. suspect if L htx or ptx w/o rib fx, or pneumomediastinum, d/t incr pressure of low chest/abd= tear in esoph!
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Thoracic_Trauma_(General)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;(Burbulys 2004/Trauma Reports 4/04 /A-Digest 7/04) -by Lampe
&lt;/p&gt;



</content><folder>Trauma</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="thoracotomy"><name>Thoracotomy</name><content>&lt;p&gt;2001 ACS-COT Recs on EDT
&lt;/p&gt;&lt;p&gt;1) Rarely in pts sustaining cardiopulmonary arrest secondary to blunt trauma due to the unacceptably low survival rate and poor neurologic outcomes
&lt;/p&gt;&lt;p&gt;2) Should be limited to those that arrive with vital signs at the TC &amp;amp; have a witnessed cp arrest
&lt;/p&gt;&lt;p&gt;3) Best applied to pts sustaining penetrating cardiac injuries who arrive at a TC after a short transport with witnessed signs of life
&lt;/p&gt;&lt;p&gt;4) Should be done on pts with penetrating, non-cardiac thoracic injuries
&lt;/p&gt;&lt;p&gt;5) Should be done in pts with exsanguinating abdominal vascular injuries, although these pts have a low survival rate
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;level 2 recs and applies to peds
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;THORACOTOMY INDICATIONS
&lt;/p&gt;&lt;p&gt;(Fernandez Lec 2003)
&lt;/p&gt;&lt;p&gt;1. Penetrating Chest trauma w/ signs of life in field (pulse palp, respirations, cardiac activity on monitor &amp;gt; 40 bpm, pupillary reactivity)
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Stab wounds have better survival than GSWs (19% vs. 8%)
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Some authors recommend thoracotomy in penetrating abd. trauma w/ persistent hypotension or arrest (surv 5%)
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;2. Blunt Trauma w/ signs of life lost in ED. No long term survival in blunt trauma pts who lose signs of life in field.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Thoracotomy in OR
&lt;/p&gt;&lt;p&gt;1. Thoracoabdominal trauma pts w/ persistent SBP &amp;lt; 70-80 despite aggressive resus.
&lt;/p&gt;&lt;p&gt;2. Chest tube drainage &amp;gt; 1500 ml initially or &amp;gt; 200 mL/hr for 2-4hr
&lt;/p&gt;&lt;p&gt;3. Evidence of cardiac tamponade or progressively inc hemothorax.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Fascinating Facts
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;1) 1st introduced 1882 Dr. Block in his canine heart lac expt., 1889 Tuffier had 1st succesful open massage, Dr. Beck popularized it for the next 50-60 yrs and became the standard of care in the OR, and fell out of favor as external defib and closed heart massage was introduced
&lt;/p&gt;&lt;p&gt;2) 80% of tamponade d/t SW
&lt;/p&gt;&lt;p&gt;3) 5 goals of EDT are to release tamponade, control intrathoracic/caridac bleeding, control air embolism, open massage, temporary occlusion of the desc aorta= optimizing blood flow to brain and heart
&lt;/p&gt;&lt;p&gt;4) each hemithorax can contain about 50% of the pts blood volume before it becomes obvious!!
&lt;/p&gt;&lt;p&gt;5) external cardiac compression can provide 10-20% of baseline cardiac output (reasonable salvage up to 15 min, and diminished survival at 30 min), open cardiac massage deliver up to 60% of baseline (aortic pressure &amp;amp; CO can be kept at 50-70% which allows reasonable salvage at 30 min). also w/ hypovolemia, ext cardiac compression provides inadequate coronay and cerebral perfusion. (chest '77, j. trauma '82)
&lt;/p&gt;&lt;p&gt;6) cross clamp aorta can incr afterload &amp;amp; O2 demand on heart. Up to 30 min is tolerated, &amp;gt;30min=isch &amp;amp; anaeorobic metab=acidemia=multi organ dysf(x), removing clamp=wash out of metabolic by-products &amp;amp; inflamm mediator, =shock=organ failure
&lt;/p&gt;&lt;p&gt;7) fyi internal mammory vessels are .5-1cm lateral to the sternum, try and avoid:)
&lt;/p&gt;&lt;p&gt;8) Post aorta clamping sbp &amp;lt;70=survival unlikely. sbp&amp;gt;160-180=strain on LV can lead to acute failure so remove clamp.
&lt;/p&gt;&lt;p&gt;9) survival rate of 7035 EDTs was 7.8% (11.2% for penetr, &amp;amp; 1.6% for blunt, 31.1% for penetr cardiac inj). 142 peds had overall surv of 6.3%. (j. surg 2001)
&lt;/p&gt;&lt;p&gt;10) One study of 4520 EDTs had 15% of survivors w/ severe neurologic defecits.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;TECHNIQUE
&lt;/p&gt;&lt;p&gt;1. Intubate, NGT, sedate at same time
&lt;/p&gt;&lt;p&gt;2. Left arm overhead, towel under, prepare autotransfuser, incision in L intercostal space, sternum to axilla. Go through skin, tissue &amp;amp; muscle in one pass.
&lt;/p&gt;&lt;p&gt;3. Cut muscle with scissors, halt respirations and use other hand to widen the hole, push lung out of way. Incise to post axillary line.
&lt;/p&gt;&lt;p&gt;4. Rib spreader with rachet bar down
&lt;/p&gt;&lt;p&gt;5. Relieve Tamponade - by a pericardiotomy, pick up pericardium anterior to phrenic nerve, start incision (nick w/ scalpel) near diaphragm &amp;amp; open pericardium parallel to phrenic nerve
&lt;/p&gt;&lt;p&gt;6. Clamp sites of active bleeding
&lt;/p&gt;&lt;p&gt;7. Internally Defibrillate
&lt;/p&gt;&lt;p&gt;8. Internal Cardiac Massage - one- handed vs. two-handed, inspect myocardium for lacerations, may close with a Foley and purse-string stitch or 2 horizontal mattresses.
&lt;/p&gt;&lt;p&gt;9. Cross Clamp the Aorta, indicated after persistent hypotension after pericardiotomy and fluid resus. NGT in esophagus, thus, aorta post ngt. (see facts #8)
&lt;/p&gt;&lt;p&gt;10. Autotransfuse thoracic blood
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;(Trauma Reports 12/03) -by Lampe
&lt;/p&gt;



</content><folder>Procedures</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="thoracotomy_(peds)"><name>Thoracotomy (Peds)</name><content>&lt;p&gt;PEDS INDICATIONS
&lt;/p&gt;&lt;p&gt;1. Chest tube output
&lt;/p&gt;&lt;p&gt;&amp;gt;10-15mL/kg evacuated
&lt;/p&gt;&lt;p&gt;&amp;gt;2-4mL/kg/hr continuous
&lt;/p&gt;&lt;p&gt;2. Continuous air leak
&lt;/p&gt;



</content><folder>Procedures</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="thrombocytopenia"><name>Thrombocytopenia</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Definition"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Definition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Transfusion_Criteria"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Transfusion Criteria&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Causes"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Causes&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Pediatrics"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Pediatrics&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Thrombocytopenia&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Definition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Definition"&gt;Definition&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;&amp;lt;150,000 platelets/&#181;L
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Thrombocytopenia&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Transfusion Criteria"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Transfusion_Criteria"&gt;Transfusion Criteria&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;&amp;lt;50,000 &amp;amp; severe bleed or invasive procedure
&lt;/li&gt;&lt;li&gt;&amp;lt;20,000 &amp;amp; fever, petechia, or infection
&lt;/li&gt;&lt;li&gt;&amp;lt;5,000-10,000 --&amp;gt; always?
&lt;ol&gt;&lt;li&gt;Usually ineffective in ITP (give only in severe bleed; best after IVIg)
&lt;/li&gt;&lt;li&gt;DIC may worsen with platlet tranfusion
&lt;/li&gt;&lt;li&gt;Likely contraindicated in TTP
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Thrombocytopenia&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Causes"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Causes"&gt;Causes&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Decreased production
&lt;ol&gt;&lt;li&gt;marrow infiltration, aplastic anemia, drugs (ETOH), viral infect
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Increased destruction
&lt;ol&gt;&lt;li&gt;ITP, TTP, HUS, DIC, drugs (heparin)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Increased loss
&lt;ol&gt;&lt;li&gt;hemorrhage, hemodialysis
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Splenic sequestration
&lt;/li&gt;&lt;li&gt; Pseudothrombocytopenia (clumped)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Thrombocytopenia&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Pediatrics"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Pediatrics"&gt;Pediatrics&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1 unit platelets per 5kg body weight will raise count by 50k
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Thrombocytopenia&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1/26/06 DONALDSON (addapted from Tintinalli's, Lampe, Charfan)
&lt;/p&gt;



</content><folder>Heme/Onc</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="thyroid_(general)"><name>Thyroid (General)</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Thyroid_(General)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Spectrum of Disease
&lt;/p&gt;&lt;p&gt;Hypo &amp;lt;--&amp;gt; Hyper
&lt;/p&gt;&lt;p&gt;myxedema coma &amp;lt;&amp;lt; hypothyroid &amp;lt; euthyroid &amp;lt; hyperthyroid &amp;lt;&amp;lt; thyroid storm
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Thyroid_(General)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Other"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Other"&gt;Other&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;cretinism- no congenital t3/t4
&lt;/li&gt;&lt;li&gt;parafollicular C cells make calcitonin to keep the bone in
&lt;/li&gt;&lt;li&gt;endemic goiter- if pt from area c low iodine I intake
&lt;/li&gt;&lt;li&gt;free t3 &amp;amp; t4 determines thyroid state- not total plasma conc
&lt;/li&gt;&lt;li&gt;t4-&amp;gt; t3 active &amp;amp; rt3 inactive
&lt;/li&gt;&lt;li&gt;trh -&amp;gt; tsh -&amp;gt; t4 -&amp;gt;t3. t3 I's pittry
&lt;/li&gt;&lt;li&gt;hthal pitutry gland
&lt;/li&gt;&lt;li&gt;thyroid state changes dtr relax and contract speed and bmr O2 use.
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Thyroid_(General)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Endo: Thyroid Storm
&lt;/p&gt;&lt;p&gt;Endo: Hyperthyroidism
&lt;/p&gt;&lt;p&gt;Endo: Myxedema Coma
&lt;/p&gt;&lt;p&gt;Endo: Hypothyroidism
&lt;/p&gt;



</content><folder>Endo</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="thyroid_storm"><name>Thyroid Storm</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Classic_Triad"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;Classic Triad&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Burch_.26_Wartofsky_Diagnostic_Criteria"&gt;&lt;span class="tocnumber"&gt;2.2&lt;/span&gt; &lt;span class="toctext"&gt;Burch &amp;amp; Wartofsky Diagnostic Criteria&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Sources"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Sources&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Thyroid_Storm&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt; Background &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Precipitating events:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Infection
&lt;/li&gt;&lt;li&gt;Thyroid or nonthyroidal surgery
&lt;/li&gt;&lt;li&gt;Trauma
&lt;/li&gt;&lt;li&gt;Infection
&lt;/li&gt;&lt;li&gt;Acute iodine load
&lt;/li&gt;&lt;li&gt;Thyroiditis
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Thyroid_Storm&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt; Diagnosis &lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Thyroid_Storm&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Classic Triad"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Classic_Triad"&gt; Classic Triad &lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Hyperthermia
&lt;/li&gt;&lt;li&gt;Tachycardia
&lt;/li&gt;&lt;li&gt;AMS
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Thyroid_Storm&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Burch &amp;amp; Wartofsky Diagnostic Criteria"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Burch_.26_Wartofsky_Diagnostic_Criteria"&gt; Burch &amp;amp; Wartofsky Diagnostic Criteria &lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;&lt;b&gt;I. Thermoregulatory dysfunction (Temperature)&lt;/b&gt;
&lt;/p&gt;
&lt;table border="1"&gt;

&lt;tr&gt;
&lt;td&gt; 99-99.9
&lt;/td&gt;&lt;td&gt; 5
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 100-100.9
&lt;/td&gt;&lt;td&gt; 10
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 101-101.9
&lt;/td&gt;&lt;td&gt; 15
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 102-102.9
&lt;/td&gt;&lt;td&gt; 20
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 103-103.9
&lt;/td&gt;&lt;td&gt; 25
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 104.0
&lt;/td&gt;&lt;td&gt; 30
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;p&gt;&lt;b&gt;II. Central nervous system effects&lt;/b&gt;
&lt;/p&gt;
&lt;table border="1"&gt;

&lt;tr&gt;
&lt;td&gt; Mild (Agitation)
&lt;/td&gt;&lt;td&gt; 10
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Moderate (delirium, psychosis, extreme lethargy)
&lt;/td&gt;&lt;td&gt; 20
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Severe (seizure, coma)
&lt;/td&gt;&lt;td&gt; 30
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;p&gt;&lt;b&gt;III. Gastrointestinal-hepatic dysfunction&lt;/b&gt;
&lt;/p&gt;
&lt;table border="1"&gt;

&lt;tr&gt;
&lt;td&gt; Moderate (diarrhea, n/v, abd pain)
&lt;/td&gt;&lt;td&gt; 10
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Severe (unexplained jaundice)
&lt;/td&gt;&lt;td&gt; 20
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;p&gt;&lt;b&gt;IV. Cardiovascular dysfunction (tachycardia)&lt;/b&gt;
&lt;/p&gt;
&lt;table border="1"&gt;

&lt;tr&gt;
&lt;td&gt; 99-109
&lt;/td&gt;&lt;td&gt; 5
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 110-119
&lt;/td&gt;&lt;td&gt; 10
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 120-129
&lt;/td&gt;&lt;td&gt; 15
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 130-139
&lt;/td&gt;&lt;td&gt; 20
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 140
&lt;/td&gt;&lt;td&gt; 25
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;p&gt;&lt;b&gt;V. Congestive heart failure&lt;/b&gt;
&lt;/p&gt;
&lt;table border="1"&gt;

&lt;tr&gt;
&lt;td&gt; Mild (pedal edema)
&lt;/td&gt;&lt;td&gt; 5
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Moderate (bibasilar rales)
&lt;/td&gt;&lt;td&gt; 10
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Severe (pulm edema, A. fib)
&lt;/td&gt;&lt;td&gt; 15
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;p&gt;&lt;b&gt;VI. Precipitant history&lt;/b&gt;
&lt;/p&gt;
&lt;table border="1"&gt;

&lt;tr&gt;
&lt;td&gt; Negative
&lt;/td&gt;&lt;td&gt; 0
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Positive
&lt;/td&gt;&lt;td&gt; 10
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;p&gt;&lt;b&gt;Scoring&lt;/b&gt;
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;&amp;gt;45 = Highly suggestive of thyroid storm
&lt;/li&gt;&lt;li&gt;25-44 = Suggestive of impending storm
&lt;/li&gt;&lt;li&gt;&amp;lt;25 = Unlikely to represent storm
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Thyroid_Storm&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt; Treatment &lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Block new hormone synthesis
&lt;ol&gt;&lt;li&gt;PTU 600-1000 mg PO or PR followed by 200-250mg q4hr
&lt;ol&gt;&lt;li&gt;Preferred to methimazole b/c also blocks T4&amp;gt;T3 conversion
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Methimazole 20-25mg q4hr
&lt;ol&gt;&lt;li&gt;Longer acting than PTU
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Block hormone release
&lt;ol&gt;&lt;li&gt;Wolff-Chaikoff effect: increased iodine concentration leads to transient decrease of T3/T4
&lt;/li&gt;&lt;li&gt;Potassium iodide 5 gtt q6hr (Give 1hr after PTU)
&lt;ol&gt;&lt;li&gt;1st line
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Lithium 300mg q6hr
&lt;ol&gt;&lt;li&gt;Consider if iodine allergic
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Block Beta-adrenergic tone and peripheral T4&amp;gt;T3 conversion
&lt;ol&gt;&lt;li&gt;Propranolol PO 60-80 q4hr (if pt can tolerate PO)
&lt;/li&gt;&lt;li&gt;Propranolol IV 1mg over 10 min; if tolerates then 1-3mg boluses q3hr
&lt;/li&gt;&lt;li&gt;Esmolol 250-500&amp;nbsp;?/kg loading dose, then 50-100&amp;nbsp;?g/kg/min
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Treat possible adrenal insufficiency (also blocks T4&amp;gt;T3)
&lt;ol&gt;&lt;li&gt;Hydrocortisone 100-300mg IV bolus, followed by 100mg q8hr
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Treat fever
&lt;ol&gt;&lt;li&gt;Active cooling measures
&lt;/li&gt;&lt;li&gt;Only consider acetaminophen if rule-out hepatic dysfunction
&lt;/li&gt;&lt;li&gt;Avoid aspirin (increases levels of free thryoid hormone)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Other Measures
&lt;ol&gt;&lt;li&gt;Fluid Resuscitation
&lt;ol&gt;&lt;li&gt;D5NS (most pts have depleted glycogen stores)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Agitation control
&lt;ol&gt;&lt;li&gt;Benzos
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Thyroid hormone elimination
&lt;ol&gt;&lt;li&gt;Cholestyramine 4g q6hr
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Dialysis, plasmapharesis, or plasma exchange
&lt;ol&gt;&lt;li&gt;Consider if progressive deterioration despite multidrug tx
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Thyroid_Storm&amp;amp;action=edit&amp;amp;section=6" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt; See Also &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Endo: Thyroid Data
&lt;/p&gt;&lt;p&gt;Endo: Hyperthyroidism
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Thyroid_Storm&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Sources"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Sources"&gt; Sources &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Burch, HB, Wartofsky, L, Endocrinol Metab Clin North Am 1993; 22:263, UpToDate
&lt;/p&gt;



</content><folder>Endo</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="torsades_de_pointes"><name>Torsades De Pointes</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Torsades_De_Pointes&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Drugs that inhibit P450
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;erythromycin
&lt;/li&gt;&lt;li&gt;biaxin
&lt;/li&gt;&lt;li&gt;ketoconozole
&lt;/li&gt;&lt;li&gt;itraconozole
&lt;/li&gt;&lt;/ol&gt;
&lt;ul&gt;&lt;li&gt;certain antihistamines like terfandadine or astemizole, inhibit the delayed rectifier potassium channel
&lt;/li&gt;&lt;li&gt;terfenadine is completely metabolized in liver. Once metabolized, has no cardiac activity
&lt;/li&gt;&lt;li&gt;unmetabolized terfenadine has quinidine- like activity- gives torsades
&lt;/li&gt;&lt;li&gt;if P450 enz inhibited by other drug, then will have increase in concentration of unmetabolized terfanadine.
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Torsades_De_Pointes&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Mg (1-2gm over 1-2 minutes; then, 1-2gm/hr gtt)
&lt;/li&gt;&lt;li&gt;Overdrive pacing (hr = 90-120)
&lt;/li&gt;&lt;li&gt;Isoproterenol (if no pacing, 2-8 mcg/min)
&lt;/li&gt;&lt;li&gt;lidocaine
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Torsades_De_Pointes&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;10/07 DONALDSON (adapted from Tintinalli, Lampe)
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="torsion_of_testicular_appendages"><name>Torsion of Testicular Appendages</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Torsion_of_Testicular_Appendages&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;scrotum has several vestigial appendages that can twist, become ischemic and cause pain
&lt;/li&gt;&lt;li&gt;appendix testis present in 92%, superior aspect of testicle between testis and epididymis
&lt;/li&gt;&lt;li&gt;appendix epididymis present in 23%, tip of epididymis
&lt;/li&gt;&lt;li&gt;common between 7-14 years old
&lt;/li&gt;&lt;li&gt;rivals testicular torsion in incidence
&lt;/li&gt;&lt;li&gt;after several days of ischemia due to torsion, the appendage will necrose and eventually get reabsorbed
&lt;/li&gt;&lt;li&gt;no affect on fertility or surrounding structures
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Torsion_of_Testicular_Appendages&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;scrotal pain (milder and more gradual onset compared to testicular torsion) localized to one point of testicle
&lt;/li&gt;&lt;li&gt;exam shows hard, tender 2-3mm nodule at upper pole of testicle
&lt;/li&gt;&lt;li&gt;transillumination, ischemic appendage appears as blue dot (highly specific, only 10% sensitive)
&lt;/li&gt;&lt;li&gt;UA negative
&lt;/li&gt;&lt;li&gt;US shows normal to increased blood flow to involved appendage, symmetric testicles
&lt;ol&gt;&lt;li&gt;"Mickey Mouse" sign: juxtaposotion of testicle, enlarged appendix and epididymis
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Torsion_of_Testicular_Appendages&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;UA
&lt;/li&gt;&lt;li&gt;testicular US
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Torsion_of_Testicular_Appendages&amp;amp;action=edit&amp;amp;section=4" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;testicular torsion
&lt;/li&gt;&lt;li&gt;testicular mass
&lt;/li&gt;&lt;li&gt;epididymitis
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Torsion_of_Testicular_Appendages&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;scrotal elevation
&lt;/li&gt;&lt;li&gt;ice
&lt;/li&gt;&lt;li&gt;NSAIDS
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Torsion_of_Testicular_Appendages&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;outpatient
&lt;/li&gt;&lt;li&gt;symptoms resolve in 7-10 days
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Torsion_of_Testicular_Appendages&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from Rosen's
&lt;/p&gt;



</content><folder>GU</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="toxic_shock_syndrome"><name>Toxic Shock Syndrome</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#Epidemiology"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;Epidemiology&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Etiology"&gt;&lt;span class="tocnumber"&gt;1.2&lt;/span&gt; &lt;span class="toctext"&gt;Etiology&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Risk_Factors"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Risk Factors&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Toxic_Shock_Syndrome&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Toxic_Shock_Syndrome&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Epidemiology"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Epidemiology"&gt;Epidemiology&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;1-2/100,000 cases/yr
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Toxic_Shock_Syndrome&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Etiology"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Etiology"&gt;Etiology&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;S. aureus strain that produces toxic shock syndrome toxin-1 (superantigen)
&lt;/p&gt;&lt;p&gt;Superantigens stimulate T-cell proliferation independent of antigen-specific binding --&amp;gt; massive cytokine production
&lt;/p&gt;&lt;p&gt;Also effect neutrophil chemotaxis suppression, blockage of reticuloendothelial system
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Toxic_Shock_Syndrome&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Risk Factors"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Risk_Factors"&gt;Risk Factors&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;postop pts
&lt;/li&gt;&lt;li&gt;nasal packing
&lt;/li&gt;&lt;li&gt;abscess
&lt;/li&gt;&lt;li&gt;burns
&lt;/li&gt;&lt;li&gt;tampons
&lt;/li&gt;&lt;li&gt;IUDs
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Toxic_Shock_Syndrome&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Fever: temperature &amp;gt;38.9&#176;C
&lt;/li&gt;&lt;li&gt; Rash: diffuse macular erythroderma
&lt;/li&gt;&lt;li&gt; Hypotension: systolic blood pressure &amp;lt;90 mm Hg (adults) or &amp;lt;5th percentile for age (children younger than 16 years), or orthostatic hypotension, dizziness, or syncope
&lt;/li&gt;&lt;li&gt; Multisystem dysfunction: at least 3:
&lt;ol&gt;&lt;li&gt; Gastrointestinal: vomiting or diarrhea at onset of illness
&lt;/li&gt;&lt;li&gt; Muscular: severe myalgias, or serum creatine phosphokinase level (CPK) greater than twice the upper limit of normal
&lt;/li&gt;&lt;li&gt; Mucous membranes: vaginal, oropharyngeal, or conjunctival hyperemia
&lt;/li&gt;&lt;li&gt; Renal: blood urea nitrogen or creatinine level greater than twice the upper limit of normal, or pyuria (5 leukocytes per high-power field), in the absence of urinary tract infection
&lt;/li&gt;&lt;li&gt; Hepatic: total serum bilirubin or transaminase level greater than twice the upper limit of normal
&lt;/li&gt;&lt;li&gt; Hematologic: platelets&amp;lt;100,000/L
&lt;/li&gt;&lt;li&gt; Central nervous system: disorientation or alteration in consciousness but no focal neurologic signs at a time when fever and hypotension are absent.
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Desquamation: One to 2 weeks after the onset of illness (typically palms and soles)
&lt;/li&gt;&lt;li&gt; Evidence against an alternative diagnosis: If obtained:
&lt;ol&gt;&lt;li&gt; negative culture results for blood, throat, or cerebrospinal fluid
&lt;/li&gt;&lt;li&gt; absence of an increase in antibody titers to the agents of leptospirosis, measles, or Rocky Mountain spotted fever.
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;^&#8220;Confirmed&#8221; case meets all 6 criteria; &#8220;probable&#8221; case meets 5 of the 6.
&lt;/p&gt;&lt;p&gt;&#8224;Blood culture may be positive for S aureus.
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Toxic_Shock_Syndrome&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Abx, including Clindamycin, Vanc
&lt;/li&gt;&lt;li&gt;Supportive, pressors often
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Toxic_Shock_Syndrome&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;AnnalsofEM Nov 2009
&lt;/p&gt;



</content><folder>ID</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="toxidromes"><name>Toxidromes</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Exam"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Exam&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Toxidromes"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Toxidromes&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Toxidromes&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Exam"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Exam"&gt;Exam&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- All VS (Temp, RR,HR, BP)
&lt;/p&gt;&lt;p&gt;- Neuro Exam
&lt;/p&gt;
&lt;pre&gt;    Level of consciousness
&lt;/pre&gt;
&lt;pre&gt;    Pupillary exam
&lt;/pre&gt;
&lt;pre&gt;    Motor response
&lt;/pre&gt;
&lt;p&gt;- Skin Exam - moisture, temp
&lt;/p&gt;&lt;p&gt;- Lung Exam
&lt;/p&gt;&lt;p&gt;- Bowel Sounds
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Toxidromes&amp;amp;action=edit&amp;amp;section=2" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;I. HYPERTHERMIA
&lt;/p&gt;&lt;p&gt;1) Altered Metabolism
&lt;/p&gt;&lt;p&gt;- salicylates
&lt;/p&gt;&lt;p&gt;- withdrawal states
&lt;/p&gt;&lt;p&gt;- thyroid hormones
&lt;/p&gt;&lt;p&gt;- dinitrophenols
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;2) Increased Muscle Activity
&lt;/p&gt;&lt;p&gt;- withdrawal, sympathomimetics
&lt;/p&gt;&lt;p&gt;- MAOI
&lt;/p&gt;&lt;p&gt;-PCP, LSD
&lt;/p&gt;&lt;p&gt;- lithium, amoxapine
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;3) Impaired Heat Dissipation
&lt;/p&gt;&lt;p&gt;- anticholinergics
&lt;/p&gt;&lt;p&gt;- antihistamines
&lt;/p&gt;&lt;p&gt;- antipsychotics (TCAs)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;4) Malignant Hyperthermia
&lt;/p&gt;&lt;p&gt;- anesthestics
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;5) Neuroleptic Malignant Syndrome
&lt;/p&gt;&lt;p&gt;- phenothiazines, Lithium, LevoDopa
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;II. HYPOTHERMIA
&lt;/p&gt;&lt;p&gt;1) Exposure
&lt;/p&gt;&lt;p&gt;- alcohol, sedative hypnotics
&lt;/p&gt;&lt;p&gt;- narcotics, TCAs, phenothiazines
&lt;/p&gt;&lt;p&gt;- Insulin (hypoglycemia)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;III. INCREASED RESPIRATORY RATE
&lt;/p&gt;&lt;p&gt;1) Direct Stimulation
&lt;/p&gt;&lt;p&gt;- salicylates
&lt;/p&gt;&lt;p&gt;- metabolic acidosis
&lt;/p&gt;&lt;p&gt;- dintirophenol, pentachlorophenol
&lt;/p&gt;&lt;p&gt;- hepatorenal failure
&lt;/p&gt;&lt;p&gt;- CNS stimulants (cocaine, amphet,
&lt;/p&gt;&lt;p&gt;theophylline)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;IV. TISSUE HYPOXIA
&lt;/p&gt;&lt;p&gt;- CO
&lt;/p&gt;&lt;p&gt;- cyanide
&lt;/p&gt;&lt;p&gt;-hydrogen sulfide
&lt;/p&gt;&lt;p&gt;- methemoglobinemia
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;V. RESPIRATORY DEPRESSION
&lt;/p&gt;&lt;p&gt;1) Central Depression
&lt;/p&gt;&lt;p&gt;- antipsychotics
&lt;/p&gt;&lt;p&gt;- chlorinated hydrocarbons
&lt;/p&gt;&lt;p&gt;- alcohols/glycols, sedative/hyp
&lt;/p&gt;&lt;p&gt;- TCAs
&lt;/p&gt;&lt;p&gt;- Lomitil
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;2) Muscle Failure
&lt;/p&gt;&lt;p&gt;- organophosphates
&lt;/p&gt;&lt;p&gt;- marine toxins
&lt;/p&gt;&lt;p&gt;- nicotine
&lt;/p&gt;&lt;p&gt;- strychnine
&lt;/p&gt;&lt;p&gt;- botulinis
&lt;/p&gt;&lt;p&gt;- Mojave rattlesnake, Cobra
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;VI. AUTONOMIC NERVOUS SYSTEM
&lt;/p&gt;&lt;p&gt;1) Parasympathetic - ACh is transm
&lt;/p&gt;&lt;p&gt;a) Muscarinic
&lt;/p&gt;&lt;p&gt;-receptors in heart, eye, lung, GI, skin and sweat glands
&lt;/p&gt;&lt;p&gt;- Bradycardia
&lt;/p&gt;&lt;p&gt;- Miosis
&lt;/p&gt;&lt;p&gt;- Bronchorrhea / Bronchospasm
&lt;/p&gt;&lt;p&gt;- Hyperperistalsis (SLUDGE)
&lt;/p&gt;&lt;p&gt;- Sweating
&lt;/p&gt;&lt;p&gt;- Vasodilation
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;b) Nicotinic
&lt;/p&gt;&lt;p&gt;- receptors in both sympathetic and parasympathetic nervous systems
&lt;/p&gt;&lt;p&gt;- fasciculations, flaccid paralysis
&lt;/p&gt;&lt;p&gt;- tachycardia, hypertension?
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;2) Sympathetic
&lt;/p&gt;&lt;p&gt;ALPHA EFFECTS - vessels, eye, skin
&lt;/p&gt;&lt;p&gt;- Mydriasis, HTN, Sweating
&lt;/p&gt;&lt;p&gt;BETA EFFECTS - heart, lungs
&lt;/p&gt;&lt;p&gt;- Tachycardia, Bronchodilation
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Toxidromes&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Toxidromes"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Toxidromes"&gt;Toxidromes&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1. MIXED CHOLINERGIC (ORGANOPH) Temp Normal
&lt;/p&gt;&lt;p&gt;RR Increased (spasm -M
&lt;/p&gt;&lt;p&gt;inc secretions)
&lt;/p&gt;&lt;p&gt;Decreased (N- paralysis)
&lt;/p&gt;&lt;p&gt;HR Tachycardia (N-pregang
&lt;/p&gt;&lt;p&gt;or Normal or Brady (M)
&lt;/p&gt;&lt;p&gt;BP HTN (N)
&lt;/p&gt;&lt;p&gt;LOC Normal to Lethargic
&lt;/p&gt;&lt;p&gt;Pupils Miotic (M) or Nl or Mydr (N)
&lt;/p&gt;&lt;p&gt;Motor Facciculations, Flacid Paral
&lt;/p&gt;&lt;p&gt;Skin Sweating (mod to marked
&lt;/p&gt;&lt;p&gt;Lungs Bronchospasm/ rrhea
&lt;/p&gt;&lt;p&gt;BSs Hyperactive (SLUDGE)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;ANTICHOLINERGIC
&lt;/p&gt;&lt;p&gt;(TCAs, antihist, phenothiazines)
&lt;/p&gt;&lt;p&gt;Temp Nl to Inc (dec sweating)
&lt;/p&gt;&lt;p&gt;RR Nl to Dec
&lt;/p&gt;&lt;p&gt;HR Tachy (unopposed B1)
&lt;/p&gt;&lt;p&gt;LOC Nl or delirious, agitated,
&lt;/p&gt;&lt;p&gt;psychotic, comatose
&lt;/p&gt;&lt;p&gt;Pupils Mydriasis (unoppos alpha)
&lt;/p&gt;&lt;p&gt;Motor Nl
&lt;/p&gt;&lt;p&gt;Skin Dry, hot
&lt;/p&gt;&lt;p&gt;Lungs Nl
&lt;/p&gt;&lt;p&gt;BSs Decr to Absent
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;SYMPATHOMIMETIC
&lt;/p&gt;&lt;p&gt;(Cocaine, amphet, ecstasy, ketamine
&lt;/p&gt;&lt;p&gt;Temp Nl to Inc (muscle activ inc)
&lt;/p&gt;&lt;p&gt;RR Inc or Dec
&lt;/p&gt;&lt;p&gt;HR Inc (Beta 1)
&lt;/p&gt;&lt;p&gt;BP Inc (alpha 1)
&lt;/p&gt;&lt;p&gt;LOC Nl, agitated, del or psycho
&lt;/p&gt;&lt;p&gt;Pupils Mydriatic (alpha 1)
&lt;/p&gt;&lt;p&gt;Motor Nl to Agitated
&lt;/p&gt;&lt;p&gt;Skin Sweating
&lt;/p&gt;&lt;p&gt;Lungs Nl
&lt;/p&gt;&lt;p&gt;BSs Nl to Dec
&lt;/p&gt;&lt;p&gt;- usually more tachy and higher BP than anticholinergic and not dry as in anticholinergic.
&lt;/p&gt;&lt;p&gt;- Dexatrim or Ephedrine - alpha stim, can give phentolamine or Nipride
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;SYMPATHOLYTIC (Clonidine)
&lt;/p&gt;&lt;p&gt;Temp Nl to Dec
&lt;/p&gt;&lt;p&gt;RR Nl to Dec
&lt;/p&gt;&lt;p&gt;HR, BP Nl to Dec
&lt;/p&gt;&lt;p&gt;LOC Nl, Lethargic, or Comatose
&lt;/p&gt;&lt;p&gt;Pupils Nl to Miotic
&lt;/p&gt;&lt;p&gt;Motor Nl
&lt;/p&gt;&lt;p&gt;Skin Dry
&lt;/p&gt;&lt;p&gt;Lungs Nl
&lt;/p&gt;&lt;p&gt;BSs Nl to Dec
&lt;/p&gt;&lt;p&gt;- Consider Sympatholytic when looking at Sedative OD or someone who doesn't respond to Narcan.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;SEDATIVE / HYPNOTIC
&lt;/p&gt;&lt;p&gt;Temp Nl to Dec
&lt;/p&gt;&lt;p&gt;RR, HR Nl to Dec All Nl
&lt;/p&gt;&lt;p&gt;LOC Nl to Leth
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Toxidromes&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;DONALDSON (Adapted from BIRNBAUMER - 7/18/02)
&lt;/p&gt;



</content><folder>Tox</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="traditional_chinese_medicine"><name>Traditional Chinese Medicine</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Traditional_Chinese_Medicine&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Major Groups"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Major_Groups"&gt;Major Groups&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1) Aconitine Group
&lt;/p&gt;
&lt;pre&gt;    -Cardiotoxicity (ventricular arrhythmia + hypotension)
&lt;/pre&gt;
&lt;p&gt;2) Podophyllin Group
&lt;/p&gt;
&lt;pre&gt;    -Neurotoxicity (convulsion + coma)
&lt;/pre&gt;
&lt;p&gt;3) Anticholinergic group
&lt;/p&gt;
&lt;pre&gt;    -Tachy arrythmia + altered mental status
&lt;/pre&gt;
&lt;p&gt;4) Digoxin-like agents
&lt;/p&gt;&lt;p&gt;5) Other
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Traditional_Chinese_Medicine&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;EPI
&lt;/p&gt;



</content><folder>Tox</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="transfusion_reactions"><name>Transfusion Reactions</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Transfusion_Reactions&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Acute"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Acute"&gt;Acute&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Intravascular Hemolytic TR
&lt;ol&gt;&lt;li&gt;ABO inconpatability --&amp;gt; serious
&lt;/li&gt;&lt;li&gt;Sx: fever/ch/joint or back pain/shock
&lt;/li&gt;&lt;li&gt;Tx: stop, fluids+lasix, re-check blood
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Febrile TR
&lt;ol&gt;&lt;li&gt;anitbodies --&amp;gt; mild
&lt;/li&gt;&lt;li&gt;Sx: fever/ch/malaise
&lt;/li&gt;&lt;li&gt;Tx: R/O above
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Allergic
&lt;ol&gt;&lt;li&gt;Tx as allergic Rx --&amp;gt; range
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Transfusion-Related Acute Lung Injury (TRALI)
&lt;ol&gt;&lt;li&gt;Sx: acute ARDS-like injury --&amp;gt; severe
&lt;/li&gt;&lt;li&gt;Tx: stop trans, Tx as ARDS
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Sepsis (Bacterial Contamination)
&lt;/li&gt;&lt;li&gt; Fluid Overload
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Transfusion_Reactions&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Delayed"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Delayed"&gt;Delayed&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Extravascular Hemolytic TR
&lt;ol&gt;&lt;li&gt;days-weeks after --&amp;gt; mild
&lt;/li&gt;&lt;li&gt;Sx: fever/anemia/jaundice
&lt;/li&gt;&lt;li&gt;Tx: none
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Graft-vs-Host
&lt;ol&gt;&lt;li&gt;in leukemia/lymphoma pt if given trans after chemo (use leuk-poor components)
&lt;/li&gt;&lt;li&gt;Sx: fever/rash/n/v/inc LFTs/pancytopenia --&amp;gt; severe
&lt;/li&gt;&lt;li&gt;Tx: no effective Tx --&amp;gt; death
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Hemosiderosis
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Transfusion_Reactions&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;2/18/06 DONALDSON (adapted from Rosen)
&lt;/p&gt;



</content><folder>Heme/Onc</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="transfusions"><name>Transfusions</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#PRBCs"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;PRBCs&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#Usual_Dose"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;Usual Dose&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Indications_.28by_Hb.29"&gt;&lt;span class="tocnumber"&gt;1.2&lt;/span&gt; &lt;span class="toctext"&gt;Indications (by Hb)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#FFP"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;FFP&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Usual_Dose_2"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;Usual Dose&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-6"&gt;&lt;a href="#Indications"&gt;&lt;span class="tocnumber"&gt;2.2&lt;/span&gt; &lt;span class="toctext"&gt;Indications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Platelets"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Platelets&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-8"&gt;&lt;a href="#Usual_Dose_3"&gt;&lt;span class="tocnumber"&gt;3.1&lt;/span&gt; &lt;span class="toctext"&gt;Usual Dose&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-9"&gt;&lt;a href="#Indications_2"&gt;&lt;span class="tocnumber"&gt;3.2&lt;/span&gt; &lt;span class="toctext"&gt;Indications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-10"&gt;&lt;a href="#Risks"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Risks&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-11"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Transfusions&amp;amp;action=edit&amp;amp;section=1" title="Edit section: PRBCs"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="PRBCs"&gt;PRBCs&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Transfusions&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Usual Dose"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Usual_Dose"&gt;Usual Dose&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;1 U of PRBCs (250 mL or 3 mL/kg in peds) --&amp;gt; incr Hgb ~1.0
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Transfusions&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Indications (by Hb)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Indications_.28by_Hb.29"&gt;Indications (by Hb)&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Normal (rarely if &amp;gt;10; almost always if &amp;lt;6)
&lt;/li&gt;&lt;li&gt;Critically ill, otherwise healthy (keep &amp;gt; 7-9)
&lt;/li&gt;&lt;li&gt;Ischemic heart dz/critically ill age &amp;gt;65 (keep &amp;gt;10)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Transfusions&amp;amp;action=edit&amp;amp;section=4" title="Edit section: FFP"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="FFP"&gt;FFP&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Transfusions&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Usual Dose"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Usual_Dose_2"&gt;Usual Dose&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;10-20 ml/kg (average adult = 3-6 units)
&lt;/li&gt;&lt;li&gt;2 U of FFP (450 mL) should correct most early coagulopathies
&lt;/li&gt;&lt;li&gt;An INR of 2.0 correlates w/ PT 1.5 times nl
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Transfusions&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Indications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Indications"&gt;Indications&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Active bleeding AND PT/PTT &amp;gt;1.5 times nl (INR &amp;gt;2.0)
&lt;/li&gt;&lt;li&gt; INR &amp;gt;20.0
&lt;/li&gt;&lt;li&gt; Massive PRBC transfusion (&amp;gt;9 U)
&lt;/li&gt;&lt;li&gt; DIC not corrected by cryo.
&lt;/li&gt;&lt;li&gt; Coumadin overdose AND life threat bleed/invasive procedure
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Transfusions&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Platelets"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Platelets"&gt;Platelets&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Transfusions&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Usual Dose"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Usual_Dose_3"&gt;Usual Dose&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;1 U per 10kg (~6-10 U) --&amp;gt; incr plat ~25,000.
&lt;/li&gt;&lt;li&gt;1 U (25-50 mL = "6-pack") --&amp;gt; incr plat 5-10,000 (adult) or 20,000 (20 kg child)
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Transfusions&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Indications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Indications_2"&gt;Indications&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;See "HEME: Thrombocytopenia
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Transfusions&amp;amp;action=edit&amp;amp;section=10" title="Edit section: Risks"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Risks"&gt;Risks&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Hep B ~1:100,000
&lt;/li&gt;&lt;li&gt;Hep C ~1:1 million
&lt;/li&gt;&lt;li&gt;HIV 1:2 million
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Transfusions&amp;amp;action=edit&amp;amp;section=11" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;2/18/06 DONALDSON (addapted from Rosen, Lampe, Charfen)
&lt;/p&gt;



</content><folder>Heme/Onc</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="transient_(toxic)_synovitis_(hip)"><name>Transient (Toxic) Synovitis (Hip)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Prognosis"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Prognosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Transient_(Toxic)_Synovitis_(Hip)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Short-lived acute inflam of synovium of hip
&lt;/p&gt;&lt;p&gt;Usually unilateral
&lt;/p&gt;&lt;p&gt;Ages 2y-10y (peak 3-6)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Transient_(Toxic)_Synovitis_(Hip)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Presentation
&lt;/p&gt;&lt;p&gt;- 70% present after recent viral URI
&lt;/p&gt;&lt;p&gt;- pts may have a low grade fever
&lt;/p&gt;&lt;p&gt;-Pain at hip radiates to thigh &amp;amp; knee
&lt;/p&gt;&lt;p&gt;-Hip held in flex &amp;amp; adduction
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Radiography:
&lt;/p&gt;&lt;p&gt;-AP pelvis may show effusion (joint widening)
&lt;/p&gt;&lt;p&gt;-Ultrasound: effusion present in 95%
&lt;/p&gt;&lt;p&gt;Labs:
&lt;/p&gt;&lt;p&gt;-CBC and ESR/CRP nl to slightly elevated 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Dx of exclusion
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;if any of following think septic hip: T &amp;gt;37.5, ESR &amp;gt;20. Pts w/ this had lower temp w/ avg wbc of 11.2 vs 13.2 if septic hip, but large degree of overlap! best test to differentiate is PE, w/ septic hip xtreme pain w/ minimal movt, TTS usu can tolerate ranging until xtreme movts!
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Transient_(Toxic)_Synovitis_(Hip)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-Bed rest
&lt;/p&gt;&lt;p&gt;-NSAIDs
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Transient_(Toxic)_Synovitis_(Hip)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Prognosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Prognosis"&gt;Prognosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-75% have resolution of sxs w/in 2 weeks; may last up to a month
&lt;/p&gt;&lt;p&gt;-Repeat XR in 6 mo to r/o L-C-P (2-6% will develop L-C-P)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Transient_(Toxic)_Synovitis_(Hip)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Peds: Hip Pain
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="transient_ischemic_attack_(tia)"><name>Transient Ischemic Attack (TIA)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Definition"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Definition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-7"&gt;&lt;a href="#ABCD2_SCORE"&gt;&lt;span class="tocnumber"&gt;6.1&lt;/span&gt; &lt;span class="toctext"&gt;ABCD2 SCORE&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Transient_Ischemic_Attack_(TIA)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Definition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Definition"&gt; Definition &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;"Transient episode of neurological dysfunction caused by focal brain, spinal cord, or retinal ischemia without infarction.&#8221; Stroke 2009;40[6]:2276
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Transient_Ischemic_Attack_(TIA)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt; Background &lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Ischemic
&lt;ol&gt;&lt;li&gt;Thrombosis
&lt;/li&gt;&lt;li&gt;Vasculitis
&lt;/li&gt;&lt;li&gt;Dissection
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Embolic
&lt;ol&gt;&lt;li&gt;Cardiac
&lt;/li&gt;&lt;li&gt;Carotids
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Vasospasm
&lt;/li&gt;&lt;li&gt;Hypotension (watershed)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Transient_Ischemic_Attack_(TIA)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt; DDx &lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Hypoglycemia
&lt;/li&gt;&lt;li&gt;Infectious endocarditis
&lt;/li&gt;&lt;li&gt;Complex migraines
&lt;/li&gt;&lt;li&gt;Peripheral cranial nerve lesions
&lt;/li&gt;&lt;li&gt;Seizure
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Transient_Ischemic_Attack_(TIA)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt; Work-Up &lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Head CT
&lt;/li&gt;&lt;li&gt;Labs
&lt;ol&gt;&lt;li&gt;CBC (thrombocytosis)
&lt;/li&gt;&lt;li&gt;Chemistry (hyponatremia)
&lt;/li&gt;&lt;li&gt;Coags
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;ECG (a-fib)
&lt;/li&gt;&lt;li&gt;CXR
&lt;/li&gt;&lt;li&gt;&amp;nbsp;?MRI/MRA or&amp;nbsp;?Neuro labs (ESR?, lipids?)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Transient_Ischemic_Attack_(TIA)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt; Treatment &lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Head of bed lowered
&lt;/li&gt;&lt;li&gt;Permissive hypertension
&lt;/li&gt;&lt;li&gt;NS 500cc bolus, then 150cc/hr (non-CHF/fluid overloaded)
&lt;/li&gt;&lt;li&gt;ASA
&lt;/li&gt;&lt;li&gt;Heparin if cardiac embolic source/a-fib (usually different vascular territories)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Transient_Ischemic_Attack_(TIA)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt; Disposition &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;AHA/ASA guidelines: Reasonable to hospitalize patients with TIA who present w/in 72 hr of symptom onset and meet any of the following criteria:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;ABCD2 score of &#8805; 3
&lt;/li&gt;&lt;li&gt;ABCD2 score of 0-2 and uncertainty that the diagnostic workup can be completed within two days as an outpatient
&lt;/li&gt;&lt;li&gt;ABCD2 score of 0-2 and other evidence that the event was caused by focal ischemia
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Transient_Ischemic_Attack_(TIA)&amp;amp;action=edit&amp;amp;section=7" title="Edit section: ABCD2 SCORE"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="ABCD2_SCORE"&gt; ABCD2 SCORE &lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt;Age &amp;gt; 60 (1 pt)
&lt;/li&gt;&lt;li&gt;Blood pressure (SBP &amp;gt;140 OR diastolic &amp;gt;90) (1 pt)
&lt;/li&gt;&lt;li&gt;Clinical Features
&lt;ul&gt;&lt;li&gt;unilateral weakness (2 pt)
&lt;/li&gt;&lt;li&gt;isolated speech disturbance (1 pt)
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Duration of symptoms
&lt;ul&gt;&lt;li&gt;&amp;gt;60 min (2 pt)
&lt;/li&gt;&lt;li&gt;10-59 min (1 pt)
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Diabetes (1 pt)
&lt;/li&gt;&lt;/ul&gt;
&lt;table style="width: 500px" border="1" cellpadding="1" cellspacing="1"&gt;

&lt;tr&gt;
&lt;td&gt; &lt;b&gt;Points&lt;br /&gt;&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Risk&lt;br /&gt;&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Two Days&lt;br /&gt;&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;Seven Days &lt;br /&gt;&lt;/b&gt;
&lt;/td&gt;&lt;td&gt; &lt;b&gt;90 Days&lt;br /&gt;&lt;/b&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 0-3&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Low&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 1.0%&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 1.2%&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 3.1%&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 4-5&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Moderate&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 4.1%&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 5.9%&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 9.8%&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; 6-7&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; High&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 8.1%&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 11.7%&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 17.8%&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;p&gt;None with score &amp;lt; 3 had CVA within one week in study
&lt;/p&gt;&lt;p&gt;National Stroke Association reccomends hospitalization be considered for pts with first TIA w/in past 24-48 hours, and is generally recommended for pts with the following conditions:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Crescendo TIA
&lt;/li&gt;&lt;li&gt;Duration of symptoms &amp;gt; 1hr
&lt;/li&gt;&lt;li&gt;Symptomatic carotid stenosis &amp;gt; 50%
&lt;/li&gt;&lt;li&gt;Known cardiac source of embolus
&lt;/li&gt;&lt;li&gt;Known hypercoaguable state
&lt;/li&gt;&lt;li&gt;High risk of early stroke after TIA
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;TIA ADMIT (nmlly neg sy; &amp;lt;1hr)
&lt;/p&gt;&lt;p&gt;1) any Johnson criteria
&lt;/p&gt;&lt;p&gt;2) &amp;lt;1 wk from onset
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Transient_Ischemic_Attack_(TIA)&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt; Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;DONALDSON (Smith, Lampe, NEJM '07, Pani)
&lt;/p&gt;



</content><folder>Neuro</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="trauma_(peds)"><name>Trauma (Peds)</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Trauma_(Peds)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Peds triad is appearance, work of breathing &amp;amp; circulation (skin color)
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Childs size allows for dist of injuries, thus mutliple trauma is common &amp;amp; internal organs more susceptible to injury d/t more ant placement of liver &amp;amp; spleen (&amp;amp; less protective muscle &amp;amp; fat), Kidenys also less well protected and more mobile=more prone to decel injury
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Wadell Triad in auto/ped= CHI, abd inj, femur Fx
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;AIRWAY/BREATHING
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Cricoid ring is narrowest part of airway allowing for uncuffed tubes up to 6.0 ETT or up to about 8 yrs
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;CIRCULATION
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Key is to recognize &amp;amp; Rx shock early (before decr BP), s/s of shock= child may have lost 25% of BV
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;BP not usu helpful sign of blood loss in peds, can be in shock w/ incr, decr or nl BP b/c kids are more effective at incre HR &amp;amp; SVR (pp=key)
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;In field stop bleeding w/ pressure &amp;amp; elevation, MAST never shown to help kids
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;In ED give IVF @ 20cc/kg, if unresponsive after 40cc/kg give PRBC @ 10cc/kg (can start w/ PRBC if presents in decompensated shock &amp;amp; multip inj suspected)
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Chest Tube in Peds is 4 X ETT
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Dip urine if NO blood stop, if blood send UA (+blood on dip= NO correlation w/ RBCs), if on UA &amp;gt;20 RBC's do CT to chk kidneys (Renal inj common, followed by bladder, urethra/ureteral are xtremely rare
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;In sick trauma can skip c/s and just immobilize!
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;CT A/P is study of choice but may miss hollow visceral injury (may take 1-2 days to see periton. signs)
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Shock w/ no response to IVF, think T-PTX or card tamponade
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Unstable pts, no response to IVF/PRBC= OR!
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;DISABILITY
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;SCIWORA (2-21% of pts&amp;lt;8yr w/ spinal inj)
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;C/S increased preodontoid space (up to 4-5mm vs 3mm in adult)
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;pseudosubluxation C2 on C3 in 40% (up to teens), chk for true sublux by drawing line from ant cortical margin of spinous process (spinolaminar) of C1 to spinolaminar line of C3 (line of Swischuk), if line is &amp;gt;1-2mm from ant cort margin of C2 spinous process suspect TRUE sublux OR Fx!
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Chance Fx (L spine Fx) from forward flexion over lap belt (usu of L1-L4), 50% assoc w/ intraabdominal inj!
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;80% of peds trauma deaths assoc w/ neurologic inj (see HCT/Head trauma memo)
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;MISC.
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;suspect physical abuse (cause of 60% femur fx if &amp;lt;1y &amp;amp; 100% non-supracond hum fx &amp;lt;3y), skeletal survey if &amp;lt;3y &amp;amp; suspect abuse.
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;missed inj common, usu d/t aloc, etoh. kids usu decr b/c we are hypervigilent. most common is muscskel so MUST xray joint above &amp;amp; below injured ext!! If BHT or ortho &amp;amp; nd OR r/o abd inj 1st!!
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Re-exam is key, try &amp;amp; do gd secondary survey before OR.
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Lat c-s xr alone misses 15% of fx! nd all 3 views.
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Trauma_(Peds)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Gausche 2004 -by Lampe
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="trauma_in_pregnancy"><name>Trauma in Pregnancy</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis_.28Abruption.29"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis (Abruption)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Treatment_.26_Disposition"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment &amp;amp; Disposition&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Risk_Factors_.28ATLS.29"&gt;&lt;span class="tocnumber"&gt;3.1&lt;/span&gt; &lt;span class="toctext"&gt;Risk Factors (ATLS)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Abnormal_Monitoring"&gt;&lt;span class="tocnumber"&gt;3.2&lt;/span&gt; &lt;span class="toctext"&gt;Abnormal Monitoring&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Trauma_in_Pregnancy&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Concern for trauma and abruption
&lt;/li&gt;&lt;li&gt;Viable = &amp;gt;20-24wk (~fundus above umbilicus)
&lt;/li&gt;&lt;li&gt;nl FHR = 120-160 beats/min
&lt;/li&gt;&lt;li&gt;For maternal vitals see OB/GYN: Vitals
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Trauma_in_Pregnancy&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis (Abruption)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis_.28Abruption.29"&gt;Diagnosis (Abruption)&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Symptoms
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Vag bleed
&lt;/li&gt;&lt;li&gt;Cramps/contractions
&lt;/li&gt;&lt;li&gt;Uterine tenderness
&lt;/li&gt;&lt;li&gt;Hypovolemia
&lt;/li&gt;&lt;li&gt;Abnl fetal HR
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;US only 50% acurate
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Trauma_in_Pregnancy&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment &amp;amp; Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment_.26_Disposition"&gt;Treatment &amp;amp; Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Nonviable fetus (&amp;lt;20-24wks)
&lt;ol&gt;&lt;li&gt;Standard treatment for trauma
&lt;/li&gt;&lt;li&gt;Consider RhoGAM
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Viable fetus (&amp;gt;20-24wks)
&lt;ol&gt;&lt;li&gt;Consider RhoGAM
&lt;/li&gt;&lt;li&gt;Monitor (fetal) all for 4-6hrs --&amp;gt;
&lt;/li&gt;&lt;li&gt;Extend Monitoring to 24hrs, if risk factor or abnormal 6hr monitoring
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Trauma_in_Pregnancy&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Risk Factors (ATLS)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Risk_Factors_.28ATLS.29"&gt;Risk Factors (ATLS)&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Maternal heart rate &amp;gt; 100
&lt;/li&gt;&lt;li&gt;Injury  Severity Score &amp;gt; 9
&lt;/li&gt;&lt;li&gt;Evidence of placental abruption
&lt;/li&gt;&lt;li&gt;Fetal heart rate  &amp;gt; 160 or  &amp;lt;120
&lt;/li&gt;&lt;li&gt;Ejection during a motor vehicle crash
&lt;/li&gt;&lt;li&gt;Motorcycle or pedestrian collisions
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Trauma_in_Pregnancy&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Abnormal Monitoring"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Abnormal_Monitoring"&gt;Abnormal Monitoring&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;&amp;gt;3 contractions/hr
&lt;/li&gt;&lt;li&gt;Persistant uterine TTP
&lt;/li&gt;&lt;li&gt;Worisome strip
&lt;/li&gt;&lt;li&gt;Vag bleed
&lt;/li&gt;&lt;li&gt;PROM
&lt;/li&gt;&lt;li&gt;Serious maternal injury
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;Partial abrution w/ stable mom/fetus and &amp;lt;32wk may have expectant care (with easy access to emergent C-section)
&lt;/p&gt;&lt;p&gt;Abrupion = risk DIC
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Trauma_in_Pregnancy&amp;amp;action=edit&amp;amp;section=6" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;See OB/GYN: Fetal Maternal Hemorrhage (RhoGAM)
&lt;/p&gt;&lt;p&gt;See Procedures: Perimortum C-Section
&lt;/p&gt;&lt;p&gt;See OB/GYN: Abruption
&lt;/p&gt;&lt;p&gt;See OB/GYN: Vitals
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Trauma_in_Pregnancy&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;3/29/06 DONALDSON (adapted from Rosen)
&lt;/p&gt;



</content><folder>OB/GYN</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="traumatic_hyphema"><name>Traumatic Hyphema</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Clinical_Features"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Clinical Features&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Prognosis"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Prognosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Traumatic_Hyphema&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Typically casued by blunt trauma to the orbit 
&lt;/li&gt;&lt;li&gt;Main concern = rebleeding and elevated intraocular pressure
&lt;/li&gt;&lt;li&gt;Worse around days 3-5 
&lt;/li&gt;&lt;li&gt;Can result in permanent vision loss 
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Traumatic_Hyphema&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Clinical Features"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Clinical_Features"&gt;Clinical Features&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Blood in the anterior chamber 
&lt;/li&gt;&lt;li&gt;Vision loss
&lt;/li&gt;&lt;li&gt;Eye pain
&lt;/li&gt;&lt;li&gt;Direct and consenual photophobia 
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Traumatic_Hyphema&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Slit lamp
&lt;/li&gt;&lt;li&gt;Check pressure once globe rupture is excluded!
&lt;/li&gt;&lt;li&gt;Consider CT
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Traumatic_Hyphema&amp;amp;action=edit&amp;amp;section=4" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Ruptured globe
&lt;/li&gt;&lt;li&gt;Retinal detachment
&lt;/li&gt;&lt;li&gt;Rebleeding
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Traumatic_Hyphema&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Elevation of the head
&lt;/li&gt;&lt;li&gt;Eye shield
&lt;/li&gt;&lt;li&gt;Pharmacologic control of pain and emesis 
&lt;/li&gt;&lt;li&gt;Bed rest
&lt;/li&gt;&lt;li&gt;No reading (accommodation may further stress injured blood vessels)
&lt;/li&gt;&lt;li&gt;Cycloplegic
&lt;ol&gt;&lt;li&gt;For comfort if globe rupture has been excluded
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Topical steroid 
&lt;/li&gt;&lt;li&gt;Treat any underlying coagulopathy
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Traumatic_Hyphema&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Inpatient:
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;suspected child abuse
&lt;/li&gt;&lt;li&gt;bleeding dyscrasia
&lt;/li&gt;&lt;li&gt;sickle hemoglobinopathy
&lt;/li&gt;&lt;li&gt;intraocular hypertension on initial examination
&lt;/li&gt;&lt;li&gt;delayed presentation
&lt;/li&gt;&lt;li&gt;large hyphemas (&amp;gt;50% anterior chamber) 
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Traumatic_Hyphema&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Prognosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Prognosis"&gt;Prognosis&lt;/span&gt;&lt;/h2&gt;
&lt;table border="1"&gt;
&lt;tr&gt;
&lt;td&gt; Grade
&lt;/td&gt;&lt;td&gt; Ant Chamber Filling&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; Nl Vision Prognosis&lt;br /&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; I
&lt;/td&gt;&lt;td&gt; &amp;lt;33%
&lt;/td&gt;&lt;td&gt; 90%
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; II
&lt;/td&gt;&lt;td&gt; 33-50%
&lt;/td&gt;&lt;td&gt; 70%
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; III
&lt;/td&gt;&lt;td&gt; &amp;gt;50%
&lt;/td&gt;&lt;td&gt; 50%
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; IV
&lt;/td&gt;&lt;td&gt; 100%
&lt;/td&gt;&lt;td&gt; 50%
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Traumatic_Hyphema&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;UpToDate
&lt;/p&gt;



</content><folder>Ophtho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="traumatic_iritis"><name>Traumatic Iritis</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Traumatic_Iritis&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; cell &amp;amp; flare like uveitis
&lt;/li&gt;&lt;li&gt; high risk rebleeding in 5 days
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Traumatic_Iritis&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; tx c atropine, prednisone
&lt;/li&gt;&lt;li&gt; consider aminocaproic acid to decrease rate of fibrin degradation and prevent rebleeding
&lt;/li&gt;&lt;li&gt; elevate head of bed to prevent staining
&lt;/li&gt;&lt;li&gt; no valsalva
&lt;/li&gt;&lt;li&gt; recheck q d X 5 d, then 2 d p stopping amicar.
&lt;/li&gt;&lt;/ol&gt;




</content><folder>Ophtho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="travel_medicine"><name>Travel Medicine</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Fever"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Fever&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#Malaria"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;Malaria&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Dengue"&gt;&lt;span class="tocnumber"&gt;1.2&lt;/span&gt; &lt;span class="toctext"&gt;Dengue&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Rickettsia.2F_Typhus"&gt;&lt;span class="tocnumber"&gt;1.3&lt;/span&gt; &lt;span class="toctext"&gt;Rickettsia/ Typhus&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Leptospirosis"&gt;&lt;span class="tocnumber"&gt;1.4&lt;/span&gt; &lt;span class="toctext"&gt;Leptospirosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-6"&gt;&lt;a href="#Typhoid_Fever"&gt;&lt;span class="tocnumber"&gt;1.5&lt;/span&gt; &lt;span class="toctext"&gt;Typhoid Fever&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-7"&gt;&lt;a href="#Hemorrhagic_Fever"&gt;&lt;span class="tocnumber"&gt;1.6&lt;/span&gt; &lt;span class="toctext"&gt;Hemorrhagic Fever&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#CNS_Changes_and_Fever"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;CNS Changes and Fever&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#Resp_Sx_and_Fever"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Resp Sx and Fever&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-10"&gt;&lt;a href="#Sex.2F_Blood_Exposure_and_Fever"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Sex/ Blood Exposure and Fever&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-11"&gt;&lt;a href="#Eosinophilic_Fever"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Eosinophilic Fever&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-12"&gt;&lt;a href="#Diarrhea"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Diarrhea&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-13"&gt;&lt;a href="#Skin_Conditions"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Skin Conditions&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-14"&gt;&lt;a href="#Papules"&gt;&lt;span class="tocnumber"&gt;7.1&lt;/span&gt; &lt;span class="toctext"&gt;Papules&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-15"&gt;&lt;a href="#Sub_Q_Swelling_and_Nodules"&gt;&lt;span class="tocnumber"&gt;7.2&lt;/span&gt; &lt;span class="toctext"&gt;Sub Q Swelling and Nodules&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-16"&gt;&lt;a href="#Ulcers"&gt;&lt;span class="tocnumber"&gt;7.3&lt;/span&gt; &lt;span class="toctext"&gt;Ulcers&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-17"&gt;&lt;a href="#Linear_and_Migratory_Lesions"&gt;&lt;span class="tocnumber"&gt;7.4&lt;/span&gt; &lt;span class="toctext"&gt;Linear and Migratory Lesions&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-18"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Travel_Medicine&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Fever"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Fever"&gt;Fever&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; get incubation period- if &amp;gt; 1mo, dengue, rickettsia, viral hem fvr less likely
&lt;/li&gt;&lt;li&gt; cbc c diff, thick smear, lft, ua, blood/ stool cx, cxr, serologies for specific viruses
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Travel_Medicine&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Malaria"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Malaria"&gt;Malaria&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; most imp cause of fvr
&lt;/li&gt;&lt;li&gt; plasmodium falciparum can be rapidly fatal and needs to be ruled out soon
&lt;/li&gt;&lt;li&gt; p falciparum from sub Saharan Africa, 90% of pt have sx within 1 mo of return
&lt;/li&gt;&lt;li&gt; p vivax- Asia and Latin, 50% pt have sx within 1 mo- 2% up to 1 yr out
&lt;/li&gt;&lt;li&gt; chemoprophylaxsis does not guarantee protection
&lt;/li&gt;&lt;li&gt; usually have fvr, but 10- 40% may not
&lt;/li&gt;&lt;li&gt; fvr q 48- 72 hr pathognomic of vivax, ovale, malariae infc
&lt;/li&gt;&lt;li&gt; can also have ha, cough, gi sx
&lt;/li&gt;&lt;li&gt; check thick smear initially and if neg, repeat in 12- 24 hrs
&lt;/li&gt;&lt;li&gt; thrombocytopenia and splenomegaly common
&lt;/li&gt;&lt;li&gt; p falciparum unpredictable- admit and monitor for hypoglycemia
&lt;/li&gt;&lt;li&gt; iv meds if renal, resp failure, ams, sx, shock, anemia, p falcip rbc load &amp;gt;4% in nonimmune pt
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Travel_Medicine&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Dengue"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Dengue"&gt;Dengue&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;aedes mosquito in urban area
&lt;/li&gt;&lt;li&gt; incubate for 4- 7d, influenza like prodrome, fvr, ha, myalgia, LN, rash
&lt;/li&gt;&lt;li&gt; dengue shock syndrome and hem fvr rare in travelers- usually in pt c prev infc
&lt;/li&gt;&lt;li&gt; leukopenia, thrombocytopenia
&lt;/li&gt;&lt;li&gt; dx by 4x increase in acute/ conv titres
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Travel_Medicine&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Rickettsia/ Typhus"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Rickettsia.2F_Typhus"&gt;Rickettsia/ Typhus&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; fvr, ha, myalgia
&lt;/li&gt;&lt;li&gt; xmitted by arthropods/ ticks
&lt;/li&gt;&lt;li&gt; painless eschar at inoculation site imp clue
&lt;/li&gt;&lt;li&gt; camping, hiking in grassy/ scrub area
&lt;/li&gt;&lt;li&gt; regional LN, rash, leukopenia, thrombocytopenia
&lt;/li&gt;&lt;li&gt; dx clinically
&lt;/li&gt;&lt;li&gt; tx c tetracycline
&lt;/li&gt;&lt;li&gt; confirm serologically
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Travel_Medicine&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Leptospirosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Leptospirosis"&gt;Leptospirosis&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; fvr, myalgia, ha, rash
&lt;/li&gt;&lt;li&gt; conjuntival suffusion characteristic but not common
&lt;/li&gt;&lt;li&gt; exp to fresh water while rafting, kayaking
&lt;/li&gt;&lt;li&gt; biphasic illness with meningitis, uveitis, transminitis, proteinuria, hematuria
&lt;/li&gt;&lt;li&gt; tx c pcn or tetra
&lt;/li&gt;&lt;li&gt; confirm by serology
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Travel_Medicine&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Typhoid Fever"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Typhoid_Fever"&gt;Typhoid Fever&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; fvr, ha
&lt;/li&gt;&lt;li&gt; visiting friends in India, Phillipines Latin
&lt;/li&gt;&lt;li&gt; abd pain, constipation, -diarrhea rare
&lt;/li&gt;&lt;li&gt; leukopenia, thrombocytopenia, dry cough, LN
&lt;/li&gt;&lt;li&gt; insidious onset unlike dengue or rickettsia
&lt;/li&gt;&lt;li&gt; dx by blood cx for salmonella enterica serotype typhi
&lt;/li&gt;&lt;li&gt; serology unreliable
&lt;/li&gt;&lt;li&gt; tx empirically with flouroquinolone or 3rd gen cephal
&lt;/li&gt;&lt;li&gt; vaccine partially effecive and breakthrough infc possible
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Travel_Medicine&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Hemorrhagic Fever"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Hemorrhagic_Fever"&gt;Hemorrhagic Fever&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; meningococcemia, malaria, leptospirosis, rickettsia- all treatable with abx
&lt;/li&gt;&lt;li&gt; also untreatable viruses- dengue, yellow fvr- but hem forms rarely seen in travelers
&lt;/li&gt;&lt;li&gt; also consider Ebola and Lassa fever- public health hazard
&lt;/li&gt;&lt;li&gt; h/o visit to rural area or contact with ill people in endemic area
&lt;/li&gt;&lt;li&gt; usually 3 wk after exposure
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Travel_Medicine&amp;amp;action=edit&amp;amp;section=8" title="Edit section: CNS Changes and Fever"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="CNS_Changes_and_Fever"&gt;CNS Changes and Fever&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; malaria, tb, typhoid fvr, rickettsia, poliomyelitis, rabies, viral (Japanese/ West Nile/ tick borne) encephalitis
&lt;/li&gt;&lt;li&gt; meningococcal meningitis assoc with Haj to Mecca
&lt;/li&gt;&lt;li&gt; eosinophilic meningitis assoc c coccidiomycosis or angiostrongyliasis- rat lung worm to brain
&lt;/li&gt;&lt;li&gt; trypanosomiasis by tsetse fly- Africal sleeping sickness- red chancre at site of fly bite, fvr, ha, myalgia going to meningoencephalitis. May see trypansosomes in smear in acute phase
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Travel_Medicine&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Resp Sx and Fever"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Resp_Sx_and_Fever"&gt;Resp Sx and Fever&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; consider strep pneumonia, influenza, mycoplasma, legionella, tb
&lt;/li&gt;&lt;li&gt; Q Fever- coxiella burnetti- fvr, pna, hepatitis and animal exposure
&lt;/li&gt;&lt;li&gt; Lofflers syn- pulm infiltrates, eosinophilia from transient migration of larval helminthes through lungs
&lt;/li&gt;&lt;li&gt; Cough also seen in malaria, typhoid fvr, scrub typhus, dengue
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Travel_Medicine&amp;amp;action=edit&amp;amp;section=10" title="Edit section: Sex/ Blood Exposure and Fever"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Sex.2F_Blood_Exposure_and_Fever"&gt;Sex/ Blood Exposure and Fever&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; can have fvr without genital findings- hiv, syphilis (treponema pallidum) cmv, ebv, hep B
&lt;/li&gt;&lt;li&gt; also from tattoo, piercing, share razor, blood xfsn
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Travel_Medicine&amp;amp;action=edit&amp;amp;section=11" title="Edit section: Eosinophilic Fever"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Eosinophilic_Fever"&gt;Eosinophilic Fever&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; &amp;gt;400 per cubic mm
&lt;/li&gt;&lt;li&gt; due to blood CA or allergy or helminthic infc
&lt;/li&gt;&lt;li&gt; hookworm, ascariasis, strongyloides, schistosomiasis, filariasis, visceral larva migrans, trichinosis, cocci
&lt;/li&gt;&lt;li&gt; eval with stool for O&amp;amp;P
&lt;/li&gt;&lt;li&gt; serology
&lt;/li&gt;&lt;li&gt; blood smear
&lt;/li&gt;&lt;li&gt; skin snips for microfilariae
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Travel_Medicine&amp;amp;action=edit&amp;amp;section=12" title="Edit section: Diarrhea"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diarrhea"&gt;Diarrhea&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; most respond to antibiotics or antimotility agents
&lt;/li&gt;&lt;li&gt; as duration of diarrhea increases, higher chance of parasitic cause
&lt;/li&gt;&lt;li&gt; giardia, cryptosporidiosis, entamoeba, cyclospora
&lt;/li&gt;&lt;li&gt; dysentery if stool bloody, fvr or wbc in stool- invasive inflamm enteropathy
&lt;/li&gt;&lt;li&gt; has abrupt onset, metastatic lesions, reactive arthopathies, or campylobacter assoc guillain barre- maybe flouroquinolone resis esp in SE Asia
&lt;/li&gt;&lt;li&gt; amoebic dysentery insidious and can get amoebic liver abscess
&lt;/li&gt;&lt;li&gt; if do not find infc cause of dysentery, eval pt for IBD or CA
&lt;/li&gt;&lt;li&gt; prolonged diarrhea and malabsorption- giardia or tropical sprue- does not respond to removal of gluten from diet- tx with tetra and folate
&lt;/li&gt;&lt;li&gt; also consider postinfectious disaccharidase deficiency or irritable bowel dz
&lt;/li&gt;&lt;li&gt; if diarrhea starts &amp;gt;1 mo after travel- not caused by travel
&lt;/li&gt;&lt;li&gt; tx regular travelers diarrhea with fluids, antimotility agents, abx- fluoro or macrolide
&lt;/li&gt;&lt;li&gt; tx invasive enteropathy- bloody/ fvr- same but no antimotility agents
&lt;/li&gt;&lt;li&gt; if bloody stool but no fvr, consider enterhemorrhagic E coli- do not give abx since will get hemolytic uremic syndrome in kids
&lt;/li&gt;&lt;li&gt;examine stool if diarrhea invasive, persistent, unresponsive to standard tx or immune compromised
&lt;/li&gt;&lt;li&gt; if persistent diarrhea, give empiric flouro or macrolide or consid metronidazole for giardia- most common parasite
&lt;/li&gt;&lt;li&gt; try lactose free diet
&lt;/li&gt;&lt;li&gt; chronic diarrhea usually self limited within 1 yr
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Travel_Medicine&amp;amp;action=edit&amp;amp;section=13" title="Edit section: Skin Conditions"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Skin_Conditions"&gt;Skin Conditions&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Travel_Medicine&amp;amp;action=edit&amp;amp;section=14" title="Edit section: Papules"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Papules"&gt;Papules&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; insect bites- cluster or linear distribution
&lt;/li&gt;&lt;li&gt; scabies- if sex active or backpacker
&lt;/li&gt;&lt;li&gt; seabathers eruption- confined to skin covered by swim suit- jellyfish larvae trapped under cloth
&lt;/li&gt;&lt;li&gt; cercarial dermatitis- skin exposed to freshwater schistosomes or coastal water clam diggers itch
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Travel_Medicine&amp;amp;action=edit&amp;amp;section=15" title="Edit section: Sub Q Swelling and Nodules"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Sub_Q_Swelling_and_Nodules"&gt;Sub Q Swelling and Nodules&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; myasis- skin invaded by fly larvae- like boil but with central opening in which larvae may hide
&lt;/li&gt;&lt;li&gt; tungiasis
&lt;/li&gt;&lt;li&gt; loa loa
&lt;/li&gt;&lt;li&gt; trypanosomiasis
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Travel_Medicine&amp;amp;action=edit&amp;amp;section=16" title="Edit section: Ulcers"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Ulcers"&gt;Ulcers&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; pyoderma/ ecthyma- secondary staph cellulitits post bite
&lt;/li&gt;&lt;li&gt; leishmaniasis
&lt;/li&gt;&lt;li&gt; mycobacterium marinum
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Travel_Medicine&amp;amp;action=edit&amp;amp;section=17" title="Edit section: Linear and Migratory Lesions"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Linear_and_Migratory_Lesions"&gt;Linear and Migratory Lesions&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; cutaneous larvae migrans- by soil contact with dog/ cat feces
&lt;/li&gt;&lt;li&gt; photodermatitis
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Travel_Medicine&amp;amp;action=edit&amp;amp;section=18" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Mistry
&lt;/p&gt;



</content><folder>ID</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="trials_-_cardiology"><name>Trials - Cardiology</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#ASA_in_USA"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;ASA in USA&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#CURE:_Clopidogrel_in_USA_to_prevent_Recurrent_ischemic_Events."&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;CURE: Clopidogrel in USA to prevent Recurrent ischemic Events.&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#ESSENCE"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;ESSENCE&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#EPILOG"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;EPILOG&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#ESPIRIT"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;ESPIRIT&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#FRAXIS"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;FRAXIS&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#FRISC"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;FRISC&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#GUSTO_IV-_ACS"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;GUSTO IV- ACS&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#LIFE"&gt;&lt;span class="tocnumber"&gt;9&lt;/span&gt; &lt;span class="toctext"&gt;LIFE&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-10"&gt;&lt;a href="#PRISM"&gt;&lt;span class="tocnumber"&gt;10&lt;/span&gt; &lt;span class="toctext"&gt;PRISM&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-11"&gt;&lt;a href="#PRISM-PLUS"&gt;&lt;span class="tocnumber"&gt;11&lt;/span&gt; &lt;span class="toctext"&gt;PRISM-PLUS&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-12"&gt;&lt;a href="#PURSUIT"&gt;&lt;span class="tocnumber"&gt;12&lt;/span&gt; &lt;span class="toctext"&gt;PURSUIT&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-13"&gt;&lt;a href="#TIMI_11B"&gt;&lt;span class="tocnumber"&gt;13&lt;/span&gt; &lt;span class="toctext"&gt;TIMI 11B&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Trials_-_Cardiology&amp;amp;action=edit&amp;amp;section=1" title="Edit section: ASA in USA"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="ASA_in_USA"&gt;ASA in USA&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;VA Cooperative
&lt;/p&gt;&lt;p&gt;NEJM 1983;309: 396-403
&lt;/p&gt;&lt;p&gt;At 12w asa had 51% dec in death &amp;amp; MI. 1,266 men c USA 324mq ASA vs placebo.
&lt;/p&gt;&lt;p&gt;Cairns JA: asa or sulfinpyrazone. ASA c 51&amp;nbsp;% dec in death or MI and 70% dec in all cause mortality. No benefit c sulf.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Trials_-_Cardiology&amp;amp;action=edit&amp;amp;section=2" title="Edit section: CURE: Clopidogrel in USA to prevent Recurrent ischemic Events."&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="CURE:_Clopidogrel_in_USA_to_prevent_Recurrent_ischemic_Events."&gt;CURE: Clopidogrel in USA to prevent Recurrent ischemic Events.&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;12,562 pt in RCT c USA or NSTEMI -&amp;gt; clopidogrel c/in 24 h (300 then 75) in addition to ASA. 9.3 vs 11.5&amp;nbsp;% CV death , MI, or stroke. Also less inpt ischemia &amp;amp; revascularization, less thrombolitic or GP IIb/IIIa. But excess major bleeding and minor especially in CABG. *Enoxaparin shows modest benefit with inc in minor bleeding not major in USA. Other LMWH dont.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Trials_-_Cardiology&amp;amp;action=edit&amp;amp;section=3" title="Edit section: ESSENCE"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="ESSENCE"&gt;ESSENCE&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;NEJM 1997;337:447
&lt;/p&gt;&lt;p&gt;3171 patients
&lt;/p&gt;&lt;p&gt;Compared enoxaparin (1mq/kg BID) to UFH (5000 U bolus then ptt to 55-56) 48h-8d. 16.2% less death, MI, recurrent angina at 14days and 19% less at 30d. Only trends in MI and death. Only 46% of UFH group reached target PTT by 12-24h. Minor bleeding: 11.9 vs 7.2% in UFH. Major bleeding 6.5 vs 7.0%.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Trials_-_Cardiology&amp;amp;action=edit&amp;amp;section=4" title="Edit section: EPILOG"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="EPILOG"&gt;EPILOG&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;1328 pts
&lt;/p&gt;&lt;p&gt;-&amp;gt;Follow up to EPIC: addition of low-
&lt;/p&gt;&lt;p&gt;dose heparin to abciximab brought bleeding risk same as placebo c 64% reduction of death, MI, and revascularization.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Trials_-_Cardiology&amp;amp;action=edit&amp;amp;section=5" title="Edit section: ESPIRIT"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="ESPIRIT"&gt;ESPIRIT&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Lancet 2000; 356:2037-44
&lt;/p&gt;&lt;p&gt;-&amp;gt;Primary endpoint of death, MI, revascularization, or bailout GP was reduced from 10.5 to 6.6%. More bleeding but no diff in transfusion.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Trials_-_Cardiology&amp;amp;action=edit&amp;amp;section=6" title="Edit section: FRAXIS"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="FRAXIS"&gt;FRAXIS&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;EurHJ 1999;20:1553
&lt;/p&gt;&lt;p&gt;Nardoparin pts had more events than UFH.
&lt;/p&gt;&lt;p&gt;Coumadin &amp;amp; ASA.
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Several earlier small trials showed benefit to long term coumadin c ASA. (e.q. ATACS)
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;OASIS pilot moderat dose dec by 58%.
&lt;/p&gt;&lt;p&gt;OASIS-2: 3712 pts ASA plus moderate coumadin. CVD/MI/CVA p 5 months was 7.65% vs 8.4%.
&lt;/p&gt;&lt;p&gt;CARS was discountinued early c NO benefit c either 1 or 3 mg plus 81mg ASA vs 160 ASA. Lancet 997; 350:389.
&lt;/p&gt;&lt;p&gt;CHAMP: p MI no benefit c coumadin plus ASA 81 vs 162.
&lt;/p&gt;&lt;p&gt;HTN
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Trials_-_Cardiology&amp;amp;action=edit&amp;amp;section=7" title="Edit section: FRISC"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="FRISC"&gt;FRISC&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Lancet 1996; 347:561
&lt;/p&gt;&lt;p&gt;1,506 pt c USA or NQWMI c Dalteparin bid x 6d then QD x 35-45d. 63% reduction in death or MI in first 6d. Still seen at 40 days but excess events when dose decreased. 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Trials_-_Cardiology&amp;amp;action=edit&amp;amp;section=8" title="Edit section: GUSTO IV- ACS"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="GUSTO_IV-_ACS"&gt;GUSTO IV- ACS&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Lancet 2001;357:1915
&lt;/p&gt;&lt;p&gt;-&amp;gt;No benefit from abciximab in USA/NSTEMI s early invasive tx.
&lt;/p&gt;&lt;p&gt;7800 pt c USA/NSTEMI &amp;amp; TnI or ST depression. ASA &amp;amp; UFH/LMWH c placebo, abciximab 24 h, or abciximab 48h. 30 d death or MI 8.O% vs 8.2 vs 9.1 (nonsignificant). 48h also s benefit.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Trials_-_Cardiology&amp;amp;action=edit&amp;amp;section=9" title="Edit section: LIFE"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="LIFE"&gt;LIFE&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Lancet 3/02
&lt;/p&gt;&lt;p&gt;4yr f/u
&lt;/p&gt;&lt;p&gt;-&amp;gt;Losartan showed reduction of CV M&amp;amp;M vs atenolol in pts c HTN and LVH. Most of benefit in stroke reduction. Also c 25% reduction in development of DM.
&lt;/p&gt;&lt;p&gt;GPIIb/IIIa
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Trials_-_Cardiology&amp;amp;action=edit&amp;amp;section=10" title="Edit section: PRISM"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="PRISM"&gt;PRISM&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;NEJM 1998;338:1498
&lt;/p&gt;&lt;p&gt;-&amp;gt;Benefit c tirofiban in USA/NQWMI especially c TnI.
&lt;/p&gt;&lt;p&gt;3232 pts c USA/NQWMI comparing tirofiban c heparin: @48h 3.8% vs 5.6% for death/MI/refractory angina. @ 30d 15.9 vs 17.1% nonsignificant. @30d death or MI 5.8 vs 7.1% p=0.11. Subgroup analysis showed greater benefit c elevated TnI.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Trials_-_Cardiology&amp;amp;action=edit&amp;amp;section=11" title="Edit section: PRISM-PLUS"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="PRISM-PLUS"&gt;PRISM-PLUS&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;NEJM 1998;338:1488
&lt;/p&gt;&lt;p&gt;-&amp;gt; Tirofiban and UFH combo is beneficial in USA/NQWMI c or s PCI.
&lt;/p&gt;&lt;p&gt;1915 pts c USA/NQWMI tirofiban, UFH, or combination for 48-108h. Tirofiban alone arm was dropped 2&#65533; excess mortality. Combo reduced death/MI/refractory angina @ 7d from 17.9 to 12.9% p=0.004. @30 d reduced by 22%. Death or MI by 43% @7d, 30% @ 30d, 22% @ 6m.
&lt;/p&gt;&lt;p&gt;--In pts not undergoing PCI, significant benefit was only seen in HIGH risk pts
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Trials_-_Cardiology&amp;amp;action=edit&amp;amp;section=12" title="Edit section: PURSUIT"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="PURSUIT"&gt;PURSUIT&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;NEJM 1998; 339:436
&lt;/p&gt;&lt;p&gt;-&amp;gt;Eptifibatide beneficial in USA/NSTEMI c or s PCI.
&lt;/p&gt;&lt;p&gt;10948 pts c USA/NSQWMI c Eptifibatide in addition to standard tx. @ 30d death/MI 14.2% vs 15.7%. @ 96h 7.6 vs 9.1%.
&lt;/p&gt;&lt;p&gt;?EPIC (JACC 1997; 30:149-56) 321 pts
&lt;/p&gt;&lt;p&gt;-&amp;gt;Abciximab bolus + infusion vs abciximab bolus c placements infusion vs placebo in high risk patients undergroinq PCI . Abciximab bolus and infusion reduced rate of MI' death, revascularization by 35% at 30d, 23% at 6m, 13% at 3years. Most of affect from reduction of repeat CABG/PCI . Higher rate of bleedinq.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Trials_-_Cardiology&amp;amp;action=edit&amp;amp;section=13" title="Edit section: TIMI 11B"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="TIMI_11B"&gt;TIMI 11B&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Circ 1999;100:1602.
&lt;/p&gt;&lt;p&gt;Compared enoxaparin (30mg IV then SC) c UFH. Study included outpt portion. Death or MI were 5.7 vs 6.9% at 14d and 7.9vs 8.9&amp;nbsp;% at 43d. Minor bleeding 9.1 vs 2.5%. Major bleeding 1.5 vs 1.0%.
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="trials_-_comprehensive"><name>Trials - Comprehensive</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#ASA_in_USA"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;ASA in USA&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#CLOT"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;CLOT&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#CURE:_Clopidogrel_in_USA_to_prevent_Recurrent_ischemic_Events."&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;CURE: Clopidogrel in USA to prevent Recurrent ischemic Events.&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#ESSENCE"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;ESSENCE&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#EPILOG"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;EPILOG&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#ESPIRIT"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;ESPIRIT&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#FRAXIS"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;FRAXIS&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#FRISC"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;FRISC&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#GUSTO_IV-_ACS"&gt;&lt;span class="tocnumber"&gt;9&lt;/span&gt; &lt;span class="toctext"&gt;GUSTO IV- ACS&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-10"&gt;&lt;a href="#LIFE"&gt;&lt;span class="tocnumber"&gt;10&lt;/span&gt; &lt;span class="toctext"&gt;LIFE&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-11"&gt;&lt;a href="#PRISM"&gt;&lt;span class="tocnumber"&gt;11&lt;/span&gt; &lt;span class="toctext"&gt;PRISM&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-12"&gt;&lt;a href="#PRISM-PLUS"&gt;&lt;span class="tocnumber"&gt;12&lt;/span&gt; &lt;span class="toctext"&gt;PRISM-PLUS&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-13"&gt;&lt;a href="#PURSUIT"&gt;&lt;span class="tocnumber"&gt;13&lt;/span&gt; &lt;span class="toctext"&gt;PURSUIT&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-14"&gt;&lt;a href="#TIMI_11B"&gt;&lt;span class="tocnumber"&gt;14&lt;/span&gt; &lt;span class="toctext"&gt;TIMI 11B&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Trials_-_Comprehensive&amp;amp;action=edit&amp;amp;section=1" title="Edit section: ASA in USA"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="ASA_in_USA"&gt;ASA in USA&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;VA Cooperative
&lt;/p&gt;&lt;p&gt;NEJM 1983;309: 396-403
&lt;/p&gt;&lt;p&gt;At 12w asa had 51% dec in death &amp;amp; MI. 1,266 men c USA 324mq ASA vs placebo.
&lt;/p&gt;&lt;p&gt;Cairns JA: asa or sulfinpyrazone. ASA c 51&amp;nbsp;% dec in death or MI and 70% dec in all cause mortality. No benefit c sulf.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Trials_-_Comprehensive&amp;amp;action=edit&amp;amp;section=2" title="Edit section: CLOT"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="CLOT"&gt;CLOT&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Comparison of Low-Molecular-Weight Heparin versus Oral Anticoagulant Therapy for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer
&lt;/p&gt;&lt;p&gt;NEJM 2003;349:146-153
&lt;/p&gt;&lt;p&gt;LMWH (dalteparin) v. coumarin derivative over a 6-month period for the prevention of recurrent thromboembolism in patients with cancer.
&lt;/p&gt;&lt;p&gt;Dalteparin was associated with significantly fewer episodes of recurrent thromboembolism than the oral anticoagulant (9% vs. 17%, respectively). Rates of bleeding and overall survival were similar in the two groups.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Trials_-_Comprehensive&amp;amp;action=edit&amp;amp;section=3" title="Edit section: CURE: Clopidogrel in USA to prevent Recurrent ischemic Events."&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="CURE:_Clopidogrel_in_USA_to_prevent_Recurrent_ischemic_Events."&gt;CURE: Clopidogrel in USA to prevent Recurrent ischemic Events.&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;12,562 pt in RCT c USA or NSTEMI -&amp;gt; clopidogrel c/in 24 h (300 then 75) in addition to ASA. 9.3 vs 11.5&amp;nbsp;% CV death , MI, or stroke. Also less inpt ischemia &amp;amp; revascularization, less thrombolitic or GP IIb/IIIa. But excess major bleeding and minor especially in CABG. *Enoxaparin shows modest benefit with inc in minor bleeding not major in USA. Other LMWH dont.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Trials_-_Comprehensive&amp;amp;action=edit&amp;amp;section=4" title="Edit section: ESSENCE"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="ESSENCE"&gt;ESSENCE&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;NEJM 1997;337:447
&lt;/p&gt;&lt;p&gt;3171 patients
&lt;/p&gt;&lt;p&gt;Compared enoxaparin (1mq/kg BID) to UFH (5000 U bolus then ptt to 55-56) 48h-8d. 16.2% less death, MI, recurrent angina at 14days and 19% less at 30d. Only trends in MI and death. Only 46% of UFH group reached target PTT by 12-24h. Minor bleeding: 11.9 vs 7.2% in UFH. Major bleeding 6.5 vs 7.0%.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Trials_-_Comprehensive&amp;amp;action=edit&amp;amp;section=5" title="Edit section: EPILOG"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="EPILOG"&gt;EPILOG&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;1328 pts
&lt;/p&gt;&lt;p&gt;-&amp;gt;Follow up to EPIC: addition of low-
&lt;/p&gt;&lt;p&gt;dose heparin to abciximab brought bleeding risk same as placebo c 64% reduction of death, MI, and revascularization.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Trials_-_Comprehensive&amp;amp;action=edit&amp;amp;section=6" title="Edit section: ESPIRIT"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="ESPIRIT"&gt;ESPIRIT&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Lancet 2000; 356:2037-44
&lt;/p&gt;&lt;p&gt;-&amp;gt;Primary endpoint of death, MI, revascularization, or bailout GP was reduced from 10.5 to 6.6%. More bleeding but no diff in transfusion.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Trials_-_Comprehensive&amp;amp;action=edit&amp;amp;section=7" title="Edit section: FRAXIS"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="FRAXIS"&gt;FRAXIS&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;EurHJ 1999;20:1553
&lt;/p&gt;&lt;p&gt;Nardoparin pts had more events than UFH.
&lt;/p&gt;&lt;p&gt;Coumadin &amp;amp; ASA.
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Several earlier small trials showed benefit to long term coumadin c ASA. (e.q. ATACS)
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;OASIS pilot moderat dose dec by 58%.
&lt;/p&gt;&lt;p&gt;OASIS-2: 3712 pts ASA plus moderate coumadin. CVD/MI/CVA p 5 months was 7.65% vs 8.4%.
&lt;/p&gt;&lt;p&gt;CARS was discountinued early c NO benefit c either 1 or 3 mg plus 81mg ASA vs 160 ASA. Lancet 997; 350:389.
&lt;/p&gt;&lt;p&gt;CHAMP: p MI no benefit c coumadin plus ASA 81 vs 162.
&lt;/p&gt;&lt;p&gt;HTN
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Trials_-_Comprehensive&amp;amp;action=edit&amp;amp;section=8" title="Edit section: FRISC"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="FRISC"&gt;FRISC&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Lancet 1996; 347:561
&lt;/p&gt;&lt;p&gt;1,506 pt c USA or NQWMI c Dalteparin bid x 6d then QD x 35-45d. 63% reduction in death or MI in first 6d. Still seen at 40 days but excess events when dose decreased. 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Trials_-_Comprehensive&amp;amp;action=edit&amp;amp;section=9" title="Edit section: GUSTO IV- ACS"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="GUSTO_IV-_ACS"&gt;GUSTO IV- ACS&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Lancet 2001;357:1915
&lt;/p&gt;&lt;p&gt;-&amp;gt;No benefit from abciximab in USA/NSTEMI s early invasive tx.
&lt;/p&gt;&lt;p&gt;7800 pt c USA/NSTEMI &amp;amp; TnI or ST depression. ASA &amp;amp; UFH/LMWH c placebo, abciximab 24 h, or abciximab 48h. 30 d death or MI 8.O% vs 8.2 vs 9.1 (nonsignificant). 48h also s benefit.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Trials_-_Comprehensive&amp;amp;action=edit&amp;amp;section=10" title="Edit section: LIFE"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="LIFE"&gt;LIFE&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Lancet 3/02
&lt;/p&gt;&lt;p&gt;4yr f/u
&lt;/p&gt;&lt;p&gt;-&amp;gt;Losartan showed reduction of CV M&amp;amp;M vs atenolol in pts c HTN and LVH. Most of benefit in stroke reduction. Also c 25% reduction in development of DM.
&lt;/p&gt;&lt;p&gt;GPIIb/IIIa
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Trials_-_Comprehensive&amp;amp;action=edit&amp;amp;section=11" title="Edit section: PRISM"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="PRISM"&gt;PRISM&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;NEJM 1998;338:1498
&lt;/p&gt;&lt;p&gt;-&amp;gt;Benefit c tirofiban in USA/NQWMI especially c TnI.
&lt;/p&gt;&lt;p&gt;3232 pts c USA/NQWMI comparing tirofiban c heparin: @48h 3.8% vs 5.6% for death/MI/refractory angina. @ 30d 15.9 vs 17.1% nonsignificant. @30d death or MI 5.8 vs 7.1% p=0.11. Subgroup analysis showed greater benefit c elevated TnI.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Trials_-_Comprehensive&amp;amp;action=edit&amp;amp;section=12" title="Edit section: PRISM-PLUS"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="PRISM-PLUS"&gt;PRISM-PLUS&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;NEJM 1998;338:1488
&lt;/p&gt;&lt;p&gt;-&amp;gt; Tirofiban and UFH combo is beneficial in USA/NQWMI c or s PCI.
&lt;/p&gt;&lt;p&gt;1915 pts c USA/NQWMI tirofiban, UFH, or combination for 48-108h. Tirofiban alone arm was dropped 2&#65533; excess mortality. Combo reduced death/MI/refractory angina @ 7d from 17.9 to 12.9% p=0.004. @30 d reduced by 22%. Death or MI by 43% @7d, 30% @ 30d, 22% @ 6m.
&lt;/p&gt;&lt;p&gt;--In pts not undergoing PCI, significant benefit was only seen in HIGH risk pts
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Trials_-_Comprehensive&amp;amp;action=edit&amp;amp;section=13" title="Edit section: PURSUIT"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="PURSUIT"&gt;PURSUIT&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;NEJM 1998; 339:436
&lt;/p&gt;&lt;p&gt;-&amp;gt;Eptifibatide beneficial in USA/NSTEMI c or s PCI.
&lt;/p&gt;&lt;p&gt;10948 pts c USA/NSQWMI c Eptifibatide in addition to standard tx. @ 30d death/MI 14.2% vs 15.7%. @ 96h 7.6 vs 9.1%.
&lt;/p&gt;&lt;p&gt;?EPIC (JACC 1997; 30:149-56) 321 pts
&lt;/p&gt;&lt;p&gt;-&amp;gt;Abciximab bolus + infusion vs abciximab bolus c placements infusion vs placebo in high risk patients undergroinq PCI . Abciximab bolus and infusion reduced rate of MI' death, revascularization by 35% at 30d, 23% at 6m, 13% at 3years. Most of affect from reduction of repeat CABG/PCI . Higher rate of bleedinq.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Trials_-_Comprehensive&amp;amp;action=edit&amp;amp;section=14" title="Edit section: TIMI 11B"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="TIMI_11B"&gt;TIMI 11B&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Circ 1999;100:1602.
&lt;/p&gt;&lt;p&gt;Compared enoxaparin (30mg IV then SC) c UFH. Study included outpt portion. Death or MI were 5.7 vs 6.9% at 14d and 7.9vs 8.9&amp;nbsp;% at 43d. Minor bleeding 9.1 vs 2.5%. Major bleeding 1.5 vs 1.0%.
&lt;/p&gt;



</content><folder>Misc/General</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="tricyclic_antidepressants_(tca)"><name>Tricyclic Antidepressants (TCA)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#_2"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tricyclic_Antidepressants_(TCA)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Mechanisms
&lt;/p&gt;&lt;p&gt;A. Peripheral effects
&lt;/p&gt;
&lt;pre&gt;    1. Voltage-gated Na channel blockade
&lt;/pre&gt;
&lt;pre&gt;    2. Ach receptor blockade
&lt;/pre&gt;
&lt;pre&gt;    3. Alpha receptor blockade
&lt;/pre&gt;
&lt;p&gt;B. Central effects
&lt;/p&gt;
&lt;pre&gt;    1. GABA receptor blockade
&lt;/pre&gt;
&lt;pre&gt;    2. Dopamine receptor blockade
&lt;/pre&gt;
&lt;pre&gt;    3. Norepinephrine receptor blockade
&lt;/pre&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tricyclic_Antidepressants_(TCA)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: "&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id=""&gt; &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- peak absortion in 2-4-hrs
&lt;/p&gt;&lt;p&gt;- anticholinergic
&lt;/p&gt;&lt;p&gt;- liver metab
&lt;/p&gt;&lt;p&gt;colinergic effect delays absortion- so observe 6hs
&lt;/p&gt;&lt;p&gt;4 Major Effects- cause CV and CNS sxs
&lt;/p&gt;&lt;p&gt;1- sodium channel blolking effect
&lt;/p&gt;&lt;p&gt;2- alpha 1 block
&lt;/p&gt;&lt;p&gt;3- anticholinergic effect- tachy hot skin mydriasis ileus urinary retention
&lt;/p&gt;&lt;p&gt;4- inhibit norepi- serotonin reutake- initial hyperTN and increased cateclolamines but eventual depletion makes late hjpoTN and bradycardia
&lt;/p&gt;&lt;p&gt;Na BLOCK
&lt;/p&gt;&lt;p&gt;- phase 0 myocardial depol prolonged by Na channel block
&lt;/p&gt;&lt;p&gt;- qrs &amp;gt; l00 ms
&lt;/p&gt;&lt;p&gt;- neg inotrope
&lt;/p&gt;&lt;p&gt;- impaired excitation- contraction coupling
&lt;/p&gt;&lt;p&gt;- vasodilatation from alpha block
&lt;/p&gt;&lt;p&gt;- delerivm sedation coma sz by anticholinergic effect 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tricyclic_Antidepressants_(TCA)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: "&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="_2"&gt; &lt;/span&gt;&lt;/h2&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tricyclic_Antidepressants_(TCA)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Primary Manifestations
&lt;/p&gt;&lt;p&gt;A. Cardiovascular
&lt;/p&gt;
&lt;pre&gt;    1. Conduction defects
&lt;/pre&gt;
&lt;pre&gt;         - sinus tachycardia
&lt;/pre&gt;
&lt;pre&gt;         - prolonged QT
&lt;/pre&gt;
&lt;pre&gt;         - prolonged PR
&lt;/pre&gt;
&lt;pre&gt;         - prolonged QRS
&lt;/pre&gt;
&lt;pre&gt;         - rightward shift in terminal 40msec in aVR (R wave)
&lt;/pre&gt;
&lt;pre&gt;    2. Hypotension
&lt;/pre&gt;
&lt;p&gt;B. CNS
&lt;/p&gt;
&lt;pre&gt;    1. Seizures
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;CLINICAL SXS- four Cs
&lt;/p&gt;&lt;p&gt;- convulsion
&lt;/p&gt;&lt;p&gt;- coma
&lt;/p&gt;&lt;p&gt;- CV collapse
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tricyclic_Antidepressants_(TCA)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;A. Airway
&lt;/p&gt;&lt;p&gt;B. Breathing
&lt;/p&gt;&lt;p&gt;C. Circulation
&lt;/p&gt;
&lt;pre&gt;    1. Conduction defects
&lt;/pre&gt;
&lt;pre&gt;         - NaHCO3 (1-2 mEq/kg IV bolus, then 1L D5W + 3 amps NaHCO3 @ 200cc/hr)
&lt;/pre&gt;
&lt;pre&gt;         - titrate to serum pH ~7.50 and QRS &amp;lt; 100msec
&lt;/pre&gt;
&lt;pre&gt;         - hyperventilate
&lt;/pre&gt;
&lt;pre&gt;         - avoid IA, IB, IC antiarrhythmics, B-blockers, Ca channel blockers
&lt;/pre&gt;
&lt;pre&gt;    2. Hypotension
&lt;/pre&gt;
&lt;pre&gt;         - isotonic saline
&lt;/pre&gt;
&lt;pre&gt;         - norepinephrine
&lt;/pre&gt;
&lt;pre&gt;         - dobutamine
&lt;/pre&gt;
&lt;pre&gt;         - avoid dopamine
&lt;/pre&gt;
&lt;pre&gt;             * B2 effect may worsen hypotension
&lt;/pre&gt;
&lt;p&gt;D. Seizures
&lt;/p&gt;
&lt;pre&gt;    1. Benzodiazepines
&lt;/pre&gt;
&lt;pre&gt;    2. Barbiturates
&lt;/pre&gt;
&lt;pre&gt;    3. General anesthesia
&lt;/pre&gt;
&lt;pre&gt;    4. Avoid dilantin
&lt;/pre&gt;
&lt;pre&gt;         - may induce arrhythmias
&lt;/pre&gt;
&lt;p&gt;E. GI decontamination
&lt;/p&gt;
&lt;pre&gt;    1. Gastric lavage if &amp;lt; 1 hr after ingestion
&lt;/pre&gt;
&lt;pre&gt;    2. Activated charcoal
&lt;/pre&gt;
&lt;pre&gt;         - repeat doses may help
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;TX
&lt;/p&gt;&lt;p&gt;- vent support to avoid resp acidosis since acidosis inhibits fast Na channels
&lt;/p&gt;&lt;p&gt;- charcoal
&lt;/p&gt;&lt;p&gt;- lavage in 1h
&lt;/p&gt;&lt;p&gt;- alkalinize to increase Na cnannel conduction
&lt;/p&gt;&lt;p&gt;- diuresis or dialysis not helful since are protein bound and large vol of distribution
&lt;/p&gt;&lt;p&gt;- fluids
&lt;/p&gt;&lt;p&gt;- bicarb ifqrs wide until pH max 7.55 or qrs narrows
&lt;/p&gt;&lt;p&gt;- vasopressors- norepi and dopamine
&lt;/p&gt;&lt;p&gt;- hypertonic saline or hyperventilation same effect but bicarb better
&lt;/p&gt;&lt;p&gt;- no dilantin- causes V tach
&lt;/p&gt;&lt;p&gt;- tx sx c benzos then phenobarb
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tricyclic_Antidepressants_(TCA)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;A. Admit unless asymptomatic w/out e/o toxic ingestion at 6hrs
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tricyclic_Antidepressants_(TCA)&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;(Haukoos 09/02)
&lt;/p&gt;



</content><folder>Tox</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="troponin_(ddx)"><name>Troponin (DDx)</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Troponin_(DDx)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: False (Non-CAD) Positives"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="False_.28Non-CAD.29_Positives"&gt;False (Non-CAD) Positives&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Pericarditis
&lt;/li&gt;&lt;li&gt;Myocaritis
&lt;/li&gt;&lt;li&gt;PE
&lt;/li&gt;&lt;li&gt;CHF
&lt;/li&gt;&lt;li&gt;Severe sepsis/septic shock
&lt;/li&gt;&lt;li&gt;Renal failure
&lt;/li&gt;&lt;li&gt;Cardioversion
&lt;/li&gt;&lt;li&gt;Cardiotoxic meds
&lt;/li&gt;&lt;li&gt;Amyloidosis
&lt;/li&gt;&lt;li&gt;Rheumatoid Factor
&lt;/li&gt;&lt;li&gt;Heterophilic antibodies
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Troponin_(DDx)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Cards: Cardiac Enzymes
&lt;/p&gt;&lt;p&gt;Cards: CK-MB
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Troponin_(DDx)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;4/19/07 DONALDSON (adapted from Ryu, medscape)
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="tuberculosis_(tb)"><name>Tuberculosis (TB)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Epidemilogy"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Epidemilogy&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Consequences"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Consequences&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Adverse_Effects"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Adverse Effects&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Current_Recs"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Current Recs&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#HIV_Pts"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;HIV Pts&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Extrapulm_TB"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Extrapulm TB&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Drug_Resis"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;Drug Resis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#Management_of_Latent_TB"&gt;&lt;span class="tocnumber"&gt;9&lt;/span&gt; &lt;span class="toctext"&gt;Management of Latent TB&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-10"&gt;&lt;a href="#TB_Skin_Test"&gt;&lt;span class="tocnumber"&gt;10&lt;/span&gt; &lt;span class="toctext"&gt;TB Skin Test&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-11"&gt;&lt;a href="#BCG"&gt;&lt;span class="tocnumber"&gt;11&lt;/span&gt; &lt;span class="toctext"&gt;BCG&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-12"&gt;&lt;a href="#Latent_Tx.2F_PPD_.2B_Tx"&gt;&lt;span class="tocnumber"&gt;12&lt;/span&gt; &lt;span class="toctext"&gt;Latent Tx/ PPD + Tx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tuberculosis_(TB)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Epidemilogy"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Epidemilogy"&gt;Epidemilogy&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- tb resurfaced due to poor public health systems, HIV, and immigration
&lt;/p&gt;&lt;p&gt;- rate of tb now declining due to better public health and decrease xmission of tb from pt with active tb
&lt;/p&gt;&lt;p&gt;- many people with latent tb- poses threat if turns active
&lt;/p&gt;&lt;p&gt;- globally, 1/3 of world pop infcted
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tuberculosis_(TB)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Consequences"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Consequences"&gt;Consequences&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- xmited by air particles 1-5 microns
&lt;/p&gt;&lt;p&gt;- xmission influenced by source criteria- number of bacteria excreted and nature of encounter
&lt;/p&gt;&lt;p&gt;- infc by 1- 5 bacteria in terminal alveolus
&lt;/p&gt;&lt;p&gt;- primary tb usually mild and self limited- often undiagnosed- bacteria seed other organs for subsequent reactivation later
&lt;/p&gt;&lt;p&gt;- 5% of time, infc goes from latent to active dz in 2 yrs
&lt;/p&gt;&lt;p&gt;- most active tb is from latent reactivation buy and also be from infc by second strain of tb- esp if immune compromised or heavy exposure to new bacilli
&lt;/p&gt;&lt;p&gt;- classic sxs- fvr, sweats, anorexia, wt loss, weakness
&lt;/p&gt;&lt;p&gt;- organ specific sxs- pulm- cough, CP, hemoptysis
&lt;/p&gt;&lt;p&gt;primary tb cxr shows infc in mid to lower lungs with lymphadenopathy- reactivation is upper lobe cavitations
&lt;/p&gt;&lt;p&gt;- signs and sxs more vaied if hiv
&lt;/p&gt;&lt;p&gt;- lung most common site, but also lymph nodes, pleura, bone, joints. also gu, cns, abd, pericardium
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tuberculosis_(TB)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- reportable in all states- even if tx'd in private sector, reporting helps with compliance, tracking contacts, emerging resis patterns, education, outbreaks
&lt;/p&gt;&lt;p&gt;Anti TB Drugs
&lt;/p&gt;&lt;p&gt;- 5 first line drugs
&lt;/p&gt;&lt;p&gt;- second line drugs are less effective or more toxic- only use if pt cannot tolerate first line or resis
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tuberculosis_(TB)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Adverse Effects"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Adverse_Effects"&gt;Adverse Effects&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;INH- hepatitis, neuropathy, cns effects, elevated dilantin lvl, antabuse interaction, give with vit B6
&lt;/p&gt;&lt;p&gt;Rif- fvr, low platelets, reduces blood levels of other drugs, caused orange urine
&lt;/p&gt;&lt;p&gt;PZA- hyperuricemia
&lt;/p&gt;&lt;p&gt;Ethambutol- color discrimination, visual acuity, optic neuritis
&lt;/p&gt;&lt;p&gt;Strep- auditory and renal dysfnctn
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tuberculosis_(TB)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Current Recs"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Current_Recs"&gt;Current Recs&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- always use INH for duration of tx- effective, low cost, tolerable- if not mixed with rifampin- go 18 mo
&lt;/p&gt;&lt;p&gt;- if double with INH/ rif- 9 mo for cure
&lt;/p&gt;&lt;p&gt;- if triple with inh/ rif/ pza (pza for first 2 mo) shorten lenght to 6 mo
&lt;/p&gt;&lt;p&gt;- try 3-4 meds initially and then 2 drugs afterwards
&lt;/p&gt;&lt;p&gt;- consider local patterns of resis and schedule of administration likely to ensure adherance
&lt;/p&gt;&lt;p&gt;- direct observation helps ensure compliance
&lt;/p&gt;&lt;p&gt;- most common regimen- ihn/rif/pza for 8 wks, inh/rif for 16 wks with freq direct observation, and add ethambutol or streptomycin until susceptibility documented
&lt;/p&gt;&lt;p&gt;- if cx ned, stop p 2 mo of inh/rif
&lt;/p&gt;&lt;p&gt;- noncompliance not related to race, gender, education....cdc rec direct observation, and rewards
&lt;/p&gt;&lt;p&gt;- get cxs- helps with resis
&lt;/p&gt;&lt;p&gt;- baseline lfts, creatinine,cbc
&lt;/p&gt;&lt;p&gt;- if use pza- check uric acid
&lt;/p&gt;&lt;p&gt;- if use ethambutol- check vision and red/green color perception
&lt;/p&gt;&lt;p&gt;- baseline cxr
&lt;/p&gt;&lt;p&gt;- if cx neg, go by sxs and cxr at 3 mo
&lt;/p&gt;&lt;p&gt;- sputum cx going from pos to neg - objective tx success- should change in 2 mo
&lt;/p&gt;&lt;p&gt;- if longer than 3 mo, consider nonadherence, malabsorption, resis
&lt;/p&gt;&lt;p&gt;- can also test urine for color in rif, urate in pza
&lt;/p&gt;&lt;p&gt;- cx sputum at end of tx to document cure
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tuberculosis_(TB)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: HIV Pts"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="HIV_Pts"&gt;HIV Pts&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- hiv pt who adhere to standard tx do not have increased tx failure
&lt;/p&gt;&lt;p&gt;- tx 6 mo- longer if slow response
&lt;/p&gt;&lt;p&gt;- protease inhibitors and NNRT inhibitors mixed with rif cause rif toxicity and low levels of PI and NNRTI- avoid by using rifabutin
&lt;/p&gt;&lt;p&gt;- do not use PI ritonivir or NNRTI delavirdine with rifabutin
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tuberculosis_(TB)&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Extrapulm TB"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Extrapulm_TB"&gt;Extrapulm TB&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- since fewer bacilli in extrapulm site and good tissue penetration of drugs, tx should be no more difficult
&lt;/p&gt;&lt;p&gt;- use regular 6 mo regimen
&lt;/p&gt;&lt;p&gt;- 12 mo for meningitis in kids, bone/ joint or miliary tb
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tuberculosis_(TB)&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Drug Resis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Drug_Resis"&gt;Drug Resis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- inh resis tx with rif, pza, ethambutol for 6 mo
&lt;/p&gt;&lt;p&gt;- rif resis- inh, ethm for 18 mo or inh, pza, strep for 9 mo
&lt;/p&gt;&lt;p&gt;- mulitidrug resis- resis to inh and rif- curable even in poor countries
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tuberculosis_(TB)&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Management of Latent TB"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Management_of_Latent_TB"&gt;Management of Latent TB&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- test for tb only in high risk pt and those who will benefit from tx.
&lt;/p&gt;&lt;p&gt;- if test low risk population- will get too many false postives
&lt;/p&gt;&lt;p&gt;- test hiv pt, immigrants, homeless, long term care residents, health workers
&lt;/p&gt;&lt;p&gt;- those at risk for progression from latent to active dz are immune suppressed ore recently exposed to infectious tb- highest rate of progression is from pt with both hiv and tb- also dm, crf, CA, organ xplant, ivda,
&lt;/p&gt;&lt;p&gt;- silicosis, abnormal cxr, too thin person also indication for testing
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tuberculosis_(TB)&amp;amp;action=edit&amp;amp;section=10" title="Edit section: TB Skin Test"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="TB_Skin_Test"&gt;TB Skin Test&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- PPD is gold standard for latent tb testing- intradermal not multipronged
&lt;/p&gt;&lt;p&gt;- measure induration not redness 48- 72 hrs
&lt;/p&gt;&lt;p&gt;- 5 mm- positve if pt with weak immune response- hiv, steroid use, recent exposure and body hasn't had time to mount immune response, abnormal cxr
&lt;/p&gt;&lt;p&gt;- 15 mm- positive if low risk pt
&lt;/p&gt;&lt;p&gt;- 10 mm- all other pts
&lt;/p&gt;&lt;p&gt;- if long standing infc, may actually have neg test initially- if give second skin test will be positve since first test reinvigorated immune sys- so if pt needs serial testing- do second test in 2 wks- called 2 Step Testing- if second postive represents long standing infc not recent infection
&lt;/p&gt;&lt;p&gt;- ppd will not cause 10 mm induration in uninfected pt ever
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tuberculosis_(TB)&amp;amp;action=edit&amp;amp;section=11" title="Edit section: BCG"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="BCG"&gt;BCG&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- not recommended in US but used elsewhere
&lt;/p&gt;&lt;p&gt;- size and persistence of tb reaction p bcg vary with bcg dose and manufacturer
&lt;/p&gt;&lt;p&gt;- CDC rec ignoring hx of bcg when giving and interpreting ppd test since bcg only givien in high risk populations in first place
&lt;/p&gt;&lt;p&gt;- anergy testing not recommended in tb testing of hiv pt since results highly variable and not reproducible.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tuberculosis_(TB)&amp;amp;action=edit&amp;amp;section=12" title="Edit section: Latent Tx/ PPD + Tx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Latent_Tx.2F_PPD_.2B_Tx"&gt;Latent Tx/ PPD + Tx&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- 9 mo inh if no hiv and neg cxr. 12 mo better but less compliance and more cost
&lt;/p&gt;&lt;p&gt;- 9 mo ihn if hiv + or pos cxr or age &amp;lt;18yr
&lt;/p&gt;&lt;p&gt;- can also do 2 mo of rif and pza or 4 mo of rif alone
&lt;/p&gt;&lt;p&gt;- baseline labs if hiv +, preg, etoh, liver dz
&lt;/p&gt;&lt;p&gt;- if duration of tx interrupted, add on additional 3 mo of inh. If lapse is greater than 3 mo, restart whole tx
&lt;/p&gt;&lt;p&gt;- if previously tx pt reexposed to tb, repeat tx not recommended
&lt;/p&gt;



</content><folder>ID</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="tumor_lysis_syndrome_(tls)"><name>Tumor Lysis Syndrome (TLS)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Definition"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Definition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Etiology"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Etiology&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Epidemiology"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Epidemiology&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Pathophysiology"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Pathophysiology&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Risk_Factors"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Risk Factors&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Signs.2FSymptoms"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Signs/Symptoms&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Work_Up"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Work Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Imaging"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;Imaging&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#Management"&gt;&lt;span class="tocnumber"&gt;9&lt;/span&gt; &lt;span class="toctext"&gt;Management&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-10"&gt;&lt;a href="#Urine_Alkalinization"&gt;&lt;span class="tocnumber"&gt;9.1&lt;/span&gt; &lt;span class="toctext"&gt;Urine Alkalinization&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-11"&gt;&lt;a href="#Acute_Kidney_Injury_.28Cr_.3E_1.5.29"&gt;&lt;span class="tocnumber"&gt;9.2&lt;/span&gt; &lt;span class="toctext"&gt;Acute Kidney Injury (Cr &amp;gt; 1.5)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-12"&gt;&lt;a href="#Dialysis_.28criteria.29"&gt;&lt;span class="tocnumber"&gt;9.3&lt;/span&gt; &lt;span class="toctext"&gt;Dialysis (criteria)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-13"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;10&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-14"&gt;&lt;a href="#Cairo-Bishop_Definitions"&gt;&lt;span class="tocnumber"&gt;11&lt;/span&gt; &lt;span class="toctext"&gt;Cairo-Bishop Definitions&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-15"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;12&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tumor_Lysis_Syndrome_(TLS)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Definition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Definition"&gt;Definition&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Massive release of intracellular products from malignant cells after antitumor rx or spontaneously, resulting in constellation of metabolic and subsequent clinical derangements (see Cairo-Bishop below):
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Hyperuricemia
&lt;/li&gt;&lt;li&gt;Hyperkalemia
&lt;/li&gt;&lt;li&gt;Hyperphosphatemia
&lt;/li&gt;&lt;li&gt;Hypocalcemia
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tumor_Lysis_Syndrome_(TLS)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Etiology"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Etiology"&gt;Etiology&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Usually occurs within 1-5 days of starting chemotherapy or radiation for rapidly growing tumors (esp leukemia/lymphoma)
&lt;/li&gt;&lt;li&gt; Can present spontaneously in certain lymphoproliferative malignancies before they are diagnosed
&lt;/li&gt;&lt;li&gt; Categorized according to tumor classification (heme v. solid tumor) and relationship to antitumor rx (spontaneous v. treatment-associated)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tumor_Lysis_Syndrome_(TLS)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Epidemiology"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Epidemiology"&gt;Epidemiology&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Most common among non-Hodgkin lymphoma (esp. Burkitt lymphoma), acute and chronic leukemia
&lt;/li&gt;&lt;li&gt;Solid tumors (rare): metastatic breast CA, small cell and NSC lung CA, seminoma, invasive thymoma, metastatic medulloblastoma, Merkel cell CA, ovarian CA, rhabdomyosarcoma, metastatic melanoma, vulvar CA
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tumor_Lysis_Syndrome_(TLS)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Pathophysiology"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Pathophysiology"&gt;Pathophysiology&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Lysed tumor cells release nucleic acid metabolites, phosphorus and potassium into circulation
&lt;/li&gt;&lt;li&gt;Nucleic acids degrade into purine metabolites which are then processed by xanthine oxidase into uric acid (excreted in urine)
&lt;/li&gt;&lt;li&gt;Phosphorus binds calcium leading to hypocalcemia
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tumor_Lysis_Syndrome_(TLS)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Risk Factors"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Risk_Factors"&gt;Risk Factors&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;High cell proliferation rate
&lt;/li&gt;&lt;li&gt;Large tumor burden (LDH) &amp;gt; 1500 IU/L, WBC &#8805; 50 x 103 cells/L
&lt;/li&gt;&lt;li&gt;Extensive BM involvement
&lt;/li&gt;&lt;li&gt;Tumor infiltration of the kidney
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tumor_Lysis_Syndrome_(TLS)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Signs/Symptoms"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Signs.2FSymptoms"&gt;Signs/Symptoms&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Hyperuricemia (nausea, vomiting, lethargy, renal failure)
&lt;/li&gt;&lt;li&gt;Hyperkalemia (arrythmias)
&lt;/li&gt;&lt;li&gt;Hyperphosphatemia (renal failure)
&lt;/li&gt;&lt;li&gt;Hypocalcemia (anorexia, cramping, tetany, confusion, seizures, V tach/torsades)
&lt;/li&gt;&lt;li&gt;Acute renal failure
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tumor_Lysis_Syndrome_(TLS)&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Work Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work_Up"&gt;Work Up&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; CBC, Chem (including phos, ionized Ca)
&lt;/li&gt;&lt;li&gt; Uric Acid, LDH
&lt;/li&gt;&lt;li&gt; UA 
&lt;/li&gt;&lt;li&gt; Lactate 
&lt;/li&gt;&lt;li&gt; ECG (hyperK, hypoCa)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tumor_Lysis_Syndrome_(TLS)&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Imaging"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Imaging"&gt;Imaging&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Avoid IV contrast
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tumor_Lysis_Syndrome_(TLS)&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Management"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Management"&gt;Management&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Hypocalcemia (&#8804; 7mg/dL or 25% dec in baseline)
&lt;ol&gt;&lt;li&gt; Calcium gluconate 50-200mg IV (only if symptomatic)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Hyperphosphatemia (&#8805;4.5 mg/dL or 25% increase; &#8805; 6.5mg/dL in children)
&lt;ol&gt;&lt;li&gt;  Aluminum hydroxide (50-150mg/kg PO q4-6h)
&lt;/li&gt;&lt;li&gt; Dialysis if refractory
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Hyperuricemia (&#8805;8mg/dL or 25% increase)
&lt;ol&gt;&lt;li&gt;  Allopurinol 10mg/kg/d PO q8 OR 200-400 mg/m2 IV q12; renally dosed
&lt;ol&gt;&lt;li&gt; Inhibition of xanthine oxidase can last 18-30h
&lt;/li&gt;&lt;li&gt; Acts slowly and only against FUTURE production of uric acid
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Urate Oxidase Rx (eg Rasburicase 0.05-0.2mg/kg IV)
&lt;ol&gt;&lt;li&gt; uric acid final product of purine metabolism in humans; in mammals urate oxidase converts uric acid to allantoin (5-10x more soluble)
&lt;/li&gt;&lt;li&gt; Can be used for BOTH prevention and treatment
&lt;/li&gt;&lt;li&gt; Expensive
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Hyperkalemia (see Hyperkalemia) 
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;Diuretics (only if euvolemic)
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tumor_Lysis_Syndrome_(TLS)&amp;amp;action=edit&amp;amp;section=10" title="Edit section: Urine Alkalinization"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Urine_Alkalinization"&gt;Urine Alkalinization&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;NaHCO3 to urine pH &amp;gt;= 7.0
&lt;/li&gt;&lt;li&gt;uric acid solubility increases in alkaline environment
&lt;/li&gt;&lt;li&gt;no better than NS hydration
&lt;/li&gt;&lt;li&gt;not currently recommended
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tumor_Lysis_Syndrome_(TLS)&amp;amp;action=edit&amp;amp;section=11" title="Edit section: Acute Kidney Injury (Cr &amp;amp;gt; 1.5)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Acute_Kidney_Injury_.28Cr_.3E_1.5.29"&gt;Acute Kidney Injury (Cr &amp;gt; 1.5)&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Hydration with NS: goal UO 3L/24h
&lt;ol&gt;&lt;li&gt;decreases uric acid concentration in serum and renal tubules and  reduces uric acid precipitation
&lt;/li&gt;&lt;li&gt;if vol overload--&amp;gt;dialysis
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tumor_Lysis_Syndrome_(TLS)&amp;amp;action=edit&amp;amp;section=12" title="Edit section: Dialysis (criteria)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Dialysis_.28criteria.29"&gt;Dialysis (criteria)&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;K &amp;gt; 6mEq/L
&lt;/li&gt;&lt;li&gt;Significant renal insufficiency
&lt;/li&gt;&lt;li&gt;Uric Acid &amp;gt; 10 mg/dl
&lt;/li&gt;&lt;li&gt;Symptomatic hypocalcemia
&lt;/li&gt;&lt;li&gt;Serum phosphorus &amp;gt; 10mg/dl
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tumor_Lysis_Syndrome_(TLS)&amp;amp;action=edit&amp;amp;section=13" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Admission
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tumor_Lysis_Syndrome_(TLS)&amp;amp;action=edit&amp;amp;section=14" title="Edit section: Cairo-Bishop Definitions"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Cairo-Bishop_Definitions"&gt;Cairo-Bishop Definitions&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Laboratory Tumor Lysis SyndromeUric acid level: &#8805; 8 mg/dL or 25% increase from baseline
&lt;/li&gt;&lt;li&gt;Potassium level: &#8805; 6.0 mEq/L or 25% increase from baseline
&lt;/li&gt;&lt;li&gt;Phosphorus: &#8805; 6.5 mg/dL for children Phosphorus concentration: &#8805; 4.5 mg/dL for adults or 25% increase from baseline
&lt;/li&gt;&lt;li&gt;Calcium level: &#8804; 7 mg/dL or 25% decrease from baseline
&lt;/li&gt;&lt;li&gt;Clinical Tumor Lysis Syndrome: Laboratory tumor lysis syndrome plus 1 or more of the following criteria:
&lt;/li&gt;&lt;li&gt;Creatinine &amp;gt; 1.5 times upper limit of age-adjusted reference range
&lt;/li&gt;&lt;li&gt;Cardiac dysrhythmia or sudden death Seizure
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Tumor_Lysis_Syndrome_(TLS)&amp;amp;action=edit&amp;amp;section=15" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;EM Practice March '10
&lt;/p&gt;



</content><folder>Heme/Onc</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="types_of_insulin"><name>Types of Insulin</name><content>&lt;table border="1" width="342"&gt;

&lt;tr&gt;
&lt;td&gt; &lt;u&gt;&lt;b&gt;Type&lt;/b&gt;&lt;/u&gt;
&lt;/td&gt;&lt;td&gt; &lt;u&gt;&lt;b&gt;Onset of action (h)&lt;/b&gt;&lt;/u&gt;
&lt;/td&gt;&lt;td&gt; &lt;u&gt;&lt;b&gt;Peak action&lt;/b&gt;&lt;/u&gt;
&lt;/td&gt;&lt;td&gt; &lt;u&gt;&lt;b&gt;Effective duration&lt;/b&gt;&lt;/u&gt;
&lt;/td&gt;&lt;td&gt; &lt;u&gt;&lt;b&gt;Max duration&lt;/b&gt;&lt;/u&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td colspan="5"&gt; &lt;b&gt;RAPID ACTING&lt;/b&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;
&lt;p&gt;Lispro
&lt;/p&gt;&lt;p&gt;(humalog)
&lt;/p&gt;
&lt;/td&gt;&lt;td&gt; 0.25-0.5&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 0.5-1.25
&lt;/td&gt;&lt;td&gt; 3-4
&lt;/td&gt;&lt;td&gt; 4-6
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;
&lt;p&gt;Aspart
&lt;/p&gt;&lt;p&gt;(novolog)
&lt;/p&gt;
&lt;/td&gt;&lt;td&gt; 0.25-0.5&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 0.5-1.25
&lt;/td&gt;&lt;td&gt; 3-4
&lt;/td&gt;&lt;td&gt; 4-6
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;
&lt;p&gt;Glulisine
&lt;/p&gt;&lt;p&gt;(apidra)
&lt;/p&gt;
&lt;/td&gt;&lt;td&gt; 0.25-0.5
&lt;/td&gt;&lt;td&gt; 0.25-1.25&lt;br /&gt;
&lt;/td&gt;&lt;td&gt; 3-4
&lt;/td&gt;&lt;td&gt; 4-6
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td colspan="5"&gt; &lt;b&gt;SHORT ACTING&lt;br /&gt;&lt;/b&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; Regular
&lt;/td&gt;&lt;td&gt; 0.5-1
&lt;/td&gt;&lt;td&gt; 2-3
&lt;/td&gt;&lt;td&gt; 3-6
&lt;/td&gt;&lt;td&gt; 6-8
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td colspan="5"&gt; INTERMEDIATE ACTING
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt; NPH
&lt;/td&gt;&lt;td&gt; 2-4
&lt;/td&gt;&lt;td&gt; 6-10
&lt;/td&gt;&lt;td&gt; 10-16
&lt;/td&gt;&lt;td&gt; 14-18
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td colspan="5"&gt; &lt;b&gt;LONG ACTING&lt;/b&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;
&lt;p&gt;glargine
&lt;/p&gt;&lt;p&gt;(Lantus)
&lt;/p&gt;
&lt;/td&gt;&lt;td&gt; 3-4
&lt;/td&gt;&lt;td&gt; 8-16
&lt;/td&gt;&lt;td&gt; 18-20
&lt;/td&gt;&lt;td&gt; 20-24
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;
&lt;p&gt;detemir
&lt;/p&gt;&lt;p&gt;(Levemir)
&lt;/p&gt;
&lt;/td&gt;&lt;td&gt; 3-4
&lt;/td&gt;&lt;td&gt; 6-8
&lt;/td&gt;&lt;td&gt; 14
&lt;/td&gt;&lt;td&gt; ~20
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;




</content><folder>Drugs</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="uti"><name>UTI</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#Repeat"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;Repeat&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=UTI&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Post-menopausal --&amp;gt; 7 dy course (Cipro or Nitro)
&lt;/li&gt;&lt;li&gt; Pregnant --&amp;gt; 7dy course (Nitro or Keflex)
&lt;/li&gt;&lt;li&gt; Male --&amp;gt; 10dy course (R/O prostatitis, urethritis)
&lt;/li&gt;&lt;li&gt; Complicated (risk for subclinical pyelonephritis ~25%)
&lt;ol&gt;&lt;li&gt; Structureal urologic abnlty
&lt;/li&gt;&lt;li&gt; Neurologic dysfx (elderly)
&lt;/li&gt;&lt;li&gt; Hx of UCI relapse
&lt;/li&gt;&lt;li&gt; Prior hx of pyelo
&lt;/li&gt;&lt;li&gt; Frequent UTIs
&lt;/li&gt;&lt;li&gt; Sx &amp;gt;7dys
&lt;/li&gt;&lt;li&gt; DM or other immunosuppresed
&lt;/li&gt;&lt;li&gt;--&amp;gt; increased course vs. admit
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=UTI&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Repeat"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Repeat"&gt;Repeat&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;&amp;gt;3 UTIs/yr = R/O structural abnlty
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Cipro 250mg BID
&lt;/li&gt;&lt;li&gt;Bactrim DS BID
&lt;/li&gt;&lt;li&gt;Nitrofurantoin 100mg BID
&lt;/li&gt;&lt;li&gt;Keflex 250mg QID
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=UTI&amp;amp;action=edit&amp;amp;section=3" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Peds: UTI
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=UTI&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;10/07 DONALDSON (adapted from Tintinalli)
&lt;/p&gt;



</content><folder>GU</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="uti_(peds)"><name>UTI (Peds)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=UTI_(Peds)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- 75% of children &amp;lt; 5 y/o with febrile UTIs have pyelo, 27-64% will have permanent renal scarring.
&lt;/p&gt;&lt;p&gt;- 10 fold increase in UTIs for uncirc boys
&lt;/p&gt;&lt;p&gt;-After 12 mos, occult UTI w/ (-) UA xtremely rare!
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=UTI_(Peds)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- bag urine results in 83% false pos.
&lt;/p&gt;&lt;p&gt;- send urine cx on all febrile infants, 20% will have negative UA
&lt;/p&gt;&lt;p&gt;-Neg UA= neg LE, Nit, GS &amp;amp; &amp;lt;5 WBC
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=UTI_(Peds)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;UTI: cephalexin or cefixime, 10-14 days for infants and 7 days for children
&lt;/p&gt;&lt;p&gt;- treatment: infants 10-14 day course, children 7 day course of cephalexin or cefixime.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=UTI_(Peds)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-Admit all pyelos &amp;lt;3 mo or if vomiting
&lt;/p&gt;



</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="ulcerative_stds"><name>Ulcerative STDs</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Chancroid"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Chancroid&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#HSV_.28usually_type_2.29"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;HSV (usually type 2)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Syphilis"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Syphilis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ulcerative_STDs&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Chancroid"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Chancroid"&gt;Chancroid&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; cause: H ducreyi 
&lt;/li&gt;&lt;li&gt; multiple painful lesions
&lt;/li&gt;&lt;li&gt; painful inguinal lymphadenopathy (buboes) that may become an abscess and rupture
&lt;/li&gt;&lt;li&gt; Treatment: 
&lt;ol&gt;&lt;li&gt; clean area with soap and water
&lt;/li&gt;&lt;li&gt; I&amp;amp;D any fluctuant buboes
&lt;/li&gt;&lt;li&gt; treat for other STDs as well
&lt;/li&gt;&lt;li&gt; Antibiotics:
&lt;ol&gt;&lt;li&gt; Azithromycin 1g PO x 1 OR
&lt;/li&gt;&lt;li&gt; Cetriaxone 250 mg IM x 1 with Erythromycin 500 mg PO QID x 7 days OR
&lt;/li&gt;&lt;li&gt; Ciprofloxacin 500mg PO BID x 3 days 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ulcerative_STDs&amp;amp;action=edit&amp;amp;section=2" title="Edit section: HSV (usually type 2)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="HSV_.28usually_type_2.29"&gt;HSV (usually type 2)&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; multiple painful lesions
&lt;/li&gt;&lt;li&gt; no buboes (occ shoddy LAD)
&lt;/li&gt;&lt;li&gt; more common in African Americans 
&lt;/li&gt;&lt;li&gt; starts with small clumps of blisters that may have been preceded with local pain, tingling, itching, and burning
&lt;/li&gt;&lt;li&gt; +/- constiutional symptoms (fever, fatigue, myalgias, headaches)
&lt;/li&gt;&lt;li&gt; Treatment:
&lt;ol&gt;&lt;li&gt; antivirals
&lt;/li&gt;&lt;li&gt; acyclovir
&lt;/li&gt;&lt;li&gt; famciclovir
&lt;/li&gt;&lt;li&gt; valacyclovir
&lt;/li&gt;&lt;li&gt; pain medications 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ulcerative_STDs&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Syphilis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Syphilis"&gt;Syphilis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Cause: Treponema pallidum 
&lt;/li&gt;&lt;li&gt; single nonpainful lesion with punched out base and rolled edges (lesion is highly infectious)
&lt;/li&gt;&lt;li&gt; Treatment: 
&lt;ol&gt;&lt;li&gt; Benzathine penicillin G 2.4 million units IM x 1 (for primary or secondary infection) 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ulcerative_STDs&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Tung 7/2010 (adapted from emedicine)
&lt;/p&gt;&lt;p&gt;DONALDSON 5/4/07 (adapted from Birbaumer)
&lt;/p&gt;



</content><folder>Derm</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="ultrasound_basics"><name>Ultrasound Basics</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#GB"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;GB&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#AAA"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;AAA&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Cardiac"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Cardiac&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#FAST"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;FAST&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ultrasound_Basics&amp;amp;action=edit&amp;amp;section=1" title="Edit section: GB"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="GB"&gt;GB&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-Measure CBD from inner to inner, normal is up to 6mm to age 69, then add 1 mm per decade (ie 7 mm @ age 70 is nl)
&lt;/p&gt;&lt;p&gt;-Nl GB wall is &amp;lt;3-4 mm
&lt;/p&gt;&lt;p&gt;-For acalculous cholecystitis the GB will be &amp;gt;10cm long &amp;amp; &amp;gt; 4 cm wide
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ultrasound_Basics&amp;amp;action=edit&amp;amp;section=2" title="Edit section: AAA"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="AAA"&gt;AAA&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-Measure outer wall to outer wall
&lt;/p&gt;&lt;p&gt;-Nl aorta is &amp;lt;2.9 cm, must measure from below diaphragm in both planes to bifurcation!
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ultrasound_Basics&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Cardiac"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Cardiac"&gt;Cardiac&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-In parasternal view w/ dot pointing to Lt arm, the nl aortic root (to look for type A dissection) is &amp;lt;3.8 cm
&lt;/p&gt;&lt;p&gt;-One trick is to find aorta &amp;amp; drop probe flat under ribs to see aorta.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ultrasound_Basics&amp;amp;action=edit&amp;amp;section=4" title="Edit section: FAST"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="FAST"&gt;FAST&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;-Always point dot to pt Rt (usu at 45 degrees) or @ pt head
&lt;/p&gt;&lt;p&gt;-Morrisons pouch is best seen w/ probe around mid ax to ant ax line. This is the most sensitive spot to see fluid w/ pt in trendelenberg. Nd 150-500cc of blood to see here depending on skill of sonographer.
&lt;/p&gt;&lt;p&gt;-Splenorenal put in post ax line. Nd 400-500cc blood to see
&lt;/p&gt;&lt;p&gt;-Also chk bladder for free fluid in pelvis &amp;amp; pericardium for effussion
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ultrasound_Basics&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;By Lampe (9/04)
&lt;/p&gt;



</content><folder>Rads</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="ultrasound_in_shock_and_hypotension"><name>Ultrasound in Shock and Hypotension</name><content>&lt;p&gt;Rapid Ultrasound for Shock and Hypotension (RUSH) using the HI-MAP approach
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#H_.E2.80.93_Heart"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;H &#8211; Heart&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#M_.E2.80.93_Morison.27s"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;M &#8211; Morison's&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#A_.E2.80.93_Aorta"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;A &#8211; Aorta&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#P_.E2.80.93_Pneumothorax"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;P &#8211; Pneumothorax&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ultrasound_in_Shock_and_Hypotension&amp;amp;action=edit&amp;amp;section=1" title="Edit section: H &#8211; Heart"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="H_.E2.80.93_Heart"&gt;H &#8211; Heart&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Pericardial effusion can be seen with parasternal long view. LV assessment is also from the parasternal long view. A change in size less than 30% between systole and diastole indicates poor LV function. Alternatively, the LV is hyperdynamic if walls move more than 90% or touch at the end of systole, which can happen with hypovolemia or sepsis.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;In four-chamber view, RV should  be &amp;lt;60% of LV size &#8211; when RV is about the same size or larger than LV, think RV failure.
&lt;/p&gt;
&lt;pre&gt; ==I &#8211; IVC==
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt;
Start with the probe longitudinal and subxiphoid and slide  1-2 cm to the patient&#8217;s right. Look at IVC changes to inspiration. If the IVC is less than 1.5 cm and collapses on inspiration, the CVP is low and the patient probably needs fluid. A larger (&amp;gt;2.5cm) noncollapsing IVC suggests high CVP and the patient&#8217;s hypotension may require inotropes or reducing afterload.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;&lt;ul&gt;&lt;li&gt;Note: IVC assessment in vented patients requires a tidal volume of 10 mL/kg during the exam. A change in [(inspiratory size &#8211; expiratory size) / expiratory size] &amp;gt; 18% predicts good response to IVF.
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ultrasound_in_Shock_and_Hypotension&amp;amp;action=edit&amp;amp;section=2" title="Edit section: M &#8211; Morison's"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="M_.E2.80.93_Morison.27s"&gt;M &#8211; Morison's&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;the familiar Morison&#8217;s pouch and FAST views, covered in Ultrasound Basics. Tilting the probe chestward can show fluid at the lung/diaphragm interface.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ultrasound_in_Shock_and_Hypotension&amp;amp;action=edit&amp;amp;section=3" title="Edit section: A &#8211; Aorta"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="A_.E2.80.93_Aorta"&gt;A &#8211; Aorta&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;The aorta (also covered in ultrasound basics) can be seen in cross section sliding down from the subxiphoid to the umbilicus. If the aorta is larger than 5 cm below the heart or in the suprarenal, infrarenal or bifurcation views, you must assume ruptured AAA.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ultrasound_in_Shock_and_Hypotension&amp;amp;action=edit&amp;amp;section=4" title="Edit section: P &#8211; Pneumothorax"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="P_.E2.80.93_Pneumothorax"&gt;P &#8211; Pneumothorax&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;PTX can be seen by ultrasound. Using a high-frequency  probe, scan longitudinally in both anterior 3rd intercostal spaces
&lt;/p&gt;&lt;p&gt;using M-mode. Finding an ocean/beach or seashore sign reassures that there is no pneumothorax under the probe (immobile soft tissue and
&lt;/p&gt;&lt;p&gt;muscle on the top of the M-mode image looks like an ocean, and the sliding lung tissue looks on the bottom looks like a beach). If the
&lt;/p&gt;&lt;p&gt;whole image looks like the ocean pattern (stratosphere sign), a pneumothorax is likely.
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Ultrasound_in_Shock_and_Hypotension&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from Scott Weingart and others -- &lt;a href="http://emcrit.org/ultrasound/The%20RUSH%20Examfinal.htm" class="external free" rel="nofollow"&gt;http://emcrit.org/ultrasound/The%20RUSH%20Examfinal.htm&lt;/a&gt;
&lt;/p&gt;



</content><folder>Rads</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="unstable_angina_-_nstemi"><name>Unstable Angina - NSTEMI</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#TIMI_RISK_STRATIFICATION_SCORE"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;TIMI RISK STRATIFICATION SCORE&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Unstable_Angina_-_NSTEMI&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;CAD kills more Americans each year than any other dz
&lt;/li&gt;&lt;li&gt;Study w/ 400,000 pts w/ confirmed MI showed 33% had NO CP on presentation to ED!! (esp older, female, dm and chf)
&lt;/li&gt;&lt;li&gt;5% of NSTEMI will develop cardiogenic shock (60% mort!)
&lt;/li&gt;&lt;li&gt;Non-diagnostic ECG helpful to risk stratify, pts w/ confirmed MI but nl ECG had only 50% mort in house of pts w/ diagnostic ECGs (circulation,2002)
&lt;/li&gt;&lt;li&gt;Pt age &amp;gt;65 w/ MI and anemia had 33% reduction in 30 day mort if transfused to keep HCT &amp;gt;30 (NEJM 10/01)
&lt;/li&gt;&lt;li&gt;Clear link has been established between quantity of troponin and risk of death (tpi not up in CRI)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Unstable_Angina_-_NSTEMI&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;ACS (clinical evidence of ischemia)= UA, NSTEMI (UA sx w/ postive enzymes) and STEMI
&lt;/li&gt;&lt;li&gt;Angina is considered Unstable with 1 or more:
&lt;ol&gt;&lt;li&gt;occurs for the 1st time
&lt;/li&gt;&lt;li&gt;occurs at rest
&lt;/li&gt;&lt;li&gt;accelerating frequency or severity
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;ECG is key, but is entirely normal in 8% of all confirmed MI's; normal or non-specific in 50% UA/NSTEMI; but accuracy improves with prior ECG &amp;amp; serial tracings
&lt;/li&gt;&lt;li&gt;Intensity of Rx should be based on likelihood that a pts Sx are d/t an acute coronary thombosis
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Unstable_Angina_-_NSTEMI&amp;amp;action=edit&amp;amp;section=3" title="Edit section: TIMI RISK STRATIFICATION SCORE"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="TIMI_RISK_STRATIFICATION_SCORE"&gt;TIMI RISK STRATIFICATION SCORE&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;1 point for each
&lt;ol&gt;&lt;li&gt;Age &#8805;65 years
&lt;/li&gt;&lt;li&gt;Presence of at least three risk factors for CHD
&lt;/li&gt;&lt;li&gt;Prior coronary stenosis of &#8805;50 percent
&lt;/li&gt;&lt;li&gt;Presence of ST segment deviation on admission ECG
&lt;/li&gt;&lt;li&gt;At least two anginal episodes in prior 24 hours
&lt;/li&gt;&lt;li&gt;Elevated serum cardiac biomarkers
&lt;/li&gt;&lt;li&gt;Use of aspirin in prior seven days 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Likelihood of mortality, new or recurrent MI, or require  revascularization at 14 days
&lt;ol&gt;&lt;li&gt;Score of 0/1 - 4.7 percent
&lt;/li&gt;&lt;li&gt;Score of 2 - 8.3 percent
&lt;/li&gt;&lt;li&gt;Score of 3 - 13.2 percent
&lt;/li&gt;&lt;li&gt;Score of 4 - 19.9 percent
&lt;/li&gt;&lt;li&gt;Score of 5 - 26.2 percent 
&lt;/li&gt;&lt;li&gt;Score of 6/7 - 40.9 percent
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Unstable_Angina_-_NSTEMI&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Anti-ischemia
&lt;ol&gt;&lt;li&gt;Oxygen
&lt;ol&gt;&lt;li&gt;ACC recs O2 for sats &amp;lt;90% (evidence indeterminant)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Nitrates
&lt;ol&gt;&lt;li&gt;no mortality benifit
&lt;/li&gt;&lt;li&gt;dilates coronary arts, decr preload, slight decr afterload.  theoretically leads to decr O2 demand of heart.
&lt;/li&gt;&lt;li&gt;use of viagra within 24 hr can lead to profound and prolonged vasodilation and death!
&lt;/li&gt;&lt;li&gt;B-block to avoid reflex tachy.
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;B-Blockers
&lt;ol&gt;&lt;li&gt;Goal HR is 50-60.
&lt;/li&gt;&lt;li&gt;Contraindicated if HR&amp;lt;50 or SBP&amp;lt;90, acute CHF or pr &amp;gt;240ms
&lt;/li&gt;&lt;li&gt;(Decr progression from UA to MI by 13%(jama 10/88))
&lt;/li&gt;&lt;li&gt;decr inotropic and chronotropic response to catechols, thus decr O2 consumption.
&lt;/li&gt;&lt;li&gt;Decr progression from UA to MI by 13%(jama 10/88)
&lt;/li&gt;&lt;li&gt;Contraindicated if HR&amp;lt;50 or SBP&amp;lt;90, acute CHF or pr&amp;gt;240ms.
&lt;/li&gt;&lt;li&gt;use dilt or verap if cant use b-block (nifedipine clearly harmful)
&lt;/li&gt;&lt;li&gt;no IV BB in ED, PO within 24 H
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;ACE Inhibitor
&lt;ol&gt;&lt;li&gt;start short-acting (captopril) within 24 hours of admission
&lt;/li&gt;&lt;li&gt;reduces RR of 30 day mort by 7% (circulation 6/98)
&lt;/li&gt;&lt;li&gt;those w/ recent MI (esp ant) and LVdysf(x) benefit most.
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Transfusion
&lt;ol&gt;&lt;li&gt;transfuse to keep Hb &amp;gt;10 (NEJM 10/01; 33% reduction in 30 day mort)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;MSO4
&lt;ol&gt;&lt;li&gt;may use if pain after 3 doses of NTG.
&lt;/li&gt;&lt;li&gt;reduces pain and theoretically can decr HR and SBP and O2 demand
&lt;/li&gt;&lt;li&gt;use associated with higher mortality in MI pts (and cause of higher mortality in CHF exacerbation pts)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Antiplatelet
&lt;ol&gt;&lt;li&gt;(plaque rupture=exposed  endothelium=platelets=thrombus)
&lt;/li&gt;&lt;li&gt;ASA
&lt;ol&gt;&lt;li&gt;rec dose is 160-325mg chewed.
&lt;/li&gt;&lt;li&gt;reduces death from MI from 12.5-6.4% (circualtion 10/02)
&lt;/li&gt;&lt;li&gt;inhibits COX-1, reducing thromboxane A2
&lt;/li&gt;&lt;li&gt;should be used in all ACS unless contraindicated (far better than any new drugs we have)!! (circualtion 10/02). 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Clopidogrel (plavix, 300mg po then 75qd)
&lt;ol&gt;&lt;li&gt;in addition to ASA
&lt;/li&gt;&lt;li&gt;used over ticlopidine b/c faster onset &amp;amp; less s/e (ttp,aplastic anemia etc).
&lt;/li&gt;&lt;li&gt;mortality benifit with NSTEMI
&lt;/li&gt;&lt;li&gt;ADP antagonist, noncompet inhibits platelet adp receptor.
&lt;/li&gt;&lt;li&gt;main risk and contraind is bleeding (stop 7days before cabg)
&lt;/li&gt;&lt;li&gt;CURE trial showed decr in CV death, MI or stroke from 11.5% to 9.3% w/ this drug.
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;GPIIb/IIIa(-) = Integrillin (eptifibatide)
&lt;ol&gt;&lt;li&gt;blocks this receptor on platelet.
&lt;/li&gt;&lt;li&gt;oral forms incr mort!!!
&lt;/li&gt;&lt;li&gt;high-risk pts benefit most.
&lt;/li&gt;&lt;li&gt;Integrillin (eptifibatide) studied in PURSUIT trial, found 30 day death or MI decr from 15.7% to 14.2%.
&lt;/li&gt;&lt;li&gt;incr ICH not seen w/ use.
&lt;/li&gt;&lt;li&gt;benefit if early pci is planned, and&amp;nbsp;? to no benefit if PCI not planned
&lt;/li&gt;&lt;li&gt;reserved (if no pci) for positive tpi or isch/ecg changes despite asa, lovenox, b-block etc.
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Antithombotics
&lt;ol&gt;&lt;li&gt;(in 2002 ACC/AHA mgt of UA/NSTEMI includes class1A evidence to anticoagulate w/ heparin or lovenox along w/ asa +/- plavix)
&lt;/li&gt;&lt;li&gt;Heparin vs. Lovenox
&lt;ol&gt;&lt;li&gt;class1A evidence to anticoagulate w/ heparin or lovenox along w/ asa
&lt;/li&gt;&lt;li&gt;+/- plavix in NSTEMI
&lt;/li&gt;&lt;li&gt;Unfractionated Heparin
&lt;ol&gt;&lt;li&gt;Bolus 60-70u/kg (max 5000), followed by infusion of 12-15u/kg/hr (max 1000/hr), w/ goal ptt 45-75s
&lt;ol&gt;&lt;li&gt;activates antithrombin which prevents thrombus propagation but does NOT cause lysis
&lt;/li&gt;&lt;li&gt;Hirudin is approved only for pts w/ HIT.
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;LMWH:  enoxaparin (lovenox)
&lt;ol&gt;&lt;li&gt;1mg/kg sc BID
&lt;/li&gt;&lt;li&gt;safer (20% decr in death,MI or urgent revasc w/ LMWH vs UFH)
&lt;/li&gt;&lt;li&gt;AHA recomends for mod &amp;amp; high risk UA/NSTEMI unless CABG w/in 24hrs
&lt;/li&gt;&lt;li&gt;adjust for CrCl&amp;lt;30ml and extremes of weight
&lt;/li&gt;&lt;li&gt;No needd to monitor labs!
&lt;/li&gt;&lt;li&gt;ESSENCE showed 20% decr in death, MI or urgent revasc w/ LMWH vs UFH.
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Thrombolytics 
&lt;ol&gt;&lt;li&gt;in the case of UA/NSTEMI have been shown to increase the risk of MI, with no benefit, and all the risks of TNK!
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Angiography, if
&lt;ol&gt;&lt;li&gt;Hemodynamic instability or cardiogenic shock
&lt;/li&gt;&lt;li&gt;Severe left ventricular dysfunction or heart failure
&lt;/li&gt;&lt;li&gt;Recurrent or persistent rest angina despite intensive medical therapy
&lt;/li&gt;&lt;li&gt;New or worsening mitral regurgitation or new ventricular septal defect
&lt;/li&gt;&lt;li&gt;Sustained ventricular arrhythmias 
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Early (within 24hr) referral for angiography
&lt;ol&gt;&lt;li&gt;TIMI risk score greater than 2
&lt;/li&gt;&lt;li&gt;New or presumably new ST segment depression
&lt;/li&gt;&lt;li&gt;Elevated cardiac enzymes
&lt;/li&gt;&lt;li&gt;Prior PCI within six months or prior CABG 
&lt;/li&gt;&lt;li&gt;Recurrent angina or ischemia at rest or with low level activity despite intensive antiischemic therapy
&lt;/li&gt;&lt;li&gt;LVEF &amp;lt;40 percent
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Unstable_Angina_-_NSTEMI&amp;amp;action=edit&amp;amp;section=5" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Cards: Cocaine CP
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Unstable_Angina_-_NSTEMI&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from Pani, Donaldson, Lampe, EM Practice, UpToDate
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="updating_and_creating_notes_on_wikem"><name>Updating and Creating Notes on WikEM</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Website_Address"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Website Address&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Creating_a_New_Note"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Creating a New Note&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Editing_Notes"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Editing Notes&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#General_Comments"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;General Comments&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Style_Guidelines"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Style Guidelines&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Standardized_Abbreviations"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Standardized Abbreviations&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Updating_and_Creating_Notes_on_WikEM&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Website Address"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Website_Address"&gt;Website Address&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;You must go to www.WikEM.org on a computer or smart phone to edit content.  You cannot currently edit from the downloaded WikEM smartphone software (sorry, we're working on it).
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Updating_and_Creating_Notes_on_WikEM&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Creating a New Note"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Creating_a_New_Note"&gt;Creating a New Note &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;To create a new note:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Search for the term in the search field in the upper right hand corner of the page
&lt;ol&gt;&lt;li&gt;If you find a note with a similar theme, please edit it with your new content (see below)
&lt;/li&gt;&lt;li&gt;If you don't find a note on your subject, click on the link: Create the page on this wiki!
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Please follow formatting guidelines below
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Updating_and_Creating_Notes_on_WikEM&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Editing Notes"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Editing_Notes"&gt; Editing Notes &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;To edit a note:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Find the note using the "Categories" tab on the Navigation field on the left side of the page or search for it via the search field in the upper right hand corner
&lt;/li&gt;&lt;li&gt;Click on the "Edit" in the middle of the page above the note
&lt;/li&gt;&lt;li&gt;Edit away
&lt;ol&gt;&lt;li&gt;Please follow formatting guidelines below
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Updating_and_Creating_Notes_on_WikEM&amp;amp;action=edit&amp;amp;section=4" title="Edit section: General Comments"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="General_Comments"&gt;General Comments&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Before making new notes, please first use the search function to see if there are already similar or related note!  If there are, make your additions to the existing note, unless you're adding distinctly new content.
&lt;/li&gt;&lt;li&gt;Keep entries concise and as simple as possible, so that you can look up information quickly.  Preference is for "notes," not "chapters" (i.e. think Pepid, not UpToDate)
&lt;/li&gt;&lt;li&gt;Remember that the user format is the PDA (view it on your PDA to see the final format)
&lt;/li&gt;&lt;li&gt;Focus on practical knowledge (with little to no pathophysiology or non-useful facts)
&lt;/li&gt;&lt;li&gt;Reference other Memos if appropriate (as done above)
&lt;/li&gt;&lt;li&gt;Put your source(s) at the bottom, if appropriate (the date and your name will be included automatically at the bottom in the future, so no need to add it as is currently seen on some notes)
&lt;/li&gt;&lt;li&gt;Feel free to divide notes into several notes, or combine them, if it makes them more useful
&lt;/li&gt;&lt;li&gt;Use one of the templates (see above) if appropriate
&lt;/li&gt;&lt;li&gt;Do not use "*" signs, as the wiki software uses this for other purposes.  Please use "^".
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Updating_and_Creating_Notes_on_WikEM&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Style Guidelines"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Style_Guidelines"&gt;Style Guidelines&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;All major headings should be set to  Format: Heading 2. Headings should not be entered in all caps. 
A maximum of 3 indent levels should be used in all articles. Beyond 3 indent levels text becomes hard to read on mobile devices
All tables should be sized to be 300px wide. If content is not readable in this size please consider reformatting to an outline or some another format
Embedding images is NOT supported, please do not include images in any entries.
Valid text formatting includes: bold, underline, italics, strike through, foreground color, background color. Any other formatting may interfere with mobile display. Please note that text formatting is currently not available on the blackberry, so please use it very limitedly (or not at all)
Cite other notes as "Folder: Name-of-Note" (e.g.  Peds: Rash)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Updating_and_Creating_Notes_on_WikEM&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Standardized Abbreviations"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Standardized_Abbreviations"&gt;Standardized Abbreviations&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;CXR	Chest X-Ray / Radiograph
&lt;/p&gt;&lt;p&gt;DM	Diabetes Mellitus
&lt;/p&gt;&lt;p&gt;HTN	Hypertension
&lt;/p&gt;&lt;p&gt;Ddx 	Differential Diagnosis
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Updating_and_Creating_Notes_on_WikEM&amp;amp;action=edit&amp;amp;section=7" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Wik-EM: Template 1 (General)
&lt;/p&gt;&lt;p&gt;Wik-EM: Template 2 (Drug)
&lt;/p&gt;&lt;p&gt;Wik-EM: Template 3 (List)
&lt;/p&gt;&lt;p&gt;Wik-EM: Template 4 (Ddx)
&lt;/p&gt;



</content><folder>WikEM</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="urine_output"><name>Urine Output</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Urine_Output&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Normal"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Normal"&gt;Normal&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adult &amp;gt;0.5mL/kg/hr
&lt;/p&gt;&lt;p&gt;Child &amp;gt;1ml/kg/hr
&lt;/p&gt;&lt;p&gt;Neonate (&amp;lt;1yr) &amp;gt;2mL/kg/hr
&lt;/p&gt;



</content><folder>FEN</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="uterine_rupture"><name>Uterine Rupture</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Uterine_Rupture&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;- by weak ut wall or increased ut pressure- scarring from prev c
&lt;/p&gt;&lt;p&gt;section, or increased pressure by concealed  abruption, abd trauma,
&lt;/p&gt;&lt;p&gt;invasive moles, choriocarcinoma. also placenta acreta/ increta/
&lt;/p&gt;&lt;p&gt;percreta- placenta invades ut wall just below surfac (acrete) to
&lt;/p&gt;&lt;p&gt;completelly through it (percreta).
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Uterine_Rupture&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;increase in ut pain
&lt;/li&gt;&lt;li&gt;loss of pre normal contraction
&lt;/li&gt;&lt;li&gt;fetal distress
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Uterine_Rupture&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Emergent surg
&lt;/p&gt;



</content><folder>OB/GYN</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="uveitis"><name>Uveitis</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Clinical_Manifestations"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Clinical Manifestations&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Uveitis&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Uveitis = inflammation of iris, ciliary body, and/or choroid
&lt;ol&gt;&lt;li&gt; Anterior uveitis
&lt;ol&gt;&lt;li&gt; Inflammation of iris and/or ciliary body
&lt;/li&gt;&lt;li&gt; Types:
&lt;ol&gt;&lt;li&gt; Iritis
&lt;/li&gt;&lt;li&gt; Iridocyclitis
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Posterior uveitis = choroiditis
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Uveitis&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Clinical Manifestations"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Clinical_Manifestations"&gt;Clinical Manifestations&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Anterior uveitis
&lt;ol&gt;&lt;li&gt; Pain
&lt;/li&gt;&lt;li&gt; Redness (primarily noted at the limbus)
&lt;/li&gt;&lt;li&gt; Constricted pupil
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Posterior uveitis
&lt;ol&gt;&lt;li&gt; Reduced visual acuity
&lt;/li&gt;&lt;li&gt; Floaters
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Uveitis&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Cell &amp;amp; flare
&lt;/li&gt;&lt;li&gt; Hypopyon
&lt;/li&gt;&lt;li&gt; Photophobia
&lt;/li&gt;&lt;li&gt; CXR (uveitis often associated with sarcoidosis, TB)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Uveitis&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Infectious
&lt;ol&gt;&lt;li&gt; Treat the underlying infection
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Noninfectious
&lt;ol&gt;&lt;li&gt; Steroid
&lt;ol&gt;&lt;li&gt; Prednisolone 1%
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Cycloplegic
&lt;ol&gt;&lt;li&gt; Relieves pain and prevents formation of posterior synechiae
&lt;/li&gt;&lt;li&gt; Scopolamine 0.25% OR cyclopentolate 1%
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Ophtho consult within 24 hours
&lt;/li&gt;&lt;/ol&gt;




</content><folder>Ophtho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="va_micu_rotation"><name>VA MICU Rotation</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Pre_Day-1"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Pre Day-1&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Basics"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Basics&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Admission"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Admission&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Discharge.2FTransfer"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Discharge/Transfer&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Call_Room"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Call Room&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=VA_MICU_Rotation&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt; Background &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;VA Coordinator is Christine Seydel. 310-268-3034. Email christine.seydel@va.gov. She works from Monday-Thursday.
&lt;/p&gt;&lt;p&gt;Call schedule at the website: www.amion.com. The login is cedarsim
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=VA_MICU_Rotation&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Pre Day-1"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Pre_Day-1"&gt; Pre Day-1 &lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Complete online training
&lt;/li&gt;&lt;li&gt;www.ees-learning.net
&lt;/li&gt;&lt;li&gt;select: VHA Mandatory Training for Trainees
&lt;/li&gt;&lt;li&gt;Complete the course module (takes about 1-1.5 hrs to complete)
&lt;/li&gt;&lt;li&gt;Print out 2 copies of your certificates and bring them with you.
&lt;/li&gt;&lt;li&gt;Westwood VA is located just west of the 405 on Wilshire Blvd.
&lt;/li&gt;&lt;li&gt;&lt;a href="http://www1.va.gov/directory/guide/facility.asp?ID=78&amp;amp;dnum=ALL" class="external free" rel="nofollow"&gt;http://www1.va.gov/directory/guide/facility.asp?ID=78&amp;amp;dnum=ALL&lt;/a&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;&lt;br /&gt;
1. Go to Human Resources which is on the north side of Wilshire near the Chapel looking building on the hill- opposite side of main hospital. Find Bldg 218, Rm 14 Human Resources at 310-478-3711 Extension 48395. Monday thru Friday from 7:00 AM to 3:00 PM.
&lt;/p&gt;&lt;p&gt;They will make you pledge an oath to the USA and take your fingerprints. You do not need a new ID badge. You can use Harbor&#8217;s.
&lt;/p&gt;&lt;p&gt;2. Next, go to main hospital.
&lt;/p&gt;&lt;p&gt;No parking permit is needed if you park in lot 2 or 6. On weekends, do not use lot 6- they have motorcycle class. Lot 2 is near the ED and empty on weekends. You can take Sawtelle and it will lead you directly into Lot 2. Lot 6 is to the west of the hospital. DO NOT park in the front of the hospital.
&lt;/p&gt;&lt;p&gt;3. Go to room 1605 for hospital codes. Bring your printed certificates for the CPRS lady. Tell CPRS to place your pager as VA pager 5582. (310) 478-3711 ext. 41289
&lt;/p&gt;&lt;p&gt;4. Take the printed certificates also to the Residency Office which is in 3East.
&lt;/p&gt;&lt;p&gt;At that time, ask Chris (coordinator) for your meal voucher = money for each night you are on call. $7 each weekday and $13 on the weekend calls. Make sure you log onto Amion and print out your call schedule, as the form for reimbursement requires it.
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=VA_MICU_Rotation&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Basics"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Basics"&gt; Basics &lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;MICU/CCU/SICU is in 5 West.
&lt;/li&gt;&lt;li&gt;pCU 5 South C
&lt;/li&gt;&lt;li&gt;Telemetry (cards) 5 South B 
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;--The ICU is broken into 3 teams that consist of an intern and a resident. Call is usually q3. Call is from 8 AM-8PM. Any patient you admit before 7 PM goes to your team. Any patient you admit after 7 PM goes to the next day&#8217;s team. The night float resident comes in at 8 PM and then is responsible for the overnight admissions, which goes to the next day&#8217;s team. Please be aware that you may come in the next morning with brand new patients on your list.
&lt;/p&gt;&lt;p&gt;--You admit any medical patient who needs any sort of monitoring. Even neuro stroke patients watch overnight and rarely surgery patients as well.
&lt;/p&gt;&lt;p&gt;--You transfer patients to and receive patients from the ward
&lt;/p&gt;&lt;p&gt;-- The nursing care at the wards at the VA is like our 6W ward. That is poorly monitored. So do not hastily transfer to ward to diurese your service. You will likely run a code in the ward- when someone has already been dead for a few hours.
&lt;/p&gt;&lt;p&gt;--Rounds usually begin around 8:30. However, if you have any CCU patients on your service, the CCU fellow and attending round at 7:30 and you must be present. Also, if you are on call for the day and there are any CCU patients on the entire MICU service (even if they&#8217;re not yours), you must be present for the 7:30 rounds.
&lt;/p&gt;&lt;p&gt;--The ED is not always run by EM docs. Responses like no we didn&#8217;t LP the possible meningitis patient when he came in 6 hrs ago can occur. Some of them do not know how to place IJs. So, go see patient in ED soon after getting the call.
&lt;/p&gt;&lt;p&gt;--Code pager always goes off at 9 am for test.
&lt;/p&gt;&lt;p&gt;-You carry the code pager and the "rapid response" pager. Do not ignore these pages- but you will likely get many false alarms.
&lt;/p&gt;&lt;p&gt;--To page people in the VA, VA pager dial 11 first. Cedars pager dial 19 first. UCLA pager 1-800-BEEP-231 first.
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=VA_MICU_Rotation&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Admission"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Admission"&gt; Admission &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;--You can get 2 types of admits:   From the ED and transfers from other services and the general medicine floor.   For the floor transfers, go see the patient before accepting the transfer.   You are able to block the transfer if you think it is not acceptable, however, it can be easier just to take the patient.  If you accept the transfer, the primary team needs to write a transfer summary note as well as delayed orders to your service.   The intern caps officially at 5 patients and then you see the remainder of the admits on your own.
&lt;/p&gt;&lt;p&gt;--At night, if you get an admit, ask the MICU if they have room for the patient prior to transfer, the nurses greatly appreciate this.
&lt;/p&gt;&lt;p&gt;--To consult a service, you call the service as well as place a consult in the computer. Overnight, any surgical consult including neurosurgery is a general surgery intern.
&lt;/p&gt;&lt;p&gt;--Procedures: it depends on the fellow but procedures on your own are ok if you feel comfortable. The fellow can also help.
&lt;/p&gt;&lt;p&gt;--Intubations: if you are comfortable, you can intubate patients yourself without anesthesia. However, RSI drugs are not necessarily readily avaialble and you may have to push the drugs yourself. If the fellow is around he can help you out. Anesthesia (usually a CRNA) will likely always steal your tube. Even if you are the one running a code. But you can always ask to do the intubation.
&lt;/p&gt;&lt;p&gt;--Signout&#8212;the interns sign out to each other. Usually the residents would just heads-up each other if they felt a patient was unstable, etc.
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=VA_MICU_Rotation&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Discharge/Transfer"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Discharge.2FTransfer"&gt; Discharge/Transfer &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;--To transfer someone, you usually will call general medicine and transfer the patient to the medicine ward.
&lt;/p&gt;&lt;p&gt;--To do this, call the gmed admit team BEFORE 2 PM/EARLY. Make sure to ask them who they are, the attending&#8217;s name, and the team number. You/your intern will need to then write DELAYED transfer orders and a transfer note. It will not allow you to finish your transfer orders unless you know the gmed attending.
&lt;/p&gt;&lt;p&gt;--After calling for transfer, the patient remains officially your patient until they physically leave the monitor and go to ward.
&lt;/p&gt;&lt;p&gt;--If you discharge somebody directly from the MICU, you must write a discharge summary in the computer. The same goes for death notes.
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=VA_MICU_Rotation&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Call Room"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Call_Room"&gt; Call Room &lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Call room is on 6th floor East, follow signs for resident quarters.
&lt;/li&gt;&lt;li&gt;Door code is 5-2-3-1.
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;--Remember to bring food and drinks. Cafeteria closes at 3 pm. There is NO food in the hospital on the weekends. There is free lunch in the 3East conference room on Mondays, Wednesdays, Thursdays, and Fridays, usually sandwiches or pizzas. There is a fridge in the call room for you to store your food.
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=VA_MICU_Rotation&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt; Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;9/11/05 Dorcas Atkinson, Lisa Dabby, Chirag Shah
&lt;/p&gt;&lt;p&gt;7/10/08 Rachelle Sohren's Guide to the VA Rotation
&lt;/p&gt;&lt;p&gt;7/6/09 Jonie Hsiao
&lt;/p&gt;&lt;p&gt;7/18/09 Tina Nguyen
&lt;/p&gt;



</content><folder>Harbor Admin</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="va_moonlighting"><name>VA Moonlighting</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Computer"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Computer&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Consultation"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Consultation&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Schedule"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Schedule&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Admission"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Admission&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Discharge"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Discharge&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Transfer"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Transfer&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;8&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=VA_Moonlighting&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Contact ED director at the VA is Dr. Jennifer Chen as of 9/2009. jennifer.chen6@va.gov
&lt;/p&gt;&lt;p&gt;ER Call Rm: 4512
&lt;/p&gt;&lt;p&gt;Old ECG
&lt;/p&gt;&lt;p&gt;--&amp;gt;Tools --&amp;gt; Vista Imaging
&lt;/p&gt;&lt;p&gt;or --&amp;gt; Vista Web (remote)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=VA_Moonlighting&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Computer"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Computer"&gt;Computer &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;ENCOUNTER
&lt;/p&gt;&lt;p&gt;Note:
&lt;/p&gt;&lt;p&gt;--&amp;gt;visit encounter
&lt;/p&gt;&lt;p&gt;--&amp;gt; "WLA-Emergency Rm Note"
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Labs:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Chem 7 = "Anion Gap"
&lt;/li&gt;&lt;li&gt;Trop = "Cardiac Risk Eval Panel"
&lt;/li&gt;&lt;li&gt;(no CK-MB)
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;Abx:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;--&amp;gt; "Outpatient IV Piggyback"
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=VA_Moonlighting&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Consultation"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Consultation"&gt;Consultation&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;VA Pager: x11
&lt;/li&gt;&lt;li&gt;Rads On Call: 5376
&lt;/li&gt;&lt;li&gt;Rads Tech (Head CT): 5420
&lt;/li&gt;&lt;li&gt;Psych: 5625
&lt;/li&gt;&lt;li&gt;Neuro: 5159
&lt;/li&gt;&lt;li&gt;Hosp Main: 310-478-3711
&lt;/li&gt;&lt;li&gt;ER: 83169
&lt;/li&gt;&lt;li&gt;SICU (surg): 83179
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;Admission Pagers:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;GMED (stops after 2am) 5846
&lt;/li&gt;&lt;li&gt;MICU (6am change team) 5840
&lt;/li&gt;&lt;li&gt;CCU (6am change team) 5838
&lt;/li&gt;&lt;li&gt;Surg (all) 5164
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=VA_Moonlighting&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Schedule"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Schedule"&gt;Schedule&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;amion.com (on call)
&lt;/p&gt;&lt;p&gt;password = cedars im
&lt;/p&gt;&lt;p&gt;vhaglaweb3/
&lt;/p&gt;&lt;p&gt;--&amp;gt;pt care
&lt;/p&gt;&lt;p&gt;--&amp;gt; surg on call
&lt;/p&gt;&lt;p&gt;--&amp;gt;clinic schedule
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=VA_Moonlighting&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Admission"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Admission"&gt;Admission&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;--&amp;gt; ED Order screen
&lt;/p&gt;&lt;p&gt;-no location
&lt;/p&gt;&lt;p&gt;+service
&lt;/p&gt;&lt;p&gt;Beds:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;ICU (2:1) MICU/CCU/SICU
&lt;/li&gt;&lt;li&gt;HICU (3:1) Q2hr check; O2 monitor
&lt;/li&gt;&lt;li&gt;Tele (4:1) Cards; No O2 monitor/neuro check
&lt;/li&gt;&lt;li&gt;Ward (8:1) General Med/Subsurg
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=VA_Moonlighting&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Discharge"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Discharge"&gt;Discharge&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Follow-up:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;consult note with time told to F/U
&lt;/li&gt;&lt;li&gt;PACC procedure room
&lt;ol&gt;&lt;li&gt;(for dressing changes, wound check, etc)
&lt;/li&gt;&lt;li&gt;order specific instrutions "Nursing orders"
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Pt calls for F/U: 310-268-3366
&lt;/li&gt;&lt;li&gt;Triage nurse: 800-952-4852
&lt;/li&gt;&lt;li&gt;Paperwork: "After Care Instructions"
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=VA_Moonlighting&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Transfer"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Transfer"&gt;Transfer&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Accepting:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;No inpatient hospital to ER afterhours
&lt;/li&gt;&lt;li&gt;No trauma
&lt;/li&gt;&lt;li&gt;Transfer coordinator 310-268-3318
&lt;/li&gt;&lt;li&gt;Get aproval for subspecialty prior to accept
&lt;/li&gt;&lt;li&gt;Admin on duty = MAOD
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=VA_Moonlighting&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;8/1/06 DONALDSON
&lt;/p&gt;



</content><folder>Harbor Admin</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="vtach_vs_aberrant_svt"><name>VTACH vs Aberrant SVT</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Brugada.27s_Criteria"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Brugada's Criteria&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#VTach_vs._SVT"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;VTach vs. SVT&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#V_TACH"&gt;&lt;span class="tocnumber"&gt;3.1&lt;/span&gt; &lt;span class="toctext"&gt;V TACH&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#SVT_With_Aberrancy"&gt;&lt;span class="tocnumber"&gt;3.2&lt;/span&gt; &lt;span class="toctext"&gt;SVT With Aberrancy&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=VTACH_vs_Aberrant_SVT&amp;amp;action=edit&amp;amp;section=1" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Cards: Tachycardia (Wide)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=VTACH_vs_Aberrant_SVT&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Brugada's Criteria"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Brugada.27s_Criteria"&gt;Brugada's Criteria&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Lack of precordial RS complex. yes=VT
&lt;/li&gt;&lt;li&gt;R onset to S nadir &amp;gt; 100ms of 2.5 sm boxes in one precordial lead. yes=VT
&lt;/li&gt;&lt;li&gt;AV dissociation. yes=VT
&lt;/li&gt;&lt;li&gt;Morphology criteria for VT present both in precordial leads v1-2 and v6. yes-VT
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=VTACH_vs_Aberrant_SVT&amp;amp;action=edit&amp;amp;section=3" title="Edit section: VTach vs. SVT"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="VTach_vs._SVT"&gt;VTach vs. SVT &lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=VTACH_vs_Aberrant_SVT&amp;amp;action=edit&amp;amp;section=4" title="Edit section: V TACH"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="V_TACH"&gt;V TACH&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;age &amp;gt;50
&lt;/li&gt;&lt;li&gt;h/o MI, CHF, CABG, ASHD, mitral valve prolapse, prev v tach
&lt;/li&gt;&lt;li&gt;cannon A waves
&lt;/li&gt;&lt;li&gt;variation in arterial pulse
&lt;/li&gt;&lt;li&gt;variable first heat sound
&lt;/li&gt;&lt;li&gt;fusion beats
&lt;/li&gt;&lt;li&gt;AV dissociation
&lt;/li&gt;&lt;li&gt;QRS &amp;gt; 0.14sec
&lt;/li&gt;&lt;li&gt;extreme LAD &amp;lt;-30degree
&lt;/li&gt;&lt;li&gt;no response to vagal maneuvers
&lt;/li&gt;&lt;li&gt;specific QRS pattern- V1- R, qR or RS, V6- S, rS or qR
&lt;/li&gt;&lt;li&gt;concordance
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=VTACH_vs_Aberrant_SVT&amp;amp;action=edit&amp;amp;section=5" title="Edit section: SVT With Aberrancy"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="SVT_With_Aberrancy"&gt;SVT With Aberrancy&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;age &amp;lt;35
&lt;/li&gt;&lt;li&gt;mitral valve prolapse, esp c h/o WPW
&lt;/li&gt;&lt;li&gt;prev SVT
&lt;/li&gt;&lt;li&gt;no cannon A waves
&lt;/li&gt;&lt;li&gt;no variability in arterial pulse
&lt;/li&gt;&lt;li&gt;no variability of first heart sound
&lt;/li&gt;&lt;li&gt;no fusion beats
&lt;/li&gt;&lt;li&gt;p waves preceding qrs cmplx
&lt;/li&gt;&lt;li&gt;QRS usually &amp;lt;0.14 sec
&lt;/li&gt;&lt;li&gt;axis normal or slightly abnormal
&lt;/li&gt;&lt;li&gt;slow or terminate with vagal maneuver
&lt;/li&gt;&lt;li&gt;specific QRS pattern- V1-rsR', V6qRs (R wave in V1 or V2 &amp;lt; 1 box wide)
&lt;/li&gt;&lt;li&gt;In Peds SVT w/ Aberrancy = #1 cause of wide tachycardia
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=VTACH_vs_Aberrant_SVT&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;7/2/09 Pani 
&lt;/p&gt;&lt;p&gt;4/2/10 Niemann
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="vaginal_bleed_non-pregnant_(vb-)"><name>Vaginal Bleed Non-Pregnant (VB-)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#DDX"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;DDX&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Systemic_Causes"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;Systemic Causes&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Reproductive_Tract_Causes"&gt;&lt;span class="tocnumber"&gt;2.2&lt;/span&gt; &lt;span class="toctext"&gt;Reproductive Tract Causes&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Vaginal_Bleed_Non-Pregnant_(VB-)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Normal menstruation: 28 + 7 day cycles; 4+ 3 days of bleeding
&lt;/p&gt;&lt;p&gt;Menorrhagia: prolonged (&amp;gt;7 days) or excessive (&amp;gt;80mL daily) of uterine bleeding occurring at regular intervals 
&lt;/p&gt;&lt;p&gt;Metrorrhagia: uterine bleeding occurring at irregular and more frequent than normal intervals
&lt;/p&gt;&lt;p&gt;Menometrorrhagia: prolonged/excessive bleeding occurring at irregular and ore frequent intervals than normal
&lt;/p&gt;&lt;p&gt;Postmenopausal bleeding: recurrence of bleeding in a menopausal woman 1 year after cessation of cycles 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Vaginal_Bleed_Non-Pregnant_(VB-)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: DDX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX"&gt;DDX&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Vaginal_Bleed_Non-Pregnant_(VB-)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Systemic Causes"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Systemic_Causes"&gt;Systemic Causes&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Secondary anovulation
&lt;/li&gt;&lt;li&gt;Coagulopathy
&lt;/li&gt;&lt;li&gt;Endocrinopathies (Cushings, PCOS, DM, thyroid abnl)
&lt;/li&gt;&lt;li&gt;Cirrhosis
&lt;/li&gt;&lt;li&gt;Stress/weight gain/excessive diet or exercise
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Vaginal_Bleed_Non-Pregnant_(VB-)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Reproductive Tract Causes"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Reproductive_Tract_Causes"&gt;Reproductive Tract Causes&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Dysfunctional uterine bleeding
&lt;/li&gt;&lt;li&gt;Ruptured ovarian cyst
&lt;/li&gt;&lt;li&gt;Vaginal lac/trauma
&lt;/li&gt;&lt;li&gt;Foreign Body
&lt;/li&gt;&lt;li&gt;IUD
&lt;/li&gt;&lt;li&gt;Uterine fibroids
&lt;/li&gt;&lt;li&gt;Atrophic endometrium
&lt;/li&gt;&lt;li&gt;AVM
&lt;/li&gt;&lt;li&gt;Cancer (Endometrial, cervical, vaginal, genital)
&lt;/li&gt;&lt;li&gt;Polyps
&lt;/li&gt;&lt;li&gt;Endometrial hyperplasia
&lt;/li&gt;&lt;li&gt;Infection
&lt;/li&gt;&lt;li&gt;Lichen sclerosis
&lt;/li&gt;&lt;li&gt;Urethral prolapse
&lt;/li&gt;&lt;li&gt;Inflammation (vulvitis, vaginitis, endometritis)
&lt;/li&gt;&lt;li&gt;Iatrogenic (OCPs, Hormone replacement, psychotropic drugs)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Vaginal_Bleed_Non-Pregnant_(VB-)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; Icon
&lt;/li&gt;&lt;li&gt; Hb
&lt;/li&gt;&lt;li&gt;&amp;nbsp;?Orthostatics
&lt;/li&gt;&lt;li&gt;&amp;nbsp;?IVF/blood
&lt;/li&gt;&lt;li&gt;&amp;nbsp;?CBC
&lt;/li&gt;&lt;li&gt;&amp;nbsp;?Coags only if h/o or suspect coaulopathy 
&lt;/li&gt;&lt;li&gt;&amp;nbsp;?TSH
&lt;/li&gt;&lt;li&gt;&amp;nbsp;?pelvic u/s
&lt;/li&gt;&lt;li&gt; 2 large bore IV's if unstable
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Vaginal_Bleed_Non-Pregnant_(VB-)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; gyn consult (emergently if unstable)
&lt;/li&gt;&lt;li&gt; IV estrogen can stop bleeding quickly, consider starting patient on OCPs (speak to GYN first before! may affect EMB results)
&lt;/li&gt;&lt;li&gt; temporizing bleeding with foley balloon or kerlix soaked in saline and thrombin
&lt;/li&gt;&lt;li&gt; if local bleeding from trauma - suture or silver nitrate
&lt;/li&gt;&lt;/ol&gt;




</content><folder>OB/GYN</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="vaginal_bleed_pregnant_(greater_than_20wks)"><name>Vaginal Bleed Pregnant (greater than 20wks)</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Vaginal_Bleed_Pregnant_(greater_than_20wks)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; abruption
&lt;/li&gt;&lt;li&gt; previa
&lt;/li&gt;&lt;li&gt; uterine rupture
&lt;/li&gt;&lt;li&gt; vasa previa- (isolated fetal hem)
&lt;/li&gt;&lt;li&gt; bloody show
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Vaginal_Bleed_Pregnant_(greater_than_20wks)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;OB/GYN:  Abruption
&lt;/p&gt;&lt;p&gt;OB/GYN:  Placenta Previa
&lt;/p&gt;&lt;p&gt;OB/GYN:  Uterine Rupture
&lt;/p&gt;&lt;p&gt;OB/GYN:  Vasa Previa
&lt;/p&gt;



</content><folder>OB/GYN</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="vaginal_bleed_pregnant_(less_than_20wks)"><name>Vaginal Bleed Pregnant (less than 20wks)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#DDX"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;DDX&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Evaluation"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Evaluation&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Work-Up"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Work-Up&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Vaginal_Bleed_Pregnant_(less_than_20wks)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Occurs in 20-40% of 1st trimester pregnancies
&lt;/li&gt;&lt;li&gt; Once IUP is confirmed by ultrasound no utility in obtaining B-hCG
&lt;/li&gt;&lt;li&gt; Ultrasound
&lt;ol&gt;&lt;li&gt; Do not use hCG to determine whether ultrasound should be obtained
&lt;ol&gt;&lt;li&gt; "Discrimatory Zone" values are for IUP visualization, not ectopic visualization
&lt;ol&gt;&lt;li&gt; Pelvic - can visualize IUP at hCG ~ &amp;gt;1500
&lt;/li&gt;&lt;li&gt; Abd - can visualize IUP at hCG ~ &amp;gt;6000
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Vaginal_Bleed_Pregnant_(less_than_20wks)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: DDX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX"&gt;DDX&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Ectopic Pregnancy
&lt;ol&gt;&lt;li&gt; hCG &amp;gt; 1500 + no IUP
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Miscarriage
&lt;ol&gt;&lt;li&gt; Complete Abortion
&lt;ol&gt;&lt;li&gt; &amp;lt;12 weeks + no IUP
&lt;/li&gt;&lt;li&gt; Distinguish from ectopic based on decreasing hCG, decreased bleeding
&lt;ol&gt;&lt;li&gt; Only need to send hCG if unable to examine POC
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Threatened Abortion
&lt;ol&gt;&lt;li&gt; Closed os + IUP + cramps and/or bleeding
&lt;/li&gt;&lt;li&gt; If &amp;lt; 11wks &amp;gt;90% go to term
&lt;/li&gt;&lt;li&gt; If between 11 and 20 weeks 50% go to term
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Inevitable Abortion
&lt;ol&gt;&lt;li&gt; Open os + contractions/cramps
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Incomplete Abortion
&lt;ol&gt;&lt;li&gt; &amp;gt;12 wks + passage of only portion of POC
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Missed Abortion
&lt;ol&gt;&lt;li&gt; &amp;lt;20 wks + no cardiac activity
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Non-pregnancy related bleeding
&lt;ol&gt;&lt;li&gt; Cancer
&lt;/li&gt;&lt;li&gt; Fibroids
&lt;/li&gt;&lt;li&gt; Cervicitis
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Vaginal_Bleed_Pregnant_(less_than_20wks)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Evaluation"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Evaluation"&gt;Evaluation&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; History
&lt;ol&gt;&lt;li&gt; Previous spontaneous abortion?
&lt;/li&gt;&lt;li&gt; Extent of bleeding, clots, tissue
&lt;/li&gt;&lt;li&gt; Presence of cramping
&lt;/li&gt;&lt;li&gt; Light-headedness?
&lt;/li&gt;&lt;li&gt; Risk Factors for Ectopic
&lt;ol&gt;&lt;li&gt; PID
&lt;/li&gt;&lt;li&gt; IUD
&lt;/li&gt;&lt;li&gt; Adnexal surgery
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Physical
&lt;ol&gt;&lt;li&gt; Uterus able to palpated in abdomen ~ 12 weeks
&lt;/li&gt;&lt;li&gt; Uterus able to visualzed by abdominal ultrasound ~ 10 weeks
&lt;/li&gt;&lt;li&gt; Open OS decreases, but does not rule-out, ectopic
&lt;/li&gt;&lt;li&gt; If find POC send to pathology to rule-out trophoblastic disease
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Vaginal_Bleed_Pregnant_(less_than_20wks)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Work-Up"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Work-Up"&gt;Work-Up&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; B-hCG (quant)
&lt;/li&gt;&lt;li&gt; CBC
&lt;/li&gt;&lt;li&gt; T&amp;amp;S (Rh) vs. T&amp;amp;C
&lt;/li&gt;&lt;li&gt; IVF vs. blood
&lt;/li&gt;&lt;li&gt; UA
&lt;/li&gt;&lt;li&gt; RhoGAM if indicated
&lt;/li&gt;&lt;li&gt; Hemabate/Pitocin if indicated
&lt;/li&gt;&lt;li&gt; Ultrasound
&lt;ol&gt;&lt;li&gt; IUP = Threatened AB
&lt;ol&gt;&lt;li&gt; Ectopic ruled-out unless on fertility drugs
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Empty uterus + free fluid/adnexal mass = Ectopic
&lt;/li&gt;&lt;li&gt; Empty uterus + no free fluid / no mass:
&lt;ol&gt;&lt;li&gt; BHC-G:
&lt;ol&gt;&lt;li&gt; &amp;gt;6,000 = Ectopic
&lt;/li&gt;&lt;li&gt; 1,000 - 1,500 = indeterminante (?D&amp;amp;C if undesired)
&lt;/li&gt;&lt;li&gt; &amp;lt;1,500 = follow serial B-HCG levels (x 48hrs)
&lt;ol&gt;&lt;li&gt; Increased &amp;gt;66% = nL IUP 
&lt;/li&gt;&lt;li&gt; Increased &amp;lt; 66% = Ectopic
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Vaginal_Bleed_Pregnant_(less_than_20wks)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;UpToDate, Rosen's
&lt;/p&gt;



</content><folder>OB/GYN</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="valproate_od"><name>Valproate OD</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Valproate_OD&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;CNS depression
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Valproate_OD&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;if pt not waking up, check ammonia and give carnitine
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Valproate_OD&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;9/09  PANI (Adapted from Donaldson, Mistry, Pharmacopia)
&lt;/p&gt;



</content><folder>Tox</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="valvular_emergencies_(valve)"><name>Valvular Emergencies (Valve)</name><content>&lt;p&gt;Symptomatic
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Mitral Regurg
&lt;ol&gt;&lt;li&gt;Rx: reduce afterload (e.g. nitroprusside, NTG)
&lt;/li&gt;&lt;li&gt;If 2nd to AMI, Rx: NTG
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Mitral Stenosis
&lt;ol&gt;&lt;li&gt;Rx: rate control if tachy
&lt;/li&gt;&lt;li&gt;Associated with hemoptysis
&lt;/li&gt;&lt;li&gt;Transfuse + surg
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Aortic Regurg
&lt;ol&gt;&lt;li&gt;Rx: reduce afterload (e.g. nitroprusside, NTG)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Aortic Stenosis
&lt;ol&gt;&lt;li&gt;Rx: rate control if tachy
&lt;/li&gt;&lt;li&gt;Do not reduce afterload!! (use nitrates very cautiously)
&lt;/li&gt;&lt;li&gt;Admit if symptomatic (e.g. syncope)
&lt;/li&gt;&lt;li&gt;+ A.fib = emergency, consider emergent cardioversion
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;Consider emerg surg for all if primary cause of sx or refractory to Rx
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Valvular_Emergencies_(Valve)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Cards: Heart Murmur Sounds
&lt;/p&gt;&lt;p&gt;Cards: Heart Murmur Maneuvers
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Valvular_Emergencies_(Valve)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;10/07 DONALDSON (adapted from Tintinalli, emedicine)
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="varicocele"><name>Varicocele</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Varicocele&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;dilatation of pampiniform plexus and internal spermatic vein-occurs in 15-20% of all fertile males, 40% of infertile males
&lt;/li&gt;&lt;li&gt;80-90% occur on L due to anatomy
&lt;/li&gt;&lt;li&gt;large (easily visualized), moderate (upon palpation), and small (palpable w valsalva)
&lt;/li&gt;&lt;li&gt;can impair sperm production/function
&lt;/li&gt;&lt;li&gt;sudden appearance can be related to renal malignancy causing obstruction of venous return.
&lt;/li&gt;&lt;li&gt;nutcracker syndrome - when SMA compresses L renal vein causing varicocele.
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Varicocele&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;hx: worse w standing/valsalva. feeling of dullness/heaviness. scrotal discomfort.-doppler ultrasound. vein = 3mm or larger ==Work-Up==
&lt;/li&gt;&lt;li&gt;physical exam  ("bag of worms"). have the pt valsalva-may cause ipsilateral testicular atrophy-ultrasound ==DDx==
&lt;/li&gt;&lt;li&gt;hydrocele, hematocele, spermatocele-malignancy. sertoli-leydig, testicular ca-abscess 
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Varicocele&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;scrotal support
&lt;/li&gt;&lt;li&gt;Surgical tx if palpable and continued pain, infertility. varicocelectomy. ==Disposition==
&lt;/li&gt;&lt;li&gt;if scrotal u/s confirm presence of only varicocele. followup as outpt w urology, non-urgent.
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Varicocele&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from(emed, mayo, utd)
&lt;/p&gt;



</content><folder>GU</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="vasa_previa"><name>Vasa Previa</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Vasa_Previa&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;painless bleeding from fetal origin
&lt;/li&gt;&lt;li&gt;mother's life not in danger
&lt;/li&gt;&lt;li&gt;defect in placental formation
&lt;/li&gt;&lt;li&gt; umbilical vessels travel through placental membranes unsupported by other placental tissue
&lt;/li&gt;&lt;li&gt; also caused by extra lobe on placnta
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Vasa_Previa&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; suspect of mother with min vag bleeding and no pain, no contractions, no mat symptoms but fetus with signficant distress
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Vasa_Previa&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;c-section
&lt;/p&gt;



</content><folder>OB/GYN</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="vascular"><name>Vascular</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Types"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Types&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#Complete_Occlusive"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;Complete Occlusive&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Non-occlusive"&gt;&lt;span class="tocnumber"&gt;1.2&lt;/span&gt; &lt;span class="toctext"&gt;Non-occlusive&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Warm_Ischemia_Time"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Warm Ischemia Time&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-7"&gt;&lt;a href="#Hard_signs-_go_straight_to_OR"&gt;&lt;span class="tocnumber"&gt;4.1&lt;/span&gt; &lt;span class="toctext"&gt;Hard signs- go straight to OR&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-8"&gt;&lt;a href="#Soft_Signs"&gt;&lt;span class="tocnumber"&gt;4.2&lt;/span&gt; &lt;span class="toctext"&gt;Soft Signs&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#_2"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-10"&gt;&lt;a href="#Arterial_Pressure_Index_.28API.29"&gt;&lt;span class="tocnumber"&gt;5.1&lt;/span&gt; &lt;span class="toctext"&gt;Arterial Pressure Index (API)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-11"&gt;&lt;a href="#Duplex_Doppler"&gt;&lt;span class="tocnumber"&gt;5.2&lt;/span&gt; &lt;span class="toctext"&gt;Duplex Doppler&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-12"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-13"&gt;&lt;a href="#Hard_.28.3E90.25_risk_of_arterial_injury.3B_50.25_require_intervention.29"&gt;&lt;span class="tocnumber"&gt;6.1&lt;/span&gt; &lt;span class="toctext"&gt;Hard (&amp;gt;90% risk of arterial injury; 50% require intervention)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-14"&gt;&lt;a href="#Soft_.2830.25_risk_of_arterial_injury.29"&gt;&lt;span class="tocnumber"&gt;6.2&lt;/span&gt; &lt;span class="toctext"&gt;Soft (30% risk of arterial injury)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-15"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;7&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Vascular&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Types"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Types"&gt;Types&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Vascular&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Complete Occlusive"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Complete_Occlusive"&gt;Complete Occlusive&lt;/span&gt;&lt;/h3&gt;
&lt;pre&gt;Transection
&lt;/pre&gt;
&lt;pre&gt;Thrombosis
&lt;/pre&gt;
&lt;pre&gt;Embolism
&lt;/pre&gt;
&lt;pre&gt;Reversible spasm
&lt;/pre&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Vascular&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Non-occlusive"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Non-occlusive"&gt;Non-occlusive&lt;/span&gt;&lt;/h3&gt;
&lt;pre&gt;Lacerations
&lt;/pre&gt;
&lt;pre&gt;Intimal flaps
&lt;/pre&gt;
&lt;pre&gt;Pseudoaneurysm
&lt;/pre&gt;
&lt;pre&gt;A/V fistula
&lt;/pre&gt;
&lt;pre&gt;Compartment syndrome
&lt;/pre&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Vascular&amp;amp;action=edit&amp;amp;section=4" title="Edit section: "&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id=""&gt; &lt;/span&gt;&lt;/h2&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Vascular&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Warm Ischemia Time"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Warm_Ischemia_Time"&gt;Warm Ischemia Time&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;6 hours (10% irreversible damage)
&lt;/p&gt;&lt;p&gt;12 hours (90% irreversible damage)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Vascular&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Vascular&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Hard signs- go straight to OR"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Hard_signs-_go_straight_to_OR"&gt;Hard signs- go straight to OR &lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;1 Absent distal pulses
&lt;/p&gt;&lt;p&gt;2 signs of distal ischemia
&lt;/p&gt;
&lt;pre&gt;    Pain, pallor, paresthesia, paralysis, poikilothermia
&lt;/pre&gt;
&lt;p&gt;3 palpable bruit or audible thrill at injury site
&lt;/p&gt;&lt;p&gt;4 active pulsatile hem
&lt;/p&gt;&lt;p&gt;5 large expanding hematoma
&lt;/p&gt;&lt;p&gt;6 pulsatile hematoma
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Vascular&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Soft Signs"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Soft_Signs"&gt;Soft Signs &lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;1 small nonexpanding hematoma
&lt;/p&gt;&lt;p&gt;2 periferal nerve deficit
&lt;/p&gt;&lt;p&gt;3 hx of pulsatile or significant hem at time of injury
&lt;/p&gt;&lt;p&gt;4 unexplained hypotension
&lt;/p&gt;&lt;p&gt;5 bony injury (fx, dislocation, penetration) or proximity penetrating wound
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Vascular&amp;amp;action=edit&amp;amp;section=9" title="Edit section: "&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="_2"&gt; &lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Vascular&amp;amp;action=edit&amp;amp;section=10" title="Edit section: Arterial Pressure Index (API)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Arterial_Pressure_Index_.28API.29"&gt;Arterial Pressure Index (API)&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Doppler-determined arterial systolic pressure in injured limb divided by pressure in uninjured limb
&lt;/p&gt;&lt;p&gt;&amp;lt;0.90 abnormal
&lt;/p&gt;&lt;p&gt;allows for serial, objective monitoring
&lt;/p&gt;&lt;p&gt;only detects obstructive lesions
&lt;/p&gt;&lt;p&gt;unreliable in proximal injuries, popliteal injuries, shotgun wounds, multiple wounds, shock
&lt;/p&gt;&lt;p&gt;false negative with deep femoral artery injury
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Vascular&amp;amp;action=edit&amp;amp;section=11" title="Edit section: Duplex Doppler"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Duplex_Doppler"&gt;Duplex Doppler&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;S 95-100%; Sp 97-100%; Acc 98-100%
&lt;/p&gt;&lt;p&gt;sens for vessel injury, thrombosis, pseudoaneurysm, intimal flap and A-V fistula
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Vascular&amp;amp;action=edit&amp;amp;section=12" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Vascular&amp;amp;action=edit&amp;amp;section=13" title="Edit section: Hard (&amp;amp;gt;90% risk of arterial injury; 50% require intervention)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Hard_.28.3E90.25_risk_of_arterial_injury.3B_50.25_require_intervention.29"&gt;Hard (&amp;gt;90% risk of arterial injury; 50% require intervention)&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Immediate arterial exploration without further investigation
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Vascular&amp;amp;action=edit&amp;amp;section=14" title="Edit section: Soft (30% risk of arterial injury)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Soft_.2830.25_risk_of_arterial_injury.29"&gt;Soft (30% risk of arterial injury)&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;API --&amp;gt; if &amp;lt; 0.9 obs/admit for 24h, serial API, consider:
&lt;/p&gt;&lt;p&gt;Doppler U/S
&lt;/p&gt;&lt;p&gt;CTA
&lt;/p&gt;&lt;p&gt;Eval of compartment syndrome
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Vascular&amp;amp;action=edit&amp;amp;section=15" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Birnbaumer, Donaldson
&lt;/p&gt;



</content><folder>Trauma</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="vascular_catagories"><name>Vascular Catagories</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Acute_Arterial_Occlusion"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Acute Arterial Occlusion&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Angiogram_Complications"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Angiogram Complications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Specific_Arteries"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Specific Arteries&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#cilostazol_.28Pletal.29"&gt;&lt;span class="tocnumber"&gt;4.1&lt;/span&gt; &lt;span class="toctext"&gt;cilostazol (Pletal)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-6"&gt;&lt;a href="#pentoxifylline_.28Trental.29"&gt;&lt;span class="tocnumber"&gt;4.2&lt;/span&gt; &lt;span class="toctext"&gt;pentoxifylline (Trental)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Vascular_Catagories&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Acute Arterial Occlusion"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Acute_Arterial_Occlusion"&gt;Acute Arterial Occlusion&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;paresthesia
&lt;/li&gt;&lt;li&gt;pain
&lt;/li&gt;&lt;li&gt;paralysis
&lt;/li&gt;&lt;li&gt;pulseless
&lt;/li&gt;&lt;li&gt;pallor
&lt;/li&gt;&lt;li&gt;poikilothermia
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Vascular_Catagories&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Angiogram Complications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Angiogram_Complications"&gt;Angiogram Complications&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;hematoma (visual exam), arteriovenous fistula (bruit), retroperitoneal bleed (peritoneal sign), renal failure (creatinine)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Vascular_Catagories&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Specific Arteries"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Specific_Arteries"&gt;Specific Arteries&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;brachiocephalic a
&lt;ol&gt;&lt;li&gt;common carotid a + subclavian a
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;subclavian a
&lt;ol&gt;&lt;li&gt;axillary a + vertebral a
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;external iliac artery
&lt;ol&gt;&lt;li&gt;femoral (superficial femoral a) -&amp;gt; popliteal -&amp;gt; anterior tibial (lateral, branches first) -&amp;gt; perineal (middle) and posterior tibial (medial)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;internal iliac a
&lt;ol&gt;&lt;li&gt;hypogastric a
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;ectasia
&lt;ol&gt;&lt;li&gt;dilatation
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Vascular_Catagories&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Vascular_Catagories&amp;amp;action=edit&amp;amp;section=5" title="Edit section: cilostazol (Pletal)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="cilostazol_.28Pletal.29"&gt;cilostazol (Pletal)&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;claudication, phosphodiesterase III inhibitor
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Vascular_Catagories&amp;amp;action=edit&amp;amp;section=6" title="Edit section: pentoxifylline (Trental)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="pentoxifylline_.28Trental.29"&gt;pentoxifylline (Trental)&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;nonselective phosphodiesterase inhibitor -&amp;gt; tumor necrosis factor inhibitor, claudication, decreases blood viscosity via an effect on the RBC membrane, minor increase in excercise tolerance
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="vent_(ards)"><name>Vent (ARDS)</name><content>&lt;p&gt;Inclusion criteria:
&lt;/p&gt;&lt;p&gt;ARDS defined as PaO2/FiO2 ratio &amp;lt;300, bilateral alveolar infiltrates on CXR, no evidence of CHF
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Treatment:
&lt;/p&gt;&lt;p&gt;1) TV 6cc/kg ideal body weight
&lt;/p&gt;&lt;p&gt;2) Increased PEEP with decreased FiO2--&amp;gt;
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;FiO2 (PEEP)
&lt;/p&gt;&lt;p&gt;0.4 (5-8)
&lt;/p&gt;&lt;p&gt;0.5 (8-10)
&lt;/p&gt;&lt;p&gt;0.6 (10)
&lt;/p&gt;&lt;p&gt;0.7 (10-14)
&lt;/p&gt;&lt;p&gt;0.8 (14)
&lt;/p&gt;&lt;p&gt;0.9 (14-18)
&lt;/p&gt;&lt;p&gt;1.0 (18-24)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Adjust to:
&lt;/p&gt;&lt;p&gt;1) pH = 7.3-7.45 adjust rate (6-35) prn
&lt;/p&gt;&lt;p&gt;2) PaO2 = 55-80 (or SaO2 = 88-95%)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;Outcome: decreased mortality &amp;amp; #days on the ventilator
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;2/2/06 DONALDSON (adapted from Lampe; NEJM May 200?)
&lt;/p&gt;



</content><folder>Pulm</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="vent_(general)"><name>Vent (General)</name><content>&lt;p&gt;Modes
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;CPAP
&lt;/p&gt;&lt;p&gt;- needs spont breathing pt
&lt;/p&gt;&lt;p&gt;- not for fatiguing pt
&lt;/p&gt;&lt;p&gt;- no back up rate
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;CONTROL MODE
&lt;/p&gt;&lt;p&gt;- only in OR
&lt;/p&gt;&lt;p&gt;- machine initiates and delivers breath
&lt;/p&gt;&lt;p&gt;- fixed rate and TV
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;ASSIST CONTROL (AC)
&lt;/p&gt;&lt;p&gt;- preset rate and TV
&lt;/p&gt;&lt;p&gt;- pt able to trigger additional breaths
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;SYNCH INTERM MANDATORY VENT (SIMV)
&lt;/p&gt;&lt;p&gt;- preset rate and TV synch to pt effort
&lt;/p&gt;&lt;p&gt;- for each additional breath triggered by pt- vent delivers variable TV depending on pt effort and condition of lung
&lt;/p&gt;&lt;p&gt;- because of pt effort- not recommended for tired or septic pt
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;PRESSURE SUPP0RT
&lt;/p&gt;&lt;p&gt;- use with SIMV or PEEP- not AC
&lt;/p&gt;&lt;p&gt;- preset boost during inspiration of spont gen breath
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;GENERAL
&lt;/p&gt;&lt;p&gt;RR X TV =
&lt;/p&gt;



</content><folder>Pulm</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="vent_(initial_-_changes)"><name>Vent (Initial - Changes)</name><content>&lt;p&gt;INITIAL
&lt;/p&gt;&lt;p&gt;1.  FiO2   100% and ween down
&lt;/p&gt;&lt;p&gt;2.  Rate  8-12/min  (consider 5-6 for asthma w/ permissive hypercapnea)
&lt;/p&gt;&lt;p&gt;3.  Mode
&lt;/p&gt;
&lt;pre&gt;-A/C =  defalt (most)
&lt;/pre&gt;
&lt;pre&gt;-SIMV = with obstructive airway disease and an intact respiratory
&lt;/pre&gt;
&lt;p&gt;effort (e.g. some COPD, asthma)
&lt;/p&gt;
&lt;pre&gt;-PC = with intact respiratory effort and non-severe respiratory
&lt;/pre&gt;
&lt;p&gt;failure (prefered in chronic vent)
&lt;/p&gt;&lt;p&gt;4.  Peep  0-5 mmH20
&lt;/p&gt;&lt;p&gt;5.  TV  5-8 cc/kg  (eg. 500-600cc)  (adjust to plateau pressure &amp;lt;35 cmH20)
&lt;/p&gt;&lt;p&gt;6.  I/E    1:3
&lt;/p&gt;&lt;p&gt;7.  PS (pressure support) 5-8cm to overcome ET
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;DZ TV*        RR          I:E       PEEP
&lt;/p&gt;&lt;p&gt;Nl lung  8    10-12      1:2       4
&lt;/p&gt;&lt;p&gt;Obstruct   6      5-8 1:4    4
&lt;/p&gt;&lt;p&gt;ARDS  6         12-20 1:2  2-15
&lt;/p&gt;&lt;p&gt;Hypovol     8      10-12 1:2  0-4
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;cc/kg
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;&lt;ul&gt;&lt;li&gt;FiO2 always = 1.0
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;CHANGES
&lt;/p&gt;&lt;p&gt;1.  PaO2  (ween to SaO2 &amp;gt;90% &amp;amp; PaO2 &amp;gt;60)
&lt;/p&gt;
&lt;pre&gt;-FiO2  (ween to &amp;lt;0.5 if poss)
&lt;/pre&gt;
&lt;pre&gt;-PEEP (see ARDS schedule; if &amp;gt;10, should have art line)
&lt;/pre&gt;
&lt;p&gt;(rule of 7s:  decrease 1 FiO2 = 7 pO2)
&lt;/p&gt;&lt;p&gt;2.  PCO2
&lt;/p&gt;
&lt;pre&gt;-TV
&lt;/pre&gt;
&lt;pre&gt;-Rate
&lt;/pre&gt;
&lt;p&gt;(VE-1  x  pCO2-1  =  VE-2  x  pCO2-2)
&lt;/p&gt;&lt;p&gt;VE = minute ventilation (RR x TV)
&lt;/p&gt;&lt;p&gt;3.  pH
&lt;/p&gt;&lt;p&gt;-to increase pH 0.01 --&amp;gt; decrease pCO2 by 1
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;MISC (normally already set)
&lt;/p&gt;&lt;p&gt;1.  Inspiratory flow rate = 60L/min (100L/min with asthma)
&lt;/p&gt;&lt;p&gt;2.  Sensitivity = 1-2 cmH2O
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;MODES
&lt;/p&gt;&lt;p&gt;1)  A/C = Assist Control (helps instigated breaths, extra breaths all of set TV)
&lt;/p&gt;&lt;p&gt;-delivers preset breaths (full assisted tidal volume) in coordination
&lt;/p&gt;&lt;p&gt;with the respiratory effort
&lt;/p&gt;&lt;p&gt;-spontaneous breathing (above rate) is not allowed
&lt;/p&gt;&lt;p&gt;-beneficial for patients requiring a high minute-ventilation (reduces
&lt;/p&gt;&lt;p&gt;oxygen consumption and CO2 production of the respiratory muscles)
&lt;/p&gt;&lt;p&gt;-may worsen obstructive airway disease by air trapping or breath stacking
&lt;/p&gt;&lt;p&gt;2)  SIMV = Synchronous Intermittent Mandatory Ventilation  (senses not
&lt;/p&gt;&lt;p&gt;to give with breathing if present, extra breaths of pt's TV)
&lt;/p&gt;&lt;p&gt;-preset breaths in coordination with the respiratory effort
&lt;/p&gt;&lt;p&gt;-spontaneous breathing allowed between breaths
&lt;/p&gt;&lt;p&gt;-synchronization attempts to limit the barotrauma by not delivering a
&lt;/p&gt;&lt;p&gt;breath when already maximally inhaled (vs. IMV)
&lt;/p&gt;&lt;p&gt;3)  PS = Pressure Support (controls via pressure, good if pressures
&lt;/p&gt;&lt;p&gt;getting too high)
&lt;/p&gt;&lt;p&gt;-limits barotrauma and decreases the work of breathing in the
&lt;/p&gt;&lt;p&gt;spontaneously breathing patient
&lt;/p&gt;&lt;p&gt;-level of pressure set (not TV) to assist spontaneous efforts
&lt;/p&gt;&lt;p&gt;-most ventilators allow back-up respiratory rate (in case of apnea)
&lt;/p&gt;&lt;p&gt;-mode of choice in patients whose respiratory failure is not severe
&lt;/p&gt;&lt;p&gt;and who have an adequate respiratory drive (improved patient comfort,
&lt;/p&gt;&lt;p&gt;reduced cardiovascular effects, reduced risk of barotrauma, and
&lt;/p&gt;&lt;p&gt;improved distribution of gas)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;For the paralyzed patient, there is no difference in
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;minute-ventilation or airway pressures between A/C and SIMV
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;2/8/06  DONALDSON  (adapted from emedicine, Lampe)
&lt;/p&gt;



</content><folder>Pulm</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="vent_(non-invasive)"><name>Vent (Non-Invasive)</name><content>&lt;p&gt;CPAP = noninvasive PS
&lt;/p&gt;&lt;p&gt;BL-PAP = noninvasive PC (presure ventilation)
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;INDICATION - intact resp drive with more readily reversible etiology
&lt;/p&gt;&lt;p&gt;Possible uses:
&lt;/p&gt;&lt;p&gt;1) *COPD
&lt;/p&gt;&lt;p&gt;2) OSA
&lt;/p&gt;&lt;p&gt;3) Pulm edema
&lt;/p&gt;&lt;p&gt;4) PNA
&lt;/p&gt;&lt;p&gt;5) Status asthmaticus
&lt;/p&gt;&lt;p&gt;6) CHF exacb
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Consensus statement declares BL-PAP first line for COPD
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;BL-PAP SETTINGS
&lt;/p&gt;&lt;p&gt;Initial: IPAP = 8, EPAP = 3 (3-5L/min flow; 100% FiO2)
&lt;/p&gt;&lt;p&gt;Titrate: increase IPAP @ 2cmH2O increments to comfort
&lt;/p&gt;&lt;p&gt;-nl pt --&amp;gt; increase EPAP in sync @ 2cmH2O incremnts
&lt;/p&gt;&lt;p&gt;-hypercapnic --&amp;gt; increase EPAP in sync @ 1:2.5 ratio
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;keep EPAP &amp;lt;8-10
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;2/14/06 DONALDSON (adapted from Rosen)
&lt;/p&gt;



</content><folder>Pulm</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="vent_(weaning)"><name>Vent (Weaning)</name><content>&lt;p&gt;WEANING PARAMATERS
&lt;/p&gt;&lt;p&gt;1) PaO2/FiO2 &amp;gt;200
&lt;/p&gt;&lt;p&gt;2) Tidal volume 5cc/kg
&lt;/p&gt;&lt;p&gt;3) RR &amp;lt;40
&lt;/p&gt;&lt;p&gt;4) Vital cap 10cc/kg
&lt;/p&gt;&lt;p&gt;5) Min vent. &amp;lt;10L/min
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;greater predictive value
&lt;/p&gt;&lt;p&gt;max inspir. pressure greater -90cmH2O female
&lt;/p&gt;&lt;p&gt;-120 male threshold -25 cm h2o
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;RSBI: rate/tidal volume &amp;lt; 100 min/L.
&lt;/p&gt;



</content><folder>Pulm</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="vertebral_fx"><name>Vertebral Fx</name><content>&lt;p&gt;LUMBAR
&lt;/p&gt;&lt;p&gt;CT IF:
&lt;/p&gt;&lt;p&gt;-Compression
&lt;/p&gt;&lt;p&gt;-Wedge
&lt;/p&gt;&lt;p&gt;&amp;gt;50% height (r/o middle column &amp;amp; burst)
&lt;/p&gt;



</content><folder>Ortho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="vertigo"><name>Vertigo</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Workup"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Workup&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#Basic"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;Basic&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Central"&gt;&lt;span class="tocnumber"&gt;1.2&lt;/span&gt; &lt;span class="toctext"&gt;Central&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Peripheral"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;Peripheral&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-6"&gt;&lt;a href="#Central_2"&gt;&lt;span class="tocnumber"&gt;2.2&lt;/span&gt; &lt;span class="toctext"&gt;Central&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-7"&gt;&lt;a href="#Diagnostic_Algorithm"&gt;&lt;span class="tocnumber"&gt;2.3&lt;/span&gt; &lt;span class="toctext"&gt;Diagnostic Algorithm&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-10"&gt;&lt;a href="#Symptomatic"&gt;&lt;span class="tocnumber"&gt;4.1&lt;/span&gt; &lt;span class="toctext"&gt;Symptomatic&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-11"&gt;&lt;a href="#BPV_Testing.5E"&gt;&lt;span class="tocnumber"&gt;4.2&lt;/span&gt; &lt;span class="toctext"&gt;BPV Testing^&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-12"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Vertigo&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Workup"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Workup"&gt;Workup&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Vertigo&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Basic"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Basic"&gt;Basic&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Glu check
&lt;/li&gt;&lt;li&gt; Full neuro (including nystagmus, cerebellar, EOM)
&lt;/li&gt;&lt;li&gt; TM exam
&lt;/li&gt;&lt;li&gt; CT/MRI age &amp;gt;55 (some studies)
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Vertigo&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Central"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Central"&gt;Central&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Above +
&lt;ol&gt;&lt;li&gt; CT/MRI
&lt;/li&gt;&lt;li&gt; B pulses/BP (subclavian steal)
&lt;/li&gt;&lt;li&gt; Bruits
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Vertigo&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Vertigo&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Peripheral"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Peripheral"&gt;Peripheral&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;sudden onset
&lt;/li&gt;&lt;li&gt;severe intensity
&lt;/li&gt;&lt;li&gt;seconds-hours or intermittent for days
&lt;/li&gt;&lt;li&gt;unidirectional/bilateral horizontal/rotary nystagmus
&lt;ol&gt;&lt;li&gt;(fatigable, suppressed by fixation)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;positional (often one specific)
&lt;/li&gt;&lt;li&gt;no focal neuro
&lt;/li&gt;&lt;li&gt;poss auditory findings (incld tinnitus)
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Vertigo&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Central"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Central_2"&gt;Central&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;gradual onset
&lt;/li&gt;&lt;li&gt;mild intensity
&lt;/li&gt;&lt;li&gt;weeks-months (continuous)
&lt;/li&gt;&lt;li&gt;horizontal or vertical nystagmus
&lt;ol&gt;&lt;li&gt;(nonfatigable, not suppressed by fixation)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;not positional; or associated with mult positions
&lt;/li&gt;&lt;li&gt;usually focal neuro
&lt;/li&gt;&lt;li&gt;no auditory findings
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Vertigo&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Diagnostic Algorithm"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnostic_Algorithm"&gt;Diagnostic Algorithm&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Systemic^
&lt;ol&gt;&lt;li&gt;DM
&lt;/li&gt;&lt;li&gt;Hypothyroidism
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Peripheral
&lt;ol&gt;&lt;li&gt; Non-auditory
&lt;ol&gt;&lt;li&gt; BPV
&lt;ol&gt;&lt;li&gt;pos Hallpike
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Vestibular neuronitis
&lt;/li&gt;&lt;li&gt;neg Hallpike
&lt;/li&gt;&lt;li&gt;severe x hrs, then lessons dys
&lt;/li&gt;&lt;li&gt;mild may persist x wk-mos
&lt;/li&gt;&lt;li&gt;occ assoc w/ past infect/toxin
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Auditory (hearing loss)
&lt;ol&gt;&lt;li&gt; TMs Cl
&lt;ol&gt;&lt;li&gt; Meniere's dz
&lt;ol&gt;&lt;li&gt;clusters
&lt;/li&gt;&lt;li&gt;sx-free intervals
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Acoustic neuroma^^
&lt;ol&gt;&lt;li&gt;progresses to central sx
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Toxic (drug) labyrinthitis*
&lt;ol&gt;&lt;li&gt; aminoglycosides
&lt;/li&gt;&lt;li&gt;anticonvulsants
&lt;/li&gt;&lt;li&gt;alcohols
&lt;/li&gt;&lt;li&gt;quinine/quinidine
&lt;/li&gt;&lt;li&gt;minocycline
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Serous labyrinthitis
&lt;ol&gt;&lt;li&gt;h/o antecedent ENT infection
&lt;/li&gt;&lt;li&gt;nontoxic/minimal fever
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; TM abnl
&lt;ol&gt;&lt;li&gt; Foreign body in ear canal
&lt;/li&gt;&lt;li&gt; Acute suppurative labyrinthitis^
&lt;ol&gt;&lt;li&gt; acute OM
&lt;/li&gt;&lt;li&gt; febrile/toxic
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Perilymphatic fistula (chronic labyrinth)^^
&lt;ol&gt;&lt;li&gt;?abnl TM
&lt;/li&gt;&lt;li&gt;chronic hx
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Central^
&lt;ol&gt;&lt;li&gt; Cerebellar hemorrhage
&lt;ol&gt;&lt;li&gt;toxic appearing
&lt;/li&gt;&lt;li&gt;severe vertigo, HA, n/v, ataxia
&lt;/li&gt;&lt;li&gt;cerebellar findings
&lt;/li&gt;&lt;li&gt;poss ipsilateral 6th
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Vertebrobasilar artery insufficiency (VBI)
&lt;ol&gt;&lt;li&gt;elderly
&lt;/li&gt;&lt;li&gt;h/o cardiac/vasc dz
&lt;/li&gt;&lt;li&gt;HA; poss dysarthria/numbness
&lt;/li&gt;&lt;li&gt;h/o neck hyperextension
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; PICA occlusion (Wallenberg)
&lt;ol&gt;&lt;li&gt;ipsilateral Horners
&lt;/li&gt;&lt;li&gt;ipsilateral face pain/temp dec
&lt;/li&gt;&lt;li&gt;contralateral paralysis pharynx
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Subclavian steal sy
&lt;ol&gt;&lt;li&gt;unequal UE pulse/BP
&lt;/li&gt;&lt;li&gt;scyncopal attacks during exercise
&lt;/li&gt;&lt;li&gt;arm fatigue
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt;Vertebrobasilar migraine
&lt;/li&gt;&lt;li&gt; MS
&lt;ol&gt;&lt;li&gt;bilat internuclear opthalmo^
&lt;/li&gt;&lt;li&gt;20-40 year olds
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Temporal lobe epilepsy
&lt;ol&gt;&lt;li&gt;memory impairment/trancelike state
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Trauma
&lt;ol&gt;&lt;li&gt; Head
&lt;ol&gt;&lt;li&gt;Postconcussive sy
&lt;/li&gt;&lt;li&gt; Temporal bone fx
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Neck trauma (c-spin/lig/whiplash)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Infection
&lt;ol&gt;&lt;li&gt; Encephalitis
&lt;/li&gt;&lt;li&gt; Meningitis
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Brain abcess
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;^Must R/O
&lt;/p&gt;&lt;p&gt;Bilat internuclear opthalmo (MLF) = abduction of bilat eyes okay w/ acomidation but not medial gaze
&lt;/p&gt;&lt;p&gt;^^ENT follow-up
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Vertigo&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Admit if unable to walk (all)
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Vertigo&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Vertigo&amp;amp;action=edit&amp;amp;section=10" title="Edit section: Symptomatic"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Symptomatic"&gt;Symptomatic&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Diazepam (PO/IV)
&lt;/li&gt;&lt;li&gt; Meclizine
&lt;/li&gt;&lt;li&gt; Benadryl
&lt;/li&gt;&lt;li&gt; Promethazine
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Vertigo&amp;amp;action=edit&amp;amp;section=11" title="Edit section: BPV Testing^"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="BPV_Testing.5E"&gt;BPV Testing^&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Hallpike (test): quickly from sitting to supine, head to one side, brought 30deg off stretcher; + = nystag/reproduced symptoms
&lt;/p&gt;&lt;p&gt;Eply (treatment): Head at 45deg rotation, 30deg hyperextension; 30 sec motions--&amp;gt;RUQ,LUQ,LLQ,sitting w/slight flexion (for pos Hallpike on right)
&lt;/p&gt;&lt;p&gt;Brandt-Daroff (home treatment)
&lt;/p&gt;&lt;p&gt;^caution if concern for VBI
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Vertigo&amp;amp;action=edit&amp;amp;section=12" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;2/26/06 DONALDSON (adapted from Rosen)
&lt;/p&gt;



</content><folder>Neuro</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="viral_hepatitis"><name>Viral Hepatitis</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Causes"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Causes&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#Hep_B"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;Hep B&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Hepatitis_C"&gt;&lt;span class="tocnumber"&gt;1.2&lt;/span&gt; &lt;span class="toctext"&gt;Hepatitis C&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Admit_Criteria"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;Admit Criteria&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#See_Also"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;See Also&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Viral_Hepatitis&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Causes"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Causes"&gt;Causes&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Viral_Hepatitis&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Hep B"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Hep_B"&gt;Hep B&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;HBsAg: first +; if + long time may be chronic; implies infection -infectivity.
&lt;/p&gt;&lt;p&gt;Anti-HBs: + p clearance of Ag or vaccination; appears p windon period; if Ag neg then implies recovery, noninfectious
&lt;/p&gt;&lt;p&gt;Anti-HBc: +in window; appears early; IgM = acute &amp;amp; in flares; IgG always present.
&lt;/p&gt;&lt;p&gt;HBe-Ag: implies viral replication &amp;amp; infectivity; if + &amp;gt; 3 months may be chronic.
&lt;/p&gt;&lt;p&gt;HBV dna: like HBe-Ag but more sensitive &amp;amp; precise.
&lt;/p&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Viral_Hepatitis&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Hepatitis C"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Hepatitis_C"&gt;Hepatitis C&lt;/span&gt;&lt;/h3&gt;
&lt;p&gt;Risk: Drugs (IVDA/intranasal cocaine), hemodialysis, transplant-92, needle stick, maternal-fetal transmission (5%), sex.
&lt;/p&gt;&lt;p&gt;Blood products: cyro&amp;gt; 1987, PRBC&amp;gt;94, 1/10000-100000.
&lt;/p&gt;&lt;p&gt;of 100 pt infected&amp;gt;85 chronic, 70 chronic active, 15 cirrohsis, hcc, 5 die.
&lt;/p&gt;&lt;p&gt;No vaccine.
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;acutely&amp;gt;asymptomatic: 60%
&lt;/li&gt;&lt;li&gt;syx&amp;gt;constitutional
&lt;/li&gt;&lt;li&gt;chronic: HCC 1- 4%
&lt;/li&gt;&lt;li&gt;extrahepatic: PAN, cryoglobulinemia, porphyria cutanatardica.
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;LFTs q3-6 months if all normal then q1year.
&lt;/p&gt;&lt;p&gt;LFTs: do NOT indicate infectivity or chronicty.
&lt;/p&gt;&lt;p&gt;Infectious: based on PCR
&lt;/p&gt;&lt;p&gt;Tx: alpha interferon 50% respond in 1 year. May try ribavarin in conjuction if failed.
&lt;/p&gt;&lt;p&gt;SE: fatigue, worsened hepatitis.
&lt;/p&gt;&lt;p&gt;ribavirin- anemi
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Viral_Hepatitis&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Viral_Hepatitis&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Admit Criteria"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Admit_Criteria"&gt;Admit Criteria&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; INR &amp;gt;2
&lt;/li&gt;&lt;li&gt; Unable tol POs
&lt;/li&gt;&lt;li&gt; Pain control
&lt;/li&gt;&lt;li&gt; Bilirubin &amp;gt;30
&lt;/li&gt;&lt;li&gt; Hypoglycemia
&lt;/li&gt;&lt;li&gt; Significant comorbid illness/immunocomp
&lt;/li&gt;&lt;li&gt; &amp;gt;50 years
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Viral_Hepatitis&amp;amp;action=edit&amp;amp;section=6" title="Edit section: See Also"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="See_Also"&gt;See Also&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;GI: Jaundice
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Viral_Hepatitis&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from Stevens, Donaldson, Pani
&lt;/p&gt;



</content><folder>GI</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="vitamin_k"><name>Vitamin K</name><content>&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Vitamin_K&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Is cofactor for vit k dependent clotting factors 2-7-9-10
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt; used by liver
&lt;/li&gt;&lt;li&gt; fat soluble
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;Due to
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt; nutritional def
&lt;/li&gt;&lt;li&gt; malabsorption- since is fat soluble
&lt;/li&gt;&lt;li&gt; cholestasis- need bile salts to absorb vit k
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Vitamin_K&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Warfarin OD"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Warfarin_OD"&gt;Warfarin OD&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; hold coumadin
&lt;/li&gt;&lt;li&gt; vit k- works in 12- 24 hrs
&lt;/li&gt;&lt;li&gt; FFP- risk viral transmission or vol overload
&lt;/li&gt;&lt;/ol&gt;




</content><folder>Drugs</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="volvulus"><name>Volvulus</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#DDx"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;DDx&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Volvulus&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; can occur any time but 75% of cases in 1st month of life, d/t Ladd's bands lead to rotation.
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Volvulus&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; S/S: sudden onset vomiting, abd pain &amp;amp; feeding intol in an otherwise healthy infant, bilious vomiting in 77-100% of cases. Volume depletion, grunting resps, jaundice (33%), shock, diffuse abd tenderness, bloody stools (late).* In '93 Torres etal found 22 pts undergoing surgery for malrotation 50% had nl abd exams and 32% had distension but no tenderness.
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt; AXR* dilated stomach &amp;amp; duodenum w/o distal gas
&lt;/li&gt;&lt;li&gt; can have nl xr.
&lt;/li&gt;&lt;li&gt; upper GI series shows narrowing at site of obstruction with corckscrewing around the SMA
&lt;/li&gt;&lt;li&gt; Clockwise whirlpool sign using color doppler flow has a sensitivity 92%,spec 100%,PPV 100%
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Volvulus&amp;amp;action=edit&amp;amp;section=3" title="Edit section: DDx"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDx"&gt;DDx&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; duodenal webs, duodenal stenosis, duodenal or ileal atresia, ileus (but bilious vomiting in a young infant IS THIS DZ UNTIL proven otherwise)
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Volvulus&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; supportive care w/ aggressive fluids, NGT, ABX (amp, gent, clinda)
&lt;/li&gt;&lt;li&gt; Stable pt can have UGI series to confirm Dx
&lt;/li&gt;&lt;li&gt; shock pt needs surgery asap "time is bowel" (6 hr before bowel is dead)
&lt;/li&gt;&lt;/ul&gt;




</content><folder>Peds</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="warfarin_(coumadin)"><name>Warfarin (Coumadin)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Dosing"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Dosing&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Range_.28INR.29"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Range (INR)&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Reversal"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Reversal&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Potentiators"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Potentiators&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Warfarin_(Coumadin)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Dosing"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Dosing"&gt;Dosing&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Day 1: 5 to 7.5 mg po at night (to ensure absorption on an empty stomach),
&lt;/li&gt;&lt;li&gt;Day 2, 3, 4...: 2.5 to 7.5 mg po qhs (most often 5 mg)
&lt;/li&gt;&lt;/ol&gt;
&lt;ul&gt;&lt;li&gt;An increase in INR of &amp;gt;0.3-0.4 units per day necessitates dose reduction
&lt;/li&gt;&lt;li&gt;CHF, liver disease, Vitamin K def, drugs may influence warfarin response
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Warfarin_(Coumadin)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Range (INR)"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Range_.28INR.29"&gt;Range (INR)&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;2.5 to 3.5: mechanical prosthetic valves or recurrent thromboembolism
&lt;/p&gt;&lt;p&gt;2.0-3.0: all other indications
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Warfarin_(Coumadin)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Reversal"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Reversal"&gt;Reversal&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;FFP (10-20/kg) to decr INR to 1.5 (should occur in 6-24 hr)
&lt;/li&gt;&lt;li&gt;+/- Vitamin K (10 mg IM) (takes 24hrs to affect &amp;amp; 2wk to wear off)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Warfarin_(Coumadin)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Potentiators"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Potentiators"&gt;Potentiators&lt;/span&gt;&lt;/h2&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Warfarin_(Coumadin)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;1/26/06 DONALDSON (addapted from Lampe), EMP 1/11
&lt;/p&gt;



</content><folder>Drugs</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="warfarin_(coumadin)_reversal"><name>Warfarin (Coumadin) Reversal</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Excessive_Anticoagulation"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Excessive Anticoagulation&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#INR_.3C_5_No_Bleeding"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;INR &amp;lt; 5 No Bleeding&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#INR_5-9_No_Bleeding"&gt;&lt;span class="tocnumber"&gt;2.2&lt;/span&gt; &lt;span class="toctext"&gt;INR 5-9 No Bleeding&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#INR_.E2.89.A5_9_No_Bleeding"&gt;&lt;span class="tocnumber"&gt;2.3&lt;/span&gt; &lt;span class="toctext"&gt;INR &#8805; 9 No Bleeding&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Specific_Reversal_Reasons"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Specific Reversal Reasons&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-7"&gt;&lt;a href="#Undergoing_Surgery"&gt;&lt;span class="tocnumber"&gt;3.1&lt;/span&gt; &lt;span class="toctext"&gt;Undergoing Surgery&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-8"&gt;&lt;a href="#Serious_Bleeding"&gt;&lt;span class="tocnumber"&gt;3.2&lt;/span&gt; &lt;span class="toctext"&gt;Serious Bleeding&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-9"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-10"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Warfarin_(Coumadin)_Reversal&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Vitamin K Guidelines for Warfarin (Coumadin) Reversal
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Warfarin_(Coumadin)_Reversal&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Excessive Anticoagulation"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Excessive_Anticoagulation"&gt;Excessive Anticoagulation&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Warfarin_(Coumadin)_Reversal&amp;amp;action=edit&amp;amp;section=3" title="Edit section: INR &amp;amp;lt; 5 No Bleeding"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="INR_.3C_5_No_Bleeding"&gt;INR &amp;lt; 5 No Bleeding&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;&#8595; dose or omit dose
&lt;/li&gt;&lt;li&gt;Resume at &#8595; dose once INR therapeutic
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Warfarin_(Coumadin)_Reversal&amp;amp;action=edit&amp;amp;section=4" title="Edit section: INR 5-9 No Bleeding"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="INR_5-9_No_Bleeding"&gt;INR 5-9 No Bleeding&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Omit 1-2 doses
&lt;/li&gt;&lt;li&gt; Resume at &#8595; dose once INR therapeutic
&lt;/li&gt;&lt;li&gt; Vit K 1-2.5mg po if patient is at high risk for bleeding
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Warfarin_(Coumadin)_Reversal&amp;amp;action=edit&amp;amp;section=5" title="Edit section: INR &#8805; 9 No Bleeding"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="INR_.E2.89.A5_9_No_Bleeding"&gt;INR &#8805; 9 No Bleeding &lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Hold warfarin
&lt;/li&gt;&lt;li&gt; Vit K 2.5-5mg po
&lt;/li&gt;&lt;li&gt; INR will &#8595; in 24-48h
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Warfarin_(Coumadin)_Reversal&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Specific Reversal Reasons"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Specific_Reversal_Reasons"&gt;Specific Reversal Reasons&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Warfarin_(Coumadin)_Reversal&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Undergoing Surgery"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Undergoing_Surgery"&gt;Undergoing Surgery&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Omit dose
&lt;/li&gt;&lt;li&gt; Give vit K 2-4mg po
&lt;/li&gt;&lt;li&gt; &#8595; in INR will occur in 24h
&lt;/li&gt;&lt;li&gt; If INR still high, may give additional Vit K 1-2mg po
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Warfarin_(Coumadin)_Reversal&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Serious Bleeding"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Serious_Bleeding"&gt;Serious Bleeding&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Hold warfarin
&lt;/li&gt;&lt;li&gt; Vit K 5-10mg subQ/IV
&lt;/li&gt;&lt;li&gt; FFP
&lt;/li&gt;&lt;li&gt; PCC or rFVIIa
&lt;/li&gt;&lt;li&gt; Vit K may be repeated q12h
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Warfarin_(Coumadin)_Reversal&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Oral route for vitamin K is preferred due to superior efficacy compared to subcutaneous route. #Oral vitamin K is available in tablet and solution formulations.
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Warfarin_(Coumadin)_Reversal&amp;amp;action=edit&amp;amp;section=10" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Ansell J, Hirsh J, Poller L et al. The Pharmacology and Management of the Vitamin K Antagonists. CHEST. 126(3S):204S-233S.
&lt;/p&gt;



</content><folder>Heme/Onc</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="weakness"><name>Weakness</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Workup"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Workup&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Upper_Motor_Neuron"&gt;&lt;span class="tocnumber"&gt;3.1&lt;/span&gt; &lt;span class="toctext"&gt;Upper Motor Neuron&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-5"&gt;&lt;a href="#Lower_Motor_Neuron"&gt;&lt;span class="tocnumber"&gt;3.2&lt;/span&gt; &lt;span class="toctext"&gt;Lower Motor Neuron&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-6"&gt;&lt;a href="#End-Plate.2FMuscle"&gt;&lt;span class="tocnumber"&gt;3.3&lt;/span&gt; &lt;span class="toctext"&gt;End-Plate/Muscle&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#DDX"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;DDX&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-8"&gt;&lt;a href="#Emergent_Threat.2FED_Workup"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Emergent Threat/ED Workup&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-9"&gt;&lt;a href="#Intubation_Indications"&gt;&lt;span class="tocnumber"&gt;5.1&lt;/span&gt; &lt;span class="toctext"&gt;Intubation Indications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-10"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Weakness&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Acute/Generalized
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Weakness&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Workup"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Workup"&gt;Workup&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;cbc
&lt;/li&gt;&lt;li&gt;chem 10  (esp. K, Mg, Ca, Phos)
&lt;/li&gt;&lt;li&gt;ecg
&lt;/li&gt;&lt;li&gt;+/- CK (r/o myopathy)
&lt;/li&gt;&lt;li&gt;+/- FVC (eval impending resp failure, i.e. Myasthenia)
&lt;/li&gt;&lt;li&gt;+/- ABG/CT/LP/TSH/UA (rhabdo)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Weakness&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Weakness&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Upper Motor Neuron"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Upper_Motor_Neuron"&gt;Upper Motor Neuron&lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt; BRAIN
&lt;ul&gt;&lt;li&gt;Weakness - variable
&lt;/li&gt;&lt;li&gt;Bowel/Bladder -
&lt;/li&gt;&lt;li&gt;Reflexes - increased
&lt;/li&gt;&lt;li&gt;Sens - diminished
&lt;/li&gt;&lt;li&gt;Pain - no
&lt;/li&gt;&lt;li&gt;Asymmetric/unilateral
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt; CORD
&lt;ul&gt;&lt;li&gt;Weakness - fixed level
&lt;/li&gt;&lt;li&gt;Bowel/Bladder - YES
&lt;/li&gt;&lt;li&gt;Reflexes - increased
&lt;/li&gt;&lt;li&gt;Sens - diminished
&lt;/li&gt;&lt;li&gt;Pain - +/-
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Weakness&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Lower Motor Neuron"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Lower_Motor_Neuron"&gt;Lower Motor Neuron&lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt; NERVE
&lt;ul&gt;&lt;li&gt;Weakness - distal and ascends
&lt;/li&gt;&lt;li&gt;Bowel/Bladder - NO
&lt;/li&gt;&lt;li&gt;Reflexes - diminished
&lt;/li&gt;&lt;li&gt;Sens - nl/paresthesias
&lt;/li&gt;&lt;li&gt;Pain - no
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Weakness&amp;amp;action=edit&amp;amp;section=6" title="Edit section: End-Plate/Muscle"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="End-Plate.2FMuscle"&gt;End-Plate/Muscle&lt;/span&gt;&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt; MOTOR END PLATE
&lt;ul&gt;&lt;li&gt;Weakness - head and descends
&lt;/li&gt;&lt;li&gt;Bowel/Bladder - NO
&lt;/li&gt;&lt;li&gt;Reflexes - nl/diminished
&lt;/li&gt;&lt;li&gt;Sens - nl
&lt;/li&gt;&lt;li&gt;Pain - no
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;MUSCLE
&lt;ul&gt;&lt;li&gt;Weakness - proximal
&lt;/li&gt;&lt;li&gt;Bowel/Bladder - NO
&lt;/li&gt;&lt;li&gt;Reflexes - nl/diminished
&lt;/li&gt;&lt;li&gt;Sens - nl
&lt;/li&gt;&lt;li&gt;Pain - +/-
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Weakness&amp;amp;action=edit&amp;amp;section=7" title="Edit section: DDX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX"&gt;DDX&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; UPPER
&lt;ol&gt;&lt;li&gt; Multiple sclerosis
&lt;/li&gt;&lt;li&gt; Poliomyelitis
&lt;/li&gt;&lt;li&gt; ALS (upper &amp;amp; lower motor)
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; CORD
&lt;ol&gt;&lt;li&gt; Painful
&lt;ol&gt;&lt;li&gt; Cord compression
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Painless
&lt;ol&gt;&lt;li&gt; Transverse myelitis
&lt;/li&gt;&lt;li&gt; Spinal cord infarct
&lt;/li&gt;&lt;li&gt; Intramedullary tumor
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; NERVE
&lt;ol&gt;&lt;li&gt; Guillian-Barre
&lt;/li&gt;&lt;li&gt; Toxic neuropthy (Ciguatera)
&lt;/li&gt;&lt;li&gt; Tick paralysis
&lt;/li&gt;&lt;li&gt; Diabetic neuropathy
&lt;/li&gt;&lt;li&gt; Porphyria
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; MOTOR END PLATE
&lt;ol&gt;&lt;li&gt; Myasthenia gravis
&lt;/li&gt;&lt;li&gt; Botulism (descending)
&lt;/li&gt;&lt;li&gt; Organophosphate poisoning
&lt;/li&gt;&lt;li&gt; Lambert-Eaton
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; MUSCLE
&lt;ol&gt;&lt;li&gt; Painful
&lt;ol&gt;&lt;li&gt; Rhabdo
&lt;/li&gt;&lt;li&gt; Alcoholic
&lt;/li&gt;&lt;li&gt; Myopathy
&lt;/li&gt;&lt;li&gt; Polymyositis
&lt;/li&gt;&lt;li&gt; Dermatomyositis
&lt;/li&gt;&lt;li&gt; Toxins
&lt;/li&gt;&lt;li&gt; Hypophos
&lt;/li&gt;&lt;li&gt; Hypo-kalemia
&lt;/li&gt;&lt;li&gt; Polymyalgia rheum
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Painless
&lt;ol&gt;&lt;li&gt; Familial periodic paralysis
&lt;/li&gt;&lt;li&gt; Endocrine
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; MIXED
&lt;ol&gt;&lt;li&gt; Upper &amp;amp; Lower Motor Neuron
&lt;ol&gt;&lt;li&gt; ALS
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; Sensory &amp;amp; Motor
&lt;ol&gt;&lt;li&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; NON-NEUROMUSCULAR
&lt;ol&gt;&lt;li&gt; MI
&lt;/li&gt;&lt;li&gt; Resp failure
&lt;/li&gt;&lt;li&gt; Sepsis
&lt;/li&gt;&lt;li&gt; Dehydration
&lt;/li&gt;&lt;li&gt; Anxiety
&lt;/li&gt;&lt;li&gt; Fibromyalgia/chronic fatigue
&lt;/li&gt;&lt;li&gt; Malignancy
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Weakness&amp;amp;action=edit&amp;amp;section=8" title="Edit section: Emergent Threat/ED Workup"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Emergent_Threat.2FED_Workup"&gt;Emergent Threat/ED Workup&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; CORD
&lt;ol&gt;&lt;li&gt; paralysis
&lt;/li&gt;&lt;li&gt; MRI, neurologist
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; NERVE
&lt;ol&gt;&lt;li&gt; resp failure
&lt;/li&gt;&lt;li&gt; FEV1, airway mgt, ticks?, neurologist
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; MOTOR END PLATE
&lt;ol&gt;&lt;li&gt; resp failure
&lt;/li&gt;&lt;li&gt; FEV1, airway mgt, Tensilon Test?
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;li&gt; MUSCLE
&lt;ol&gt;&lt;li&gt; Rhabdo
&lt;/li&gt;&lt;li&gt; urine myoglobin, serum CK, BUN/Cr
&lt;/li&gt;&lt;li&gt; serum K+
&lt;/li&gt;&lt;/ol&gt;
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Weakness&amp;amp;action=edit&amp;amp;section=9" title="Edit section: Intubation Indications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Intubation_Indications"&gt;Intubation Indications&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; Severe fatigue
&lt;/li&gt;&lt;li&gt; Inability protect airway
&lt;/li&gt;&lt;li&gt; Rapidly increasing PaCO2
&lt;/li&gt;&lt;li&gt; Hypoxemia despite O2
&lt;/li&gt;&lt;li&gt; FVC &amp;lt;12 mL/kg
&lt;/li&gt;&lt;li&gt; Neg Insp Force &amp;lt;20 cm H2O
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Weakness&amp;amp;action=edit&amp;amp;section=10" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;2/26/06 DONALDSON (adapted from Rosen, Lampe, Birnbaumer)
&lt;/p&gt;&lt;p&gt;adapted from Hockberger
&lt;/p&gt;



</content><folder>Neuro</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="wellen's_syndrome"><name>Wellen's Syndrome</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Definition"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Definition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Criteria"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Criteria&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Wellen%27s_Syndrome&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Definition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Definition"&gt;Definition&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;A specific EKG abnormality in the precordial leads that is associated with critical stenosis of the LAD
&lt;/li&gt;&lt;li&gt;Note this can be a TRANSIENT finding (will often persist for hours after pain resolved, then dissapear)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Wellen%27s_Syndrome&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Criteria"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Criteria"&gt;Criteria&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Purely a T wave abnormality - no ST segment involement. If present in at least 2 leads of V1-V4 - 90% specificity for proximal LAD stenosisType 1 (classic) - deep symmetric t wave inversionsType 2 (less common) - biphasic t wave
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Wellen%27s_Syndrome&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;Pts typically present with angina/UA. Treat symptomatically ==Disposition==
&lt;/li&gt;&lt;li&gt;This is highly specific - pts need a cardiac catheterization urgently
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Wellen%27s_Syndrome&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Adapted from Marriott, Mattu (lecture)
&lt;/p&gt;



</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="west_nile_virus"><name>West Nile Virus</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-2"&gt;&lt;a href="#Virolgy"&gt;&lt;span class="tocnumber"&gt;1.1&lt;/span&gt; &lt;span class="toctext"&gt;Virolgy&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Ecology"&gt;&lt;span class="tocnumber"&gt;1.2&lt;/span&gt; &lt;span class="toctext"&gt;Ecology&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Epidemiology"&gt;&lt;span class="tocnumber"&gt;1.3&lt;/span&gt; &lt;span class="toctext"&gt;Epidemiology&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-7"&gt;&lt;a href="#Prognosis"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Prognosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=West_Nile_Virus&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=West_Nile_Virus&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Virolgy"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Virolgy"&gt;Virolgy&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; rna virus
&lt;/li&gt;&lt;li&gt; virus family assoc with St Louise encephalitis, Japanese encephalitis, Murray Vallen enceph, and Kunjin enceph
&lt;/li&gt;&lt;li&gt; 2 lineage of west nile- only lineage 1 assoc with human dz- originated in middle east/ isreal
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=West_Nile_Virus&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Ecology"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Ecology"&gt;Ecology&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; bird- mosquito- bird cycle
&lt;/li&gt;&lt;li&gt; passerine birds are amplification host
&lt;/li&gt;&lt;li&gt; starts in spring, ends in fall when mosquitos dormant
&lt;/li&gt;&lt;li&gt; Culex mosquitos
&lt;/li&gt;&lt;li&gt; Unclear if human infc from culex bite or other bridge vector mosq species
&lt;/li&gt;&lt;li&gt; House sparrows have high level of viremia and are amplifiers
&lt;/li&gt;&lt;li&gt; Humans and horses also but viremia is low so are not important amplifiers
&lt;/li&gt;&lt;li&gt; Wnv (west nile virus) in birds feces and oral secretions
&lt;/li&gt;&lt;li&gt; Bird to bird xmission possible in lab
&lt;/li&gt;&lt;li&gt; Birds can be infected by eating infc mosquitoes, infc birds and infc rodents but importance of oral spread in nature unclear
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=West_Nile_Virus&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Epidemiology"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Epidemiology"&gt;Epidemiology&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt; found in Africa, middle east, Russia, australia,
&lt;/li&gt;&lt;li&gt; most human infc in August and Sept but can happen from May to Dec
&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;Human Xmission
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt; most from mosq bites
&lt;/li&gt;&lt;li&gt; maternal fetal
&lt;/li&gt;&lt;li&gt; breast milk
&lt;/li&gt;&lt;li&gt; blood xfsn
&lt;/li&gt;&lt;li&gt; percutaneous lab infc
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=West_Nile_Virus&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; most people assymptomatic
&lt;/li&gt;&lt;li&gt; severity increases with age
&lt;/li&gt;&lt;li&gt; 2- 14 day incubation
&lt;/li&gt;&lt;li&gt; illness for 3- 6 days
&lt;/li&gt;&lt;li&gt; malaise, anorexia, nv, eye pain, HA, myalgia, rash
&lt;/li&gt;&lt;li&gt; 20% of infc people get west nile fever
&lt;/li&gt;&lt;li&gt; &amp;lt;1% get severe neuro problem- encephalitis, meningitis, acute flaccid paralysis (afp)
&lt;/li&gt;&lt;li&gt; can also get movement disorder- tremor, myoclonus, parkinsonism, bradykinesia
&lt;/li&gt;&lt;li&gt; weakness from afp asymmetric, can affect upper or lower limbs and can happen without meningitis
&lt;/li&gt;&lt;li&gt; afp also gets hypo/ areflexic, acute bowel and bladder dysfnctn and absence of pain or sens changes
&lt;/li&gt;&lt;li&gt; afp csf has increased protein, and pleocytosis
&lt;/li&gt;&lt;li&gt; afp not like gullain barre but more like polio with destruction of spinal anterior horn cells
&lt;/li&gt;&lt;li&gt; can also have cranial nerve, optic neuritis, sz
&lt;/li&gt;&lt;li&gt; also myocarditis, pancreatitis, fulminant hepatitis
&lt;/li&gt;&lt;/ol&gt;
&lt;ol&gt;&lt;li&gt; perf wbc count normal or sl elevated
&lt;/li&gt;&lt;li&gt; csf- pleocytosis with lymphocyte predominance and elevated protein
&lt;/li&gt;&lt;li&gt; ct neg
&lt;/li&gt;&lt;li&gt; mri usually neg but can show focal lesion in pons, basal gang, thal
&lt;/li&gt;&lt;li&gt; dx by blood or csf igm
&lt;/li&gt;&lt;li&gt; igm does not cross BBB so csf igm indicated cns infc
&lt;/li&gt;&lt;li&gt; false positive is recently vaccinated for yellow fever, Jap enceph, or recently infected with relate flavivirus- St Louse, Dengue
&lt;/li&gt;&lt;li&gt; confirmation by 4X increase of acute/ conv titres of antibodies
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=West_Nile_Virus&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt;Treatment&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; supportive
&lt;/li&gt;&lt;li&gt; no studies to support ribavirin, interferon, gamma globulin, steroids, anticonvulsants, or osmotic agents
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=West_Nile_Virus&amp;amp;action=edit&amp;amp;section=7" title="Edit section: Prognosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Prognosis"&gt;Prognosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt; 4- 18% fatality
&lt;/li&gt;&lt;li&gt; older age greatest risk for death
&lt;/li&gt;&lt;li&gt; risk for poor neuro outcome and death- encephalitis, severe muscle weakness, ams, DM, immune suppression
&lt;/li&gt;&lt;li&gt; can have significant morbidity and loss of function even in those pts that survive and are discharged to home
&lt;/li&gt;&lt;li&gt; parkinsons, tremor, gait, balance problem most common neuro finding after dc to home
&lt;/li&gt;&lt;li&gt; initial severe encephalopathy did not mean poor neuro outcome
&lt;/li&gt;&lt;li&gt; afp pts have v poor recovery
&lt;/li&gt;&lt;/ol&gt;




</content><folder>ID</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="wikem_website"><name>WikEM Website</name><content>&lt;p&gt;www.WikEM.org
&lt;/p&gt;



</content><folder>WikEM</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="wolf_parkinson_white_(wpw)"><name>Wolf Parkinson White (WPW)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;
&lt;ul&gt;
&lt;li class="toclevel-2 tocsection-3"&gt;&lt;a href="#Orthodromic_Tachycrd"&gt;&lt;span class="tocnumber"&gt;2.1&lt;/span&gt; &lt;span class="toctext"&gt;Orthodromic Tachycrd&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-2 tocsection-4"&gt;&lt;a href="#Antidromic_Tachycrd"&gt;&lt;span class="tocnumber"&gt;2.2&lt;/span&gt; &lt;span class="toctext"&gt;Antidromic Tachycrd&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#DDX"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;DDX&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Wolf_Parkinson_White_(WPW)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt;Background&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;usually 150- 300 bpm
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Wolf_Parkinson_White_(WPW)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt;Diagnosis&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;short PR interval &amp;lt;0.12 sec
&lt;/li&gt;&lt;li&gt;QRS duration &amp;gt;0.10 sec
&lt;/li&gt;&lt;li&gt;delta wave/ slurred upstroke
&lt;/li&gt;&lt;li&gt;short PR interval due to loss of normal AV node conduction delay
&lt;/li&gt;&lt;li&gt;delta wave due to early activation of vent myocardium
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Wolf_Parkinson_White_(WPW)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Orthodromic Tachycrd"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Orthodromic_Tachycrd"&gt;Orthodromic Tachycrd&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;the accessory path used for retrograde reentry conduction and AV node used for anterograde conduction. QRS is narrow, delta wave absent
&lt;/li&gt;&lt;li&gt;TX with CA channel blockers, beta blockers, procainamide, adenosine.
&lt;/li&gt;&lt;li&gt;Cardiovert (sync) if unstable with 50- 100J (0.5- 2J/kg for kids)
&lt;/li&gt;&lt;/ol&gt;
&lt;h3&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Wolf_Parkinson_White_(WPW)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Antidromic Tachycrd"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Antidromic_Tachycrd"&gt;Antidromic Tachycrd&lt;/span&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;access path used for anterograde conduction and AV node used for retrograde reentry.
&lt;/li&gt;&lt;li&gt;do not use beta blckrs of ca chnnl blckrs since will block down AV node only and not acc path and will actually speed up arrhythmia.
&lt;/li&gt;&lt;li&gt;TX with procainamide- 100mg q10 min until arrhrythmia terminated or max dose of 1000mg given. If no success, then cardiovert.
&lt;/li&gt;&lt;li&gt;Cardiovert (sync) if unstable with 50- 100J (0.5- 2J/kg for kids)
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Wolf_Parkinson_White_(WPW)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: DDX"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="DDX"&gt;DDX&lt;/span&gt;&lt;/h2&gt;
&lt;ol&gt;&lt;li&gt;idiopathic
&lt;/li&gt;&lt;li&gt;hypertrophic cardiomyopathy
&lt;/li&gt;&lt;li&gt;transposition of great vesses
&lt;/li&gt;&lt;li&gt;endocardial fibroelastosis
&lt;/li&gt;&lt;li&gt;mitral valve prolapse
&lt;/li&gt;&lt;li&gt;tricuspid atresia
&lt;/li&gt;&lt;li&gt;ebstein disease
&lt;/li&gt;&lt;/ol&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Wolf_Parkinson_White_(WPW)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt;Disposition&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Admission:
&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;admit if cardioverted, chest pain, CHF, electrolyte imbalance.
&lt;/li&gt;&lt;li&gt;if easily terminated can be discharged with outpt electrophysiological study
&lt;/li&gt;&lt;/ol&gt;




</content><folder>Cards</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="wound_management"><name>Wound Management</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Indications"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Indications&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Anesthesia"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Anesthesia&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Irrigation"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Irrigation&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Wound_Management&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Indications"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Indications"&gt;Indications&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Do not close body wounds &amp;gt;12 hr old
&lt;/li&gt;&lt;li&gt; Do not close face/scalp wounds &amp;gt;24 hr old
&lt;/li&gt;&lt;li&gt; If don't close, prepare wound as if going to close* Irrigate, explore, use non-adherent or vaseline gauze to prevent wound edges from closing, wrap, give keflex for 5 days, do not touch for 3 days, on 3rd day remove packing, irrigate &amp;amp; sew if appears clean, finish ABX
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Wound_Management&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Anesthesia"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Anesthesia"&gt;Anesthesia&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Lidocaine or bupivicaine without epinephrine in fingers, nose, toes, and penis
&lt;/li&gt;&lt;li&gt; Bupivicaine lasts longer (6-8 hr) than lidocaine (30-90 min) so consider using if the wound will take longer than an hour to close
&lt;/li&gt;&lt;li&gt; Be sure to use anesthesia prior to irrigation
&lt;/li&gt;&lt;li&gt; Use a 25 or 27 gauge needle to inject
&lt;/li&gt;&lt;li&gt; Lidocaine (but not bupivicaine) may be buffered 10:1 with bicarbonate to reduce pain of injection
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; Lidocaine (1% solution (10mg/mL)* Maximum safe dose = 5mg/kg (~300mg)
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt; Lidocaine + epinephrine* Maximum safe dose = 7mg/kg (~500mg)
&lt;/li&gt;&lt;li&gt; Delays healing, increases infection risk?
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt; Bupivicaine (0.25%)* Maximum safe dose = 175mg
&lt;/li&gt;&lt;li&gt; Do not inject intravascularly (refractory cardiac arrest)
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt; Bupivicaine + epinephrine* Maximum safe dose = 225mg
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;See also Tox: Lidocaine
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Wound_Management&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Irrigation"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Irrigation"&gt;Irrigation&lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt; Debridement is most important step in reducing infection/ promoting healing
&lt;/li&gt;&lt;li&gt; High pressure irrigation (can be achieved with 19 gauge syringe)
&lt;/li&gt;&lt;li&gt; Tap water is as effective as sterile water/ normal saline
&lt;/li&gt;&lt;li&gt; Irrigation optional for face/scalp
&lt;/li&gt;&lt;/ul&gt;
&lt;pre&gt;Skin Preparation
&lt;/pre&gt;
&lt;ul&gt;&lt;li&gt; Avoid betadine/chlorhexadine in wound
&lt;/li&gt;&lt;li&gt; Not necessary to remove hair (if do, avoid using razor)
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
Sutures
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;See Trauma: Sutures
&lt;/p&gt;&lt;p&gt;Exploration
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; Once anesthesia achieved and wound irrigated, explore wound with sterile or non-sterile gloves and look for foreign bodies or fractures/step offs
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt; Check Neuro motor and sensation distal to injury prior to anesthesia.
&lt;/li&gt;&lt;li&gt; Splinting &#8211; wounds over flexor surfaces or under lots of tension often do better with splints for a few days.
&lt;/li&gt;&lt;li&gt; Documentation &#8211; done on EMSTAT under "Physician" then "wound care/lacerations"
&lt;/li&gt;&lt;li&gt; Follow-up&amp;nbsp;: patients need wound care sheet, wound check in 2 days for concerning or contaminated wounds and suture removal in&amp;nbsp;? days.
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
interrupted in ED b/c if inf, can remove individual sutures vs entire running suture! any glass= MUST xray!
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;pre-wash around wound, not in it, vaseline gauze helps remove road rash! irrigate a lot! debride only dead tissue.
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;before anesthesia check pulse, motor &amp;amp; sens! nv structures run together, injury to one= likely inj to others!
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Put LET in open wound and EMLA on intact skin b/c doesnt work in open wound!
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Td .55cc IM to pts &amp;gt;7 y w/ no booster w/in 5 yr (nd q 10 yr booster to maintain immunity), Hypertet 250 u IM @ diff site from Td if NO Hx of Td, advise them to get f/u Td @ 1mo &amp;amp; 1 yr; age&amp;gt;60 = high risk of poor immunization
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Stop bleeding w/ 5 min constant pressure, ice, elevate, lido w/ epi (takes 10 min to work....WAIT!), can inflate bp cuff above sbp for NO more than 40 min! nd dry wound before sew it or hematoma!
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Absorbable for deeps, never if high risk for inf, good for hard to reach places like kids mouth, vicryl lasts longer, chromic faster &amp;amp; good for oral mucosa. Any braided suture stronger but higher risk of inf b/c bacteria btwn braids!
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;steristrips good but not if tension or wet! also doesnt fix dead space. apply w/ benzoin.
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;scalpels: #11 for I&amp;amp;D, #15 for debridement &amp;amp; wound revision.
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;most important part of suturing is eversion (b/c contracture during healing) of lac &amp;amp; layer to layer alignment, approximate edges loosely (or ischemia sets in)!
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;horizontal mattress spreads tension over wound, not for wounds under high tension; vertical mattress to close dead space &amp;amp; eversion, NOT high tension wounds!
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;flaps will be viable if base:length ration is 3.
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;entire repair judged by drsng, keep moist NOT wet w/ bandaid, xeroform or ointment (if no bdg). takes months for wound to improve to final state. Always replace drsng that has become wet, bandaid usually fine after 1st bdg wears out.
&lt;/li&gt;&lt;/ul&gt;
&lt;ul&gt;&lt;li&gt;Wound chk at 48-72 hrs ONLY if high risk wound. Checking before 48 Hr is pointless b/c this is how long it takes bacteria to proliferate, so if concerned chk wound in 48-72 hr!!
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Wound_Management&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt;Source&lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;Coates 2004- By Lampe
&lt;/p&gt;&lt;p&gt;UpToDate
&lt;/p&gt;



</content><folder>Trauma</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="wrist_(fx)"><name>Wrist (Fx)</name><content>&lt;table id="toc" class="toc"&gt;&lt;tr&gt;&lt;td&gt;&lt;div id="toctitle"&gt;&lt;h2&gt;Contents&lt;/h2&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li class="toclevel-1 tocsection-1"&gt;&lt;a href="#Background"&gt;&lt;span class="tocnumber"&gt;1&lt;/span&gt; &lt;span class="toctext"&gt;Background&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-2"&gt;&lt;a href="#Diagnosis"&gt;&lt;span class="tocnumber"&gt;2&lt;/span&gt; &lt;span class="toctext"&gt;Diagnosis&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-3"&gt;&lt;a href="#Imaging"&gt;&lt;span class="tocnumber"&gt;3&lt;/span&gt; &lt;span class="toctext"&gt;Imaging&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-4"&gt;&lt;a href="#Treatment"&gt;&lt;span class="tocnumber"&gt;4&lt;/span&gt; &lt;span class="toctext"&gt;Treatment&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-5"&gt;&lt;a href="#Disposition"&gt;&lt;span class="tocnumber"&gt;5&lt;/span&gt; &lt;span class="toctext"&gt;Disposition&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;li class="toclevel-1 tocsection-6"&gt;&lt;a href="#Source"&gt;&lt;span class="tocnumber"&gt;6&lt;/span&gt; &lt;span class="toctext"&gt;Source&lt;/span&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;script&gt;if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } &lt;/script&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Wrist_(Fx)&amp;amp;action=edit&amp;amp;section=1" title="Edit section: Background"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Background"&gt; Background &lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Scaphoid fractures account for 70% of all carpal fractures
&lt;/li&gt;&lt;li&gt;Ulnar nerve damage associated with fractures of hamate or pisiform
&lt;/li&gt;&lt;li&gt;50% of pisiform fx associated with injury to distal radius or other carpal bone
&lt;/li&gt;&lt;li&gt;If bone fragment seen posterior to carpus on lateral, very likely triquetrum fx
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Wrist_(Fx)&amp;amp;action=edit&amp;amp;section=2" title="Edit section: Diagnosis"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Diagnosis"&gt; Diagnosis &lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;&lt;b&gt;Mechamism of injury&lt;/b&gt;
&lt;ul&gt;&lt;li&gt;Hyperextension (FOOSH)
&lt;ul&gt;&lt;li&gt;Scaphoid, lunate, triquetrum, or pisiform fractures
&lt;/li&gt;&lt;li&gt;Consider oblique views
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Hyperflexion
&lt;ul&gt;&lt;li&gt;Triquetrum fracture
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Axial loading
&lt;ul&gt;&lt;li&gt;of the wrist: scaphoid fx, scapholunate dissociation
&lt;/li&gt;&lt;li&gt;thumb: trapezium fx
&lt;/li&gt;&lt;li&gt;index: trapezoid fx
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Direct blow to palmar surface
&lt;ul&gt;&lt;li&gt;Pisiform or hamate fractures
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;&lt;b&gt;Specific Bone Fx&lt;/b&gt;
&lt;ul&gt;&lt;li&gt;Scaphoid
&lt;ul&gt;&lt;li&gt;Pain in the snuffbox (especially with ulnar deviation)
&lt;/li&gt;&lt;li&gt;Grip strength reduced
&lt;/li&gt;&lt;li&gt;Often associated with perilunate dislocation
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Lunate
&lt;ul&gt;&lt;li&gt;Pain aggravated by wrist motion or gripping
&lt;/li&gt;&lt;li&gt;Pain with axial loading of the 3rd digit
&lt;/li&gt;&lt;li&gt;Often associated with other injuries
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Triquetrum
&lt;ul&gt;&lt;li&gt;TTP just distal to the ulnar styloidPain on the ulnar aspect of the wrist
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Pisiform
&lt;ul&gt;&lt;li&gt;Pain/swelling at the palmar and ulnar aspects of the wrist
&lt;/li&gt;&lt;li&gt;TTP over the hypothenar eminence
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Hamate
&lt;ul&gt;&lt;li&gt;Sudden wrist pain when a swinging motion has been interrupted
&lt;/li&gt;&lt;li&gt;TTP over hypothenar eminence
&lt;/li&gt;&lt;li&gt;4th, 5th digit paresthesia if fx involves ulnar nerve
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Capitate
&lt;ul&gt;&lt;li&gt;Pain/swelling on dorsum of hand
&lt;/li&gt;&lt;li&gt;Rarely fractured in isolation
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Trapezoid
&lt;ul&gt;&lt;li&gt;Point tenderness just proximal to 2nd metacarpal base
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Trapezium
&lt;ul&gt;&lt;li&gt;Pain/weakness with making "OK" sign or touching thumb to tip of 5th digit
&lt;/li&gt;&lt;li&gt;Significant discomfort
&lt;/li&gt;&lt;li&gt;Minimal swelling
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Wrist_(Fx)&amp;amp;action=edit&amp;amp;section=3" title="Edit section: Imaging"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Imaging"&gt; Imaging &lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Checklist
&lt;/li&gt;&lt;/ul&gt;
&lt;ol&gt;&lt;li&gt;Palmar tilt of the radius is present on the lateral view
&lt;/li&gt;&lt;li&gt;Radial articular surface lies distal to the ulna
&lt;/li&gt;&lt;li&gt;Dorsal surface of the distal radius is smooth
&lt;/li&gt;&lt;li&gt;Waist of the scaphoid is intact
&lt;/li&gt;&lt;li&gt;Capitate sits in the concavity of the lunate
&lt;/li&gt;&lt;li&gt;Intercarpal joints are no more than 2mm wide; adjacent surfaces are parallel
&lt;/li&gt;&lt;/ol&gt;
&lt;ul&gt;&lt;li&gt;PA
&lt;ul&gt;&lt;li&gt;Evaluate zone of vulnerability
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Lateral
&lt;ul&gt;&lt;li&gt;Evaluate scapholunate angle (should be between 40o and 60o)
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Oblique
&lt;/li&gt;&lt;li&gt;Also consider:
&lt;ul&gt;&lt;li&gt;PA with maximal ulnar deviation ("Scaphoid View")
&lt;ul&gt;&lt;li&gt;Scaphoid fx
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Carpal tunnel view
&lt;ul&gt;&lt;li&gt;Hamate hook fx
&lt;/li&gt;&lt;li&gt;Trapezium fx
&lt;/li&gt;&lt;li&gt;Pisiform Fx
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;PA clenched fist view
&lt;ul&gt;&lt;li&gt;Consider for scapholunate instability (space &amp;gt;2mm suggests ligamentous disruption)
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;CT
&lt;ul&gt;&lt;li&gt;Trapezoid fx
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Wrist_(Fx)&amp;amp;action=edit&amp;amp;section=4" title="Edit section: Treatment"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Treatment"&gt; Treatment &lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Scaphoid Fx
&lt;ul&gt;&lt;li&gt;Thumb-spica spint (or preferably a cast) until repeat xrays performed at 10 days
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Lunate Fx
&lt;ul&gt;&lt;li&gt;Double sugar tong or long-arm thumb spica splint
&lt;/li&gt;&lt;li&gt;May lead to osteonecrosis if not recognized and treated
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Triquetrum Fx
&lt;ul&gt;&lt;li&gt;Volar splint w/ wrist in slight dorsiflexion and the MCP free
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Pisiform Fx
&lt;ul&gt;&lt;li&gt;Volar or dorsal splint
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Hamate Fx
&lt;ul&gt;&lt;li&gt;Volar splint
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Capitate Fx
&lt;ul&gt;&lt;li&gt;Sugar-tong or short arm thumb spica splint
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Trapezoid Fx
&lt;ul&gt;&lt;li&gt;Volar splint
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Trapezium Fx
&lt;ul&gt;&lt;li&gt;Short arm thumb-spica
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Dislocations
&lt;ul&gt;&lt;li&gt;Scapholunate
&lt;ul&gt;&lt;li&gt;Volar splint, referral within 1 week
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Lunate/perilunate
&lt;ul&gt;&lt;li&gt;Volar spint, immediate reduction
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Wrist_(Fx)&amp;amp;action=edit&amp;amp;section=5" title="Edit section: Disposition"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Disposition"&gt; Disposition &lt;/span&gt;&lt;/h2&gt;
&lt;ul&gt;&lt;li&gt;Scaphoid Fx
&lt;ul&gt;&lt;li&gt;Always refer to a hand surgeon b/c may lead to osteonecrosis if not recognized/treated
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Lunate Fx
&lt;ul&gt;&lt;li&gt;Always refer to a hand surgeon b/c may lead to osteonecrosis if not recognized/treated
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Triquetrum Fx
&lt;ul&gt;&lt;li&gt;Refer for displacment &amp;gt;1mm
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Pisiform Fx
&lt;ul&gt;&lt;li&gt;Tend to do well with casting; refer for casting if unable to obtain in the ED
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Hamate Fx
&lt;ul&gt;&lt;li&gt;Refer for dislocation, pts who need to return to actvitiy ASAP
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Capitate Fx
&lt;ul&gt;&lt;li&gt;Always refer to a hand surgeon b/c may lead to osteonecrosis if not recognized/treated
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Trapezoid Fx
&lt;ul&gt;&lt;li&gt;Refer for comminution or dislocation
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;li&gt;Trapezium Fx
&lt;ul&gt;&lt;li&gt;Refer for displacement &amp;gt;2mm, intraarticular fx w/ &amp;gt;1mm incongruity, comminuted fx
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;br /&gt;
&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Lunate/perilunate dislocation
&lt;ul&gt;&lt;li&gt;Consult hand surgeon for immediate reduction(very difficult to reduce)
&lt;/li&gt;&lt;/ul&gt;
&lt;/li&gt;&lt;/ul&gt;
&lt;h2&gt;&lt;span class="editsection"&gt;[&lt;a href="/w/index.php?title=Wrist_(Fx)&amp;amp;action=edit&amp;amp;section=6" title="Edit section: Source"&gt;edit&lt;/a&gt;]&lt;/span&gt; &lt;span class="mw-headline" id="Source"&gt; Source &lt;/span&gt;&lt;/h2&gt;
&lt;p&gt;UpToDate, Accident &amp;amp; Emergency Radiology, Harwood-Nuss
&lt;/p&gt;&lt;p&gt;&lt;br /&gt;&lt;br /&gt; &lt;br /&gt;
&lt;/p&gt;



</content><folder>Ortho</folder><last_update>1301616061</last_update><author>WikEM</author></page><page id="wrist_bones"><name>Wrist Bones</name><content>&lt;p&gt;distal
&lt;/p&gt;&lt;p&gt;thumb
&lt;/p&gt;&lt;p&gt;sm fingr
&lt;/p&gt;&lt;p&gt;that they cannot handle
&lt;/p&gt;&lt;p&gt;some loves try positions
&lt;/p&gt;&lt;p&gt;prox
&lt;/p&gt;&lt;p&gt;&lt;br /&gt; 
&lt;/p&gt;&lt;p&gt;trapezium trapezoid capitate hamate
&lt;/p&gt;&lt;p&gt;scaphoid lunate triquetrium pisiform
&lt;/p&gt;



</content><folder>Rads</folder><last_update>1301616061</last_update><author>WikEM</author></page></pages></root>